diff --git a/.dockerignore b/.dockerignore index f9db1a61..da78c7c9 100644 --- a/.dockerignore +++ b/.dockerignore @@ -1,4 +1,9 @@ -db +# Dug stuff +db/ +crawl/ +local_storage/ +anno_fails.txt +dug.log # Python stuff **/__pycache__ @@ -19,4 +24,4 @@ tests/.pytest_cache # Build artifacts build/ dist/ -**/*.egg-info +**/*.egg-info \ No newline at end of file diff --git a/Jenkinsfile b/Jenkinsfile index 4ded3865..3d9b780b 100644 --- a/Jenkinsfile +++ b/Jenkinsfile @@ -1,5 +1,11 @@ pipeline { - agent any + agent { + kubernetes { + cloud 'kubernetes' + label 'agent-docker' + defaultContainer 'agent-docker' + } + } stages { stage('Install') { steps { @@ -17,11 +23,14 @@ pipeline { } stage('Publish') { when { - tag "release-*" + buildingTag() + } + environment { + DOCKERHUB_CREDS = credentials('rencibuild_dockerhub_machine_user') } steps { sh ''' - make build + echo $DOCKERHUB_CREDS_PSW | docker login -u $DOCKERHUB_CREDS_USR --password-stdin make publish ''' } diff --git a/Makefile b/Makefile index d5f01428..170d70c4 100644 --- a/Makefile +++ b/Makefile @@ -29,52 +29,19 @@ install: ${PYTHON} -m pip install -r requirements.txt ${PYTHON} -m pip install . -#test.lint: Run flake8 on the source code -test.lint: - ${PYTHON} -m flake8 src - -#test.doc: Run doctests in the source code -test.doc: - ${PYTHON} -m pytest --doctest-modules src - -#test.unit: Run unit tests -test.unit: - ${PYTHON} -m pytest tests/unit - #test: Run all tests -test: test.doc test.unit - -#build: Build wheel and source distribution packages -build.python: - echo "Building distribution packages for version $(VERSION)" - ${PYTHON} -m pip install --upgrade build - ${PYTHON} -m build --sdist --wheel . - echo "Successfully built version $(VERSION)" +test: + # ${PYTHON} -m flake8 src + ${PYTHON} -m pytest --doctest-modules src + ${PYTHON} -m pytest tests -#build.image: Build the Docker image -build.image: +#build: Build Docker image +build: echo "Building docker image: ${DOCKER_IMAGE}" docker build -t ${DOCKER_IMAGE} -f Dockerfile . echo "Successfully built: ${DOCKER_IMAGE}" -build.image.test: - echo "Testing dockerfile" - -#build: Build Python artifacts and Docker image -build: build.python build.image build.image.test - -#all: Alias to clean, install, test, build, and image -all: clean install test build - -#publish.image: Push the Docker image -publish.image: +#publish: Build and push docker image +publish: build docker tag ${DOCKER_IMAGE} ${DOCKER_REPO}/${DOCKER_IMAGE} docker push ${DOCKER_REPO}/${DOCKER_IMAGE} - -#publish.python: Push the build artifacts to PyPI -publish.python: - echo "publishing wheel..." - echo "publishing source..." - -#publish: Push all build artifacts to appropriate repositories -publish: publish.python publish.image \ No newline at end of file diff --git a/data/topmed_tags_v2.0.json b/data/topmed_tags_v2.0.json new file mode 100644 index 00000000..95993dd7 --- /dev/null +++ b/data/topmed_tags_v2.0.json @@ -0,0 +1,847 @@ +[ +{ + "model": "tags.tag", + "pk": 1, + "fields": { + "created": "2017-12-19T01:11:01Z", + "modified": "2018-08-02T19:31:20Z", + "title": "LDL in blood", + "lower_title": "ldl in blood", + "description": "Quantitative measure of low-density lipoprotein (LDL) cholesterol concentration in blood", + "instructions": "Include variables that represent a measurement of the concentration of LDL-cholesterol in the blood. Include variables from all time points and all repeated measures at each time point, e.g. LDL-cholesterol measured at multiple exams, and LDL-cholesterol measured multiple times at the same exam. Include all instances of duplicated variables, e.g. LDL-cholesterol variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. LDL-cholesterol in mg/dL and LDL-cholesterol in mmol/L. Include variables that are measured directly (e.g. by NMR) and those estimated via the Friedewald (or other) equation. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables for which LDL-cholesterol measurement was made in whole blood, serum, or plasma. Include variables that represent both fasting and non-fasting measurement of LDL-cholesterol. Do not include variables representing VLDL or LDL-P measurements. Do not include variables representing heavy LDL, light LDL, or other subfractions of total LDL-cholesterol.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 2, + "fields": { + "created": "2017-12-19T01:11:20Z", + "modified": "2018-06-01T18:00:25Z", + "title": "HDL in blood", + "lower_title": "hdl in blood", + "description": "Quantitative measure of high-density lipoprotein (HDL) cholesterol concentration in blood", + "instructions": "Include variables that represent a measurement of the concentration of HDL-cholesterol in the blood. Include variables from all time points and all repeated measures at each time point, e.g. HDL-cholesterol measured at multiple exams, and HDL-cholesterol measured multiple times at the same exam. Include all instances of duplicated variables, e.g. HDL-cholesterol variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. HDL-cholesterol in mg/dL and HDL-cholesterol in mmol/L. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables for which HDL-cholesterol measurement was made in whole blood, serum, or plasma. Include variables that represent both fasting and non-fasting measurement of HDL-cholesterol. Do not include variables representing HDL2, HDL3, or other subfractions of total HDL-cholesterol.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 3, + "fields": { + "created": "2017-12-19T01:11:36Z", + "modified": "2018-04-17T22:54:21Z", + "title": "Triglycerides in blood", + "lower_title": "triglycerides in blood", + "description": "Quantitative measure of triglyceride concentration in blood", + "instructions": "Include variables that represent a measurement of the concentration of triglycerides in the blood. Include variables from all time points and all repeated measures at each time point, e.g. triglycerides measured at multiple exams, and triglycerides measured multiple times at the same exam. Include all instances of duplicated variables, e.g. triglycerides variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. triglycerides in mg/dL and triglycerides in mmol/L. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables for which triglycerides measurement was made in whole blood, serum, or plasma. Include variables that represent both fasting and non-fasting measurement of triglycerides.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 4, + "fields": { + "created": "2017-12-19T01:11:51Z", + "modified": "2018-04-17T22:54:29Z", + "title": "Total cholesterol in blood", + "lower_title": "total cholesterol in blood", + "description": "Quantitative measure of total cholesterol concentration in blood", + "instructions": "Include variables that represent a measurement of the concentration of total cholesterol in the blood. Include variables from all time points and all repeated measures at each time point, e.g. total cholesterol measured at multiple exams, and total cholesterol measured multiple times at the same exam. Include all instances of duplicated variables, e.g. total cholesterol variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. total cholesterol in mg/dL and total cholesterol in mmol/L. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables for which total cholesterol measurement was made in whole blood, serum, or plasma. Include variables that represent both fasting and non-fasting measurement of total cholesterol.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 7, + "fields": { + "created": "2017-12-26T20:22:15Z", + "modified": "2018-05-10T21:18:15Z", + "title": "Resting arm systolic BP", + "lower_title": "resting arm systolic bp", + "description": "Quantitative measure of resting systolic blood pressure in the arm", + "instructions": "Include variables that represent a resting arm systolic BP measurement, measured in the upper arm while sitting or lying down. Include variables measured by any device, including mercury or other manometer, aneroid gauge, oscillometric device, or Doppler/ultrasound. Include variables from all time points and all repeated measures at each time point, e.g. resting arm systolic BP measured at multiple exams, and resting arm systolic BP measured multiple times at the same exam. Include all instances of duplicated variables, e.g. resting arm systolic BP variables included in multiple datasets. Include both individual measures of resting arm systolic BP and averages thereof. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables containing zero-reading data needed to calibrate resting arm systolic BP measures e.g. from a random-zero sphygmomanometer. Do not include ambulatory BP variables from a portable BP monitor, but do include any resting arm systolic BP measurements from a manometer or oscillometric device used to calibrate the ambulatory BP apparatus. Do not include ankle systolic BP measurements for calculating ankle-brachial index (ABI), but do include resting arm systolic BP components used to calculate ABI. Do not include variables for which resting arm systolic BP is a component, e.g. ABI. Do not include variables indicating hypertension status or hypertension medication use.", + "creator": 17 + } +}, +{ + "model": "tags.tag", + "pk": 8, + "fields": { + "created": "2017-12-26T20:23:09Z", + "modified": "2018-05-10T21:16:28Z", + "title": "Resting arm diastolic BP", + "lower_title": "resting arm diastolic bp", + "description": "Quantitative measure of resting diastolic blood pressure in the arm", + "instructions": "Include variables that represent a resting arm diastolic BP measurement, measured in the upper arm while sitting or lying down. Include variables measured by any device, including mercury or other manometer, aneroid gauge, oscillometric device, or Doppler/ultrasound. Include variables from all time points and all repeated measures at each time point, e.g. resting arm diastolic BP measured at multiple exams, and resting arm diastolic BP measured multiple times at the same exam. Include all instances of duplicated variables, e.g. resting arm diastolic BP variables included in multiple datasets. Include both individual measures of resting arm diastolic BP and averages thereof. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables containing zero-reading data needed to calibrate resting arm diastolic BP measures e.g. from a random-zero sphygmomanometer. Do not include ambulatory BP variables from a portable BP monitor, but do include any resting arm diastolic BP measurements from a manometer or oscillometric device used to calibrate the ambulatory BP apparatus. Do not include variables indicating hypertension status or hypertension medication use.", + "creator": 17 + } +}, +{ + "model": "tags.tag", + "pk": 12, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-08-02T19:37:15Z", + "title": "Height", + "lower_title": "height", + "description": "Standing body height measurement", + "instructions": "Include variables that represent a study subject's body height measurement, as measured when standing. Include variables from all time points and all repeated measures within each time point, e.g. height measured at multiple exams. Include all instances of duplicated variables, e.g. height variables included in multiple datasets. Include variables in all measurement units available, e.g. height in inches and height in centimeters. Do not include variables for which height is a component, e.g. BMI. Do not include sitting height variables. Do not include self-reported height variables.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 13, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-08-02T19:36:57Z", + "title": "Weight", + "lower_title": "weight", + "description": "Body weight measurement", + "instructions": "Include variables that represent a study subject's body weight measurement. Include variables from all time points and all repeated measures within each time point, e.g. weight measured at multiple exams. Include all instances of duplicated variables, e.g. weight variables included in multiple datasets. Include variables in all measurement units available, e.g. weight in kilograms and weight in pounds. Do not include variables for which weight is a component, e.g. BMI. Do not include self-reported weight variables.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 14, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-04-17T22:55:03Z", + "title": "BMI", + "lower_title": "bmi", + "description": "Body mass index (weight divided by the square of height)", + "instructions": "Include variables that represent calculated BMI. The units of BMI are usually kilograms per meter squared, but variables with other units should be included. Include variables from all time points and all repeated measures within each time point, e.g. BMI measured at multiple exams. Include all instances of duplicated variables, e.g. BMI variables included in multiple datasets. Do not include variables that represent the height and weight components used to derive BMI.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 15, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-04-17T22:55:11Z", + "title": "Waist circumference", + "lower_title": "waist circumference", + "description": "Waist circumference measurement", + "instructions": "Include variables that represent a waist circumference measurement. Include variables from all time points and all repeated measures within each time point, e.g. waist circumference measured at multiple exams. Include all instances of duplicated variables, e.g. waist circumference variables included in multiple datasets. Include variables in all measurement units available, e.g. waist circumference in inches and waist circumference in centimeters. Do not include variables of which waist circumference is a component, e.g. waist-hip ratio.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 16, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-04-17T22:55:18Z", + "title": "Hip circumference", + "lower_title": "hip circumference", + "description": "Hip circumference measurement", + "instructions": "Include variables that represent a hip circumference measurement. Include variables from all time points and all repeated measures within each time point, e.g. hip circumference measured at multiple exams. Include all instances of duplicated variables, e.g. hip circumference variables included in multiple datasets. Include variables in all measurement units available, e.g. hip circumference in inches and hip circumference in centimeters. Do not include variables of which hip circumference is a component, e.g. waist-hip ratio.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 17, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-04-17T22:55:26Z", + "title": "Waist-hip ratio", + "lower_title": "waist-hip ratio", + "description": "Ratio of waist to hip circumference", + "instructions": "Include variables that represent a calculated waist circumference to hip circumference ratio. Include variables from all time points and all repeated measures within each time point, e.g. waist-hip ratio at multiple exams. Include all instances of duplicated variables, e.g. waist-hip ratio variables included in multiple datasets. Do not include variables that represent the separate waist circumference and hip circumference components used to derive the waist-hip ratio.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 18, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-10-04T19:11:38Z", + "title": "Ischemic stroke", + "lower_title": "ischemic stroke", + "description": "Qualitative indicator of ischemic stroke status", + "instructions": "Include variables that represent whether or when a subject has experienced ischemic stroke. Include variables that represent prevalent and/or incident ischemic stroke status. Include variables that represent ischemic stroke event data, including event status and time-to-event variables. Include variables that indicate age at ischemic stroke events, e.g. self-reported age at an ischemic stroke event or followup time to an ischemic stroke event. Include variables indicating ischemic stroke status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. ischemic stroke variables included in multiple datasets. Include variables that indicate the subtype of ischemic stroke, e.g. thrombotic or embolic. Include variables that indicate cerebral embolism status. Do not include related stroke symptom variables such as aphasia, hemiparesis, hyperflexia, or other factors used to calculate/infer stroke status. Do not include variables that indicate transient ischemic attack (TIA) status. Do not include variables that indicate medication use related to ischemic stroke, e.g. aspirin use. For variables that identify multiple stroke types (e.g. value = ischemic, hemorrhagic, other, none), tag with all three stroke tags.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 19, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-05-15T17:46:18Z", + "title": "Hemorrhagic stroke", + "lower_title": "hemorrhagic stroke", + "description": "Qualitative indicator of hemorrhagic stroke status", + "instructions": "Include variables that represent whether or when a subject has experienced hemorrhagic stroke. Include variables that represent prevalent and/or incident hemorrhagic stroke status. Include variables that represent hemorrhagic stroke event data, including event status and time-to-event variables. Include variables that indicate age at hemorrhagic stroke events, e.g. self-reported age at a hemorrhagic stroke event or followup time to a hemorrhagic stroke event. Include variables indicating hemorrhagic stroke status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. hemorrhagic stroke variables included in multiple datasets. Include variables that indicate the subtype of hemorrhagic stroke, e.g. intracerebral or subarachnoid. Do not include related stroke symptom variables such as aphasia, hemiparesis, hyperflexia, or other factors used to calculate/infer stroke status. Do not include variables that indicate transient ischemic attack (TIA) status. Do not include variables that indicate medication use related to hemorrhagic stroke, e.g. aspirin use. For variables that identify multiple stroke types (e.g. value = ischemic, hemorrhagic, other, none), tag with all three stroke tags.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 20, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-05-15T17:47:18Z", + "title": "Other stroke", + "lower_title": "other stroke", + "description": "Qualitative indicator of other/unspecified stroke status", + "instructions": "Include variables that represent whether or when a subject has experienced a stroke of unknown/unspecified type (\"other stroke\"). Include variables that represent prevalent and/or incident other stroke status. Include variables that represent other stroke event data, including event status and time-to-event variables. Include variables that indicate age at other stroke events, e.g. self-reported age at an other stroke event or followup time to an other stroke event. Include variables indicating other stroke status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. other stroke variables included in multiple datasets. Do not include related stroke symptom variables such as aphasia, hemiparesis, hyperflexia, or other factors used to calculate/infer stroke status. Do not include variables that indicate transient ischemic attack (TIA) status, unless they also include stroke of unknown/unspecified type. Do not include variables that indicate medication use related to other stroke, e.g. aspirin use. For variables that identify multiple stroke types (e.g. value = ischemic, hemorrhagic, other, none), tag with all three stroke tags.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 21, + "fields": { + "created": "2018-02-13T05:58:02Z", + "modified": "2018-03-13T18:39:53Z", + "title": "Age at enrollment/collection", + "lower_title": "age at enrollment/collection", + "description": "Participant age at enrollment or age at which data or biosamples were collected", + "instructions": "Include variables that represent age directly and all variables used to calculate age (e.g. days since exam/visit). Include variables representing age at enrollment/recruitment; age at blood draw; age at other biosample collection; age at imaging exam; days since baseline visit; days since enrollment/recruitment; etc. Include all instances of duplicated variables, e.g. age at exam 1 found in two different datasets. Include variables in all measurement units available, e.g. age at enrollment in whole years and age at enrollment in days. These types of variables usually provide age for multiple different phenotypes. For example, age at blood draw corresponds to age at measurement of all blood chemistry analytes assayed from that blood draw; age at clinic visit for imaging provides age for all traits derived from the images, etc. Do not include variables that represent the timing of a specific event, diagnosis, or behavior, e.g. age at asthma diagnosis, age at smoking initiation, and time of a time-to-event variable such as MI events. ", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 22, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-08-02T19:36:38Z", + "title": "Gender", + "lower_title": "gender", + "description": "Self-reported sex or gender identity", + "instructions": "Include variables that represent a study subject's self-reported sex or self-reported gender identity. Include only self-reported information. Multiple categories of gender may be included among the values of such variables, such as male, female, transgender, and others. Include variables from all time points and all repeated self-reported variables within each time point. Include all instances of duplicated variables, e.g. gender variables from two different datasets. Do not include variables representing genetic or other categorizations of sex assigned by clinicians or research investigators. Do not include variables that represent gender or self-reported sex of anyone other than the study subject, e.g. gender or self-reported sex of a family member.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 23, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-08-02T19:36:18Z", + "title": "Race/ancestry/ethnicity", + "lower_title": "race/ancestry/ethnicity", + "description": "Self-reported race, ancestry or ethnicity", + "instructions": "Include variables that represent a study subject's race, ancestral geographic origins, ethnicity, or a combination of both. Include only self-reported responses. Include variables with self-reported values such as \"white\", \"black\", \"European\", \"Asian\", \"Native American\", \"African\", \"Spanish\", \"Samoan\", \"Puerto Rican\", \"Amish\", \"Hispanic\", etc. Include indicator variables for Hispanic/Latino ethnicity. Include all instances of duplicated variables, e.g. variables from multiple exams or different datasets. Do not include genetically-determined ancestry variables (e.g. principal components of genotypes) or categories (e.g. mtDNA haplogroups). Do not include variables indicating a subject's country of origin or birthplace, or the country of origin or birthplace of the subject's parent(s) or grandparent(s). Do not include variables indicating self-reported race, ancestry or ethnicity of the subject's parent(s) or grandparent(s).", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 24, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:55:50Z", + "title": "CAC", + "lower_title": "cac", + "description": "Quantitative measure of coronary artery calcification (CAC) by computed tomography (CT) scan", + "instructions": "Include variables that represent a CAC measurement from a CT scan. Include both individual and composite measures of coronary artery calcification (CAC), such as Agatston score, density or mass, and volume. Examples of individual measures are CAC score for left main artery or right coronary artery. An example of a composite measure is total CAC score across four arterial regions. Include both corrected/adjusted and uncorrected/unadjusted measures of CAC. Include variables from all time points and all repeated measures within each time point, e.g. CAC measured at multiple exams.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 25, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-07-13T20:12:51Z", + "title": "Carotid IMT", + "lower_title": "carotid imt", + "description": "Quantitative measure of carotid intima media thickness (IMT) by ultrasound", + "instructions": "Include variables that represent a carotid IMT measurement from an ultrasound. Include variables from all time points and all repeated measures within each time point, e.g. carotid IMT measured at multiple exams. Include both individual and composite measures of carotid IMT. An example of an individual measure of carotid IMT is maximum right common carotid far wall thickness. An example of a composite carotid IMT measure is mean maximum common carotid far wall thickness. Include measures by ultrasound only. Include both corrected/adjusted and uncorrected/unadjusted measures. Include all instances of duplicated variables, e.g. carotid IMT variables included in multiple datasets. Do not include qualitative assessment of plaque and stenosis. Do not include measurements by methods other than ultrasound.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 26, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:54:30Z", + "title": "Myocardial infarction", + "lower_title": "myocardial infarction", + "description": "Qualitative indicator of myocardial infarction (MI) status", + "instructions": "Include variables that represent whether or when a subject has experienced MI. Include variables that represent prevalent and/or incident MI status. Include variables that represent MI event data, including event status and time-to-event variables. Include variables that indicate age at MI events, e.g. self-reported age at an MI event or followup time to an MI event. Include variables indicating MI status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include variables indicating 'silent MI' status (MI status determined by EKG only). Include all instances of duplicated variables, e.g. MI events variables included in multiple datasets. Do not include variables that indicate possible MI treatments, e.g. coronary artery bypass surgery (CABG) or angioplasty. Do not include variables that indicate medication use related to MI, e.g. beta blocker, statin, or aspirin use.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 27, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:48:04Z", + "title": "Coronary angioplasty", + "lower_title": "coronary angioplasty", + "description": "Qualitative indicator of coronary angioplasty status", + "instructions": "Include variables that represent whether or when a subject has experienced a coronary angioplasty. Include variables that represent prevalent and/or incident coronary angioplasty status. Include variables that represent coronary angioplasty event data, including event status and time-to-event variables. Include variables that indicate age at coronary angioplasty events, e.g. self-reported age at a coronary angioplasty event or followup time to a coronary angioplasty event. Include variables indicating coronary angioplasty status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits (e.g. evidence of coronary stent in CT scan). Include all instances of duplicated variables, e.g. coronary angioplasty events variables included in multiple datasets.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 28, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:48:27Z", + "title": "Coronary artery bypass graft", + "lower_title": "coronary artery bypass graft", + "description": "Qualitative indicator of coronary artery bypass graft (CABG) status", + "instructions": "Include variables that represent whether or when a subject has experienced a CABG. Include variables that represent prevalent and/or incident CABG status. Include variables that represent CABG event data, including event status and time-to-event variables. Include variables that indicate age at CABG events, e.g. self-reported age at a CABG event or followup time to a CABG event. Include variables indicating CABG status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. CABG events variables included in multiple datasets.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 29, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:48:57Z", + "title": "Heart failure", + "lower_title": "heart failure", + "description": "Qualitative indicator of heart failure status", + "instructions": "Include variables that represent whether or when a subject has experienced heart failure. Include variables that represent prevalent and/or incident heart failure status. Include variables that represent heart failure event data, including event status and time-to-event variables. Include variables that indicate age at heart failure events, e.g. self-reported age at a heart failure event or followup time to a heart failure event. Include variables indicating heart failure status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. heart failure events variables included in multiple datasets. Do not include variables that indicate medication use related to heart failure, e.g. diuretic use.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 30, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:49:33Z", + "title": "Hypertension", + "lower_title": "hypertension", + "description": "Qualitative indicator of hypertension status", + "instructions": "Include variables that represent whether or when a subject has had hypertension. Include variables that represent prevalent and/or incident hypertension status. Include variables that represent hypertension event data, including event status and time-to-event variables. Include variables that indicate age at hypertension events, e.g. self-reported age at hypertension diagnosis or followup time to hypertension diagnosis. Include variables indicating hypertension status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. hypertension status variables included in multiple datasets. Do not include variables that indicate medication use related to hypertension treatment, e.g. beta blocker, ACE inhibitor, or calcium channel blocker use. Do not include systolic or diastolic blood pressure measurements or hypertension medication status that could be used to derive hypertension status.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 31, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:56:35Z", + "title": "Blood glucose", + "lower_title": "blood glucose", + "description": "Quantitative measure of the concentration of glucose in blood.", + "instructions": "Include variables that represent a measurement of the concentration of glucose in the blood. Include variables from all time points and all repeated measures within each time point, e.g. blood glucose measured at multiple exams. Include all instances of duplicated variables, e.g. blood glucose variables included in multiple datasets. Include variables in all measurement units available, e.g. blood glucose in mg/dL and blood glucose in mmol/L. Include single-time-point blood glucose measurements, as well as time-series blood glucose measurements, e.g. blood glucose measurements from the Oral Glucose Tolerance Test (OGTT) and Frequently Sampled Intravenous Glucose Tolerance test (FSIGT). For OGTT and FSIGT blood glucose measures, also include variables representing measurement time points. Include both random and fasting blood glucose measurements. Include both corrected/adjusted and uncorrected/unadjusted blood glucose measures. Do not include variables for which blood glucose is a component, e.g. diabetes status indicators.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 32, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:56:43Z", + "title": "Insulin in blood", + "lower_title": "insulin in blood", + "description": "Quantitative measure of the concentration of insulin in blood.", + "instructions": "Include variables that represent a measurement of the concentration of insulin in the blood. Include variables from all time points and all repeated measures within each time point, e.g. insulin measured at multiple exams. Include all instances of duplicated variables, e.g. insulin variables included in multiple datasets. Include variables in all measurement units available, e.g. insulin in mg/dL and insulin in mmol/L. Include single-time-point insulin measurements, as well as time-series insulin measurements, e.g. insulin measurements from the Oral Glucose Tolerance Test (OGTT) and Frequently Sampled Intravenous Glucose Tolerance test (FSIGT), when available. For OGTT and FSIGT insulin measures, also include variables representing measurement time points. Include both random and fasting insulin measurements. Include both corrected/adjusted and uncorrected/unadjusted insulin measures. Do not include variables for which insulin is a component, e.g. diabetes status indicators.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 33, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-08-24T22:20:27Z", + "title": "HbA1c", + "lower_title": "hba1c", + "description": "Quantitative measure of glycated hemoglobin (hemoglobin A1c, or HbA1c) in blood", + "instructions": "Include variables that represent a measurement of HbA1c in the blood. Include variables from all time points and all repeated measures at each time point, e.g. HbA1c measured at multiple exams, and HbA1c measured multiple times at the same exam. Include all instances of duplicated variables, e.g. HbA1c variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. HbA1c in mg/dL and HbA1c in mmol/L and HbA1c as the percentage of total hemoglobin that is glycated.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 34, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-06-26T00:09:32Z", + "title": "Diabetes", + "lower_title": "diabetes", + "description": "Qualitative indicator of diabetes mellitus status", + "instructions": "Include variables that represent whether or when a subject has experienced diabetes. Include variables that represent prevalent and/or incident diabetes status. Include variables that represent diabetes onset event data, including event status and time-to-event variables. Include variables that indicate age at diabetes onset, e.g. self-reported age at diabetes diagnosis or followup time to diabetes diagnosis. Include variables indicating diabetes status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. diabetes onset variables included in multiple datasets. Include categorical variables indicating diabetes categories, e.g. non-diabetic, pre-diabetic, and diabetic, or other subcategories of diabetes. Do not include variables that indicate possible diabetes treatments, e.g. glucose meter use. Do not include variables that indicate medication use related to diabetes, e.g. insulin injection or metformin use. Do not include quantitative measures of insulin, glucose, diabetes medication status, or other factors used to calculate/infer diabetes status. Do not include variables that indicate conditions related to diabetes, e.g. diabetic retinopathy.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 35, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:50:15Z", + "title": "Atrial fibrillation/flutter", + "lower_title": "atrial fibrillation/flutter", + "description": "Qualitative indicator of atrial fibrillation or atrial flutter status", + "instructions": "Include variables that represent whether or when a subject has experienced atrial fibrillation or flutter. Include variables that represent prevalent and/or incident atrial fibrillation status. Include variables that represent atrial fibrillation event data, including event status and time-to-event variables. Include variables that indicate age at atrial fibrillation events, e.g. self-reported age at an atrial fibrillation event or followup time to an atrial fibrillation event. Include variables indicating atrial fibrillation status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. atrial fibrillation events variables included in multiple datasets. Do not include variables that indicate possible atrial fibrillation treatments, e.g. cardioversion or surgical interventions. Do not include variables that indicate medication use related to atrial fibrillation treatment, e.g. anticoagulant use.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 36, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-10-19T17:55:25Z", + "title": "QRS duration from EKG", + "lower_title": "qrs duration from ekg", + "description": "Quantitative measure of QRS duration from electrocardiogram (EKG) data", + "instructions": "Include variables that represent a QRS duration measurement from an EKG. Include variables from all time points and all repeated measures within each time point, e.g. QRS duration measured at multiple exams. Include all instances of duplicated variables, e.g. QRS duration variables included in multiple datasets. Include variables in all measurement units available, e.g. QRS duration in milliseconds and QRS duration in seconds. Include variables from individual leads, as well as the composite variable. Include both corrected/adjusted and uncorrected/unadjusted measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 37, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-10-19T17:55:17Z", + "title": "QT interval from EKG", + "lower_title": "qt interval from ekg", + "description": "Quantitative measure of QT interval from electrocardiogram (EKG) data", + "instructions": "Include variables that represent a QT interval measurement from an EKG. Include variables from all time points and all repeated measures within each time point, e.g. QT interval measured at multiple exams. Include all instances of duplicated variables, e.g. QT interval variables included in multiple datasets. Include variables in all measurement units available, e.g. QT interval in milliseconds and QT interval in seconds. Include variables from individual leads, as well as the composite variable. Include both corrected/adjusted and uncorrected/unadjusted measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 38, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-10-19T17:55:10Z", + "title": "PR interval from EKG", + "lower_title": "pr interval from ekg", + "description": "Quantitative measure of PR interval from electrocardiogram (EKG) data", + "instructions": "Include variables that represent a PR interval measurement from an EKG. Include variables from all time points and all repeated measures within each time point, e.g. PR interval measured at multiple exams. Include all instances of duplicated variables, e.g. PR interval variables included in multiple datasets. Include variables in all measurement units available, e.g. PR interval in milliseconds and PR interval in seconds. Include variables from individual leads, as well as the composite variable. Include both corrected/adjusted and uncorrected/unadjusted measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 39, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:53:41Z", + "title": "Resting heart rate from EKG", + "lower_title": "resting heart rate from ekg", + "description": "Quantitative measure of resting heart rate (HR) from electrocardiogram (EKG) data", + "instructions": "Include variables that represent a resting heart rate measurement from an EKG, or an RR interval variable that could be used to calculate resting heart rate. Include variables from all time points and all repeated measures within each time point, e.g. resting heart rate measured at multiple exams. Include all instances of duplicated variables, e.g. resting heart rate variables included in multiple datasets. Include variables in all measurement units available, e.g. resting heart rate in beats per minute. Include both corrected/adjusted and uncorrected/unadjusted measures. Do not include resting heart rate measured by means other than EKG, e.g. pulse or heart rate monitor. Do not include heart rate measured during exercise or other non-resting heart rate variables.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 40, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-06-12T21:52:11Z", + "title": "LVH from EKG", + "lower_title": "lvh from ekg", + "description": "Index of left ventricular hypertrophy (LVH) determined from electrocardiogram (EKG) data", + "instructions": "Include variables that represent indices of LVH, determined from EKG data. Include LVH index variables determined by Cornell, Sokolow-Lyon, Romhilt-Estes, or other criteria. Include variables containing a quantitative score (e.g. Romhilt-Estes point score) or a binary indicator of LVH status (e.g. LVH status from Cornell voltage criteria). Include variables from all time points and all repeated measures within each time point, e.g. LVH index determined at multiple exams. Include all instances of duplicated variables, e.g. LVH index variables repeated in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Do not include measures of LVH determined by other means, e.g. LVH from echocardiography, or LVH from cardiac MRI. Do not include variables that represent the components used to derive LVH index, such as individual voltages or ST segment abnormalities.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 41, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:50:35Z", + "title": "Pacemaker", + "lower_title": "pacemaker", + "description": "Qualitative indicator of pacemaker implant status", + "instructions": "Include variables that represent whether or when a subject has had a pacemaker implant. Include variables that represent prevalent and/or incident pacemaker implant status. Include variables that represent pacemaker implant event data, including implantation event status and time-to-event variables. Include variables that indicate age at pacemaker implant events, e.g. self-reported age at pacemaker implantation or followup time to pacemaker implantation. Include variables indicating pacemaker implant status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. pacemaker implant variables included in multiple datasets.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 42, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:57:45Z", + "title": "Hematocrit", + "lower_title": "hematocrit", + "description": "Quantitative measure of the fraction of blood volume that is composed of red blood cells", + "instructions": "Include variables that represent a hematocrit measurement, usually from a Complete Blood Count (CBC), but also from any other hematocrit measurement from blood. Include variables from all time points and all repeated measures within each time point, e.g. hematocrit measured at multiple exams. Include all instances of duplicated variables, e.g. hematocrit variables included in multiple datasets. Include variables in all measurement units available, e.g. hematocrit as a proportion and hematocrit as a percentage. Include both corrected/adjusted and uncorrected/unadjusted measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 43, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-06-01T18:09:37Z", + "title": "Hemoglobin", + "lower_title": "hemoglobin", + "description": "Quantitative measure of total hemoglobin concentration in blood", + "instructions": "Include variables that represent a total hemoglobin concentration measurement. Variables to include will usually be from a Complete Blood Count (CBC), but hemoglobin concentration measurements from other blood panels or individual blood tests should also be included. Include variables from all time points and all repeated measures within each time point, e.g. hemoglobin concentration measured at multiple exams. Include all instances of duplicated variables, e.g. hemoglobin concentration variables included in multiple datasets. Include variables in all measurement units available, e.g. hemoglobin concentration in grams/dL and hemoglobin concentration in grams/L. Do not include mean corpuscular hemoglobin or mean corpuscular hemoglobin concentration variables, which measure hemoglobin per red blood cell.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 44, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-06-01T18:10:43Z", + "title": "Platelet count", + "lower_title": "platelet count", + "description": "Quantitative measure of platelet cell number per volume of blood", + "instructions": "Include variables that represent a platelet count measurement, usually from a Complete Blood Count (CBC), but also from any other platelet count measurement from blood. Include variables from all time points and all repeated measures within each time point, e.g. platelet count measured at multiple exams. Include all instances of duplicated variables, e.g. platelet count variables included in multiple datasets. Include variables in all measurement units available, e.g. platelets count as cells/L and platelets count as billion cells/L. Include both corrected/adjusted and uncorrected/unadjusted measures. Do not include mean platelet volume variables.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 45, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-06-01T18:10:19Z", + "title": "Red blood cell count", + "lower_title": "red blood cell count", + "description": "Quantitative measure of red blood cell number per volume of blood", + "instructions": "Include variables that represent a red blood cell count measurement, usually from a Complete Blood Count (CBC), but also from any other red blood cell count measurement from blood. Include variables from all time points and all repeated measures within each time point, e.g. red blood cell count measured at multiple exams. Include all instances of duplicated variables, e.g. red blood cell count variables included in multiple datasets. Include variables in all measurement units available, e.g. red blood cell count in cells/L and red blood cell count in cells/mcL. Include both corrected/adjusted and uncorrected/unadjusted measures. Do not include mean corpuscular volume variables.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 46, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-06-05T22:20:41Z", + "title": "White blood cell count", + "lower_title": "white blood cell count", + "description": "Quantitative measure of white blood cell number per volume of blood", + "instructions": "Include variables that represent a white blood cell count measurement, usually from a Complete Blood Count (CBC), but also from any other white blood cell count measurement from blood. Include variables from all time points and all repeated measures within each time point, e.g. white blood cell count measured at multiple exams. Include all instances of duplicated variables, e.g. white blood cell count variables included in multiple datasets. Include variables in all measurement units available, e.g. white blood cell count in cells/L and white blood cell count in cells/mcL. Include both corrected/adjusted and uncorrected/unadjusted measures. Do not include variables counting neutrophils, basophils, monocytes, lymphocytes, or other white blood cell subtypes.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 47, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:58:54Z", + "title": "Fibrinogen in blood", + "lower_title": "fibrinogen in blood", + "description": "Quantitative measure of fibrinogen concentration in blood", + "instructions": "Include variables that represent a fibrinogen concentration measurement. Include variables from all time points and all repeated measures within each time point, e.g. fibrinogen measured at multiple exams. Include all instances of duplicated variables, e.g. fibrinogen variables included in multiple datasets. Include variables in all measurement units available, e.g. fibrinogen in mg/dL and fibrinogen in g/L. Include both corrected/adjusted and uncorrected/unadjusted measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 48, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:59:00Z", + "title": "Factor VII", + "lower_title": "factor vii", + "description": "Quantitative measure of factor VII activity or concentration in blood", + "instructions": "Include variables that represent measurement of factor VII activity or concentration in blood. Include variables from all time points and all repeated measures within each time point, e.g. factor VII measured at multiple exams. Include all instances of duplicated variables, e.g. factor VII variables included in multiple datasets. Include variables in all measurement units available, e.g. factor VII activity in percentage and factor VII concentration in IU/L. Include both corrected/adjusted and uncorrected/unadjusted measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 49, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:59:07Z", + "title": "Factor VIII", + "lower_title": "factor viii", + "description": "Quantitative measure of factor VIII activity or concentration in blood", + "instructions": "Include variables that represent measurement of factor VIII activity or concentration in blood. Include variables from all time points and all repeated measures within each time point, e.g. factor VIII measured at multiple exams. Include all instances of duplicated variables, e.g. factor VIII variables included in multiple datasets. Include variables in all measurement units available, e.g. factor VIII activity in percentage and factor VIII concentration in IU/L. Include both corrected/adjusted and uncorrected/unadjusted measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 50, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T23:01:58Z", + "title": "von Willebrand factor", + "lower_title": "von willebrand factor", + "description": "Quantitative measure of von Willebrand factor (vWf) activity or concentration in blood", + "instructions": "Include variables that represent measurement of vWF activity or concentration in blood. Include variables from all time points and all repeated measures within each time point, e.g. vWf measured at multiple exams. Include all instances of duplicated variables, e.g. vWf variables included in multiple datasets. Include variables in all measurement units available, e.g. vWf activity in percentage and vWF concentration in IU/L. Include both corrected/adjusted and uncorrected/unadjusted measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 51, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-05-15T17:50:57Z", + "title": "VTE", + "lower_title": "vte", + "description": "Qualitative indicator of venous thromboembolism (VTE) status", + "instructions": "Include variables that represent whether or when a subject has experienced VTE. VTE includes both deep venous thrombosis and pulmonary embolism. VTE does not include arterial thrombosis or arterial embolism. Include variables that represent prevalent and/or incident VTE status. Include variables that represent VTE event data, including event status and time-to-event variables. Include variables that indicate age at VTE events, e.g. self-reported age at a VTE event or followup time to a VTE event. Include variables indicating VTE status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. VTE variables included in multiple datasets. Include variables indicating deep vein thrombosis (DVT) status, pulmonary embolism status, and VTE status of unknown type. Include variables that specify VTE type. Do not include variables that indicate possible VTE treatments, e.g. surgical procedures. Do not include variables that indicate medication use related to VTE, e.g. anticoagulant or thrombolytic use.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 52, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:59:12Z", + "title": "CRP in blood", + "lower_title": "crp in blood", + "description": "Quantitative measure of C-reactive protein (CRP) concentration in blood", + "instructions": "Include variables that represent a measurement of the concentration of CRP in the blood. Include variables from all time points and all repeated measures at each time point, e.g. CRP measured at multiple exams, and CRP measured multiple times at the same exam. Include all instances of duplicated variables, e.g. CRP variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. CRP in mg/dL and CRP in mmol/L.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 53, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:59:18Z", + "title": "Interleukin 6 in blood", + "lower_title": "interleukin 6 in blood", + "description": "Quantitative measure of Interleukin 6 (IL-6) concentration in blood", + "instructions": "Include variables that represent a measurement of the concentration of IL-6 in the blood. Include variables from all time points and all repeated measures at each time point, e.g. IL-6 measured at multiple exams, and IL-6 measured multiple times at the same exam. Include all instances of duplicated variables, e.g. IL-6 variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. IL-6 in mg/dL and IL-6 in mmol/L.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 54, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:59:26Z", + "title": "Creatinine in blood", + "lower_title": "creatinine in blood", + "description": "Quantitative measure of creatinine concentration in blood", + "instructions": "Include variables that represent a measurement of the concentration of creatinine in the blood. Include variables from all time points and all repeated measures at each time point, e.g. creatinine measured at multiple exams, and creatinine measured multiple times at the same exam. Include all instances of duplicated variables, e.g. creatinine variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. creatinine in mg/dL and creatinine in mmol/L.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 55, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:59:32Z", + "title": "Cystatin C in blood", + "lower_title": "cystatin c in blood", + "description": "Quantitative measure of cystatin C concentration in blood", + "instructions": "Include variables that represent a measurement of the concentration of cystatin C in the blood. Include variables from all time points and all repeated measures at each time point, e.g. cystatin C measured at multiple exams, and cystatin C measured multiple times at the same exam. Include all instances of duplicated variables, e.g. cystatin C variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. cystatin C in mg/dL and cystatin C in mmol/L.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 56, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-07-13T20:13:30Z", + "title": "Albumin-creatinine ratio in urine", + "lower_title": "albumin-creatinine ratio in urine", + "description": "Quantitative measure of the ratio of albumin concentration to creatinine concentration in urine", + "instructions": "Include quantitative variables that represent the calculated urine albumin-creatinine ratio. Include variables from all time points and all repeated measures within each time point, e.g. albumin-creatinine ratio variables included in multiple datasets. Include all instances of duplicated variables, e.g. albumin-creatinine ratio measured for different datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Do not include variables that represent the albumin and creatinine components used to derive albumin-creatinine ratio.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 57, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:59:47Z", + "title": "GFR", + "lower_title": "gfr", + "description": "Quantitative measure of glomerular filtration rate (GFR)", + "instructions": "Include variables that represent calculated glomerular filtration rate (GFR). Include all GFR variables, regardless of how they were calculated, e.g. eGFR from creatinine-based approximations (by any available formula) or direct measurements based on inulin clearance. Include variables from all time points and all repeated measures at each time point, e.g. GFR measured at multiple exams, and GFR measured multiple times at the same exam. Include all instances of duplicated variables, e.g. GFR variables included in multiple datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables in all measurement units available, e.g. GFR in mL/min and GFR in L/min. Do not include variables that represent the creatinine or other component variables used to derive the calculated GFR.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 62, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-07-13T20:23:05Z", + "title": "FVC", + "lower_title": "fvc", + "description": "Quantitative measure of forced vital capacity (FVC) measured using spirometry", + "instructions": "Include variables that represent an FVC measurement. Include variables from all time points and all repeated measures at each time point, e.g. FVC measured at multiple exams, and FVC measured multiple times at the same exam. Include all instances of duplicated variables, e.g. FVC variables included in multiple datasets. Include variables in all measurement units available, e.g. FVC in liters and FVC in milliliters. Include both individual measures of FVC and averages or maximum values thereof. Include both corrected/adjusted and uncorrected/unadjusted measures, including percent predicted FVC. Include measures both pre- and post-bronchodilator administration.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 63, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-07-13T20:23:22Z", + "title": "FEV1", + "lower_title": "fev1", + "description": "Forced expiratory volume in 1 second (FEV1) measured using spirometry", + "instructions": "Include variables that represent an FEV1 measurement. Include variables from all time points and all repeated measures at each time point, e.g. FEV1 measured at multiple exams, and FEV1 measured multiple times at the same exam. Include all instances of duplicated variables, e.g. FEV1 variables included in multiple datasets. Include variables in all measurement units available, e.g. FEV1 in liters and FEV1 in milliliters. Include both individual measures of FEV1 and averages or maximum values thereof. Include both corrected/adjusted and uncorrected/unadjusted measures including percent predicted FEV1. Include measures both pre- and post-bronchodilator administration.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 64, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-11-15T19:32:21Z", + "title": "Asthma", + "lower_title": "asthma", + "description": "Qualitative indicator of asthma status", + "instructions": "Include variables that represent whether or when a subject has experienced asthma. Include variables that represent prevalent and/or incident asthma status. Include variables that represent asthma onset event data, including event status and time-to-event variables. Include variables that indicate age at asthma onset, e.g. self-reported age at asthma diagnosis or followup time to asthma diagnosis. Include variables indicating asthma status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. asthma onset variables included in multiple datasets. Do not include variables that indicate possible asthma treatments, e.g. bronchial thermoplasty or immunotherapy. Do not include variables that indicate medication use related to asthma, e.g. albuterol inhaler, beta agonist, or corticosteroid use. Do not include quantitative measures of lung function, spirometry, response to bronchodilator, or other factors used to calculate/infer asthma status. This tag should only be used for qualitative indicators of asthma status and its timing; variables that describe asthma symptoms or severity should be tagged as \u201casthma severity\u201d instead.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 65, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-11-15T19:34:14Z", + "title": "Asthma severity", + "lower_title": "asthma severity", + "description": "Qualitative and quantitative measures of asthma severity", + "instructions": "Include variables that represent measures or qualitative descriptors of asthma severity. Include variables determined by a clinician or examiner and self-reported variables. Examples include questionnaire responses regarding asthma severity (e.g. seasonality), description of asthma symptoms, asthma exacerbations (e.g. respiratory infections), asthma attack frequency, or medical care or hospitalization for asthma. Include variables from all time points and all repeated measures at each time point, e.g. asthma severity at multiple exams, or asthma severity assessed multiple times at the same exam. Include all instances of duplicated variables, e.g. asthma severity variables included in multiple datasets. Include variables in all available units, e.g. asthma symptom frequency per week and asthma symptom frequency per year. Do not include variables indicating asthma status or spirometry measures. Do not include variables that are already tagged as \"asthma\".", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 66, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-09-04T17:30:49Z", + "title": "COPD", + "lower_title": "copd", + "description": "Qualitative indicator of Chronic Obstructive Pulmonary Disease (COPD) status", + "instructions": "Include variables that represent whether or when a subject has experienced COPD. COPD includes emphysema and chronic bronchitis. Include variables that represent prevalent and/or incident COPD status. Include variables that represent COPD event data, including event status and time-to-event variables. Include variables that indicate age at COPD events, e.g. self-reported age at COPD onset or followup time to COPD diagnosis. Include variables indicating COPD status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. COPD variables included in multiple datasets. Do not include variables that indicate possible COPD treatments, e.g. supplemental oxygen administration or lung transplant. Do not include variables that indicate medication use related to COPD, e.g. corticosteroid or bronchodilator use. Do not include variables that are quantitative measures of lung function that can be used to calculate COPD status, such as FVC, FEV1, or other spirometry measures.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 67, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-12-15T00:46:31Z", + "title": "Sleep apnea", + "lower_title": "sleep apnea", + "description": "Qualitative indicator of sleep apnea status", + "instructions": "Include variables that represent whether or when a subject has experienced sleep apnea. Include variables indicating sleep apnea of any type (obstructive, central, or complex). Include variables indicating the type of sleep apnea, e.g. a categorical variable with values 'obstructive', 'central', and 'complex'. Include variables that represent prevalent and/or incident sleep apnea status. Include variables that represent sleep apnea event data, including event status and time-to-event variables. Include variables that indicate age at sleep apnea events, e.g. self-reported age at sleep apnea onset or followup time to sleep apnea diagnosis. Include variables indicating sleep apnea status based on any method of determination, including self report, adjudication, clinical verification, medical records, ICD codes, or calculation/inference from related traits. Include all instances of duplicated variables, e.g. sleep apnea variables included in multiple datasets. Do not include variables that indicate possible sleep apnea treatments, e.g. CPAP or supplemental oxygen use. Do not include quantitative measures that can be used to calculate sleep apnea status, such as AHI. Do not include categorical variables derived from AHI, e.g. AHI > 50.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 68, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-12-15T00:44:32Z", + "title": "AHI", + "lower_title": "ahi", + "description": "Quantitative measure of Apnea-Hypopnea Index (AHI), a measure of sleep apnea severity", + "instructions": "Include variables that represent an AHI measurement. Include variables from all time points and all repeated measures within each time point, e.g. AHI measured at multiple exams. Include all instances of duplicated variables, e.g. AHI variables included in multiple datasets. Include variables in all measurement units available, e.g. AHI in events per hour or in events per day. Include both corrected/adjusted and uncorrected/unadjusted measures. Include variables that represent subtypes of AHI, e.g. obstructive apnea hypopnea index (OAHI), obstructive apnea index (OAI), central apnea index (CAI), etc. Do not include component variables, e.g. variables representing the total number of hypopneas or apneas during sleep. If the respiratory disturbance index (RDI) was defined in the same way as AHI, then you may include RDI variables. Do not include RDI variables if they include respiratory effort related arousals (RERAs).", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 69, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-03-13T18:39:53Z", + "title": "Cigarette smoking", + "lower_title": "cigarette smoking", + "description": "Qualitative and quantitative measures of cigarette smoking history and cigarette smoking status", + "instructions": "Include variables that represent qualitative or quantitative descriptors of a subject's cigarette smoking behavior. Include smoking initiation age or date, smoking cessation date or age, duration of smoking, estimates of smoking heaviness (e.g. cigarettes per day or per week), number or timing of smoking cessation attempts, smoking cessation strategies attempted, current and former smoking behavior status (e.g. ever-smoker or never-smoker or former-smoker status), etc. Include estimates of lifetime cigarette smoking exposure, e.g. cigarette pack years. Do not include variables describing use of other substances, e.g. cigars, chewing tobacco, marijuana or other drugs, e-cigarettes (vaping), etc. Do not include variables related to smoking-related health conditions e.g. lung cancer, COPD, emphysema, etc. Do not include variables related to second-hand smoke exposure.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 70, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-03-13T18:39:53Z", + "title": "Subcohort", + "lower_title": "subcohort", + "description": "Categorical indicator of membership in different study subcohorts (i.e. participant subsets within a study who were recruited at different times and/or enrolled in different sub-studies)", + "instructions": "Include all variables that represent a subject's membership in a \"subcohort\" - a subset within a study determined by enrollment time, sub-study, or other distinguishing group factor. Examples include original or offspring (etc.) cohort in Framingham Heart Study and the observational study and clinical trial subsets of the Women's Health Initiative. Include all variables representing subcohort membership, e.g. a master variable in the study's subject file. Include variables duplicated in multiple datasets, e.g. a variable indicating subject membership in several or every dataset file in the study. If your study does not contain variables indicating subcohort membership, then you may not need to use this tag in your study, e.g. if the data from each subcohort is contained in different datasets.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 71, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-03-13T18:39:53Z", + "title": "Clinic visit", + "lower_title": "clinic visit", + "description": "Categorical indicator of the clinical visit (exam, year, etc.) during which observations, measurements and/or other data/biosample collections were made", + "instructions": "Include all variables that represent the clinical visit/exam/year at which a measurement/observation was made. Examples include visit names like 'baseline', 'exam 1', 'visit 1', 'ancillary study A', or categorical codes representing such values. Include all variables representing clinic visit, e.g. a variable representing clinic visit coded as '1', '2', '3', etc.; a variable representing visit year as '1995', '1998', '2002', etc. If your study does not contain variables indicating clinic visit, then you may not need to use this tag in your study, e.g. if the data from each clinic visit is separated into different datasets.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 72, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-04-17T22:41:52Z", + "title": "Fasting", + "lower_title": "fasting", + "description": "Qualitative or quantitative indicator describing or quantifying fasting status prior to blood draw for any blood sample-derived measurement", + "instructions": "Include variables indicating fasting status or fasting time related to other blood sample-derived variables. Include both qualitative indicators of fasting status and quantitative measures such as hours of fasting. Include fasting variables from all time points and all repeated measures within each time point, e.g. fasting status variables at multiple exams. Include all instances of duplicated variables, e.g. fasting status for two different blood draws in different datasets. Include both corrected/adjusted and uncorrected/unadjusted measures. ", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 73, + "fields": { + "created": "2018-03-13T18:39:53Z", + "modified": "2018-03-13T18:39:53Z", + "title": "Geographic site", + "lower_title": "geographic site", + "description": "Categorical indicator of the clinic, recruitment site, and/or field center at which participants were recruited, and/or where data or biosamples were collected.", + "instructions": "Include variables indicating the clinic site, recruitment site, and/or field center at which participants were recruited and/or where data or biosamples were collected. Include variables for which specific clinic/field center names or geographic locations are provided (e.g. a categorical variable with values 'Cleveland Clinic', and 'New York') and those for which this information is encoded (e.g. a categorical variable with values 'A', 'B', and 'C'). Include all instances of duplicated variables, e.g. redundant clinic site variables in multiple datasets. If your study does not contain variables indicating geographic site, and/or does not contain data from multiple geographic sites, then you may not need to use this tag in your study.", + "creator": 7 + } +}, +{ + "model": "tags.tag", + "pk": 74, + "fields": { + "created": "2018-05-22T17:22:03Z", + "modified": "2018-10-09T17:09:49Z", + "title": "Medication/supplement use", + "lower_title": "medication/supplement use", + "description": "Qualitative or quantitative indicator of use of any kind of medication, vitamin, mineral, or dietary supplement", + "instructions": "Include variables indicating, describing or quantifying use-characteristics for any type of medication, vitamin, mineral, or dietary supplement. Include variables describing which medications, vitamin, minerals, or dietary supplements have been or are being used, how frequently, and in what dosage. Include medications, vitamin, minerals, or dietary supplements taken orally, by inhalation (e.g. albuterol), or by injection (e.g. insulin). Include variables in medication inventories; variables indicating use of specific drugs (e.g. statin use); variables indicating use of an entire drug class (e.g. lipid-lowering medication use, beta-blocker use, or anticoagulant use); dosage variables; and variables obtained from questionnaires (e.g. \"Do you use an inhaler for asthma treatment?\" or \"Have you ever taken blood-thinning medication?\"). Include medication treatment indicator variables in clinical trial data. Include variables relating to medication use even if they are found in a dataset that is not specifically related to medication use (e.g. a variable indicating inhaler use in a spirometry dataset or a variable indicating antihypertensive medication use in a questionnaire dataset). Include variables indicating treatment of a specific condition, when that treatment usually refers to a medication (e.g. \"Are you being treated for hypertension?\" or \"Are you being treated for diabetes?\").", + "creator": 7 + } +} +] diff --git a/data/topmed_variables_v2.0.csv b/data/topmed_variables_v2.0.csv new file mode 100644 index 00000000..18e73eb0 --- /dev/null +++ b/data/topmed_variables_v2.0.csv @@ -0,0 +1,15912 @@ +tag_pk tag_title variable_phv variable_full_accession dataset_full_accession study_full_accession study_name study_phs study_version created modified variable_name variable_description +1 LDL in blood 82951 phv00082951.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:10:23+00:00 2017-12-20 22:10:23+00:00 ldl1 LDL CHOLESTEROL (mg/dl) +1 LDL in blood 84971 phv00084971.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:10:23+00:00 2017-12-20 22:10:23+00:00 ldl1 LDL CHOLESTEROL (mg/dl) +1 LDL in blood 87098 phv00087098.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:10:23+00:00 2017-12-20 22:10:23+00:00 ldlf LDL CHOLESTEROL (mg/dl) +1 LDL in blood 253017 phv00253017.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2017-12-22 18:09:21+00:00 2017-12-22 18:09:21+00:00 ldl_baseline LDL value as calculated by Friedewald equation at baseline visit +1 LDL in blood 125931 phv00125931.v1.p1 pht001945.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:14:28+00:00 2017-12-22 18:14:28+00:00 LDLC Ldlc: HDL cholesterol - mg/dL +1 LDL in blood 126042 phv00126042.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:14:28+00:00 2017-12-22 18:14:28+00:00 LDL01SI LDL cholesterol (mmol/L) +1 LDL in blood 126047 phv00126047.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:14:28+00:00 2017-12-22 18:14:28+00:00 LDL01F Fasting low density lipoprotein cholesterol (mg/dl) (LDL) +1 LDL in blood 204764 phv00204764.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2017-12-22 22:54:23+00:00 2017-12-22 22:54:23+00:00 LDL02 Recalibrated LDL cholesterol [Cohort, Exam 1] +1 LDL in blood 100492 phv00100492.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2017-12-22 22:59:20+00:00 2017-12-22 22:59:20+00:00 LDLADJ Adjusted LDL (mg/dl) +1 LDL in blood 258740 phv00258740.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2017-12-22 23:07:14+00:00 2017-12-22 23:07:14+00:00 LDL_C LDL-C from venous blood sample (mg/dL) +1 LDL in blood 123971 phv00123971.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-22 23:08:47+00:00 2017-12-22 23:08:47+00:00 ldl Ldl (mg/dL) +1 LDL in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-01-12 23:42:13+00:00 2018-01-12 23:42:13+00:00 TESTVAL Test Result Value +1 LDL in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-01-12 23:44:11+00:00 2018-01-12 23:44:11+00:00 TESTNAME Test Name +1 LDL in blood 1206 phv00001206.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 19:17:27+00:00 2018-03-02 19:17:27+00:00 FB29 BLOOD ANALYSIS: CHOLESTEROL, BETA +1 LDL in blood 1381 phv00001381.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 19:17:50+00:00 2018-03-02 19:17:50+00:00 FC23 BLOOD ANALYSIS: BETA CHOLESTEROL (MG/100 ML) +1 LDL in blood 1401 phv00001401.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 19:18:20+00:00 2018-03-02 19:18:20+00:00 FC45 BLOOD ANALYSIS, FASTING: BETA CHOLESTEROL (MG/100 ML) +1 LDL in blood 1584 phv00001584.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 19:18:48+00:00 2018-03-02 19:18:48+00:00 FD39 BLOOD ANALYSIS, FASTING: BETA CHOLESTEROL (SEE VARIABLE #40 FOR DECK 132 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) +1 LDL in blood 1591 phv00001591.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 19:19:03+00:00 2018-03-02 19:19:03+00:00 FD46 BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - BETA (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) +1 LDL in blood 7539 phv00007539.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 19:56:03+00:00 2018-03-02 19:56:03+00:00 A12 LDL CHOLESTEROL +1 LDL in blood 7975 phv00007975.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 19:56:38+00:00 2018-03-02 19:56:38+00:00 B357 BLOOD ANALYSIS-FASTING LIPIDS LDL CHOLESTEROL +1 LDL in blood 8733 phv00008733.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 19:58:37+00:00 2018-03-02 19:58:37+00:00 C442 LDL +1 LDL in blood 277026 phv00277026.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:01:23+00:00 2018-03-02 20:01:23+00:00 CALC_LDL1 Calculated LDL cholesterol, Exam 1 +1 LDL in blood 277027 phv00277027.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:01:32+00:00 2018-03-02 20:01:32+00:00 CALC_LDL2 Calculated LDL cholesterol, Exam 2 +1 LDL in blood 277104 phv00277104.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:01:42+00:00 2018-03-02 20:01:42+00:00 CALC_LDL1 Calculated LDL cholesterol, Exam 1 +1 LDL in blood 277105 phv00277105.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:01:52+00:00 2018-03-02 20:01:52+00:00 CALC_LDL2 Calculated LDL cholesterol, Exam 2 +1 LDL in blood 277106 phv00277106.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:02:02+00:00 2018-03-02 20:02:02+00:00 CALC_LDL3 Calculated LDL cholesterol, Exam 3 +1 LDL in blood 277107 phv00277107.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:02:12+00:00 2018-03-02 20:02:12+00:00 CALC_LDL4 Calculated LDL cholesterol, Exam 4 +1 LDL in blood 277108 phv00277108.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:02:22+00:00 2018-03-02 20:02:22+00:00 CALC_LDL5 Calculated LDL cholesterol, Exam 5 +1 LDL in blood 277109 phv00277109.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:02:33+00:00 2018-03-02 20:02:33+00:00 CALC_LDL6 Calculated LDL cholesterol, Exam 6 +1 LDL in blood 277110 phv00277110.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:02:43+00:00 2018-03-02 20:02:43+00:00 CALC_LDL7 Calculated LDL cholesterol, Exam 7 +1 LDL in blood 277111 phv00277111.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:02:53+00:00 2018-03-02 20:02:53+00:00 CALC_LDL8 Calculated LDL cholesterol, Exam 8 +1 LDL in blood 277112 phv00277112.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 20:03:04+00:00 2018-03-02 20:03:04+00:00 CALC_LDL9 Calculated LDL cholesterol, Exam 9 +1 LDL in blood 253241 phv00253241.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:02:22+00:00 2018-03-14 22:02:22+00:00 LABA69 LDL-cholesterol (mg/dL) (LABA69) +1 LDL in blood 204641 phv00204641.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:00:48+00:00 2018-03-15 13:00:48+00:00 LDL22 Visit 2, re-calculated LDL-C in mg/dL [Cohort, Exam 2] +1 LDL in blood 204650 phv00204650.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:01:21+00:00 2018-03-15 13:01:21+00:00 LDLSIU22 Visit 2, LDL cholesterol in mmol/L [Cohort, Exam 2] +1 LDL in blood 204768 phv00204768.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:01:53+00:00 2018-03-15 13:01:53+00:00 LDLSIU02 Recalibrated LDL cholesterol in SI units [Cohort, Exam 1] +1 LDL in blood 204868 phv00204868.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:02:33+00:00 2018-03-15 13:02:33+00:00 LDL32 Re-calibrated LDL cholesterol in mg/dL [Cohort, Exam 3] +1 LDL in blood 204869 phv00204869.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:03:06+00:00 2018-03-15 13:03:06+00:00 LDLSIU32 Re-calibrated LDL cholesterol in mmol/L [Cohort, Exam 3] +1 LDL in blood 204960 phv00204960.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:03:31+00:00 2018-03-15 13:03:31+00:00 LDL41 Re-calibrated LDL cholesterol in mg/dL [Cohort, Exam 4] +1 LDL in blood 204967 phv00204967.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:03:48+00:00 2018-03-15 13:03:48+00:00 LDLSIU41 Re-calibrated LDL cholesterol in mmol/L [Cohort, Exam 4] +1 LDL in blood 113703 phv00113703.v2.p2 pht001588.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:46:33+00:00 2018-04-17 14:46:33+00:00 AL1LDL LDL CHOLESTEROL (MG/DL) +1 LDL in blood 115101 phv00115101.v2.p2 pht001644.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:46:33+00:00 2018-04-17 14:46:33+00:00 BL1LDL BL1LDL +1 LDL in blood 116372 phv00116372.v2.p2 pht001695.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:46:33+00:00 2018-04-17 14:46:33+00:00 CL1LDL LDL CHOLESTEROL (MG/DL) +1 LDL in blood 117573 phv00117573.v2.p2 pht001742.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:46:33+00:00 2018-04-17 14:46:33+00:00 DL1LDL LDL CHOLESTEROL (MG/DL) +1 LDL in blood 119616 phv00119616.v2.p2 pht001802.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:46:33+00:00 2018-04-17 14:46:33+00:00 EL1LDL LDL CHOLESTEROL (mg/dL) +1 LDL in blood 120671 phv00120671.v2.p2 pht001848.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:46:33+00:00 2018-04-17 14:46:33+00:00 FL1LDL LDL CHOLESTEROL (mg/dL) +1 LDL in blood 207664 phv00207664.v1.p1 pht004123.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 19:49:11+00:00 2018-04-25 19:49:11+00:00 LIPC5 LDL cholesterol (value in mg/dL) Q5 [Lipid Lab, exam 3] +1 LDL in blood 207680 phv00207680.v1.p1 pht004124.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 19:50:28+00:00 2018-04-25 19:50:28+00:00 LIPD8 LDL cholesterol. Q8 [Lipid Lab, exam 4] +1 LDL in blood 160493 phv00160493.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:26:43+00:00 2018-04-26 01:26:43+00:00 ldlp31c LDL PARTICLES (TOTAL) (nmol/L) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS +1 LDL in blood 85919 phv00085919.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:26:52+00:00 2018-04-26 01:26:52+00:00 ldl2 LDL CHOLESTEROL (mg/dl) +1 LDL in blood 86401 phv00086401.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:27:18+00:00 2018-04-26 01:27:18+00:00 ldl3 LDL CHOLESTEROL (mg/dl) +1 LDL in blood 86832 phv00086832.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:27:25+00:00 2018-04-26 01:27:25+00:00 ldl4 LDL CHOLESTEROL (mg/dl) +1 LDL in blood 175238 phv00175238.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:27:38+00:00 2018-04-26 01:27:38+00:00 ldl5 LDL CHOLESTEROL (mg/dl) +1 LDL in blood 175866 phv00175866.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:27:44+00:00 2018-04-26 01:27:44+00:00 ldl1 LDL CHOLESTEROL (mg/dl) +1 LDL in blood 175885 phv00175885.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:27:49+00:00 2018-04-26 01:27:49+00:00 ldl LDL +1 LDL in blood 175950 phv00175950.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:27:56+00:00 2018-04-26 01:27:56+00:00 ldlf FAMILY COHORT: LDL CHOLESTEROL (mg/dl) +1 LDL in blood 176661 phv00176661.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:28:02+00:00 2018-04-26 01:28:02+00:00 ldl5 LDL CHOLESTEROL (mg/dl) +1 LDL in blood 100043 phv00100043.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 17:52:06+00:00 2018-05-03 17:52:06+00:00 LDLUNADJ UNADJUSTED CALCULATED LDL (mg/dl) +1 LDL in blood 100282 phv00100282.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 17:57:38+00:00 2018-05-03 17:57:38+00:00 LDLADJ Adjusted LDL (mg/dl) +1 LDL in blood 106415 phv00106415.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 17:58:20+00:00 2018-05-03 17:58:20+00:00 LDLUNADJ UNADJUSTED CALCULATED LDL (mg/dl) +1 LDL in blood 106416 phv00106416.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 17:58:35+00:00 2018-05-03 17:58:35+00:00 LDLADJ Adjusted LDL (mg/dl) +1 LDL in blood 106992 phv00106992.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 17:58:52+00:00 2018-05-03 17:58:52+00:00 LDLUNADJ CALCULATED LDL (mg/dl) +1 LDL in blood 107344 phv00107344.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 17:59:10+00:00 2018-05-03 17:59:10+00:00 LDLADJ Adjusted LDL (mg/dl) +1 LDL in blood 77391 phv00077391.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 16:04:09+00:00 2018-05-15 16:04:09+00:00 CORELDLC Core LDL Cholesterol (Mg/dl) +1 LDL in blood 123972 phv00123972.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:43:12+00:00 2018-08-14 20:43:12+00:00 ldl_orig Ldl - original value +1 LDL in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:03:40+00:00 2018-08-23 18:03:40+00:00 TESTABBR Test abbreviation +1 LDL in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:03:40+00:00 2018-08-23 18:03:40+00:00 TESTDESC Test Description +1 LDL in blood 258741 phv00258741.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:53:36+00:00 2018-09-06 12:53:36+00:00 LDL_mmol LDL-C from venous blood sample (mmol) +2 HDL in blood 82952 phv00082952.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:06:09+00:00 2017-12-20 22:06:09+00:00 hdl1 HDL CHOLESTEROL (mg/dl) +2 HDL in blood 84972 phv00084972.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:06:09+00:00 2017-12-20 22:06:09+00:00 hdl1 HDL CHOLESTEROL (mg/dl) +2 HDL in blood 87099 phv00087099.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:06:09+00:00 2017-12-20 22:06:09+00:00 hdlf HDL CHOLESTEROL (mg/dl) +2 HDL in blood 126041 phv00126041.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:18:36+00:00 2017-12-22 18:18:36+00:00 HDL01SI HDL cholesterol (mmol/L) +2 HDL in blood 126046 phv00126046.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:18:36+00:00 2017-12-22 18:18:36+00:00 HDL01F Fasting high density lipoprotein cholesterol (mg/dl) (HDL) +2 HDL in blood 125930 phv00125930.v1.p1 pht001945.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:18:36+00:00 2017-12-22 18:18:36+00:00 HDLC Hdlc: HDL cholesterol - mg/dL +2 HDL in blood 253018 phv00253018.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2017-12-22 18:18:36+00:00 2017-12-22 18:18:36+00:00 hdl_baseline HDL value at baseline visit +2 HDL in blood 277575 phv00277575.v1.p1 pht006041.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2017-12-22 18:18:36+00:00 2017-12-22 18:18:36+00:00 HDL HDL Cholesterol result value Collection Interval: 1996-2000 +2 HDL in blood 307856 phv00307856.v1.p1 pht006655.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2017-12-22 18:18:36+00:00 2017-12-22 18:18:36+00:00 HDL HDL Cholesterol result value Collection Interval: 1996-2000 +2 HDL in blood 204761 phv00204761.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2017-12-22 22:49:33+00:00 2017-12-22 22:49:33+00:00 HDL01 HDL cholesterol (recalibrated lipid) [Cohort, Exam 1] +2 HDL in blood 100426 phv00100426.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2017-12-22 22:56:56+00:00 2017-12-22 22:56:56+00:00 HDL44 HDL (mg/dl) +2 HDL in blood 123968 phv00123968.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-22 23:02:07+00:00 2017-12-22 23:02:07+00:00 hdl Hdl (mg/dL) +2 HDL in blood 258743 phv00258743.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2017-12-22 23:04:09+00:00 2017-12-22 23:04:09+00:00 HDL_C HDL-C from venous blood sample (mg/dL) +2 HDL in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-01-12 23:42:38+00:00 2018-01-12 23:42:38+00:00 TESTVAL Test Result Value +2 HDL in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-01-12 23:44:18+00:00 2018-01-12 23:44:18+00:00 TESTNAME Test Name +2 HDL in blood 1207 phv00001207.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:14:47+00:00 2018-02-28 12:14:47+00:00 FB30 BLOOD ANALYSIS: CHOLESTEROL, ALPHA +2 HDL in blood 1382 phv00001382.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:15:21+00:00 2018-02-28 12:15:21+00:00 FC24 BLOOD ANALYSIS: ALPHA CHOLESTEROL (MG/100 ML) +2 HDL in blood 1399 phv00001399.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:15:49+00:00 2018-02-28 12:15:49+00:00 FC43 BLOOD ANALYSIS, FASTING: ALPHA CHOLESTEROL (MG/100 ML) +2 HDL in blood 1582 phv00001582.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:16:53+00:00 2018-02-28 12:16:53+00:00 FD37 BLOOD ANALYSIS, FASTING: ALPHA CHOLESTEROL (SEE VARIABLE #40 FOR DECK 132 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) +2 HDL in blood 1589 phv00001589.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:17:14+00:00 2018-02-28 12:17:14+00:00 FD44 BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - ALPHA (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) +2 HDL in blood 2656 phv00002656.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:17:48+00:00 2018-02-28 12:17:48+00:00 FH333 BLOOD ANALYSIS: HDL CHOLESTEROL +2 HDL in blood 4519 phv00004519.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:18:35+00:00 2018-02-28 12:18:35+00:00 FM544 BLOOD ANALYSIS - HDL CHOLESTEROL +2 HDL in blood 5552 phv00005552.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:19:05+00:00 2018-02-28 12:19:05+00:00 FO732 BLOOD ANALYSIS - HDL CHOLESTEROL +2 HDL in blood 6028 phv00006028.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:19:38+00:00 2018-02-28 12:19:38+00:00 FP596 BLOOD ANALYSIS - HDL CHOLESTEROL +2 HDL in blood 6320 phv00006320.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:20:13+00:00 2018-02-28 12:20:13+00:00 FQ397 HDL CHOLESTEROL +2 HDL in blood 6660 phv00006660.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:20:43+00:00 2018-02-28 12:20:43+00:00 FR438 BLOOD ANALYSIS - HDL CHOLESTEROL +2 HDL in blood 6667 phv00006667.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:21:09+00:00 2018-02-28 12:21:09+00:00 FS534 HDL CHOLESTEROL MG/100ML +2 HDL in blood 7528 phv00007528.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:21:43+00:00 2018-02-28 12:21:43+00:00 FT544 HDL CHOLESTEROL MG/100ML +2 HDL in blood 7972 phv00007972.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:22:23+00:00 2018-02-28 12:22:23+00:00 B354 BLOOD ANALYSIS-FASTING LIPIDS ALPHA CHOLESTEROL BOTTOM FRACTION +2 HDL in blood 7973 phv00007973.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:22:47+00:00 2018-02-28 12:22:47+00:00 B355 BLOOD ANALYSIS-FASTING LIPIDS HDL CHOLESTEROL - ALSO KNOWN AS ALPHA CHOLESTEROL - MEASURED BY ELECTROPHORESIS +2 HDL in blood 8728 phv00008728.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:24:15+00:00 2018-02-28 12:24:15+00:00 C431 HDL CHOLESTEROL +2 HDL in blood 9122 phv00009122.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:25:05+00:00 2018-02-28 12:25:05+00:00 D449 HDL CHOLESTEROL +2 HDL in blood 9574 phv00009574.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:25:52+00:00 2018-02-28 12:25:52+00:00 E668 BLOOD ANALYSIS - HDL CHOLESTEROL +2 HDL in blood 10134 phv00010134.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:26:32+00:00 2018-02-28 12:26:32+00:00 F725 BLOOD ANAYLSIS - HDL CHOLESTEROL +2 HDL in blood 10141 phv00010141.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:27:32+00:00 2018-02-28 12:27:32+00:00 G703 HDL CHOLESTEROL MG/100ML +2 HDL in blood 21392 phv00021392.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:27:56+00:00 2018-02-28 12:27:56+00:00 G3A713 HDL CHOLESTEROL, MG/DL +2 HDL in blood 55263 phv00055263.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:31:01+00:00 2018-02-28 12:31:01+00:00 HDL HDL cholesterol (mg/dl) +2 HDL in blood 70732 phv00070732.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:31:47+00:00 2018-02-28 12:31:47+00:00 FU577 LAB VALUES: HDL CHOLESTEROL, MG/DL +2 HDL in blood 71891 phv00071891.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:32:11+00:00 2018-02-28 12:32:11+00:00 HDL_CHOL HDL cholesterol, plasma +2 HDL in blood 172176 phv00172176.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:33:14+00:00 2018-02-28 12:33:14+00:00 HDL HDL cholesterol (sample type: plasma) +2 HDL in blood 227059 phv00227059.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:33:48+00:00 2018-02-28 12:33:48+00:00 HDL HDL cholesterol (sample type: EDTA plasma) +2 HDL in blood 255345 phv00255345.v1.p10 pht005143.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:34:20+00:00 2018-02-28 12:34:20+00:00 HDL HDL Cholesterol (sample type: plasma) +2 HDL in blood 275405 phv00275405.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:34:55+00:00 2018-02-28 12:34:55+00:00 HDL HDL cholesterol (sample type: EDTA plasma) Collection Interval: Exam 2 +2 HDL in blood 275414 phv00275414.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:35:12+00:00 2018-02-28 12:35:12+00:00 HDL_CHOL HDL cholesterol (sample type: plasma) Collection Interval: Omni 1 Exam 3 +2 HDL in blood 277040 phv00277040.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:35:39+00:00 2018-02-28 12:35:39+00:00 HDL1 HDL cholesterol, Exam 1 +2 HDL in blood 277041 phv00277041.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:35:51+00:00 2018-02-28 12:35:51+00:00 HDL2 HDL cholesterol, Exam 2 +2 HDL in blood 277162 phv00277162.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:36:43+00:00 2018-02-28 12:36:43+00:00 HDL1 HDL cholesterol, Exam 1 +2 HDL in blood 277163 phv00277163.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:36:51+00:00 2018-02-28 12:36:51+00:00 HDL2 HDL cholesterol, Exam 2 +2 HDL in blood 277164 phv00277164.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:36:59+00:00 2018-02-28 12:36:59+00:00 HDL3 HDL cholesterol, Exam 3 +2 HDL in blood 277165 phv00277165.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:37:09+00:00 2018-02-28 12:37:09+00:00 HDL4 HDL cholesterol, Exam 4 +2 HDL in blood 277166 phv00277166.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:37:18+00:00 2018-02-28 12:37:18+00:00 HDL5 HDL cholesterol, Exam 5 +2 HDL in blood 277167 phv00277167.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:37:27+00:00 2018-02-28 12:37:27+00:00 HDL6 HDL cholesterol, Exam 6 +2 HDL in blood 277168 phv00277168.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:37:36+00:00 2018-02-28 12:37:36+00:00 HDL7 HDL cholesterol, Exam 7 +2 HDL in blood 277169 phv00277169.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:37:46+00:00 2018-02-28 12:37:46+00:00 HDL8 HDL cholesterol, Exam 8 +2 HDL in blood 277170 phv00277170.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:37:56+00:00 2018-02-28 12:37:56+00:00 HDL9 HDL cholesterol, Exam 9 +2 HDL in blood 7537 phv00007537.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:43:49+00:00 2018-02-28 12:43:49+00:00 A10 HDL CHOLESTROL +2 HDL in blood 227018 phv00227018.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-28 12:47:32+00:00 2018-02-28 12:47:32+00:00 HDL HDL cholesterol (Sample type - EDTA plasma) Collection Interval: Exam 1 +2 HDL in blood 253239 phv00253239.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:02:01+00:00 2018-03-14 22:02:01+00:00 LABA68 HDL-cholesterol (mg/dL) (LABA68) +2 HDL in blood 204765 phv00204765.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:53:44+00:00 2018-03-15 13:53:44+00:00 HDLSIU02 Recalibrated HDL cholesterol in SI units [Cohort, Exam 1] +2 HDL in blood 204645 phv00204645.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:54:11+00:00 2018-03-15 13:54:11+00:00 HDLSIU21 Visit 2, HDL cholesterol in mmol/L [Cohort, Exam 2] +2 HDL in blood 204867 phv00204867.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:55:59+00:00 2018-03-15 13:55:59+00:00 HDLSIU31 Re-calibrated HDL cholesterol in mmol/L [Cohort, Exam 3] +2 HDL in blood 204966 phv00204966.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 13:57:54+00:00 2018-03-15 13:57:54+00:00 HDLSIU41 Re-calibrated HDL cholesterol in mmol/L [Cohort, Exam 4] +2 HDL in blood 214065 phv00214065.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:41:34+00:00 2018-03-15 17:41:34+00:00 HDL HDL cholesterol (mg/dl) +2 HDL in blood 207651 phv00207651.v1.p1 pht004122.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:56:58+00:00 2018-03-15 17:56:58+00:00 LIPB03A HDL cholesterol (value). Q3a [Lipid Lab, exam 2] +2 HDL in blood 207662 phv00207662.v1.p1 pht004123.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 18:00:32+00:00 2018-03-15 18:00:32+00:00 LIPC3A HDL cholesterol (value in mg/dL) Q3a [Lipid Lab, exam 3] +2 HDL in blood 207677 phv00207677.v1.p1 pht004124.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 18:01:17+00:00 2018-03-15 18:01:17+00:00 LIPD3A HDL cholesterol (value). Q3a [Lipid Lab, exam 4] +2 HDL in blood 113702 phv00113702.v2.p2 pht001588.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:48:32+00:00 2018-04-17 14:48:32+00:00 AL1HDL TOTAL HDL CHOLESTEROL (MG/DL) +2 HDL in blood 115100 phv00115100.v2.p2 pht001644.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:48:32+00:00 2018-04-17 14:48:32+00:00 BL1HDL BL1HDL +2 HDL in blood 116371 phv00116371.v2.p2 pht001695.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:48:32+00:00 2018-04-17 14:48:32+00:00 CL1HDL TOTAL HDL CHOLESTEROL (MG/DL) +2 HDL in blood 117572 phv00117572.v2.p2 pht001742.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:48:32+00:00 2018-04-17 14:48:32+00:00 DL1HDL TOTAL HDL CHOLESTEROL (MG/DL) +2 HDL in blood 119613 phv00119613.v2.p2 pht001802.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:48:33+00:00 2018-04-17 14:48:33+00:00 EL1HDL TOTAL HDL CHOLESTEROL (mg/dL) +2 HDL in blood 120670 phv00120670.v2.p2 pht001848.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:48:33+00:00 2018-04-17 14:48:33+00:00 FL1HDL TOTAL HDL CHOLESTEROL (mg/dL) +2 HDL in blood 160497 phv00160497.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:38:28+00:00 2018-04-26 02:38:28+00:00 hdlp31c HDL PARTICLES (TOTAL) (umol/L) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS +2 HDL in blood 160506 phv00160506.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:38:35+00:00 2018-04-26 02:38:35+00:00 nhdlc31c CALCULATED HDL CHOLESTEROL (mg/dL) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS +2 HDL in blood 85920 phv00085920.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:38:42+00:00 2018-04-26 02:38:42+00:00 hdl2 HDL CHOLESTEROL (mg/dl) +2 HDL in blood 86402 phv00086402.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:38:49+00:00 2018-04-26 02:38:49+00:00 hdl3 HDL CHOLESTEROL (mg/dl) +2 HDL in blood 86833 phv00086833.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:38:55+00:00 2018-04-26 02:38:55+00:00 hdl4 HDL CHOLESTEROL (mg/dl) +2 HDL in blood 175239 phv00175239.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:39:12+00:00 2018-04-26 02:39:12+00:00 hdl5 HDL CHOLESTROL (mg/dl) +2 HDL in blood 176662 phv00176662.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:39:18+00:00 2018-04-26 02:39:18+00:00 hdl5 HDL CHOLESTROL (mg/dl) +2 HDL in blood 100042 phv00100042.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:00:14+00:00 2018-05-03 18:00:14+00:00 HDL44 HDL (mg/dl) +2 HDL in blood 105865 phv00105865.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:00:37+00:00 2018-05-03 18:00:37+00:00 HDL44 HDL (mg/dl) +2 HDL in blood 106991 phv00106991.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:00:55+00:00 2018-05-03 18:00:55+00:00 HDL44 HDL (mg/dl) +2 HDL in blood 77388 phv00077388.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 16:21:09+00:00 2018-05-15 16:21:09+00:00 COREHDLC Core HDL Cholesterol (Mg/dl) +2 HDL in blood 308048 phv00308048.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:13:09+00:00 2018-08-02 19:13:09+00:00 SHDL Serum High-Density Lipoprotein result value Collection Interval: 2000-2004 +2 HDL in blood 307766 phv00307766.v1.p1 pht006650.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:13:17+00:00 2018-08-02 19:13:17+00:00 HDL HDL Cholesterol Collection Interval: 2006-2011 +2 HDL in blood 277855 phv00277855.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:13:25+00:00 2018-08-02 19:13:25+00:00 SHDL Serum High-Density Lipoprotein result value Collection Interval: 2000-2004 +2 HDL in blood 277407 phv00277407.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:13:33+00:00 2018-08-02 19:13:33+00:00 SHDLV Serum High-Density Lipoprotein Average result value Collection Interval: 2009-2011 +2 HDL in blood 277306 phv00277306.v1.p1 pht006031.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:13:43+00:00 2018-08-02 19:13:43+00:00 HDL HDL Cholesterol Collection Interval: 2007-2009 +2 HDL in blood 122566 phv00122566.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:42:41+00:00 2018-08-14 20:42:41+00:00 CHOLHDL HDL levels +2 HDL in blood 123969 phv00123969.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:42:53+00:00 2018-08-14 20:42:53+00:00 hdl_orig Hdl - original value +2 HDL in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:56:35+00:00 2018-08-23 17:56:35+00:00 TESTABBR Test abbreviation +2 HDL in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:56:35+00:00 2018-08-23 17:56:35+00:00 TESTDESC Test Description +2 HDL in blood 259055 phv00259055.v1.p1 pht003918.v2.p1 phs000741.v2.p1 GOLDN 741 2 2018-09-06 12:19:34+00:00 2018-09-06 12:19:34+00:00 HDL High Density Lipoprotein +2 HDL in blood 258744 phv00258744.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:53:57+00:00 2018-09-06 12:53:57+00:00 HDL_mmol HDL-C from venous blood sample (mmol) +3 Triglycerides in blood 87101 phv00087101.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:11:59+00:00 2017-12-20 22:13:35+00:00 trigf TRIGLYCERIDES (mg/dl) +3 Triglycerides in blood 82950 phv00082950.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:12:46+00:00 2017-12-20 22:12:46+00:00 trig1 TRIGLYCERIDES (mg/dl) +3 Triglycerides in blood 84968 phv00084968.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:13:06+00:00 2017-12-20 22:13:06+00:00 trig1 TRIGLYCERIDES (mg/dl) +3 Triglycerides in blood 125933 phv00125933.v1.p1 pht001945.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:29:07+00:00 2017-12-22 18:29:07+00:00 TRR Trr: triglyceride - mg/dL +3 Triglycerides in blood 277574 phv00277574.v1.p1 pht006041.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2017-12-22 18:35:25+00:00 2017-12-22 18:35:25+00:00 TRIG Triglyceride result value Collection Interval: 1996-2000 +3 Triglycerides in blood 126043 phv00126043.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:38:23+00:00 2017-12-22 18:38:23+00:00 TRG01SI Triglycerides (mmol/L) +3 Triglycerides in blood 126048 phv00126048.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:38:23+00:00 2017-12-22 18:38:23+00:00 TRG01F Fasting triglyceride level (mg/dl) +3 Triglycerides in blood 253019 phv00253019.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2017-12-22 18:38:23+00:00 2017-12-22 18:38:23+00:00 trigs_baseline Triglycerides value at baseline visit +3 Triglycerides in blood 307855 phv00307855.v1.p1 pht006655.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2017-12-22 18:38:23+00:00 2017-12-22 18:38:23+00:00 TRIG Triglyceride result value Collection Interval: 1996-2000 +3 Triglycerides in blood 204738 phv00204738.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2017-12-22 22:48:33+00:00 2017-12-22 22:48:33+00:00 TRGSIU01 Total triglycerides In SI units [Cohort, Exam 1] +3 Triglycerides in blood 100425 phv00100425.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2017-12-22 22:55:37+00:00 2017-12-22 22:55:37+00:00 TRIG44 TRIGLYCERIDE (mg/dl) +3 Triglycerides in blood 123974 phv00123974.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-22 23:01:08+00:00 2017-12-22 23:01:08+00:00 triglyceride Triglyceride (mg/dL) +3 Triglycerides in blood 258736 phv00258736.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2017-12-22 23:03:39+00:00 2017-12-22 23:03:39+00:00 NetTG Net Triglycerides from venous blood sample (mg/dL) +3 Triglycerides in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-01-12 23:42:46+00:00 2018-01-12 23:42:46+00:00 TESTVAL Test Result Value +3 Triglycerides in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-01-12 23:44:24+00:00 2018-01-12 23:44:24+00:00 TESTNAME Test Name +3 Triglycerides in blood 253240 phv00253240.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:01:39+00:00 2018-03-14 22:01:39+00:00 LABA67 Triglycerides (mg/dL) (LABA67) +3 Triglycerides in blood 207636 phv00207636.v1.p1 pht004121.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:11:01+00:00 2018-03-15 14:11:01+00:00 LIPA02 Total Triglycerides (mg/dL) [Lipid Lab, exam 1] +3 Triglycerides in blood 204651 phv00204651.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:27:45+00:00 2018-03-15 17:27:45+00:00 TRGSIU21 Visit 2, total triglycerides in Mmol/L [Cohort, Exam 2] +3 Triglycerides in blood 204877 phv00204877.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:28:20+00:00 2018-03-15 17:28:20+00:00 TRGSIU31 Triglycerides in SI units [Cohort, Exam 3] +3 Triglycerides in blood 204968 phv00204968.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:28:41+00:00 2018-03-15 17:28:41+00:00 TRGSIU41 Visit 4, triglycerides in SI units [Cohort, Exam 4] +3 Triglycerides in blood 207649 phv00207649.v1.p1 pht004122.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:29:18+00:00 2018-03-15 17:29:18+00:00 LIPB02A Triglyceride (value). Q2a [Lipid Lab, exam 2] +3 Triglycerides in blood 207661 phv00207661.v1.p1 pht004123.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:32:24+00:00 2018-03-15 17:32:24+00:00 LIPC2A Triglyceride (value in mg/dL). Q2a [Lipid Lab, exam 3] +3 Triglycerides in blood 207676 phv00207676.v1.p1 pht004124.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:35:33+00:00 2018-03-15 17:35:33+00:00 LIPD2A Triglyceride (value). Q2a [Lipid Lab, exam 4] +3 Triglycerides in blood 214066 phv00214066.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:38:32+00:00 2018-03-15 17:38:32+00:00 TRIG Triglycerides mg/dl +3 Triglycerides in blood 113701 phv00113701.v2.p2 pht001588.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:49:33+00:00 2018-04-17 14:49:33+00:00 AL1NTRIG TRIGLYCERIDES (MG/DL) +3 Triglycerides in blood 115099 phv00115099.v2.p2 pht001644.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:49:33+00:00 2018-04-17 14:49:33+00:00 BL1NTRIG BL1NTRIG +3 Triglycerides in blood 116373 phv00116373.v2.p2 pht001695.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:49:33+00:00 2018-04-17 14:49:33+00:00 CL1NTRIG TRIGLYCERIDES (MG/DL) +3 Triglycerides in blood 117574 phv00117574.v2.p2 pht001742.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:49:33+00:00 2018-04-17 14:49:33+00:00 DL1NTRIG TRIGLYCERIDES (MG/DL) +3 Triglycerides in blood 119614 phv00119614.v2.p2 pht001802.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:49:33+00:00 2018-04-17 14:49:33+00:00 EL1NTRIG TRIGLYCERIDES (mg/dL) +3 Triglycerides in blood 120668 phv00120668.v2.p2 pht001848.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:49:33+00:00 2018-04-17 14:49:33+00:00 FL1NTRIG TRIGLYCERIDES (mg/dL) +3 Triglycerides in blood 85918 phv00085918.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:41:32+00:00 2018-04-26 02:41:32+00:00 trig2 TRIGLYCERIDES (mg/dl) +3 Triglycerides in blood 86400 phv00086400.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:41:38+00:00 2018-04-26 02:41:38+00:00 trig3 TRIGLYCERIDES (mg/dl) +3 Triglycerides in blood 86831 phv00086831.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:41:44+00:00 2018-04-26 02:41:44+00:00 trig4 TRIGLYCERIDES (mg/dl) +3 Triglycerides in blood 175237 phv00175237.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:41:52+00:00 2018-04-26 02:41:52+00:00 trig5 TRIGLYCERIDES (mg/dl) +3 Triglycerides in blood 176660 phv00176660.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:41:58+00:00 2018-04-26 02:41:58+00:00 trig5 TRIGLYCERIDES (mg/dl) +3 Triglycerides in blood 160504 phv00160504.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:42:53+00:00 2018-04-26 02:42:53+00:00 ntrg31c CALCULATED TOTAL TRIGLYCERIDES (mg/dL) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS +3 Triglycerides in blood 55264 phv00055264.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:35:11+00:00 2018-04-26 17:35:11+00:00 Trig Triglycerides mg/dl +3 Triglycerides in blood 71892 phv00071892.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:35:40+00:00 2018-04-26 17:35:40+00:00 TRIG Triglycerides, plasma +3 Triglycerides in blood 172172 phv00172172.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:36:10+00:00 2018-04-26 17:36:10+00:00 TRIG Triglycerides (sample type: plasma) +3 Triglycerides in blood 227015 phv00227015.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:36:37+00:00 2018-04-26 17:36:37+00:00 TRIG Triglycerides (Sample type - EDTA plasma) Collection Interval: Exam 1 +3 Triglycerides in blood 227056 phv00227056.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:36:57+00:00 2018-04-26 17:36:57+00:00 TRIG Triglycerides (sample type: EDTA plasma) +3 Triglycerides in blood 255342 phv00255342.v1.p10 pht005143.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:37:24+00:00 2018-04-26 17:37:24+00:00 TRIG Triglycerides (sample type: plasma) +3 Triglycerides in blood 275403 phv00275403.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:37:45+00:00 2018-04-26 17:37:45+00:00 TRIG Triglyceride (sample type: EDTA plasma) Collection Interval: Exam 2 +3 Triglycerides in blood 275415 phv00275415.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:38:06+00:00 2018-04-26 17:38:06+00:00 TRIG Triglycerides (sample type: plasma) Collection Interval: Omni 1 Exam 3 +3 Triglycerides in blood 931 phv00000931.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:39:37+00:00 2018-04-26 17:39:37+00:00 MF489 BLOOD ANALYSIS: TRIGLYCERIDES, WHOLE SERUM, EXAM 7 +3 Triglycerides in blood 1052 phv00001052.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:42:44+00:00 2018-04-26 17:42:44+00:00 FA18 BLOOD ANALYSIS: TRIGLYCERIDES, CENTRIFUGED (MG PER 100 ML) +3 Triglycerides in blood 1053 phv00001053.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:43:02+00:00 2018-04-26 17:43:02+00:00 FA19 BLOOD ANALYSIS: TRIGLYCERIDES, CENTRIFUGED (MG PER 100 ML) +3 Triglycerides in blood 1054 phv00001054.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:43:40+00:00 2018-04-26 17:43:40+00:00 FA20 BLOOD ANALYSIS: TRIGLYCERIDES, WHOLE SERUM +3 Triglycerides in blood 1209 phv00001209.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:44:06+00:00 2018-04-26 17:44:06+00:00 FB32 BLOOD ANALYSIS: TRIGLYCERIDE, WHOLE SERUM +3 Triglycerides in blood 1390 phv00001390.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:44:29+00:00 2018-04-26 17:44:29+00:00 FC32 BLOOD ANALYSIS: TRIGLYCERIDE (EQ/HL) +3 Triglycerides in blood 1402 phv00001402.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:45:05+00:00 2018-04-26 17:45:05+00:00 FC46 BLOOD ANALYSIS: FASTING: TRIGLYCERIDE +3 Triglycerides in blood 1593 phv00001593.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:45:23+00:00 2018-04-26 17:45:23+00:00 FD48 BLOOD ANALYSIS, FASTING: TRIGLYCERIDE +3 Triglycerides in blood 1594 phv00001594.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:45:49+00:00 2018-04-26 17:45:49+00:00 FD49 BLOOD ANALYSIS: FASTING LIPIDS, TRIGLYCERIDE +3 Triglycerides in blood 6321 phv00006321.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:46:12+00:00 2018-04-26 17:46:12+00:00 FQ398 TRIGLYCERIDE +3 Triglycerides in blood 6661 phv00006661.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:46:42+00:00 2018-04-26 17:46:42+00:00 FR439 BLOOD ANALYSIS - TRIGYCERLIDE +3 Triglycerides in blood 6669 phv00006669.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:47:22+00:00 2018-04-26 17:47:22+00:00 FS536 TRIGLYCERIDES MG/100ML +3 Triglycerides in blood 7530 phv00007530.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:47:43+00:00 2018-04-26 17:47:43+00:00 FT546 TRIGLYCERIDES MG/100ML +3 Triglycerides in blood 7540 phv00007540.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:48:05+00:00 2018-04-26 17:48:05+00:00 A13 TRIGLYCERIDES +3 Triglycerides in blood 7976 phv00007976.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:48:48+00:00 2018-04-26 17:48:48+00:00 B358 BLOOD ANALYSIS-FASTING LIPIDS TRIGLYCERIDE +3 Triglycerides in blood 8105 phv00008105.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:49:36+00:00 2018-04-26 17:49:36+00:00 B758 TRIGLYCERIDES +3 Triglycerides in blood 8730 phv00008730.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:50:13+00:00 2018-04-26 17:50:13+00:00 C433 TRIGLYCERIDE +3 Triglycerides in blood 9124 phv00009124.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:51:35+00:00 2018-04-26 17:51:35+00:00 D451 TRIGLYCERIDE +3 Triglycerides in blood 9576 phv00009576.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:52:53+00:00 2018-04-26 17:52:53+00:00 E670 BLOOD ANALYSIS - TRIGLYCERIDES +3 Triglycerides in blood 10136 phv00010136.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:53:24+00:00 2018-04-26 17:53:24+00:00 F727 BLOOD ANALYSIS - TRIGLYCERIDES +3 Triglycerides in blood 10144 phv00010144.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:54:03+00:00 2018-04-26 17:54:03+00:00 G706 TRIGLYCERIDES MG/100ML +3 Triglycerides in blood 21393 phv00021393.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 17:54:58+00:00 2018-04-26 17:54:58+00:00 G3A714 TRIGLYCERIDES, MG/DL +3 Triglycerides in blood 70733 phv00070733.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:14:53+00:00 2018-04-26 18:14:53+00:00 FU576 LAB VALUES: TRIGLYCERIDES, MG/DL +3 Triglycerides in blood 81038 phv00081038.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:15:19+00:00 2018-04-26 18:15:19+00:00 TG Plasma Total Triglycerides Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +3 Triglycerides in blood 277049 phv00277049.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:16:05+00:00 2018-04-26 18:16:05+00:00 TRIG1 Triglycerides, Exam 1 +3 Triglycerides in blood 277050 phv00277050.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:16:20+00:00 2018-04-26 18:16:20+00:00 TRIG2 Triglycerides, Exam 2 +3 Triglycerides in blood 277203 phv00277203.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:16:44+00:00 2018-04-26 18:16:44+00:00 TRIG1 Triglycerides, Exam 1 +3 Triglycerides in blood 277204 phv00277204.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:17:35+00:00 2018-04-26 18:17:35+00:00 TRIG2 Triglycerides, Exam 2 +3 Triglycerides in blood 277205 phv00277205.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:18:02+00:00 2018-04-26 18:18:02+00:00 TRIG3 Triglycerides, Exam 3 +3 Triglycerides in blood 277206 phv00277206.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:18:51+00:00 2018-04-26 18:18:51+00:00 TRIG4 Triglycerides, Exam 4 +3 Triglycerides in blood 277207 phv00277207.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:19:35+00:00 2018-04-26 18:19:35+00:00 TRIG5 Triglycerides, Exam 5 +3 Triglycerides in blood 277208 phv00277208.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:20:14+00:00 2018-04-26 18:20:14+00:00 TRIG6 Triglycerides, Exam 6 +3 Triglycerides in blood 277209 phv00277209.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:20:31+00:00 2018-04-26 18:20:31+00:00 TRIG7 Triglycerides, Exam 7 +3 Triglycerides in blood 277210 phv00277210.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:21:04+00:00 2018-04-26 18:21:04+00:00 TRIG8 Triglycerides, Exam 8 +3 Triglycerides in blood 277211 phv00277211.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-04-26 18:21:20+00:00 2018-04-26 18:21:20+00:00 TRIG9 Triglycerides, Exam 9 +3 Triglycerides in blood 100041 phv00100041.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:01:36+00:00 2018-05-03 18:01:36+00:00 TRIG44 TRIGLYCERIDE (mg/dl) +3 Triglycerides in blood 105864 phv00105864.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:02:02+00:00 2018-05-03 18:02:02+00:00 TRIG44 TRIGLYCERIDE (mg/dl) +3 Triglycerides in blood 106990 phv00106990.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:02:15+00:00 2018-05-03 18:02:15+00:00 TRIG44 TRIGLYCERIDE (mg/dl) +3 Triglycerides in blood 77397 phv00077397.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-07 23:10:22+00:00 2018-05-07 23:10:22+00:00 CORETRI Core Triglyceride (Mg/dl) +3 Triglycerides in blood 307767 phv00307767.v1.p1 pht006650.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:16:06+00:00 2018-08-02 19:16:06+00:00 TRIG Triglyceride Collection Interval: 2006-2011 +3 Triglycerides in blood 277307 phv00277307.v1.p1 pht006031.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:16:14+00:00 2018-08-02 19:16:14+00:00 TRIG Triglyceride Collection Interval: 2007-2009 +3 Triglycerides in blood 123975 phv00123975.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:42:08+00:00 2018-08-14 20:42:08+00:00 triglyceride_orig Triglyceride - original value +3 Triglycerides in blood 277405 phv00277405.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:20:31+00:00 2018-08-14 22:20:31+00:00 STRV Serum Triglycerides Average result value Collection Interval: 2009-2011 +3 Triglycerides in blood 277850 phv00277850.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:10:10+00:00 2018-08-14 23:10:10+00:00 STRV Serum Triglycerides Average result value Collection Interval: 2000-2004 +3 Triglycerides in blood 308043 phv00308043.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:11:38+00:00 2018-08-16 00:11:38+00:00 STRV Serum Triglycerides Average result value Collection Interval: 2000-2004 +3 Triglycerides in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:08:58+00:00 2018-08-23 18:08:58+00:00 TESTABBR Test abbreviation +3 Triglycerides in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:08:58+00:00 2018-08-23 18:08:58+00:00 TESTDESC Test Description +3 Triglycerides in blood 259054 phv00259054.v1.p1 pht003918.v2.p1 phs000741.v2.p1 GOLDN 741 2 2018-09-06 12:18:38+00:00 2018-09-06 12:18:38+00:00 TG Fasting Triglyceride level +3 Triglycerides in blood 258737 phv00258737.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:52:20+00:00 2018-09-06 12:52:20+00:00 Triglycerides_mmol Net Triglycerides from venous blood sample (mmol) +4 Total cholesterol in blood 84974 phv00084974.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:17:41+00:00 2017-12-20 22:17:41+00:00 chol1 TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 82956 phv00082956.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:18:13+00:00 2017-12-20 22:18:13+00:00 chol1 TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 87100 phv00087100.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2017-12-20 22:18:51+00:00 2017-12-20 22:18:51+00:00 cholf TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 126040 phv00126040.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:40:52+00:00 2017-12-22 18:40:52+00:00 TCL01SI Total cholesterol (mmol/L) +4 Total cholesterol in blood 126045 phv00126045.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:40:52+00:00 2017-12-22 18:40:52+00:00 TCL01F Fasting total cholesterol (mg/dl) (TCL) +4 Total cholesterol in blood 125927 phv00125927.v1.p1 pht001945.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2017-12-22 18:40:52+00:00 2017-12-22 18:40:52+00:00 CHR Chr: total cholesterol - mg/dL +4 Total cholesterol in blood 253020 phv00253020.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2017-12-22 18:40:52+00:00 2017-12-22 18:40:52+00:00 totchol_baseline Total cholesterol value at baseline visit +4 Total cholesterol in blood 277573 phv00277573.v1.p1 pht006041.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2017-12-22 18:40:52+00:00 2017-12-22 18:40:52+00:00 CHOL Cholesterol result value Collection Interval: 1996-2000 +4 Total cholesterol in blood 307854 phv00307854.v1.p1 pht006655.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2017-12-22 18:40:52+00:00 2017-12-22 18:40:52+00:00 CHOL Cholesterol result value Collection Interval: 1996-2000 +4 Total cholesterol in blood 204735 phv00204735.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2017-12-22 22:50:20+00:00 2017-12-22 22:50:20+00:00 TCHSIU01 Total cholesterol in SI units [Cohort, Exam 1] +4 Total cholesterol in blood 100491 phv00100491.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2017-12-22 22:56:24+00:00 2017-12-22 22:56:24+00:00 CHOLADJ Adjusted Cholesterol (mg/dl) +4 Total cholesterol in blood 123953 phv00123953.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-22 23:01:37+00:00 2017-12-22 23:01:37+00:00 cholesterol Cholesterol (mg/dL) +4 Total cholesterol in blood 258733 phv00258733.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2017-12-22 23:04:38+00:00 2017-12-22 23:04:38+00:00 Cholesterol Cholesterol from venous blood sample (mg/dL) +4 Total cholesterol in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-01-12 23:42:55+00:00 2018-01-12 23:42:55+00:00 TESTVAL Test Result Value +4 Total cholesterol in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-01-12 23:44:33+00:00 2018-01-12 23:44:33+00:00 TESTNAME Test Name +4 Total cholesterol in blood 253238 phv00253238.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:01:50+00:00 2018-03-14 22:01:50+00:00 LABA66 Total cholesterol (mg/dL) (LABA66) +4 Total cholesterol in blood 207635 phv00207635.v1.p1 pht004121.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:10:35+00:00 2018-03-15 14:10:35+00:00 LIPA01 Total cholesterol (mg/dL) [Lipid Lab, exam 1] +4 Total cholesterol in blood 204644 phv00204644.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:21:57+00:00 2018-03-15 17:21:57+00:00 TCHSIU21 Visit 2, total cholesterol in Mmol/L [Cohort, Exam 2] +4 Total cholesterol in blood 204875 phv00204875.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:24:36+00:00 2018-03-15 17:24:36+00:00 TCHSIU31 Total cholesterol in SI units [Cohort, Exam 3] +4 Total cholesterol in blood 204965 phv00204965.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:24:59+00:00 2018-03-15 17:24:59+00:00 TCHSIU41 Visit 4, total cholesterol in SI units [Cohort, Exam 4] +4 Total cholesterol in blood 214064 phv00214064.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:41:13+00:00 2018-03-15 17:41:13+00:00 CHOL Cholesterol mg/dl +4 Total cholesterol in blood 207660 phv00207660.v1.p1 pht004123.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 17:58:44+00:00 2018-03-15 17:58:44+00:00 LIPC1A Cholesterol (value in mg/dL). Q1a [Lipid Lab, exam 3] +4 Total cholesterol in blood 207675 phv00207675.v1.p1 pht004124.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 18:07:16+00:00 2018-03-15 18:07:16+00:00 LIPD1A Cholesterol (value). Q1a [Lipid Lab, exam 4] +4 Total cholesterol in blood 207647 phv00207647.v1.p1 pht004122.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 18:08:35+00:00 2018-03-15 18:08:35+00:00 LIPB01A Cholesterol (value). Q1a [Lipid Lab, exam 2] +4 Total cholesterol in blood 113700 phv00113700.v2.p2 pht001588.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:50:30+00:00 2018-04-17 14:50:30+00:00 AL1CHOL TOTAL CHOLESTEROL (MG/DL) +4 Total cholesterol in blood 115098 phv00115098.v2.p2 pht001644.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:50:30+00:00 2018-04-17 14:50:30+00:00 BL1CHOL BL1CHOL +4 Total cholesterol in blood 116369 phv00116369.v2.p2 pht001695.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:50:30+00:00 2018-04-17 14:50:30+00:00 CL1CHOL TOTAL CHOLESTEROL (MG/DL) +4 Total cholesterol in blood 117570 phv00117570.v2.p2 pht001742.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:50:30+00:00 2018-04-17 14:50:30+00:00 DL1CHOL TOTAL PLASMA CHOLESTEROL (MG/DL) +4 Total cholesterol in blood 119612 phv00119612.v2.p2 pht001802.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:50:30+00:00 2018-04-17 14:50:30+00:00 EL1CHOL TOTAL PLASMA CHOLESTEROL (mg/dL) +4 Total cholesterol in blood 120669 phv00120669.v2.p2 pht001848.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:50:30+00:00 2018-04-17 14:50:30+00:00 FL1CHOL TOTAL PLASMA CHOLESTEROL (mg/dL) +4 Total cholesterol in blood 85921 phv00085921.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:44:46+00:00 2018-04-26 02:44:46+00:00 chol2 TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 86404 phv00086404.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:45:00+00:00 2018-04-26 02:45:00+00:00 chol3 TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 86836 phv00086836.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:45:07+00:00 2018-04-26 02:45:07+00:00 chol4 TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 175242 phv00175242.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:45:16+00:00 2018-04-26 02:45:16+00:00 chol5 TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 175867 phv00175867.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:45:22+00:00 2018-04-26 02:45:22+00:00 chol1 TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 175951 phv00175951.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:45:28+00:00 2018-04-26 02:45:28+00:00 cholf FAMILY COHORT: TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 176665 phv00176665.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 02:45:36+00:00 2018-04-26 02:45:36+00:00 chol5 TOTAL CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 100040 phv00100040.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:07:28+00:00 2018-05-03 18:07:28+00:00 CHOLUNAD UNADJUSTED CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 100083 phv00100083.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:07:43+00:00 2018-05-03 18:07:43+00:00 CHOLADJ Adjusted Cholesterol (mg/dl) +4 Total cholesterol in blood 101790 phv00101790.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:08:15+00:00 2018-05-03 18:08:15+00:00 CHOL44 CHOLESTEROL +4 Total cholesterol in blood 102573 phv00102573.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:08:24+00:00 2018-05-03 18:08:24+00:00 CHOL44 CHOLESTEROL +4 Total cholesterol in blood 106389 phv00106389.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:08:44+00:00 2018-05-03 18:08:44+00:00 CHOLADJ Adjusted Cholesterol +4 Total cholesterol in blood 106414 phv00106414.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:09:02+00:00 2018-05-03 18:09:02+00:00 CHOLUNAD UNADJUSTED CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 106989 phv00106989.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:09:22+00:00 2018-05-03 18:09:22+00:00 CHOL44 CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 107325 phv00107325.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:09:59+00:00 2018-05-03 18:09:59+00:00 CHOLADJ Adjusted Cholesterol (mg/dl) +4 Total cholesterol in blood 108160 phv00108160.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:10:11+00:00 2018-05-03 18:10:11+00:00 CHOL44 CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 108574 phv00108574.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:10:23+00:00 2018-05-03 18:10:23+00:00 CHOL44 CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 109342 phv00109342.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:10:36+00:00 2018-05-03 18:10:36+00:00 CHOL44 CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 110484 phv00110484.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:10:58+00:00 2018-05-03 18:10:58+00:00 CHOL44 CHOLESTEROL (mg/dl) +4 Total cholesterol in blood 110489 phv00110489.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:11:07+00:00 2018-05-03 18:11:07+00:00 CHOLADJ CHOL44 ADJUSTED FOR DRIFT (mg/dl) +4 Total cholesterol in blood 7536 phv00007536.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:08:57+00:00 2018-05-09 12:08:57+00:00 A9 TOTAL CHOLESTEROL +4 Total cholesterol in blood 7970 phv00007970.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:09:20+00:00 2018-05-09 12:09:20+00:00 B352 BLOOD ANALYSIS-FASTING LIPIDS TOTAL CHOLESTEROL +4 Total cholesterol in blood 8087 phv00008087.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:09:49+00:00 2018-05-09 12:09:49+00:00 B740 CHOLESTEROL +4 Total cholesterol in blood 8726 phv00008726.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:10:53+00:00 2018-05-09 12:10:53+00:00 C429 TOTAL CHOLESTEROL +4 Total cholesterol in blood 55262 phv00055262.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:11:33+00:00 2018-05-09 12:11:33+00:00 Chol Cholesterol mg/dl +4 Total cholesterol in blood 172171 phv00172171.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:11:59+00:00 2018-05-09 12:11:59+00:00 CHOL Cholesterol (sample type: plasma) +4 Total cholesterol in blood 227014 phv00227014.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:13:08+00:00 2018-05-09 12:13:08+00:00 CHOL Total cholesterol (Sample type - EDTA plasma) Collection Interval: Exam 1 +4 Total cholesterol in blood 227055 phv00227055.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:14:16+00:00 2018-05-09 12:14:16+00:00 CHOL Cholesterol (sample type: EDTA plasma) +4 Total cholesterol in blood 255341 phv00255341.v1.p10 pht005143.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:14:46+00:00 2018-05-09 12:14:46+00:00 CHOL Total Cholesterol (sample type: plasma) +4 Total cholesterol in blood 275402 phv00275402.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:15:15+00:00 2018-05-09 12:15:15+00:00 CHOL Total Cholesterol (sample type: EDTA plasma) Collection Interval: Exam 2 +4 Total cholesterol in blood 9121 phv00009121.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:15:56+00:00 2018-05-09 12:15:56+00:00 D448 TOTAL CHOLESTEROL +4 Total cholesterol in blood 9573 phv00009573.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:16:32+00:00 2018-05-09 12:16:32+00:00 E667 BLOOD ANALYSIS - TOTAL CHOLESTEROL +4 Total cholesterol in blood 10135 phv00010135.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:17:06+00:00 2018-05-09 12:17:06+00:00 F726 BLOOD ANALYSIS - TOTAL CHOLESTEROL +4 Total cholesterol in blood 1050 phv00001050.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:17:24+00:00 2018-05-09 12:17:24+00:00 FA16 BLOOD ANALYSIS: CHOLESTEROL (MG PER 100 ML) +4 Total cholesterol in blood 1205 phv00001205.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:17:44+00:00 2018-05-09 12:17:44+00:00 FB28 BLOOD ANALYSIS: CHOLESTEROL, TOTAL +4 Total cholesterol in blood 1377 phv00001377.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:22:06+00:00 2018-05-09 12:22:06+00:00 FC19 BLOOD ANALYSIS: SERUM CHOLESTEROL (MG/100 ML) +4 Total cholesterol in blood 1380 phv00001380.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:22:25+00:00 2018-05-09 12:22:25+00:00 FC22 BLOOD ANALYSIS: TOTAL CHOLESTEROL (MG/100 ML) +4 Total cholesterol in blood 1398 phv00001398.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:22:46+00:00 2018-05-09 12:22:46+00:00 FC42 BLOOD ANALYSIS, FASTING: TOTAL CHOLESTEROL (MG/100 ML) +4 Total cholesterol in blood 1581 phv00001581.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:23:06+00:00 2018-05-09 12:23:06+00:00 FD36 BLOOD ANALYSIS, FASTING: TOTAL CHOLESTEROL SERUM & PLASMA (SEE VARIABLE #40 FOR DECK 132 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) +4 Total cholesterol in blood 1586 phv00001586.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:23:48+00:00 2018-05-09 12:23:48+00:00 FD41 BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - TOTAL SERUM & PLASMA (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) +4 Total cholesterol in blood 2033 phv00002033.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:20:47+00:00 2018-05-09 14:20:47+00:00 FF80 BLOOD ANALYSIS, CHOLESTEROL +4 Total cholesterol in blood 2417 phv00002417.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:21:08+00:00 2018-05-09 14:21:08+00:00 FG313 BLOOD ANALYSIS, CHOLESTEROL +4 Total cholesterol in blood 2655 phv00002655.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:21:51+00:00 2018-05-09 14:21:51+00:00 FH332 BLOOD ANALYSIS: CHOLESTEROL +4 Total cholesterol in blood 4518 phv00004518.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:22:18+00:00 2018-05-09 14:22:18+00:00 FM545 BLOOD ANALYSIS - TOTAL CHOLESTEROL +4 Total cholesterol in blood 5551 phv00005551.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:23:14+00:00 2018-05-09 14:23:14+00:00 FO731 BLOOD ANALYSIS - TOTAL CHOLESTEROL +4 Total cholesterol in blood 6027 phv00006027.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:23:58+00:00 2018-05-09 14:23:58+00:00 FP595 BLOOD ANALYSIS - TOTAL CHOLESTEROL +4 Total cholesterol in blood 6319 phv00006319.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:24:31+00:00 2018-05-09 14:24:31+00:00 FQ396 TOTAL CHOLESTEROL +4 Total cholesterol in blood 6659 phv00006659.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:25:04+00:00 2018-05-09 14:25:04+00:00 FR437 BLOOD ANALYSYS - TOTAL CHOLESTEROL +4 Total cholesterol in blood 6668 phv00006668.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:25:55+00:00 2018-05-09 14:25:55+00:00 FS535 TOTAL CHOLESTEROL MG/100ML +4 Total cholesterol in blood 7529 phv00007529.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:26:25+00:00 2018-05-09 14:26:25+00:00 FT545 TOTAL CHOLESTEROL MG/100ML +4 Total cholesterol in blood 70731 phv00070731.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:26:55+00:00 2018-05-09 14:26:55+00:00 FU575 LAB VALUES: TOTAL CHOLESTEROL, MG/DL +4 Total cholesterol in blood 21391 phv00021391.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:27:31+00:00 2018-05-09 14:27:31+00:00 G3A712 TOTAL CHOLESTEROL, MG/DL +4 Total cholesterol in blood 10142 phv00010142.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:27:52+00:00 2018-05-09 14:27:52+00:00 G704 TOTAL CHOLESTEROL MG/100ML +4 Total cholesterol in blood 626 phv00000626.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:28:44+00:00 2018-05-09 14:28:44+00:00 MF160 BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 2 +4 Total cholesterol in blood 647 phv00000647.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:29:01+00:00 2018-05-09 14:29:01+00:00 MF182 BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 3 +4 Total cholesterol in blood 672 phv00000672.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:29:19+00:00 2018-05-09 14:29:19+00:00 MF208 BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 4 +4 Total cholesterol in blood 763 phv00000763.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:29:36+00:00 2018-05-09 14:29:36+00:00 MF311 BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 5 +4 Total cholesterol in blood 846 phv00000846.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:29:57+00:00 2018-05-09 14:29:57+00:00 MF397 BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 6 +4 Total cholesterol in blood 927 phv00000927.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:30:39+00:00 2018-05-09 14:30:39+00:00 MF485 BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 7 +4 Total cholesterol in blood 1018 phv00001018.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:30:57+00:00 2018-05-09 14:30:57+00:00 MF581 BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 1 OR EXAM 2 +4 Total cholesterol in blood 534 phv00000534.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:31:22+00:00 2018-05-09 14:31:22+00:00 MF62 BLOOD ANALYSIS: SERUM CHOLESTEROL, EXAM 1 +4 Total cholesterol in blood 277047 phv00277047.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:32:01+00:00 2018-05-09 14:32:01+00:00 TC1 Total cholesterol, Exam 1 +4 Total cholesterol in blood 277194 phv00277194.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:32:12+00:00 2018-05-09 14:32:12+00:00 TC1 Total cholesterol, Exam 1 +4 Total cholesterol in blood 277048 phv00277048.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:32:23+00:00 2018-05-09 14:32:23+00:00 TC2 Total cholesterol, Exam 2 +4 Total cholesterol in blood 277195 phv00277195.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:32:34+00:00 2018-05-09 14:32:34+00:00 TC2 Total cholesterol, Exam 2 +4 Total cholesterol in blood 277196 phv00277196.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:32:46+00:00 2018-05-09 14:32:46+00:00 TC3 Total cholesterol, Exam 3 +4 Total cholesterol in blood 277197 phv00277197.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:32:57+00:00 2018-05-09 14:32:57+00:00 TC4 Total cholesterol, Exam 4 +4 Total cholesterol in blood 277198 phv00277198.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:33:09+00:00 2018-05-09 14:33:09+00:00 TC5 Total cholesterol, Exam 5 +4 Total cholesterol in blood 277199 phv00277199.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:33:20+00:00 2018-05-09 14:33:20+00:00 TC6 Total cholesterol, Exam 6 +4 Total cholesterol in blood 277200 phv00277200.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:33:31+00:00 2018-05-09 14:33:31+00:00 TC7 Total cholesterol, Exam 7 +4 Total cholesterol in blood 277201 phv00277201.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:33:42+00:00 2018-05-09 14:33:42+00:00 TC8 Total cholesterol, Exam 8 +4 Total cholesterol in blood 277202 phv00277202.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:33:53+00:00 2018-05-09 14:33:53+00:00 TC9 Total cholesterol, Exam 9 +4 Total cholesterol in blood 71890 phv00071890.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:34:08+00:00 2018-05-09 14:34:08+00:00 TOT_CHOL Total cholesterol, plasma +4 Total cholesterol in blood 275413 phv00275413.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 14:34:18+00:00 2018-05-09 14:34:18+00:00 TOT_CHOL Total cholesterol (sample type: plasma) Collection Interval: Omni 1 Exam 3 +4 Total cholesterol in blood 77396 phv00077396.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 16:37:59+00:00 2018-05-15 16:37:59+00:00 CORETCHO Core Total Cholesterol (Mg/dl) +4 Total cholesterol in blood 307765 phv00307765.v1.p1 pht006650.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:15:31+00:00 2018-08-02 19:15:31+00:00 CHOL Total Cholesterol Collection Interval: 2006-2011 +4 Total cholesterol in blood 277305 phv00277305.v1.p1 pht006031.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:15:39+00:00 2018-08-02 19:15:39+00:00 CHOL Total Cholesterol Collection Interval: 2007-2009 +4 Total cholesterol in blood 123954 phv00123954.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:39:26+00:00 2018-08-14 20:39:26+00:00 cholesterol_orig Cholesterol - original value +4 Total cholesterol in blood 277402 phv00277402.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:21:02+00:00 2018-08-14 22:21:02+00:00 SCHV Serum Cholesterol Average result value Collection Interval: 2009-2011 +4 Total cholesterol in blood 277847 phv00277847.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:10:37+00:00 2018-08-14 23:10:37+00:00 SCHV Serum Cholesterol Average result value Collection Interval: 2000-2004 +4 Total cholesterol in blood 308040 phv00308040.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:12:08+00:00 2018-08-16 00:12:08+00:00 SCHV Serum Cholesterol Average result value Collection Interval: 2000-2004 +4 Total cholesterol in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:07:55+00:00 2018-08-23 18:07:55+00:00 TESTABBR Test abbreviation +4 Total cholesterol in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:07:55+00:00 2018-08-23 18:07:55+00:00 TESTDESC Test Description +4 Total cholesterol in blood 258734 phv00258734.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:51:51+00:00 2018-09-06 12:51:51+00:00 Cholesterol_mmol Cholesterol from venous blood sample (mmol) +7 Resting arm systolic BP 226390 phv00226390.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2017-12-26 20:47:32+00:00 2017-12-26 20:47:32+00:00 SBPA5 Average systolic blood pressure (SBPA5) +7 Resting arm systolic BP 259052 phv00259052.v1.p1 pht003918.v2.p1 phs000741.v2.p1 GOLDN 741 2 2017-12-27 17:38:18+00:00 2017-12-27 17:38:18+00:00 SBP Systolic Blood pressure +7 Resting arm systolic BP 258702 phv00258702.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2017-12-27 17:51:04+00:00 2017-12-27 17:51:04+00:00 Systolic_BP_Av3 Systolic blood pressure (average of all three measurements) +7 Resting arm systolic BP 258701 phv00258701.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2017-12-27 17:51:34+00:00 2017-12-27 17:51:34+00:00 Systolic_BP Systolic blood pressure (average of last two measurements) +7 Resting arm systolic BP 252995 phv00252995.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2017-12-27 20:57:20+00:00 2017-12-27 20:57:20+00:00 sbp_baseline Systolic blood pressure at baseline visit +7 Resting arm systolic BP 122561 phv00122561.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-27 23:03:26+00:00 2017-12-27 23:03:26+00:00 SYS1 1st systolic bp +7 Resting arm systolic BP 122563 phv00122563.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-27 23:03:34+00:00 2017-12-27 23:03:34+00:00 SYS2 2nd systolic bp +7 Resting arm systolic BP 122647 phv00122647.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-27 23:03:41+00:00 2017-12-27 23:03:41+00:00 mnsys Mean systolic - two readings +7 Resting arm systolic BP 100435 phv00100435.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-01-08 21:26:58+00:00 2018-01-08 21:26:58+00:00 AVZMSYS AVE ZERO MUD SYSTOL (mm Hg) +7 Resting arm systolic BP 128370 phv00128370.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:08:54+00:00 2018-02-22 21:08:54+00:00 SBPA13 13: Systolic (first BP) +7 Resting arm systolic BP 128372 phv00128372.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:08:54+00:00 2018-02-22 21:08:54+00:00 SBPA15 15: Zero reading (first BP) +7 Resting arm systolic BP 128373 phv00128373.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:08:54+00:00 2018-02-22 21:08:54+00:00 SBPA16 16: Systolic (second BP) +7 Resting arm systolic BP 128375 phv00128375.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:08:54+00:00 2018-02-22 21:08:54+00:00 SBPA18 18: Zero Reading (second BP) +7 Resting arm systolic BP 128376 phv00128376.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:08:54+00:00 2018-02-22 21:08:54+00:00 SBPA19 19: Systolic (computed net average) +7 Resting arm systolic BP 125871 phv00125871.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:39:11+00:00 2018-02-22 21:39:11+00:00 BAPA9A 9a: Sphygmomanometer (SBP) +7 Resting arm systolic BP 125876 phv00125876.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:42:46+00:00 2018-02-22 21:42:46+00:00 BAPA10A 10a: Sphygmomanometer (SBP) +7 Resting arm systolic BP 125881 phv00125881.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:42:46+00:00 2018-02-22 21:42:46+00:00 BAPA11A 11a: Sphygmomanometer (SBP) +7 Resting arm systolic BP 125886 phv00125886.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:42:46+00:00 2018-02-22 21:42:46+00:00 BAPA12A 12a: Sphygmomanometer (SBP) +7 Resting arm systolic BP 125891 phv00125891.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:42:46+00:00 2018-02-22 21:42:46+00:00 BAPA13A 13a: Sphygmomanometer (SBP) +7 Resting arm systolic BP 125896 phv00125896.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:42:46+00:00 2018-02-22 21:42:46+00:00 BAPA14A 14a: Sphygmomanometer (mean accepted SBP) +7 Resting arm systolic BP 210281 phv00210281.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:57:43+00:00 2018-03-19 16:57:43+00:00 SBPA12 [First blood pressure measurement]. 1st systolic. Q12 [Siting Blood Pressure, exam 1] +7 Resting arm systolic BP 210284 phv00210284.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:58:39+00:00 2018-03-19 16:58:39+00:00 SBPA15 [Second blood pressure measurement]. 2nd systolic. Q15 [Siting Blood Pressure, exam 1] +7 Resting arm systolic BP 210287 phv00210287.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:59:06+00:00 2018-03-19 16:59:06+00:00 SBPA18 [Third blood pressure measurement]. 3rd systolic. Q18 [Siting Blood Pressure, exam 1] +7 Resting arm systolic BP 210290 phv00210290.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:59:27+00:00 2018-03-19 16:59:27+00:00 SBPA21 [Computed net average of second and third blood pressure measurement]. 2nd and 3rd systolic. Q21 [Siting Blood Pressure, exam 1] +7 Resting arm systolic BP 210307 phv00210307.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:59:49+00:00 2018-03-19 16:59:49+00:00 SBPB12 First blood pressure measurement, systolic. Q12 [Sitting Blood Pressure, exam 2] +7 Resting arm systolic BP 210310 phv00210310.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:00:06+00:00 2018-03-19 17:00:06+00:00 SBPB15 Second blood pressure measurement, systolic. Q15 [Sitting Blood Pressure, exam 2] +7 Resting arm systolic BP 210313 phv00210313.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:00:47+00:00 2018-03-19 17:00:47+00:00 SBPB18 Third blood pressure measurement, systolic. Q18 [Sitting Blood Pressure, exam 2] +7 Resting arm systolic BP 210316 phv00210316.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:01:20+00:00 2018-03-19 17:01:20+00:00 SBPB21 Computed net average of second and third blood pressure measurements, systolic. Q21 [Sitting Blood Pressure, exam 2] +7 Resting arm systolic BP 210331 phv00210331.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:01:43+00:00 2018-03-19 17:01:43+00:00 SBPC13 1st systolic blood pressure measurement, systolic. Q13 [Sitting Blood Pressure, exam 3] +7 Resting arm systolic BP 210334 phv00210334.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:02:04+00:00 2018-03-19 17:02:04+00:00 SBPC16 2nd systolic blood pressure measurement, systolic. Q16 [Sitting Blood Pressure, exam 3] +7 Resting arm systolic BP 210337 phv00210337.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:02:20+00:00 2018-03-19 17:02:20+00:00 SBPC19 3rd systolic blood pressure measurement, systolic. Q19 [Sitting Blood Pressure, exam 3] +7 Resting arm systolic BP 210340 phv00210340.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:02:40+00:00 2018-03-19 17:02:40+00:00 SBPC22 [Computed net average of second and third blood pressure measurements]. 2nd and 3rd systolic blood pressure average. Q22 [Sitting Blood Pressure, exam 3] +7 Resting arm systolic BP 210357 phv00210357.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:03:06+00:00 2018-03-19 17:03:06+00:00 SBPD13 1st systolic blood pressure measurement. Q13 [Sitting Blood Pressure, exam 4] +7 Resting arm systolic BP 210360 phv00210360.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:03:23+00:00 2018-03-19 17:03:23+00:00 SBPD16 2nd systolic blood pressure measurement. Q16 [Sitting Blood Pressure, exam 4] +7 Resting arm systolic BP 210363 phv00210363.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:03:46+00:00 2018-03-19 17:03:46+00:00 SBPD19 1st and 2nd systolic blood pressure average. Q19 [Sitting Blood Pressure, exam 4] +7 Resting arm systolic BP 214058 phv00214058.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:04:09+00:00 2018-03-19 17:04:09+00:00 SYSTBP Seated Systolic Blood Pressure +7 Resting arm systolic BP 214088 phv00214088.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:05:15+00:00 2018-03-19 17:05:15+00:00 SYST120 Seated systolic BP- first reading +7 Resting arm systolic BP 214090 phv00214090.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:05:37+00:00 2018-03-19 17:05:37+00:00 SYST220 Seated systolic BP- second reading +7 Resting arm systolic BP 214092 phv00214092.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:06:08+00:00 2018-03-19 17:06:08+00:00 SYST320 Seated systolic BP- third reading +7 Resting arm systolic BP 210283 phv00210283.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:35:13+00:00 2018-03-19 17:35:13+00:00 SBPA14 [First blood pressure measurement]. 1st zero reading. Q14 [Siting Blood Pressure, exam 1] +7 Resting arm systolic BP 210286 phv00210286.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:35:48+00:00 2018-03-19 17:35:48+00:00 SBPA17 [Second blood pressure measurement]. 2nd zero reading. Q17 [Siting Blood Pressure, exam 1] +7 Resting arm systolic BP 210289 phv00210289.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:36:17+00:00 2018-03-19 17:36:17+00:00 SBPA20 [Third blood pressure measurement]. 3rd zero reading. Q20 [Siting Blood Pressure, exam 1] +7 Resting arm systolic BP 210309 phv00210309.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:37:36+00:00 2018-03-19 17:37:36+00:00 SBPB14 First blood pressure measurement, zero reading. Q14 [Sitting Blood Pressure, exam 2] +7 Resting arm systolic BP 210312 phv00210312.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:37:55+00:00 2018-03-19 17:37:55+00:00 SBPB17 Second blood pressure measurement, zero reading. Q17 [Sitting Blood Pressure, exam 2] +7 Resting arm systolic BP 210315 phv00210315.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:38:17+00:00 2018-03-19 17:38:17+00:00 SBPB20 Third blood pressure measurement, zero reading. Q20 [Sitting Blood Pressure, exam 2] +7 Resting arm systolic BP 210333 phv00210333.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:39:14+00:00 2018-03-19 17:39:14+00:00 SBPC15 1st blood pressure measurement, zero reading. Q15 [Sitting Blood Pressure, exam 3] +7 Resting arm systolic BP 210336 phv00210336.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:39:37+00:00 2018-03-19 17:39:37+00:00 SBPC18 2nd blood pressure measurement, zero reading. Q18 [Sitting Blood Pressure, exam 3] +7 Resting arm systolic BP 210339 phv00210339.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:40:06+00:00 2018-03-19 17:40:06+00:00 SBPC21 3rd blood pressure measurement, zero reading. Q21 [Sitting Blood Pressure, exam 3] +7 Resting arm systolic BP 210359 phv00210359.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:40:48+00:00 2018-03-19 17:40:48+00:00 SBPD15 1st blood pressure measurement, zero reading. Q15 [Sitting Blood Pressure, exam 4] +7 Resting arm systolic BP 210362 phv00210362.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:41:07+00:00 2018-03-19 17:41:07+00:00 SBPD18 2nd blood pressure measurement, zero reading. Q18 [Sitting Blood Pressure, exam 4] +7 Resting arm systolic BP 202844 phv00202844.v1.p1 pht004027.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:58:20+00:00 2018-03-19 17:58:20+00:00 ARMSBP13 Redefined supine brachial systolic blood pressure [Ankle Brachial BP Index, exam 1] +7 Resting arm systolic BP 202853 phv00202853.v1.p1 pht004028.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:59:42+00:00 2018-03-19 17:59:42+00:00 ARMSBP33 Redefined supine brachial systolic blood pressure [Ankle Brachial BP Index, exam 3] +7 Resting arm systolic BP 202863 phv00202863.v1.p1 pht004029.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 18:00:26+00:00 2018-03-19 18:00:26+00:00 ARMSBP43 Redefined supine brachial systolic blood pressure [Ankle Brachial BP Index, exam 4] +7 Resting arm systolic BP 112475 phv00112475.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02R1S FIRST READING SBP +7 Resting arm systolic BP 112477 phv00112477.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02RZ1S RZ1 SBP +7 Resting arm systolic BP 112479 phv00112479.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02SBP1 FIRST CORRECTED SBP (A02R1S - A02RZ1S) +7 Resting arm systolic BP 112481 phv00112481.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02R2S SECOND READING SBP +7 Resting arm systolic BP 112483 phv00112483.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02RZ2S RZ2 SBP +7 Resting arm systolic BP 112485 phv00112485.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02SBP2 SECOND CORRECTED SBP (A02R2S - A02RZ2S) +7 Resting arm systolic BP 112487 phv00112487.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02R3S THIRD READING SBP +7 Resting arm systolic BP 112489 phv00112489.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02RZ3S RZ3 SBP +7 Resting arm systolic BP 112491 phv00112491.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02SBP3 THIRD CORRECTED SBP (A02R3S - A02RZ3S) +7 Resting arm systolic BP 112494 phv00112494.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 A02SBP MEAN OF 2ND AND 3RD SBPS +7 Resting arm systolic BP 114113 phv00114113.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02R1S FIRST READING SBP. Q 11 +7 Resting arm systolic BP 114115 phv00114115.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02RZ1S RZ1 SBP. Q 12 +7 Resting arm systolic BP 114117 phv00114117.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02SBP1 FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13 +7 Resting arm systolic BP 114119 phv00114119.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02R2S SECOND READING SBP. Q 14 +7 Resting arm systolic BP 114121 phv00114121.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02RZ2S RZ2 SBP. Q 15 +7 Resting arm systolic BP 114123 phv00114123.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02SBP2 SECOND CORRECTED SBP (R2_S - RZ2_S). Q 16 +7 Resting arm systolic BP 114125 phv00114125.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02R3S THIRD READING SBP. Q 17 +7 Resting arm systolic BP 114127 phv00114127.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02RZ3S RZ3 SBP. Q 18 +7 Resting arm systolic BP 114129 phv00114129.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02SBP3 THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19 +7 Resting arm systolic BP 114131 phv00114131.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02SUMSY SECOND & THIRD SYS (R2_RZ2_S + R3_RZ3_D). Q 20 +7 Resting arm systolic BP 114133 phv00114133.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 B02AVGSY AVERAGE SBP (SUM_S/2). Q 21 +7 Resting arm systolic BP 115330 phv00115330.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02R1S FIRST READING SBP. Q 11 +7 Resting arm systolic BP 115332 phv00115332.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02RZ1S RZ1 SBP. Q 12 +7 Resting arm systolic BP 115334 phv00115334.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02SBP1 FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13 +7 Resting arm systolic BP 115336 phv00115336.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02R2S SECOND READING SBP. Q 14 +7 Resting arm systolic BP 115338 phv00115338.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02RZ2S RZ2 SBP. Q 15 +7 Resting arm systolic BP 115340 phv00115340.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02SBP2 SECOND CORRECTED SBP (R2_S - RZ2_S). Q 16 +7 Resting arm systolic BP 115342 phv00115342.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02R3S THIRD READING SBP. Q 17 +7 Resting arm systolic BP 115344 phv00115344.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02RZ3S RZ3 SBP. Q 18 +7 Resting arm systolic BP 115346 phv00115346.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02SBP3 THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19 +7 Resting arm systolic BP 115348 phv00115348.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02SUMSY 2ND AND 3RD SYS (R2_RZ2_S + R3_RZ3_D). Q 20 +7 Resting arm systolic BP 115350 phv00115350.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 C02AVGSY AVERAGE SBP (SUM_S/2). Q 21 +7 Resting arm systolic BP 116553 phv00116553.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02R1S FIRST READING SBP. Q 11 +7 Resting arm systolic BP 116555 phv00116555.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02RZ1S RZ1 SBP. Q 12 +7 Resting arm systolic BP 116557 phv00116557.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02SBP1 FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13 +7 Resting arm systolic BP 116559 phv00116559.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02R2S SECOND READING SBP. Q 14 +7 Resting arm systolic BP 116561 phv00116561.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02RZ2S RZ2 SBP. Q 15 +7 Resting arm systolic BP 116563 phv00116563.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02SBP2 SECOND CORRECTED SBP (R2_S - RZ2_S). Q 16 +7 Resting arm systolic BP 116565 phv00116565.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02R3S THIRD READING SBP. Q 17 +7 Resting arm systolic BP 116567 phv00116567.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02RZ3S RZ3 SBP. Q 18 +7 Resting arm systolic BP 116569 phv00116569.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02SBP3 THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19 +7 Resting arm systolic BP 116571 phv00116571.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02SUMSY 2ND AND 3RD SYS (R2_RZ2_S + R3_RZ3_D). Q 20 +7 Resting arm systolic BP 116573 phv00116573.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 D02AVGSY AVERAGE SBP (SUM_S/2). Q 21 +7 Resting arm systolic BP 118276 phv00118276.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02R1S FIRST READING SBP. Q 11 +7 Resting arm systolic BP 118278 phv00118278.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02RZ1S RZ1 SBP. Q 12 +7 Resting arm systolic BP 118280 phv00118280.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02SBP1 FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13 +7 Resting arm systolic BP 118282 phv00118282.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02R2S SECOND READING SBP. Q 14 +7 Resting arm systolic BP 118284 phv00118284.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02RZ2S RZ2 SBP. Q 15 +7 Resting arm systolic BP 118286 phv00118286.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02SBP2 SECOND CORRECTED SBP (R2_S - RZ2_S). Q 16 +7 Resting arm systolic BP 118288 phv00118288.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02R3S THIRD READING SBP. Q 17 +7 Resting arm systolic BP 118290 phv00118290.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02RZ3S RZ3 SBP. Q 18 +7 Resting arm systolic BP 118292 phv00118292.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02SBP3 THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19 +7 Resting arm systolic BP 118294 phv00118294.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02SUMSY 2ND AND 3RD SYS (R2_RZ2_S + R3_RZ3_S). Q 20 +7 Resting arm systolic BP 118296 phv00118296.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 E02AVGSY AVERAGE SBP (SUM_S/2). Q 21 +7 Resting arm systolic BP 119703 phv00119703.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02R1S FIRST READING SBP. Q 11 +7 Resting arm systolic BP 119705 phv00119705.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02RZ1S RZ1 SBP. Q 12 +7 Resting arm systolic BP 119707 phv00119707.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02SBP1 FIRST CORRECTED SBP (R1_S - RZ1_S). Q 13 +7 Resting arm systolic BP 119709 phv00119709.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02R2S SECOND READING SBP. Q 14 +7 Resting arm systolic BP 119711 phv00119711.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02RZ2S RZ2 SBP. Q 15 +7 Resting arm systolic BP 119713 phv00119713.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02SBP2 SECOND CORRECTED SBP (R2_S - RZ2_S). Q 16 +7 Resting arm systolic BP 119715 phv00119715.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02R3S THIRD READING SBP. Q 17 +7 Resting arm systolic BP 119717 phv00119717.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02RZ3S RZ3 SBP. Q 18 +7 Resting arm systolic BP 119719 phv00119719.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02SBP3 THIRD CORRECTED SBP (R3_S - RZ3_S). Q 19 +7 Resting arm systolic BP 119721 phv00119721.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02SUMSY 2ND AND 3RD SYS (R2_RZ2_S + R3_RZ3_S). Q 20 +7 Resting arm systolic BP 119723 phv00119723.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:13:47+00:00 2018-04-17 15:13:47+00:00 F02AVGSY AVERAGE SBP (SUM_S/2). Q 21 +7 Resting arm systolic BP 115205 phv00115205.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:14:34+00:00 2018-04-19 20:14:34+00:00 C1MSBP AVERAGE SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 116135 phv00116135.v2.p2 pht001680.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:15:10+00:00 2018-04-19 20:15:10+00:00 C40SBP SYSTOLIC BLOOD PRESSURE +7 Resting arm systolic BP 116228 phv00116228.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:15:43+00:00 2018-04-19 20:15:43+00:00 C42AYS1 SYSTOLIC Y-TUBED BP -1ST READING +7 Resting arm systolic BP 116236 phv00116236.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:16:40+00:00 2018-04-19 20:16:40+00:00 C42AYS3 SYSTOLIC Y-TUBED BP -3RD READING +7 Resting arm systolic BP 116240 phv00116240.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:17:03+00:00 2018-04-19 20:17:03+00:00 C42AYS4 SYSTOLIC Y-TUBED BP -4TH READING +7 Resting arm systolic BP 116244 phv00116244.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:17:25+00:00 2018-04-19 20:17:25+00:00 C42AYS5 SYSTOLIC Y-TUBED BP -5TH READING +7 Resting arm systolic BP 116252 phv00116252.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:18:00+00:00 2018-04-19 20:18:00+00:00 C42AYS7 SYSTOLIC Y-TUBED BP - 7TH READING +7 Resting arm systolic BP 116256 phv00116256.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:18:17+00:00 2018-04-19 20:18:17+00:00 C42AYS8 SYSTOLIC Y-TUBED BP - 8TH READING +7 Resting arm systolic BP 116260 phv00116260.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:18:41+00:00 2018-04-19 20:18:41+00:00 C42AYS9 SYSTOLIC Y-TUBED BP - 9TH READING +7 Resting arm systolic BP 116264 phv00116264.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:19:00+00:00 2018-04-19 20:19:00+00:00 C42AYS10 SYSTOLIC Y-TUBED BP - 10TH READING +7 Resting arm systolic BP 116272 phv00116272.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:19:46+00:00 2018-04-19 20:19:46+00:00 C42AEYS2 END OF TEST Y-TUBED SYSTOLIC -2ND READ +7 Resting arm systolic BP 116276 phv00116276.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:20:12+00:00 2018-04-19 20:20:12+00:00 C42AEYS3 END OF TEST Y-TUBED SYSTOLIC -3RD READ +7 Resting arm systolic BP 119238 phv00119238.v2.p2 pht001789.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:21:36+00:00 2018-04-19 20:21:36+00:00 E40SBP SYSTOLIC BLOOD PRESSURE. Q 3 +7 Resting arm systolic BP 83399 phv00083399.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:59:53+00:00 2018-04-23 03:59:53+00:00 s1bp1 SEATED BP: SYSTOLIC 1ST READING (mmHg) +7 Resting arm systolic BP 83403 phv00083403.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:59:59+00:00 2018-04-23 03:59:59+00:00 s2bp1 SEATED BP: SYSTOLIC 2ND READING (mmHg) +7 Resting arm systolic BP 83406 phv00083406.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:00:06+00:00 2018-04-23 04:00:06+00:00 s3bp1 SEATED BP: SYSTOLIC 3RD READING (mmHg) +7 Resting arm systolic BP 83410 phv00083410.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:00:12+00:00 2018-04-23 04:00:12+00:00 sbp1c SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 84494 phv00084494.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:00:20+00:00 2018-04-23 04:00:20+00:00 presys1 SYSTOLIC BLOOD PRESSURE BEFORE SERIES 7 MRI +7 Resting arm systolic BP 84496 phv00084496.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:00:28+00:00 2018-04-23 04:00:28+00:00 postsys1 SYSTOLIC BLOOD PRESSURE AFTER SERIES 7 MRI +7 Resting arm systolic BP 85703 phv00085703.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:00:36+00:00 2018-04-23 04:00:36+00:00 sbpcp1 SYSTOLIC BLOOD PRESSURE (FROM OSCILLOMETRIC CUFF), (mmHg) +7 Resting arm systolic BP 85732 phv00085732.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:00:56+00:00 2018-04-23 04:00:56+00:00 s1bp1 SEATED BP: SYSTOLIC 1ST READING (mmHg) +7 Resting arm systolic BP 85735 phv00085735.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:03+00:00 2018-04-23 04:01:03+00:00 s2bp1 SEATED BP: SYSTOLIC 2ND READING (mmHg) +7 Resting arm systolic BP 85737 phv00085737.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:08+00:00 2018-04-23 04:01:08+00:00 s3bp1 SEATED BP: SYSTOLIC 3RD READING (mmHg) +7 Resting arm systolic BP 85740 phv00085740.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:15+00:00 2018-04-23 04:01:15+00:00 sbp1c SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 86224 phv00086224.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:21+00:00 2018-04-23 04:01:21+00:00 sbp2c SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 86232 phv00086232.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:27+00:00 2018-04-23 04:01:27+00:00 s1bp2 SEATED BP: SYSTOLIC 1ST READING (mmHg) +7 Resting arm systolic BP 86234 phv00086234.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:32+00:00 2018-04-23 04:01:32+00:00 s2bp2 SEATED BP: SYSTOLIC 2ND READING (mmHg) +7 Resting arm systolic BP 86236 phv00086236.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:37+00:00 2018-04-23 04:01:37+00:00 s3bp2 SEATED BP: SYSTOLIC 3RD READING (mmHg) +7 Resting arm systolic BP 86707 phv00086707.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:42+00:00 2018-04-23 04:01:42+00:00 sbp3c SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 86715 phv00086715.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:47+00:00 2018-04-23 04:01:47+00:00 s1bp3 SEATED BP: SYSTOLIC 1ST READING (mmHg) +7 Resting arm systolic BP 86718 phv00086718.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:52+00:00 2018-04-23 04:01:52+00:00 s2bp3 SEATED BP: SYSTOLIC 2ND READING (mmHg) +7 Resting arm systolic BP 86720 phv00086720.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:01:57+00:00 2018-04-23 04:01:57+00:00 s3bp3 SEATED BP: SYSTOLIC 3RD READING (mmHg) +7 Resting arm systolic BP 87029 phv00087029.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:02:02+00:00 2018-04-23 04:02:02+00:00 sbp4c SEATED SYSTOLIC BLOOD PRESSURE (mmhg) +7 Resting arm systolic BP 87037 phv00087037.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:02:07+00:00 2018-04-23 04:02:07+00:00 s1bp4 SEATED BP: SYSTOLIC 1ST READING (mmhg) +7 Resting arm systolic BP 87040 phv00087040.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:02:12+00:00 2018-04-23 04:02:12+00:00 s2bp4 SEATED BP: SYSTOLIC 2ND READING (mmhg) +7 Resting arm systolic BP 87042 phv00087042.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:03:19+00:00 2018-04-23 04:03:19+00:00 s3bp4 SEATED BP: SYSTOLIC 3RD READING (mmhg) +7 Resting arm systolic BP 87084 phv00087084.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:03:26+00:00 2018-04-23 04:03:26+00:00 sbpfc MEAN: SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 87505 phv00087505.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:03:33+00:00 2018-04-23 04:03:33+00:00 s1bpf 1ST READING: SEATED SYSTOLIC BP (mmHg) +7 Resting arm systolic BP 87509 phv00087509.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:03:41+00:00 2018-04-23 04:03:41+00:00 s2bpf 2ND READING: SEATED SYSTOLIC BP (mmHg) +7 Resting arm systolic BP 87512 phv00087512.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:03:46+00:00 2018-04-23 04:03:46+00:00 s3bpf 3RD READING: SEATED SYSTOLIC BP (mmHg) +7 Resting arm systolic BP 175587 phv00175587.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:03:51+00:00 2018-04-23 04:03:51+00:00 s1bp5 SEATED BP: SYSTOLIC 1ST READING (mmHg) +7 Resting arm systolic BP 175591 phv00175591.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:03:59+00:00 2018-04-23 04:03:59+00:00 s2bp5 SEATED BP: SYSTOLIC 2ND READING (mmHg) +7 Resting arm systolic BP 175594 phv00175594.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:04:04+00:00 2018-04-23 04:04:04+00:00 s3bp5 SEATED BP: SYSTOLIC 3RD READING (mmHg) +7 Resting arm systolic BP 175601 phv00175601.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:04:10+00:00 2018-04-23 04:04:10+00:00 sbp5c SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 175862 phv00175862.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:04:20+00:00 2018-04-23 04:04:20+00:00 sbp1c SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 175947 phv00175947.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:04:27+00:00 2018-04-23 04:04:27+00:00 sbpfc FAMILY COHORT: MEAN: SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 177021 phv00177021.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:04:45+00:00 2018-04-23 04:04:45+00:00 s1bp5 SEATED BP: SYSTOLIC 1ST READING (mmHg) +7 Resting arm systolic BP 177025 phv00177025.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:04:50+00:00 2018-04-23 04:04:50+00:00 s2bp5 SEATED BP: SYSTOLIC 2ND READING (mmHg) +7 Resting arm systolic BP 177028 phv00177028.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:04:56+00:00 2018-04-23 04:04:56+00:00 s3bp5 SEATED BP: SYSTOLIC 3RD READING (mmHg) +7 Resting arm systolic BP 177035 phv00177035.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:05:01+00:00 2018-04-23 04:05:01+00:00 sbp5c SEATED SYSTOLIC BLOOD PRESSURE (mmHg) +7 Resting arm systolic BP 79854 phv00079854.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 23:28:12+00:00 2018-04-24 23:28:12+00:00 SYSTBP1 Systolic blood pressure (1st reading) +7 Resting arm systolic BP 79856 phv00079856.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 23:28:12+00:00 2018-04-24 23:28:12+00:00 SYSTBP2 Systolic blood pressure (2nd reading) +7 Resting arm systolic BP 79863 phv00079863.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 23:28:12+00:00 2018-04-24 23:28:12+00:00 SYST Systolic BP +7 Resting arm systolic BP 205847 phv00205847.v1.p1 pht004079.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 21:29:14+00:00 2018-04-25 21:29:14+00:00 ECHA7 Systolic blood pressure 7 [Cohort (Jackson only), Exam 3] +7 Resting arm systolic BP 283297 phv00283297.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-25 23:52:06+00:00 2018-04-25 23:52:06+00:00 SYSTBP1 Systolic blood pressure (1st reading) +7 Resting arm systolic BP 283299 phv00283299.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-26 00:00:08+00:00 2018-04-26 00:00:08+00:00 SYSTBP2 Systolic blood pressure (2nd reading) +7 Resting arm systolic BP 283536 phv00283536.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-26 00:01:52+00:00 2018-04-26 00:01:52+00:00 SYST F136 Systolic blood pressure at onset, mm/Hg +7 Resting arm systolic BP 101961 phv00101961.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:17:05+00:00 2018-05-03 18:17:05+00:00 AVESYS SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 102574 phv00102574.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:17:15+00:00 2018-05-03 18:17:15+00:00 AVESYS SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 104697 phv00104697.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:17:25+00:00 2018-05-03 18:17:25+00:00 AVESYS SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 105432 phv00105432.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:17:40+00:00 2018-05-03 18:17:40+00:00 AVESYS AVE SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 106794 phv00106794.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:17:53+00:00 2018-05-03 18:17:53+00:00 AVESYS SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 107774 phv00107774.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:18:04+00:00 2018-05-03 18:18:04+00:00 AVESYS SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 108830 phv00108830.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:18:16+00:00 2018-05-03 18:18:16+00:00 AVESYS SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 110337 phv00110337.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:18:33+00:00 2018-05-03 18:18:33+00:00 AVESYS SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 99441 phv00099441.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:19:52+00:00 2018-05-03 18:19:52+00:00 AVZMSYS AVE ZERO MUDDLER SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 104020 phv00104020.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:20:30+00:00 2018-05-03 18:20:30+00:00 AVZMSYS AVE ZERO MUDDLER SYSTOLIC BP (mm Hg) +7 Resting arm systolic BP 1569 phv00001569.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:32:47+00:00 2018-05-03 18:32:47+00:00 FD22 BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 1811 phv00001811.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:33:15+00:00 2018-05-03 18:33:15+00:00 FE75 BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 2026 phv00002026.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:35:53+00:00 2018-05-03 18:35:53+00:00 FF71 BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 1372 phv00001372.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:36:24+00:00 2018-05-03 18:36:24+00:00 FC14 BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN (MM HG) +7 Resting arm systolic BP 1195 phv00001195.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:38:29+00:00 2018-05-03 18:38:29+00:00 FB18 BLOOD PRESSURE: SYSTOLIC, TAKEN BY NURSE +7 Resting arm systolic BP 1197 phv00001197.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:38:46+00:00 2018-05-03 18:38:46+00:00 FB20 BLOOD PRESSURE: SYSTOLIC, PHYSICIAN'S FIRST READING +7 Resting arm systolic BP 1199 phv00001199.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:39:00+00:00 2018-05-03 18:39:00+00:00 FB22 BLOOD PRESSURE: SYSTOLIC, PHYSICIAN'S SECOND READING +7 Resting arm systolic BP 1370 phv00001370.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:39:24+00:00 2018-05-03 18:39:24+00:00 FC12 BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE (MM HG) +7 Resting arm systolic BP 1374 phv00001374.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:39:42+00:00 2018-05-03 18:39:42+00:00 FC16 BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN (MM HG) +7 Resting arm systolic BP 1567 phv00001567.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:39:57+00:00 2018-05-03 18:39:57+00:00 FD20 BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE +7 Resting arm systolic BP 1571 phv00001571.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:40:15+00:00 2018-05-03 18:40:15+00:00 FD24 BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 1809 phv00001809.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:40:39+00:00 2018-05-03 18:40:39+00:00 FE73 BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE +7 Resting arm systolic BP 1813 phv00001813.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:41:01+00:00 2018-05-03 18:41:01+00:00 FE77 BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 2024 phv00002024.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:41:22+00:00 2018-05-03 18:41:22+00:00 FF69 BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE +7 Resting arm systolic BP 2028 phv00002028.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:41:43+00:00 2018-05-03 18:41:43+00:00 FF73 BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 2208 phv00002208.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:42:04+00:00 2018-05-03 18:42:04+00:00 FG68 BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE +7 Resting arm systolic BP 2212 phv00002212.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:42:52+00:00 2018-05-03 18:42:52+00:00 FG72 BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 2429 phv00002429.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:43:14+00:00 2018-05-03 18:43:14+00:00 FH68 BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE +7 Resting arm systolic BP 2433 phv00002433.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:44:05+00:00 2018-05-03 18:44:05+00:00 FH72 BLOOD PRESSURE, SYSTOLIC, SECOND READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 2673 phv00002673.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:45:25+00:00 2018-05-03 18:45:25+00:00 FI21 BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE (MM HG) +7 Resting arm systolic BP 2675 phv00002675.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:45:50+00:00 2018-05-03 18:45:50+00:00 FI23 BLOOD PRESSURE, SYSTOLIC, FIRST TAKEN BY PHYSICIAN (MM HG) +7 Resting arm systolic BP 2677 phv00002677.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:46:10+00:00 2018-05-03 18:46:10+00:00 FI25 BLOOD PRESSURE, SYSTOLIC, SECOND TAKEN BY PHYSICIAN +7 Resting arm systolic BP 3172 phv00003172.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:46:50+00:00 2018-05-03 18:46:50+00:00 FJ270 BLOOD PRESSURE: SYSTOLIC - SUPINE +7 Resting arm systolic BP 3176 phv00003176.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:47:37+00:00 2018-05-03 18:47:37+00:00 FJ274 BLOOD PRESSURE: SYSTOLIC - 2ND READING BY PHYSICIAN +7 Resting arm systolic BP 3591 phv00003591.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:48:30+00:00 2018-05-03 18:48:30+00:00 FK369 BLOOD PRESSURE: SYSTOLIC - 2ND PHYSICIAN +7 Resting arm systolic BP 3306 phv00003306.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:49:08+00:00 2018-05-03 18:49:08+00:00 FK55 BLOOD PRESSURE, SYSTOLIC-NURSE +7 Resting arm systolic BP 4546 phv00004546.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:50:15+00:00 2018-05-03 18:50:15+00:00 FN310 BLOOD PRESSURE: SYSTOLIC - 1ST MD READING +7 Resting arm systolic BP 4548 phv00004548.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:50:38+00:00 2018-05-03 18:50:38+00:00 FN404 BLOOD PRESSURE: SYSTOLIC - 2ND MD READING +7 Resting arm systolic BP 5138 phv00005138.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:51:20+00:00 2018-05-03 18:51:20+00:00 FO329 BLOOD PRESSURE: SYSTOLIC - 1ST M.D. READING +7 Resting arm systolic BP 5228 phv00005228.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:52:00+00:00 2018-05-03 18:52:00+00:00 FO424 BLOOD PRESSURE: SYSTOLIC - 2ND MD READING +7 Resting arm systolic BP 5766 phv00005766.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:53:23+00:00 2018-05-03 18:53:23+00:00 FP296 BLOOD PRESSURE: SYSTOLIC - 1ST MD READING +7 Resting arm systolic BP 5855 phv00005855.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:54:55+00:00 2018-05-03 18:54:55+00:00 FP390 BLOOD PRESSURE: SYSTOLIC - 2ND MD READING +7 Resting arm systolic BP 254610 phv00254610.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:57:12+00:00 2018-05-03 18:57:12+00:00 fv019 Blood Pressure: First reading - Systolic (nearest 2mm Hg) Collection Interval: Exam 29 +7 Resting arm systolic BP 254707 phv00254707.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 18:57:54+00:00 2018-05-03 18:57:54+00:00 fv153 Blood Pressure: Second reading - Systolic blood pressure to nearest 2 mm Hg Collection Interval: Exam 29 +7 Resting arm systolic BP 620 phv00000620.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:00:23+00:00 2018-05-03 19:00:23+00:00 MF154 BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 2 +7 Resting arm systolic BP 622 phv00000622.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:00:38+00:00 2018-05-03 19:00:38+00:00 MF156 BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 2 +7 Resting arm systolic BP 624 phv00000624.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:00:53+00:00 2018-05-03 19:00:53+00:00 MF158 BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 2 +7 Resting arm systolic BP 640 phv00000640.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:01:13+00:00 2018-05-03 19:01:13+00:00 MF174 BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 3 +7 Resting arm systolic BP 642 phv00000642.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:01:27+00:00 2018-05-03 19:01:27+00:00 MF176 BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 3 +7 Resting arm systolic BP 644 phv00000644.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:01:43+00:00 2018-05-03 19:01:43+00:00 MF178 BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 3 +7 Resting arm systolic BP 719 phv00000719.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:02:07+00:00 2018-05-03 19:02:07+00:00 MF264 BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 4 +7 Resting arm systolic BP 721 phv00000721.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:02:21+00:00 2018-05-03 19:02:21+00:00 MF266 BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 4 +7 Resting arm systolic BP 757 phv00000757.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:02:33+00:00 2018-05-03 19:02:33+00:00 MF305 BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 5 +7 Resting arm systolic BP 759 phv00000759.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:02:46+00:00 2018-05-03 19:02:46+00:00 MF307 BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 5 +7 Resting arm systolic BP 761 phv00000761.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:03:03+00:00 2018-05-03 19:03:03+00:00 MF309 BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 5 +7 Resting arm systolic BP 833 phv00000833.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:03:19+00:00 2018-05-03 19:03:19+00:00 MF384 BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 6 +7 Resting arm systolic BP 835 phv00000835.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:03:34+00:00 2018-05-03 19:03:34+00:00 MF386 BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 6 +7 Resting arm systolic BP 837 phv00000837.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:03:53+00:00 2018-05-03 19:03:53+00:00 MF388 BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 6 +7 Resting arm systolic BP 918 phv00000918.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:04:09+00:00 2018-05-03 19:04:09+00:00 MF476 BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 7 +7 Resting arm systolic BP 920 phv00000920.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:04:29+00:00 2018-05-03 19:04:29+00:00 MF478 BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 7 +7 Resting arm systolic BP 922 phv00000922.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:04:45+00:00 2018-05-03 19:04:45+00:00 MF480 BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 7 +7 Resting arm systolic BP 528 phv00000528.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:08:12+00:00 2018-05-03 19:08:12+00:00 MF56 BLOOD PRESSURE: ADMISSION, SYSTOLIC, EXAM 1 +7 Resting arm systolic BP 530 phv00000530.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:08:27+00:00 2018-05-03 19:08:27+00:00 MF58 BLOOD PRESSURE: FIRST EXAMINER, SYSTOLIC, EXAM 1 +7 Resting arm systolic BP 532 phv00000532.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-03 19:08:53+00:00 2018-05-03 19:08:53+00:00 MF60 BLOOD PRESSURE: SECOND EXAMINER, SYSTOLIC, EXAM 1 +7 Resting arm systolic BP 8539 phv00008539.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 11:53:47+00:00 2018-05-04 11:53:47+00:00 C184 FIRST SYSTOLIC BLOOD PRESSURE BY PHYSICIAN +7 Resting arm systolic BP 250293 phv00250293.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 11:54:32+00:00 2018-05-04 11:54:32+00:00 e035 Numerical Data - Part I: Nurse's blood pressure - Systolic (nearest 2mm Hg) Collection Interval: Exam 1 +7 Resting arm systolic BP 251070 phv00251070.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 11:56:31+00:00 2018-05-04 11:56:31+00:00 g450 Numerical Data - Part I: Technician's blood pressure - Systolic (nearest 2 mm Hg) Collection Interval: Exam 2 +7 Resting arm systolic BP 7572 phv00007572.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 11:58:04+00:00 2018-05-04 11:58:04+00:00 A53 NURSE SYSTOLIC BLOOD PRESSURE +7 Resting arm systolic BP 254087 phv00254087.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:01:06+00:00 2018-05-04 12:01:06+00:00 j116 Physical Exam - Blood Pressure: Physician Blood Pressure first reading - Systolic +7 Resting arm systolic BP 254154 phv00254154.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:01:25+00:00 2018-05-04 12:01:25+00:00 j255 Physical Exam - Blood Pressure: Physician Blood Pressure second reading - Systolic +7 Resting arm systolic BP 10433 phv00010433.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:02:33+00:00 2018-05-04 12:02:33+00:00 G354 PHYSICIAN SYSTOLIC BLOOD PRESSURE - SECOND READING (TO NEAREST 2 MM HG) +7 Resting arm systolic BP 250915 phv00250915.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:03:03+00:00 2018-05-04 12:03:03+00:00 g271 Physical Exam - Head, Neck and Respiratory: Physician blood pressure (first reading), systolic (nearest 2mm Hg) Collection Interval: Exam 2 +7 Resting arm systolic BP 255001 phv00255001.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:07:53+00:00 2018-05-04 12:07:53+00:00 fw020 Physical Exam - Physician blood pressure 1st reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 30 +7 Resting arm systolic BP 274721 phv00274721.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:08:15+00:00 2018-05-04 12:08:15+00:00 FX020 Physical Exam - Physician blood pressure 1st reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 31 +7 Resting arm systolic BP 275078 phv00275078.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:08:34+00:00 2018-05-04 12:08:34+00:00 fy020 Physical Exam - Physician blood pressure 1st reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 32 +7 Resting arm systolic BP 255097 phv00255097.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:08:57+00:00 2018-05-04 12:08:57+00:00 fw174 Physical Exam - Physician blood pressure 2nd reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 30 +7 Resting arm systolic BP 274822 phv00274822.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:09:15+00:00 2018-05-04 12:09:15+00:00 FX174 Physical Exam - Physician blood pressure 2nd reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 31 +7 Resting arm systolic BP 275179 phv00275179.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:09:30+00:00 2018-05-04 12:09:30+00:00 fy174 Physical Exam - Physician blood pressure 2nd reading - systolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 32 +7 Resting arm systolic BP 250561 phv00250561.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:10:50+00:00 2018-05-04 12:10:50+00:00 e485 Physical Exam - Physician Blood Pressure First Reading - Systolic (nearest 2mm Hg) Collection Interval: Exam 1 +7 Resting arm systolic BP 250652 phv00250652.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:11:24+00:00 2018-05-04 12:11:24+00:00 e581 Physical Exam - Physician Blood Pressure Second Reading - Systolic (nearest 2mm Hg) Collection Interval: Exam 1 +7 Resting arm systolic BP 177352 phv00177352.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:13:26+00:00 2018-05-04 12:13:26+00:00 g3b0149 Physical Exam-Blood Pressure: Physician Blood Pressure first reading - Systolic +7 Resting arm systolic BP 177417 phv00177417.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:14:17+00:00 2018-05-04 12:14:17+00:00 g3b0280 Physical Exam-Blood Pressure: Physician Blood Pressure second reading - Systolic +7 Resting arm systolic BP 8756 phv00008756.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:15:17+00:00 2018-05-04 12:15:17+00:00 D192 PHYSICIAN - SYSTOLIC BLOOD PRESSURE - 1ST READING +7 Resting arm systolic BP 8758 phv00008758.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:15:33+00:00 2018-05-04 12:15:33+00:00 D288 PHYSICIAN - SYSTOLIC BLOOD PRESSURE - 2ND READING +7 Resting arm systolic BP 6512 phv00006512.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:16:57+00:00 2018-05-04 12:16:57+00:00 FR239 PHYSICIAN BLOOD PRESSURE (FIRST READING) SYSTOLIC (TO NEAREST 2 MM HG) +7 Resting arm systolic BP 6607 phv00006607.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:17:17+00:00 2018-05-04 12:17:17+00:00 FR380 PHYSICIAN BLOOD PRESSURE (SECOND READING) SYSTOLIC (TO NEAREST 2 MM HG) +7 Resting arm systolic BP 251341 phv00251341.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:18:06+00:00 2018-05-04 12:18:06+00:00 h111 Physician Blood Pressure first reading - Systolic (nearest 2 mm Hg) Collection Interval: Exam 3 +7 Resting arm systolic BP 251408 phv00251408.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:18:36+00:00 2018-05-04 12:18:36+00:00 h233 Physician Blood Pressure second reading - Systolic (nearest 2 mm Hg) Collection Interval: Exam 3 +7 Resting arm systolic BP 72212 phv00072212.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:18:58+00:00 2018-05-04 12:18:58+00:00 H233 PHYSICIAN BLOOD PRESSURE, 2ND READING: SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) +7 Resting arm systolic BP 72138 phv00072138.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:19:21+00:00 2018-05-04 12:19:21+00:00 H111 PHYSICIAN BLOOD PRESSURE, FIRST READING: SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) +7 Resting arm systolic BP 6921 phv00006921.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:20:21+00:00 2018-05-04 12:20:21+00:00 FS312 PHYSICIAN SYSTOLIC BLOOD PRESSURE - 1ST READING (TO NEAREST 2MM HG) +7 Resting arm systolic BP 7041 phv00007041.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:20:51+00:00 2018-05-04 12:20:51+00:00 FS479 PHYSICIAN SYSTOLIC BLOOD PRESSURE - 2ND READING (TO NEAREST 2 MM HG) +7 Resting arm systolic BP 10360 phv00010360.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:21:31+00:00 2018-05-04 12:21:31+00:00 G271 PHYSICIAN SYSTOLIC BLOOD PRESSURE - FIRST READING (TO NEAREST 2 MM HG) +7 Resting arm systolic BP 9905 phv00009905.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:23:10+00:00 2018-05-04 12:23:10+00:00 F476 PHYSICIAN SYSTOLIC BLOOD PRESSURE - FIRST READING (TO NEAREST 2MM HG) +7 Resting arm systolic BP 250994 phv00250994.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:56:26+00:00 2018-05-04 12:56:26+00:00 g354 Physical Exam - Final Blood Pressure: Physician blood pressure (second reading) - Systolic (nearest 2 mm Hg) Collection Interval: Exam 2 +7 Resting arm systolic BP 10000 phv00010000.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:57:44+00:00 2018-05-04 12:57:44+00:00 F576 PHYSICIAN SYSTOLIC BLOOD PRESSURE - SECOND READING (TO NEAREST 2MM HG) +7 Resting arm systolic BP 7574 phv00007574.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:58:28+00:00 2018-05-04 12:58:28+00:00 A55 PHYSICIAN SYSTOLIC BLOOD PRESSURE, FIRST +7 Resting arm systolic BP 7576 phv00007576.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:58:43+00:00 2018-05-04 12:58:43+00:00 A57 PHYSICIAN SYSTOLIC BLOOD PRESSURE, SECOND +7 Resting arm systolic BP 3690 phv00003690.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 12:59:30+00:00 2018-05-04 12:59:30+00:00 FL388 PHYSICIAN SYSTOLIC BP 2ND READING +7 Resting arm systolic BP 4108 phv00004108.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:00:15+00:00 2018-05-04 13:00:15+00:00 FM427 PHYSICIAN SYSTOLIC BP 2ND READING (UNEQUAL # OF UNKNOWN SBP'S AND DBP'S) +7 Resting arm systolic BP 3688 phv00003688.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:00:44+00:00 2018-05-04 13:00:44+00:00 FL291 PHYSICIAN SYSTOLIC PRESSURE 1ST READ +7 Resting arm systolic BP 4106 phv00004106.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:01:12+00:00 2018-05-04 13:01:12+00:00 FM331 PHYSICIAN SYSTOLIC PRESSURE 1ST READ (UNEQUAL # OF UNKNOWN SBP'S AND DBP'S) +7 Resting arm systolic BP 55256 phv00055256.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:02:47+00:00 2018-05-04 13:02:47+00:00 SystBP Seated Systolic Blood Pressure +7 Resting arm systolic BP 55285 phv00055285.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:03:15+00:00 2018-05-04 13:03:15+00:00 SYST120 Seated systolic BP- first reading +7 Resting arm systolic BP 55287 phv00055287.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:03:25+00:00 2018-05-04 13:03:25+00:00 SYST220 Seated systolic BP- second reading +7 Resting arm systolic BP 55289 phv00055289.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:03:37+00:00 2018-05-04 13:03:37+00:00 SYST320 Seated systolic BP- third reading +7 Resting arm systolic BP 8630 phv00008630.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:04:31+00:00 2018-05-04 13:04:31+00:00 C286 SECOND SYSTOLIC BLOOD PRESSURE BY PHYSICIAN +7 Resting arm systolic BP 55182 phv00055182.v4.p10 pht000394.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:05:45+00:00 2018-05-04 13:05:45+00:00 WT018 SUPINE SBP +7 Resting arm systolic BP 8770 phv00008770.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:09:09+00:00 2018-05-04 13:09:09+00:00 D413 SYSTOLIC BLOOD PRESSURE-NURSE +7 Resting arm systolic BP 9558 phv00009558.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:09:37+00:00 2018-05-04 13:09:37+00:00 E035 SYSTOLIC BLOOD PRESSURE - NURSE +7 Resting arm systolic BP 10122 phv00010122.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:10:36+00:00 2018-05-04 13:10:36+00:00 F026 SYSTOLIC BLOOD PRESSURE - NURSE (TO NEAREST 2MM HG) +7 Resting arm systolic BP 1045 phv00001045.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:11:00+00:00 2018-05-04 13:11:00+00:00 FA11 SYSTOLIC BLOOD PRESSURE, SECOND EXAMINER (MM HG) +7 Resting arm systolic BP 1041 phv00001041.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:11:18+00:00 2018-05-04 13:11:18+00:00 FA7 SYSTOLIC BLOOD PRESSURE, NURSE (MM HG) +7 Resting arm systolic BP 1043 phv00001043.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:11:36+00:00 2018-05-04 13:11:36+00:00 FA9 SYSTOLIC BLOOD PRESSURE, FIRST EXAMINER (MM HG) +7 Resting arm systolic BP 3675 phv00003675.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:12:22+00:00 2018-05-04 13:12:22+00:00 FL021 SYSTOLIC BLOOD PRESSURE-NURSE +7 Resting arm systolic BP 4091 phv00004091.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:12:56+00:00 2018-05-04 13:12:56+00:00 FM31 SYSTOLIC BLOOD PRESSURE-NURSE +7 Resting arm systolic BP 4533 phv00004533.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:33:05+00:00 2018-05-04 13:33:05+00:00 FN21 SYSTOLIC BLOOD PRESSURE - NURSE +7 Resting arm systolic BP 5548 phv00005548.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:34:38+00:00 2018-05-04 13:34:38+00:00 FO020 SYSTOLIC NURSE'S BLOOD PRESSURE +7 Resting arm systolic BP 5934 phv00005934.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:45:07+00:00 2018-05-04 13:45:07+00:00 FP025 SYSTOLIC BLOOD PRESSURE - NURSE +7 Resting arm systolic BP 6041 phv00006041.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:45:34+00:00 2018-05-04 13:45:34+00:00 FQ013 SYSTOLIC BLOOD PRESSURE-NUMERICAL DATA I (FIRST READING) TO NEAREST 2 MM HG +7 Resting arm systolic BP 6043 phv00006043.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:45:49+00:00 2018-05-04 13:45:49+00:00 FQ017 SYSTOLIC BLOOD PRESSURE-NUMERICAL DATA I (SECOND READING) TO NEAREST 2 MM HG +7 Resting arm systolic BP 6250 phv00006250.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:46:13+00:00 2018-05-04 13:46:13+00:00 FQ304 SYSTOLIC BLOOD PRESSURE-2ND EXAMINER (FIRST READING) TO NEAREST 2 MM HG +7 Resting arm systolic BP 6252 phv00006252.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:46:33+00:00 2018-05-04 13:46:33+00:00 FQ308 SYSTOLIC BLOOD PRESSURE-2ND EXAMINER (SECOND READING) TO NEAREST 2 MM HG +7 Resting arm systolic BP 6680 phv00006680.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:46:56+00:00 2018-05-04 13:46:56+00:00 FS015 SYSTOLIC BLOOD PRESSURE - TECHNICIAN (TO NEAREST 2MM HG) +7 Resting arm systolic BP 7474 phv00007474.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:47:15+00:00 2018-05-04 13:47:15+00:00 FT483 SYSTOLIC BLOOD PRESSURE - 2ND READING (TO NEAREST 2 MM HG) +7 Resting arm systolic BP 70375 phv00070375.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:47:35+00:00 2018-05-04 13:47:35+00:00 FU019 SYSTOLIC BLOOD PRESSURE - 1ST READING (TO NEAREST 2 MM HG) +7 Resting arm systolic BP 70500 phv00070500.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:47:59+00:00 2018-05-04 13:47:59+00:00 FU195 SYSTOLIC BLOOD PRESSURE - 2ND READING(TO NEAREST 2 MM HG) +7 Resting arm systolic BP 273914 phv00273914.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:52:48+00:00 2018-05-04 13:52:48+00:00 g3a290 Systolic blood pressure: Physician's first reading Collection Interval: Exam 1 +7 Resting arm systolic BP 274407 phv00274407.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:53:05+00:00 2018-05-04 13:53:05+00:00 g3a290 Systolic blood pressure: Physician's first reading +7 Resting arm systolic BP 21092 phv00021092.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:53:26+00:00 2018-05-04 13:53:26+00:00 G3A290 SYSTOLIC BLOOD PRESSURE: PHYSICIAN'S FIRST READING (TO NEAREST 2MM HG) +7 Resting arm systolic BP 21147 phv00021147.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:54:06+00:00 2018-05-04 13:54:06+00:00 G3A347 SYSTOLIC BLOOD PRESSURE: PHYSICIAN'S SECOND READING (TO NEAREST 2MM HG) +7 Resting arm systolic BP 273969 phv00273969.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:54:17+00:00 2018-05-04 13:54:17+00:00 g3a347 Systolic blood pressure: Physician's second reading Collection Interval: Exam 1 +7 Resting arm systolic BP 274462 phv00274462.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:54:28+00:00 2018-05-04 13:54:28+00:00 g3a347 Systolic blood pressure: Physician's second reading +7 Resting arm systolic BP 21239 phv00021239.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:55:01+00:00 2018-05-04 13:55:01+00:00 G3A456 SYSTOLIC BLOOD PRESSURE: TECHNICIAN'S READING +7 Resting arm systolic BP 274061 phv00274061.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:55:12+00:00 2018-05-04 13:55:12+00:00 g3a456 Systolic blood pressure: Technician's reading Collection Interval: Exam 1 +7 Resting arm systolic BP 274552 phv00274552.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:55:21+00:00 2018-05-04 13:55:21+00:00 g3a456 Systolic blood pressure: Technician's reading +7 Resting arm systolic BP 10507 phv00010507.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:56:23+00:00 2018-05-04 13:56:23+00:00 G450 SYSTOLIC BLOOD PRESSURE - TECHNICIAN (TO NEAREST 2 MM HG) +7 Resting arm systolic BP 56853 phv00056853.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:57:21+00:00 2018-05-04 13:57:21+00:00 pm220a1 Systolic pressure, first seated bp reading +7 Resting arm systolic BP 56855 phv00056855.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:57:37+00:00 2018-05-04 13:57:37+00:00 pm220b1 Systolic pressure, second seated bp reading +7 Resting arm systolic BP 56857 phv00056857.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:57:54+00:00 2018-05-04 13:57:54+00:00 pm220c1 Systolic pressure, third seated bp reading +7 Resting arm systolic BP 254768 phv00254768.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:58:56+00:00 2018-05-04 13:58:56+00:00 fv263 Technician's Blood Pressure (Clinic only) - Systolic (nearest 2 mm Hg) Collection Interval: Exam 29 +7 Resting arm systolic BP 7110 phv00007110.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:59:28+00:00 2018-05-04 13:59:28+00:00 FT018 TECHNICIAN'S SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) +7 Resting arm systolic BP 70557 phv00070557.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 13:59:55+00:00 2018-05-04 13:59:55+00:00 FU270 TECHNICIAN'S SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) +7 Resting arm systolic BP 7683 phv00007683.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 14:03:49+00:00 2018-05-04 14:03:49+00:00 B22 BLOOD PRESSURE, SYSTOLIC, TAKEN BY NURSE +7 Resting arm systolic BP 7687 phv00007687.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 14:04:06+00:00 2018-05-04 14:04:06+00:00 B26 BLOOD PRESSURE, SYSTOLIC, SECOND PHYSICIAN +7 Resting arm systolic BP 8711 phv00008711.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 14:04:38+00:00 2018-05-04 14:04:38+00:00 C414 BP-SYSTOLIC - NURSE +7 Resting arm systolic BP 9395 phv00009395.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 14:05:05+00:00 2018-05-04 14:05:05+00:00 E485 BLOOD PRESSURE: SYSTOLIC - 1ST MD READING +7 Resting arm systolic BP 9486 phv00009486.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-04 14:05:44+00:00 2018-05-04 14:05:44+00:00 E581 BLOOD PRESSURE: SYSTOLIC - 2ND MD READING +7 Resting arm systolic BP 251691 phv00251691.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:21:19+00:00 2018-05-14 12:21:19+00:00 h630 Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Systolic Blood Pressures by Doppler, to be taken in the following order with participant supine after 5 minutes of rest - Left arm Collection Interval: Exam 3 +7 Resting arm systolic BP 251692 phv00251692.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:21:54+00:00 2018-05-14 12:21:54+00:00 h631 Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Systolic Blood Pressures by Doppler, to be taken in the following order with participant supine after 5 minutes of rest - Left arm Collection Interval: Exam 3 +7 Resting arm systolic BP 251688 phv00251688.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:22:14+00:00 2018-05-14 12:22:14+00:00 h627 Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Systolic Blood Pressures by Doppler, to be taken in the following order with participant supine after 5 minutes of rest - Right arm Collection Interval: Exam 3 +7 Resting arm systolic BP 251696 phv00251696.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:22:51+00:00 2018-05-14 12:22:51+00:00 h635 Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Third Systolic Blood Pressure Measurement (order as in repeat SBP) - Left arm Collection Interval: Exam 3 +7 Resting arm systolic BP 251699 phv00251699.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:23:21+00:00 2018-05-14 12:23:21+00:00 h638 Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Third Systolic Blood Pressure Measurement (order as in repeat SBP) - Right arm Collection Interval: Exam 3 +7 Resting arm systolic BP 251695 phv00251695.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:23:40+00:00 2018-05-14 12:23:40+00:00 h634 Doppler Ankle Brachial Blood Pressure Measurements - Tech Obtained: Repeat Systolic Blood Pressure Measurements (reverse order) - Right arm Collection Interval: Exam 3 +7 Resting arm systolic BP 257543 phv00257543.v1.p10 pht005149.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:24:19+00:00 2018-05-14 12:24:19+00:00 G3B0554 Ankle Brachial Blood Pressure Measurements: first systolic blood pressure, left arm +7 Resting arm systolic BP 257540 phv00257540.v1.p10 pht005149.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:24:56+00:00 2018-05-14 12:24:56+00:00 G3B0551 Ankle Brachial Blood Pressure Measurements: first systolic blood pressure, right arm +7 Resting arm systolic BP 257544 phv00257544.v1.p10 pht005149.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:25:27+00:00 2018-05-14 12:25:27+00:00 G3B0555 Ankle Brachial Blood Pressure Measurements: repeat systolic blood pressure, left arm +7 Resting arm systolic BP 257547 phv00257547.v1.p10 pht005149.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:25:49+00:00 2018-05-14 12:25:49+00:00 G3B0558 Ankle Brachial Blood Pressure Measurements: repeat systolic blood pressure, right arm +7 Resting arm systolic BP 257548 phv00257548.v1.p10 pht005149.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:26:19+00:00 2018-05-14 12:26:19+00:00 G3B0562 Ankle Brachial Blood Pressure Measurements: third systolic blood pressure, left arm +7 Resting arm systolic BP 257551 phv00257551.v1.p10 pht005149.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:26:54+00:00 2018-05-14 12:26:54+00:00 G3B0559 Ankle Brachial Blood Pressure Measurements: third systolic blood pressure, right arm +7 Resting arm systolic BP 257564 phv00257564.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:31:31+00:00 2018-05-14 12:31:31+00:00 j810 Ankle Brachial Blood Pressure Measurements: First systolic blood pressure, left arm +7 Resting arm systolic BP 257561 phv00257561.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:31:55+00:00 2018-05-14 12:31:55+00:00 j807 Ankle Brachial Blood Pressure Measurements: First systolic blood pressure, right arm +7 Resting arm systolic BP 257565 phv00257565.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:32:16+00:00 2018-05-14 12:32:16+00:00 j811 Ankle Brachial Blood Pressure Measurements: Repeat systolic blood pressure, left arm +7 Resting arm systolic BP 257568 phv00257568.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:32:45+00:00 2018-05-14 12:32:45+00:00 j814 Ankle Brachial Blood Pressure Measurements: Repeat systolic blood pressure, right arm +7 Resting arm systolic BP 257572 phv00257572.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:33:09+00:00 2018-05-14 12:33:09+00:00 j818 Ankle Brachial Blood Pressure Measurements: Third systolic blood pressure, left arm +7 Resting arm systolic BP 257569 phv00257569.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:33:28+00:00 2018-05-14 12:33:28+00:00 j815 Ankle Brachial Blood Pressure Measurements: Third systolic blood pressure, right arm +7 Resting arm systolic BP 23140 phv00023140.v1.p10 pht000138.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:34:39+00:00 2018-05-14 12:34:39+00:00 L_AR_REP REPEAT SYSTOLIC BLOOD PRESSURE MEASUREMENT BY DOPPLER IN LEFT ARM +7 Resting arm systolic BP 23141 phv00023141.v1.p10 pht000138.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:35:18+00:00 2018-05-14 12:35:18+00:00 R_AR_REP REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT BY DOPPLER IN RIGHT ARM +7 Resting arm systolic BP 23132 phv00023132.v1.p10 pht000138.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:35:57+00:00 2018-05-14 12:35:57+00:00 L_ARM SYSTOLIC BLOOD PRESSURE BY DOPPLER IN LEFT ARM +7 Resting arm systolic BP 23131 phv00023131.v1.p10 pht000138.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:36:34+00:00 2018-05-14 12:36:34+00:00 R_ARM SYSTOLIC BLOOD PRESSURE BY DOPPLER IN RIGHT ARM +7 Resting arm systolic BP 21592 phv00021592.v5.p10 pht000077.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:37:36+00:00 2018-05-14 12:37:36+00:00 L_ARM SYSTOLIC BLOOD PRESSURE BY DOPPLER IN LEFT ARM +7 Resting arm systolic BP 21600 phv00021600.v5.p10 pht000077.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:38:18+00:00 2018-05-14 12:38:18+00:00 L_ARM_RE REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT (BY DOPPLER) ON LEFT ARM +7 Resting arm systolic BP 21601 phv00021601.v5.p10 pht000077.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:39:10+00:00 2018-05-14 12:39:10+00:00 R_ARM_RE REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT (BY DOPPLER) ON RIGHT ARM +7 Resting arm systolic BP 21591 phv00021591.v5.p10 pht000077.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:39:32+00:00 2018-05-14 12:39:32+00:00 R_ARM SYSTOLIC BLOOD PRESSURE BY DOPPLER IN RIGHT ARM +7 Resting arm systolic BP 21581 phv00021581.v5.p10 pht000076.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:40:28+00:00 2018-05-14 12:40:28+00:00 L_AR_REP REPEAT SYSTOLIC BLOOD PRESSURE MEASUREMENT BY DOPPLER IN LEFT ARM +7 Resting arm systolic BP 21582 phv00021582.v5.p10 pht000076.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:41:08+00:00 2018-05-14 12:41:08+00:00 R_AR_REP REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT BY DOPPLER IN RIGHT ARM +7 Resting arm systolic BP 21572 phv00021572.v5.p10 pht000076.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:41:29+00:00 2018-05-14 12:41:29+00:00 R_ARM SYSTOLIC BLOOD PRESSURE BY DOPPLER IN RIGHT ARM +7 Resting arm systolic BP 8160 phv00008160.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:43:05+00:00 2018-05-14 12:43:05+00:00 B516 SYSTOLIC-RESTING, SIT +7 Resting arm systolic BP 2210 phv00002210.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 12:44:27+00:00 2018-05-14 12:44:27+00:00 FG70 BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 21599 phv00021599.v5.p10 pht000077.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:43:34+00:00 2018-05-14 13:43:34+00:00 R_AN_REP REPEAT SYSTOLIC BLOOD PRESURE MEASUREMENT (BY DOPPLER) ON RIGHT ANKLE +7 Resting arm systolic BP 24479 phv00024479.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:44:01+00:00 2018-05-14 13:44:01+00:00 sbp BRACHIAL SYSTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) +7 Resting arm systolic BP 56835 phv00056835.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:46:38+00:00 2018-05-14 13:46:38+00:00 avg23bps_s2 Average of 2nd and 3rd Systolic BP measures +7 Resting arm systolic BP 7685 phv00007685.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:46:58+00:00 2018-05-14 13:46:58+00:00 B24 BLOOD PRESSURE, SYSTOLIC, FIRST PHYSICIAN +7 Resting arm systolic BP 24374 phv00024374.v4.p10 pht000194.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:47:27+00:00 2018-05-14 13:47:27+00:00 BR05 MEAN SYSTOLIC BASELINE BLOOD PRESSURE, MMHG +7 Resting arm systolic BP 24456 phv00024456.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:47:59+00:00 2018-05-14 13:47:59+00:00 brsbp BASELINE SYSTOLIC BLOOD PRESSURE (RENAMED FROM EF23) +7 Resting arm systolic BP 276847 phv00276847.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:48:59+00:00 2018-05-14 13:48:59+00:00 CHF035 Vital Signs - Systolic Blood Pressure +7 Resting arm systolic BP 2431 phv00002431.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:50:00+00:00 2018-05-14 13:50:00+00:00 FH70 BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 3246 phv00003246.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:50:50+00:00 2018-05-14 13:50:50+00:00 FJ366 BLOOD PRESSURE, SYSTOLIC, BY NURSE +7 Resting arm systolic BP 6336 phv00006336.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:51:55+00:00 2018-05-14 13:51:55+00:00 FR013 TECHNICIAN SYSTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) WERE NOT DONE +7 Resting arm systolic BP 21573 phv00021573.v5.p10 pht000076.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:53:54+00:00 2018-05-14 13:53:54+00:00 L_ARM SYSTOLIC BLOOD PRESSURE BY DOPPLER IN LEFT ARM +7 Resting arm systolic BP 55283 phv00055283.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:54:30+00:00 2018-05-14 13:54:30+00:00 PLPSYS20 Palpated Systolic BP +7 Resting arm systolic BP 56851 phv00056851.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 13:54:58+00:00 2018-05-14 13:54:58+00:00 pm219a Palpated systolic (for pulse obliteration pressure) +7 Resting arm systolic BP 56863 phv00056863.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:00:01+00:00 2018-05-14 14:00:01+00:00 pm226c Right or left arm brachial systolic bp (first reading) +7 Resting arm systolic BP 56868 phv00056868.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:00:30+00:00 2018-05-14 14:00:30+00:00 pm226h Right or Left arm brachial systolic bp (second reading) +7 Resting arm systolic BP 72632 phv00072632.v4.p10 pht000748.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:00:52+00:00 2018-05-14 14:00:52+00:00 PSBP Mean systolic baseline blood pressure +7 Resting arm systolic BP 24412 phv00024412.v4.p10 pht000194.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:01:18+00:00 2018-05-14 14:01:18+00:00 sbp BRACHIAL SYSTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) +7 Resting arm systolic BP 72661 phv00072661.v4.p10 pht000748.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:01:53+00:00 2018-05-14 14:01:53+00:00 sbp Systolic blood pressure entered by technician +7 Resting arm systolic BP 24865 phv00024865.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:02:14+00:00 2018-05-14 14:02:14+00:00 sbp BRACHIAL SYSTOLIC PRESSURE (FROM TONOMETRY DATA) (MMHG) +7 Resting arm systolic BP 24778 phv00024778.v5.p10 pht000209.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:02:29+00:00 2018-05-14 14:02:29+00:00 sbp BRACHIAL SYSTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) (OLD NAME: TONSBP) +7 Resting arm systolic BP 24824 phv00024824.v4.p10 pht000210.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:02:47+00:00 2018-05-14 14:02:47+00:00 sbp BRACHIAL SYSTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) +7 Resting arm systolic BP 277045 phv00277045.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:04:29+00:00 2018-05-14 14:04:29+00:00 SBP1 Average systolic blood pressure, Exam 1 +7 Resting arm systolic BP 277185 phv00277185.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:04:40+00:00 2018-05-14 14:04:40+00:00 SBP1 Average systolic blood pressure, Exam 1 +7 Resting arm systolic BP 277046 phv00277046.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:04:51+00:00 2018-05-14 14:04:51+00:00 SBP2 Average systolic blood pressure, Exam 2 +7 Resting arm systolic BP 277186 phv00277186.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:05:00+00:00 2018-05-14 14:05:00+00:00 SBP2 Average systolic blood pressure, Exam 2 +7 Resting arm systolic BP 277187 phv00277187.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:05:10+00:00 2018-05-14 14:05:10+00:00 SBP3 Average systolic blood pressure, Exam 3 +7 Resting arm systolic BP 277188 phv00277188.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:05:18+00:00 2018-05-14 14:05:18+00:00 SBP4 Average systolic blood pressure, Exam 4 +7 Resting arm systolic BP 277189 phv00277189.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:05:27+00:00 2018-05-14 14:05:27+00:00 SBP5 Average systolic blood pressure, Exam 5 +7 Resting arm systolic BP 277190 phv00277190.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:05:38+00:00 2018-05-14 14:05:38+00:00 SBP6 Average systolic blood pressure, Exam 6 +7 Resting arm systolic BP 277191 phv00277191.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:05:50+00:00 2018-05-14 14:05:50+00:00 SBP7 Average systolic blood pressure, Exam 7 +7 Resting arm systolic BP 277192 phv00277192.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:06:01+00:00 2018-05-14 14:06:01+00:00 SBP8 Average systolic blood pressure, Exam 8 +7 Resting arm systolic BP 277193 phv00277193.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:06:12+00:00 2018-05-14 14:06:12+00:00 SBP9 Average systolic blood pressure, Exam 9 +7 Resting arm systolic BP 24891 phv00024891.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:06:45+00:00 2018-05-14 14:06:45+00:00 TM12 MANUAL BLOOD PRESSURE: SYSTOLIC (FIRST IF ODD ID#) (MMHG) +7 Resting arm systolic BP 24893 phv00024893.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 14:07:02+00:00 2018-05-14 14:07:02+00:00 TM14 AUTO BLOOD PRESSURE AND PULSE: SYSTOLIC (FIRST IF EVEN ID#) (MMHG) +7 Resting arm systolic BP 24461 phv00024461.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 18:05:11+00:00 2018-05-14 18:05:11+00:00 EF34 POST SYSTOLIC BLOOD PRESSURE +7 Resting arm systolic BP 2947 phv00002947.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 18:06:10+00:00 2018-05-14 18:06:10+00:00 FJ4 BLOOD PRESSURE, SYSTOLIC, FIRST READING TAKEN BY PHYSICIAN +7 Resting arm systolic BP 3316 phv00003316.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 18:07:37+00:00 2018-05-14 18:07:37+00:00 FK68 BLOOD PRESSURE, SYSTOLIC +7 Resting arm systolic BP 7358 phv00007358.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 18:09:03+00:00 2018-05-14 18:09:03+00:00 FT319 MEDICAL HISTORY - BLOOD PRESSURE - 1ST READING (TO NEAREST 2MM HG) +7 Resting arm systolic BP 174611 phv00174611.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-05-16 02:20:44+00:00 2018-05-16 02:20:44+00:00 rbrach5 RIGHT BRACHIAL BP (mmHg) +7 Resting arm systolic BP 176034 phv00176034.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-05-16 02:20:55+00:00 2018-05-16 02:20:55+00:00 rbrach5 RIGHT BRACHIAL BP (mmHg) +7 Resting arm systolic BP 82665 phv00082665.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-05-16 02:21:06+00:00 2018-05-16 02:21:06+00:00 rbrach1 RIGHT BRACHIAL BP (mmHg) +7 Resting arm systolic BP 84466 phv00084466.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-05-16 02:21:13+00:00 2018-05-16 02:21:13+00:00 rbrach1 RIGHT BRACHIAL BP (mmHg) +7 Resting arm systolic BP 86286 phv00086286.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-05-16 02:21:21+00:00 2018-05-16 02:21:21+00:00 rbrach3 RIGHT BRACHIAL BP (mmHg) +7 Resting arm systolic BP 87482 phv00087482.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-05-16 02:21:29+00:00 2018-05-16 02:21:29+00:00 rbrachf SYSTOLIC READINGS: RIGHT BRACHIAL +7 Resting arm systolic BP 124560 phv00124560.v1.p1 pht001921.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-05-23 15:59:15+00:00 2018-05-23 15:59:15+00:00 ABBA5 5: Doppler systolic BP (mm Hg) +7 Resting arm systolic BP 124562 phv00124562.v1.p1 pht001921.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-05-23 16:00:37+00:00 2018-05-23 16:00:37+00:00 ABBA7 7: First brachial Doppler BP (mm Hg) +7 Resting arm systolic BP 124567 phv00124567.v1.p1 pht001921.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-05-23 16:00:51+00:00 2018-05-23 16:00:51+00:00 ABBA12 12: Second brachial BP (mm Hg) +7 Resting arm systolic BP 123001 phv00123001.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-06-18 19:15:42+00:00 2018-06-18 19:15:42+00:00 sbp Mean Systolic BP +7 Resting arm systolic BP 277302 phv00277302.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:51:10+00:00 2018-08-02 18:51:10+00:00 DINA_SYS3 Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 2007-2009 +7 Resting arm systolic BP 277298 phv00277298.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:51:20+00:00 2018-08-02 18:51:20+00:00 DINA_SYS2 Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 2007-2009 +7 Resting arm systolic BP 277294 phv00277294.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:51:29+00:00 2018-08-02 18:51:29+00:00 DINA_SYS1 Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 2007-2009 +7 Resting arm systolic BP 277344 phv00277344.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:52:07+00:00 2018-08-02 18:52:07+00:00 DINA_SYS3 Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 2009-2011 +7 Resting arm systolic BP 277340 phv00277340.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:52:16+00:00 2018-08-02 18:52:16+00:00 DINA_SYS2 Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 2009-2011 +7 Resting arm systolic BP 277336 phv00277336.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:52:24+00:00 2018-08-02 18:52:24+00:00 DINA_SYS1 Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 2009-2011 +7 Resting arm systolic BP 307737 phv00307737.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:52:32+00:00 2018-08-02 18:52:32+00:00 BpTRU_SYS3 BpTRU: Systolic; 3rd of 3 readings Collection Interval: 2007-2009 +7 Resting arm systolic BP 307735 phv00307735.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:52:50+00:00 2018-08-02 18:52:50+00:00 BpTRU_SYS2 BpTRU: Systolic; 2nd of 3 readings Collection Interval: 2007-2009 +7 Resting arm systolic BP 307733 phv00307733.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:52:59+00:00 2018-08-02 18:52:59+00:00 BpTRU_SYS1 BpTRU: Systolic; 1st of 3 readings Collection Interval: 2007-2009 +7 Resting arm systolic BP 277772 phv00277772.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:53:40+00:00 2018-08-02 18:53:40+00:00 RAND_SYS3 Random Zero Sphygmomanometer BP: Systolic #3 Collection Interval: 2000-2004 +7 Resting arm systolic BP 277770 phv00277770.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:53:51+00:00 2018-08-02 18:53:51+00:00 RAND_SYS2 Random Zero Sphygmomanometer BP: Systolic #2 Collection Interval: 2000-2004 +7 Resting arm systolic BP 277768 phv00277768.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:54:00+00:00 2018-08-02 18:54:00+00:00 RAND_SYS1 Random Zero Sphygmomanometer BP: Systolic #1 Collection Interval: 2000-2004 +7 Resting arm systolic BP 277664 phv00277664.v1.p1 pht006045.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:54:09+00:00 2018-08-02 18:54:09+00:00 ECHOSYS Dinamap BP while lying on Echo bed: systolic Collection Interval: 2001-2004 +7 Resting arm systolic BP 277533 phv00277533.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:54:17+00:00 2018-08-02 18:54:17+00:00 DINA_SYS3 Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 277529 phv00277529.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:54:26+00:00 2018-08-02 18:54:26+00:00 DINA_SYS2 Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 277525 phv00277525.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:54:34+00:00 2018-08-02 18:54:34+00:00 DINA_SYS1 Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 277522 phv00277522.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:54:44+00:00 2018-08-02 18:54:44+00:00 RAND_SYS3 Random-zero sphygmomanometer: Systolic; 3rd of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 277520 phv00277520.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:54:53+00:00 2018-08-02 18:54:53+00:00 RAND_SYS2 Random-zero sphygmomanometer: Systolic; 2nd of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 277518 phv00277518.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:55:01+00:00 2018-08-02 18:55:01+00:00 RAND_SYS1 Random-zero sphygmomanometer: Systolic; 1st of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 307750 phv00307750.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:55:52+00:00 2018-08-02 18:55:52+00:00 BpTRU_SYS3 BpTRU: Systolic; 3rd of 3 readings Collection Interval: 2006-2011 +7 Resting arm systolic BP 307748 phv00307748.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:55:59+00:00 2018-08-02 18:55:59+00:00 BpTRU_SYS2 BpTRU: Systolic; 2nd of 3 readings Collection Interval: 2006-2011 +7 Resting arm systolic BP 307746 phv00307746.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:56:07+00:00 2018-08-02 18:56:07+00:00 BpTRU_SYS1 BpTRU: Systolic; 1st of 3 readings Collection Interval: 2006-2011 +7 Resting arm systolic BP 277787 phv00277787.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:56:15+00:00 2018-08-02 18:56:15+00:00 RSYSBP Ankle brachial index measurement: Right arm systolic blood pressure Collection Interval: 2000-2004 +7 Resting arm systolic BP 277786 phv00277786.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:56:23+00:00 2018-08-02 18:56:23+00:00 LSYSBP Ankle brachial index measurement: Left arm systolic blood pressure Collection Interval: 2000-2004 +7 Resting arm systolic BP 277783 phv00277783.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:56:31+00:00 2018-08-02 18:56:31+00:00 DINA_SYS3 Dinamap BP: Systolic #3 Collection Interval: 2000-2004 +7 Resting arm systolic BP 277779 phv00277779.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:56:38+00:00 2018-08-02 18:56:38+00:00 DINA_SYS2 Dinamap BP: Systolic #2 Collection Interval: 2000-2004 +7 Resting arm systolic BP 277775 phv00277775.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:56:45+00:00 2018-08-02 18:56:45+00:00 DINA_SYS1 Dinamap BP: Systolic #1 Collection Interval: 2000-2004 +7 Resting arm systolic BP 307963 phv00307963.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:57:23+00:00 2018-08-02 18:57:23+00:00 RAND_SYS3 Random Zero Sphygmomanometer BP: Systolic #3 Collection Interval: 2000-2004 +7 Resting arm systolic BP 307961 phv00307961.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:57:31+00:00 2018-08-02 18:57:31+00:00 RAND_SYS2 Random Zero Sphygmomanometer BP: Systolic #2 Collection Interval: 2000-2004 +7 Resting arm systolic BP 307959 phv00307959.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:57:46+00:00 2018-08-02 18:57:46+00:00 RAND_SYS1 Random Zero Sphygmomanometer BP: Systolic #1 Collection Interval: 2000-2004 +7 Resting arm systolic BP 307814 phv00307814.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:57:54+00:00 2018-08-02 18:57:54+00:00 DINA_SYS3 Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 307810 phv00307810.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:58:03+00:00 2018-08-02 18:58:03+00:00 DINA_SYS2 Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 307806 phv00307806.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:58:11+00:00 2018-08-02 18:58:11+00:00 DINA_SYS1 Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 307803 phv00307803.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:58:19+00:00 2018-08-02 18:58:19+00:00 RAND_SYS3 Random-zero sphygmomanometer: Systolic; 3rd of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 307801 phv00307801.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:58:27+00:00 2018-08-02 18:58:27+00:00 RAND_SYS2 Random-zero sphygmomanometer: Systolic; 2nd of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 307799 phv00307799.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:58:35+00:00 2018-08-02 18:58:35+00:00 RAND_SYS1 Random-zero sphygmomanometer: Systolic; 1st of 3 readings Collection Interval: 1996-2000 +7 Resting arm systolic BP 307762 phv00307762.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:58:45+00:00 2018-08-02 18:58:45+00:00 DINA_SYS3 Dinamap: Systolic pressure; 3rd of 3 readings Collection Interval: 2006-2011 +7 Resting arm systolic BP 307758 phv00307758.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:58:54+00:00 2018-08-02 18:58:54+00:00 DINA_SYS2 Dinamap: Systolic pressure; 2nd of 3 readings Collection Interval: 2006-2011 +7 Resting arm systolic BP 307754 phv00307754.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:59:06+00:00 2018-08-02 18:59:06+00:00 DINA_SYS1 Dinamap: Systolic pressure; 1st of 3 readings Collection Interval: 2006-2011 +7 Resting arm systolic BP 307978 phv00307978.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:59:31+00:00 2018-08-02 18:59:31+00:00 RSYSBP Ankle brachial index measurement: Right arm systolic blood pressure Collection Interval: 2000-2004 +7 Resting arm systolic BP 307977 phv00307977.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:59:39+00:00 2018-08-02 18:59:39+00:00 LSYSBP Ankle brachial index measurement: Left arm systolic blood pressure Collection Interval: 2000-2004 +7 Resting arm systolic BP 307974 phv00307974.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:59:48+00:00 2018-08-02 18:59:48+00:00 DINA_SYS3 Dinamap BP: Systolic #3 Collection Interval: 2000-2004 +7 Resting arm systolic BP 307970 phv00307970.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:59:56+00:00 2018-08-02 18:59:56+00:00 DINA_SYS2 Dinamap BP: Systolic #2 Collection Interval: 2000-2004 +7 Resting arm systolic BP 307966 phv00307966.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:00:05+00:00 2018-08-02 19:00:05+00:00 DINA_SYS1 Dinamap BP: Systolic #1 Collection Interval: 2000-2004 +7 Resting arm systolic BP 159590 phv00159590.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-02 19:10:33+00:00 2018-08-02 19:10:33+00:00 sysBP Systolic blood pressure [mmHg] Collection Interval: Collected in Exam 1 +7 Resting arm systolic BP 277669 phv00277669.v1.p1 pht006045.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:00:58+00:00 2018-08-14 23:00:58+00:00 ECHO_SBP Systolic BP Collection Interval: 2001-2004 +7 Resting arm systolic BP 123110 phv00123110.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:03:36+00:00 2018-08-17 20:03:36+00:00 RARMBP1 Ankle-Arm: Right Arm Systolic Blood Pressure 1 +7 Resting arm systolic BP 123113 phv00123113.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:03:45+00:00 2018-08-17 20:03:45+00:00 LARMBP1 Ankle-Arm: Left Arm Systolic Blood Pressure 1 +7 Resting arm systolic BP 123114 phv00123114.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:03:57+00:00 2018-08-17 20:03:57+00:00 LARMBP2 Ankle-Arm: Left Arm Systolic Blood Pressure 2 +7 Resting arm systolic BP 123117 phv00123117.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:04:07+00:00 2018-08-17 20:04:07+00:00 RARMBP2 Ankle-Arm: Right Arm Systolic Blood Pressure 2 +7 Resting arm systolic BP 123844 phv00123844.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:57:34+00:00 2018-08-21 17:57:34+00:00 PM10SYS1 BP: 10 PM - Systolic 1 +7 Resting arm systolic BP 123847 phv00123847.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:58:09+00:00 2018-08-21 17:58:09+00:00 PM10SYS2 BP: 10 PM - Systolic 2 +7 Resting arm systolic BP 123850 phv00123850.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:58:24+00:00 2018-08-21 17:58:24+00:00 PM10SYS3 BP: 10 PM - Systolic 3 +7 Resting arm systolic BP 123854 phv00123854.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:58:38+00:00 2018-08-21 17:58:38+00:00 AM7SYS1 BP: 7 AM - Systolic 1 +7 Resting arm systolic BP 123857 phv00123857.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:58:58+00:00 2018-08-21 17:58:58+00:00 AM7SYS2 BP: 7 AM - Systolic 2 +7 Resting arm systolic BP 123860 phv00123860.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:59:10+00:00 2018-08-21 17:59:10+00:00 AM7SYS3 BP: 7 AM - Systolic 3 +7 Resting arm systolic BP 123864 phv00123864.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:23:29+00:00 2018-08-21 18:23:29+00:00 AM10SYS1 BP: 10 AM - Systolic 1 +7 Resting arm systolic BP 123867 phv00123867.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:23:42+00:00 2018-08-21 18:23:42+00:00 AM10SYS2 BP: 10 AM - Systolic 2 +7 Resting arm systolic BP 123870 phv00123870.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:23:53+00:00 2018-08-21 18:23:53+00:00 AM10SYS3 BP: 10 AM - Systolic 3 +7 Resting arm systolic BP 124246 phv00124246.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:51:06+00:00 2018-08-21 18:51:06+00:00 pm10sys BP: 10 PM Systolic +7 Resting arm systolic BP 124248 phv00124248.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:51:17+00:00 2018-08-21 18:51:17+00:00 am7sys BP: 7 AM Systolic +7 Resting arm systolic BP 124250 phv00124250.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:51:28+00:00 2018-08-21 18:51:28+00:00 am10sys BP: 10 AM Systolic +7 Resting arm systolic BP 114878 phv00114878.v2.p2 pht001633.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:42:34+00:00 2018-08-22 23:42:34+00:00 B28SBP4 PRE-INSTRUCTION BASELINE SBP #4 +7 Resting arm systolic BP 114874 phv00114874.v2.p2 pht001633.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:42:49+00:00 2018-08-22 23:42:49+00:00 B28SBP3 PRE-INSTRUCTION BASELINE SBP #3 +7 Resting arm systolic BP 114870 phv00114870.v2.p2 pht001633.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:43:03+00:00 2018-08-22 23:43:03+00:00 B28SBP2 PRE-INSTRUCTION BASELINE SBP #2 +7 Resting arm systolic BP 114866 phv00114866.v2.p2 pht001633.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:43:17+00:00 2018-08-22 23:43:17+00:00 B28SBP1 PRE-INSTRUCTION BASELINE SBP #1 +7 Resting arm systolic BP 116232 phv00116232.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 18:49:37+00:00 2018-08-23 18:49:37+00:00 C42AYS2 SYSTOLIC Y-TUBED BP -2ND READING +7 Resting arm systolic BP 116268 phv00116268.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 18:50:32+00:00 2018-08-23 18:50:32+00:00 C42AEYS1 END OF TEST Y-TUBED SYSTOLIC -1ST READ +7 Resting arm systolic BP 116248 phv00116248.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 18:50:50+00:00 2018-08-23 18:50:50+00:00 C42AYS6 SYSTOLIC Y-TUBED BP - 6TH READING +7 Resting arm systolic BP 258089 phv00258089.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:04:54+00:00 2018-08-24 17:04:54+00:00 ABPA1A Right brachial systolic blood pressure (mm HG) (ABPA1A) +7 Resting arm systolic BP 258094 phv00258094.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:05:06+00:00 2018-08-24 17:05:06+00:00 ABPA1F Left brachial systolic blood pressure (mm HG) (ABPA1F) +8 Resting arm diastolic BP 226391 phv00226391.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2017-12-26 20:47:50+00:00 2017-12-26 20:47:50+00:00 SBPA6 Average diastolic blood pressure (SBPA6) +8 Resting arm diastolic BP 259053 phv00259053.v1.p1 pht003918.v2.p1 phs000741.v2.p1 GOLDN 741 2 2017-12-27 17:37:35+00:00 2017-12-27 17:37:35+00:00 DBP Diastolic blood pressure +8 Resting arm diastolic BP 258704 phv00258704.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2017-12-27 17:50:35+00:00 2017-12-27 17:50:35+00:00 Diastolic_BP_Av3 Diastolic blood pressure (average of all three measurements) +8 Resting arm diastolic BP 258703 phv00258703.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2017-12-27 17:50:54+00:00 2017-12-27 17:50:54+00:00 Diastolic_BP Diastolic blood pressure (average of last two measurements) +8 Resting arm diastolic BP 252996 phv00252996.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2017-12-27 20:57:59+00:00 2017-12-27 20:57:59+00:00 dbp_baseline Diastolic blood pressure at baseline visit +8 Resting arm diastolic BP 122562 phv00122562.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-27 23:04:02+00:00 2017-12-27 23:04:02+00:00 DIAS1 1st diastolic bp +8 Resting arm diastolic BP 122564 phv00122564.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-27 23:04:08+00:00 2017-12-27 23:04:08+00:00 DIAS2 2nd diastolic bp +8 Resting arm diastolic BP 122648 phv00122648.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2017-12-27 23:04:16+00:00 2017-12-27 23:04:16+00:00 mndias Mean diastolic - two readings +8 Resting arm diastolic BP 100436 phv00100436.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-01-08 21:27:18+00:00 2018-01-08 21:27:18+00:00 AVZMDIA AVE ZERO MUD DIASTOL-adj (mm Hg) +8 Resting arm diastolic BP 128371 phv00128371.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:10:22+00:00 2018-02-22 21:10:22+00:00 SBPA14 14: Diastolic (first BP) +8 Resting arm diastolic BP 128372 phv00128372.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:10:22+00:00 2018-02-22 21:10:22+00:00 SBPA15 15: Zero reading (first BP) +8 Resting arm diastolic BP 128374 phv00128374.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:10:22+00:00 2018-02-22 21:10:22+00:00 SBPA17 17: Diastolic (second BP) +8 Resting arm diastolic BP 128375 phv00128375.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:10:22+00:00 2018-02-22 21:10:22+00:00 SBPA18 18: Zero Reading (second BP) +8 Resting arm diastolic BP 128377 phv00128377.v1.p1 pht001974.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:10:22+00:00 2018-02-22 21:10:22+00:00 SBPA20 20: Diastolic (computed net average) +8 Resting arm diastolic BP 125872 phv00125872.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:39:31+00:00 2018-02-22 21:39:31+00:00 BAPA9B 9b: Sphygmomanometer (DBP) +8 Resting arm diastolic BP 125877 phv00125877.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:45:49+00:00 2018-02-22 21:45:49+00:00 BAPA10B 10b: Sphygmomanometer (DBP) +8 Resting arm diastolic BP 125882 phv00125882.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:45:49+00:00 2018-02-22 21:45:49+00:00 BAPA11B 11b: Sphygmomanometer (DBP) +8 Resting arm diastolic BP 125887 phv00125887.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:45:49+00:00 2018-02-22 21:45:49+00:00 BAPA12B 12b: Sphygmomanometer (DBP) +8 Resting arm diastolic BP 125892 phv00125892.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:45:49+00:00 2018-02-22 21:45:49+00:00 BAPA13B 13b: Sphygmomanometer (DBP) +8 Resting arm diastolic BP 125897 phv00125897.v1.p1 pht001941.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:45:49+00:00 2018-02-22 21:45:49+00:00 BAPA14B 14b: Sphygmomanometer (mean accepted DBP) +8 Resting arm diastolic BP 529 phv00000529.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:35:49+00:00 2018-02-27 12:35:49+00:00 MF57 BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 1 +8 Resting arm diastolic BP 531 phv00000531.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:36:09+00:00 2018-02-27 12:36:09+00:00 MF59 BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 1 +8 Resting arm diastolic BP 533 phv00000533.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:36:20+00:00 2018-02-27 12:36:20+00:00 MF61 BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 1 +8 Resting arm diastolic BP 621 phv00000621.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:36:33+00:00 2018-02-27 12:36:33+00:00 MF155 BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 2 +8 Resting arm diastolic BP 623 phv00000623.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:36:43+00:00 2018-02-27 12:36:43+00:00 MF157 BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 2 +8 Resting arm diastolic BP 625 phv00000625.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:36:55+00:00 2018-02-27 12:36:55+00:00 MF159 BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 2 +8 Resting arm diastolic BP 641 phv00000641.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:37:09+00:00 2018-02-27 12:37:09+00:00 MF175 BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 3 +8 Resting arm diastolic BP 643 phv00000643.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:37:19+00:00 2018-02-27 12:37:19+00:00 MF177 BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 3 +8 Resting arm diastolic BP 645 phv00000645.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:37:33+00:00 2018-02-27 12:37:33+00:00 MF179 BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 3 +8 Resting arm diastolic BP 720 phv00000720.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:37:43+00:00 2018-02-27 12:37:43+00:00 MF265 BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 4 +8 Resting arm diastolic BP 722 phv00000722.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:37:53+00:00 2018-02-27 12:37:53+00:00 MF267 BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 4 +8 Resting arm diastolic BP 758 phv00000758.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:38:04+00:00 2018-02-27 12:38:04+00:00 MF306 BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 5 +8 Resting arm diastolic BP 760 phv00000760.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:39:14+00:00 2018-02-27 12:39:14+00:00 MF308 BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 5 +8 Resting arm diastolic BP 762 phv00000762.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:39:26+00:00 2018-02-27 12:39:26+00:00 MF310 BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 5 +8 Resting arm diastolic BP 834 phv00000834.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:39:40+00:00 2018-02-27 12:39:40+00:00 MF385 BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 6 +8 Resting arm diastolic BP 836 phv00000836.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:39:51+00:00 2018-02-27 12:39:51+00:00 MF387 BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 6 +8 Resting arm diastolic BP 838 phv00000838.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:40:04+00:00 2018-02-27 12:40:04+00:00 MF389 BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 6 +8 Resting arm diastolic BP 919 phv00000919.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:40:16+00:00 2018-02-27 12:40:16+00:00 MF477 BLOOD PRESSURE: ADMISSION, DIASTOLIC, EXAM 7 +8 Resting arm diastolic BP 921 phv00000921.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:40:30+00:00 2018-02-27 12:40:30+00:00 MF479 BLOOD PRESSURE: FIRST EXAMINER, DIASTOLIC, EXAM 7 +8 Resting arm diastolic BP 923 phv00000923.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:40:44+00:00 2018-02-27 12:40:44+00:00 MF481 BLOOD PRESSURE: SECOND EXAMINER, DIASTOLIC, EXAM 7 +8 Resting arm diastolic BP 1042 phv00001042.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:43:35+00:00 2018-02-27 12:43:35+00:00 FA8 DIASTOLIC BLOOD PRESSURE, NURSE (MM HG) +8 Resting arm diastolic BP 1044 phv00001044.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:43:45+00:00 2018-02-27 12:43:45+00:00 FA10 DIASTOLIC BLOOD PRESSURE, FIRST EXAMINER (MM HG) +8 Resting arm diastolic BP 1046 phv00001046.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:44:00+00:00 2018-02-27 12:44:00+00:00 FA12 DIASTOLIC BLOOD PRESSURE, SECOND EXAMINER (MM HG) +8 Resting arm diastolic BP 1196 phv00001196.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:44:17+00:00 2018-02-27 12:44:17+00:00 FB19 BLOOD PRESSURE: DIASTOLIC, TAKEN BY NURSE +8 Resting arm diastolic BP 1198 phv00001198.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:44:30+00:00 2018-02-27 12:44:30+00:00 FB21 BLOOD PRESSURE: DIASTOLIC, PHYSICIAN'S FIRST READING +8 Resting arm diastolic BP 1200 phv00001200.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:44:44+00:00 2018-02-27 12:44:44+00:00 FB23 BLOOD PRESSURE: DIASTOLIC, PHYSICIAN'S SECOND READING +8 Resting arm diastolic BP 1371 phv00001371.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:45:08+00:00 2018-02-27 12:45:08+00:00 FC13 BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE (MM HG) +8 Resting arm diastolic BP 1373 phv00001373.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:45:19+00:00 2018-02-27 12:45:19+00:00 FC15 BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN (MM HG) +8 Resting arm diastolic BP 1375 phv00001375.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:45:32+00:00 2018-02-27 12:45:32+00:00 FC17 BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN (MM HG) +8 Resting arm diastolic BP 1568 phv00001568.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:46:32+00:00 2018-02-27 12:46:32+00:00 FD21 BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE +8 Resting arm diastolic BP 1570 phv00001570.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:46:50+00:00 2018-02-27 12:46:50+00:00 FD23 BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 1572 phv00001572.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:47:02+00:00 2018-02-27 12:47:02+00:00 FD25 BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 1810 phv00001810.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:47:18+00:00 2018-02-27 12:47:18+00:00 FE74 BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE +8 Resting arm diastolic BP 1812 phv00001812.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:47:33+00:00 2018-02-27 12:47:33+00:00 FE76 BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 1814 phv00001814.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:47:45+00:00 2018-02-27 12:47:45+00:00 FE78 BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 2025 phv00002025.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:48:05+00:00 2018-02-27 12:48:05+00:00 FF70 BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE +8 Resting arm diastolic BP 2027 phv00002027.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:48:17+00:00 2018-02-27 12:48:17+00:00 FF72 BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 2029 phv00002029.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:48:28+00:00 2018-02-27 12:48:28+00:00 FF74 BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 2209 phv00002209.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:48:50+00:00 2018-02-27 12:48:50+00:00 FG69 BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE +8 Resting arm diastolic BP 2211 phv00002211.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:49:05+00:00 2018-02-27 12:49:05+00:00 FG71 BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 2213 phv00002213.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:49:17+00:00 2018-02-27 12:49:17+00:00 FG73 BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 2430 phv00002430.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:49:28+00:00 2018-02-27 12:49:28+00:00 FH69 BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE +8 Resting arm diastolic BP 2432 phv00002432.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:49:39+00:00 2018-02-27 12:49:39+00:00 FH71 BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 2434 phv00002434.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:49:56+00:00 2018-02-27 12:49:56+00:00 FH73 BLOOD PRESSURE, DIASTOLIC, SECOND READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 2674 phv00002674.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:50:10+00:00 2018-02-27 12:50:10+00:00 FI22 BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE (MM HG) +8 Resting arm diastolic BP 2676 phv00002676.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:50:21+00:00 2018-02-27 12:50:21+00:00 FI24 BLOOD PRESSURE, DIASTOLIC, FIRST TAKEN BY PHYSICIAN (MM HG) +8 Resting arm diastolic BP 2678 phv00002678.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:50:33+00:00 2018-02-27 12:50:33+00:00 FI26 BLOOD PRESSURE, DIASTOLIC, SECOND TAKEN BY PHYSICIAN (MM HG) +8 Resting arm diastolic BP 2948 phv00002948.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:52:58+00:00 2018-02-27 12:52:58+00:00 FJ5 BLOOD PRESSURE, DIASTOLIC, FIRST READING TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 3173 phv00003173.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:53:15+00:00 2018-02-27 12:53:15+00:00 FJ271 BLOOD PRESSURE: DIASTOLIC - SUPINE +8 Resting arm diastolic BP 3177 phv00003177.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:53:43+00:00 2018-02-27 12:53:43+00:00 FJ275 BLOOD PRESSURE: DIASTOLIC - 2ND READING BY PHYSICIAN +8 Resting arm diastolic BP 3247 phv00003247.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:54:01+00:00 2018-02-27 12:54:01+00:00 FJ367 BLOOD PRESSURE, DIASTOLIC, BY NURSE +8 Resting arm diastolic BP 3307 phv00003307.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:54:16+00:00 2018-02-27 12:54:16+00:00 FK56 BLOOD PRESSURE, DIASTOLIC-NURSE +8 Resting arm diastolic BP 3317 phv00003317.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:55:36+00:00 2018-02-27 12:55:36+00:00 FK69 BLOOD PRESSURE, DIASTOLIC +8 Resting arm diastolic BP 3592 phv00003592.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:56:20+00:00 2018-02-27 12:56:20+00:00 FK370 BLOOD PRESSURE: DIASTOLIC - 2ND PHYSICIAN +8 Resting arm diastolic BP 3676 phv00003676.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:56:35+00:00 2018-02-27 12:56:35+00:00 FL022 DIASTOLIC BLOOD PRESSURE-NURSE +8 Resting arm diastolic BP 3689 phv00003689.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:56:49+00:00 2018-02-27 12:56:49+00:00 FL292 PHYSICIAN DIASTOLIC PRESSURE 1ST READ +8 Resting arm diastolic BP 3691 phv00003691.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:57:03+00:00 2018-02-27 12:57:03+00:00 FL389 PHYSICIAN DIASTOLIC BP 2ND READING +8 Resting arm diastolic BP 4092 phv00004092.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:57:27+00:00 2018-02-27 12:57:27+00:00 FM32 DIASTOLIC BLOOD PRESSURE-NURSE +8 Resting arm diastolic BP 4107 phv00004107.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:57:46+00:00 2018-02-27 12:57:46+00:00 FM332 PHYSICIAN DIASTOLIC PRESSURE 1ST READ (UNEQUAL # OF UNKNOWN SBP'S AND DBP'S) +8 Resting arm diastolic BP 4109 phv00004109.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:58:02+00:00 2018-02-27 12:58:02+00:00 FM428 PHYSICIAN DIASTOLIC BP 2ND READING (UNEQUAL # OF UNKNOWN SBP'S AND DBP'S) +8 Resting arm diastolic BP 4534 phv00004534.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:58:22+00:00 2018-02-27 12:58:22+00:00 FN22 DIASTOLIC BLOOD PRESSURE - NURSE +8 Resting arm diastolic BP 4547 phv00004547.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:58:36+00:00 2018-02-27 12:58:36+00:00 FN311 BLOOD PRESSURE: DIASTOLIC - 1ST MD READING +8 Resting arm diastolic BP 4549 phv00004549.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:58:48+00:00 2018-02-27 12:58:48+00:00 FN405 BLOOD PRESSURE: DIASTOLIC - 2ND MD READING +8 Resting arm diastolic BP 5139 phv00005139.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:59:09+00:00 2018-02-27 12:59:09+00:00 FO330 BLOOD PRESSURE: DIASTOLIC - 1ST M.D. READING +8 Resting arm diastolic BP 5229 phv00005229.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:59:26+00:00 2018-02-27 12:59:26+00:00 FO425 BLOOD PRESSURE: DIASTOLIC - 2ND MD READING +8 Resting arm diastolic BP 5549 phv00005549.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 12:59:55+00:00 2018-02-27 12:59:55+00:00 FO021 DIASTOLIC NURSE'S BLOOD PRESSURE +8 Resting arm diastolic BP 5767 phv00005767.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:00:10+00:00 2018-02-27 13:00:10+00:00 FP297 BLOOD PRESSURE: DIASTOLIC - 1ST MD READING +8 Resting arm diastolic BP 5856 phv00005856.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:00:21+00:00 2018-02-27 13:00:21+00:00 FP391 BLOOD PRESSURE: DIASTOLIC - 2ND MD READING +8 Resting arm diastolic BP 5935 phv00005935.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:00:35+00:00 2018-02-27 13:00:35+00:00 FP026 DIASTOLIC BLOOD PRESSURE - NURSE +8 Resting arm diastolic BP 6042 phv00006042.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:00:51+00:00 2018-02-27 13:00:51+00:00 FQ014 DIASTOLIC BLOOD PRESSURE-NUMERICAL DATA I (FIRST READING) TO NEAREST 2 MM HG +8 Resting arm diastolic BP 6044 phv00006044.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:01:05+00:00 2018-02-27 13:01:05+00:00 FQ018 DIASTOLIC BLOOD PRESSURE-NUMERICAL DATA I (SECOND READING) TO NEAREST 2 MM HG +8 Resting arm diastolic BP 6251 phv00006251.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:01:18+00:00 2018-02-27 13:01:18+00:00 FQ305 DIASTOLIC BLOOD PRESSURE-2ND EXAMINER (FIRST READING) TO NEAREST 2 MM HG +8 Resting arm diastolic BP 6253 phv00006253.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:01:29+00:00 2018-02-27 13:01:29+00:00 FQ309 DIASTOLIC BLOOD PRESURE-2ND EXAMINER (SECOND READING) TO NEAREST 2 MM HG +8 Resting arm diastolic BP 6337 phv00006337.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:02:28+00:00 2018-02-27 13:02:28+00:00 FR014 TECHNICIAN DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) WERE NOT DONE +8 Resting arm diastolic BP 6513 phv00006513.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:30:52+00:00 2018-02-27 13:30:52+00:00 FR240 PHYSICIAN BLOOD PRESSURE (FIRST READING) DIASTOLIC (TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 6608 phv00006608.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:31:09+00:00 2018-02-27 13:31:09+00:00 FR381 PHYSICIAN BLOOD PRESSURE (SECOND READING) DIASTOLIC (TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 6681 phv00006681.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:31:22+00:00 2018-02-27 13:31:22+00:00 FS016 DIASTOLIC BLOOD PRESSURE - TECHNICIAN (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 6922 phv00006922.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:31:36+00:00 2018-02-27 13:31:36+00:00 FS313 PHYSICIAN DIASTOLIC BLOOD PRESSURE - 1ST READING (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 7042 phv00007042.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:32:11+00:00 2018-02-27 13:32:11+00:00 FS480 PHYSICIAN DIASTOLIC BLOOD PRESSURE - 2ND READING (TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 7111 phv00007111.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:32:30+00:00 2018-02-27 13:32:30+00:00 FT019 TECHNICIANS'S DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 7475 phv00007475.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:32:44+00:00 2018-02-27 13:32:44+00:00 FT484 DIASTOLIC BLOOD PRESSURE - 2ND READING (TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 7573 phv00007573.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:33:20+00:00 2018-02-27 13:33:20+00:00 A54 NURSE DIASTOLIC BLOOD PRESSURE +8 Resting arm diastolic BP 7575 phv00007575.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:33:30+00:00 2018-02-27 13:33:30+00:00 A56 PHYSICIAN DIASTOLIC BLOOD PRESSURE, FIRST +8 Resting arm diastolic BP 7577 phv00007577.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:33:40+00:00 2018-02-27 13:33:40+00:00 A58 PHYSICIAN DIASTOLIC BLOOD PRESSURE, SECOND +8 Resting arm diastolic BP 7684 phv00007684.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:34:05+00:00 2018-02-27 13:34:05+00:00 B23 BLOOD PRESSURE, DIASTOLIC, TAKEN BY NURSE +8 Resting arm diastolic BP 7686 phv00007686.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:34:16+00:00 2018-02-27 13:34:16+00:00 B25 BLOOD PRESSURE, DIASTOLIC, FIRST PHYSICIAN +8 Resting arm diastolic BP 7688 phv00007688.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:34:29+00:00 2018-02-27 13:34:29+00:00 B27 BLOOD PRESSURE, DIASTOLIC, SECOND TAKEN BY PHYSICIAN +8 Resting arm diastolic BP 8161 phv00008161.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:35:21+00:00 2018-02-27 13:35:21+00:00 B517 DIASTOLIC-RESTING, SIT +8 Resting arm diastolic BP 8540 phv00008540.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:40:11+00:00 2018-02-27 13:40:11+00:00 C185 FIRST DIASTOLIC BLOOD PRESSURE BY PHYSICIAN +8 Resting arm diastolic BP 8712 phv00008712.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:41:04+00:00 2018-02-27 13:41:04+00:00 C415 BP-DIASTOLIC- NURSE +8 Resting arm diastolic BP 8757 phv00008757.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:41:25+00:00 2018-02-27 13:41:25+00:00 D193 PHYSICIAN - DIASTOLIC BLOOD PRESSURE - 1ST READING +8 Resting arm diastolic BP 8759 phv00008759.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:41:43+00:00 2018-02-27 13:41:43+00:00 D289 PHYSICIAN - DIASTOLIC BLOOD PRESSURE - 2ND READING +8 Resting arm diastolic BP 8771 phv00008771.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:41:55+00:00 2018-02-27 13:41:55+00:00 D414 DIASTOLIC BLOOD PRESSURE-NURSE +8 Resting arm diastolic BP 9396 phv00009396.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:42:15+00:00 2018-02-27 13:42:15+00:00 E486 BLOOD PRESSURE: DIASTOLIC - 1ST MD READING +8 Resting arm diastolic BP 9487 phv00009487.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:44:12+00:00 2018-02-27 13:44:12+00:00 E582 BLOOD PRESSURE: DIASTOLIC - 2ND MD READING +8 Resting arm diastolic BP 9559 phv00009559.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:44:23+00:00 2018-02-27 13:44:23+00:00 E036 DIASTOLIC BLOOD PRESSURE - NURSE +8 Resting arm diastolic BP 9906 phv00009906.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:44:34+00:00 2018-02-27 13:44:34+00:00 F477 PHYSICIAN DIASTOLIC BLOOD PRESSURE - FIRST READING (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 10001 phv00010001.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:44:57+00:00 2018-02-27 13:44:57+00:00 F577 PHYSICIAN DIASTOLIC BLOOD PRESSURE - SECOND READING (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 10123 phv00010123.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:45:19+00:00 2018-02-27 13:45:19+00:00 F027 DIASTOLIC BLOOD PRESSURE - NURSE (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 10361 phv00010361.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:45:33+00:00 2018-02-27 13:45:33+00:00 G272 PHYSICIAN DIASTOLIC BLOOD PRESSURE - FIRST READING (TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 10434 phv00010434.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:46:01+00:00 2018-02-27 13:46:01+00:00 G355 PHYSICIAN DIASTOLIC BLOOD PRESSURE - SECOND READING (TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 10508 phv00010508.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:46:15+00:00 2018-02-27 13:46:15+00:00 G451 DIASTOLIC BLOOD PRESSURE - TECHNICIAN (TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 21093 phv00021093.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:46:28+00:00 2018-02-27 13:46:28+00:00 G3A291 DIASTOLIC BLOOD PRESSURE: PHYSICIAN'S FIRST READING (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 21148 phv00021148.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:46:43+00:00 2018-02-27 13:46:43+00:00 G3A348 DIASTOLIC BLOOD PRESSURE: PHYSICIAN'S SECOND READING (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 21240 phv00021240.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:46:54+00:00 2018-02-27 13:46:54+00:00 G3A457 DIASTOLIC BLOOD PRESSURE: TECHNICIAN'S READING +8 Resting arm diastolic BP 55257 phv00055257.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:48:47+00:00 2018-02-27 13:48:47+00:00 DiasBP Seated Diastolic Blood Pressure +8 Resting arm diastolic BP 55286 phv00055286.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:51:02+00:00 2018-02-27 13:51:02+00:00 DIAS120 Seated diastolic BP- first reading +8 Resting arm diastolic BP 55288 phv00055288.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:51:11+00:00 2018-02-27 13:51:11+00:00 DIAS220 Seated diastolic BP- second reading +8 Resting arm diastolic BP 55290 phv00055290.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:51:19+00:00 2018-02-27 13:51:19+00:00 DIAS320 Seated diastolic BP- third reading +8 Resting arm diastolic BP 56836 phv00056836.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:51:40+00:00 2018-02-27 13:51:40+00:00 avg23bpd_s2 Average of 2nd and 3rd Diastolic BP measures +8 Resting arm diastolic BP 56854 phv00056854.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:51:53+00:00 2018-02-27 13:51:53+00:00 pm220a2 Diastolic pressure, first seated bp reading +8 Resting arm diastolic BP 56856 phv00056856.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:52:10+00:00 2018-02-27 13:52:10+00:00 pm220b2 Diastolic pressure, second seated bp reading +8 Resting arm diastolic BP 70376 phv00070376.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:53:30+00:00 2018-02-27 13:53:30+00:00 FU020 DIASTOLIC BLOOD PRESSURE - 1ST READING (TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 70501 phv00070501.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:53:42+00:00 2018-02-27 13:53:42+00:00 FU196 DIASTOLIC BLOOD PRESSURE - 2ND READING(TO NEAREST 2 MM HG) +8 Resting arm diastolic BP 70558 phv00070558.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:54:01+00:00 2018-02-27 13:54:01+00:00 FU271 TECHNICIANS'S DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 72139 phv00072139.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:54:13+00:00 2018-02-27 13:54:13+00:00 H112 PHYSICIAN BLOOD PRESSURE, FIRST READING: DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 72213 phv00072213.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:54:27+00:00 2018-02-27 13:54:27+00:00 H234 PHYSICIAN BLOOD PRESSURE, 2ND READING: DIASTOLIC BLOOD PRESSURE (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 177354 phv00177354.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:55:51+00:00 2018-02-27 13:55:51+00:00 g3b0151 Physical Exam-Blood Pressure: Physician Blood Pressure first reading - Diastolic +8 Resting arm diastolic BP 177419 phv00177419.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:56:10+00:00 2018-02-27 13:56:10+00:00 g3b0282 Physical Exam-Blood Pressure: Physician Blood Pressure second reading - Diastolic +8 Resting arm diastolic BP 250294 phv00250294.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:56:40+00:00 2018-02-27 13:56:40+00:00 e036 Numerical Data - Part I: Nurse's blood pressure - Diastolic (nearest 2mm Hg) Collection Interval: Exam 1 +8 Resting arm diastolic BP 250562 phv00250562.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:56:52+00:00 2018-02-27 13:56:52+00:00 e486 Physical Exam - Physician Blood Pressure First Reading - Diastolic (nearest 2mm Hg) Collection Interval: Exam 1 +8 Resting arm diastolic BP 250653 phv00250653.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:57:15+00:00 2018-02-27 13:57:15+00:00 e582 Physical Exam - Physician Blood Pressure Second Reading - Diastolic (nearest 2mm Hg) Collection Interval: Exam 1 +8 Resting arm diastolic BP 250916 phv00250916.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:59:28+00:00 2018-02-27 13:59:28+00:00 g272 Physical Exam - Head, Neck and Respiratory: Physician blood pressure (first reading), diastolic (nearest 2 mm Hg) Collection Interval: Exam 2 +8 Resting arm diastolic BP 250995 phv00250995.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:59:47+00:00 2018-02-27 13:59:47+00:00 g355 Physical Exam - Final Blood Pressure: Physician blood pressure (second reading) - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 2 +8 Resting arm diastolic BP 251071 phv00251071.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 13:59:58+00:00 2018-02-27 13:59:58+00:00 g451 Numerical Data - Part I: Technician's blood pressure - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 2 +8 Resting arm diastolic BP 251342 phv00251342.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:00:15+00:00 2018-02-27 14:00:15+00:00 h112 Physician Blood Pressure first reading - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 3 +8 Resting arm diastolic BP 251409 phv00251409.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:00:26+00:00 2018-02-27 14:00:26+00:00 h234 Physician Blood Pressure second reading - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 3 +8 Resting arm diastolic BP 254089 phv00254089.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:00:42+00:00 2018-02-27 14:00:42+00:00 j118 Physical Exam - Blood Pressure: Physician Blood Pressure first reading - Diastolic +8 Resting arm diastolic BP 254156 phv00254156.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:00:53+00:00 2018-02-27 14:00:53+00:00 j257 Physical Exam - Blood Pressure: Physician Blood Pressure second reading - Diastolic +8 Resting arm diastolic BP 254611 phv00254611.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:01:09+00:00 2018-02-27 14:01:09+00:00 fv020 Blood Pressure: First reading - Diastolic (nearest 2mm Hg) Collection Interval: Exam 29 +8 Resting arm diastolic BP 254708 phv00254708.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:03:19+00:00 2018-02-27 14:03:19+00:00 fv154 Blood Pressure: Second reading - Diastolic blood pressure to nearest 2 mm Hg Collection Interval: Exam 29 +8 Resting arm diastolic BP 254769 phv00254769.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:03:31+00:00 2018-02-27 14:03:31+00:00 fv264 Technician's Blood Pressure (Clinic only) - Diastolic (nearest 2 mm Hg) Collection Interval: Exam 29 +8 Resting arm diastolic BP 255003 phv00255003.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:03:50+00:00 2018-02-27 14:03:50+00:00 fw022 Physical Exam - Physician blood pressure 1st reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 30 +8 Resting arm diastolic BP 255099 phv00255099.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:04:01+00:00 2018-02-27 14:04:01+00:00 fw176 Physical Exam - Physician blood pressure 2nd reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 30 +8 Resting arm diastolic BP 273915 phv00273915.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:04:14+00:00 2018-02-27 14:04:14+00:00 g3a291 Diastolic blood pressure: Physician's first reading Collection Interval: Exam 1 +8 Resting arm diastolic BP 273970 phv00273970.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:04:29+00:00 2018-02-27 14:04:29+00:00 g3a348 Diastolic blood pressure: Physician's second reading Collection Interval: Exam 1 +8 Resting arm diastolic BP 274062 phv00274062.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:04:43+00:00 2018-02-27 14:04:43+00:00 g3a457 Diastolic blood pressure: Technician's reading Collection Interval: Exam 1 +8 Resting arm diastolic BP 274408 phv00274408.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:04:55+00:00 2018-02-27 14:04:55+00:00 g3a291 Diastolic blood pressure: Physician's first reading +8 Resting arm diastolic BP 274463 phv00274463.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:05:15+00:00 2018-02-27 14:05:15+00:00 g3a348 Diastolic blood pressure: Physician's second reading +8 Resting arm diastolic BP 274553 phv00274553.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:05:26+00:00 2018-02-27 14:05:26+00:00 g3a457 Diastolic blood pressure: Technician's reading +8 Resting arm diastolic BP 274723 phv00274723.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:05:38+00:00 2018-02-27 14:05:38+00:00 FX022 Physical Exam - Physician blood pressure 1st reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 31 +8 Resting arm diastolic BP 274824 phv00274824.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:05:49+00:00 2018-02-27 14:05:49+00:00 FX176 Physical Exam - Physician blood pressure 2nd reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 31 +8 Resting arm diastolic BP 275080 phv00275080.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:06:07+00:00 2018-02-27 14:06:07+00:00 fy022 Physical Exam - Physician blood pressure 1st reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 32 +8 Resting arm diastolic BP 275181 phv00275181.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:06:19+00:00 2018-02-27 14:06:19+00:00 fy176 Physical Exam - Physician blood pressure 2nd reading - diastolic (nearest 2mm Hg) Collection Interval: Original Cohort Exam 32 +8 Resting arm diastolic BP 276848 phv00276848.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:06:46+00:00 2018-02-27 14:06:46+00:00 CHF036 Vital Signs - Diastolic Blood Pressure +8 Resting arm diastolic BP 277034 phv00277034.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:06:55+00:00 2018-02-27 14:06:55+00:00 DBP1 Average diastolic blood pressure, Exam 1 +8 Resting arm diastolic BP 277035 phv00277035.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:07:04+00:00 2018-02-27 14:07:04+00:00 DBP2 Average diastolic blood pressure, Exam 2 +8 Resting arm diastolic BP 277137 phv00277137.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:07:12+00:00 2018-02-27 14:07:12+00:00 DBP1 Average diastolic blood pressure, Exam 1 +8 Resting arm diastolic BP 277138 phv00277138.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:07:26+00:00 2018-02-27 14:07:26+00:00 DBP2 Average diastolic blood pressure, Exam 2 +8 Resting arm diastolic BP 277139 phv00277139.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:07:35+00:00 2018-02-27 14:07:35+00:00 DBP3 Average diastolic blood pressure, Exam 3 +8 Resting arm diastolic BP 277140 phv00277140.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:07:44+00:00 2018-02-27 14:07:44+00:00 DBP4 Average diastolic blood pressure, Exam 4 +8 Resting arm diastolic BP 277141 phv00277141.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:07:55+00:00 2018-02-27 14:07:55+00:00 DBP5 Average diastolic blood pressure, Exam 5 +8 Resting arm diastolic BP 277142 phv00277142.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:08:07+00:00 2018-02-27 14:08:07+00:00 DBP6 Average diastolic blood pressure, Exam 6 +8 Resting arm diastolic BP 277143 phv00277143.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:08:17+00:00 2018-02-27 14:08:17+00:00 DBP7 Average diastolic blood pressure, Exam 7 +8 Resting arm diastolic BP 277144 phv00277144.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:08:26+00:00 2018-02-27 14:08:26+00:00 DBP8 Average diastolic blood pressure, Exam 8 +8 Resting arm diastolic BP 277145 phv00277145.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:08:35+00:00 2018-02-27 14:08:35+00:00 DBP9 Average diastolic blood pressure, Exam 9 +8 Resting arm diastolic BP 55183 phv00055183.v4.p10 pht000394.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:18:06+00:00 2018-02-27 14:18:06+00:00 WT019 SUPINE DBP +8 Resting arm diastolic BP 56858 phv00056858.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 14:53:57+00:00 2018-02-27 14:53:57+00:00 pm220c2 Diastolic pressure, third seated bp reading +8 Resting arm diastolic BP 8631 phv00008631.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-27 18:25:51+00:00 2018-02-27 18:25:51+00:00 C287 SECOND DIASTOLIC BLOOD PRESSURE BY PHYSICIAN +8 Resting arm diastolic BP 210282 phv00210282.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:47:06+00:00 2018-03-19 17:47:06+00:00 SBPA13 [First blood pressure measurement]. 1st diastolic. Q13 [Siting Blood Pressure, exam 1] +8 Resting arm diastolic BP 210285 phv00210285.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:47:53+00:00 2018-03-19 17:47:53+00:00 SBPA16 [Second blood pressure measurement]. 2nd diastolic. Q16 [Siting Blood Pressure, exam 1] +8 Resting arm diastolic BP 210288 phv00210288.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:48:16+00:00 2018-03-19 17:48:16+00:00 SBPA19 [Third blood pressure measurement]. 3rd diastolic. Q19 [Siting Blood Pressure, exam 1] +8 Resting arm diastolic BP 210291 phv00210291.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:48:44+00:00 2018-03-19 17:48:44+00:00 SBPA22 [Third blood pressure measurement]. 2nd and 3rd diastolic. Q22 [Siting Blood Pressure, exam 1] +8 Resting arm diastolic BP 210308 phv00210308.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:50:23+00:00 2018-03-19 17:50:23+00:00 SBPB13 First blood pressure measurement, diastolic Q13 [Sitting Blood Pressure, exam 2] +8 Resting arm diastolic BP 210311 phv00210311.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:50:50+00:00 2018-03-19 17:50:50+00:00 SBPB16 Second blood pressure measurement, diastolic. Q16 [Sitting Blood Pressure, exam 2] +8 Resting arm diastolic BP 210314 phv00210314.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:51:26+00:00 2018-03-19 17:51:26+00:00 SBPB19 Third blood pressure measurement, diastolic. Q19 [Sitting Blood Pressure, exam 2] +8 Resting arm diastolic BP 210317 phv00210317.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:51:53+00:00 2018-03-19 17:51:53+00:00 SBPB22 Computed net average of second and third blood pressure measurements, diastolic. Q22 [Sitting Blood Pressure, exam 2] +8 Resting arm diastolic BP 210332 phv00210332.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:52:50+00:00 2018-03-19 17:52:50+00:00 SBPC14 1st diastolic blood pressure measurement, diastolic. Q14 [Sitting Blood Pressure, exam 3] +8 Resting arm diastolic BP 210335 phv00210335.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:53:14+00:00 2018-03-19 17:53:14+00:00 SBPC17 2nd diastolic blood pressure measurement, diastolic. Q17 [Sitting Blood Pressure, exam 3] +8 Resting arm diastolic BP 210338 phv00210338.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:53:38+00:00 2018-03-19 17:53:38+00:00 SBPC20 3rd diastolic blood pressure measurement, diastolic. Q20 [Sitting Blood Pressure, exam 3] +8 Resting arm diastolic BP 210341 phv00210341.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:54:08+00:00 2018-03-19 17:54:08+00:00 SBPC23 [Computed net average of second and third blood pressure measurements]. 2nd and 3rd diastolic blood pressure average. Q23 [Sitting Blood Pressure, exam 3] +8 Resting arm diastolic BP 210358 phv00210358.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:54:44+00:00 2018-03-19 17:54:44+00:00 SBPD14 1st diastolic blood pressure measurement. Q14 [Sitting Blood Pressure, exam 4] +8 Resting arm diastolic BP 210361 phv00210361.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:55:05+00:00 2018-03-19 17:55:05+00:00 SBPD17 2nd diastolic blood pressure measurement. Q17 [Sitting Blood Pressure, exam 4] +8 Resting arm diastolic BP 210364 phv00210364.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 17:55:25+00:00 2018-03-19 17:55:25+00:00 SBPD20 1st and 2nd diastolic blood pressure average. Q20 [Sitting Blood Pressure, exam 4] +8 Resting arm diastolic BP 214059 phv00214059.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:24:12+00:00 2018-03-19 19:24:12+00:00 DIASBP Seated Diastolic Blood Pressure +8 Resting arm diastolic BP 214089 phv00214089.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:24:40+00:00 2018-03-19 19:24:40+00:00 DIAS120 Seated diastolic BP- first reading +8 Resting arm diastolic BP 214091 phv00214091.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:24:57+00:00 2018-03-19 19:24:57+00:00 DIAS220 Seated diastolic BP- second reading +8 Resting arm diastolic BP 214093 phv00214093.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:25:11+00:00 2018-03-19 19:25:11+00:00 DIAS320 Seated diastolic BP- third reading +8 Resting arm diastolic BP 210283 phv00210283.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 14:57:19+00:00 2018-03-20 14:57:19+00:00 SBPA14 [First blood pressure measurement]. 1st zero reading. Q14 [Siting Blood Pressure, exam 1] +8 Resting arm diastolic BP 210286 phv00210286.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 14:57:48+00:00 2018-03-20 14:57:48+00:00 SBPA17 [Second blood pressure measurement]. 2nd zero reading. Q17 [Siting Blood Pressure, exam 1] +8 Resting arm diastolic BP 210289 phv00210289.v1.p1 pht004192.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 14:58:12+00:00 2018-03-20 14:58:12+00:00 SBPA20 [Third blood pressure measurement]. 3rd zero reading. Q20 [Siting Blood Pressure, exam 1] +8 Resting arm diastolic BP 210309 phv00210309.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 14:59:15+00:00 2018-03-20 14:59:15+00:00 SBPB14 First blood pressure measurement, zero reading. Q14 [Sitting Blood Pressure, exam 2] +8 Resting arm diastolic BP 210312 phv00210312.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 14:59:42+00:00 2018-03-20 14:59:42+00:00 SBPB17 Second blood pressure measurement, zero reading. Q17 [Sitting Blood Pressure, exam 2] +8 Resting arm diastolic BP 210315 phv00210315.v1.p1 pht004193.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:00:01+00:00 2018-03-20 15:00:01+00:00 SBPB20 Third blood pressure measurement, zero reading. Q20 [Sitting Blood Pressure, exam 2] +8 Resting arm diastolic BP 210333 phv00210333.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:00:29+00:00 2018-03-20 15:00:29+00:00 SBPC15 1st blood pressure measurement, zero reading. Q15 [Sitting Blood Pressure, exam 3] +8 Resting arm diastolic BP 210336 phv00210336.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:00:47+00:00 2018-03-20 15:00:47+00:00 SBPC18 2nd blood pressure measurement, zero reading. Q18 [Sitting Blood Pressure, exam 3] +8 Resting arm diastolic BP 210339 phv00210339.v1.p1 pht004194.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:01:14+00:00 2018-03-20 15:01:14+00:00 SBPC21 3rd blood pressure measurement, zero reading. Q21 [Sitting Blood Pressure, exam 3] +8 Resting arm diastolic BP 210359 phv00210359.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:02:00+00:00 2018-03-20 15:02:00+00:00 SBPD15 1st blood pressure measurement, zero reading. Q15 [Sitting Blood Pressure, exam 4] +8 Resting arm diastolic BP 210362 phv00210362.v1.p1 pht004195.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:02:23+00:00 2018-03-20 15:02:23+00:00 SBPD18 2nd blood pressure measurement, zero reading. Q18 [Sitting Blood Pressure, exam 4] +8 Resting arm diastolic BP 112476 phv00112476.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02R1D FIRST READING DIASTOLIC +8 Resting arm diastolic BP 112478 phv00112478.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02RZ1D RZ1 DBP +8 Resting arm diastolic BP 112480 phv00112480.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02DBP1 FIRST CORRECTED DBP (A02R1D - A02RZ1D) +8 Resting arm diastolic BP 112482 phv00112482.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02R2D SECOND READING DBP +8 Resting arm diastolic BP 112484 phv00112484.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02RZ2D RZ2 DBP +8 Resting arm diastolic BP 112486 phv00112486.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02DBP2 SECOND CORRECTED DBP (A02R2D - A02RZ2D) +8 Resting arm diastolic BP 112488 phv00112488.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02R3D THIRD READING DBP +8 Resting arm diastolic BP 112490 phv00112490.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02RZ3D RZ3 DBP +8 Resting arm diastolic BP 112492 phv00112492.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02DBP3 THIRD CORRECTED DBP (A02R3D - A02RZ3D) +8 Resting arm diastolic BP 112495 phv00112495.v2.p2 pht001560.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 A02DBP MEAN OF 2ND AND 3RD DBPS +8 Resting arm diastolic BP 114114 phv00114114.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02R1D FIRST READING DBP 5TH PHASE. Q 11 +8 Resting arm diastolic BP 114116 phv00114116.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02RZ1D RZ1 DBP. Q 12 +8 Resting arm diastolic BP 114118 phv00114118.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02DBP1 FIRST CORRECTED DBP (R1_D - RZ1_D). Q 13 +8 Resting arm diastolic BP 114120 phv00114120.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02R2D SECOND READING DBP. Q 14 +8 Resting arm diastolic BP 114122 phv00114122.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02RZ2D RZ2 DBP. Q 15 +8 Resting arm diastolic BP 114124 phv00114124.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02DBP2 SECOND CORRECTED DBP (R2_D - RZ2_D). Q 16 +8 Resting arm diastolic BP 114126 phv00114126.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02R3D THIRD READING DBP. Q 17 +8 Resting arm diastolic BP 114128 phv00114128.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02RZ3D RZ3 DBP. Q 18 +8 Resting arm diastolic BP 114130 phv00114130.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02DBP3 THIRD CORRECTED DBP (R3_D - RZ3_D). Q 19 +8 Resting arm diastolic BP 114132 phv00114132.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02SUMDI SECOND & THIRD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20 +8 Resting arm diastolic BP 114134 phv00114134.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 B02AVGDI AVERAGE DBP (SUM_D/2). Q 21 +8 Resting arm diastolic BP 115331 phv00115331.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02R1D FIRST READING DBP 5TH PHASE. Q 11 +8 Resting arm diastolic BP 115333 phv00115333.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02RZ1D RZ1 DBP. Q 12 +8 Resting arm diastolic BP 115335 phv00115335.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02DBP1 FIRST CORRECTED DBP (R1_D - RZ1_D). Q 13 +8 Resting arm diastolic BP 115337 phv00115337.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02R2D SECOND READING DBP. Q 14 +8 Resting arm diastolic BP 115339 phv00115339.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02RZ2D RZ2 DBP. Q 15 +8 Resting arm diastolic BP 115341 phv00115341.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02DBP2 SECOND CORRECTED DBP (R2_D - RZ2_D). Q 16 +8 Resting arm diastolic BP 115343 phv00115343.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02R3D THIRD READING DBP. Q 17 +8 Resting arm diastolic BP 115345 phv00115345.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02RZ3D RZ3 DBP. Q 18 +8 Resting arm diastolic BP 115347 phv00115347.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02DBP3 THIRD CORRECTED DBP (R3_D - RZ3_D). Q 19 +8 Resting arm diastolic BP 115349 phv00115349.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02SUMDI 2ND AND 3RD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20 +8 Resting arm diastolic BP 115351 phv00115351.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 C02AVGDI AVERAGE DBP (SUM_D/2). +8 Resting arm diastolic BP 116554 phv00116554.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 D02R1D FIRST READING DBP 5TH PHASE. Q 11 +8 Resting arm diastolic BP 116556 phv00116556.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 D02RZ1D RZ1 DBP. Q 12 +8 Resting arm diastolic BP 116560 phv00116560.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 D02R2D SECOND READING DBP. Q 14 +8 Resting arm diastolic BP 116562 phv00116562.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 D02RZ2D RZ2 DBP. Q 15 +8 Resting arm diastolic BP 116566 phv00116566.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 D02R3D THIRD READING DBP. Q 17 +8 Resting arm diastolic BP 116568 phv00116568.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 D02RZ3D RZ3 DBP. Q 18 +8 Resting arm diastolic BP 116572 phv00116572.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 D02SUMDI 2ND AND 3RD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20 +8 Resting arm diastolic BP 116574 phv00116574.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 D02AVGDI AVERAGE DBP (SUM_D/2). Q 21 +8 Resting arm diastolic BP 118277 phv00118277.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 E02R1D FIRST READING DBP 5TH PHASE. Q 11 +8 Resting arm diastolic BP 118279 phv00118279.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 E02RZ1D RZ1 DBP. Q 12 +8 Resting arm diastolic BP 118281 phv00118281.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 E02DBP1 FIRST CORRECTED DBP (R1_D - RZ1_D). Q 13 +8 Resting arm diastolic BP 118283 phv00118283.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 E02R2D SECOND READING DBP. Q 14 +8 Resting arm diastolic BP 118285 phv00118285.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 E02RZ2D RZ2 DBP. Q 15 +8 Resting arm diastolic BP 118287 phv00118287.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 E02DBP2 SECOND CORRECTED DBP (R2_D - RZ2_D). Q 16 +8 Resting arm diastolic BP 118289 phv00118289.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 E02R3D THIRD READING DBP. Q 17 +8 Resting arm diastolic BP 118291 phv00118291.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:08+00:00 2018-04-17 15:27:08+00:00 E02RZ3D RZ3 DBP. Q 18 +8 Resting arm diastolic BP 118293 phv00118293.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 E02DBP3 THIRD CORRECTED DBP (R3_D - RZ3_D). Q 19 +8 Resting arm diastolic BP 118295 phv00118295.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 E02SUMDI 2ND AND 3RD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20 +8 Resting arm diastolic BP 118297 phv00118297.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 E02AVGDI AVERAGE DBP (SUM_D/2). Q 21 +8 Resting arm diastolic BP 119704 phv00119704.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02R1D FIRST READING DBP 5TH PHASE. Q 11 +8 Resting arm diastolic BP 119706 phv00119706.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02RZ1D RZ1 DBP. Q 12 +8 Resting arm diastolic BP 119708 phv00119708.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02DBP1 FIRST CORRECTED DBP (R1_D - RZ1_D). Q 13 +8 Resting arm diastolic BP 119710 phv00119710.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02R2D SECOND READING DBP. Q 14 +8 Resting arm diastolic BP 119712 phv00119712.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02RZ2D RZ2 DBP. Q15 +8 Resting arm diastolic BP 119714 phv00119714.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02DBP2 SECOND CORRECTED DBP (R2_D - RZ2_D). Q 16 +8 Resting arm diastolic BP 119716 phv00119716.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02R3D THIRD READING DBP. Q 17 +8 Resting arm diastolic BP 119718 phv00119718.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02RZ3D RZ3 DBP. Q 18 +8 Resting arm diastolic BP 119720 phv00119720.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02DBP3 THIRD CORRECTED DBP (R3_D - RZ3_D). Q 19 +8 Resting arm diastolic BP 119722 phv00119722.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02SUMDI 2ND AND 3RD DIAS (R2_RZ2_D + R3_RZ3_D). Q 20 +8 Resting arm diastolic BP 119724 phv00119724.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 15:27:09+00:00 2018-04-17 15:27:09+00:00 F02AVGDI AVERAGE DBP (SUM_D/2). Q 21 +8 Resting arm diastolic BP 115204 phv00115204.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:23:31+00:00 2018-04-19 20:23:31+00:00 C1MDBP AVERAGE DIASTOLIC BLOOD PRESSURE (mmHg) +8 Resting arm diastolic BP 116229 phv00116229.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:24:04+00:00 2018-04-19 20:24:04+00:00 C42AYD1 DIASTOLIC Y-TUBED BP 1ST READING +8 Resting arm diastolic BP 116233 phv00116233.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:24:23+00:00 2018-04-19 20:24:23+00:00 C42AYD2 DIASTOLIC Y-TUBED BP 2ND READING +8 Resting arm diastolic BP 116237 phv00116237.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:24:57+00:00 2018-04-19 20:24:57+00:00 C42AYD3 DIASTOLIC Y-TUBED BP 3RD READING +8 Resting arm diastolic BP 116241 phv00116241.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:25:23+00:00 2018-04-19 20:25:23+00:00 C42AYD4 DIASTOLIC Y-TUBED BP 4TH READING +8 Resting arm diastolic BP 116245 phv00116245.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:25:41+00:00 2018-04-19 20:25:41+00:00 C42AYD5 DIASTOLIC Y-TUBED BP 5TH READING +8 Resting arm diastolic BP 116249 phv00116249.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:25:56+00:00 2018-04-19 20:25:56+00:00 C42AYD6 DIASTOLIC Y-TUBED BP 6TH READING +8 Resting arm diastolic BP 116253 phv00116253.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:26:12+00:00 2018-04-19 20:26:12+00:00 C42AYD7 DIASTOLIC Y-TUBED BP 7TH READING +8 Resting arm diastolic BP 116257 phv00116257.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:26:26+00:00 2018-04-19 20:26:26+00:00 C42AYD8 DIASTOLIC Y-TUBED BP 8TH READING +8 Resting arm diastolic BP 116261 phv00116261.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:26:47+00:00 2018-04-19 20:26:47+00:00 C42AYD9 DIASTOLIC Y-TUBED BP 9TH READING +8 Resting arm diastolic BP 116265 phv00116265.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:27:03+00:00 2018-04-19 20:27:03+00:00 C42AYD10 DIASTOLIC Y-TUBED BP 10TH READING +8 Resting arm diastolic BP 116269 phv00116269.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:27:27+00:00 2018-04-19 20:27:27+00:00 C42AEYD1 END OF TEST Y-TUBED DIASTOLIC 1ST READ +8 Resting arm diastolic BP 116273 phv00116273.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:27:50+00:00 2018-04-19 20:27:50+00:00 C42AEYD2 END OF TEST Y-TUBED DIASTOLIC 2ND READ +8 Resting arm diastolic BP 116277 phv00116277.v2.p2 pht001685.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:28:25+00:00 2018-04-19 20:28:25+00:00 C42AEYD3 END OF TEST Y-TUBED DIASTOLIC 3RD READ +8 Resting arm diastolic BP 119239 phv00119239.v2.p2 pht001789.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:28:40+00:00 2018-04-19 20:28:40+00:00 E40DBP DIASTOLIC BLOOD PRESSURE. Q 3 +8 Resting arm diastolic BP 83400 phv00083400.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:07:36+00:00 2018-04-23 04:07:36+00:00 d1bp1 SEATED BP: DIASTOLIC 1ST READING (mmHg) +8 Resting arm diastolic BP 83404 phv00083404.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:07:43+00:00 2018-04-23 04:07:43+00:00 d2bp1 SEATED BP: DIASTOLIC 2ND READING (mmHg) +8 Resting arm diastolic BP 83407 phv00083407.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:07:49+00:00 2018-04-23 04:07:49+00:00 d3bp1 SEATED BP: DIASTOLIC 3RD READING (mmHg) +8 Resting arm diastolic BP 83411 phv00083411.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:07:54+00:00 2018-04-23 04:07:54+00:00 dbp1c SEATED DIASTOLIC BLOOD PRESSURE (mmHg) +8 Resting arm diastolic BP 84495 phv00084495.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:00+00:00 2018-04-23 04:08:00+00:00 predia1 DIASTOLIC BLOOD PRESSURE BEFORE SERIES 7 MRI +8 Resting arm diastolic BP 84497 phv00084497.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:05+00:00 2018-04-23 04:08:05+00:00 postdia1 DIASTOLIC BLOOD PRESSURE AFTER SERIES 7 MRI +8 Resting arm diastolic BP 85704 phv00085704.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:11+00:00 2018-04-23 04:08:11+00:00 dbpcp1 DIASTOLIC BLOOD PRESSURE (FROM OSCILLOMETRIC CUFF), (mmHg) +8 Resting arm diastolic BP 85733 phv00085733.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:17+00:00 2018-04-23 04:08:17+00:00 d1bp1 SEATED BP: DIASTOLIC 1ST READING (mmHg) +8 Resting arm diastolic BP 85736 phv00085736.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:24+00:00 2018-04-23 04:08:24+00:00 d2bp1 SEATED BP: DIASTOLIC 2ND READING (mmHg) +8 Resting arm diastolic BP 85738 phv00085738.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:29+00:00 2018-04-23 04:08:29+00:00 d3bp1 SEATED BP: DIASTOLIC 3RD READING (mmHg) +8 Resting arm diastolic BP 85741 phv00085741.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:35+00:00 2018-04-23 04:08:35+00:00 dbp1c SEATED DIASTOLIC BLOOD PRESSURE (mmHg) +8 Resting arm diastolic BP 86225 phv00086225.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:40+00:00 2018-04-23 04:08:40+00:00 dbp2c SEATED DIASTOLIC BLOOD PRESSURE (mmHg) +8 Resting arm diastolic BP 86233 phv00086233.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:46+00:00 2018-04-23 04:08:46+00:00 d1bp2 SEATED BP: DIASTOLIC 1ST READING (mmHg) +8 Resting arm diastolic BP 86235 phv00086235.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:51+00:00 2018-04-23 04:08:51+00:00 d2bp2 SEATED BP: DIASTOLIC 2ND READING (mmHg) +8 Resting arm diastolic BP 86237 phv00086237.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:08:56+00:00 2018-04-23 04:08:56+00:00 d3bp2 SEATED BP: DIASTOLIC 3RD READING (mmHg) +8 Resting arm diastolic BP 86708 phv00086708.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:02+00:00 2018-04-23 04:09:02+00:00 dbp3c SEATED DIASTOLIC BLOOD PRESSURE (mmHg) +8 Resting arm diastolic BP 86716 phv00086716.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:06+00:00 2018-04-23 04:09:06+00:00 d1bp3 SEATED BP: DIASTOLIC 1ST READING (mmHg) +8 Resting arm diastolic BP 86719 phv00086719.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:11+00:00 2018-04-23 04:09:11+00:00 d2bp3 SEATED BP: DIASTOLIC 2ND READING (mmHg) +8 Resting arm diastolic BP 86721 phv00086721.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:18+00:00 2018-04-23 04:09:18+00:00 d3bp3 SEATED BP: DIASTOLIC 3RD READING (mmHg) +8 Resting arm diastolic BP 87030 phv00087030.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:23+00:00 2018-04-23 04:09:23+00:00 dbp4c SEATED DIASTOLIC BLOOD PRESSURE (mmhg) +8 Resting arm diastolic BP 87038 phv00087038.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:29+00:00 2018-04-23 04:09:29+00:00 d1bp4 SEATED BP: DIASTOLIC 1ST READING (mmhg) +8 Resting arm diastolic BP 87041 phv00087041.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:36+00:00 2018-04-23 04:09:36+00:00 d2bp4 SEATED BP: DIASTOLIC 2ND READING (mmhg) +8 Resting arm diastolic BP 87043 phv00087043.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:41+00:00 2018-04-23 04:09:41+00:00 d3bp4 SEATED BP: DIASTOLIC 3RD READING (mmhg) +8 Resting arm diastolic BP 87085 phv00087085.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:47+00:00 2018-04-23 04:09:47+00:00 dbpfc MEAN: SEATED DIASTOLIC BLOOD PRESSURE (mmHg) +8 Resting arm diastolic BP 87506 phv00087506.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:52+00:00 2018-04-23 04:09:52+00:00 d1bpf 1ST READING: SEATED DIASTOLIC BP (mmHg) +8 Resting arm diastolic BP 87510 phv00087510.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:09:58+00:00 2018-04-23 04:09:58+00:00 d2bpf 2ND READING: SEATED DIASTOLIC BP (mmHg) +8 Resting arm diastolic BP 87513 phv00087513.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:03+00:00 2018-04-23 04:10:03+00:00 d3bpf 3RD READING: SEATED DIASTOLIC BP (mmHg) +8 Resting arm diastolic BP 175588 phv00175588.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:08+00:00 2018-04-23 04:10:08+00:00 d1bp5 SEATED BP: DIASTOLIC 1ST READING (mmHg) +8 Resting arm diastolic BP 175592 phv00175592.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:13+00:00 2018-04-23 04:10:13+00:00 d2bp5 SEATED BP: DIASTOLIC 2ND READING (mmHg) +8 Resting arm diastolic BP 175595 phv00175595.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:18+00:00 2018-04-23 04:10:18+00:00 d3bp5 SEATED BP: DIASTOLIC 3RD READING (mmHg) +8 Resting arm diastolic BP 175602 phv00175602.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:23+00:00 2018-04-23 04:10:23+00:00 dbp5c SEATED DIASTOLIC BLOOD PRESSURE (mmHg) +8 Resting arm diastolic BP 177022 phv00177022.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:31+00:00 2018-04-23 04:10:31+00:00 d1bp5 SEATED BP: DIASTOLIC 1ST READING (mmHg) +8 Resting arm diastolic BP 177026 phv00177026.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:44+00:00 2018-04-23 04:10:44+00:00 d2bp5 SEATED BP: DIASTOLIC 2ND READING (mmHg) +8 Resting arm diastolic BP 177029 phv00177029.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:52+00:00 2018-04-23 04:10:52+00:00 d3bp5 SEATED BP: DIASTOLIC 3RD READING (mmHg) +8 Resting arm diastolic BP 177036 phv00177036.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 04:10:57+00:00 2018-04-23 04:10:57+00:00 dbp5c SEATED DIASTOLIC BLOOD PRESSURE (mmHg) +8 Resting arm diastolic BP 205848 phv00205848.v1.p1 pht004079.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 21:29:36+00:00 2018-04-25 21:29:36+00:00 ECHA8 Diastolic blood pressure 8 [Cohort (Jackson only), Exam 3] +8 Resting arm diastolic BP 101960 phv00101960.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:15:07+00:00 2018-05-03 18:15:07+00:00 AVEDIA DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 102575 phv00102575.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:15:23+00:00 2018-05-03 18:15:23+00:00 AVEDIA DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 104698 phv00104698.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:15:35+00:00 2018-05-03 18:15:35+00:00 AVEDIA DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 105433 phv00105433.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:15:46+00:00 2018-05-03 18:15:46+00:00 AVEDIA AVE DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 106795 phv00106795.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:15:59+00:00 2018-05-03 18:15:59+00:00 AVEDIA DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 107775 phv00107775.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:16:18+00:00 2018-05-03 18:16:18+00:00 AVEDIA DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 108831 phv00108831.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:16:30+00:00 2018-05-03 18:16:30+00:00 AVEDIA DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 110338 phv00110338.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:16:42+00:00 2018-05-03 18:16:42+00:00 AVEDIA DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 99442 phv00099442.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:19:17+00:00 2018-05-03 18:19:17+00:00 AVZMDIA AVE ZERO MEDDLER DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 104021 phv00104021.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:20:46+00:00 2018-05-03 18:20:46+00:00 AVZMDIA AVE ZERO MUDDLER DIASTOLIC BP (mm Hg) +8 Resting arm diastolic BP 79855 phv00079855.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-07 22:37:35+00:00 2018-05-07 22:37:35+00:00 DIASBP1 Diastolic blood pressure (1st reading) +8 Resting arm diastolic BP 79857 phv00079857.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-07 22:37:36+00:00 2018-05-07 22:37:36+00:00 DIASBP2 Diastolic blood pressure (2nd reading) +8 Resting arm diastolic BP 79865 phv00079865.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-07 22:37:36+00:00 2018-05-07 22:37:36+00:00 DIAS Diastolic BP +8 Resting arm diastolic BP 283298 phv00283298.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-07 22:37:36+00:00 2018-05-07 22:37:36+00:00 DIASBP1 Diastolic blood pressure (1st reading) +8 Resting arm diastolic BP 283300 phv00283300.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-07 22:37:36+00:00 2018-05-07 22:37:36+00:00 DIASBP2 Diastolic blood pressure (2nd reading) +8 Resting arm diastolic BP 283537 phv00283537.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-07 22:37:36+00:00 2018-05-07 22:37:36+00:00 DIAS F136 Diastolic blood pressure at onset, mm/Hg +8 Resting arm diastolic BP 7359 phv00007359.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 15:30:32+00:00 2018-05-09 15:30:32+00:00 FT320 MEDICAL HISTORY - BLOOD PRESSURE - 1ST READING (TO NEAREST 2MM HG) +8 Resting arm diastolic BP 24462 phv00024462.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:45:30+00:00 2018-05-14 11:45:30+00:00 EF35 POST DIASTOLIC BLOOD PRESSURE +8 Resting arm diastolic BP 24457 phv00024457.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:46:47+00:00 2018-05-14 11:46:47+00:00 brdbp BASELINE DIASTOLIC BLOOD PRESSURE (RENAMED FROM EF24) +8 Resting arm diastolic BP 24480 phv00024480.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:47:24+00:00 2018-05-14 11:47:24+00:00 dbp BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) +8 Resting arm diastolic BP 24413 phv00024413.v4.p10 pht000194.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:47:36+00:00 2018-05-14 11:47:36+00:00 dbp BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) +8 Resting arm diastolic BP 66713 phv00066713.v4.p10 pht000673.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:48:25+00:00 2018-05-14 11:48:25+00:00 DBP DIASTOLIC BLOOD PRESSURE ENTERED BY TECHNICIAN, MMHG +8 Resting arm diastolic BP 72660 phv00072660.v4.p10 pht000748.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:48:44+00:00 2018-05-14 11:48:44+00:00 dbp Diastolic blood pressure entered by technician +8 Resting arm diastolic BP 24866 phv00024866.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:49:12+00:00 2018-05-14 11:49:12+00:00 dbp BRACHIAL DIASTOLIC PRESSURE (FROM TONOMETRY DATA) (MMHG) +8 Resting arm diastolic BP 24779 phv00024779.v5.p10 pht000209.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:50:08+00:00 2018-05-14 11:50:08+00:00 dbp BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) (OLD NAME: TONDBP) +8 Resting arm diastolic BP 24825 phv00024825.v4.p10 pht000210.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:50:27+00:00 2018-05-14 11:50:27+00:00 dbp BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) +8 Resting arm diastolic BP 24892 phv00024892.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:51:38+00:00 2018-05-14 11:51:38+00:00 TM13 MANUAL BLOOD PRESSURE: DIASTOLIC (FIRST IF ODD ID#) (MMHG) +8 Resting arm diastolic BP 24894 phv00024894.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:51:54+00:00 2018-05-14 11:51:54+00:00 TM15 AUTO BLOOD PRESSURE AND PULSE: DIASTOLIC (FIRST IF EVEN ID#) (MMHG) +8 Resting arm diastolic BP 8197 phv00008197.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-14 11:59:51+00:00 2018-05-14 11:59:51+00:00 B553 DIASTOLIC-RESTING, SIT +8 Resting arm diastolic BP 123002 phv00123002.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-06-18 19:16:36+00:00 2018-06-18 19:16:36+00:00 dbp Mean Diastolic BP +8 Resting arm diastolic BP 277346 phv00277346.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:02:05+00:00 2018-08-02 19:02:05+00:00 DINA_DIA3 Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 2009-2011 +8 Resting arm diastolic BP 277342 phv00277342.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:02:14+00:00 2018-08-02 19:02:14+00:00 DINA_DIA2 Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 2009-2011 +8 Resting arm diastolic BP 277338 phv00277338.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:02:22+00:00 2018-08-02 19:02:22+00:00 DINA_DIA1 Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 2009-2011 +8 Resting arm diastolic BP 307738 phv00307738.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:02:32+00:00 2018-08-02 19:02:32+00:00 BpTRU_DIA3 BpTRU: Diastolic; 3rd of 3 readings Collection Interval: 2007-2009 +8 Resting arm diastolic BP 307736 phv00307736.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:02:43+00:00 2018-08-02 19:02:43+00:00 BpTRU_DIA2 BpTRU: Diastolic; 2nd of 3 readings Collection Interval: 2007-2009 +8 Resting arm diastolic BP 307734 phv00307734.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:02:51+00:00 2018-08-02 19:02:51+00:00 BpTRU_DIA1 BpTRU: Diastolic; 1st of 3 readings Collection Interval: 2007-2009 +8 Resting arm diastolic BP 277303 phv00277303.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:03:01+00:00 2018-08-02 19:03:01+00:00 DINA_DIA3 Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 2007-2009 +8 Resting arm diastolic BP 277299 phv00277299.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:03:10+00:00 2018-08-02 19:03:10+00:00 DINA_DIA2 Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 2007-2009 +8 Resting arm diastolic BP 277295 phv00277295.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:03:18+00:00 2018-08-02 19:03:18+00:00 DINA_DIA1 Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 2007-2009 +8 Resting arm diastolic BP 277771 phv00277771.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:04:00+00:00 2018-08-02 19:04:00+00:00 RAND_DIA2 Random Zero Sphygmomanometer BP: Diastolic #2 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 277769 phv00277769.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:04:08+00:00 2018-08-02 19:04:08+00:00 RAND_DIA1 Random Zero Sphygmomanometer BP: Diastolic #1 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 277665 phv00277665.v1.p1 pht006045.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:04:17+00:00 2018-08-02 19:04:17+00:00 ECHODIA Dinamap BP while lying on Echo bed: diastolic Collection Interval: 2001-2004 +8 Resting arm diastolic BP 277535 phv00277535.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:04:25+00:00 2018-08-02 19:04:25+00:00 DINA_DIA3 Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 277531 phv00277531.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:04:35+00:00 2018-08-02 19:04:35+00:00 DINA_DIA2 Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 277527 phv00277527.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:04:43+00:00 2018-08-02 19:04:43+00:00 DINA_DIA1 Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 277523 phv00277523.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:04:53+00:00 2018-08-02 19:04:53+00:00 RAND_DIA3 Random-zero sphygmomanometer: Diastolic; 3rd of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 277521 phv00277521.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:05:00+00:00 2018-08-02 19:05:00+00:00 RAND_DIA2 Random-zero sphygmomanometer: Diastolic; 2nd of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 277519 phv00277519.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:05:14+00:00 2018-08-02 19:05:14+00:00 RAND_DIA1 Random-zero sphygmomanometer: Diastolic; 1st of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 307763 phv00307763.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:05:51+00:00 2018-08-02 19:05:51+00:00 DINA_DIA3 Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 2006-2011 +8 Resting arm diastolic BP 307759 phv00307759.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:06:05+00:00 2018-08-02 19:06:05+00:00 DINA_DIA2 Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 2006-2011 +8 Resting arm diastolic BP 307755 phv00307755.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:06:16+00:00 2018-08-02 19:06:16+00:00 DINA_DIA1 Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 2006-2011 +8 Resting arm diastolic BP 307751 phv00307751.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:06:24+00:00 2018-08-02 19:06:24+00:00 BpTRU_DIA3 BpTRU: Diastolic; 3rd of 3 readings Collection Interval: 2006-2011 +8 Resting arm diastolic BP 307749 phv00307749.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:06:32+00:00 2018-08-02 19:06:32+00:00 BpTRU_DIA2 BpTRU: Diastolic; 2nd of 3 readings Collection Interval: 2006-2011 +8 Resting arm diastolic BP 307747 phv00307747.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:06:40+00:00 2018-08-02 19:06:40+00:00 BpTRU_DIA1 BpTRU: Diastolic; 1st of 3 readings Collection Interval: 2006-2011 +8 Resting arm diastolic BP 277785 phv00277785.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:06:49+00:00 2018-08-02 19:06:49+00:00 DINA_DIA3 Dinamap BP: Diastolic #3 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 277781 phv00277781.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:06:57+00:00 2018-08-02 19:06:57+00:00 DINA_DIA2 Dinamap BP: Diastolic #2 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 277777 phv00277777.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:07:06+00:00 2018-08-02 19:07:06+00:00 DINA_DIA1 Dinamap BP: Diastolic #1 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 277773 phv00277773.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:07:14+00:00 2018-08-02 19:07:14+00:00 RAND_DIA3 Random Zero Sphygmomanometer BP: Diastolic #3 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 307976 phv00307976.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:08:01+00:00 2018-08-02 19:08:01+00:00 DINA_DIA3 Dinamap BP: Diastolic #3 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 307972 phv00307972.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:08:09+00:00 2018-08-02 19:08:09+00:00 DINA_DIA2 Dinamap BP: Diastolic #2 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 307968 phv00307968.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:08:17+00:00 2018-08-02 19:08:17+00:00 DINA_DIA1 Dinamap BP: Diastolic #1 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 307964 phv00307964.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:08:25+00:00 2018-08-02 19:08:25+00:00 RAND_DIA3 Random Zero Sphygmomanometer BP: Diastolic #3 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 307962 phv00307962.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:08:34+00:00 2018-08-02 19:08:34+00:00 RAND_DIA2 Random Zero Sphygmomanometer BP: Diastolic #2 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 307960 phv00307960.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:08:44+00:00 2018-08-02 19:08:44+00:00 RAND_DIA1 Random Zero Sphygmomanometer BP: Diastolic #1 Collection Interval: 2000-2004 +8 Resting arm diastolic BP 307816 phv00307816.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:08:52+00:00 2018-08-02 19:08:52+00:00 DINA_DIA3 Dinamap: Diastolic pressure; 3rd of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 307812 phv00307812.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:09:00+00:00 2018-08-02 19:09:00+00:00 DINA_DIA2 Dinamap: Diastolic pressure; 2nd of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 307808 phv00307808.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:09:08+00:00 2018-08-02 19:09:08+00:00 DINA_DIA1 Dinamap: Diastolic pressure; 1st of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 307804 phv00307804.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:09:17+00:00 2018-08-02 19:09:17+00:00 RAND_DIA3 Random-zero sphygmomanometer: Diastolic; 3rd of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 307802 phv00307802.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:09:26+00:00 2018-08-02 19:09:26+00:00 RAND_DIA2 Random-zero sphygmomanometer: Diastolic; 2nd of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 307800 phv00307800.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 19:09:34+00:00 2018-08-02 19:09:34+00:00 RAND_DIA1 Random-zero sphygmomanometer: Diastolic; 1st of 3 readings Collection Interval: 1996-2000 +8 Resting arm diastolic BP 159583 phv00159583.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-02 19:10:41+00:00 2018-08-02 19:10:41+00:00 diasBP Diastolic blood pressure [mmHg] Collection Interval: Collected in Exam 1 +8 Resting arm diastolic BP 277670 phv00277670.v1.p1 pht006045.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:00:51+00:00 2018-08-14 23:00:51+00:00 ECHO_DBP Diastolic BP Collection Interval: 2001-2004 +8 Resting arm diastolic BP 123845 phv00123845.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:58:02+00:00 2018-08-21 17:58:02+00:00 PM10DIA1 BP: 10 PM - Diastolic 1 +8 Resting arm diastolic BP 123848 phv00123848.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:58:16+00:00 2018-08-21 17:58:16+00:00 PM10DIA2 BP: 10 PM - Diastolic 2 +8 Resting arm diastolic BP 123851 phv00123851.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:58:31+00:00 2018-08-21 17:58:31+00:00 PM10DIA3 BP: 10 PM - Diastolic 3 +8 Resting arm diastolic BP 123855 phv00123855.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:58:45+00:00 2018-08-21 17:58:45+00:00 AM7DIA1 BP: 7 AM - Diastolic 1 +8 Resting arm diastolic BP 123858 phv00123858.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:59:04+00:00 2018-08-21 17:59:04+00:00 AM7DIA2 BP: 7 AM - Diastolic 2 +8 Resting arm diastolic BP 123861 phv00123861.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:59:16+00:00 2018-08-21 17:59:16+00:00 AM7DIA3 BP: 7 AM - Diastolic 3 +8 Resting arm diastolic BP 123865 phv00123865.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:23:36+00:00 2018-08-21 18:23:36+00:00 AM10DIA1 BP: 10 AM - Diastolic 1 +8 Resting arm diastolic BP 123868 phv00123868.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:23:47+00:00 2018-08-21 18:23:47+00:00 AM10DIA2 BP: 10 AM - Diastolic 2 +8 Resting arm diastolic BP 123871 phv00123871.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:23:58+00:00 2018-08-21 18:23:58+00:00 AM10DIA3 BP: 10 AM - Diastolic 3 +8 Resting arm diastolic BP 124247 phv00124247.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:51:11+00:00 2018-08-21 18:51:11+00:00 pm10dia BP: 10 PM Diastolic +8 Resting arm diastolic BP 124249 phv00124249.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:51:21+00:00 2018-08-21 18:51:21+00:00 am7dia BP: 7 AM Diastolic +8 Resting arm diastolic BP 124251 phv00124251.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:51:34+00:00 2018-08-21 18:51:34+00:00 am10dia BP: 10 AM Diastolic +8 Resting arm diastolic BP 114879 phv00114879.v2.p2 pht001633.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:42:27+00:00 2018-08-22 23:42:27+00:00 B28DBP4 PRE-INSTRUCTION BASELINE DBP #4 +8 Resting arm diastolic BP 114875 phv00114875.v2.p2 pht001633.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:42:41+00:00 2018-08-22 23:42:41+00:00 B28DBP3 PRE-INSTRUCTION BASELINE DBP #3 +8 Resting arm diastolic BP 114871 phv00114871.v2.p2 pht001633.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:42:57+00:00 2018-08-22 23:42:57+00:00 B28DBP2 PRE-INSTRUCTION BASELINE DBP #2 +8 Resting arm diastolic BP 114867 phv00114867.v2.p2 pht001633.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:43:10+00:00 2018-08-22 23:43:10+00:00 B28DBP1 PRE-INSTRUCTION BASELINE DBP #1 +8 Resting arm diastolic BP 116136 phv00116136.v2.p2 pht001680.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 18:44:53+00:00 2018-08-23 18:44:53+00:00 C40DBP DIASTOLIC BLOOD PRESSURE +8 Resting arm diastolic BP 116570 phv00116570.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 21:38:28+00:00 2018-08-23 21:38:28+00:00 D02DBP3 THIRD CORRECTED DBP (R3_D - RZ3_D). Q 19 +12 Height 125860 phv00125860.v1.p1 pht001940.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:24:41+00:00 2018-02-22 21:24:41+00:00 antv1 1: Standing height to nearest cm +12 Height 539 phv00000539.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:47:24+00:00 2018-03-01 16:47:24+00:00 MF67 HEIGHT: FULL INCHES, EXAM 1 +12 Height 540 phv00000540.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:47:38+00:00 2018-03-01 16:47:38+00:00 MF68 HEIGHT: IN EXCESS OF FULL INCHES, EXAM 1 +12 Height 680 phv00000680.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:47:50+00:00 2018-03-01 16:47:50+00:00 MF217 STANDING HEIGHT: FULL INCHES, EXAM 4 +12 Height 681 phv00000681.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:48:03+00:00 2018-03-01 16:48:03+00:00 MF218 STANDING HEIGHT: IN EXCESS OF FULL INCHES, EXAM 4 +12 Height 744 phv00000744.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:48:21+00:00 2018-03-01 16:48:21+00:00 MF290 HEIGHT: FULL INCHES, EXAM 5 +12 Height 745 phv00000745.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:48:38+00:00 2018-03-01 16:48:38+00:00 MF291 HEIGHT: IN EXCESS OF FULL INCHES, EXAM 5 +12 Height 1367 phv00001367.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:48:51+00:00 2018-03-01 16:48:51+00:00 FC7 HEIGHT, TO NEXT LOWER QUARTER INCH +12 Height 1564 phv00001564.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:49:03+00:00 2018-03-01 16:49:03+00:00 FD13 HEIGHT, TO NEXT LOWER QUARTER INCH +12 Height 1808 phv00001808.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:50:22+00:00 2018-03-01 16:50:22+00:00 FE68 HEIGHT, TO NEXT LOWER QUARTER INCH +12 Height 2023 phv00002023.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:50:39+00:00 2018-03-01 16:50:39+00:00 FF64 HEIGHT, TO NEXT LOWER QUARTER INCH +12 Height 2207 phv00002207.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:51:15+00:00 2018-03-01 16:51:15+00:00 FG63 HEIGHT, TO NEXT LOWER QUARTER INCH (INCHES X 100; FOR USE DIVIDE BY 100) +12 Height 2428 phv00002428.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:51:34+00:00 2018-03-01 16:51:34+00:00 FH63 HEIGHT, TO NEXT LOWER QUARTER INCH (INCHES X 100; FOR USE DIVIDE BY 100) +12 Height 2671 phv00002671.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:51:58+00:00 2018-03-01 16:51:58+00:00 FI15 HEIGHT, INCHES +12 Height 2672 phv00002672.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:52:17+00:00 2018-03-01 16:52:17+00:00 FI16 HEIGHT, FRAC +12 Height 3245 phv00003245.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:52:34+00:00 2018-03-01 16:52:34+00:00 FJ361 HEIGHT (INCHES) +12 Height 3303 phv00003303.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:52:50+00:00 2018-03-01 16:52:50+00:00 FK48 HEIGHT (INCHES) +12 Height 3669 phv00003669.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:53:06+00:00 2018-03-01 16:53:06+00:00 FL010 HEIGHT +12 Height 4085 phv00004085.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:53:22+00:00 2018-03-01 16:53:22+00:00 FM20 HEIGHT (IN INCHES TO NEXT LOWER 1/4 INCH) +12 Height 4527 phv00004527.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:53:37+00:00 2018-03-01 16:53:37+00:00 FN9 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 5542 phv00005542.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:53:57+00:00 2018-03-01 16:53:57+00:00 FO008 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 5922 phv00005922.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:54:21+00:00 2018-03-01 16:54:21+00:00 FP008 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 6034 phv00006034.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:54:43+00:00 2018-03-01 16:54:43+00:00 FQ006 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 6329 phv00006329.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:54:58+00:00 2018-03-01 16:54:58+00:00 FR006 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 6673 phv00006673.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:55:16+00:00 2018-03-01 16:55:16+00:00 FS008 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 7101 phv00007101.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:55:52+00:00 2018-03-01 16:55:52+00:00 FT008 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 7570 phv00007570.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:56:11+00:00 2018-03-01 16:56:11+00:00 A51 BODY HEIGHT +12 Height 7571 phv00007571.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:56:25+00:00 2018-03-01 16:56:25+00:00 A52 FRACTIONAL BODY HEIGHT +12 Height 7677 phv00007677.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:56:41+00:00 2018-03-01 16:56:41+00:00 B14 BODY HEIGHT (CM) +12 Height 7679 phv00007679.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:56:54+00:00 2018-03-01 16:56:54+00:00 B16 BODY HEIGHT (INCHES) +12 Height 7680 phv00007680.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:57:10+00:00 2018-03-01 16:57:10+00:00 B17 BODY HEIGHT (FRACTION) +12 Height 8714 phv00008714.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:57:25+00:00 2018-03-01 16:57:25+00:00 C417 HEIGHT IN INCHES +12 Height 8763 phv00008763.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:57:40+00:00 2018-03-01 16:57:40+00:00 D402 HEIGHT (IN INCHES TO NEXT LOWER 1/4 INCH) +12 Height 9553 phv00009553.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:57:52+00:00 2018-03-01 16:57:52+00:00 E025 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 10109 phv00010109.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:58:08+00:00 2018-03-01 16:58:08+00:00 F008 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 10499 phv00010499.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:58:26+00:00 2018-03-01 16:58:26+00:00 G441 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 21231 phv00021231.v5.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 16:58:51+00:00 2018-03-01 16:58:51+00:00 G3A446 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 55258 phv00055258.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:44:20+00:00 2018-03-01 17:44:20+00:00 Height Height in centimeters +12 Height 56840 phv00056840.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:44:46+00:00 2018-03-01 17:44:46+00:00 pm207 Height in cm +12 Height 70555 phv00070555.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:45:02+00:00 2018-03-01 17:45:02+00:00 FU258 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 72337 phv00072337.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:45:24+00:00 2018-03-01 17:45:24+00:00 H399 HEIGHT (INCHES, TO NEXT LOWER 1/4 INCH) +12 Height 177539 phv00177539.v3.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:45:56+00:00 2018-03-01 17:45:56+00:00 g3b0483 Anthropometry: Height +12 Height 250288 phv00250288.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:48:14+00:00 2018-03-01 17:48:14+00:00 e025 Numerical Data - Part I: Height Collection Interval: Exam 1 +12 Height 251062 phv00251062.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:51:55+00:00 2018-03-01 17:51:55+00:00 g441 Numerical Data - Part I - Basic Information: Height (to next lower 1/4 inch) Collection Interval: Exam 2 +12 Height 251535 phv00251535.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:52:11+00:00 2018-03-01 17:52:11+00:00 h399 Numerical Data - Part I: Basic Information: Height (nearest 1/4 inch) Collection Interval: Exam 3 +12 Height 254284 phv00254284.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:52:31+00:00 2018-03-01 17:52:31+00:00 j472 Numerical Data/Anthropometry: Height +12 Height 254766 phv00254766.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:52:54+00:00 2018-03-01 17:52:54+00:00 fv260 Numerical Data (Anthropometry) - Basic Information: Height Collection Interval: Exam 29 +12 Height 255158 phv00255158.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:53:17+00:00 2018-03-01 17:53:17+00:00 fw305 Numerical Data: Basic Information: Height Collection Interval: Original Cohort Exam 30 +12 Height 274053 phv00274053.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:53:45+00:00 2018-03-01 17:53:45+00:00 g3a446 Height Collection Interval: Exam 1 +12 Height 274544 phv00274544.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:54:00+00:00 2018-03-01 17:54:00+00:00 g3a446 Height +12 Height 274883 phv00274883.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:54:22+00:00 2018-03-01 17:54:22+00:00 FX305 Numerical Data: Basic Information: Height Collection Interval: Original Cohort Exam 31 +12 Height 275241 phv00275241.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:54:39+00:00 2018-03-01 17:54:39+00:00 fy305 Numerical Data: Basic Information: Height Collection Interval: Original Cohort Exam 32 +12 Height 277042 phv00277042.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:55:03+00:00 2018-03-01 17:55:03+00:00 HGT1 Height, Exam 1 +12 Height 277043 phv00277043.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:55:13+00:00 2018-03-01 17:55:13+00:00 HGT2 Height, Exam 2 +12 Height 277171 phv00277171.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:55:24+00:00 2018-03-01 17:55:24+00:00 HGT1 Height, Exam 1 +12 Height 277172 phv00277172.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:55:35+00:00 2018-03-01 17:55:35+00:00 HGT2 Height, Exam 2 +12 Height 277173 phv00277173.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:55:50+00:00 2018-03-01 17:55:50+00:00 HGT3 Height, Exam 3 +12 Height 277174 phv00277174.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:56:01+00:00 2018-03-01 17:56:01+00:00 HGT4 Height, Exam 4 +12 Height 277175 phv00277175.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:56:13+00:00 2018-03-01 17:56:13+00:00 HGT5 Height, Exam 5 +12 Height 277176 phv00277176.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:56:28+00:00 2018-03-01 17:56:28+00:00 HGT6 Height, Exam 6 +12 Height 277177 phv00277177.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:56:40+00:00 2018-03-01 17:56:40+00:00 HGT7 Height, Exam 7 +12 Height 277178 phv00277178.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:56:53+00:00 2018-03-01 17:56:53+00:00 HGT8 Height, Exam 8 +12 Height 277179 phv00277179.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-01 17:57:07+00:00 2018-03-01 17:57:07+00:00 HGT9 Height, Exam 9 +12 Height 226281 phv00226281.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:57:03+00:00 2018-03-14 21:57:03+00:00 HEIGHT Height (corrected) +12 Height 203151 phv00203151.v1.p1 pht004032.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:44:55+00:00 2018-03-15 14:44:55+00:00 ANTA01 [Height and weight]. Standing height (to the nearest cm). Q1 [Anthropometry Form, ANTA, exam 1] +12 Height 203175 phv00203175.v1.p1 pht004034.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:45:51+00:00 2018-03-15 14:45:51+00:00 ANTC1 [Height and weight]. Standing height (to the nearest cm, rounding down). Q1 [Anthropometry Form, ANTC, exam 3] +12 Height 203193 phv00203193.v1.p1 pht004035.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:46:26+00:00 2018-03-15 14:46:26+00:00 ANTD1 [Height and weight]. Standing height (to the nearest cm, rounding down). Q1 [Anthropometry Form, ANTD, exam 4] +12 Height 113634 phv00113634.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:43:40+00:00 2018-04-17 16:43:40+00:00 A20HGT PT'S HGT, CM. Q 1 +12 Height 114829 phv00114829.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:43:40+00:00 2018-04-17 16:43:40+00:00 B20HGT SUBJECT'S HEIGHT STANDING IN CM. Q 1 +12 Height 115856 phv00115856.v2.p2 pht001671.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:43:40+00:00 2018-04-17 16:43:40+00:00 C20HGT SUBJECT'S HEIGHT STANDING (CM). Q 1 +12 Height 117230 phv00117230.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:43:40+00:00 2018-04-17 16:43:40+00:00 D20HGT SUBJECT'S HEIGHT STANDING (CM). Q 1a +12 Height 119093 phv00119093.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:43:40+00:00 2018-04-17 16:43:40+00:00 E20HGT SUBJECT'S HEIGHT STANDING (CM). Q 1a +12 Height 120994 phv00120994.v2.p2 pht001857.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:43:40+00:00 2018-04-17 16:43:40+00:00 F20HGT SUBJECT'S HEIGHT STANDING (CM). Q 1a +12 Height 79858 phv00079858.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-17 23:17:49+00:00 2018-04-17 23:17:49+00:00 HEIGHTX F80 Height cm +12 Height 283311 phv00283311.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-17 23:17:49+00:00 2018-04-17 23:17:49+00:00 HEIGHT Height, in +12 Height 283539 phv00283539.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-17 23:17:49+00:00 2018-04-17 23:17:49+00:00 HEIGHT F136 Height, cm +12 Height 115704 phv00115704.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:53:08+00:00 2018-04-19 19:53:08+00:00 C12HGT HEIGHT IN INCHES +12 Height 116480 phv00116480.v2.p2 pht001706.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:53:33+00:00 2018-04-19 19:53:33+00:00 DDXPTHT PATIENT DATA: HEIGHT (CM) +12 Height 118136 phv00118136.v2.p2 pht001755.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:54:10+00:00 2018-04-19 19:54:10+00:00 EHT HEIGHT +12 Height 118250 phv00118250.v2.p2 pht001756.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:54:24+00:00 2018-04-19 19:54:24+00:00 EHT HEIGHT +12 Height 118957 phv00118957.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:54:36+00:00 2018-04-19 19:54:36+00:00 E12HGT HEIGHT IN INCHES +12 Height 119506 phv00119506.v2.p2 pht001795.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:55:01+00:00 2018-04-19 19:55:01+00:00 E53HEIGT HEIGHT (IN) - FORM 53 +12 Height 99550 phv00099550.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 21:45:27+00:00 2018-04-20 21:45:27+00:00 STHT13 STANDING HEIGHT - CM +12 Height 100382 phv00100382.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 21:46:10+00:00 2018-04-20 21:46:10+00:00 STHT13 STANDING HEIGHT - CM +12 Height 105412 phv00105412.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 21:46:39+00:00 2018-04-20 21:46:39+00:00 STHT13 STANDING HEIGHT - CM +12 Height 110375 phv00110375.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 21:46:53+00:00 2018-04-20 21:46:53+00:00 STHT13 STANDING HEIGHT - CM +12 Height 106775 phv00106775.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 21:50:21+00:00 2018-04-20 21:50:21+00:00 STHT13 STANDING HEIGHT - CM +12 Height 82683 phv00082683.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:06:45+00:00 2018-04-23 03:06:45+00:00 htcm1 HEIGHT (cm) +12 Height 83471 phv00083471.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:06:52+00:00 2018-04-23 03:06:52+00:00 lunghta4 HEIGHT (cm) +12 Height 83706 phv00083706.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:07:00+00:00 2018-04-23 03:07:00+00:00 lunghta4 HEIGHT (cm) +12 Height 84482 phv00084482.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:07:12+00:00 2018-04-23 03:07:12+00:00 htcm1 HEIGHT (cm) +12 Height 85799 phv00085799.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:07:26+00:00 2018-04-23 03:07:26+00:00 htcm2 HEIGHT (cm) +12 Height 86298 phv00086298.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:07:33+00:00 2018-04-23 03:07:33+00:00 htcm3 HEIGHT (cm) +12 Height 86751 phv00086751.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:07:40+00:00 2018-04-23 03:07:40+00:00 htcm4 HEIGHT (cm) +12 Height 87078 phv00087078.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:07:48+00:00 2018-04-23 03:07:48+00:00 htcmf HEIGHT (cm) +12 Height 87697 phv00087697.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:07:54+00:00 2018-04-23 03:07:54+00:00 lunghta4 HEIGHT (cm) +12 Height 174630 phv00174630.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:08:00+00:00 2018-04-23 03:08:00+00:00 htcm5 HEIGHT (cm) +12 Height 175858 phv00175858.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:08:07+00:00 2018-04-23 03:08:07+00:00 htcm1 HEIGHT (cm) +12 Height 175943 phv00175943.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:08:13+00:00 2018-04-23 03:08:13+00:00 htcmf FAMILY COHORT: HEIGHT (cm) +12 Height 176053 phv00176053.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:08:19+00:00 2018-04-23 03:08:19+00:00 htcm5 HEIGHT (cm) +12 Height 206817 phv00206817.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:07:27+00:00 2018-04-25 20:07:27+00:00 HFAA19A1 [Physical exam - vital signs]. Q19a1- Height (cm/in) at hospital admission (or at onset of event) [Heart Failure Hospital Record Abstraction Form, HFA] +12 Height 206855 phv00206855.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:07:45+00:00 2018-04-25 20:07:45+00:00 HFAA19A [Physical exam - vital signs]. Q19a - Height at hospital admission (or at onset of event) [Heart Failure Hospital Record Abstraction Form, HFA] +12 Height 214060 phv00214060.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:08:02+00:00 2018-04-25 20:08:02+00:00 HEIGHT Height in centimeters +12 Height 159592 phv00159592.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:43:38+00:00 2018-08-10 21:43:38+00:00 Height_CM Height [cm] Collection Interval: Collected in Exam 1 +12 Height 277282 phv00277282.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:06:43+00:00 2018-08-14 22:06:43+00:00 HEIGHT Standing height in cm Collection Interval: 2007-2009 +12 Height 277331 phv00277331.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:12:53+00:00 2018-08-14 22:12:53+00:00 HEIGHT Height Collection Interval: 2009-2011 +12 Height 277514 phv00277514.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:40:20+00:00 2018-08-14 22:40:20+00:00 HEIGHT Standing height in cm Collection Interval: 1996-2000 +12 Height 277667 phv00277667.v1.p1 pht006045.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:00:32+00:00 2018-08-14 23:00:32+00:00 ECHO_HT Height (inches) Collection Interval: 2001-2004 +12 Height 277764 phv00277764.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:07:15+00:00 2018-08-14 23:07:15+00:00 HEIGHT HEIGHT Collection Interval: 2000-2004 +12 Height 307742 phv00307742.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:51:14+00:00 2018-08-15 23:51:14+00:00 HEIGHT Standing height Collection Interval: 2006-2011 +12 Height 307795 phv00307795.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:55:51+00:00 2018-08-15 23:55:51+00:00 HEIGHT Standing height in cm Collection Interval: 1996-2000 +12 Height 307955 phv00307955.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:08:42+00:00 2018-08-16 00:08:42+00:00 HEIGHT HEIGHT Collection Interval: 2000-2004 +12 Height 122640 phv00122640.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:54:10+00:00 2018-08-16 23:54:10+00:00 htcm Height in centimeters +12 Height 114609 phv00114609.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:23:02+00:00 2018-08-22 23:23:02+00:00 B12HGT HT, IN INCHES +12 Height 252982 phv00252982.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:12:13+00:00 2018-08-24 17:12:13+00:00 height_baseline Height at baseline visit +12 Height 258683 phv00258683.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:22:28+00:00 2018-09-06 12:22:28+00:00 Height Height of participant +12 Height 267371 phv00267371.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:12:41+00:00 2018-09-06 13:12:41+00:00 height Height in cm +12 Height 259392 phv00259392.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:24:42+00:00 2018-09-06 13:24:42+00:00 height Height during adulthood +12 Height 121870 phv00121870.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:53:53+00:00 2018-09-07 15:53:53+00:00 clotht_cms Height at time of blood clot +13 Weight 125861 phv00125861.v1.p1 pht001940.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:25:10+00:00 2018-02-22 21:25:10+00:00 antv2 2: Weight to nearest kilogram +13 Weight 632 phv00000632.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:13:19+00:00 2018-03-02 14:13:19+00:00 MF166 WEIGHT, EXAM 2 +13 Weight 646 phv00000646.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:13:35+00:00 2018-03-02 14:13:35+00:00 MF180 WEIGHT, EXAM 3 +13 Weight 679 phv00000679.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:13:52+00:00 2018-03-02 14:13:52+00:00 MF216 WEIGHT, EXAM 4 +13 Weight 746 phv00000746.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:14:22+00:00 2018-03-02 14:14:22+00:00 MF292 WEIGHT, EXAM 5 +13 Weight 829 phv00000829.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:14:41+00:00 2018-03-02 14:14:41+00:00 MF380 WEIGHT, EXAM 6 +13 Weight 915 phv00000915.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:15:00+00:00 2018-03-02 14:15:00+00:00 MF470 WEIGHT, EXAM 7 +13 Weight 541 phv00000541.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:15:15+00:00 2018-03-02 14:15:15+00:00 MF69 WEIGHT, EXAM 1 +13 Weight 1037 phv00001037.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:15:37+00:00 2018-03-02 14:15:37+00:00 FA2 WEIGHT (WHOLE POUNDS) +13 Weight 1189 phv00001189.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:15:54+00:00 2018-03-02 14:15:54+00:00 FB9 BODY WEIGHT +13 Weight 1366 phv00001366.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:16:15+00:00 2018-03-02 14:16:15+00:00 FC6 BODY WEIGHT +13 Weight 1563 phv00001563.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:16:38+00:00 2018-03-02 14:16:38+00:00 FD12 BODY WEIGHT (TO NEAREST POUND) +13 Weight 1807 phv00001807.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:16:59+00:00 2018-03-02 14:16:59+00:00 FE67 BODY WEIGHT (TO NEAREST POUND) +13 Weight 2022 phv00002022.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:17:15+00:00 2018-03-02 14:17:15+00:00 FF63 BODY WEIGHT (TO NEAREST POUND) +13 Weight 2206 phv00002206.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:17:32+00:00 2018-03-02 14:17:32+00:00 FG62 BODY WEIGHT (TO NEAREST POUND) +13 Weight 2427 phv00002427.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:17:51+00:00 2018-03-02 14:17:51+00:00 FH62 BODY WEIGHT (TO NEAREST POUND) +13 Weight 2670 phv00002670.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:18:11+00:00 2018-03-02 14:18:11+00:00 FI14 BODY WEIGHT (TO NEAREST POUND) +13 Weight 3244 phv00003244.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:18:31+00:00 2018-03-02 14:18:31+00:00 FJ360 WEIGHT (TO NEAREST POUND) +13 Weight 3302 phv00003302.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:18:51+00:00 2018-03-02 14:18:51+00:00 FK47 WEIGHT (TO NEAREST POUND) +13 Weight 3668 phv00003668.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:19:09+00:00 2018-03-02 14:19:09+00:00 FL009 WEIGHT +13 Weight 4084 phv00004084.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:19:23+00:00 2018-03-02 14:19:23+00:00 FM19 WEIGHT (TO NEAREST POUND) +13 Weight 4526 phv00004526.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:19:43+00:00 2018-03-02 14:19:43+00:00 FN8 WEIGHT (POUNDS, TO NEAREST POUND) +13 Weight 5541 phv00005541.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:19:57+00:00 2018-03-02 14:19:57+00:00 FO007 WEIGHT (TO NEAREST POUND) +13 Weight 5921 phv00005921.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:20:16+00:00 2018-03-02 14:20:16+00:00 FP007 WEIGHT (TO NEAREST POUND, WITHOUT SHOES AND IN LIGHT CLOTHES) +13 Weight 6033 phv00006033.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:20:31+00:00 2018-03-02 14:20:31+00:00 FQ005 WEIGHT (TO NEAREST POUND) +13 Weight 6328 phv00006328.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:20:45+00:00 2018-03-02 14:20:45+00:00 FR005 WEIGHT (TO NEAREST POUND) +13 Weight 6671 phv00006671.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:26:53+00:00 2018-03-02 14:26:53+00:00 FS005 WEIGHT (TO NEAREST POUND) +13 Weight 7098 phv00007098.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:27:19+00:00 2018-03-02 14:27:19+00:00 FT004 WEIGHT (TO NEAREST POUND) +13 Weight 7569 phv00007569.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:27:47+00:00 2018-03-02 14:27:47+00:00 A50 BODY WEIGHT +13 Weight 7676 phv00007676.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:29:59+00:00 2018-03-02 14:29:59+00:00 B13 BODY WEIGHT (KG) +13 Weight 7678 phv00007678.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 14:30:19+00:00 2018-03-02 14:30:19+00:00 B15 BODY WEIGHT (LB) +13 Weight 8713 phv00008713.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:16:08+00:00 2018-03-02 15:16:08+00:00 C416 WEIGHT IN POUNDS +13 Weight 9100 phv00009100.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:16:47+00:00 2018-03-02 15:16:47+00:00 D401 WEIGHT (TO NEAREST POUND) +13 Weight 9552 phv00009552.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:17:13+00:00 2018-03-02 15:17:13+00:00 E024 WEIGHT (TO NEAREST POUND) +13 Weight 10108 phv00010108.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:17:40+00:00 2018-03-02 15:17:40+00:00 F007 WEIGHT (TO NEAREST POUND) +13 Weight 10498 phv00010498.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:17:55+00:00 2018-03-02 15:17:55+00:00 G440 WEIGHT (TO NEAREST POUND) +13 Weight 21229 phv00021229.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:18:16+00:00 2018-03-02 15:18:16+00:00 G3A444 WEIGHT (TO NEAREST POUND) +13 Weight 55259 phv00055259.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:19:15+00:00 2018-03-02 15:19:15+00:00 Weight Weight in kilograms +13 Weight 55291 phv00055291.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:19:33+00:00 2018-03-02 15:19:33+00:00 WEIGHT20 Weight in kilograms +13 Weight 56838 phv00056838.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:20:00+00:00 2018-03-02 15:20:00+00:00 pm202 Weight in kilograms +13 Weight 70552 phv00070552.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:20:23+00:00 2018-03-02 15:20:23+00:00 FU252 WEIGHT (TO NEAREST POUND) +13 Weight 72335 phv00072335.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:21:06+00:00 2018-03-02 15:21:06+00:00 H393 WEIGHT (TO NEAREST POUND) +13 Weight 177537 phv00177537.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:21:50+00:00 2018-03-02 15:21:50+00:00 g3b0481 Anthropometry: Weight +13 Weight 227264 phv00227264.v1.p10 pht004809.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:22:09+00:00 2018-03-02 15:22:09+00:00 weight_kg Weight in Kg from FHS Offspring Exam 9 or OMNI1 Exam 4 Collection Interval: Test performed at Offspring Exam9 and Omni 1 Exam 4 +13 Weight 227263 phv00227263.v1.p10 pht004809.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:22:40+00:00 2018-03-02 15:22:40+00:00 wgt_new Weight from FHS Offspring Exam 9 or OMNI 1 Exam 4 Collection Interval: Test performed at Offspring Exam9 and Omni 1 Exam 4 +13 Weight 250287 phv00250287.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:23:03+00:00 2018-03-02 15:23:03+00:00 e024 Numerical Data - Part I: Weight Collection Interval: Exam 1 +13 Weight 251061 phv00251061.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:23:24+00:00 2018-03-02 15:23:24+00:00 g440 Numerical Data - Part I - Basic Information: Weight (to nearest pound) Collection Interval: Exam 2 +13 Weight 251532 phv00251532.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:23:40+00:00 2018-03-02 15:23:40+00:00 h393 Numerical Data - Part I: Basic Information: Weight (nearest pound) Collection Interval: Exam 3 +13 Weight 254286 phv00254286.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:24:08+00:00 2018-03-02 15:24:08+00:00 j474 Numerical Data/Anthropometry: Weight +13 Weight 254763 phv00254763.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:24:30+00:00 2018-03-02 15:24:30+00:00 fv254 Numerical Data (Anthropometry) - Basic Information: Weight Collection Interval: Exam 29 +13 Weight 255155 phv00255155.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:24:57+00:00 2018-03-02 15:24:57+00:00 fw298 Numerical Data: Basic Information - Weight Collection Interval: Original Cohort Exam 30 +13 Weight 274051 phv00274051.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:25:18+00:00 2018-03-02 15:25:18+00:00 g3a444 Weight Collection Interval: Exam 1 +13 Weight 274542 phv00274542.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:25:55+00:00 2018-03-02 15:25:55+00:00 g3a444 Weight +13 Weight 274880 phv00274880.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:26:15+00:00 2018-03-02 15:26:15+00:00 FX298 Numerical Data: Basic Information - Weight Collection Interval: Original Cohort Exam 31 +13 Weight 275238 phv00275238.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:26:36+00:00 2018-03-02 15:26:36+00:00 fy298 Numerical Data: Basic Information - Weight Collection Interval: Original Cohort Exam 32 +13 Weight 277055 phv00277055.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:27:04+00:00 2018-03-02 15:27:04+00:00 WGT1 Weight, Exam 1 +13 Weight 277056 phv00277056.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:27:16+00:00 2018-03-02 15:27:16+00:00 WGT2 Weight, Exam 2 +13 Weight 277227 phv00277227.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:27:30+00:00 2018-03-02 15:27:30+00:00 WGT1 Weight, Exam 1 +13 Weight 277228 phv00277228.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:27:42+00:00 2018-03-02 15:27:42+00:00 WGT2 Weight, Exam 2 +13 Weight 277229 phv00277229.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:28:02+00:00 2018-03-02 15:28:02+00:00 WGT3 Weight, Exam 3 +13 Weight 277230 phv00277230.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:28:13+00:00 2018-03-02 15:28:13+00:00 WGT4 Weight, Exam 4 +13 Weight 277231 phv00277231.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:28:25+00:00 2018-03-02 15:28:25+00:00 WGT5 Weight, Exam 5 +13 Weight 277232 phv00277232.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:28:38+00:00 2018-03-02 15:28:38+00:00 WGT6 Weight, Exam 6 +13 Weight 277233 phv00277233.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:28:51+00:00 2018-03-02 15:28:51+00:00 WGT7 Weight, Exam 7 +13 Weight 277234 phv00277234.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:29:04+00:00 2018-03-02 15:29:04+00:00 WGT8 Weight, Exam 8 +13 Weight 277235 phv00277235.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:29:20+00:00 2018-03-02 15:29:20+00:00 WGT9 Weight, Exam 9 +13 Weight 203154 phv00203154.v1.p1 pht004032.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:42:23+00:00 2018-03-15 14:42:23+00:00 ANTA04 [Height and weight]. Weight (to the nearest lb). Q4 [Anthropometry Form, ANTA, exam 1] +13 Weight 203166 phv00203166.v1.p1 pht004033.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:42:51+00:00 2018-03-15 14:42:51+00:00 ANTB01 [Wait]. Weight (to the nearest lb). Q1 [Anthropometry Form, ANTAB, exam 2] +13 Weight 203176 phv00203176.v1.p1 pht004034.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:43:30+00:00 2018-03-15 14:43:30+00:00 ANTC2 [Height and weight]. Weight (to the nearest lb, rounding down). Q2 [Anthropometry Form, ANTC, exam 3] +13 Weight 203187 phv00203187.v1.p1 pht004035.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:43:56+00:00 2018-03-15 14:43:56+00:00 ANTD2 [Height and weight]. Weight (to the nearest lb, rounding down). Q2 [Anthropometry Form, ANTD, exam 4] +13 Weight 214061 phv00214061.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:55:55+00:00 2018-03-15 14:55:55+00:00 WEIGHT Weight in kilograms +13 Weight 214094 phv00214094.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:56:22+00:00 2018-03-15 14:56:22+00:00 WEIGHT20 Weight in kilograms +13 Weight 113635 phv00113635.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:44:29+00:00 2018-04-17 16:44:29+00:00 A20WGT PT'S WGT, LBS. Q 2 +13 Weight 114831 phv00114831.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:44:29+00:00 2018-04-17 16:44:29+00:00 B20WGT SUBJECT'S WEIGHT IN POUNDS. Q 3 +13 Weight 115857 phv00115857.v2.p2 pht001671.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:44:29+00:00 2018-04-17 16:44:29+00:00 C20WGT SUBJECT'S WEIGHT (LBS). Q 2 +13 Weight 117231 phv00117231.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:44:29+00:00 2018-04-17 16:44:29+00:00 D20WGT SUBJECT'S WEIGHT (LBS). Q 2a +13 Weight 119094 phv00119094.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:44:29+00:00 2018-04-17 16:44:29+00:00 E20WGT SUBJECT'S WEIGHT (LBS). Q 2a +13 Weight 120996 phv00120996.v2.p2 pht001857.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:44:29+00:00 2018-04-17 16:44:29+00:00 F20WGT SUBJECT'S WEIGHT (LBS). Q 2a +13 Weight 114073 phv00114073.v2.p2 pht001594.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:56:43+00:00 2018-04-19 19:56:43+00:00 FY012WT WEIGHT - MON 12 +13 Weight 116479 phv00116479.v2.p2 pht001706.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:58:17+00:00 2018-04-19 19:58:17+00:00 DDXPTWT PATIENT DATA: WEIGHT (KG) +13 Weight 117442 phv00117442.v2.p2 pht001725.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:58:47+00:00 2018-04-19 19:58:47+00:00 D46X3WGT PPT WEIGHT DURING EXAM 3 +13 Weight 117443 phv00117443.v2.p2 pht001725.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:58:55+00:00 2018-04-19 19:58:55+00:00 D46X4WGT PPT WEIGHT DURING EXAM 4 +13 Weight 117926 phv00117926.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:59:37+00:00 2018-04-19 19:59:37+00:00 FY096WGT WEIGHT - MON 96 +13 Weight 118251 phv00118251.v2.p2 pht001756.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:59:51+00:00 2018-04-19 19:59:51+00:00 EWT WEIGHT +13 Weight 119261 phv00119261.v2.p2 pht001790.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:00:53+00:00 2018-04-19 20:00:53+00:00 E46X4WGT PPT WEIGHT DURING EXAM 4. Q 2 +13 Weight 119262 phv00119262.v2.p2 pht001790.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:01:10+00:00 2018-04-19 20:01:10+00:00 E46X5WGT PPT WEIGHT DURING EXAM 5. Q 2 +13 Weight 119573 phv00119573.v2.p2 pht001795.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 20:01:50+00:00 2018-04-19 20:01:50+00:00 E53WGT WEIGHT (LBS) - FORM 53 +13 Weight 99349 phv00099349.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:00:20+00:00 2018-04-20 22:00:20+00:00 WEIGHT13 WEIGHT - LBS +13 Weight 105414 phv00105414.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:08:39+00:00 2018-04-20 22:08:39+00:00 WEIGHT13 WEIGHT - LBS +13 Weight 106776 phv00106776.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:09:05+00:00 2018-04-20 22:09:05+00:00 WEIGHT13 WEIGHT - LBS +13 Weight 110376 phv00110376.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:09:19+00:00 2018-04-20 22:09:19+00:00 WEIGHT13 WEIGHT - LBS +13 Weight 102454 phv00102454.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:09:46+00:00 2018-04-20 22:09:46+00:00 WEIGHT13 WEIGHT - LBS +13 Weight 100383 phv00100383.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:09:58+00:00 2018-04-20 22:09:58+00:00 WEIGHT13 WEIGHT - LBS +13 Weight 101789 phv00101789.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:12:25+00:00 2018-04-20 22:12:25+00:00 WEIGHT33 WEIGHT IN POUNDS +13 Weight 104028 phv00104028.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:15:17+00:00 2018-04-20 22:15:17+00:00 WEIGHT33 WEIGHT IN POUNDS AT YEAR 3 VISIT +13 Weight 104759 phv00104759.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:15:37+00:00 2018-04-20 22:15:37+00:00 WEIGHT33 WEIGHT IN POUNDS +13 Weight 107778 phv00107778.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:16:00+00:00 2018-04-20 22:16:00+00:00 WEIGHT33 WEIGHT IN POUNDS AT YEAR 6 VISIT +13 Weight 108569 phv00108569.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:16:15+00:00 2018-04-20 22:16:15+00:00 WEIGHT33 WEIGHT IN POUNDS AT YEAR 7 VISIT +13 Weight 109512 phv00109512.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:16:30+00:00 2018-04-20 22:16:30+00:00 WEIGHT33 WEIGHT IN POUNDS AT YEAR 8 VISIT +13 Weight 82685 phv00082685.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:10:38+00:00 2018-04-23 03:10:38+00:00 wtlb1 WEIGHT (lbs) +13 Weight 83472 phv00083472.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:11:18+00:00 2018-04-23 03:11:18+00:00 lungwta4 WEIGHT (lbs) +13 Weight 83707 phv00083707.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:11:26+00:00 2018-04-23 03:11:26+00:00 lungwta4 WEIGHT (lbs) +13 Weight 84484 phv00084484.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:11:32+00:00 2018-04-23 03:11:32+00:00 wtlb1 WEIGHT (lbs) +13 Weight 85800 phv00085800.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:11:51+00:00 2018-04-23 03:11:51+00:00 wtlb2 WEIGHT (lbs.) +13 Weight 86299 phv00086299.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:11:58+00:00 2018-04-23 03:11:58+00:00 wtlb3 WEIGHT (lbs) +13 Weight 86752 phv00086752.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:12:07+00:00 2018-04-23 03:12:07+00:00 wtlb4 WEIGHT (lbs) +13 Weight 87079 phv00087079.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:12:13+00:00 2018-04-23 03:12:13+00:00 wtlbf WEIGHT (lbs) +13 Weight 87698 phv00087698.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:12:24+00:00 2018-04-23 03:12:24+00:00 lungwta4 WEIGHT (lbs) +13 Weight 174632 phv00174632.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:12:41+00:00 2018-04-23 03:12:41+00:00 wtlb5 WEIGHT (lbs) +13 Weight 174745 phv00174745.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:12:51+00:00 2018-04-23 03:12:51+00:00 ctwtlb5 WEIGHT AT CT +13 Weight 175859 phv00175859.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:12:57+00:00 2018-04-23 03:12:57+00:00 wtlb1 WEIGHT (lbs) +13 Weight 175944 phv00175944.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:13:03+00:00 2018-04-23 03:13:03+00:00 wtlbf FAMILY COHORT: WEIGHT (lbs) +13 Weight 176055 phv00176055.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:13:09+00:00 2018-04-23 03:13:09+00:00 wtlb5 WEIGHT (lbs) +13 Weight 176060 phv00176060.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:13:16+00:00 2018-04-23 03:13:16+00:00 bcswtkg5 BODY COMPOSITION SCALE: CURRENT BODY WEIGHT (kg) +13 Weight 176168 phv00176168.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:13:24+00:00 2018-04-23 03:13:24+00:00 ctwtlb5 WEIGHT AT CT +13 Weight 79859 phv00079859.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 22:08:59+00:00 2018-04-24 22:08:59+00:00 WEIGHTX F80 Weight kg +13 Weight 283540 phv00283540.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 22:08:59+00:00 2018-04-24 22:08:59+00:00 WEIGHTADM F136 Weight at onset, kg +13 Weight 283541 phv00283541.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 22:08:59+00:00 2018-04-24 22:08:59+00:00 WEIGHTDSCH F136 Weight, last recorded, kg +13 Weight 206818 phv00206818.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:11:05+00:00 2018-04-25 20:11:05+00:00 HFAA20A1 [Physical exam - vital signs]. Q20a1- Weight (lbs/kg) at hospital admission (or at onset of event) [Heart Failure Hospital Record Abstraction Form, HFA] +13 Weight 206819 phv00206819.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:11:24+00:00 2018-04-25 20:11:24+00:00 HFAA20B1 [Physical exam - vital signs]. Q20b1- Weight (lbs/kg) at hospital discharge (or last recorded) [Heart Failure Hospital Record Abstraction Form, HFA] +13 Weight 206856 phv00206856.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:12:51+00:00 2018-04-25 20:12:51+00:00 HFAA20A [Physical exam - vital signs]. Q20a - Weight at hospital admission (or at onset of event) [Heart Failure Hospital Record Abstraction Form, HFA] +13 Weight 206857 phv00206857.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:13:04+00:00 2018-04-25 20:13:04+00:00 HFAA20B [Physical exam - vital signs]. Q20b - Weight at hospital discharge (or last recorded) [Heart Failure Hospital Record Abstraction Form, HFA] +13 Weight 283312 phv00283312.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:23:45+00:00 2018-05-15 17:23:45+00:00 WEIGHT Weight, lb +13 Weight 159591 phv00159591.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:57:11+00:00 2018-08-10 21:57:11+00:00 Weight_KG Weight [kg] Collection Interval: Collected in Exam 1 +13 Weight 277283 phv00277283.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:06:55+00:00 2018-08-14 22:06:55+00:00 WEIGHT Standing weight in kg Collection Interval: 2007-2009 +13 Weight 277332 phv00277332.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:12:46+00:00 2018-08-14 22:12:46+00:00 WEIGHT Weight Collection Interval: 2009-2011 +13 Weight 277515 phv00277515.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:40:13+00:00 2018-08-14 22:40:13+00:00 WEIGHT Weight in kg Collection Interval: 1996-2000 +13 Weight 277668 phv00277668.v1.p1 pht006045.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:00:25+00:00 2018-08-14 23:00:25+00:00 ECHO_WT Weight (pounds) Collection Interval: 2001-2004 +13 Weight 277765 phv00277765.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:07:08+00:00 2018-08-14 23:07:08+00:00 WEIGHT WEIGHT Collection Interval: 2000-2004 +13 Weight 307743 phv00307743.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:51:06+00:00 2018-08-15 23:51:06+00:00 WEIGHT Standing weight Collection Interval: 2006-2011 +13 Weight 307796 phv00307796.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:55:44+00:00 2018-08-15 23:55:44+00:00 WEIGHT Weight in kg Collection Interval: 1996-2000 +13 Weight 307956 phv00307956.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:08:34+00:00 2018-08-16 00:08:34+00:00 WEIGHT WEIGHT Collection Interval: 2000-2004 +13 Weight 122639 phv00122639.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:54:01+00:00 2018-08-16 23:54:01+00:00 wtkg Weight in kilograms +13 Weight 123776 phv00123776.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:54:53+00:00 2018-08-21 17:54:53+00:00 WHTKG Weight (kg) +13 Weight 253218 phv00253218.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:31:28+00:00 2018-08-24 16:31:28+00:00 ANTA4 Weight (kg) (ANTA4) +13 Weight 252979 phv00252979.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:11:43+00:00 2018-08-24 17:11:43+00:00 weight_baseline Weight at baseline visit +13 Weight 118137 phv00118137.v2.p2 pht001755.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 18:12:43+00:00 2018-08-28 18:12:43+00:00 EWT WEIGHT +13 Weight 258684 phv00258684.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:22:50+00:00 2018-09-06 12:22:50+00:00 Weight Weight of participant +13 Weight 267372 phv00267372.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:12:13+00:00 2018-09-06 13:12:13+00:00 weight Weight in kg +13 Weight 259393 phv00259393.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:25:06+00:00 2018-09-06 13:25:06+00:00 weight Weight at index date +13 Weight 121871 phv00121871.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:56:44+00:00 2018-09-07 15:56:44+00:00 clotwt_kgs Weight at time of blood clot +14 BMI 126013 phv00126013.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 19:55:29+00:00 2018-02-22 19:55:29+00:00 BMI01 Body mass index, visit 1 +14 BMI 56588 phv00056588.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:07:39+00:00 2018-02-26 19:07:39+00:00 BMI_s1 BMI = weight/((height/100)*(height/100)) +14 BMI 56833 phv00056833.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:09:01+00:00 2018-02-26 19:09:01+00:00 bmi_s2 Body Mass Index (BMI = pm202/((pm207/100)*(pm207/100))) +14 BMI 277024 phv00277024.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:42:18+00:00 2018-02-26 19:42:18+00:00 BMI1 Body mass index, Exam 1 +14 BMI 277025 phv00277025.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:42:51+00:00 2018-02-26 19:42:51+00:00 BMI2 Body mass index, Exam 2 +14 BMI 277095 phv00277095.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:43:12+00:00 2018-02-26 19:43:12+00:00 BMI1 Body mass index, Exam 1 +14 BMI 277096 phv00277096.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:43:32+00:00 2018-02-26 19:43:32+00:00 BMI2 Body mass index, Exam 2 +14 BMI 277097 phv00277097.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:43:47+00:00 2018-02-26 19:43:47+00:00 BMI3 Body mass index, Exam 3 +14 BMI 277098 phv00277098.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:44:00+00:00 2018-02-26 19:44:00+00:00 BMI4 Body mass index, Exam 4 +14 BMI 277099 phv00277099.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:44:16+00:00 2018-02-26 19:44:16+00:00 BMI5 Body mass index, Exam 5 +14 BMI 277100 phv00277100.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:44:33+00:00 2018-02-26 19:44:33+00:00 BMI6 Body mass index, Exam 6 +14 BMI 277101 phv00277101.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:44:47+00:00 2018-02-26 19:44:47+00:00 BMI7 Body mass index, Exam 7 +14 BMI 277102 phv00277102.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:45:03+00:00 2018-02-26 19:45:03+00:00 BMI8 Body mass index, Exam 8 +14 BMI 277103 phv00277103.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:45:17+00:00 2018-02-26 19:45:17+00:00 BMI9 Body mass index, Exam 9 +14 BMI 4077 phv00004077.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:49:15+00:00 2018-02-26 19:49:15+00:00 FL517 BODY MASS INDEX, EXAM19 +14 BMI 4521 phv00004521.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:49:33+00:00 2018-02-26 19:49:33+00:00 FM537 BODY MASS INDEX +14 BMI 4933 phv00004933.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:49:48+00:00 2018-02-26 19:49:48+00:00 FN505 BODY MASS INDEX +14 BMI 5554 phv00005554.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:49:59+00:00 2018-02-26 19:49:59+00:00 FO726 BODY MASS INDEX +14 BMI 6023 phv00006023.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:50:13+00:00 2018-02-26 19:50:13+00:00 FP590 BODY MASS INDEX +14 BMI 6323 phv00006323.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:50:31+00:00 2018-02-26 19:50:31+00:00 FQ392 BODY MASS INDEX +14 BMI 6657 phv00006657.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:50:45+00:00 2018-02-26 19:50:45+00:00 FR432 BODY MASS INDEX (ROUNDED TO HUNDREDTHS) +14 BMI 7092 phv00007092.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:50:59+00:00 2018-02-26 19:50:59+00:00 FS537 BODY MASS INDEX +14 BMI 7531 phv00007531.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:51:15+00:00 2018-02-26 19:51:15+00:00 FT537 BODY MASS INDEX +14 BMI 8735 phv00008735.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:51:31+00:00 2018-02-26 19:51:31+00:00 C448 BODY MASS INDEX +14 BMI 9118 phv00009118.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:51:45+00:00 2018-02-26 19:51:45+00:00 D443 BODY MASS INDEX +14 BMI 9570 phv00009570.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:52:02+00:00 2018-02-26 19:52:02+00:00 E662 BODY MASS INDEX +14 BMI 10130 phv00010130.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:52:17+00:00 2018-02-26 19:52:17+00:00 F719 BODY MASS INDEX +14 BMI 10691 phv00010691.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:52:39+00:00 2018-02-26 19:52:39+00:00 G709 BODY MASS INDEX +14 BMI 70735 phv00070735.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-02-26 19:53:02+00:00 2018-02-26 19:53:02+00:00 FU580 BODY MASS INDEX, CALCULATED: (FU252 0.454)/((FU258 2.54)/100) 2; FU252 WEIGHT, FU258 HEIGHT +14 BMI 226255 phv00226255.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:55:33+00:00 2018-03-14 21:55:33+00:00 BMI BMI (kg/m2) +14 BMI 204719 phv00204719.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:33:24+00:00 2018-03-15 14:33:24+00:00 BMI01 Body Mass Index in Kg/(m2) [Cohort, Exam 1] +14 BMI 204637 phv00204637.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:37:48+00:00 2018-03-15 14:37:48+00:00 BMI21 Visit 2, Body Mass Index in kg/m2 [Cohort, Exam 2] +14 BMI 204836 phv00204836.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:38:49+00:00 2018-03-15 14:38:49+00:00 BMI32 Body Mass Index in kg/m**2 [Cohort, Exam 3] +14 BMI 205014 phv00205014.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:39:28+00:00 2018-03-15 14:39:28+00:00 BMI41 Body Mass Index in Kg/M**2 [Cohort, Exam 4] +14 BMI 215389 phv00215389.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:41:17+00:00 2018-03-15 14:41:17+00:00 BMI_S1 BMI = weight/((height/100)*(height/100)) +14 BMI 113661 phv00113661.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:42:13+00:00 2018-04-17 16:42:13+00:00 A20BMI BODY MASS INDEX, KG/M**2 +14 BMI 114862 phv00114862.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:42:13+00:00 2018-04-17 16:42:13+00:00 B20BMI B20BMI +14 BMI 115869 phv00115869.v2.p2 pht001671.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:42:13+00:00 2018-04-17 16:42:13+00:00 C20BMI BODY MASS INDEX (KG/M**2) +14 BMI 117249 phv00117249.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:42:13+00:00 2018-04-17 16:42:13+00:00 D20BMI BODY MASS INDEX (KG/M**2) +14 BMI 119120 phv00119120.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:42:13+00:00 2018-04-17 16:42:13+00:00 E20BMI BODY MASS INDEX (KG/M**2) +14 BMI 121003 phv00121003.v2.p2 pht001857.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:42:13+00:00 2018-04-17 16:42:13+00:00 F20BMI BODY MASS INDEX (KG/M**2) +14 BMI 79867 phv00079867.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-17 23:05:14+00:00 2018-04-17 23:05:14+00:00 BMIX BMI +14 BMI 283344 phv00283344.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-17 23:05:14+00:00 2018-04-17 23:05:14+00:00 BMI Body-mass Index (BMI), kg/m2 +14 BMI 283345 phv00283345.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-17 23:05:14+00:00 2018-04-17 23:05:14+00:00 BMIC Body-mass Index (BMI), kg/m2 +14 BMI 99468 phv00099468.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:18:43+00:00 2018-04-20 22:18:43+00:00 BMI BODY MASS INDEX +14 BMI 100386 phv00100386.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:18:55+00:00 2018-04-20 22:18:55+00:00 BMI BODY MASS INDEX (kg/m2) +14 BMI 105306 phv00105306.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:19:06+00:00 2018-04-20 22:19:06+00:00 BMI BODY MASS INDEX (kg/m2) +14 BMI 106840 phv00106840.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:19:21+00:00 2018-04-20 22:19:21+00:00 BMI BODY MASS INDEX (kg/m2) +14 BMI 110612 phv00110612.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:19:35+00:00 2018-04-20 22:19:35+00:00 BMI BODY MASS INDEX (kg/m2) +14 BMI 82691 phv00082691.v2.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:07+00:00 2018-04-23 03:15:07+00:00 bmi1c BODY MASS INDEX (kg)/(m^2) +14 BMI 83481 phv00083481.v2.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:15+00:00 2018-04-23 03:15:15+00:00 lbmia4 BMI +14 BMI 83716 phv00083716.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:23+00:00 2018-04-23 03:15:23+00:00 lbmia4 BMI +14 BMI 84490 phv00084490.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:28+00:00 2018-04-23 03:15:28+00:00 bmi1c BODY MASS INDEX (kg)/(m^2) +14 BMI 85803 phv00085803.v3.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:34+00:00 2018-04-23 03:15:34+00:00 bmi2c BODY MASS INDEX (kg/m^2) +14 BMI 86302 phv00086302.v3.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:39+00:00 2018-04-23 03:15:39+00:00 bmi3c BODY MASS INDEX (kg/m^2) +14 BMI 86755 phv00086755.v3.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:45+00:00 2018-04-23 03:15:45+00:00 bmi4c BODY MASS INDEX (kg/m^2) +14 BMI 87080 phv00087080.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:51+00:00 2018-04-23 03:15:51+00:00 bmifc BODY MASS INDEX +14 BMI 87707 phv00087707.v2.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:15:57+00:00 2018-04-23 03:15:57+00:00 lbmia4 BMI +14 BMI 174644 phv00174644.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:16:03+00:00 2018-04-23 03:16:03+00:00 bmi5c BODY MASS INDEX (kg/m^2) +14 BMI 174746 phv00174746.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:16:08+00:00 2018-04-23 03:16:08+00:00 ctbmi5 BMI AT CT +14 BMI 176067 phv00176067.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:16:16+00:00 2018-04-23 03:16:16+00:00 bmi5c BODY MASS INDEX (kg/m^2) +14 BMI 176169 phv00176169.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:16:22+00:00 2018-04-23 03:16:22+00:00 ctbmi5 BMI AT CT +14 BMI 219025 phv00219025.v1.p3 pht004326.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:16:28+00:00 2018-04-23 03:16:28+00:00 bmisc BODY MASS INDEX (KG/M^2) AT MESA STRESS EXAM +14 BMI 159593 phv00159593.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:56:26+00:00 2018-08-10 20:56:26+00:00 BMI BMI Collection Interval: Collected in Exam 1 +14 BMI 122641 phv00122641.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:54:17+00:00 2018-08-16 23:54:17+00:00 bmi Body mass index +14 BMI 122994 phv00122994.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:53:16+00:00 2018-08-17 19:53:16+00:00 lnbmi Log (BMI) +14 BMI 252983 phv00252983.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:12:24+00:00 2018-08-24 17:12:24+00:00 bmi_baseline Body mass index at baseline visit +14 BMI 258685 phv00258685.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:23:06+00:00 2018-09-06 12:23:06+00:00 BMI Body mass index of participant +14 BMI 267373 phv00267373.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:13:00+00:00 2018-09-06 13:13:00+00:00 bmi BMI +15 Waist circumference 125862 phv00125862.v1.p1 pht001940.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-22 21:25:33+00:00 2018-02-22 21:25:33+00:00 antv3a 3a: Waist to nearest cm +15 Waist circumference 203159 phv00203159.v1.p1 pht004032.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:51:52+00:00 2018-03-19 16:51:52+00:00 ANTA07A [Body size]. Waist girth (to the nearest cm). Q7a [Anthropometry Form, ANTA, exam 1] +15 Waist circumference 203171 phv00203171.v1.p1 pht004033.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:52:11+00:00 2018-03-19 16:52:11+00:00 ANTB04A [Body size]. Waist girth (nearest cm). Q4a [Anthropometry Form, ANTAB, exam 2] +15 Waist circumference 203177 phv00203177.v1.p1 pht004034.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:52:32+00:00 2018-03-19 16:52:32+00:00 ANTC3A [Body size]. Waist girth (to the nearest cm, rounding down). Q3a [Anthropometry Form, ANTC, exam 3] +15 Waist circumference 203188 phv00203188.v1.p1 pht004035.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:52:53+00:00 2018-03-19 16:52:53+00:00 ANTD3A [Body size]. Waist girth (to the nearest cm, rounding down). Q3a [Anthropometry Form, ANTD, exam 4] +15 Waist circumference 214062 phv00214062.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:53:19+00:00 2018-03-19 16:53:19+00:00 WAIST Waist measurement in centimeters +15 Waist circumference 23150 phv00023150.v3.p10 pht000139.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:46:08+00:00 2018-03-21 14:46:08+00:00 WAIST WAIST CIRCUMFERENCE, MM +15 Waist circumference 23159 phv00023159.v3.p10 pht000140.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:46:32+00:00 2018-03-21 14:46:32+00:00 WAIST WAIST CIRCUMFERENCE, MM +15 Waist circumference 686 phv00000686.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:47:41+00:00 2018-03-21 14:47:41+00:00 MF223 GIRTH: WAIST, EXAM 4 +15 Waist circumference 748 phv00000748.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:48:08+00:00 2018-03-21 14:48:08+00:00 MF294 GIRTH: WAIST, EXAM 5 +15 Waist circumference 3672 phv00003672.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:49:00+00:00 2018-03-21 14:49:00+00:00 FL018 WAIST GIRTH +15 Waist circumference 4088 phv00004088.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:49:36+00:00 2018-03-21 14:49:36+00:00 FM28 WAIST GIRTH (INCHES WITH 2 DECIMALS) +15 Waist circumference 5544 phv00005544.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:50:10+00:00 2018-03-21 14:50:10+00:00 FO016 WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +15 Waist circumference 5924 phv00005924.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:50:36+00:00 2018-03-21 14:50:36+00:00 FP015 WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +15 Waist circumference 8767 phv00008767.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:51:21+00:00 2018-03-21 14:51:21+00:00 D410 WAIST GIRTH (INCHES WITH 2 DECIMALS) +15 Waist circumference 9555 phv00009555.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:51:46+00:00 2018-03-21 14:51:46+00:00 E032 WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +15 Waist circumference 10112 phv00010112.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:52:16+00:00 2018-03-21 14:52:16+00:00 F016 WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +15 Waist circumference 10502 phv00010502.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:52:35+00:00 2018-03-21 14:52:35+00:00 G445 REGIONAL ANTHROPOMETRY - WAIST GIRTH (INCHES) (TO NEXT LOWER 1/4 INCH) +15 Waist circumference 72341 phv00072341.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 14:54:09+00:00 2018-03-21 14:54:09+00:00 H403 WAIST GIRTH AT UMBILICUS (INCHES, TO NEXT LOWER 1/4 INCH) +15 Waist circumference 274057 phv00274057.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 15:00:23+00:00 2018-03-21 15:00:23+00:00 g3a451 Waist girth Collection Interval: Exam 1 +15 Waist circumference 177543 phv00177543.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 15:01:08+00:00 2018-03-21 15:01:08+00:00 g3b0487 Anthropometry: Waist girth at umbilicus +15 Waist circumference 250290 phv00250290.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 15:01:36+00:00 2018-03-21 15:01:36+00:00 e032 Numerical Data - Part I: Waist girth Collection Interval: Exam 1 +15 Waist circumference 251065 phv00251065.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 15:02:11+00:00 2018-03-21 15:02:11+00:00 g445 Numerical Data - Part I - Regional Anthropometry: Waist girth (to next lower 1/4 inch) Collection Interval: Exam 2 +15 Waist circumference 251538 phv00251538.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 18:53:44+00:00 2018-03-21 18:53:44+00:00 h403 Numerical Data - Part I: Regional Anthropometry: Waist Girth at umbilicus (to next lower 1/4 inch) Collection Interval: Exam 3 +15 Waist circumference 21235 phv00021235.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-21 18:54:34+00:00 2018-03-21 18:54:34+00:00 G3A451 WAIST GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +15 Waist circumference 277053 phv00277053.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:34:24+00:00 2018-03-22 11:34:24+00:00 WAIST1 Waist girth, Exam 1 +15 Waist circumference 277054 phv00277054.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:34:45+00:00 2018-03-22 11:34:45+00:00 WAIST2 Waist girth, Exam 2 +15 Waist circumference 277221 phv00277221.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:35:15+00:00 2018-03-22 11:35:15+00:00 WAIST4 Waist girth, Exam 4 +15 Waist circumference 277222 phv00277222.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:35:39+00:00 2018-03-22 11:35:39+00:00 WAIST5 Waist girth, Exam 5 +15 Waist circumference 277223 phv00277223.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:36:06+00:00 2018-03-22 11:36:06+00:00 WAIST6 Waist girth, Exam 6 +15 Waist circumference 277224 phv00277224.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:36:23+00:00 2018-03-22 11:36:23+00:00 WAIST7 Waist girth, Exam 7 +15 Waist circumference 277225 phv00277225.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:36:40+00:00 2018-03-22 11:36:40+00:00 WAIST8 Waist girth, Exam 8 +15 Waist circumference 277226 phv00277226.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:36:58+00:00 2018-03-22 11:36:58+00:00 WAIST9 Waist girth, Exam 9 +15 Waist circumference 72342 phv00072342.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:38:11+00:00 2018-03-22 11:38:11+00:00 H405 WAIST GIRT AT ILIAC CREST (INCHES, TO NEXT LOWER 1/4 INCH +15 Waist circumference 55260 phv00055260.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:38:50+00:00 2018-03-22 11:38:50+00:00 Waist Waist measurement in centimeters +15 Waist circumference 251540 phv00251540.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:41:08+00:00 2018-03-22 11:41:08+00:00 h405 Numerical Data - Part I: Regional Anthropometry: Waist Girth at iliac crest (to next lower 1/4 inch) Collection Interval: Exam 3 +15 Waist circumference 254291 phv00254291.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 11:41:45+00:00 2018-03-22 11:41:45+00:00 j480 Numerical Data/Anthropometry: Waist girth at umbilicus +15 Waist circumference 274548 phv00274548.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-22 12:36:56+00:00 2018-03-22 12:36:56+00:00 g3a451 Waist girth +15 Waist circumference 113650 phv00113650.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 A20WST1 MEAS. 1: WAIST GIRTH, CM. Q 4 +15 Waist circumference 113651 phv00113651.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 A20WST2 MEAS. 2: WAIST GIRTH, CM. Q 4 +15 Waist circumference 113659 phv00113659.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 A20WST MEAN WAIST GIRTH, CM +15 Waist circumference 114853 phv00114853.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 B20WST1 WAIST 1. Q 5c +15 Waist circumference 114854 phv00114854.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 B20WST2 WAIST 2. Q 5c +15 Waist circumference 114855 phv00114855.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 B20WST MEAN( B20WST1, B20WST2 ) +15 Waist circumference 115859 phv00115859.v2.p2 pht001671.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 C20WST1 WAIST GIRTH (CM). Q 4b +15 Waist circumference 117233 phv00117233.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 D20WST1 WAIST GIRTH 1 (CM). Q 4a +15 Waist circumference 117234 phv00117234.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 D20WST2 WAIST GIRTH 2 (CM). Q 4a +15 Waist circumference 117247 phv00117247.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 D20WST MEAN (D20WST1, D20WST2) (CM) +15 Waist circumference 119095 phv00119095.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 E20WST1 WAIST GIRTH 1 (CM). Q 4a +15 Waist circumference 119096 phv00119096.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 E20WST2 WAIST GIRTH 2 (CM). Q 4a +15 Waist circumference 119117 phv00119117.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 E20WST MEAN (E20WST1, E20WST2) (CM) +15 Waist circumference 120998 phv00120998.v2.p2 pht001857.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:46:12+00:00 2018-04-17 16:46:12+00:00 F20WST1 WAIST GIRTH 1 (CM). Q 3a +15 Waist circumference 99351 phv00099351.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:20:21+00:00 2018-04-20 22:20:21+00:00 WAIST13 WAIST CIRCUMFERENCE - CM +15 Waist circumference 100385 phv00100385.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:20:32+00:00 2018-04-20 22:20:32+00:00 WAIST13 WAIST CIRCUMFERENCE - CM +15 Waist circumference 102455 phv00102455.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:20:45+00:00 2018-04-20 22:20:45+00:00 WAIST13 WAIST CIRCUMFERENCE - CM +15 Waist circumference 105416 phv00105416.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:21:00+00:00 2018-04-20 22:21:00+00:00 WAIST13 WAIST CIRCUMFERENCE - CM +15 Waist circumference 106778 phv00106778.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:21:12+00:00 2018-04-20 22:21:12+00:00 WAIST13 WAIST CIRCUMFERENCE - CM +15 Waist circumference 110377 phv00110377.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:21:25+00:00 2018-04-20 22:21:25+00:00 WAIST13 WAIST CIRCUMFERENCE - CM +15 Waist circumference 82687 phv00082687.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:18:57+00:00 2018-04-23 03:18:57+00:00 waistcm1 WAIST CIRCUMFERENCE (cm) +15 Waist circumference 84486 phv00084486.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:19:04+00:00 2018-04-23 03:19:04+00:00 waistcm1 WAIST CIRCUMFERENCE (cm) +15 Waist circumference 85801 phv00085801.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:19:11+00:00 2018-04-23 03:19:11+00:00 waistcm2 WAIST CIRCUMFERENCE (cm) +15 Waist circumference 86301 phv00086301.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:19:24+00:00 2018-04-23 03:19:24+00:00 waistcm3 WAIST CIRCUMFERENCE (cm) +15 Waist circumference 86754 phv00086754.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:19:31+00:00 2018-04-23 03:19:31+00:00 waistcm4 WAIST CIRCUMFERENCE (cm) +15 Waist circumference 87519 phv00087519.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:19:38+00:00 2018-04-23 03:19:38+00:00 waistcmf WAIST (cm) +15 Waist circumference 174634 phv00174634.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:19:45+00:00 2018-04-23 03:19:45+00:00 waistcm5 WAIST CIRCUMFERENCE (cm) +15 Waist circumference 176057 phv00176057.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:19:50+00:00 2018-04-23 03:19:50+00:00 waistcm5 WAIST CIRCUMFERENCE (cm) +15 Waist circumference 79860 phv00079860.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 22:44:33+00:00 2018-04-24 22:44:33+00:00 WAISTX F80 Waist circumference cm +15 Waist circumference 283313 phv00283313.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 22:44:33+00:00 2018-04-24 22:44:33+00:00 WAIST Waist circumference, in +15 Waist circumference 277284 phv00277284.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:07:21+00:00 2018-08-14 22:07:21+00:00 WAIST Waist circumference in cm Collection Interval: 2007-2009 +15 Waist circumference 277333 phv00277333.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:12:39+00:00 2018-08-14 22:12:39+00:00 WAIST Waist circumference Collection Interval: 2009-2011 +15 Waist circumference 277516 phv00277516.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:41:10+00:00 2018-08-14 22:41:10+00:00 WAIST Waist circumference (cm) Collection Interval: 1996-2000 +15 Waist circumference 277766 phv00277766.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:07:01+00:00 2018-08-14 23:07:01+00:00 WAIST Waist circumference(cm) Collection Interval: 2000-2004 +15 Waist circumference 307744 phv00307744.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:50:59+00:00 2018-08-15 23:50:59+00:00 WAIST Waist circumference Collection Interval: 2006-2011 +15 Waist circumference 307797 phv00307797.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:55:36+00:00 2018-08-15 23:55:36+00:00 WAIST Waist circumference (cm) Collection Interval: 1996-2000 +15 Waist circumference 307957 phv00307957.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:08:21+00:00 2018-08-16 00:08:21+00:00 WAIST Waist circumference (cm) Collection Interval: 2000-2004 +15 Waist circumference 122555 phv00122555.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:46:41+00:00 2018-08-16 23:46:41+00:00 WAIST Waist size (cm) +15 Waist circumference 122996 phv00122996.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:53:00+00:00 2018-08-17 19:53:00+00:00 waistcm Mean waist circumference (cm) +15 Waist circumference 253219 phv00253219.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:32:08+00:00 2018-08-24 16:32:08+00:00 ANTA10A Waist girth (cm) (ANTA10A) +15 Waist circumference 252980 phv00252980.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:11:53+00:00 2018-08-24 17:11:53+00:00 waist_baseline Waist circumference at baseline visit +15 Waist circumference 258690 phv00258690.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:33:53+00:00 2018-09-06 12:33:53+00:00 Abd_Circ Abdominal Circumference Average +16 Hip circumference 3673 phv00003673.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:47:15+00:00 2018-03-02 15:47:15+00:00 FL019 HIP GIRTH +16 Hip circumference 4089 phv00004089.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:47:34+00:00 2018-03-02 15:47:34+00:00 FM29 HIP GIRTH (INCHES WITH 2 DECIMALS) +16 Hip circumference 4531 phv00004531.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:47:58+00:00 2018-03-02 15:47:58+00:00 FN18 HIP GIRTH (INCHES WITH 2 DECIMALS) +16 Hip circumference 5545 phv00005545.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:48:16+00:00 2018-03-02 15:48:16+00:00 FO017 HIP GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +16 Hip circumference 5925 phv00005925.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:48:33+00:00 2018-03-02 15:48:33+00:00 FP016 HIP GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +16 Hip circumference 8768 phv00008768.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:48:50+00:00 2018-03-02 15:48:50+00:00 D411 HIP GIRTH (INCHES WITH 2 DECIMALS) +16 Hip circumference 9556 phv00009556.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:49:09+00:00 2018-03-02 15:49:09+00:00 E033 HIP GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +16 Hip circumference 10113 phv00010113.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:49:24+00:00 2018-03-02 15:49:24+00:00 F017 HIP GIRTH (INCHES, TO NEXT LOWER 1/4 INCH) +16 Hip circumference 10503 phv00010503.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:49:54+00:00 2018-03-02 15:49:54+00:00 G446 REGIONAL ANTHROPOMETRY - HIP GIRTH (INCHES) (TO NEXT LOWER 1/4 INCH) +16 Hip circumference 55261 phv00055261.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:50:18+00:00 2018-03-02 15:50:18+00:00 Hip Hip measurement in centimeters +16 Hip circumference 177545 phv00177545.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:50:58+00:00 2018-03-02 15:50:58+00:00 g3b0489 Anthropometry: Hip girth +16 Hip circumference 250291 phv00250291.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:51:40+00:00 2018-03-02 15:51:40+00:00 e033 Numerical Data - Part I: Hip girth Collection Interval: Exam 1 +16 Hip circumference 251066 phv00251066.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 15:52:03+00:00 2018-03-02 15:52:03+00:00 g446 Numerical Data - Part I - Regional Anthropometry: Hip girth (to next lower 1/4 inch) Collection Interval: Exam 2 +16 Hip circumference 254293 phv00254293.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 16:01:48+00:00 2018-03-02 16:01:48+00:00 j482 Numerical Data/Anthropometry: Hip girth +16 Hip circumference 277044 phv00277044.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 16:02:24+00:00 2018-03-02 16:02:24+00:00 HIP2 Hip girth, Exam 2 +16 Hip circumference 277180 phv00277180.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 16:02:35+00:00 2018-03-02 16:02:35+00:00 HIP4 Hip girth, Exam 4 +16 Hip circumference 277181 phv00277181.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 16:03:07+00:00 2018-03-02 16:03:07+00:00 HIP5 Hip girth, Exam 5 +16 Hip circumference 277182 phv00277182.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 16:03:19+00:00 2018-03-02 16:03:19+00:00 HIP6 Hip girth, Exam 6 +16 Hip circumference 277183 phv00277183.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 16:03:32+00:00 2018-03-02 16:03:32+00:00 HIP7 Hip girth, Exam 7 +16 Hip circumference 277184 phv00277184.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-03-02 16:03:43+00:00 2018-03-02 16:03:43+00:00 HIP9 Hip girth, Exam 9 +16 Hip circumference 203160 phv00203160.v1.p1 pht004032.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:15:51+00:00 2018-03-19 20:15:51+00:00 ANTA07B [Body size]. Hip girth (to the nearest cm). Q7b [Anthropometry Form, ANTA, exam 1] +16 Hip circumference 203172 phv00203172.v1.p1 pht004033.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:16:08+00:00 2018-03-19 20:16:08+00:00 ANTB04B [Body size]. Hip girth (nearest cm). Q4b [Anthropometry Form, ANTAB, exam 2] +16 Hip circumference 203178 phv00203178.v1.p1 pht004034.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:16:28+00:00 2018-03-19 20:16:28+00:00 ANTC3B [Body size].Hip girth (to the nearest cm, rounding down). Q3b [Anthropometry Form, ANTC, exam 3] +16 Hip circumference 203189 phv00203189.v1.p1 pht004035.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:16:59+00:00 2018-03-19 20:16:59+00:00 ANTD3B [Height and weight]. Hip girth (to the nearest cm, rounding down). Q3b [Anthropometry Form, ANTD, exam 4] +16 Hip circumference 113648 phv00113648.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 A20HIPS1 MEAS. 1: HIP GIRTH, CM. Q 4 +16 Hip circumference 113649 phv00113649.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 A20HIPS2 MEAS. 2: HIP GIRTH, CM. Q 4 +16 Hip circumference 113658 phv00113658.v2.p2 pht001583.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 A20HIP MEAN HIP GIRTH, CM +16 Hip circumference 114850 phv00114850.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 B20HIPS1 HIPS 1. Q 5b +16 Hip circumference 114851 phv00114851.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 B20HIPS2 HIPS 2. Q 5b +16 Hip circumference 114852 phv00114852.v2.p2 pht001632.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 B20HIP MEAN( B20HIPS1, B20HIPS2 ) +16 Hip circumference 115860 phv00115860.v2.p2 pht001671.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 C20HIPS1 HIP GIRTH (CM), Q 4c +16 Hip circumference 117235 phv00117235.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 D20HIPS1 HIP GIRTH 1 (CM). Q 4b +16 Hip circumference 117236 phv00117236.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 D20HIPS2 HIP GIRTH 2 (CM). Q 4b +16 Hip circumference 117248 phv00117248.v2.p2 pht001720.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 D20HIP MEAN (D20HIPS1, D20HIPS2) (CM) +16 Hip circumference 119097 phv00119097.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 E20HIPS1 HIP GIRTH 1 (CM). Q 4b +16 Hip circumference 119098 phv00119098.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 E20HIPS2 HIP GIRTH 2 (CM). Q 4b +16 Hip circumference 119118 phv00119118.v2.p2 pht001785.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:52:36+00:00 2018-04-17 16:52:36+00:00 E20HIP MEAN (E20HIPS1, E20HIPS2) (CM) +16 Hip circumference 99350 phv00099350.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:21:57+00:00 2018-04-20 22:21:57+00:00 HIP13 HIP CIRCUMFERENCE - CM +16 Hip circumference 100384 phv00100384.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:22:10+00:00 2018-04-20 22:22:10+00:00 HIP13 HIP CIRCUMFERENCE - CM +16 Hip circumference 105415 phv00105415.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:22:20+00:00 2018-04-20 22:22:20+00:00 HIP13 HIP CIRCUMFERENCE - CM +16 Hip circumference 106777 phv00106777.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-04-20 22:22:46+00:00 2018-04-20 22:22:46+00:00 HIP13 HIP CIRCUMFERENCE - CM +16 Hip circumference 176058 phv00176058.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:20:38+00:00 2018-04-23 03:20:38+00:00 hipcm5 HIP CIRCUMFERENCE (cm) +16 Hip circumference 82688 phv00082688.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:20:46+00:00 2018-04-23 03:20:46+00:00 hipcm1 HIP CIRCUMFERENCE (cm) +16 Hip circumference 84489 phv00084489.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:20:54+00:00 2018-04-23 03:20:54+00:00 hipcm1 HIP CIRCUMFERENCE (CM) +16 Hip circumference 85802 phv00085802.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:21:03+00:00 2018-04-23 03:21:03+00:00 hipcm2 HIP CIRCUMFERENCE (cm) +16 Hip circumference 86300 phv00086300.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:21:09+00:00 2018-04-23 03:21:09+00:00 hipcm3 HIP CIRCUMFERENCE (cm) +16 Hip circumference 86753 phv00086753.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:21:17+00:00 2018-04-23 03:21:17+00:00 hipcm4 HIP CIRCUMFERENCE (cm) +16 Hip circumference 87518 phv00087518.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:21:23+00:00 2018-04-23 03:21:23+00:00 hipcmf HIP (cm) +16 Hip circumference 174635 phv00174635.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:21:29+00:00 2018-04-23 03:21:29+00:00 hipcm5 HIP CIRCUMFERENCE (cm) +16 Hip circumference 79861 phv00079861.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 22:55:33+00:00 2018-04-24 22:55:33+00:00 HIPX F80 Hip circumference cm +16 Hip circumference 214063 phv00214063.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:19:07+00:00 2018-04-25 20:19:07+00:00 HIP Hip measurement in centimeters +16 Hip circumference 277285 phv00277285.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:07:11+00:00 2018-08-14 22:07:11+00:00 HIP Hip circumference in cm Collection Interval: 2007-2009 +16 Hip circumference 277334 phv00277334.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:12:30+00:00 2018-08-14 22:12:30+00:00 HIP Hip circumference Collection Interval: 2009-2011 +16 Hip circumference 277517 phv00277517.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:41:04+00:00 2018-08-14 22:41:04+00:00 HIP Hip circumference (cm) Collection Interval: 1996-2000 +16 Hip circumference 277767 phv00277767.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:06:55+00:00 2018-08-14 23:06:55+00:00 HIP Hip circumference(cm) Collection Interval: 2000-2004 +16 Hip circumference 307745 phv00307745.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:50:52+00:00 2018-08-15 23:50:52+00:00 HIP Hip circumference Collection Interval: 2006-2011 +16 Hip circumference 307798 phv00307798.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:55:29+00:00 2018-08-15 23:55:29+00:00 HIP Hip circumference (cm) Collection Interval: 1996-2000 +16 Hip circumference 307958 phv00307958.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:08:27+00:00 2018-08-16 00:08:27+00:00 HIP Hip circumference (cm) Collection Interval: 2000-2004 +16 Hip circumference 122554 phv00122554.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:46:32+00:00 2018-08-16 23:46:32+00:00 HIP Hip size (cm) +16 Hip circumference 122997 phv00122997.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:52:53+00:00 2018-08-17 19:52:53+00:00 hipcm Mean hip circumference (cm) +16 Hip circumference 253220 phv00253220.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:32:19+00:00 2018-08-24 16:32:19+00:00 ANTA10B Hip girth (cm) (ANTA10B) +16 Hip circumference 258691 phv00258691.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:23:29+00:00 2018-09-06 12:23:29+00:00 Hip_Circ Hip Circumference Average +17 Waist-hip ratio 226399 phv00226399.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:57:55+00:00 2018-03-14 21:57:55+00:00 WAIST_HIP Waist to Hip Ratio +17 Waist-hip ratio 204640 phv00204640.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:53:58+00:00 2018-03-19 16:53:58+00:00 WSTHPR21 Visit 2, waist-hip ratio [Cohort, Exam 2] +17 Waist-hip ratio 204723 phv00204723.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:54:17+00:00 2018-03-19 16:54:17+00:00 WSTHPR01 Waist-to-hip ratio [Cohort, Exam 1] +17 Waist-hip ratio 204872 phv00204872.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:54:39+00:00 2018-03-19 16:54:39+00:00 WSTHPR31 Waist-to-hip ratio [Cohort, Exam 3] +17 Waist-hip ratio 204954 phv00204954.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:55:19+00:00 2018-03-19 16:55:19+00:00 WSTHPR41 Waist-to-hip ratio [Cohort, Exam 4] +17 Waist-hip ratio 79869 phv00079869.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-04-24 23:00:41+00:00 2018-04-24 23:00:41+00:00 WHRX Waist hip ratio +17 Waist-hip ratio 252981 phv00252981.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:12:03+00:00 2018-08-24 17:12:03+00:00 whr_baseline Waist hip ratio at baseline visit +18 Ischemic stroke 87878 phv00087878.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:32:42+00:00 2018-04-29 00:32:42+00:00 strktt TIME TO STROKE OR LAST FOLLOW-UP (DAYS) +18 Ischemic stroke 87877 phv00087877.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:32:52+00:00 2018-04-29 00:32:52+00:00 strktype STROKE TYPE +18 Ischemic stroke 218146 phv00218146.v1.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:47:48+00:00 2018-04-29 00:47:48+00:00 strkbis1 BRAIN INFARCTION SUBTYPE 1 +18 Ischemic stroke 218147 phv00218147.v1.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:47:56+00:00 2018-04-29 00:47:56+00:00 strkbis2 BRAIN INFARCTION SUBTYPE 2 +18 Ischemic stroke 218148 phv00218148.v1.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:48:03+00:00 2018-04-29 00:48:03+00:00 strkbis3 BRAIN INFARCTION SUBTYPE 3 +18 Ischemic stroke 87876 phv00087876.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-05-01 00:10:42+00:00 2018-05-01 00:10:42+00:00 strk STROKE +18 Ischemic stroke 207614 phv00207614.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:16:48+00:00 2018-05-03 14:16:48+00:00 INISC07 Def/Prob Ischemic Inc. Stroke by 2007 +18 Ischemic stroke 207619 phv00207619.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:18:47+00:00 2018-05-03 14:18:47+00:00 FTISC07 Follow-up ISC strokes (days) +18 Ischemic stroke 100830 phv00100830.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:22:48+00:00 2018-06-29 16:22:48+00:00 STKTYPE STROKE TYPE +18 Ischemic stroke 192507 phv00192507.v3.p3 pht003402.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:16:30+00:00 2018-07-02 22:16:30+00:00 STRKISCH Ischemic Stroke +18 Ischemic stroke 193187 phv00193187.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:16:30+00:00 2018-07-02 22:16:30+00:00 STRKISCH Ischemic Stroke +18 Ischemic stroke 193802 phv00193802.v3.p3 pht003415.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:16:30+00:00 2018-07-02 22:16:30+00:00 STRKISCH Ischemic Stroke +18 Ischemic stroke 193823 phv00193823.v3.p3 pht003416.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:16:30+00:00 2018-07-02 22:16:30+00:00 STRKISCH Ischemic Stroke +18 Ischemic stroke 71905 phv00071905.v4.p10 pht000743.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 18:34:11+00:00 2018-08-09 18:34:11+00:00 CVA_TYPE Type of CVA Collection Interval: Through 2005 +18 Ischemic stroke 207624 phv00207624.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 19:37:04+00:00 2018-08-09 19:37:04+00:00 YRISC07 Event Year for INISC07 +18 Ischemic stroke 207629 phv00207629.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 19:37:12+00:00 2018-08-09 19:37:12+00:00 AGISC07 Age for INISC07 +18 Ischemic stroke 204442 phv00204442.v1.p1 pht004060.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:44:15+00:00 2018-08-16 18:44:15+00:00 SDXA5 [Review of computer's MI diagnosis]. Stroke diagnosis. Q5 [Stroke Final Diagnosis Form, SDX] +18 Ischemic stroke 203810 phv00203810.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:46:00+00:00 2018-08-16 18:46:00+00:00 COMPDIAG Computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +18 Ischemic stroke 203812 phv00203812.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:46:28+00:00 2018-08-16 18:46:28+00:00 YEAR Event year from STRC12, STRC14 Or CELB04 [Cohort Surveillance Stroke Derived Variable Dictionary] +18 Ischemic stroke 203813 phv00203813.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:49:15+00:00 2018-08-16 18:49:15+00:00 FINALDX Final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +18 Ischemic stroke 203814 phv00203814.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:49:34+00:00 2018-08-16 18:49:34+00:00 COMP_DX Formatted computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +18 Ischemic stroke 203815 phv00203815.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:49:58+00:00 2018-08-16 18:49:58+00:00 FINAL_DX Formatted final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +18 Ischemic stroke 190981 phv00190981.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:15:40+00:00 2018-08-24 22:15:40+00:00 DATE Date of Event +18 Ischemic stroke 36471 phv00036471.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:15:47+00:00 2018-08-24 22:15:47+00:00 DATE Date of Event Collection Interval: Events reviewed through 12/2015 +18 Ischemic stroke 190979 phv00190979.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:15:55+00:00 2018-08-24 22:15:55+00:00 EVENT Event Number +18 Ischemic stroke 36469 phv00036469.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:16:02+00:00 2018-08-24 22:16:02+00:00 EVENT Event Number Collection Interval: Events reviewed through 12/2015 +18 Ischemic stroke 276974 phv00276974.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:16:40+00:00 2018-08-24 22:16:40+00:00 stroke_tiadate Date of stroke/TIA (or censoring date) +18 Ischemic stroke 276972 phv00276972.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:16:47+00:00 2018-08-24 22:16:47+00:00 stroke_tiatype Stroke/TIA type +18 Ischemic stroke 276971 phv00276971.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:16:54+00:00 2018-08-24 22:16:54+00:00 stroke_tia Stroke/TIA status +18 Ischemic stroke 276965 phv00276965.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:17:01+00:00 2018-08-24 22:17:01+00:00 stroke Stroke status +18 Ischemic stroke 276968 phv00276968.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:17:08+00:00 2018-08-24 22:17:08+00:00 strokedate Date of stroke +18 Ischemic stroke 276966 phv00276966.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-24 22:17:16+00:00 2018-08-24 22:17:16+00:00 stroke_type Stroke type +18 Ischemic stroke 121308 phv00121308.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:17:03+00:00 2018-08-30 20:17:03+00:00 Y01STKDG STROKE DIAGNOSIS TYPE +18 Ischemic stroke 121307 phv00121307.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:17:16+00:00 2018-08-30 20:17:16+00:00 Y01STROK STROKE +18 Ischemic stroke 121525 phv00121525.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:17:57+00:00 2018-08-30 20:17:57+00:00 Y01STKDG STROKE DIAGNOSIS TYPE +18 Ischemic stroke 121524 phv00121524.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:18:11+00:00 2018-08-30 20:18:11+00:00 Y01STROK STROKE +18 Ischemic stroke 259387 phv00259387.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-07 16:13:18+00:00 2018-09-07 16:13:18+00:00 sttype Stroke type +18 Ischemic stroke 121730 phv00121730.v1.p2 pht001874.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-13 19:49:33+00:00 2018-12-13 19:49:33+00:00 Z33ESTYP STROKE TYPE +18 Ischemic stroke 259383 phv00259383.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:10:57+00:00 2018-12-20 19:10:57+00:00 priorstk Prior Stroke +19 Hemorrhagic stroke 87877 phv00087877.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:35:03+00:00 2018-04-29 00:35:03+00:00 strktype STROKE TYPE +19 Hemorrhagic stroke 87876 phv00087876.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:35:37+00:00 2018-04-29 00:35:37+00:00 strk STROKE +19 Hemorrhagic stroke 87878 phv00087878.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:36:57+00:00 2018-04-29 00:36:57+00:00 strktt TIME TO STROKE OR LAST FOLLOW-UP (DAYS) +19 Hemorrhagic stroke 207615 phv00207615.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:17:08+00:00 2018-05-03 14:17:08+00:00 INHEM07 Def/Prob Hemorrhagic Inc. Stroke by 2007 +19 Hemorrhagic stroke 207616 phv00207616.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:17:45+00:00 2018-05-03 14:17:45+00:00 INCHM07 Def/Prob Combined Hemm Inc. Stroke by 2007 +19 Hemorrhagic stroke 207620 phv00207620.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:19:03+00:00 2018-05-03 14:19:03+00:00 FTHEM07 Follow-up HEM strokes (days) +19 Hemorrhagic stroke 207621 phv00207621.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:19:29+00:00 2018-05-03 14:19:29+00:00 FTCHM07 Follow-up CHM strokes (days) +19 Hemorrhagic stroke 100830 phv00100830.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:23:08+00:00 2018-06-29 16:23:08+00:00 STKTYPE STROKE TYPE +19 Hemorrhagic stroke 192504 phv00192504.v3.p3 pht003402.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:15:35+00:00 2018-07-02 22:15:35+00:00 STRKHEMO Hemorrhagic Stroke +19 Hemorrhagic stroke 193184 phv00193184.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:15:35+00:00 2018-07-02 22:15:35+00:00 STRKHEMO Hemorrhagic Stroke +19 Hemorrhagic stroke 193801 phv00193801.v3.p3 pht003415.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:15:35+00:00 2018-07-02 22:15:35+00:00 STRKHEMO Hemorrhagic Stroke +19 Hemorrhagic stroke 193822 phv00193822.v3.p3 pht003416.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:15:35+00:00 2018-07-02 22:15:35+00:00 STRKHEMO Hemorrhagic Stroke +19 Hemorrhagic stroke 36469 phv00036469.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:17:19+00:00 2018-07-03 12:17:19+00:00 EVENT Event Number Collection Interval: Events reviewed through 12/2015 +19 Hemorrhagic stroke 190979 phv00190979.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:18:08+00:00 2018-07-03 12:18:08+00:00 EVENT Event Number +19 Hemorrhagic stroke 36471 phv00036471.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:20:46+00:00 2018-07-03 12:20:46+00:00 DATE Date of Event Collection Interval: Events reviewed through 12/2015 +19 Hemorrhagic stroke 190981 phv00190981.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:21:26+00:00 2018-07-03 12:21:26+00:00 DATE Date of Event +19 Hemorrhagic stroke 276966 phv00276966.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:22:41+00:00 2018-07-03 12:22:41+00:00 stroke_type Stroke type +19 Hemorrhagic stroke 276968 phv00276968.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:52:19+00:00 2018-07-03 12:52:19+00:00 strokedate Date of stroke +19 Hemorrhagic stroke 276965 phv00276965.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:53:12+00:00 2018-07-03 12:53:12+00:00 stroke Stroke status +19 Hemorrhagic stroke 276971 phv00276971.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:55:32+00:00 2018-07-03 12:55:32+00:00 stroke_tia Stroke/TIA status +19 Hemorrhagic stroke 276972 phv00276972.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:56:18+00:00 2018-07-03 12:56:18+00:00 stroke_tiatype Stroke/TIA type +19 Hemorrhagic stroke 276974 phv00276974.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:58:29+00:00 2018-07-03 12:58:29+00:00 stroke_tiadate Date of stroke/TIA (or censoring date) +19 Hemorrhagic stroke 71905 phv00071905.v4.p10 pht000743.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 18:34:18+00:00 2018-08-09 18:34:18+00:00 CVA_TYPE Type of CVA Collection Interval: Through 2005 +19 Hemorrhagic stroke 207625 phv00207625.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 18:51:40+00:00 2018-08-09 18:51:40+00:00 YRHEM07 Event year for INHEM07 +19 Hemorrhagic stroke 207626 phv00207626.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 18:51:48+00:00 2018-08-09 18:51:48+00:00 YRCHM07 Event year for INCHM07 +19 Hemorrhagic stroke 207630 phv00207630.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 18:51:56+00:00 2018-08-09 18:51:56+00:00 AGHEM07 Age for INHEM07 +19 Hemorrhagic stroke 207631 phv00207631.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 18:52:03+00:00 2018-08-09 18:52:03+00:00 AGCHM07 Age for INCHM07 +19 Hemorrhagic stroke 204442 phv00204442.v1.p1 pht004060.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:44:21+00:00 2018-08-16 18:44:21+00:00 SDXA5 [Review of computer's MI diagnosis]. Stroke diagnosis. Q5 [Stroke Final Diagnosis Form, SDX] +19 Hemorrhagic stroke 203810 phv00203810.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:46:06+00:00 2018-08-16 18:46:06+00:00 COMPDIAG Computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +19 Hemorrhagic stroke 203812 phv00203812.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:46:33+00:00 2018-08-16 18:46:33+00:00 YEAR Event year from STRC12, STRC14 Or CELB04 [Cohort Surveillance Stroke Derived Variable Dictionary] +19 Hemorrhagic stroke 203813 phv00203813.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:49:21+00:00 2018-08-16 18:49:21+00:00 FINALDX Final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +19 Hemorrhagic stroke 203814 phv00203814.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:49:41+00:00 2018-08-16 18:49:41+00:00 COMP_DX Formatted computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +19 Hemorrhagic stroke 203815 phv00203815.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:50:05+00:00 2018-08-16 18:50:05+00:00 FINAL_DX Formatted final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +19 Hemorrhagic stroke 121308 phv00121308.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:17:09+00:00 2018-08-30 20:17:09+00:00 Y01STKDG STROKE DIAGNOSIS TYPE +19 Hemorrhagic stroke 121307 phv00121307.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:17:21+00:00 2018-08-30 20:17:21+00:00 Y01STROK STROKE +19 Hemorrhagic stroke 121525 phv00121525.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:18:03+00:00 2018-08-30 20:18:03+00:00 Y01STKDG STROKE DIAGNOSIS TYPE +19 Hemorrhagic stroke 121524 phv00121524.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:18:18+00:00 2018-08-30 20:18:18+00:00 Y01STROK STROKE +19 Hemorrhagic stroke 259387 phv00259387.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-07 16:13:27+00:00 2018-09-07 16:13:27+00:00 sttype Stroke type +19 Hemorrhagic stroke 121730 phv00121730.v1.p2 pht001874.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-13 19:49:14+00:00 2018-12-13 19:49:14+00:00 Z33ESTYP STROKE TYPE +19 Hemorrhagic stroke 259383 phv00259383.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:10:37+00:00 2018-12-20 19:10:37+00:00 priorstk Prior Stroke +20 Other stroke 128093 phv00128093.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-23 15:41:16+00:00 2018-02-23 15:41:16+00:00 PFHA5A 5a: Has doctor said you had Stroke? +20 Other stroke 128094 phv00128094.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-23 15:41:16+00:00 2018-02-23 15:41:16+00:00 PFHA5B 5b: Age when told you had stroke? +20 Other stroke 128395 phv00128395.v1.p1 pht001976.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-23 15:41:16+00:00 2018-02-23 15:41:16+00:00 SSFA1 1: Told by a physician you had a stroke +20 Other stroke 128396 phv00128396.v1.p1 pht001976.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-02-23 15:41:16+00:00 2018-02-23 15:41:16+00:00 SSFA2 2: When did first stroke occur +20 Other stroke 204684 phv00204684.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 12:30:48+00:00 2018-05-03 12:30:48+00:00 PRVSTR21 Prevalent stroke at visit 2 [Cohort, Exam 2] +20 Other stroke 204912 phv00204912.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 12:37:35+00:00 2018-05-03 12:37:35+00:00 PRVSTR31 Prevalent stroke at visit 3 [Cohort, Exam 3] +20 Other stroke 205007 phv00205007.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 12:37:59+00:00 2018-05-03 12:37:59+00:00 PRVSTR41 Prevalent stroke at visit 4 [Cohort, Exam 4] +20 Other stroke 202904 phv00202904.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:16:20+00:00 2018-05-03 13:16:20+00:00 AFUcomp29_A [Stroke/TIA]. Since our last contact have you been told by a physician that you had a stroke, slight stroke, transient ischemic attack or TIA? [Annual Follow-up Questionnaire Form, AFUA] +20 Other stroke 204458 phv00204458.v1.p1 pht004061.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:18:05+00:00 2018-05-03 13:18:05+00:00 STRC23 [Hospital information]. History of prior stroke. Q23 [Cohort Stroke Abstraction Form] +20 Other stroke 203758 phv00203758.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:49:47+00:00 2018-05-03 13:49:47+00:00 CORA06J Did the coroner's report mention any of the following as contributing to or being present at death? Recent stroke, other or unspecified type. Q6j [Coroner / Medical Examiner Form] +20 Other stroke 203794 phv00203794.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:50:16+00:00 2018-05-03 13:50:16+00:00 CORA21A Is there a history of stroke prior to this event? Q21a [Coroner / Medical Examiner Form] +20 Other stroke 203795 phv00203795.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:51:03+00:00 2018-05-03 13:51:03+00:00 CORA21B Did a stroke occur within four weeks prior to this event? Q21b [Coroner / Medical Examiner Form] +20 Other stroke 203812 phv00203812.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:52:50+00:00 2018-05-03 13:52:50+00:00 YEAR Event year from STRC12, STRC14 Or CELB04 [Cohort Surveillance Stroke Derived Variable Dictionary] +20 Other stroke 203941 phv00203941.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:54:06+00:00 2018-05-03 13:54:06+00:00 HRAA28G [Second transfer]. Were any of the following mentioned as being present during this hospital stay? Stroke Present? Q28g [Hospital Abstraction Form] +20 Other stroke 203984 phv00203984.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:54:36+00:00 2018-05-03 13:54:36+00:00 HRAA39 [Second transfer]. Is there a history of stroke prior to this event? Q39 [Hospital Abstraction Form] +20 Other stroke 203985 phv00203985.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:55:03+00:00 2018-05-03 13:55:03+00:00 HRAA40 [Second transfer]. Did a stroke occur within 4 weeks prior to this event? Q40 [Hospital Abstraction Form] +20 Other stroke 204310 phv00204310.v1.p1 pht004054.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:55:47+00:00 2018-05-03 13:55:47+00:00 IFIA18 [History]. Did ( ) ever have a stroke? Q18 [Informant Interview Form, IFI] +20 Other stroke 204311 phv00204311.v1.p1 pht004054.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:56:14+00:00 2018-05-03 13:56:14+00:00 IFIA19A [History]. Did he/she have a stroke within four weeks of his/her final illness? Q19a [Informant Interview Form, IFI] +20 Other stroke 204347 phv00204347.v1.p1 pht004054.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:56:40+00:00 2018-05-03 13:56:40+00:00 IFIA19 [History]. Stroke in four weeks before death. Q19 [Informant Interview Form, IFI] +20 Other stroke 204410 phv00204410.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:57:03+00:00 2018-05-03 13:57:03+00:00 PHQA03I [Medical history]. Did the decedent have a history of any of the following? Stroke (CVA). Q3i [Physician Questionnaire Form, exam 1] +20 Other stroke 204442 phv00204442.v1.p1 pht004060.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:58:01+00:00 2018-05-03 13:58:01+00:00 SDXA5 [Review of computer's MI diagnosis]. Stroke diagnosis. Q5 [Stroke Final Diagnosis Form, SDX] +20 Other stroke 204445 phv00204445.v1.p1 pht004060.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 13:59:18+00:00 2018-05-03 13:59:18+00:00 SDXA1CY Year of SDX completion [Stroke Final Diagnosis Form, SDX] +20 Other stroke 204563 phv00204563.v1.p1 pht004061.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:08:07+00:00 2018-05-03 14:08:07+00:00 STRC24Y [Hospital information]. History of prior stroke. Month/year of first stroke: year. Q24 [Cohort Stroke Abstraction Form] +20 Other stroke 204564 phv00204564.v1.p1 pht004061.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:08:41+00:00 2018-05-03 14:08:41+00:00 STRC25Y [Hospital information]. History of prior stroke. Month/year of most recent stroke: year. Q25 [Cohort Stroke Abstraction Form] +20 Other stroke 204602 phv00204602.v1.p1 pht004061.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:09:34+00:00 2018-05-03 14:09:34+00:00 FUSTR24 Follow up days for STRC24 (DATE OF FIRST STROKE) from exam 1 +20 Other stroke 204603 phv00204603.v1.p1 pht004061.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:09:58+00:00 2018-05-03 14:09:58+00:00 FUSTR25 Follow up days for STRC25 (DATE OF MOST RECENT STROKE) from exam 1 +20 Other stroke 206814 phv00206814.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:13:18+00:00 2018-05-03 14:13:18+00:00 HFAA14A [Medical history]. Q14a - Stroke/transient ischemic attack [Heart Failure Hospital Record Abstraction Form, HFA] +20 Other stroke 206998 phv00206998.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:13:49+00:00 2018-05-03 14:13:49+00:00 HFAA75 Q75 - Stroke (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +20 Other stroke 207025 phv00207025.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:14:19+00:00 2018-05-03 14:14:19+00:00 HFAA16Q [Medical history]. Q16q - Precipitating factor: stroke/transient ischemic attack (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +20 Other stroke 207314 phv00207314.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:14:45+00:00 2018-05-03 14:14:45+00:00 HOM10D Has a doctor ever said that you had any of the following: stroke? Q10d [Home Interview, exam 1] +20 Other stroke 207612 phv00207612.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:15:27+00:00 2018-05-03 14:15:27+00:00 INDP07 Def/Prob incident stroke by 2007 +20 Other stroke 207613 phv00207613.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:16:00+00:00 2018-05-03 14:16:00+00:00 INDPP07 Def/Prob/Poss Inc. Stroke by 2007 +20 Other stroke 207617 phv00207617.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:18:10+00:00 2018-05-03 14:18:10+00:00 FTDP07 Follow-up DP strokes (days) +20 Other stroke 207618 phv00207618.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:18:30+00:00 2018-05-03 14:18:30+00:00 FTDPP07 Follow-up DPP strokes (days) +20 Other stroke 210409 phv00210409.v1.p1 pht004197.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:20:33+00:00 2018-05-03 14:20:33+00:00 STROKE01 Stroke [Stroke, exam 1] +20 Other stroke 210402 phv00210402.v1.p1 pht004197.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:21:36+00:00 2018-05-03 14:21:36+00:00 STKLC01 Stroke-left carotid [Stroke, exam 1] +20 Other stroke 210403 phv00210403.v1.p1 pht004197.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:21:54+00:00 2018-05-03 14:21:54+00:00 STKRC01 Stroke-right carotid [Stroke, exam 1] +20 Other stroke 210421 phv00210421.v1.p1 pht004198.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:23:35+00:00 2018-05-03 14:23:35+00:00 STKLC21 Stroke-left carotid [Stroke, exam 2] +20 Other stroke 210422 phv00210422.v1.p1 pht004198.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:23:52+00:00 2018-05-03 14:23:52+00:00 STKRC21 Stroke-right carotid [Stroke, exam 2] +20 Other stroke 210428 phv00210428.v1.p1 pht004198.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:24:17+00:00 2018-05-03 14:24:17+00:00 STROKE21 Stroke [Stroke, exam 2] +20 Other stroke 210440 phv00210440.v1.p1 pht004199.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:24:51+00:00 2018-05-03 14:24:51+00:00 STKLC31 Stroke-left carotid [Stroke, exam 3] +20 Other stroke 210441 phv00210441.v1.p1 pht004199.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:25:09+00:00 2018-05-03 14:25:09+00:00 STKRC31 Stroke-right carotid [Stroke, exam 3] +20 Other stroke 210442 phv00210442.v1.p1 pht004199.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:25:57+00:00 2018-05-03 14:25:57+00:00 STKVB31 Stroke-vertebrobasilar system [VBI] [Stroke, exam 3] +20 Other stroke 210423 phv00210423.v1.p1 pht004198.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:26:26+00:00 2018-05-03 14:26:26+00:00 STKVB21 Stroke-vertebrobasilar system [VBI] [Stroke, exam 2] +20 Other stroke 210404 phv00210404.v1.p1 pht004197.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:26:51+00:00 2018-05-03 14:26:51+00:00 STKVB01 Stroke-vertebrobasilar system [VBI] [Stroke, exam 1] +20 Other stroke 210447 phv00210447.v1.p1 pht004199.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:27:29+00:00 2018-05-03 14:27:29+00:00 STROKE31 Stroke [Stroke, exam 3] +20 Other stroke 210459 phv00210459.v1.p1 pht004200.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:27:56+00:00 2018-05-03 14:27:56+00:00 STKLC41 Stroke-left carotid [Stroke, exam 4] +20 Other stroke 210460 phv00210460.v1.p1 pht004200.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:28:12+00:00 2018-05-03 14:28:12+00:00 STKRC41 Stroke-right carotid [Stroke, exam 4] +20 Other stroke 210461 phv00210461.v1.p1 pht004200.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:28:30+00:00 2018-05-03 14:28:30+00:00 STKVB41 Stroke-vertebrobasilar system [VBI] [Stroke, exam 4] +20 Other stroke 210466 phv00210466.v1.p1 pht004200.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:28:51+00:00 2018-05-03 14:28:51+00:00 STROKE41 Stroke [Stroke, exam 4] +20 Other stroke 210471 phv00210471.v1.p1 pht004201.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:29:23+00:00 2018-05-03 14:29:23+00:00 TIAB01 [Medical history]. Have you ever been told by a physician that you had a stroke, slight stroke, transient ischemic attack or transient ischemic attack [TIA]? Q1 [TIA/Stroke, exam 1] +20 Other stroke 210594 phv00210594.v1.p1 pht004201.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:32:31+00:00 2018-05-03 14:32:31+00:00 HX_STROKE History of stroke [TIA/Stroke, exam 1] +20 Other stroke 210597 phv00210597.v1.p1 pht004202.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:33:29+00:00 2018-05-03 14:33:29+00:00 TIAC01 [Medical history]. Since the last ARIC visit, have you been told by a physician that you had a stroke, slight stroke, transient ischemic attack or transient ischemic attack [TIA]? Q1 [TIA/Stroke, exam 2] +20 Other stroke 210596 phv00210596.v1.p1 pht004202.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:33:57+00:00 2018-05-03 14:33:57+00:00 TIACCY Contact year [4] [TIA/Stroke, exam 2] +20 Other stroke 210470 phv00210470.v1.p1 pht004201.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:35:43+00:00 2018-05-03 14:35:43+00:00 TIABCY Contact year [1] [TIA/Stroke, exam 1] +20 Other stroke 210598 phv00210598.v1.p1 pht004202.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:38:05+00:00 2018-05-03 14:38:05+00:00 TIAC02 [Medical history]. During this time, when did the (first) stroke or transient ischemic attack [TIA] occur? Q2 [TIA/Stroke, exam 2] +20 Other stroke 210785 phv00210785.v1.p1 pht004203.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:39:25+00:00 2018-05-03 14:39:25+00:00 TIADCY Contact year [7] [TIA/Stroke, exam 3] +20 Other stroke 210786 phv00210786.v1.p1 pht004203.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:39:45+00:00 2018-05-03 14:39:45+00:00 TIAD1 [Medical history]. Since the last ARIC visit, have you been told by a physician that you had a stroke, slight stroke, transient ischemic attack or transient ischemic attack [TIA]? Q1 [TIA/Stroke, exam 3] +20 Other stroke 210840 phv00210840.v1.p1 pht004204.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:40:32+00:00 2018-05-03 14:40:32+00:00 TIAE1 [Medical history]. Since the last ARIC visit, have you been told by a physician that you had a stroke, slight stroke, transient ischemic attack or transient ischemic attack [TIA]? Q1 [TIA/Stroke Form, Cohort Visit 4] +20 Other stroke 210894 phv00210894.v1.p1 pht004204.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:41:22+00:00 2018-05-03 14:41:22+00:00 TIAECY Contact year [10] [TIA/Stroke Form, Cohort Visit 4] +20 Other stroke 210963 phv00210963.v1.p1 pht004205.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 14:42:16+00:00 2018-05-03 14:42:16+00:00 TIBECY Administrative information. Contact Year [10]. [TIA/Stroke Form, Cohort Visit 4] +20 Other stroke 87877 phv00087877.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-05-16 02:22:38+00:00 2018-05-16 02:22:38+00:00 strktype STROKE TYPE +20 Other stroke 126146 phv00126146.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 14:28:43+00:00 2018-06-08 14:28:43+00:00 STR01 Stroke(self-reported) +20 Other stroke 125007 phv00125007.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:28:15+00:00 2018-06-08 15:28:15+00:00 AFUA8 8. Told by a physician that you had a stroke, slight stroke, transient ischemic attack, or TIA? +20 Other stroke 125092 phv00125092.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:30:45+00:00 2018-06-08 16:30:45+00:00 AFUA8 8. Told by a physician that you had a stroke, slight stroke, transient ischemic attack, or TIA? +20 Other stroke 125177 phv00125177.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:52:32+00:00 2018-06-08 16:52:32+00:00 AFUB8 8. Told by a physician that you had a stroke, slight stroke, transient ischemic attack, or TIA? +20 Other stroke 125263 phv00125263.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:00:12+00:00 2018-06-08 17:00:12+00:00 AFUB8 8. Told by a physician that you had a stroke, slight stroke, transient ischemic attack, or TIA? +20 Other stroke 125390 phv00125390.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:15:05+00:00 2018-06-08 17:15:05+00:00 AFUC22A 22a. Since our last contact, have you been told by a physician that you had a stroke +20 Other stroke 125610 phv00125610.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:47:31+00:00 2018-06-08 19:47:31+00:00 AFUI8 TOLD BY DOCTOR HAD STROKE, TIA Q8 +20 Other stroke 125698 phv00125698.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:55:52+00:00 2018-06-08 19:55:52+00:00 AFUJ8 TOLD BY DOCTOR HAD STROKE, TIA Q8 +20 Other stroke 125521 phv00125521.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:09:54+00:00 2018-06-08 20:09:54+00:00 AFUI8 TOLD BY DOCTOR HAD STROKE, TIA Q8 +20 Other stroke 125785 phv00125785.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:15:07+00:00 2018-06-08 20:15:07+00:00 AFUK8A TOLD BY DOCTOR HAD STROKE, TIA Q8A +20 Other stroke 117058 phv00117058.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 D08TIA STROKE OR TIA. Q 19 +20 Other stroke 117059 phv00117059.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 D08TIAAG AGE FIRST DIAGNOSED WITH STROKE/TIA. Q 19 +20 Other stroke 117941 phv00117941.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 FY096TIA STROKE OR TIA - MON 108 +20 Other stroke 117942 phv00117942.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 FY096TAA AGE FIRST TOLD STROKE OR TIA - MON 96 +20 Other stroke 117970 phv00117970.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 FY108TIA STROKE OR TIA - MON 108 +20 Other stroke 118538 phv00118538.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 E08TIA STROKE OR TIA? Q 21 +20 Other stroke 118539 phv00118539.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 E08TIAAG AGE DIAGNOSED-STROKE/TIA. Q 21 +20 Other stroke 119916 phv00119916.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 F08TIA STROKE OR TIA? Q22 +20 Other stroke 119926 phv00119926.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:00+00:00 2018-06-18 20:38:00+00:00 F08TIAAG AGE DIAGNOSED-STROKE/TIA. Q 22 +20 Other stroke 119927 phv00119927.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:01+00:00 2018-06-18 20:38:01+00:00 F08TIAYR HAD STROKE IN THE PAST YEAR? Q 22 +20 Other stroke 121266 phv00121266.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:01+00:00 2018-06-18 20:38:01+00:00 Y01STKEP ENDPT - STROKE +20 Other stroke 121307 phv00121307.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:01+00:00 2018-06-18 20:38:01+00:00 Y01STROK STROKE +20 Other stroke 121308 phv00121308.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:01+00:00 2018-06-18 20:38:01+00:00 Y01STKDG STROKE DIAGNOSIS TYPE +20 Other stroke 121463 phv00121463.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:01+00:00 2018-06-18 20:38:01+00:00 Y00STROK DISCHG DIAG - STROKE, TIA +20 Other stroke 121482 phv00121482.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:01+00:00 2018-06-18 20:38:01+00:00 Y01STKEP ENDPT - STROKE +20 Other stroke 121524 phv00121524.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:38:01+00:00 2018-06-18 20:38:01+00:00 Y01STROK STROKE +20 Other stroke 100792 phv00100792.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:17:48+00:00 2018-06-29 16:17:48+00:00 INCSTRK INCIDENT STROKE +20 Other stroke 100793 phv00100793.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:18:03+00:00 2018-06-29 16:18:03+00:00 TTOSTK TIME TO STROKE +20 Other stroke 100794 phv00100794.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:18:26+00:00 2018-06-29 16:18:26+00:00 STBLMOD STK MODIFIED BL STAT +20 Other stroke 100815 phv00100815.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:19:56+00:00 2018-06-29 16:19:56+00:00 STKBASE STROKE AT BL (SELF-REPORT) +20 Other stroke 100830 phv00100830.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:23:23+00:00 2018-06-29 16:23:23+00:00 STKTYPE STROKE TYPE +20 Other stroke 100824 phv00100824.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:24:05+00:00 2018-06-29 16:24:05+00:00 EVTYPE EVENT TYPE +20 Other stroke 100825 phv00100825.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:24:21+00:00 2018-06-29 16:24:21+00:00 TTOEVENT TIME TO EVENT +20 Other stroke 197704 phv00197704.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:56:05+00:00 2018-06-29 18:56:05+00:00 stroke Prevalent stroke +20 Other stroke 274016 phv00274016.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 11:49:51+00:00 2018-07-03 11:49:51+00:00 g3a394 CDI - Stroke/TIA Collection Interval: Exam 1 +20 Other stroke 274509 phv00274509.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 11:50:04+00:00 2018-07-03 11:50:04+00:00 g3a394 CDI - Stroke/TIA +20 Other stroke 255320 phv00255320.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:02:22+00:00 2018-07-03 12:02:22+00:00 fw591 Circulatory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Stroke, TIA Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +20 Other stroke 274797 phv00274797.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:04:33+00:00 2018-07-03 12:04:33+00:00 FX131 Medical History - Cerebrovascular Disease: Have you been told by a doctor you had a stroke or TIA? Collection Interval: Original Cohort Exam 31 +20 Other stroke 275154 phv00275154.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:05:36+00:00 2018-07-03 12:05:36+00:00 fy131 Medical History - Cerebrovascular Disease: Have you been told by a doctor you had a stroke or TIA? Collection Interval: Original Cohort Exam 32 +20 Other stroke 275379 phv00275379.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:06:06+00:00 2018-07-03 12:06:06+00:00 fy591 Circulatory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for stroke, TIA? Collection Interval: Original Cohort Exam 32 +20 Other stroke 6304 phv00006304.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:07:05+00:00 2018-07-03 12:07:05+00:00 FQ375 SECOND EXAMINER OPINION - OTHER STROKE/TIA/PARKINSON'S DISEASE IN INTERIM +20 Other stroke 10098 phv00010098.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:10:11+00:00 2018-07-03 12:10:11+00:00 F708 DID YOU HAVE A STROKE BEFORE AGE 65 +20 Other stroke 23793 phv00023793.v1.p10 pht000160.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:10:52+00:00 2018-07-03 12:10:52+00:00 datestro DATE OF STROKE, NUMBER OF DAYS SINCE EXAM 1 +20 Other stroke 23900 phv00023900.v1.p10 pht000172.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:11:07+00:00 2018-07-03 12:11:07+00:00 datestro DATE OF STROKE, NUMBER OF DAYS SINCE EXAM 1 +20 Other stroke 195499 phv00195499.v1.p10 pht003463.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:14:27+00:00 2018-07-03 12:14:27+00:00 ex2_prevstrk Exclude for prevalent Stroke +20 Other stroke 195500 phv00195500.v1.p10 pht003463.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:15:14+00:00 2018-07-03 12:15:14+00:00 ex2_exclude Exclude for prevalent Dementia or Stroke +20 Other stroke 36469 phv00036469.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:17:32+00:00 2018-07-03 12:17:32+00:00 EVENT Event Number Collection Interval: Events reviewed through 12/2015 +20 Other stroke 190979 phv00190979.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:18:17+00:00 2018-07-03 12:18:17+00:00 EVENT Event Number +20 Other stroke 36471 phv00036471.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:20:56+00:00 2018-07-03 12:20:56+00:00 DATE Date of Event Collection Interval: Events reviewed through 12/2015 +20 Other stroke 190981 phv00190981.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:21:36+00:00 2018-07-03 12:21:36+00:00 DATE Date of Event +20 Other stroke 276966 phv00276966.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:22:51+00:00 2018-07-03 12:22:51+00:00 stroke_type Stroke type +20 Other stroke 276968 phv00276968.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:52:29+00:00 2018-07-03 12:52:29+00:00 strokedate Date of stroke +20 Other stroke 276965 phv00276965.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:53:19+00:00 2018-07-03 12:53:19+00:00 stroke Stroke status +20 Other stroke 276971 phv00276971.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:55:47+00:00 2018-07-03 12:55:47+00:00 stroke_tia Stroke/TIA status +20 Other stroke 276972 phv00276972.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:56:28+00:00 2018-07-03 12:56:28+00:00 stroke_tiatype Stroke/TIA type +20 Other stroke 276974 phv00276974.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 12:58:37+00:00 2018-07-03 12:58:37+00:00 stroke_tiadate Date of stroke/TIA (or censoring date) +20 Other stroke 276989 phv00276989.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:00:10+00:00 2018-07-03 13:00:10+00:00 HOSP5 Hospitalization for stroke Collection Interval: 1975 through 2014 +20 Other stroke 71905 phv00071905.v4.p10 pht000743.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 18:35:08+00:00 2018-08-09 18:35:08+00:00 CVA_TYPE Type of CVA Collection Interval: Through 2005 +20 Other stroke 87876 phv00087876.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-08-09 18:45:33+00:00 2018-08-09 18:45:33+00:00 strk STROKE +20 Other stroke 85761 phv00085761.v3.p3 pht001117.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-08-09 18:45:50+00:00 2018-08-09 18:45:50+00:00 fhxstka2 AGE OF FIRST STROKE DX +20 Other stroke 87878 phv00087878.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-08-09 18:46:05+00:00 2018-08-09 18:46:05+00:00 strktt TIME TO STROKE OR LAST FOLLOW-UP (DAYS) +20 Other stroke 87144 phv00087144.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-08-09 18:46:23+00:00 2018-08-09 18:46:23+00:00 strokef STROKE +20 Other stroke 85760 phv00085760.v3.p3 pht001117.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-08-09 18:46:40+00:00 2018-08-09 18:46:40+00:00 fhxstk2 HISTORY OF STROKE INDICATOR +20 Other stroke 87883 phv00087883.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-08-09 18:47:01+00:00 2018-08-09 18:47:01+00:00 dthtype DEATH TYPE +20 Other stroke 207622 phv00207622.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 19:36:16+00:00 2018-08-09 19:36:16+00:00 YRDPP07 Event year for INDPP07 +20 Other stroke 207623 phv00207623.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 19:36:23+00:00 2018-08-09 19:36:23+00:00 YRDP07 Event year for INDP07 +20 Other stroke 207627 phv00207627.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 19:36:31+00:00 2018-08-09 19:36:31+00:00 AGDPP07 Age for INDPP07 +20 Other stroke 207628 phv00207628.v1.p1 pht004120.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-09 19:36:39+00:00 2018-08-09 19:36:39+00:00 AGDP07 Age for INDP07 +20 Other stroke 159619 phv00159619.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:44:12+00:00 2018-08-10 21:44:12+00:00 Stroke Stroke Collection Interval: Collected in Exam 1 +20 Other stroke 277440 phv00277440.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:32:09+00:00 2018-08-14 22:32:09+00:00 STROKE Have you ever been told by a physician that you had a stroke cerebral hemorrhage or brain attack? Collection Interval: 2009-2011 +20 Other stroke 277441 phv00277441.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:32:18+00:00 2018-08-14 22:32:18+00:00 STRK_YR In what year or how old were you when you were first told this? - year Collection Interval: 2009-2011 +20 Other stroke 277442 phv00277442.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:32:28+00:00 2018-08-14 22:32:28+00:00 STRK_AGE In what year or how old were you when you were first told this? - age Collection Interval: 2009-2011 +20 Other stroke 277607 phv00277607.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:50:19+00:00 2018-08-14 22:50:19+00:00 STRK_AGE In what year or how old were you when it first occurred? - age Collection Interval: 1996-2000 +20 Other stroke 277606 phv00277606.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:50:25+00:00 2018-08-14 22:50:25+00:00 STRK_YR In what year or how old were you when it first occurred? - year Collection Interval: 1996-2000 +20 Other stroke 277605 phv00277605.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:50:38+00:00 2018-08-14 22:50:38+00:00 STROKE Have you ever been told by a physician that you had a stroke or cerebral hemorrhage? Collection Interval: 1996-2000 +20 Other stroke 277656 phv00277656.v1.p1 pht006044.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:58:58+00:00 2018-08-14 22:58:58+00:00 STROKE Self-reported stroke Collection Interval: 2002-2006 +20 Other stroke 277891 phv00277891.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:16:49+00:00 2018-08-14 23:16:49+00:00 STRK_AGE In what year or how old were you when it first occurred? - age Collection Interval: 2000-2004 +20 Other stroke 277890 phv00277890.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:16:56+00:00 2018-08-14 23:16:56+00:00 STRK_YR In what year or how old were you when it first occurred? - year Collection Interval: 2000-2004 +20 Other stroke 277889 phv00277889.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:17:02+00:00 2018-08-14 23:17:02+00:00 STROKE Have you ever been told by a physician that you had a stroke/cerebral hemorrhage/ or brain attack? Collection Interval: 2000-2004 +20 Other stroke 307888 phv00307888.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:01:24+00:00 2018-08-16 00:01:24+00:00 STRK_AGE In what year or how old were you when it first occurred? - age Collection Interval: 1996-2000 +20 Other stroke 307887 phv00307887.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:01:31+00:00 2018-08-16 00:01:31+00:00 STRK_YR In what year or how old were you when it first occurred? - year Collection Interval: 1996-2000 +20 Other stroke 307886 phv00307886.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:01:38+00:00 2018-08-16 00:01:38+00:00 STROKE Have you ever been told by a physician that you had a stroke or cerebral hemorrhage? Collection Interval: 1996-2000 +20 Other stroke 307937 phv00307937.v1.p1 pht006658.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:06:44+00:00 2018-08-16 00:06:44+00:00 STROKE Self-reported stroke Collection Interval: 2002-2006 +20 Other stroke 307946 phv00307946.v1.p1 pht006658.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:07:50+00:00 2018-08-16 00:07:50+00:00 MR_STROKE Stroke Flag: Determined by MR Scan Collection Interval: 2002-2006 +20 Other stroke 308084 phv00308084.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:16:24+00:00 2018-08-16 00:16:24+00:00 STRK_AGE In what year or how old were you when it first occurred? - age Collection Interval: 2000-2004 +20 Other stroke 308083 phv00308083.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:16:30+00:00 2018-08-16 00:16:30+00:00 STRK_YR In what year or how old were you when it first occurred? - year Collection Interval: 2000-2004 +20 Other stroke 308082 phv00308082.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:16:38+00:00 2018-08-16 00:16:38+00:00 STROKE Have you ever been told by a physician that you had a stroke/cerebral hemorrhage/ or brain attack? Collection Interval: 2000-2004 +20 Other stroke 203810 phv00203810.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:46:11+00:00 2018-08-16 18:46:11+00:00 COMPDIAG Computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +20 Other stroke 203813 phv00203813.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:49:26+00:00 2018-08-16 18:49:26+00:00 FINALDX Final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +20 Other stroke 203814 phv00203814.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:49:47+00:00 2018-08-16 18:49:47+00:00 COMP_DX Formatted computer diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +20 Other stroke 203815 phv00203815.v1.p1 pht004048.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-16 18:50:10+00:00 2018-08-16 18:50:10+00:00 FINAL_DX Formatted final diagnosis [Cohort Surveillance Stroke Derived Variable Dictionary] +20 Other stroke 122293 phv00122293.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:29:54+00:00 2018-08-16 23:29:54+00:00 STROKE Stroke (A) +20 Other stroke 122294 phv00122294.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:30:00+00:00 2018-08-16 23:30:00+00:00 STRDIAG Stroke diagnosed by doctor (A) +20 Other stroke 122295 phv00122295.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:30:07+00:00 2018-08-16 23:30:07+00:00 STRAGE Age when stroke noted (A) +20 Other stroke 124310 phv00124310.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 19:01:33+00:00 2018-08-21 19:01:33+00:00 STRODIDAY Days from visit date - Diagnosed Stroke (CVA) +20 Other stroke 252985 phv00252985.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:12:49+00:00 2018-08-24 17:12:49+00:00 stroke_baseline Self report stroke at baseline visit +20 Other stroke 121525 phv00121525.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:50:31+00:00 2018-08-30 19:50:31+00:00 Y01STKDG STROKE DIAGNOSIS TYPE +20 Other stroke 121730 phv00121730.v1.p2 pht001874.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:12:10+00:00 2018-08-30 20:12:10+00:00 Z33ESTYP STROKE TYPE +20 Other stroke 121729 phv00121729.v1.p2 pht001874.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:12:29+00:00 2018-08-30 20:12:29+00:00 Z33ESTRK STROKE +20 Other stroke 258768 phv00258768.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:05:10+00:00 2018-09-06 13:05:10+00:00 Stroke Have you ever had a stroke? Self-report +20 Other stroke 259383 phv00259383.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:19:59+00:00 2018-09-06 13:19:59+00:00 priorstk Prior Stroke +20 Other stroke 259387 phv00259387.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:22:27+00:00 2018-09-06 13:22:27+00:00 sttype Stroke type +20 Other stroke 121848 phv00121848.v1.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 13:26:48+00:00 2018-09-07 13:26:48+00:00 stroke Ever had a stroke +20 Other stroke 190834 phv00190834.v6.p10 pht003317.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 13:59:34+00:00 2018-09-27 13:59:34+00:00 LASTSOE Date of the latest record in the 2015 SOE dataset (vr_soe_2015_a_0991) +21 Age at enrollment/collection 226251 phv00226251.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:55:18+00:00 2018-03-14 21:55:18+00:00 AGE Age +21 Age at enrollment/collection 126009 phv00126009.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:33:32+00:00 2018-03-16 01:33:32+00:00 AGE01 Age(yrs) at baseline clinic visit +21 Age at enrollment/collection 204623 phv00204623.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 13:52:15+00:00 2018-03-27 13:52:15+00:00 V2AGE22 Age at visit 2 [Cohort, Exam 2] +21 Age at enrollment/collection 204712 phv00204712.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 13:52:35+00:00 2018-03-27 13:52:35+00:00 V1AGE01 Age at visit 1 [Cohort, Exam 1] +21 Age at enrollment/collection 204871 phv00204871.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 13:52:57+00:00 2018-03-27 13:52:57+00:00 V3AGE31 Age at visit 3 [Cohort, Exam 3] +21 Age at enrollment/collection 204975 phv00204975.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 13:53:18+00:00 2018-03-27 13:53:18+00:00 V4AGE41 Age at visit 4 [Cohort, Exam 4] +21 Age at enrollment/collection 204693 phv00204693.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 13:57:53+00:00 2018-03-27 13:57:53+00:00 V2DAYS Days since exam 1 [Cohort, Exam 2] +21 Age at enrollment/collection 204921 phv00204921.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 13:58:11+00:00 2018-03-27 13:58:11+00:00 V3DAYS Days since exam 1 [Cohort, Exam 3] +21 Age at enrollment/collection 205017 phv00205017.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 13:58:31+00:00 2018-03-27 13:58:31+00:00 V4DAYS Days since exam 1 [Cohort, Exam 4] +21 Age at enrollment/collection 112421 phv00112421.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:42:53+00:00 2018-04-17 14:42:53+00:00 A01AGE1 EXAM 1 AGE, TELEPHONE INTERVIEW +21 Age at enrollment/collection 112439 phv00112439.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 14:43:42+00:00 2018-04-17 14:43:42+00:00 A01AGE2 AGE VERIFY +21 Age at enrollment/collection 82639 phv00082639.v2.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:42:38+00:00 2018-04-23 02:42:38+00:00 age1c AGE +21 Age at enrollment/collection 84442 phv00084442.v3.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:46:04+00:00 2018-04-23 02:46:04+00:00 age1c AGE +21 Age at enrollment/collection 85773 phv00085773.v3.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:46:15+00:00 2018-04-23 02:46:15+00:00 age2c AGE AT EXAM 2 +21 Age at enrollment/collection 86259 phv00086259.v4.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:46:24+00:00 2018-04-23 02:46:24+00:00 age3c AGE AT EXAM3 +21 Age at enrollment/collection 86727 phv00086727.v3.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:46:35+00:00 2018-04-23 02:46:35+00:00 age4c AGE AT EXAM 4 +21 Age at enrollment/collection 87071 phv00087071.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:46:44+00:00 2018-04-23 02:46:44+00:00 agefc AGE +21 Age at enrollment/collection 174588 phv00174588.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:46:51+00:00 2018-04-23 02:46:51+00:00 age5c AGE AT EXAM 5 +21 Age at enrollment/collection 87678 phv00087678.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:46:59+00:00 2018-04-23 02:46:59+00:00 lagea4 AGE AT SPIROMETRY +21 Age at enrollment/collection 175854 phv00175854.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:47:20+00:00 2018-04-23 02:47:20+00:00 age1c AGE +21 Age at enrollment/collection 175875 phv00175875.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:47:28+00:00 2018-04-23 02:47:28+00:00 age AGE +21 Age at enrollment/collection 176011 phv00176011.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:47:35+00:00 2018-04-23 02:47:35+00:00 age5c AGE AT EXAM 5 +21 Age at enrollment/collection 176846 phv00176846.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:47:49+00:00 2018-04-23 02:47:49+00:00 mriage5 AGE AT EXAM 5 MRI +21 Age at enrollment/collection 219024 phv00219024.v1.p3 pht004326.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:47:56+00:00 2018-04-23 02:47:56+00:00 agesc AGE AT STRESS EXAM +21 Age at enrollment/collection 83452 phv00083452.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:48:59+00:00 2018-04-23 02:48:59+00:00 lagea4 AGE AT SPIROMETRY +21 Age at enrollment/collection 83687 phv00083687.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:49:09+00:00 2018-04-23 02:49:09+00:00 lagea4 AGE AT SPIROMETRY +21 Age at enrollment/collection 175939 phv00175939.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:53:23+00:00 2018-04-29 00:53:23+00:00 agefc FAMILY COHORT: AGE +21 Age at enrollment/collection 176077 phv00176077.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:53:35+00:00 2018-04-29 00:53:35+00:00 ageans5 Q3) HOW OLD ARE YOU? (PPT RESPONSE) +21 Age at enrollment/collection 176078 phv00176078.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:53:45+00:00 2018-04-29 00:53:45+00:00 age5 Q3) HOW OLD ARE YOU? +21 Age at enrollment/collection 85818 phv00085818.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:06:33+00:00 2018-04-29 01:06:33+00:00 E12CTDyC TIME BETWEEN CT SCANS, IN DAYS +21 Age at enrollment/collection 86272 phv00086272.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:06:39+00:00 2018-04-29 01:06:39+00:00 E13DyC TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS +21 Age at enrollment/collection 86309 phv00086309.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:06:47+00:00 2018-04-29 01:06:47+00:00 E13CTDyC TIME BETWEEN EXAM 1 AND 3 CT SCANS, IN DAYS +21 Age at enrollment/collection 86740 phv00086740.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:06:53+00:00 2018-04-29 01:06:53+00:00 e14dyc TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS +21 Age at enrollment/collection 90111 phv00090111.v1.p3 pht001205.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:09:45+00:00 2018-04-29 01:09:45+00:00 e14ctdyc TIME BETWEEN EXAM 1 AND 4 CT SCANS, IN DAYS +21 Age at enrollment/collection 90112 phv00090112.v1.p3 pht001205.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:09:50+00:00 2018-04-29 01:09:50+00:00 e24ctdyc TIME BETWEEN EXAM 2/3 AND 4 CT SCANS, IN DAYS +21 Age at enrollment/collection 174590 phv00174590.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:09:56+00:00 2018-04-29 01:09:56+00:00 e15dyc TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS +21 Age at enrollment/collection 174740 phv00174740.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:10:02+00:00 2018-04-29 01:10:02+00:00 e15ctdyc TIME BETWEEN EXAM 1 AND 5 CT SCANS, (DAYS) +21 Age at enrollment/collection 176013 phv00176013.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:10:08+00:00 2018-04-29 01:10:08+00:00 e15dyc TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS +21 Age at enrollment/collection 176163 phv00176163.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:10:17+00:00 2018-04-29 01:10:17+00:00 e15ctdyc TIME BETWEEN EXAM 1 AND 5 CT SCANS, (DAYS) +21 Age at enrollment/collection 176836 phv00176836.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:10:22+00:00 2018-04-29 01:10:22+00:00 e15mridyc TIME BETWEEN EXAM 1 AND EXAM 5 MRI SCANS, IN DAYS +21 Age at enrollment/collection 191695 phv00191695.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:10:27+00:00 2018-04-29 01:10:27+00:00 e15ecgdyc TIME BETWEEN EXAM 1 AND EXAM 5 ECG READINGS, IN DAYS +21 Age at enrollment/collection 85786 phv00085786.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:10:40+00:00 2018-04-29 01:10:40+00:00 E12DyC TIME BETWEEN EXAM VISITS, IN DAYS +21 Age at enrollment/collection 215388 phv00215388.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-31 16:22:14+00:00 2018-05-31 16:22:14+00:00 AGE_S1 Age = StdyDtqa - DOB +21 Age at enrollment/collection 126008 phv00126008.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:02:58+00:00 2018-06-12 01:02:58+00:00 AGE01HI Age(yrs) at home induction interview +21 Age at enrollment/collection 127576 phv00127576.v1.p1 pht001956.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-19 13:23:18+00:00 2018-06-19 13:23:18+00:00 AGE01HI Participant's age of eligibility at H +21 Age at enrollment/collection 125067 phv00125067.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:28:18+00:00 2018-07-09 19:28:18+00:00 AFUA1M (Month only) 1. Date of status determination +21 Age at enrollment/collection 125068 phv00125068.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:28:32+00:00 2018-07-09 19:28:32+00:00 AFUA1Y (Year only) 1. Date of status determination +21 Age at enrollment/collection 125153 phv00125153.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:32:16+00:00 2018-07-09 19:32:16+00:00 AFUA1Y (Year only) 1. Date of status determination +21 Age at enrollment/collection 125152 phv00125152.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:32:30+00:00 2018-07-09 19:32:30+00:00 AFUA1M (Month only) 1. Date of status determination +21 Age at enrollment/collection 125238 phv00125238.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:39:34+00:00 2018-07-09 19:39:34+00:00 AFUB1M (Month only) 1. Date of status determination +21 Age at enrollment/collection 125239 phv00125239.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:39:51+00:00 2018-07-09 19:39:51+00:00 AFUB1Y (Year only) 1. Date of status determination +21 Age at enrollment/collection 125324 phv00125324.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:50:08+00:00 2018-07-09 19:50:08+00:00 AFUB1M (Month only) 1. Date of status determination +21 Age at enrollment/collection 125325 phv00125325.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:50:20+00:00 2018-07-09 19:50:20+00:00 AFUB1Y (Year only) 1. Date of status determination +21 Age at enrollment/collection 125499 phv00125499.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:56:24+00:00 2018-07-09 19:56:24+00:00 AFUC1M (Month only) 1. Date of status determination +21 Age at enrollment/collection 125500 phv00125500.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:56:36+00:00 2018-07-09 19:56:36+00:00 AFUC1Y (Year only) 1. Date of status determination +21 Age at enrollment/collection 125579 phv00125579.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:02:25+00:00 2018-07-09 20:02:25+00:00 AFUI1Y YEAR OF STATUS Q1 +21 Age at enrollment/collection 125578 phv00125578.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:02:38+00:00 2018-07-09 20:02:38+00:00 AFUI1M MONTH OF STATUS Q1 +21 Age at enrollment/collection 125667 phv00125667.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:06:38+00:00 2018-07-09 20:06:38+00:00 AFUI1M MONTH OF STATUS Q1 +21 Age at enrollment/collection 125668 phv00125668.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:06:58+00:00 2018-07-09 20:06:58+00:00 AFUI1Y YEAR OF STATUS Q1 +21 Age at enrollment/collection 125758 phv00125758.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:15:54+00:00 2018-07-09 20:15:54+00:00 AFUJ1D DAY OF STATUS Q1 +21 Age at enrollment/collection 125759 phv00125759.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:16:13+00:00 2018-07-09 20:16:13+00:00 AFUJ1M MONTH OF STATUS Q1 +21 Age at enrollment/collection 125760 phv00125760.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:16:24+00:00 2018-07-09 20:16:24+00:00 AFUJ1Y YEAR OF STATUS Q1 +21 Age at enrollment/collection 125756 phv00125756.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:16:51+00:00 2018-07-09 20:16:51+00:00 AFUJ1 DATE STATUS DETERMINED Q1 +21 Age at enrollment/collection 125843 phv00125843.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:31:30+00:00 2018-07-09 20:31:30+00:00 AFUK1M MONTH OF STATUS Q1 +21 Age at enrollment/collection 125844 phv00125844.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:31:43+00:00 2018-07-09 20:31:43+00:00 AFUK1Y YEAR OF STATUS Q1 +21 Age at enrollment/collection 125920 phv00125920.v1.p1 pht001943.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 17:38:32+00:00 2018-07-12 17:38:32+00:00 DOBYR CARe PARTICIPANT DATE OF BIRTH YEAR +21 Age at enrollment/collection 125585 phv00125585.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:24:28+00:00 2018-07-12 18:24:28+00:00 FTRA1M (Month only) 1: Date of clinic visit +21 Age at enrollment/collection 125672 phv00125672.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:24:49+00:00 2018-07-12 18:24:49+00:00 FTRA1M (Month only) 1: Date of clinic visit +21 Age at enrollment/collection 125854 phv00125854.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:25:20+00:00 2018-07-12 18:25:20+00:00 FTRA1M (Month only) 1: Date of clinic visit +21 Age at enrollment/collection 125679 phv00125679.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:25:58+00:00 2018-07-12 18:25:58+00:00 FTRA1 1: Date of clinic visit +21 Age at enrollment/collection 125855 phv00125855.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:26:24+00:00 2018-07-12 18:26:24+00:00 FTRA1Y (Year only) 1: Date of clinic visit +21 Age at enrollment/collection 125673 phv00125673.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:26:53+00:00 2018-07-12 18:26:53+00:00 FTRA1Y (Year only) 1: Date of clinic visit +21 Age at enrollment/collection 125586 phv00125586.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:27:16+00:00 2018-07-12 18:27:16+00:00 FTRA1Y (Year only) 1: Date of clinic visit +21 Age at enrollment/collection 159836 phv00159836.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:44:14+00:00 2018-08-10 20:44:14+00:00 Age_Enroll Age at enrollment Collection Interval: Collected in Exam 1 +21 Age at enrollment/collection 71906 phv00071906.v3.p10 pht000743.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-13 17:53:20+00:00 2018-08-13 17:53:20+00:00 mri_date Date of brain MRI scan Collection Interval: Through 2005 +21 Age at enrollment/collection 277280 phv00277280.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:06:11+00:00 2018-08-14 22:06:11+00:00 AGE Age at time of examination in years Collection Interval: 2007-2009 +21 Age at enrollment/collection 277327 phv00277327.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:12:03+00:00 2018-08-14 22:12:03+00:00 AGE Age at time of examination in years Collection Interval: 2009-2011 +21 Age at enrollment/collection 277507 phv00277507.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:40:43+00:00 2018-08-14 22:40:43+00:00 AGE Age at time of examination in years Collection Interval: 1996-2000 +21 Age at enrollment/collection 277654 phv00277654.v1.p1 pht006044.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:57:21+00:00 2018-08-14 22:57:21+00:00 AGE_MR Age at time of MR examination in years Collection Interval: 2002-2006 +21 Age at enrollment/collection 277758 phv00277758.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:07:31+00:00 2018-08-14 23:07:31+00:00 AGE Age at time of examination in years Collection Interval: 2000-2004 +21 Age at enrollment/collection 307740 phv00307740.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:51:32+00:00 2018-08-15 23:51:32+00:00 AGE Age at time of examination in years Collection Interval: 2006-2011 +21 Age at enrollment/collection 307788 phv00307788.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:54:56+00:00 2018-08-15 23:54:56+00:00 AGE Age at time of examination in years Collection Interval: 1996-2000 +21 Age at enrollment/collection 307935 phv00307935.v1.p1 pht006658.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:06:58+00:00 2018-08-16 00:06:58+00:00 AGE_MR Age at time of MR examination in years Collection Interval: 2002-2006 +21 Age at enrollment/collection 307949 phv00307949.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:08:59+00:00 2018-08-16 00:08:59+00:00 AGE Age at time of examination in years Collection Interval: 2000-2004 +21 Age at enrollment/collection 122015 phv00122015.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:02:11+00:00 2018-08-16 23:02:11+00:00 age Subject age at time of study +21 Age at enrollment/collection 113714 phv00113714.v2.p2 pht001589.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:09:39+00:00 2018-08-17 21:09:39+00:00 EXAMAGE CALCULATED AGE AT EXAM 1 +21 Age at enrollment/collection 124328 phv00124328.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 19:02:43+00:00 2018-08-21 19:02:43+00:00 age_dna Age at DNA draw +21 Age at enrollment/collection 114610 phv00114610.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:22:52+00:00 2018-08-22 23:22:52+00:00 B12AGE AGE OF SUBJECT +21 Age at enrollment/collection 115119 phv00115119.v2.p2 pht001645.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:52:11+00:00 2018-08-22 23:52:11+00:00 EXAMAGE AGE AT EXAM 1 (VERIFIED AT EXAM 2) +21 Age at enrollment/collection 115705 phv00115705.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:29:24+00:00 2018-08-23 17:29:24+00:00 C12AGE C12AGE +21 Age at enrollment/collection 116378 phv00116378.v2.p2 pht001697.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:10:44+00:00 2018-08-23 19:10:44+00:00 EXAMAGE CALCULATED AGE AT EXAM 1 +21 Age at enrollment/collection 116390 phv00116390.v2.p2 pht001697.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:11:19+00:00 2018-08-23 19:11:19+00:00 EX3_AGE CALCULATED AGE AT EXAM 3 +21 Age at enrollment/collection 116478 phv00116478.v2.p2 pht001706.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 21:31:07+00:00 2018-08-23 21:31:07+00:00 DDXSPAGE SPINE: AGE AT EXAM +21 Age at enrollment/collection 116492 phv00116492.v2.p2 pht001706.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 21:34:30+00:00 2018-08-23 21:34:30+00:00 DDXHPAGE HIP: AGE AT EXAM +21 Age at enrollment/collection 116506 phv00116506.v2.p2 pht001706.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 21:35:55+00:00 2018-08-23 21:35:55+00:00 DDXWBAGE WHOLE BODY: AGE AT EXAM +21 Age at enrollment/collection 252976 phv00252976.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:11:25+00:00 2018-08-24 17:11:25+00:00 age_baseline Age at baseline study +21 Age at enrollment/collection 252977 phv00252977.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:11:34+00:00 2018-08-24 17:11:34+00:00 age_at_dna Age at blood draw +21 Age at enrollment/collection 117592 phv00117592.v2.p2 pht001744.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:54:28+00:00 2018-08-24 22:54:28+00:00 EX4_AGE CALCULATED AGE AT EXAM 4 +21 Age at enrollment/collection 117579 phv00117579.v2.p2 pht001744.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:54:41+00:00 2018-08-24 22:54:41+00:00 EXAMAGE CALCULATED AGE AT EXAM 1 +21 Age at enrollment/collection 118135 phv00118135.v2.p2 pht001755.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 18:12:52+00:00 2018-08-28 18:12:52+00:00 EAGE AGE +21 Age at enrollment/collection 118249 phv00118249.v2.p2 pht001756.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 18:14:50+00:00 2018-08-28 18:14:50+00:00 EAGE AGE +21 Age at enrollment/collection 118959 phv00118959.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:37:01+00:00 2018-08-28 23:37:01+00:00 E12AGE AGE - SPIROMETER +21 Age at enrollment/collection 119507 phv00119507.v2.p2 pht001795.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:59:09+00:00 2018-08-29 20:59:09+00:00 E53AGE AGE - FORM 53 +21 Age at enrollment/collection 119637 phv00119637.v2.p2 pht001804.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:03:09+00:00 2018-08-29 21:03:09+00:00 EX5_AGE CALCULATED AGE AT EXAM 5 +21 Age at enrollment/collection 119631 phv00119631.v2.p2 pht001804.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:03:22+00:00 2018-08-29 21:03:22+00:00 EXAMAGE CALCULATED AGE AT EXAM 1 +21 Age at enrollment/collection 120748 phv00120748.v2.p2 pht001851.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:14:43+00:00 2018-08-29 23:14:43+00:00 EX6_AGE CALCULATED AGE AT EXAM 6 +21 Age at enrollment/collection 120739 phv00120739.v2.p2 pht001851.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:15:39+00:00 2018-08-29 23:15:39+00:00 EXAMAGE CALCULATED AGE AT EXAM 1 +21 Age at enrollment/collection 202104 phv00202104.v2.p1 pht003918.v2.p1 phs000741.v2.p1 GOLDN 741 2 2018-09-06 12:08:17+00:00 2018-09-06 12:08:17+00:00 age Age of participant +21 Age at enrollment/collection 258680 phv00258680.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:22:09+00:00 2018-09-06 12:22:09+00:00 Dec_Age Age at enrollment +21 Age at enrollment/collection 258650 phv00258650.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:11:11+00:00 2018-09-06 13:11:11+00:00 age Subject age +21 Age at enrollment/collection 259378 phv00259378.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:18:11+00:00 2018-09-06 13:18:11+00:00 age Age at index date +21 Age at enrollment/collection 121846 phv00121846.v1.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 13:26:10+00:00 2018-09-07 13:26:10+00:00 enrollage Age at Time of Enrollment +21 Age at enrollment/collection 78437 phv00078437.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:36:57+00:00 2018-09-21 17:36:57+00:00 AGE Age at screening +21 Age at enrollment/collection 79440 phv00079440.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:37:36+00:00 2018-09-21 17:37:36+00:00 F43AGE Age when completed Form 43 +21 Age at enrollment/collection 169576 phv00169576.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:39:39+00:00 2018-09-21 17:39:39+00:00 F154FINDYS Days since randomization or enrollment to form finish +21 Age at enrollment/collection 78411 phv00078411.v6.p3 pht000997.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:40:28+00:00 2018-09-21 17:40:28+00:00 LSTVISDY Days from rand to last visit +21 Age at enrollment/collection 78413 phv00078413.v6.p3 pht000997.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:40:35+00:00 2018-09-21 17:40:35+00:00 LSTMAMDY Days from rand to last mammogram +21 Age at enrollment/collection 78415 phv00078415.v6.p3 pht000997.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:40:41+00:00 2018-09-21 17:40:41+00:00 LSTPAPDY Days from rand to last pap smear +21 Age at enrollment/collection 78419 phv00078419.v6.p3 pht000997.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:41:43+00:00 2018-09-21 17:41:43+00:00 LSTASPDY Days from rand to last aspiration +21 Age at enrollment/collection 79874 phv00079874.v6.p3 pht001020.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:41:48+00:00 2018-09-21 17:41:48+00:00 PELVICDY Days from randomization to pelvic exam +21 Age at enrollment/collection 79911 phv00079911.v6.p3 pht001021.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:41:53+00:00 2018-09-21 17:41:53+00:00 ENDODY Days from randomization to endometrial aspiration +21 Age at enrollment/collection 79926 phv00079926.v6.p3 pht001022.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:42:00+00:00 2018-09-21 17:42:00+00:00 TVUDY Days from randomization to ultrasound +21 Age at enrollment/collection 79946 phv00079946.v6.p3 pht001023.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:42:06+00:00 2018-09-21 17:42:06+00:00 CBECLCDY Days from randomization to CBE +21 Age at enrollment/collection 80000 phv00080000.v6.p3 pht001026.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:42:11+00:00 2018-09-21 17:42:11+00:00 PAPCOLDY Days from randomization to pap smear collection +21 Age at enrollment/collection 77319 phv00077319.v6.p3 pht000983.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:42:47+00:00 2018-09-21 17:42:47+00:00 HIPDAYS Hip scan days from randomization/enrollment +21 Age at enrollment/collection 77332 phv00077332.v6.p3 pht000984.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:43:11+00:00 2018-09-21 17:43:11+00:00 SPNDAYS Spine scan days from randomization/enrollment +21 Age at enrollment/collection 77341 phv00077341.v6.p3 pht000985.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:43:24+00:00 2018-09-21 17:43:24+00:00 WBDAYS Whole body scan days from randomization/enrollment +21 Age at enrollment/collection 77363 phv00077363.v6.p3 pht000986.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:43:57+00:00 2018-09-21 17:43:57+00:00 CBCDAYS CBC Days since randomization/enrollment +21 Age at enrollment/collection 77372 phv00077372.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:44:09+00:00 2018-09-21 17:44:09+00:00 COREDAYS Core Days since randomization/enrollment +21 Age at enrollment/collection 77441 phv00077441.v6.p3 pht000989.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:44:41+00:00 2018-09-21 17:44:41+00:00 ECGBASEDAYS Baseline ECG days since randomization +21 Age at enrollment/collection 77444 phv00077444.v6.p3 pht000989.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:44:46+00:00 2018-09-21 17:44:46+00:00 ECGFUDAYS Follow-up ECG days since randomization +21 Age at enrollment/collection 77451 phv00077451.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:45:30+00:00 2018-09-21 17:45:30+00:00 F143DAYS F143 Days since enrollment +21 Age at enrollment/collection 77672 phv00077672.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:45:39+00:00 2018-09-21 17:45:39+00:00 F144DAYS F144 Days since enrollment +21 Age at enrollment/collection 77798 phv00077798.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:45:49+00:00 2018-09-21 17:45:49+00:00 F145DAYS F145 Days since enrollment +21 Age at enrollment/collection 77908 phv00077908.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:45:59+00:00 2018-09-21 17:45:59+00:00 F146DAYS F146 Days since enrollment +21 Age at enrollment/collection 78110 phv00078110.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:46:08+00:00 2018-09-21 17:46:08+00:00 F147DAYS F147 Days since enrollment +21 Age at enrollment/collection 78234 phv00078234.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:46:40+00:00 2018-09-21 17:46:40+00:00 F148DAYS F148 Days since enrollment +21 Age at enrollment/collection 78358 phv00078358.v6.p3 pht000996.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:46:50+00:00 2018-09-21 17:46:50+00:00 F149DAYS F149 Days since enrollment +21 Age at enrollment/collection 78386 phv00078386.v6.p3 pht000997.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:47:30+00:00 2018-09-21 17:47:30+00:00 F20DAYS F20 Days since randomization/enrollment +21 Age at enrollment/collection 78436 phv00078436.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:47:51+00:00 2018-09-21 17:47:51+00:00 F2DAYS F2 Days since randomization +21 Age at enrollment/collection 78507 phv00078507.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:48:03+00:00 2018-09-21 17:48:03+00:00 F30DAYS F30 Days since randomization/enrollment +21 Age at enrollment/collection 78607 phv00078607.v6.p3 pht001000.v7.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:48:13+00:00 2018-09-21 17:48:13+00:00 F31DAYS F31 Days since randomization/enrollment +21 Age at enrollment/collection 78667 phv00078667.v6.p3 pht001001.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:48:23+00:00 2018-09-21 17:48:23+00:00 F32DAYS F32 Days since randomization/enrollment +21 Age at enrollment/collection 78773 phv00078773.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:48:33+00:00 2018-09-21 17:48:33+00:00 F34DAYS F34 Days since randomization/enrollment +21 Age at enrollment/collection 78831 phv00078831.v6.p3 pht001004.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:48:43+00:00 2018-09-21 17:48:43+00:00 F35DAYS F35 Days since randomization +21 Age at enrollment/collection 78870 phv00078870.v6.p3 pht001005.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:48:55+00:00 2018-09-21 17:48:55+00:00 F37DAYS F37 Days since randomization/enrollment +21 Age at enrollment/collection 79088 phv00079088.v6.p3 pht001006.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:49:07+00:00 2018-09-21 17:49:07+00:00 F38DAYS F38 Days since randomization/enrollment +21 Age at enrollment/collection 79231 phv00079231.v6.p3 pht001007.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:49:24+00:00 2018-09-21 17:49:24+00:00 F39DAYS F39 Days since randomization/enrollment +21 Age at enrollment/collection 79307 phv00079307.v6.p3 pht001008.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:49:53+00:00 2018-09-21 17:49:53+00:00 F40DAYS F40 Days since randomization/enrollment +21 Age at enrollment/collection 79315 phv00079315.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:50:03+00:00 2018-09-21 17:50:03+00:00 F41DAYS F41 Days since randomization/enrollment +21 Age at enrollment/collection 79333 phv00079333.v6.p3 pht001010.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:50:13+00:00 2018-09-21 17:50:13+00:00 F42DAYS F42 Days since enrollment +21 Age at enrollment/collection 79439 phv00079439.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:50:25+00:00 2018-09-21 17:50:25+00:00 F43DAYS F43 Days since randomization/enrollment +21 Age at enrollment/collection 79557 phv00079557.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:50:44+00:00 2018-09-21 17:50:44+00:00 F48DAYS F48 Days since enrollment +21 Age at enrollment/collection 79852 phv00079852.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:55:28+00:00 2018-09-21 17:55:28+00:00 F80DAYS F80 Days since randomization/enrollment +21 Age at enrollment/collection 79873 phv00079873.v6.p3 pht001020.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:55:39+00:00 2018-09-21 17:55:39+00:00 F81DAYS F81 Days since randomization +21 Age at enrollment/collection 79910 phv00079910.v6.p3 pht001021.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:55:48+00:00 2018-09-21 17:55:48+00:00 F82DAYS F82 Days since randomization +21 Age at enrollment/collection 79925 phv00079925.v6.p3 pht001022.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:55:58+00:00 2018-09-21 17:55:58+00:00 F83DAYS F83 Days since randomization +21 Age at enrollment/collection 79945 phv00079945.v6.p3 pht001023.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:56:19+00:00 2018-09-21 17:56:19+00:00 F84DAYS F84 Days since randomization +21 Age at enrollment/collection 79984 phv00079984.v6.p3 pht001025.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:56:58+00:00 2018-09-21 17:56:58+00:00 F90DAYS F90 Days since randomization +21 Age at enrollment/collection 79999 phv00079999.v6.p3 pht001026.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:57:20+00:00 2018-09-21 17:57:20+00:00 F92DAYS F92 Days since randomization +21 Age at enrollment/collection 80432 phv00080432.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:58:03+00:00 2018-09-21 17:58:03+00:00 CADDAYS Days since CT randomization to CaD randomization +21 Age at enrollment/collection 111542 phv00111542.v6.p3 pht001514.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:58:16+00:00 2018-09-21 17:58:16+00:00 F134DAYS F134 Days since randomization or enrollment +21 Age at enrollment/collection 111657 phv00111657.v6.p3 pht001517.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:58:30+00:00 2018-09-21 17:58:30+00:00 F60DAYS F60 Days since randomization/enrollment +21 Age at enrollment/collection 154928 phv00154928.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:58:55+00:00 2018-09-21 17:58:55+00:00 ECGDAYS ECG Days since randomization +21 Age at enrollment/collection 155607 phv00155607.v5.p3 pht002120.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:59:23+00:00 2018-09-21 17:59:23+00:00 F85DAYS F85 Days from randomization +21 Age at enrollment/collection 155608 phv00155608.v5.p3 pht002120.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:59:30+00:00 2018-09-21 17:59:30+00:00 MAMMDY Days from randomization to mammogram +21 Age at enrollment/collection 156382 phv00156382.v5.p3 pht002125.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:59:54+00:00 2018-09-21 17:59:54+00:00 F60DAYS F60 Days since randomization/enrollment +21 Age at enrollment/collection 169401 phv00169401.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:00:07+00:00 2018-09-21 18:00:07+00:00 F150DAYS F150 Days since randomization +21 Age at enrollment/collection 169509 phv00169509.v4.p3 pht002750.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:00:25+00:00 2018-09-21 18:00:25+00:00 F153DAYS F153 Days since randomization or enrollment +21 Age at enrollment/collection 169529 phv00169529.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:00:49+00:00 2018-09-21 18:00:49+00:00 F153DAYS F153 Days since randomization or enrollment +21 Age at enrollment/collection 169547 phv00169547.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:01:18+00:00 2018-09-21 18:01:18+00:00 F154DAYS Days since randomization or enrollment +21 Age at enrollment/collection 169605 phv00169605.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:01:40+00:00 2018-09-21 18:01:40+00:00 F44DAYS F44 Days since randomization/enrollment +21 Age at enrollment/collection 202367 phv00202367.v2.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:02:56+00:00 2018-09-21 18:02:56+00:00 LAST33WHIDY Days enrollment to last WHI Form 33/33D +21 Age at enrollment/collection 202368 phv00202368.v2.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:03:02+00:00 2018-09-21 18:03:02+00:00 LAST33EXT1DY Days enrollment to last Ext1 Form 33/33D +21 Age at enrollment/collection 202379 phv00202379.v2.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:03:42+00:00 2018-09-21 18:03:42+00:00 LAST33WHIDY Days enrollment to last WHI form 33/33D +21 Age at enrollment/collection 202380 phv00202380.v2.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:03:48+00:00 2018-09-21 18:03:48+00:00 LAST33EXT1DY Days enrollment to last Ext1 form 33/33D +21 Age at enrollment/collection 192298 phv00192298.v3.p3 pht003395.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:04:16+00:00 2018-09-21 18:04:16+00:00 EXTDAYS Days since randomization/enrollment to WHI Extension 1 enrollment +21 Age at enrollment/collection 192301 phv00192301.v3.p3 pht003395.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:04:24+00:00 2018-09-21 18:04:24+00:00 EXT2DAYS Days since randomization/enrollment to WHI Extension 2 enrollment +21 Age at enrollment/collection 192307 phv00192307.v3.p3 pht003396.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:05:16+00:00 2018-09-21 18:05:16+00:00 F151DAYS F151 Days since randomization or enrollment +21 Age at enrollment/collection 192336 phv00192336.v3.p3 pht003397.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:05:35+00:00 2018-09-21 18:05:35+00:00 F33DAYS F33 Days since randomization/enrollment +21 Age at enrollment/collection 192362 phv00192362.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:05:47+00:00 2018-09-21 18:05:47+00:00 F45DAYS F45 Days since randomization/enrollment +21 Age at enrollment/collection 192421 phv00192421.v3.p3 pht003399.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:06:07+00:00 2018-09-21 18:06:07+00:00 FUSTARTDY Days since rand/enroll to start of participant's follow-up status +21 Age at enrollment/collection 192422 phv00192422.v3.p3 pht003399.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:06:12+00:00 2018-09-21 18:06:12+00:00 FUENDDY Days since rand/enroll to end of participant's follow-up status +21 Age at enrollment/collection 192446 phv00192446.v3.p3 pht003400.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:07:27+00:00 2018-09-21 18:07:27+00:00 PRDY F130 Days to Progesterone receptor assay +21 Age at enrollment/collection 192443 phv00192443.v3.p3 pht003400.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:07:34+00:00 2018-09-21 18:07:34+00:00 ERDY F130 Days to Estrogen Assay +21 Age at enrollment/collection 192469 phv00192469.v3.p3 pht003401.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:08:09+00:00 2018-09-21 18:08:09+00:00 ERDY F130 Days to Estrogen Assay +21 Age at enrollment/collection 192472 phv00192472.v3.p3 pht003401.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:08:16+00:00 2018-09-21 18:08:16+00:00 PRDY F130 Days to Progesterone receptor assay +21 Age at enrollment/collection 192821 phv00192821.v3.p3 pht003402.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:18:35+00:00 2018-09-21 18:18:35+00:00 ENDEXT1DY Days enrollment to end of Ext1 followup +21 Age at enrollment/collection 193503 phv00193503.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:23:33+00:00 2018-09-21 18:23:33+00:00 ENDWHIDY Days enrollment to end of WHI core study followup +21 Age at enrollment/collection 193504 phv00193504.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:23:39+00:00 2018-09-21 18:23:39+00:00 ENDEXT1DY Days enrollment to end of Ext1 followup +21 Age at enrollment/collection 193505 phv00193505.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:23:45+00:00 2018-09-21 18:23:45+00:00 ENDFOLLOWDY Days enrollment to end of followup +21 Age at enrollment/collection 193683 phv00193683.v3.p3 pht003413.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:25:55+00:00 2018-09-21 18:25:55+00:00 LAST33DY Days enrollment to last form 33/33D +21 Age at enrollment/collection 193795 phv00193795.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:27:06+00:00 2018-09-21 18:27:06+00:00 LAST33DY Days enrollment to last form 33/33D +21 Age at enrollment/collection 202398 phv00202398.v2.p3 pht003418.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:28:13+00:00 2018-09-21 18:28:13+00:00 DRAWDY Draw Days since randomization/enrollment +21 Age at enrollment/collection 193863 phv00193863.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:28:40+00:00 2018-09-21 18:28:40+00:00 TESTDY Test Days Since Draw +21 Age at enrollment/collection 282954 phv00282954.v1.p3 pht006212.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:29:09+00:00 2018-09-21 18:29:09+00:00 STARTDY Days from CT randomization to start of CaD adherence period +21 Age at enrollment/collection 282955 phv00282955.v1.p3 pht006212.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:29:15+00:00 2018-09-21 18:29:15+00:00 STCADDY Days from CaD randomization to start of CaD adherence period +21 Age at enrollment/collection 282956 phv00282956.v1.p3 pht006212.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:29:22+00:00 2018-09-21 18:29:22+00:00 ENDDY Days from CT randomization to end of CaD adherence period +21 Age at enrollment/collection 282957 phv00282957.v1.p3 pht006212.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:29:29+00:00 2018-09-21 18:29:29+00:00 ENDCADDY Days from CaD randomization to end of CaD adherence period +21 Age at enrollment/collection 282967 phv00282967.v1.p3 pht006213.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:29:53+00:00 2018-09-21 18:29:53+00:00 STARTDY Days from rand to start of HRT adherence period +21 Age at enrollment/collection 282968 phv00282968.v1.p3 pht006213.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:29:59+00:00 2018-09-21 18:29:59+00:00 ENDDY Days from rand to end of HRT adherence period +21 Age at enrollment/collection 282978 phv00282978.v1.p3 pht006214.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:30:47+00:00 2018-09-21 18:30:47+00:00 F155DAYS F155 Days since randomization or enrollment +21 Age at enrollment/collection 283187 phv00283187.v1.p3 pht006215.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:31:26+00:00 2018-09-21 18:31:26+00:00 F156DAYS F156 Days since randomization or enrollment +21 Age at enrollment/collection 283255 phv00283255.v1.p3 pht006216.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:32:13+00:00 2018-09-21 18:32:13+00:00 F157DAYS F157 Days since randomization or enrollment +21 Age at enrollment/collection 283286 phv00283286.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:32:49+00:00 2018-09-21 18:32:49+00:00 F301DY F301 Days since randomization or enrollment +21 Age at enrollment/collection 283289 phv00283289.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:32:54+00:00 2018-09-21 18:32:54+00:00 EXAMDY Exam days since randomization +21 Age at enrollment/collection 283402 phv00283402.v1.p3 pht006218.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:33:31+00:00 2018-09-21 18:33:31+00:00 F60DAYS F60 Days since randomization/enrollment +21 Age at enrollment/collection 283455 phv00283455.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:40:37+00:00 2018-09-21 18:40:37+00:00 ENDWHIDY Days enrollment to end of WHI core study followup +21 Age at enrollment/collection 283456 phv00283456.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:40:44+00:00 2018-09-21 18:40:44+00:00 ENDEXT1DY Days enrollment to end of Ext1 followup +21 Age at enrollment/collection 283457 phv00283457.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:40:50+00:00 2018-09-21 18:40:50+00:00 ENDFOLLOWDY Days enrollment to end of followup +21 Age at enrollment/collection 283458 phv00283458.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:40:56+00:00 2018-09-21 18:40:56+00:00 F135DY F135 Days from enrollment to Form 135 completion +21 Age at enrollment/collection 56587 phv00056587.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age_s1 Age = StdyDtqa - DOB +21 Age at enrollment/collection 56723 phv00056723.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age_s2 Age (age = formdate - DOB) +21 Age at enrollment/collection 177891 phv00177891.v3.p10 pht003097.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 adate1 Acquisition date time +21 Age at enrollment/collection 177930 phv00177930.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age1 Age at Exam 1 +21 Age at enrollment/collection 177948 phv00177948.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age10 Age at Exam 10 +21 Age at enrollment/collection 177950 phv00177950.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age11 Age at Exam 11 +21 Age at enrollment/collection 177952 phv00177952.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age12 Age at Exam 12 +21 Age at enrollment/collection 177954 phv00177954.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age13 Age at Exam 13 +21 Age at enrollment/collection 177956 phv00177956.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age14 Age at Exam 14 +21 Age at enrollment/collection 177958 phv00177958.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age15 Age at Exam 15 +21 Age at enrollment/collection 177960 phv00177960.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age16 Age at Exam 16 +21 Age at enrollment/collection 177962 phv00177962.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age17 Age at Exam 17 +21 Age at enrollment/collection 177964 phv00177964.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age18 Age at Exam 18 +21 Age at enrollment/collection 177966 phv00177966.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age19 Age at Exam 19 +21 Age at enrollment/collection 253991 phv00253991.v1.p10 pht004374.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 age Age at NP battery (years) +21 Age at enrollment/collection 277020 phv00277020.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 AGE1 Age at Exam 1 +21 Age at enrollment/collection 277077 phv00277077.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:09:55+00:00 2018-09-27 14:09:55+00:00 AGE1 Age at Exam 1 +21 Age at enrollment/collection 177932 phv00177932.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age2 Age at Exam 2 +21 Age at enrollment/collection 177970 phv00177970.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age21 Age at Exam 21 +21 Age at enrollment/collection 177972 phv00177972.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age22 Age at Exam 22 +21 Age at enrollment/collection 177974 phv00177974.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age23 Age at Exam 23 +21 Age at enrollment/collection 177976 phv00177976.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age24 Age at Exam 24 +21 Age at enrollment/collection 177978 phv00177978.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age25 Age at Exam 25 +21 Age at enrollment/collection 177980 phv00177980.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age26 Age at Exam 26 +21 Age at enrollment/collection 177982 phv00177982.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age27 Age at Exam 27 +21 Age at enrollment/collection 177984 phv00177984.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age28 Age at Exam 28 +21 Age at enrollment/collection 226999 phv00226999.v1.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age29 Age at Exam 29 +21 Age at enrollment/collection 177968 phv00177968.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 age20 Age at Exam 20 +21 Age at enrollment/collection 277021 phv00277021.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 AGE2 Age at Exam 2 +21 Age at enrollment/collection 277078 phv00277078.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:13:58+00:00 2018-09-27 14:13:58+00:00 AGE2 Age at Exam 2 +21 Age at enrollment/collection 177934 phv00177934.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age3 Age at Exam 3 +21 Age at enrollment/collection 177936 phv00177936.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age4 Age at Exam 4 +21 Age at enrollment/collection 177938 phv00177938.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age5 Age at Exam 5 +21 Age at enrollment/collection 177940 phv00177940.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age6 Age at Exam 6 +21 Age at enrollment/collection 177942 phv00177942.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age7 Age at Exam 7 +21 Age at enrollment/collection 177944 phv00177944.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age8 Age at Exam 8 +21 Age at enrollment/collection 177946 phv00177946.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age9 Age at Exam 9 +21 Age at enrollment/collection 227002 phv00227002.v1.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age30 Age at Exam 30 +21 Age at enrollment/collection 227005 phv00227005.v1.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age31 Age at Exam 31 +21 Age at enrollment/collection 227008 phv00227008.v1.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 age32 Age at Exam 32 +21 Age at enrollment/collection 277079 phv00277079.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 AGE3 Age at Exam 3 +21 Age at enrollment/collection 277080 phv00277080.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 AGE4 Age at Exam 4 +21 Age at enrollment/collection 277081 phv00277081.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 AGE5 Age at Exam 5 +21 Age at enrollment/collection 277082 phv00277082.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 AGE6 Age at Exam 6 +21 Age at enrollment/collection 277083 phv00277083.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 AGE7 Age at Exam 7 +21 Age at enrollment/collection 277084 phv00277084.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 AGE8 Age at Exam 8 +21 Age at enrollment/collection 277085 phv00277085.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:16:15+00:00 2018-09-27 14:16:15+00:00 AGE9 Age at Exam 9 +21 Age at enrollment/collection 22793 phv00022793.v5.p10 pht000113.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 assayday DATE OF TESTING: NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 24370 phv00024370.v5.p10 pht000193.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 aldodate DATE SAMPLE OBTAINED - NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 24639 phv00024639.v1.p10 pht000201.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 AGEYRS AGE AT KNEE X_RAY FILMS +21 Age at enrollment/collection 56608 phv00056608.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 alcohdt Usual Alcohol Intake Date +21 Age at enrollment/collection 56610 phv00056610.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 choldt Cholesterol/HDL/Triglycerides Date +21 Age at enrollment/collection 64594 phv00064594.v1.p10 pht000603.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 AGEYRS AGE AT KNEE X_RAY FILMS +21 Age at enrollment/collection 64599 phv00064599.v2.p10 pht000604.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 AGEYRS AGE AT KNEE X_RAY FILMS +21 Age at enrollment/collection 66684 phv00066684.v4.p10 pht000670.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 blddrwdt Blood draw date Collection Interval: Offspring Exam 8 and Omni 1 Exam 3 +21 Age at enrollment/collection 227267 phv00227267.v1.p10 pht004809.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 CollectionDate Urine collection date Collection Interval: Test performed at Offspring Exam9 and Omni 1 Exam 4 +21 Age at enrollment/collection 238804 phv00238804.v1.p10 pht004811.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 awcdate Header Start Date (K8) v: awcdate +21 Age at enrollment/collection 250279 phv00250279.v1.p10 pht004812.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:18:08+00:00 2018-09-27 14:18:08+00:00 awcdate Header Start Date (K8) v: awcdate +21 Age at enrollment/collection 23156 phv00023156.v3.p10 pht000139.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate CT SCAN DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 23165 phv00023165.v3.p10 pht000140.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 CTDATE DATE OF CT TEST , NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 66818 phv00066818.v2.p10 pht000675.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate DATE OF CT SCAN, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 76334 phv00076334.v2.p10 pht000903.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of CT Scan Collection Interval: 2002-2005 +21 Age at enrollment/collection 76346 phv00076346.v3.p10 pht000904.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of CT Scan +21 Age at enrollment/collection 76357 phv00076357.v2.p10 pht000905.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate CT Scan Date Collection Interval: 2002-2005 +21 Age at enrollment/collection 76363 phv00076363.v3.p10 pht000906.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of CT Scan +21 Age at enrollment/collection 90345 phv00090345.v2.p10 pht001224.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of CT Scan Collection Interval: 2002-2005 +21 Age at enrollment/collection 90351 phv00090351.v2.p10 pht001225.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of CT Scan +21 Age at enrollment/collection 90355 phv00090355.v2.p10 pht001226.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of CT Scan Collection Interval: 2002-2005 +21 Age at enrollment/collection 90359 phv00090359.v2.p10 pht001227.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of CT Scan +21 Age at enrollment/collection 195453 phv00195453.v1.p10 pht003459.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of CT scan +21 Age at enrollment/collection 196517 phv00196517.v1.p10 pht003629.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 ctdate Date of round 2 CT scan +21 Age at enrollment/collection 257598 phv00257598.v1.p10 pht005153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 CT_DATE CT scan date +21 Age at enrollment/collection 257624 phv00257624.v1.p10 pht005156.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 CT_DATE CT scan date Collection Interval: 2002 - 2005 +21 Age at enrollment/collection 257650 phv00257650.v1.p10 pht005158.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 CT_DATE CT scan date +21 Age at enrollment/collection 257661 phv00257661.v1.p10 pht005159.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:27:28+00:00 2018-09-27 14:27:28+00:00 CTDATE CT scan date +21 Age at enrollment/collection 21691 phv00021691.v5.p10 pht000080.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:10+00:00 2018-09-27 14:34:10+00:00 date DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 21936 phv00021936.v5.p10 pht000092.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:10+00:00 2018-09-27 14:34:10+00:00 date TEST DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 22789 phv00022789.v5.p10 pht000112.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:10+00:00 2018-09-27 14:34:10+00:00 date EXAM 6 DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 36346 phv00036346.v4.p10 pht000298.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:10+00:00 2018-09-27 14:34:10+00:00 date EXAM DATE: NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 56634 phv00056634.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:10+00:00 2018-09-27 14:34:10+00:00 date Date Test Administered +21 Age at enrollment/collection 64606 phv00064606.v2.p10 pht000605.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:10+00:00 2018-09-27 14:34:10+00:00 date CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 64617 phv00064617.v2.p10 pht000606.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:10+00:00 2018-09-27 14:34:10+00:00 date CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 65269 phv00065269.v2.p10 pht000607.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:10+00:00 2018-09-27 14:34:10+00:00 date CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 65288 phv00065288.v1.p10 pht000608.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:11+00:00 2018-09-27 14:34:11+00:00 date CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 219227 phv00219227.v2.p10 pht004361.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:34:11+00:00 2018-09-27 14:34:11+00:00 DATE Framingham Heart Study exam date (blood draw date) +21 Age at enrollment/collection 21750 phv00021750.v1.p10 pht000086.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date_d DATE BLOOD DRAWN, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 21751 phv00021751.v1.p10 pht000086.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date_t DATE OF TEST, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 23628 phv00023628.v1.p10 pht000155.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date1920 COLLECTION DATE FOR EXAM 19/20 HBA, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 24535 phv00024535.v3.p10 pht000196.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date1 CARDIAC MRI SCAN DATE ENTERED ONTO PAPER FORM - NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 56611 phv00056611.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date10 Date questionnaire was completed +21 Age at enrollment/collection 56617 phv00056617.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date02 Date form filled out +21 Age at enrollment/collection 177993 phv00177993.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date10 Exam date for Exam 10 +21 Age at enrollment/collection 177994 phv00177994.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date11 Exam date for Exam 11 +21 Age at enrollment/collection 177995 phv00177995.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date12 Exam date for Exam 12 +21 Age at enrollment/collection 177996 phv00177996.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date13 Exam date for Exam 13 +21 Age at enrollment/collection 177997 phv00177997.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date14 Exam date for Exam 14 +21 Age at enrollment/collection 177998 phv00177998.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date15 Exam date for Exam 15 +21 Age at enrollment/collection 177999 phv00177999.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date16 Exam date for Exam 16 +21 Age at enrollment/collection 178000 phv00178000.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date17 Exam date for Exam 17 +21 Age at enrollment/collection 178001 phv00178001.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date18 Exam date for Exam 18 +21 Age at enrollment/collection 178002 phv00178002.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 date19 Exam date for Exam 19 +21 Age at enrollment/collection 277063 phv00277063.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 DATE1 Date of Exam 1 +21 Age at enrollment/collection 277263 phv00277263.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:43:29+00:00 2018-09-27 14:43:29+00:00 DATE1 Date of Exam 1 +21 Age at enrollment/collection 23627 phv00023627.v1.p10 pht000155.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date22 COLLECTION DATE FOR EXAM 22 HBA, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 56613 phv00056613.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date20 Date questionnaire was completed +21 Age at enrollment/collection 142460 phv00142460.v1.p10 pht002080.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date22 Date of Follow-up X-ray Collection Interval: Exams 10, 14, and 22 +21 Age at enrollment/collection 177985 phv00177985.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date2 Exam date for Exam 2 +21 Age at enrollment/collection 178003 phv00178003.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date20 Exam date for Exam 20 +21 Age at enrollment/collection 178004 phv00178004.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date21 Exam date for Exam 21 +21 Age at enrollment/collection 178005 phv00178005.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date22 Exam date for Exam 22 +21 Age at enrollment/collection 178006 phv00178006.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date23 Exam date for Exam 23 +21 Age at enrollment/collection 178007 phv00178007.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date24 Exam date for Exam 24 +21 Age at enrollment/collection 178008 phv00178008.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date25 Exam date for Exam 25 +21 Age at enrollment/collection 178009 phv00178009.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date26 Exam date for Exam 26 +21 Age at enrollment/collection 178010 phv00178010.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date27 Exam date for Exam 27 +21 Age at enrollment/collection 178011 phv00178011.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date28 Exam date for Exam 28 +21 Age at enrollment/collection 226998 phv00226998.v1.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 date29 Exam date for Exam 29 +21 Age at enrollment/collection 277064 phv00277064.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 DATE2 Date of Exam 2 +21 Age at enrollment/collection 277264 phv00277264.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:46:17+00:00 2018-09-27 14:46:17+00:00 DATE2 Date of Exam 2 +21 Age at enrollment/collection 56614 phv00056614.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date50 Date of Study +21 Age at enrollment/collection 177986 phv00177986.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date3 Exam date for Exam 3 +21 Age at enrollment/collection 177987 phv00177987.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date4 Exam date for Exam 4 +21 Age at enrollment/collection 177988 phv00177988.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date5 Exam date for Exam 5 +21 Age at enrollment/collection 177989 phv00177989.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date6 Exam date for Exam 6 +21 Age at enrollment/collection 177990 phv00177990.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date7 Exam date for Exam 7 +21 Age at enrollment/collection 177991 phv00177991.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date8 Exam date for Exam 8 +21 Age at enrollment/collection 177992 phv00177992.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date9 Exam date for Exam 9 +21 Age at enrollment/collection 227001 phv00227001.v1.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date30 Exam date for Exam 30 +21 Age at enrollment/collection 227004 phv00227004.v1.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date31 Exam date for Exam 31 +21 Age at enrollment/collection 227007 phv00227007.v1.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 date32 Exam date for Exam 32 +21 Age at enrollment/collection 277265 phv00277265.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 DATE3 Date of Exam 3 +21 Age at enrollment/collection 277266 phv00277266.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 DATE4 Date of Exam 4 +21 Age at enrollment/collection 277267 phv00277267.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 DATE5 Date of Exam 5 +21 Age at enrollment/collection 277268 phv00277268.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 DATE6 Date of Exam 6 +21 Age at enrollment/collection 277269 phv00277269.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 DATE7 Date of Exam 7 +21 Age at enrollment/collection 277270 phv00277270.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 DATE8 Date of Exam 8 +21 Age at enrollment/collection 277271 phv00277271.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:49:27+00:00 2018-09-27 14:49:27+00:00 DATE9 Date of Exam 9 +21 Age at enrollment/collection 23246 phv00023246.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 EBCT02 DATE OF CT TESTING, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 23555 phv00023555.v5.p10 pht000151.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 DRAWDATE DATE BLOOD DRAWN, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 54699 phv00054699.v1.p10 pht000390.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 E005 AGE AT LAST BIRTHDAY +21 Age at enrollment/collection 54982 phv00054982.v1.p10 pht000390.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 E365 AGE (SAME AS E005), AGE AT LAST BIRTHDAY +21 Age at enrollment/collection 55155 phv00055155.v4.p10 pht000392.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 e_dte DATE OF EXAMINATION, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 56618 phv00056618.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 ecgdt Date of ECG +21 Age at enrollment/collection 66688 phv00066688.v4.p10 pht000671.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 drawdate DATE OF SAMPLE DRAWN, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 70894 phv00070894.v4.p10 pht000683.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 drawdate DATE OF BLOOD DRAWN DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 70901 phv00070901.v1.p10 pht000685.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 drawdate BLOOD DRAW DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 69674 phv00069674.v4.p10 pht000686.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 drawdate BLOOD DRAW DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 70905 phv00070905.v4.p10 pht000694.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 drawdt BLOOD DRAW DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 71898 phv00071898.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 drawdate Date blood drawn or urine sample obtained +21 Age at enrollment/collection 72014 phv00072014.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 ecgdate_s1 Date of ECG for first sleep study Collection Interval: 1998-2003 +21 Age at enrollment/collection 72015 phv00072015.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 ecgdate_s2 Date of ECG for second sleep study Collection Interval: 1998-2003 +21 Age at enrollment/collection 220753 phv00220753.v1.p10 pht004369.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 DRAW_DATE Date of DNA draw +21 Age at enrollment/collection 220760 phv00220760.v1.p10 pht004370.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 DRAW_DATE Date of DNA draw +21 Age at enrollment/collection 275421 phv00275421.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:52:14+00:00 2018-09-27 14:52:14+00:00 DRAWDATE Date blood drawn or urine sample obtained Collection Interval: Omni 1 Exam 3 +21 Age at enrollment/collection 21871 phv00021871.v4.p10 pht000089.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate DATE OF FILLING QUESTIONNAIRE, NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 21923 phv00021923.v1.p10 pht000090.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 edate DATE OF EXAM, NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 23772 phv00023772.v1.p10 pht000158.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 edate_a DATE OF EXAM - PART A, NUMBER OF DAYS FROM EXAM 1 DATE +21 Age at enrollment/collection 23773 phv00023773.v1.p10 pht000158.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 edate_b DATE OF EXAM - PART B, NUMBER OF DAYS FROM EXAM 1 DATE +21 Age at enrollment/collection 24575 phv00024575.v5.p10 pht000198.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 edate DATE BLOOD DRAWN, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 55022 phv00055022.v1.p10 pht000390.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate1 EXAM DATE PART I, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 55023 phv00055023.v1.p10 pht000390.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate2 EXAM DATE PART II, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 55024 phv00055024.v1.p10 pht000390.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate3 EXAM DATE PART III, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 55088 phv00055088.v1.p10 pht000391.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate EYE EXAMINATION DATE +21 Age at enrollment/collection 66803 phv00066803.v4.p10 pht000674.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 edate BLOOD DRAWN DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 253873 phv00253873.v1.p10 pht000690.v11.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate Date of neuropsychological test battery +21 Age at enrollment/collection 253875 phv00253875.v1.p10 pht000691.v11.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate Date of neuropsychological test battery +21 Age at enrollment/collection 227019 phv00227019.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 EDATE Blood draw date Collection Interval: Exam 1 +21 Age at enrollment/collection 227101 phv00227101.v1.p10 pht004806.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 EDATE Blood draw date Collection Interval: Exam 1 +21 Age at enrollment/collection 255346 phv00255346.v1.p10 pht005143.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 EDATE Exam date +21 Age at enrollment/collection 257949 phv00257949.v1.p10 pht005174.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate EXAM DATE +21 Age at enrollment/collection 257971 phv00257971.v1.p10 pht005175.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 examdate EXAM DATE Collection Interval: Exam performed at Exam 17 through Exam 32 +21 Age at enrollment/collection 275409 phv00275409.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 EDATE Blood draw date Collection Interval: Exam 2 +21 Age at enrollment/collection 275426 phv00275426.v1.p10 pht006012.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:55:48+00:00 2018-09-27 14:55:48+00:00 EDATE Exam 1 date +21 Age at enrollment/collection 156623 phv00156623.v3.p10 pht000169.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 f6_7scdt Femur scan date +21 Age at enrollment/collection 56620 phv00056620.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 fevfvcdt FEV1 FVC Date +21 Age at enrollment/collection 56621 phv00056621.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 heightdt Height Date +21 Age at enrollment/collection 57972 phv00057972.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 formdate_ql Date questionnaire completed, Number of days since Exam 1 +21 Age at enrollment/collection 69853 phv00069853.v4.p10 pht000687.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 gfibdate BLOOD DRAW DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 121924 phv00121924.v1.p10 pht001182.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 f2scdt Femur scan date +21 Age at enrollment/collection 121943 phv00121943.v3.p10 pht001892.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 f2scdt Femur scan date +21 Age at enrollment/collection 159558 phv00159558.v3.p10 pht002236.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 exdate Date of foot study call back exam Collection Interval: Exam dates from 12/2000 to 6/2008 +21 Age at enrollment/collection 162081 phv00162081.v1.p10 pht002346.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 f2scdt Femur scan date Collection Interval: Test done at Generation 3 Exam 2 between April 2010 and March 2011 +21 Age at enrollment/collection 163499 phv00163499.v1.p10 pht002430.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 g3ex2date Quadriceps strength measure date +21 Age at enrollment/collection 163508 phv00163508.v3.p10 pht002431.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 exdate Foot study date Collection Interval: Original Cohort Exams 27 and 28, Offspring Exam 8 +21 Age at enrollment/collection 163512 phv00163512.v1.p10 pht002432.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 g3ex2date Osteoporosis study questionnaire date +21 Age at enrollment/collection 172208 phv00172208.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 exdate Framingham Heart Study Exam date (blood draw date) +21 Age at enrollment/collection 177805 phv00177805.v2.p10 pht003096.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 f7_5scdt Femur scan date for exam 7.5 Collection Interval: Scans done from January 2002 through July 2008 +21 Age at enrollment/collection 177807 phv00177807.v2.p10 pht003096.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 f8cbscdt Femur scan date for exam 8 callback Collection Interval: Scans done from January 2002 through July 2008 +21 Age at enrollment/collection 227061 phv00227061.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 14:58:16+00:00 2018-09-27 14:58:16+00:00 EXDATE Framingham Heart Study exam date (blood draw date) +21 Age at enrollment/collection 21813 phv00021813.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hex6_03 EXAM DATE - PART A, NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 21814 phv00021814.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hex6_36 IMPEDANCE & REFLECTANCE: IMPED PROGRAM - RIGHT EAR. DATE - NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 21815 phv00021815.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hex6_37 IMPEDANCE & REFLECTANCE: IMPED PROGRAM - LEFT EAR. DATE - NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 21816 phv00021816.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hex6_38 DPOAE: EMAV PROGRAM - RIGHT EAR. DATE - NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 21817 phv00021817.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hex6_39 DPOAE: EMAV PROGRAM - LEFT EAR. DATE - NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 21818 phv00021818.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hex6_46 DPOAE: VIRTUAL 330 - RIGHT EAR TEST EACH EAR HAVING PTA >= 50 DP HL. DO DP - GRAM AND I/O FUNCTION AT 2KHZ. DATE - NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 21819 phv00021819.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hex6_47 DPOAE: VIRTUAL 330 - RIGHT EAR TEST EACH EAR HAVING PTA <= 50 DP HL. DO DP - GRAM AND I/O FUNCTION AT 2KHZ. DATE - NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 21820 phv00021820.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hex6_54 EXAM DATE - PART B, NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 36495 phv00036495.v4.p10 pht000313.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 labdate DATE WHEN SPECIMEN WERE COLLECTED, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 56622 phv00056622.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 hipdt Hip Date +21 Age at enrollment/collection 190832 phv00190832.v6.p10 pht003317.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 LASTATT Date of last exam attended through 2012 +21 Age at enrollment/collection 202020 phv00202020.v3.p10 pht003905.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 mr99date MRI Date +21 Age at enrollment/collection 220874 phv00220874.v2.p10 pht004375.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:02:54+00:00 2018-09-27 15:02:54+00:00 KADATE Date of Kaplan Albert exam Collection Interval: Questionnaire administered at Original cohort Exams 14 and 15 +21 Age at enrollment/collection 257714 phv00257714.v1.p10 pht003313.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:12:09+00:00 2018-09-27 15:12:09+00:00 mri_date Date of MRI Collection Interval: 12/2000 - 6/2009 +21 Age at enrollment/collection 202028 phv00202028.v4.p10 pht003906.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:12:09+00:00 2018-09-27 15:12:09+00:00 mri_date Brain MRI scan date +21 Age at enrollment/collection 220687 phv00220687.v1.p10 pht004364.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:12:09+00:00 2018-09-27 15:12:09+00:00 mri_date Scan Date of MRI Collection Interval: 2005-2010 +21 Age at enrollment/collection 220701 phv00220701.v3.p10 pht004365.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:12:09+00:00 2018-09-27 15:12:09+00:00 mri_date Date of MRI scan Collection Interval: Brain MRI Scans Dates 3/1999 to 8/2011 +21 Age at enrollment/collection 220738 phv00220738.v3.p10 pht004366.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:12:09+00:00 2018-09-27 15:12:09+00:00 mri_date Date of MRI scan +21 Age at enrollment/collection 220742 phv00220742.v1.p10 pht004367.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:12:09+00:00 2018-09-27 15:12:09+00:00 mri_date MRI Scan Date Collection Interval: 1999-2005 +21 Age at enrollment/collection 257780 phv00257780.v1.p10 pht005165.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:12:09+00:00 2018-09-27 15:12:09+00:00 mri_date MRI date +21 Age at enrollment/collection 276647 phv00276647.v1.p10 pht006016.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:12:09+00:00 2018-09-27 15:12:09+00:00 mri_date Date of MRI scan +21 Age at enrollment/collection 24754 phv00024754.v4.p10 pht000207.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:15:17+00:00 2018-09-27 15:15:17+00:00 mridate NUMBER OF DAYS BETWEEN EXAM 1 AND NEUROPSYCH BATTERY TEST +21 Age at enrollment/collection 65292 phv00065292.v2.p10 pht000609.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:15:17+00:00 2018-09-27 15:15:17+00:00 OSSage AGE AT X-RAY +21 Age at enrollment/collection 72714 phv00072714.v4.p10 pht000748.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:15:17+00:00 2018-09-27 15:15:17+00:00 pdate Date of PAT scan +21 Age at enrollment/collection 76396 phv00076396.v3.p10 pht000909.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:15:17+00:00 2018-09-27 15:15:17+00:00 of67quad_date Quadriceps Strength: Measurement Date +21 Age at enrollment/collection 202067 phv00202067.v3.p10 pht003910.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:15:17+00:00 2018-09-27 15:15:17+00:00 NPDATE Neuropsychological battery exam date +21 Age at enrollment/collection 220862 phv00220862.v3.p10 pht004374.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:15:17+00:00 2018-09-27 15:15:17+00:00 np_date Date of NP battery +21 Age at enrollment/collection 257586 phv00257586.v1.p10 pht005151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:15:17+00:00 2018-09-27 15:15:17+00:00 Ns2fscdt Femur scan date Collection Interval: Test performed at Exam 2 +21 Age at enrollment/collection 257587 phv00257587.v1.p10 pht005151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:15:17+00:00 2018-09-27 15:15:17+00:00 Ns2sscdt Spine scan date Collection Interval: Test performed at Exam 2 +21 Age at enrollment/collection 57974 phv00057974.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 pm203 Date of wt measurment, Number of days since Exam 1 +21 Age at enrollment/collection 57975 phv00057975.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 pm208 Date of ht measurement, Number of days since Exam 1 +21 Age at enrollment/collection 57976 phv00057976.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 pm213 Date of neck measurement, Number of days since Exam 1 +21 Age at enrollment/collection 57977 phv00057977.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 pm221 Date of seated bp measurement, Number of days since Exam 1 +21 Age at enrollment/collection 57978 phv00057978.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 pm228 Date of AAI measurement, Number of days since Exam 1 +21 Age at enrollment/collection 57979 phv00057979.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 pm233 Date of ECG measurement, Number of days since Exam 1 +21 Age at enrollment/collection 70902 phv00070902.v1.p10 pht000685.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 rundate LABORATORY ANALYSIS DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 72016 phv00072016.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 psgdate_s1 Date of PSG for first sleep study Collection Interval: 1998-2003 +21 Age at enrollment/collection 72017 phv00072017.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 psgdate_s2 Date of PSG for second sleep study Collection Interval: 1998-2003 +21 Age at enrollment/collection 121925 phv00121925.v2.p10 pht001182.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 s2scdt Spine scan date +21 Age at enrollment/collection 121942 phv00121942.v3.p10 pht001892.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 s2scdt Spine scan date +21 Age at enrollment/collection 141875 phv00141875.v3.p10 pht002073.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 psgdate Date of Polysomnogram Collection Interval: Test performed 1995-1998 +21 Age at enrollment/collection 162082 phv00162082.v1.p10 pht002346.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:18:33+00:00 2018-09-27 15:18:33+00:00 s2scdt Spine scan date Collection Interval: Test done at Generation 3 Exam 2 between April 2010 and March 2011 +21 Age at enrollment/collection 156624 phv00156624.v3.p10 pht000169.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:22:22+00:00 2018-09-27 15:22:22+00:00 s6_7scdt Spine scan date +21 Age at enrollment/collection 36378 phv00036378.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:22:22+00:00 2018-09-27 15:22:22+00:00 sampdate DATE ECG DONE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 177806 phv00177806.v2.p10 pht003096.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:22:22+00:00 2018-09-27 15:22:22+00:00 s7_5scdt Spine scan date for exam 7.5 Collection Interval: Scans done from January 2002 through July 2008 +21 Age at enrollment/collection 177808 phv00177808.v2.p10 pht003096.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:22:22+00:00 2018-09-27 15:22:22+00:00 s8cbscdt Spine scan date for exam 8 callback Collection Interval: Scans done from January 2002 through July 2008 +21 Age at enrollment/collection 24587 phv00024587.v2.p10 pht000200.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 sample_date IGF BLOOD DRAW DATE, NUMBER OF DAYS SINE EXAM 1 +21 Age at enrollment/collection 54674 phv00054674.v2.p10 pht000387.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scandate DATE OF THE SCAN, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 54690 phv00054690.v3.p10 pht000388.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scandate DATE OF THE CT SCAN, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 121955 phv00121955.v3.p10 pht001893.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scandate QCT image scan date +21 Age at enrollment/collection 121971 phv00121971.v2.p10 pht001894.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scandate QCT Image Scan Date +21 Age at enrollment/collection 171910 phv00171910.v1.p10 pht002854.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scandate CT Scan date +21 Age at enrollment/collection 202016 phv00202016.v2.p10 pht003904.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 SCAN_DATE1 Round 1 CT Dates +21 Age at enrollment/collection 202017 phv00202017.v2.p10 pht003904.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 SCAN_DATE2 Round 2 CT Dates +21 Age at enrollment/collection 257591 phv00257591.v1.p10 pht005152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scan_date CT SCAN DATE +21 Age at enrollment/collection 257604 phv00257604.v1.p10 pht005154.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scan_date CT SCAN DATE +21 Age at enrollment/collection 257639 phv00257639.v1.p10 pht005157.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scan_date CT SCAN DATE +21 Age at enrollment/collection 257667 phv00257667.v1.p10 pht005160.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scan_date CT SCAN DATE +21 Age at enrollment/collection 257672 phv00257672.v1.p10 pht005161.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scan_date CT scan date +21 Age at enrollment/collection 257676 phv00257676.v1.p10 pht005162.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scan_date CT SCAN DATE +21 Age at enrollment/collection 257682 phv00257682.v1.p10 pht005163.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scan_date CT SCAN DATE +21 Age at enrollment/collection 276582 phv00276582.v1.p10 pht006014.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:37:20+00:00 2018-09-27 15:37:20+00:00 scandate Scan Date Collection Interval: Test Performed after Offspring Exam 9 +21 Age at enrollment/collection 23551 phv00023551.v5.p10 pht000150.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 SDATE STUDY DATE, NUMBER OF DAYS FROM EXAM 1 +21 Age at enrollment/collection 24436 phv00024436.v4.p10 pht000194.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdate STUDY DATE, DAYS SINCE EXAM 1 +21 Age at enrollment/collection 24509 phv00024509.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdate DATE OF SCAN, DAYS SINCE EXAM 1 +21 Age at enrollment/collection 24801 phv00024801.v5.p10 pht000209.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdate STUDY DATE, DAYS SINCE EXAM 1 (OLD NAME:SDATE2) +21 Age at enrollment/collection 24845 phv00024845.v4.p10 pht000210.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdate STUDY DATE, DAYS SINCE EXAM 1 +21 Age at enrollment/collection 24906 phv00024906.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdate STUDY DATE, DAYS SINCE EXAM 1 +21 Age at enrollment/collection 66764 phv00066764.v4.p10 pht000673.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdate STUDY DATE, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 73842 phv00073842.v4.p10 pht000832.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_8_1 Study date +21 Age at enrollment/collection 76412 phv00076412.v4.p10 pht000910.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_8_1 Study Date +21 Age at enrollment/collection 167130 phv00167130.v5.p10 pht002572.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdate STUDY DATE +21 Age at enrollment/collection 167261 phv00167261.v1.p10 pht002573.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdate STUDY DATE +21 Age at enrollment/collection 196545 phv00196545.v2.p10 pht003631.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_2 Study Date +21 Age at enrollment/collection 196562 phv00196562.v2.p10 pht003632.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_2 Study Date +21 Age at enrollment/collection 257782 phv00257782.v1.p10 pht005166.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_1 Study Date +21 Age at enrollment/collection 257812 phv00257812.v1.p10 pht005167.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_3 Study Date Collection Interval: Omni 1 Exam 3 +21 Age at enrollment/collection 257816 phv00257816.v1.p10 pht005168.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_9 Study Date Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +21 Age at enrollment/collection 257831 phv00257831.v1.p10 pht005169.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_9_1 Study Date Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +21 Age at enrollment/collection 257847 phv00257847.v1.p10 pht005170.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 sdt_1 Study Date +21 Age at enrollment/collection 276640 phv00276640.v1.p10 pht006015.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:42:22+00:00 2018-09-27 15:42:22+00:00 SDATE Study date +21 Age at enrollment/collection 23197 phv00023197.v3.p10 pht000144.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:40+00:00 2018-09-27 15:44:40+00:00 studydat DATE OF TEST, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 23203 phv00023203.v3.p10 pht000145.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:40+00:00 2018-09-27 15:44:40+00:00 studydat DATE OF TEST, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 24883 phv00024883.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:40+00:00 2018-09-27 15:44:40+00:00 TM02 DATE OF FHS CLINIC EXAM? +21 Age at enrollment/collection 55248 phv00055248.v4.p10 pht000394.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:40+00:00 2018-09-27 15:44:40+00:00 study_da DATE WALKTEST COMPLETED, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 56627 phv00056627.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:40+00:00 2018-09-27 15:44:40+00:00 stdatep PSG start date +21 Age at enrollment/collection 56628 phv00056628.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:40+00:00 2018-09-27 15:44:40+00:00 stdydtqa PSG Study Date +21 Age at enrollment/collection 56629 phv00056629.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:40+00:00 2018-09-27 15:44:40+00:00 stdydtsn PSG study date +21 Age at enrollment/collection 56630 phv00056630.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 sysdiadt Systolic/Diastolic Blood Pressure Date +21 Age at enrollment/collection 57980 phv00057980.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 sh331 Today's date, Number of days since Exam 1 +21 Age at enrollment/collection 57981 phv00057981.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 stdatep PSG start date, Number of days since Exam 1 +21 Age at enrollment/collection 156710 phv00156710.v1.p10 pht002147.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 studydat DATE OF TEST Collection Interval: Scan done 2002 - 2005 +21 Age at enrollment/collection 162093 phv00162093.v1.p10 pht002347.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 studydat Date of CT test Collection Interval: CT scans done between 2002-2005 +21 Age at enrollment/collection 162101 phv00162101.v2.p10 pht002348.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 stdydtqa1 PSG study date Collection Interval: Test done 1995 - 1998 +21 Age at enrollment/collection 166998 phv00166998.v1.p10 pht002571.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 studydat DATE OF TEST Collection Interval: Scans done between 2002-2005 +21 Age at enrollment/collection 190765 phv00190765.v2.p10 pht003311.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 stdydtqa PSG study date Collection Interval: Tests performed between 1995 and 1998 +21 Age at enrollment/collection 196579 phv00196579.v2.p10 pht003633.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 sdt_alb_2 Study Date, Albuterol +21 Age at enrollment/collection 196596 phv00196596.v2.p10 pht003634.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 sdt_alb_8 Study date, Albuterol Collection Interval: Offspring Exam 8, Omni 1 Exam 3 +21 Age at enrollment/collection 257865 phv00257865.v1.p10 pht005171.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:44:41+00:00 2018-09-27 15:44:41+00:00 sdt_post_9_1 Study date, Albuterol Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +21 Age at enrollment/collection 156625 phv00156625.v3.p10 pht000169.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 u6_7dte Heel ultrasound date +21 Age at enrollment/collection 56631 phv00056631.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 wtcldt20 Date, if weight measured at clinic on other date +21 Age at enrollment/collection 56632 phv00056632.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 waistdt Waist Date +21 Age at enrollment/collection 56633 phv00056633.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 weightdt Weight Date +21 Age at enrollment/collection 56720 phv00056720.v2.p10 pht000396.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 visitdt Date of follow-up visit, Number of days since exam 1 +21 Age at enrollment/collection 65398 phv00065398.v2.p10 pht000610.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 wb22scdt WHOLEBODY SCAN DATE EX22, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 65397 phv00065397.v2.p10 pht000610.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 wb23scdt WHOLEBODY SCAN DATE EX23, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 65451 phv00065451.v4.p10 pht000611.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 wb6_7scdt WHOLEBODY SCAN DATE EX6/7, NUMBER OF DAYS SINCE EXAM 1 +21 Age at enrollment/collection 142459 phv00142459.v1.p10 pht002080.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 xdate10 Date of Baseline X-ray Collection Interval: Exams 10, 14, and 22 +21 Age at enrollment/collection 156751 phv00156751.v3.p10 pht002149.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 wb2scdt Whole body DXA scan date +21 Age at enrollment/collection 162111 phv00162111.v1.p10 pht002349.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 15:46:45+00:00 2018-09-27 15:46:45+00:00 wb2scdt Whole body DXA scan date Collection Interval: Test done at Generation 3 Exam 2 between September 2010 to March 2011 +21 Age at enrollment/collection 98799 phv00098799.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:14:35+00:00 2018-09-27 18:14:35+00:00 AGE01 SELF-REPORTED AGE AT BASELINE +21 Age at enrollment/collection 99568 phv00099568.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:17:17+00:00 2018-09-27 18:17:17+00:00 AGEBL CALCULATED AGE AT BASELINE +21 Age at enrollment/collection 100487 phv00100487.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:17:49+00:00 2018-09-27 18:17:49+00:00 AGEBL CALCULATED AGE AT BASELINE +21 Age at enrollment/collection 102006 phv00102006.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:18:32+00:00 2018-09-27 18:18:32+00:00 AGEY10 Age at visit +21 Age at enrollment/collection 102583 phv00102583.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:18:42+00:00 2018-09-27 18:18:42+00:00 AGEY11 AGE AT YEAR 11 +21 Age at enrollment/collection 104377 phv00104377.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:18:54+00:00 2018-09-27 18:18:54+00:00 AGEY3 CALCULATED AGE AT YR 3 VISIT +21 Age at enrollment/collection 104783 phv00104783.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:19:05+00:00 2018-09-27 18:19:05+00:00 AGEY4 CALCULATED AGE AT YR 4 VISIT +21 Age at enrollment/collection 105116 phv00105116.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:19:23+00:00 2018-09-27 18:19:23+00:00 AGE01 SELF-REPORTED AGE AT BASELINE +21 Age at enrollment/collection 105622 phv00105622.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:19:35+00:00 2018-09-27 18:19:35+00:00 AGEBL CALCULATED AGE AT BASELINE VISIT +21 Age at enrollment/collection 106844 phv00106844.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:19:55+00:00 2018-09-27 18:19:55+00:00 AGEY5 CALCULATED AGE AT YR 5 VISIT +21 Age at enrollment/collection 107780 phv00107780.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:20:08+00:00 2018-09-27 18:20:08+00:00 AGEY6 CALCULATED AGE AT YR 6 VISIT +21 Age at enrollment/collection 108813 phv00108813.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:20:21+00:00 2018-09-27 18:20:21+00:00 AGEY7 CALCULATED AGE AT YR 7 VISIT +21 Age at enrollment/collection 109604 phv00109604.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:20:31+00:00 2018-09-27 18:20:31+00:00 AGEY8 CALCULATED AGE AT YR 8 VISIT +21 Age at enrollment/collection 109855 phv00109855.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:20:44+00:00 2018-09-27 18:20:44+00:00 AGEY9 CALCULATED AGE AT YR 9 VISIT +21 Age at enrollment/collection 276886 phv00276886.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:36:21+00:00 2018-10-10 17:36:21+00:00 CHF011d Date of hospital admit +21 Age at enrollment/collection 276887 phv00276887.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:37:05+00:00 2018-10-10 17:37:05+00:00 CHF015d Date of HF onset, if different +21 Age at enrollment/collection 276846 phv00276846.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:37:25+00:00 2018-10-10 17:37:25+00:00 CHF031 Vital Signs - date same as onset +21 Age at enrollment/collection 276888 phv00276888.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:37:54+00:00 2018-10-10 17:37:54+00:00 CHF034d Date of Vital Signs - If no +21 Age at enrollment/collection 276852 phv00276852.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:38:12+00:00 2018-10-10 17:38:12+00:00 CHF040 Hematologic labs date same as onset +21 Age at enrollment/collection 276894 phv00276894.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:38:41+00:00 2018-10-10 17:38:41+00:00 CHF043 Lab tests - if no, enter date +21 Age at enrollment/collection 276857 phv00276857.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:38:59+00:00 2018-10-10 17:38:59+00:00 CHF048 Chemistry labs date same as onset +21 Age at enrollment/collection 276889 phv00276889.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:39:22+00:00 2018-10-10 17:39:22+00:00 CHF051d Date of Chem labs - if no +21 Age at enrollment/collection 276863 phv00276863.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:39:42+00:00 2018-10-10 17:39:42+00:00 CHF057 Albumin - Protein Labs date same as onset +21 Age at enrollment/collection 276895 phv00276895.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:40:00+00:00 2018-10-10 17:40:00+00:00 CHF060 Albumin labs - if no, enter date +21 Age at enrollment/collection 276866 phv00276866.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:40:29+00:00 2018-10-10 17:40:29+00:00 CHF063 Cardiac marker date same as onset +21 Age at enrollment/collection 276890 phv00276890.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:40:47+00:00 2018-10-10 17:40:47+00:00 CHF066d Date of Cardiac marker - if no +21 Age at enrollment/collection 276816 phv00276816.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:41:18+00:00 2018-10-10 17:41:18+00:00 CHF087 ECG date same as onset +21 Age at enrollment/collection 276891 phv00276891.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:41:42+00:00 2018-10-10 17:41:42+00:00 CHF090d Date of ECG - if no +21 Age at enrollment/collection 252987 phv00252987.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-12-20 00:35:04+00:00 2018-12-20 00:35:04+00:00 cac_score_age Age when CAC score was obtained +22 Gender 226279 phv00226279.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:56:47+00:00 2018-03-14 21:56:47+00:00 GENDER Gender (F=Female, M=Male) +22 Gender 204634 phv00204634.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:59:11+00:00 2018-03-15 14:59:11+00:00 GENDER Sex (from FTRA22) [Cohort, Exam 2] +22 Gender 204711 phv00204711.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 14:59:38+00:00 2018-03-15 14:59:38+00:00 GENDER Sex (uncorrected from FTRA22) [Cohort, Exam 1] +22 Gender 204963 phv00204963.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:00:06+00:00 2018-03-15 15:00:06+00:00 GENDER Sex (From FTRA22) [Cohort, Exam 4] +22 Gender 112420 phv00112420.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:54:41+00:00 2018-04-17 16:54:41+00:00 A01SEX EXAM 1 SEX, TELEPHONE INTERVIEW +22 Gender 113152 phv00113152.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:54:41+00:00 2018-04-17 16:54:41+00:00 SEX SEX (VERIFIED AT EXAM 2) +22 Gender 113716 phv00113716.v2.p2 pht001589.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:54:41+00:00 2018-04-17 16:54:41+00:00 SEX SEX (VERIFIED AT EXAM 2) +22 Gender 115114 phv00115114.v2.p2 pht001645.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:54:41+00:00 2018-04-17 16:54:41+00:00 SEX SEX (VERIFIED AT EXAM 2) +22 Gender 116380 phv00116380.v2.p2 pht001697.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:54:41+00:00 2018-04-17 16:54:41+00:00 SEX SEX (VERIFIED AT EXAM 2) +22 Gender 114611 phv00114611.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-18 15:10:00+00:00 2018-04-18 15:10:00+00:00 B12SEX SEX OF SUBJECT +22 Gender 116485 phv00116485.v2.p2 pht001706.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-18 15:14:15+00:00 2018-04-18 15:14:15+00:00 DDXPTSEX PATIENT DATA: SEX +22 Gender 117581 phv00117581.v2.p2 pht001744.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-18 15:20:52+00:00 2018-04-18 15:20:52+00:00 SEX SEX (VERIFIED AT EXAM 2) +22 Gender 119473 phv00119473.v2.p2 pht001795.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-18 15:21:48+00:00 2018-04-18 15:21:48+00:00 E53SEX SEX - FORM 53 +22 Gender 119633 phv00119633.v2.p2 pht001804.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-18 15:22:00+00:00 2018-04-18 15:22:00+00:00 SEX SEX (VERIFIED AT PPTS LAST EXAM) +22 Gender 120741 phv00120741.v2.p2 pht001851.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-18 15:22:12+00:00 2018-04-18 15:22:12+00:00 SEX SEX (VERIFIED AT PPTS LAST EXAM) +22 Gender 82643 phv00082643.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:59:57+00:00 2018-04-23 02:59:57+00:00 gender1 GENDER +22 Gender 84446 phv00084446.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:00:09+00:00 2018-04-23 03:00:09+00:00 gender1 GENDER +22 Gender 85782 phv00085782.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:00:15+00:00 2018-04-23 03:00:15+00:00 gender1 GENDER +22 Gender 86268 phv00086268.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:00:22+00:00 2018-04-23 03:00:22+00:00 gender1 GENDER +22 Gender 86736 phv00086736.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:00:28+00:00 2018-04-23 03:00:28+00:00 gender1 GENDER +22 Gender 87073 phv00087073.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:00:35+00:00 2018-04-23 03:00:35+00:00 genderf GENDER +22 Gender 174586 phv00174586.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:00:41+00:00 2018-04-23 03:00:41+00:00 gender1 GENDER +22 Gender 175856 phv00175856.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:00:46+00:00 2018-04-23 03:00:46+00:00 gender1 GENDER +22 Gender 175877 phv00175877.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:00:52+00:00 2018-04-23 03:00:52+00:00 gender GENDER +22 Gender 175940 phv00175940.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:01:00+00:00 2018-04-23 03:01:00+00:00 genderf FAMILY COHORT: GENDER +22 Gender 176009 phv00176009.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:01:06+00:00 2018-04-23 03:01:06+00:00 gender1 GENDER +22 Gender 219022 phv00219022.v1.p3 pht004326.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:01:13+00:00 2018-04-23 03:01:13+00:00 gender1 GENDER +22 Gender 207078 phv00207078.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:33:35+00:00 2018-04-25 20:33:35+00:00 HHXB10 [Reproductive history]. Sex of participant. Q10 [Health/Medical History, exam 2] +22 Gender 208795 phv00208795.v1.p1 pht004142.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 20:34:01+00:00 2018-04-25 20:34:01+00:00 PFTA02 Sex (M, F) [Pulmonary Function Test, exam 1] +22 Gender 127524 phv00127524.v1.p1 pht001956.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 19:50:11+00:00 2018-04-26 19:50:11+00:00 ELGA4 4: Participant's gender +22 Gender 126012 phv00126012.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 19:50:51+00:00 2018-04-26 19:50:51+00:00 GENDER Gender of participant +22 Gender 125811 phv00125811.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 19:55:53+00:00 2018-04-26 19:55:53+00:00 AFUK18 GENDER OF PARTICIPANT (M,F) Q18 +22 Gender 125724 phv00125724.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 19:57:32+00:00 2018-04-26 19:57:32+00:00 AFUJ18 GENDER OF PARTICIPANT (M,F) Q18 +22 Gender 125635 phv00125635.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 19:58:26+00:00 2018-04-26 19:58:26+00:00 AFUI18 GENDER OF PARTICIPANT (M,F) Q18 +22 Gender 125546 phv00125546.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 19:58:46+00:00 2018-04-26 19:58:46+00:00 AFUI18 GENDER OF PARTICIPANT (M,F) Q18 +22 Gender 125034 phv00125034.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 20:01:36+00:00 2018-04-26 20:01:36+00:00 AFUA18 18. Is the participant male or female? +22 Gender 125119 phv00125119.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 20:01:54+00:00 2018-04-26 20:01:54+00:00 AFUA18 18. Is the participant male or female? +22 Gender 125205 phv00125205.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 20:02:16+00:00 2018-04-26 20:02:16+00:00 AFUB18 18. Is the participant male or female? +22 Gender 125291 phv00125291.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-26 20:02:31+00:00 2018-04-26 20:02:31+00:00 AFUB18 18. Is the participant male or female? +22 Gender 98797 phv00098797.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:03:18+00:00 2018-05-03 18:03:18+00:00 GEND01 GENDER +22 Gender 100302 phv00100302.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:04:06+00:00 2018-05-03 18:04:06+00:00 GEND01 GENDER +22 Gender 100810 phv00100810.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:04:25+00:00 2018-05-03 18:04:25+00:00 GEND01 GENDER +22 Gender 101950 phv00101950.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:04:39+00:00 2018-05-03 18:04:39+00:00 GEND01 GENDER +22 Gender 105644 phv00105644.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:04:56+00:00 2018-05-03 18:04:56+00:00 GEND01 GENDER +22 Gender 106545 phv00106545.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:05:10+00:00 2018-05-03 18:05:10+00:00 GEND01 GENDER +22 Gender 108393 phv00108393.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:05:24+00:00 2018-05-03 18:05:24+00:00 GEND01 GENDER +22 Gender 109144 phv00109144.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:06:02+00:00 2018-05-03 18:06:02+00:00 GEND01 GENDER +22 Gender 109854 phv00109854.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:06:21+00:00 2018-05-03 18:06:21+00:00 GEND01 GENDER +22 Gender 197400 phv00197400.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:06:36+00:00 2018-05-03 18:06:36+00:00 gender Gender +22 Gender 177929 phv00177929.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 11:57:21+00:00 2018-05-09 11:57:21+00:00 sex Participant gender +22 Gender 21228 phv00021228.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 11:58:46+00:00 2018-05-09 11:58:46+00:00 G3A440 SEX OF PARTICIPANT +22 Gender 253990 phv00253990.v1.p10 pht004374.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 11:59:45+00:00 2018-05-09 11:59:45+00:00 SEX Participant sex +22 Gender 277017 phv00277017.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:00:17+00:00 2018-05-09 12:00:17+00:00 SEX Sex of participant +22 Gender 277067 phv00277067.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-09 12:00:46+00:00 2018-05-09 12:00:46+00:00 SEX Sex of participant +22 Gender 159571 phv00159571.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:36:53+00:00 2018-08-10 21:36:53+00:00 gender Gender Collection Interval: Collected in Exam 1 +22 Gender 277506 phv00277506.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:40:51+00:00 2018-08-14 22:40:51+00:00 GENDER Participants gender Collection Interval: 1996-2000 +22 Gender 307787 phv00307787.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:55:06+00:00 2018-08-15 23:55:06+00:00 GENDER Participants gender Collection Interval: 1996-2000 +22 Gender 115706 phv00115706.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:29:06+00:00 2018-08-23 17:29:06+00:00 C12SEX C12SEX +22 Gender 253224 phv00253224.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:37:01+00:00 2018-08-24 16:37:01+00:00 GENDERNUM Gender (0=Female, 1=Male) +22 Gender 252975 phv00252975.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:11:10+00:00 2018-08-24 17:11:10+00:00 SEX Sex of participant +22 Gender 118961 phv00118961.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:36:39+00:00 2018-08-28 23:36:39+00:00 E12SEX SEX - SPIROMETER +22 Gender 202103 phv00202103.v2.p1 pht003918.v2.p1 phs000741.v2.p1 GOLDN 741 2 2018-09-06 12:07:24+00:00 2018-09-06 12:07:24+00:00 sex Gender of participant +22 Gender 258679 phv00258679.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:21:53+00:00 2018-09-06 12:21:53+00:00 Gender Gender of participant +22 Gender 258649 phv00258649.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:10:34+00:00 2018-09-06 13:10:34+00:00 gender Gender of participant +22 Gender 259379 phv00259379.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:18:50+00:00 2018-09-06 13:18:50+00:00 sex Sex +22 Gender 121845 phv00121845.v1.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 13:25:47+00:00 2018-09-07 13:25:47+00:00 gender Gender +23 Race/ancestry/ethnicity 204633 phv00204633.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:14:48+00:00 2018-03-15 15:14:48+00:00 RACEGRP Race (from FTRA23) [Cohort, Exam 2] +23 Race/ancestry/ethnicity 204710 phv00204710.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:15:25+00:00 2018-03-15 15:15:25+00:00 RACEGRP Race (from FTRA23) [Cohort, Exam 1] +23 Race/ancestry/ethnicity 204962 phv00204962.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:15:50+00:00 2018-03-15 15:15:50+00:00 RACEGRP Race (from FTRA23) [Cohort, Exam 4] +23 Race/ancestry/ethnicity 214052 phv00214052.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:16:14+00:00 2018-03-15 15:16:14+00:00 RACE Race +23 Race/ancestry/ethnicity 112422 phv00112422.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:55:42+00:00 2018-04-17 16:55:42+00:00 A01RACE1 EXAM 1 RACE, TELEPHONE INTERVIEW +23 Race/ancestry/ethnicity 112440 phv00112440.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:55:42+00:00 2018-04-17 16:55:42+00:00 A01RACE2 RACE VERIFY +23 Race/ancestry/ethnicity 113715 phv00113715.v2.p2 pht001589.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:56:08+00:00 2018-04-17 16:56:08+00:00 RACE RACE (VERIFIED AY EXAM 2) +23 Race/ancestry/ethnicity 115113 phv00115113.v2.p2 pht001645.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 16:56:08+00:00 2018-04-17 16:56:08+00:00 RACE RACE (VERIFIED AT EXAM 2) +23 Race/ancestry/ethnicity 114607 phv00114607.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:29:04+00:00 2018-04-19 19:29:04+00:00 B12RACE RACE CODE +23 Race/ancestry/ethnicity 116379 phv00116379.v2.p2 pht001697.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:29:21+00:00 2018-04-19 19:29:21+00:00 RACE RACE (VERIFIED AY EXAM 2) +23 Race/ancestry/ethnicity 117580 phv00117580.v2.p2 pht001744.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:30:05+00:00 2018-04-19 19:30:05+00:00 RACE RACE (VERIFIED AY EXAM 2) +23 Race/ancestry/ethnicity 119632 phv00119632.v2.p2 pht001804.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:30:31+00:00 2018-04-19 19:30:31+00:00 RACE RACE (VERIFIED AT PPTS LAST EXAM) +23 Race/ancestry/ethnicity 120740 phv00120740.v2.p2 pht001851.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-19 19:30:49+00:00 2018-04-19 19:30:49+00:00 RACE RACE (VERIFIED AT PPTS LAST EXAM) +23 Race/ancestry/ethnicity 219021 phv00219021.v1.p3 pht004326.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:51:24+00:00 2018-04-23 02:51:24+00:00 race1c RACE +23 Race/ancestry/ethnicity 176008 phv00176008.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:51:32+00:00 2018-04-23 02:51:32+00:00 race1c RACE / ETHNICITY +23 Race/ancestry/ethnicity 175967 phv00175967.v1.p3 pht003088.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:51:40+00:00 2018-04-23 02:51:40+00:00 racegrp RACE GROUP +23 Race/ancestry/ethnicity 175941 phv00175941.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:51:54+00:00 2018-04-23 02:51:54+00:00 racefc FAMILY COHORT: RACE AND ETHNICITY +23 Race/ancestry/ethnicity 175876 phv00175876.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:52:05+00:00 2018-04-23 02:52:05+00:00 race RACE +23 Race/ancestry/ethnicity 175855 phv00175855.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:52:22+00:00 2018-04-23 02:52:22+00:00 race1c RACE +23 Race/ancestry/ethnicity 174585 phv00174585.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:52:35+00:00 2018-04-23 02:52:35+00:00 race1c RACE / ETHNICITY +23 Race/ancestry/ethnicity 87074 phv00087074.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:52:46+00:00 2018-04-23 02:52:46+00:00 racefc RACE AND ETHNICITY +23 Race/ancestry/ethnicity 86729 phv00086729.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:52:55+00:00 2018-04-23 02:52:55+00:00 race1c RACE / ETHNICITY +23 Race/ancestry/ethnicity 86261 phv00086261.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:53:06+00:00 2018-04-23 02:53:06+00:00 race1c RACE / ETHNICITY +23 Race/ancestry/ethnicity 85775 phv00085775.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:53:14+00:00 2018-04-23 02:53:14+00:00 race1c RACE / ETHNICITY +23 Race/ancestry/ethnicity 84444 phv00084444.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:53:22+00:00 2018-04-23 02:53:22+00:00 race1c RACE / ETHNICITY +23 Race/ancestry/ethnicity 82641 phv00082641.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:53:29+00:00 2018-04-23 02:53:29+00:00 race1c RACE +23 Race/ancestry/ethnicity 87659 phv00087659.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:54:29+00:00 2018-04-23 02:54:29+00:00 scrhispf SPANISH/HISPANIC/LATINO +23 Race/ancestry/ethnicity 86734 phv00086734.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:54:35+00:00 2018-04-23 02:54:35+00:00 othhisp1 OTHER HISPANIC +23 Race/ancestry/ethnicity 86266 phv00086266.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:54:46+00:00 2018-04-23 02:54:46+00:00 othhisp1 OTHER HISPANIC +23 Race/ancestry/ethnicity 85780 phv00085780.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:54:53+00:00 2018-04-23 02:54:53+00:00 othhisp1 OTHER HISPANIC +23 Race/ancestry/ethnicity 85776 phv00085776.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:55:56+00:00 2018-04-23 02:55:56+00:00 mexican1 MEXICAN, CHICANO, MEXICAN-AMERICAN +23 Race/ancestry/ethnicity 86262 phv00086262.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:56:08+00:00 2018-04-23 02:56:08+00:00 mexican1 MEXICAN, CHICANO, MEXICAN-AMERICAN +23 Race/ancestry/ethnicity 86730 phv00086730.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:56:16+00:00 2018-04-23 02:56:16+00:00 mexican1 MEXICAN, CHICANO, MEXICAN-AMERICAN +23 Race/ancestry/ethnicity 85777 phv00085777.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:57:04+00:00 2018-04-23 02:57:04+00:00 dominic1 DOMINICAN +23 Race/ancestry/ethnicity 86263 phv00086263.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:57:10+00:00 2018-04-23 02:57:10+00:00 dominic1 DOMINICAN +23 Race/ancestry/ethnicity 86731 phv00086731.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:57:18+00:00 2018-04-23 02:57:18+00:00 dominic1 DOMINICAN +23 Race/ancestry/ethnicity 85778 phv00085778.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:57:48+00:00 2018-04-23 02:57:48+00:00 puert1 PUERTO RICAN +23 Race/ancestry/ethnicity 86264 phv00086264.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:57:53+00:00 2018-04-23 02:57:53+00:00 puert1 PUERTO RICAN +23 Race/ancestry/ethnicity 86732 phv00086732.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:58:00+00:00 2018-04-23 02:58:00+00:00 puert1 PUERTO RICAN +23 Race/ancestry/ethnicity 85779 phv00085779.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:58:30+00:00 2018-04-23 02:58:30+00:00 cuban1 CUBAN +23 Race/ancestry/ethnicity 86265 phv00086265.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:58:38+00:00 2018-04-23 02:58:38+00:00 cuban1 CUBAN +23 Race/ancestry/ethnicity 86733 phv00086733.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 02:58:44+00:00 2018-04-23 02:58:44+00:00 cuban1 CUBAN +23 Race/ancestry/ethnicity 99569 phv00099569.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:12:02+00:00 2018-05-03 18:12:02+00:00 RACE01 RACE +23 Race/ancestry/ethnicity 100488 phv00100488.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:12:15+00:00 2018-05-03 18:12:15+00:00 RACE01 RACE +23 Race/ancestry/ethnicity 100837 phv00100837.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:12:25+00:00 2018-05-03 18:12:25+00:00 RACE01 RACE +23 Race/ancestry/ethnicity 105645 phv00105645.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:12:38+00:00 2018-05-03 18:12:38+00:00 RACE01 RACE +23 Race/ancestry/ethnicity 99434 phv00099434.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:13:32+00:00 2018-05-03 18:13:32+00:00 HISP01 HISPANIC ORIGIN +23 Race/ancestry/ethnicity 105652 phv00105652.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:13:45+00:00 2018-05-03 18:13:45+00:00 HISP01 HISPANIC ORIGIN +23 Race/ancestry/ethnicity 98800 phv00098800.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:14:07+00:00 2018-05-03 18:14:07+00:00 ROTHER01 SPECIFY OTHER RACE +23 Race/ancestry/ethnicity 105117 phv00105117.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-05-03 18:14:20+00:00 2018-05-03 18:14:20+00:00 ROTHER01 SPECIFY OTHER RACE +23 Race/ancestry/ethnicity 72539 phv00072539.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:07:05+00:00 2018-05-11 18:07:05+00:00 H701 WHICH OF THE FOLLOWING BEST DESCRIBES YOU - ETHNICITY NOT HISPANIC OR LATINO +23 Race/ancestry/ethnicity 55250 phv00055250.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:07:48+00:00 2018-05-11 18:07:48+00:00 race Race +23 Race/ancestry/ethnicity 177598 phv00177598.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:09:19+00:00 2018-05-11 18:09:19+00:00 g3b0625 Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): Caucasian or White +23 Race/ancestry/ethnicity 177599 phv00177599.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:09:35+00:00 2018-05-11 18:09:35+00:00 g3b0626 Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): African-American or Black +23 Race/ancestry/ethnicity 177600 phv00177600.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:09:52+00:00 2018-05-11 18:09:52+00:00 g3b0627 Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): Asian +23 Race/ancestry/ethnicity 177601 phv00177601.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:10:17+00:00 2018-05-11 18:10:17+00:00 g3b0628 Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): Native Hawaiian or other Pacific Islander +23 Race/ancestry/ethnicity 177602 phv00177602.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:10:36+00:00 2018-05-11 18:10:36+00:00 g3b0629 Sociodemographic questions-Self administered: Which of the following best describes your race (check ALL that apply): American Indian or Alaska native +23 Race/ancestry/ethnicity 72530 phv00072530.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:10:56+00:00 2018-05-11 18:10:56+00:00 H702 WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE CAUCASIAN OR WHITE +23 Race/ancestry/ethnicity 251748 phv00251748.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:11:20+00:00 2018-05-11 18:11:20+00:00 h702 Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): Caucasian or white Collection Interval: Exam 3 +23 Race/ancestry/ethnicity 72531 phv00072531.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:11:46+00:00 2018-05-11 18:11:46+00:00 H703 WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE AFRICAN AMERICAN OR BLACK +23 Race/ancestry/ethnicity 251749 phv00251749.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:12:01+00:00 2018-05-11 18:12:01+00:00 h703 Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): African-American or black Collection Interval: Exam 3 +23 Race/ancestry/ethnicity 72532 phv00072532.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:12:52+00:00 2018-05-11 18:12:52+00:00 H704 WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE ASIAN +23 Race/ancestry/ethnicity 251750 phv00251750.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:13:06+00:00 2018-05-11 18:13:06+00:00 h704 Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): Asian Collection Interval: Exam 3 +23 Race/ancestry/ethnicity 72533 phv00072533.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:13:26+00:00 2018-05-11 18:13:26+00:00 H705 WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER +23 Race/ancestry/ethnicity 251751 phv00251751.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:13:44+00:00 2018-05-11 18:13:44+00:00 h705 Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): Native Hawaiian or other Pacific Islander Collection Interval: Exam 3 +23 Race/ancestry/ethnicity 72534 phv00072534.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:14:08+00:00 2018-05-11 18:14:08+00:00 H706 WHICH OF THE FOLLOWING BEST DESCRIBES YOU - RACE AMERICAN INDIAN OR ALASKA NATIVE +23 Race/ancestry/ethnicity 72538 phv00072538.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:15:45+00:00 2018-05-11 18:15:45+00:00 H700 WHICH OF THE FOLLOWING BEST DESCRIBES YOU - ETHNICITY HISPANIC OR LATINO +23 Race/ancestry/ethnicity 177597 phv00177597.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:16:39+00:00 2018-05-11 18:16:39+00:00 g3b0624 Sociodemographic questions-Self administered: Which of the following best describes your ethnicity (check ONE)? +23 Race/ancestry/ethnicity 251746 phv00251746.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:19:48+00:00 2018-05-11 18:19:48+00:00 h700 Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your ethnicity (check which applies): Hispanic or Latino Collection Interval: Exam 3 +23 Race/ancestry/ethnicity 251747 phv00251747.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:20:11+00:00 2018-05-11 18:20:11+00:00 h701 Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your ethnicity (check which applies): Not Hispanic or Latino Collection Interval: Exam 3 +23 Race/ancestry/ethnicity 21244 phv00021244.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:26:44+00:00 2018-05-11 18:26:44+00:00 G3A483 WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): CAUCASIAN OR WHITE +23 Race/ancestry/ethnicity 21245 phv00021245.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:27:23+00:00 2018-05-11 18:27:23+00:00 G3A484 WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): SPANISH/HISPANIC/LATINO +23 Race/ancestry/ethnicity 21246 phv00021246.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:27:42+00:00 2018-05-11 18:27:42+00:00 G3A485 WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): AFRICAN-AMERICAN OR BLACK +23 Race/ancestry/ethnicity 21247 phv00021247.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:28:13+00:00 2018-05-11 18:28:13+00:00 G3A486 WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): ASIAN +23 Race/ancestry/ethnicity 21248 phv00021248.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:28:34+00:00 2018-05-11 18:28:34+00:00 G3A487 WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER +23 Race/ancestry/ethnicity 21249 phv00021249.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:29:06+00:00 2018-05-11 18:29:06+00:00 G3A488 WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): AMERICAN INDIAN OR ALASKA NATIVE +23 Race/ancestry/ethnicity 21250 phv00021250.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:29:33+00:00 2018-05-11 18:29:33+00:00 G3A489 WHICH OF THE FOLLOWING BEST DESCRIBES YOU? (CHECK ALL THAT APPLY): OTHER +23 Race/ancestry/ethnicity 274066 phv00274066.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:33:11+00:00 2018-05-11 18:33:11+00:00 g3a483 Which of the following best describe you? (check all that apply): Caucasian or white Collection Interval: Exam 1 +23 Race/ancestry/ethnicity 274067 phv00274067.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:33:30+00:00 2018-05-11 18:33:30+00:00 g3a484 Which of the following best describe you? (check all that apply): Spanish/Hispanic/Latino Collection Interval: Exam 1 +23 Race/ancestry/ethnicity 274068 phv00274068.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:33:44+00:00 2018-05-11 18:33:44+00:00 g3a485 Which of the following best describe you? (check all that apply): African-american or black Collection Interval: Exam 1 +23 Race/ancestry/ethnicity 274069 phv00274069.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:34:17+00:00 2018-05-11 18:34:17+00:00 g3a486 Which of the following best describe you? (check all that apply): Asian Collection Interval: Exam 1 +23 Race/ancestry/ethnicity 274070 phv00274070.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:34:35+00:00 2018-05-11 18:34:35+00:00 g3a487 Which of the following best describe you? (check all that apply): Native Hawaiian or other Pacific Islander Collection Interval: Exam 1 +23 Race/ancestry/ethnicity 274071 phv00274071.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:35:02+00:00 2018-05-11 18:35:02+00:00 g3a488 Which of the following best describe you? (check all that apply): American Indian or Alaska native Collection Interval: Exam 1 +23 Race/ancestry/ethnicity 274072 phv00274072.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:35:30+00:00 2018-05-11 18:35:30+00:00 g3a489 Which of the following best describe you? (check all that apply): Other Collection Interval: Exam 1 +23 Race/ancestry/ethnicity 274557 phv00274557.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:37:05+00:00 2018-05-11 18:37:05+00:00 g3a483 Which of the following best describe you? (check all that apply): Caucasian or white +23 Race/ancestry/ethnicity 274558 phv00274558.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:37:20+00:00 2018-05-11 18:37:20+00:00 g3a484 Which of the following best describe you? (check all that apply): Spanish/Hispanic/Latino +23 Race/ancestry/ethnicity 274559 phv00274559.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:37:34+00:00 2018-05-11 18:37:34+00:00 g3a485 Which of the following best describe you? (check all that apply): African-american or black +23 Race/ancestry/ethnicity 274560 phv00274560.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:37:47+00:00 2018-05-11 18:37:47+00:00 g3a486 Which of the following best describe you? (check all that apply): Asian +23 Race/ancestry/ethnicity 274561 phv00274561.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:38:04+00:00 2018-05-11 18:38:04+00:00 g3a487 Which of the following best describe you? (check all that apply): Native Hawaiian or other Pacific Islander +23 Race/ancestry/ethnicity 274562 phv00274562.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:38:19+00:00 2018-05-11 18:38:19+00:00 g3a488 Which of the following best describe you? (check all that apply): American Indian or Alaska native +23 Race/ancestry/ethnicity 274563 phv00274563.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:38:39+00:00 2018-05-11 18:38:39+00:00 g3a489 Which of the following best describe you? (check all that apply): Other +23 Race/ancestry/ethnicity 251752 phv00251752.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-11 18:51:50+00:00 2018-05-11 18:51:50+00:00 h706 Sociodemographic Questions - Part I - Self-administered: Which of the following best describes your race (check ALL that apply): American Indian or Alaska native Collection Interval: Exam 3 +23 Race/ancestry/ethnicity 79316 phv00079316.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 SPANISH Are you Spanish/Hispanic/Latino +23 Race/ancestry/ethnicity 79317 phv00079317.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 WHITE White +23 Race/ancestry/ethnicity 79318 phv00079318.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 BLACK Black, African-American, or Negro +23 Race/ancestry/ethnicity 79319 phv00079319.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 AMERINDIAN American Indian or Alaskan Native +23 Race/ancestry/ethnicity 79320 phv00079320.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 ASIAINDIAN Asian Indian +23 Race/ancestry/ethnicity 79321 phv00079321.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 CHINESE Chinese +23 Race/ancestry/ethnicity 79322 phv00079322.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 FILIPINO Filipino +23 Race/ancestry/ethnicity 79323 phv00079323.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 JAPANESE Japanese +23 Race/ancestry/ethnicity 79324 phv00079324.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 KOREAN Korean +23 Race/ancestry/ethnicity 79325 phv00079325.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 VIETNAMESE Vietnamese +23 Race/ancestry/ethnicity 79326 phv00079326.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 OTHERASIAN Other Asian +23 Race/ancestry/ethnicity 79327 phv00079327.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 HAWAIIAN Native Hawaiian +23 Race/ancestry/ethnicity 79328 phv00079328.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 GUAMANIAN Guamanian or Chamorro +23 Race/ancestry/ethnicity 79329 phv00079329.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 SAMOAN Samoan +23 Race/ancestry/ethnicity 79330 phv00079330.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 OTHRPACISL Other Pacific Islander +23 Race/ancestry/ethnicity 79331 phv00079331.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:01:58+00:00 2018-05-15 17:01:58+00:00 OTHERRACE Some other race +23 Race/ancestry/ethnicity 78450 phv00078450.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-05-15 17:03:49+00:00 2018-05-15 17:03:49+00:00 RACE Racial or ethnic group +23 Race/ancestry/ethnicity 159572 phv00159572.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:53:37+00:00 2018-08-10 21:53:37+00:00 race Race Collection Interval: Collected in Exam 1 +23 Race/ancestry/ethnicity 159573 phv00159573.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:53:47+00:00 2018-08-10 21:53:47+00:00 ethnic Your ethnic background Collection Interval: Collected in Exam 1 +23 Race/ancestry/ethnicity 277509 phv00277509.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:40:28+00:00 2018-08-14 22:40:28+00:00 RACE Self-reported race/ethnicity Collection Interval: 1996-2000 +23 Race/ancestry/ethnicity 307790 phv00307790.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:54:41+00:00 2018-08-15 23:54:41+00:00 RACE Self-reported race/ethnicity Collection Interval: 1996-2000 +23 Race/ancestry/ethnicity 122968 phv00122968.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:06:38+00:00 2018-08-17 00:06:38+00:00 AMINDIAN Race - Native American (0=no,1=yes) +23 Race/ancestry/ethnicity 122969 phv00122969.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:06:43+00:00 2018-08-17 00:06:43+00:00 ASIAN Race - Asian (0=no,1=yes) +23 Race/ancestry/ethnicity 122970 phv00122970.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:06:49+00:00 2018-08-17 00:06:49+00:00 BLACK Race - Black (0=no,1=yes) +23 Race/ancestry/ethnicity 122971 phv00122971.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:06:54+00:00 2018-08-17 00:06:54+00:00 HAWAIIP Race - Hawaiian or Pacific Islander (0=no,1=yes) +23 Race/ancestry/ethnicity 122972 phv00122972.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:07:00+00:00 2018-08-17 00:07:00+00:00 WHITE Race - Caucasian (0=no,1=yes) +23 Race/ancestry/ethnicity 122991 phv00122991.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:51:18+00:00 2018-08-17 19:51:18+00:00 race Subject's Race +23 Race/ancestry/ethnicity 122992 phv00122992.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:51:31+00:00 2018-08-17 19:51:31+00:00 ethnicity Subject's Ethnicity +23 Race/ancestry/ethnicity 122993 phv00122993.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:51:41+00:00 2018-08-17 19:51:41+00:00 othrace Subject's Race description +23 Race/ancestry/ethnicity 226254 phv00226254.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:10:11+00:00 2018-08-22 21:10:11+00:00 BKGRD1_C7 7-level re-classification of Hispanic/Latino background +23 Race/ancestry/ethnicity 116486 phv00116486.v2.p2 pht001706.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 21:33:48+00:00 2018-08-23 21:33:48+00:00 DDXPTETH PATIENT DATA: ETHNIC +23 Race/ancestry/ethnicity 253242 phv00253242.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:54:34+00:00 2018-08-24 16:54:34+00:00 REGION "6-Groups for Hispanic/Latino background, plus 1 ""unknown"" group for missing or other" +23 Race/ancestry/ethnicity 258651 phv00258651.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:11:27+00:00 2018-09-06 13:11:27+00:00 race Race of participant +23 Race/ancestry/ethnicity 259380 phv00259380.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:19:08+00:00 2018-09-06 13:19:08+00:00 race Race +23 Race/ancestry/ethnicity 259381 phv00259381.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:19:17+00:00 2018-09-06 13:19:17+00:00 ethnicity Ethnicity +23 Race/ancestry/ethnicity 121875 phv00121875.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:57:35+00:00 2018-09-07 15:57:35+00:00 Hispanic Hispanic or Latino +23 Race/ancestry/ethnicity 121876 phv00121876.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:58:35+00:00 2018-09-07 15:58:35+00:00 race_afram Race - black or african american +23 Race/ancestry/ethnicity 121877 phv00121877.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:59:14+00:00 2018-09-07 15:59:14+00:00 race_amind Race - american indian/alaska native +23 Race/ancestry/ethnicity 121878 phv00121878.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:59:27+00:00 2018-09-07 15:59:27+00:00 race_asian Race - asian +23 Race/ancestry/ethnicity 121879 phv00121879.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:59:37+00:00 2018-09-07 15:59:37+00:00 race_other Race - other +23 Race/ancestry/ethnicity 121880 phv00121880.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:59:55+00:00 2018-09-07 15:59:55+00:00 race_pacisl Race - native hawaiian or other pacific islander +23 Race/ancestry/ethnicity 121881 phv00121881.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 16:00:04+00:00 2018-09-07 16:00:04+00:00 race_white Race - white +24 CAC 82657 phv00082657.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:28:26+00:00 2018-04-23 03:28:26+00:00 agatum1c MEAN: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 82660 phv00082660.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:28:47+00:00 2018-04-23 03:28:47+00:00 agatpm1c MEAN: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 82661 phv00082661.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:28:55+00:00 2018-04-23 03:28:55+00:00 agatpm1t NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E1 +24 CAC 82856 phv00082856.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:01+00:00 2018-04-23 03:29:01+00:00 agatu11c SCAN 1: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 82857 phv00082857.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:06+00:00 2018-04-23 03:29:06+00:00 agatu21c SCAN 2: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 82862 phv00082862.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:12+00:00 2018-04-23 03:29:12+00:00 agatp11c SCAN 1: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 82863 phv00082863.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:19+00:00 2018-04-23 03:29:19+00:00 agatp21c SCAN 2: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 84517 phv00084517.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:24+00:00 2018-04-23 03:29:24+00:00 agatum1c MEAN: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 84521 phv00084521.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:30+00:00 2018-04-23 03:29:30+00:00 agatpm1c MEAN: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 84522 phv00084522.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:35+00:00 2018-04-23 03:29:35+00:00 agatpm1t NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E1 +24 CAC 84526 phv00084526.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:40+00:00 2018-04-23 03:29:40+00:00 agatu11c SCAN 1: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 84530 phv00084530.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:45+00:00 2018-04-23 03:29:45+00:00 agatp11c SCAN 1: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 84534 phv00084534.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:51+00:00 2018-04-23 03:29:51+00:00 agatu21c SCAN 2: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 84538 phv00084538.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:29:57+00:00 2018-04-23 03:29:57+00:00 agatp21c SCAN 2: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 85810 phv00085810.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:02+00:00 2018-04-23 03:30:02+00:00 AGATUM2C MEAN TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 85813 phv00085813.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:08+00:00 2018-04-23 03:30:08+00:00 AGATPM2C MEAN TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 85814 phv00085814.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:15+00:00 2018-04-23 03:30:15+00:00 agatpm2t NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E2 +24 CAC 85819 phv00085819.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:20+00:00 2018-04-23 03:30:20+00:00 AGATU12C SCAN 1: TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 85820 phv00085820.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:25+00:00 2018-04-23 03:30:25+00:00 AGATU22C SCAN 2: TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 85825 phv00085825.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:31+00:00 2018-04-23 03:30:31+00:00 AGATP12C SCAN 1: TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 85826 phv00085826.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:35+00:00 2018-04-23 03:30:35+00:00 AGATP22C SCAN 2: TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 86310 phv00086310.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:41+00:00 2018-04-23 03:30:41+00:00 AGATUM3C MEAN TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 86313 phv00086313.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:46+00:00 2018-04-23 03:30:46+00:00 AGATPM3C MEAN TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 86314 phv00086314.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:51+00:00 2018-04-23 03:30:51+00:00 agatpm3t NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E3 +24 CAC 86318 phv00086318.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:30:56+00:00 2018-04-23 03:30:56+00:00 AGATU13C SCAN 1: TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 86319 phv00086319.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:31:58+00:00 2018-04-23 03:31:58+00:00 AGATU23C SCAN 2: TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 86324 phv00086324.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:03+00:00 2018-04-23 03:32:03+00:00 AGATP13C SCAN 1: TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 86325 phv00086325.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:08+00:00 2018-04-23 03:32:08+00:00 AGATP23C SCAN 2: TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 86769 phv00086769.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:16+00:00 2018-04-23 03:32:16+00:00 agatpm4t NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E4 +24 CAC 86773 phv00086773.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:22+00:00 2018-04-23 03:32:22+00:00 AGATU14C SCAN 1: TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 86774 phv00086774.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:27+00:00 2018-04-23 03:32:27+00:00 AGATU24C SCAN 2: TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 86779 phv00086779.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:32+00:00 2018-04-23 03:32:32+00:00 AGATP14C SCAN 1: TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 86780 phv00086780.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:38+00:00 2018-04-23 03:32:38+00:00 AGATP24C SCAN 2: TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 87105 phv00087105.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:43+00:00 2018-04-23 03:32:43+00:00 agatpmfc MEAN: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 87106 phv00087106.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:49+00:00 2018-04-23 03:32:49+00:00 lnagatfc NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) +24 CAC 87531 phv00087531.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:32:55+00:00 2018-04-23 03:32:55+00:00 agatumfc MEAN: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 87536 phv00087536.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:33:01+00:00 2018-04-23 03:33:01+00:00 agatu1fc SCAN 1: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 87537 phv00087537.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:33:06+00:00 2018-04-23 03:33:06+00:00 agatu2fc SCAN 2: AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 87544 phv00087544.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:33:14+00:00 2018-04-23 03:33:14+00:00 agatp1fc SCAN 1: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 87545 phv00087545.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:33:20+00:00 2018-04-23 03:33:20+00:00 agatp2fc SCAN 2: AGATSTON CALCIUM SCORE, PHANTOM-ADJUSTED +24 CAC 174608 phv00174608.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:36:47+00:00 2018-04-23 03:36:47+00:00 agatpm5t NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E5 +24 CAC 174752 phv00174752.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:36:52+00:00 2018-04-23 03:36:52+00:00 pagatm5 TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 174753 phv00174753.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:36:57+00:00 2018-04-23 03:36:57+00:00 uagatm5 TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 176031 phv00176031.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:37:02+00:00 2018-04-23 03:37:02+00:00 agatpm5t NATURAL LOG-TRANSFORMED PHANTOM-ADJUSTED AGATSTON SCORE (POSITIVE SCORES ONLY) - E5 +24 CAC 176175 phv00176175.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:37:08+00:00 2018-04-23 03:37:08+00:00 pagatm5 TOTAL AGATSTON CALCIUM SCORE, PHANTOM ADJUSTED +24 CAC 176176 phv00176176.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:37:13+00:00 2018-04-23 03:37:13+00:00 uagatm5 TOTAL AGATSTON CALCIUM SCORE, UNADJUSTED +24 CAC 126002 phv00126002.v1.p1 pht001948.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:00:01+00:00 2018-06-12 01:00:01+00:00 CSTA24 24. Agatston score all coronary (does not include others) +24 CAC 23216 phv00023216.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:20:06+00:00 2018-06-14 17:20:06+00:00 EBCT08 CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.: LEFT MAIN +24 CAC 23217 phv00023217.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:20:36+00:00 2018-06-14 17:20:36+00:00 EBCT09 CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.: LEFT ANTERIOR DESCENDING +24 CAC 23218 phv00023218.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:20:52+00:00 2018-06-14 17:20:52+00:00 EBCT10 CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.: LEFT CIRCUMFLEX +24 CAC 23219 phv00023219.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:21:03+00:00 2018-06-14 17:21:03+00:00 EBCT11 CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.: RIGHT CORONARY +24 CAC 23220 phv00023220.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:21:13+00:00 2018-06-14 17:21:13+00:00 EBCT12 CORONARY ARTERY CALCIUM SCORE - WEIGHT EQ.: TOTAL +24 CAC 23221 phv00023221.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:21:24+00:00 2018-06-14 17:21:24+00:00 EBCT13 CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3): LEFT MAIN +24 CAC 23222 phv00023222.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:21:35+00:00 2018-06-14 17:21:35+00:00 EBCT14 CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3): LEFT ANTERIOR DESCENDING +24 CAC 23223 phv00023223.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:21:45+00:00 2018-06-14 17:21:45+00:00 EBCT15 CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3): LEFT CIRCUMFLEX +24 CAC 23224 phv00023224.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:21:57+00:00 2018-06-14 17:21:57+00:00 EBCT16 CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3): RIGHT CORONARY +24 CAC 23225 phv00023225.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:22:07+00:00 2018-06-14 17:22:07+00:00 EBCT17 CORONARY ARTERY CALCIUM SCORE - VOLUME(MM3): TOTAL +24 CAC 23226 phv00023226.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:22:16+00:00 2018-06-14 17:22:16+00:00 EBCT18 CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.: LEFT MAIN +24 CAC 23227 phv00023227.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:22:26+00:00 2018-06-14 17:22:26+00:00 EBCT19 CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.: LEFT ANTERIOR DESCENDING +24 CAC 23228 phv00023228.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:22:37+00:00 2018-06-14 17:22:37+00:00 EBCT20 CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.: LEFT CIRCUMFLEX +24 CAC 23229 phv00023229.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:22:46+00:00 2018-06-14 17:22:46+00:00 EBCT21 CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.: RIGHT CORONARY +24 CAC 23230 phv00023230.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:22:57+00:00 2018-06-14 17:22:57+00:00 EBCT22 CORONARY ARTERY CALCIUM SCORE - VOLUME/W.E.: TOTAL +24 CAC 23231 phv00023231.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:23:07+00:00 2018-06-14 17:23:07+00:00 EBCT23 CORONARY ARTERY CALCIUM SCORE - SCORE: LEFT MAIN +24 CAC 23232 phv00023232.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:23:17+00:00 2018-06-14 17:23:17+00:00 EBCT24 CORONARY ARTERY CALCIUM SCORE - SCORE: LEFT ANTERIOR DESCENDING +24 CAC 23233 phv00023233.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:23:28+00:00 2018-06-14 17:23:28+00:00 EBCT25 CORONARY ARTERY CALCIUM SCORE - SCORE: LEFT CIRCUMFLEX +24 CAC 23234 phv00023234.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:23:38+00:00 2018-06-14 17:23:38+00:00 EBCT26 CORONARY ARTERY CALCIUM SCORE - SCORE: RIGHT CORONARY +24 CAC 23235 phv00023235.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:23:49+00:00 2018-06-14 17:23:49+00:00 EBCT27 CORONARY ARTERY CALCIUM SCORE - SCORE: TOTAL +24 CAC 23194 phv00023194.v3.p10 pht000144.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:28:32+00:00 2018-06-14 17:28:32+00:00 CA1 CORONARY ARTERY SCAN 1 CALCIUM SCORE (AGATSTON) +24 CAC 23195 phv00023195.v3.p10 pht000144.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:28:41+00:00 2018-06-14 17:28:41+00:00 CA2 CORONARY ARTERY SCAN 2 CALCIUM SCORE (AGATSTON) +24 CAC 23200 phv00023200.v3.p10 pht000145.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:28:52+00:00 2018-06-14 17:28:52+00:00 CA1 CORONARY ARTERY SCAN 1 CALCIUM SCORE (AGATSTON) +24 CAC 23201 phv00023201.v3.p10 pht000145.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:29:05+00:00 2018-06-14 17:29:05+00:00 CA2 CORONARY ARTERY SCAN 2 CALCIUM SCORE (AGATSTON) +24 CAC 257670 phv00257670.v1.p10 pht005161.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:34:09+00:00 2018-06-14 17:34:09+00:00 CAC_S Coronary artery calcium score (Agatston) +24 CAC 257671 phv00257671.v1.p10 pht005161.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:34:54+00:00 2018-06-14 17:34:54+00:00 CAC_V Coronary artery calcium volume +24 CAC 100691 phv00100691.v1.p1 pht001459.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:50:23+00:00 2018-06-27 23:50:23+00:00 CACSCORE Coronary Artery Calcification by electron beam CYT scan +24 CAC 118019 phv00118019.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-08 23:01:59+00:00 2018-08-08 23:01:59+00:00 ER2TSCOR Total: Agatston Score +24 CAC 277347 phv00277347.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:16:10+00:00 2018-08-14 22:16:10+00:00 MD1CAC_S CAC SCORE IN WHOLE HEART Collection Interval: 2009-2011 +24 CAC 307984 phv00307984.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:09:48+00:00 2018-08-16 00:09:48+00:00 R3WHS24 CAC Score in whole heart; Results of CT scan run 2 of 2 Collection Interval: 2000-2004 +24 CAC 307983 phv00307983.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:09:55+00:00 2018-08-16 00:09:55+00:00 R3WHS14 CAC Score in whole heart; Results of CT scan run 1 of 2 Collection Interval: 2000-2004 +24 CAC 252986 phv00252986.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:13:06+00:00 2018-08-24 17:13:06+00:00 cac_agatston_score Coronary artery calcification score +24 CAC 118018 phv00118018.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:23:12+00:00 2018-08-27 23:23:12+00:00 ER2TSCR9 9 PIX TOTAL SCORE +24 CAC 118017 phv00118017.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:23:19+00:00 2018-08-27 23:23:19+00:00 ER2TSCR8 8 PIX TOTAL SCORE +24 CAC 118016 phv00118016.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:23:26+00:00 2018-08-27 23:23:26+00:00 ER2TSCR7 7 PIX TOTAL SCORE +24 CAC 118015 phv00118015.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:23:32+00:00 2018-08-27 23:23:32+00:00 ER2TSCR6 6 PIX TOTAL SCORE +24 CAC 118014 phv00118014.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:23:39+00:00 2018-08-27 23:23:39+00:00 ER2TSCR5 5 PIX TOTAL SCORE +24 CAC 118013 phv00118013.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:23:46+00:00 2018-08-27 23:23:46+00:00 ER2TSCR4 4 PIX TOTAL SCORE +24 CAC 118012 phv00118012.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:23:53+00:00 2018-08-27 23:23:53+00:00 ER2TSCR3 3 PIX TOTAL SCORE +24 CAC 118011 phv00118011.v2.p2 pht001754.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:24:00+00:00 2018-08-27 23:24:00+00:00 ER2TSCR2 2 PIX TOTAL SCORE +24 CAC 120787 phv00120787.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:39:16+00:00 2018-08-29 23:39:16+00:00 FR3SCR41 SCAN 1 ARTERY 4 UNADJUSTED AGATSTON SCORE +24 CAC 120786 phv00120786.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:39:22+00:00 2018-08-29 23:39:22+00:00 FR3SCR31 SCAN 1 ARTERY 3 UNADJUSTED AGATSTON SCORE +24 CAC 120785 phv00120785.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:39:28+00:00 2018-08-29 23:39:28+00:00 FR3SCR21 SCAN 1 ARTERY 2 UNADJUSTED AGATSTON SCORE +24 CAC 120784 phv00120784.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:39:35+00:00 2018-08-29 23:39:35+00:00 FR3SCR11 SCAN 1 ARTERY 1 UNADJUSTED AGATSTON SCORE +24 CAC 120783 phv00120783.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:39:42+00:00 2018-08-29 23:39:42+00:00 FR3VOL41 SCAN 1 ARTERY 4 UNADJUSTED VOLUME +24 CAC 120782 phv00120782.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:39:49+00:00 2018-08-29 23:39:49+00:00 FR3VOL31 SCAN 1 ARTERY 3 UNADJUSTED VOLUME +24 CAC 120781 phv00120781.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:39:57+00:00 2018-08-29 23:39:57+00:00 FR3VOL21 SCAN 1 ARTERY 2 UNADJUSTED VOLUME +24 CAC 120780 phv00120780.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:40:12+00:00 2018-08-29 23:40:12+00:00 FR3VOL11 SCAN 1 ARTERY 1 UNADJUSTED VOLUME +24 CAC 120795 phv00120795.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:40:46+00:00 2018-08-29 23:40:46+00:00 FR3ARM41 SCAN 1 ARTERY 4 CALCIUM MASS +24 CAC 120794 phv00120794.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:40:52+00:00 2018-08-29 23:40:52+00:00 FR3ARM31 SCAN 1 ARTERY 3 CALCIUM MASS +24 CAC 120793 phv00120793.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:40:58+00:00 2018-08-29 23:40:58+00:00 FR3ARM21 SCAN 1 ARTERY 2 CALCIUM MASS +24 CAC 120792 phv00120792.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:41:04+00:00 2018-08-29 23:41:04+00:00 FR3ARM11 SCAN 1 ARTERY 1 CALCIUM MASS +24 CAC 120791 phv00120791.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:41:11+00:00 2018-08-29 23:41:11+00:00 FR3ISV41 SCAN 1 ARTERY 4 UNADJUSTED ISOVOL +24 CAC 120790 phv00120790.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:41:18+00:00 2018-08-29 23:41:18+00:00 FR3ISV31 SCAN 1 ARTERY 3 UNADJUSTED ISOVOL +24 CAC 120789 phv00120789.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:41:26+00:00 2018-08-29 23:41:26+00:00 FR3ISV21 SCAN 1 ARTERY 2 UNADJUSTED ISOVOL +24 CAC 120788 phv00120788.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:41:34+00:00 2018-08-29 23:41:34+00:00 FR3ISV11 SCAN 1 ARTERY 1 UNADJUSTED ISOVOL +24 CAC 120815 phv00120815.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:42:41+00:00 2018-08-29 23:42:41+00:00 FR3PHS41 SCAN 1 ARTERY 4 ADJUSTED AGATSTON SCORE +24 CAC 120814 phv00120814.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:42:47+00:00 2018-08-29 23:42:47+00:00 FR3PHS31 SCAN 1 ARTERY 3 ADJUSTED AGATSTON SCORE +24 CAC 120813 phv00120813.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:42:53+00:00 2018-08-29 23:42:53+00:00 FR3PHS21 SCAN 1 ARTERY 2 ADJUSTED AGATSTON SCORE +24 CAC 120812 phv00120812.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:42:59+00:00 2018-08-29 23:42:59+00:00 FR3PHS11 SCAN 1 ARTERY 1 ADJUSTED AGATSTON SCORE +24 CAC 120811 phv00120811.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:43:07+00:00 2018-08-29 23:43:07+00:00 FR3PVL41 SCAN 1 ARTERY 4 ADJUSTED VOLUME +24 CAC 120810 phv00120810.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:43:13+00:00 2018-08-29 23:43:13+00:00 FR3PVL31 SCAN 1 ARTERY 3 ADJUSTED VOLUME +24 CAC 120809 phv00120809.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:43:19+00:00 2018-08-29 23:43:19+00:00 FR3PVL21 SCAN 1 ARTERY 2 ADJUSTED VOLUME +24 CAC 120808 phv00120808.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:43:25+00:00 2018-08-29 23:43:25+00:00 FR3PVL11 SCAN 1 ARTERY 1 ADJUSTED VOLUME +24 CAC 120819 phv00120819.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:44:32+00:00 2018-08-29 23:44:32+00:00 FR3PHI41 SCAN 1 ARTERY 4 ADJUSED ISOVOL +24 CAC 120818 phv00120818.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:44:38+00:00 2018-08-29 23:44:38+00:00 FR3PHI31 SCAN 1 ARTERY 3 ADJUSED ISOVOL +24 CAC 120817 phv00120817.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:44:44+00:00 2018-08-29 23:44:44+00:00 FR3PHI21 SCAN 1 ARTERY 2 ADJUSED ISOVOL +24 CAC 120816 phv00120816.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:44:50+00:00 2018-08-29 23:44:50+00:00 FR3PHI11 SCAN 1 ARTERY 1 ADJUSED ISOVOL +24 CAC 120845 phv00120845.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:45:51+00:00 2018-08-29 23:45:51+00:00 FR3SCR42 SCAN 2 ARTERY 4 UNADJUSTED AGATSTON SCORE +24 CAC 120844 phv00120844.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:45:56+00:00 2018-08-29 23:45:56+00:00 FR3SCR32 SCAN 2 ARTERY 3 UNADJUSTED AGATSTON SCORE +24 CAC 120843 phv00120843.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:46:03+00:00 2018-08-29 23:46:03+00:00 FR3SCR22 SCAN 2 ARTERY 2 UNADJUSTED AGATSTON SCORE +24 CAC 120842 phv00120842.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:46:09+00:00 2018-08-29 23:46:09+00:00 FR3SCR12 SCAN 2 ARTERY 1 UNADJUSTED AGATSTON SCORE +24 CAC 120841 phv00120841.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:46:15+00:00 2018-08-29 23:46:15+00:00 FR3VOL42 SCAN 2 ARTERY 4 UNADJUSTED VOLUME +24 CAC 120840 phv00120840.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:46:22+00:00 2018-08-29 23:46:22+00:00 FR3VOL32 SCAN 2 ARTERY 3 UNADJUSTED VOLUME +24 CAC 120839 phv00120839.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:46:28+00:00 2018-08-29 23:46:28+00:00 FR3VOL22 SCAN 2 ARTERY 2 UNADJUSTED VOLUME +24 CAC 120838 phv00120838.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:46:36+00:00 2018-08-29 23:46:36+00:00 FR3VOL12 SCAN 2 ARTERY 1 UNADJUSTED VOLUME +24 CAC 120853 phv00120853.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:47:00+00:00 2018-08-29 23:47:00+00:00 FR3ARM42 SCAN 2 ARTERY 4 CALCIUM MASS +24 CAC 120852 phv00120852.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:47:06+00:00 2018-08-29 23:47:06+00:00 FR3ARM32 SCAN 2 ARTERY 3 CALCIUM MASS +24 CAC 120851 phv00120851.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:47:12+00:00 2018-08-29 23:47:12+00:00 FR3ARM22 SCAN 2 ARTERY 2 CALCIUM MASS +24 CAC 120850 phv00120850.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:47:19+00:00 2018-08-29 23:47:19+00:00 FR3ARM12 SCAN 2 ARTERY 1 CALCIUM MASS +24 CAC 120849 phv00120849.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:47:25+00:00 2018-08-29 23:47:25+00:00 FR3ISV42 SCAN 2 ARTERY 4 UNADJUSTED ISOVOL +24 CAC 120848 phv00120848.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:47:32+00:00 2018-08-29 23:47:32+00:00 FR3ISV32 SCAN 2 ARTERY 3 UNADJUSTED ISOVOL +24 CAC 120847 phv00120847.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:47:37+00:00 2018-08-29 23:47:37+00:00 FR3ISV22 SCAN 2 ARTERY 2 UNADJUSTED ISOVOL +24 CAC 120846 phv00120846.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:47:44+00:00 2018-08-29 23:47:44+00:00 FR3ISV12 SCAN 2 ARTERY 1 UNADJUSTED ISOVOL +24 CAC 120873 phv00120873.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:50:32+00:00 2018-08-29 23:50:32+00:00 FR3PHS42 SCAN 2 ARTERY 4 ADJUSTED AGATSTON SCORE +24 CAC 120872 phv00120872.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:50:39+00:00 2018-08-29 23:50:39+00:00 FR3PHS32 SCAN 2 ARTERY 3 ADJUSTED AGATSTON SCORE +24 CAC 120871 phv00120871.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:50:46+00:00 2018-08-29 23:50:46+00:00 FR3PHS22 SCAN 2 ARTERY 2 ADJUSTED AGATSTON SCORE +24 CAC 120870 phv00120870.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:50:53+00:00 2018-08-29 23:50:53+00:00 FR3PHS12 SCAN 2 ARTERY 1 ADJUSTED AGATSTON SCORE +24 CAC 120869 phv00120869.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:51:00+00:00 2018-08-29 23:51:00+00:00 FR3PVL42 SCAN 2 ARTERY 4 ADJUSTED VOLUME +24 CAC 120868 phv00120868.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:51:06+00:00 2018-08-29 23:51:06+00:00 FR3PVL32 SCAN 2 ARTERY 3 ADJUSTED VOLUME +24 CAC 120867 phv00120867.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:51:12+00:00 2018-08-29 23:51:12+00:00 FR3PVL22 SCAN 2 ARTERY 2 ADJUSTED VOLUME +24 CAC 120866 phv00120866.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:51:19+00:00 2018-08-29 23:51:19+00:00 FR3PVL12 SCAN 2 ARTERY 1 ADJUSTED VOLUME +24 CAC 120887 phv00120887.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:51:57+00:00 2018-08-29 23:51:57+00:00 FR3UAIS2 SCAN 2 UNADJUSTED ISOVOL +24 CAC 120886 phv00120886.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:03+00:00 2018-08-29 23:52:03+00:00 FR3UAIS1 SCAN 1 UNADJUSTED ISOVOL +24 CAC 120885 phv00120885.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:08+00:00 2018-08-29 23:52:08+00:00 FR3ADSC2 SCAN 2 ADJUSTED AGATSTON SCORE +24 CAC 120884 phv00120884.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:15+00:00 2018-08-29 23:52:15+00:00 FR3ADSC1 SCAN 1 ADJUSTED AGATSTON SCORE +24 CAC 120883 phv00120883.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:22+00:00 2018-08-29 23:52:22+00:00 FR3UASC2 SCAN 2 UNADJUSTED AGATSTON SCORE +24 CAC 120882 phv00120882.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:28+00:00 2018-08-29 23:52:28+00:00 FR3UASC1 SCAN 1 UNADJUSTED AGATSTON SCORE +24 CAC 120877 phv00120877.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:35+00:00 2018-08-29 23:52:35+00:00 FR3PHI42 SCAN 2 ARTERY 4 ADJUSED ISOVOL +24 CAC 120876 phv00120876.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:41+00:00 2018-08-29 23:52:41+00:00 FR3PHI32 SCAN 2 ARTERY 3 ADJUSED ISOVOL +24 CAC 120875 phv00120875.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:47+00:00 2018-08-29 23:52:47+00:00 FR3PHI22 SCAN 2 ARTERY 2 ADJUSED ISOVOL +24 CAC 120874 phv00120874.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:52:54+00:00 2018-08-29 23:52:54+00:00 FR3PHI12 SCAN 2 ARTERY 1 ADJUSED ISOVOL +24 CAC 120895 phv00120895.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:53:23+00:00 2018-08-29 23:53:23+00:00 FR3MASS2 SCAN 2 MASS +24 CAC 120894 phv00120894.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:53:28+00:00 2018-08-29 23:53:28+00:00 FR3MASS1 SCAN 1 MASS +24 CAC 120893 phv00120893.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:53:35+00:00 2018-08-29 23:53:35+00:00 FR3PVOL2 SCAN 2 ADJUSTED VOLUME +24 CAC 120892 phv00120892.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:53:41+00:00 2018-08-29 23:53:41+00:00 FR3PVOL1 SCAN 1 ADJUSTED VOLUME +24 CAC 120891 phv00120891.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:53:48+00:00 2018-08-29 23:53:48+00:00 FR3VOL2 SCAN 2 UNADJSTED VOLUME +24 CAC 120890 phv00120890.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:53:56+00:00 2018-08-29 23:53:56+00:00 FR3VOL1 SCAN 1 UNADJSTED VOLUME +24 CAC 120889 phv00120889.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:54:03+00:00 2018-08-29 23:54:03+00:00 FR3ADIS2 SCAN 2 ADJUSTED ISOVOL +24 CAC 120888 phv00120888.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:54:10+00:00 2018-08-29 23:54:10+00:00 FR3ADIS1 SCAN 1 ADJUSTED ISOVOL +24 CAC 120902 phv00120902.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:55:00+00:00 2018-08-29 23:55:00+00:00 FR3MASS AVERAGE MASS +24 CAC 120901 phv00120901.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:55:05+00:00 2018-08-29 23:55:05+00:00 FR3PHVOL AVERAGE ADJUSTED VOLUME +24 CAC 120900 phv00120900.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:55:11+00:00 2018-08-29 23:55:11+00:00 FR3VOL AVERAGE UNADJUSTED VOLUME +24 CAC 120899 phv00120899.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:55:17+00:00 2018-08-29 23:55:17+00:00 FR3UADIS AVERAGE UNADJUSTED ISOVOL +24 CAC 120898 phv00120898.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:55:24+00:00 2018-08-29 23:55:24+00:00 FR3ADJIS AVERAGE ADJUSTED ISOVOL +24 CAC 120897 phv00120897.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:55:30+00:00 2018-08-29 23:55:30+00:00 FR3ADJSC AVERAGE ADJUSTED AGASTON SCORE +24 CAC 120896 phv00120896.v2.p2 pht001854.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:55:37+00:00 2018-08-29 23:55:37+00:00 FR3UASCR AVERAGE UNADJUSTED AGATSTON SCORE +25 Carotid IMT 209827 phv00209827.v1.p1 pht004164.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:11:29+00:00 2018-04-24 20:11:29+00:00 LOPART45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 1] +25 Carotid IMT 209828 phv00209828.v1.p1 pht004164.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:11:55+00:00 2018-04-24 20:11:55+00:00 ROPART45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 1] +25 Carotid IMT 209831 phv00209831.v1.p1 pht004164.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:12:12+00:00 2018-04-24 20:12:12+00:00 LINART45 Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 1] +25 Carotid IMT 209832 phv00209832.v1.p1 pht004164.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:12:33+00:00 2018-04-24 20:12:33+00:00 RINART45 Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 1] +25 Carotid IMT 209849 phv00209849.v1.p1 pht004165.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:12:53+00:00 2018-04-24 20:12:53+00:00 LOPBWT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209850 phv00209850.v1.p1 pht004165.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:13:12+00:00 2018-04-24 20:13:12+00:00 ROPBWT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209853 phv00209853.v1.p1 pht004165.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:13:29+00:00 2018-04-24 20:13:29+00:00 LINBWT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209854 phv00209854.v1.p1 pht004165.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:13:46+00:00 2018-04-24 20:13:46+00:00 RINBWT45 Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209861 phv00209861.v1.p1 pht004166.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:14:04+00:00 2018-04-24 20:14:04+00:00 LINCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209862 phv00209862.v1.p1 pht004166.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:14:21+00:00 2018-04-24 20:14:21+00:00 RINCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RINC [right internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209863 phv00209863.v1.p1 pht004166.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:14:36+00:00 2018-04-24 20:14:36+00:00 LOPCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209864 phv00209864.v1.p1 pht004166.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:14:51+00:00 2018-04-24 20:14:51+00:00 ROPCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPC [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209873 phv00209873.v1.p1 pht004167.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:15:13+00:00 2018-04-24 20:15:13+00:00 LOPDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPD [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209874 phv00209874.v1.p1 pht004167.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:15:27+00:00 2018-04-24 20:15:27+00:00 ROPDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPD [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209877 phv00209877.v1.p1 pht004167.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:15:44+00:00 2018-04-24 20:15:44+00:00 LINDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LIND [left internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209878 phv00209878.v1.p1 pht004167.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:16:06+00:00 2018-04-24 20:16:06+00:00 RINDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RIND [right internal carotid] [Reader-trend-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209889 phv00209889.v1.p1 pht004168.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:16:21+00:00 2018-04-24 20:16:21+00:00 LOPART45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 1] +25 Carotid IMT 209890 phv00209890.v1.p1 pht004168.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:16:39+00:00 2018-04-24 20:16:39+00:00 ROPART45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 1] +25 Carotid IMT 209893 phv00209893.v1.p1 pht004168.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:16:54+00:00 2018-04-24 20:16:54+00:00 LINART45 Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 1] +25 Carotid IMT 209894 phv00209894.v1.p1 pht004168.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:17:08+00:00 2018-04-24 20:17:08+00:00 RINART45 Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 1] +25 Carotid IMT 209905 phv00209905.v1.p1 pht004169.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:17:26+00:00 2018-04-24 20:17:26+00:00 LOPBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPB [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 2] +25 Carotid IMT 209906 phv00209906.v1.p1 pht004169.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:17:42+00:00 2018-04-24 20:17:42+00:00 ROPBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPB [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 2] +25 Carotid IMT 209909 phv00209909.v1.p1 pht004169.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:17:58+00:00 2018-04-24 20:17:58+00:00 LINBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINB [left internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 2] +25 Carotid IMT 209910 phv00209910.v1.p1 pht004169.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:18:12+00:00 2018-04-24 20:18:12+00:00 RINBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RINB [right internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 2] +25 Carotid IMT 209923 phv00209923.v1.p1 pht004170.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:18:26+00:00 2018-04-24 20:18:26+00:00 LINCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 3] +25 Carotid IMT 209924 phv00209924.v1.p1 pht004170.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:18:52+00:00 2018-04-24 20:18:52+00:00 RINCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RINC [right internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 3] +25 Carotid IMT 209925 phv00209925.v1.p1 pht004170.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:19:07+00:00 2018-04-24 20:19:07+00:00 LOPCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 3] +25 Carotid IMT 209926 phv00209926.v1.p1 pht004170.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:19:19+00:00 2018-04-24 20:19:19+00:00 ROPCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPC [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 3] +25 Carotid IMT 209935 phv00209935.v1.p1 pht004171.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:19:36+00:00 2018-04-24 20:19:36+00:00 LOPDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPD [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 4] +25 Carotid IMT 209936 phv00209936.v1.p1 pht004171.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:19:51+00:00 2018-04-24 20:19:51+00:00 ROPDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPD [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, black males, exam 4] +25 Carotid IMT 209939 phv00209939.v1.p1 pht004171.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:20:08+00:00 2018-04-24 20:20:08+00:00 LINDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LIND [left internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 4] +25 Carotid IMT 209940 phv00209940.v1.p1 pht004171.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:20:26+00:00 2018-04-24 20:20:26+00:00 RINDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RIND [right internal carotid] [Reader-trend-adjusted ultrasound, black males, exam 4] +25 Carotid IMT 210147 phv00210147.v1.p1 pht004184.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:20:49+00:00 2018-04-24 20:20:49+00:00 LOPART45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 1] +25 Carotid IMT 210148 phv00210148.v1.p1 pht004184.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:21:05+00:00 2018-04-24 20:21:05+00:00 ROPART45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 1] +25 Carotid IMT 210151 phv00210151.v1.p1 pht004184.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:21:20+00:00 2018-04-24 20:21:20+00:00 LINART45 Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 1] +25 Carotid IMT 210152 phv00210152.v1.p1 pht004184.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:21:35+00:00 2018-04-24 20:21:35+00:00 RINART45 Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 1] +25 Carotid IMT 210163 phv00210163.v1.p1 pht004185.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:21:53+00:00 2018-04-24 20:21:53+00:00 LOPBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPB [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210164 phv00210164.v1.p1 pht004185.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:22:31+00:00 2018-04-24 20:22:31+00:00 ROPBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPB [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210167 phv00210167.v1.p1 pht004185.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:22:54+00:00 2018-04-24 20:22:54+00:00 LINBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINB [left common carotid: anterior angle] [Reader-trend-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210168 phv00210168.v1.p1 pht004185.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:23:09+00:00 2018-04-24 20:23:09+00:00 RINBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RINB [right internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210181 phv00210181.v1.p1 pht004186.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:23:25+00:00 2018-04-24 20:23:25+00:00 LINCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210182 phv00210182.v1.p1 pht004186.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:23:39+00:00 2018-04-24 20:23:39+00:00 RINCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RINC [right internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210183 phv00210183.v1.p1 pht004186.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:23:54+00:00 2018-04-24 20:23:54+00:00 LOPCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210184 phv00210184.v1.p1 pht004186.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:24:10+00:00 2018-04-24 20:24:10+00:00 ROPCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPC [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210193 phv00210193.v1.p1 pht004187.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:24:23+00:00 2018-04-24 20:24:23+00:00 LOPDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210194 phv00210194.v1.p1 pht004187.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:24:36+00:00 2018-04-24 20:24:36+00:00 ROPDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPD [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210197 phv00210197.v1.p1 pht004187.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:24:50+00:00 2018-04-24 20:24:50+00:00 LINDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210198 phv00210198.v1.p1 pht004187.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:25:04+00:00 2018-04-24 20:25:04+00:00 RINDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RIND [right internal carotid] [Reader-trend-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210209 phv00210209.v1.p1 pht004188.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:25:18+00:00 2018-04-24 20:25:18+00:00 LOPART45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPA [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 1] +25 Carotid IMT 210210 phv00210210.v1.p1 pht004188.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:25:32+00:00 2018-04-24 20:25:32+00:00 ROPART45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPA [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 1] +25 Carotid IMT 210213 phv00210213.v1.p1 pht004188.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:26:03+00:00 2018-04-24 20:26:03+00:00 LINART45 Imputed RTA [the reader trend adjusted] far wall thickness, LINA [left internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 1] +25 Carotid IMT 210214 phv00210214.v1.p1 pht004188.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:26:18+00:00 2018-04-24 20:26:18+00:00 RINART45 Imputed RTA [the reader trend adjusted] far wall thickness, RINA [right internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 1] +25 Carotid IMT 210225 phv00210225.v1.p1 pht004189.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:26:34+00:00 2018-04-24 20:26:34+00:00 LOPBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPB [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210226 phv00210226.v1.p1 pht004189.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:26:49+00:00 2018-04-24 20:26:49+00:00 ROPBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPB [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210229 phv00210229.v1.p1 pht004189.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:27:02+00:00 2018-04-24 20:27:02+00:00 LINBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINB [left internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210230 phv00210230.v1.p1 pht004189.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:27:17+00:00 2018-04-24 20:27:17+00:00 RINBRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RINB [right internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210243 phv00210243.v1.p1 pht004190.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:27:36+00:00 2018-04-24 20:27:36+00:00 LINCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LINC [left internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210244 phv00210244.v1.p1 pht004190.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:27:51+00:00 2018-04-24 20:27:51+00:00 RINCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RINC [right internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210245 phv00210245.v1.p1 pht004190.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:28:04+00:00 2018-04-24 20:28:04+00:00 LOPCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPC [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210246 phv00210246.v1.p1 pht004190.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:28:21+00:00 2018-04-24 20:28:21+00:00 ROPCRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPC [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210255 phv00210255.v1.p1 pht004191.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:28:35+00:00 2018-04-24 20:28:35+00:00 LOPDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LOPD [left common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210256 phv00210256.v1.p1 pht004191.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:28:50+00:00 2018-04-24 20:28:50+00:00 ROPDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, ROPD [right common carotid: optimal angle] [Reader-trend-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210259 phv00210259.v1.p1 pht004191.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:29:04+00:00 2018-04-24 20:29:04+00:00 LINDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, LIND [left internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210260 phv00210260.v1.p1 pht004191.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:29:21+00:00 2018-04-24 20:29:21+00:00 RINDRT45 Imputed RTA [the reader trend adjusted] far wall thickness, RIND [right internal carotid] [Reader-trend-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 212480 phv00212480.v1.p1 pht004209.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:40:31+00:00 2018-04-24 20:40:31+00:00 LOPADA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 1] +25 Carotid IMT 212481 phv00212481.v1.p1 pht004209.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:40:47+00:00 2018-04-24 20:40:47+00:00 ROPADA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 1] +25 Carotid IMT 212484 phv00212484.v1.p1 pht004209.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:41:01+00:00 2018-04-24 20:41:01+00:00 LINADA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black females, exam 1] +25 Carotid IMT 212485 phv00212485.v1.p1 pht004209.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:41:14+00:00 2018-04-24 20:41:14+00:00 RINADA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black females, exam 1] +25 Carotid IMT 212499 phv00212499.v1.p1 pht004210.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:41:30+00:00 2018-04-24 20:41:30+00:00 LOPADA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 1] +25 Carotid IMT 212500 phv00212500.v1.p1 pht004210.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:41:44+00:00 2018-04-24 20:41:44+00:00 ROPADA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 1] +25 Carotid IMT 212503 phv00212503.v1.p1 pht004210.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:42:02+00:00 2018-04-24 20:42:02+00:00 LINADA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black males, exam 1] +25 Carotid IMT 212518 phv00212518.v1.p1 pht004211.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:42:29+00:00 2018-04-24 20:42:29+00:00 LOPADA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 1] +25 Carotid IMT 212519 phv00212519.v1.p1 pht004211.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:42:45+00:00 2018-04-24 20:42:45+00:00 ROPADA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 1] +25 Carotid IMT 212522 phv00212522.v1.p1 pht004211.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:43:02+00:00 2018-04-24 20:43:02+00:00 LINADA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white females, exam 1] +25 Carotid IMT 212523 phv00212523.v1.p1 pht004211.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:43:18+00:00 2018-04-24 20:43:18+00:00 RINADA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white females, exam 1] +25 Carotid IMT 212537 phv00212537.v1.p1 pht004212.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:43:31+00:00 2018-04-24 20:43:31+00:00 LOPADA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 1] +25 Carotid IMT 212538 phv00212538.v1.p1 pht004212.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:43:44+00:00 2018-04-24 20:43:44+00:00 ROPADA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 1] +25 Carotid IMT 212541 phv00212541.v1.p1 pht004212.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:43:57+00:00 2018-04-24 20:43:57+00:00 LINADA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white males, exam 1] +25 Carotid IMT 212542 phv00212542.v1.p1 pht004212.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:44:12+00:00 2018-04-24 20:44:12+00:00 RINADA45 Derived average far wall thickness, right Internal carotid [Ultrasound Imputed Values, white males, exam 1] +25 Carotid IMT 212654 phv00212654.v1.p1 pht004214.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:51:06+00:00 2018-04-24 20:51:06+00:00 LOPBDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 2] +25 Carotid IMT 212655 phv00212655.v1.p1 pht004214.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:51:20+00:00 2018-04-24 20:51:20+00:00 ROPBDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 2] +25 Carotid IMT 212658 phv00212658.v1.p1 pht004214.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:51:37+00:00 2018-04-24 20:51:37+00:00 LINBDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black females, exam 2] +25 Carotid IMT 212659 phv00212659.v1.p1 pht004214.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:51:53+00:00 2018-04-24 20:51:53+00:00 RINBDA45 Derived average far wall thickness, right Internal carotid [Ultrasound Imputed Values, black females, exam 2] +25 Carotid IMT 212672 phv00212672.v1.p1 pht004215.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:52:07+00:00 2018-04-24 20:52:07+00:00 LOPBDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 2] +25 Carotid IMT 212673 phv00212673.v1.p1 pht004215.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:52:21+00:00 2018-04-24 20:52:21+00:00 ROPBDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 2] +25 Carotid IMT 212676 phv00212676.v1.p1 pht004215.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:52:35+00:00 2018-04-24 20:52:35+00:00 LINBDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black males, exam 2] +25 Carotid IMT 212677 phv00212677.v1.p1 pht004215.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:52:48+00:00 2018-04-24 20:52:48+00:00 RINBDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black males, exam 2] +25 Carotid IMT 212690 phv00212690.v1.p1 pht004216.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:53:02+00:00 2018-04-24 20:53:02+00:00 LOPBDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 2] +25 Carotid IMT 212691 phv00212691.v1.p1 pht004216.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:53:16+00:00 2018-04-24 20:53:16+00:00 ROPBDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 2] +25 Carotid IMT 212694 phv00212694.v1.p1 pht004216.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:53:30+00:00 2018-04-24 20:53:30+00:00 LINBDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white females, exam 2] +25 Carotid IMT 212695 phv00212695.v1.p1 pht004216.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:53:46+00:00 2018-04-24 20:53:46+00:00 RINBDA45 Derived average far wall thickness, right Internal carotid [Ultrasound Imputed Values, white females, exam 2] +25 Carotid IMT 212708 phv00212708.v1.p1 pht004217.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:53:59+00:00 2018-04-24 20:53:59+00:00 LOPBDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 2] +25 Carotid IMT 212709 phv00212709.v1.p1 pht004217.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:54:11+00:00 2018-04-24 20:54:11+00:00 ROPBDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 2] +25 Carotid IMT 212712 phv00212712.v1.p1 pht004217.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:56:00+00:00 2018-04-24 20:56:00+00:00 LINBDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white males, exam 2] +25 Carotid IMT 212713 phv00212713.v1.p1 pht004217.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:56:16+00:00 2018-04-24 20:56:16+00:00 RINBDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white males, exam 2] +25 Carotid IMT 213831 phv00213831.v1.p1 pht004219.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:56:32+00:00 2018-04-24 20:56:32+00:00 LOPCDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 3] +25 Carotid IMT 213832 phv00213832.v1.p1 pht004219.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:56:47+00:00 2018-04-24 20:56:47+00:00 ROPCDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 3] +25 Carotid IMT 213835 phv00213835.v1.p1 pht004219.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:57:18+00:00 2018-04-24 20:57:18+00:00 LINCDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black females, exam 3] +25 Carotid IMT 213836 phv00213836.v1.p1 pht004219.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:57:33+00:00 2018-04-24 20:57:33+00:00 RINCDA45 Derived Average Far Wall Thickness, Right Internal Carotid [Ultrasound Imputed Values, black females, exam 3] +25 Carotid IMT 213849 phv00213849.v1.p1 pht004220.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:57:50+00:00 2018-04-24 20:57:50+00:00 LOPCDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed values, black males, exam 3] +25 Carotid IMT 213850 phv00213850.v1.p1 pht004220.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:58:04+00:00 2018-04-24 20:58:04+00:00 ROPCDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed values, black males, exam 3] +25 Carotid IMT 213853 phv00213853.v1.p1 pht004220.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:58:19+00:00 2018-04-24 20:58:19+00:00 LINCDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed values, black males, exam 3] +25 Carotid IMT 213854 phv00213854.v1.p1 pht004220.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:58:34+00:00 2018-04-24 20:58:34+00:00 RINCDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed values, black males, exam 3] +25 Carotid IMT 213867 phv00213867.v1.p1 pht004221.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:58:50+00:00 2018-04-24 20:58:50+00:00 LOPCDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 3] +25 Carotid IMT 213868 phv00213868.v1.p1 pht004221.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:59:22+00:00 2018-04-24 20:59:22+00:00 ROPCDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 3] +25 Carotid IMT 213871 phv00213871.v1.p1 pht004221.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:59:35+00:00 2018-04-24 20:59:35+00:00 LINCDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white females, exam 3] +25 Carotid IMT 213872 phv00213872.v1.p1 pht004221.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 20:59:48+00:00 2018-04-24 20:59:48+00:00 RINCDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white females, exam 3] +25 Carotid IMT 213885 phv00213885.v1.p1 pht004222.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:00:03+00:00 2018-04-24 21:00:03+00:00 LOPCDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 3] +25 Carotid IMT 213886 phv00213886.v1.p1 pht004222.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:00:17+00:00 2018-04-24 21:00:17+00:00 ROPCDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 3] +25 Carotid IMT 213889 phv00213889.v1.p1 pht004222.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:00:31+00:00 2018-04-24 21:00:31+00:00 LINCDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white males, exam 3] +25 Carotid IMT 213890 phv00213890.v1.p1 pht004222.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:00:46+00:00 2018-04-24 21:00:46+00:00 RINCDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white males, exam 3] +25 Carotid IMT 213978 phv00213978.v1.p1 pht004224.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:01:03+00:00 2018-04-24 21:01:03+00:00 LOPDDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 4] +25 Carotid IMT 213979 phv00213979.v1.p1 pht004224.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:01:15+00:00 2018-04-24 21:01:15+00:00 ROPDDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black females, exam 4] +25 Carotid IMT 213982 phv00213982.v1.p1 pht004224.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:01:26+00:00 2018-04-24 21:01:26+00:00 LINDDA45 Derived Average far wall thickness, left internal carotid [Ultrasound Imputed Values, black females, exam 4] +25 Carotid IMT 213983 phv00213983.v1.p1 pht004224.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:01:41+00:00 2018-04-24 21:01:41+00:00 RINDDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black females, exam 4] +25 Carotid IMT 213996 phv00213996.v1.p1 pht004225.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:01:55+00:00 2018-04-24 21:01:55+00:00 LOPDDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 4] +25 Carotid IMT 213997 phv00213997.v1.p1 pht004225.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:02:18+00:00 2018-04-24 21:02:18+00:00 ROPDDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, black males, exam 4] +25 Carotid IMT 214000 phv00214000.v1.p1 pht004225.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:02:31+00:00 2018-04-24 21:02:31+00:00 LINDDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, black males, exam 4] +25 Carotid IMT 214001 phv00214001.v1.p1 pht004225.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:02:47+00:00 2018-04-24 21:02:47+00:00 RINDDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black males, exam 4] +25 Carotid IMT 214014 phv00214014.v1.p1 pht004226.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:03:07+00:00 2018-04-24 21:03:07+00:00 LOPDDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 4] +25 Carotid IMT 214015 phv00214015.v1.p1 pht004226.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:03:21+00:00 2018-04-24 21:03:21+00:00 ROPDDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white females, exam 4] +25 Carotid IMT 214018 phv00214018.v1.p1 pht004226.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:03:34+00:00 2018-04-24 21:03:34+00:00 LINDDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white females, exam 4] +25 Carotid IMT 214019 phv00214019.v1.p1 pht004226.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:03:46+00:00 2018-04-24 21:03:46+00:00 RINDDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white females, exam 4] +25 Carotid IMT 214032 phv00214032.v1.p1 pht004227.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:03:59+00:00 2018-04-24 21:03:59+00:00 LOPDDA45 Derived average far wall thickness, left common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 4] +25 Carotid IMT 214033 phv00214033.v1.p1 pht004227.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:04:13+00:00 2018-04-24 21:04:13+00:00 ROPDDA45 Derived average far wall thickness, right common carotid: optimal angle [Ultrasound Imputed Values, white males, exam 4] +25 Carotid IMT 214036 phv00214036.v1.p1 pht004227.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:04:28+00:00 2018-04-24 21:04:28+00:00 LINDDA45 Derived average far wall thickness, left internal carotid [Ultrasound Imputed Values, white males, exam 4] +25 Carotid IMT 214037 phv00214037.v1.p1 pht004227.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:04:42+00:00 2018-04-24 21:04:42+00:00 RINDDA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, white males, exam 4] +25 Carotid IMT 212504 phv00212504.v1.p1 pht004210.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 21:15:54+00:00 2018-04-24 21:15:54+00:00 RINADA45 Derived average far wall thickness, right internal carotid [Ultrasound Imputed Values, black males, exam 1] +25 Carotid IMT 209840 phv00209840.v1.p1 pht004164.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:17:24+00:00 2018-04-26 16:17:24+00:00 MNA45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black females, exam 1] +25 Carotid IMT 209871 phv00209871.v1.p1 pht004166.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:36:59+00:00 2018-04-26 16:36:59+00:00 MNC45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209885 phv00209885.v1.p1 pht004167.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:38:14+00:00 2018-04-26 16:38:14+00:00 MND45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209902 phv00209902.v1.p1 pht004168.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:39:00+00:00 2018-04-26 16:39:00+00:00 MNA45_1 Mean of the RT45 Variables [Reader-trend-adjusted ultrasound, black males, exam 1] +25 Carotid IMT 209917 phv00209917.v1.p1 pht004169.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:39:45+00:00 2018-04-26 16:39:45+00:00 MNB45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black males, exam 2] +25 Carotid IMT 209933 phv00209933.v1.p1 pht004170.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:40:21+00:00 2018-04-26 16:40:21+00:00 MNC45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black males, exam 3] +25 Carotid IMT 209947 phv00209947.v1.p1 pht004171.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:41:00+00:00 2018-04-26 16:41:00+00:00 MND45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, black males, exam 4] +25 Carotid IMT 210160 phv00210160.v1.p1 pht004184.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:41:43+00:00 2018-04-26 16:41:43+00:00 MNA45_1 Mean of the RT45 Variables [Reader-trend-adjusted ultrasound, white females, exam 1] +25 Carotid IMT 210175 phv00210175.v1.p1 pht004185.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:42:36+00:00 2018-04-26 16:42:36+00:00 MNB45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210191 phv00210191.v1.p1 pht004186.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:43:32+00:00 2018-04-26 16:43:32+00:00 MNC45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210205 phv00210205.v1.p1 pht004187.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:44:16+00:00 2018-04-26 16:44:16+00:00 MND45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210222 phv00210222.v1.p1 pht004188.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:44:51+00:00 2018-04-26 16:44:51+00:00 MNA45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white males, exam 1] +25 Carotid IMT 210237 phv00210237.v1.p1 pht004189.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:45:22+00:00 2018-04-26 16:45:22+00:00 MNB45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210253 phv00210253.v1.p1 pht004190.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:45:53+00:00 2018-04-26 16:45:53+00:00 MNC45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210267 phv00210267.v1.p1 pht004191.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:46:25+00:00 2018-04-26 16:46:25+00:00 MND45_1 Mean of the RT45 variables [Reader-trend-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 212494 phv00212494.v1.p1 pht004209.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:47:44+00:00 2018-04-26 16:47:44+00:00 SUM45_1 Mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 1] +25 Carotid IMT 212495 phv00212495.v1.p1 pht004209.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:47:59+00:00 2018-04-26 16:47:59+00:00 SUM45_2 Weighted mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 1] +25 Carotid IMT 212513 phv00212513.v1.p1 pht004210.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:49:39+00:00 2018-04-26 16:49:39+00:00 SUM45_1 Mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 1] +25 Carotid IMT 212514 phv00212514.v1.p1 pht004210.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:50:03+00:00 2018-04-26 16:50:03+00:00 SUM45_2 Weighted mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 1] +25 Carotid IMT 212501 phv00212501.v1.p1 pht004210.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:51:36+00:00 2018-04-26 16:51:36+00:00 LBIADA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black males, exam 1] +25 Carotid IMT 212502 phv00212502.v1.p1 pht004210.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:51:56+00:00 2018-04-26 16:51:56+00:00 RBIADA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black males, exam 1] +25 Carotid IMT 212482 phv00212482.v1.p1 pht004209.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:53:09+00:00 2018-04-26 16:53:09+00:00 LBIADA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black females, exam 1] +25 Carotid IMT 212483 phv00212483.v1.p1 pht004209.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:53:27+00:00 2018-04-26 16:53:27+00:00 RBIADA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black females, exam 1] +25 Carotid IMT 212520 phv00212520.v1.p1 pht004211.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:54:28+00:00 2018-04-26 16:54:28+00:00 LBIADA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white females, exam 1] +25 Carotid IMT 212521 phv00212521.v1.p1 pht004211.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:54:42+00:00 2018-04-26 16:54:42+00:00 RBIADA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white females, exam 1] +25 Carotid IMT 212532 phv00212532.v1.p1 pht004211.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:55:34+00:00 2018-04-26 16:55:34+00:00 SUM45_1 Mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 1] +25 Carotid IMT 212533 phv00212533.v1.p1 pht004211.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:55:49+00:00 2018-04-26 16:55:49+00:00 SUM45_2 Weighted mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 1] +25 Carotid IMT 212539 phv00212539.v1.p1 pht004212.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:56:35+00:00 2018-04-26 16:56:35+00:00 LBIADA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white males, exam 1] +25 Carotid IMT 212540 phv00212540.v1.p1 pht004212.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:56:51+00:00 2018-04-26 16:56:51+00:00 RBIADA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white males, exam 1] +25 Carotid IMT 212551 phv00212551.v1.p1 pht004212.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:57:37+00:00 2018-04-26 16:57:37+00:00 SUM45_1 Mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 1] +25 Carotid IMT 212552 phv00212552.v1.p1 pht004212.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:57:56+00:00 2018-04-26 16:57:56+00:00 SUM45_2 Weighted mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 1] +25 Carotid IMT 212656 phv00212656.v1.p1 pht004214.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:59:05+00:00 2018-04-26 16:59:05+00:00 LBIBDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black females, exam 2] +25 Carotid IMT 212657 phv00212657.v1.p1 pht004214.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 16:59:20+00:00 2018-04-26 16:59:20+00:00 RBIBDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black females, exam 2] +25 Carotid IMT 212668 phv00212668.v1.p1 pht004214.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:00:08+00:00 2018-04-26 17:00:08+00:00 SUM45_21 Mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 2] +25 Carotid IMT 212669 phv00212669.v1.p1 pht004214.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:00:23+00:00 2018-04-26 17:00:23+00:00 SUM45_22 Weighted mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 2] +25 Carotid IMT 212674 phv00212674.v1.p1 pht004215.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:01:27+00:00 2018-04-26 17:01:27+00:00 LBIBDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black males, exam 2] +25 Carotid IMT 212675 phv00212675.v1.p1 pht004215.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:01:43+00:00 2018-04-26 17:01:43+00:00 RBIBDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black males, exam 2] +25 Carotid IMT 212686 phv00212686.v1.p1 pht004215.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:02:27+00:00 2018-04-26 17:02:27+00:00 SUM45_21 Mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 2] +25 Carotid IMT 212687 phv00212687.v1.p1 pht004215.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:02:43+00:00 2018-04-26 17:02:43+00:00 SUM45_22 Weighted mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 2] +25 Carotid IMT 212692 phv00212692.v1.p1 pht004216.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:03:51+00:00 2018-04-26 17:03:51+00:00 LBIBDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white females, exam 2] +25 Carotid IMT 212693 phv00212693.v1.p1 pht004216.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:04:06+00:00 2018-04-26 17:04:06+00:00 RBIBDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white females, exam 2] +25 Carotid IMT 212704 phv00212704.v1.p1 pht004216.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:04:40+00:00 2018-04-26 17:04:40+00:00 SUM45_21 Mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 2] +25 Carotid IMT 212705 phv00212705.v1.p1 pht004216.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:04:54+00:00 2018-04-26 17:04:54+00:00 SUM45_22 Weighted mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 2] +25 Carotid IMT 212710 phv00212710.v1.p1 pht004217.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:05:45+00:00 2018-04-26 17:05:45+00:00 LBIBDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white males, exam 2] +25 Carotid IMT 212711 phv00212711.v1.p1 pht004217.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:05:59+00:00 2018-04-26 17:05:59+00:00 RBIBDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white males, exam 2] +25 Carotid IMT 212722 phv00212722.v1.p1 pht004217.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:06:43+00:00 2018-04-26 17:06:43+00:00 SUM45_21 Mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 2] +25 Carotid IMT 212723 phv00212723.v1.p1 pht004217.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:07:02+00:00 2018-04-26 17:07:02+00:00 SUM45_22 Weighted mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 2] +25 Carotid IMT 213833 phv00213833.v1.p1 pht004219.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:07:53+00:00 2018-04-26 17:07:53+00:00 LBICDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black females, exam 3] +25 Carotid IMT 213834 phv00213834.v1.p1 pht004219.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:08:09+00:00 2018-04-26 17:08:09+00:00 RBICDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black females, exam 3] +25 Carotid IMT 213845 phv00213845.v1.p1 pht004219.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:08:53+00:00 2018-04-26 17:08:53+00:00 SUM45_31 Mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 3] +25 Carotid IMT 213846 phv00213846.v1.p1 pht004219.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:09:08+00:00 2018-04-26 17:09:08+00:00 SUM45_32 Weighted mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 3] +25 Carotid IMT 213851 phv00213851.v1.p1 pht004220.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:10:44+00:00 2018-04-26 17:10:44+00:00 LBICDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed values, black males, exam 3] +25 Carotid IMT 213852 phv00213852.v1.p1 pht004220.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:11:08+00:00 2018-04-26 17:11:08+00:00 RBICDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed values, black males, exam 3] +25 Carotid IMT 213863 phv00213863.v1.p1 pht004220.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:11:55+00:00 2018-04-26 17:11:55+00:00 SUM45_31 Mean of the DA45 variables [Ultrasound Imputed values, black males, exam 3] +25 Carotid IMT 213864 phv00213864.v1.p1 pht004220.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:12:13+00:00 2018-04-26 17:12:13+00:00 SUM45_32 Weighted mean of the DA45 variables [Ultrasound Imputed values, black males, exam 3] +25 Carotid IMT 213869 phv00213869.v1.p1 pht004221.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:13:29+00:00 2018-04-26 17:13:29+00:00 LBICDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white females, exam 3] +25 Carotid IMT 213870 phv00213870.v1.p1 pht004221.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:13:42+00:00 2018-04-26 17:13:42+00:00 RBICDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white females, exam 3] +25 Carotid IMT 213881 phv00213881.v1.p1 pht004221.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:14:31+00:00 2018-04-26 17:14:31+00:00 SUM45_31 Mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 3] +25 Carotid IMT 213882 phv00213882.v1.p1 pht004221.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:14:46+00:00 2018-04-26 17:14:46+00:00 SUM45_32 Weighted mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 3] +25 Carotid IMT 213887 phv00213887.v1.p1 pht004222.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:15:48+00:00 2018-04-26 17:15:48+00:00 LBICDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white males, exam 3] +25 Carotid IMT 213888 phv00213888.v1.p1 pht004222.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:16:07+00:00 2018-04-26 17:16:07+00:00 RBICDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white males, exam 3] +25 Carotid IMT 213899 phv00213899.v1.p1 pht004222.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:16:51+00:00 2018-04-26 17:16:51+00:00 SUM45_31 Mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 3] +25 Carotid IMT 213900 phv00213900.v1.p1 pht004222.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:17:04+00:00 2018-04-26 17:17:04+00:00 SUM45_32 Weighted mean of the DA45 variables [Ultrasound Imputed Values, white males, exam 3] +25 Carotid IMT 213980 phv00213980.v1.p1 pht004224.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:17:55+00:00 2018-04-26 17:17:55+00:00 LBIDDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black females, exam 4] +25 Carotid IMT 213981 phv00213981.v1.p1 pht004224.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:18:10+00:00 2018-04-26 17:18:10+00:00 RBIDDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black females, exam 4] +25 Carotid IMT 213992 phv00213992.v1.p1 pht004224.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:19:26+00:00 2018-04-26 17:19:26+00:00 SUM45_41 Mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 4] +25 Carotid IMT 213993 phv00213993.v1.p1 pht004224.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:19:40+00:00 2018-04-26 17:19:40+00:00 SUM45_42 Weighted mean of the DA45 variables [Ultrasound Imputed Values, black females, exam 4] +25 Carotid IMT 213998 phv00213998.v1.p1 pht004225.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:20:45+00:00 2018-04-26 17:20:45+00:00 LBIDDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, black males, exam 4] +25 Carotid IMT 213999 phv00213999.v1.p1 pht004225.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:21:01+00:00 2018-04-26 17:21:01+00:00 RBIDDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, black males, exam 4] +25 Carotid IMT 214010 phv00214010.v1.p1 pht004225.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:21:47+00:00 2018-04-26 17:21:47+00:00 SUM45_41 Mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 4] +25 Carotid IMT 214011 phv00214011.v1.p1 pht004225.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:22:00+00:00 2018-04-26 17:22:00+00:00 SUM45_42 Weighted mean of the DA45 variables [Ultrasound Imputed Values, black males, exam 4] +25 Carotid IMT 214016 phv00214016.v1.p1 pht004226.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:22:52+00:00 2018-04-26 17:22:52+00:00 LBIDDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white females, exam 4] +25 Carotid IMT 214017 phv00214017.v1.p1 pht004226.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:23:06+00:00 2018-04-26 17:23:06+00:00 RBIDDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white females, exam 4] +25 Carotid IMT 214028 phv00214028.v1.p1 pht004226.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:23:54+00:00 2018-04-26 17:23:54+00:00 SUM45_41 Mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 4] +25 Carotid IMT 214029 phv00214029.v1.p1 pht004226.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 17:24:07+00:00 2018-04-26 17:24:07+00:00 SUM45_42 Weighted mean of the DA45 variables [Ultrasound Imputed Values, white females, exam 4] +25 Carotid IMT 214034 phv00214034.v1.p1 pht004227.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 18:01:23+00:00 2018-04-26 18:01:23+00:00 LBIDDA45 Derived average far wall thickness, left bifurcation [Ultrasound Imputed Values, white males, exam 4] +25 Carotid IMT 214035 phv00214035.v1.p1 pht004227.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 18:01:37+00:00 2018-04-26 18:01:37+00:00 RBIDDA45 Derived average far wall thickness, right bifurcation [Ultrasound Imputed Values, white males, exam 4] +25 Carotid IMT 214046 phv00214046.v1.p1 pht004227.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 18:02:17+00:00 2018-04-26 18:02:17+00:00 SUM45_41 Mean of the day 45 variables [Ultrasound Imputed Values, white males, exam 4] +25 Carotid IMT 214047 phv00214047.v1.p1 pht004227.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 18:02:32+00:00 2018-04-26 18:02:32+00:00 SUM45_42 Weighted mean of the day 45 variables [Ultrasound Imputed Values, white males, exam 4] +25 Carotid IMT 209957 phv00209957.v1.p1 pht004172.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:32:25+00:00 2018-04-26 20:32:25+00:00 LBIBJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209958 phv00209958.v1.p1 pht004172.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:33:36+00:00 2018-04-26 20:33:36+00:00 RBIBJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209959 phv00209959.v1.p1 pht004172.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:33:51+00:00 2018-04-26 20:33:51+00:00 LINBJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209960 phv00209960.v1.p1 pht004172.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:34:11+00:00 2018-04-26 20:34:11+00:00 RINBJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209961 phv00209961.v1.p1 pht004172.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:34:29+00:00 2018-04-26 20:34:29+00:00 LOPBJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209962 phv00209962.v1.p1 pht004172.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:34:46+00:00 2018-04-26 20:34:46+00:00 ROPBJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209964 phv00209964.v1.p1 pht004172.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:35:01+00:00 2018-04-26 20:35:01+00:00 MNB45_1S Mean of the JS45 Variables [Reader-trend-shift-adjusted ultrasound, black females, exam 2] +25 Carotid IMT 209974 phv00209974.v1.p1 pht004173.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:35:56+00:00 2018-04-26 20:35:56+00:00 LBICJS45 Imputed R/T Adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209975 phv00209975.v1.p1 pht004173.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:36:11+00:00 2018-04-26 20:36:11+00:00 RBICJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209976 phv00209976.v1.p1 pht004173.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:36:29+00:00 2018-04-26 20:36:29+00:00 LINCJS45 Imputed R/T Adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209977 phv00209977.v1.p1 pht004173.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:36:46+00:00 2018-04-26 20:36:46+00:00 RINCJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209978 phv00209978.v1.p1 pht004173.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:37:02+00:00 2018-04-26 20:37:02+00:00 LOPCJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209981 phv00209981.v1.p1 pht004173.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:37:30+00:00 2018-04-26 20:37:30+00:00 MNC45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black females, exam 3] +25 Carotid IMT 209989 phv00209989.v1.p1 pht004174.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:38:05+00:00 2018-04-26 20:38:05+00:00 LINDJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209990 phv00209990.v1.p1 pht004174.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:38:19+00:00 2018-04-26 20:38:19+00:00 RINDJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209991 phv00209991.v1.p1 pht004174.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:38:35+00:00 2018-04-26 20:38:35+00:00 LBIDJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209992 phv00209992.v1.p1 pht004174.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:38:51+00:00 2018-04-26 20:38:51+00:00 RBIDJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209993 phv00209993.v1.p1 pht004174.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:39:07+00:00 2018-04-26 20:39:07+00:00 LOPDJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209994 phv00209994.v1.p1 pht004174.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:39:22+00:00 2018-04-26 20:39:22+00:00 ROPDJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 209996 phv00209996.v1.p1 pht004174.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:39:40+00:00 2018-04-26 20:39:40+00:00 MND45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black females, exam 4] +25 Carotid IMT 210006 phv00210006.v1.p1 pht004175.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:40:48+00:00 2018-04-26 20:40:48+00:00 LBIBJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 2] +25 Carotid IMT 210007 phv00210007.v1.p1 pht004175.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:41:04+00:00 2018-04-26 20:41:04+00:00 RBIBJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 2] +25 Carotid IMT 210008 phv00210008.v1.p1 pht004175.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:41:19+00:00 2018-04-26 20:41:19+00:00 LINBJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 2] +25 Carotid IMT 210009 phv00210009.v1.p1 pht004175.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:41:35+00:00 2018-04-26 20:41:35+00:00 RINBJS45 Imputed R/T adjusted av45, shifted, RIN [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 2] +25 Carotid IMT 210010 phv00210010.v1.p1 pht004175.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:41:50+00:00 2018-04-26 20:41:50+00:00 LOPBJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 2] +25 Carotid IMT 210011 phv00210011.v1.p1 pht004175.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:42:04+00:00 2018-04-26 20:42:04+00:00 ROPBJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 2] +25 Carotid IMT 210013 phv00210013.v1.p1 pht004175.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:42:19+00:00 2018-04-26 20:42:19+00:00 MNB45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black male, exam 2] +25 Carotid IMT 210023 phv00210023.v1.p1 pht004176.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:42:58+00:00 2018-04-26 20:42:58+00:00 LBICJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 3] +25 Carotid IMT 210024 phv00210024.v1.p1 pht004176.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:43:12+00:00 2018-04-26 20:43:12+00:00 RBICJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 3] +25 Carotid IMT 210025 phv00210025.v1.p1 pht004176.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:43:26+00:00 2018-04-26 20:43:26+00:00 LINCJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 3] +25 Carotid IMT 210026 phv00210026.v1.p1 pht004176.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:43:41+00:00 2018-04-26 20:43:41+00:00 RINCJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 3] +25 Carotid IMT 210027 phv00210027.v1.p1 pht004176.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:43:55+00:00 2018-04-26 20:43:55+00:00 LOPCJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 3] +25 Carotid IMT 210028 phv00210028.v1.p1 pht004176.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:44:10+00:00 2018-04-26 20:44:10+00:00 ROPCJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 3] +25 Carotid IMT 210030 phv00210030.v1.p1 pht004176.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:44:25+00:00 2018-04-26 20:44:25+00:00 MNC45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black male, exam 3] +25 Carotid IMT 210038 phv00210038.v1.p1 pht004177.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:44:55+00:00 2018-04-26 20:44:55+00:00 LINDJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 4] +25 Carotid IMT 210039 phv00210039.v1.p1 pht004177.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:45:09+00:00 2018-04-26 20:45:09+00:00 RINDJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, black male, exam 4] +25 Carotid IMT 210040 phv00210040.v1.p1 pht004177.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:45:25+00:00 2018-04-26 20:45:25+00:00 LBIDJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 4] +25 Carotid IMT 210041 phv00210041.v1.p1 pht004177.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:45:39+00:00 2018-04-26 20:45:39+00:00 RBIDJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, black male, exam 4] +25 Carotid IMT 210042 phv00210042.v1.p1 pht004177.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:45:54+00:00 2018-04-26 20:45:54+00:00 LOPDJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 4] +25 Carotid IMT 210043 phv00210043.v1.p1 pht004177.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:46:12+00:00 2018-04-26 20:46:12+00:00 ROPDJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, black male, exam 4] +25 Carotid IMT 210045 phv00210045.v1.p1 pht004177.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:46:27+00:00 2018-04-26 20:46:27+00:00 MND45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, black male, exam 4] +25 Carotid IMT 210055 phv00210055.v1.p1 pht004178.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:47:32+00:00 2018-04-26 20:47:32+00:00 LBIBJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210056 phv00210056.v1.p1 pht004178.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:47:50+00:00 2018-04-26 20:47:50+00:00 RBIBJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210057 phv00210057.v1.p1 pht004178.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:48:05+00:00 2018-04-26 20:48:05+00:00 LINBJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210058 phv00210058.v1.p1 pht004178.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:48:20+00:00 2018-04-26 20:48:20+00:00 RINBJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210059 phv00210059.v1.p1 pht004178.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:48:33+00:00 2018-04-26 20:48:33+00:00 LOPBJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210060 phv00210060.v1.p1 pht004178.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:48:49+00:00 2018-04-26 20:48:49+00:00 ROPBJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210062 phv00210062.v1.p1 pht004178.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:49:13+00:00 2018-04-26 20:49:13+00:00 MNB45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white females, exam 2] +25 Carotid IMT 210072 phv00210072.v1.p1 pht004179.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:49:45+00:00 2018-04-26 20:49:45+00:00 LBICJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210073 phv00210073.v1.p1 pht004179.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:50:00+00:00 2018-04-26 20:50:00+00:00 RBICJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210074 phv00210074.v1.p1 pht004179.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:50:14+00:00 2018-04-26 20:50:14+00:00 LINCJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210075 phv00210075.v1.p1 pht004179.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:50:33+00:00 2018-04-26 20:50:33+00:00 RINCJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210076 phv00210076.v1.p1 pht004179.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:50:51+00:00 2018-04-26 20:50:51+00:00 LOPCJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210077 phv00210077.v1.p1 pht004179.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:51:05+00:00 2018-04-26 20:51:05+00:00 ROPCJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210079 phv00210079.v1.p1 pht004179.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:51:20+00:00 2018-04-26 20:51:20+00:00 MNC45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white females, exam 3] +25 Carotid IMT 210087 phv00210087.v1.p1 pht004180.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:51:57+00:00 2018-04-26 20:51:57+00:00 LINDJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210088 phv00210088.v1.p1 pht004180.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:52:11+00:00 2018-04-26 20:52:11+00:00 RINDJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210089 phv00210089.v1.p1 pht004180.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:52:25+00:00 2018-04-26 20:52:25+00:00 LBIDJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210090 phv00210090.v1.p1 pht004180.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:52:40+00:00 2018-04-26 20:52:40+00:00 RBIDJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210091 phv00210091.v1.p1 pht004180.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:52:54+00:00 2018-04-26 20:52:54+00:00 LOPDJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210092 phv00210092.v1.p1 pht004180.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:53:10+00:00 2018-04-26 20:53:10+00:00 ROPDJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210094 phv00210094.v1.p1 pht004180.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:53:25+00:00 2018-04-26 20:53:25+00:00 MND45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white females, exam 4] +25 Carotid IMT 210104 phv00210104.v1.p1 pht004181.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:54:02+00:00 2018-04-26 20:54:02+00:00 LBIBJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210105 phv00210105.v1.p1 pht004181.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:54:26+00:00 2018-04-26 20:54:26+00:00 RBIBJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210106 phv00210106.v1.p1 pht004181.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:54:40+00:00 2018-04-26 20:54:40+00:00 LINBJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210107 phv00210107.v1.p1 pht004181.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:54:53+00:00 2018-04-26 20:54:53+00:00 RINBJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210108 phv00210108.v1.p1 pht004181.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:55:06+00:00 2018-04-26 20:55:06+00:00 LOPBJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210109 phv00210109.v1.p1 pht004181.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:55:23+00:00 2018-04-26 20:55:23+00:00 ROPBJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210111 phv00210111.v1.p1 pht004181.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:55:39+00:00 2018-04-26 20:55:39+00:00 MNB45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white males, exam 2] +25 Carotid IMT 210121 phv00210121.v1.p1 pht004182.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:56:30+00:00 2018-04-26 20:56:30+00:00 LBICJS45 Imputed R/T Adjusted av45, Shifted, LBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210122 phv00210122.v1.p1 pht004182.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:56:44+00:00 2018-04-26 20:56:44+00:00 RBICJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210123 phv00210123.v1.p1 pht004182.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:56:59+00:00 2018-04-26 20:56:59+00:00 LINCJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210124 phv00210124.v1.p1 pht004182.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:57:14+00:00 2018-04-26 20:57:14+00:00 RINCJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210125 phv00210125.v1.p1 pht004182.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:57:30+00:00 2018-04-26 20:57:30+00:00 LOPCJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210126 phv00210126.v1.p1 pht004182.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:57:44+00:00 2018-04-26 20:57:44+00:00 ROPCJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210128 phv00210128.v1.p1 pht004182.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:58:02+00:00 2018-04-26 20:58:02+00:00 MNC45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white males, exam 3] +25 Carotid IMT 210136 phv00210136.v1.p1 pht004183.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:58:30+00:00 2018-04-26 20:58:30+00:00 LINDJS45 Imputed R/T adjusted av45, shifted, LIN [left internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210137 phv00210137.v1.p1 pht004183.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:58:45+00:00 2018-04-26 20:58:45+00:00 RINDJS45 Imputed R/T adjusted av45, shifted, RIN [right internal carotid] [Reader-trend-shift-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210138 phv00210138.v1.p1 pht004183.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:59:01+00:00 2018-04-26 20:59:01+00:00 LBIDJS45 Imputed R/T adjusted av45, shifted, LBI [left bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210139 phv00210139.v1.p1 pht004183.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:59:18+00:00 2018-04-26 20:59:18+00:00 RBIDJS45 Imputed R/T adjusted av45, shifted, RBI [right bifurcation] [Reader-trend-shift-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210140 phv00210140.v1.p1 pht004183.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:59:32+00:00 2018-04-26 20:59:32+00:00 LOPDJS45 Imputed R/T adjusted av45, shifted, LOP [left common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210141 phv00210141.v1.p1 pht004183.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 20:59:48+00:00 2018-04-26 20:59:48+00:00 ROPDJS45 Imputed R/T adjusted av45, shifted, ROP [right common carotid: optimal angle] [Reader-trend-shift-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 210143 phv00210143.v1.p1 pht004183.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-26 21:00:03+00:00 2018-04-26 21:00:03+00:00 MND45_1S Mean of the JS45 variables [Reader-trend-shift-adjusted ultrasound, white males, exam 4] +25 Carotid IMT 211101 phv00211101.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:32:07+00:00 2018-05-04 22:32:07+00:00 ROPAAV45 Average far wall width, right common carotid: optimal angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211102 phv00211102.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:33:55+00:00 2018-05-04 22:33:55+00:00 RANAAV45 Average far wall width, right common carotid: anterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211103 phv00211103.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:34:29+00:00 2018-05-04 22:34:29+00:00 RPOAAV45 Average far wall width, right common carotid: posterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211095 phv00211095.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:34:55+00:00 2018-05-04 22:34:55+00:00 LOPAAV45 Average far wall width, left common carotid: optimal angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211096 phv00211096.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:35:15+00:00 2018-05-04 22:35:15+00:00 LANAAV45 Average far wall width, left common carotid: anterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211097 phv00211097.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:35:37+00:00 2018-05-04 22:35:37+00:00 LPOAAV45 Average far wall width, left common carotid: posterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211053 phv00211053.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:36:03+00:00 2018-05-04 22:36:03+00:00 LOPAMX23 Maximum near wall width, left common carotid: optimal angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211054 phv00211054.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:36:25+00:00 2018-05-04 22:36:25+00:00 LANAMX23 Maximum near wall width, left common carotid: anterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211055 phv00211055.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:36:46+00:00 2018-05-04 22:36:46+00:00 LPOAMX23 Maximum near wall width, left common carotid: posterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211059 phv00211059.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:37:28+00:00 2018-05-04 22:37:28+00:00 ROPAMX23 Maximum near wall width, right common carotid: optimal angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211060 phv00211060.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:37:50+00:00 2018-05-04 22:37:50+00:00 RANAMX23 Maximum near wall width, right common carotid: anterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211061 phv00211061.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:38:09+00:00 2018-05-04 22:38:09+00:00 RPOAMX23 Maximum near wall width, right common carotid: posterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211081 phv00211081.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:38:33+00:00 2018-05-04 22:38:33+00:00 LOPAMX45 Maximum far wall width, left common carotid: optimal angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211082 phv00211082.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:38:58+00:00 2018-05-04 22:38:58+00:00 LANAMX45 Maximum far wall width, left common carotid: anterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211083 phv00211083.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:39:17+00:00 2018-05-04 22:39:17+00:00 LPOAMX45 Maximum far wall width, left common carotid: posterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211087 phv00211087.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:39:40+00:00 2018-05-04 22:39:40+00:00 ROPAMX45 Maximum far wall width, right common carotid: optimal angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211088 phv00211088.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:39:59+00:00 2018-05-04 22:39:59+00:00 RANAMX45 Maximum far wall width, right common carotid: anterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211089 phv00211089.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-04 22:40:24+00:00 2018-05-04 22:40:24+00:00 RPOAMX45 Maximum far wall width, right common carotid: posterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 126104 phv00126104.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:27:42+00:00 2018-06-12 01:27:42+00:00 cca45_1 Maximum likelihood estimate of average right and left common carotid far wall CIMT +25 Carotid IMT 126103 phv00126103.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:28:38+00:00 2018-06-12 01:28:38+00:00 sum45_1 Maximum likelihood estimate of the average far wall CIMT at the optimal +25 Carotid IMT 211057 phv00211057.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:25:32+00:00 2018-06-12 14:25:32+00:00 LINAMX23 Maximum near wall width, left internal carotid [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211058 phv00211058.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:25:52+00:00 2018-06-12 14:25:52+00:00 RPPAMX23 Maximum near wall width, right popliteal [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211062 phv00211062.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:26:47+00:00 2018-06-12 14:26:47+00:00 RBIAMX23 Maximum near wall width, right bifurcation [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211063 phv00211063.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:27:14+00:00 2018-06-12 14:27:14+00:00 RINAMX23 Maximum near wall width, right internal carotid [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211064 phv00211064.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:27:35+00:00 2018-06-12 14:27:35+00:00 QC1AMX23 Maximum near wall width (QC scan 0 1) [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211065 phv00211065.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:27:57+00:00 2018-06-12 14:27:57+00:00 QC2AMX23 Maximum near wall width (QC scan 02) [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211066 phv00211066.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:28:21+00:00 2018-06-12 14:28:21+00:00 LPPAAV23 Average near wall width, left popliteal [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211067 phv00211067.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:28:41+00:00 2018-06-12 14:28:41+00:00 LOPAAV23 Average near wall width, left common carotid: optimal angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211068 phv00211068.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:29:01+00:00 2018-06-12 14:29:01+00:00 LANAAV23 Average near wall width, left common carotid: anterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211069 phv00211069.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:29:19+00:00 2018-06-12 14:29:19+00:00 LPOAAV23 Average near wall width, left common carotid: posterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211070 phv00211070.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:29:42+00:00 2018-06-12 14:29:42+00:00 LBIAAV23 Average near wall width, left bifurcation [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211071 phv00211071.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:30:08+00:00 2018-06-12 14:30:08+00:00 LINAAV23 Average near wall width, left internal carotid [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211072 phv00211072.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:30:30+00:00 2018-06-12 14:30:30+00:00 RPPAAV23 Average near wall width, right popliteal [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211073 phv00211073.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:30:48+00:00 2018-06-12 14:30:48+00:00 ROPAAV23 Average near wall width, right common carotid: optimal angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211074 phv00211074.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:31:10+00:00 2018-06-12 14:31:10+00:00 RANAAV23 Average near wall width, right common carotid: anterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211075 phv00211075.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:31:29+00:00 2018-06-12 14:31:29+00:00 RPOAAV23 Average near wall width, right common carotid: posterior angle [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211076 phv00211076.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:31:47+00:00 2018-06-12 14:31:47+00:00 RBIAAV23 Average near wall width, right bifurcation [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211077 phv00211077.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:32:05+00:00 2018-06-12 14:32:05+00:00 RINAAV23 Average near wall width, right internal carotid [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211078 phv00211078.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:32:24+00:00 2018-06-12 14:32:24+00:00 QC1AAV23 Average near wall width (QC scan 0 1) [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211079 phv00211079.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:45:06+00:00 2018-06-12 14:45:06+00:00 QC2AAV23 Average near wall width (QC scan 02) [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211080 phv00211080.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:45:27+00:00 2018-06-12 14:45:27+00:00 LPPAMX45 Maximum far wall width, left popliteal [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211084 phv00211084.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:46:26+00:00 2018-06-12 14:46:26+00:00 LBIAMX45 Maximum far wall width, left bifurcation [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211085 phv00211085.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:46:43+00:00 2018-06-12 14:46:43+00:00 LINAMX45 Maximum far wall width, left internal carotid [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211086 phv00211086.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:47:08+00:00 2018-06-12 14:47:08+00:00 RPPAMX45 Maximum far wall width, right popliteal [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211090 phv00211090.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:47:48+00:00 2018-06-12 14:47:48+00:00 RBIAMX45 Maximum far wall width, right bifurcation [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211091 phv00211091.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:48:13+00:00 2018-06-12 14:48:13+00:00 RINAMX45 Maximum far wall width, right internal carotid [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211092 phv00211092.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:48:31+00:00 2018-06-12 14:48:31+00:00 QC1AMX45 Maximum far wall width (QC scan 0 1) [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211093 phv00211093.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:48:51+00:00 2018-06-12 14:48:51+00:00 QC2AMX45 Maximum far wall width (QC scan 02) [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211094 phv00211094.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:49:06+00:00 2018-06-12 14:49:06+00:00 LPPAAV45 Average far wall width, left popliteal [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211098 phv00211098.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:50:20+00:00 2018-06-12 14:50:20+00:00 LBIAAV45 Average far wall width, left bifurcation [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211099 phv00211099.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:50:43+00:00 2018-06-12 14:50:43+00:00 LINAAV45 Average far wall width, left internal carotid [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211100 phv00211100.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:51:02+00:00 2018-06-12 14:51:02+00:00 RPPAAV45 Average far wall width, right popliteal [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211104 phv00211104.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:51:56+00:00 2018-06-12 14:51:56+00:00 RBIAAV45 Average far wall width, right bifurcation [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211105 phv00211105.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:53:48+00:00 2018-06-12 14:53:48+00:00 RINAAV45 Average far wall width, right internal carotid [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211106 phv00211106.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 14:55:43+00:00 2018-06-12 14:55:43+00:00 QC1AAV45 Average far wall width (QC scan 0 1) [Ultrasound Derived Data, exam 1] +25 Carotid IMT 211107 phv00211107.v1.p1 pht004207.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:19:20+00:00 2018-06-12 16:19:20+00:00 QC2AAV45 Average far wall width (QC scan 02) [Ultrasound Derived Data, exam 1] +25 Carotid IMT 212559 phv00212559.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:19:39+00:00 2018-06-12 16:19:39+00:00 LOPBMX23 Maximum near wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212560 phv00212560.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:20:06+00:00 2018-06-12 16:20:06+00:00 LANBMX23 Maximum near wall width (left common carotid: anterior angle) +25 Carotid IMT 212561 phv00212561.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:20:27+00:00 2018-06-12 16:20:27+00:00 LPOBMX23 Maximum near wall width (left common carotid: posterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212562 phv00212562.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:20:50+00:00 2018-06-12 16:20:50+00:00 LBIBMX23 Maximum near wall width (left bifurcation) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212563 phv00212563.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:21:05+00:00 2018-06-12 16:21:05+00:00 LBNBMX23 Maximum near wall width (left bifurcation focus-near wall) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212564 phv00212564.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:21:26+00:00 2018-06-12 16:21:26+00:00 LINBMX23 Maximum near wall width (left internal carotid) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212565 phv00212565.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:21:54+00:00 2018-06-12 16:21:54+00:00 ROPBMX23 Maximum near wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212566 phv00212566.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:22:12+00:00 2018-06-12 16:22:12+00:00 RANBMX23 Maximum near wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212567 phv00212567.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:22:30+00:00 2018-06-12 16:22:30+00:00 RPOBMX23 Maximum near wall width (right common carotid: posterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212568 phv00212568.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:22:52+00:00 2018-06-12 16:22:52+00:00 RBIBMX23 Maximum near wall width (right bifurcation) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212569 phv00212569.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:23:10+00:00 2018-06-12 16:23:10+00:00 RBNBMX23 Maximum near wall width (right bifurcation focus-near wall) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212570 phv00212570.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:23:28+00:00 2018-06-12 16:23:28+00:00 RINBMX23 Maximum near wall width (right internal carotid) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212571 phv00212571.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:23:45+00:00 2018-06-12 16:23:45+00:00 QC1BMX23 Maximum near wall width (first QC repeat scan) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212572 phv00212572.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:24:03+00:00 2018-06-12 16:24:03+00:00 QC2BMX23 Maximum near wall width (QC scan 02) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212573 phv00212573.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:24:19+00:00 2018-06-12 16:24:19+00:00 LOPBAV23 Average near wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 2] [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212574 phv00212574.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:24:35+00:00 2018-06-12 16:24:35+00:00 LANBAV23 Average near wall width (left common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212575 phv00212575.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:24:51+00:00 2018-06-12 16:24:51+00:00 LPOBAV23 Average near wall width (left common carotid: posterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212576 phv00212576.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:25:04+00:00 2018-06-12 16:25:04+00:00 LBIBAV23 Average near wall width (left bifurcation) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212577 phv00212577.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:25:21+00:00 2018-06-12 16:25:21+00:00 LBNBAV23 Average near wall width (left bifurcation focus-near wall) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212578 phv00212578.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:25:35+00:00 2018-06-12 16:25:35+00:00 LINBAV23 Average near wall width (left internal carotid) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212579 phv00212579.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:25:53+00:00 2018-06-12 16:25:53+00:00 ROPBAV23 Average near wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212580 phv00212580.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:26:29+00:00 2018-06-12 16:26:29+00:00 RANBAV23 Average near wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212581 phv00212581.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:28:35+00:00 2018-06-12 16:28:35+00:00 RPOBAV23 Average near wall width (right common carotid: posterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212582 phv00212582.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:28:54+00:00 2018-06-12 16:28:54+00:00 RBIBAV23 Average near wall width (right bifurcation) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212583 phv00212583.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:29:43+00:00 2018-06-12 16:29:43+00:00 RBNBAV23 Average near wall width (right bifurcation focus-near wall) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212584 phv00212584.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:29:57+00:00 2018-06-12 16:29:57+00:00 RINBAV23 Average near wall width (right internal carotid) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212585 phv00212585.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:30:27+00:00 2018-06-12 16:30:27+00:00 QC1BAV23 Average near wall width (first QC repeat scan) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212586 phv00212586.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:30:44+00:00 2018-06-12 16:30:44+00:00 QC2BAV23 Average near wall width (QC scan 02) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212587 phv00212587.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:31:02+00:00 2018-06-12 16:31:02+00:00 LOPBMX45 Maximum far wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212588 phv00212588.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:31:16+00:00 2018-06-12 16:31:16+00:00 LANBMX45 Maximum far wall width (left common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212589 phv00212589.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:31:35+00:00 2018-06-12 16:31:35+00:00 LPOBMX45 Maximum far wall width (left common carotid: posterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212590 phv00212590.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:31:53+00:00 2018-06-12 16:31:53+00:00 LBIBMX45 Maximum far wall width (left bifurcation) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212591 phv00212591.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:32:07+00:00 2018-06-12 16:32:07+00:00 LBFBMX45 Maximum far wall width (left bifurcation focus-far wall) +25 Carotid IMT 212592 phv00212592.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:32:22+00:00 2018-06-12 16:32:22+00:00 LINBMX45 Maximum far wall width (left internal carotid) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212593 phv00212593.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:33:04+00:00 2018-06-12 16:33:04+00:00 ROPBMX45 Maximum far wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212594 phv00212594.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:33:22+00:00 2018-06-12 16:33:22+00:00 RANBMX45 Maximum far wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212595 phv00212595.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:33:40+00:00 2018-06-12 16:33:40+00:00 RPOBMX45 Maximum far wall width (right common carotid: posterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212596 phv00212596.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:33:58+00:00 2018-06-12 16:33:58+00:00 RBIBMX45 Maximum far wall width (right bifurcation) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212597 phv00212597.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:34:13+00:00 2018-06-12 16:34:13+00:00 RBFBMX45 Maximum far wall width (right bifurcation focus-far wall) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212598 phv00212598.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:34:27+00:00 2018-06-12 16:34:27+00:00 RINBMX45 Maximum far wall width (right internal carotid) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212599 phv00212599.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:34:45+00:00 2018-06-12 16:34:45+00:00 QC1BMX45 Maximum far wall width (first QC repeat scan) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212600 phv00212600.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:35:01+00:00 2018-06-12 16:35:01+00:00 QC2BMX45 Maximum far wall width (QC scan 02) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212601 phv00212601.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:35:18+00:00 2018-06-12 16:35:18+00:00 LOPBAV45 Average far wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 2] [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212602 phv00212602.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:35:38+00:00 2018-06-12 16:35:38+00:00 LANBAV45 Average far wall width (left common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212603 phv00212603.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:35:54+00:00 2018-06-12 16:35:54+00:00 LPOBAV45 Average far wall width (left common carotid: posterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212604 phv00212604.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:36:10+00:00 2018-06-12 16:36:10+00:00 LBIBAV45 Average far wall width (left bifurcation) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212605 phv00212605.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 16:36:37+00:00 2018-06-12 16:36:37+00:00 LBFBAV45 Average far wall width (left bifurcation focus-far wall) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212606 phv00212606.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:22:46+00:00 2018-06-12 19:22:46+00:00 LINBAV45 Average far wall width (left internal carotid) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212607 phv00212607.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:23:08+00:00 2018-06-12 19:23:08+00:00 ROPBAV45 Average far wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212608 phv00212608.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:23:26+00:00 2018-06-12 19:23:26+00:00 RANBAV45 Average far wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212609 phv00212609.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:23:44+00:00 2018-06-12 19:23:44+00:00 RPOBAV45 Average far wall width (right common carotid: posterior angle) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212610 phv00212610.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:24:04+00:00 2018-06-12 19:24:04+00:00 RBIBAV45 Average far wall width (right bifurcation) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212611 phv00212611.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:24:22+00:00 2018-06-12 19:24:22+00:00 RBFBAV45 Average far wall width (right bifurcation focus-far wall) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212612 phv00212612.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:24:42+00:00 2018-06-12 19:24:42+00:00 RINBAV45 Average far wall width (right internal carotid) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 212613 phv00212613.v1.p1 pht004213.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:24:59+00:00 2018-06-12 19:24:59+00:00 QC1BAV45 Average far wall width (first QC repeat scan) [Ultrasound Derived Data, exam 2] +25 Carotid IMT 213911 phv00213911.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:27:14+00:00 2018-06-12 19:27:14+00:00 LOPDMX23 Maximum near wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213912 phv00213912.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:27:33+00:00 2018-06-12 19:27:33+00:00 ROPDMX23 Maximum near wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213913 phv00213913.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:27:48+00:00 2018-06-12 19:27:48+00:00 LBIDMX23 Maximum near wall width (left bifurcation) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213914 phv00213914.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:28:10+00:00 2018-06-12 19:28:10+00:00 RBIDMX23 Maximum near wall width (right bifurcation) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213915 phv00213915.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:28:25+00:00 2018-06-12 19:28:25+00:00 LBNDMX23 Maximum near wall width (left bifurcation focus-near wall) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213916 phv00213916.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:28:41+00:00 2018-06-12 19:28:41+00:00 RBNDMX23 Maximum near wall width (right bifurcation focus-near wall) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213917 phv00213917.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:28:58+00:00 2018-06-12 19:28:58+00:00 LINDMX23 Maximum near wall width (left internal carotid) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213918 phv00213918.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:29:15+00:00 2018-06-12 19:29:15+00:00 RINDMX23 Maximum near wall width (right internal carotid) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213919 phv00213919.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:29:34+00:00 2018-06-12 19:29:34+00:00 QC1DMX23 Maximum near wall width (first QC repeat scan) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213920 phv00213920.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:29:50+00:00 2018-06-12 19:29:50+00:00 QC2DMX23 Maximum near wall width (QC scan 02) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213921 phv00213921.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:30:09+00:00 2018-06-12 19:30:09+00:00 LOPDAV23 Average near wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213922 phv00213922.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:30:24+00:00 2018-06-12 19:30:24+00:00 ROPDAV23 Average near wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213923 phv00213923.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:30:38+00:00 2018-06-12 19:30:38+00:00 LBIDAV23 Average near wall width (left bifurcation) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213924 phv00213924.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:30:52+00:00 2018-06-12 19:30:52+00:00 RBIDAV23 Average near wall width (right bifurcation) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213925 phv00213925.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:31:14+00:00 2018-06-12 19:31:14+00:00 LBNDAV23 Average near wall width (left bifurcation focus-near wall) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213926 phv00213926.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:32:15+00:00 2018-06-12 19:32:15+00:00 RBNDAV23 Average near wall width (right bifurcation focus-near wall) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213927 phv00213927.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:32:31+00:00 2018-06-12 19:32:31+00:00 LINDAV23 Average near wall width (left internal carotid) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213928 phv00213928.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:32:50+00:00 2018-06-12 19:32:50+00:00 RINDAV23 Average near wall width (right internal carotid) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213929 phv00213929.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:33:06+00:00 2018-06-12 19:33:06+00:00 QC1DAV23 Average near wall width (first QC repeat scan) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213930 phv00213930.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:33:23+00:00 2018-06-12 19:33:23+00:00 QC2DAV23 Average near wall width (QC scan 02) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213931 phv00213931.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:33:41+00:00 2018-06-12 19:33:41+00:00 LOPDMX45 Maximum far wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213932 phv00213932.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:33:55+00:00 2018-06-12 19:33:55+00:00 ROPDMX45 Maximum far wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213933 phv00213933.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:34:10+00:00 2018-06-12 19:34:10+00:00 LBIDMX45 Maximum far wall width (left bifurcation) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213934 phv00213934.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:34:28+00:00 2018-06-12 19:34:28+00:00 RBIDMX45 Maximum far wall width (right bifurcation) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213935 phv00213935.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:34:42+00:00 2018-06-12 19:34:42+00:00 LBFDMX45 Maximum far wall width (left bifurcation focus-far wall) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213936 phv00213936.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:34:57+00:00 2018-06-12 19:34:57+00:00 RBFDMX45 Maximum far wall width (right bifurcation focus-far wall) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213937 phv00213937.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:35:14+00:00 2018-06-12 19:35:14+00:00 LINDMX45 Maximum far wall width (left internal carotid) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213938 phv00213938.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:35:32+00:00 2018-06-12 19:35:32+00:00 RINDMX45 Maximum far wall width (right internal carotid) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213939 phv00213939.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:35:46+00:00 2018-06-12 19:35:46+00:00 QC1DMX45 Maximum far wall width (first QC repeat scan) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213940 phv00213940.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:36:02+00:00 2018-06-12 19:36:02+00:00 QC2DMX45 Maximum far wall width (QC scan 02) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213941 phv00213941.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:36:20+00:00 2018-06-12 19:36:20+00:00 LOPDAV45 Average far wall width (left common carotid: optimal angle) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213942 phv00213942.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:36:35+00:00 2018-06-12 19:36:35+00:00 ROPDAV45 Average far wall width (right common carotid: anterior angle) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213943 phv00213943.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:36:50+00:00 2018-06-12 19:36:50+00:00 LBIDAV45 Average far wall width (left bifurcation) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213944 phv00213944.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:37:04+00:00 2018-06-12 19:37:04+00:00 RBIDAV45 Average far wall width (right bifurcation) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213945 phv00213945.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:37:20+00:00 2018-06-12 19:37:20+00:00 LBFDAV45 Average far wall width (left bifurcation focus-far wall) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213946 phv00213946.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:37:36+00:00 2018-06-12 19:37:36+00:00 RBFDAV45 Average far wall width (right bifurcation focus-far wall) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213947 phv00213947.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:37:50+00:00 2018-06-12 19:37:50+00:00 LINDAV45 Average far wall width (left internal carotid) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213948 phv00213948.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:38:16+00:00 2018-06-12 19:38:16+00:00 RINDAV45 Average far wall width (right internal carotid) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213949 phv00213949.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:38:33+00:00 2018-06-12 19:38:33+00:00 QC1DAV45 Average far wall width (first QC repeat scan) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 213950 phv00213950.v1.p1 pht004223.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-12 19:59:54+00:00 2018-06-12 19:59:54+00:00 QC2DAV45 Average far wall width (QC scan 02) [Ultrasound Derived Data, exam 4] +25 Carotid IMT 100864 phv00100864.v1.p1 pht001468.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:52:45+00:00 2018-06-27 23:52:45+00:00 CCA_FWME Mean of the mean far wall intima media t (var=CCA_FWME) +25 Carotid IMT 100865 phv00100865.v1.p1 pht001468.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:52:58+00:00 2018-06-27 23:52:58+00:00 ICA_FWME Mean of the mean far wall intima-media t +25 Carotid IMT 100444 phv00100444.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:58:40+00:00 2018-06-27 23:58:40+00:00 MAXINT MAXINT FROM BASELINE REREADS (mm) +25 Carotid IMT 100446 phv00100446.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:59:16+00:00 2018-06-27 23:59:16+00:00 MAXCOM AVE N&F WALL MAX COM (mm) +25 Carotid IMT 100094 phv00100094.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:04:36+00:00 2018-06-28 00:04:36+00:00 MAXCOM AVE N&F WALL MAX, COM (mm) +25 Carotid IMT 100095 phv00100095.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:04:48+00:00 2018-06-28 00:04:48+00:00 MAXINT AVE N&F WALL MAX, INT (mm) +25 Carotid IMT 101179 phv00101179.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:06:14+00:00 2018-06-28 00:06:14+00:00 MAXCOMBL ORIGINAL BASELINE MAXCOM +25 Carotid IMT 101180 phv00101180.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:06:27+00:00 2018-06-28 00:06:27+00:00 MAXINTBL ORIGINAL BASELINE MAXINT +25 Carotid IMT 101287 phv00101287.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:07:31+00:00 2018-06-28 00:07:31+00:00 MAXCOM55 BL REREAD MAXCOM +25 Carotid IMT 101288 phv00101288.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:07:49+00:00 2018-06-28 00:07:49+00:00 MAXINT55 BL REREAD MAXINT +25 Carotid IMT 101289 phv00101289.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:08:02+00:00 2018-06-28 00:08:02+00:00 MAXCOM41 YEAR 5 MAXCOM +25 Carotid IMT 101290 phv00101290.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:08:13+00:00 2018-06-28 00:08:13+00:00 MAXINT41 YEAR 5 MAXINT +25 Carotid IMT 102978 phv00102978.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:08:30+00:00 2018-06-28 00:08:30+00:00 MAXCOM92 AVE N&F WALL MAX, COMMON, YR 11 +25 Carotid IMT 102979 phv00102979.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:08:49+00:00 2018-06-28 00:08:49+00:00 MAXINT92 AVE N&F WALL MAX, INTERNAL, YR 11 +25 Carotid IMT 101130 phv00101130.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:41:57+00:00 2018-06-29 16:41:57+00:00 PW1BL ORIG BASELINE P WAVE, RT SIDE +25 Carotid IMT 101131 phv00101131.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:42:08+00:00 2018-06-29 16:42:08+00:00 CW1BL ORIG BASELINE C WAVE, RT SIDE +25 Carotid IMT 101137 phv00101137.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:44:01+00:00 2018-06-29 16:44:01+00:00 PW2BL ORIG BASELINE P WAVE, LEFT SIDE +25 Carotid IMT 101138 phv00101138.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:44:16+00:00 2018-06-29 16:44:16+00:00 CW2BL ORIG BASELINE C WAVE, LEFT SIDE +25 Carotid IMT 101139 phv00101139.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:44:28+00:00 2018-06-29 16:44:28+00:00 VMAX1BL ORIG BASELINE VESSEL MAX, R. COMMON +25 Carotid IMT 101140 phv00101140.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:44:40+00:00 2018-06-29 16:44:40+00:00 NMAX1BL ORIG BASELINE NEAR WALL MAX, R. COMMON +25 Carotid IMT 101147 phv00101147.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:45:00+00:00 2018-06-29 16:45:00+00:00 FMAX2BL ORIG BASELINE FAR WALL MAX, R. ANTERIOR +25 Carotid IMT 101160 phv00101160.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:45:47+00:00 2018-06-29 16:45:47+00:00 NMAX5BL ORIG BASELINE NEAR WALL MAX, L. COMMON +25 Carotid IMT 101155 phv00101155.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:46:12+00:00 2018-06-29 16:46:12+00:00 NMAX4BL ORIG BASELINE NEAR WALL MAX, R. POSTERIOR +25 Carotid IMT 101154 phv00101154.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:46:24+00:00 2018-06-29 16:46:24+00:00 VMAX4BL ORIG BASELINE VESSEL MAX, R. POSTERIOR +25 Carotid IMT 101150 phv00101150.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:47:08+00:00 2018-06-29 16:47:08+00:00 NMAX3BL ORIG BASELINE NEAR WALL MAX, R. LATERAL +25 Carotid IMT 101149 phv00101149.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:47:19+00:00 2018-06-29 16:47:19+00:00 VMAX3BL ORIG BASELINE VESSEL MAX, R. LATERAL +25 Carotid IMT 101152 phv00101152.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:47:55+00:00 2018-06-29 16:47:55+00:00 FMAX3BL ORIG BASELINE FAR WALL MAX, R. LATERAL +25 Carotid IMT 101157 phv00101157.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:48:36+00:00 2018-06-29 16:48:36+00:00 FMAX4BL ORIG BASELINE FAR WALL MAX, R. POSTERIOR +25 Carotid IMT 101159 phv00101159.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:49:02+00:00 2018-06-29 16:49:02+00:00 VMAX5BL ORIG BASELINE VESSEL MAX, L. COMMON +25 Carotid IMT 101164 phv00101164.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:49:29+00:00 2018-06-29 16:49:29+00:00 VMAX6BL ORIG BASELINE VESSEL MAX, L. ANTERIOR +25 Carotid IMT 101165 phv00101165.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:49:41+00:00 2018-06-29 16:49:41+00:00 NMAX6BL ORIG BASELINE NEAR WALL MAX, L. ANTERIOR +25 Carotid IMT 101167 phv00101167.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:50:00+00:00 2018-06-29 16:50:00+00:00 FMAX6BL ORIG BASELINE FAR WALL MAX, L. ANTERIOR +25 Carotid IMT 101169 phv00101169.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:50:43+00:00 2018-06-29 16:50:43+00:00 VMAX7BL ORIG BASELINE VESSEL MAX, L. LATERAL +25 Carotid IMT 101170 phv00101170.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:50:54+00:00 2018-06-29 16:50:54+00:00 NMAX7BL ORIG BASELINE NEAR WALL MAX, L. LATERAL +25 Carotid IMT 101174 phv00101174.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:51:20+00:00 2018-06-29 16:51:20+00:00 VMAX8BL ORIG BASELINE VESSEL MAX, L. POSTERIOR +25 Carotid IMT 101172 phv00101172.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:51:30+00:00 2018-06-29 16:51:30+00:00 FMAX7BL ORIG BASELINE FAR WALL MAX, L. LATERAL +25 Carotid IMT 101175 phv00101175.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:52:15+00:00 2018-06-29 16:52:15+00:00 NMAX8BL ORIG BASELINE NEAR WALL MAX, L. POSTERIOR +25 Carotid IMT 101177 phv00101177.v1.p1 pht001471.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:52:41+00:00 2018-06-29 16:52:41+00:00 FMAX8BL ORIG BASELINE FAR WALL MAX, L. POSTERIOR +25 Carotid IMT 101192 phv00101192.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:55:45+00:00 2018-06-29 16:55:45+00:00 VMAX192 VESSEL MAX, R COM CAROT +25 Carotid IMT 101193 phv00101193.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:55:56+00:00 2018-06-29 16:55:56+00:00 NMAX192 NEAR WALL MAX, R COM CAROT +25 Carotid IMT 101195 phv00101195.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:56:22+00:00 2018-06-29 16:56:22+00:00 FMAX192 FAR WALL MAX, R COM CAROT +25 Carotid IMT 101198 phv00101198.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:56:34+00:00 2018-06-29 16:56:34+00:00 NMAX292 NEAR WALL MAX, R ANT OBLIQ +25 Carotid IMT 101200 phv00101200.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:56:55+00:00 2018-06-29 16:56:55+00:00 FMAX292 FAR WALL MAX, R ANT OBLIQ +25 Carotid IMT 101203 phv00101203.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:57:56+00:00 2018-06-29 16:57:56+00:00 NMAX392 NEAR WALL MAX, R LAT OBLIQ +25 Carotid IMT 101210 phv00101210.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:58:45+00:00 2018-06-29 16:58:45+00:00 FMAX492 FAR WALL MAX, R POST OBLIQ +25 Carotid IMT 101212 phv00101212.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:59:15+00:00 2018-06-29 16:59:15+00:00 VMAX592 VESSEL MAX, L COM CAROT +25 Carotid IMT 101213 phv00101213.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:59:26+00:00 2018-06-29 16:59:26+00:00 NMAX592 NEAR WALL MAX, L COM CAROT +25 Carotid IMT 101215 phv00101215.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:59:46+00:00 2018-06-29 16:59:46+00:00 FMAX592 FAR WALL MAX, L COM CAROT +25 Carotid IMT 101217 phv00101217.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:00:07+00:00 2018-06-29 17:00:07+00:00 VMAX692 VESSEL MAX, L ANT OBLIQ +25 Carotid IMT 101218 phv00101218.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:00:19+00:00 2018-06-29 17:00:19+00:00 NMAX692 NEAR WALL MAX, L ANT OBLIQ +25 Carotid IMT 101220 phv00101220.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:00:42+00:00 2018-06-29 17:00:42+00:00 FMAX692 FAR WALL MAX, L ANT OBLIQ +25 Carotid IMT 101222 phv00101222.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:00:52+00:00 2018-06-29 17:00:52+00:00 VMAX792 VESSEL MAX, L LAT OBLIQ +25 Carotid IMT 101223 phv00101223.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:01:02+00:00 2018-06-29 17:01:02+00:00 NMAX792 NEAR WALL MAX, L LAT OBLIQ +25 Carotid IMT 101227 phv00101227.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:01:51+00:00 2018-06-29 17:01:51+00:00 VMAX892 VESSEL MAX, L POST OBLIQ +25 Carotid IMT 101228 phv00101228.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:02:02+00:00 2018-06-29 17:02:02+00:00 NMAX892 NEAR WALL MAX, L POST OBLIQ +25 Carotid IMT 101230 phv00101230.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:02:29+00:00 2018-06-29 17:02:29+00:00 FMAX892 FAR WALL MAX, L POST OBLIQ +25 Carotid IMT 101208 phv00101208.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:03:23+00:00 2018-06-29 17:03:23+00:00 NMAX492 NEAR WALL MAX, R POST OBLIQ +25 Carotid IMT 101205 phv00101205.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:03:45+00:00 2018-06-29 17:03:45+00:00 FMAX392 FAR WALL MAX, R LAT OBLIQ +25 Carotid IMT 101207 phv00101207.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:04:23+00:00 2018-06-29 17:04:23+00:00 VMAX492 VESSEL MAX, R POST OBLIQ +25 Carotid IMT 101202 phv00101202.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:04:53+00:00 2018-06-29 17:04:53+00:00 VMAX392 VESSEL MAX, R LAT OBLIQ +25 Carotid IMT 101197 phv00101197.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:05:33+00:00 2018-06-29 17:05:33+00:00 VMAX292 VESSEL MAX, R ANT OBLIQ +25 Carotid IMT 101235 phv00101235.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:06:54+00:00 2018-06-29 17:06:54+00:00 PW155 BL REREAD P WAVE, RT SIDE +25 Carotid IMT 101236 phv00101236.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:07:09+00:00 2018-06-29 17:07:09+00:00 PW255 BL REREAD P WAVE, LFT SIDE +25 Carotid IMT 101237 phv00101237.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:07:19+00:00 2018-06-29 17:07:19+00:00 VMAX155 BL REREAD VESSEL MAX, R. COMMON +25 Carotid IMT 101238 phv00101238.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:07:32+00:00 2018-06-29 17:07:32+00:00 NMAX155 BL REREAD NEAR WALL MAX, R. COMMON +25 Carotid IMT 101239 phv00101239.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:07:46+00:00 2018-06-29 17:07:46+00:00 FMAX155 BL REREAD FAR WALL MAX, R. COMMON +25 Carotid IMT 101240 phv00101240.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:08:09+00:00 2018-06-29 17:08:09+00:00 VMAX255 BL REREAD VESSEL MAX, R. ANTERIOR +25 Carotid IMT 101241 phv00101241.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:08:21+00:00 2018-06-29 17:08:21+00:00 NMAX255 BL REREAD NEAR WALL MAX, R. ANTERIOR +25 Carotid IMT 101242 phv00101242.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:08:32+00:00 2018-06-29 17:08:32+00:00 FMAX255 BL REREAD FAR WALL MAX, R. ANTERIOR +25 Carotid IMT 101243 phv00101243.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:08:59+00:00 2018-06-29 17:08:59+00:00 VMAX355 BL REREAD VESSEL MAX, R. LATERAL +25 Carotid IMT 101244 phv00101244.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:09:17+00:00 2018-06-29 17:09:17+00:00 NMAX355 BL REREAD NEAR WALL MAX, R. LATERAL +25 Carotid IMT 101245 phv00101245.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:09:28+00:00 2018-06-29 17:09:28+00:00 FMAX355 BL REREAD FAR WALL MAX, R. LATERAL +25 Carotid IMT 101246 phv00101246.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:09:44+00:00 2018-06-29 17:09:44+00:00 VMAX455 BL REREAD VESSEL MAX, R. POSTERIOR +25 Carotid IMT 101250 phv00101250.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:09:54+00:00 2018-06-29 17:09:54+00:00 NMAX555 BL REREAD NEAR WALL MAX, L. COMMON +25 Carotid IMT 101248 phv00101248.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:10:04+00:00 2018-06-29 17:10:04+00:00 FMAX455 BL REREAD FAR WALL MAX, R. POSTERIOR +25 Carotid IMT 101249 phv00101249.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:10:14+00:00 2018-06-29 17:10:14+00:00 VMAX555 BL REREAD VESSEL MAX, L. COMMON +25 Carotid IMT 101251 phv00101251.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:10:28+00:00 2018-06-29 17:10:28+00:00 FMAX555 BL REREAD FAR WALL MAX, L. COMMON +25 Carotid IMT 101252 phv00101252.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:10:56+00:00 2018-06-29 17:10:56+00:00 VMAX655 BL REREAD VESSEL MAX, L. ANTERIOR +25 Carotid IMT 101253 phv00101253.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:11:07+00:00 2018-06-29 17:11:07+00:00 NMAX655 BL REREAD NEAR WALL MAX, L. ANTERIOR +25 Carotid IMT 101254 phv00101254.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:11:24+00:00 2018-06-29 17:11:24+00:00 FMAX655 BL REREAD FAR WALL MAX, L. ANTERIOR +25 Carotid IMT 101255 phv00101255.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:11:42+00:00 2018-06-29 17:11:42+00:00 VMAX755 BL REREAD VESSEL MAX, L. LATERAL +25 Carotid IMT 101256 phv00101256.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:11:53+00:00 2018-06-29 17:11:53+00:00 NMAX755 BL REREAD NEAR WALL MAX, L. LATERAL +25 Carotid IMT 101257 phv00101257.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:12:04+00:00 2018-06-29 17:12:04+00:00 FMAX755 BL REREAD FAR WALL MAX, L. LATERAL +25 Carotid IMT 101258 phv00101258.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:24:52+00:00 2018-06-29 17:24:52+00:00 VMAX855 BL REREAD VESSEL MAX, L. POSTERIOR +25 Carotid IMT 101261 phv00101261.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:25:38+00:00 2018-06-29 17:25:38+00:00 PW141 YEAR 5 P WAVE, RT SIDE +25 Carotid IMT 101262 phv00101262.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:25:50+00:00 2018-06-29 17:25:50+00:00 PW241 YEAR 5 P WAVE, LFT SIDE +25 Carotid IMT 101263 phv00101263.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:26:01+00:00 2018-06-29 17:26:01+00:00 VMAX141 YEAR 5 VESSEL MAX, R. COMMON +25 Carotid IMT 101264 phv00101264.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:26:15+00:00 2018-06-29 17:26:15+00:00 NMAX141 YEAR 5 NEAR WALL MAX, R. COMMON +25 Carotid IMT 101265 phv00101265.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:26:32+00:00 2018-06-29 17:26:32+00:00 FMAX141 YEAR 5 FAR WALL MAX, R. COMMON +25 Carotid IMT 101266 phv00101266.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:26:48+00:00 2018-06-29 17:26:48+00:00 VMAX241 YEAR 5 VESSEL MAX, R. ANTERIOR +25 Carotid IMT 101268 phv00101268.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:27:01+00:00 2018-06-29 17:27:01+00:00 FMAX241 YEAR 5 FAR WALL MAX, R. ANTERIOR +25 Carotid IMT 101267 phv00101267.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:27:15+00:00 2018-06-29 17:27:15+00:00 NMAX241 YEAR 5 NEAR WALL MAX, R. ANTERIOR +25 Carotid IMT 101269 phv00101269.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:27:35+00:00 2018-06-29 17:27:35+00:00 VMAX341 YEAR 5 VESSEL MAX, R. LATERAL +25 Carotid IMT 101270 phv00101270.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:27:49+00:00 2018-06-29 17:27:49+00:00 NMAX341 YEAR 5 NEAR WALL MAX, R. LATERAL +25 Carotid IMT 101271 phv00101271.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:27:59+00:00 2018-06-29 17:27:59+00:00 FMAX341 YEAR 5 FAR WALL MAX, R. LATERAL +25 Carotid IMT 101272 phv00101272.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:28:07+00:00 2018-06-29 17:28:07+00:00 VMAX441 YEAR 5 VESSEL MAX, R. POSTERIOR +25 Carotid IMT 101273 phv00101273.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:28:25+00:00 2018-06-29 17:28:25+00:00 NMAX441 YEAR 5 NEAR WALL MAX, R. POSTERIOR +25 Carotid IMT 101274 phv00101274.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:28:37+00:00 2018-06-29 17:28:37+00:00 FMAX441 YEAR 5 FAR WALL MAX, R. POSTERIOR +25 Carotid IMT 101275 phv00101275.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:28:49+00:00 2018-06-29 17:28:49+00:00 VMAX541 YEAR 5 VESSEL MAX, L. COMMON +25 Carotid IMT 101276 phv00101276.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:29:04+00:00 2018-06-29 17:29:04+00:00 NMAX541 YEAR 5 NEAR WALL MAX, L. COMMON +25 Carotid IMT 101277 phv00101277.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:29:14+00:00 2018-06-29 17:29:14+00:00 FMAX541 YEAR 5 FAR WALL MAX, L. COMMON +25 Carotid IMT 101278 phv00101278.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:29:26+00:00 2018-06-29 17:29:26+00:00 VMAX641 YEAR 5 VESSEL MAX, L. ANTERIOR +25 Carotid IMT 101279 phv00101279.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:29:37+00:00 2018-06-29 17:29:37+00:00 NMAX641 YEAR 5 NEAR WALL MAX, L. ANTERIOR +25 Carotid IMT 101280 phv00101280.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:33:02+00:00 2018-06-29 17:33:02+00:00 FMAX641 YEAR 5 FAR WALL MAX, L. ANTERIOR +25 Carotid IMT 101281 phv00101281.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:33:54+00:00 2018-06-29 17:33:54+00:00 VMAX741 YEAR 5 VESSEL MAX, L. LATERAL +25 Carotid IMT 101282 phv00101282.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:34:04+00:00 2018-06-29 17:34:04+00:00 NMAX741 YEAR 5 NEAR WALL MAX, L. LATERAL +25 Carotid IMT 101283 phv00101283.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:34:13+00:00 2018-06-29 17:34:13+00:00 FMAX741 YEAR 5 FAR WALL MAX, L. LATERAL +25 Carotid IMT 101284 phv00101284.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:34:31+00:00 2018-06-29 17:34:31+00:00 VMAX841 YEAR 5 VESSEL MAX, L. POSTERIOR +25 Carotid IMT 101285 phv00101285.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:34:43+00:00 2018-06-29 17:34:43+00:00 NMAX841 YEAR 5 NEAR WALL MAX, L. POSTERIOR +25 Carotid IMT 101286 phv00101286.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:34:56+00:00 2018-06-29 17:34:56+00:00 FMAX841 YEAR 5 FAR WALL MAX, L. POSTERIOR +25 Carotid IMT 101300 phv00101300.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:36:29+00:00 2018-06-29 17:36:29+00:00 FMAX348 FAR WALL MAX, LONGITUDINAL +25 Carotid IMT 101301 phv00101301.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:36:38+00:00 2018-06-29 17:36:38+00:00 VMAX448 VESSEL MAX, WIDEST PORTION +25 Carotid IMT 21730 phv00021730.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:38:52+00:00 2018-07-03 17:38:52+00:00 CCD_MEME MEAN OF MEAN IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN DIASTOLE (MM) +25 Carotid IMT 21728 phv00021728.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:39:12+00:00 2018-07-03 17:39:12+00:00 CCD_MEMX MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN DIASTOLE (MM) +25 Carotid IMT 21731 phv00021731.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:39:27+00:00 2018-07-03 17:39:27+00:00 CCS_MEME MEAN OF MEAN IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN SYSTOLE (MM) +25 Carotid IMT 21729 phv00021729.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:39:37+00:00 2018-07-03 17:39:37+00:00 CCS_MEMX MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID ARTERIES IN SYSTOLE (MM) +25 Carotid IMT 21733 phv00021733.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:39:51+00:00 2018-07-03 17:39:51+00:00 ICB_MEME MEAN OF MEAN IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID BULB/INTERNAL CAROTID ARTERY (MM) +25 Carotid IMT 21732 phv00021732.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:40:31+00:00 2018-07-03 17:40:31+00:00 ICB_MEMX MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT COMMON CAROTID BULB/INTERNAL CAROTID ARTERY (MM) +25 Carotid IMT 21735 phv00021735.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:40:48+00:00 2018-07-03 17:40:48+00:00 ICD_MEME MEAN OF MEAN IMT FOR BOTH LEFT AND RIGHT DISTAL INTERNAL CAROTID ARTERIES (MM) +25 Carotid IMT 21734 phv00021734.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:40:58+00:00 2018-07-03 17:40:58+00:00 ICD_MEMX MEAN OF MAX IMT FOR BOTH LEFT AND RIGHT DISTAL INTERNAL CAROTID ARTERIES (MM) +25 Carotid IMT 21721 phv00021721.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:41:23+00:00 2018-07-03 17:41:23+00:00 LB_MEME MEAN OF MEAN IMT LEFT COMMON CAROTID BULB/INTERNAL CAROTID ARTERY (MM) +25 Carotid IMT 21720 phv00021720.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:41:36+00:00 2018-07-03 17:41:36+00:00 LB_MEMX MEAN OF MAX IMT LEFT COMMON CAROTID BULB/INTERNAL CAROTID ARTERY (MM) +25 Carotid IMT 21719 phv00021719.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:41:49+00:00 2018-07-03 17:41:49+00:00 LCD_MEME MEAN OF MEAN IMT LEFT COMMON CAROTID ARTERY IN DIASTOLE (MM) +25 Carotid IMT 21717 phv00021717.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:42:00+00:00 2018-07-03 17:42:00+00:00 LCD_MEMX MEAN OF MAX IMT LEFT COMMON CAROTID ARTERY IN DIASTOLE (MM) +25 Carotid IMT 21718 phv00021718.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:42:51+00:00 2018-07-03 17:42:51+00:00 LCS_MEME MEAN OF MEAN IMT LEFT COMMON CAROTID ARTERY IN SYSTOLE (MM) +25 Carotid IMT 21716 phv00021716.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:43:56+00:00 2018-07-03 17:43:56+00:00 LCS_MEMX MEAN OF MAX IMT LEFT COMMON CAROTID ARTERY IN SYSTOLE (MM) +25 Carotid IMT 21723 phv00021723.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:44:11+00:00 2018-07-03 17:44:11+00:00 LI_MEME MEAN OF MEAN IMT LEFT INTERNAL CAROTID ARTERY PROPER (MM) +25 Carotid IMT 21722 phv00021722.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:44:20+00:00 2018-07-03 17:44:20+00:00 LI_MEMX MEAN OF MAX IMT LEFT INTERNAL CAROTID ARTERY PROPER (MM) +25 Carotid IMT 21736 phv00021736.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:44:59+00:00 2018-07-03 17:44:59+00:00 R_MAXIMT MAX IMT ON RIGHT SIDE (MM) +25 Carotid IMT 21713 phv00021713.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:45:26+00:00 2018-07-03 17:45:26+00:00 RB_MEME MEAN OF MEAN IMT RIGHT COMMON CAROTID BULB/INTERNAL CAROTID ARTERY (MM) +25 Carotid IMT 21712 phv00021712.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:45:36+00:00 2018-07-03 17:45:36+00:00 RB_MEMX MEAN OF MAX IMT RIGHT COMMON CAROTID BULB/INTERNAL CAROTID ARTERY (MM) +25 Carotid IMT 21707 phv00021707.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:45:59+00:00 2018-07-03 17:45:59+00:00 RCD_MEME MEAN OF MEAN IMT RIGHT COMMON CAROTID ARTERY IN DIASTOLE (MM) +25 Carotid IMT 21705 phv00021705.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:46:11+00:00 2018-07-03 17:46:11+00:00 RCD_MEMX MEAN OF MAX IMT RIGHT COMMON CAROTID ARTERY IN DIASTOLE (MM) +25 Carotid IMT 21706 phv00021706.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:46:32+00:00 2018-07-03 17:46:32+00:00 RCS_MEME MEAN OF MEAN IMT RIGHT COMMON CAROTID ARTERY IN SYSTOLE (MM) +25 Carotid IMT 21704 phv00021704.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:46:45+00:00 2018-07-03 17:46:45+00:00 RCS_MEMX MEAN OF MAX IMT RIGHT COMMON CAROTID ARTERY IN SYSTOLE (MM) +25 Carotid IMT 21715 phv00021715.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:47:02+00:00 2018-07-03 17:47:02+00:00 RI_MEME MEAN OF MEAN IMT RIGHT INTERNAL CAROTID ARTERY PROPER (MM) +25 Carotid IMT 21714 phv00021714.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:47:12+00:00 2018-07-03 17:47:12+00:00 RI_MEMX MEAN OF MAX IMT RIGHT INTERNAL CAROTID ARTERY PROPER (MM) +25 Carotid IMT 76366 phv00076366.v4.p10 pht000907.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:48:19+00:00 2018-07-03 17:48:19+00:00 cca_fw_mean_imt Mean of the mean common carotid IMT far wall of both sides +25 Carotid IMT 76367 phv00076367.v4.p10 pht000907.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:48:30+00:00 2018-07-03 17:48:30+00:00 ica_fw_mean_imt Mean of the mean internal carotid IMT far wall both sides +25 Carotid IMT 21737 phv00021737.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:53:17+00:00 2018-07-03 17:53:17+00:00 L_MAXIMT MAX IMT ON LEFT SIDE (MM) +25 Carotid IMT 128575 phv00128575.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:58:38+00:00 2018-07-09 20:58:38+00:00 sum45_1 Maximum likelihood estimate of the average far wall CIMT at the optimal +25 Carotid IMT 128576 phv00128576.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:58:51+00:00 2018-07-09 20:58:51+00:00 cca45_1 Maximum likelihood estimate of average right and left common carotid far wall CIMT across circumferential views +25 Carotid IMT 128525 phv00128525.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 21:01:06+00:00 2018-07-09 21:01:06+00:00 lco_av45 Average far wall CIMT for the left common carotid artery in millimeters +25 Carotid IMT 128526 phv00128526.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 21:01:06+00:00 2018-07-09 21:01:06+00:00 rco_av45 Average far wall CIMT for the right common carotid artery in millimeters +25 Carotid IMT 128527 phv00128527.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 21:01:06+00:00 2018-07-09 21:01:06+00:00 lbo_av45 Left bifurcation optimal average far wall in millimeters +25 Carotid IMT 128528 phv00128528.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 21:01:06+00:00 2018-07-09 21:01:06+00:00 rbo_av45 Right bifurcation optimal average far wall in millimeters +25 Carotid IMT 128529 phv00128529.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 21:01:06+00:00 2018-07-09 21:01:06+00:00 lio_av45 Left Internal optimal average far wall in millimeters +25 Carotid IMT 128530 phv00128530.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 21:01:06+00:00 2018-07-09 21:01:06+00:00 rio_av45 Right internal optimal average far wall in millimeters +25 Carotid IMT 128531 phv00128531.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 lcl_av45 Left common lateral average far wall in millimeters +25 Carotid IMT 128532 phv00128532.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 lca_av45 Left common anterior average far wall in millimeters +25 Carotid IMT 128533 phv00128533.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 lcp_av45 Left common posterior average far wall in millimeters +25 Carotid IMT 128534 phv00128534.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 rcl_av45 Right common lateral average far wall in millimeters +25 Carotid IMT 128535 phv00128535.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 rca_av45 Right common anterior average far wall in millimeters +25 Carotid IMT 128536 phv00128536.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 rcp_av45 Right common posterior average far wall in millimeters +25 Carotid IMT 128537 phv00128537.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 lbo_mx45 Left bifurcation optimal maximum far wall in millimeters +25 Carotid IMT 128538 phv00128538.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 rbo_mx45 Right bifurcation optimal maximum far wall in millimeters +25 Carotid IMT 128539 phv00128539.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:38:11+00:00 2018-07-10 13:38:11+00:00 lio_mx45 Left internal optimal maximum far wall in millimeters +25 Carotid IMT 128540 phv00128540.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rio_mx45 Right internal optimal maximum far wall in millimeters +25 Carotid IMT 128541 phv00128541.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lcl_mx45 Left common lateral maximum far wall in millimeters +25 Carotid IMT 128542 phv00128542.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lca_mx45 Left common anterior maximum far wall in millimeters +25 Carotid IMT 128543 phv00128543.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lcp_mx45 Left common posterior maximum far wall in millimeters +25 Carotid IMT 128544 phv00128544.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rcl_mx45 Right common lateral maximum far wall in millimeters +25 Carotid IMT 128545 phv00128545.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rca_mx45 Right common anterior maximum far wall in millimeters +25 Carotid IMT 128546 phv00128546.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rcp_mx45 Right common posterior maximum far wall in millimeters +25 Carotid IMT 128547 phv00128547.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lbo_av23 Left bifurcation optimal average near wall in millimeters +25 Carotid IMT 128548 phv00128548.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rbo_av23 Right bifurcation optimal average near wall in millimeters +25 Carotid IMT 128549 phv00128549.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lio_av23 Left internal optimal average near wall in millimeters +25 Carotid IMT 128550 phv00128550.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rio_av23 Right internal optimal average near wall in millimeters +25 Carotid IMT 128551 phv00128551.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lcl_av23 Left common lateral average near wall in millimeters +25 Carotid IMT 128552 phv00128552.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lca_av23 Left common anterior average near wall in millimeters +25 Carotid IMT 128553 phv00128553.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lcp_av23 Left common posterior average near wall in millimeters +25 Carotid IMT 128554 phv00128554.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rcl_av23 Right common lateral average near wall in millimeters +25 Carotid IMT 128555 phv00128555.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rca_av23 Right common anterior average near wall in millimeters +25 Carotid IMT 128556 phv00128556.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 rcp_av23 Right common posterior average near wall in millimeters +25 Carotid IMT 128557 phv00128557.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:42:21+00:00 2018-07-10 13:42:21+00:00 lbo_mx23 Left bifurcation optimal maximum near wall in millimeters +25 Carotid IMT 128558 phv00128558.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 rbo_mx23 Right bifurcation optimal maximum near wall in millimeters +25 Carotid IMT 128559 phv00128559.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 lio_mx23 Left internal optimal maximum near wall in millimeters +25 Carotid IMT 128560 phv00128560.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 rio_mx23 Right internal optimal maximum near wall in millimeters +25 Carotid IMT 128561 phv00128561.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 lcl_mx23 Left common lateral maximum near wall in millimeters +25 Carotid IMT 128562 phv00128562.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 lca_mx23 Left common anterior maximum near wall in millimeters +25 Carotid IMT 128563 phv00128563.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 lcp_mx23 Left common posterior maximum near wall in millimeters +25 Carotid IMT 128564 phv00128564.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 rcl_mx23 Right common lateral maximum near wall in millimeters +25 Carotid IMT 128565 phv00128565.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 rca_mx23 Right common anterior maximum near wall in millimeters +25 Carotid IMT 128566 phv00128566.v1.p1 pht001978.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 13:44:15+00:00 2018-07-10 13:44:15+00:00 rcp_mx23 Right common posterior maximum near wall in millimeters +25 Carotid IMT 252988 phv00252988.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-02 18:38:28+00:00 2018-08-02 18:38:28+00:00 imt_mean_farwall_cca_baseline Carotid intima-media far wall thickness at baseline visit +25 Carotid IMT 115224 phv00115224.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:15:07+00:00 2018-08-03 19:15:07+00:00 C1LCPMAX MAXIMUM THICKNESS OF LCP (mm) +25 Carotid IMT 115223 phv00115223.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:15:16+00:00 2018-08-03 19:15:16+00:00 C1LCPMEN MEAN INTIMA-MEDIA THICKNESS OF LCP (mm) +25 Carotid IMT 115221 phv00115221.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:15:25+00:00 2018-08-03 19:15:25+00:00 C1RCAMAX MAXIMUM THICKNESS OF RCA (mm) +25 Carotid IMT 115220 phv00115220.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:15:35+00:00 2018-08-03 19:15:35+00:00 C1RCAMEN MEAN INTIMA-MEDIA THICKNESS OF RCA (mm) +25 Carotid IMT 115218 phv00115218.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:15:44+00:00 2018-08-03 19:15:44+00:00 C1LCAMAX MAXIMUM THICKNESS OF LCA (mm) +25 Carotid IMT 115217 phv00115217.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:15:53+00:00 2018-08-03 19:15:53+00:00 C1LCAMEN MEAN INTIMA-MEDIA THICKNESS OF LCA (mm) +25 Carotid IMT 115215 phv00115215.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:16:01+00:00 2018-08-03 19:16:01+00:00 C1RCOMAX MAXIMUM THICKNESS OF RCO (mm) +25 Carotid IMT 115214 phv00115214.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:16:09+00:00 2018-08-03 19:16:09+00:00 C1RCOMEN MEAN INTIMA-MEDIA THICKNESS OF RCO (mm) +25 Carotid IMT 115212 phv00115212.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:16:18+00:00 2018-08-03 19:16:18+00:00 C1LCOMAX MAXIMUM THICKNESS OF LCO (mm) +25 Carotid IMT 115211 phv00115211.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:16:25+00:00 2018-08-03 19:16:25+00:00 C1LCOMEN MEAN INTIMA-MEDIA THICKNESS OF LCO (mm) +25 Carotid IMT 115239 phv00115239.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:16:52+00:00 2018-08-03 19:16:52+00:00 C1RIMAX MAXIMUM THICKNESS OF RI (mm) +25 Carotid IMT 115238 phv00115238.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:17:00+00:00 2018-08-03 19:17:00+00:00 C1RIMEN MEAN INTIMA-MEDIA THICKNESS OF RI (mm) +25 Carotid IMT 115236 phv00115236.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:17:08+00:00 2018-08-03 19:17:08+00:00 C1LIMAX MAXIMUM THICKNESS OF LI (mm) +25 Carotid IMT 115233 phv00115233.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:17:16+00:00 2018-08-03 19:17:16+00:00 C1RBMAX MAXIMUM THICKNESS OF RB (mm) +25 Carotid IMT 115232 phv00115232.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:17:24+00:00 2018-08-03 19:17:24+00:00 C1RBMEN MEAN INTIMA-MEDIA THICKNESS OF RB (mm) +25 Carotid IMT 115230 phv00115230.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:17:32+00:00 2018-08-03 19:17:32+00:00 C1LBMAX MAXIMUM THICKNESS OF LB (mm) +25 Carotid IMT 115229 phv00115229.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:17:41+00:00 2018-08-03 19:17:41+00:00 C1LBMEN MEAN INTIMA-MEDIA THICKNESS OF LB (mm) +25 Carotid IMT 115227 phv00115227.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:17:48+00:00 2018-08-03 19:17:48+00:00 C1RCPMAX MAXIMUM THICKNESS OF RCP (mm) +25 Carotid IMT 115226 phv00115226.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:17:57+00:00 2018-08-03 19:17:57+00:00 C1RCPMEN MEAN INTIMA-MEDIA THICKNESS OF RCP (mm) +25 Carotid IMT 115235 phv00115235.v2.p2 pht001650.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 19:20:09+00:00 2018-08-03 19:20:09+00:00 C1LIMEN MEAN INTIMA-MEDIA THICKNESS OF LI(mm) +25 Carotid IMT 111971 phv00111971.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:29:31+00:00 2018-09-04 23:29:31+00:00 rcfwmax4 RIGHT COMMON CAROTID FAR WALL MAX +25 Carotid IMT 111972 phv00111972.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:29:41+00:00 2018-09-04 23:29:41+00:00 rcfwmin4 RIGHT COMMON CAROTID FAR WALL MIN +25 Carotid IMT 111973 phv00111973.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:29:52+00:00 2018-09-04 23:29:52+00:00 rcfwmn4 RIGHT COMMON CAROTID FAR WALL MEAN +25 Carotid IMT 111975 phv00111975.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:30:01+00:00 2018-09-04 23:30:01+00:00 rcnwmax4 RIGHT COMMON CAROTID NEAR WALL MAX +25 Carotid IMT 111976 phv00111976.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:30:10+00:00 2018-09-04 23:30:10+00:00 rcnwmin4 RIGHT COMMON CAROTID NEAR WALL MIN +25 Carotid IMT 111977 phv00111977.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:30:20+00:00 2018-09-04 23:30:20+00:00 rcnwmn4 RIGHT COMMON CAROTID NEAR WALL MEAN +25 Carotid IMT 112048 phv00112048.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:31:28+00:00 2018-09-04 23:31:28+00:00 lcfwmin4 LEFT COMMON CAROTID FAR WALL MIN +25 Carotid IMT 112049 phv00112049.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:31:37+00:00 2018-09-04 23:31:37+00:00 lcfwmn4 LEFT COMMON CAROTID FAR WALL MEAN +25 Carotid IMT 112051 phv00112051.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:31:46+00:00 2018-09-04 23:31:46+00:00 lcnwmax4 LEFT COMMON CAROTID NEAR WALL MAX +25 Carotid IMT 112052 phv00112052.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:32:00+00:00 2018-09-04 23:32:00+00:00 lcnwmin4 LEFT COMMON CAROTID NEAR WALL MIN +25 Carotid IMT 112053 phv00112053.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:32:11+00:00 2018-09-04 23:32:11+00:00 lcnwmn4 LEFT COMMON CAROTID NEAR WALL MEAN +25 Carotid IMT 112125 phv00112125.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:32:52+00:00 2018-09-04 23:32:52+00:00 maxcom4c COMMON CAROTID INTIMAL-MEDIAL THICKNESS +25 Carotid IMT 84966 phv00084966.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:34:25+00:00 2018-09-04 23:34:25+00:00 ccafwm1 MEAN OF MEAN FAR WALL IMT FOR COMMON CAROTID ARTERY +25 Carotid IMT 84967 phv00084967.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-04 23:34:32+00:00 2018-09-04 23:34:32+00:00 icafwm1 MEAN OF MEAN FAR WALL IMT FOR INTERNAL CAROTID ARTERY +25 Carotid IMT 84793 phv00084793.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:58:34+00:00 2018-10-22 04:58:34+00:00 maxcom1c COMMON CAROTID INTIMAL-MEDIAL THICKNESS (mm) +25 Carotid IMT 84794 phv00084794.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:58:43+00:00 2018-10-22 04:58:43+00:00 maxint1c INTERNAL CAROTID INTIMAL-MEDIAL THICKNESS (mm) +25 Carotid IMT 87109 phv00087109.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:58:49+00:00 2018-10-22 04:58:49+00:00 maxcomfc COMMON CAROTID INTIMAL-MEDIAL THICKNESS (mm) +25 Carotid IMT 87110 phv00087110.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:58:56+00:00 2018-10-22 04:58:56+00:00 maxintfc INTERNAL CAROTID INTIMAL-MEDIAL THICKNESS (mm) +25 Carotid IMT 112126 phv00112126.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:59:12+00:00 2018-10-22 04:59:12+00:00 maxint4c INTERNAL CAROTID INTIMAL-MEDIAL THICKNESS +25 Carotid IMT 175615 phv00175615.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:07:45+00:00 2018-10-22 05:07:45+00:00 ldccamnavg5 LT DISTAL CCA MEAN CIMT (mm) AVG +25 Carotid IMT 175617 phv00175617.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:07:54+00:00 2018-10-22 05:07:54+00:00 ldccamnv15 LT DISTAL CCA MEAN CIMT (mm) V1 +25 Carotid IMT 175619 phv00175619.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:08:00+00:00 2018-10-22 05:08:00+00:00 ldccamnv25 LT DISTAL CCA MEAN CIMT (mm) V2 +25 Carotid IMT 175621 phv00175621.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:08:05+00:00 2018-10-22 05:08:05+00:00 ldccamnv35 LT DISTAL CCA MEAN CIMT (mm) V3 +25 Carotid IMT 175623 phv00175623.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:08:12+00:00 2018-10-22 05:08:12+00:00 ldccamxavg5 LT DISTAL CCA MAX CIMT (mm) AVG +25 Carotid IMT 175625 phv00175625.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:08:18+00:00 2018-10-22 05:08:18+00:00 ldccamxv15 LT DISTAL CCA MAX CIMT (mm) V1 +25 Carotid IMT 175627 phv00175627.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:08:28+00:00 2018-10-22 05:08:28+00:00 ldccamxv25 LT DISTAL CCA MAX CIMT (mm) V2 +25 Carotid IMT 175629 phv00175629.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:08:35+00:00 2018-10-22 05:08:35+00:00 ldccamxv35 LT DISTAL CCA MAX CIMT (mm) V3 +25 Carotid IMT 175631 phv00175631.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:08:43+00:00 2018-10-22 05:08:43+00:00 licamnavg5 LT ICA MEAN CIMT (mm) AVG +25 Carotid IMT 175633 phv00175633.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:08:57+00:00 2018-10-22 05:08:57+00:00 licamnv15 LT ICA MEAN CIMT (mm) V1 +25 Carotid IMT 175635 phv00175635.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:03+00:00 2018-10-22 05:09:03+00:00 licamnv25 LT ICA MEAN CIMT (mm) V2 +25 Carotid IMT 175637 phv00175637.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:10+00:00 2018-10-22 05:09:10+00:00 licamnv35 LT ICA MEAN CIMT (mm) V3 +25 Carotid IMT 175639 phv00175639.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:16+00:00 2018-10-22 05:09:16+00:00 licamxavg5 LT ICA MAX CIMT (mm) AVG +25 Carotid IMT 175641 phv00175641.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:22+00:00 2018-10-22 05:09:22+00:00 licamxv15 LT ICA MAX CIMT (mm) V1 +25 Carotid IMT 175643 phv00175643.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:28+00:00 2018-10-22 05:09:28+00:00 licamxv25 LT ICA MAX CIMT (mm) V2 +25 Carotid IMT 175645 phv00175645.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:35+00:00 2018-10-22 05:09:35+00:00 licamxv35 LT ICA MAX CIMT (mm) V3 +25 Carotid IMT 175647 phv00175647.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:41+00:00 2018-10-22 05:09:41+00:00 lbmnavg5 LT BULB MEAN CIMT (mm) AVG +25 Carotid IMT 175649 phv00175649.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:47+00:00 2018-10-22 05:09:47+00:00 lbmnv15 LT BULB MEAN CIMT (mm) V1 +25 Carotid IMT 175651 phv00175651.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:53+00:00 2018-10-22 05:09:53+00:00 lbmnv25 LT BULB MEAN CIMT (mm) V2 +25 Carotid IMT 175653 phv00175653.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:09:59+00:00 2018-10-22 05:09:59+00:00 lbmnv35 LT BULB MEAN CIMT (mm) V3 +25 Carotid IMT 175655 phv00175655.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:06+00:00 2018-10-22 05:10:06+00:00 lbmxavg5 LT BULB MAX CIMT (mm) AVG +25 Carotid IMT 175657 phv00175657.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:11+00:00 2018-10-22 05:10:11+00:00 lbmxv15 LT BULB MAX CIMT (mm) V1 +25 Carotid IMT 175659 phv00175659.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:17+00:00 2018-10-22 05:10:17+00:00 lbmxv25 LT BULB MAX CIMT (mm) V2 +25 Carotid IMT 175661 phv00175661.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:24+00:00 2018-10-22 05:10:24+00:00 lbmxv35 LT BULB MAX CIMT (mm) V3 +25 Carotid IMT 175675 phv00175675.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:29+00:00 2018-10-22 05:10:29+00:00 rdccamnavg5 RT DISTAL CCA MEAN CIMT (mm) AVG +25 Carotid IMT 175677 phv00175677.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:35+00:00 2018-10-22 05:10:35+00:00 rdccamnv15 RT DISTAL CCA MEAN CIMT (mm) V1 +25 Carotid IMT 175679 phv00175679.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:42+00:00 2018-10-22 05:10:42+00:00 rdccamnv25 RT DISTAL CCA MEAN CIMT (mm) V2 +25 Carotid IMT 175681 phv00175681.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:48+00:00 2018-10-22 05:10:48+00:00 rdccamnv35 RT DISTAL CCA MEAN CIMT (mm) V3 +25 Carotid IMT 175683 phv00175683.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:10:54+00:00 2018-10-22 05:10:54+00:00 rdccamxavg5 RT DISTAL CCA MAX CIMT (mm) AVG +25 Carotid IMT 175685 phv00175685.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:00+00:00 2018-10-22 05:11:00+00:00 rdccamxv15 RT DISTAL CCA MAX CIMT (mm) V1 +25 Carotid IMT 175687 phv00175687.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:06+00:00 2018-10-22 05:11:06+00:00 rdccamxv25 RT DISTAL CCA MAX CIMT (mm) V2 +25 Carotid IMT 175689 phv00175689.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:12+00:00 2018-10-22 05:11:12+00:00 rdccamxv35 RT DISTAL CCA MAX CIMT (mm) V3 +25 Carotid IMT 175691 phv00175691.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:18+00:00 2018-10-22 05:11:18+00:00 ricamnavg5 RT ICA MEAN CIMT (mm) AVG +25 Carotid IMT 175693 phv00175693.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:24+00:00 2018-10-22 05:11:24+00:00 ricamnv15 RT ICA MEAN CIMT (mm) V1 +25 Carotid IMT 175695 phv00175695.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:29+00:00 2018-10-22 05:11:29+00:00 ricamnv25 RT ICA MEAN CIMT (mm) V2 +25 Carotid IMT 175697 phv00175697.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:35+00:00 2018-10-22 05:11:35+00:00 ricamnv35 RT ICA MEAN CIMT (mm) V3 +25 Carotid IMT 175699 phv00175699.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:42+00:00 2018-10-22 05:11:42+00:00 ricamxavg5 RT ICA MAX CIMT (mm) AVG +25 Carotid IMT 175701 phv00175701.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:11:48+00:00 2018-10-22 05:11:48+00:00 ricamxv15 RT ICA MAX CIMT (mm) V1 +25 Carotid IMT 175703 phv00175703.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:01+00:00 2018-10-22 05:14:01+00:00 ricamxv25 RT ICA MAX CIMT (mm) V2 +25 Carotid IMT 175705 phv00175705.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:16+00:00 2018-10-22 05:14:16+00:00 ricamxv35 RT ICA MAX CIMT (mm) V3 +25 Carotid IMT 175707 phv00175707.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:21+00:00 2018-10-22 05:14:21+00:00 rbmnavg5 RT BULB MEAN CIMT (mm) AVG +25 Carotid IMT 175709 phv00175709.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:27+00:00 2018-10-22 05:14:27+00:00 rbmnv15 RT BULB MEAN CIMT (mm) V1 +25 Carotid IMT 175711 phv00175711.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:33+00:00 2018-10-22 05:14:33+00:00 rbmnv25 RT BULB MEAN CIMT (mm) V2 +25 Carotid IMT 175713 phv00175713.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:39+00:00 2018-10-22 05:14:39+00:00 rbmnv35 RT BULB MEAN CIMT (mm) V3 +25 Carotid IMT 175715 phv00175715.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:44+00:00 2018-10-22 05:14:44+00:00 rbmxavg5 RT BULB MAX CIMT (mm) AVG +25 Carotid IMT 175717 phv00175717.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:50+00:00 2018-10-22 05:14:50+00:00 rbmxv15 RT BULB MAX CIMT (mm) V1 +25 Carotid IMT 175719 phv00175719.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:14:56+00:00 2018-10-22 05:14:56+00:00 rbmxv25 RT BULB MAX CIMT (mm) V2 +25 Carotid IMT 175721 phv00175721.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:02+00:00 2018-10-22 05:15:02+00:00 rbmxv35 RT BULB MAX CIMT (mm) V3 +25 Carotid IMT 177049 phv00177049.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:07+00:00 2018-10-22 05:15:07+00:00 ldccamnavg5 LT DISTAL CCA MEAN CIMT (mm) AVG +25 Carotid IMT 177051 phv00177051.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:13+00:00 2018-10-22 05:15:13+00:00 ldccamnv15 LT DISTAL CCA MEAN CIMT (mm) V1 +25 Carotid IMT 177053 phv00177053.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:20+00:00 2018-10-22 05:15:20+00:00 ldccamnv25 LT DISTAL CCA MEAN CIMT (mm) V2 +25 Carotid IMT 177055 phv00177055.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:25+00:00 2018-10-22 05:15:25+00:00 ldccamnv35 LT DISTAL CCA MEAN CIMT (mm) V3 +25 Carotid IMT 177057 phv00177057.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:33+00:00 2018-10-22 05:15:33+00:00 ldccamxavg5 LT DISTAL CCA MAX CIMT (mm) AVG +25 Carotid IMT 177059 phv00177059.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:39+00:00 2018-10-22 05:15:39+00:00 ldccamxv15 LT DISTAL CCA MAX CIMT (mm) V1 +25 Carotid IMT 177061 phv00177061.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:44+00:00 2018-10-22 05:15:44+00:00 ldccamxv25 LT DISTAL CCA MAX CIMT (mm) V2 +25 Carotid IMT 177063 phv00177063.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:51+00:00 2018-10-22 05:15:51+00:00 ldccamxv35 LT DISTAL CCA MAX CIMT (mm) V3 +25 Carotid IMT 177065 phv00177065.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:15:58+00:00 2018-10-22 05:15:58+00:00 licamnavg5 LT ICA MEAN CIMT (mm) AVG +25 Carotid IMT 177067 phv00177067.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:04+00:00 2018-10-22 05:16:04+00:00 licamnv15 LT ICA MEAN CIMT (mm) V1 +25 Carotid IMT 177069 phv00177069.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:09+00:00 2018-10-22 05:16:09+00:00 licamnv25 LT ICA MEAN CIMT (mm) V2 +25 Carotid IMT 177071 phv00177071.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:15+00:00 2018-10-22 05:16:15+00:00 licamnv35 LT ICA MEAN CIMT (mm) V3 +25 Carotid IMT 177073 phv00177073.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:21+00:00 2018-10-22 05:16:21+00:00 licamxavg5 LT ICA MAX CIMT (mm) AVG +25 Carotid IMT 177075 phv00177075.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:27+00:00 2018-10-22 05:16:27+00:00 licamxv15 LT ICA MAX CIMT (mm) V1 +25 Carotid IMT 177077 phv00177077.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:32+00:00 2018-10-22 05:16:32+00:00 licamxv25 LT ICA MAX CIMT (mm) V2 +25 Carotid IMT 177079 phv00177079.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:38+00:00 2018-10-22 05:16:38+00:00 licamxv35 LT ICA MAX CIMT (mm) V3 +25 Carotid IMT 177081 phv00177081.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:44+00:00 2018-10-22 05:16:44+00:00 lbmnavg5 LT BULB MEAN CIMT (mm) AVG +25 Carotid IMT 177083 phv00177083.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:49+00:00 2018-10-22 05:16:49+00:00 lbmnv15 LT BULB MEAN CIMT (mm) V1 +25 Carotid IMT 177085 phv00177085.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:16:55+00:00 2018-10-22 05:16:55+00:00 lbmnv25 LT BULB MEAN CIMT (mm) V2 +25 Carotid IMT 177087 phv00177087.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:17:00+00:00 2018-10-22 05:17:00+00:00 lbmnv35 LT BULB MEAN CIMT (mm) V3 +25 Carotid IMT 177089 phv00177089.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:17:06+00:00 2018-10-22 05:17:06+00:00 lbmxavg5 LT BULB MAX CIMT (mm) AVG +25 Carotid IMT 177091 phv00177091.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:17:12+00:00 2018-10-22 05:17:12+00:00 lbmxv15 LT BULB MAX CIMT (mm) V1 +25 Carotid IMT 177093 phv00177093.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:17:17+00:00 2018-10-22 05:17:17+00:00 lbmxv25 LT BULB MAX CIMT (mm) V2 +25 Carotid IMT 177095 phv00177095.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:17:23+00:00 2018-10-22 05:17:23+00:00 lbmxv35 LT BULB MAX CIMT (mm) V3 +25 Carotid IMT 177109 phv00177109.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:17:29+00:00 2018-10-22 05:17:29+00:00 rdccamnavg5 RT DISTAL CCA MEAN CIMT (mm) AVG +25 Carotid IMT 177111 phv00177111.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:17:36+00:00 2018-10-22 05:17:36+00:00 rdccamnv15 RT DISTAL CCA MEAN CIMT (mm) V1 +25 Carotid IMT 177113 phv00177113.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:17:41+00:00 2018-10-22 05:17:41+00:00 rdccamnv25 RT DISTAL CCA MEAN CIMT (mm) V2 +25 Carotid IMT 177115 phv00177115.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:21:16+00:00 2018-10-22 05:21:16+00:00 rdccamnv35 RT DISTAL CCA MEAN CIMT (mm) V3 +25 Carotid IMT 177117 phv00177117.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:21:22+00:00 2018-10-22 05:21:22+00:00 rdccamxavg5 RT DISTAL CCA MAX CIMT (mm) AVG +25 Carotid IMT 177119 phv00177119.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:21:27+00:00 2018-10-22 05:21:27+00:00 rdccamxv15 RT DISTAL CCA MAX CIMT (mm) V1 +25 Carotid IMT 177121 phv00177121.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:21:33+00:00 2018-10-22 05:21:33+00:00 rdccamxv25 RT DISTAL CCA MAX CIMT (mm) V2 +25 Carotid IMT 177123 phv00177123.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:21:38+00:00 2018-10-22 05:21:38+00:00 rdccamxv35 RT DISTAL CCA MAX CIMT (mm) V3 +25 Carotid IMT 177125 phv00177125.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:21:44+00:00 2018-10-22 05:21:44+00:00 ricamnavg5 RT ICA MEAN CIMT (mm) AVG +25 Carotid IMT 177127 phv00177127.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:21:50+00:00 2018-10-22 05:21:50+00:00 ricamnv15 RT ICA MEAN CIMT (mm) V1 +25 Carotid IMT 177129 phv00177129.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:21:56+00:00 2018-10-22 05:21:56+00:00 ricamnv25 RT ICA MEAN CIMT (mm) V2 +25 Carotid IMT 177131 phv00177131.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:02+00:00 2018-10-22 05:22:02+00:00 ricamnv35 RT ICA MEAN CIMT (mm) V3 +25 Carotid IMT 177133 phv00177133.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:07+00:00 2018-10-22 05:22:07+00:00 ricamxavg5 RT ICA MAX CIMT (mm) AVG +25 Carotid IMT 177135 phv00177135.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:14+00:00 2018-10-22 05:22:14+00:00 ricamxv15 RT ICA MAX CIMT (mm) V1 +25 Carotid IMT 177137 phv00177137.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:20+00:00 2018-10-22 05:22:20+00:00 ricamxv25 RT ICA MAX CIMT (mm) V2 +25 Carotid IMT 177139 phv00177139.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:25+00:00 2018-10-22 05:22:25+00:00 ricamxv35 RT ICA MAX CIMT (mm) V3 +25 Carotid IMT 177141 phv00177141.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:32+00:00 2018-10-22 05:22:32+00:00 rbmnavg5 RT BULB MEAN CIMT (mm) AVG +25 Carotid IMT 177143 phv00177143.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:39+00:00 2018-10-22 05:22:39+00:00 rbmnv15 RT BULB MEAN CIMT (mm) V1 +25 Carotid IMT 177145 phv00177145.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:45+00:00 2018-10-22 05:22:45+00:00 rbmnv25 RT BULB MEAN CIMT (mm) V2 +25 Carotid IMT 177147 phv00177147.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:51+00:00 2018-10-22 05:22:51+00:00 rbmnv35 RT BULB MEAN CIMT (mm) V3 +25 Carotid IMT 177149 phv00177149.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:22:57+00:00 2018-10-22 05:22:57+00:00 rbmxavg5 RT BULB MAX CIMT (mm) AVG +25 Carotid IMT 177151 phv00177151.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:23:03+00:00 2018-10-22 05:23:03+00:00 rbmxv15 RT BULB MAX CIMT (mm) V1 +25 Carotid IMT 177153 phv00177153.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:23:08+00:00 2018-10-22 05:23:08+00:00 rbmxv25 RT BULB MAX CIMT (mm) V2 +25 Carotid IMT 177155 phv00177155.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:23:15+00:00 2018-10-22 05:23:15+00:00 rbmxv35 RT BULB MAX CIMT (mm) V3 +25 Carotid IMT 84956 phv00084956.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:34:44+00:00 2018-10-22 05:34:44+00:00 rcfwmax1 RIGHT COMMON CAROTID FAR WALL MAX (mm) +25 Carotid IMT 84957 phv00084957.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:34:50+00:00 2018-10-22 05:34:50+00:00 rcfwmin1 RIGHT COMMON CAROTID FAR WALL MIN (mm) +25 Carotid IMT 84958 phv00084958.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:35:17+00:00 2018-10-22 05:35:17+00:00 rcfwmn1 RIGHT COMMON CAROTID FAR WALL MEAN (mm) +25 Carotid IMT 84959 phv00084959.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:35:24+00:00 2018-10-22 05:35:24+00:00 rcnwmax1 RIGHT COMMON CAROTID NEAR WALL MAX (mm) +25 Carotid IMT 84960 phv00084960.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:35:30+00:00 2018-10-22 05:35:30+00:00 rcnwmin1 RIGHT COMMON CAROTID NEAR WALL MIN (mm) +25 Carotid IMT 84961 phv00084961.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:35:37+00:00 2018-10-22 05:35:37+00:00 rcnwmn1 RIGHT COMMON CAROTID NEAR WALL MEAN (mm) +25 Carotid IMT 87557 phv00087557.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:35:55+00:00 2018-10-22 05:35:55+00:00 rcfwmaxf RIGHT COMMON CAROTID FAR WALL MAX (mm) +25 Carotid IMT 87558 phv00087558.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:36:01+00:00 2018-10-22 05:36:01+00:00 rcnwmaxf RIGHT COMMON CAROTID NEAR WALL MAX (mm) +25 Carotid IMT 128698 phv00128698.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:36:07+00:00 2018-10-22 05:36:07+00:00 rcfwmnf RIGHT COMMON CAROTID FAR WALL MEAN +25 Carotid IMT 84878 phv00084878.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:39:36+00:00 2018-10-22 05:39:36+00:00 lcfwmin1 LEFT COMMON CAROTID FAR WALL MIN (mm) +25 Carotid IMT 84879 phv00084879.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:39:42+00:00 2018-10-22 05:39:42+00:00 lcfwmn1 LEFT COMMON CAROTID FAR WALL MEAN (mm) +25 Carotid IMT 84881 phv00084881.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:39:47+00:00 2018-10-22 05:39:47+00:00 lcnwmax1 LEFT COMMON CAROTID NEAR WALL MAX (mm) +25 Carotid IMT 84882 phv00084882.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:39:52+00:00 2018-10-22 05:39:52+00:00 lcnwmin1 LEFT COMMON CAROTID NEAR WALL MIN (mm) +25 Carotid IMT 84883 phv00084883.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:39:59+00:00 2018-10-22 05:39:59+00:00 lcnwmn1 LEFT COMMON CAROTID NEAR WALL MEAN (mm) +25 Carotid IMT 87559 phv00087559.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:40:40+00:00 2018-10-22 05:40:40+00:00 lcfwmaxf LEFT COMMON CAROTID FAR WALL MAX (mm) +25 Carotid IMT 87560 phv00087560.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:40:45+00:00 2018-10-22 05:40:45+00:00 lcnwmaxf LEFT COMMON CAROTID NEAR WALL MAX (mm) +25 Carotid IMT 112047 phv00112047.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:40:51+00:00 2018-10-22 05:40:51+00:00 lcfwmax4 LEFT COMMON CAROTID FAR WALL MAX +25 Carotid IMT 84877 phv00084877.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:41:39+00:00 2018-10-22 05:41:39+00:00 lcfwmax1 LEFT COMMON CAROTID FAR WALL MAX (mm) +25 Carotid IMT 84820 phv00084820.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:44:11+00:00 2018-10-22 05:44:11+00:00 rafwmax1 RIGHT ANTERIOR OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 84821 phv00084821.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:44:17+00:00 2018-10-22 05:44:17+00:00 rafwmin1 RIGHT ANTERIOR OBLIQUE FAR WALL MIN (mm) +25 Carotid IMT 84822 phv00084822.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:44:23+00:00 2018-10-22 05:44:23+00:00 rafwmn1 RIGHT ANTERIOR OBLIQUE FAR WALL MEAN (mm) +25 Carotid IMT 84824 phv00084824.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:44:28+00:00 2018-10-22 05:44:28+00:00 ranwmax1 RIGHT ANTERIOR OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 84825 phv00084825.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:44:34+00:00 2018-10-22 05:44:34+00:00 ranwmin1 RIGHT ANTERIOR OBLIQUE NEAR WALL MIN (mm) +25 Carotid IMT 84826 phv00084826.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:44:42+00:00 2018-10-22 05:44:42+00:00 ranwmn1 RIGHT ANTERIOR OBLIQUE NEAR WALL MEAN (mm) +25 Carotid IMT 84896 phv00084896.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:45:23+00:00 2018-10-22 05:45:23+00:00 lafwmax1 LEFT ANTERIOR OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 84897 phv00084897.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:45:28+00:00 2018-10-22 05:45:28+00:00 lafwmin1 LEFT ANTERIOR OBLIQUE FAR WALL MIN (mm) +25 Carotid IMT 84898 phv00084898.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:45:34+00:00 2018-10-22 05:45:34+00:00 lafwmn1 LEFT ANTERIOR OBLIQUE FAR WALL MEAN (mm) +25 Carotid IMT 84900 phv00084900.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:45:40+00:00 2018-10-22 05:45:40+00:00 lanwmax1 LEFT ANTERIOR OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 84901 phv00084901.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:45:45+00:00 2018-10-22 05:45:45+00:00 lanwmin1 LEFT ANTERIOR OBLIQUE NEAR WALL MIN (mm) +25 Carotid IMT 84902 phv00084902.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:45:50+00:00 2018-10-22 05:45:50+00:00 lanwmn1 LEFT ANTERIOR OBLIQUE NEAR WALL MEAN (mm) +25 Carotid IMT 87561 phv00087561.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:46:28+00:00 2018-10-22 05:46:28+00:00 rafwmaxf RIGHT ANTERIOR OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 87562 phv00087562.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:46:35+00:00 2018-10-22 05:46:35+00:00 ranwmaxf RIGHT ANTERIOR OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 87567 phv00087567.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:46:40+00:00 2018-10-22 05:46:40+00:00 lafwmaxf LEFT ANTERIOR OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 87568 phv00087568.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:46:46+00:00 2018-10-22 05:46:46+00:00 lanwmaxf LEFT ANTERIOR OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 111993 phv00111993.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:46:51+00:00 2018-10-22 05:46:51+00:00 rafwmax4 RIGHT ANTERIOR OBLIQUE FAR WALL MAX +25 Carotid IMT 111994 phv00111994.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:46:58+00:00 2018-10-22 05:46:58+00:00 rafwmin4 RIGHT ANTERIOR OBLIQUE FAR WALL MIN +25 Carotid IMT 111995 phv00111995.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:47:03+00:00 2018-10-22 05:47:03+00:00 rafwmn4 RIGHT ANTERIOR OBLIQUE FAR WALL MEAN +25 Carotid IMT 111997 phv00111997.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:47:08+00:00 2018-10-22 05:47:08+00:00 ranwmax4 RIGHT ANTERIOR OBLIQUE NEAR WALL MAX +25 Carotid IMT 111998 phv00111998.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:47:13+00:00 2018-10-22 05:47:13+00:00 ranwmin4 RIGHT ANTERIOR OBLIQUE NEAR WALL MIN +25 Carotid IMT 111999 phv00111999.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:48:18+00:00 2018-10-22 05:48:18+00:00 ranwmn4 RIGHT ANTERIOR OBLIQUE NEAR WALL MEAN +25 Carotid IMT 112069 phv00112069.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:48:56+00:00 2018-10-22 05:48:56+00:00 lafwmax4 LEFT ANTERIOR OBLIQUE FAR WALL MAX +25 Carotid IMT 112070 phv00112070.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:49:02+00:00 2018-10-22 05:49:02+00:00 lafwmin4 LEFT ANTERIOR OBLIQUE FAR WALL MIN +25 Carotid IMT 112071 phv00112071.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:49:07+00:00 2018-10-22 05:49:07+00:00 lafwmn4 LEFT ANTERIOR OBLIQUE FAR WALL MEAN +25 Carotid IMT 112073 phv00112073.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:49:14+00:00 2018-10-22 05:49:14+00:00 lanwmax4 LEFT ANTERIOR OBLIQUE NEAR WALL MAX +25 Carotid IMT 112074 phv00112074.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:49:19+00:00 2018-10-22 05:49:19+00:00 lanwmin4 LEFT ANTERIOR OBLIQUE NEAR WALL MIN +25 Carotid IMT 112075 phv00112075.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:49:24+00:00 2018-10-22 05:49:24+00:00 lanwmn4 LEFT ANTERIOR OBLIQUE NEAR WALL MEAN +25 Carotid IMT 84840 phv00084840.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:52:16+00:00 2018-10-22 05:52:16+00:00 rlfwmin1 RIGHT LATERAL OBLIQUE FAR WALL MIN (mm) +25 Carotid IMT 84841 phv00084841.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:52:21+00:00 2018-10-22 05:52:21+00:00 rlfwmn1 RIGHT LATERAL OBLIQUE FAR WALL MEAN (mm) +25 Carotid IMT 84843 phv00084843.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:52:27+00:00 2018-10-22 05:52:27+00:00 rlnwmax1 RIGHT LATERAL OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 84844 phv00084844.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:52:33+00:00 2018-10-22 05:52:33+00:00 rlnwmin1 RIGHT LATERAL OBLIQUE NEAR WALL MIN (mm) +25 Carotid IMT 84845 phv00084845.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:52:38+00:00 2018-10-22 05:52:38+00:00 rlnwmn1 RIGHT LATERAL OBLIQUE NEAR WALL MEAN (mm) +25 Carotid IMT 84915 phv00084915.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:53:20+00:00 2018-10-22 05:53:20+00:00 llfwmax1 LEFT LATERAL OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 84916 phv00084916.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:53:26+00:00 2018-10-22 05:53:26+00:00 llfwmin1 LEFT LATERAL OBLIQUE FAR WALL MIN (mm) +25 Carotid IMT 84917 phv00084917.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:53:32+00:00 2018-10-22 05:53:32+00:00 llfwmn1 LEFT LATERAL OBLIQUE FAR WALL MEAN (mm) +25 Carotid IMT 84919 phv00084919.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:53:38+00:00 2018-10-22 05:53:38+00:00 llnwmax1 LEFT LATERAL OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 84920 phv00084920.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:53:43+00:00 2018-10-22 05:53:43+00:00 llnwmin1 LEFT LATERAL OBLIQUE NEAR WALL MIN (mm) +25 Carotid IMT 84921 phv00084921.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:53:49+00:00 2018-10-22 05:53:49+00:00 llnwmn1 LEFT LATERAL OBLIQUE NEAR WALL MEAN (mm) +25 Carotid IMT 87569 phv00087569.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:54:29+00:00 2018-10-22 05:54:29+00:00 llfwmaxf LEFT LATERAL OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 87570 phv00087570.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:54:49+00:00 2018-10-22 05:54:49+00:00 llnwmaxf LEFT LATERAL OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 112011 phv00112011.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:54:54+00:00 2018-10-22 05:54:54+00:00 rlfwmax4 RIGHT LATERAL OBLIQUE FAR WALL MAX +25 Carotid IMT 112012 phv00112012.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:55:00+00:00 2018-10-22 05:55:00+00:00 rlfwmin4 RIGHT LATERAL OBLIQUE FAR WALL MIN +25 Carotid IMT 112013 phv00112013.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:55:05+00:00 2018-10-22 05:55:05+00:00 rlfwmn4 RIGHT LATERAL OBLIQUE FAR WALL MEAN +25 Carotid IMT 112015 phv00112015.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:55:10+00:00 2018-10-22 05:55:10+00:00 rlnwmax4 RIGHT LATERAL OBLIQUE NEAR WALL MAX +25 Carotid IMT 112016 phv00112016.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:55:15+00:00 2018-10-22 05:55:15+00:00 rlnwmin4 RIGHT LATERAL OBLIQUE NEAR WALL MIN +25 Carotid IMT 84839 phv00084839.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:55:21+00:00 2018-10-22 05:55:21+00:00 rlfwmax1 RIGHT LATERAL OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 112017 phv00112017.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:56:33+00:00 2018-10-22 05:56:33+00:00 rlnwmn4 RIGHT LATERAL OBLIQUE NEAR WALL MEAN +25 Carotid IMT 112087 phv00112087.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:57:16+00:00 2018-10-22 05:57:16+00:00 llfwmax4 LEFT LATERAL OBLIQUE FAR WALL MAX +25 Carotid IMT 112088 phv00112088.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:57:22+00:00 2018-10-22 05:57:22+00:00 llfwmin4 LEFT LATERAL OBLIQUE FAR WALL MIN +25 Carotid IMT 112089 phv00112089.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:57:29+00:00 2018-10-22 05:57:29+00:00 llfwmn4 LEFT LATERAL OBLIQUE FAR WALL MEAN +25 Carotid IMT 112091 phv00112091.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:57:34+00:00 2018-10-22 05:57:34+00:00 llnwmax4 LEFT LATERAL OBLIQUE NEAR WALL MAX +25 Carotid IMT 112092 phv00112092.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:57:41+00:00 2018-10-22 05:57:41+00:00 llnwmin4 LEFT LATERAL OBLIQUE NEAR WALL MIN +25 Carotid IMT 112093 phv00112093.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 05:57:49+00:00 2018-10-22 05:57:49+00:00 llnwmn4 LEFT LATERAL OBLIQUE NEAR WALL MEAN +25 Carotid IMT 84859 phv00084859.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:00:43+00:00 2018-10-22 06:00:43+00:00 rpfwmin1 RIGHT POSTERIOR OBLIQUE FAR WALL MIN (mm) +25 Carotid IMT 84860 phv00084860.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:00:48+00:00 2018-10-22 06:00:48+00:00 rpfwmn1 RIGHT POSTERIOR OBLIQUE FAR WALL MEAN (mm) +25 Carotid IMT 84862 phv00084862.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:00:54+00:00 2018-10-22 06:00:54+00:00 rpnwmax1 RIGHT POSTERIOR OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 84863 phv00084863.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:01:00+00:00 2018-10-22 06:01:00+00:00 rpnwmin1 RIGHT POSTERIOR OBLIQUE NEAR WALL MIN (mm) +25 Carotid IMT 84864 phv00084864.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:01:09+00:00 2018-10-22 06:01:09+00:00 rpnwmn1 RIGHT POSTERIOR OBLIQUE NEAR WALL MEAN (mm) +25 Carotid IMT 84934 phv00084934.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:01:49+00:00 2018-10-22 06:01:49+00:00 lpfwmax1 LEFT POSTERIOR OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 84935 phv00084935.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:01:56+00:00 2018-10-22 06:01:56+00:00 lpfwmin1 LEFT POSTERIOR OBLIQUE FAR WALL MIN (mm) +25 Carotid IMT 84936 phv00084936.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:02:02+00:00 2018-10-22 06:02:02+00:00 lpfwmn1 LEFT POSTERIOR OBLIQUE FAR WALL MEAN (mm) +25 Carotid IMT 84938 phv00084938.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:02:08+00:00 2018-10-22 06:02:08+00:00 lpnwmax1 LEFT POSTERIOR OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 84939 phv00084939.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:02:15+00:00 2018-10-22 06:02:15+00:00 lpnwmin1 LEFT POSTERIOR OBLIQUE NEAR WALL MIN (mm) +25 Carotid IMT 84940 phv00084940.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:02:21+00:00 2018-10-22 06:02:21+00:00 lpnwmn1 LEFT POSTERIOR OBLIQUE NEAR WALL MEAN (mm) +25 Carotid IMT 87565 phv00087565.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:01+00:00 2018-10-22 06:03:01+00:00 rpfwmnf RIGHT POSTERIOR OBLIQUE FAR WALL MEAN (mm) +25 Carotid IMT 87566 phv00087566.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:09+00:00 2018-10-22 06:03:09+00:00 rpnwmaxf RIGHT POSTERIOR OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 87571 phv00087571.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:14+00:00 2018-10-22 06:03:14+00:00 lpfwmaxf LEFT POSTERIOR OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 87572 phv00087572.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:20+00:00 2018-10-22 06:03:20+00:00 lpnwmaxf LEFT POSTERIOR OBLIQUE NEAR WALL MAX (mm) +25 Carotid IMT 112029 phv00112029.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:26+00:00 2018-10-22 06:03:26+00:00 rpfwmax4 RIGHT POSTERIOR OBLIQUE FAR WALL MAX +25 Carotid IMT 112030 phv00112030.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:31+00:00 2018-10-22 06:03:31+00:00 rpfwmin4 RIGHT POSTERIOR OBLIQUE FAR WALL MIN +25 Carotid IMT 112031 phv00112031.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:37+00:00 2018-10-22 06:03:37+00:00 rpfwmn4 RIGHT POSTERIOR OBLIQUE FAR WALL MEAN +25 Carotid IMT 112033 phv00112033.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:43+00:00 2018-10-22 06:03:43+00:00 rpnwmax4 RIGHT POSTERIOR OBLIQUE NEAR WALL MAX +25 Carotid IMT 112034 phv00112034.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:50+00:00 2018-10-22 06:03:50+00:00 rpnwmin4 RIGHT POSTERIOR OBLIQUE NEAR WALL MIN +25 Carotid IMT 84858 phv00084858.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:03:56+00:00 2018-10-22 06:03:56+00:00 rpfwmax1 RIGHT POSTERIOR OBLIQUE FAR WALL MAX (mm) +25 Carotid IMT 112035 phv00112035.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:05:00+00:00 2018-10-22 06:05:00+00:00 rpnwmn4 RIGHT POSTERIOR OBLIQUE NEAR WALL MEAN +25 Carotid IMT 112105 phv00112105.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:05:43+00:00 2018-10-22 06:05:43+00:00 lpfwmax4 LEFT POSTERIOR OBLIQUE FAR WALL MAX +25 Carotid IMT 112106 phv00112106.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:05:48+00:00 2018-10-22 06:05:48+00:00 lpfwmin4 LEFT POSTERIOR OBLIQUE FAR WALL MIN +25 Carotid IMT 112107 phv00112107.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:05:55+00:00 2018-10-22 06:05:55+00:00 lpfwmn4 LEFT POSTERIOR OBLIQUE FAR WALL MEAN +25 Carotid IMT 112109 phv00112109.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:06:01+00:00 2018-10-22 06:06:01+00:00 lpnwmax4 LEFT POSTERIOR OBLIQUE NEAR WALL MAX +25 Carotid IMT 112110 phv00112110.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:06:09+00:00 2018-10-22 06:06:09+00:00 lpnwmin4 LEFT POSTERIOR OBLIQUE NEAR WALL MIN +25 Carotid IMT 112111 phv00112111.v1.p3 pht001528.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 06:06:14+00:00 2018-10-22 06:06:14+00:00 lpnwmn4 LEFT POSTERIOR OBLIQUE NEAR WALL MEAN +26 Myocardial infarction 85757 phv00085757.v3.p3 pht001117.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:43:31+00:00 2018-04-23 03:43:31+00:00 fhxmia2 AGE OF FIRST MI DX +26 Myocardial infarction 87853 phv00087853.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:43:43+00:00 2018-04-23 03:43:43+00:00 mi MYOCARDIAL INFARCTION (MI) +26 Myocardial infarction 87854 phv00087854.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:43:50+00:00 2018-04-23 03:43:50+00:00 mitype MI TYPE +26 Myocardial infarction 87855 phv00087855.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:44:07+00:00 2018-04-23 03:44:07+00:00 mitt TIME TO MI OR LAST FOLLOW-UP (DAYS) +26 Myocardial infarction 174566 phv00174566.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:44:44+00:00 2018-04-23 03:44:44+00:00 major21 MAJOR ABNORMALITY 2 PER MINNESOTA CODE: MAJOR Q WAVE ABNORMALITIES [OLD MYOCARDIAL INFARCTION (MI)] +26 Myocardial infarction 175077 phv00175077.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:44:50+00:00 2018-04-23 03:44:50+00:00 major25 MAJOR Q WAVE ABNORMALITIES [OLD MYOCARDIAL INFARCTION (MI)] +26 Myocardial infarction 176500 phv00176500.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:44:58+00:00 2018-04-23 03:44:58+00:00 major25 MAJOR Q WAVE ABNORMALITIES [OLD MYOCARDIAL INFARCTION (MI)] +26 Myocardial infarction 176844 phv00176844.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:45:04+00:00 2018-04-23 03:45:04+00:00 myoscar5 MYOCARDIAL SCAR (VISUAL ASSESSMENT OF ANY SIZE) USING LATE GAD ENHANCEMENT IMAGES +26 Myocardial infarction 83492 phv00083492.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:45:47+00:00 2018-04-23 03:45:47+00:00 sphaa4 HEART ATTACK IN PAST MONTH +26 Myocardial infarction 83727 phv00083727.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:46:11+00:00 2018-04-23 03:46:11+00:00 sphaa4 HEART ATTACK IN PAST MONTH +26 Myocardial infarction 87142 phv00087142.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:46:25+00:00 2018-04-23 03:46:25+00:00 heartaf HEART ATTACK +26 Myocardial infarction 87718 phv00087718.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:46:32+00:00 2018-04-23 03:46:32+00:00 sphaa4 HEART ATTACK IN PAST MONTH +26 Myocardial infarction 121263 phv00121263.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-02 19:31:23+00:00 2018-05-02 19:31:23+00:00 Y01MIEP ENDPT - MYOCARDIAL INFARCTION +26 Myocardial infarction 121479 phv00121479.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-02 19:31:23+00:00 2018-05-02 19:31:23+00:00 Y01MIEP ENDPT - MYOCARDIAL INFARCTION +26 Myocardial infarction 121288 phv00121288.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-02 20:24:08+00:00 2018-05-02 20:24:08+00:00 Y01MI MYOCARDIAL INFARCTION? +26 Myocardial infarction 121505 phv00121505.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-02 20:24:08+00:00 2018-05-02 20:24:08+00:00 Y01MI MYOCARDIAL INFARCTION? +26 Myocardial infarction 207493 phv00207493.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:20:32+00:00 2018-05-03 20:20:32+00:00 MI07 Hospitalized myocardial infarction by 2007 +26 Myocardial infarction 207512 phv00207512.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:21:10+00:00 2018-05-03 20:21:10+00:00 SMI07 ECG MI by 2007 +26 Myocardial infarction 207525 phv00207525.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:21:33+00:00 2018-05-03 20:21:33+00:00 FUMI07 Follow up time for MI07 (days) +26 Myocardial infarction 207524 phv00207524.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:21:52+00:00 2018-05-03 20:21:52+00:00 FUSMI07 Follow up time for SMI07 (days) +26 Myocardial infarction 207532 phv00207532.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:22:25+00:00 2018-05-03 20:22:25+00:00 YRSMI07 Event year for SMI07 +26 Myocardial infarction 207539 phv00207539.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:22:49+00:00 2018-05-03 20:22:49+00:00 AGSMI07 Age for SMI07 +26 Myocardial infarction 204704 phv00204704.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:27:31+00:00 2018-05-03 20:27:31+00:00 ECGMI04 Prevalent myocardial infarction from adjudicated electrocardiograms [Cohort, Exam 1] +26 Myocardial infarction 204705 phv00204705.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:27:50+00:00 2018-05-03 20:27:50+00:00 PREVMI05 Prevalent MI from ECG or medical history [Cohort, Exam 1] +26 Myocardial infarction 204709 phv00204709.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:28:19+00:00 2018-05-03 20:28:19+00:00 MACHMI02 Prevalent myocardial infarction from original machine coded ECGs [Cohort, Exam 1] +26 Myocardial infarction 204748 phv00204748.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:29:08+00:00 2018-05-03 20:29:08+00:00 MDDXMI02 MD diagnosed myocardial infarction [Cohort, Exam 1] +26 Myocardial infarction 204749 phv00204749.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:29:26+00:00 2018-05-03 20:29:26+00:00 HXOFMI02 History of myocardial infarction [Cohort, Exam 1] +26 Myocardial infarction 204613 phv00204613.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:31:16+00:00 2018-05-03 20:31:16+00:00 MDDXMI21 Visit 2, MD diagnosed myocardial infarction [Cohort, Exam 2] +26 Myocardial infarction 204614 phv00204614.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:31:34+00:00 2018-05-03 20:31:34+00:00 HXOFMI21 Visit 2, history of myocardial infarction [Cohort, Exam 2] +26 Myocardial infarction 204620 phv00204620.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:32:12+00:00 2018-05-03 20:32:12+00:00 ECGMI24 Prevalent myocardial infarction from adjudicated ECG [Cohort, Exam 2] +26 Myocardial infarction 204622 phv00204622.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:32:47+00:00 2018-05-03 20:32:47+00:00 MACHMI22 Previous myocardial infarction from machine coded [Cohort, Exam 2] +26 Myocardial infarction 204831 phv00204831.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:34:20+00:00 2018-05-03 20:34:20+00:00 MDDXMI31 Visit 3, MD diagnosed myocardial infarction [Cohort, Exam 3] +26 Myocardial infarction 204832 phv00204832.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:34:36+00:00 2018-05-03 20:34:36+00:00 HXOFMI31 Visit 3, history of myocardial infarction [Cohort, Exam 3] +26 Myocardial infarction 204841 phv00204841.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:35:18+00:00 2018-05-03 20:35:18+00:00 ECGMI32 Prevalent myocardial infarction from adjudicated ECG [Cohort, Exam 3] +26 Myocardial infarction 204842 phv00204842.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:35:44+00:00 2018-05-03 20:35:44+00:00 MACHMI31 Pre myocardial infarction from machine coded ECG [Cohort, Exam 3] +26 Myocardial infarction 204935 phv00204935.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:38:35+00:00 2018-05-03 20:38:35+00:00 MDDXMI41 Visit 4, MD diagnosed myocardial infarction [Cohort, Exam 4] +26 Myocardial infarction 204936 phv00204936.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:38:53+00:00 2018-05-03 20:38:53+00:00 HXOFMI41 Visit 4, history of myocardial infarction [Cohort, Exam 4] +26 Myocardial infarction 204944 phv00204944.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:39:21+00:00 2018-05-03 20:39:21+00:00 ECGMI41 Prevalent myocardial infarction from adjudicated ECG [Cohort, Exam 4] +26 Myocardial infarction 204945 phv00204945.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:39:39+00:00 2018-05-03 20:39:39+00:00 MACHMI41 Pre myocardial infarction from machine coded ECG [Cohort, Exam 4] +26 Myocardial infarction 206805 phv00206805.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-17 15:56:04+00:00 2018-05-17 15:56:04+00:00 HFAA11K [Medical history]. Q11k - Myocardial infarction [Heart Failure Hospital Record Abstraction Form, HFA] +26 Myocardial infarction 206841 phv00206841.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-17 15:58:17+00:00 2018-05-17 15:58:17+00:00 HFAA26A [Physical exam and symptoms - findings]. Did the patient have any of the following CARDIOVASCULAR signs or symptoms? (Anytime during hospitalization) Q26a - MI (Age Undetermined) - removed from current form version [Heart Failure Hospital Record Abstraction Form, HFA] +26 Myocardial infarction 206999 phv00206999.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-17 16:05:35+00:00 2018-05-17 16:05:35+00:00 HFAA76 Q76 - Myocardial infarction (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +26 Myocardial infarction 6230 phv00006230.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:32:58+00:00 2018-05-18 18:32:58+00:00 FQ282 MI LOCATION - ANTERIOR +26 Myocardial infarction 6231 phv00006231.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:33:39+00:00 2018-05-18 18:33:39+00:00 FQ283 MI LOCATION - INFERIOR +26 Myocardial infarction 6232 phv00006232.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:34:05+00:00 2018-05-18 18:34:05+00:00 FQ284 MI LOCATION - TRUE POSTERIOR +26 Myocardial infarction 6625 phv00006625.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:34:41+00:00 2018-05-18 18:34:41+00:00 FR399 ECG - MI - ANTERIOR +26 Myocardial infarction 6626 phv00006626.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:35:06+00:00 2018-05-18 18:35:06+00:00 FR400 ECG - MI - INFERIOR +26 Myocardial infarction 6627 phv00006627.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:35:30+00:00 2018-05-18 18:35:30+00:00 FR401 ECG - MI - TRUE POSTERIOR +26 Myocardial infarction 7665 phv00007665.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:36:14+00:00 2018-05-18 18:36:14+00:00 A163 MYOCARDIAL INFARCTION +26 Myocardial infarction 71969 phv00071969.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:36:29+00:00 2018-05-18 18:36:29+00:00 antlatmi_s1 Anterolateral myocardial infarction (MI) for first sleep study Collection Interval: 1998-2003 +26 Myocardial infarction 72008 phv00072008.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:36:43+00:00 2018-05-18 18:36:43+00:00 antlatmi_s2 Anterolateral myocardial infarction (MI) for second sleep study Collection Interval: 1998-2003 +26 Myocardial infarction 71967 phv00071967.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:36:58+00:00 2018-05-18 18:36:58+00:00 antsepmi_s1 Anteroseptal myocardial infarction (MI) for first sleep study Collection Interval: 1998-2003 +26 Myocardial infarction 72006 phv00072006.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:37:16+00:00 2018-05-18 18:37:16+00:00 antsepmi_s2 Anteroseptal myocardial infarction (MI) for second sleep study Collection Interval: 1998-2003 +26 Myocardial infarction 7906 phv00007906.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:37:50+00:00 2018-05-18 18:37:50+00:00 B274 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 8653 phv00008653.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:38:04+00:00 2018-05-18 18:38:04+00:00 C309 ECG: MYOCARDIAL INFARCTION--ANTERIOR +26 Myocardial infarction 8654 phv00008654.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:38:16+00:00 2018-05-18 18:38:16+00:00 C310 ECG: MYOCARDIAL INFARCTION--INFERIOR +26 Myocardial infarction 8655 phv00008655.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:38:30+00:00 2018-05-18 18:38:30+00:00 C311 ECG: MYOCARDIAL INFARCTION--TRUE POSTERIOR +26 Myocardial infarction 9049 phv00009049.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:38:43+00:00 2018-05-18 18:38:43+00:00 D313 ECG: ANTERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 9050 phv00009050.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:39:17+00:00 2018-05-18 18:39:17+00:00 D314 ECG: INFERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 9051 phv00009051.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:39:30+00:00 2018-05-18 18:39:30+00:00 D315 ECG: TRUE POSTERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 9504 phv00009504.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:40:16+00:00 2018-05-18 18:40:16+00:00 E599 ECG: MYOCARDIAL INFARCT-ANTERIOR +26 Myocardial infarction 250670 phv00250670.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:40:29+00:00 2018-05-18 18:40:29+00:00 e599 Electrocardiograph - Part II: Myocardial Infarction Location - Anterior Collection Interval: Exam 1 +26 Myocardial infarction 9505 phv00009505.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:40:43+00:00 2018-05-18 18:40:43+00:00 E600 ECG: MYOCARDIAL INFARCT-INFERIOR +26 Myocardial infarction 250671 phv00250671.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:41:00+00:00 2018-05-18 18:41:00+00:00 e600 Electrocardiograph - Part II: Myocardial Infarction Location- Inferior Collection Interval: Exam 1 +26 Myocardial infarction 9506 phv00009506.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:41:14+00:00 2018-05-18 18:41:14+00:00 E601 ECG: MYOCARDIAL INFARCT-TRUE POSTERIOR +26 Myocardial infarction 250672 phv00250672.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:41:29+00:00 2018-05-18 18:41:29+00:00 e601 Electrocardiograph - Part II: Myocardial Infarction Location- True Posterior Collection Interval: Exam 1 +26 Myocardial infarction 10018 phv00010018.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:42:34+00:00 2018-05-18 18:42:34+00:00 F594 MYOCARDIAL INFARCTION LOCATION: ANTERIOR +26 Myocardial infarction 10019 phv00010019.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:42:50+00:00 2018-05-18 18:42:50+00:00 F595 MYOCARDIAL INFARCTION LOCATION: INFERIOR +26 Myocardial infarction 10020 phv00010020.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:43:06+00:00 2018-05-18 18:43:06+00:00 F596 MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR +26 Myocardial infarction 1170 phv00001170.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:43:54+00:00 2018-05-18 18:43:54+00:00 FA170 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 1332 phv00001332.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:44:08+00:00 2018-05-18 18:44:08+00:00 FB184 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 1527 phv00001527.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:44:22+00:00 2018-05-18 18:44:22+00:00 FC193 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 1718 phv00001718.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:44:40+00:00 2018-05-18 18:44:40+00:00 FD189 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 1995 phv00001995.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:45:37+00:00 2018-05-18 18:45:37+00:00 FE282 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 2175 phv00002175.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:45:56+00:00 2018-05-18 18:45:56+00:00 FF245 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 2370 phv00002370.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:46:13+00:00 2018-05-18 18:46:13+00:00 FG253 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 2610 phv00002610.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:46:52+00:00 2018-05-18 18:46:52+00:00 FH270 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 2816 phv00002816.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-18 18:47:07+00:00 2018-05-18 18:47:07+00:00 FI181 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 3199 phv00003199.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:38:45+00:00 2018-05-21 12:38:45+00:00 FJ297 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 3614 phv00003614.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:39:27+00:00 2018-05-21 12:39:27+00:00 FK392 ECG: MYOCARDIAL INFARCTION +26 Myocardial infarction 4021 phv00004021.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:39:44+00:00 2018-05-21 12:39:44+00:00 FL413 ECG: ANTERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 4022 phv00004022.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:39:57+00:00 2018-05-21 12:39:57+00:00 FL414 ECG: INFERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 4023 phv00004023.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:40:22+00:00 2018-05-21 12:40:22+00:00 FL415 ECG: TRUE POSTERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 4445 phv00004445.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:40:38+00:00 2018-05-21 12:40:38+00:00 FM452 ECG: ANTERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 4446 phv00004446.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:40:52+00:00 2018-05-21 12:40:52+00:00 FM453 ECG: INFERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 4447 phv00004447.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:41:12+00:00 2018-05-21 12:41:12+00:00 FM454 ECG: TRUE POSTERIOR MYOCARDIAL INFARCTION +26 Myocardial infarction 4886 phv00004886.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:42:06+00:00 2018-05-21 12:42:06+00:00 FN428 ECG: MYOCARDIAL INFARCT-ANTERIOR +26 Myocardial infarction 4887 phv00004887.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:42:20+00:00 2018-05-21 12:42:20+00:00 FN429 ECG: MYOCARDIAL INFARCT-INFERIOR +26 Myocardial infarction 4888 phv00004888.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:42:35+00:00 2018-05-21 12:42:35+00:00 FN430 ECG: MYOCARDIAL INFARCT-TRUE POSTERIOR +26 Myocardial infarction 5246 phv00005246.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:42:53+00:00 2018-05-21 12:42:53+00:00 FO442 ECG: MYOCARDIAL INFARCT-ANTERIOR +26 Myocardial infarction 5247 phv00005247.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:43:07+00:00 2018-05-21 12:43:07+00:00 FO443 ECG: MYOCARDIAL INFARCT-INFERIOR +26 Myocardial infarction 5248 phv00005248.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:43:21+00:00 2018-05-21 12:43:21+00:00 FO444 ECG: MYOCARDIAL INFARCT-TRUE POSTERIOR +26 Myocardial infarction 5873 phv00005873.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:43:37+00:00 2018-05-21 12:43:37+00:00 FP408 ECG: MYOCARDIAL INFARCT-ANTERIOR +26 Myocardial infarction 5874 phv00005874.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:43:52+00:00 2018-05-21 12:43:52+00:00 FP409 ECG: MYOCARDIAL INFARCT-INFERIOR +26 Myocardial infarction 5875 phv00005875.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:44:09+00:00 2018-05-21 12:44:09+00:00 FP410 ECG: MYOCARDIAL INFARCT-TRUE POSTERIOR +26 Myocardial infarction 7059 phv00007059.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:45:16+00:00 2018-05-21 12:45:16+00:00 FS498 ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR +26 Myocardial infarction 7060 phv00007060.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:45:31+00:00 2018-05-21 12:45:31+00:00 FS499 ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR +26 Myocardial infarction 7061 phv00007061.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:45:50+00:00 2018-05-21 12:45:50+00:00 FS500 ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR +26 Myocardial infarction 7494 phv00007494.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:46:35+00:00 2018-05-21 12:46:35+00:00 FT504 ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR +26 Myocardial infarction 7495 phv00007495.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:46:50+00:00 2018-05-21 12:46:50+00:00 FT505 ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR +26 Myocardial infarction 70520 phv00070520.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:47:25+00:00 2018-05-21 12:47:25+00:00 FU216 ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR +26 Myocardial infarction 70521 phv00070521.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:47:39+00:00 2018-05-21 12:47:39+00:00 FU217 ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR +26 Myocardial infarction 70522 phv00070522.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:47:56+00:00 2018-05-21 12:47:56+00:00 FU218 ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR +26 Myocardial infarction 254729 phv00254729.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:48:18+00:00 2018-05-21 12:48:18+00:00 fv218 Electrocardiograph: Myocardial Infarction Location: Anterior Collection Interval: Exam 29 +26 Myocardial infarction 254730 phv00254730.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:48:45+00:00 2018-05-21 12:48:45+00:00 fv219 Electrocardiograph: Myocardial Infarction Location: Inferior Collection Interval: Exam 29 +26 Myocardial infarction 254731 phv00254731.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:49:02+00:00 2018-05-21 12:49:02+00:00 fv220 Electrocardiograph: Myocardial Infarction Location: True Posterior Collection Interval: Exam 29 +26 Myocardial infarction 255120 phv00255120.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:49:42+00:00 2018-05-21 12:49:42+00:00 fw259 Electrocardiograph: Myocardial Infarction Location - Anterior Collection Interval: Original Cohort Exam 30 +26 Myocardial infarction 255121 phv00255121.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:49:57+00:00 2018-05-21 12:49:57+00:00 fw260 Electrocardiograph: Myocardial Infarction Location - Inferior Collection Interval: Original Cohort Exam 30 +26 Myocardial infarction 255122 phv00255122.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:50:11+00:00 2018-05-21 12:50:11+00:00 fw261 Electrocardiograph: Myocardial Infarction Location - True Posterior Collection Interval: Original Cohort Exam 30 +26 Myocardial infarction 255312 phv00255312.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:50:28+00:00 2018-05-21 12:50:28+00:00 fw582 Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Heart attack or myocardial infarction or MI Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +26 Myocardial infarction 274773 phv00274773.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:51:00+00:00 2018-05-21 12:51:00+00:00 FX085 Medical History - Chest Discomfort: Have you since your last exam been told by your doctor you have/had a heart attack or myocardial infarction? Collection Interval: Original Cohort Exam 31 +26 Myocardial infarction 274845 phv00274845.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:52:31+00:00 2018-05-21 12:52:31+00:00 FX259 Electrocardiograph: Myocardial Infarction Location - Anterior Collection Interval: Original Cohort Exam 31 +26 Myocardial infarction 274846 phv00274846.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:52:44+00:00 2018-05-21 12:52:44+00:00 FX260 Electrocardiograph: Myocardial Infarction Location - Inferior Collection Interval: Original Cohort Exam 31 +26 Myocardial infarction 274847 phv00274847.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:52:58+00:00 2018-05-21 12:52:58+00:00 FX261 Electrocardiograph: Myocardial Infarction Location - True Posterior Collection Interval: Original Cohort Exam 31 +26 Myocardial infarction 275037 phv00275037.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:53:23+00:00 2018-05-21 12:53:23+00:00 FX582 Heart Problems (Form B) - Since last exam or medical history update, have you seen a doctor or other healthcare provider or been hospitalized for heart attack or myocardial infarction or MI ? Collection Interval: Original Cohort Exam 31 +26 Myocardial infarction 275130 phv00275130.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:54:07+00:00 2018-05-21 12:54:07+00:00 fy085 Medical History - Chest Discomfort: Have you since your last exam been told by your doctor you have/had a heart attack or myocardial infarction? Collection Interval: Original Cohort Exam 32 +26 Myocardial infarction 275203 phv00275203.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:54:21+00:00 2018-05-21 12:54:21+00:00 fy259 Electrocardiograph: Myocardial Infarction Location - Anterior Collection Interval: Original Cohort Exam 32 +26 Myocardial infarction 275204 phv00275204.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:54:34+00:00 2018-05-21 12:54:34+00:00 fy260 Electrocardiograph: Myocardial Infarction Location - Inferior Collection Interval: Original Cohort Exam 32 +26 Myocardial infarction 275205 phv00275205.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:54:48+00:00 2018-05-21 12:54:48+00:00 fy261 Electrocardiograph: Myocardial Infarction Location - True Posterior Collection Interval: Original Cohort Exam 32 +26 Myocardial infarction 275371 phv00275371.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:55:03+00:00 2018-05-21 12:55:03+00:00 fy582 Heart Problems (Form B) - Since your last Framingham Heart Study exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for heart attack or myocardial infarction or MI? Collection Interval: Original Cohort Exam 32 +26 Myocardial infarction 10451 phv00010451.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:55:29+00:00 2018-05-21 12:55:29+00:00 G372 ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR +26 Myocardial infarction 251012 phv00251012.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:55:43+00:00 2018-05-21 12:55:43+00:00 g372 Electrocardiograph - Part II - Myocardial Infarction Location: Anterior Collection Interval: Exam 2 +26 Myocardial infarction 10452 phv00010452.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:56:02+00:00 2018-05-21 12:56:02+00:00 G373 ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR +26 Myocardial infarction 251013 phv00251013.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:56:19+00:00 2018-05-21 12:56:19+00:00 g373 Electrocardiograph - Part II - Myocardial Infarction Location: Inferior Collection Interval: Exam 2 +26 Myocardial infarction 10453 phv00010453.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:56:33+00:00 2018-05-21 12:56:33+00:00 G374 ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR +26 Myocardial infarction 251014 phv00251014.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:56:46+00:00 2018-05-21 12:56:46+00:00 g374 Electrocardiograph - Part II - Myocardial Infarction Location: True posterior Collection Interval: Exam 2 +26 Myocardial infarction 21036 phv00021036.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:57:16+00:00 2018-05-21 12:57:16+00:00 G3A184 HAVE YOU EVER BEEN TOLD BY A DOCTOR YOU HAD A HEART ATTACK OR MYOCARDIAL INFARCTION? +26 Myocardial infarction 273870 phv00273870.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:57:29+00:00 2018-05-21 12:57:29+00:00 g3a184 Have you ever been told by a doctor you had a heart attack or myocardial infarction? Collection Interval: Exam 1 +26 Myocardial infarction 274363 phv00274363.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:57:46+00:00 2018-05-21 12:57:46+00:00 g3a184 Have you ever been told by a doctor you had a heart attack or myocardial infarction? +26 Myocardial infarction 21167 phv00021167.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:58:07+00:00 2018-05-21 12:58:07+00:00 G3A367 ECG: MYOCARDIAL INFARCTION LOCATION: ANTERIOR +26 Myocardial infarction 273989 phv00273989.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:58:20+00:00 2018-05-21 12:58:20+00:00 g3a367 ECG: Myocardial infarction location: Anterior Collection Interval: Exam 1 +26 Myocardial infarction 274482 phv00274482.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:58:35+00:00 2018-05-21 12:58:35+00:00 g3a367 ECG: Myocardial infarction location: Anterior +26 Myocardial infarction 21168 phv00021168.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:58:56+00:00 2018-05-21 12:58:56+00:00 G3A368 ECG: MYOCARDIAL INFARCTION LOCATION: INFERIOR +26 Myocardial infarction 273990 phv00273990.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:59:11+00:00 2018-05-21 12:59:11+00:00 g3a368 ECG: Myocardial infarction location: Inferior Collection Interval: Exam 1 +26 Myocardial infarction 274483 phv00274483.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:59:25+00:00 2018-05-21 12:59:25+00:00 g3a368 ECG: Myocardial infarction location: Inferior +26 Myocardial infarction 21169 phv00021169.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:59:40+00:00 2018-05-21 12:59:40+00:00 G3A369 ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR +26 Myocardial infarction 273991 phv00273991.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 12:59:53+00:00 2018-05-21 12:59:53+00:00 g3a369 ECG: Myocardial infarction location: True posterior Collection Interval: Exam 1 +26 Myocardial infarction 274484 phv00274484.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:00:09+00:00 2018-05-21 13:00:09+00:00 g3a369 ECG: Myocardial infarction location: True posterior +26 Myocardial infarction 177477 phv00177477.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:04:20+00:00 2018-05-21 13:04:20+00:00 g3b0384 Electrocardiograph: Myocardial Infarction Location: Anterior +26 Myocardial infarction 177478 phv00177478.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:04:32+00:00 2018-05-21 13:04:32+00:00 g3b0385 Electrocardiograph: Myocardial Infarction Location: Inferior +26 Myocardial infarction 177479 phv00177479.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:04:46+00:00 2018-05-21 13:04:46+00:00 g3b0386 Electrocardiograph: Myocardial Infarction Location: True Posterior +26 Myocardial infarction 72156 phv00072156.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:05:43+00:00 2018-05-21 13:05:43+00:00 H131 SINCE YOUR LAST EXAM, HAVE YOU BEEN TOLD BY A DOCTOR YOU HAD A HEART ATTACK OR MYOCARDIAL INFARCTION? +26 Myocardial infarction 251472 phv00251472.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:06:00+00:00 2018-05-21 13:06:00+00:00 h319 Electrocardiograph - Part II: Myocardial Infarction Location: Anterior Collection Interval: Exam 3 +26 Myocardial infarction 251473 phv00251473.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:06:13+00:00 2018-05-21 13:06:13+00:00 h320 Electrocardiograph - Part II: Myocardial Infarction Location: Inferior Collection Interval: Exam 3 +26 Myocardial infarction 251474 phv00251474.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:06:32+00:00 2018-05-21 13:06:32+00:00 h321 Electrocardiograph - Part II: Myocardial Infarction Location: True Posterior Collection Interval: Exam 3 +26 Myocardial infarction 276988 phv00276988.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:08:19+00:00 2018-05-21 13:08:19+00:00 HOSP4 Hospitalization for myocardial infarction Collection Interval: 1975 through 2014 +26 Myocardial infarction 71968 phv00071968.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:09:06+00:00 2018-05-21 13:09:06+00:00 infmi_s1 Inferior myocardial infarction (MI) for first sleep study Collection Interval: 1998-2003 +26 Myocardial infarction 72007 phv00072007.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:09:21+00:00 2018-05-21 13:09:21+00:00 infmi_s2 Inferior myocardial infarction (MI) for second sleep study Collection Interval: 1998-2003 +26 Myocardial infarction 254221 phv00254221.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:09:40+00:00 2018-05-21 13:09:40+00:00 j374 Electrocardiograph-Part II: Myocardial Infarction Location: Anterior +26 Myocardial infarction 254222 phv00254222.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:09:55+00:00 2018-05-21 13:09:55+00:00 j375 Electrocardiograph-Part II: Myocardial Infarction Location: Inferior +26 Myocardial infarction 254223 phv00254223.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:10:10+00:00 2018-05-21 13:10:10+00:00 j376 Electrocardiograph-Part II: Myocardial Infarction Location: True Posterior +26 Myocardial infarction 571 phv00000571.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:10:28+00:00 2018-05-21 13:10:28+00:00 MF101 ECG: MYOCARDIAL INFARCTION, EXAM 2 +26 Myocardial infarction 649 phv00000649.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:10:42+00:00 2018-05-21 13:10:42+00:00 MF184 ECG: MYOCARDIAL INFARCTION, EXAM 3 +26 Myocardial infarction 734 phv00000734.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:11:22+00:00 2018-05-21 13:11:22+00:00 MF279 ECG: MYOCARDIAL INFARCTION, EXAM 4 +26 Myocardial infarction 817 phv00000817.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:11:40+00:00 2018-05-21 13:11:40+00:00 MF367 ECG: MYOCARDIAL INFARCTION, EXAM 5 +26 Myocardial infarction 517 phv00000517.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:11:57+00:00 2018-05-21 13:11:57+00:00 MF43 ECG: MYOCARDIAL INFARCTION, EXAM 1 +26 Myocardial infarction 883 phv00000883.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:12:13+00:00 2018-05-21 13:12:13+00:00 MF437 ECG: MYOCARDIAL INFARCTION, EXAM 6 +26 Myocardial infarction 1007 phv00001007.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:12:30+00:00 2018-05-21 13:12:30+00:00 MF567 ECG: MYOCARDIAL INFARCTION, EXAM 7 +26 Myocardial infarction 71981 phv00071981.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:12:51+00:00 2018-05-21 13:12:51+00:00 truposmi_s1 True posterior myocardial infarction (MI) for first sleep study Collection Interval: 1998-2003 +26 Myocardial infarction 36471 phv00036471.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:14:42+00:00 2018-05-21 13:14:42+00:00 DATE Date of Event Collection Interval: Events reviewed through 12/2015 +26 Myocardial infarction 36469 phv00036469.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:15:00+00:00 2018-05-21 13:15:00+00:00 EVENT Event Number Collection Interval: Events reviewed through 12/2015 +26 Myocardial infarction 277010 phv00277010.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 13:16:36+00:00 2018-05-21 13:16:36+00:00 HDATE Hospitalization date Collection Interval: 1975 through 2014 +26 Myocardial infarction 7496 phv00007496.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-21 17:25:00+00:00 2018-05-21 17:25:00+00:00 FT506 ECG: MYOCARDIAL INFARCTION LOCATION: TRUE POSTERIOR +26 Myocardial infarction 121461 phv00121461.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:35:51+00:00 2018-05-24 17:35:51+00:00 Y00MI DISCHG DIAG - MYOCARDIAL INFARCTION +26 Myocardial infarction 203786 phv00203786.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:43:24+00:00 2018-05-29 13:43:24+00:00 CORA15A Is there a history of a myocardial infarction prior to the onset of this event? Q15a [Coroner / Medical Examiner Form] +26 Myocardial infarction 203749 phv00203749.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:43:57+00:00 2018-05-29 13:43:57+00:00 CORA06A Did the coroner's report mention any of the following as contributing to or being present at death? Recent myocardial infarction. Q6a [Coroner / Medical Examiner Form] +26 Myocardial infarction 203840 phv00203840.v1.p1 pht004050.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:45:10+00:00 2018-05-29 13:45:10+00:00 WCARICDX Worst computer myocardial infarction diagnosis for hospitalized event [CHD Derived Variable Dictionary - Events Cohort] +26 Myocardial infarction 203841 phv00203841.v1.p1 pht004050.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:45:37+00:00 2018-05-29 13:45:37+00:00 CMIDX Myocardial infarction classification of an event [CHD Derived Variable Dictionary - Events Cohort] +26 Myocardial infarction 203902 phv00203902.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:45:59+00:00 2018-05-29 13:45:59+00:00 HRAA19F [Second transfer]. Is there a history of myocardial infarction prior to onset of this event? Q19f [Hospital Abstraction Form] +26 Myocardial infarction 203903 phv00203903.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:46:21+00:00 2018-05-29 13:46:21+00:00 HRAA19G [Second transfer]. Did a myocardial infarction occur within four weeks of this event? Q19g [Hospital Abstraction Form] +26 Myocardial infarction 203907 phv00203907.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:47:00+00:00 2018-05-29 13:47:00+00:00 HRAA20D [Second transfer]. Is there mention of acute myocardial infarction [MI] in the discharge summary? Q20d [Hospital Abstraction Form] +26 Myocardial infarction 203975 phv00203975.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:47:22+00:00 2018-05-29 13:47:22+00:00 HRAA32 [Second transfer]. Is there a history of myocardial infarction prior to the onset of this event? Q32 [Hospital Abstraction Form] +26 Myocardial infarction 204408 phv00204408.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:47:42+00:00 2018-05-29 13:47:42+00:00 PHQA03F [Medical history]. Did the decedent have a history of any of the following? Myocardial infarction. Q3f [Physician Questionnaire Form, exam 1] +26 Myocardial infarction 204460 phv00204460.v1.p1 pht004061.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:48:01+00:00 2018-05-29 13:48:01+00:00 STRC28 [Hospital information]. History of myocardial infarction prior to the onset of this event. Q28 [Cohort Stroke Abstraction Form] +26 Myocardial infarction 204461 phv00204461.v1.p1 pht004061.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:48:26+00:00 2018-05-29 13:48:26+00:00 STRC29A [Hospital information]. Are any of the following conditions documented as having been present within four weeks prior to or during this hospitalization? Myocardial infarction. Q29a [Cohort Stroke Abstraction Form] +26 Myocardial infarction 204740 phv00204740.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:49:52+00:00 2018-05-29 13:49:52+00:00 RPOSMI01 Rose possible myocardial infarction [Cohort, Exam 1] +26 Myocardial infarction 207023 phv00207023.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:53:42+00:00 2018-05-29 13:53:42+00:00 HFAA16O [Medical history]. Q16o - Precipitating factor: myocardial infarction (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +26 Myocardial infarction 207500 phv00207500.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 13:54:43+00:00 2018-05-29 13:54:43+00:00 SOURCINC Incident Source: myocardial infarction or fatal coronary heart disease +26 Myocardial infarction 207502 phv00207502.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 19:58:07+00:00 2018-05-29 19:58:07+00:00 SOURCIS Incident Source: myocardial infarction , fatal coronary heart disease or SMI +26 Myocardial infarction 207513 phv00207513.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 19:58:53+00:00 2018-05-29 19:58:53+00:00 ECGMI_V2 ECG serial change myocardial infarction by V2 +26 Myocardial infarction 207514 phv00207514.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 19:59:17+00:00 2018-05-29 19:59:17+00:00 ECGMI_V3 ECG serial change myocardial infarction by V3 +26 Myocardial infarction 207515 phv00207515.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 19:59:38+00:00 2018-05-29 19:59:38+00:00 ECGMI_V4 ECG serial change myocardial infarction by V4 +26 Myocardial infarction 216060 phv00216060.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 20:00:25+00:00 2018-05-29 20:00:25+00:00 V2ECG21 Myocardial infarction, by Minnesota code [ECG data, exam 2] +26 Myocardial infarction 215643 phv00215643.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 20:00:53+00:00 2018-05-29 20:00:53+00:00 V1ECG21 Myocardial infarction, by Minnesota code [ECG data, exam 1] +26 Myocardial infarction 216894 phv00216894.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-29 20:01:17+00:00 2018-05-29 20:01:17+00:00 V4ECG21 Myocardial infarction, by Minnesota code [ECG data, exam 4] +26 Myocardial infarction 124993 phv00124993.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:22:43+00:00 2018-06-08 15:22:43+00:00 AFUA7A 7a. Heart attack +26 Myocardial infarction 125008 phv00125008.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:28:34+00:00 2018-06-08 15:28:34+00:00 AFUA9 9. Were you (was [name]) hospitalized for a heart attack since our last contact? +26 Myocardial infarction 125078 phv00125078.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:28:59+00:00 2018-06-08 16:28:59+00:00 AFUA7A 7a. Heart attack +26 Myocardial infarction 125093 phv00125093.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:31:11+00:00 2018-06-08 16:31:11+00:00 AFUA9 9. Were you (was [name]) hospitalized for a heart attack since our last contact? +26 Myocardial infarction 125163 phv00125163.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:45:02+00:00 2018-06-08 16:45:02+00:00 AFUB7A 7a. Heart attack +26 Myocardial infarction 125178 phv00125178.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:52:51+00:00 2018-06-08 16:52:51+00:00 AFUB9 9. Were you (was [name]) hospitalized for a heart attack since our last contact? +26 Myocardial infarction 125249 phv00125249.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:58:43+00:00 2018-06-08 16:58:43+00:00 AFUB7A 7a. Heart attack +26 Myocardial infarction 125264 phv00125264.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:00:27+00:00 2018-06-08 17:00:27+00:00 AFUB9 9. Were you (was [name]) hospitalized for a heart attack since our last contact? +26 Myocardial infarction 125392 phv00125392.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:15:21+00:00 2018-06-08 17:15:21+00:00 AFUC23 23. Were you hospitalized for a heart attack since our last contact? +26 Myocardial infarction 125597 phv00125597.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:45:08+00:00 2018-06-08 19:45:08+00:00 AFUI7A DOCTOR - HEART ATTACK Q7A +26 Myocardial infarction 125611 phv00125611.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:48:03+00:00 2018-06-08 19:48:03+00:00 AFUI9 BEEN HOSPITLIZED FOR HEART ATTACK Q9 +26 Myocardial infarction 125685 phv00125685.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:53:01+00:00 2018-06-08 19:53:01+00:00 AFUJ7A DOCTOR - HEART ATTACK Q7A +26 Myocardial infarction 125699 phv00125699.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:56:11+00:00 2018-06-08 19:56:11+00:00 AFUJ9 BEEN HOSPITLIZED FOR HEART ATTACK Q9 +26 Myocardial infarction 125509 phv00125509.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:05:22+00:00 2018-06-08 20:05:22+00:00 AFUI7A DOCTOR - HEART ATTACK Q7A +26 Myocardial infarction 125522 phv00125522.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:10:24+00:00 2018-06-08 20:10:24+00:00 AFUI9 BEEN HOSPITLIZED FOR HEART ATTACK Q9 +26 Myocardial infarction 125773 phv00125773.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:13:27+00:00 2018-06-08 20:13:27+00:00 AFUK7A DOCTOR - HEART ATTACK Q7A +26 Myocardial infarction 125787 phv00125787.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:15:29+00:00 2018-06-08 20:15:29+00:00 AFUK9 BEEN HOSPITLIZED FOR HEART ATTACK Q9 +26 Myocardial infarction 126085 phv00126085.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:22:24+00:00 2018-06-12 01:22:24+00:00 XMI01MD History of MD diagnosed MI +26 Myocardial infarction 126088 phv00126088.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:23:46+00:00 2018-06-12 01:23:46+00:00 XMI01 History of MI(derived) +26 Myocardial infarction 207503 phv00207503.v1.p1 pht004116.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-06-15 13:36:09+00:00 2018-06-15 13:36:09+00:00 SOURCISP Incident Source: myocardial infarction , fatal coronary heart disease, procedure or SMI +26 Myocardial infarction 127710 phv00127710.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:19:36+00:00 2018-06-20 15:19:36+00:00 MHXA34 34: Age when first heart attack. +26 Myocardial infarction 127708 phv00127708.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:20:27+00:00 2018-06-20 15:20:27+00:00 MHXA32 32: Hospitalized for heart attack a week +? +26 Myocardial infarction 127707 phv00127707.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:20:53+00:00 2018-06-20 15:20:53+00:00 MHXA31 31: What did the doctor say it was? +26 Myocardial infarction 127693 phv00127693.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:23:36+00:00 2018-06-20 15:23:36+00:00 MHXA17 17: What did the doctor say it was? +26 Myocardial infarction 128091 phv00128091.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:19:29+00:00 2018-06-20 18:19:29+00:00 PFHA4A 4a: Has doctor said you had Heart attack? +26 Myocardial infarction 128092 phv00128092.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:19:41+00:00 2018-06-20 18:19:41+00:00 PFHA4B 4b: Age when told you had heart attack? +26 Myocardial infarction 100798 phv00100798.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:40:24+00:00 2018-06-27 23:40:24+00:00 INCMI INCIDENT MI +26 Myocardial infarction 100799 phv00100799.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:40:44+00:00 2018-06-27 23:40:44+00:00 FATALMI FATAL OR NONFATAL MI +26 Myocardial infarction 100800 phv00100800.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:40:59+00:00 2018-06-27 23:40:59+00:00 MIBLMOD MI MODIFIED BL STAT +26 Myocardial infarction 100801 phv00100801.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:41:20+00:00 2018-06-27 23:41:20+00:00 TTOMI TIME TO MI +26 Myocardial infarction 100817 phv00100817.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:46:39+00:00 2018-06-27 23:46:39+00:00 MIBLMOD MI MODIFIED BL STAT +26 Myocardial infarction 100811 phv00100811.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:19:40+00:00 2018-06-29 16:19:40+00:00 MIBASE MI AT BL (SELF-REPORT) +26 Myocardial infarction 100824 phv00100824.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:45:47+00:00 2018-06-29 17:45:47+00:00 EVTYPE EVENT TYPE +26 Myocardial infarction 100825 phv00100825.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:46:54+00:00 2018-06-29 17:46:54+00:00 TTOEVENT TIME TO EVENT +26 Myocardial infarction 197703 phv00197703.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:56:15+00:00 2018-06-29 18:56:15+00:00 mi Prevalent heart attacks +26 Myocardial infarction 215676 phv00215676.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-05 15:32:44+00:00 2018-07-05 15:32:44+00:00 V1ECG56 Novacode prevalent myocardial infarction/ischemia; by software [ECG data, exam 1] +26 Myocardial infarction 216093 phv00216093.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-05 15:33:21+00:00 2018-07-05 15:33:21+00:00 V2ECG56 Novacode prevalent myocardial infarction/ischemia; by software [ECG data, exam 2] +26 Myocardial infarction 216510 phv00216510.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-05 15:34:03+00:00 2018-07-05 15:34:03+00:00 V3ECG56 Novacode prevalent myocardial infarction/ischemia; by software [ECG data, exam 3] +26 Myocardial infarction 216927 phv00216927.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-05 15:34:30+00:00 2018-07-05 15:34:30+00:00 V4ECG56 Novacode prevalent myocardial infarction/ischemia; by software [ECG data, exam 4] +26 Myocardial infarction 190979 phv00190979.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 18:16:58+00:00 2018-08-09 18:16:58+00:00 EVENT Event Number +26 Myocardial infarction 190981 phv00190981.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 18:17:27+00:00 2018-08-09 18:17:27+00:00 DATE Date of Event +26 Myocardial infarction 159615 phv00159615.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:43:13+00:00 2018-08-10 21:43:13+00:00 HeartAttack Heart attack [MI] Collection Interval: Collected in Exam 1 +26 Myocardial infarction 277435 phv00277435.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:29:07+00:00 2018-08-14 22:29:07+00:00 MI_AGE In what year or how old were you when it first occurred? - age Collection Interval: 2009-2011 +26 Myocardial infarction 277434 phv00277434.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:29:15+00:00 2018-08-14 22:29:15+00:00 MI_YR In what year or how old were you when it first occurred? - year Collection Interval: 2009-2011 +26 Myocardial infarction 277433 phv00277433.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:29:22+00:00 2018-08-14 22:29:22+00:00 MI Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 2009-2011 +26 Myocardial infarction 277600 phv00277600.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:48:33+00:00 2018-08-14 22:48:33+00:00 MI_AGE In what year or how old were you when it first occurred? - age Collection Interval: 1996-2000 +26 Myocardial infarction 277599 phv00277599.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:48:40+00:00 2018-08-14 22:48:40+00:00 MI_YR In what year or how old were you when it first occurred? - year Collection Interval: 1996-2000 +26 Myocardial infarction 277598 phv00277598.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:48:46+00:00 2018-08-14 22:48:46+00:00 MI Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 1996-2000 +26 Myocardial infarction 277884 phv00277884.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:15:47+00:00 2018-08-14 23:15:47+00:00 MI_AGE In what year or how old were you when it first occurred? - age Collection Interval: 2000-2004 +26 Myocardial infarction 277883 phv00277883.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:15:53+00:00 2018-08-14 23:15:53+00:00 MI_YR In what year or how old were you when it first occurred? - year Collection Interval: 2000-2004 +26 Myocardial infarction 277882 phv00277882.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:16:00+00:00 2018-08-14 23:16:00+00:00 MI Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 2000-2004 +26 Myocardial infarction 307881 phv00307881.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:00:37+00:00 2018-08-16 00:00:37+00:00 MI_AGE In what year or how old were you when it first occurred? - age Collection Interval: 1996-2000 +26 Myocardial infarction 307880 phv00307880.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:00:44+00:00 2018-08-16 00:00:44+00:00 MI_YR In what year or how old were you when it first occurred? - year Collection Interval: 1996-2000 +26 Myocardial infarction 307879 phv00307879.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:00:51+00:00 2018-08-16 00:00:51+00:00 MI Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 1996-2000 +26 Myocardial infarction 308077 phv00308077.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:17:31+00:00 2018-08-16 00:17:31+00:00 MI_AGE In what year or how old were you when it first occurred? - age Collection Interval: 2000-2004 +26 Myocardial infarction 308076 phv00308076.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:17:37+00:00 2018-08-16 00:17:37+00:00 MI_YR In what year or how old were you when it first occurred? - year Collection Interval: 2000-2004 +26 Myocardial infarction 308075 phv00308075.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:17:47+00:00 2018-08-16 00:17:47+00:00 MI Have you ever been told by a physician that you had a heart attack or myocardial infarction? Collection Interval: 2000-2004 +26 Myocardial infarction 122273 phv00122273.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:23:43+00:00 2018-08-16 23:23:43+00:00 HRTATTK Heart attack (A) +26 Myocardial infarction 122274 phv00122274.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:23:50+00:00 2018-08-16 23:23:50+00:00 HRTDIAG Heart attack diagnosed by doctor (A) +26 Myocardial infarction 122275 phv00122275.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:23:57+00:00 2018-08-16 23:23:57+00:00 HRTAGE Age when heart attack noted (A) +26 Myocardial infarction 113026 phv00113026.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:19:37+00:00 2018-08-17 18:19:37+00:00 A09HRTAG AGE AT HEART ATTACK +26 Myocardial infarction 113025 phv00113025.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:19:45+00:00 2018-08-17 18:19:45+00:00 A09HRTAK HAS/HAD HEART ATTACK? +26 Myocardial infarction 123755 phv00123755.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:52:24+00:00 2018-08-21 17:52:24+00:00 INFARCT ECG: Infarct +26 Myocardial infarction 124278 phv00124278.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 19:01:01+00:00 2018-08-21 19:01:01+00:00 DIAHRTDAY Days from visit date - Diagnosed Myocardial Infarction +26 Myocardial infarction 114391 phv00114391.v2.p2 pht001607.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:21:43+00:00 2018-08-22 21:21:43+00:00 B09HRTST STATUS, HEART ATTACK. Q 1 +26 Myocardial infarction 114390 phv00114390.v2.p2 pht001607.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:21:57+00:00 2018-08-22 21:21:57+00:00 B09HRTAG AGE AT HEART ATTACK. Q 1 +26 Myocardial infarction 114389 phv00114389.v2.p2 pht001607.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:22:14+00:00 2018-08-22 21:22:14+00:00 B09HRTAK HAD HEART ATTACK? Q 1 +26 Myocardial infarction 115430 phv00115430.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 16:57:12+00:00 2018-08-23 16:57:12+00:00 C08HRTAG AGE HEART ATTACK DIAGNOSED. Q 3 +26 Myocardial infarction 115429 phv00115429.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 16:57:19+00:00 2018-08-23 16:57:19+00:00 C08HRTAK HEART ATTACK. Q 3 +26 Myocardial infarction 116961 phv00116961.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:17:48+00:00 2018-08-24 00:17:48+00:00 D08HRTAG AGE AT HEART ATTACK. Q 3 +26 Myocardial infarction 116960 phv00116960.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:17:55+00:00 2018-08-24 00:17:55+00:00 D08HRTAK HEART ATTACK? Q 3 +26 Myocardial infarction 226366 phv00226366.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:27:27+00:00 2018-08-24 16:27:27+00:00 MI_ECG Myocardial infarction defined by ECG results +26 Myocardial infarction 258068 phv00258068.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:02:20+00:00 2018-08-24 17:02:20+00:00 MHEA4 Heart attack - self (MHEA4) +26 Myocardial infarction 252984 phv00252984.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:12:35+00:00 2018-08-24 17:12:35+00:00 mi_baseline Self report heart attack at baseline visit +26 Myocardial infarction 117946 phv00117946.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:09:19+00:00 2018-08-27 23:09:19+00:00 FY096HAK HEART ATTACK? - MON 96 +26 Myocardial infarction 118435 phv00118435.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:43:23+00:00 2018-08-28 22:43:23+00:00 E08HRTAG AGE DIAGNOSED-HEART ATTACK. Q 8 +26 Myocardial infarction 118434 phv00118434.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:43:30+00:00 2018-08-28 22:43:30+00:00 E08HRTAK HEART ATTACK? Q 8 +26 Myocardial infarction 119814 phv00119814.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:10:10+00:00 2018-08-29 21:10:10+00:00 F08HRTAG AGE DIAGNOSED-HEART ATTACK. Q 3 +26 Myocardial infarction 119809 phv00119809.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:10:17+00:00 2018-08-29 21:10:17+00:00 F08HRTAK HEART ATTACK? Q 3 +26 Myocardial infarction 258767 phv00258767.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:04:51+00:00 2018-09-06 13:04:51+00:00 Heart_attack Have you ever had a heart attack? Self-report +26 Myocardial infarction 259382 phv00259382.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:19:43+00:00 2018-09-06 13:19:43+00:00 priormi Prior MI +26 Myocardial infarction 121850 phv00121850.v1.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:49:40+00:00 2018-09-07 15:49:40+00:00 MI Ever had a heart attack (mi) +26 Myocardial infarction 190834 phv00190834.v6.p10 pht003317.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 13:59:52+00:00 2018-09-27 13:59:52+00:00 LASTSOE Date of the latest record in the 2015 SOE dataset (vr_soe_2015_a_0991) +27 Coronary angioplasty 82875 phv00082875.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:49:07+00:00 2018-04-23 03:49:07+00:00 angct1 ANGIOPLASTY AT ANY TIME IN THE PAST? +27 Coronary angioplasty 87147 phv00087147.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:49:16+00:00 2018-04-23 03:49:16+00:00 ballnf BALLOON ANGIOPLASTY +27 Coronary angioplasty 90119 phv00090119.v1.p3 pht001205.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:49:22+00:00 2018-04-23 03:49:22+00:00 angct4 ANGIOPLASTY AT ANY TIME IN THE PAST? +27 Coronary angioplasty 174749 phv00174749.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:49:49+00:00 2018-04-23 03:49:49+00:00 angct5 ANGIOPLASTY AT ANY TIME IN THE PAST? +27 Coronary angioplasty 176172 phv00176172.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:49:56+00:00 2018-04-23 03:49:56+00:00 angct5 ANGIOPLASTY AT ANY TIME IN THE PAST? +27 Coronary angioplasty 87862 phv00087862.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:51:05+00:00 2018-04-23 03:51:05+00:00 ptca PTCA, COR. STENT, OR COR. ATHERECTOMY +27 Coronary angioplasty 87863 phv00087863.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:51:11+00:00 2018-04-23 03:51:11+00:00 ptcatype PTCA TYPE +27 Coronary angioplasty 87864 phv00087864.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:51:17+00:00 2018-04-23 03:51:17+00:00 ptcatt TIME TO PTCA OR LAST FOLLOW-UP (DAYS) +27 Coronary angioplasty 202950 phv00202950.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:08:37+00:00 2018-05-03 16:08:37+00:00 AFUcomp15a_G [Invasive procedures]. Did you have angioplasty of the coronary arteries [Annual Follow-up Questionnaire Form, AFUG] +27 Coronary angioplasty 203793 phv00203793.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:09:19+00:00 2018-05-03 16:09:19+00:00 CORA20 Is there a history of coronary angioplasty prior to this event? Q20 [Coroner / Medical Examiner Form] +27 Coronary angioplasty 203945 phv00203945.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:10:06+00:00 2018-05-03 16:10:06+00:00 HRAA29C [Second transfer]. Were the following special procedures or operations performed during this hospital stay? Coronary angioplasty. Q29c [Hospital Abstraction Form] +27 Coronary angioplasty 203981 phv00203981.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:11:47+00:00 2018-05-03 16:11:47+00:00 HRAA37 [Second transfer]. Is there a history of coronary angioplasty prior to this event? Q37 [Hospital Abstraction Form] +27 Coronary angioplasty 204406 phv00204406.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:12:24+00:00 2018-05-03 16:12:24+00:00 PHQA03D [Medical history]. Did the decedent have a history of any of the following? Coronary angioplasty. Q3d [Physician Questionnaire Form, exam 1] +27 Coronary angioplasty 207175 phv00207175.v1.p1 pht004104.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:15:02+00:00 2018-05-03 16:15:02+00:00 HHXC7A [Invasive procedures]. PROBE FOR TYPE OF PROCEDURE. Angioplasty of the coronary arteries: Q7a [Health/Medical History, exam 3] +27 Coronary angioplasty 207215 phv00207215.v1.p1 pht004106.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:16:52+00:00 2018-05-03 16:16:52+00:00 HHXD7A [Invasive procedures]. Did you have: angioplasty of the coronary arteries: Q7a [Health/Medical History, exam 4] +27 Coronary angioplasty 208854 phv00208854.v1.p1 pht004143.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:17:24+00:00 2018-05-03 16:17:24+00:00 PHEA09A [Invasive procedures]. [Probe for type of procedure]. Angioplasty of coronary artery(ies)? Q9a [Physical Examination Form, exam 1] +27 Coronary angioplasty 214102 phv00214102.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:18:05+00:00 2018-05-03 16:18:05+00:00 CA15 MD said pt had coronary angioplasty? +27 Coronary angioplasty 125027 phv00125027.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:15:30+00:00 2018-06-08 16:15:30+00:00 AFUA15A 15a. Angioplasty of the coronary arteries +27 Coronary angioplasty 125112 phv00125112.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:39:10+00:00 2018-06-08 16:39:10+00:00 AFUA15A 15a. Angioplasty of the coronary arteries +27 Coronary angioplasty 125198 phv00125198.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:54:47+00:00 2018-06-08 16:54:47+00:00 AFUB15A 15a. Angioplasty of the coronary arteries +27 Coronary angioplasty 125284 phv00125284.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:01:19+00:00 2018-06-08 17:01:19+00:00 AFUB15A 15a. Angioplasty of the coronary arteries +27 Coronary angioplasty 125463 phv00125463.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:16:44+00:00 2018-06-08 17:16:44+00:00 AFUC45A 45a. Angioplasty or stent of the coronary arteries +27 Coronary angioplasty 125628 phv00125628.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:48:56+00:00 2018-06-08 19:48:56+00:00 AFUI15A ANGIOPLASTY OF CORONARY ARTERIES Q15A +27 Coronary angioplasty 125717 phv00125717.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:57:03+00:00 2018-06-08 19:57:03+00:00 AFUJ15A ANGIOPLASTY OF CORONARY ARTERIES Q15A +27 Coronary angioplasty 125539 phv00125539.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:11:20+00:00 2018-06-08 20:11:20+00:00 AFUI15A ANGIOPLASTY OF CORONARY ARTERIES Q15A +27 Coronary angioplasty 125804 phv00125804.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:17:42+00:00 2018-06-08 20:17:42+00:00 AFUK15A ANGIOPLA./STENT - CORONARY ARTERIES Q15A +27 Coronary angioplasty 5072 phv00005072.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:47:38+00:00 2018-06-14 17:47:38+00:00 FO230 HISTORY OF CORONARY ARTERY ANGIOPLASTY +27 Coronary angioplasty 6202 phv00006202.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:52:43+00:00 2018-06-14 17:52:43+00:00 FQ219 CORONARY ARTERY ANGIOPLASTY - INTERIM +27 Coronary angioplasty 6598 phv00006598.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:53:03+00:00 2018-06-14 17:53:03+00:00 FR342 CARDIOVASCULAR PROCEDURES (IN THE INTERIM ONLY, NOT LIFETIME) CORONARY ARTERY ANGIOPLASTY (IF YES OR MAYBE, FILL IN FR343 AND FR344) +27 Coronary angioplasty 7032 phv00007032.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:53:22+00:00 2018-06-14 17:53:22+00:00 FS441 CORONARY ARTERY ANGIOPLASTY +27 Coronary angioplasty 7465 phv00007465.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:53:39+00:00 2018-06-14 17:53:39+00:00 FT445 CORONARY ARTERY ANGIOPLASTY +27 Coronary angioplasty 9388 phv00009388.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:54:06+00:00 2018-06-14 17:54:06+00:00 E453 HISTORY OF CORONARY ARTERY ANGIOPLASTY +27 Coronary angioplasty 9896 phv00009896.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:54:27+00:00 2018-06-14 17:54:27+00:00 F428 CORONARY ARTERY ANGIOPLASTY +27 Coronary angioplasty 10351 phv00010351.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:54:46+00:00 2018-06-14 17:54:46+00:00 G233 CORONARY ARTERY ANGIOPLASTY +27 Coronary angioplasty 21082 phv00021082.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:55:19+00:00 2018-06-14 17:55:19+00:00 G3A252 CORONARY ARTERY ANGIOPLASTY SEE NOTE BELOW +27 Coronary angioplasty 55299 phv00055299.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:55:42+00:00 2018-06-14 17:55:42+00:00 CA15 MD said pt had coronary angioplasty? +27 Coronary angioplasty 70491 phv00070491.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:56:00+00:00 2018-06-14 17:56:00+00:00 FU157 CORONARY ARTERY ANGIOPLASTY +27 Coronary angioplasty 72203 phv00072203.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:56:18+00:00 2018-06-14 17:56:18+00:00 H212 CORONARY ARTERY ANGIOPLASTY/STENT/PCI +27 Coronary angioplasty 54692 phv00054692.v7.p10 pht000389.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:57:25+00:00 2018-06-14 17:57:25+00:00 PROCNUM Cardiovascular procedure codes +27 Coronary angioplasty 54697 phv00054697.v7.p10 pht000389.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 17:58:08+00:00 2018-06-14 17:58:08+00:00 PROCDATE Date of cardiovascular procedure +27 Coronary angioplasty 127730 phv00127730.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:29:09+00:00 2018-06-20 15:29:09+00:00 MHXA52B2 52b2: Specify other heart procedures +27 Coronary angioplasty 127737 phv00127737.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:33:24+00:00 2018-06-20 15:33:24+00:00 MHXA54A 54a: Ever had angioplasty of coronary arteries? +27 Coronary angioplasty 100780 phv00100780.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:42:00+00:00 2018-06-27 23:42:00+00:00 INCANGIO INCIDENT ANGIOPLASTY +27 Coronary angioplasty 100781 phv00100781.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:42:19+00:00 2018-06-27 23:42:19+00:00 TTOANGI TIME TO ANGIOPLASTY +27 Coronary angioplasty 100782 phv00100782.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:42:36+00:00 2018-06-27 23:42:36+00:00 CORARTBL CORONARY ARTERY ANGIOPLASTY AT BL +27 Coronary angioplasty 100824 phv00100824.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:46:07+00:00 2018-06-29 17:46:07+00:00 EVTYPE EVENT TYPE +27 Coronary angioplasty 100825 phv00100825.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:47:10+00:00 2018-06-29 17:47:10+00:00 TTOEVENT TIME TO EVENT +27 Coronary angioplasty 193548 phv00193548.v2.p3 pht003409.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:08:22+00:00 2018-06-29 23:08:22+00:00 DTHCABGPTCA F124 Coronary Death CABG/PTCA +27 Coronary angioplasty 193199 phv00193199.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:09:20+00:00 2018-06-29 23:09:20+00:00 PTCA PTCA +27 Coronary angioplasty 192519 phv00192519.v3.p3 pht003402.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:10:04+00:00 2018-06-29 23:10:04+00:00 PTCA PTCA +27 Coronary angioplasty 193058 phv00193058.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:11:42+00:00 2018-06-29 23:11:42+00:00 PTCA PTCA +27 Coronary angioplasty 193000 phv00193000.v3.p3 pht003405.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:12:17+00:00 2018-06-29 23:12:17+00:00 PTCA PTCA +27 Coronary angioplasty 283435 phv00283435.v1.p3 pht006220.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:13:39+00:00 2018-06-29 23:13:39+00:00 DTHCABGPTCA F124 Coronary Death CABG/PTCA +27 Coronary angioplasty 283700 phv00283700.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:14:34+00:00 2018-06-29 23:14:34+00:00 PTCA F136 PTCA +27 Coronary angioplasty 78536 phv00078536.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:15:23+00:00 2018-06-29 23:15:23+00:00 PTCA Angioplasty of coronary arteries ever +27 Coronary angioplasty 121382 phv00121382.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-06 18:36:14+00:00 2018-08-06 18:36:14+00:00 Y01STENT PTCA, CORONARY STENT OR ATHERECTOMY? +27 Coronary angioplasty 121602 phv00121602.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-06 18:36:30+00:00 2018-08-06 18:36:30+00:00 Y01STENT PTCA, CORONARY STENT OR ATHERECTOMY? +27 Coronary angioplasty 159632 phv00159632.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:19:45+00:00 2018-08-10 21:19:45+00:00 Angioplasty Angioplasty or cardiac stents placed Collection Interval: Collected in Exam 1 +27 Coronary angioplasty 277439 phv00277439.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:30:06+00:00 2018-08-14 22:30:06+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 2009-2011 +27 Coronary angioplasty 277438 phv00277438.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:30:26+00:00 2018-08-14 22:30:26+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 2009-2011 +27 Coronary angioplasty 277437 phv00277437.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:30:51+00:00 2018-08-14 22:30:51+00:00 ARTERIES Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2009-2011 +27 Coronary angioplasty 277602 phv00277602.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:49:27+00:00 2018-08-14 22:49:27+00:00 ARTERIES Ever had coronary bypass surgery/angioplasty/or balloon dilation because arteries of the heart were blocked? Collection Interval: 1996-2000 +27 Coronary angioplasty 277603 phv00277603.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:49:42+00:00 2018-08-14 22:49:42+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 1996-2000 +27 Coronary angioplasty 277604 phv00277604.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:49:56+00:00 2018-08-14 22:49:56+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 1996-2000 +27 Coronary angioplasty 277888 phv00277888.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:15:05+00:00 2018-08-14 23:15:05+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 2000-2004 +27 Coronary angioplasty 277887 phv00277887.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:15:18+00:00 2018-08-14 23:15:18+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 2000-2004 +27 Coronary angioplasty 277886 phv00277886.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:15:32+00:00 2018-08-14 23:15:32+00:00 ARTERIES Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2000-2004 +27 Coronary angioplasty 307885 phv00307885.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:01:51+00:00 2018-08-16 00:01:51+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 1996-2000 +27 Coronary angioplasty 307884 phv00307884.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:02:04+00:00 2018-08-16 00:02:04+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 1996-2000 +27 Coronary angioplasty 307883 phv00307883.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:02:17+00:00 2018-08-16 00:02:17+00:00 ARTERIES Ever had coronary bypass surgery/angioplasty/or balloon dilation because arteries of the heart were blocked? Collection Interval: 1996-2000 +27 Coronary angioplasty 308081 phv00308081.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:16:45+00:00 2018-08-16 00:16:45+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 2000-2004 +27 Coronary angioplasty 308080 phv00308080.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:16:59+00:00 2018-08-16 00:16:59+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 2000-2004 +27 Coronary angioplasty 308079 phv00308079.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:17:13+00:00 2018-08-16 00:17:13+00:00 ARTERIES Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2000-2004 +27 Coronary angioplasty 122383 phv00122383.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:34:28+00:00 2018-08-16 23:34:28+00:00 ANGIOP Has had coronary angioplasty +27 Coronary angioplasty 124262 phv00124262.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 19:00:02+00:00 2018-08-21 19:00:02+00:00 ANGIODAY Days from visit date - Diagnosed Coronary Angioplasty +27 Coronary angioplasty 204151 phv00204151.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-27 22:40:44+00:00 2018-09-27 22:40:44+00:00 HRAA29P1 [Second transfer]. Holter monitoring. Pacemaker (temporary, wires). Coronary stent. Q29p1 [Hospital Abstraction Form] +27 Coronary angioplasty 255316 phv00255316.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 17:42:43+00:00 2018-10-10 17:42:43+00:00 fw586 Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Procedure to unblock narrowed blood vessels to your heart muscles Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +28 Coronary artery bypass graft 87865 phv00087865.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:53:46+00:00 2018-04-23 03:53:46+00:00 cbg CORONARY BYPASS GRAFT (CBG) +28 Coronary artery bypass graft 87866 phv00087866.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:53:53+00:00 2018-04-23 03:53:53+00:00 cbgtype CBG TYPE +28 Coronary artery bypass graft 87867 phv00087867.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:53:59+00:00 2018-04-23 03:53:59+00:00 cbgtt TIME TO CBG OR LAST FOLLOW-UP (DAYS) +28 Coronary artery bypass graft 206900 phv00206900.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 18:59:49+00:00 2018-04-24 18:59:49+00:00 HFAA32B3 [Diagnostic tests]. Q32b3 - Were coronary bypass grafts present? [Heart Failure Hospital Record Abstraction Form, HFA] +28 Coronary artery bypass graft 206912 phv00206912.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 19:00:12+00:00 2018-04-24 19:00:12+00:00 HFAA51 Q51 - Interventions: coronary artery bypass graft (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +28 Coronary artery bypass graft 206795 phv00206795.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 19:06:36+00:00 2018-04-24 19:06:36+00:00 HFAA11E1 [Medical history]. Q11e1- Cardiac procedures: CABG [Heart Failure Hospital Record Abstraction Form, HFA] +28 Coronary artery bypass graft 121381 phv00121381.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:39:49+00:00 2018-05-24 17:39:49+00:00 Y01BAPAS CORONARY ARTERY BYPASS GRAFT? +28 Coronary artery bypass graft 121601 phv00121601.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:40:01+00:00 2018-05-24 17:40:01+00:00 Y01BAPAS CORONARY ARTERY BYPASS GRAFT? +28 Coronary artery bypass graft 125018 phv00125018.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:12:44+00:00 2018-06-08 16:12:44+00:00 AFUA13A 13a. Coronary bypass +28 Coronary artery bypass graft 125103 phv00125103.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:38:45+00:00 2018-06-08 16:38:45+00:00 AFUA13A 13a. Coronary bypass +28 Coronary artery bypass graft 125189 phv00125189.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:54:25+00:00 2018-06-08 16:54:25+00:00 AFUB13A 13a. Coronary bypass +28 Coronary artery bypass graft 125275 phv00125275.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:00:57+00:00 2018-06-08 17:00:57+00:00 AFUB13A 13a. Coronary bypass +28 Coronary artery bypass graft 125452 phv00125452.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:16:25+00:00 2018-06-08 17:16:25+00:00 AFUC42A 42. Did you have coronary bypass +28 Coronary artery bypass graft 125620 phv00125620.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:48:32+00:00 2018-06-08 19:48:32+00:00 AFUI13A CORONARY BYPASS Q13A +28 Coronary artery bypass graft 125709 phv00125709.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:56:36+00:00 2018-06-08 19:56:36+00:00 AFUJ13A CORONARY BYPASS Q13A +28 Coronary artery bypass graft 125531 phv00125531.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:10:55+00:00 2018-06-08 20:10:55+00:00 AFUI13A CORONARY BYPASS Q13A +28 Coronary artery bypass graft 125796 phv00125796.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:16:03+00:00 2018-06-08 20:16:03+00:00 AFUK13A CORONARY BYPASS Q13A +28 Coronary artery bypass graft 54653 phv00054653.v1.p10 pht000386.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:09:25+00:00 2018-06-14 18:09:25+00:00 procedure TYPE OF PROCEDURE +28 Coronary artery bypass graft 54659 phv00054659.v1.p10 pht000386.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:09:44+00:00 2018-06-14 18:09:44+00:00 procdate PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1 +28 Coronary artery bypass graft 255315 phv00255315.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:11:05+00:00 2018-06-14 18:11:05+00:00 fw585 Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Heart bypass operation or coronary bypass surgery or CABG Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +28 Coronary artery bypass graft 275040 phv00275040.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:11:19+00:00 2018-06-14 18:11:19+00:00 FX585 Heart Problems (Form B) - Since last exam or medical history update, have you seen a doctor or other healthcare provider or been hospitalized for heart bypass operation or coronary bypass surgery or CABG? Collection Interval: Original Cohort Exam 31 +28 Coronary artery bypass graft 275374 phv00275374.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:11:31+00:00 2018-06-14 18:11:31+00:00 fy585 Heart Problems (Form B) - Since your last Framingham Heart Study exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for heart bypass operation or coronary bypass surgery or CABG? Collection Interval: Original Cohort Exam 32 +28 Coronary artery bypass graft 4774 phv00004774.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:12:34+00:00 2018-06-14 18:12:34+00:00 FN300 HISTORY OF CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 5074 phv00005074.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:12:44+00:00 2018-06-14 18:12:44+00:00 FO233 HISTORY OF CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 5692 phv00005692.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:12:53+00:00 2018-06-14 18:12:53+00:00 FP183 CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 6203 phv00006203.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:13:02+00:00 2018-06-14 18:13:02+00:00 FQ220 CORONARY BYPASS SURGERY - INTERIM +28 Coronary artery bypass graft 6600 phv00006600.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:20:22+00:00 2018-06-14 18:20:22+00:00 FR345 CARDIOVASCULAR PROCEDURES (IN THE INTERIM ONLY, NOT LIFETIME) CORONARY BYPASS SURGERY (IF YES, FILL IN FR346) +28 Coronary artery bypass graft 7034 phv00007034.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:22:00+00:00 2018-06-14 18:22:00+00:00 FS444 CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 7467 phv00007467.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:22:13+00:00 2018-06-14 18:22:13+00:00 FT448 CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 9390 phv00009390.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:22:25+00:00 2018-06-14 18:22:25+00:00 E456 HISTORY OF CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 9898 phv00009898.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:22:38+00:00 2018-06-14 18:22:38+00:00 F431 CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 10097 phv00010097.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:23:04+00:00 2018-06-14 18:23:04+00:00 F707 DID YOU HAVE HEART BYPASS SURGERY BEFORE AGE 55 +28 Coronary artery bypass graft 10353 phv00010353.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:23:20+00:00 2018-06-14 18:23:20+00:00 G236 CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 21084 phv00021084.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:23:42+00:00 2018-06-14 18:23:42+00:00 G3A255 CORONARY BYPASS SURGERY SEE NOTE BELOW +28 Coronary artery bypass graft 54692 phv00054692.v7.p10 pht000389.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:24:29+00:00 2018-06-14 18:24:29+00:00 PROCNUM Cardiovascular procedure codes +28 Coronary artery bypass graft 54697 phv00054697.v7.p10 pht000389.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:24:58+00:00 2018-06-14 18:24:58+00:00 PROCDATE Date of cardiovascular procedure +28 Coronary artery bypass graft 70493 phv00070493.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:29:15+00:00 2018-06-14 18:29:15+00:00 FU160 CORONARY BYPASS SURGERY +28 Coronary artery bypass graft 127728 phv00127728.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:26:41+00:00 2018-06-20 15:26:41+00:00 MHXA52A 52a: Have a coronary bypass? +28 Coronary artery bypass graft 100783 phv00100783.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:42:56+00:00 2018-06-27 23:42:56+00:00 INCBYPS INCIDENT BYPASS SURGERY +28 Coronary artery bypass graft 100784 phv00100784.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:43:18+00:00 2018-06-27 23:43:18+00:00 TTOBYPS TIME TO BYPASS SURGERY +28 Coronary artery bypass graft 100785 phv00100785.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:43:35+00:00 2018-06-27 23:43:35+00:00 BPSSURBL CORONARY BYPASS SURGERY AT BL +28 Coronary artery bypass graft 100824 phv00100824.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:46:21+00:00 2018-06-29 17:46:21+00:00 EVTYPE EVENT TYPE +28 Coronary artery bypass graft 100825 phv00100825.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:47:21+00:00 2018-06-29 17:47:21+00:00 TTOEVENT TIME TO EVENT +28 Coronary artery bypass graft 78535 phv00078535.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:18:56+00:00 2018-06-29 23:18:56+00:00 CABG Coronary bypass surgery ever +28 Coronary artery bypass graft 192480 phv00192480.v3.p3 pht003402.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:19:34+00:00 2018-06-29 23:19:34+00:00 CABG CABG +28 Coronary artery bypass graft 193157 phv00193157.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:20:17+00:00 2018-06-29 23:20:17+00:00 CABG CABG +28 Coronary artery bypass graft 193052 phv00193052.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:20:35+00:00 2018-06-29 23:20:35+00:00 CABG CABG +28 Coronary artery bypass graft 192995 phv00192995.v3.p3 pht003405.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:20:55+00:00 2018-06-29 23:20:55+00:00 CABG CABG +28 Coronary artery bypass graft 283699 phv00283699.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:21:13+00:00 2018-06-29 23:21:13+00:00 CABG F136 CABG +28 Coronary artery bypass graft 283519 phv00283519.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:12:38+00:00 2018-07-02 22:12:38+00:00 CABGHX F136 History of CABG +28 Coronary artery bypass graft 127730 phv00127730.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 18:23:26+00:00 2018-08-06 18:23:26+00:00 MHXA52B2 52b2: Specify other heart procedures +28 Coronary artery bypass graft 159631 phv00159631.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:57:27+00:00 2018-08-10 20:57:27+00:00 CABG Coronary artery bypass surgery [CABG] Collection Interval: Collected in Exam 1 +28 Coronary artery bypass graft 277439 phv00277439.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:30:13+00:00 2018-08-14 22:30:13+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 2009-2011 +28 Coronary artery bypass graft 277438 phv00277438.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:30:33+00:00 2018-08-14 22:30:33+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 2009-2011 +28 Coronary artery bypass graft 277437 phv00277437.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:30:59+00:00 2018-08-14 22:30:59+00:00 ARTERIES Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2009-2011 +28 Coronary artery bypass graft 277602 phv00277602.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:49:33+00:00 2018-08-14 22:49:33+00:00 ARTERIES Ever had coronary bypass surgery/angioplasty/or balloon dilation because arteries of the heart were blocked? Collection Interval: 1996-2000 +28 Coronary artery bypass graft 277603 phv00277603.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:49:48+00:00 2018-08-14 22:49:48+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 1996-2000 +28 Coronary artery bypass graft 277604 phv00277604.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:50:02+00:00 2018-08-14 22:50:02+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 1996-2000 +28 Coronary artery bypass graft 277888 phv00277888.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:15:11+00:00 2018-08-14 23:15:11+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 2000-2004 +28 Coronary artery bypass graft 277887 phv00277887.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:15:24+00:00 2018-08-14 23:15:24+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 2000-2004 +28 Coronary artery bypass graft 277886 phv00277886.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:15:38+00:00 2018-08-14 23:15:38+00:00 ARTERIES Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2000-2004 +28 Coronary artery bypass graft 307885 phv00307885.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:01:56+00:00 2018-08-16 00:01:56+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 1996-2000 +28 Coronary artery bypass graft 307884 phv00307884.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:02:10+00:00 2018-08-16 00:02:10+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 1996-2000 +28 Coronary artery bypass graft 307883 phv00307883.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:02:23+00:00 2018-08-16 00:02:23+00:00 ARTERIES Ever had coronary bypass surgery/angioplasty/or balloon dilation because arteries of the heart were blocked? Collection Interval: 1996-2000 +28 Coronary artery bypass graft 308081 phv00308081.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:16:51+00:00 2018-08-16 00:16:51+00:00 ART_AGE In what year or how old were you when you first had this procedure? - age Collection Interval: 2000-2004 +28 Coronary artery bypass graft 308080 phv00308080.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:17:04+00:00 2018-08-16 00:17:04+00:00 ART_YR In what year or how old were you when you first had this procedure? - year Collection Interval: 2000-2004 +28 Coronary artery bypass graft 308079 phv00308079.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:17:20+00:00 2018-08-16 00:17:20+00:00 ARTERIES Have you ever had coronary bypass surgery/angioplasty/balloon dilation/or stent because of blocked arteries? Collection Interval: 2000-2004 +28 Coronary artery bypass graft 90120 phv00090120.v1.p3 pht001205.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-08-16 20:47:07+00:00 2018-08-16 20:47:07+00:00 coronct4 CORONARY BYPASS AT ANY TIME IN THE PAST? +28 Coronary artery bypass graft 122382 phv00122382.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:34:43+00:00 2018-08-16 23:34:43+00:00 BYPASS Have you had a coronary bypass +28 Coronary artery bypass graft 283435 phv00283435.v1.p3 pht006220.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 16:25:06+00:00 2018-08-21 16:25:06+00:00 DTHCABGPTCA F124 Coronary Death CABG/PTCA +28 Coronary artery bypass graft 193548 phv00193548.v2.p3 pht003409.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 16:25:15+00:00 2018-08-21 16:25:15+00:00 DTHCABGPTCA F124 Coronary Death CABG/PTCA +29 Heart failure 87870 phv00087870.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:55:23+00:00 2018-04-23 03:55:23+00:00 chf CONGESTIVE HEART FAILURE (CHF) +29 Heart failure 87871 phv00087871.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:55:30+00:00 2018-04-23 03:55:30+00:00 chftype CHF TYPE +29 Heart failure 87872 phv00087872.v6.p3 pht001123.v7.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:55:43+00:00 2018-04-23 03:55:43+00:00 chftt TIME TO CHF OR LAST FOLLOW-UP (DAYS) +29 Heart failure 87140 phv00087140.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 03:55:49+00:00 2018-04-23 03:55:49+00:00 hfailf HEART FAILURE +29 Heart failure 121265 phv00121265.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-02 20:20:08+00:00 2018-05-02 20:20:08+00:00 Y01CHFEP ENDPT - CONGESTIVE HEART FAILURE +29 Heart failure 121301 phv00121301.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-02 20:20:08+00:00 2018-05-02 20:20:08+00:00 Y01CHF CONGESTIVE HEAT FAILURE +29 Heart failure 121481 phv00121481.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-02 20:20:08+00:00 2018-05-02 20:20:08+00:00 Y01CHFEP ENDPT - CONGESTIVE HEART FAILURE +29 Heart failure 121518 phv00121518.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-02 20:20:08+00:00 2018-05-02 20:20:08+00:00 Y01CHF CONGESTIVE HEAT FAILURE +29 Heart failure 204697 phv00204697.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:26:38+00:00 2018-05-03 20:26:38+00:00 PREVHF01 Prevalent heart failure at baseline [Cohort, Exam 1] +29 Heart failure 202927 phv00202927.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:49:00+00:00 2018-05-03 20:49:00+00:00 AFUcomp7b_G [General health]. Has a doctor ever said you had any of the following? Heart failure or congestive heart failure [Annual Follow-up Questionnaire Form, AFUG] +29 Heart failure 202981 phv00202981.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:50:08+00:00 2018-05-03 20:50:08+00:00 AFUcomp9_L [General health]. Since we last contacted you on mm/dd/yyyy, has a doctor said that you had hear failure or congestive heart failure? [Annual Follow-up Questionnaire Form, AFUL] +29 Heart failure 206748 phv00206748.v1.p1 pht004101.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-17 15:48:04+00:00 2018-05-17 15:48:04+00:00 HDXA1C_DAYS Date of HDX completion HDXA1C [Heart Failure Diagnosis Form, HDXA] +29 Heart failure 113052 phv00113052.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:40:58+00:00 2018-05-24 17:40:58+00:00 A09CHF HAS/HAD CONGESTIVE HEART FAILURE +29 Heart failure 121462 phv00121462.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:41:35+00:00 2018-05-24 17:41:35+00:00 Y00CHF DISCHG DIAG - CONGESTIVE HEART FAILURE +29 Heart failure 124994 phv00124994.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:23:09+00:00 2018-06-08 15:23:09+00:00 AFUA7B 7b. Heart failure or congestive heart failure +29 Heart failure 125079 phv00125079.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:29:14+00:00 2018-06-08 16:29:14+00:00 AFUA7B 7b. Heart failure or congestive heart failure +29 Heart failure 125164 phv00125164.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:45:17+00:00 2018-06-08 16:45:17+00:00 AFUB7B 7b. Heart failure or congestive heart failure +29 Heart failure 125250 phv00125250.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:58:58+00:00 2018-06-08 16:58:58+00:00 AFUB7B 7b. Heart failure or congestive heart failure +29 Heart failure 125336 phv00125336.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:09:14+00:00 2018-06-08 17:09:14+00:00 AFUC7B 7b. Ever reported a heart failure diagnosis in AFU without documented +29 Heart failure 125337 phv00125337.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:09:47+00:00 2018-06-08 17:09:47+00:00 AFUC8 8. In the previous JHS phone call in (mm/dd/yyyy) you indicated that you had been diagnosed +29 Heart failure 125345 phv00125345.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:11:07+00:00 2018-06-08 17:11:07+00:00 AFUC9 9. Since we last contacted you, has doctor said that you had heart failure +29 Heart failure 125598 phv00125598.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:45:51+00:00 2018-06-08 19:45:51+00:00 AFUI7B DOCTOR - HEART FAILURE Q7B +29 Heart failure 125686 phv00125686.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:53:25+00:00 2018-06-08 19:53:25+00:00 AFUJ7B DOCTOR - HEART FAILURE Q7B +29 Heart failure 125510 phv00125510.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:05:41+00:00 2018-06-08 20:05:41+00:00 AFUI7B DOCTOR - HEART FAILURE Q7B +29 Heart failure 125774 phv00125774.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:13:44+00:00 2018-06-08 20:13:44+00:00 AFUK7B DOCTOR - HEART FAILURE Q7B +29 Heart failure 190816 phv00190816.v6.p10 pht003316.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:42:58+00:00 2018-06-15 11:42:58+00:00 chf Congestive Heart Failure (CHF) status +29 Heart failure 190822 phv00190822.v6.p10 pht003316.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:43:43+00:00 2018-06-15 11:43:43+00:00 chfdate Date of Congestive Heart Failure (CHF) status +29 Heart failure 276886 phv00276886.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:45:54+00:00 2018-06-15 11:45:54+00:00 CHF011d Date of hospital admit +29 Heart failure 276887 phv00276887.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:46:13+00:00 2018-06-15 11:46:13+00:00 CHF015d Date of HF onset, if different +29 Heart failure 36469 phv00036469.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:46:56+00:00 2018-06-15 11:46:56+00:00 EVENT Event Number Collection Interval: Events reviewed through 12/2015 +29 Heart failure 36471 phv00036471.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:47:17+00:00 2018-06-15 11:47:17+00:00 DATE Date of Event Collection Interval: Events reviewed through 12/2015 +29 Heart failure 7918 phv00007918.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:49:38+00:00 2018-06-15 11:49:38+00:00 B286 X RAY: CHF +29 Heart failure 9299 phv00009299.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:49:57+00:00 2018-06-15 11:49:57+00:00 E346 1ST EXAMINER BELIEVES CHF +29 Heart failure 255313 phv00255313.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:50:39+00:00 2018-06-15 11:50:39+00:00 fw583 Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Heart failure or congestive heart failure or CHF Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +29 Heart failure 275038 phv00275038.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:50:50+00:00 2018-06-15 11:50:50+00:00 FX583 Heart Problems (Form B) - Since last exam or medical history update, have you seen a doctor or other healthcare provider or been hospitalized for heart failure or congestive heart failure or CHF? Collection Interval: Original Cohort Exam 31 +29 Heart failure 275372 phv00275372.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:51:00+00:00 2018-06-15 11:51:00+00:00 fy583 Heart Problems (Form B) - Since your last Framingham Heart Study exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for heart failure or congestive heart failure or CHF ? Collection Interval: Original Cohort Exam 32 +29 Heart failure 6537 phv00006537.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:51:59+00:00 2018-06-15 11:51:59+00:00 FR264 RESPIRATORY SYMPTOMS - BEEN TOLD THAT YOU HAVE HAD HEART FAILURE OR CONGESTIVE HEART FAILURE IN THE INTERIM +29 Heart failure 6968 phv00006968.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:52:15+00:00 2018-06-15 11:52:15+00:00 FS359 BEEN TOLD YOU HAVE HAD HEART FAILURE OR CONGESTIVE HEART FAILURE IN THE INTERIM +29 Heart failure 7400 phv00007400.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:52:35+00:00 2018-06-15 11:52:35+00:00 FT361 BEEN TOLD YOU HAVE HAD HEART FAILURE OR CONGESTIVE HEART FAILURE IN THE INTERIM +29 Heart failure 10278 phv00010278.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:52:50+00:00 2018-06-15 11:52:50+00:00 G135 BEEN TOLD THAT YOU HAVE HAD HEART FAILURE OR CONGESTIVE HEART FAILURE IN THE INTERIM +29 Heart failure 21020 phv00021020.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:53:05+00:00 2018-06-15 11:53:05+00:00 G3A165 HAVE YOU BEEN TOLD YOU HAD HEART FAILURE OR CONGESTIVE HEART FAILURE? +29 Heart failure 70433 phv00070433.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:53:20+00:00 2018-06-15 11:53:20+00:00 FU077 SHORTNESS OF BREATH: HAVE YOU SINCE YOUR LAST EXAM BEEN TOLD YOU HAD HEART FAILURE OR CONGESTIVE HEART FAILURE? +29 Heart failure 72131 phv00072131.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:53:36+00:00 2018-06-15 11:53:36+00:00 H108 SINCE YOUR LAST EXAM HAVE YOU BEEN TOLD YOU HAD HEART FAILURE OR CONGESTIVE HEART FAILURE? +29 Heart failure 273854 phv00273854.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:54:02+00:00 2018-06-15 11:54:02+00:00 g3a165 Have you been told you had heart failure or congestive heart failure? Collection Interval: Exam 1 +29 Heart failure 274347 phv00274347.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:54:12+00:00 2018-06-15 11:54:12+00:00 g3a165 Have you been told you had heart failure or congestive heart failure? +29 Heart failure 274757 phv00274757.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:54:31+00:00 2018-06-15 11:54:31+00:00 FX060 Medical History - Respiratory Symptoms: Have you been told by your doctor you had heart failure or congestive heart failure? Collection Interval: Original Cohort Exam 31 +29 Heart failure 275114 phv00275114.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:54:45+00:00 2018-06-15 11:54:45+00:00 fy060 Medical History - Respiratory Symptoms: Have you been told by your doctor you had heart failure or congestive heart failure? Collection Interval: Original Cohort Exam 32 +29 Heart failure 6538 phv00006538.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:55:36+00:00 2018-06-15 11:55:36+00:00 FR265 RESPIRATORY SYMPTOMS - BEEN HOSPITALIZED FOR HEART FAILURE IN INTERIM +29 Heart failure 6969 phv00006969.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:55:49+00:00 2018-06-15 11:55:49+00:00 FS360 BEEN HOSPITALIZED FOR HEART FAILURE IN INTERIM +29 Heart failure 7401 phv00007401.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:56:02+00:00 2018-06-15 11:56:02+00:00 FT362 BEEN HOSPITALIZED FOR HEART FAILURE IN INTERIM +29 Heart failure 10279 phv00010279.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:56:22+00:00 2018-06-15 11:56:22+00:00 G136 BEEN HOSPITALIZED FOR HEART FAILURE IN THE INTERIM +29 Heart failure 21021 phv00021021.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:56:39+00:00 2018-06-15 11:56:39+00:00 G3A166 HAVE YOU BEEN HOSPITALIZED FOR HEART FAILURE? +29 Heart failure 70434 phv00070434.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:56:55+00:00 2018-06-15 11:56:55+00:00 FU078 SHORTNESS OF BREATH: HAVE YOU SINCE YOUR LAST EXAM BEEN HOSPITALIZED FOR HEART FAILURE? +29 Heart failure 72132 phv00072132.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:57:08+00:00 2018-06-15 11:57:08+00:00 H109 SINCE YOUR LAST EXAM HAVE YOU BEEN HOSPITALIZED FOR HEART FAILURE? +29 Heart failure 177351 phv00177351.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:57:30+00:00 2018-06-15 11:57:30+00:00 g3b0147 Medical History-Respiratory Symptoms: Have you been hospitalized for heart failure? +29 Heart failure 250846 phv00250846.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:57:46+00:00 2018-06-15 11:57:46+00:00 g136 Medical History - Respiratory and Heart: Been hospitalized for heart failure in interim Collection Interval: Exam 2 +29 Heart failure 251340 phv00251340.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:58:00+00:00 2018-06-15 11:58:00+00:00 h109 Medical History - Respiratory Symptoms - Part II - Shortness of breath: Since your last exam have you been hospitalized for heart failure? Collection Interval: Exam 3 +29 Heart failure 254086 phv00254086.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:58:20+00:00 2018-06-15 11:58:20+00:00 j114 Medical History - Respiratory Symptoms, Part II-Shortness of breath: Since your last exam: Have you been hospitalized for heart failure? +29 Heart failure 254649 phv00254649.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:58:34+00:00 2018-06-15 11:58:34+00:00 fv063 Medical History - Respiratory Symptoms: Have you since your last exam been hospitalized for heart failure? Collection Interval: Exam 29 +29 Heart failure 255037 phv00255037.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:58:48+00:00 2018-06-15 11:58:48+00:00 fw064 Medical History - Respiratory Symptoms: Have you been hospitalized for heart failure? Variable appears on Form A only Collection Interval: Original Cohort Exam 30 +29 Heart failure 273855 phv00273855.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:59:01+00:00 2018-06-15 11:59:01+00:00 g3a166 Have you been hospitalized for heart failure? Collection Interval: Exam 1 +29 Heart failure 274348 phv00274348.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:59:30+00:00 2018-06-15 11:59:30+00:00 g3a166 Have you been hospitalized for heart failure? +29 Heart failure 274758 phv00274758.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 11:59:47+00:00 2018-06-15 11:59:47+00:00 FX064 Medical History - Respiratory Symptoms: Have you been hospitalized for heart failure? Collection Interval: Original Cohort Exam 31 +29 Heart failure 275115 phv00275115.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 12:00:03+00:00 2018-06-15 12:00:03+00:00 fy064 Medical History - Respiratory Symptoms: Have you been hospitalized for heart failure? Collection Interval: Original Cohort Exam 32 +29 Heart failure 276986 phv00276986.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 12:00:25+00:00 2018-06-15 12:00:25+00:00 HOSP2 Hospitalization for heart failure Collection Interval: 1975 through 2014 +29 Heart failure 113053 phv00113053.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:22:47+00:00 2018-06-18 20:22:47+00:00 A09CHFAG AGE, CONGESTIVE HEART FAILURE +29 Heart failure 113054 phv00113054.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-06-18 20:22:47+00:00 2018-06-18 20:22:47+00:00 A09CHFST STATUS OF CONGESTIVE HRT FAILURE +29 Heart failure 100786 phv00100786.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:43:54+00:00 2018-06-27 23:43:54+00:00 INCCHF INCIDENT CHF +29 Heart failure 100787 phv00100787.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:44:15+00:00 2018-06-27 23:44:15+00:00 TTOCHF TIME TO CHF +29 Heart failure 100788 phv00100788.v1.p1 pht001464.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:44:46+00:00 2018-06-27 23:44:46+00:00 CHBLMOD CHF MODIFIED BL STAT +29 Heart failure 100819 phv00100819.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:48:18+00:00 2018-06-27 23:48:18+00:00 CHBLMOD CHF MODIFIED BL STAT +29 Heart failure 100813 phv00100813.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:22:04+00:00 2018-06-29 16:22:04+00:00 CHFBASE CHF AT BL (SELF-REPORT) +29 Heart failure 100824 phv00100824.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:46:33+00:00 2018-06-29 17:46:33+00:00 EVTYPE EVENT TYPE +29 Heart failure 100825 phv00100825.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:47:41+00:00 2018-06-29 17:47:41+00:00 TTOEVENT TIME TO EVENT +29 Heart failure 77636 phv00077636.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF_3 Heart failure +29 Heart failure 77761 phv00077761.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF_4 Heart failure +29 Heart failure 77871 phv00077871.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF_5 Heart failure +29 Heart failure 78035 phv00078035.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF_6 Heart Failure +29 Heart failure 78175 phv00078175.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF_7 Heart Failure +29 Heart failure 78316 phv00078316.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF_8 Heart failure +29 Heart failure 78486 phv00078486.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF_F2 Heart failure ever +29 Heart failure 78533 phv00078533.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF_F30 Congestive heart failure ever +29 Heart failure 192489 phv00192489.v3.p3 pht003402.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF CHF +29 Heart failure 192996 phv00192996.v3.p3 pht003405.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF CHF +29 Heart failure 193053 phv00193053.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:59:53+00:00 2018-07-02 21:59:53+00:00 CHF CHF +29 Heart failure 193166 phv00193166.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:02:16+00:00 2018-07-02 22:02:16+00:00 CHF CHF +29 Heart failure 202363 phv00202363.v2.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:04:10+00:00 2018-07-02 22:04:10+00:00 F33CHF F33 Congestive Heart Failure +29 Heart failure 202375 phv00202375.v2.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:04:10+00:00 2018-07-02 22:04:10+00:00 F33CHF F33 Congestive Heart Failure +29 Heart failure 193035 phv00193035.v3.p3 pht003405.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:04:10+00:00 2018-07-02 22:04:10+00:00 CHFFATAL CHF fatal +29 Heart failure 193097 phv00193097.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:04:10+00:00 2018-07-02 22:04:10+00:00 CHFFATAL CHF fatal +29 Heart failure 193703 phv00193703.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:04:10+00:00 2018-07-02 22:04:10+00:00 F33CHFHOSP F33 Hospitalized Heart Failure +29 Heart failure 283453 phv00283453.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:11:43+00:00 2018-07-02 22:11:43+00:00 UNCHF Definite or possible decompensated heart failure for this case +29 Heart failure 283463 phv00283463.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:11:43+00:00 2018-07-02 22:11:43+00:00 HFDIAG F135 Heart failure diagnosis +29 Heart failure 283464 phv00283464.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:11:43+00:00 2018-07-02 22:11:43+00:00 ADHFTYPE HF type for definite or probable decompensated heart failure +29 Heart failure 283487 phv00283487.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:11:43+00:00 2018-07-02 22:11:43+00:00 DIASHF F136 Diastolic HF +29 Heart failure 283488 phv00283488.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:11:43+00:00 2018-07-02 22:11:43+00:00 SYSTHF F136 Systolic HF +29 Heart failure 283489 phv00283489.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:11:44+00:00 2018-07-02 22:11:44+00:00 RIGHTSIDEHF F136 Right-sided HF +29 Heart failure 283490 phv00283490.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:11:44+00:00 2018-07-02 22:11:44+00:00 INFILTRATHF F136 Infiltrative HF +29 Heart failure 283572 phv00283572.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:11:44+00:00 2018-07-02 22:11:44+00:00 CHFPVD F136 CHFPVD +29 Heart failure 190979 phv00190979.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 18:30:55+00:00 2018-08-09 18:30:55+00:00 EVENT Event Number +29 Heart failure 190981 phv00190981.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 18:31:12+00:00 2018-08-09 18:31:12+00:00 DATE Date of Event +29 Heart failure 159609 phv00159609.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:39:53+00:00 2018-08-10 21:39:53+00:00 CongestHeartFail Congestive heart failure Collection Interval: Collected in Exam 1 +29 Heart failure 122280 phv00122280.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:24:34+00:00 2018-08-16 23:24:34+00:00 HRTFAIL Heart failure (A) +29 Heart failure 122281 phv00122281.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:24:41+00:00 2018-08-16 23:24:41+00:00 HTFDIAG Heart failure diagnosed by doctor (A) +29 Heart failure 122282 phv00122282.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:24:49+00:00 2018-08-16 23:24:49+00:00 HTFAGE Age when heart failure noted (A) +29 Heart failure 122283 phv00122283.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:25:02+00:00 2018-08-16 23:25:02+00:00 HTFPRES Heart failure problem still present (A) +29 Heart failure 114420 phv00114420.v2.p2 pht001607.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:25:40+00:00 2018-08-22 21:25:40+00:00 B09CHFST STATUS OF CONGESTIVE HRT FAIL. Q 10 +29 Heart failure 114419 phv00114419.v2.p2 pht001607.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:25:57+00:00 2018-08-22 21:25:57+00:00 B09CHFAG AGE DX, CONGESTIVE HEART FAIL. Q 10 +29 Heart failure 114418 phv00114418.v2.p2 pht001607.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:26:12+00:00 2018-08-22 21:26:12+00:00 B09CHF HAS(/D) CONGESTIVE HEART FAIL. Q 10 +29 Heart failure 226365 phv00226365.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:27:37+00:00 2018-08-24 16:27:37+00:00 MHEA5 Heart failure - self (MHEA5) +29 Heart failure 190834 phv00190834.v6.p10 pht003317.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 13:59:20+00:00 2018-09-27 13:59:20+00:00 LASTSOE Date of the latest record in the 2015 SOE dataset (vr_soe_2015_a_0991) +30 Hypertension 203796 phv00203796.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:50:36+00:00 2018-03-21 17:50:36+00:00 CORA22 Is there a history of hypertension (high blood pressure) prior to this event? Q22 [Coroner / Medical Examiner Form] +30 Hypertension 203982 phv00203982.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:52:09+00:00 2018-03-21 17:52:09+00:00 HRAA38 [Second transfer]. Is there a history of hypertension (high blood pressure) prior to this event? Q38 [Hospital Abstraction Form] +30 Hypertension 204407 phv00204407.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:52:24+00:00 2018-03-21 17:52:24+00:00 PHQA03E [Medical history]. Did the decedent have a history of any of the following? Hypertension. Q3e [Physician Questionnaire Form, exam 1] +30 Hypertension 204652 phv00204652.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:52:57+00:00 2018-03-21 17:52:57+00:00 HYPERT24 Visit 2, hypertension, definition 4 [Cohort, Exam 2] +30 Hypertension 204653 phv00204653.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:53:15+00:00 2018-03-21 17:53:15+00:00 HYPERT25 Visit 2, hypertension, definition 5 [Cohort, Exam 2] +30 Hypertension 204654 phv00204654.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:53:37+00:00 2018-03-21 17:53:37+00:00 HYPERT26 Visit 2, hypertension, definition 6 [Cohort, Exam 2] +30 Hypertension 204727 phv00204727.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:53:56+00:00 2018-03-21 17:53:56+00:00 HYPERT04 Hypertension, definition 4; replaces HYPERT01 [Cohort, Exam 1] +30 Hypertension 204728 phv00204728.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:54:11+00:00 2018-03-21 17:54:11+00:00 HYPERT05 Hypertension, definition 5; replaces HYPER02 [Cohort, Exam 1] +30 Hypertension 204729 phv00204729.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:54:30+00:00 2018-03-21 17:54:30+00:00 HYPERT06 Hypertension, definition 6; replaces HYPERT03 [Cohort, Exam 1] +30 Hypertension 204855 phv00204855.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:54:49+00:00 2018-03-21 17:54:49+00:00 HYPERT34 Visit 3, hypertension, definition 4 [Cohort, Exam 3] +30 Hypertension 204856 phv00204856.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:55:02+00:00 2018-03-21 17:55:02+00:00 HYPERT35 Visit 3, hypertension, definition 5 [Cohort, Exam 3] +30 Hypertension 204857 phv00204857.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:55:15+00:00 2018-03-21 17:55:15+00:00 HYPERT36 Visit 3, hypertension, definition 6 [Cohort, Exam 3] +30 Hypertension 204946 phv00204946.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:55:30+00:00 2018-03-21 17:55:30+00:00 HYPERT44 Hypertension, definition 4 [Cohort, Exam 4] +30 Hypertension 204947 phv00204947.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:55:52+00:00 2018-03-21 17:55:52+00:00 HYPERT45 Hypertension, definition 5 [Cohort, Exam 4] +30 Hypertension 204948 phv00204948.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:56:05+00:00 2018-03-21 17:56:05+00:00 HYPERT46 Hypertension, definition 6 [Cohort, Exam 4] +30 Hypertension 206804 phv00206804.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:56:31+00:00 2018-03-21 17:56:31+00:00 HFAA11J [Medical history]. Q11j - Cardio His: hypertension [Heart Failure Hospital Record Abstraction Form, HFA] +30 Hypertension 206806 phv00206806.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:58:14+00:00 2018-03-21 17:58:14+00:00 HFAA11L [Medical history]. Q11l - Pulmonary hypertension [Heart Failure Hospital Record Abstraction Form, HFA] +30 Hypertension 206881 phv00206881.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:58:32+00:00 2018-03-21 17:58:32+00:00 HFAA29D10 [Diagnostic tests]. Record the following if present on transthoracic echocardiogram: Q29d10- Pulmonary hypertension [Heart Failure Hospital Record Abstraction Form, HFA] +30 Hypertension 207064 phv00207064.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:58:59+00:00 2018-03-21 17:58:59+00:00 HHXB05A [Medical care]. Has a doctor ever said you had any of the following: (read each disease name and code N if No or never tested.) Q5 High blood pressure or hypertension (high blood). Q5A [Health/Medical History, exam 2] +30 Hypertension 207311 phv00207311.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 17:59:43+00:00 2018-03-21 17:59:43+00:00 HOM10A Has a doctor ever said that you had any of the following: high blood pressure or hypertension? Q10a [Home Interview, exam 1] +30 Hypertension 208966 phv00208966.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:00:34+00:00 2018-03-21 18:00:34+00:00 PHXA8A [Medical care]. Has a doctor ever said you had high blood pressure or hypertension (high blood). Q8a [Personal History Form, exam 3] +30 Hypertension 214055 phv00214055.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:00:49+00:00 2018-03-21 18:00:49+00:00 SRHYPE Self-reported hypertension +30 Hypertension 202928 phv00202928.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:29:58+00:00 2018-03-21 18:29:58+00:00 AFUcomp7c_G [General health]. Has a doctor ever said you had any of the following? High blood pressure [Annual Follow-up Questionnaire Form, AFUG] +30 Hypertension 203033 phv00203033.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:30:50+00:00 2018-03-21 18:30:50+00:00 AFUcomp14_M [General health]. Since we last contacted you has a doctor said you had high blood pressure? [Annual Follow-up Questionnaire Form, AFUM] +30 Hypertension 82655 phv00082655.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:49:39+00:00 2018-04-23 22:49:39+00:00 htn1c HYPERTENSION BY JNC VI (1997) CRITERIA +30 Hypertension 82656 phv00082656.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:49:44+00:00 2018-04-23 22:49:44+00:00 htnstg1c HYPERTENSION STAGE +30 Hypertension 84459 phv00084459.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:49:49+00:00 2018-04-23 22:49:49+00:00 htn1c HYPERTENSION BY JNC VI (1997) CRITERIA +30 Hypertension 84460 phv00084460.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:49:54+00:00 2018-04-23 22:49:54+00:00 htnstg1c HYPERTENSION STAGE +30 Hypertension 85797 phv00085797.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:00+00:00 2018-04-23 22:50:00+00:00 htn2c HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 2 +30 Hypertension 85798 phv00085798.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:06+00:00 2018-04-23 22:50:06+00:00 htnstg2c HYPERTENSION STAGE +30 Hypertension 86282 phv00086282.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:12+00:00 2018-04-23 22:50:12+00:00 htn3c HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 3 +30 Hypertension 86283 phv00086283.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:18+00:00 2018-04-23 22:50:18+00:00 htnstg3c HYPERTENSION STAGE +30 Hypertension 86749 phv00086749.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:24+00:00 2018-04-23 22:50:24+00:00 htn4c HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 4 +30 Hypertension 86750 phv00086750.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:30+00:00 2018-04-23 22:50:30+00:00 htnstg4c HYPERTENSION STAGE +30 Hypertension 87094 phv00087094.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:36+00:00 2018-04-23 22:50:36+00:00 htnfc HYPERTENSION BY JNC VI (1997) CRITERIA +30 Hypertension 87095 phv00087095.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:42+00:00 2018-04-23 22:50:42+00:00 htnstgfc HYPERTENSION STAGE BY JNC VI (1997) CRITERIA; REFERENCE 2 +30 Hypertension 174595 phv00174595.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:48+00:00 2018-04-23 22:50:48+00:00 htnstg5c HYPERTENSION STAGE +30 Hypertension 174605 phv00174605.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:53+00:00 2018-04-23 22:50:53+00:00 htn5c HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5 +30 Hypertension 175865 phv00175865.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:50:59+00:00 2018-04-23 22:50:59+00:00 htn1c HYPERTENSION BY JNC VI (1997) CRITERIA +30 Hypertension 175882 phv00175882.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:51:06+00:00 2018-04-23 22:51:06+00:00 htn HTN +30 Hypertension 176018 phv00176018.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:51:11+00:00 2018-04-23 22:51:11+00:00 htnstg5c HYPERTENSION STAGE +30 Hypertension 176028 phv00176028.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:51:16+00:00 2018-04-23 22:51:16+00:00 htn5c HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5 +30 Hypertension 82997 phv00082997.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:52:28+00:00 2018-04-23 22:52:28+00:00 highbp1 HYPERTENSION: SELF-REPORT +30 Hypertension 85233 phv00085233.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:52:36+00:00 2018-04-23 22:52:36+00:00 highbp1 HYPERTENSION: SELF-REPORT +30 Hypertension 85762 phv00085762.v3.p3 pht001117.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:52:41+00:00 2018-04-23 22:52:41+00:00 fhxhbp2 HISTORY OF HYPERTENSION INDICATOR +30 Hypertension 85763 phv00085763.v3.p3 pht001117.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:52:56+00:00 2018-04-23 22:52:56+00:00 fhxhbpa2 AGE OF FIRST HYPERTENSION DX +30 Hypertension 87153 phv00087153.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:53:05+00:00 2018-04-23 22:53:05+00:00 highbpf HIGH BLOOD PRESSURE OR HYPERTENSION +30 Hypertension 175955 phv00175955.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 22:53:12+00:00 2018-04-23 22:53:12+00:00 highbpf FAMILY COHORT: HIGH BLOOD PRESSURE OR HYPERTENSION +30 Hypertension 116955 phv00116955.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:44:14+00:00 2018-05-24 17:44:14+00:00 D08HBPPR WAS HYPERTENSION DURING PREGNANCY? Q 1 +30 Hypertension 118429 phv00118429.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:45:16+00:00 2018-05-24 17:45:16+00:00 E08HBPPR WAS HYPERTENSION DURING PREGNANCY? Q 1 +30 Hypertension 119808 phv00119808.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:45:33+00:00 2018-05-24 17:45:33+00:00 F08HBPPR WAS HYPERTENSION DURING PREGNANCY? +30 Hypertension 121273 phv00121273.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:46:10+00:00 2018-05-24 17:46:10+00:00 Y01HTNEP ENDPT - HYPERTENSION +30 Hypertension 121368 phv00121368.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:46:47+00:00 2018-05-24 17:46:47+00:00 Y01HTN HYPERTENSION +30 Hypertension 121469 phv00121469.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:49:36+00:00 2018-05-24 17:49:36+00:00 Y00HTN DISCHG DIAG - HYPERTENSION +30 Hypertension 121489 phv00121489.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 17:49:51+00:00 2018-05-24 17:49:51+00:00 Y01HTNEP ENDPT - HYPERTENSION +30 Hypertension 121587 phv00121587.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 18:06:12+00:00 2018-05-24 18:06:12+00:00 Y01HTN HYPERTENSION +30 Hypertension 124995 phv00124995.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:23:59+00:00 2018-06-08 15:23:59+00:00 AFUA7C 7c. High blood pressure +30 Hypertension 125080 phv00125080.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:29:38+00:00 2018-06-08 16:29:38+00:00 AFUA7C 7c. High blood pressure +30 Hypertension 125165 phv00125165.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:45:34+00:00 2018-06-08 16:45:34+00:00 AFUB7C 7c. High blood pressure +30 Hypertension 125251 phv00125251.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:59:20+00:00 2018-06-08 16:59:20+00:00 AFUB7C 7c. High blood pressure +30 Hypertension 125365 phv00125365.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:12:06+00:00 2018-06-08 17:12:06+00:00 AFUC14 14. Has a doctor ever said that you had high blood pressure? +30 Hypertension 125599 phv00125599.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:46:07+00:00 2018-06-08 19:46:07+00:00 AFUI7C DOCTOR - HIGH BP Q7C +30 Hypertension 125687 phv00125687.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:53:44+00:00 2018-06-08 19:53:44+00:00 AFUJ7C DOCTOR - HIGH BP Q7C +30 Hypertension 125511 phv00125511.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:08:55+00:00 2018-06-08 20:08:55+00:00 AFUI7C DOCTOR - HIGH BP Q7C +30 Hypertension 125775 phv00125775.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:14:00+00:00 2018-06-08 20:14:00+00:00 AFUK7C DOCTOR - HIGH BP Q7C +30 Hypertension 10093 phv00010093.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:35:00+00:00 2018-06-18 15:35:00+00:00 F703 DID YOU EVER HAVE HIGH BLOOD PRESSURE +30 Hypertension 7583 phv00007583.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:35:48+00:00 2018-06-18 15:35:48+00:00 A70 HISTORY OF HYPERTENSION +30 Hypertension 7991 phv00007991.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:36:06+00:00 2018-06-18 15:36:06+00:00 B373 HYPERTENSION-ON TREAT OR ELEVATED BP +30 Hypertension 21631 phv00021631.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:36:36+00:00 2018-06-18 15:36:36+00:00 BW30 LIVE-BIRTH PREGNANCY #1: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY? +30 Hypertension 21643 phv00021643.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:36:51+00:00 2018-06-18 15:36:51+00:00 BW43 LIVE-BIRTH PREGNANCY #2: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY? +30 Hypertension 21655 phv00021655.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:37:11+00:00 2018-06-18 15:37:11+00:00 BW56 LIVE-BIRTH PREGNANCY #3: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY? +30 Hypertension 21667 phv00021667.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:37:20+00:00 2018-06-18 15:37:20+00:00 BW69 LIVE-BIRTH PREGNANCY #4: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY? +30 Hypertension 21679 phv00021679.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:37:29+00:00 2018-06-18 15:37:29+00:00 BW82 LIVE-BIRTH PREGNANCY #5: DID YOU HAVE HYPERTENSION DURING THIS PREGNANCY? +30 Hypertension 8676 phv00008676.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:38:01+00:00 2018-06-18 15:38:01+00:00 C332 CDI: HYPERTENSION +30 Hypertension 4044 phv00004044.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:38:30+00:00 2018-06-18 15:38:30+00:00 FL436 CDI: HYPERTENSION +30 Hypertension 20898 phv00020898.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:38:59+00:00 2018-06-18 15:38:59+00:00 G3A038 IF EVER BEEN PREGNANT: DURING ANY OF THESE PREGNANCIES, WERE YOU TOLD YOU HAD HYPERTENSION (HIGH BLOOD PRESSURE)? +30 Hypertension 273732 phv00273732.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:39:09+00:00 2018-06-18 15:39:09+00:00 g3a038 If ever been pregnant: During any of these pregnancies, were you told you had hypertension (high blood pressure)? Collection Interval: Exam 1 +30 Hypertension 274225 phv00274225.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:39:18+00:00 2018-06-18 15:39:18+00:00 g3a038 If ever been pregnant: During any of these pregnancies, were you told you had hypertension (high blood pressure)? +30 Hypertension 177249 phv00177249.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:40:24+00:00 2018-06-18 15:40:24+00:00 g3b0013 Medical History - Medications: Since your last exam have you been told by doctor you have high blood pressure or hypertension? +30 Hypertension 177263 phv00177263.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:40:44+00:00 2018-06-18 15:40:44+00:00 g3b0034 Medical History-Female Reproductive History: During any of these pregnancies, were you told you had high blood pressure or hypertension? +30 Hypertension 251798 phv00251798.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:41:53+00:00 2018-06-18 15:41:53+00:00 h778 Medical History - Female Reproductive History: During any of these pregnancies, were you told you had high blood pressure (hypertension)? Collection Interval: Exam 3 +30 Hypertension 254023 phv00254023.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:42:33+00:00 2018-06-18 15:42:33+00:00 j014 Medical History - Medications: Since your last exam have you been told by doctor you have high blood pressure or hypertension? +30 Hypertension 254036 phv00254036.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:42:54+00:00 2018-06-18 15:42:54+00:00 j036 Medical History - Female Reproductive History, Part 1: Since your last exam, during any of these pregnancies, were you told you had high blood pressure or hypertension? +30 Hypertension 487 phv00000487.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:43:13+00:00 2018-06-18 15:43:13+00:00 MF13 HISTORY OF HYPERTENSION, EXAM 1 +30 Hypertension 55253 phv00055253.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:43:33+00:00 2018-06-18 15:43:33+00:00 SRHype Self-Reported Hypertension +30 Hypertension 56625 phv00056625.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:44:04+00:00 2018-06-18 15:44:04+00:00 srhypedt Self-Reported Hypertension Date +30 Hypertension 7926 phv00007926.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:44:37+00:00 2018-06-18 15:44:37+00:00 B294 HYPERTENSIVE STATUS +30 Hypertension 2180 phv00002180.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:46:08+00:00 2018-06-18 15:46:08+00:00 FF250 CLINICAL DIAGNOSTIC IMPRESSION: HYPERTENSIVE STATUS (BASED ON TWO BLOOD PRESSURE READINGS TAKEN BY PHYSICIAN) +30 Hypertension 2375 phv00002375.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:47:02+00:00 2018-06-18 15:47:02+00:00 FG258 CLINICAL DIAGNOSTIC IMPRESSION: HYPERTENSIVE STATUS (BASED ON TWO BLOOD PRESSURE READINGS TAKEN BY PHYSICIAN) +30 Hypertension 3634 phv00003634.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:48:00+00:00 2018-06-18 15:48:00+00:00 FK412 HEART: HYPERTENSIVE STATUS +30 Hypertension 126039 phv00126039.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:44:53+00:00 2018-06-20 17:44:53+00:00 HTN017 Hypertension status per JNC7 +30 Hypertension 126037 phv00126037.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:46:10+00:00 2018-06-20 17:46:10+00:00 BP601 JNC 6 BP classification +30 Hypertension 126036 phv00126036.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:46:27+00:00 2018-06-20 17:46:27+00:00 BP701 JNC 7 BP classification +30 Hypertension 128087 phv00128087.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:17:00+00:00 2018-06-20 18:17:00+00:00 PFHA2A 2a: Has doctor said you have high blood pressure? +30 Hypertension 128088 phv00128088.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:17:29+00:00 2018-06-20 18:17:29+00:00 PFHA2B 2b: Age when told you had high blood pressure? +30 Hypertension 99658 phv00099658.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:49:23+00:00 2018-06-29 17:49:23+00:00 HYPER CALC. HTN STATUS +30 Hypertension 100496 phv00100496.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:49:51+00:00 2018-06-29 17:49:51+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 102009 phv00102009.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:50:01+00:00 2018-06-29 17:50:01+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 104380 phv00104380.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:50:23+00:00 2018-06-29 17:50:23+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 105096 phv00105096.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:50:33+00:00 2018-06-29 17:50:33+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 106417 phv00106417.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:50:43+00:00 2018-06-29 17:50:43+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 107346 phv00107346.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:50:54+00:00 2018-06-29 17:50:54+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 108217 phv00108217.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:51:07+00:00 2018-06-29 17:51:07+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 108908 phv00108908.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:51:17+00:00 2018-06-29 17:51:17+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 110523 phv00110523.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:51:26+00:00 2018-06-29 17:51:26+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 99459 phv00099459.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:54:52+00:00 2018-06-29 17:54:52+00:00 IHYPER CALC. ISO SYS HTN +30 Hypertension 100433 phv00100433.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:55:06+00:00 2018-06-29 17:55:06+00:00 IHYPER CALC ISO SYS HTN +30 Hypertension 101958 phv00101958.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:55:18+00:00 2018-06-29 17:55:18+00:00 IHYPER CALC. ISO SYS HTN +30 Hypertension 105628 phv00105628.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 17:55:28+00:00 2018-06-29 17:55:28+00:00 IHYPER CALC ISO SYS HTN +30 Hypertension 78556 phv00078556.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:47:22+00:00 2018-07-02 21:47:22+00:00 HYPT Hypertension ever +30 Hypertension 78602 phv00078602.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:47:22+00:00 2018-07-02 21:47:22+00:00 HTNTRT Hypertension +30 Hypertension 283526 phv00283526.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:47:22+00:00 2018-07-02 21:47:22+00:00 HYPERTNHX F136 History of hypertension +30 Hypertension 283528 phv00283528.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:47:22+00:00 2018-07-02 21:47:22+00:00 PULMHTNHX F136 History of pulmonary hypertension +30 Hypertension 283592 phv00283592.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:47:22+00:00 2018-07-02 21:47:22+00:00 TTEPULMHTN F136 TTE pulmonary hypertension +30 Hypertension 159612 phv00159612.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:46:05+00:00 2018-08-10 21:46:05+00:00 HighBloodPres High blood pressure Collection Interval: Collected in Exam 1 +30 Hypertension 277418 phv00277418.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:26:24+00:00 2018-08-14 22:26:24+00:00 HYT Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 2009-2011 +30 Hypertension 277419 phv00277419.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:26:48+00:00 2018-08-14 22:26:48+00:00 HYT_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 2009-2011 +30 Hypertension 277420 phv00277420.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:26:55+00:00 2018-08-14 22:26:55+00:00 HYT_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 2009-2011 +30 Hypertension 277501 phv00277501.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:38:06+00:00 2018-08-14 22:38:06+00:00 PGHYTAGE In what year or how old were you when the pregnancy-related hypertension first occurred? - age Collection Interval: 2009-2011 +30 Hypertension 277500 phv00277500.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:38:13+00:00 2018-08-14 22:38:13+00:00 PGHYTYR In what year or how old were you when the pregnancy-related hypertension first occurred? - year Collection Interval: 2009-2011 +30 Hypertension 277498 phv00277498.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:38:20+00:00 2018-08-14 22:38:20+00:00 PG_HYT During any of these pregancies were you ever told by a physician that you had high blood pressure or hyt? Collection Interval: 2009-2011 +30 Hypertension 277594 phv00277594.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:48:03+00:00 2018-08-14 22:48:03+00:00 HYT_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 1996-2000 +30 Hypertension 277593 phv00277593.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:48:10+00:00 2018-08-14 22:48:10+00:00 HYT_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 1996-2000 +30 Hypertension 277592 phv00277592.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:48:17+00:00 2018-08-14 22:48:17+00:00 HYT Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 1996-2000 +30 Hypertension 277869 phv00277869.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:14:23+00:00 2018-08-14 23:14:23+00:00 HYT_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 2000-2004 +30 Hypertension 277868 phv00277868.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:14:29+00:00 2018-08-14 23:14:29+00:00 HYT_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 2000-2004 +30 Hypertension 277867 phv00277867.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:14:35+00:00 2018-08-14 23:14:35+00:00 HYT Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 2000-2004 +30 Hypertension 277962 phv00277962.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:50:03+00:00 2018-08-15 23:50:03+00:00 PGHYTAGE In what year or how old were you when the pregnancy-related hypertension first occurred? - age Collection Interval: 2000-2004 +30 Hypertension 277961 phv00277961.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:50:10+00:00 2018-08-15 23:50:10+00:00 PGHYTYR In what year or how old were you when the pregnancy-related hypertension first occurred? - year Collection Interval: 2000-2004 +30 Hypertension 277959 phv00277959.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:50:17+00:00 2018-08-15 23:50:17+00:00 PG_HYT During any of these pregancies were you ever told by a physician that you had high blood pressure or hyt? Collection Interval: 2000-2004 +30 Hypertension 307875 phv00307875.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:00:01+00:00 2018-08-16 00:00:01+00:00 HYT_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 1996-2000 +30 Hypertension 307874 phv00307874.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:00:08+00:00 2018-08-16 00:00:08+00:00 HYT_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 1996-2000 +30 Hypertension 307873 phv00307873.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:00:14+00:00 2018-08-16 00:00:14+00:00 HYT Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 1996-2000 +30 Hypertension 308062 phv00308062.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:15:23+00:00 2018-08-16 00:15:23+00:00 HYT_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 2000-2004 +30 Hypertension 308061 phv00308061.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:15:30+00:00 2018-08-16 00:15:30+00:00 HYT_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 2000-2004 +30 Hypertension 308060 phv00308060.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:15:38+00:00 2018-08-16 00:15:38+00:00 HYT Have you ever been told by a physician that you have high blood pressure or hypertension? Collection Interval: 2000-2004 +30 Hypertension 308155 phv00308155.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:25:40+00:00 2018-08-16 00:25:40+00:00 PGHYTAGE In what year or how old were you when the pregnancy-related hypertension first occurred? - age Collection Interval: 2000-2004 +30 Hypertension 308154 phv00308154.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:25:47+00:00 2018-08-16 00:25:47+00:00 PGHYTYR In what year or how old were you when the pregnancy-related hypertension first occurred? - year Collection Interval: 2000-2004 +30 Hypertension 308152 phv00308152.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:25:54+00:00 2018-08-16 00:25:54+00:00 PG_HYT During any of these pregancies were you ever told by a physician that you had high blood pressure or hyt? Collection Interval: 2000-2004 +30 Hypertension 122289 phv00122289.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:26:42+00:00 2018-08-16 23:26:42+00:00 HIBP Person reports high blood pressure (AC) +30 Hypertension 122292 phv00122292.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:27:02+00:00 2018-08-16 23:27:02+00:00 BPPRES High blood pressure still present (AC) +30 Hypertension 112992 phv00112992.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:16:00+00:00 2018-08-17 18:16:00+00:00 A08HBP HIGH BLOOD PRESSURE +30 Hypertension 113022 phv00113022.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:18:28+00:00 2018-08-17 18:18:28+00:00 A09HBPST STILL HAVE HBP? Q 1.01C +30 Hypertension 113021 phv00113021.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:18:36+00:00 2018-08-17 18:18:36+00:00 A09HBPAG AGE WHEN TOLD HAD HBP. Q 1.01B +30 Hypertension 113020 phv00113020.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:18:43+00:00 2018-08-17 18:18:43+00:00 A09HBPG1 HBP DX BASED ON > 1 VISIT? Q 1.01A +30 Hypertension 123016 phv00123016.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:53:44+00:00 2018-08-17 19:53:44+00:00 hibloodp High Blood Pressure +30 Hypertension 123017 phv00123017.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:54:25+00:00 2018-08-17 19:54:25+00:00 htndx HTN: self report of MD dx of HTN +30 Hypertension 123018 phv00123018.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:54:34+00:00 2018-08-17 19:54:34+00:00 htnx HTN: self report of MD dx of HTN or sys GE 140 or dia GE 90 or meds +30 Hypertension 123019 phv00123019.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:54:46+00:00 2018-08-17 19:54:46+00:00 htn HTN: abnormal bp (sys GE 140 or dia GE 90) or meds +30 Hypertension 114340 phv00114340.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:51:48+00:00 2018-08-17 21:51:48+00:00 B08HBP HIGH BLOOD PRESSURE. Q 6 +30 Hypertension 124274 phv00124274.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 19:00:41+00:00 2018-08-21 19:00:41+00:00 DIABPDAY Days from visit date - Diagnosed High Blood Pressure: +30 Hypertension 114387 phv00114387.v2.p2 pht001606.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:11:01+00:00 2018-08-22 21:11:01+00:00 B09HBPST STILL HAVE HBP? Q 1.01C +30 Hypertension 114386 phv00114386.v2.p2 pht001606.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:11:17+00:00 2018-08-22 21:11:17+00:00 B09HBPAG AGE WHEN TOLD HAD HBP. Q 1.01B +30 Hypertension 114385 phv00114385.v2.p2 pht001606.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:11:33+00:00 2018-08-22 21:11:33+00:00 B09HBPG1 HBP DX BASED ON > 1 VISIT? Q 1.01A +30 Hypertension 115075 phv00115075.v2.p2 pht001640.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:48:11+00:00 2018-08-22 23:48:11+00:00 B09P_HBP GESTATIONAL HBP, ANY PREGNANCY? Q 11b +30 Hypertension 115425 phv00115425.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 16:57:27+00:00 2018-08-23 16:57:27+00:00 C08HBPAG AGE HIGH BP DIAGNOSED. Q 1 +30 Hypertension 115424 phv00115424.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 16:57:34+00:00 2018-08-23 16:57:34+00:00 C08HBP HIGH BLOOD PRESSURE. Q 1 +30 Hypertension 116340 phv00116340.v2.p2 pht001690.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:02:19+00:00 2018-08-23 19:02:19+00:00 C09P_HBP GESTATIONAL HBP? +30 Hypertension 116956 phv00116956.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:17:16+00:00 2018-08-24 00:17:16+00:00 D08HBPAG AGE WHEN TOLD HAD HBP. Q 1 +30 Hypertension 116954 phv00116954.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:17:26+00:00 2018-08-24 00:17:26+00:00 D08HBP HIGH BLOOD PRESSURE? Q 1 +30 Hypertension 117517 phv00117517.v2.p2 pht001733.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:45:45+00:00 2018-08-24 22:45:45+00:00 D09P_HBP GESTATIONAL HBP? Q 11b +30 Hypertension 117936 phv00117936.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:09:36+00:00 2018-08-27 23:09:36+00:00 FY096BPA AGE FIRST TOLD HIGH BP - MON 96 +30 Hypertension 117935 phv00117935.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:09:43+00:00 2018-08-27 23:09:43+00:00 FY096HBP HIGH BLOOD PRESSURE? - MON 96 +30 Hypertension 118430 phv00118430.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:43:37+00:00 2018-08-28 22:43:37+00:00 E08HBPAG AGE DIAGNOSED-HBP. Q 1 +30 Hypertension 118428 phv00118428.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:43:47+00:00 2018-08-28 22:43:47+00:00 E08HBP HIGH BLOOD PRESSURE? Q 1 +30 Hypertension 119587 phv00119587.v2.p2 pht001797.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:00:26+00:00 2018-08-29 21:00:26+00:00 E09P_HBP GESTATIONAL HBP? +30 Hypertension 119807 phv00119807.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:07:56+00:00 2018-08-29 21:07:56+00:00 F08HBPAG AGE DIAGNOSED-HBP. Q 1 +30 Hypertension 119802 phv00119802.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:08:07+00:00 2018-08-29 21:08:07+00:00 F08HBP HIGH BLOOD PRESSURE? Q 1 +30 Hypertension 120648 phv00120648.v2.p2 pht001843.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:08:40+00:00 2018-08-29 23:08:40+00:00 F09P_HBP GESTATIONAL HBP? Q 11b +30 Hypertension 121374 phv00121374.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:34:18+00:00 2018-08-30 00:34:18+00:00 Y01HTNTP TYPE OF HYPERTENSION +30 Hypertension 121593 phv00121593.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:55:57+00:00 2018-08-30 19:55:57+00:00 Y01HTNTP TYPE OF HYPERTENSION +30 Hypertension 258746 phv00258746.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:56:22+00:00 2018-09-06 12:56:22+00:00 Hypertension Based on Sys>140 OR Dias>90 (Based on physical examination & questionnaire data) +30 Hypertension 258747 phv00258747.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:57:13+00:00 2018-09-06 12:57:13+00:00 Hypertension_diagnosis Self-reported Hypertension diagnosis +30 Hypertension 258748 phv00258748.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:58:50+00:00 2018-09-06 12:58:50+00:00 Hyp_diagnosis_years How many years ago were you diagnosed with hypertension? +30 Hypertension 258756 phv00258756.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:01:02+00:00 2018-09-06 13:01:02+00:00 Hypertension_13 Hypertension based on average of two BP measurements or hypertension meds +30 Hypertension 258757 phv00258757.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:01:13+00:00 2018-09-06 13:01:13+00:00 Hypertension_All3 Hypertension diagnosis based on average of all three BP measurements or hypertension meds +30 Hypertension 102986 phv00102986.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-10 22:40:26+00:00 2018-12-10 22:40:26+00:00 HYPER CALCULATED HTN STATUS +30 Hypertension 259389 phv00259389.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:43:19+00:00 2018-12-20 19:43:19+00:00 htnind Treated hypertension at index date +31 Blood glucose 127613 phv00127613.v1.p1 pht001959.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:23:49+00:00 2018-03-16 01:23:49+00:00 GLUCOSE Glucose mg/dL +31 Blood glucose 203882 phv00203882.v1.p1 pht004052.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:09:40+00:00 2018-03-19 16:09:40+00:00 CHMB07 Glucose (mg Per dL) Dec Pt Req. Q7 [Clinical Chemistry Lab, exam 2] +31 Blood glucose 204643 phv00204643.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:10:07+00:00 2018-03-19 16:10:07+00:00 GLUSIU21 Visit 2, blood glucose in mmol/L [Cohort, Exam 2] +31 Blood glucose 204730 phv00204730.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:10:39+00:00 2018-03-19 16:10:39+00:00 GLUCOS01 Derived glucose value in mg/dL [Cohort, Exam 1] +31 Blood glucose 204734 phv00204734.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:11:08+00:00 2018-03-19 16:11:08+00:00 GLUSIU01 Recalibrated glucose in SI units [Cohort, Exam 1] +31 Blood glucose 204969 phv00204969.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:11:34+00:00 2018-03-19 16:11:34+00:00 GLUSIU41 Visit 4, fasting glucose in SI units [Cohort, Exam 4] +31 Blood glucose 204970 phv00204970.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:11:55+00:00 2018-03-19 16:11:55+00:00 GL2SIU41 Visit 4 , two hour glucose in SI units [Cohort, Exam 4] +31 Blood glucose 207663 phv00207663.v1.p1 pht004123.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:14:31+00:00 2018-03-19 16:14:31+00:00 LIPC4A Glucose (value in mg/dL) Q4a [Lipid Lab, exam 3] +31 Blood glucose 207678 phv00207678.v1.p1 pht004124.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:15:01+00:00 2018-03-19 16:15:01+00:00 LIPD4A Fasting glucose (value). Q4a [Lipid Lab, exam 4] +31 Blood glucose 207679 phv00207679.v1.p1 pht004124.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:15:35+00:00 2018-03-19 16:15:35+00:00 LIPD5A Two-hour glucose (value). Q5a [Lipid Lab, exam 4] +31 Blood glucose 112414 phv00112414.v2.p2 pht001557.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:46:19+00:00 2018-04-17 19:46:19+00:00 AL3_GLU GLUCOSE (MG/100 ML) +31 Blood glucose 117552 phv00117552.v2.p2 pht001737.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:46:19+00:00 2018-04-17 19:46:19+00:00 DL7GLU YEAR 7 GLUCOSE (ug/dL) +31 Blood glucose 119598 phv00119598.v2.p2 pht001799.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:46:19+00:00 2018-04-17 19:46:19+00:00 EL7GLU YEAR 10 FASTING GLUCOSE (mg/dL) +31 Blood glucose 119599 phv00119599.v2.p2 pht001799.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:46:19+00:00 2018-04-17 19:46:19+00:00 EL7GLU2H YEAR 10 2 HR GLUCOSE (mg/dL) +31 Blood glucose 119600 phv00119600.v2.p2 pht001799.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:46:19+00:00 2018-04-17 19:46:19+00:00 EL7GLUR YR 10 FASTING GLU (mg/dL) - RETURN VISIT +31 Blood glucose 120661 phv00120661.v2.p2 pht001845.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:46:19+00:00 2018-04-17 19:46:19+00:00 FL7GLU FASTING GLUCOSE (mg/dL) +31 Blood glucose 82953 phv00082953.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:18:42+00:00 2018-04-23 23:18:42+00:00 glucos1c FASTING GLUCOSE CALIBRATED (mg/dl) +31 Blood glucose 82954 phv00082954.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:18:48+00:00 2018-04-23 23:18:48+00:00 glucos1u FASTING GLUCOSE ORIGINAL (mg/dl) +31 Blood glucose 84969 phv00084969.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:18:53+00:00 2018-04-23 23:18:53+00:00 glucos1c EXAM 1 FASTING GLUCOSE- CALIBRATED +31 Blood glucose 84970 phv00084970.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:01+00:00 2018-04-23 23:19:01+00:00 glucos1u EXAM 1 FASTING GLUCOSE- ORIGINAL +31 Blood glucose 85932 phv00085932.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:08+00:00 2018-04-23 23:19:08+00:00 glucos2c EXAM 2 FASTING GLUCOSE- CALIBRATED +31 Blood glucose 86415 phv00086415.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:16+00:00 2018-04-23 23:19:16+00:00 glucos3c EXAM 3 FASTING GLUCOSE- CALIBRATED +31 Blood glucose 86834 phv00086834.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:22+00:00 2018-04-23 23:19:22+00:00 glucos4c EXAM 4 FASTING GLUCOSE- CALIBRATED +31 Blood glucose 87088 phv00087088.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:28+00:00 2018-04-23 23:19:28+00:00 glucosfc EXAM 1 FASTING GLUCOSE- CALIBRATED +31 Blood glucose 175240 phv00175240.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:34+00:00 2018-04-23 23:19:34+00:00 glucose5 FASTING GLUCOSE (mg/dl) +31 Blood glucose 175863 phv00175863.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:41+00:00 2018-04-23 23:19:41+00:00 glucos1c EXAM 1 FASTING GLUCOSE- CALIBRATED +31 Blood glucose 175887 phv00175887.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:52+00:00 2018-04-23 23:19:52+00:00 glucose GLUCOSE +31 Blood glucose 175948 phv00175948.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:19:59+00:00 2018-04-23 23:19:59+00:00 glucosfc FAMILY COHORT: EXAM 1 FASTING GLUCOSE- CALIBRATED +31 Blood glucose 176663 phv00176663.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:20:05+00:00 2018-04-23 23:20:05+00:00 glucose5 FASTING GLUCOSE (mg/dl) +31 Blood glucose 219026 phv00219026.v1.p3 pht004326.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:20:15+00:00 2018-04-23 23:20:15+00:00 glucossc FASTING GLUCOSE- CALIBRATED AT MESA STRESS EXAM +31 Blood glucose 172173 phv00172173.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:26:24+00:00 2018-06-05 15:26:24+00:00 GLUC Fasting glucose (sample type: plasma) +31 Blood glucose 227016 phv00227016.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:26:42+00:00 2018-06-05 15:26:42+00:00 GLUC Glucose (Sample type - EDTA plasma) Collection Interval: Exam 1 +31 Blood glucose 227057 phv00227057.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:27:03+00:00 2018-06-05 15:27:03+00:00 GLUC Glucose (sample type: EDTA plasma) +31 Blood glucose 255343 phv00255343.v1.p10 pht005143.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:27:29+00:00 2018-06-05 15:27:29+00:00 GLUC Glucose (sample type: plasma) +31 Blood glucose 275404 phv00275404.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:27:49+00:00 2018-06-05 15:27:49+00:00 GLUC Glucose (sample type: EDTA plasma) Collection Interval: Exam 2 +31 Blood glucose 172174 phv00172174.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:28:44+00:00 2018-06-05 15:28:44+00:00 GLUC2 Post glucose (two hours post glucose tolerance test beverage taken) (sample type: plasma) +31 Blood glucose 227017 phv00227017.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:29:09+00:00 2018-06-05 15:29:09+00:00 GLUC2 Post glucose (oral glucose tolerance test, at 2 hours) (Sample type - serum) Collection Interval: Exam 1 +31 Blood glucose 71893 phv00071893.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:30:21+00:00 2018-06-05 15:30:21+00:00 GLUCOSE Glucose, plasma +31 Blood glucose 275416 phv00275416.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:30:52+00:00 2018-06-05 15:30:52+00:00 GLUCOSE Glucose (sample type: plasma) Collection Interval: Omni 1 Exam 3 +31 Blood glucose 126017 phv00126017.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:08:10+00:00 2018-06-12 01:08:10+00:00 FPG01 Fasting glucose +31 Blood glucose 126020 phv00126020.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:09:14+00:00 2018-06-12 01:09:14+00:00 FPG01SI Fasting glucose (mM) +31 Blood glucose 100045 phv00100045.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:14:09+00:00 2018-06-28 00:14:09+00:00 GLU44 BASELINE GLUCOSE (mg/dl) +31 Blood glucose 100051 phv00100051.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:14:20+00:00 2018-06-28 00:14:20+00:00 GLU244 2 HR GLUCOSE (mg/dl) +31 Blood glucose 100427 phv00100427.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:14:30+00:00 2018-06-28 00:14:30+00:00 GLU44 BASELINE GLUCOSE (mg/dl) +31 Blood glucose 105867 phv00105867.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:14:40+00:00 2018-06-28 00:14:40+00:00 GLU44 BASELINE GLUCOSE (mg/dl) +31 Blood glucose 106408 phv00106408.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:14:50+00:00 2018-06-28 00:14:50+00:00 GLUADJ Glu44 adjusted for drift +31 Blood glucose 106994 phv00106994.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:15:05+00:00 2018-06-28 00:15:05+00:00 GLU44 BASELINE GLUCOSE (mg/dl) +31 Blood glucose 107338 phv00107338.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:15:20+00:00 2018-06-28 00:15:20+00:00 GLUADJ Glu44 adjusted for drift +31 Blood glucose 110485 phv00110485.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:16:04+00:00 2018-06-28 00:16:04+00:00 GLU44 Fasting glucose (mg/dl) +31 Blood glucose 110490 phv00110490.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:16:18+00:00 2018-06-28 00:16:18+00:00 GLUADJ GLU44 ADJUSTED FOR DRIFT (mg/dl) +31 Blood glucose 110486 phv00110486.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:16:30+00:00 2018-06-28 00:16:30+00:00 GLU244 2 HR GLUCOSE (mg/dl) +31 Blood glucose 7558 phv00007558.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:29:49+00:00 2018-07-03 13:29:49+00:00 A31 GLUCOSE +31 Blood glucose 8084 phv00008084.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:30:25+00:00 2018-07-03 13:30:25+00:00 B737 GLUCOSE +31 Blood glucose 277022 phv00277022.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:31:05+00:00 2018-07-03 13:31:05+00:00 BG1 Blood glucose, Exam 1 (includes fasting and non-fasting) +31 Blood glucose 277086 phv00277086.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:31:16+00:00 2018-07-03 13:31:16+00:00 BG1 Blood glucose, Exam 1 (includes fasting and non-fasting) +31 Blood glucose 277023 phv00277023.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:31:29+00:00 2018-07-03 13:31:29+00:00 BG2 Blood glucose, Exam 2 (includes fasting and non-fasting) +31 Blood glucose 277087 phv00277087.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:31:38+00:00 2018-07-03 13:31:38+00:00 BG2 Blood glucose, Exam 2 (includes fasting and non-fasting) +31 Blood glucose 277088 phv00277088.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:31:49+00:00 2018-07-03 13:31:49+00:00 BG3 Blood glucose, Exam 3 (includes fasting and non-fasting) +31 Blood glucose 277089 phv00277089.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:32:16+00:00 2018-07-03 13:32:16+00:00 BG4 Blood glucose, Exam 4 (includes fasting and non-fasting) +31 Blood glucose 277090 phv00277090.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:32:28+00:00 2018-07-03 13:32:28+00:00 BG5 Blood glucose, Exam 5 (includes fasting and non-fasting) +31 Blood glucose 277091 phv00277091.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:32:37+00:00 2018-07-03 13:32:37+00:00 BG6 Blood glucose, Exam 6 (includes fasting and non-fasting) +31 Blood glucose 277092 phv00277092.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:32:46+00:00 2018-07-03 13:32:46+00:00 BG7 Blood glucose, Exam 7 (includes fasting and non-fasting) +31 Blood glucose 277093 phv00277093.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:32:56+00:00 2018-07-03 13:32:56+00:00 BG8 Blood glucose, Exam 8 (includes fasting and non-fasting) +31 Blood glucose 277094 phv00277094.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:33:10+00:00 2018-07-03 13:33:10+00:00 BG9 Blood glucose, Exam 9 (includes fasting and non-fasting) +31 Blood glucose 80784 phv00080784.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:33:22+00:00 2018-07-03 13:33:22+00:00 BLS1 BLOOD GLUCOSE AT EXAM 1 +31 Blood glucose 80791 phv00080791.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:33:35+00:00 2018-07-03 13:33:35+00:00 BLS10 BLOOD GLUCOSE AT EXAM 10 +31 Blood glucose 80792 phv00080792.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:33:46+00:00 2018-07-03 13:33:46+00:00 BLS13 BLOOD GLUCOSE AT EXAM 13 +31 Blood glucose 80793 phv00080793.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:34:11+00:00 2018-07-03 13:34:11+00:00 BLS14 BLOOD GLUCOSE AT EXAM 14 +31 Blood glucose 80794 phv00080794.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:34:21+00:00 2018-07-03 13:34:21+00:00 BLS15 BLOOD GLUCOSE AT EXAM 15 +31 Blood glucose 80795 phv00080795.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:34:47+00:00 2018-07-03 13:34:47+00:00 BLS16 BLOOD GLUCOSE AT EXAM 16 +31 Blood glucose 80796 phv00080796.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:34:58+00:00 2018-07-03 13:34:58+00:00 BLS17 BLOOD GLUCOSE AT EXAM 17 +31 Blood glucose 80797 phv00080797.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:35:07+00:00 2018-07-03 13:35:07+00:00 BLS18 BLOOD GLUCOSE AT EXAM 18 +31 Blood glucose 80798 phv00080798.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:35:17+00:00 2018-07-03 13:35:17+00:00 BLS19 BLOOD GLUCOSE AT EXAM 19 +31 Blood glucose 80785 phv00080785.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:35:32+00:00 2018-07-03 13:35:32+00:00 BLS2 BLOOD GLUCOSE AT EXAM 2 +31 Blood glucose 80799 phv00080799.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:35:45+00:00 2018-07-03 13:35:45+00:00 BLS20 BLOOD GLUCOSE AT EXAM 20 +31 Blood glucose 80781 phv00080781.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:36:16+00:00 2018-07-03 13:36:16+00:00 BLS21 BLOOD GLUCOSE AT EXAM 21 +31 Blood glucose 80782 phv00080782.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:36:26+00:00 2018-07-03 13:36:26+00:00 BLS22 BLOOD GLUCOSE AT EXAM 22 +31 Blood glucose 80783 phv00080783.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:36:35+00:00 2018-07-03 13:36:35+00:00 BLS23 BLOOD GLUCOSE AT EXAM 23 +31 Blood glucose 80800 phv00080800.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:36:44+00:00 2018-07-03 13:36:44+00:00 BLS26 BLOOD GLUCOSE AT EXAM 26 +31 Blood glucose 80801 phv00080801.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:36:54+00:00 2018-07-03 13:36:54+00:00 BLS27 BLOOD GLUCOSE AT EXAM 27 +31 Blood glucose 80786 phv00080786.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:37:08+00:00 2018-07-03 13:37:08+00:00 BLS3 BLOOD GLUCOSE AT EXAM 3 +31 Blood glucose 80787 phv00080787.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:37:19+00:00 2018-07-03 13:37:19+00:00 BLS4 BLOOD GLUCOSE AT EXAM 4 +31 Blood glucose 80788 phv00080788.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:37:39+00:00 2018-07-03 13:37:39+00:00 BLS6 BLOOD GLUCOSE AT EXAM 6 +31 Blood glucose 80789 phv00080789.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:37:53+00:00 2018-07-03 13:37:53+00:00 BLS8 BLOOD GLUCOSE AT EXAM 8 +31 Blood glucose 80790 phv00080790.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:38:04+00:00 2018-07-03 13:38:04+00:00 BLS9 BLOOD GLUCOSE AT EXAM 9 +31 Blood glucose 8731 phv00008731.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:41:35+00:00 2018-07-03 13:41:35+00:00 C434 GLUCOSE IN BLOOD +31 Blood glucose 276862 phv00276862.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:41:53+00:00 2018-07-03 13:41:53+00:00 CHF056 Chemistry - Glucose +31 Blood glucose 9125 phv00009125.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:42:15+00:00 2018-07-03 13:42:15+00:00 D452 GLUCOSE +31 Blood glucose 9577 phv00009577.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:42:31+00:00 2018-07-03 13:42:31+00:00 E671 BLOOD ANALYSIS - GLUCOSE - BASELINE +31 Blood glucose 9578 phv00009578.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:42:53+00:00 2018-07-03 13:42:53+00:00 E672 BLOOD ANALYSIS - GLUCOSE - 2 HOUR POST +31 Blood glucose 10798 phv00010798.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:43:49+00:00 2018-07-03 13:43:49+00:00 F_GLUC3 FASTING BLOOD GLUCOSE AT EXAM 3 (SOURCE: C434 (EXAM 3)) +31 Blood glucose 10799 phv00010799.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:43:59+00:00 2018-07-03 13:43:59+00:00 F_GLUC4 FASTING BLOOD GLUCOSE AT EXAM 4 (SOURCE: D452 (EXAM 4)) +31 Blood glucose 10800 phv00010800.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:44:07+00:00 2018-07-03 13:44:07+00:00 F_GLUC5 FASTING BLOOD GLUCOSE AT EXAM 5 (SOURCE: E671 (EXAM 5)) +31 Blood glucose 10801 phv00010801.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:44:16+00:00 2018-07-03 13:44:16+00:00 F_GLUC6 FASTING BLOOD GLUCOSE AT EXAM 6 (SOURCE: F724 (EXAM 6)) +31 Blood glucose 10802 phv00010802.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:44:25+00:00 2018-07-03 13:44:25+00:00 F_GLUC7 FASTING BLOOD GLUCOSE AT EXAM 7 (SOURCE: G705 (EXAM 7)) +31 Blood glucose 10133 phv00010133.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:45:32+00:00 2018-07-03 13:45:32+00:00 F724 BLOOD ANALYSIS - GLUCOSE - BASELINE +31 Blood glucose 277038 phv00277038.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:45:47+00:00 2018-07-03 13:45:47+00:00 FASTING_BG1 Fasting blood glucose, Exam 1 (fasting >= 8 hours) +31 Blood glucose 277039 phv00277039.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:45:55+00:00 2018-07-03 13:45:55+00:00 FASTING_BG2 Fasting blood glucose, Exam 2 (fasting >= 8 hours) +31 Blood glucose 277155 phv00277155.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:46:03+00:00 2018-07-03 13:46:03+00:00 FASTING_BG3 Fasting blood glucose, Exam 3 (>= 8 hours) +31 Blood glucose 277156 phv00277156.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:46:12+00:00 2018-07-03 13:46:12+00:00 FASTING_BG4 Fasting blood glucose, Exam 4 (>= 8 hours) +31 Blood glucose 277157 phv00277157.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:46:20+00:00 2018-07-03 13:46:20+00:00 FASTING_BG5 Fasting blood glucose, Exam 5 (>= 8 hours) +31 Blood glucose 277158 phv00277158.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:46:28+00:00 2018-07-03 13:46:28+00:00 FASTING_BG6 Fasting blood glucose, Exam 6 (>= 8 hours) +31 Blood glucose 277159 phv00277159.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:46:38+00:00 2018-07-03 13:46:38+00:00 FASTING_BG7 Fasting blood glucose, Exam 7 (>= 8 hours) +31 Blood glucose 277160 phv00277160.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:46:47+00:00 2018-07-03 13:46:47+00:00 FASTING_BG8 Fasting blood glucose, Exam 8 (>= 8 hours) +31 Blood glucose 277161 phv00277161.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:46:57+00:00 2018-07-03 13:46:57+00:00 FASTING_BG9 Fasting blood glucose, Exam 9 (>= 8 hours) +31 Blood glucose 1397 phv00001397.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:47:25+00:00 2018-07-03 13:47:25+00:00 FC41 BLOOD ANALYSIS: SUGAR (AFTER GLUCOSE CHALLENGE) (MG/100 ML) +31 Blood glucose 4081 phv00004081.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:48:08+00:00 2018-07-03 13:48:08+00:00 FL523 BLOOD ANALYSIS-GLUCOSE +31 Blood glucose 4517 phv00004517.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:48:22+00:00 2018-07-03 13:48:22+00:00 FM543 BLOOD ANALYSIS - GLUCOSE +31 Blood glucose 4937 phv00004937.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:48:37+00:00 2018-07-03 13:48:37+00:00 FN510 BLOOD ANALYSIS - GLUCOSE +31 Blood glucose 5550 phv00005550.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:48:49+00:00 2018-07-03 13:48:49+00:00 FO733 BLOOD ANALYSIS - GLUCOSE (NON-FASTING) +31 Blood glucose 6026 phv00006026.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:48:59+00:00 2018-07-03 13:48:59+00:00 FP597 BLOOD ANALYSIS - GLUCOSE - (NON-FASTING) +31 Blood glucose 6666 phv00006666.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:49:32+00:00 2018-07-03 13:49:32+00:00 FS533 GLUCOSE MG/100ML +31 Blood glucose 7527 phv00007527.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:49:47+00:00 2018-07-03 13:49:47+00:00 FT543 GLUCOSE MG/100ML +31 Blood glucose 70730 phv00070730.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:50:00+00:00 2018-07-03 13:50:00+00:00 FU578 LAB VALUES: GLUCOSE, MG/DL +31 Blood glucose 21394 phv00021394.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:50:36+00:00 2018-07-03 13:50:36+00:00 G3A715 GLUCOSE, MG/DL +31 Blood glucose 24364 phv00024364.v5.p10 pht000192.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:51:24+00:00 2018-07-03 13:51:24+00:00 H2PG7 2-HOUR POST-ORAL GLUCOSE CHALLENGE TEST, EXAM 7 MEASURED IN MG/DL (NOTE: ALL SUBJECTS WITH IGT AND A SUBSET OF SUBJECTS WITH NGT AT EXAM 5 [BLOCK-RANDOMLY SELECTED FROM 5 QUINTILE STRATA OF FBS] WERE OFFERED A MORNING EXAM AT CYCLE 7 INCLUDING AN ORAL GLUCOSE TOLERANCE TEST.) +31 Blood glucose 7953 phv00007953.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:52:02+00:00 2018-07-03 13:52:02+00:00 B335 BLOOD ANALYSIS: SUGAR +31 Blood glucose 1048 phv00001048.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:52:15+00:00 2018-07-03 13:52:15+00:00 FA14 BLOOD ANALYSIS: SUGAR (MG PER 100 ML) +31 Blood glucose 1203 phv00001203.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:52:27+00:00 2018-07-03 13:52:27+00:00 FB26 BLOOD ANALYSIS: SUGAR +31 Blood glucose 1379 phv00001379.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:52:37+00:00 2018-07-03 13:52:37+00:00 FC21 BLOOD ANALYSIS: SUGAR (MG/100 ML) +31 Blood glucose 1580 phv00001580.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:52:51+00:00 2018-07-03 13:52:51+00:00 FD35 BLOOD ANALYSIS, SUGAR +31 Blood glucose 1816 phv00001816.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:53:03+00:00 2018-07-03 13:53:03+00:00 FE82 BLOOD ANALYSIS, SUGAR +31 Blood glucose 2031 phv00002031.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:53:14+00:00 2018-07-03 13:53:14+00:00 FF78 BLOOD ANALYSIS, SUGAR +31 Blood glucose 2415 phv00002415.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:53:39+00:00 2018-07-03 13:53:39+00:00 FG311 BLOOD ANALYSIS, SUGAR +31 Blood glucose 2653 phv00002653.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:53:51+00:00 2018-07-03 13:53:51+00:00 FH330 BLOOD ANALYSIS: SUGAR +31 Blood glucose 2680 phv00002680.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:54:01+00:00 2018-07-03 13:54:01+00:00 FI28 BLOOD ANALYSIS, SUGAR (MG/100ML) +31 Blood glucose 3259 phv00003259.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:54:11+00:00 2018-07-03 13:54:11+00:00 FJ381 BLOOD ANALYSIS: SUGAR (MG/100ML) +31 Blood glucose 3665 phv00003665.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:54:21+00:00 2018-07-03 13:54:21+00:00 FK456 BLOOD ANALYSIS: SUGAR (MG/100ML) +31 Blood glucose 630 phv00000630.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:54:44+00:00 2018-07-03 13:54:44+00:00 MF164 BLOOD ANALYSIS: SUGAR, EXAM 2 +31 Blood glucose 636 phv00000636.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:54:56+00:00 2018-07-03 13:54:56+00:00 MF170 BLOOD ANALYSIS: SUGAR, EXAM 3 +31 Blood glucose 675 phv00000675.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:55:04+00:00 2018-07-03 13:55:04+00:00 MF211 BLOOD ANALYSIS: SUGAR, EXAM 4 +31 Blood glucose 843 phv00000843.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:55:15+00:00 2018-07-03 13:55:15+00:00 MF394 BLOOD ANALYSIS: SUGAR, EXAM 6 +31 Blood glucose 537 phv00000537.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 13:55:27+00:00 2018-07-03 13:55:27+00:00 MF65 BLOOD ANALYSIS: SUGAR, EXAM 1 +31 Blood glucose 10143 phv00010143.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 17:00:52+00:00 2018-07-03 17:00:52+00:00 G705 GLUCOSE MG/100ML +31 Blood glucose 119601 phv00119601.v2.p2 pht001799.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-03 21:45:30+00:00 2018-08-03 21:45:30+00:00 EL7GLU2R YR 10 2 HR GLU (mg/dL) - RETURN VISIT +31 Blood glucose 77384 phv00077384.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-03 21:47:21+00:00 2018-08-03 21:47:21+00:00 COREGLUC Core Glucose (Mg/dl) +31 Blood glucose 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-03 21:58:04+00:00 2018-08-03 21:58:04+00:00 TESTNAME Test Name +31 Blood glucose 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-03 21:58:22+00:00 2018-08-03 21:58:22+00:00 TESTVAL Test Result Value +31 Blood glucose 277404 phv00277404.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:20:45+00:00 2018-08-14 22:20:45+00:00 SGLV Serum Glucose Average result value Collection Interval: 2009-2011 +31 Blood glucose 277576 phv00277576.v1.p1 pht006041.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:45:05+00:00 2018-08-14 22:45:05+00:00 GLUCOSE Glucose result value Collection Interval: 1996-2000 +31 Blood glucose 277849 phv00277849.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:10:19+00:00 2018-08-14 23:10:19+00:00 SGLV Serum Glucose Average result value Collection Interval: 2000-2004 +31 Blood glucose 307857 phv00307857.v1.p1 pht006655.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:57:33+00:00 2018-08-15 23:57:33+00:00 GLUCOSE Glucose result value Collection Interval: 1996-2000 +31 Blood glucose 308042 phv00308042.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:11:50+00:00 2018-08-16 00:11:50+00:00 SGLV Serum Glucose Average result value Collection Interval: 2000-2004 +31 Blood glucose 123956 phv00123956.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:27:33+00:00 2018-08-21 18:27:33+00:00 glucose_fast Fasting glucose (mg/dL) +31 Blood glucose 123957 phv00123957.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:28:52+00:00 2018-08-21 18:28:52+00:00 glucose_fast_orig Glucose_fast - original value +31 Blood glucose 123959 phv00123959.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:28:58+00:00 2018-08-21 18:28:58+00:00 glucose_ogtt OGTT glucose (mg/dL; Oral Glucose Tolerance Test) +31 Blood glucose 123960 phv00123960.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:29:05+00:00 2018-08-21 18:29:05+00:00 glucose_ogtt_orig Glucose_ogtt - original value +31 Blood glucose 253229 phv00253229.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:45:44+00:00 2018-08-24 16:45:44+00:00 LABA70 Glucose, fasting (mg/dL) (LABA70) +31 Blood glucose 253230 phv00253230.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:45:53+00:00 2018-08-24 16:45:53+00:00 LABA71 Glucose, post OGTT (mg/dL) (LABA71) +31 Blood glucose 253001 phv00253001.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:16:15+00:00 2018-08-24 17:16:15+00:00 fastglucose_baseline Fasting glucose value at baseline visit +31 Blood glucose 121609 phv00121609.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:03:14+00:00 2018-08-30 20:03:14+00:00 Y01OBS HIGHEST BLOOD SUGAR LEVEL (NON-FAST) FROM MED REC +31 Blood glucose 121608 phv00121608.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:03:28+00:00 2018-08-30 20:03:28+00:00 Y01FBS HIGHEST FASTING BLOOD SUGAR LEVEL FROM MEDICAL RECORD +31 Blood glucose 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-04 22:04:57+00:00 2018-09-04 22:04:57+00:00 TESTABBR Test abbreviation +31 Blood glucose 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-04 22:12:20+00:00 2018-09-04 22:12:20+00:00 TESTDESC Test Description +31 Blood glucose 259056 phv00259056.v1.p1 pht003918.v2.p1 phs000741.v2.p1 GOLDN 741 2 2018-09-06 12:19:59+00:00 2018-09-06 12:19:59+00:00 FBG Fasting Blood Glucose +31 Blood glucose 258727 phv00258727.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:50:06+00:00 2018-09-06 12:50:06+00:00 Finger_Glucose Blood Glucose from finger stick assessment +31 Blood glucose 258730 phv00258730.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:50:24+00:00 2018-09-06 12:50:24+00:00 Glucose Glucose from venous blood sample +32 Insulin in blood 125954 phv00125954.v1.p1 pht001945.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:52:48+00:00 2018-03-16 01:52:48+00:00 INSULIN Insulin: the concentration of insulin in IU/mL +32 Insulin in blood 203874 phv00203874.v1.p1 pht004051.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:12:59+00:00 2018-03-19 20:12:59+00:00 CHMA16 Insulin AmIU/mL. Q16 [Clinical Chemistry Lab, exam 1] +32 Insulin in blood 204739 phv00204739.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:13:19+00:00 2018-03-19 20:13:19+00:00 INSSIU01 Insulin in SI Units [Cohort, Exam 1] +32 Insulin in blood 207683 phv00207683.v1.p1 pht004124.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:13:39+00:00 2018-03-19 20:13:39+00:00 LIPD7A Insulin (value). Q7a [Lipid Lab, exam 4] +32 Insulin in blood 214148 phv00214148.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:14:13+00:00 2018-03-19 20:14:13+00:00 INSULN1 Insulin +32 Insulin in blood 113698 phv00113698.v2.p2 pht001587.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:49:11+00:00 2018-04-17 19:49:11+00:00 AL4INS INSULIN (uU/ML) +32 Insulin in blood 117565 phv00117565.v2.p2 pht001740.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:49:11+00:00 2018-04-17 19:49:11+00:00 DL7INS0 YEAR 0 INSULIN (uU/ML) +32 Insulin in blood 117566 phv00117566.v2.p2 pht001740.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:49:11+00:00 2018-04-17 19:49:11+00:00 DL7INS7 YEAR 7 INSULIN (uU/ML) +32 Insulin in blood 119604 phv00119604.v2.p2 pht001800.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:49:11+00:00 2018-04-17 19:49:11+00:00 EL7INS YEAR 10 FASTING INSULIN (uU/mL) +32 Insulin in blood 119605 phv00119605.v2.p2 pht001800.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:49:11+00:00 2018-04-17 19:49:11+00:00 EL7INS2H YEAR 10 2 HR INSULIN (uU/mL) +32 Insulin in blood 119606 phv00119606.v2.p2 pht001800.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:49:11+00:00 2018-04-17 19:49:11+00:00 EL7INSR YR 10 FASTING INS (uU/mL) - RETURN VISIT +32 Insulin in blood 119607 phv00119607.v2.p2 pht001800.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:49:11+00:00 2018-04-17 19:49:11+00:00 EL7INS2R YR 10 2 HR INS (uU/mL) - RETURN VISIT +32 Insulin in blood 120663 phv00120663.v2.p2 pht001846.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:49:11+00:00 2018-04-17 19:49:11+00:00 FL7INS FASTING INSULIN (uU/mL) +32 Insulin in blood 160488 phv00160488.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:57:11+00:00 2018-04-23 23:57:11+00:00 inslnr1t SERUM INSULIN RECODED TO E5 ELECSYS SCALE (MU/L) +32 Insulin in blood 160512 phv00160512.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:57:17+00:00 2018-04-23 23:57:17+00:00 inslnrfc MERCODIA INSULIN RECODED TO E5 ELECSYS SCALE (MU/L) +32 Insulin in blood 160542 phv00160542.v1.p3 pht002198.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:57:25+00:00 2018-04-23 23:57:25+00:00 insln3 INSULIN (pg/mL) +32 Insulin in blood 175251 phv00175251.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:57:35+00:00 2018-04-23 23:57:35+00:00 insulin5 SERUM INSULIN (mU/L) +32 Insulin in blood 176674 phv00176674.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-23 23:57:42+00:00 2018-04-23 23:57:42+00:00 insulin5 SERUM INSULIN (mU/L) +32 Insulin in blood 126128 phv00126128.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:29:36+00:00 2018-06-12 01:29:36+00:00 INL01F Fasting insulin (uU/mL) +32 Insulin in blood 21925 phv00021925.v5.p10 pht000091.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:18:51+00:00 2018-06-15 13:18:51+00:00 PFINSLN5 PLASMA FASTING INSULIN +32 Insulin in blood 21926 phv00021926.v5.p10 pht000091.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:19:24+00:00 2018-06-15 13:19:24+00:00 P2INSLN5 PLASMA 2-H OGTT INSULIN +32 Insulin in blood 23558 phv00023558.v6.p10 pht000152.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:19:55+00:00 2018-06-15 13:19:55+00:00 P_IN7 FASTING PLASMA LINCO INSULIN (PMOL/L) +32 Insulin in blood 70362 phv00070362.v4.p10 pht000688.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:20:40+00:00 2018-06-15 13:20:40+00:00 insulin INSULIN, PMOL/L (ELISA RESULTS WERE MULTIPLIED BY A FACTOR OF 6 TO GET PMOL/L UNITS FOR INSULIN) +32 Insulin in blood 201991 phv00201991.v2.p10 pht003901.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:21:02+00:00 2018-06-15 13:21:02+00:00 INSULIN Insulin (sample: EDTA plasma) +32 Insulin in blood 201995 phv00201995.v2.p10 pht003902.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:21:14+00:00 2018-06-15 13:21:14+00:00 INSULIN Insulin (sample: EDTA plasma) +32 Insulin in blood 227080 phv00227080.v1.p10 pht004804.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:21:26+00:00 2018-06-15 13:21:26+00:00 INSULIN Insulin (sample type: EDTA plasma) +32 Insulin in blood 227085 phv00227085.v1.p10 pht004805.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:21:48+00:00 2018-06-15 13:21:48+00:00 INSULIN Insulin (sample: EDTA plasma) +32 Insulin in blood 24360 phv00024360.v4.p10 pht000191.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:28:25+00:00 2018-06-15 13:28:25+00:00 pos_in7 2 HOUR INSULIN, EXAM 7 (μU/ML) +32 Insulin in blood 100044 phv00100044.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:17:18+00:00 2018-06-28 00:17:18+00:00 INS44 BASELINE INSULIN (IU/ml) +32 Insulin in blood 100050 phv00100050.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:17:36+00:00 2018-06-28 00:17:36+00:00 INS244 2 HR INSULIN (IU/ml) +32 Insulin in blood 100428 phv00100428.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:17:48+00:00 2018-06-28 00:17:48+00:00 INS44 BASELINE INSULIN (IU/ml) +32 Insulin in blood 105866 phv00105866.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:18:12+00:00 2018-06-28 00:18:12+00:00 INS44 BASELINE INSULIN (IU/ml) +32 Insulin in blood 77389 phv00077389.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:39:20+00:00 2018-07-02 21:39:20+00:00 COREINSU Core Insulin (uIU/ml) (RIA method) +32 Insulin in blood 77390 phv00077390.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:39:20+00:00 2018-07-02 21:39:20+00:00 COREINSU2 Core Insulin (uIU/ml) (automated ES300 method) +32 Insulin in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:39:20+00:00 2018-07-02 21:39:20+00:00 TESTVAL Test Result Value +32 Insulin in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 21:39:20+00:00 2018-07-02 21:39:20+00:00 TESTNAME Test Name +32 Insulin in blood 277401 phv00277401.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:21:13+00:00 2018-08-14 22:21:13+00:00 INSULIN Plasma Insulin result value Collection Interval: 2009-2011 +32 Insulin in blood 277577 phv00277577.v1.p1 pht006041.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:44:58+00:00 2018-08-14 22:44:58+00:00 INSULIN Insulin result value Collection Interval: 1996-2000 +32 Insulin in blood 277856 phv00277856.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:11:28+00:00 2018-08-14 23:11:28+00:00 INSULIN Plasma Insulin result value Collection Interval: 2000-2004 +32 Insulin in blood 307858 phv00307858.v1.p1 pht006655.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:57:24+00:00 2018-08-15 23:57:24+00:00 INSULIN Insulin result value Collection Interval: 1996-2000 +32 Insulin in blood 308049 phv00308049.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:11:26+00:00 2018-08-16 00:11:26+00:00 INSULIN Plasma Insulin result value Collection Interval: 2000-2004 +32 Insulin in blood 123962 phv00123962.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:29:41+00:00 2018-08-21 18:29:41+00:00 insulin_fast Fasting insulin (mg/dL) +32 Insulin in blood 123963 phv00123963.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:29:49+00:00 2018-08-21 18:29:49+00:00 insulin_fast_orig Insulin_fast - original value +32 Insulin in blood 123965 phv00123965.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:29:56+00:00 2018-08-21 18:29:56+00:00 insulin_ogtt OGTT insulin (mg/dL) +32 Insulin in blood 123966 phv00123966.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:30:02+00:00 2018-08-21 18:30:02+00:00 insulin_ogtt_orig Insulin_ogtt - original value +32 Insulin in blood 253227 phv00253227.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:45:00+00:00 2018-08-24 16:45:00+00:00 INSULIN_FAST Insulin, fasting (calibrated, converted to mU/L) +32 Insulin in blood 253228 phv00253228.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:45:13+00:00 2018-08-24 16:45:13+00:00 INSULIN_OGTT Insulin, post OGTT (calibrated, converted to mU/L) +32 Insulin in blood 253000 phv00253000.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:15:59+00:00 2018-08-24 17:15:59+00:00 fastinsulin_baseline Fasting insulin value at baseline visit +32 Insulin in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-04 22:08:17+00:00 2018-09-04 22:08:17+00:00 TESTABBR Test abbreviation +32 Insulin in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-04 22:13:31+00:00 2018-09-04 22:13:31+00:00 TESTDESC Test Description +32 Insulin in blood 258729 phv00258729.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:50:44+00:00 2018-09-06 12:50:44+00:00 Insulin Insulin from venous blood sample +33 HbA1c 125929 phv00125929.v1.p1 pht001945.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:45:39+00:00 2018-03-16 01:45:39+00:00 GLYHB Glyhb: hemoglobin A1c - % +33 HbA1c 174583 phv00174583.v1.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 00:30:07+00:00 2018-04-24 00:30:07+00:00 hba1c2 SERUM HEMOGLOBIN A1C +33 HbA1c 175243 phv00175243.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 00:30:16+00:00 2018-04-24 00:30:16+00:00 hba1c5 SERUM HEMOGLOBIN A1C +33 HbA1c 176666 phv00176666.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 00:30:23+00:00 2018-04-24 00:30:23+00:00 hba1c5 SERUM HEMOGLOBIN A1C +33 HbA1c 71897 phv00071897.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:55:36+00:00 2018-06-05 14:55:36+00:00 A1C Hemoglobin A1c, whole blood +33 HbA1c 275420 phv00275420.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:55:57+00:00 2018-06-05 14:55:57+00:00 A1C Hemoglobin A1C (sample type: whole blood) Collection Interval: Omni 1 Exam 3 +33 HbA1c 172163 phv00172163.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:32:18+00:00 2018-06-05 15:32:18+00:00 HBA1C Hemoglobin A1c (sample type: whole blood) +33 HbA1c 227047 phv00227047.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:32:36+00:00 2018-06-05 15:32:36+00:00 HBA1C Hemoglobin A1c (sample type: whole blood) +33 HbA1c 126015 phv00126015.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:06:18+00:00 2018-06-12 01:06:18+00:00 A1C Hemoglobin A1C +33 HbA1c 23624 phv00023624.v1.p10 pht000155.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:34:33+00:00 2018-06-14 18:34:33+00:00 HBA1920 HBA1C% CORRESPONDING TO EXAM 19/20 DATE +33 HbA1c 23625 phv00023625.v1.p10 pht000155.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:34:59+00:00 2018-06-14 18:34:59+00:00 HBA22 HBA1C% CORRESPONDING TO EXAM 22 DATE +33 HbA1c 23630 phv00023630.v5.p10 pht000156.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:35:46+00:00 2018-06-14 18:35:46+00:00 HBA7 HBA1C % +33 HbA1c 21929 phv00021929.v5.p10 pht000091.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:36:39+00:00 2018-06-14 18:36:39+00:00 HBA1C HEMOGLOBIN A1C +33 HbA1c 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:32:04+00:00 2018-07-02 22:32:04+00:00 TESTVAL Test Result Value +33 HbA1c 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 22:32:04+00:00 2018-07-02 22:32:04+00:00 TESTNAME Test Name +33 HbA1c 258047 phv00258047.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:56:32+00:00 2018-08-24 16:56:32+00:00 HBA1C_SI Glycosylated hemoglobin (HbA1c) in SI units (mmol/mol), nearest integer +33 HbA1c 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-04 22:07:58+00:00 2018-09-04 22:07:58+00:00 TESTABBR Test abbreviation +33 HbA1c 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-04 22:13:12+00:00 2018-09-04 22:13:12+00:00 TESTDESC Test Description +34 Diabetes 204631 phv00204631.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:42:50+00:00 2018-03-19 19:42:50+00:00 DIABTS22 Visit 2, diabetes [Cohort, Exam 2] +34 Diabetes 204632 phv00204632.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:43:11+00:00 2018-03-19 19:43:11+00:00 DIABTS23 Diabetes - lower cut point 126 [mg/dL] [Cohort, Exam 2] +34 Diabetes 204752 phv00204752.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:43:30+00:00 2018-03-19 19:43:30+00:00 DIABTS02 Diabetes - lower cut point 140 [mg/dL] [Cohort, Exam 1] +34 Diabetes 204753 phv00204753.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:43:49+00:00 2018-03-19 19:43:49+00:00 DIABTS03 Diabetes - lower cut point 126 [mg/dL] [Cohort, Exam 1] +34 Diabetes 204898 phv00204898.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:44:11+00:00 2018-03-19 19:44:11+00:00 DIABTS33 Diabetes using lower cut point 140 [mg/dL] [Cohort, Exam 3] +34 Diabetes 204899 phv00204899.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:44:24+00:00 2018-03-19 19:44:24+00:00 DIABTS34 Diabetes using lower cut point 126 [mg/dL] [Cohort, Exam 3] +34 Diabetes 204958 phv00204958.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:44:42+00:00 2018-03-19 19:44:42+00:00 DIABTS41 Diabetes using lower cut point 140 Mg/dL [Cohort, Exam 4] +34 Diabetes 204959 phv00204959.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 19:45:05+00:00 2018-03-19 19:45:05+00:00 DIABTS42 Diabetes using lower cut point 126 Mg/dL [Cohort, Exam 4] +34 Diabetes 209125 phv00209125.v1.p1 pht004149.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:00:34+00:00 2018-04-10 14:00:34+00:00 REXA2A Has a doctor ever told you that you had sugar diabetes? Q2a [Retinal Examination Form, exam 3] +34 Diabetes 209161 phv00209161.v1.p1 pht004150.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:01:23+00:00 2018-04-10 14:01:23+00:00 REXB2A Has your doctor ever told you that you had diabetes? Q2A [Retinal Examination Form, exam 4] +34 Diabetes 209065 phv00209065.v1.p1 pht004146.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:02:09+00:00 2018-04-10 14:02:09+00:00 PHXB6C [Medical care]. Has a doctor ever said you had any of the following? Diabetes (sugar in the blood). Q6c [Personal History form, exam 4] +34 Diabetes 208974 phv00208974.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:02:41+00:00 2018-04-10 14:02:41+00:00 PHXA8K [Medical care]. Diabetes (sugar in the blood)? Q8k [Personal History Form, exam 3] +34 Diabetes 207067 phv00207067.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:07:43+00:00 2018-04-10 14:07:43+00:00 HHXB05D [Medical care]. Has a doctor ever said you had any of the following: (read each disease name and code N if No or Never Tested). Q5. Diabetes (sugar in the blood). Q5D [Health/Medical History, exam 2] +34 Diabetes 207315 phv00207315.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:08:42+00:00 2018-04-10 14:08:42+00:00 HOM10E Has a doctor ever said that you had any of the following: diabetes (sugar in the blood)? Q10e [Home Interview, exam 1] +34 Diabetes 206810 phv00206810.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:09:39+00:00 2018-04-10 14:09:39+00:00 HFAA12A [Medical history]. Q12a - Diabetes [Heart Failure Hospital Record Abstraction Form, HFA] +34 Diabetes 204412 phv00204412.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:12:15+00:00 2018-04-10 14:12:15+00:00 PHQA03L [Medical history]. Did the decedent have a history of any of the following? Diabetes. Q3l [Physician Questionnaire Form, exam 1] +34 Diabetes 204313 phv00204313.v1.p1 pht004054.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:12:54+00:00 2018-04-10 14:12:54+00:00 IFIA19C [History]. Did he/she have a history of diabetes? Q19c [Informant Interview Form, IFI] +34 Diabetes 203983 phv00203983.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:13:32+00:00 2018-04-10 14:13:32+00:00 HRAA38B [Second transfer]. Does this patient have diabetes (high blood sugar), either history or diagnosed this hospitalization? Q38b [Hospital Abstraction Form] +34 Diabetes 203797 phv00203797.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:13:55+00:00 2018-04-10 14:13:55+00:00 CORA22A Is there a history of diabetes? Q22a [Coroner / Medical Examiner Form] +34 Diabetes 203105 phv00203105.v1.p1 pht004031.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:14:21+00:00 2018-04-10 14:14:21+00:00 AMHA1A At what age were you first told you had diabetes? Q1a [AFU Medical History Form, AMH] +34 Diabetes 203040 phv00203040.v1.p1 pht004031.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:14:51+00:00 2018-04-10 14:14:51+00:00 AMHA1 Has a doctor ever said you had diabetes, or sugar in the blood? Q1 [AFU Medical History Form, AMH] +34 Diabetes 203034 phv00203034.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:15:13+00:00 2018-04-10 14:15:13+00:00 AFUcomp15_M [General health]. Since we last contacted you has a doctor said you have diabetes or sugar in the blood? [Annual Follow-up Questionnaire Form, AFUM] +34 Diabetes 202929 phv00202929.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-10 14:15:39+00:00 2018-04-10 14:15:39+00:00 AFUcomp7d_G [General health]. Has a doctor ever said you had any of the following? Diabetes [sugar in the blood] [Annual Follow-up Questionnaire Form, AFUG] +34 Diabetes 112995 phv00112995.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 A08DIAB DIABETES +34 Diabetes 113060 phv00113060.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 A09DIBST STATUS OF DIABETES +34 Diabetes 114343 phv00114343.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 B08DIAB DIABETES. Q 6 +34 Diabetes 114378 phv00114378.v2.p2 pht001604.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 B09DIBST STATUS OF DIABETES. Q 1.04B +34 Diabetes 115076 phv00115076.v2.p2 pht001640.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 B09P_DIB GESTATIONAL DIABETES, ANY PREGNANCY? Q 11c +34 Diabetes 115439 phv00115439.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 C08DIAB DIABETES. Q 4 +34 Diabetes 116341 phv00116341.v2.p2 pht001690.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 C09P_DIB GESTATIONAL DIABETES? +34 Diabetes 116970 phv00116970.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 D08DIAB DIABETES? Q 4 +34 Diabetes 117518 phv00117518.v2.p2 pht001733.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 D09P_DIB GESTATIONAL DIABETES? Q 11c +34 Diabetes 117939 phv00117939.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 FY096DBT DIABETES? - MON 96 +34 Diabetes 117969 phv00117969.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 FY108DBT DIABETES? - MON 108 +34 Diabetes 118444 phv00118444.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 E08DIAB DIABETES? Q 4 +34 Diabetes 118445 phv00118445.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 E08GDM DIABETES DURING PREGNANCY. Q 4 +34 Diabetes 119588 phv00119588.v2.p2 pht001797.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 E09P_DIB GESTATIONAL DIABETES? +34 Diabetes 119805 phv00119805.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 F08DIAB DIABETES? Q 4 +34 Diabetes 119820 phv00119820.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 F08GDM DIABETES DURING PREGNANCY. Q 4 +34 Diabetes 120649 phv00120649.v2.p2 pht001843.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:56:24+00:00 2018-04-17 19:56:24+00:00 F09P_DIB GESTATIONAL DIABETES? Q 11c +34 Diabetes 82652 phv00082652.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:57:19+00:00 2018-04-24 01:57:19+00:00 dm031c EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM +34 Diabetes 82653 phv00082653.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:57:25+00:00 2018-04-24 01:57:25+00:00 dm031t RECODE OF DM031C COMBINING UNTREATED AND TREATED DIABETES - E1 +34 Diabetes 82654 phv00082654.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:57:34+00:00 2018-04-24 01:57:34+00:00 dm031t2 SECONDARY RECODE OF DM031C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E1 +34 Diabetes 83011 phv00083011.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:57:41+00:00 2018-04-24 01:57:41+00:00 dbpreg1 WOMEN: DIABETES OCCUR ONLY DURING PREGNANCY +34 Diabetes 195568 phv00195568.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:57:48+00:00 2018-04-24 01:57:48+00:00 dmtype1c EXAM 1 DIABETES TYPE +34 Diabetes 84456 phv00084456.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:57:55+00:00 2018-04-24 01:57:55+00:00 dm031c EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM +34 Diabetes 84457 phv00084457.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:58:13+00:00 2018-04-24 01:58:13+00:00 dm031t RECODE OF DM031C COMBINING UNTREATED AND TREATED DIABETES - E1 +34 Diabetes 84458 phv00084458.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:58:39+00:00 2018-04-24 01:58:39+00:00 dm031t2 SECONDARY RECODE OF DM031C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E1 +34 Diabetes 85242 phv00085242.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:58:46+00:00 2018-04-24 01:58:46+00:00 diabet1 DIABETES: SELF-REPORT +34 Diabetes 85247 phv00085247.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:58:54+00:00 2018-04-24 01:58:54+00:00 dbpreg1 WOMEN: DIABETES OCCUR ONLY DURING PREGNANCY +34 Diabetes 128697 phv00128697.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:58:59+00:00 2018-04-24 01:58:59+00:00 dmtype1c DIABETES TYPE +34 Diabetes 85764 phv00085764.v3.p3 pht001117.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 01:59:07+00:00 2018-04-24 01:59:07+00:00 fhxdb2 HISTORY OF DIABETES INDICATOR +34 Diabetes 85765 phv00085765.v3.p3 pht001117.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:00:58+00:00 2018-04-24 02:00:58+00:00 fhxdba2 AGE OF FIRST DIABETES DX +34 Diabetes 85794 phv00085794.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:05+00:00 2018-04-24 02:01:05+00:00 dm032c EXAM 2 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM +34 Diabetes 85795 phv00085795.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:12+00:00 2018-04-24 02:01:12+00:00 dm032t RECODE OF DM032C COMBINING UNTREATED AND TREATED DIABETES - E2 +34 Diabetes 85796 phv00085796.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:20+00:00 2018-04-24 02:01:20+00:00 dm032t2 SECONDARY RECODE OF DM032C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E2 +34 Diabetes 85837 phv00085837.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:26+00:00 2018-04-24 02:01:26+00:00 eydiab2 DIABETES, OR HIGH BLOOD SUGAR OR SUGAR IN YOUR URINE +34 Diabetes 86279 phv00086279.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:33+00:00 2018-04-24 02:01:33+00:00 dm033c EXAM 3 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM +34 Diabetes 86280 phv00086280.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:38+00:00 2018-04-24 02:01:38+00:00 dm033t RECODE OF DM033C COMBINING UNTREATED AND TREATED DIABETES - E3 +34 Diabetes 86281 phv00086281.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:45+00:00 2018-04-24 02:01:45+00:00 dm033t2 SECONDARY RECODE OF DM033C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E3 +34 Diabetes 86746 phv00086746.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:52+00:00 2018-04-24 02:01:52+00:00 dm034c EXAM 4 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM +34 Diabetes 86747 phv00086747.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:01:57+00:00 2018-04-24 02:01:57+00:00 dm034t RECODE OF DM034C COMBINING UNTREATED AND TREATED DIABETES - E4 +34 Diabetes 86748 phv00086748.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:02:02+00:00 2018-04-24 02:02:02+00:00 dm034t2 SECONDARY RECODE OF DM034C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E4 +34 Diabetes 87089 phv00087089.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:02:08+00:00 2018-04-24 02:02:08+00:00 dm03fc DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM +34 Diabetes 87090 phv00087090.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:02:14+00:00 2018-04-24 02:02:14+00:00 dm03ft RECODE OF DM03FC COMBINING UNTREATED AND TREATED DIABETES - E1 +34 Diabetes 87091 phv00087091.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:02:20+00:00 2018-04-24 02:02:20+00:00 dm03ft2 SECONDARY RECODE OF DM03FC OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E1 +34 Diabetes 87159 phv00087159.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:02:28+00:00 2018-04-24 02:02:28+00:00 diabetf DIABETES +34 Diabetes 87161 phv00087161.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:02:40+00:00 2018-04-24 02:02:40+00:00 dbagef DIABETES: AGE FIRST TREATED +34 Diabetes 87164 phv00087164.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:06:47+00:00 2018-04-24 02:06:47+00:00 dbpregf DIABETES: OCCUR ONLY DURING PREGNANCY +34 Diabetes 165067 phv00165067.v1.p3 pht002515.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:07:07+00:00 2018-04-24 02:07:07+00:00 indm1a INCIDENT DIABETES MELLITUS EXAM 2, 3, 4 +34 Diabetes 174594 phv00174594.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:07:14+00:00 2018-04-24 02:07:14+00:00 dm035c DIABETES 2003 ADA FASTING CRITERIA +34 Diabetes 174609 phv00174609.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:07:19+00:00 2018-04-24 02:07:19+00:00 dm035t RECODE OF DM035C COMBINING UNTREATED AND TREATED DIABETES - E5 +34 Diabetes 174610 phv00174610.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:07:25+00:00 2018-04-24 02:07:25+00:00 dm035t2 SECONDARY RECODE OF DM035C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E5 +34 Diabetes 175291 phv00175291.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:07:30+00:00 2018-04-24 02:07:30+00:00 diab5 DIABETES: DEVELOPED SINCE LAST MESA VISIT +34 Diabetes 175888 phv00175888.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:07:37+00:00 2018-04-24 02:07:37+00:00 diabetes DIABETES +34 Diabetes 175956 phv00175956.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:07:57+00:00 2018-04-24 02:07:57+00:00 diabetf FAMILY COHORT: DIABETES +34 Diabetes 176017 phv00176017.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:08:03+00:00 2018-04-24 02:08:03+00:00 dm035c DIABETES 2003 ADA FASTING CRITERIA +34 Diabetes 176032 phv00176032.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:08:08+00:00 2018-04-24 02:08:08+00:00 dm035t RECODE OF DM035C COMBINING UNTREATED AND TREATED DIABETES - E5 +34 Diabetes 176033 phv00176033.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:08:13+00:00 2018-04-24 02:08:13+00:00 dm035t2 SECONDARY RECODE OF DM035C OMITTING IFG AND COMBINING UNTREATED AND TREATED DIABETES - E5 +34 Diabetes 176714 phv00176714.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:08:19+00:00 2018-04-24 02:08:19+00:00 diab5 DIABETES: DEVELOPED SINCE LAST MESA VISIT +34 Diabetes 197115 phv00197115.v1.p3 pht003659.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:08:24+00:00 2018-04-24 02:08:24+00:00 dmage AGE AT DIABETES DIAGNOSIS +34 Diabetes 197117 phv00197117.v1.p3 pht003659.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:08:29+00:00 2018-04-24 02:08:29+00:00 dmsrtt TIME TO SELF-REPORTED INCIDENT DIABETES +34 Diabetes 197118 phv00197118.v1.p3 pht003659.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:08:35+00:00 2018-04-24 02:08:35+00:00 dmittt TIME TO INCIDENT TREATED DIABETES +34 Diabetes 197119 phv00197119.v1.p3 pht003659.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:08:41+00:00 2018-04-24 02:08:41+00:00 dmoe OBSERVED DIABETES (UNTREATED AND TREATED) AT ANY MESA EXAM +34 Diabetes 197120 phv00197120.v1.p3 pht003659.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:09:10+00:00 2018-04-24 02:09:10+00:00 dmoett TIME TO OBSERVED DIABETES (UNTREATED AND TREATED) AT ANY MESA EXAM +34 Diabetes 197148 phv00197148.v1.p3 pht003659.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:09:17+00:00 2018-04-24 02:09:17+00:00 dmittp INCIDENT TREATED DIABETES: TIME POINT DIAGNOSIS DETERMINED +34 Diabetes 197149 phv00197149.v1.p3 pht003659.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:09:23+00:00 2018-04-24 02:09:23+00:00 dmite2dyc TIME FROM INCIDENT TREATED DIABETES DIAGNOSIS TO EXAM 2 (DAYS) +34 Diabetes 197150 phv00197150.v1.p3 pht003659.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:09:29+00:00 2018-04-24 02:09:29+00:00 dmite5dyc TIME FROM INCIDENT TREATED DIABETES DIAGNOSIS TO EXAM 5 (DAYS) +34 Diabetes 115440 phv00115440.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 18:26:42+00:00 2018-05-24 18:26:42+00:00 C08DIBAG AGE DIABETES DIAGNOSED. Q 4 +34 Diabetes 117940 phv00117940.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 18:28:28+00:00 2018-05-24 18:28:28+00:00 FY096DBA AGE FIRST TOLD DIABETES - MON 96 +34 Diabetes 113059 phv00113059.v2.p2 pht001570.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 18:35:21+00:00 2018-05-24 18:35:21+00:00 A09DIBAG AGE, DIABETES DX'D +34 Diabetes 116972 phv00116972.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-05-24 18:36:55+00:00 2018-05-24 18:36:55+00:00 D08DIBAG AGE AT DIABETES. Q 4 +34 Diabetes 124996 phv00124996.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:25:06+00:00 2018-06-08 15:25:06+00:00 AFUA7D 7d. Diabetes or sugar in the blood +34 Diabetes 125081 phv00125081.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:29:53+00:00 2018-06-08 16:29:53+00:00 AFUA7D 7d. Diabetes or sugar in the blood +34 Diabetes 125166 phv00125166.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:45:51+00:00 2018-06-08 16:45:51+00:00 AFUB7D 7d. Diabetes or sugar in the blood +34 Diabetes 125252 phv00125252.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:59:33+00:00 2018-06-08 16:59:33+00:00 AFUB7D 7d. Diabetes or sugar in the blood +34 Diabetes 125366 phv00125366.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:12:23+00:00 2018-06-08 17:12:23+00:00 AFUC15 15. Has a doctor ever said that you have diabetes or sugar in the blood? +34 Diabetes 125600 phv00125600.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:46:40+00:00 2018-06-08 19:46:40+00:00 AFUI7D DOCTOR - DIABETES Q7D +34 Diabetes 125688 phv00125688.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:54:01+00:00 2018-06-08 19:54:01+00:00 AFUJ7D DOCTOR - DIABETES Q7D +34 Diabetes 125512 phv00125512.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:09:12+00:00 2018-06-08 20:09:12+00:00 AFUI7D DOCTOR - DIABETES Q7D +34 Diabetes 125776 phv00125776.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:14:17+00:00 2018-06-08 20:14:17+00:00 AFUK7D DOCTOR - DIABETES Q7D +34 Diabetes 126025 phv00126025.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:10:27+00:00 2018-06-12 01:10:27+00:00 History History of diabetes +34 Diabetes 126028 phv00126028.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:11:59+00:00 2018-06-12 01:11:59+00:00 DMA0104 Diabetes status (Type I or II) +34 Diabetes 126027 phv00126027.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:13:08+00:00 2018-06-12 01:13:08+00:00 AgeOnset Age of diagnosis +34 Diabetes 126029 phv00126029.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:17:04+00:00 2018-06-12 01:17:04+00:00 DM20104 Type 2 diabetes status (ADA 2004) +34 Diabetes 126030 phv00126030.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:18:18+00:00 2018-06-12 01:18:18+00:00 DM10104 Type 1 diabetes status (ADA 2004) +34 Diabetes 126031 phv00126031.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:18:41+00:00 2018-06-12 01:18:41+00:00 DM2014F Type 2 diabetes status (ADA 2004) Fasting +34 Diabetes 21630 phv00021630.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:00:17+00:00 2018-06-18 13:00:17+00:00 BW29 LIVE-BIRTH PREGNANCY #1: DID YOU HAVE DIABETES DURING THIS PREGNANCY? +34 Diabetes 21642 phv00021642.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:00:36+00:00 2018-06-18 13:00:36+00:00 BW42 LIVE-BIRTH PREGNANCY #2: DID YOU HAVE DIABETES DURING THIS PREGNANCY? +34 Diabetes 21654 phv00021654.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:01:10+00:00 2018-06-18 13:01:10+00:00 BW55 LIVE-BIRTH PREGNANCY #3: DID YOU HAVE DIABETES DURING THIS PREGNANCY? +34 Diabetes 21666 phv00021666.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:01:39+00:00 2018-06-18 13:01:39+00:00 BW68 LIVE-BIRTH PREGNANCY #4: DID YOU HAVE DIABETES DURING THIS PREGNANCY? +34 Diabetes 21678 phv00021678.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:01:59+00:00 2018-06-18 13:01:59+00:00 BW81 LIVE-BIRTH PREGNANCY #5: DID YOU HAVE DIABETES DURING THIS PREGNANCY? +34 Diabetes 80883 phv00080883.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:05:11+00:00 2018-06-18 13:05:11+00:00 dm140_curr1 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 1 +34 Diabetes 80892 phv00080892.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:05:22+00:00 2018-06-18 13:05:22+00:00 dm140_curr10 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 10 +34 Diabetes 80893 phv00080893.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:05:31+00:00 2018-06-18 13:05:31+00:00 dm140_curr11 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 11 +34 Diabetes 80894 phv00080894.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:05:40+00:00 2018-06-18 13:05:40+00:00 dm140_curr12 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 12 +34 Diabetes 80895 phv00080895.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:05:49+00:00 2018-06-18 13:05:49+00:00 dm140_curr13 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 13 +34 Diabetes 80896 phv00080896.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:05:57+00:00 2018-06-18 13:05:57+00:00 dm140_curr14 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 14 +34 Diabetes 80897 phv00080897.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:06:06+00:00 2018-06-18 13:06:06+00:00 dm140_curr15 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 15 +34 Diabetes 80898 phv00080898.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:06:14+00:00 2018-06-18 13:06:14+00:00 dm140_curr16 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 16 +34 Diabetes 80899 phv00080899.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:06:24+00:00 2018-06-18 13:06:24+00:00 dm140_curr17 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 17 +34 Diabetes 80900 phv00080900.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:06:32+00:00 2018-06-18 13:06:32+00:00 dm140_curr18 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 18 +34 Diabetes 80901 phv00080901.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:06:41+00:00 2018-06-18 13:06:41+00:00 dm140_curr19 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 19 +34 Diabetes 80884 phv00080884.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:07:22+00:00 2018-06-18 13:07:22+00:00 dm140_curr2 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 2 +34 Diabetes 80902 phv00080902.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:07:32+00:00 2018-06-18 13:07:32+00:00 dm140_curr20 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 20 +34 Diabetes 80903 phv00080903.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:07:40+00:00 2018-06-18 13:07:40+00:00 dm140_curr21 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 21 +34 Diabetes 80904 phv00080904.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:07:50+00:00 2018-06-18 13:07:50+00:00 dm140_curr22 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 22 +34 Diabetes 80905 phv00080905.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:07:59+00:00 2018-06-18 13:07:59+00:00 dm140_curr23 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 23 +34 Diabetes 80906 phv00080906.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:08:08+00:00 2018-06-18 13:08:08+00:00 dm140_curr24 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 24 +34 Diabetes 80907 phv00080907.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:08:16+00:00 2018-06-18 13:08:16+00:00 dm140_curr25 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 25 +34 Diabetes 80908 phv00080908.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:08:27+00:00 2018-06-18 13:08:27+00:00 dm140_curr26 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 26 +34 Diabetes 80909 phv00080909.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:08:36+00:00 2018-06-18 13:08:36+00:00 dm140_curr27 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 27 +34 Diabetes 80885 phv00080885.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:10:49+00:00 2018-06-18 13:10:49+00:00 dm140_curr3 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 3 +34 Diabetes 80886 phv00080886.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:11:18+00:00 2018-06-18 13:11:18+00:00 dm140_curr4 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 4 +34 Diabetes 80887 phv00080887.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:11:28+00:00 2018-06-18 13:11:28+00:00 dm140_curr5 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 5 +34 Diabetes 80888 phv00080888.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:11:38+00:00 2018-06-18 13:11:38+00:00 dm140_curr6 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 6 +34 Diabetes 80889 phv00080889.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:11:47+00:00 2018-06-18 13:11:47+00:00 dm140_curr7 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 7 +34 Diabetes 80890 phv00080890.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:11:58+00:00 2018-06-18 13:11:58+00:00 dm140_curr8 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 8 +34 Diabetes 80891 phv00080891.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:12:07+00:00 2018-06-18 13:12:07+00:00 dm140_curr9 DIABETES MELLITUS STATUS (140 mg/dl) AT EXAM 9 +34 Diabetes 80910 phv00080910.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:14:50+00:00 2018-06-18 13:14:50+00:00 dm140_hx1 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 1 +34 Diabetes 80919 phv00080919.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:15:08+00:00 2018-06-18 13:15:08+00:00 dm140_hx10 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 10 +34 Diabetes 80920 phv00080920.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:16:24+00:00 2018-06-18 13:16:24+00:00 dm140_hx11 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 11 +34 Diabetes 80921 phv00080921.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:16:33+00:00 2018-06-18 13:16:33+00:00 dm140_hx12 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 12 +34 Diabetes 80922 phv00080922.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:16:43+00:00 2018-06-18 13:16:43+00:00 dm140_hx13 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 13 +34 Diabetes 80923 phv00080923.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:16:52+00:00 2018-06-18 13:16:52+00:00 dm140_hx14 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 14 +34 Diabetes 80924 phv00080924.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:17:02+00:00 2018-06-18 13:17:02+00:00 dm140_hx15 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 15 +34 Diabetes 80925 phv00080925.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:17:12+00:00 2018-06-18 13:17:12+00:00 dm140_hx16 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 16 +34 Diabetes 80926 phv00080926.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:17:21+00:00 2018-06-18 13:17:21+00:00 dm140_hx17 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 17 +34 Diabetes 80927 phv00080927.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:17:35+00:00 2018-06-18 13:17:35+00:00 dm140_hx18 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 18 +34 Diabetes 80928 phv00080928.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:17:47+00:00 2018-06-18 13:17:47+00:00 dm140_hx19 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 19 +34 Diabetes 80911 phv00080911.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:18:28+00:00 2018-06-18 13:18:28+00:00 dm140_hx2 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 2 +34 Diabetes 80929 phv00080929.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:18:39+00:00 2018-06-18 13:18:39+00:00 dm140_hx20 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 20 +34 Diabetes 80930 phv00080930.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:18:49+00:00 2018-06-18 13:18:49+00:00 dm140_hx21 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 21 +34 Diabetes 80931 phv00080931.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:19:01+00:00 2018-06-18 13:19:01+00:00 dm140_hx22 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 22 +34 Diabetes 80932 phv00080932.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:19:10+00:00 2018-06-18 13:19:10+00:00 dm140_hx23 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 23 +34 Diabetes 80933 phv00080933.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:19:19+00:00 2018-06-18 13:19:19+00:00 dm140_hx24 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 24 +34 Diabetes 80934 phv00080934.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:19:32+00:00 2018-06-18 13:19:32+00:00 dm140_hx25 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 25 +34 Diabetes 80935 phv00080935.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:19:43+00:00 2018-06-18 13:19:43+00:00 dm140_hx26 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 26 +34 Diabetes 80936 phv00080936.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:19:52+00:00 2018-06-18 13:19:52+00:00 dm140_hx27 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 27 +34 Diabetes 80912 phv00080912.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:20:20+00:00 2018-06-18 13:20:20+00:00 dm140_hx3 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 3 +34 Diabetes 80913 phv00080913.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:20:32+00:00 2018-06-18 13:20:32+00:00 dm140_hx4 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 4 +34 Diabetes 80914 phv00080914.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:20:46+00:00 2018-06-18 13:20:46+00:00 dm140_hx5 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 5 +34 Diabetes 80915 phv00080915.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:21:58+00:00 2018-06-18 13:21:58+00:00 dm140_hx6 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 6 +34 Diabetes 80916 phv00080916.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:22:09+00:00 2018-06-18 13:22:09+00:00 dm140_hx7 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 7 +34 Diabetes 80917 phv00080917.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:22:19+00:00 2018-06-18 13:22:19+00:00 dm140_hx8 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 8 +34 Diabetes 80918 phv00080918.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:22:31+00:00 2018-06-18 13:22:31+00:00 dm140_hx9 HISTORY OF DIABETES MELLITUS (140 mg/dl) AT EXAM 9 +34 Diabetes 80937 phv00080937.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:23:11+00:00 2018-06-18 13:23:11+00:00 dm150_curr1 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 1 +34 Diabetes 80946 phv00080946.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:23:21+00:00 2018-06-18 13:23:21+00:00 dm150_curr10 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 10 +34 Diabetes 80947 phv00080947.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:23:30+00:00 2018-06-18 13:23:30+00:00 dm150_curr11 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 11 +34 Diabetes 80948 phv00080948.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:23:38+00:00 2018-06-18 13:23:38+00:00 dm150_curr12 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 12 +34 Diabetes 80949 phv00080949.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:23:49+00:00 2018-06-18 13:23:49+00:00 dm150_curr13 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 13 +34 Diabetes 80951 phv00080951.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:23:59+00:00 2018-06-18 13:23:59+00:00 dm150_curr15 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 15 +34 Diabetes 80952 phv00080952.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:24:07+00:00 2018-06-18 13:24:07+00:00 dm150_curr16 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 16 +34 Diabetes 80953 phv00080953.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:24:17+00:00 2018-06-18 13:24:17+00:00 dm150_curr17 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 17 +34 Diabetes 80954 phv00080954.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:24:30+00:00 2018-06-18 13:24:30+00:00 dm150_curr18 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 18 +34 Diabetes 80955 phv00080955.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:24:39+00:00 2018-06-18 13:24:39+00:00 dm150_curr19 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 19 +34 Diabetes 80938 phv00080938.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:32:23+00:00 2018-06-18 13:32:23+00:00 dm150_curr2 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 2 +34 Diabetes 80956 phv00080956.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:32:43+00:00 2018-06-18 13:32:43+00:00 dm150_curr20 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 20 +34 Diabetes 80957 phv00080957.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:32:55+00:00 2018-06-18 13:32:55+00:00 dm150_curr21 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 21 +34 Diabetes 80958 phv00080958.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:33:05+00:00 2018-06-18 13:33:05+00:00 dm150_curr22 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 22 +34 Diabetes 80959 phv00080959.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:33:15+00:00 2018-06-18 13:33:15+00:00 dm150_curr23 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 23 +34 Diabetes 80960 phv00080960.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:33:24+00:00 2018-06-18 13:33:24+00:00 dm150_curr24 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 24 +34 Diabetes 80961 phv00080961.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:33:34+00:00 2018-06-18 13:33:34+00:00 dm150_curr25 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 25 +34 Diabetes 80962 phv00080962.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:33:46+00:00 2018-06-18 13:33:46+00:00 dm150_curr26 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 26 +34 Diabetes 80963 phv00080963.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:35:20+00:00 2018-06-18 13:35:20+00:00 dm150_curr27 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 27 +34 Diabetes 80939 phv00080939.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:35:53+00:00 2018-06-18 13:35:53+00:00 dm150_curr3 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 3 +34 Diabetes 80940 phv00080940.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:36:08+00:00 2018-06-18 13:36:08+00:00 dm150_curr4 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 4 +34 Diabetes 80941 phv00080941.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:36:20+00:00 2018-06-18 13:36:20+00:00 dm150_curr5 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 5 +34 Diabetes 80942 phv00080942.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:36:30+00:00 2018-06-18 13:36:30+00:00 dm150_curr6 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 6 +34 Diabetes 80943 phv00080943.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:36:41+00:00 2018-06-18 13:36:41+00:00 dm150_curr7 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 7 +34 Diabetes 80944 phv00080944.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:36:58+00:00 2018-06-18 13:36:58+00:00 dm150_curr8 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 8 +34 Diabetes 80945 phv00080945.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:37:07+00:00 2018-06-18 13:37:07+00:00 dm150_curr9 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 9 +34 Diabetes 80964 phv00080964.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:37:45+00:00 2018-06-18 13:37:45+00:00 dm150_hx1 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 1 +34 Diabetes 80973 phv00080973.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:38:00+00:00 2018-06-18 13:38:00+00:00 dm150_hx10 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 10 +34 Diabetes 80974 phv00080974.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:38:10+00:00 2018-06-18 13:38:10+00:00 dm150_hx11 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 11 +34 Diabetes 80975 phv00080975.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:38:19+00:00 2018-06-18 13:38:19+00:00 dm150_hx12 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 12 +34 Diabetes 80976 phv00080976.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:38:30+00:00 2018-06-18 13:38:30+00:00 dm150_hx13 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 13 +34 Diabetes 80977 phv00080977.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:38:41+00:00 2018-06-18 13:38:41+00:00 dm150_hx14 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 14 +34 Diabetes 80978 phv00080978.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:38:52+00:00 2018-06-18 13:38:52+00:00 dm150_hx15 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 15 +34 Diabetes 80979 phv00080979.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:39:01+00:00 2018-06-18 13:39:01+00:00 dm150_hx16 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 16 +34 Diabetes 80980 phv00080980.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:39:11+00:00 2018-06-18 13:39:11+00:00 dm150_hx17 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 17 +34 Diabetes 80981 phv00080981.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:39:22+00:00 2018-06-18 13:39:22+00:00 dm150_hx18 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 18 +34 Diabetes 80982 phv00080982.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:39:32+00:00 2018-06-18 13:39:32+00:00 dm150_hx19 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 19 +34 Diabetes 80965 phv00080965.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:46:45+00:00 2018-06-18 13:46:45+00:00 dm150_hx2 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 2 +34 Diabetes 80983 phv00080983.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:47:02+00:00 2018-06-18 13:47:02+00:00 dm150_hx20 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 20 +34 Diabetes 80984 phv00080984.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:47:15+00:00 2018-06-18 13:47:15+00:00 dm150_hx21 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 21 +34 Diabetes 80985 phv00080985.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:47:27+00:00 2018-06-18 13:47:27+00:00 dm150_hx22 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 22 +34 Diabetes 80986 phv00080986.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:47:37+00:00 2018-06-18 13:47:37+00:00 dm150_hx23 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 23 +34 Diabetes 80987 phv00080987.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:47:47+00:00 2018-06-18 13:47:47+00:00 dm150_hx24 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 24 +34 Diabetes 80988 phv00080988.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:47:56+00:00 2018-06-18 13:47:56+00:00 dm150_hx25 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 25 +34 Diabetes 80989 phv00080989.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:48:07+00:00 2018-06-18 13:48:07+00:00 dm150_hx26 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 26 +34 Diabetes 80990 phv00080990.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:48:17+00:00 2018-06-18 13:48:17+00:00 dm150_hx27 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 27 +34 Diabetes 80966 phv00080966.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:49:40+00:00 2018-06-18 13:49:40+00:00 dm150_hx3 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 3 +34 Diabetes 80967 phv00080967.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:49:53+00:00 2018-06-18 13:49:53+00:00 dm150_hx4 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 4 +34 Diabetes 80968 phv00080968.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:50:02+00:00 2018-06-18 13:50:02+00:00 dm150_hx5 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 5 +34 Diabetes 80969 phv00080969.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:50:12+00:00 2018-06-18 13:50:12+00:00 dm150_hx6 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 6 +34 Diabetes 80970 phv00080970.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:50:22+00:00 2018-06-18 13:50:22+00:00 dm150_hx7 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 7 +34 Diabetes 80971 phv00080971.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:50:31+00:00 2018-06-18 13:50:31+00:00 dm150_hx8 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 8 +34 Diabetes 80972 phv00080972.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:50:40+00:00 2018-06-18 13:50:40+00:00 dm150_hx9 HISTORY OF DIABETES MELLITUS (150 mg/dl) AT EXAM 9 +34 Diabetes 80829 phv00080829.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:51:09+00:00 2018-06-18 13:51:09+00:00 dm200_curr1 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 1 +34 Diabetes 80838 phv00080838.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:51:20+00:00 2018-06-18 13:51:20+00:00 dm200_curr10 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 10 +34 Diabetes 80839 phv00080839.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:51:30+00:00 2018-06-18 13:51:30+00:00 dm200_curr11 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 11 +34 Diabetes 80840 phv00080840.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:51:39+00:00 2018-06-18 13:51:39+00:00 dm200_curr12 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 12 +34 Diabetes 80841 phv00080841.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:51:48+00:00 2018-06-18 13:51:48+00:00 dm200_curr13 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 13 +34 Diabetes 80842 phv00080842.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:51:57+00:00 2018-06-18 13:51:57+00:00 dm200_curr14 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 14 +34 Diabetes 80843 phv00080843.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:52:06+00:00 2018-06-18 13:52:06+00:00 dm200_curr15 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 15 +34 Diabetes 80844 phv00080844.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:52:15+00:00 2018-06-18 13:52:15+00:00 dm200_curr16 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 16 +34 Diabetes 80845 phv00080845.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:52:24+00:00 2018-06-18 13:52:24+00:00 dm200_curr17 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 17 +34 Diabetes 80846 phv00080846.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:52:34+00:00 2018-06-18 13:52:34+00:00 dm200_curr18 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 18 +34 Diabetes 80847 phv00080847.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:52:44+00:00 2018-06-18 13:52:44+00:00 dm200_curr19 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 19 +34 Diabetes 80830 phv00080830.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:53:19+00:00 2018-06-18 13:53:19+00:00 dm200_curr2 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 2 +34 Diabetes 80848 phv00080848.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:53:30+00:00 2018-06-18 13:53:30+00:00 dm200_curr20 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 20 +34 Diabetes 80849 phv00080849.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:53:39+00:00 2018-06-18 13:53:39+00:00 dm200_curr21 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 21 +34 Diabetes 80850 phv00080850.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:53:48+00:00 2018-06-18 13:53:48+00:00 dm200_curr22 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 22 +34 Diabetes 80851 phv00080851.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:53:58+00:00 2018-06-18 13:53:58+00:00 dm200_curr23 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 23 +34 Diabetes 80852 phv00080852.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:54:07+00:00 2018-06-18 13:54:07+00:00 dm200_curr24 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 24 +34 Diabetes 80853 phv00080853.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:54:16+00:00 2018-06-18 13:54:16+00:00 dm200_curr25 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 25 +34 Diabetes 80854 phv00080854.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:54:25+00:00 2018-06-18 13:54:25+00:00 dm200_curr26 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 26 +34 Diabetes 80855 phv00080855.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:54:37+00:00 2018-06-18 13:54:37+00:00 dm200_curr27 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 27 +34 Diabetes 80831 phv00080831.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:57:32+00:00 2018-06-18 13:57:32+00:00 dm200_curr3 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 3 +34 Diabetes 80832 phv00080832.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:57:45+00:00 2018-06-18 13:57:45+00:00 dm200_curr4 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 4 +34 Diabetes 80833 phv00080833.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:57:55+00:00 2018-06-18 13:57:55+00:00 dm200_curr5 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 5 +34 Diabetes 80834 phv00080834.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:58:03+00:00 2018-06-18 13:58:03+00:00 dm200_curr6 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 6 +34 Diabetes 80835 phv00080835.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:58:11+00:00 2018-06-18 13:58:11+00:00 dm200_curr7 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 7 +34 Diabetes 80836 phv00080836.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:58:19+00:00 2018-06-18 13:58:19+00:00 dm200_curr8 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 8 +34 Diabetes 80837 phv00080837.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:58:28+00:00 2018-06-18 13:58:28+00:00 dm200_curr9 DIABETES MELLITUS STATUS (200 mg/dl) AT EXAM 9 +34 Diabetes 80856 phv00080856.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:58:54+00:00 2018-06-18 13:58:54+00:00 dm200_hx1 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 1 +34 Diabetes 80865 phv00080865.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:59:02+00:00 2018-06-18 13:59:02+00:00 dm200_hx10 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 10 +34 Diabetes 80866 phv00080866.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:59:11+00:00 2018-06-18 13:59:11+00:00 dm200_hx11 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 11 +34 Diabetes 80867 phv00080867.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:59:19+00:00 2018-06-18 13:59:19+00:00 dm200_hx12 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 12 +34 Diabetes 80868 phv00080868.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:59:27+00:00 2018-06-18 13:59:27+00:00 dm200_hx13 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 13 +34 Diabetes 80869 phv00080869.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:59:35+00:00 2018-06-18 13:59:35+00:00 dm200_hx14 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 14 +34 Diabetes 80870 phv00080870.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:59:43+00:00 2018-06-18 13:59:43+00:00 dm200_hx15 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 15 +34 Diabetes 80871 phv00080871.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 13:59:52+00:00 2018-06-18 13:59:52+00:00 dm200_hx16 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 16 +34 Diabetes 80872 phv00080872.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:00:00+00:00 2018-06-18 14:00:00+00:00 dm200_hx17 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 17 +34 Diabetes 80873 phv00080873.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:00:09+00:00 2018-06-18 14:00:09+00:00 dm200_hx18 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 18 +34 Diabetes 80874 phv00080874.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:00:18+00:00 2018-06-18 14:00:18+00:00 dm200_hx19 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 19 +34 Diabetes 80857 phv00080857.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:00:54+00:00 2018-06-18 14:00:54+00:00 dm200_hx2 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 2 +34 Diabetes 80875 phv00080875.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:01:04+00:00 2018-06-18 14:01:04+00:00 dm200_hx20 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 20 +34 Diabetes 80876 phv00080876.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:01:13+00:00 2018-06-18 14:01:13+00:00 dm200_hx21 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 21 +34 Diabetes 80877 phv00080877.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:01:22+00:00 2018-06-18 14:01:22+00:00 dm200_hx22 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 22 +34 Diabetes 80878 phv00080878.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:01:31+00:00 2018-06-18 14:01:31+00:00 dm200_hx23 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 23 +34 Diabetes 80879 phv00080879.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:01:40+00:00 2018-06-18 14:01:40+00:00 dm200_hx24 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 24 +34 Diabetes 80880 phv00080880.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:01:49+00:00 2018-06-18 14:01:49+00:00 dm200_hx25 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 25 +34 Diabetes 80881 phv00080881.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:01:58+00:00 2018-06-18 14:01:58+00:00 dm200_hx26 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 26 +34 Diabetes 80882 phv00080882.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:02:11+00:00 2018-06-18 14:02:11+00:00 dm200_hx27 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 27 +34 Diabetes 80858 phv00080858.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:02:45+00:00 2018-06-18 14:02:45+00:00 dm200_hx3 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 3 +34 Diabetes 80859 phv00080859.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:02:56+00:00 2018-06-18 14:02:56+00:00 dm200_hx4 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 4 +34 Diabetes 80860 phv00080860.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:03:05+00:00 2018-06-18 14:03:05+00:00 dm200_hx5 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 5 +34 Diabetes 80861 phv00080861.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:03:14+00:00 2018-06-18 14:03:14+00:00 dm200_hx6 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 6 +34 Diabetes 80862 phv00080862.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:03:23+00:00 2018-06-18 14:03:23+00:00 dm200_hx7 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 7 +34 Diabetes 80863 phv00080863.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:03:32+00:00 2018-06-18 14:03:32+00:00 dm200_hx8 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 8 +34 Diabetes 80864 phv00080864.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:03:43+00:00 2018-06-18 14:03:43+00:00 dm200_hx9 HISTORY OF DIABETES MELLITUS (200 mg/dl) AT EXAM 9 +34 Diabetes 10791 phv00010791.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:09:25+00:00 2018-06-18 14:09:25+00:00 DIAB1 DIABETES MELLITUS STATUS AT EXAM 1 (SOURCE: CALCULATED) +34 Diabetes 10792 phv00010792.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:09:36+00:00 2018-06-18 14:09:36+00:00 DIAB2 DIABETES MELLITUS STATUS AT EXAM 2 (SOURCE: CALCULATED) +34 Diabetes 10793 phv00010793.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:09:44+00:00 2018-06-18 14:09:44+00:00 DIAB3 DIABETES MELLITUS STATUS AT EXAM 3 (SOURCE: CALCULATED) +34 Diabetes 10794 phv00010794.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:09:53+00:00 2018-06-18 14:09:53+00:00 DIAB4 DIABETES MELLITUS STATUS AT EXAM 4 (SOURCE: CALCULATED) +34 Diabetes 10795 phv00010795.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:10:01+00:00 2018-06-18 14:10:01+00:00 DIAB5 DIABETES MELLITUS STATUS AT EXAM 5 (SOURCE: CALCULATED) +34 Diabetes 10796 phv00010796.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:10:10+00:00 2018-06-18 14:10:10+00:00 DIAB6 DIABETES MELLITUS STATUS AT EXAM 6 (SOURCE: CALCULATED) +34 Diabetes 10797 phv00010797.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:10:19+00:00 2018-06-18 14:10:19+00:00 DIAB7 DIABETES MELLITUS STATUS AT EXAM 7 (SOURCE: CALCULATED) +34 Diabetes 255335 phv00255335.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:17:37+00:00 2018-06-18 14:17:37+00:00 fw611 Other Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Diabetes Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +34 Diabetes 275060 phv00275060.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:18:14+00:00 2018-06-18 14:18:14+00:00 FX611 Other Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for diabetes? Collection Interval: Original Cohort Exam 31 +34 Diabetes 275394 phv00275394.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:19:12+00:00 2018-06-18 14:19:12+00:00 fy611 Other Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for diabetes? Collection Interval: Original Cohort Exam 32 +34 Diabetes 177253 phv00177253.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:28:04+00:00 2018-06-18 14:28:04+00:00 g3b0017 Medical History - Medications: Since your last exam have you been told by a doctor you have high blood sugar or diabetes? +34 Diabetes 177265 phv00177265.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:28:40+00:00 2018-06-18 14:28:40+00:00 g3b0036 Medical History-Female Reproductive History: During any of these pregnancies, were you told you had high blood sugar or diabetes? +34 Diabetes 72059 phv00072059.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:29:15+00:00 2018-06-18 14:29:15+00:00 H016 SINCE YOUR LAST EXAM HAVE YOU BEEN TOLD BY A DOCTOR YOU HAVE HIGH BLOOD SUGAR OR DIABETES? +34 Diabetes 251277 phv00251277.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:29:27+00:00 2018-06-18 14:29:27+00:00 h016 Medical History - Medications: Since your last exam have you been told by a doctor you have high blood sugar or diabetes? Collection Interval: Exam 3 +34 Diabetes 251799 phv00251799.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:37:06+00:00 2018-06-18 14:37:06+00:00 h779 Medical History - Female Reproductive History: During any of these pregnancies, were you told you have high blood sugar (gestational diabetes)? Collection Interval: Exam 3 +34 Diabetes 254027 phv00254027.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:41:16+00:00 2018-06-18 14:41:16+00:00 j018 Medical History - Medications: Since your last exam have you been told by a doctor you have high blood sugar or diabetes? +34 Diabetes 254038 phv00254038.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:44:56+00:00 2018-06-18 14:44:56+00:00 j038 Medical History - Female Reproductive History, Part 1: Since your last exam, during any of these pregnancies, were you told you had high blood sugar or diabetes? +34 Diabetes 964 phv00000964.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 14:45:26+00:00 2018-06-18 14:45:26+00:00 MF522 LIFETIME HISTORY OF DIABETES: AGE AT WHICH DIABETES WAS DIAGNOSED, EXAM 7 +34 Diabetes 273718 phv00273718.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:09:17+00:00 2018-06-18 15:09:17+00:00 g3a019 If yes to G33A016, did diabetes occur in pregnancy only? Collection Interval: Exam 1 +34 Diabetes 20884 phv00020884.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:09:58+00:00 2018-06-18 15:09:58+00:00 G3A019 IF YES TO G33A016, DID DIABETES OCCUR IN PREGNANCY ONLY? +34 Diabetes 274211 phv00274211.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:10:11+00:00 2018-06-18 15:10:11+00:00 g3a019 If yes to G33A016, did diabetes occur in pregnancy only? +34 Diabetes 80950 phv00080950.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 15:20:03+00:00 2018-06-18 15:20:03+00:00 dm150_curr14 DIABETES MELLLITUS STATUS (150 mg/dl) AT EXAM 14 +34 Diabetes 128095 phv00128095.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:20:13+00:00 2018-06-20 18:20:13+00:00 PFHA6A 6a: Had doctor said you had Sugar/diabetes? +34 Diabetes 128096 phv00128096.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:20:30+00:00 2018-06-20 18:20:30+00:00 PFHA6B 6b: Age told you had diabetes? +34 Diabetes 98820 phv00098820.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:57:24+00:00 2018-06-28 00:57:24+00:00 DIAB01 DIABETES from eligibility questionnaire +34 Diabetes 99025 phv00099025.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:57:48+00:00 2018-06-28 00:57:48+00:00 DIABET07 DIABETES from med hx +34 Diabetes 99345 phv00099345.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:57:59+00:00 2018-06-28 00:57:59+00:00 DIABET12 DIABETES from self rpt at blood draw +34 Diabetes 99462 phv00099462.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:58:13+00:00 2018-06-28 00:58:13+00:00 DIABWHO WHO CALC. DIAB STATUS +34 Diabetes 99552 phv00099552.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:58:24+00:00 2018-06-28 00:58:24+00:00 DIABADA ADA Diabetic Status +34 Diabetes 100338 phv00100338.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:58:44+00:00 2018-06-28 00:58:44+00:00 DIABET RPDT HISTORY OF DIABETES +34 Diabetes 99924 phv00099924.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:59:12+00:00 2018-06-28 00:59:12+00:00 DIAB30 DIABETIC +34 Diabetes 101530 phv00101530.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:59:24+00:00 2018-06-28 00:59:24+00:00 DIABET59 HAVE DIABETES +34 Diabetes 101785 phv00101785.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:59:42+00:00 2018-06-28 00:59:42+00:00 DIABET12 DIABETES +34 Diabetes 101793 phv00101793.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 00:59:55+00:00 2018-06-28 00:59:55+00:00 DIAB74 Dr said you had diabetes +34 Diabetes 101794 phv00101794.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:00:10+00:00 2018-06-28 01:00:10+00:00 DIABYR74 Number of years you've been diabetic +34 Diabetes 102446 phv00102446.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:00:25+00:00 2018-06-28 01:00:25+00:00 DIABET12 DIABETES +34 Diabetes 103169 phv00103169.v1.p1 pht001476.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:00:57+00:00 2018-06-28 01:00:57+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 103222 phv00103222.v1.p1 pht001477.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:01:09+00:00 2018-06-28 01:01:09+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 103327 phv00103327.v1.p1 pht001479.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:01:35+00:00 2018-06-28 01:01:35+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 103379 phv00103379.v1.p1 pht001480.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:03:48+00:00 2018-06-28 01:03:48+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 103432 phv00103432.v1.p1 pht001481.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:04:21+00:00 2018-06-28 01:04:21+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 103484 phv00103484.v1.p1 pht001482.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:04:49+00:00 2018-06-28 01:04:49+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 103537 phv00103537.v1.p1 pht001483.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:05:15+00:00 2018-06-28 01:05:15+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 103642 phv00103642.v1.p1 pht001485.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:05:43+00:00 2018-06-28 01:05:43+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 103745 phv00103745.v1.p1 pht001487.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:06:04+00:00 2018-06-28 01:06:04+00:00 DIABET32 TOLD BY MD YOU HAD DIABETES +34 Diabetes 104107 phv00104107.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:06:44+00:00 2018-06-28 01:06:44+00:00 DIABET37 DIABETES +34 Diabetes 104826 phv00104826.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:07:42+00:00 2018-06-28 01:07:42+00:00 DIABET39 DIABETES +34 Diabetes 105137 phv00105137.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:07:53+00:00 2018-06-28 01:07:53+00:00 DIAB01 DIABETES +34 Diabetes 105964 phv00105964.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:08:03+00:00 2018-06-28 01:08:03+00:00 DIABET57 DIABETES +34 Diabetes 105965 phv00105965.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:08:19+00:00 2018-06-28 01:08:19+00:00 DIABYR57 HOW LONG HAD DIABETES +34 Diabetes 106406 phv00106406.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:08:45+00:00 2018-06-28 01:08:45+00:00 DIABADA 1 'Normal' 2 'IFG' 3 'New Diabetes' 4 'K +34 Diabetes 107092 phv00107092.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:09:08+00:00 2018-06-28 01:09:08+00:00 DIABET29 HAVE DIABETES +34 Diabetes 107337 phv00107337.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:09:42+00:00 2018-06-28 01:09:42+00:00 DIABADA ADA Diabetic Status +34 Diabetes 107948 phv00107948.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:09:50+00:00 2018-06-28 01:09:50+00:00 DIABET59 HAVE DIABETES +34 Diabetes 108622 phv00108622.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:10:00+00:00 2018-06-28 01:10:00+00:00 DIABET59 HAVE DIABETES +34 Diabetes 109389 phv00109389.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:10:10+00:00 2018-06-28 01:10:10+00:00 DIABET59 HAVE DIABETES +34 Diabetes 110345 phv00110345.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:10:20+00:00 2018-06-28 01:10:20+00:00 DIABET12 DIABETES +34 Diabetes 110521 phv00110521.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:10:48+00:00 2018-06-28 01:10:48+00:00 DIABADA ADA Diabetic Status +34 Diabetes 110522 phv00110522.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:11:00+00:00 2018-06-28 01:11:00+00:00 DIABWHO WHO Diabetic Status +34 Diabetes 197453 phv00197453.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-28 01:11:17+00:00 2018-06-28 01:11:17+00:00 diabet15 MD said pt had diabetes? (no observations) +34 Diabetes 78464 phv00078464.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 20:30:35+00:00 2018-07-02 20:30:35+00:00 DIAB Diabetes ever +34 Diabetes 78471 phv00078471.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 20:30:35+00:00 2018-07-02 20:30:35+00:00 DIABNW Diabetes now +34 Diabetes 111545 phv00111545.v6.p3 pht001514.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 20:30:35+00:00 2018-07-02 20:30:35+00:00 F134DIAB Diabetes/high blood sugar ever +34 Diabetes 283531 phv00283531.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 20:32:50+00:00 2018-07-02 20:32:50+00:00 DIABHX F136 History of diabetes +34 Diabetes 126032 phv00126032.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 14:56:01+00:00 2018-07-10 14:56:01+00:00 DMT01 Diabetes type +34 Diabetes 159611 phv00159611.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:21:49+00:00 2018-08-10 21:21:49+00:00 Diabetes Diabetes Collection Interval: Collected in Exam 1 +34 Diabetes 277449 phv00277449.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:33:14+00:00 2018-08-14 22:33:14+00:00 HBS_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 2009-2011 +34 Diabetes 277448 phv00277448.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:33:21+00:00 2018-08-14 22:33:21+00:00 HBS_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 2009-2011 +34 Diabetes 277447 phv00277447.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:33:29+00:00 2018-08-14 22:33:29+00:00 HBS Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 2009-2011 +34 Diabetes 277611 phv00277611.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:54:18+00:00 2018-08-14 22:54:18+00:00 HBS_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 1996-2000 +34 Diabetes 277610 phv00277610.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:54:24+00:00 2018-08-14 22:54:24+00:00 HBS_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 1996-2000 +34 Diabetes 277609 phv00277609.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:54:30+00:00 2018-08-14 22:54:30+00:00 HBS Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 1996-2000 +34 Diabetes 277898 phv00277898.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:16:29+00:00 2018-08-14 23:16:29+00:00 HBS_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 2000-2004 +34 Diabetes 277897 phv00277897.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:16:36+00:00 2018-08-14 23:16:36+00:00 HBS_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 2000-2004 +34 Diabetes 277896 phv00277896.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:16:42+00:00 2018-08-14 23:16:42+00:00 HBS Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 2000-2004 +34 Diabetes 307892 phv00307892.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:03:55+00:00 2018-08-16 00:03:55+00:00 HBS_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 1996-2000 +34 Diabetes 307891 phv00307891.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:04:02+00:00 2018-08-16 00:04:02+00:00 HBS_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 1996-2000 +34 Diabetes 307890 phv00307890.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:04:10+00:00 2018-08-16 00:04:10+00:00 HBS Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 1996-2000 +34 Diabetes 308091 phv00308091.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:21:15+00:00 2018-08-16 00:21:15+00:00 HBS_AGE In what year or how old were you when it was first diagnosed? - age Collection Interval: 2000-2004 +34 Diabetes 308090 phv00308090.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:21:21+00:00 2018-08-16 00:21:21+00:00 HBS_YR In what year or how old were you when it was first diagnosed? - year Collection Interval: 2000-2004 +34 Diabetes 308089 phv00308089.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:21:28+00:00 2018-08-16 00:21:28+00:00 HBS Have you ever been told by a physician that you had diabetes or high blood sugar? Collection Interval: 2000-2004 +34 Diabetes 122241 phv00122241.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:12:22+00:00 2018-08-16 23:12:22+00:00 DIABETES Diabetes (AC) +34 Diabetes 122242 phv00122242.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:13:09+00:00 2018-08-16 23:13:09+00:00 DIADIAG Diabetes diagnosed by doctor (AC) +34 Diabetes 122243 phv00122243.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:13:17+00:00 2018-08-16 23:13:17+00:00 DIAAGE Age when diabetes noted (AC) +34 Diabetes 122244 phv00122244.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:13:24+00:00 2018-08-16 23:13:24+00:00 DIAPRES Diabetes still present (AC) +34 Diabetes 123023 phv00123023.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:55:20+00:00 2018-08-17 19:55:20+00:00 diabetesdx Diabetes: self report of MD dx of diabetes +34 Diabetes 114377 phv00114377.v2.p2 pht001604.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:55:53+00:00 2018-08-17 21:55:53+00:00 B09DIBAG AGE AT 1ST DIABETES. Q 1.04A +34 Diabetes 124253 phv00124253.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:52:04+00:00 2018-08-21 18:52:04+00:00 diabetesx Diabetes: self report of MD dx of diabetes or meds +34 Diabetes 124255 phv00124255.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:52:43+00:00 2018-08-21 18:52:43+00:00 diabetes2 Diabetes: MD dx of diabetes or meds or abn fasting (ogtt not considered) +34 Diabetes 124256 phv00124256.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:52:51+00:00 2018-08-21 18:52:51+00:00 diabetes3 Diabetes: broad definition: MD dx or meds or abn fasting or abn ogtt glucose +34 Diabetes 124254 phv00124254.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:54:39+00:00 2018-08-21 18:54:39+00:00 diabetes1 Diabetes: meds or abn fasting or abn ogtt glucose +34 Diabetes 124276 phv00124276.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 19:00:54+00:00 2018-08-21 19:00:54+00:00 DIADIADAY Days from visit date - Diagnosed Diabetes +34 Diabetes 226261 phv00226261.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:21:26+00:00 2018-08-22 21:21:26+00:00 DIABETES2 3-Level grouped diabetes - ADA +34 Diabetes 226262 phv00226262.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:21:43+00:00 2018-08-22 21:21:43+00:00 DIABETES2_INDICATOR Diabetes indicator - ADA +34 Diabetes 116971 phv00116971.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:19:40+00:00 2018-08-24 00:19:40+00:00 D08GDM DIABETES DURING PREGNANCY. Q 4 +34 Diabetes 226357 phv00226357.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:25:04+00:00 2018-08-24 16:25:04+00:00 MHEA16 Diabetes - self (MHEA16) +34 Diabetes 226359 phv00226359.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:26:39+00:00 2018-08-24 16:26:39+00:00 MHEA16B Diabetes - pregnancy self (MHEA16B) +34 Diabetes 258040 phv00258040.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:55:20+00:00 2018-08-24 16:55:20+00:00 DIABETES_LAB 3-Level grouped diabetes - Lab +34 Diabetes 258041 phv00258041.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:55:30+00:00 2018-08-24 16:55:30+00:00 DIABETES_SELF Diabetes - self report only +34 Diabetes 252998 phv00252998.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:15:27+00:00 2018-08-24 17:15:27+00:00 t2diabetes_baseline Has Type 2 diabetes based on medication, self-report, fasting glucose at baseline visit +34 Diabetes 118385 phv00118385.v2.p2 pht001759.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:42:21+00:00 2018-08-28 22:42:21+00:00 E05DIAB EVER BEEN TOLD YOU ARE DIABETIC? Q 14 +34 Diabetes 118446 phv00118446.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:45:46+00:00 2018-08-28 22:45:46+00:00 E08DIBAG AGE DIAGNOSED-DIABETES. Q 4 +34 Diabetes 119819 phv00119819.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:10:01+00:00 2018-08-29 21:10:01+00:00 F08DIBAG AGE DIAGNOSED-DIABETES. Q 4 +34 Diabetes 121271 phv00121271.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:26:11+00:00 2018-08-30 00:26:11+00:00 Y01DIBEP ENDPT - DIABETES MELLITUS +34 Diabetes 121363 phv00121363.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:32:29+00:00 2018-08-30 00:32:29+00:00 Y01DMTYP TYPE OF DIABETES MELLITUS +34 Diabetes 121354 phv00121354.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:33:11+00:00 2018-08-30 00:33:11+00:00 Y01DIAB DIABETES MELLITUS +34 Diabetes 121467 phv00121467.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:47:34+00:00 2018-08-30 19:47:34+00:00 Y00DIAB DISCHG DIAG - DIABETES MELLITUS +34 Diabetes 121487 phv00121487.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:49:01+00:00 2018-08-30 19:49:01+00:00 Y01DIBEP ENDPT - DIABETES MELLITUS +34 Diabetes 121582 phv00121582.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:53:51+00:00 2018-08-30 19:53:51+00:00 Y01DMTYP TYPE OF DIABETES MELLITUS +34 Diabetes 121573 phv00121573.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:54:35+00:00 2018-08-30 19:54:35+00:00 Y01DIAB DIABETES MELLITUS +34 Diabetes 258758 phv00258758.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:01:46+00:00 2018-09-06 13:01:46+00:00 Diabetes_Status Diabetes Status (based on venous blood sample ONLY) +34 Diabetes 258759 phv00258759.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:02:19+00:00 2018-09-06 13:02:19+00:00 Diabetes_Binary Diabetes Status (based on venous blood sample and questionnaire data) +34 Diabetes 258760 phv00258760.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:02:51+00:00 2018-09-06 13:02:51+00:00 Diabetes_diagnosis Have you ever been diagnosed with diabetes? (Based on questionnaire) +34 Diabetes 258761 phv00258761.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:03:08+00:00 2018-09-06 13:03:08+00:00 Diabetes_diagnosis_years How many years ago were you diagnosed with diabetes? +34 Diabetes 259390 phv00259390.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:43:07+00:00 2018-12-20 19:43:07+00:00 dmind Treated diabetes milletus at index date +35 Atrial fibrillation/flutter 82701 phv00082701.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:20:04+00:00 2018-04-24 02:20:04+00:00 ecgafib1 ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 82843 phv00082843.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:20:22+00:00 2018-04-24 02:20:22+00:00 afib1c ECG ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 84553 phv00084553.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:20:28+00:00 2018-04-24 02:20:28+00:00 afib1c ATRIAL FIBRILLATION / FLUTTER BY NOVACODE +35 Atrial fibrillation/flutter 174570 phv00174570.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:20:36+00:00 2018-04-24 02:20:36+00:00 major61 MAJOR ABNORMALITY 6 PER MINNESOTA CODE: ATRIAL FIBRILLATION OR FLUTTER +35 Atrial fibrillation/flutter 174578 phv00174578.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:20:49+00:00 2018-04-24 02:20:49+00:00 major10b1 MAJOR ABNORMALITY 10B: ATRIAL FLUTTER OR INTERMITTENT ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 87141 phv00087141.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:20:57+00:00 2018-04-24 02:20:57+00:00 scrafibf CURRENT ATRIAL FIBRILLATION OR A FIBRILLATING HEART +35 Atrial fibrillation/flutter 90303 phv00090303.v5.p3 pht001217.v5.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:21:05+00:00 2018-04-24 02:21:05+00:00 afib ATRIAL FIBRILLATION DIAGNOSIS +35 Atrial fibrillation/flutter 90304 phv00090304.v5.p3 pht001217.v5.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:21:15+00:00 2018-04-24 02:21:15+00:00 afibtt ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS) +35 Atrial fibrillation/flutter 90305 phv00090305.v5.p3 pht001217.v5.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:21:24+00:00 2018-04-24 02:21:24+00:00 afibcd ATRIAL FIBRILLATION CODE +35 Atrial fibrillation/flutter 90306 phv00090306.v5.p3 pht001217.v5.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:21:30+00:00 2018-04-24 02:21:30+00:00 afiblbl ATRIAL FIBRILLATION CODE DESCRIPTION +35 Atrial fibrillation/flutter 174900 phv00174900.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:21:37+00:00 2018-04-24 02:21:37+00:00 ncs055 ATRIAL FIBRILLATION OR FLUTTER, BY SOFTWARE +35 Atrial fibrillation/flutter 174911 phv00174911.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:21:42+00:00 2018-04-24 02:21:42+00:00 ncvf055 ATRIAL FIBRILLATION OR FLUTTER, BY VISUAL FLAG +35 Atrial fibrillation/flutter 174922 phv00174922.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:21:50+00:00 2018-04-24 02:21:50+00:00 ncvf155 ATRIAL FLUTTER OR FIBRILLATION, BY VISUAL FLAG +35 Atrial fibrillation/flutter 175081 phv00175081.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:21:56+00:00 2018-04-24 02:21:56+00:00 major65 ATRIAL FIBRILLATION OR FLUTTER +35 Atrial fibrillation/flutter 175089 phv00175089.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:22:08+00:00 2018-04-24 02:22:08+00:00 major10b5 ATRIAL FLUTTER/INTERMITTENT ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 175125 phv00175125.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:22:13+00:00 2018-04-24 02:22:13+00:00 afib5c ECG ATRIAL FIBRILLATION / FLUTTER +35 Atrial fibrillation/flutter 176281 phv00176281.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:22:23+00:00 2018-04-24 02:22:23+00:00 prafib5 PRESENCE OF: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 176292 phv00176292.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:22:29+00:00 2018-04-24 02:22:29+00:00 ecgafib5 CONFIRMED: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 176323 phv00176323.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:22:36+00:00 2018-04-24 02:22:36+00:00 ncs055 ATRIAL FIBRILLATION OR FLUTTER, BY SOFTWARE +35 Atrial fibrillation/flutter 176334 phv00176334.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:22:42+00:00 2018-04-24 02:22:42+00:00 ncvf055 ATRIAL FIBRILLATION OR FLUTTER, BY VISUAL FLAG +35 Atrial fibrillation/flutter 176345 phv00176345.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:22:50+00:00 2018-04-24 02:22:50+00:00 ncvf155 ATRIAL FLUTTER OR FIBRILLATION, BY VISUAL FLAG +35 Atrial fibrillation/flutter 176504 phv00176504.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:22:54+00:00 2018-04-24 02:22:54+00:00 major65 ATRIAL FIBRILLATION OR FLUTTER +35 Atrial fibrillation/flutter 176512 phv00176512.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:23:18+00:00 2018-04-24 02:23:18+00:00 major10b5 ATRIAL FLUTTER/INTERMITTENT ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 176548 phv00176548.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:23:23+00:00 2018-04-24 02:23:23+00:00 afib5c ECG ATRIAL FIBRILLATION / FLUTTER +35 Atrial fibrillation/flutter 82703 phv00082703.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:35:36+00:00 2018-04-24 02:35:36+00:00 ecgaflt1 ATRIAL FLUTTER +35 Atrial fibrillation/flutter 176283 phv00176283.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:35:44+00:00 2018-04-24 02:35:44+00:00 praflt5 PRESENCE OF: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 176294 phv00176294.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:35:52+00:00 2018-04-24 02:35:52+00:00 ecgaflt5 CONFIRMED: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 202989 phv00202989.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:35:52+00:00 2018-04-24 15:35:52+00:00 AFUcomp12_L [General health]. Has a doctor ever said that you had an irregular heart beat called atrial fibrillation, or atrial fibrillation on a heart scan or electrocardiogram tracing? [Annual Follow-up Questionnaire Form, AFUL] +35 Atrial fibrillation/flutter 203032 phv00203032.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:36:20+00:00 2018-04-24 15:36:20+00:00 AFUcomp12_M [General health]. Since we last contacted you has a doctor said that you had an irregular heart beat called atrial fibrillation, or atrial fibrillation on a heart scan or electrocardiogram tracing? [Annual Follow-up Questionnaire Form, AFUM] +35 Atrial fibrillation/flutter 203303 phv00203303.v1.p1 pht004037.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:36:41+00:00 2018-04-24 15:36:41+00:00 AF Atrial fibrillation [Atrial Fibrillation, exam 1] +35 Atrial fibrillation/flutter 203304 phv00203304.v1.p1 pht004037.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:37:00+00:00 2018-04-24 15:37:00+00:00 AFL Atrial flutter [Atrial Fibrillation, exam 1] +35 Atrial fibrillation/flutter 203306 phv00203306.v1.p1 pht004038.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:37:21+00:00 2018-04-24 15:37:21+00:00 AF Atrial fibrillation [Atrial Fibrillation, exam 2] +35 Atrial fibrillation/flutter 203307 phv00203307.v1.p1 pht004038.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:37:41+00:00 2018-04-24 15:37:41+00:00 AFL Atrial flutter [Atrial Fibrillation, exam 2] +35 Atrial fibrillation/flutter 203309 phv00203309.v1.p1 pht004039.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:37:58+00:00 2018-04-24 15:37:58+00:00 AF Atrial fibrillation [Atrial Fibrillation, exam 3] +35 Atrial fibrillation/flutter 203310 phv00203310.v1.p1 pht004039.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:38:16+00:00 2018-04-24 15:38:16+00:00 AFL Atrial flutter [Atrial Fibrillation, exam 3] +35 Atrial fibrillation/flutter 203312 phv00203312.v1.p1 pht004040.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:38:38+00:00 2018-04-24 15:38:38+00:00 AF Atrial fibrillation [Atrial Fibrillation, exam 4] +35 Atrial fibrillation/flutter 203313 phv00203313.v1.p1 pht004040.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:38:59+00:00 2018-04-24 15:38:59+00:00 AFL Atrial flutter [Atrial Fibrillation, exam 4] +35 Atrial fibrillation/flutter 204377 phv00204377.v1.p1 pht004058.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:41:19+00:00 2018-04-24 15:41:19+00:00 I_COTHER Censoring date for follow up time of cohort participants for all types of events (including atrial fibrillation/ atrial flutter events) [Cohort Surveillance CHD Occurrence Data Dictionary] +35 Atrial fibrillation/flutter 204463 phv00204463.v1.p1 pht004061.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:41:45+00:00 2018-04-24 15:41:45+00:00 STRC29C [Hospital information]. Are any of the following conditions documented as having been present within four weeks prior to or during this hospitalization? Atrial fibrillation. Q29c [Cohort Stroke Abstraction Form] +35 Atrial fibrillation/flutter 206790 phv00206790.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:42:52+00:00 2018-04-24 15:42:52+00:00 HFAA11B1 [Medical history]. Q11b1- Arrhythmia: atrial fibrillation/atrial flutter [Heart Failure Hospital Record Abstraction Form, HFA] +35 Atrial fibrillation/flutter 206843 phv00206843.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:43:18+00:00 2018-04-24 15:43:18+00:00 HFAA26C [Physical exam and symptoms - findings]. Did the patient have any of the following CARDIOVASCULAR signs or symptoms? (Anytime during hospitalization) Q26c - Atrial Fibrillation / Atrial Flutter (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +35 Atrial fibrillation/flutter 207019 phv00207019.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:43:49+00:00 2018-04-24 15:43:49+00:00 HFAA16K [Medical history]. Q16k - Precipitating factor: atrial fibrillation/flutter (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +35 Atrial fibrillation/flutter 207561 phv00207561.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:44:07+00:00 2018-04-24 15:44:07+00:00 AFECGV1 Prevalent atrial fibrillation at visit 1 +35 Atrial fibrillation/flutter 207563 phv00207563.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:44:41+00:00 2018-04-24 15:44:41+00:00 AFDTHBY05 Fatal atrial fibrillation event by 31DECYY as indicated by death certificate +35 Atrial fibrillation/flutter 207564 phv00207564.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:45:06+00:00 2018-04-24 15:45:06+00:00 AFECGBY05 Incident atrial fibrillation event at visit 2, 3, or 4 +35 Atrial fibrillation/flutter 207565 phv00207565.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:45:25+00:00 2018-04-24 15:45:25+00:00 FT05AFECG Follow-up time (in days) for an incident atrial fibrillation event at visit 2, 3, or 4 +35 Atrial fibrillation/flutter 207566 phv00207566.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:45:51+00:00 2018-04-24 15:45:51+00:00 AFHOSP1BY05 Incident atrial fibrillation event as determined by hospital discharge codes on the cohort eligibility form (CEL) +35 Atrial fibrillation/flutter 207568 phv00207568.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:46:11+00:00 2018-04-24 15:46:11+00:00 AFINCBY05 Incident atrial fibrillation event as determined by any source by 31DECYY. +35 Atrial fibrillation/flutter 207569 phv00207569.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:46:39+00:00 2018-04-24 15:46:39+00:00 FT05AFINC Follow-up time (in days) for an incident atrial fibrillation event as determined by hospital discharge codes on the cohort eligibility form (CEL) +35 Atrial fibrillation/flutter 215644 phv00215644.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:47:00+00:00 2018-04-24 15:47:00+00:00 V1ECG22 Atrial fibrillation flag [ECG data, exam 1] +35 Atrial fibrillation/flutter 215654 phv00215654.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:47:20+00:00 2018-04-24 15:47:20+00:00 V1ECG34 Atrial fibrillation or flutter, by visual flag [ECG data, exam 1] +35 Atrial fibrillation/flutter 215662 phv00215662.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:47:39+00:00 2018-04-24 15:47:39+00:00 V1ECG42 Atrial flutter rr fibrillation, by visual flag [ECG data, exam 1] +35 Atrial fibrillation/flutter 215702 phv00215702.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:48:17+00:00 2018-04-24 15:48:17+00:00 V1ECG82 Atrial fibrillation/flutter; by visual flag [ECG data, exam 1] +35 Atrial fibrillation/flutter 215721 phv00215721.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:48:37+00:00 2018-04-24 15:48:37+00:00 V1ECG101 Atrial fibrillation [ECG data, exam 1] +35 Atrial fibrillation/flutter 216061 phv00216061.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:48:56+00:00 2018-04-24 15:48:56+00:00 V2ECG22 Atrial fibrillation flag [ECG data, exam 2] +35 Atrial fibrillation/flutter 216071 phv00216071.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:49:12+00:00 2018-04-24 15:49:12+00:00 V2ECG34 Atrial fibrillation or flutter, by visual flag [ECG data, exam 2] +35 Atrial fibrillation/flutter 216079 phv00216079.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:49:27+00:00 2018-04-24 15:49:27+00:00 V2ECG42 Atrial flutter rr fibrillation, by visual flag [ECG data, exam 2] +35 Atrial fibrillation/flutter 216119 phv00216119.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:49:52+00:00 2018-04-24 15:49:52+00:00 V2ECG82 Atrial fibrillation/flutter; by visual flag [ECG data, exam 2] +35 Atrial fibrillation/flutter 216138 phv00216138.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:50:11+00:00 2018-04-24 15:50:11+00:00 V2ECG101 Atrial fibrillation [ECG data, exam 2] +35 Atrial fibrillation/flutter 216478 phv00216478.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:50:28+00:00 2018-04-24 15:50:28+00:00 V3ECG22 Atrial fibrillation flag [ECG data, exam 3] +35 Atrial fibrillation/flutter 216488 phv00216488.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:50:47+00:00 2018-04-24 15:50:47+00:00 V3ECG34 Atrial fibrillation or flutter, by visual flag [ECG data, exam 3] +35 Atrial fibrillation/flutter 216496 phv00216496.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:51:04+00:00 2018-04-24 15:51:04+00:00 V3ECG42 Atrial flutter rr fibrillation, by visual flag [ECG data, exam 3] +35 Atrial fibrillation/flutter 216536 phv00216536.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:51:22+00:00 2018-04-24 15:51:22+00:00 V3ECG82 Atrial fibrillation/flutter; by visual flag [ECG data, exam 3] +35 Atrial fibrillation/flutter 216555 phv00216555.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:51:40+00:00 2018-04-24 15:51:40+00:00 V3ECG101 Atrial fibrillation [ECG data, exam 3] +35 Atrial fibrillation/flutter 216895 phv00216895.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:51:55+00:00 2018-04-24 15:51:55+00:00 V4ECG22 Atrial fibrillation flag [ECG data, exam 4] +35 Atrial fibrillation/flutter 216913 phv00216913.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:52:26+00:00 2018-04-24 15:52:26+00:00 V4ECG42 Atrial flutter rr fibrillation, by visual flag [ECG data, exam 4] +35 Atrial fibrillation/flutter 216953 phv00216953.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:52:46+00:00 2018-04-24 15:52:46+00:00 V4ECG82 Atrial fibrillation/flutter; by visual flag [ECG data, exam 4] +35 Atrial fibrillation/flutter 216972 phv00216972.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:53:07+00:00 2018-04-24 15:53:07+00:00 V4ECG101 Atrial fibrillation [ECG data, exam 4] +35 Atrial fibrillation/flutter 207570 phv00207570.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:02:08+00:00 2018-04-24 16:02:08+00:00 AFLINCBY05 Incident atrial flutter event as determined by hospital discharge codes on the cohort eligibility form (CEL) or at cohort visits 2, 3, or 4 +35 Atrial fibrillation/flutter 207571 phv00207571.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:02:39+00:00 2018-04-24 16:02:39+00:00 FT05AFLINC Follow-up time for an incident atrial flutter event as determined by hospital discharge codes on the cohort eligibility form (CEL) or at cohort visits 2, 3, or 4 +35 Atrial fibrillation/flutter 215645 phv00215645.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:03:01+00:00 2018-04-24 16:03:01+00:00 V1ECG23 Atrial flutter flag [ECG data, exam 1] +35 Atrial fibrillation/flutter 215729 phv00215729.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:04:32+00:00 2018-04-24 16:04:32+00:00 V1ECG109 Major10b: atrial flutter [ECG data, exam 1] +35 Atrial fibrillation/flutter 216062 phv00216062.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:04:58+00:00 2018-04-24 16:04:58+00:00 V2ECG23 Atrial flutter flag [ECG data, exam 2] +35 Atrial fibrillation/flutter 216146 phv00216146.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:11:57+00:00 2018-04-24 16:11:57+00:00 V2ECG109 Major10b: atrial flutter [ECG data, exam 2] +35 Atrial fibrillation/flutter 216479 phv00216479.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:14:59+00:00 2018-04-24 16:14:59+00:00 V3ECG23 Atrial flutter flag [ECG data, exam 3] +35 Atrial fibrillation/flutter 216563 phv00216563.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:15:48+00:00 2018-04-24 16:15:48+00:00 V3ECG109 Major10b: atrial flutter [ECG data, exam 3] +35 Atrial fibrillation/flutter 216896 phv00216896.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:16:18+00:00 2018-04-24 16:16:18+00:00 V4ECG23 Atrial flutter flag [ECG data, exam 4] +35 Atrial fibrillation/flutter 216905 phv00216905.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:16:50+00:00 2018-04-24 16:16:50+00:00 V4ECG34 Atrial fibrillation or flutter, by visual flag [ECG data, exam 4] +35 Atrial fibrillation/flutter 216980 phv00216980.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 16:17:43+00:00 2018-04-24 16:17:43+00:00 V4ECG109 Major10b: atrial flutter [ECG data, exam 4] +35 Atrial fibrillation/flutter 207567 phv00207567.v1.p1 pht004118.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-02 15:01:50+00:00 2018-05-02 15:01:50+00:00 FT05AFHOSP1 Follow-up time for AFHOSP1by05 +35 Atrial fibrillation/flutter 100069 phv00100069.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:02:37+00:00 2018-06-29 18:02:37+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 100324 phv00100324.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:02:47+00:00 2018-06-29 18:02:47+00:00 AFIB HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 100457 phv00100457.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:02:58+00:00 2018-06-29 18:02:58+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 100678 phv00100678.v1.p1 pht001456.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:03:09+00:00 2018-06-29 18:03:09+00:00 INCAFIB Incident AFIB from all sources +35 Atrial fibrillation/flutter 100679 phv00100679.v1.p1 pht001456.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:03:19+00:00 2018-06-29 18:03:19+00:00 TTOAFIB Time from baseline to AFIB incident +35 Atrial fibrillation/flutter 101531 phv00101531.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:03:33+00:00 2018-06-29 18:03:33+00:00 AFIB59 HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 101983 phv00101983.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:03:51+00:00 2018-06-29 18:03:51+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 102608 phv00102608.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:04:01+00:00 2018-06-29 18:04:01+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 102679 phv00102679.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:04:15+00:00 2018-06-29 18:04:15+00:00 AFIB59 HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103165 phv00103165.v1.p1 pht001476.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:04:31+00:00 2018-06-29 18:04:31+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103218 phv00103218.v1.p1 pht001477.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:04:42+00:00 2018-06-29 18:04:42+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103270 phv00103270.v1.p1 pht001478.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:04:57+00:00 2018-06-29 18:04:57+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103323 phv00103323.v1.p1 pht001479.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:05:17+00:00 2018-06-29 18:05:17+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103375 phv00103375.v1.p1 pht001480.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:05:36+00:00 2018-06-29 18:05:36+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103428 phv00103428.v1.p1 pht001481.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:05:47+00:00 2018-06-29 18:05:47+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103480 phv00103480.v1.p1 pht001482.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:05:56+00:00 2018-06-29 18:05:56+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103533 phv00103533.v1.p1 pht001483.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:06:07+00:00 2018-06-29 18:06:07+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103585 phv00103585.v1.p1 pht001484.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:06:22+00:00 2018-06-29 18:06:22+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103638 phv00103638.v1.p1 pht001485.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:06:36+00:00 2018-06-29 18:06:36+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 103690 phv00103690.v1.p1 pht001486.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:06:47+00:00 2018-06-29 18:06:47+00:00 AFIB32 TOLD BY MD YOU HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 104340 phv00104340.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:06:58+00:00 2018-06-29 18:06:58+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 104994 phv00104994.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:07:07+00:00 2018-06-29 18:07:07+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 105967 phv00105967.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:07:15+00:00 2018-06-29 18:07:15+00:00 AFIB57 HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 106361 phv00106361.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:07:24+00:00 2018-06-29 18:07:24+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 107042 phv00107042.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:07:45+00:00 2018-06-29 18:07:45+00:00 AFIB29 HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 107300 phv00107300.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:08:00+00:00 2018-06-29 18:08:00+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 107949 phv00107949.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:08:08+00:00 2018-06-29 18:08:08+00:00 AFIB59 HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 108176 phv00108176.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:08:16+00:00 2018-06-29 18:08:16+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 108623 phv00108623.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:08:31+00:00 2018-06-29 18:08:31+00:00 AFIB59 HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 108798 phv00108798.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:08:42+00:00 2018-06-29 18:08:42+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 109328 phv00109328.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:08:56+00:00 2018-06-29 18:08:56+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 109390 phv00109390.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:09:09+00:00 2018-06-29 18:09:09+00:00 AFIB59 HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 109876 phv00109876.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:09:20+00:00 2018-06-29 18:09:20+00:00 ECGAFIB ATRIAL FIB BY ECG +35 Atrial fibrillation/flutter 110052 phv00110052.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:09:31+00:00 2018-06-29 18:09:31+00:00 AFIB59 HAD ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 197352 phv00197352.v1.p1 pht003697.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:09:42+00:00 2018-06-29 18:09:42+00:00 AFIB A-fib/flutter +35 Atrial fibrillation/flutter 197387 phv00197387.v1.p1 pht003698.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:09:57+00:00 2018-06-29 18:09:57+00:00 afib A-fib/flutter +35 Atrial fibrillation/flutter 78538 phv00078538.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 18:39:47+00:00 2018-06-29 18:39:47+00:00 ATRIALFB Atrial fibrillation ever +35 Atrial fibrillation/flutter 193727 phv00193727.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 18:42:14+00:00 2018-06-29 18:42:14+00:00 F33AFIBHSP F33 Hospitalized Atrial Fibrillation +35 Atrial fibrillation/flutter 193154 phv00193154.v3.p3 pht003407.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 18:44:25+00:00 2018-06-29 18:44:25+00:00 AFIBR Atrial Fibrillation +35 Atrial fibrillation/flutter 77763 phv00077763.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 21:59:05+00:00 2018-06-29 21:59:05+00:00 ATRIALFB_4 Atrial fibrillation +35 Atrial fibrillation/flutter 77873 phv00077873.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:00:18+00:00 2018-06-29 22:00:18+00:00 ATRIALFB_5 Atrial fibrillation +35 Atrial fibrillation/flutter 77638 phv00077638.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:01:44+00:00 2018-06-29 22:01:44+00:00 ATRIALFB_3 Atrial fibrillation +35 Atrial fibrillation/flutter 78037 phv00078037.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:01:44+00:00 2018-06-29 22:01:44+00:00 ATRIALFB_6 Atrial fibrillation +35 Atrial fibrillation/flutter 78177 phv00078177.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:01:44+00:00 2018-06-29 22:01:44+00:00 ATRIALFB_7 Atrial fibrillation +35 Atrial fibrillation/flutter 78318 phv00078318.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:01:44+00:00 2018-06-29 22:01:44+00:00 ATRIALFB_8 Atrial fibrillation +35 Atrial fibrillation/flutter 193051 phv00193051.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:04:08+00:00 2018-06-29 22:04:08+00:00 AFIBR Atrial Fibrillation +35 Atrial fibrillation/flutter 283695 phv00283695.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:06:44+00:00 2018-06-29 22:06:44+00:00 AFIB F136 Atrial fibrillation +35 Atrial fibrillation/flutter 193729 phv00193729.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:09:32+00:00 2018-06-29 22:09:32+00:00 F33AFIBOP F33 Outpatient Atrial Fibrillation +35 Atrial fibrillation/flutter 154931 phv00154931.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:37:50+00:00 2018-06-29 22:37:50+00:00 ATR_FLUT Atrial flutter +35 Atrial fibrillation/flutter 154930 phv00154930.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:38:06+00:00 2018-06-29 22:38:06+00:00 ATR_FIBR Atrial fibrillation +35 Atrial fibrillation/flutter 7660 phv00007660.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:37:57+00:00 2018-07-03 18:37:57+00:00 A158 ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 71976 phv00071976.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:38:13+00:00 2018-07-03 18:38:13+00:00 afib_s1 Atrial fibrillation/flutter for first sleep study Collection Interval: 1998-2003 +35 Atrial fibrillation/flutter 71993 phv00071993.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:38:22+00:00 2018-07-03 18:38:22+00:00 afib_s2 Atrial fibrillation/flutter for second sleep study Collection Interval: 1998-2003 +35 Atrial fibrillation/flutter 273699 phv00273699.v1.p10 pht003315.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:38:32+00:00 2018-07-03 18:38:32+00:00 afx Atrial fibrillation/atrial flutter (AF) status +35 Atrial fibrillation/flutter 190813 phv00190813.v6.p10 pht003315.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:38:43+00:00 2018-07-03 18:38:43+00:00 afxdate Date of atrial fibrillation/atrial flutter status +35 Atrial fibrillation/flutter 7901 phv00007901.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:38:55+00:00 2018-07-03 18:38:55+00:00 B269 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 8130 phv00008130.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:39:05+00:00 2018-07-03 18:39:05+00:00 B486 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 8646 phv00008646.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:39:15+00:00 2018-07-03 18:39:15+00:00 C302 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 276820 phv00276820.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:39:27+00:00 2018-07-03 18:39:27+00:00 CHF094 ECG rhythm - Atrial Fibrillation +35 Atrial fibrillation/flutter 9042 phv00009042.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:39:38+00:00 2018-07-03 18:39:38+00:00 D306 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 1339 phv00001339.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:39:49+00:00 2018-07-03 18:39:49+00:00 FB191 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 1534 phv00001534.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:39:58+00:00 2018-07-03 18:39:58+00:00 FC200 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 1725 phv00001725.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:40:09+00:00 2018-07-03 18:40:09+00:00 FD196 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 1990 phv00001990.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:40:30+00:00 2018-07-03 18:40:30+00:00 FE277 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 2170 phv00002170.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:40:42+00:00 2018-07-03 18:40:42+00:00 FF240 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 2365 phv00002365.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:40:54+00:00 2018-07-03 18:40:54+00:00 FG248 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 2605 phv00002605.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:41:03+00:00 2018-07-03 18:41:03+00:00 FH265 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 2811 phv00002811.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:41:16+00:00 2018-07-03 18:41:16+00:00 FI176 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 2916 phv00002916.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:41:27+00:00 2018-07-03 18:41:27+00:00 FI236 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 3193 phv00003193.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:41:36+00:00 2018-07-03 18:41:36+00:00 FJ291 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 3608 phv00003608.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:41:46+00:00 2018-07-03 18:41:46+00:00 FK386 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 4014 phv00004014.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:41:56+00:00 2018-07-03 18:41:56+00:00 FL406 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 4438 phv00004438.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:42:05+00:00 2018-07-03 18:42:05+00:00 FM445 ECG: ATRIAL FIBRILLATION +35 Atrial fibrillation/flutter 4879 phv00004879.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:42:15+00:00 2018-07-03 18:42:15+00:00 FN421 ECG: ATRIAL FIBRILLATION OR ATRIAL FLUTTER +35 Atrial fibrillation/flutter 255317 phv00255317.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:42:44+00:00 2018-07-03 18:42:44+00:00 fw587 Heart Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Atrial fibrillation or atrial flutter (A-fib or AF) Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +35 Atrial fibrillation/flutter 274775 phv00274775.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:43:02+00:00 2018-07-03 18:43:02+00:00 FX097 Medical History - Atrial Fibrillation/Syncope: Have you been told you have/had a heart rhythm problem called atrial fibrillation? Collection Interval: Original Cohort Exam 31 +35 Atrial fibrillation/flutter 275042 phv00275042.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:43:20+00:00 2018-07-03 18:43:20+00:00 FX587 Heart Problems (Form B) - Since last exam or medical history update, have you seen a doctor or other healthcare provider or been hospitalized for atrial fibrillation or atrial flutter? Collection Interval: Original Cohort Exam 31 +35 Atrial fibrillation/flutter 275132 phv00275132.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:43:36+00:00 2018-07-03 18:43:36+00:00 fy097 Medical History - Atrial Fibrillation/Syncope: Have you been told you have/had a heart rhythm problem called atrial fibrillation? Collection Interval: Original Cohort Exam 32 +35 Atrial fibrillation/flutter 275376 phv00275376.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:43:51+00:00 2018-07-03 18:43:51+00:00 fy587 Heart Problems (Form B) - Since your last Framingham Heart Study exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for atrial fibrillation or atrial flutter? Collection Interval: Original Cohort Exam 32 +35 Atrial fibrillation/flutter 21037 phv00021037.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:44:18+00:00 2018-07-03 18:44:18+00:00 G3A189 HAVE YOU BEEN TOLD YOU HAVE/HAD ATRIAL FIBRILLATION? +35 Atrial fibrillation/flutter 273871 phv00273871.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:44:33+00:00 2018-07-03 18:44:33+00:00 g3a189 Have you been told you have/had atrial fibrillation? Collection Interval: Exam 1 +35 Atrial fibrillation/flutter 274364 phv00274364.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:44:47+00:00 2018-07-03 18:44:47+00:00 g3a189 Have you been told you have/had atrial fibrillation? +35 Atrial fibrillation/flutter 72165 phv00072165.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:45:12+00:00 2018-07-03 18:45:12+00:00 H136 HAVE YOU BEEN TOLD YOU HAVE/HAD A HEART RHYTHM PROBLEM CALLED ATRIAL FIBRILLATION? +35 Atrial fibrillation/flutter 7661 phv00007661.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:46:07+00:00 2018-07-03 18:46:07+00:00 A159 ATRIAL FLUTTER +35 Atrial fibrillation/flutter 7902 phv00007902.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:46:27+00:00 2018-07-03 18:46:27+00:00 B270 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 8131 phv00008131.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:46:38+00:00 2018-07-03 18:46:38+00:00 B487 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 8647 phv00008647.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:46:47+00:00 2018-07-03 18:46:47+00:00 C303 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 9043 phv00009043.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:46:57+00:00 2018-07-03 18:46:57+00:00 D307 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 1340 phv00001340.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:47:06+00:00 2018-07-03 18:47:06+00:00 FB192 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 1535 phv00001535.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:47:16+00:00 2018-07-03 18:47:16+00:00 FC201 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 1726 phv00001726.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:47:27+00:00 2018-07-03 18:47:27+00:00 FD197 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 1991 phv00001991.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:47:39+00:00 2018-07-03 18:47:39+00:00 FE278 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 2171 phv00002171.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:47:52+00:00 2018-07-03 18:47:52+00:00 FF241 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 2366 phv00002366.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:48:02+00:00 2018-07-03 18:48:02+00:00 FG249 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 2606 phv00002606.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:48:11+00:00 2018-07-03 18:48:11+00:00 FH266 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 2812 phv00002812.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:48:26+00:00 2018-07-03 18:48:26+00:00 FI177 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 2917 phv00002917.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:48:36+00:00 2018-07-03 18:48:36+00:00 FI237 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 3194 phv00003194.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:48:45+00:00 2018-07-03 18:48:45+00:00 FJ292 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 3609 phv00003609.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:48:55+00:00 2018-07-03 18:48:55+00:00 FK387 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 4015 phv00004015.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:49:12+00:00 2018-07-03 18:49:12+00:00 FL407 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 4439 phv00004439.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:49:25+00:00 2018-07-03 18:49:25+00:00 FM446 ECG: ATRIAL FLUTTER +35 Atrial fibrillation/flutter 9494 phv00009494.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:50:03+00:00 2018-07-03 18:50:03+00:00 E589 ECG: RHYTHM +35 Atrial fibrillation/flutter 250660 phv00250660.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:50:22+00:00 2018-07-03 18:50:22+00:00 e589 Electrocardiograph - Part I: Rhythm Collection Interval: Exam 1 +35 Atrial fibrillation/flutter 10008 phv00010008.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:50:36+00:00 2018-07-03 18:50:36+00:00 F584 RHYTHM +35 Atrial fibrillation/flutter 5236 phv00005236.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:50:54+00:00 2018-07-03 18:50:54+00:00 FO432 ECG: RHYTHM +35 Atrial fibrillation/flutter 5863 phv00005863.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:51:09+00:00 2018-07-03 18:51:09+00:00 FP398 ECG: RHYTHM +35 Atrial fibrillation/flutter 6220 phv00006220.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:51:19+00:00 2018-07-03 18:51:19+00:00 FQ272 ECG - RHYTHM +35 Atrial fibrillation/flutter 6615 phv00006615.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:51:29+00:00 2018-07-03 18:51:29+00:00 FR389 ECG - RHYTHM +35 Atrial fibrillation/flutter 7049 phv00007049.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:51:53+00:00 2018-07-03 18:51:53+00:00 FS488 ECG: RHYTHM +35 Atrial fibrillation/flutter 7484 phv00007484.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:52:05+00:00 2018-07-03 18:52:05+00:00 FT494 ECG: RHYTHM +35 Atrial fibrillation/flutter 70510 phv00070510.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:52:41+00:00 2018-07-03 18:52:41+00:00 FU206 ECG: RHYTHM +35 Atrial fibrillation/flutter 254719 phv00254719.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:53:02+00:00 2018-07-03 18:53:02+00:00 fv208 Electrocardiograph: Rhythm - predominant Collection Interval: Exam 29 +35 Atrial fibrillation/flutter 255109 phv00255109.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:53:13+00:00 2018-07-03 18:53:13+00:00 fw248 Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 30 +35 Atrial fibrillation/flutter 255110 phv00255110.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:53:37+00:00 2018-07-03 18:53:37+00:00 fw249 Electrocardiograph: Rhythm - predominant other or combination Collection Interval: Original Cohort Exam 30 +35 Atrial fibrillation/flutter 274834 phv00274834.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:53:51+00:00 2018-07-03 18:53:51+00:00 FX248 Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 31 +35 Atrial fibrillation/flutter 274835 phv00274835.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:54:02+00:00 2018-07-03 18:54:02+00:00 FX249 Electrocardiograph: Rhythm - predominant other or combination Collection Interval: Original Cohort Exam 31 +35 Atrial fibrillation/flutter 275192 phv00275192.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:54:15+00:00 2018-07-03 18:54:15+00:00 fy248 Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 32 +35 Atrial fibrillation/flutter 275193 phv00275193.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:54:23+00:00 2018-07-03 18:54:23+00:00 fy249 Electrocardiograph: Rhythm - predominant other or combination Collection Interval: Original Cohort Exam 32 +35 Atrial fibrillation/flutter 10441 phv00010441.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:54:49+00:00 2018-07-03 18:54:49+00:00 G362 ECG: RHYTHM PREDOMINANT +35 Atrial fibrillation/flutter 251002 phv00251002.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:55:01+00:00 2018-07-03 18:55:01+00:00 g362 Electrocardiograph - Part I: Rhythm - predominant Collection Interval: Exam 2 +35 Atrial fibrillation/flutter 21157 phv00021157.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:55:18+00:00 2018-07-03 18:55:18+00:00 G3A357 ECG: RHYTHM--PREDOMINANT +35 Atrial fibrillation/flutter 273979 phv00273979.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:55:26+00:00 2018-07-03 18:55:26+00:00 g3a357 ECG: Rhythm--predominant Collection Interval: Exam 1 +35 Atrial fibrillation/flutter 274472 phv00274472.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:55:34+00:00 2018-07-03 18:55:34+00:00 g3a357 ECG: Rhythm--predominant +35 Atrial fibrillation/flutter 72266 phv00072266.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:55:51+00:00 2018-07-03 18:55:51+00:00 H309 ECG: RHYTHM PREDOMINANT +35 Atrial fibrillation/flutter 251462 phv00251462.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:56:01+00:00 2018-07-03 18:56:01+00:00 h309 Electrocardiograph - Part I: Rhythm - predominant Collection Interval: Exam 3 +35 Atrial fibrillation/flutter 254211 phv00254211.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:56:18+00:00 2018-07-03 18:56:18+00:00 j364 Electrocardiograph-Part I: Rhythm--predominant +35 Atrial fibrillation/flutter 76370 phv00076370.v6.p10 pht000908.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:56:39+00:00 2018-07-03 18:56:39+00:00 RHYTHM Type of rhythm +35 Atrial fibrillation/flutter 253900 phv00253900.v1.p10 pht003334.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:58:13+00:00 2018-07-03 18:58:13+00:00 ECG_HR Hour of ECG (time of day) Collection Interval: Cases reviewed 1/1949 - 12/2012 +35 Atrial fibrillation/flutter 253901 phv00253901.v1.p10 pht003334.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:58:35+00:00 2018-07-03 18:58:35+00:00 ECG_MIN Minute of ECG (time of day) Collection Interval: Cases reviewed 1/1949 - 12/2012 +35 Atrial fibrillation/flutter 253904 phv00253904.v1.p10 pht003334.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:58:58+00:00 2018-07-03 18:58:58+00:00 ECGDATE Date of ECG Collection Interval: Cases reviewed 1/1949 - 12/2012 +35 Atrial fibrillation/flutter 253887 phv00253887.v1.p10 pht003334.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:59:23+00:00 2018-07-03 18:59:23+00:00 RHYTHM Type of rhythm Collection Interval: Cases reviewed 1/1949 - 12/2012 +35 Atrial fibrillation/flutter 76369 phv00076369.v6.p10 pht000908.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 19:05:39+00:00 2018-07-03 19:05:39+00:00 ECG_HR Hour of ECG (time of day) +35 Atrial fibrillation/flutter 76382 phv00076382.v6.p10 pht000908.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 19:05:51+00:00 2018-07-03 19:05:51+00:00 ECG_MIN Minute of ECG (time of day) +35 Atrial fibrillation/flutter 76387 phv00076387.v6.p10 pht000908.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 19:06:24+00:00 2018-07-03 19:06:24+00:00 ECGDATE Date of ECG +35 Atrial fibrillation/flutter 177467 phv00177467.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 19:12:16+00:00 2018-07-03 19:12:16+00:00 g3b0374 Electrocardiograph: Rhythm--predominant +35 Atrial fibrillation/flutter 226264 phv00226264.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:26:11+00:00 2018-08-22 21:26:11+00:00 ECGA109 Novacode 1.5; Atrial flutter or fibrillation, by visual flag (ECGA109) +35 Atrial fibrillation/flutter 259385 phv00259385.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:21:37+00:00 2018-09-06 13:21:37+00:00 prioraf Prior AF +36 QRS duration from EKG 205437 phv00205437.v1.p1 pht004071.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:39:27+00:00 2018-03-21 18:39:27+00:00 ECGC54 QRS interval [ECG Machine Coding (ECGC), exam 2] +36 QRS duration from EKG 205506 phv00205506.v1.p1 pht004072.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:39:42+00:00 2018-03-21 18:39:42+00:00 ECGD54 QRS interval [ECG Machine Coding (ECGD04), exam 3] +36 QRS duration from EKG 205565 phv00205565.v1.p1 pht004073.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:39:57+00:00 2018-03-21 18:39:57+00:00 ECGE54 QRS interval [ECG Machine Coding (ECGE04), exam 4] +36 QRS duration from EKG 205595 phv00205595.v1.p1 pht004074.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:40:12+00:00 2018-03-21 18:40:12+00:00 ECGMA54 QRS interval [ECG Composite 12 Lead (with adjudications as needed) (ECGMA03), exam 1] +36 QRS duration from EKG 205649 phv00205649.v1.p1 pht004075.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:40:26+00:00 2018-03-21 18:40:26+00:00 ECGMB54 QRS interval [Cohort, Exam 2] +36 QRS duration from EKG 205723 phv00205723.v1.p1 pht004076.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:40:40+00:00 2018-03-21 18:40:40+00:00 ECGMC54 QRS interval [ECG Composite 12 Lead (with adjudications as needed) (ECGMC35), exam 3] +36 QRS duration from EKG 205780 phv00205780.v1.p1 pht004077.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:40:58+00:00 2018-03-21 18:40:58+00:00 ECGMD54 QRS interval [ECG Composite 12 Lead (with adjudications as needed) (ECGMD41), exam 4] +36 QRS duration from EKG 205843 phv00205843.v1.p1 pht004078.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 18:41:35+00:00 2018-03-21 18:41:35+00:00 ECGB54 QRS interval [ECG Machine Coding, exam 1] +36 QRS duration from EKG 215632 phv00215632.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 19:56:25+00:00 2018-03-21 19:56:25+00:00 V1ECG8 QRS duration [ECG data, exam 1] +36 QRS duration from EKG 216049 phv00216049.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 19:56:55+00:00 2018-03-21 19:56:55+00:00 V2ECG8 QRS duration [ECG data, exam 2] +36 QRS duration from EKG 216466 phv00216466.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 19:57:09+00:00 2018-03-21 19:57:09+00:00 V3ECG8 QRS duration [ECG data, exam 3] +36 QRS duration from EKG 216883 phv00216883.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 19:57:22+00:00 2018-03-21 19:57:22+00:00 V4ECG8 QRS duration [ECG data, exam 4] +36 QRS duration from EKG 127162 phv00127162.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-23 18:57:21+00:00 2018-04-23 18:57:21+00:00 ecga43 QRSDUR - QRS Duration +36 QRS duration from EKG 159098 phv00159098.v2.p3 pht002195.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:38:49+00:00 2018-04-24 02:38:49+00:00 qrsdur1 QRS Duration +36 QRS duration from EKG 82715 phv00082715.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:40:59+00:00 2018-04-24 02:40:59+00:00 qrsdur1 QRS INTERVAL (msec) +36 QRS duration from EKG 84567 phv00084567.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:41:10+00:00 2018-04-24 02:41:10+00:00 qrsdur1 QRS INTERVAL (MSEC) +36 QRS duration from EKG 174885 phv00174885.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:46:54+00:00 2018-04-24 02:46:54+00:00 qrsdur5 QRS INTERVAL (MSEC) +36 QRS duration from EKG 176308 phv00176308.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 02:47:03+00:00 2018-04-24 02:47:03+00:00 qrsdur5 QRS INTERVAL (MSEC) +36 QRS duration from EKG 250999 phv00250999.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:34:02+00:00 2018-06-15 17:34:02+00:00 g359 Electrocardiograph - Part I - Rates and Intervals: QRS interval Collection Interval: Exam 2 +36 QRS duration from EKG 250657 phv00250657.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:37:22+00:00 2018-06-15 17:37:22+00:00 e586 Electrocardiograph - Part I: Rates and Intervals: QRS interval Collection Interval: Exam 1 +36 QRS duration from EKG 251459 phv00251459.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:38:02+00:00 2018-06-15 17:38:02+00:00 h306 Electrocardiograph - Part I: Rates and Intervals: QRS interval Collection Interval: Exam 3 +36 QRS duration from EKG 177464 phv00177464.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:43:48+00:00 2018-06-15 17:43:48+00:00 g3b0371 Electrocardiograph: Rates and Intervals: QRS interval +36 QRS duration from EKG 254208 phv00254208.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:46:02+00:00 2018-06-15 17:46:02+00:00 j361 Electrocardiograph-Part I: Rates and Intervals: QRS interval +36 QRS duration from EKG 254716 phv00254716.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:55:19+00:00 2018-06-15 17:55:19+00:00 fv205 Electrocardiograph: Rates and Intervals: QRS interval Collection Interval: Exam 29 +36 QRS duration from EKG 255106 phv00255106.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:08:10+00:00 2018-06-15 18:08:10+00:00 fw245 Electrocardiograph: Rates and Intervals: QRS Interval (milliseconds) Collection Interval: Original Cohort Exam 30 +36 QRS duration from EKG 274831 phv00274831.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:11:09+00:00 2018-06-15 18:11:09+00:00 FX245 Electrocardiograph: Rates and Intervals: QRS Interval (milliseconds) Collection Interval: Original Cohort Exam 31 +36 QRS duration from EKG 275189 phv00275189.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:15:44+00:00 2018-06-15 18:15:44+00:00 fy245 Electrocardiograph: Rates and Intervals: QRS Interval (milliseconds) Collection Interval: Original Cohort Exam 32 +36 QRS duration from EKG 36361 phv00036361.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:20:51+00:00 2018-06-15 18:20:51+00:00 DIGECG_QRS1 QRS INTERVAL CYCLE 1 LEAD II (MS)(INTERVAL FROM QRS ONSET TO QRS OFFSET) +36 QRS duration from EKG 36362 phv00036362.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:21:27+00:00 2018-06-15 18:21:27+00:00 DIGECG_QRS2 QRS INTERVAL CYCLE 2 LEAD II (MS) (INTERVAL FROM QRS ONSET TO QRS OFFSET) +36 QRS duration from EKG 36363 phv00036363.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:21:44+00:00 2018-06-15 18:21:44+00:00 DIGECG_QRS3 QRS INTERVAL CYCLE 1 LEAD V2 (MS) (INTERVAL FROM QRS ONSET TO QRS OFFSET), DONE ON GEN 3 ONLY +36 QRS duration from EKG 36364 phv00036364.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:22:03+00:00 2018-06-15 18:22:03+00:00 DIGECG_QRS4 QRS INTERVAL CYCLE 1 LEAD V5 (MS) (INTERVAL FROM QRS ONSET TO QRS OFFSET), DONE ON GEN 3 ONLY +36 QRS duration from EKG 23257 phv00023257.v5.p10 pht000149.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:37:44+00:00 2018-06-15 18:37:44+00:00 DG7 QRS INTERVAL +36 QRS duration from EKG 7649 phv00007649.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:39:23+00:00 2018-06-15 18:39:23+00:00 A147 QRS INTERVAL +36 QRS duration from EKG 10005 phv00010005.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:40:49+00:00 2018-06-15 18:40:49+00:00 F581 QRS INTERVAL (HUNDREDTHS OF A SECOND) +36 QRS duration from EKG 7889 phv00007889.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:18:26+00:00 2018-06-19 13:18:26+00:00 B257 ECG: QRS INTERVAL +36 QRS duration from EKG 8635 phv00008635.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:18:34+00:00 2018-06-19 13:18:34+00:00 C291 ECG: QRS INTERVAL +36 QRS duration from EKG 9031 phv00009031.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:18:44+00:00 2018-06-19 13:18:44+00:00 D294 ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 9491 phv00009491.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:18:52+00:00 2018-06-19 13:18:52+00:00 E586 ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 1174 phv00001174.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:19:00+00:00 2018-06-19 13:19:00+00:00 FA174 ECG: QRS INTERVAL +36 QRS duration from EKG 1526 phv00001526.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:19:08+00:00 2018-06-19 13:19:08+00:00 FC192 ECG: QRS INTERVAL +36 QRS duration from EKG 1717 phv00001717.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:19:17+00:00 2018-06-19 13:19:17+00:00 FD188 ECG: QRS INTERVAL +36 QRS duration from EKG 1978 phv00001978.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:19:26+00:00 2018-06-19 13:19:26+00:00 FE265 ECG: QRS INTERVAL +36 QRS duration from EKG 2158 phv00002158.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:19:35+00:00 2018-06-19 13:19:35+00:00 FF228 ECG: QRS INTERVAL +36 QRS duration from EKG 2353 phv00002353.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:19:44+00:00 2018-06-19 13:19:44+00:00 FG236 ECG: QRS INTERVAL +36 QRS duration from EKG 2593 phv00002593.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:19:53+00:00 2018-06-19 13:19:53+00:00 FH253 ECG: QRS INTERVAL +36 QRS duration from EKG 2801 phv00002801.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:20:02+00:00 2018-06-19 13:20:02+00:00 FI166 ECG: QRS INTERVAL +36 QRS duration from EKG 3180 phv00003180.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:20:12+00:00 2018-06-19 13:20:12+00:00 FJ278 ECG: QRS INTERVAL +36 QRS duration from EKG 3595 phv00003595.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:20:20+00:00 2018-06-19 13:20:20+00:00 FK373 ECG: QRS INTERVAL +36 QRS duration from EKG 4003 phv00004003.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:20:28+00:00 2018-06-19 13:20:28+00:00 FL394 ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 4427 phv00004427.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:20:37+00:00 2018-06-19 13:20:37+00:00 FM433 ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 4869 phv00004869.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:20:45+00:00 2018-06-19 13:20:45+00:00 FN410 ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 5233 phv00005233.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:20:55+00:00 2018-06-19 13:20:55+00:00 FO429 ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 5860 phv00005860.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:21:04+00:00 2018-06-19 13:21:04+00:00 FP395 ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 6217 phv00006217.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:21:15+00:00 2018-06-19 13:21:15+00:00 FQ269 ECG - QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 6219 phv00006219.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:21:25+00:00 2018-06-19 13:21:25+00:00 FQ271 ECG - QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 6612 phv00006612.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:21:42+00:00 2018-06-19 13:21:42+00:00 FR386 ECG - QRS INTERVAL (HUNDREDTHS OF A SECOND) +36 QRS duration from EKG 7046 phv00007046.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:22:05+00:00 2018-06-19 13:22:05+00:00 FS485 ECG: QRS INTERVAL (HUNDREDTHS OF A SECOND) +36 QRS duration from EKG 7481 phv00007481.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:23:04+00:00 2018-06-19 13:23:04+00:00 FT491 ECG RATES AND INTERVALS: QRS INTERVAL (HUNDREDTHS OF A SECOND) +36 QRS duration from EKG 70507 phv00070507.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:23:31+00:00 2018-06-19 13:23:31+00:00 FU203 ECG RATES AND INTERVALS: QRS INTERVAL (HUNDREDTHS OF A SECOND) +36 QRS duration from EKG 10438 phv00010438.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:23:48+00:00 2018-06-19 13:23:48+00:00 G359 ECG: QRS INTERVAL (HUNDREDTHS OF A SECOND) +36 QRS duration from EKG 21154 phv00021154.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:24:02+00:00 2018-06-19 13:24:02+00:00 G3A354 ECG: QRS INTERVAL (HUNDREDTHS OF A SECOND) +36 QRS duration from EKG 273976 phv00273976.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:24:10+00:00 2018-06-19 13:24:10+00:00 g3a354 ECG: QRS interval Collection Interval: Exam 1 +36 QRS duration from EKG 274469 phv00274469.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:24:18+00:00 2018-06-19 13:24:18+00:00 g3a354 ECG: QRS interval +36 QRS duration from EKG 72263 phv00072263.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:24:41+00:00 2018-06-19 13:24:41+00:00 H306 ECG: QRS INTERVAL (HUNDREDTHS OF SECOND) +36 QRS duration from EKG 1331 phv00001331.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:33:32+00:00 2018-06-19 13:33:32+00:00 FB183 ECG: ORS INTERVAL +36 QRS duration from EKG 127128 phv00127128.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:42:39+00:00 2018-06-20 01:42:39+00:00 QRSduration QRSduration +36 QRS duration from EKG 127421 phv00127421.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:25:46+00:00 2018-06-20 13:25:46+00:00 ecga302 QRSDI - QRS Duration in lead I +36 QRS duration from EKG 127422 phv00127422.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:26:03+00:00 2018-06-20 13:26:03+00:00 ecga303 QRSDII - QRS Duration in lead II +36 QRS duration from EKG 127423 phv00127423.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:26:15+00:00 2018-06-20 13:26:15+00:00 ecga304 QRSDIII - QRS Duration in lead III +36 QRS duration from EKG 127424 phv00127424.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:26:28+00:00 2018-06-20 13:26:28+00:00 ecga305 QRSDAVR - QRS Duration in lead AVR +36 QRS duration from EKG 127425 phv00127425.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:26:56+00:00 2018-06-20 13:26:56+00:00 ecga306 QRSDAVL - QRS Duration in lead AVL +36 QRS duration from EKG 127426 phv00127426.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:27:16+00:00 2018-06-20 13:27:16+00:00 ecga307 QRSDAVF - QRS Duration in lead AVF +36 QRS duration from EKG 127427 phv00127427.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:27:31+00:00 2018-06-20 13:27:31+00:00 ecga308 QRSDV1 - QRS Duration in lead V1 +36 QRS duration from EKG 127428 phv00127428.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:27:51+00:00 2018-06-20 13:27:51+00:00 ecga309 QRSDV2 - QRS Duration in lead V2 +36 QRS duration from EKG 127429 phv00127429.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:28:08+00:00 2018-06-20 13:28:08+00:00 ecga310 QRSDV3 - QRS Duration in lead V3 +36 QRS duration from EKG 127430 phv00127430.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:28:19+00:00 2018-06-20 13:28:19+00:00 ecga311 QRSDV4 - QRS Duration in lead V4 +36 QRS duration from EKG 127431 phv00127431.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:28:31+00:00 2018-06-20 13:28:31+00:00 ecga312 QRSDV5 - QRS Duration in lead V5 +36 QRS duration from EKG 127432 phv00127432.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:28:44+00:00 2018-06-20 13:28:44+00:00 ecga313 QRSDV6 - QRS Duration in lead V6 +36 QRS duration from EKG 100061 phv00100061.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:26:52+00:00 2018-06-29 18:26:52+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 100451 phv00100451.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:27:04+00:00 2018-06-29 18:27:04+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 101976 phv00101976.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:28:28+00:00 2018-06-29 18:28:28+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 102977 phv00102977.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:29:15+00:00 2018-06-29 18:29:15+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 104332 phv00104332.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:29:28+00:00 2018-06-29 18:29:28+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 104986 phv00104986.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:30:00+00:00 2018-06-29 18:30:00+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 106353 phv00106353.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:30:24+00:00 2018-06-29 18:30:24+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 107292 phv00107292.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:30:47+00:00 2018-06-29 18:30:47+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 108168 phv00108168.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:31:10+00:00 2018-06-29 18:31:10+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 108791 phv00108791.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:31:31+00:00 2018-06-29 18:31:31+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 109322 phv00109322.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:31:45+00:00 2018-06-29 18:31:45+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 109868 phv00109868.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:32:18+00:00 2018-06-29 18:32:18+00:00 QRSINT42 QRS INTERVAL, MSEC +36 QRS duration from EKG 155364 phv00155364.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:38:15+00:00 2018-06-29 23:38:15+00:00 QRS_DUR QRS Interval Duration (ms) +36 QRS duration from EKG 123558 phv00123558.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:41:00+00:00 2018-08-21 17:41:00+00:00 QRSDURAN ECG: QRS Duration (ms) +36 QRS duration from EKG 226263 phv00226263.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:22:02+00:00 2018-08-22 21:22:02+00:00 ECGA10 QRS duration (ECGA10) +36 QRS duration from EKG 253002 phv00253002.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:16:33+00:00 2018-08-24 17:16:33+00:00 ekg_qrs_baseline QRS duration measured by electrocardiogram at baseline visit +37 QT interval from EKG 215633 phv00215633.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:55:29+00:00 2018-03-21 20:55:29+00:00 V1ECG9 QT duration [ECG data, exam 1] +37 QT interval from EKG 216050 phv00216050.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:56:36+00:00 2018-03-21 20:56:36+00:00 V2ECG9 QT duration [ECG data, exam 2] +37 QT interval from EKG 216467 phv00216467.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:57:29+00:00 2018-03-21 20:57:29+00:00 V3ECG9 QT duration [ECG data, exam 3] +37 QT interval from EKG 216884 phv00216884.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:58:19+00:00 2018-03-21 20:58:19+00:00 V4ECG9 QT duration [ECG data, exam 4] +37 QT interval from EKG 205943 phv00205943.v1.p1 pht004080.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:25:55+00:00 2018-03-21 21:25:55+00:00 ERHA18 QT duration (Millisec). Q18 [ECG Rhythm Strip, exam 1] +37 QT interval from EKG 127166 phv00127166.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-23 18:54:55+00:00 2018-04-23 18:54:55+00:00 ecga47 QTDUR - QT Duration +37 QT interval from EKG 84568 phv00084568.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:04:21+00:00 2018-04-24 03:04:21+00:00 qtdur1 QT INTERVAL (MSEC) +37 QT interval from EKG 82716 phv00082716.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:06:05+00:00 2018-04-24 03:06:05+00:00 qtdur1 QT INTERVAL (msec) +37 QT interval from EKG 174886 phv00174886.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:06:11+00:00 2018-04-24 03:06:11+00:00 qtdur5 QT INTERVAL (MSEC) +37 QT interval from EKG 176309 phv00176309.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:06:17+00:00 2018-04-24 03:06:17+00:00 qtdur5 QT INTERVAL (MSEC) +37 QT interval from EKG 251000 phv00251000.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:34:31+00:00 2018-06-15 17:34:31+00:00 g360 Electrocardiograph - Part I - Rates and Intervals: Q-T interval Collection Interval: Exam 2 +37 QT interval from EKG 250658 phv00250658.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:38:38+00:00 2018-06-15 17:38:38+00:00 e587 Electrocardiograph - Part I: Rates and Intervals: Q-T interval Collection Interval: Exam 1 +37 QT interval from EKG 251460 phv00251460.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:39:25+00:00 2018-06-15 17:39:25+00:00 h307 Electrocardiograph - Part I: Rates and Intervals: Q-T interval Collection Interval: Exam 3 +37 QT interval from EKG 177465 phv00177465.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:44:06+00:00 2018-06-15 17:44:06+00:00 g3b0372 Electrocardiograph: Rates and Intervals: Q-T interval +37 QT interval from EKG 254209 phv00254209.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:46:46+00:00 2018-06-15 17:46:46+00:00 j362 Electrocardiograph-Part I: Rates and Intervals: Q-T interval +37 QT interval from EKG 254717 phv00254717.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:57:37+00:00 2018-06-15 17:57:37+00:00 fv206 Electrocardiograph: Rates and Intervals: Q-T interval Collection Interval: Exam 29 +37 QT interval from EKG 255107 phv00255107.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:08:41+00:00 2018-06-15 18:08:41+00:00 fw246 Electrocardiograph: Rates and Intervals: Q-T Interval (milliseconds) Collection Interval: Original Cohort Exam 30 +37 QT interval from EKG 274832 phv00274832.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:11:34+00:00 2018-06-15 18:11:34+00:00 FX246 Electrocardiograph: Rates and Intervals: Q-T Interval (milliseconds) Collection Interval: Original Cohort Exam 31 +37 QT interval from EKG 275190 phv00275190.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:16:06+00:00 2018-06-15 18:16:06+00:00 fy246 Electrocardiograph: Rates and Intervals: Q-T Interval (milliseconds) Collection Interval: Original Cohort Exam 32 +37 QT interval from EKG 36353 phv00036353.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:23:11+00:00 2018-06-15 18:23:11+00:00 DIGECG_QT1 QT INTERVAL CYCLE 1 LEAD II (MS) (INTERVAL FROM QRS ONSET TO T-WAVE OFFSET) +37 QT interval from EKG 36354 phv00036354.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:23:31+00:00 2018-06-15 18:23:31+00:00 DIGECG_QT2 QT INTERVAL CYCLE 2 LEAD II (MS) (INTERVAL FROM QRS ONSET TO T-WAVE OFFSET) +37 QT interval from EKG 36355 phv00036355.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:23:49+00:00 2018-06-15 18:23:49+00:00 DIGECG_QT3 QT INTERVAL CYCLE 1 LEAD V2 (MS) (INTERVAL FROM QRS ONSET TO T-WAVE OFFSET) +37 QT interval from EKG 36356 phv00036356.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:24:06+00:00 2018-06-15 18:24:06+00:00 DIGECG_QT4 QT INTERVAL CYCLE 1 LEAD V5 (MS) (INTERVAL FROM QRS ONSET TO T-WAVE OFFSET) +37 QT interval from EKG 23258 phv00023258.v5.p10 pht000149.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:38:16+00:00 2018-06-15 18:38:16+00:00 DG8 QT INTERVAL +37 QT interval from EKG 7650 phv00007650.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:39:38+00:00 2018-06-15 18:39:38+00:00 A148 QT INTERVAL +37 QT interval from EKG 10006 phv00010006.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:41:35+00:00 2018-06-15 18:41:35+00:00 F582 Q-T INTERVAL (HUNDREDTHS OF A SECOND) +37 QT interval from EKG 7890 phv00007890.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:25:39+00:00 2018-06-19 13:25:39+00:00 B258 ECG: QT INTERVAL +37 QT interval from EKG 8636 phv00008636.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:25:56+00:00 2018-06-19 13:25:56+00:00 C292 ECG: QT INTERVAL +37 QT interval from EKG 9032 phv00009032.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:26:14+00:00 2018-06-19 13:26:14+00:00 D295 ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 9492 phv00009492.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:26:32+00:00 2018-06-19 13:26:32+00:00 E587 ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 1979 phv00001979.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:27:00+00:00 2018-06-19 13:27:00+00:00 FE266 ECG: QT INTERVAL +37 QT interval from EKG 2159 phv00002159.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:27:22+00:00 2018-06-19 13:27:22+00:00 FF229 ECG: QT INTERVAL +37 QT interval from EKG 2354 phv00002354.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:27:35+00:00 2018-06-19 13:27:35+00:00 FG237 ECG: QT INTERVAL +37 QT interval from EKG 2594 phv00002594.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:27:49+00:00 2018-06-19 13:27:49+00:00 FH254 ECG: QT INTERVAL +37 QT interval from EKG 2802 phv00002802.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:28:02+00:00 2018-06-19 13:28:02+00:00 FI167 ECG: Q-T INTERVAL +37 QT interval from EKG 3181 phv00003181.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:28:17+00:00 2018-06-19 13:28:17+00:00 FJ279 ECG: QT INTERVAL +37 QT interval from EKG 3596 phv00003596.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:28:31+00:00 2018-06-19 13:28:31+00:00 FK374 ECG: QT INTERVAL +37 QT interval from EKG 4004 phv00004004.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:28:45+00:00 2018-06-19 13:28:45+00:00 FL395 ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 4428 phv00004428.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:28:59+00:00 2018-06-19 13:28:59+00:00 FM434 ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 4870 phv00004870.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:29:35+00:00 2018-06-19 13:29:35+00:00 FN411 ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 5234 phv00005234.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:29:48+00:00 2018-06-19 13:29:48+00:00 FO430 ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 5861 phv00005861.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:30:05+00:00 2018-06-19 13:30:05+00:00 FP396 ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 6218 phv00006218.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:30:22+00:00 2018-06-19 13:30:22+00:00 FQ270 ECG - Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 6613 phv00006613.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:30:38+00:00 2018-06-19 13:30:38+00:00 FR387 ECG - Q-T INTERVAL (HUNDREDTHS OF A SECOND) +37 QT interval from EKG 7047 phv00007047.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:30:51+00:00 2018-06-19 13:30:51+00:00 FS486 ECG: Q-T INTERVAL (HUNDREDTHS OF A SECOND) +37 QT interval from EKG 7482 phv00007482.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:31:06+00:00 2018-06-19 13:31:06+00:00 FT492 ECG RATES AND INTERVALS: Q-T INTERVAL (HUNDREDTHS OF A SECOND) +37 QT interval from EKG 70508 phv00070508.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:31:26+00:00 2018-06-19 13:31:26+00:00 FU204 ECG RATES AND INTERVALS: Q-T INTERVAL (HUNDREDTHS OF A SECOND) +37 QT interval from EKG 10439 phv00010439.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:31:40+00:00 2018-06-19 13:31:40+00:00 G360 ECG: Q-T INTERVAL (HUNDREDTHS OF A SECOND) +37 QT interval from EKG 21155 phv00021155.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:32:01+00:00 2018-06-19 13:32:01+00:00 G3A355 ECG: Q-T INTERVAL (HUNDREDTHS OF A SECOND) +37 QT interval from EKG 273977 phv00273977.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:32:10+00:00 2018-06-19 13:32:10+00:00 g3a355 ECG: Q-T interval Collection Interval: Exam 1 +37 QT interval from EKG 274470 phv00274470.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:32:19+00:00 2018-06-19 13:32:19+00:00 g3a355 ECG: Q-T interval +37 QT interval from EKG 72264 phv00072264.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:32:34+00:00 2018-06-19 13:32:34+00:00 H307 ECG: Q-T INTERVAL (HUNDREDTHS OF SECOND) +37 QT interval from EKG 100059 phv00100059.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:11:42+00:00 2018-06-29 18:11:42+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 100450 phv00100450.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:12:12+00:00 2018-06-29 18:12:12+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 101974 phv00101974.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:12:21+00:00 2018-06-29 18:12:21+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 102596 phv00102596.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:12:43+00:00 2018-06-29 18:12:43+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 104330 phv00104330.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:13:02+00:00 2018-06-29 18:13:02+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 104984 phv00104984.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:13:23+00:00 2018-06-29 18:13:23+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 106351 phv00106351.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:14:20+00:00 2018-06-29 18:14:20+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 107290 phv00107290.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:14:43+00:00 2018-06-29 18:14:43+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 108166 phv00108166.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:15:17+00:00 2018-06-29 18:15:17+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 108789 phv00108789.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:15:38+00:00 2018-06-29 18:15:38+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 109320 phv00109320.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:16:19+00:00 2018-06-29 18:16:19+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 109866 phv00109866.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:16:29+00:00 2018-06-29 18:16:29+00:00 QT42 Q-T INTERVAL, MSEC +37 QT interval from EKG 155365 phv00155365.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 18:57:41+00:00 2018-07-02 18:57:41+00:00 QTC_DUR Bazett's Heart Rate-Corrected QT Interval (ms) +37 QT interval from EKG 155366 phv00155366.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 18:57:41+00:00 2018-07-02 18:57:41+00:00 QT_DUR QT Interval Duration (ms) +37 QT interval from EKG 123559 phv00123559.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:41:12+00:00 2018-08-21 17:41:12+00:00 QT ECG: QT (ms) +37 QT interval from EKG 123560 phv00123560.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:41:23+00:00 2018-08-21 17:41:23+00:00 QTC ECG: QTc (ms) +37 QT interval from EKG 226265 phv00226265.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:26:48+00:00 2018-08-22 21:26:48+00:00 ECGA11 QT duration (ECGA11) +37 QT interval from EKG 226266 phv00226266.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:28:06+00:00 2018-08-22 21:28:06+00:00 ECGA12 QTc calculated (ECGA12) +37 QT interval from EKG 253003 phv00253003.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:16:44+00:00 2018-08-24 17:16:44+00:00 ekg_qt_baseline QT interval measured by electrocardiogram at baseline visit +38 PR interval from EKG 215631 phv00215631.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:55:13+00:00 2018-03-21 20:55:13+00:00 V1ECG7 PR duration [ECG data, exam 1] +38 PR interval from EKG 216048 phv00216048.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:56:08+00:00 2018-03-21 20:56:08+00:00 V2ECG7 PR duration [ECG data, exam 2] +38 PR interval from EKG 216465 phv00216465.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:57:15+00:00 2018-03-21 20:57:15+00:00 V3ECG7 PR duration [ECG data, exam 3] +38 PR interval from EKG 216882 phv00216882.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:58:05+00:00 2018-03-21 20:58:05+00:00 V4ECG7 PR duration [ECG data, exam 4] +38 PR interval from EKG 127290 phv00127290.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-23 18:58:21+00:00 2018-04-23 18:58:21+00:00 ecga171 PRDURII - PR Duration in lead II +38 PR interval from EKG 82714 phv00082714.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:30:40+00:00 2018-04-24 03:30:40+00:00 prdur1 PR INTERVAL (msec) +38 PR interval from EKG 82837 phv00082837.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:30:48+00:00 2018-04-24 03:30:48+00:00 prdur1c PR INTERVAL (msec) - WITH 0=SUPRESSED RECODED TO MISSING +38 PR interval from EKG 84566 phv00084566.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:30:55+00:00 2018-04-24 03:30:55+00:00 prdur1 PR INTERVAL (MSEC) +38 PR interval from EKG 84689 phv00084689.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:31:01+00:00 2018-04-24 03:31:01+00:00 prdur1c PR INTERVAL (MSEC) - WITH 0=SUPRESSED RECODED TO MISSING +38 PR interval from EKG 159097 phv00159097.v2.p3 pht002195.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:31:07+00:00 2018-04-24 03:31:07+00:00 prdur1 PR Interval +38 PR interval from EKG 174884 phv00174884.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:31:16+00:00 2018-04-24 03:31:16+00:00 prdur5 PR INTERVAL (MSEC) +38 PR interval from EKG 175123 phv00175123.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:31:22+00:00 2018-04-24 03:31:22+00:00 prdur5c PR INTERVAL (msec) - WITH 0=SUPRESSED RECODED TO MISSING +38 PR interval from EKG 176307 phv00176307.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:31:32+00:00 2018-04-24 03:31:32+00:00 prdur5 PR INTERVAL (MSEC) +38 PR interval from EKG 176546 phv00176546.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:35:24+00:00 2018-04-24 03:35:24+00:00 prdur5c PR INTERVAL (msec) - WITH 0=SUPRESSED RECODED TO MISSING +38 PR interval from EKG 250998 phv00250998.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:33:12+00:00 2018-06-15 17:33:12+00:00 g358 Electrocardiograph - Part I - Rates and Intervals: P-R interval Collection Interval: Exam 2 +38 PR interval from EKG 251458 phv00251458.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:36:28+00:00 2018-06-15 17:36:28+00:00 h305 Electrocardiograph - Part I: Rates and Intervals: P-R Interval Collection Interval: Exam 3 +38 PR interval from EKG 177463 phv00177463.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:43:04+00:00 2018-06-15 17:43:04+00:00 g3b0370 Electrocardiograph: Rates and Intervals: P-R Interval +38 PR interval from EKG 254207 phv00254207.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:45:42+00:00 2018-06-15 17:45:42+00:00 j360 Electrocardiograph-Part I: Rates and Intervals: P-R Interval +38 PR interval from EKG 254715 phv00254715.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 17:55:05+00:00 2018-06-15 17:55:05+00:00 fv204 Electrocardiograph: Rates and Intervals: P-R Interval Collection Interval: Exam 29 +38 PR interval from EKG 255105 phv00255105.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:00:00+00:00 2018-06-15 18:00:00+00:00 fw244 Electrocardiograph: Rates and Intervals: P-R Interval (milliseconds) Collection Interval: Original Cohort Exam 30 +38 PR interval from EKG 274830 phv00274830.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:10:40+00:00 2018-06-15 18:10:40+00:00 FX244 Electrocardiograph: Rates and Intervals: P-R Interval (milliseconds) Collection Interval: Original Cohort Exam 31 +38 PR interval from EKG 275188 phv00275188.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:15:15+00:00 2018-06-15 18:15:15+00:00 fy244 Electrocardiograph: Rates and Intervals: P-R Interval (milliseconds) Collection Interval: Original Cohort Exam 32 +38 PR interval from EKG 36357 phv00036357.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:19:02+00:00 2018-06-15 18:19:02+00:00 DIGECG_PR1 PR INTERVAL CYCLE 1 LEAD II (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET) +38 PR interval from EKG 36358 phv00036358.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:19:26+00:00 2018-06-15 18:19:26+00:00 DIGECG_PR2 PR INTERVAL CYCLE 2 LEAD II (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET) +38 PR interval from EKG 36359 phv00036359.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:19:54+00:00 2018-06-15 18:19:54+00:00 DIGECG_PR3 PR INTERVAL CYCLE 1 LEAD V2 (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET), DONE ON GEN 3 ONLY +38 PR interval from EKG 36360 phv00036360.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:20:12+00:00 2018-06-15 18:20:12+00:00 DIGECG_PR4 PR INTERVAL CYCLE 1 LEAD V5 (MS) (INTERVAL FROM P-WAVE ONSET TO QRS ONSET), DONE ON GEN 3 ONLY +38 PR interval from EKG 23256 phv00023256.v5.p10 pht000149.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:37:11+00:00 2018-06-15 18:37:11+00:00 DG6 P-R INTERVAL +38 PR interval from EKG 7648 phv00007648.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:39:08+00:00 2018-06-15 18:39:08+00:00 A146 P-R INTERVAL +38 PR interval from EKG 10004 phv00010004.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:40:21+00:00 2018-06-15 18:40:21+00:00 F580 P-R INTERVAL (HUNDREDTHS OF A SECOND) +38 PR interval from EKG 250656 phv00250656.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 18:56:41+00:00 2018-06-15 18:56:41+00:00 e585 Electrocardiograph - Part I: Rates and Intervals: P-R interval Collection Interval: Exam 1 +38 PR interval from EKG 7888 phv00007888.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:01:40+00:00 2018-06-19 13:01:40+00:00 B256 ECG: P-R INTERVAL +38 PR interval from EKG 8634 phv00008634.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:02:09+00:00 2018-06-19 13:02:09+00:00 C290 ECG: P-R INTERVAL +38 PR interval from EKG 9030 phv00009030.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:02:40+00:00 2018-06-19 13:02:40+00:00 D293 ECG: P-R INTERVAL (HUNDREDTHS OF SECOND) +38 PR interval from EKG 9490 phv00009490.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:02:59+00:00 2018-06-19 13:02:59+00:00 E585 ECG: P-R INTERVAL (HUNDREDTHS OF SECOND) +38 PR interval from EKG 1330 phv00001330.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:03:22+00:00 2018-06-19 13:03:22+00:00 FB182 ECG: P-R INTERVAL +38 PR interval from EKG 1525 phv00001525.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:03:39+00:00 2018-06-19 13:03:39+00:00 FC191 ECG: P-R INTERVAL +38 PR interval from EKG 1716 phv00001716.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:03:53+00:00 2018-06-19 13:03:53+00:00 FD187 ECG: P-R INTERVAL +38 PR interval from EKG 1977 phv00001977.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:04:24+00:00 2018-06-19 13:04:24+00:00 FE264 ECG: P-R INTERVAL +38 PR interval from EKG 2157 phv00002157.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:04:44+00:00 2018-06-19 13:04:44+00:00 FF227 ECG: P-R INTERVAL +38 PR interval from EKG 2352 phv00002352.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:05:07+00:00 2018-06-19 13:05:07+00:00 FG235 ECG: P-R INTERVAL +38 PR interval from EKG 2592 phv00002592.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:05:23+00:00 2018-06-19 13:05:23+00:00 FH252 ECG: P-R INTERVAL +38 PR interval from EKG 2800 phv00002800.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:05:37+00:00 2018-06-19 13:05:37+00:00 FI165 ECG: P-R INTERVAL +38 PR interval from EKG 3179 phv00003179.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:05:59+00:00 2018-06-19 13:05:59+00:00 FJ277 ECG: P-R INTERVAL +38 PR interval from EKG 3594 phv00003594.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:06:20+00:00 2018-06-19 13:06:20+00:00 FK372 ECG: P-R INTERVAL +38 PR interval from EKG 4002 phv00004002.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:06:34+00:00 2018-06-19 13:06:34+00:00 FL393 ECG: P-R INTERVAL (HUNDREDTHS OF SECOND) +38 PR interval from EKG 4426 phv00004426.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:06:52+00:00 2018-06-19 13:06:52+00:00 FM432 ECG: P-R INTERVAL (HUNDREDTHS OF SECOND) +38 PR interval from EKG 4868 phv00004868.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:07:21+00:00 2018-06-19 13:07:21+00:00 FN409 ECG: P-R INTERVAL (HUNDREDTHS OF SECOND) +38 PR interval from EKG 5232 phv00005232.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:07:38+00:00 2018-06-19 13:07:38+00:00 FO428 ECG: P-R INTERVAL (HUNDREDTHS OF SECOND) +38 PR interval from EKG 5859 phv00005859.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:07:55+00:00 2018-06-19 13:07:55+00:00 FP394 ECG: P-R INTERVAL (HUNDREDTHS OF SECOND) +38 PR interval from EKG 6216 phv00006216.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:10:08+00:00 2018-06-19 13:10:08+00:00 FQ268 ECG - P-R INTERVAL (HUNDREDTHS OF SECOND) +38 PR interval from EKG 6611 phv00006611.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:10:22+00:00 2018-06-19 13:10:22+00:00 FR385 ECG - P-R INTERVAL (HUNDREDTHS OF A SECOND) +38 PR interval from EKG 7045 phv00007045.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:10:41+00:00 2018-06-19 13:10:41+00:00 FS484 ECG: P-R INTERVAL (HUNDREDTHS OF A SECOND) +38 PR interval from EKG 7480 phv00007480.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:10:55+00:00 2018-06-19 13:10:55+00:00 FT490 ECG RATES AND INTERVALS: P-R INTERVAL (HUNDREDTHS OF A SECOND) +38 PR interval from EKG 70506 phv00070506.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:11:23+00:00 2018-06-19 13:11:23+00:00 FU202 ECG RATES AND INTERVALS: P-R INTERVAL (HUNDREDTHS OF A SECOND) +38 PR interval from EKG 10437 phv00010437.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:11:39+00:00 2018-06-19 13:11:39+00:00 G358 ECG: P-R INTERVAL (HUNDREDTHS OF A SECOND) +38 PR interval from EKG 21153 phv00021153.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:12:00+00:00 2018-06-19 13:12:00+00:00 G3A353 ECG: P-R INTERVAL (HUNDREDTHS OF A SECOND) +38 PR interval from EKG 273975 phv00273975.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:12:08+00:00 2018-06-19 13:12:08+00:00 g3a353 ECG: P-R interval Collection Interval: Exam 1 +38 PR interval from EKG 274468 phv00274468.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:12:18+00:00 2018-06-19 13:12:18+00:00 g3a353 ECG: P-R interval +38 PR interval from EKG 72262 phv00072262.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 13:12:44+00:00 2018-06-19 13:12:44+00:00 H305 ECG: P-R INTERVAL (HUNDREDTHS OF A SECOND) +38 PR interval from EKG 127289 phv00127289.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:38:29+00:00 2018-06-20 13:38:29+00:00 ecga170 PRDURI - PR Duration in lead I +38 PR interval from EKG 127291 phv00127291.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:38:49+00:00 2018-06-20 13:38:49+00:00 ecga172 PRDURIII - PR Duration in lead III +38 PR interval from EKG 127292 phv00127292.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:40:03+00:00 2018-06-20 13:40:03+00:00 ecga173 PRDURAVR - PR Duration in lead AVR +38 PR interval from EKG 127293 phv00127293.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:40:14+00:00 2018-06-20 13:40:14+00:00 ecga174 PRDURAVL - PR Duration in lead AVL +38 PR interval from EKG 127294 phv00127294.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:40:27+00:00 2018-06-20 13:40:27+00:00 ecga175 PRDURAVF - PR Duration in lead AVF +38 PR interval from EKG 127295 phv00127295.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:40:39+00:00 2018-06-20 13:40:39+00:00 ecga176 PRDURV1 - PR Duration in lead V1 +38 PR interval from EKG 127296 phv00127296.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:41:02+00:00 2018-06-20 13:41:02+00:00 ecga177 PRDURV2 - PR Duration in lead V2 +38 PR interval from EKG 127297 phv00127297.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:41:13+00:00 2018-06-20 13:41:13+00:00 ecga178 PRDURV3 - PR Duration in lead V3 +38 PR interval from EKG 127298 phv00127298.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:41:33+00:00 2018-06-20 13:41:33+00:00 ecga179 PRDURV4 - PR Duration in lead V4 +38 PR interval from EKG 127299 phv00127299.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:41:45+00:00 2018-06-20 13:41:45+00:00 ecga180 PRDURV5 - PR Duration in lead V5 +38 PR interval from EKG 127300 phv00127300.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:41:57+00:00 2018-06-20 13:41:57+00:00 ecga181 PRDURV6 - PR Duration in lead V6 +38 PR interval from EKG 100058 phv00100058.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:33:59+00:00 2018-06-29 18:33:59+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 101973 phv00101973.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:34:11+00:00 2018-06-29 18:34:11+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 102595 phv00102595.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:34:21+00:00 2018-06-29 18:34:21+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 104329 phv00104329.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:34:32+00:00 2018-06-29 18:34:32+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 104983 phv00104983.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:34:43+00:00 2018-06-29 18:34:43+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 106350 phv00106350.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:35:00+00:00 2018-06-29 18:35:00+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 107289 phv00107289.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:35:12+00:00 2018-06-29 18:35:12+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 108165 phv00108165.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:35:21+00:00 2018-06-29 18:35:21+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 108788 phv00108788.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:35:39+00:00 2018-06-29 18:35:39+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 109319 phv00109319.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:35:49+00:00 2018-06-29 18:35:49+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 109865 phv00109865.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:36:05+00:00 2018-06-29 18:36:05+00:00 PR42 P-R INTERVAL, MSEC +38 PR interval from EKG 155286 phv00155286.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:35:43+00:00 2018-06-29 23:35:43+00:00 PR_DUR PR Interval (msec) +38 PR interval from EKG 123557 phv00123557.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:40:46+00:00 2018-08-21 17:40:46+00:00 PRINTERV ECG: PR Interval (ms) +38 PR interval from EKG 226275 phv00226275.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:34:33+00:00 2018-08-22 21:34:33+00:00 ECGA9 PR duration (ECGA9) +38 PR interval from EKG 253004 phv00253004.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:16:55+00:00 2018-08-24 17:16:55+00:00 ekg_pr_baseline PR interval measured by electrocardiogram at baseline visit +39 Resting heart rate from EKG 216881 phv00216881.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 20:59:05+00:00 2018-03-21 20:59:05+00:00 V4ECG6 Heart rate [ECG data, exam 4] +39 Resting heart rate from EKG 216464 phv00216464.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:01:16+00:00 2018-03-21 21:01:16+00:00 V3ECG6 Heart rate [ECG data, exam 3] +39 Resting heart rate from EKG 216047 phv00216047.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:02:06+00:00 2018-03-21 21:02:06+00:00 V2ECG6 Heart rate [ECG data, exam 2] +39 Resting heart rate from EKG 215630 phv00215630.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:02:34+00:00 2018-03-21 21:02:34+00:00 V1ECG6 Heart rate [ECG data, exam 1] +39 Resting heart rate from EKG 205820 phv00205820.v1.p1 pht004078.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:04:00+00:00 2018-03-21 21:04:00+00:00 ECGB31 Heart rate [ECG Machine Coding, exam 1] +39 Resting heart rate from EKG 205779 phv00205779.v1.p1 pht004077.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:04:38+00:00 2018-03-21 21:04:38+00:00 ECGMD31 Heart rate [ECG Composite 12 Lead (with adjudications as needed) (ECGMD41), exam 4] +39 Resting heart rate from EKG 205722 phv00205722.v1.p1 pht004076.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:05:55+00:00 2018-03-21 21:05:55+00:00 ECGMC31 Heart rate [ECG Composite 12 Lead (with adjudications as needed) (ECGMC35), exam 3] +39 Resting heart rate from EKG 205674 phv00205674.v1.p1 pht004075.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:06:39+00:00 2018-03-21 21:06:39+00:00 ECGMB31 Heart rate [Cohort, Exam 2] +39 Resting heart rate from EKG 205617 phv00205617.v1.p1 pht004074.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:07:22+00:00 2018-03-21 21:07:22+00:00 ECGMA31 Heart rate [ECG Composite 12 Lead (with adjudications as needed) (ECGMA03), exam 1] +39 Resting heart rate from EKG 205564 phv00205564.v1.p1 pht004073.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:08:03+00:00 2018-03-21 21:08:03+00:00 ECGE31 Heart rate [ECG Machine Coding (ECGE04), exam 4] +39 Resting heart rate from EKG 205505 phv00205505.v1.p1 pht004072.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:11:57+00:00 2018-03-21 21:11:57+00:00 ECGD31 Heart rate [ECG Machine Coding (ECGD04), exam 3] +39 Resting heart rate from EKG 205414 phv00205414.v1.p1 pht004071.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:12:52+00:00 2018-03-21 21:12:52+00:00 ECGC31 Heart rate [ECG Machine Coding (ECGC), exam 2] +39 Resting heart rate from EKG 205946 phv00205946.v1.p1 pht004080.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:26:18+00:00 2018-03-21 21:26:18+00:00 ERHA21 Heart rate per minute. Q21 [ECG Rhythm Strip, exam 1] +39 Resting heart rate from EKG 206106 phv00206106.v1.p1 pht004083.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:27:38+00:00 2018-03-21 21:27:38+00:00 ESMA141 Heart rate-1st ECG-beats per minute [ECG Serial Change, exam 2] +39 Resting heart rate from EKG 206107 phv00206107.v1.p1 pht004083.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:28:12+00:00 2018-03-21 21:28:12+00:00 ESMA142 Heart rate-follow up ECG-beats per minute [ECG Serial Change, exam 2] +39 Resting heart rate from EKG 206255 phv00206255.v1.p1 pht004084.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:29:58+00:00 2018-03-21 21:29:58+00:00 ESMB141 Heart rate-1st ECG-beats per minute [ECG Serial Change, exam 3] +39 Resting heart rate from EKG 206256 phv00206256.v1.p1 pht004084.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:30:15+00:00 2018-03-21 21:30:15+00:00 ESMB142 Heart rate-fup ECG-beats per minute [ECG Serial Change, exam 3] +39 Resting heart rate from EKG 206405 phv00206405.v1.p1 pht004085.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:33:59+00:00 2018-03-21 21:33:59+00:00 ESMC141 Heart rate-1st ECG-beats per minute [ECG Serial Change, exam 4] +39 Resting heart rate from EKG 206406 phv00206406.v1.p1 pht004085.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-21 21:34:18+00:00 2018-03-21 21:34:18+00:00 ESMC142 Heart rate-fup ECG-beats per minute [ECG Serial Change, exam 4] +39 Resting heart rate from EKG 127168 phv00127168.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-23 18:51:09+00:00 2018-04-23 18:51:09+00:00 ecga49 VRATE - V Rate +39 Resting heart rate from EKG 82700 phv00082700.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:34:55+00:00 2018-04-24 03:34:55+00:00 hrtrate1 HEART RATE (beats/min) +39 Resting heart rate from EKG 84546 phv00084546.v3.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:35:03+00:00 2018-04-24 03:35:03+00:00 hrtrate1 HEART RATE (BEATS/MIN) +39 Resting heart rate from EKG 176280 phv00176280.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:35:11+00:00 2018-04-24 03:35:11+00:00 hrtrate5 HEART RATE (60 SECOND): +39 Resting heart rate from EKG 159096 phv00159096.v2.p3 pht002195.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:36:23+00:00 2018-04-24 03:36:23+00:00 heartrt1 Heart Rate +39 Resting heart rate from EKG 7887 phv00007887.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:19:39+00:00 2018-06-18 18:19:39+00:00 B255 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 8633 phv00008633.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:28:59+00:00 2018-06-18 18:28:59+00:00 C289 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 8760 phv00008760.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:29:12+00:00 2018-06-18 18:29:12+00:00 D292 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 9489 phv00009489.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:29:20+00:00 2018-06-18 18:29:20+00:00 E584 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 1181 phv00001181.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:29:28+00:00 2018-06-18 18:29:28+00:00 FA181 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 1329 phv00001329.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:29:41+00:00 2018-06-18 18:29:41+00:00 FB181 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 1524 phv00001524.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:29:52+00:00 2018-06-18 18:29:52+00:00 FC190 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 1715 phv00001715.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:30:02+00:00 2018-06-18 18:30:02+00:00 FD186 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 1976 phv00001976.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:30:10+00:00 2018-06-18 18:30:10+00:00 FE263 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 2156 phv00002156.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:30:20+00:00 2018-06-18 18:30:20+00:00 FF226 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 2351 phv00002351.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:30:32+00:00 2018-06-18 18:30:32+00:00 FG234 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 2591 phv00002591.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:30:41+00:00 2018-06-18 18:30:41+00:00 FH251 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 2799 phv00002799.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:30:49+00:00 2018-06-18 18:30:49+00:00 FI164 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 3178 phv00003178.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:30:58+00:00 2018-06-18 18:30:58+00:00 FJ276 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 3593 phv00003593.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:31:07+00:00 2018-06-18 18:31:07+00:00 FK371 ECG: VENTRICULAR RATE +39 Resting heart rate from EKG 3692 phv00003692.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:31:15+00:00 2018-06-18 18:31:15+00:00 FL392 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 4110 phv00004110.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:31:24+00:00 2018-06-18 18:31:24+00:00 FM431 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 4550 phv00004550.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:31:32+00:00 2018-06-18 18:31:32+00:00 FN408 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 5231 phv00005231.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:31:42+00:00 2018-06-18 18:31:42+00:00 FO427 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 5858 phv00005858.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:31:50+00:00 2018-06-18 18:31:50+00:00 FP393 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 6215 phv00006215.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:32:00+00:00 2018-06-18 18:32:00+00:00 FQ267 ECG - VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 6610 phv00006610.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:32:09+00:00 2018-06-18 18:32:09+00:00 FR384 ECG - VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 7044 phv00007044.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:32:18+00:00 2018-06-18 18:32:18+00:00 FS483 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 7479 phv00007479.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:32:26+00:00 2018-06-18 18:32:26+00:00 FT489 ECG RATES AND INTERVALS: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 70505 phv00070505.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:32:34+00:00 2018-06-18 18:32:34+00:00 FU201 ECG RATES AND INTERVALS: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 10436 phv00010436.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:32:48+00:00 2018-06-18 18:32:48+00:00 G357 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 21152 phv00021152.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:32:57+00:00 2018-06-18 18:32:57+00:00 G3A352 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 273974 phv00273974.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:33:05+00:00 2018-06-18 18:33:05+00:00 g3a352 ECG: Ventricular rate per minute Collection Interval: Exam 1 +39 Resting heart rate from EKG 274467 phv00274467.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:33:14+00:00 2018-06-18 18:33:14+00:00 g3a352 ECG: Ventricular rate per minute +39 Resting heart rate from EKG 72261 phv00072261.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:33:22+00:00 2018-06-18 18:33:22+00:00 H304 ECG: VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 742 phv00000742.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:33:30+00:00 2018-06-18 18:33:30+00:00 MF287 ECG: VENTRICULAR RATE, EXAM 4 +39 Resting heart rate from EKG 824 phv00000824.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:33:39+00:00 2018-06-18 18:33:39+00:00 MF374 ECG: VENTRICULAR RATE, EXAM 5 +39 Resting heart rate from EKG 890 phv00000890.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:33:49+00:00 2018-06-18 18:33:49+00:00 MF444 ECG: VENTRICULAR RATE, EXAM 6 +39 Resting heart rate from EKG 1015 phv00001015.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:33:58+00:00 2018-06-18 18:33:58+00:00 MF575 ECG: VENTRICULAR RATE, EXAM 7 +39 Resting heart rate from EKG 277212 phv00277212.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:34:07+00:00 2018-06-18 18:34:07+00:00 VENT_RT1 Ventricular rate per minute by ECG, Exam 1 +39 Resting heart rate from EKG 277213 phv00277213.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:34:16+00:00 2018-06-18 18:34:16+00:00 VENT_RT2 Ventricular rate per minute by ECG, Exam 2 +39 Resting heart rate from EKG 277214 phv00277214.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:34:24+00:00 2018-06-18 18:34:24+00:00 VENT_RT3 Ventricular rate per minute by ECG, Exam 3 +39 Resting heart rate from EKG 277215 phv00277215.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:34:33+00:00 2018-06-18 18:34:33+00:00 VENT_RT4 Ventricular rate per minute by ECG, Exam 4 +39 Resting heart rate from EKG 277216 phv00277216.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:34:42+00:00 2018-06-18 18:34:42+00:00 VENT_RT5 Ventricular rate per minute by ECG, Exam 5 +39 Resting heart rate from EKG 277217 phv00277217.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:34:51+00:00 2018-06-18 18:34:51+00:00 VENT_RT6 Ventricular rate per minute by ECG, Exam 6 +39 Resting heart rate from EKG 277218 phv00277218.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:35:00+00:00 2018-06-18 18:35:00+00:00 VENT_RT7 Ventricular rate per minute by ECG, Exam 7 +39 Resting heart rate from EKG 277219 phv00277219.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:35:12+00:00 2018-06-18 18:35:12+00:00 VENT_RT8 Ventricular rate per minute by ECG, Exam 8 +39 Resting heart rate from EKG 277220 phv00277220.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:35:21+00:00 2018-06-18 18:35:21+00:00 VENT_RT9 Ventricular rate per minute by ECG, Exam 9 +39 Resting heart rate from EKG 277051 phv00277051.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 14:56:46+00:00 2018-06-19 14:56:46+00:00 VENT_RT1 Ventricular beats per minute by ECG, Exam 1 +39 Resting heart rate from EKG 277052 phv00277052.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 14:57:04+00:00 2018-06-19 14:57:04+00:00 VENT_RT2 Ventricular beats per minute by ECG, Exam 2 +39 Resting heart rate from EKG 100054 phv00100054.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:49:59+00:00 2018-06-29 18:49:59+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 101969 phv00101969.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:50:10+00:00 2018-06-29 18:50:10+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 102591 phv00102591.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:50:22+00:00 2018-06-29 18:50:22+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 104326 phv00104326.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:50:33+00:00 2018-06-29 18:50:33+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 104980 phv00104980.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:50:46+00:00 2018-06-29 18:50:46+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 106347 phv00106347.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:51:04+00:00 2018-06-29 18:51:04+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 107286 phv00107286.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:51:15+00:00 2018-06-29 18:51:15+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 108162 phv00108162.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:51:27+00:00 2018-06-29 18:51:27+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 108784 phv00108784.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:51:37+00:00 2018-06-29 18:51:37+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 109315 phv00109315.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:51:48+00:00 2018-06-29 18:51:48+00:00 HRATE42 HEART RATE +39 Resting heart rate from EKG 109861 phv00109861.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:51:58+00:00 2018-06-29 18:51:58+00:00 HRATE42 Heart Rate +39 Resting heart rate from EKG 155154 phv00155154.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:28:21+00:00 2018-06-29 23:28:21+00:00 HEART_RT Heart rate (beats/minute) +39 Resting heart rate from EKG 36349 phv00036349.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:13:21+00:00 2018-07-03 18:13:21+00:00 DIGECG_RR1 RR INTERVAL CYCLE 1 LEAD II (MS)(INTERVAL FROM R-WAVE TO CONSECUTIVE R-WAVE) +39 Resting heart rate from EKG 36350 phv00036350.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:13:42+00:00 2018-07-03 18:13:42+00:00 DIGECG_RR2 RR INTERVAL CYCLE 2 LEAD II (MS)(INTERVAL FROM R-WAVE TO CONSECUTIVE R-WAVE) +39 Resting heart rate from EKG 36351 phv00036351.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:13:52+00:00 2018-07-03 18:13:52+00:00 DIGECG_RR3 RR INTERVAL CYCLE 1 LEAD V2 (MS) (INTERVAL FROM R-WAVE TO CONSECUTIVE R-WAVE) +39 Resting heart rate from EKG 36352 phv00036352.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:14:03+00:00 2018-07-03 18:14:03+00:00 DIGECG_RR4 RR INTERVAL CYCLE 1 LEAD V5 (MS) (INTERVAL FROM R-WAVE TO CONSECUTIVE R-WAVE) +39 Resting heart rate from EKG 23255 phv00023255.v5.p10 pht000149.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:14:41+00:00 2018-07-03 18:14:41+00:00 DG5 VENTRICULAR RATE +39 Resting heart rate from EKG 8001 phv00008001.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:15:06+00:00 2018-07-03 18:15:06+00:00 B384 TARGET HEART RATE +39 Resting heart rate from EKG 8162 phv00008162.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:15:30+00:00 2018-07-03 18:15:30+00:00 B518 HEART RATE-RESTING, SIT +39 Resting heart rate from EKG 254206 phv00254206.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:16:04+00:00 2018-07-03 18:16:04+00:00 j359 Electrocardiograph-Part I: Rates and Intervals: Ventricular rate per minute +39 Resting heart rate from EKG 177818 phv00177818.v3.p10 pht003097.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:17:05+00:00 2018-07-03 18:17:05+00:00 vrate Ventricular rate +39 Resting heart rate from EKG 177462 phv00177462.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:17:59+00:00 2018-07-03 18:17:59+00:00 g3b0369 Electrocardiograph: Rates and Intervals: Ventricular rate per minute +39 Resting heart rate from EKG 7647 phv00007647.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:19:02+00:00 2018-07-03 18:19:02+00:00 A145 VENTRICULAR RATE +39 Resting heart rate from EKG 10003 phv00010003.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:19:39+00:00 2018-07-03 18:19:39+00:00 F579 VENTRICULAR RATE PER MINUTE +39 Resting heart rate from EKG 254714 phv00254714.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:20:03+00:00 2018-07-03 18:20:03+00:00 fv203 Electrocardiograph: Rates and Intervals: Ventricular rate per minute Collection Interval: Exam 29 +39 Resting heart rate from EKG 255104 phv00255104.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:20:24+00:00 2018-07-03 18:20:24+00:00 fw243 Electrocardiograph: Rates and Intervals: Ventricular rate per minute Collection Interval: Original Cohort Exam 30 +39 Resting heart rate from EKG 274829 phv00274829.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:20:36+00:00 2018-07-03 18:20:36+00:00 FX243 Electrocardiograph: Rates and Intervals: Ventricular rate per minute Collection Interval: Original Cohort Exam 31 +39 Resting heart rate from EKG 275187 phv00275187.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:20:47+00:00 2018-07-03 18:20:47+00:00 fy243 Electrocardiograph: Rates and Intervals: Ventricular rate per minute Collection Interval: Original Cohort Exam 32 +39 Resting heart rate from EKG 251457 phv00251457.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:21:53+00:00 2018-07-03 18:21:53+00:00 h304 Electrocardiograph - Part I: Rates and Intervals: Ventricular rate per minute Collection Interval: Exam 3 +39 Resting heart rate from EKG 71974 phv00071974.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:22:11+00:00 2018-07-03 18:22:11+00:00 ventrate_s1 Ventricular rate for first sleep study Collection Interval: 1998-2003 +39 Resting heart rate from EKG 71987 phv00071987.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:22:21+00:00 2018-07-03 18:22:21+00:00 ventrate_s2 Ventricular rate for second sleep study Collection Interval: 1998-2003 +39 Resting heart rate from EKG 55184 phv00055184.v4.p10 pht000394.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:22:50+00:00 2018-07-03 18:22:50+00:00 WT020 SUPINE HEART RATE +39 Resting heart rate from EKG 250655 phv00250655.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:30:52+00:00 2018-07-03 18:30:52+00:00 e584 Electrocardiograph - Part I: Rates and Intervals: Ventricular rate per minute Collection Interval: Exam 1 +39 Resting heart rate from EKG 250997 phv00250997.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-07-03 18:32:53+00:00 2018-07-03 18:32:53+00:00 g357 Electrocardiograph - Part I - Rates and Intervals: Ventricular rate per minute Collection Interval: Exam 2 +39 Resting heart rate from EKG 253005 phv00253005.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:17:26+00:00 2018-08-24 17:17:26+00:00 ekg_hr_baseline Heart rate measured by electrocardiogram at baseline visit +40 LVH from EKG 204610 phv00204610.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:42:07+00:00 2018-03-20 15:42:07+00:00 LVHSCR21 Cornell voltage in UV (S In V3+r In AVL) [Cohort, Exam 2] +40 LVH from EKG 204611 phv00204611.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:43:44+00:00 2018-03-20 15:43:44+00:00 NLVHSC21 Cornell voltage in mm [Cohort, Exam 2] +40 LVH from EKG 204612 phv00204612.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:44:04+00:00 2018-03-20 15:44:04+00:00 CLVH21 LVH present by Cornell definition [Cohort, Exam 2] +40 LVH from EKG 204698 phv00204698.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:44:25+00:00 2018-03-20 15:44:25+00:00 LVHSCR01 Absolute value of ECGRA198 plus ECGRA170 Cornell voltage in Uv (S In V3+r In Avl) [Cohort, Exam 1] +40 LVH from EKG 204699 phv00204699.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:44:48+00:00 2018-03-20 15:44:48+00:00 NLVHSC01 Cornell voltage in nm [Cohort, Exam 1] +40 LVH from EKG 204700 phv00204700.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:45:06+00:00 2018-03-20 15:45:06+00:00 CLVH01 LVH present by Cornell definition [Cohort, Exam 1] +40 LVH from EKG 204828 phv00204828.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:45:34+00:00 2018-03-20 15:45:34+00:00 LVHSCR31 Cornell voltage in UV (S in V3+r in AVL) [Cohort, Exam 3] +40 LVH from EKG 204829 phv00204829.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:45:54+00:00 2018-03-20 15:45:54+00:00 NLVHSC31 Cornell voltage in mm [Cohort, Exam 3] +40 LVH from EKG 204830 phv00204830.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:46:12+00:00 2018-03-20 15:46:12+00:00 CLVH31 LVH present by Cornell definition [Cohort, Exam 3] +40 LVH from EKG 204932 phv00204932.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:46:32+00:00 2018-03-20 15:46:32+00:00 LVHSCR41 Cornell voltage in UV (S in visit 3+r in AVL) [Cohort, Exam 4] +40 LVH from EKG 204933 phv00204933.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:46:53+00:00 2018-03-20 15:46:53+00:00 NLVHSC41 Cornell voltage in mm [Cohort, Exam 4] +40 LVH from EKG 204934 phv00204934.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:47:16+00:00 2018-03-20 15:47:16+00:00 CLVH41 LVH present by Cornell definition [Cohort, Exam 4] +40 LVH from EKG 215647 phv00215647.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:49:05+00:00 2018-03-20 15:49:05+00:00 V1ECG25 Left ventricular hypertrophy, by Cornell voltage [ECG data, exam 1] +40 LVH from EKG 215648 phv00215648.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:49:22+00:00 2018-03-20 15:49:22+00:00 V1ECG26 Left ventricular hpertrophy, by Cornell voltage product [ECG data, exam 1] +40 LVH from EKG 215649 phv00215649.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:50:01+00:00 2018-03-20 15:50:01+00:00 V1ECG27 Left ventricular hypertrophy, by Minnesota code [ECG data, exam 1] +40 LVH from EKG 215650 phv00215650.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:50:22+00:00 2018-03-20 15:50:22+00:00 V1ECG28 Left ventricular hypertrophy, by Sokolow-Lyon [ECG data, exam 1] +40 LVH from EKG 215677 phv00215677.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:50:55+00:00 2018-03-20 15:50:55+00:00 V1ECG57 Novacode left ventricular hypertrophy; by software [ECG data, exam 1] +40 LVH from EKG 215720 phv00215720.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:51:29+00:00 2018-03-20 15:51:29+00:00 V1ECG100 Left ventricular hypertrophy plus major STT change [ECG data, exam 1] +40 LVH from EKG 216064 phv00216064.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:51:47+00:00 2018-03-20 15:51:47+00:00 V2ECG25 Left ventricular hypertrophy, by Cornell voltage [ECG data, exam 2] +40 LVH from EKG 216065 phv00216065.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:52:05+00:00 2018-03-20 15:52:05+00:00 V2ECG26 Left ventricular hpertrophy, by Cornell voltage product [ECG data, exam 2] +40 LVH from EKG 216066 phv00216066.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:52:30+00:00 2018-03-20 15:52:30+00:00 V2ECG27 Left ventricular hypertrophy, by Minnesota code [ECG data, exam 2] +40 LVH from EKG 216067 phv00216067.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:52:51+00:00 2018-03-20 15:52:51+00:00 V2ECG28 Left ventricular hypertrophy, by Sokolow-Lyon [ECG data, exam 2] +40 LVH from EKG 216094 phv00216094.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:53:27+00:00 2018-03-20 15:53:27+00:00 V2ECG57 Novacode left ventricular hypertrophy; by software [ECG data, exam 2] +40 LVH from EKG 216137 phv00216137.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:53:47+00:00 2018-03-20 15:53:47+00:00 V2ECG100 Left ventricular hypertrophy plus major STT change [ECG data, exam 2] +40 LVH from EKG 216481 phv00216481.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:55:59+00:00 2018-03-20 15:55:59+00:00 V3ECG25 Left ventricular hypertrophy, by Cornell voltage [ECG data, exam 3] +40 LVH from EKG 216482 phv00216482.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:57:01+00:00 2018-03-20 15:57:01+00:00 V3ECG26 Left ventricular hpertrophy, by Cornell voltage product [ECG data, exam 3] +40 LVH from EKG 216483 phv00216483.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:57:21+00:00 2018-03-20 15:57:21+00:00 V3ECG27 Left ventricular hypertrophy, by Minnesota code [ECG data, exam 3] +40 LVH from EKG 216484 phv00216484.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:57:43+00:00 2018-03-20 15:57:43+00:00 V3ECG28 Left ventricular hypertrophy, by Sokolow-Lyon [ECG data, exam 3] +40 LVH from EKG 216511 phv00216511.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:57:59+00:00 2018-03-20 15:57:59+00:00 V3ECG57 Novacode left ventricular hypertrophy; by software [ECG data, exam 3] +40 LVH from EKG 216554 phv00216554.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:58:16+00:00 2018-03-20 15:58:16+00:00 V3ECG100 Left ventricular hypertrophy plus major STT change [ECG data, exam 3] +40 LVH from EKG 216898 phv00216898.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:58:34+00:00 2018-03-20 15:58:34+00:00 V4ECG25 Left ventricular hypertrophy, by Cornell voltage [ECG data, exam 4] +40 LVH from EKG 216899 phv00216899.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:58:50+00:00 2018-03-20 15:58:50+00:00 V4ECG26 Left ventricular hpertrophy, by Cornell voltage product [ECG data, exam 4] +40 LVH from EKG 216900 phv00216900.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:59:07+00:00 2018-03-20 15:59:07+00:00 V4ECG27 Left ventricular hypertrophy, by Minnesota code [ECG data, exam 4] +40 LVH from EKG 216901 phv00216901.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:59:27+00:00 2018-03-20 15:59:27+00:00 V4ECG28 Left ventricular hypertrophy, by Sokolow-Lyon [ECG data, exam 4] +40 LVH from EKG 216928 phv00216928.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 15:59:44+00:00 2018-03-20 15:59:44+00:00 V4ECG57 Novacode left ventricular hypertrophy; by software [ECG data, exam 4] +40 LVH from EKG 216971 phv00216971.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-20 16:00:00+00:00 2018-03-20 16:00:00+00:00 V4ECG100 Left ventricular hypertrophy plus major STT change [ECG data, exam 4] +40 LVH from EKG 82842 phv00082842.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:42:07+00:00 2018-04-24 03:42:07+00:00 ecglvh1c ECG LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 84552 phv00084552.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:42:14+00:00 2018-04-24 03:42:14+00:00 ecglvh1c LEFT VENTRICULAR HYPERTROPHY BY NOVACODE +40 LVH from EKG 175124 phv00175124.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:42:24+00:00 2018-04-24 03:42:24+00:00 ecglvh5c ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE +40 LVH from EKG 218150 phv00218150.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:42:41+00:00 2018-04-24 03:42:41+00:00 lvhcv5 LEFT VENTRICULAR HYPERTROPHY, BY CORNELL VOLTAGE +40 LVH from EKG 176547 phv00176547.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:42:46+00:00 2018-04-24 03:42:46+00:00 ecglvh5c ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE +40 LVH from EKG 176503 phv00176503.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:43:36+00:00 2018-04-24 03:43:36+00:00 major55 LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 175080 phv00175080.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:43:42+00:00 2018-04-24 03:43:42+00:00 major55 LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 174569 phv00174569.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 03:43:48+00:00 2018-04-24 03:43:48+00:00 major51 MAJOR ABNORMALITY 5 PER MINNESOTA CODE: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 205852 phv00205852.v1.p1 pht004079.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 21:30:28+00:00 2018-04-25 21:30:28+00:00 ECHA12 Left ventricular hypertrophy 12 [Cohort (Jackson only), Exam 3] +40 LVH from EKG 6249 phv00006249.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:38:45+00:00 2018-06-15 13:38:45+00:00 FQ301 LVH +40 LVH from EKG 7666 phv00007666.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:40:54+00:00 2018-06-15 13:40:54+00:00 A164 LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 10037 phv00010037.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:41:25+00:00 2018-06-15 13:41:25+00:00 F613 LVH (IF COMPLETE LBBB PRESENT, LVH=UNKNOWN) +40 LVH from EKG 71950 phv00071950.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:42:08+00:00 2018-06-15 13:42:08+00:00 lvh3_1_s1 Left ventricular hypertrophy (LVH) voltage for first sleep study Collection Interval: 1998-2003 +40 LVH from EKG 71951 phv00071951.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:52:46+00:00 2018-06-15 13:52:46+00:00 lvh3_3_s1 Left ventricular hypertrophy (LVH) voltage for first sleep study Collection Interval: 1998-2003 +40 LVH from EKG 71982 phv00071982.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:53:11+00:00 2018-06-15 13:53:11+00:00 lvh3_1_s2 Left ventricular hypertrophy (LVH) voltage for second sleep study Collection Interval: 1998-2003 +40 LVH from EKG 71983 phv00071983.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:53:49+00:00 2018-06-15 13:53:49+00:00 lvh3_3_s2 Left ventricular hypertrophy (LVH) voltage for second sleep study Collection Interval: 1998-2003 +40 LVH from EKG 71954 phv00071954.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:56:53+00:00 2018-06-15 13:56:53+00:00 lvhst_s1 Left ventricular hypertrophy (LVH) with S-T,T-wave abnormality for first sleep study Collection Interval: 1998-2003 +40 LVH from EKG 71986 phv00071986.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 13:57:09+00:00 2018-06-15 13:57:09+00:00 lvhst_s2 Left ventricular hypertrophy (LVH) with S-T,T-wave abnormality for second sleep study Collection Interval: 1998-2003 +40 LVH from EKG 277036 phv00277036.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:01:07+00:00 2018-06-15 14:01:07+00:00 DLVH1 Definite left ventricular hypertrophy, Exam 1 +40 LVH from EKG 277037 phv00277037.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:01:18+00:00 2018-06-15 14:01:18+00:00 DLVH2 Definite left ventricular hypertrophy, Exam 2 +40 LVH from EKG 277146 phv00277146.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:01:27+00:00 2018-06-15 14:01:27+00:00 DLVH1 Definite left ventricular hypertrophy, Exam 1 +40 LVH from EKG 277147 phv00277147.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:01:37+00:00 2018-06-15 14:01:37+00:00 DLVH2 Definite left ventricular hypertrophy, Exam 2 +40 LVH from EKG 277148 phv00277148.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:01:46+00:00 2018-06-15 14:01:46+00:00 DLVH3 Definite left ventricular hypertrophy, Exam 3 +40 LVH from EKG 277149 phv00277149.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:01:54+00:00 2018-06-15 14:01:54+00:00 DLVH4 Definite left ventricular hypertrophy, Exam 4 +40 LVH from EKG 277150 phv00277150.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:02:03+00:00 2018-06-15 14:02:03+00:00 DLVH5 Definite left ventricular hypertrophy, Exam 5 +40 LVH from EKG 277151 phv00277151.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:02:12+00:00 2018-06-15 14:02:12+00:00 DLVH6 Definite left ventricular hypertrophy, Exam 6 +40 LVH from EKG 277152 phv00277152.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:02:21+00:00 2018-06-15 14:02:21+00:00 DLVH7 Definite left ventricular hypertrophy, Exam 7 +40 LVH from EKG 277153 phv00277153.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:02:30+00:00 2018-06-15 14:02:30+00:00 DLVH8 Definite left ventricular hypertrophy, Exam 8 +40 LVH from EKG 277154 phv00277154.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-15 14:02:39+00:00 2018-06-15 14:02:39+00:00 DLVH9 Definite left ventricular hypertrophy, Exam 9 +40 LVH from EKG 7907 phv00007907.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:39:06+00:00 2018-06-18 18:39:06+00:00 B275 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 8674 phv00008674.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:39:32+00:00 2018-06-18 18:39:32+00:00 C330 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 9070 phv00009070.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:39:51+00:00 2018-06-18 18:39:51+00:00 D334 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 9523 phv00009523.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:40:25+00:00 2018-06-18 18:40:25+00:00 E618 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 250689 phv00250689.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:40:34+00:00 2018-06-18 18:40:34+00:00 e618 Electrocardiograph - Part II: Hypertrophy, enlargement, and other ECG Diagnoses: Left ventricular hypertrophy Collection Interval: Exam 1 +40 LVH from EKG 1172 phv00001172.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:40:46+00:00 2018-06-18 18:40:46+00:00 FA172 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 1333 phv00001333.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:40:57+00:00 2018-06-18 18:40:57+00:00 FB185 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 1528 phv00001528.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:41:05+00:00 2018-06-18 18:41:05+00:00 FC194 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 1996 phv00001996.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:42:40+00:00 2018-06-18 18:42:40+00:00 FE283 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 2176 phv00002176.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:43:34+00:00 2018-06-18 18:43:34+00:00 FF246 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 2371 phv00002371.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:44:11+00:00 2018-06-18 18:44:11+00:00 FG254 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 2611 phv00002611.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:44:24+00:00 2018-06-18 18:44:24+00:00 FH271 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 2817 phv00002817.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:44:37+00:00 2018-06-18 18:44:37+00:00 FI182 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 3616 phv00003616.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:45:22+00:00 2018-06-18 18:45:22+00:00 FK394 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 4042 phv00004042.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:46:54+00:00 2018-06-18 18:46:54+00:00 FL434 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 4466 phv00004466.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:47:05+00:00 2018-06-18 18:47:05+00:00 FM473 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 4903 phv00004903.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:47:41+00:00 2018-06-18 18:47:41+00:00 FN445 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 5265 phv00005265.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:48:11+00:00 2018-06-18 18:48:11+00:00 FO461 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 5892 phv00005892.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:48:56+00:00 2018-06-18 18:48:56+00:00 FP427 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 650 phv00000650.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:49:43+00:00 2018-06-18 18:49:43+00:00 MF185 ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 3 +40 LVH from EKG 735 phv00000735.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:49:53+00:00 2018-06-18 18:49:53+00:00 MF280 ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 4 +40 LVH from EKG 818 phv00000818.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:50:02+00:00 2018-06-18 18:50:02+00:00 MF368 ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 5 +40 LVH from EKG 884 phv00000884.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:50:13+00:00 2018-06-18 18:50:13+00:00 MF438 ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 6 +40 LVH from EKG 1009 phv00001009.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:50:24+00:00 2018-06-18 18:50:24+00:00 MF569 ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 7 +40 LVH from EKG 6643 phv00006643.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:52:33+00:00 2018-06-18 18:52:33+00:00 FR417 ECG - LVH +40 LVH from EKG 7078 phv00007078.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:53:03+00:00 2018-06-18 18:53:03+00:00 FS517 ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN) +40 LVH from EKG 7513 phv00007513.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:53:29+00:00 2018-06-18 18:53:29+00:00 FT523 ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN) +40 LVH from EKG 70539 phv00070539.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:54:37+00:00 2018-06-18 18:54:37+00:00 FU235 ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN) +40 LVH from EKG 10470 phv00010470.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:55:49+00:00 2018-06-18 18:55:49+00:00 G391 ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN) +40 LVH from EKG 21186 phv00021186.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:57:03+00:00 2018-06-18 18:57:03+00:00 G3A386 ECG: LVH (IF COMPLETE LBBB PRESENT, LVH = UNKNOWN) +40 LVH from EKG 274008 phv00274008.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:57:13+00:00 2018-06-18 18:57:13+00:00 g3a386 ECG: LVH Collection Interval: Exam 1 +40 LVH from EKG 274501 phv00274501.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 18:57:22+00:00 2018-06-18 18:57:22+00:00 g3a386 ECG: LVH +40 LVH from EKG 254748 phv00254748.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:44:01+00:00 2018-06-19 12:44:01+00:00 fv237 Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses: LVH Collection Interval: Exam 29 +40 LVH from EKG 255139 phv00255139.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:44:12+00:00 2018-06-19 12:44:12+00:00 fw278 Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses - LVH Collection Interval: Original Cohort Exam 30 +40 LVH from EKG 274864 phv00274864.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:44:21+00:00 2018-06-19 12:44:21+00:00 FX278 Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses - LVH Collection Interval: Original Cohort Exam 31 +40 LVH from EKG 275222 phv00275222.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:44:34+00:00 2018-06-19 12:44:34+00:00 fy278 Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses - LVH Collection Interval: Original Cohort Exam 32 +40 LVH from EKG 251031 phv00251031.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:44:46+00:00 2018-06-19 12:44:46+00:00 g391 Electrocardiograph - Part II - Hypertrophy, enlargement, and other ECG Diagnoses: LVH Collection Interval: Exam 2 +40 LVH from EKG 177496 phv00177496.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:45:39+00:00 2018-06-19 12:45:39+00:00 g3b0403 Electrocardiograph: Hypertrophy, enlargement, and other ECG Diagnoses: LVH +40 LVH from EKG 251491 phv00251491.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:45:52+00:00 2018-06-19 12:45:52+00:00 h338 Electrocardiograph - Part II: Hypertrophy, enlargement, and other ECG Diagnoses: LVH Collection Interval: Exam 3 +40 LVH from EKG 254240 phv00254240.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:46:04+00:00 2018-06-19 12:46:04+00:00 j393 Electrocardiograph-Part II: Hypertrophy, enlargement, and other ECG Diagnoses: LVH +40 LVH from EKG 72295 phv00072295.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 12:46:39+00:00 2018-06-19 12:46:39+00:00 H338 ECG: LVH (IF COMPLETE LBBB PRESENT, RVH = UNKNOWN) +40 LVH from EKG 1719 phv00001719.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 14:20:51+00:00 2018-06-19 14:20:51+00:00 FD190 ECG: LEFT VENTRICULAR HYPERTROPHY +40 LVH from EKG 567 phv00000567.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 14:21:37+00:00 2018-06-19 14:21:37+00:00 MF97 ECG: LEFT VENTRICULAR HYPERTROPHY, EXAM 2 +40 LVH from EKG 518 phv00000518.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-19 15:26:00+00:00 2018-06-19 15:26:00+00:00 MF44 ECG: VENTRICULAR HYPERTROPHY OR STRAIN, EXAM 1 +40 LVH from EKG 127130 phv00127130.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:57:41+00:00 2018-06-20 13:57:41+00:00 ecga11 HRVCVOLT - cornell voltage criteria +40 LVH from EKG 100067 phv00100067.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:36:42+00:00 2018-06-29 18:36:42+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 100455 phv00100455.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:36:57+00:00 2018-06-29 18:36:57+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 101981 phv00101981.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:37:10+00:00 2018-06-29 18:37:10+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 102606 phv00102606.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:37:26+00:00 2018-06-29 18:37:26+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 104992 phv00104992.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:37:36+00:00 2018-06-29 18:37:36+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 106359 phv00106359.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:37:50+00:00 2018-06-29 18:37:50+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 107298 phv00107298.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:38:01+00:00 2018-06-29 18:38:01+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 108174 phv00108174.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:38:17+00:00 2018-06-29 18:38:17+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 108796 phv00108796.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:38:30+00:00 2018-06-29 18:38:30+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 109326 phv00109326.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:38:45+00:00 2018-06-29 18:38:45+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 109874 phv00109874.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:38:54+00:00 2018-06-29 18:38:54+00:00 ECGLVH LV HYPERTROPHY BY ECG +40 LVH from EKG 197326 phv00197326.v1.p1 pht003697.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:44:08+00:00 2018-06-29 18:44:08+00:00 lvh3_1 Left ventricular hypertrophy (LVH) Voltage (MN code 3-1) +40 LVH from EKG 197327 phv00197327.v1.p1 pht003697.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:44:18+00:00 2018-06-29 18:44:18+00:00 lvh3_3 Left ventricular hypertrophy (LVH) Voltage (MN code 3-3) +40 LVH from EKG 197330 phv00197330.v1.p1 pht003697.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:44:32+00:00 2018-06-29 18:44:32+00:00 lvhst Left ventricular hypertrophy (LVH) with ST, T-wave abnormality +40 LVH from EKG 197361 phv00197361.v1.p1 pht003698.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:45:37+00:00 2018-06-29 18:45:37+00:00 lvh3_1 Left ventricular hypertrophy (LVH) Voltage (MN code 3-1) +40 LVH from EKG 197362 phv00197362.v1.p1 pht003698.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:45:48+00:00 2018-06-29 18:45:48+00:00 lvh3_3 Left ventricular hypertrophy (LVH) Voltage (MN code 3-3) +40 LVH from EKG 197365 phv00197365.v1.p1 pht003698.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 18:45:58+00:00 2018-06-29 18:45:58+00:00 lvhst Left ventricular hypertrophy (LVH) with ST, T-wave abnormality +40 LVH from EKG 155170 phv00155170.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:31:35+00:00 2018-06-29 23:31:35+00:00 LVHI Left Ventricular Hypertrophy Index +40 LVH from EKG 155171 phv00155171.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:31:35+00:00 2018-06-29 23:31:35+00:00 LVHI_CAT Left Ventricular Hypertrophy Index > 120 (1,0) +40 LVH from EKG 155172 phv00155172.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 23:31:35+00:00 2018-06-29 23:31:35+00:00 LVH_MINN LVH by Minnesota Code +41 Pacemaker 216978 phv00216978.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:48:35+00:00 2018-04-12 16:48:35+00:00 V4ECG107 Pacemaker [ECG data, exam 4] +41 Pacemaker 216949 phv00216949.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:49:05+00:00 2018-04-12 16:49:05+00:00 V4ECG78 Artificial pacemaker; by Visual flag [ECG data, exam 4] +41 Pacemaker 216914 phv00216914.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:49:42+00:00 2018-04-12 16:49:42+00:00 V4ECG43 Electronic pacemaker, by visual flag [ECG data, exam 4] +41 Pacemaker 216906 phv00216906.v1.p1 pht004234.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:50:44+00:00 2018-04-12 16:50:44+00:00 V4ECG35 Ventricular or dual-chamber pacemaker, by visual flag [ECG data, exam 4] +41 Pacemaker 216561 phv00216561.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:52:30+00:00 2018-04-12 16:52:30+00:00 V3ECG107 Pacemaker [ECG data, exam 3] +41 Pacemaker 216532 phv00216532.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:53:04+00:00 2018-04-12 16:53:04+00:00 V3ECG78 Artificial pacemaker; by Visual flag [ECG data, exam 3] +41 Pacemaker 216497 phv00216497.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:53:34+00:00 2018-04-12 16:53:34+00:00 V3ECG43 Electronic pacemaker, by visual flag [ECG data, exam 3] +41 Pacemaker 216489 phv00216489.v1.p1 pht004233.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:54:44+00:00 2018-04-12 16:54:44+00:00 V3ECG35 Ventricular or dual-chamber pacemaker, by visual flag [ECG data, exam 3] +41 Pacemaker 216144 phv00216144.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:55:53+00:00 2018-04-12 16:55:53+00:00 V2ECG107 Pacemaker [ECG data, exam 2] +41 Pacemaker 216115 phv00216115.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:56:44+00:00 2018-04-12 16:56:44+00:00 V2ECG78 Artificial pacemaker; by Visual flag [ECG data, exam 2] +41 Pacemaker 216080 phv00216080.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:57:13+00:00 2018-04-12 16:57:13+00:00 V2ECG43 Electronic pacemaker, by visual flag [ECG data, exam 2] +41 Pacemaker 216072 phv00216072.v1.p1 pht004232.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 16:59:00+00:00 2018-04-12 16:59:00+00:00 V2ECG35 Ventricular or dual-chamber pacemaker, by visual flag [ECG data, exam 2] +41 Pacemaker 215727 phv00215727.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 17:00:18+00:00 2018-04-12 17:00:18+00:00 V1ECG107 Pacemaker [ECG data, exam 1] +41 Pacemaker 215698 phv00215698.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 17:00:58+00:00 2018-04-12 17:00:58+00:00 V1ECG78 Artificial pacemaker; by Visual flag [ECG data, exam 1] +41 Pacemaker 215663 phv00215663.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 17:01:23+00:00 2018-04-12 17:01:23+00:00 V1ECG43 Electronic pacemaker, by visual flag [ECG data, exam 1] +41 Pacemaker 215655 phv00215655.v1.p1 pht004231.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 17:02:22+00:00 2018-04-12 17:02:22+00:00 V1ECG35 Ventricular or dual-chamber pacemaker, by visual flag [ECG data, exam 1] +41 Pacemaker 207815 phv00207815.v1.p1 pht004128.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 17:05:03+00:00 2018-04-12 17:05:03+00:00 MSCA4 [Exclusion]. Do you have a cardiac pacemaker or a heart valve prosthesis? Q4 [MRI Screening Form, exam 3] +41 Pacemaker 206911 phv00206911.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 17:05:32+00:00 2018-04-12 17:05:32+00:00 HFAA50 Q50 - Interventions: biventricular Pacemaker (CRT) (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +41 Pacemaker 206910 phv00206910.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 18:43:10+00:00 2018-04-12 18:43:10+00:00 HFAA49 Q49 - Interventions: pacemaker Placement (Non-Biventricular) (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +41 Pacemaker 206798 phv00206798.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 18:43:32+00:00 2018-04-12 18:43:32+00:00 HFAA11E4 [Medical history]. Q11e4- Cardiac procedures: pacemaker [Heart Failure Hospital Record Abstraction Form, HFA] +41 Pacemaker 205047 phv00205047.v1.p1 pht004067.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 18:44:54+00:00 2018-04-12 18:44:54+00:00 DSRA9 Do you have a cardiac pacemaker? Q9 [Dental Screening Form, exam 4] +41 Pacemaker 204151 phv00204151.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 18:45:34+00:00 2018-04-12 18:45:34+00:00 HRAA29P1 [Second transfer]. Holter monitoring. Pacemaker (temporary, wires). Coronary stent. Q29p1 [Hospital Abstraction Form] +41 Pacemaker 203962 phv00203962.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-12 18:45:59+00:00 2018-04-12 18:45:59+00:00 HRAA29P [Second transfer]. Were the following special procedures or operations performed during this hospital stay? Pacemaker (temporary, wires). Q29p [Hospital Abstraction Form] +41 Pacemaker 127142 phv00127142.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-04-23 18:59:42+00:00 2018-04-23 18:59:42+00:00 ecga23 AVD6XX - Atrioventricular (A-V) conduction defects (6 codes, the preceding 6 is not shown when a code is present) +41 Pacemaker 82702 phv00082702.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 21:18:10+00:00 2018-04-24 21:18:10+00:00 ecgpmk1 PACEMAKER +41 Pacemaker 174576 phv00174576.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:07:59+00:00 2018-04-24 23:07:59+00:00 major91 MAJOR ABNORMALITY 9 PER MINNESOTA CODE: PACEMAKER +41 Pacemaker 87149 phv00087149.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:08:06+00:00 2018-04-24 23:08:06+00:00 pmkrf PACEMAKER IMPLANT +41 Pacemaker 174642 phv00174642.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:08:13+00:00 2018-04-24 23:08:13+00:00 pacem5 BODY COMPOSITION SCALE: DOES PPT HAVE A PACEMAKER? +41 Pacemaker 174901 phv00174901.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:08:19+00:00 2018-04-24 23:08:19+00:00 ncs065 VENTRICULAR OR DUAL-CHAMBER PACEMAKER, BY SOFTWARE +41 Pacemaker 174912 phv00174912.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:08:26+00:00 2018-04-24 23:08:26+00:00 ncvf065 VENTRICULAR OR DUAL-CHAMBER PACEMAKER, BY VISUAL FLAG +41 Pacemaker 174923 phv00174923.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:08:47+00:00 2018-04-24 23:08:47+00:00 ncvf165 ELECTRONIC PACEMAKER, BY VISUAL FLAG +41 Pacemaker 175087 phv00175087.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:09:01+00:00 2018-04-24 23:09:01+00:00 major95 PACEMAKER +41 Pacemaker 176065 phv00176065.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:09:56+00:00 2018-04-24 23:09:56+00:00 pacem5 BODY COMPOSITION SCALE: DOES PPT HAVE A PACEMAKER? +41 Pacemaker 176282 phv00176282.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:10:01+00:00 2018-04-24 23:10:01+00:00 prpmk5 PRESENCE OF: PACEMAKER +41 Pacemaker 176293 phv00176293.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:10:08+00:00 2018-04-24 23:10:08+00:00 ecgpmk5 CONFIRMED: PACEMAKER +41 Pacemaker 176346 phv00176346.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:10:15+00:00 2018-04-24 23:10:15+00:00 ncvf165 ELECTRONIC PACEMAKER, BY VISUAL FLAG +41 Pacemaker 176335 phv00176335.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:10:27+00:00 2018-04-24 23:10:27+00:00 ncvf065 VENTRICULAR OR DUAL-CHAMBER PACEMAKER, BY VISUAL FLAG +41 Pacemaker 176324 phv00176324.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:10:33+00:00 2018-04-24 23:10:33+00:00 ncs065 VENTRICULAR OR DUAL-CHAMBER PACEMAKER, BY SOFTWARE +41 Pacemaker 176510 phv00176510.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:10:47+00:00 2018-04-24 23:10:47+00:00 major95 PACEMAKER +41 Pacemaker 127730 phv00127730.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:29:16+00:00 2018-06-20 15:29:16+00:00 MHXA52B2 52b2: Specify other heart procedures +41 Pacemaker 99037 phv00099037.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 17:26:47+00:00 2018-07-30 17:26:47+00:00 IMPLAN07 A PACEMAKER IMPLANT +41 Pacemaker 100332 phv00100332.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 17:27:01+00:00 2018-07-30 17:27:01+00:00 IMPLAN A PACEMAKER IMPLANT +41 Pacemaker 105980 phv00105980.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 17:27:14+00:00 2018-07-30 17:27:14+00:00 IMPLAN57 A PACEMAKER IMPLANT +41 Pacemaker 54692 phv00054692.v7.p10 pht000389.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 23:18:41+00:00 2018-08-07 23:18:41+00:00 PROCNUM Cardiovascular procedure codes +41 Pacemaker 54697 phv00054697.v7.p10 pht000389.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 23:19:20+00:00 2018-08-07 23:19:20+00:00 PROCDATE Date of cardiovascular procedure +41 Pacemaker 5236 phv00005236.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:52:15+00:00 2018-08-10 11:52:15+00:00 FO432 ECG: RHYTHM +41 Pacemaker 5863 phv00005863.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:52:46+00:00 2018-08-10 11:52:46+00:00 FP398 ECG: RHYTHM +41 Pacemaker 6220 phv00006220.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:53:19+00:00 2018-08-10 11:53:19+00:00 FQ272 ECG - RHYTHM +41 Pacemaker 6615 phv00006615.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:54:14+00:00 2018-08-10 11:54:14+00:00 FR389 ECG - RHYTHM +41 Pacemaker 7049 phv00007049.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:54:56+00:00 2018-08-10 11:54:56+00:00 FS488 ECG: RHYTHM +41 Pacemaker 7484 phv00007484.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:55:28+00:00 2018-08-10 11:55:28+00:00 FT494 ECG: RHYTHM +41 Pacemaker 70510 phv00070510.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:56:02+00:00 2018-08-10 11:56:02+00:00 FU206 ECG: RHYTHM +41 Pacemaker 9494 phv00009494.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:57:05+00:00 2018-08-10 11:57:05+00:00 E589 ECG: RHYTHM +41 Pacemaker 250660 phv00250660.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:58:21+00:00 2018-08-10 11:58:21+00:00 e589 Electrocardiograph - Part I: Rhythm Collection Interval: Exam 1 +41 Pacemaker 10008 phv00010008.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 11:59:24+00:00 2018-08-10 11:59:24+00:00 F584 RHYTHM +41 Pacemaker 10441 phv00010441.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:00:26+00:00 2018-08-10 12:00:26+00:00 G362 ECG: RHYTHM PREDOMINANT +41 Pacemaker 251002 phv00251002.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:01:08+00:00 2018-08-10 12:01:08+00:00 g362 Electrocardiograph - Part I: Rhythm - predominant Collection Interval: Exam 2 +41 Pacemaker 72266 phv00072266.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:08:07+00:00 2018-08-10 12:08:07+00:00 H309 ECG: RHYTHM PREDOMINANT +41 Pacemaker 251462 phv00251462.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:08:56+00:00 2018-08-10 12:08:56+00:00 h309 Electrocardiograph - Part I: Rhythm - predominant Collection Interval: Exam 3 +41 Pacemaker 21157 phv00021157.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:09:46+00:00 2018-08-10 12:09:46+00:00 G3A357 ECG: RHYTHM--PREDOMINANT +41 Pacemaker 273979 phv00273979.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:10:34+00:00 2018-08-10 12:10:34+00:00 g3a357 ECG: Rhythm--predominant Collection Interval: Exam 1 +41 Pacemaker 274472 phv00274472.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:11:06+00:00 2018-08-10 12:11:06+00:00 g3a357 ECG: Rhythm--predominant +41 Pacemaker 71977 phv00071977.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:11:51+00:00 2018-08-10 12:11:51+00:00 paced_s1 Paced for first sleep study Collection Interval: 1998-2003 +41 Pacemaker 71995 phv00071995.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:12:10+00:00 2018-08-10 12:12:10+00:00 paced_s2 Paced for second sleep study Collection Interval: 1998-2003 +41 Pacemaker 276818 phv00276818.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:12:54+00:00 2018-08-10 12:12:54+00:00 CHF092 ECG rhythm - A. Paced +41 Pacemaker 276819 phv00276819.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:13:12+00:00 2018-08-10 12:13:12+00:00 CHF093 ECG rhythm - V. Paced +41 Pacemaker 8140 phv00008140.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:16:54+00:00 2018-08-10 12:16:54+00:00 B496 ECG: PACEMAKER +41 Pacemaker 9029 phv00009029.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:17:09+00:00 2018-08-10 12:17:09+00:00 D291 PACEMAKER +41 Pacemaker 9394 phv00009394.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:17:20+00:00 2018-08-10 12:17:20+00:00 E464 HISTORY OF PERMANENT PACEMAKER INSERTION +41 Pacemaker 9899 phv00009899.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:17:31+00:00 2018-08-10 12:17:31+00:00 F433 PERMANENT PACEMAKER INSERTION +41 Pacemaker 2926 phv00002926.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:17:45+00:00 2018-08-10 12:17:45+00:00 FI246 ECG: PACEMAKER +41 Pacemaker 4001 phv00004001.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:17:58+00:00 2018-08-10 12:17:58+00:00 FL391 PACEMAKER +41 Pacemaker 4425 phv00004425.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:18:15+00:00 2018-08-10 12:18:15+00:00 FM430 ECG: PACEMAKER +41 Pacemaker 4778 phv00004778.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:18:34+00:00 2018-08-10 12:18:34+00:00 FN308 HISTORY OF PERMANENT PACEMAKER INSERTION +41 Pacemaker 4867 phv00004867.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:18:47+00:00 2018-08-10 12:18:47+00:00 FN407 PACEMAKER +41 Pacemaker 5078 phv00005078.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:19:03+00:00 2018-08-10 12:19:03+00:00 FO241 HISTORY OF PERMANENT PACEMAKER INSERTION +41 Pacemaker 5693 phv00005693.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:19:22+00:00 2018-08-10 12:19:22+00:00 FP185 PERMANENT PACEMAKER INSERTION +41 Pacemaker 6204 phv00006204.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:19:44+00:00 2018-08-10 12:19:44+00:00 FQ221 PERMANENT PACEMAKER INSERTION - INTERIM +41 Pacemaker 6601 phv00006601.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:20:01+00:00 2018-08-10 12:20:01+00:00 FR347 CARDIOVASCULAR PROCEDURES (IN THE INTERIM ONLY, NOT LIFETIME) PERMANENT PACEMAKER INSERTION (IF YES, FILL IN FR348) +41 Pacemaker 7035 phv00007035.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:20:22+00:00 2018-08-10 12:20:22+00:00 FS446 PERMANENT PACEMAKER INSERTION +41 Pacemaker 7468 phv00007468.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:20:35+00:00 2018-08-10 12:20:35+00:00 FT450 PERMANENT PACEMAKER INSERTION +41 Pacemaker 70494 phv00070494.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:20:49+00:00 2018-08-10 12:20:49+00:00 FU162 PERMANENT PACEMAKER INSERTION +41 Pacemaker 10354 phv00010354.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:21:08+00:00 2018-08-10 12:21:08+00:00 G238 PERMANENT PACEMAKER INSERTION +41 Pacemaker 21085 phv00021085.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:21:43+00:00 2018-08-10 12:21:43+00:00 G3A257 PERMANENT PACEMAKER INSERTION SEE NOTE BELOW +41 Pacemaker 72205 phv00072205.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:21:59+00:00 2018-08-10 12:21:59+00:00 H217 PERMANENT PACEMAKER INSERTION +41 Pacemaker 177467 phv00177467.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:24:16+00:00 2018-08-10 12:24:16+00:00 g3b0374 Electrocardiograph: Rhythm--predominant +41 Pacemaker 254211 phv00254211.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:24:51+00:00 2018-08-10 12:24:51+00:00 j364 Electrocardiograph-Part I: Rhythm--predominant +41 Pacemaker 254719 phv00254719.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:25:18+00:00 2018-08-10 12:25:18+00:00 fv208 Electrocardiograph: Rhythm - predominant Collection Interval: Exam 29 +41 Pacemaker 255109 phv00255109.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:25:46+00:00 2018-08-10 12:25:46+00:00 fw248 Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 30 +41 Pacemaker 274834 phv00274834.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:26:07+00:00 2018-08-10 12:26:07+00:00 FX248 Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 31 +41 Pacemaker 275192 phv00275192.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:26:32+00:00 2018-08-10 12:26:32+00:00 fy248 Electrocardiograph: Rhythm - predominant Collection Interval: Original Cohort Exam 32 +41 Pacemaker 76371 phv00076371.v6.p10 pht000908.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:41:39+00:00 2018-08-10 12:41:39+00:00 ECGLOC ECG location +41 Pacemaker 253889 phv00253889.v1.p10 pht003334.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-10 12:41:51+00:00 2018-08-10 12:41:51+00:00 ECGLOC ECG location Collection Interval: Cases reviewed 1/1949 - 12/2012 +41 Pacemaker 193137 phv00193137.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 15:47:34+00:00 2018-08-20 15:47:34+00:00 AFPACEMKR AV node ablation and pacemaker +41 Pacemaker 283522 phv00283522.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 15:47:34+00:00 2018-08-20 15:47:34+00:00 PACEMKRHX F136 History of pacemaker +42 Hematocrit 127614 phv00127614.v1.p1 pht001959.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:22:25+00:00 2018-03-16 01:22:25+00:00 HEMATOCRIT Hematocrit % +42 Hematocrit 207255 phv00207255.v1.p1 pht004107.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:41:41+00:00 2018-03-19 20:41:41+00:00 HMTA01 Hematocrit % (MAV). Q1 [Hematology Form, exam 1] +42 Hematocrit 207270 phv00207270.v1.p1 pht004108.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:42:01+00:00 2018-03-19 20:42:01+00:00 HMTB01 Hematocrit % (MAV). Q1 [Hematology Form, exam 2] +42 Hematocrit 207289 phv00207289.v1.p1 pht004109.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:42:25+00:00 2018-03-19 20:42:25+00:00 HMTC5 Hematocrit. Q5 [Hematology Lab, exam 3] +42 Hematocrit 207301 phv00207301.v1.p1 pht004110.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:42:55+00:00 2018-03-19 20:42:55+00:00 HMTC5 Hematocrit. Q5 [Hematology Lab, exam 4] +42 Hematocrit 128724 phv00128724.v1.p3 pht001984.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:40:15+00:00 2018-04-24 23:40:15+00:00 hctdifa HEMATOCRIT FROM CBC DIFFERENTIAL, % +42 Hematocrit 218992 phv00218992.v1.p3 pht004319.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-24 23:40:23+00:00 2018-04-24 23:40:23+00:00 hct5 HEMATOCRIT (%) +42 Hematocrit 81031 phv00081031.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:33:38+00:00 2018-06-05 15:33:38+00:00 HCT Hematocrit Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +42 Hematocrit 172181 phv00172181.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:34:05+00:00 2018-06-05 15:34:05+00:00 HCT Hematocrit (sample type: whole blood) +42 Hematocrit 227028 phv00227028.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:34:41+00:00 2018-06-05 15:34:41+00:00 HCT Hematocrit (sample type: whole blood) +42 Hematocrit 7643 phv00007643.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:02:22+00:00 2018-06-18 17:02:22+00:00 A141 H.C.T. +42 Hematocrit 7555 phv00007555.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:02:44+00:00 2018-06-18 17:02:44+00:00 A28 HEMATOCRIT +42 Hematocrit 7952 phv00007952.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:03:03+00:00 2018-06-18 17:03:03+00:00 B334 BLOOD ANALYSIS: HEMATOCRIT +42 Hematocrit 8111 phv00008111.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:03:31+00:00 2018-06-18 17:03:31+00:00 B764 HCT +42 Hematocrit 1202 phv00001202.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:04:08+00:00 2018-06-18 17:04:08+00:00 FB25 BLOOD ANALYSIS: HEMATOCRIT +42 Hematocrit 1376 phv00001376.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:04:35+00:00 2018-06-18 17:04:35+00:00 FC18 HEMATOCRIT +42 Hematocrit 1579 phv00001579.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:04:53+00:00 2018-06-18 17:04:53+00:00 FD34 BLOOD ANALYSIS, HEMATOCRIT +42 Hematocrit 1815 phv00001815.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:05:15+00:00 2018-06-18 17:05:15+00:00 FE81 BLOOD ANALYSIS, HEMATOCRIT +42 Hematocrit 2030 phv00002030.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:06:25+00:00 2018-06-18 17:06:25+00:00 FF77 BLOOD ANALYSIS, HEMATOCRIT +42 Hematocrit 2414 phv00002414.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:06:48+00:00 2018-06-18 17:06:48+00:00 FG310 BLOOD ANALYSIS, HEMATOCRIT +42 Hematocrit 2652 phv00002652.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:07:07+00:00 2018-06-18 17:07:07+00:00 FH329 BLOOD ANALYSIS: HEMATOCRIT +42 Hematocrit 2679 phv00002679.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:07:46+00:00 2018-06-18 17:07:46+00:00 FI27 BLOOD ANALYSIS, HEMATOCRIT (%) +42 Hematocrit 3258 phv00003258.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:08:15+00:00 2018-06-18 17:08:15+00:00 FJ380 BLOOD ANALYSIS: HEMATOCRIT (%) +42 Hematocrit 3664 phv00003664.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:08:40+00:00 2018-06-18 17:08:40+00:00 FK455 BLOOD ANALYSIS: HEMATOCRIT (%) +42 Hematocrit 4080 phv00004080.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:09:33+00:00 2018-06-18 17:09:33+00:00 FL522 BLOOD ANALYSIS-HEMATOCRIT +42 Hematocrit 4516 phv00004516.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:10:04+00:00 2018-06-18 17:10:04+00:00 FM542 BLOOD ANALYSIS - HEMATOCRIT +42 Hematocrit 4936 phv00004936.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:10:31+00:00 2018-06-18 17:10:31+00:00 FN511 BLOOD ANALYSIS - HEMATOCRIT +42 Hematocrit 677 phv00000677.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:11:01+00:00 2018-06-18 17:11:01+00:00 MF213 BLOOD ANALYSIS: HEMATOCRIT, EXAM 4 +42 Hematocrit 765 phv00000765.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:11:38+00:00 2018-06-18 17:11:38+00:00 MF313 BLOOD ANALYSIS: HEMATOCRIT, EXAM 5 +42 Hematocrit 842 phv00000842.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:12:01+00:00 2018-06-18 17:12:01+00:00 MF393 BLOOD ANALYSIS: HEMATOCRIT, EXAM 6 +42 Hematocrit 929 phv00000929.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:12:45+00:00 2018-06-18 17:12:45+00:00 MF487 BLOOD ANALYSIS: HEMATOCRIT, EXAM 7 +42 Hematocrit 276854 phv00276854.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:13:19+00:00 2018-06-18 17:13:19+00:00 CHF045 Hematologic - Hct +42 Hematocrit 1047 phv00001047.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 17:14:15+00:00 2018-06-18 17:14:15+00:00 FA13 HEMATOCRIT (PERCENT) +42 Hematocrit 112689 phv00112689.v2.p2 pht001563.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:38:23+00:00 2018-07-06 19:38:23+00:00 A05HCT HEMATOCRIT (%) +42 Hematocrit 99860 phv00099860.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:30:38+00:00 2018-07-30 16:30:38+00:00 HEMATO23 HEMATOCRIT (%) +42 Hematocrit 100413 phv00100413.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:30:50+00:00 2018-07-30 16:30:50+00:00 HEMATO23 HEMATOCRIT (%) +42 Hematocrit 105618 phv00105618.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:31:14+00:00 2018-07-30 16:31:14+00:00 HEMATO23 HEMATOCRIT (%) +42 Hematocrit 106920 phv00106920.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:31:41+00:00 2018-07-30 16:31:41+00:00 HEMATO23 HEMATOCRIT (%) +42 Hematocrit 77365 phv00077365.v6.p3 pht000986.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 15:48:59+00:00 2018-08-20 15:48:59+00:00 HEMATOCR Hematocrit (%) +42 Hematocrit 283662 phv00283662.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 15:48:59+00:00 2018-08-20 15:48:59+00:00 HEMATOCRIT F136 Hematocrit, % +42 Hematocrit 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:23:05+00:00 2018-08-20 22:23:05+00:00 TESTVAL Test Result Value +42 Hematocrit 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:23:05+00:00 2018-08-20 22:23:05+00:00 TESTNAME Test Name +42 Hematocrit 226303 phv00226303.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:40:50+00:00 2018-08-22 21:40:50+00:00 LABA4 % Hematocrit (LABA4) +42 Hematocrit 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:00:14+00:00 2018-08-23 18:00:14+00:00 TESTABBR Test abbreviation +42 Hematocrit 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:00:14+00:00 2018-08-23 18:00:14+00:00 TESTDESC Test Description +42 Hematocrit 253008 phv00253008.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:21:32+00:00 2018-08-24 17:21:32+00:00 hematocrit_baseline Hematocrit value at baseline visit +43 Hemoglobin 127615 phv00127615.v1.p1 pht001959.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:15:26+00:00 2018-03-16 01:15:26+00:00 HEMOGLOBIN Hemoglobin G/DL +43 Hemoglobin 207256 phv00207256.v1.p1 pht004107.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:52:55+00:00 2018-03-19 20:52:55+00:00 HMTA02 Hemoglobin g/dL (MAV). Q2 [Hematology Form, exam 1] +43 Hemoglobin 207271 phv00207271.v1.p1 pht004108.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:53:17+00:00 2018-03-19 20:53:17+00:00 HMTB02 Hemoglobin g/dL (MAV). Q2 [Hematology Form, exam 2] +43 Hemoglobin 207288 phv00207288.v1.p1 pht004109.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:53:38+00:00 2018-03-19 20:53:38+00:00 HMTC4 Hemoglobin. Q4 [Hematology Lab, exam 3] +43 Hemoglobin 207300 phv00207300.v1.p1 pht004110.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:54:03+00:00 2018-03-19 20:54:03+00:00 HMTC4 Hemoglobin. Q4 [Hematology Lab, exam 4] +43 Hemoglobin 85933 phv00085933.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 03:01:03+00:00 2018-04-25 03:01:03+00:00 hemogl2 SERUM HEMOGLOBIN +43 Hemoglobin 128727 phv00128727.v1.p3 pht001984.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 03:01:13+00:00 2018-04-25 03:01:13+00:00 hgbdifa HEMOGLOBIN FROM CBC DIFFERENTIAL, gm/dl +43 Hemoglobin 218993 phv00218993.v1.p3 pht004319.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 03:01:20+00:00 2018-04-25 03:01:20+00:00 hgb5 HEMOGLOBIN (g/dL) +43 Hemoglobin 81032 phv00081032.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:40:08+00:00 2018-06-05 15:40:08+00:00 HGB Hemoglobin Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +43 Hemoglobin 172180 phv00172180.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:40:29+00:00 2018-06-05 15:40:29+00:00 HGB Hemoglobin (sample type: whole blood) +43 Hemoglobin 227027 phv00227027.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:40:51+00:00 2018-06-05 15:40:51+00:00 HGB Hemoglobin (sample type: whole blood) +43 Hemoglobin 112688 phv00112688.v2.p2 pht001563.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:40:03+00:00 2018-07-06 19:40:03+00:00 A05HGB HEMOGLOBIN (G/DL) +43 Hemoglobin 99859 phv00099859.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:29:15+00:00 2018-07-30 16:29:15+00:00 HEMOGL23 HEMOGLOBIN (g/dl) +43 Hemoglobin 100412 phv00100412.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:29:29+00:00 2018-07-30 16:29:29+00:00 HEMOGL23 HEMOGLOBIN (g/dl) +43 Hemoglobin 105617 phv00105617.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:29:45+00:00 2018-07-30 16:29:45+00:00 HEMOGL23 HEMOGLOBIN (g/dl) +43 Hemoglobin 106919 phv00106919.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:29:59+00:00 2018-07-30 16:29:59+00:00 HEMOGL23 HEMOGLOBIN (g/dl) +43 Hemoglobin 535 phv00000535.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:50:08+00:00 2018-08-09 13:50:08+00:00 MF63 BLOOD ANALYSIS: HEMOGLOBIN, EXAM 1 +43 Hemoglobin 627 phv00000627.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:50:41+00:00 2018-08-09 13:50:41+00:00 MF161 BLOOD ANALYSIS: HEMOGLOBIN, EXAM 2 +43 Hemoglobin 634 phv00000634.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:51:14+00:00 2018-08-09 13:51:14+00:00 MF168 BLOOD ANALYSIS: HEMOGLOBIN, EXAM 3 +43 Hemoglobin 673 phv00000673.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:52:01+00:00 2018-08-09 13:52:01+00:00 MF209 BLOOD ANALYSIS: HEMOGLOBIN, EXAM 4 +43 Hemoglobin 764 phv00000764.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:52:34+00:00 2018-08-09 13:52:34+00:00 MF312 BLOOD ANALYSIS: HEMOGLOBIN, EXAM 5 +43 Hemoglobin 841 phv00000841.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:53:07+00:00 2018-08-09 13:53:07+00:00 MF392 BLOOD ANALYSIS: HEMOGLOBIN, EXAM 6 +43 Hemoglobin 7642 phv00007642.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:57:51+00:00 2018-08-09 13:57:51+00:00 A140 H.G.B. +43 Hemoglobin 8110 phv00008110.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:58:28+00:00 2018-08-09 13:58:28+00:00 B763 HGB +43 Hemoglobin 276333 phv00276333.v1.p10 pht006013.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 13:59:41+00:00 2018-12-12 00:33:03+00:00 zHemoglobin Hemoglobin (Sample type: Citrated plasma) +43 Hemoglobin 276853 phv00276853.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:00:22+00:00 2018-08-09 14:00:22+00:00 CHF044 Hematologic - Hgb +43 Hemoglobin 77366 phv00077366.v6.p3 pht000986.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 15:51:35+00:00 2018-08-20 15:51:35+00:00 HEMOGLBN Hemoglobin (gm/dl) +43 Hemoglobin 283661 phv00283661.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 15:51:35+00:00 2018-08-20 15:51:35+00:00 HEMOGLOBIN F136 Hemoglobin, g/dl +43 Hemoglobin 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 20:22:20+00:00 2018-08-20 20:22:20+00:00 TESTVAL Test Result Value +43 Hemoglobin 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 20:22:20+00:00 2018-08-20 20:22:20+00:00 TESTNAME Test Name +43 Hemoglobin 226302 phv00226302.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:42:57+00:00 2018-08-22 21:42:57+00:00 LABA3 Hemoglobin (g/dL) (LABA3) +43 Hemoglobin 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:01:20+00:00 2018-08-23 18:01:20+00:00 TESTABBR Test abbreviation +43 Hemoglobin 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:01:20+00:00 2018-08-23 18:01:20+00:00 TESTDESC Test Description +43 Hemoglobin 253007 phv00253007.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:19:59+00:00 2018-08-24 17:19:59+00:00 hemoglobin_baseline Hemoglobin value at baseline visit +44 Platelet count 127616 phv00127616.v1.p1 pht001959.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:19:06+00:00 2018-03-16 01:19:06+00:00 PLATELET Platelet TH/CMM +44 Platelet count 207258 phv00207258.v1.p1 pht004107.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:42:53+00:00 2018-03-19 16:42:53+00:00 HMTA04 Platelet count x1000/mm3 (MAV). Q4 [Hematology Form, exam 1] +44 Platelet count 207273 phv00207273.v1.p1 pht004108.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:43:16+00:00 2018-03-19 16:43:16+00:00 HMTB04 Platelet count x1000/mm3 (MAV). Q4 [Hematology Form, exam 2] +44 Platelet count 207294 phv00207294.v1.p1 pht004109.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:43:38+00:00 2018-03-19 16:43:38+00:00 HMTC10 Platelet count Q10 [Hematology Lab, exam 3] +44 Platelet count 207306 phv00207306.v1.p1 pht004110.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:43:57+00:00 2018-03-19 16:43:57+00:00 HMTC10 Platelet count. Q10 [Hematology Lab, exam 4] +44 Platelet count 128760 phv00128760.v1.p3 pht001984.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 21:06:57+00:00 2018-04-25 21:06:57+00:00 pltca PLATELET COUNT x10^3/ul +44 Platelet count 218991 phv00218991.v1.p3 pht004319.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 21:07:03+00:00 2018-04-25 21:07:03+00:00 plt5 PLATELETS (x10E3/uL) +44 Platelet count 81034 phv00081034.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:43:33+00:00 2018-06-05 15:43:33+00:00 PLATELET Platelet Count Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +44 Platelet count 172186 phv00172186.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:44:14+00:00 2018-06-05 15:44:14+00:00 PLT Platelet count (sample type: whole blood) +44 Platelet count 227033 phv00227033.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:44:42+00:00 2018-06-05 15:44:42+00:00 PLT Platelet count (sample type: whole blood) +44 Platelet count 112690 phv00112690.v2.p2 pht001563.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:43:12+00:00 2018-07-06 19:43:12+00:00 A05PLATL PLATELET COUNT +44 Platelet count 99861 phv00099861.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:33:01+00:00 2018-07-30 16:33:01+00:00 PLATE23 PLATELET COUNT (/cc.mm) +44 Platelet count 100414 phv00100414.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:33:19+00:00 2018-07-30 16:33:19+00:00 PLATE23 PLATELET COUNT (/cc.mm) +44 Platelet count 105619 phv00105619.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:33:32+00:00 2018-07-30 16:33:32+00:00 PLATE23 PLATELET COUNT (/cc.mm) +44 Platelet count 106921 phv00106921.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:33:46+00:00 2018-07-30 16:33:46+00:00 PLATE23 PLATELET COUNT (/cc.mm) +44 Platelet count 24567 phv00024567.v5.p10 pht000198.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-08 18:45:03+00:00 2018-08-08 18:45:03+00:00 PRPPC PLATELET COUNT ON PLATELET-RICH PLASMA (NOT WHOLE BLOOD) +44 Platelet count 227102 phv00227102.v1.p10 pht004806.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-08 18:45:22+00:00 2018-08-08 18:45:22+00:00 PRPPC Platelet count on platelet-rich plasma Collection Interval: Exam 1 +44 Platelet count 276856 phv00276856.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-08 18:45:50+00:00 2018-08-08 18:45:50+00:00 CHF047 Hematologic - Platelet +44 Platelet count 77367 phv00077367.v6.p3 pht000986.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 15:54:10+00:00 2018-08-20 15:54:10+00:00 PLATELET Platelet count (Kcell/microliter) +44 Platelet count 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:26:47+00:00 2018-08-20 22:26:47+00:00 TESTVAL Test Result Value +44 Platelet count 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:26:47+00:00 2018-08-20 22:26:47+00:00 TESTNAME Test Name +44 Platelet count 226310 phv00226310.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:52:27+00:00 2018-08-22 21:52:27+00:00 LABA9 Platelet count (x10e9) (LABA9) +44 Platelet count 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:05:23+00:00 2018-08-23 18:05:23+00:00 TESTABBR Test abbreviation +44 Platelet count 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:05:23+00:00 2018-08-23 18:05:23+00:00 TESTDESC Test Description +44 Platelet count 253009 phv00253009.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:21:43+00:00 2018-08-24 17:21:43+00:00 platelet_count_baseline Platelet count at baseline visit +45 Red blood cell count 127629 phv00127629.v1.p1 pht001959.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:21:29+00:00 2018-03-16 01:21:29+00:00 RED_CELL_COUNT Red cell count M/CMM +45 Red blood cell count 207287 phv00207287.v1.p1 pht004109.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:39:27+00:00 2018-03-19 16:39:27+00:00 HMTC3 Red blood count. Q3 [Hematology Lab, exam 3] +45 Red blood cell count 207299 phv00207299.v1.p1 pht004110.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:39:46+00:00 2018-03-19 16:39:46+00:00 HMTC3 Red blood count. Q3 [Hematology Lab, exam 4] +45 Red blood cell count 128762 phv00128762.v1.p3 pht001984.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 21:08:17+00:00 2018-04-25 21:08:17+00:00 rbcdifa RED BLOOD CELL COUNT FROM CBC DIFFERENTIAL, m/cmm +45 Red blood cell count 218990 phv00218990.v1.p3 pht004319.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 21:08:24+00:00 2018-04-25 21:08:24+00:00 rbc5 RED BLOOD CELL (RBC) (x10E6/uL) +45 Red blood cell count 81029 phv00081029.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:45:36+00:00 2018-06-05 15:45:36+00:00 RBC Red Blood Cell Count Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +45 Red blood cell count 172179 phv00172179.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:46:00+00:00 2018-06-05 15:46:00+00:00 RBC Red blood count (sample type: whole blood) +45 Red blood cell count 227026 phv00227026.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:46:37+00:00 2018-06-05 15:46:37+00:00 RBC Red blood cell count (sample type: whole blood) +45 Red blood cell count 112687 phv00112687.v2.p2 pht001563.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:45:10+00:00 2018-07-06 19:45:10+00:00 A05RBC RED CELL COUNT (X 1,000,000) +45 Red blood cell count 226294 phv00226294.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-07-20 15:53:32+00:00 2018-07-20 15:53:32+00:00 LABA2 Red Blood Count (x10e12) (LABA2) +45 Red blood cell count 8109 phv00008109.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 16:56:25+00:00 2018-08-09 16:56:25+00:00 B762 RBC +45 Red blood cell count 7641 phv00007641.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 16:57:31+00:00 2018-08-09 16:57:31+00:00 A139 RED BLOOD COUNT +45 Red blood cell count 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:31:21+00:00 2018-08-20 22:31:21+00:00 TESTVAL Test Result Value +45 Red blood cell count 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:31:21+00:00 2018-08-20 22:31:21+00:00 TESTNAME Test Name +45 Red blood cell count 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:06:01+00:00 2018-08-23 18:06:01+00:00 TESTABBR Test abbreviation +45 Red blood cell count 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:06:01+00:00 2018-08-23 18:06:01+00:00 TESTDESC Test Description +45 Red blood cell count 253010 phv00253010.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:21:53+00:00 2018-08-24 17:21:53+00:00 red_blood_cell_count_baseline Red blood cell count value at baseline visit +46 White blood cell count 127631 phv00127631.v1.p1 pht001959.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:19:58+00:00 2018-03-16 01:19:58+00:00 WBC White blood cells TH/CMM +46 White blood cell count 207257 phv00207257.v1.p1 pht004107.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:33:31+00:00 2018-03-19 16:33:31+00:00 HMTA03 White blood count x1000/mm3 (MAV). Q3 [Hematology Form, exam 1] +46 White blood cell count 207272 phv00207272.v1.p1 pht004108.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:33:54+00:00 2018-03-19 16:33:54+00:00 HMTB03 White blood count x1000/mm3 (MAV). Q3 [Hematology Form, exam 2] +46 White blood cell count 207286 phv00207286.v1.p1 pht004109.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:34:15+00:00 2018-03-19 16:34:15+00:00 HMTC2 White blood count. Q2 [Hematology Lab, exam 3] +46 White blood cell count 207298 phv00207298.v1.p1 pht004110.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:34:34+00:00 2018-03-19 16:34:34+00:00 HMTC2 White blood count. Q2 [Hematology Lab, exam 4] +46 White blood cell count 128764 phv00128764.v1.p3 pht001984.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:18:12+00:00 2018-04-25 22:18:12+00:00 wbca WHITE BLOOD CELL COUNT x10^3/ul +46 White blood cell count 218997 phv00218997.v1.p3 pht004319.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:18:19+00:00 2018-04-25 22:18:19+00:00 wbc5 WHITE BLOOD CELL COUNT (x10E3/uL) +46 White blood cell count 81030 phv00081030.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:48:50+00:00 2018-06-05 15:48:50+00:00 WBC White Blood Cell Count Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +46 White blood cell count 172178 phv00172178.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:49:53+00:00 2018-06-05 15:49:53+00:00 WBC White blood count (sample type: whole blood) +46 White blood cell count 227025 phv00227025.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:50:22+00:00 2018-06-05 15:50:22+00:00 WBC White blood cell count (sample type: whole blood) +46 White blood cell count 7640 phv00007640.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 16:52:53+00:00 2018-06-18 16:52:53+00:00 A138 WHITE BLOOD COUNT +46 White blood cell count 8108 phv00008108.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 16:54:03+00:00 2018-06-18 16:54:03+00:00 B761 WBC +46 White blood cell count 276855 phv00276855.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-18 16:54:41+00:00 2018-06-18 16:54:41+00:00 CHF046 Hematologic - WBC +46 White blood cell count 112686 phv00112686.v2.p2 pht001563.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:46:04+00:00 2018-07-06 19:46:04+00:00 A05WBC WHITE CELL COUNT (X 1000) +46 White blood cell count 99858 phv00099858.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:34:27+00:00 2018-07-30 16:34:27+00:00 WBLD23 WHITE BLOOD COUNT (x1,000/cubic mm) +46 White blood cell count 100411 phv00100411.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:34:39+00:00 2018-07-30 16:34:39+00:00 WBLD23 WHITE BLOOD COUNT (x1, 000/cubic mm) +46 White blood cell count 105616 phv00105616.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:34:50+00:00 2018-07-30 16:34:50+00:00 WBLD23 WHITE BLOOD COUNT (x1,000/cubic mm) +46 White blood cell count 106918 phv00106918.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:35:07+00:00 2018-07-30 16:35:07+00:00 WBLD23 WHITE BLOOD COUNT (x1, 000/cubic mm) +46 White blood cell count 77368 phv00077368.v6.p3 pht000986.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:32:37+00:00 2018-08-20 22:32:37+00:00 WBC White blood cell (Kcell/microliter) +46 White blood cell count 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:32:37+00:00 2018-08-20 22:32:37+00:00 TESTVAL Test Result Value +46 White blood cell count 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:32:37+00:00 2018-08-20 22:32:37+00:00 TESTNAME Test Name +46 White blood cell count 226283 phv00226283.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:36:52+00:00 2018-08-22 21:36:52+00:00 LABA1 White blood count (x10e9) (LABA1) +46 White blood cell count 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:09:48+00:00 2018-08-23 18:09:48+00:00 TESTABBR Test abbreviation +46 White blood cell count 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:09:48+00:00 2018-08-23 18:09:48+00:00 TESTDESC Test Description +46 White blood cell count 253006 phv00253006.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:19:43+00:00 2018-08-24 17:19:43+00:00 white_blood_cell_count_baseline White blood cell count value at baseline visit +47 Fibrinogen in blood 206650 phv00206650.v1.p1 pht004098.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:49:19+00:00 2018-03-19 16:49:19+00:00 HEMA09 Fibrinogen value [Hemostasis Lab, exam 1] +47 Fibrinogen in blood 206658 phv00206658.v1.p1 pht004099.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:49:37+00:00 2018-03-19 16:49:37+00:00 HEMC03 Fibrinogen value [Hemostasis Lab, exam 3] +47 Fibrinogen in blood 85014 phv00085014.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:20:25+00:00 2018-04-25 22:20:25+00:00 fib1 FIBRINOGEN ANTIGEN (mg/dl) +47 Fibrinogen in blood 82965 phv00082965.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:20:33+00:00 2018-04-25 22:20:33+00:00 fib1 FIBRINOGEN ANTIGEN (mg/dl) +47 Fibrinogen in blood 86823 phv00086823.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:20:45+00:00 2018-04-25 22:20:45+00:00 fib4 FIBRINOGEN ANTIGEN (mg/dl) +47 Fibrinogen in blood 160532 phv00160532.v1.p3 pht002198.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:20:50+00:00 2018-04-25 22:20:50+00:00 fibrgn3 FIBRINOGEN (mg/dL) +47 Fibrinogen in blood 115091 phv00115091.v2.p2 pht001642.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:49:02+00:00 2018-07-06 19:49:02+00:00 BLEFIBR FIBRINOGEN (MG/DL) +47 Fibrinogen in blood 116363 phv00116363.v2.p2 pht001694.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:49:02+00:00 2018-07-06 19:49:02+00:00 CLEFIBR FIBRINOGEN (MG/DL) +47 Fibrinogen in blood 117550 phv00117550.v2.p2 pht001736.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:49:02+00:00 2018-07-06 19:49:02+00:00 DLEFIBR2 Y7 FIBRINOGEN (MG/DL) - 2003 RUN +47 Fibrinogen in blood 117558 phv00117558.v2.p2 pht001739.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:49:02+00:00 2018-07-06 19:49:02+00:00 DLEFIBR FIBRINOGEN (MG/DL) +47 Fibrinogen in blood 116349 phv00116349.v2.p2 pht001692.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-14 19:46:26+00:00 2018-07-14 19:46:26+00:00 CL6FIBR PLASMA FIBRINOGEN (MG/DL) +47 Fibrinogen in blood 100037 phv00100037.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:37:10+00:00 2018-07-30 16:37:10+00:00 FIB44 FIBRINOGEN (mg/dl) +47 Fibrinogen in blood 100423 phv00100423.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:38:47+00:00 2018-07-30 16:38:47+00:00 FIB44 FIBRINOGEN (mg/dl) +47 Fibrinogen in blood 105862 phv00105862.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:39:22+00:00 2018-07-30 16:39:22+00:00 FIB44 FIBRINOGEN (mg/dl) +47 Fibrinogen in blood 106987 phv00106987.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:39:36+00:00 2018-07-30 16:39:36+00:00 FIB44 FIBRINOGEN (mg/dl) +47 Fibrinogen in blood 1384 phv00001384.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 17:54:14+00:00 2018-08-06 17:54:14+00:00 FC26 BLOOD ANALYSIS: FIBRINOGEN (MG/100 ML) +47 Fibrinogen in blood 5553 phv00005553.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 17:55:45+00:00 2018-08-06 17:55:45+00:00 FO734 BLOOD ANALYSIS - FIBRINOGEN +47 Fibrinogen in blood 6029 phv00006029.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 17:56:12+00:00 2018-08-06 17:56:12+00:00 FP598 BLOOD ANALYSIS - FIBRINOGEN +47 Fibrinogen in blood 21397 phv00021397.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 17:56:36+00:00 2018-08-06 17:56:36+00:00 G3A718 FIBRINOGEN MG/DL +47 Fibrinogen in blood 21747 phv00021747.v1.p10 pht000086.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 17:57:16+00:00 2018-08-06 17:57:16+00:00 FIB FIBRINOGEN IN MG/DL - FIBRINOGEN LEVELS WERE PERFORMED FROM CITRATED PLASMA ON AN ELECTRA 800 AUTOMATIC COAGULATION TIMER (MEDICAL LABORATORY AUTOMATION, INC., PLEASANTVILLE, N.Y.) USING COMMERCIAL REAGENTS. +47 Fibrinogen in blood 21740 phv00021740.v5.p10 pht000084.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 18:51:37+00:00 2018-08-06 18:51:37+00:00 FIBRINOG FIBRINOGEN VALUE +47 Fibrinogen in blood 21745 phv00021745.v5.p10 pht000085.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 18:52:10+00:00 2018-08-06 18:52:10+00:00 FIBRIN FIBRINOGEN (MG/100ML) +47 Fibrinogen in blood 21754 phv00021754.v5.p10 pht000087.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 18:53:07+00:00 2018-08-06 18:53:07+00:00 FIBRNGEN FIBRINOGEN FROM PLASMA (MG/100ML) +47 Fibrinogen in blood 275425 phv00275425.v1.p10 pht006012.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 18:53:59+00:00 2018-08-06 18:53:59+00:00 FIBRNGEN Concentration of fibrinogen +47 Fibrinogen in blood 227093 phv00227093.v1.p10 pht004806.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 18:54:21+00:00 2018-08-06 18:54:21+00:00 FIBRIN Fibrinogen Collection Interval: Exam 1 +47 Fibrinogen in blood 21748 phv00021748.v1.p10 pht000086.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-06 18:56:25+00:00 2018-08-06 18:56:25+00:00 QBC FIBRINOGEN IN MG/DL- QBC METHOD +47 Fibrinogen in blood 277398 phv00277398.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:18:58+00:00 2018-08-14 22:18:58+00:00 FIBRINOGEN Fibrinogen level result value Collection Interval: 2009-2011 +47 Fibrinogen in blood 277842 phv00277842.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:09:09+00:00 2018-08-14 23:09:09+00:00 FIBR Fibrinogen level result value Collection Interval: 2000-2004 +47 Fibrinogen in blood 308035 phv00308035.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:12:27+00:00 2018-08-16 00:12:27+00:00 FIBR Fibrinogen level result value Collection Interval: 2000-2004 +47 Fibrinogen in blood 77383 phv00077383.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:36:15+00:00 2018-08-20 22:36:15+00:00 COREFIBR Core Fibrinogen (mg/dl) +47 Fibrinogen in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:36:15+00:00 2018-08-20 22:36:15+00:00 TESTVAL Test Result Value +47 Fibrinogen in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-20 22:36:15+00:00 2018-08-20 22:36:15+00:00 TESTNAME Test Name +47 Fibrinogen in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:55:28+00:00 2018-08-23 17:55:28+00:00 TESTABBR Test abbreviation +47 Fibrinogen in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:55:28+00:00 2018-08-23 17:55:28+00:00 TESTDESC Test Description +47 Fibrinogen in blood 252991 phv00252991.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:14:05+00:00 2018-08-24 17:14:05+00:00 fibrinogen_baseline Fibrinogen value at baseline visit +48 Factor VII 206651 phv00206651.v1.p1 pht004098.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:47:41+00:00 2018-03-19 16:47:41+00:00 HEMA11 Factor VII value [Hemostasis Lab, exam 1] +48 Factor VII 206657 phv00206657.v1.p1 pht004099.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:48:04+00:00 2018-03-19 16:48:04+00:00 HEMC01 Factor VII value [Hemostasis Lab, exam 3] +48 Factor VII 116361 phv00116361.v2.p2 pht001694.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:51:17+00:00 2018-07-06 19:51:17+00:00 CLEFACT7 FACTOR VII (%) +48 Factor VII 115090 phv00115090.v2.p2 pht001642.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:52:17+00:00 2018-07-06 19:52:17+00:00 BLEFACT7 FACTOR VII (%) +48 Factor VII 117556 phv00117556.v2.p2 pht001739.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:52:18+00:00 2018-07-06 19:52:18+00:00 DLEFACT7 FACTOR VII (%) +48 Factor VII 117563 phv00117563.v2.p2 pht001739.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-14 19:49:05+00:00 2018-07-14 19:49:05+00:00 DLEF7ANT FACTOR VII ANTIGEN (%) +48 Factor VII 100038 phv00100038.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:40:29+00:00 2018-07-30 16:40:29+00:00 F744 FACTOR VII (%) +48 Factor VII 100424 phv00100424.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:40:43+00:00 2018-07-30 16:40:43+00:00 F744 FACTOR VII (%) +48 Factor VII 105863 phv00105863.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:40:58+00:00 2018-07-30 16:40:58+00:00 F744 FACTOR VII (%) +48 Factor VII 106988 phv00106988.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:41:13+00:00 2018-07-30 16:41:13+00:00 F744 FACTOR VII (%) +48 Factor VII 24570 phv00024570.v5.p10 pht000198.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 16:51:10+00:00 2018-08-07 16:51:10+00:00 FACTOR7 FACTOR VII (%) +48 Factor VII 227096 phv00227096.v1.p10 pht004806.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 16:51:45+00:00 2018-08-07 16:51:45+00:00 FACTOR7 Factor VII Collection Interval: Exam 1 +48 Factor VII 275764 phv00275764.v1.p10 pht006013.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 16:53:04+00:00 2018-08-07 16:53:04+00:00 zCoagulation_Factor_VII Coagulation_Factor_VII (Sample type: Citrated plasma) +48 Factor VII 77381 phv00077381.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:02:51+00:00 2018-08-21 00:02:51+00:00 COREF7AG Core Factor VII Antigen, activity (%) +48 Factor VII 77382 phv00077382.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:02:51+00:00 2018-08-21 00:02:51+00:00 COREF7C Core Factor VII concentration (%) +48 Factor VII 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:02:51+00:00 2018-08-21 00:02:51+00:00 TESTVAL Test Result Value +48 Factor VII 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:02:51+00:00 2018-08-21 00:02:51+00:00 TESTNAME Test Name +48 Factor VII 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:54:44+00:00 2018-08-23 17:54:44+00:00 TESTABBR Test abbreviation +48 Factor VII 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:54:44+00:00 2018-08-23 17:54:44+00:00 TESTDESC Test Description +49 Factor VIII 206649 phv00206649.v1.p1 pht004098.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:47:06+00:00 2018-03-19 16:47:06+00:00 HEMA07 Factor VIII C value [Hemostasis Lab, exam 1] +49 Factor VIII 84463 phv00084463.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:51:12+00:00 2018-04-25 22:51:12+00:00 f81c CALIBRATED FACTOR VIII (%) +49 Factor VIII 85019 phv00085019.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:51:20+00:00 2018-04-25 22:51:20+00:00 f81 FACTOR VIII (%) +49 Factor VIII 160522 phv00160522.v1.p3 pht002105.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:52:19+00:00 2018-04-25 22:52:19+00:00 fviii_ss FACTOR VIII % +49 Factor VIII 116362 phv00116362.v2.p2 pht001694.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:54:02+00:00 2018-07-06 19:54:02+00:00 CLEFACT8 FACTOR VIII (%) +49 Factor VIII 117557 phv00117557.v2.p2 pht001739.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:54:02+00:00 2018-07-06 19:54:02+00:00 DLEFACT8 FACTOR VIII (%) +49 Factor VIII 100039 phv00100039.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:42:01+00:00 2018-07-30 16:42:01+00:00 F844 FACTOR VIII (%) +49 Factor VIII 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:04:25+00:00 2018-08-21 00:04:25+00:00 TESTVAL Test Result Value +49 Factor VIII 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:04:25+00:00 2018-08-21 00:04:25+00:00 TESTNAME Test Name +49 Factor VIII 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:55:12+00:00 2018-08-23 17:55:12+00:00 TESTABBR Test abbreviation +49 Factor VIII 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:55:12+00:00 2018-08-23 17:55:12+00:00 TESTDESC Test Description +50 von Willebrand factor 206654 phv00206654.v1.p1 pht004098.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:45:40+00:00 2018-03-19 16:45:40+00:00 HEMA17 Von Willebrand Factor - Antigen value [Hemostasis Lab, exam 1] +50 von Willebrand factor 85076 phv00085076.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 22:52:56+00:00 2018-04-25 22:52:56+00:00 vwf1 PERCENT VON WILLEBRAND FACTOR (vWF) +50 von Willebrand factor 115092 phv00115092.v2.p2 pht001642.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:56:44+00:00 2018-07-06 19:56:44+00:00 BLEVWANT VON WILLEBRAND ANTIGEN (%) +50 von Willebrand factor 116364 phv00116364.v2.p2 pht001694.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:56:44+00:00 2018-07-06 19:56:44+00:00 CLEVWANT VON WILLEBRAND ANTIGEN (%) +50 von Willebrand factor 116365 phv00116365.v2.p2 pht001694.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:56:44+00:00 2018-07-06 19:56:44+00:00 CLEVWACT VON WILLEBRAND ACTIVITY (%) +50 von Willebrand factor 117559 phv00117559.v2.p2 pht001739.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:56:44+00:00 2018-07-06 19:56:44+00:00 DLEVWANT VON WILLEBRAND ANTIGEN (%) +50 von Willebrand factor 117560 phv00117560.v2.p2 pht001739.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-06 19:56:44+00:00 2018-07-06 19:56:44+00:00 DLEVWACT VON WILLEBRAND ACTIVITY (%) +50 von Willebrand factor 227097 phv00227097.v1.p10 pht004806.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 16:59:40+00:00 2018-08-07 16:59:40+00:00 vwf Von Willebrand factor Collection Interval: Exam 1 +50 von Willebrand factor 275717 phv00275717.v1.p10 pht006013.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 17:00:25+00:00 2018-12-12 00:33:03+00:00 zvWF VWF (Sample type: Citrated plasma) +50 von Willebrand factor 24571 phv00024571.v5.p10 pht000198.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 17:01:07+00:00 2018-08-07 17:01:07+00:00 VW_FACTO VON WILLEBRAND FACTOR (%) +50 von Willebrand factor 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:05:52+00:00 2018-08-21 00:05:52+00:00 TESTVAL Test Result Value +50 von Willebrand factor 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:05:52+00:00 2018-08-21 00:05:52+00:00 TESTNAME Test Name +50 von Willebrand factor 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:09:26+00:00 2018-08-23 18:09:26+00:00 TESTABBR Test abbreviation +50 von Willebrand factor 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:09:26+00:00 2018-08-23 18:09:26+00:00 TESTDESC Test Description +51 VTE 202930 phv00202930.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 13:58:00+00:00 2018-04-25 13:58:00+00:00 AFUcomp7e_G [General health]. Has a doctor ever said you had any of the following? Blood clot in a leg [deep vein thrombosis] [Annual Follow-up Questionnaire Form, AFUG] +51 VTE 202992 phv00202992.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 13:58:15+00:00 2018-04-25 13:58:15+00:00 AFUcomp16d_L [General health]. Were you hospitalized for a blood clot in a leg or deep vein thrombosis at that time? [Annual Follow-up Questionnaire Form, AFUL] +51 VTE 203035 phv00203035.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 13:58:28+00:00 2018-04-25 13:58:28+00:00 AFUcomp16_M [General health]. Since we last contacted you has a doctor said that you had a blood clot in a leg or deep vein thrombosis? [Annual Follow-up Questionnaire Form, AFUM] +51 VTE 207698 phv00207698.v1.p1 pht004125.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 13:58:42+00:00 2018-04-25 13:58:42+00:00 MHQA9A Has a doctor ever told you that you had a blood clot in a leg (deep vein thrombosis)? This does not include varicose veins or phlebitis. Q9A [Medical History Questionnaire, exam 4] +51 VTE 121341 phv00121341.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-14 20:01:56+00:00 2018-07-14 20:01:56+00:00 Y01VTD VENOUS THROMBOEMBOLIC DISEASE +51 VTE 121466 phv00121466.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-14 20:02:20+00:00 2018-07-14 20:02:20+00:00 Y00VT_PE DISCHG DIAG - VENOUS THROMB/PULMONARY EMBOL +51 VTE 121560 phv00121560.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-14 20:03:18+00:00 2018-07-14 20:03:18+00:00 Y01VTD VENOUS THROMBOEMBOLIC DISEASE +51 VTE 273565 phv00273565.v1.p1 pht005981.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:43:46+00:00 2018-07-30 16:43:46+00:00 vt Lite: VT case (through dec01) +51 VTE 273566 phv00273566.v1.p1 pht005981.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:44:00+00:00 2018-07-30 16:44:00+00:00 ttoevent Days from baseline to VT or censoring (through dec01) +51 VTE 273567 phv00273567.v1.p1 pht005981.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:44:12+00:00 2018-07-30 16:44:12+00:00 vtpehx01 LITE : Self-report of DVT or PE at baseline +51 VTE 273568 phv00273568.v1.p1 pht005981.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:44:23+00:00 2018-07-30 16:44:23+00:00 second LITE: primary or secondary VTE by MD review (through dec01) +51 VTE 276977 phv00276977.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:02:27+00:00 2018-08-09 15:02:27+00:00 EVENT1 First event Collection Interval: 1975 through 2014 +51 VTE 276978 phv00276978.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:02:46+00:00 2018-08-09 15:02:46+00:00 EVENT2 Second event Collection Interval: 1975 through 2014 +51 VTE 276979 phv00276979.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:03:15+00:00 2018-08-09 15:03:15+00:00 EVENT3 Third event Collection Interval: 1975 through 2014 +51 VTE 276980 phv00276980.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:03:36+00:00 2018-08-09 15:03:36+00:00 EVENT4 Fourth event Collection Interval: 1975 through 2014 +51 VTE 7028 phv00007028.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:04:27+00:00 2018-08-09 15:04:27+00:00 FS434 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - LEFT +51 VTE 7029 phv00007029.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:04:54+00:00 2018-08-09 15:04:54+00:00 FS435 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - RIGHT +51 VTE 7461 phv00007461.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:05:33+00:00 2018-08-09 15:05:33+00:00 FT437 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) +51 VTE 10342 phv00010342.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:06:29+00:00 2018-08-09 15:06:29+00:00 G220 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - LEFT +51 VTE 10343 phv00010343.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:07:13+00:00 2018-08-09 15:07:13+00:00 G221 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - RIGHT +51 VTE 70486 phv00070486.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:08:05+00:00 2018-08-09 15:08:05+00:00 FU149 VENOUS DISEASE: SINCE LAST EXAM HAVE YOU HAD A DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) +51 VTE 70487 phv00070487.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:08:45+00:00 2018-08-09 15:08:45+00:00 FU150 VENOUS DISEASE: SINCE LAST EXAM HAVE YOU HAD A PULMONARY EMBOLUS (BLOOD CLOTS IN LUNGS) +51 VTE 255326 phv00255326.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:09:42+00:00 2018-08-09 15:09:42+00:00 fw597 Circulatory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Blood clot or embolism in leg or lung Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +51 VTE 275051 phv00275051.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:11:38+00:00 2018-08-09 15:11:38+00:00 FX597 Circulatory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for blood clot or embolism in leg or lung? Collection Interval: Original Cohort Exam 31 +51 VTE 275385 phv00275385.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:12:11+00:00 2018-08-09 15:12:11+00:00 fy597 Circulatory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for blood clot or embolism in leg or lung? Collection Interval: Original Cohort Exam 32 +51 VTE 21065 phv00021065.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:20:09+00:00 2018-08-09 15:20:09+00:00 G3A230 HAVE YOU EVER HAD A DEEP VEIN THROMBOSIS (BLOOD IN LEG OR ARMS) +51 VTE 273898 phv00273898.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:20:31+00:00 2018-08-09 15:20:31+00:00 g3a230 Have you ever had a deep vein thrombosis (blood in leg or arms) Collection Interval: Exam 1 +51 VTE 274391 phv00274391.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:20:55+00:00 2018-08-09 15:20:55+00:00 g3a230 Have you ever had a deep vein thrombosis (blood in leg or arms) +51 VTE 1100 phv00001100.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:21:38+00:00 2018-08-09 15:21:38+00:00 FA81 HOSPITALIZED SINCE LAST EXAM FOR PULMONARY EMBOLUS +51 VTE 21066 phv00021066.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:22:24+00:00 2018-08-09 15:22:24+00:00 G3A231 HAVE YOU EVER HAD A PULMONARY EMBOLUS (BLOOD CLOT IN LUNGS) +51 VTE 273899 phv00273899.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:22:52+00:00 2018-08-09 15:22:52+00:00 g3a231 Have you ever had a pulmonary embolus (blood clot in lungs) Collection Interval: Exam 1 +51 VTE 274392 phv00274392.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:23:17+00:00 2018-08-09 15:23:17+00:00 g3a231 Have you ever had a pulmonary embolus (blood clot in lungs) +51 VTE 257557 phv00257557.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:24:10+00:00 2018-08-09 15:24:10+00:00 j803 Ankle Brachial Blood Pressure Measurements: Had any problems with blood clots in legs? +51 VTE 71923 phv00071923.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:26:48+00:00 2018-08-09 15:26:48+00:00 PE024 PE FINAL DIAGNOSTIC SUMMARY: SOE 110 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71924 phv00071924.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:27:16+00:00 2018-08-09 15:27:16+00:00 PE025 PE FINAL DIAGNOSTIC SUMMARY: SOE 111 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71925 phv00071925.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:27:36+00:00 2018-08-09 15:27:36+00:00 PE026 PE FINAL DIAGNOSTIC SUMMARY: SOE 112 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71926 phv00071926.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:28:00+00:00 2018-08-09 15:28:00+00:00 PE027 PE FINAL DIAGNOSTIC SUMMARY: SOE 113 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71927 phv00071927.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:28:22+00:00 2018-08-09 15:28:22+00:00 PE028 PE FINAL DIAGNOSTIC SUMMARY: Other PE 1 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71930 phv00071930.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:29:17+00:00 2018-08-09 15:29:17+00:00 PE031 DVT FINAL DIAGNOSTIC SUMMARY: SOE 114 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71931 phv00071931.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:30:12+00:00 2018-08-09 15:30:12+00:00 PE032 DVT FINAL DIAGNOSTIC SUMMARY: Other DVT 1 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 10478 phv00010478.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:34:22+00:00 2018-08-09 15:34:22+00:00 G404 CDI: DEEP VEIN THROMBOSIS +51 VTE 193695 phv00193695.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:15:48+00:00 2018-08-21 00:15:48+00:00 F33VTEHOSP F33 Hospitalized Blood Clot (DVT or PE) +51 VTE 193696 phv00193696.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:15:48+00:00 2018-08-21 00:15:48+00:00 F33VTEHOSPDY Days enrollment to F33 Hospitalized Blood Clot +51 VTE 193697 phv00193697.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:15:48+00:00 2018-08-21 00:15:48+00:00 F33VTEOP F33 Outpatient DVT or PE +51 VTE 193698 phv00193698.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:15:48+00:00 2018-08-21 00:15:48+00:00 F33VTEOPDY Days enrollment to F33 Outpatient DVT or PE +51 VTE 121342 phv00121342.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:30:43+00:00 2018-08-30 00:30:43+00:00 Y01DVTDG DIAGNOSIS FOR DEEP VEIN THROMBOSIS +51 VTE 121349 phv00121349.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:31:38+00:00 2018-08-30 00:31:38+00:00 Y01PEDG DIAGNOSIS FOR PULMONARY EMBOLISM +51 VTE 121486 phv00121486.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:43:49+00:00 2018-08-30 19:43:49+00:00 Y01VTDEP ENDPT - DEEP VEIN THROMB/PULMONARY EMBOL +51 VTE 121270 phv00121270.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:43:57+00:00 2018-08-30 19:43:57+00:00 Y01VTDEP ENDPT - DEEP VEIN THROMB/PULMONARY EMBOL +51 VTE 121561 phv00121561.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:52:40+00:00 2018-08-30 19:52:40+00:00 Y01DVTDG DIAGNOSIS FOR DEEP VEIN THROMBOSIS +51 VTE 121568 phv00121568.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:53:25+00:00 2018-08-30 19:53:25+00:00 Y01PEDG DIAGNOSIS FOR PULMONARY EMBOLISM +51 VTE 121735 phv00121735.v1.p2 pht001874.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:12:00+00:00 2018-08-30 20:12:00+00:00 Z33EPE PULMONARY EMOBOLUS +51 VTE 121860 phv00121860.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:50:48+00:00 2018-09-07 15:50:48+00:00 VTE Ever had a blood clot in your vein +51 VTE 71936 phv00071936.v3.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:56:53+00:00 2018-09-28 14:56:53+00:00 pe004 PULMONARY EMBOLUS: Date of clinical occurrence Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71942 phv00071942.v3.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:57:08+00:00 2018-09-28 14:57:08+00:00 pe011 DEEP VENOUS THROMBOSIS: Date of clinical occurrence Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 277005 phv00277005.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:57:52+00:00 2018-09-28 14:57:52+00:00 EDATE1 First event date Collection Interval: 1975 through 2014 +51 VTE 277006 phv00277006.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:58:07+00:00 2018-09-28 14:58:07+00:00 EDATE2 Second event date Collection Interval: 1975 through 2014 +51 VTE 277007 phv00277007.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:58:24+00:00 2018-09-28 14:58:24+00:00 EDATE3 Third event date Collection Interval: 1975 through 2014 +51 VTE 277008 phv00277008.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:58:38+00:00 2018-09-28 14:58:38+00:00 EDATE4 Fourth event date Collection Interval: 1975 through 2014 +51 VTE 259384 phv00259384.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:14:09+00:00 2018-12-20 19:14:09+00:00 priorvt Prior VT +51 VTE 259388 phv00259388.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:14:20+00:00 2018-12-20 19:14:20+00:00 vttype VT type +52 CRP in blood 125941 phv00125941.v1.p1 pht001945.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:48:04+00:00 2018-03-16 01:48:04+00:00 HSCRP Hscrp: high sensitivity C-reactive protein in mg/dL +52 CRP in blood 116475 phv00116475.v2.p2 pht001705.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:00:15+00:00 2018-04-17 20:00:15+00:00 DL6CRPBN Y7 CRP (BNII Method) in uG per ML +52 CRP in blood 120758 phv00120758.v2.p2 pht001853.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:00:15+00:00 2018-04-17 20:00:15+00:00 FL6CRP C-REACTIVE PROTEIN IN uG PER ML +52 CRP in blood 120759 phv00120759.v2.p2 pht001853.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:00:15+00:00 2018-04-17 20:00:15+00:00 FL6CRPBN RERUN CRP (uG/ml - BNII METHOD) +52 CRP in blood 82967 phv00082967.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:34:38+00:00 2018-04-25 23:34:38+00:00 crp1 C-REACTIVE PROTEIN (CRP) (mg/L) +52 CRP in blood 85015 phv00085015.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:34:46+00:00 2018-04-25 23:34:46+00:00 crp1 C-REACTIVE PROTEIN (CRP) (mg/L) +52 CRP in blood 85016 phv00085016.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:34:52+00:00 2018-04-25 23:34:52+00:00 crp1t NATURAL LOG TRANSFORMED C-REACTIVE PROTEIN (CRP) +52 CRP in blood 87661 phv00087661.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:34:59+00:00 2018-04-25 23:34:59+00:00 crpf C-REACTIVE PROTEIN (CRP), (mg/L) +52 CRP in blood 87662 phv00087662.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:35:07+00:00 2018-04-25 23:35:07+00:00 crpft NATURAL LOG TRANSFORMED C-REACTIVE PROTEIN (CRP) +52 CRP in blood 160534 phv00160534.v1.p3 pht002198.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:35:15+00:00 2018-04-25 23:35:15+00:00 crp3 CRP (mg/L) +52 CRP in blood 86825 phv00086825.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:36:09+00:00 2018-04-25 23:36:09+00:00 crp4 C-REACTIVE PROTEIN (mg/l) +52 CRP in blood 21690 phv00021690.v5.p10 pht000080.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:32:29+00:00 2018-06-05 14:32:29+00:00 CRP CONCENTRATION OF C-REACTIVE PROTEIN, MG/L +52 CRP in blood 21693 phv00021693.v5.p10 pht000081.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:33:54+00:00 2018-06-05 14:33:54+00:00 CRP CONCENTRATION OF C-REACTIVE PROTEIN, MG/L +52 CRP in blood 21697 phv00021697.v5.p10 pht000082.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:34:48+00:00 2018-06-05 14:34:48+00:00 CRP C-REACTIVE PROTEIN FROM SERUM (MG/L) +52 CRP in blood 36343 phv00036343.v4.p10 pht000298.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:35:19+00:00 2018-06-05 14:35:19+00:00 crp CONCENTRATION OF C-REACTIVE PROTEIN, MG/L +52 CRP in blood 172158 phv00172158.v4.p10 pht002888.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:35:56+00:00 2018-06-05 14:35:56+00:00 crp C-Reactive protein +52 CRP in blood 172177 phv00172177.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:09:20+00:00 2018-06-05 15:09:20+00:00 CRP C-reactive protein (CRP) (sample type: serum) +52 CRP in blood 227060 phv00227060.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:09:56+00:00 2018-06-05 15:09:56+00:00 CRP C-reactive protein (sample type: serum) +52 CRP in blood 100498 phv00100498.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:45:46+00:00 2018-07-30 16:45:46+00:00 CRPBLORG C-reactive protein, original values (mg/dL) +52 CRP in blood 100499 phv00100499.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:45:58+00:00 2018-07-30 16:45:58+00:00 CRPBLADJ C-reactive protein, adjusted original va +52 CRP in blood 106421 phv00106421.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:46:11+00:00 2018-07-30 16:46:11+00:00 CRPYR5 C-reactive protein, year5 (mg/L) +52 CRP in blood 107353 phv00107353.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:46:24+00:00 2018-07-30 16:46:24+00:00 CRPYR5 C-reactive protein, year5 (mg/L) +52 CRP in blood 277397 phv00277397.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:18:45+00:00 2018-08-14 22:18:45+00:00 CCRPV C reactive protein result value Collection Interval: 2009-2011 +52 CRP in blood 277841 phv00277841.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:09:19+00:00 2018-08-14 23:09:19+00:00 CCRP C reactive protein result value Collection Interval: 2000-2004 +52 CRP in blood 308034 phv00308034.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:10:28+00:00 2018-08-16 00:10:28+00:00 CCRP C reactive protein result value Collection Interval: 2000-2004 +52 CRP in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:21:34+00:00 2018-08-21 00:21:34+00:00 TESTVAL Test Result Value +52 CRP in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:21:34+00:00 2018-08-21 00:21:34+00:00 TESTNAME Test Name +52 CRP in blood 123990 phv00123990.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:40:47+00:00 2018-08-21 18:40:47+00:00 crpam Crp am (ug/mL) +52 CRP in blood 123991 phv00123991.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:40:53+00:00 2018-08-21 18:40:53+00:00 crpam_orig Crp am - original value +52 CRP in blood 123993 phv00123993.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:40:57+00:00 2018-08-21 18:40:57+00:00 lncrpam Log (Crp am) +52 CRP in blood 123994 phv00123994.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:41:02+00:00 2018-08-21 18:41:02+00:00 crppm Crp pm (ug/mL) +52 CRP in blood 123995 phv00123995.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:41:08+00:00 2018-08-21 18:41:08+00:00 crppm_orig Crp pm - original value +52 CRP in blood 123997 phv00123997.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:41:13+00:00 2018-08-21 18:41:13+00:00 lncrppm Log (crp pm) +52 CRP in blood 124170 phv00124170.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:47:44+00:00 2018-08-21 18:47:44+00:00 ln_crpam Log CRP am +52 CRP in blood 124171 phv00124171.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:47:55+00:00 2018-08-21 18:47:55+00:00 ln_crppm Log CRP pm +52 CRP in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:53:00+00:00 2018-08-23 17:53:00+00:00 TESTABBR Test abbreviation +52 CRP in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:53:00+00:00 2018-08-23 17:53:00+00:00 TESTDESC Test Description +52 CRP in blood 252992 phv00252992.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:14:18+00:00 2018-08-24 17:14:18+00:00 crp_baseline CRP value at baseline visit +53 Interleukin 6 in blood 121064 phv00121064.v2.p2 pht001862.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:02:33+00:00 2018-04-17 20:02:33+00:00 FL6IL6 IL6 PG/ML +53 Interleukin 6 in blood 85009 phv00085009.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:37:31+00:00 2018-04-25 23:37:31+00:00 il61 INTERLEUKIN-6 (IL-6) (pg/mL) +53 Interleukin 6 in blood 85011 phv00085011.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:37:38+00:00 2018-04-25 23:37:38+00:00 il61t NATURAL LOG TRANSFORMED INTERLEUKIN-6 (IL-6) +53 Interleukin 6 in blood 160518 phv00160518.v1.p3 pht002105.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:37:52+00:00 2018-04-25 23:37:52+00:00 il6_ss IL6 (PG/ML) +53 Interleukin 6 in blood 160530 phv00160530.v1.p3 pht002198.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:38:02+00:00 2018-04-25 23:38:02+00:00 il63 IL6 (pg/mL) +53 Interleukin 6 in blood 219027 phv00219027.v1.p3 pht004326.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:38:10+00:00 2018-04-25 23:38:10+00:00 il6_ss IL6 RESULTS (PG/ML) +53 Interleukin 6 in blood 100500 phv00100500.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:47:48+00:00 2018-07-30 16:47:48+00:00 IL6BL IL-6 at baseline (pg/ml) +53 Interleukin 6 in blood 23796 phv00023796.v5.p10 pht000161.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:06:27+00:00 2018-08-09 14:06:27+00:00 il6 INTERLEUKIN-6 FROM SERUM (PG/ML) +53 Interleukin 6 in blood 80999 phv00080999.v3.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:06:48+00:00 2018-08-09 14:06:48+00:00 il6 Interleukin-6 concentration +53 Interleukin 6 in blood 172223 phv00172223.v4.p10 pht002891.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:07:16+00:00 2018-08-09 14:07:16+00:00 il6 Interleukin-6 +53 Interleukin 6 in blood 80991 phv00080991.v3.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:08:36+00:00 2018-08-09 14:08:36+00:00 raw1 Interleukin-6 raw OD reading for first well +53 Interleukin 6 in blood 80992 phv00080992.v3.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:09:38+00:00 2018-08-09 14:09:38+00:00 blcor1 Interleukin-6 baseline corrected OD reading for first well +53 Interleukin 6 in blood 80993 phv00080993.v3.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:10:32+00:00 2018-08-09 14:10:32+00:00 conc1 Interleukin-6 concentration for first well +53 Interleukin 6 in blood 80994 phv00080994.v3.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:11:13+00:00 2018-08-09 14:11:13+00:00 raw2 Interleukin-6 raw OD reading for second well +53 Interleukin 6 in blood 80995 phv00080995.v3.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:11:56+00:00 2018-08-09 14:11:56+00:00 blcor2 Interleukin-6 baseline corrected OD reading for second well +53 Interleukin 6 in blood 80997 phv00080997.v3.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:12:39+00:00 2018-08-09 14:12:39+00:00 mresult Interleukin-6 mean concentration +53 Interleukin 6 in blood 172220 phv00172220.v4.p10 pht002891.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:13:31+00:00 2018-08-09 14:13:31+00:00 res1 Interleukin-6 result for first well +53 Interleukin 6 in blood 172221 phv00172221.v4.p10 pht002891.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:14:17+00:00 2018-08-09 14:14:17+00:00 res2 Interleukin-6 result for second well +53 Interleukin 6 in blood 80996 phv00080996.v3.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 14:14:58+00:00 2018-08-09 14:14:58+00:00 conc2 Interleukin-6 concentration for second well +53 Interleukin 6 in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:23:50+00:00 2018-08-21 00:23:50+00:00 TESTVAL Test Result Value +53 Interleukin 6 in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:23:50+00:00 2018-08-21 00:23:50+00:00 TESTNAME Test Name +53 Interleukin 6 in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:02:17+00:00 2018-08-23 18:02:17+00:00 TESTABBR Test abbreviation +53 Interleukin 6 in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 18:02:17+00:00 2018-08-23 18:02:17+00:00 TESTDESC Test Description +53 Interleukin 6 in blood 252993 phv00252993.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:14:44+00:00 2018-08-24 17:14:44+00:00 il6_baseline IL6 value at baseline visit +54 Creatinine in blood 127612 phv00127612.v1.p1 pht001959.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:35:08+00:00 2018-03-16 01:35:08+00:00 CREATININE Creatinine mg/dL +54 Creatinine in blood 203867 phv00203867.v1.p1 pht004051.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:17:36+00:00 2018-03-19 16:17:36+00:00 CHMA09 Creatinine (mg/dL). Q9 [Clinical Chemistry Lab, exam 1] +54 Creatinine in blood 203883 phv00203883.v1.p1 pht004052.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:17:55+00:00 2018-03-19 16:17:55+00:00 CHMB08 Creatinine (mg Per dL) Dec Pt Req. Q8 [Clinical Chemistry Lab, exam 2] +54 Creatinine in blood 207682 phv00207682.v1.p1 pht004124.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:19:24+00:00 2018-03-19 16:19:24+00:00 LIPD6A Creatinine (value). Q6a [Lipid Lab, exam 4] +54 Creatinine in blood 112413 phv00112413.v2.p2 pht001557.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:06:08+00:00 2018-04-17 20:06:08+00:00 AL3CREAT CREATININE (MG/DL) +54 Creatinine in blood 118008 phv00118008.v2.p2 pht001753.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:06:08+00:00 2018-04-17 20:06:08+00:00 EL7CREAT SERUM CREATININE (mg/dL) +54 Creatinine in blood 119692 phv00119692.v2.p2 pht001807.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:06:08+00:00 2018-04-17 20:06:08+00:00 FL7CREAT SERUM CREATININE (mg/dL) +54 Creatinine in blood 82955 phv00082955.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:40:38+00:00 2018-04-25 23:40:38+00:00 creatin1 CREATININE (mg/dl) +54 Creatinine in blood 84973 phv00084973.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:40:44+00:00 2018-04-25 23:40:44+00:00 creatin1 CREATININE (mg/dl) +54 Creatinine in blood 86403 phv00086403.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:40:51+00:00 2018-04-25 23:40:51+00:00 creatin3 CREATININE (mg/dl) +54 Creatinine in blood 86835 phv00086835.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:40:58+00:00 2018-04-25 23:40:58+00:00 creatin4 CREATININE (mg/dl) +54 Creatinine in blood 87102 phv00087102.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:41:07+00:00 2018-04-25 23:41:07+00:00 creatinf CREATININE (mg/dl) +54 Creatinine in blood 175241 phv00175241.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:41:13+00:00 2018-04-25 23:41:13+00:00 creatin5 SERUM CREATININE (mg/dl) +54 Creatinine in blood 176664 phv00176664.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-25 23:41:20+00:00 2018-04-25 23:41:20+00:00 creatin5 SERUM CREATININE (mg/dl) +54 Creatinine in blood 206961 phv00206961.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:43:08+00:00 2018-05-10 14:43:08+00:00 HFAA44B [Biochemical analysis]. Q44b - Serum creatinine (mg/dL) last [Heart Failure Hospital Record Abstraction Form, HFA] +54 Creatinine in blood 206960 phv00206960.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:43:37+00:00 2018-05-10 14:43:37+00:00 HFAA44A [Biochemical analysis]. Q44a - Serum creatinine (mg/dL) worst [Heart Failure Hospital Record Abstraction Form, HFA] +54 Creatinine in blood 204180 phv00204180.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:44:19+00:00 2018-05-10 14:44:19+00:00 HRAA43DD [Biomarkers]. Serum creatinine. Q43dd [Hospital Abstraction Form] +54 Creatinine in blood 204187 phv00204187.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:44:47+00:00 2018-05-10 14:44:47+00:00 HRAA56AD1 [Biomarkers: day four]. First serum creatinine. Q56ad1 [Hospital Abstraction Form] +54 Creatinine in blood 204188 phv00204188.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:45:10+00:00 2018-05-10 14:45:10+00:00 HRAA56AD3 [Biomarkers: day four]. Second serum creatinine. Q56ad3 [Hospital Abstraction Form] +54 Creatinine in blood 204189 phv00204189.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:45:39+00:00 2018-05-10 14:45:39+00:00 HRAA56AD5 [Biomarkers: day four]. Last serum creatinine. Q56ad5 [Hospital Abstraction Form] +54 Creatinine in blood 276860 phv00276860.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:45:37+00:00 2018-06-04 18:45:37+00:00 CHF054 Chemistry - Creatinine +54 Creatinine in blood 277030 phv00277030.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:46:44+00:00 2018-06-04 18:46:44+00:00 CREAT1 Creatinine, Exam 1 +54 Creatinine in blood 277031 phv00277031.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:46:54+00:00 2018-06-04 18:46:54+00:00 CREAT2 Creatinine, Exam 2 +54 Creatinine in blood 277122 phv00277122.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:47:07+00:00 2018-06-04 18:47:07+00:00 CREAT2 Creatinine, Exam 2 +54 Creatinine in blood 277123 phv00277123.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:47:17+00:00 2018-06-04 18:47:17+00:00 CREAT5 Creatinine, Exam 5 +54 Creatinine in blood 277124 phv00277124.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:47:26+00:00 2018-06-04 18:47:26+00:00 CREAT6 Creatinine, Exam 6 +54 Creatinine in blood 277125 phv00277125.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:47:49+00:00 2018-06-04 18:47:49+00:00 CREAT7 Creatinine, Exam 7 +54 Creatinine in blood 277126 phv00277126.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:48:00+00:00 2018-06-04 18:48:00+00:00 CREAT8 Creatinine, Exam 8 +54 Creatinine in blood 277127 phv00277127.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:48:09+00:00 2018-06-04 18:48:09+00:00 CREAT9 Creatinine, Exam 9 +54 Creatinine in blood 2416 phv00002416.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:49:06+00:00 2018-06-04 18:49:06+00:00 FG312 BLOOD ANALYSIS, CREATININE +54 Creatinine in blood 2654 phv00002654.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:49:26+00:00 2018-06-04 18:49:26+00:00 FH331 BLOOD ANALYSIS: CREATININE +54 Creatinine in blood 6662 phv00006662.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:49:44+00:00 2018-06-04 18:49:44+00:00 FR440 BLOOD ANALYSIS - CREATININE +54 Creatinine in blood 6322 phv00006322.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:50:59+00:00 2018-06-04 18:50:59+00:00 FQ399 CREATININE +54 Creatinine in blood 6665 phv00006665.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:51:54+00:00 2018-06-04 18:51:54+00:00 FS532 CREATININE MG/100ML +54 Creatinine in blood 7526 phv00007526.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:52:11+00:00 2018-06-04 18:52:11+00:00 FT542 CREATININE MG/100ML +54 Creatinine in blood 23207 phv00023207.v5.p10 pht000146.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:52:30+00:00 2018-06-04 18:52:30+00:00 HIT_CREA SERUM CREATININE (MG/100ML) +54 Creatinine in blood 70734 phv00070734.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:53:28+00:00 2018-06-04 18:53:28+00:00 FU579 LAB VALUES: CREATININE, MG/DL +54 Creatinine in blood 21396 phv00021396.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:54:02+00:00 2018-06-04 18:54:02+00:00 G3A717 CREATININE, MG/DL +54 Creatinine in blood 80753 phv00080753.v2.p10 pht001039.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:54:45+00:00 2018-06-04 18:54:45+00:00 screconc Serum creatinine concentration +54 Creatinine in blood 24648 phv00024648.v5.p10 pht000202.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:57:17+00:00 2018-06-05 14:57:17+00:00 CREAT CREATININE (MG/DL) +54 Creatinine in blood 24666 phv00024666.v5.p10 pht000203.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:57:41+00:00 2018-06-05 14:57:41+00:00 CREAT CREATININE (MG/DL) +54 Creatinine in blood 81024 phv00081024.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 14:58:04+00:00 2018-06-05 14:58:04+00:00 CREAT Creatinine Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +54 Creatinine in blood 172175 phv00172175.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:05:04+00:00 2018-06-05 15:05:04+00:00 CREAT Creatinine (sample type: serum) +54 Creatinine in blood 227058 phv00227058.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:05:31+00:00 2018-06-05 15:05:31+00:00 CREAT Creatinine (sample type: serum) +54 Creatinine in blood 255344 phv00255344.v1.p10 pht005143.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:06:45+00:00 2018-06-05 15:06:45+00:00 CREAT Creatinine (sample type: serum) +54 Creatinine in blood 71894 phv00071894.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:07:55+00:00 2018-06-05 15:07:55+00:00 CREATINI Creatinine, serum +54 Creatinine in blood 275417 phv00275417.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:08:17+00:00 2018-06-05 15:08:17+00:00 CREATINI Creatinine (sample type: serum) Collection Interval: Omni 1 Exam 3 +54 Creatinine in blood 275408 phv00275408.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:41:41+00:00 2018-06-05 15:41:41+00:00 HIT_CREA Creatinine (sample type: serum) Collection Interval: Exam 2 +54 Creatinine in blood 126131 phv00126131.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:34:49+00:00 2018-06-12 01:34:49+00:00 CRT01CC Creatinine calibrated to cleveland clinic-equivalent MN LAB (mg/dl) +54 Creatinine in blood 100049 phv00100049.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:48:15+00:00 2018-07-30 16:48:15+00:00 CRE44 CREATININE (mg/dl) +54 Creatinine in blood 100432 phv00100432.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:48:27+00:00 2018-07-30 16:48:27+00:00 CRE44 CREATININE (mg/dl) +54 Creatinine in blood 100484 phv00100484.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:48:38+00:00 2018-07-30 16:48:38+00:00 CREADJ New cohort cre44 adjusted for drift (mg/--incomplete) +54 Creatinine in blood 105871 phv00105871.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:48:56+00:00 2018-07-30 16:48:56+00:00 CRE44 CREATININE (mg/dl) +54 Creatinine in blood 106410 phv00106410.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:49:08+00:00 2018-07-30 16:49:08+00:00 CREADJ Cre44 adjusted for drift +54 Creatinine in blood 106998 phv00106998.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:49:20+00:00 2018-07-30 16:49:20+00:00 CRE44 CREATININE (mg/dl) +54 Creatinine in blood 110488 phv00110488.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:49:34+00:00 2018-07-30 16:49:34+00:00 CRE44 CREATININE (mg/dl) +54 Creatinine in blood 110492 phv00110492.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:49:48+00:00 2018-07-30 16:49:48+00:00 CREADJ CRE44 ADJUSTED FOR DRIFT (mg/dl) +54 Creatinine in blood 124035 phv00124035.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:50:40+00:00 2018-08-14 20:50:40+00:00 creatinine Creatinine (mg/dL) +54 Creatinine in blood 124036 phv00124036.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:50:51+00:00 2018-08-14 20:50:51+00:00 creatinine_orig Creatinine - original value +54 Creatinine in blood 124179 phv00124179.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:51:08+00:00 2018-08-14 20:51:08+00:00 creatinine_gL Creatinine (g/L) +54 Creatinine in blood 277309 phv00277309.v1.p1 pht006031.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:09:46+00:00 2018-08-14 22:09:46+00:00 SCREATP Serum Creatinine Collection Interval: 2007-2009 +54 Creatinine in blood 277403 phv00277403.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:20:54+00:00 2018-08-14 22:20:54+00:00 SCRV Serum Creatinine Average result value Collection Interval: 2009-2011 +54 Creatinine in blood 277578 phv00277578.v1.p1 pht006041.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:44:48+00:00 2018-08-14 22:44:48+00:00 SCR_PLUS Serum Creatinine Collection Interval: 1996-2000 +54 Creatinine in blood 277848 phv00277848.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:10:26+00:00 2018-08-14 23:10:26+00:00 SCR_PLUS Serum Creatinine Collection Interval: 2000-2004 +54 Creatinine in blood 307769 phv00307769.v1.p1 pht006650.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:52:50+00:00 2018-08-15 23:52:50+00:00 SCREATP Serum Creatinine Collection Interval: 2006-2011 +54 Creatinine in blood 307859 phv00307859.v1.p1 pht006655.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:57:17+00:00 2018-08-15 23:57:17+00:00 SCR_PLUS Serum Creatinine Collection Interval: 1996-2000 +54 Creatinine in blood 308041 phv00308041.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:11:58+00:00 2018-08-16 00:11:58+00:00 SCR_PLUS Serum Creatinine Collection Interval: 2000-2004 +54 Creatinine in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:25:02+00:00 2018-08-21 00:25:02+00:00 TESTVAL Test Result Value +54 Creatinine in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:25:02+00:00 2018-08-21 00:25:02+00:00 TESTNAME Test Name +54 Creatinine in blood 283659 phv00283659.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:25:02+00:00 2018-08-21 00:25:02+00:00 SERUMCREAT F136 Serum creatinine, mg/dl +54 Creatinine in blood 226307 phv00226307.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:45:02+00:00 2018-08-22 21:45:02+00:00 LABA76 Creatinine (mg/dL) (LABA76) +54 Creatinine in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-04 22:06:13+00:00 2018-09-04 22:06:13+00:00 TESTABBR Test abbreviation +54 Creatinine in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-04 22:12:32+00:00 2018-09-04 22:12:32+00:00 TESTDESC Test Description +54 Creatinine in blood 161767 phv00161767.v3.p10 pht002234.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-12-11 23:56:48+00:00 2018-12-11 23:56:48+00:00 creatinine Creatinine +54 Creatinine in blood 166800 phv00166800.v3.p10 pht002566.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-12-11 23:58:29+00:00 2018-12-11 23:58:29+00:00 creatinine Creatinine +54 Creatinine in blood 172326 phv00172326.v1.p10 pht002895.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-12-11 23:58:41+00:00 2018-12-11 23:58:41+00:00 creatinine Creatinine +55 Cystatin C in blood 84545 phv00084545.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:11:51+00:00 2018-04-26 00:11:51+00:00 cystatc1 CYSTATIN C (mg/L) +55 Cystatin C in blood 196280 phv00196280.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:11:57+00:00 2018-04-26 00:11:57+00:00 cystatc5 CYSTATIN-C (mg/L) AT EXAM 5 +55 Cystatin C in blood 275482 phv00275482.v1.p10 pht006013.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 16:45:41+00:00 2018-08-07 16:45:41+00:00 zCystatin_C Cystatin_C (Sample type: Citrated plasma) +55 Cystatin C in blood 23208 phv00023208.v5.p10 pht000146.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-07 16:47:03+00:00 2018-08-07 16:47:03+00:00 cys CYSTATIN C (MG/L) +55 Cystatin C in blood 277308 phv00277308.v1.p1 pht006031.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:09:56+00:00 2018-08-14 22:09:56+00:00 CYSTATIN Cystatin C Collection Interval: 2007-2009 +55 Cystatin C in blood 307768 phv00307768.v1.p1 pht006650.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:53:08+00:00 2018-08-15 23:53:08+00:00 CYSTATIN Cystatin C Collection Interval: 2006-2011 +55 Cystatin C in blood 193862 phv00193862.v3.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:26:56+00:00 2018-08-21 00:26:56+00:00 TESTVAL Test Result Value +55 Cystatin C in blood 282937 phv00282937.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:26:56+00:00 2018-08-21 00:26:56+00:00 TESTNAME Test Name +55 Cystatin C in blood 124064 phv00124064.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:45:58+00:00 2018-08-21 18:45:58+00:00 cystatinc Plasma cystatin c am (mg/L) +55 Cystatin C in blood 124065 phv00124065.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:46:04+00:00 2018-08-21 18:46:04+00:00 cystatinc_orig Cystatin c - original value +55 Cystatin C in blood 282935 phv00282935.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:53:28+00:00 2018-08-23 17:53:28+00:00 TESTABBR Test abbreviation +55 Cystatin C in blood 282938 phv00282938.v1.p3 pht003419.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-23 17:53:28+00:00 2018-08-23 17:53:28+00:00 TESTDESC Test Description +56 Albumin-creatinine ratio in urine 119620 phv00119620.v2.p2 pht001803.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:09:51+00:00 2018-04-17 20:09:51+00:00 EL8RATIO ALB/CREAT RATIO (mg/g): 1000(UALB/UCRET) +56 Albumin-creatinine ratio in urine 120679 phv00120679.v2.p2 pht001849.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:09:51+00:00 2018-04-17 20:09:51+00:00 FL1RATIO ALB/CREAT RATIO (mg/g) 1000*(UALB/UCRET) +56 Albumin-creatinine ratio in urine 83437 phv00083437.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:14:20+00:00 2018-04-26 00:14:20+00:00 ualbcre1 URINARY ALBUMIN/CREATININE (mg/g) +56 Albumin-creatinine ratio in urine 85746 phv00085746.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:14:26+00:00 2018-04-26 00:14:26+00:00 ualbcre1 URINARY ALBUMIN/CREATININE (mg/g) +56 Albumin-creatinine ratio in urine 85929 phv00085929.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:14:45+00:00 2018-04-26 00:14:45+00:00 ualbcre2 URINARY ALBUMIN/CREATININE (mg/g) +56 Albumin-creatinine ratio in urine 86412 phv00086412.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:14:53+00:00 2018-04-26 00:14:53+00:00 ualbcre3 URINARY ALBUMIN/CREATININE (mg/g) +56 Albumin-creatinine ratio in urine 175607 phv00175607.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:15:01+00:00 2018-04-26 00:15:01+00:00 ualbcre5 URINARY ALBUMIN/CREATININE (mg/g) +56 Albumin-creatinine ratio in urine 177041 phv00177041.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:15:22+00:00 2018-04-26 00:15:22+00:00 ualbcre5 URINARY ALBUMIN/CREATININE (mg/g) +56 Albumin-creatinine ratio in urine 127643 phv00127643.v1.p1 pht001960.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 13:59:00+00:00 2018-06-20 13:59:00+00:00 RS_UA_CR_RATIO Spot UA creatinine ratio mg/g +56 Albumin-creatinine ratio in urine 127651 phv00127651.v1.p1 pht001961.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 14:03:12+00:00 2018-06-20 14:03:12+00:00 uacr24h 24 hour urine albumin creatinine ratio: mg/g +56 Albumin-creatinine ratio in urine 110615 phv00110615.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 17:13:18+00:00 2018-07-30 17:13:18+00:00 UAB72 MICROALBUMEN (mg/g creatinine) +56 Albumin-creatinine ratio in urine 124041 phv00124041.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:44:31+00:00 2018-08-21 18:44:31+00:00 mcratio M:c ratio (ug/mg) +56 Albumin-creatinine ratio in urine 124042 phv00124042.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 18:44:42+00:00 2018-08-21 18:44:42+00:00 mcratio_orig M:c ratio - original value +56 Albumin-creatinine ratio in urine 226309 phv00226309.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:52:10+00:00 2018-08-22 21:52:10+00:00 LABA81 Albumin/creatinine ratio (mg/g) (LABA81) +57 GFR 82961 phv00082961.v2.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:36:42+00:00 2018-04-26 00:36:42+00:00 egfr1c ESTIMATED GLOMERULAR FILTRATION RATE BY SIMPLIFIED MDRD EQUATION +57 GFR 195567 phv00195567.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:36:48+00:00 2018-04-26 00:36:48+00:00 cepgfr1c EXAM 1 EGFR USING CKD-EPI EQUATION (ML/MIN/1.73 M2) (GFR) +57 GFR 84464 phv00084464.v3.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:36:56+00:00 2018-04-26 00:36:56+00:00 egfr1c ESTIMATED GLOMERULAR FILTRATION RATE BY SIMPLIFIED MDRD EQUATION +57 GFR 111943 phv00111943.v3.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:37:02+00:00 2018-04-26 00:37:02+00:00 cepgfr1c EXAM 1 (CALIBRATED CR) EGFR USING CKD-EPI EQUATION +57 GFR 86284 phv00086284.v5.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:37:11+00:00 2018-04-26 00:37:11+00:00 egfr3c EXAM 3 GLOMERULAR FILTRATION RATE (GFR) +57 GFR 111948 phv00111948.v5.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 00:37:21+00:00 2018-04-26 00:37:21+00:00 cepgfr3c EXAM 3 (CALIBRATED CR) eGFR USING CKD-EPI EQUATION +57 GFR 111951 phv00111951.v4.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:06:25+00:00 2018-04-26 01:06:25+00:00 egfr4c GLOMERULAR FILTRATION RATE (GFR) +57 GFR 111952 phv00111952.v4.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:06:33+00:00 2018-04-26 01:06:33+00:00 cepgfr4c EXAM 4 (CALIBRATED CR) EGFR USING CKD-EPI EQUATION +57 GFR 87096 phv00087096.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:06:42+00:00 2018-04-26 01:06:42+00:00 egfrfc ESTIMATED GLOMERULAR FILTRATION RATE BY SIMPLIFIED MDRD EQUATION +57 GFR 174602 phv00174602.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:06:48+00:00 2018-04-26 01:06:48+00:00 egfr5c EXAM 5 eGFR USING MDRD EQUATION (mL/min/1.73 m2) (GFR) +57 GFR 174604 phv00174604.v2.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:06:59+00:00 2018-04-26 01:06:59+00:00 cepgfr5c EXAM 5 eGFR USING CKD-EPI EQUATION (mL/min/1.73 m2) (GFR) +57 GFR 176025 phv00176025.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:07:05+00:00 2018-04-26 01:07:05+00:00 egfr5c EXAM 5 eGFR USING MDRD EQUATION (mL/min/1.73 m2) (GFR) +57 GFR 176027 phv00176027.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-26 01:07:11+00:00 2018-04-26 01:07:11+00:00 cepgfr5c EXAM 5 eGFR USING CKD-EPI EQUATION (mL/min/1.73 m2) (GFR) +57 GFR 126132 phv00126132.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:34:35+00:00 2018-06-12 01:34:35+00:00 GFR01CC EGFR based on the MDRD formula +62 FVC 208817 phv00208817.v1.p1 pht004142.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:28:33+00:00 2018-03-19 20:28:33+00:00 PFTA24 FVC (liters) [Pulmonary Function Test, exam 1] +62 FVC 113262 phv00113262.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:44+00:00 2018-04-17 17:09:44+00:00 A12FVC1 FVC, TRIAL 1 +62 FVC 114615 phv00114615.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:44+00:00 2018-04-17 17:09:44+00:00 B12FVC1 FORCED VITAL CAPACITY, TRIAL #1 +62 FVC 115620 phv00115620.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:44+00:00 2018-04-17 17:09:44+00:00 C12FVC1 FORCED VITAL CAPACITY, TRIAL #1 +62 FVC 115632 phv00115632.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 C12FVC2 FORCED VITAL CAPACITY, TRIAL #2 +62 FVC 115644 phv00115644.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 C12FVC3 FORCED VITAL CAPACITY, TRIAL #3 +62 FVC 115656 phv00115656.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 C12FVC4 FORCED VITAL CAPACITY, TRIAL #4 +62 FVC 115668 phv00115668.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 C12FVC5 FORCED VITAL CAPACITY, TRIAL #5 +62 FVC 115687 phv00115687.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 C12FVC MAXIMUM FVC +62 FVC 118839 phv00118839.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E12FVC1 FORCED VITAL CAPACITY, TRIAL #1 +62 FVC 118863 phv00118863.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E12FVC3 FORCED VITAL CAPACITY, TRIAL #3 +62 FVC 118875 phv00118875.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E12FVC4 FORCED VITAL CAPACITY, TRIAL #4 +62 FVC 118887 phv00118887.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E12FVC5 FORCED VITAL CAPACITY, TRIAL #5 +62 FVC 118899 phv00118899.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E12FVC6 FORCED VITAL CAPACITY, TRIAL #6 +62 FVC 118911 phv00118911.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E12FVC7 FORCED VITAL CAPACITY, TRIAL #7 +62 FVC 118923 phv00118923.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E12FVC8 FORCED VITAL CAPACITY, TRIAL #8 +62 FVC 118941 phv00118941.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E12FVC MAXIMUM FVC (5 TRIALS) +62 FVC 118970 phv00118970.v2.p2 pht001782.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:09:45+00:00 2018-04-17 17:09:45+00:00 E128VC MAXIMUM FVC (8 TRIALS) +62 FVC 83474 phv00083474.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 02:22:50+00:00 2018-04-28 02:22:50+00:00 fvca4 FORCED VITAL CAPACITY (ml) +62 FVC 83709 phv00083709.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 02:23:00+00:00 2018-04-28 02:23:00+00:00 fvca4 FORCED VITAL CAPACITY (ml) +62 FVC 87700 phv00087700.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 02:30:02+00:00 2018-04-28 02:30:02+00:00 fvca4 FORCED VITAL CAPACITY (ml) +62 FVC 214068 phv00214068.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 16:59:24+00:00 2018-05-10 16:59:24+00:00 FVC Forced vital capacity (Liters) +62 FVC 128209 phv00128209.v1.p1 pht001969.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:58:13+00:00 2018-06-20 17:58:13+00:00 pula17 BEST_FVC - Best forced vital capacity from best curve (best curve is an acceptable curve that has Max [FVC + FEV1 ] ): measured in liters +62 FVC 128219 phv00128219.v1.p1 pht001969.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:58:13+00:00 2018-06-20 17:58:13+00:00 pula27 SCND_FVC - Best forced vital capacity from 2nd best curve (Second best curve is second highest [FVC + FEV1 ] ): measured in liters +62 FVC 128229 phv00128229.v1.p1 pht001969.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:58:13+00:00 2018-06-20 17:58:13+00:00 pula37 THRD_FVC - Best forced vital capacity from 3rd best curve (Third best curve is third highest [ FVC + FEV1 ] ): measured in liters +62 FVC 128242 phv00128242.v1.p1 pht001969.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:47:39+00:00 2018-07-09 20:47:39+00:00 FVC01PP Derived FVC % predicted +62 FVC 159849 phv00159849.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:34:00+00:00 2018-08-10 21:34:00+00:00 FVCpp_post FVC % pred post-bronch Collection Interval: Collected in Exam 1 +62 FVC 159852 phv00159852.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:34:35+00:00 2018-08-10 21:34:35+00:00 FVC_post FVC post-bronch Collection Interval: Collected in Exam 1 +62 FVC 159854 phv00159854.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:34:57+00:00 2018-08-10 21:34:57+00:00 FVC_pre FVC pre-bronch Collection Interval: Collected in Exam 1 +62 FVC 113295 phv00113295.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:46:56+00:00 2018-08-17 20:46:56+00:00 A12FVC4 FVC, TRIAL 4 +62 FVC 113284 phv00113284.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:47:05+00:00 2018-08-17 20:47:05+00:00 A12FVC3 FVC, TRIAL 3 +62 FVC 113273 phv00113273.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:47:14+00:00 2018-08-17 20:47:14+00:00 A12FVC2 FVC, TRIAL 2 +62 FVC 113306 phv00113306.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:47:37+00:00 2018-08-17 20:47:37+00:00 A12FVC5 FVC, TRIAL 5 +62 FVC 113317 phv00113317.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:48:53+00:00 2018-08-17 20:48:53+00:00 A12FVC6 FVC, TRIAL 6 +62 FVC 113402 phv00113402.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:55:30+00:00 2018-08-17 20:55:30+00:00 A12FVC MAXIMUM FVC +62 FVC 114663 phv00114663.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:26:03+00:00 2018-08-22 23:26:03+00:00 B12FVC5 FORCED VITAL CAPACITY, TRIAL #5 +62 FVC 114651 phv00114651.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:26:32+00:00 2018-08-22 23:26:32+00:00 B12FVC4 FORCED VITAL CAPACITY, TRIAL #4 +62 FVC 114639 phv00114639.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:26:43+00:00 2018-08-22 23:26:43+00:00 B12FVC3 FORCED VITAL CAPACITY, TRIAL #3 +62 FVC 114627 phv00114627.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:26:54+00:00 2018-08-22 23:26:54+00:00 B12FVC2 FORCED VITAL CAPACITY, TRIAL #2 +62 FVC 114694 phv00114694.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:28:01+00:00 2018-08-22 23:28:01+00:00 B12FVC MAXIMUM FVC +62 FVC 114675 phv00114675.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:28:11+00:00 2018-08-22 23:28:11+00:00 B12FVC6 FORCED VITAL CAPACITY, TRIAL #6 +62 FVC 226383 phv00226383.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:28:05+00:00 2018-08-24 16:28:05+00:00 PRBA25 FVC (mL) (PRBA25) +62 FVC 258076 phv00258076.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:03:10+00:00 2018-08-24 17:03:10+00:00 PRBA36 Predicted FVC (mL) (recalculated) (PRBA36) +62 FVC 253022 phv00253022.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:22:46+00:00 2018-08-24 17:22:46+00:00 fvc_pre_bd_baseline Forced vital capacity measured by spirometry at baseline visit +62 FVC 99664 phv00099664.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:29:54+00:00 2018-09-27 16:29:54+00:00 FVC18 FVC (L) +62 FVC 99667 phv00099667.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:30:07+00:00 2018-09-27 16:30:07+00:00 FVCPCT18 FVC PERCENT PREDICTED +62 FVC 99670 phv00099670.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:30:23+00:00 2018-09-27 16:30:23+00:00 FVCPRD18 FVC PREDICTED VALUE +62 FVC 107762 phv00107762.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:30:46+00:00 2018-09-27 16:30:46+00:00 FVC18 FVC (L) +62 FVC 107764 phv00107764.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:31:04+00:00 2018-09-27 16:31:04+00:00 FVCPRD18 FVC PREDICTED (L) +62 FVC 110359 phv00110359.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:31:20+00:00 2018-09-27 16:31:20+00:00 FVCPRD18 FVC PREDICTED (L) +62 FVC 110364 phv00110364.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:31:33+00:00 2018-09-27 16:31:33+00:00 FVC18 FVC +62 FVC 22555 phv00022555.v5.p10 pht000101.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:42+00:00 2018-10-05 15:33:42+00:00 FVC_5_1 FORCED VITAL CAPACITY - BEST EFFORT (LITERS) +62 FVC 22571 phv00022571.v4.p10 pht000102.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:42+00:00 2018-10-05 15:33:42+00:00 fvc_1_3 FORCED VITAL CAPACITY - BEST EFFORT (LITERS) +62 FVC 22584 phv00022584.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:42+00:00 2018-10-05 15:33:42+00:00 FVC_A FORCED VITAL CAPACITY - TRIAL 1 +62 FVC 22597 phv00022597.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:42+00:00 2018-10-05 15:33:42+00:00 FVC_B FORCED VITAL CAPACITY - TRIAL 1 +62 FVC 22610 phv00022610.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:42+00:00 2018-10-05 15:33:42+00:00 FVC_C FORCED VITAL CAPACITY - TRIAL 3 +62 FVC 22623 phv00022623.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:42+00:00 2018-10-05 15:33:42+00:00 FVC_D FORCED VITAL CAPACITY - TRIAL 4 +62 FVC 22636 phv00022636.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:42+00:00 2018-10-05 15:33:42+00:00 FVC_E FORCED VITAL CAPACITY - TRIAL 5 +62 FVC 22651 phv00022651.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 B_FVC FORCED VITAL CAPACITY - SUMMARY +62 FVC 22664 phv00022664.v5.p10 pht000104.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 FVC_6_1 FORCED VITAL CAPACITY - BEST EFFORT (LITERS) +62 FVC 22678 phv00022678.v5.p10 pht000105.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 FVC_3_1 FORCED VITAL CAPACITY - BEST EFFORT (LITERS) +62 FVC 22689 phv00022689.v5.p10 pht000106.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 FVC_7_1 FORCED VITAL CAPACITY - BEST EFFORT (LITERS) +62 FVC 55266 phv00055266.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 FVC Forced Vital Capacity (Litres) +62 FVC 73832 phv00073832.v4.p10 pht000832.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 fvc_8_1 Forced vital capacity - highest value among acceptable maneuvers +62 FVC 196552 phv00196552.v2.p10 pht003632.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 fvc_2 Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers +62 FVC 196569 phv00196569.v2.p10 pht003633.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 fvc_alb_2 Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers, Albuterol +62 FVC 196586 phv00196586.v2.p10 pht003634.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 fvc_alb_8 Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers, Albuterol Collection Interval: Offspring Exam 8, Omni 1 Exam 3 +62 FVC 257838 phv00257838.v1.p10 pht005169.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 FVC_9_1 Forced Vital Capacity (liters) - Highest value among acceptable maneuvers Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +62 FVC 257853 phv00257853.v1.p10 pht005170.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 fvc_1 Forced Vital Capacity (FVC) - Highest value among acceptable maneuvers +62 FVC 257872 phv00257872.v1.p10 pht005171.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:33:43+00:00 2018-10-05 15:33:43+00:00 FVC_post_9_1 Forced Vital Capacity (liters) - Highest value among acceptable maneuvers, Albuterol Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +63 FEV1 208819 phv00208819.v1.p1 pht004142.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 20:28:58+00:00 2018-03-19 20:28:58+00:00 PFTA26 FEV(1) (liters) [Pulmonary Function Test, exam 1] +63 FEV1 113263 phv00113263.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 A12FEV11 FEV1, TRIAL 1 +63 FEV1 113274 phv00113274.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 A12FEV12 FEV1, TRIAL 2 +63 FEV1 113285 phv00113285.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 A12FEV13 FEV1, TRIAL 3 +63 FEV1 113296 phv00113296.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 A12FEV14 FEV1, TRIAL 4 +63 FEV1 113307 phv00113307.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 A12FEV15 FEV1, TRIAL 5 +63 FEV1 113318 phv00113318.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 A12FEV16 FEV1, TRIAL 6 +63 FEV1 113403 phv00113403.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 A12FE1 MAXIMUM FEV1 +63 FEV1 114616 phv00114616.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 B12FEV11 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #1 +63 FEV1 114628 phv00114628.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 B12FEV12 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #2 +63 FEV1 114640 phv00114640.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 B12FEV13 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #3 +63 FEV1 114652 phv00114652.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 B12FEV14 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #4 +63 FEV1 114664 phv00114664.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 B12FEV15 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #5 +63 FEV1 114676 phv00114676.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 B12FEV16 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #6 +63 FEV1 114695 phv00114695.v2.p2 pht001627.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:17:00+00:00 2018-04-17 17:17:00+00:00 B12FE1 MAXIMUM FEV1 +63 FEV1 115621 phv00115621.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:19:59+00:00 2018-04-17 17:19:59+00:00 C12FEV11 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #1 +63 FEV1 115633 phv00115633.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:19:59+00:00 2018-04-17 17:19:59+00:00 C12FEV12 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #2 +63 FEV1 115645 phv00115645.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:19:59+00:00 2018-04-17 17:19:59+00:00 C12FEV13 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #3 +63 FEV1 115657 phv00115657.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:19:59+00:00 2018-04-17 17:19:59+00:00 C12FEV14 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #4 +63 FEV1 115669 phv00115669.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:19:59+00:00 2018-04-17 17:19:59+00:00 C12FEV15 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #5 +63 FEV1 115688 phv00115688.v2.p2 pht001667.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 17:19:59+00:00 2018-04-17 17:19:59+00:00 C12FE1 MAXIMUM FEV1 +63 FEV1 118840 phv00118840.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FEV11 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #1 +63 FEV1 118852 phv00118852.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FEV12 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #2 +63 FEV1 118864 phv00118864.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FEV13 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #3 +63 FEV1 118876 phv00118876.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FEV14 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #4 +63 FEV1 118888 phv00118888.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FEV15 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #5 +63 FEV1 118900 phv00118900.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FEV16 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #6 +63 FEV1 118912 phv00118912.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FEV17 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #7 +63 FEV1 118924 phv00118924.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FEV18 FORCED EXPIRATORY VOL/1 SECOND, TRIAL #8 +63 FEV1 118942 phv00118942.v2.p2 pht001781.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 19:34:18+00:00 2018-04-17 19:34:18+00:00 E12FE1 MAXIMUM FEV1 (5 TRIALS) +63 FEV1 83475 phv00083475.v2.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:23:37+00:00 2018-04-28 21:23:37+00:00 fev1a4 FORCED EXPIRATORY VOLUME AT 1 SECOND (ml/sec) +63 FEV1 87701 phv00087701.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:25:28+00:00 2018-04-28 21:25:28+00:00 fev1a4 FORCED EXPIRATORY VOLUME AT 1 SECOND (ml/sec) +63 FEV1 83710 phv00083710.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:40:35+00:00 2018-04-28 21:40:35+00:00 fev1a4 FORCED EXPIRATORY VOLUME AT 1 SECOND (ml/sec) +63 FEV1 214067 phv00214067.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 16:58:48+00:00 2018-05-10 16:58:48+00:00 FEV1 Forced expiratory volume in one second (Liters) +63 FEV1 128210 phv00128210.v1.p1 pht001969.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:56:44+00:00 2018-06-20 17:56:44+00:00 pula18 BEST_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the best curve: measured in liters +63 FEV1 128220 phv00128220.v1.p1 pht001969.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:56:44+00:00 2018-06-20 17:56:44+00:00 pula28 SCND_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the 2nd best curve: measured in liters +63 FEV1 128230 phv00128230.v1.p1 pht001969.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:56:44+00:00 2018-06-20 17:56:44+00:00 pula38 THRD_FEV1 - Forced expiratory volume in 1 second, FEV1.0 from the 3rd best curve: measured in liters +63 FEV1 128243 phv00128243.v1.p1 pht001969.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:48:08+00:00 2018-07-09 20:48:08+00:00 FEV01PP Derived FEV1 % predicted +63 FEV1 159853 phv00159853.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:31:48+00:00 2018-08-10 21:31:48+00:00 FEV1_pre FEV1 pre-bronch Collection Interval: Collected in Exam 1 +63 FEV1 159851 phv00159851.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:31:56+00:00 2018-08-10 21:31:56+00:00 FEV1_post FEV1 post-bronch Collection Interval: Collected in Exam 1 +63 FEV1 159848 phv00159848.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:32:04+00:00 2018-08-10 21:32:04+00:00 FEV1pp_post FEV1 % pred post-bronch Collection Interval: Collected in Exam 1 +63 FEV1 226384 phv00226384.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:28:13+00:00 2018-08-24 16:28:13+00:00 PRBA29 FEV1 (mL) (PRBA29) +63 FEV1 253023 phv00253023.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:22:55+00:00 2018-08-24 17:22:55+00:00 fev1_pre_bd_baseline Forced expiratory volume in 1 second measured by spirometry at baseline visit +63 FEV1 118971 phv00118971.v2.p2 pht001782.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:37:55+00:00 2018-08-28 23:37:55+00:00 E128E1 MAXIMUM FEV1 (8 TRIALS) +63 FEV1 99665 phv00099665.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:32:13+00:00 2018-09-27 16:32:13+00:00 FEV118 FEV1 (L) +63 FEV1 99668 phv00099668.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:32:24+00:00 2018-09-27 16:32:24+00:00 FEVPCT18 FEV PERCENT PREDICTED +63 FEV1 99671 phv00099671.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:32:37+00:00 2018-09-27 16:32:37+00:00 FEVPRD18 FEV PREDICTED VALUE +63 FEV1 107763 phv00107763.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:33:37+00:00 2018-09-27 16:33:37+00:00 FEV118 FEV1 (L) +63 FEV1 107765 phv00107765.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:33:48+00:00 2018-09-27 16:33:48+00:00 FEVPRD18 FEV1 PREDICTED (%) +63 FEV1 110360 phv00110360.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:34:19+00:00 2018-09-27 16:34:19+00:00 FEVPRD18 FEV1 PREDICTED (%) +63 FEV1 110365 phv00110365.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:34:30+00:00 2018-09-27 16:34:30+00:00 FEV118 FEV1 (L) +63 FEV1 2684 phv00002684.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:21+00:00 2018-10-05 15:24:21+00:00 FI32 LUNG FUNCTION: FEV1 +63 FEV1 3251 phv00003251.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:21+00:00 2018-10-05 15:24:21+00:00 FJ371 LUNG FUNCTION: FEV1 +63 FEV1 22556 phv00022556.v5.p10 pht000101.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:21+00:00 2018-10-05 15:24:21+00:00 FV1_5_1 FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT +63 FEV1 22569 phv00022569.v4.p10 pht000102.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:21+00:00 2018-10-05 15:24:21+00:00 fv1_1_3 FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT +63 FEV1 22586 phv00022586.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FEV1_A FORCED EXPIRATORY VOLUME - TRIAL 1 IN 1.0 SECONDS +63 FEV1 22598 phv00022598.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FEV1_B FORCED EXPIRATORY VOLUME - TRIAL 1 IN 1.0 SECONDS +63 FEV1 22611 phv00022611.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FEV1_C FORCED EXPIRATORY VOLUME - TRIAL 3 IN 1.0 SECONDS +63 FEV1 22624 phv00022624.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FEV1_D FORCED EXPIRATORY VOLUME - TRIAL 4 IN 1.0 SECONDS +63 FEV1 22637 phv00022637.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FEV1_E FORCED EXPIRATORY VOLUME - TRIAL 5 IN 1.0 SECONDS +63 FEV1 22652 phv00022652.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 B_FEV1 FORCED EXPIRATORY VOLUME - SUMMARY IN 1.0 SECONDS +63 FEV1 22665 phv00022665.v5.p10 pht000104.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FV1_6_1 FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT +63 FEV1 22679 phv00022679.v5.p10 pht000105.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FV1_3_1 FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT +63 FEV1 22690 phv00022690.v5.p10 pht000106.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FV1_7_1 FORCED EXPIRATORY VOLUME AT 1 SECOND (LITERS) - BEST EFFORT +63 FEV1 55265 phv00055265.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FEV1 Forced Expiratory Volume in One Second (Litres) +63 FEV1 73829 phv00073829.v4.p10 pht000832.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 fv1_8_1 Forced expiratory volume at 1 second - highest value among acceptable maneuvers +63 FEV1 196549 phv00196549.v2.p10 pht003632.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 fv1_2 Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers +63 FEV1 196566 phv00196566.v2.p10 pht003633.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 fv1_alb_2 Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers, Albuterol +63 FEV1 196583 phv00196583.v2.p10 pht003634.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 fv1_alb_8 Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers, Albuterol Collection Interval: Offspring Exam 8, Omni 1 Exam 3 +63 FEV1 257835 phv00257835.v1.p10 pht005169.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FV1_9_1 Forced Expiratory Volume at 1 second (liters) - Highest value among acceptable maneuvers Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +63 FEV1 257850 phv00257850.v1.p10 pht005170.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 fv1_1 Forced Expiratory Volume at 1 second (FEV1) - Highest value among acceptable maneuvers +63 FEV1 257869 phv00257869.v1.p10 pht005171.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:24:22+00:00 2018-10-05 15:24:22+00:00 FV1_post_9_1 Forced Expiratory Volume at 1 second (liters) - Highest value among acceptable maneuvers, Albuterol Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +64 Asthma 113384 phv00113384.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:17:36+00:00 2018-04-23 18:17:36+00:00 A12ASTHM EVER HAD ASTHMA +64 Asthma 113385 phv00113385.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:17:53+00:00 2018-04-23 18:17:53+00:00 A12ASSTL DOES SUBJECT STILL HAVE ASTHMA +64 Asthma 113666 phv00113666.v2.p2 pht001584.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:18:39+00:00 2018-04-23 18:18:39+00:00 A21ASMA PT HAS EXERCISE-INDUCED ASTHMA. Q 3 +64 Asthma 114600 phv00114600.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:19:00+00:00 2018-04-23 18:19:00+00:00 B12ASTHM EVER HAD ASTHMA. Q 7A +64 Asthma 114601 phv00114601.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:19:16+00:00 2018-04-23 18:19:16+00:00 B12ASSTL STILL HAS ASTHMA. Q 7B +64 Asthma 117045 phv00117045.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:19:46+00:00 2018-04-23 18:19:46+00:00 D08ASTH ASTHMA. Q 14 +64 Asthma 117047 phv00117047.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:20:08+00:00 2018-04-23 18:20:08+00:00 D08ASTYR HAD ASTHMA IN THE PAST YEAR. Q 14 +64 Asthma 117253 phv00117253.v2.p2 pht001721.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:20:33+00:00 2018-04-23 18:20:33+00:00 D21ASMA EVER HAD EXERCISE-INDUCED ASTHMA. Q 3 +64 Asthma 118519 phv00118519.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-23 18:21:03+00:00 2018-04-23 18:21:03+00:00 E08ASTH ASTHMA? Q 14 +64 Asthma 202933 phv00202933.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:13:52+00:00 2018-04-24 15:13:52+00:00 AFUcomp7h_G [General health]. Has a doctor ever said you had any of the following? Asthma [Annual Follow-up Questionnaire Form, AFUG] +64 Asthma 203002 phv00203002.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:14:27+00:00 2018-04-24 15:14:27+00:00 AFUcomp20a_L [General health]. Has a doctor ever said you had asthma? Did the doctor say that you have asthma since we last contracted you on mm/dd/yyyy? [Annual Follow-up Questionnaire Form, AFUL] +64 Asthma 206783 phv00206783.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:15:30+00:00 2018-04-24 15:15:30+00:00 HFAA10A [Medical history]. Q10a - Asthma [Heart Failure Hospital Record Abstraction Form, HFA] +64 Asthma 207069 phv00207069.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:15:54+00:00 2018-04-24 15:15:54+00:00 HHXB05F [Medical care]. Has a doctor ever said you had any of the following: (read each disease name and code N if No or Never Tested). Q5. Asthma. Q5F [Health/Medical History, exam 2] +64 Asthma 207318 phv00207318.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:17:24+00:00 2018-04-24 15:17:24+00:00 HOM10H Has a doctor ever said that you had any of the following: asthma? Q10h [Home Interview, exam 1] +64 Asthma 208976 phv00208976.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:17:46+00:00 2018-04-24 15:17:46+00:00 PHXA8M [Medical care]. Asthma? Q8m [Personal History Form, exam 3] +64 Asthma 209067 phv00209067.v1.p1 pht004146.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:18:09+00:00 2018-04-24 15:18:09+00:00 PHXB6E [Medical care]. Has a doctor ever said you had any of the following? Asthma. Q6e [Personal History form, exam 4] +64 Asthma 209714 phv00209714.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:18:28+00:00 2018-04-24 15:18:28+00:00 RPAA35 [Asthma]. Ever had asthma? Q35 [Respiratory Symptoms and Physical Activity Form, exam 1] +64 Asthma 209715 phv00209715.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:18:50+00:00 2018-04-24 15:18:50+00:00 RPAA36 [Asthma]. Was asthma confirmed by a doctor? Q36 [Respiratory Symptoms and Physical Activity Form, exam 1] +64 Asthma 209716 phv00209716.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:19:08+00:00 2018-04-24 15:19:08+00:00 RPAA37 [Asthma]. Age asthma started Q37 [Respiratory Symptoms and Physical Activity Form, exam 1] +64 Asthma 209717 phv00209717.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:19:25+00:00 2018-04-24 15:19:25+00:00 RPAA38 [Asthma]. Still have asthma? Q38 [Respiratory Symptoms and Physical Activity Form, exam 1] +64 Asthma 209718 phv00209718.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:19:44+00:00 2018-04-24 15:19:44+00:00 RPAA39 [Asthma]. Age asthma stopped. Q39 [Respiratory Symptoms and Physical Activity Form, exam 1] +64 Asthma 214107 phv00214107.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:20:03+00:00 2018-04-24 15:20:03+00:00 ASTHMA15 MD said pt had asthma? +64 Asthma 214108 phv00214108.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-24 15:20:20+00:00 2018-04-24 15:20:20+00:00 ASTH1215 Pt had attack of asthma in last 12 months? +64 Asthma 82975 phv00082975.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:45:31+00:00 2018-04-28 21:45:31+00:00 asthma1 ASTHMA: SELF-REPORT +64 Asthma 83530 phv00083530.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:45:38+00:00 2018-04-28 21:45:38+00:00 qastha4 ASTHMA +64 Asthma 83531 phv00083531.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:45:46+00:00 2018-04-28 21:45:46+00:00 qasdvya4 AGE DEVELOPED FIRST ASTHMA SYMP +64 Asthma 83532 phv00083532.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:45:53+00:00 2018-04-28 21:45:53+00:00 qasdvaa4 ASTHMA AS A CHILD +64 Asthma 83533 phv00083533.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:46:13+00:00 2018-04-28 21:46:13+00:00 qasdgya4 AGE DIAGNOSED WITH ASTHMA +64 Asthma 83537 phv00083537.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:46:19+00:00 2018-04-28 21:46:19+00:00 qasrcya4 AGE AT FIRST RECURRENCE OF ASTHMA +64 Asthma 83765 phv00083765.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:46:25+00:00 2018-04-28 21:46:25+00:00 qastha4 ASTHMA +64 Asthma 83767 phv00083767.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:46:31+00:00 2018-04-28 21:46:31+00:00 qasdvaa4 ASTHMA AS A CHILD +64 Asthma 83766 phv00083766.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:46:38+00:00 2018-04-28 21:46:38+00:00 qasdvya4 AGE DEVELOPED FIRST ASTHMA SYMP +64 Asthma 83768 phv00083768.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:46:44+00:00 2018-04-28 21:46:44+00:00 qasdgya4 AGE DIAGNOSED WITH ASTHMA +64 Asthma 83772 phv00083772.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:46:50+00:00 2018-04-28 21:46:50+00:00 qasrcya4 AGE AT FIRST RECURRENCE OF ASTHMA +64 Asthma 85211 phv00085211.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:46:56+00:00 2018-04-28 21:46:56+00:00 asthma1 ASTHMA: SELF-REPORT +64 Asthma 85936 phv00085936.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:47:23+00:00 2018-04-28 21:47:23+00:00 asthma2 ASTHMA: SELF-REPORT +64 Asthma 86418 phv00086418.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:47:29+00:00 2018-04-28 21:47:29+00:00 asthma3 ASTHMA: SELF-REPORT +64 Asthma 86870 phv00086870.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:47:34+00:00 2018-04-28 21:47:34+00:00 asthma4 ASTHMA: SELF-REPORT +64 Asthma 87119 phv00087119.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:47:41+00:00 2018-04-28 21:47:41+00:00 asthmaf ASTHMA +64 Asthma 87756 phv00087756.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:47:46+00:00 2018-04-28 21:47:46+00:00 qastha4 ASTHMA +64 Asthma 87757 phv00087757.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:47:53+00:00 2018-04-28 21:47:53+00:00 qasdvya4 AGE DEVELOPED FIRST ASTHMA SYMP +64 Asthma 87758 phv00087758.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:47:58+00:00 2018-04-28 21:47:58+00:00 qasdvaa4 ASTHMA AS A CHILD +64 Asthma 87759 phv00087759.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:04+00:00 2018-04-28 21:48:04+00:00 qasdgya4 AGE DIAGNOSED WITH ASTHMA +64 Asthma 87763 phv00087763.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:09+00:00 2018-04-28 21:48:09+00:00 qasrcya4 AGE AT FIRST RECURRENCE OF ASTHMA +64 Asthma 175295 phv00175295.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:15+00:00 2018-04-28 21:48:15+00:00 asthma5 ASTHMA: SELF-REPORT +64 Asthma 175296 phv00175296.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:21+00:00 2018-04-28 21:48:21+00:00 devlpyr5 FIRST ASTHMA SYMPTOMS: AGE +64 Asthma 175298 phv00175298.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:28+00:00 2018-04-28 21:48:28+00:00 diagyr5 DOCTOR DIAGNOSIS OF ASTHMA: AGE +64 Asthma 175302 phv00175302.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:35+00:00 2018-04-28 21:48:35+00:00 recuryr5 FIRST RECURRENCE OF ASTHMA SYMPTOMS: AGE +64 Asthma 175872 phv00175872.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:41+00:00 2018-04-28 21:48:41+00:00 asthma1 ASTHMA: SELF-REPORT +64 Asthma 175890 phv00175890.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:48+00:00 2018-04-28 21:48:48+00:00 asthma ASTHMA +64 Asthma 175954 phv00175954.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:54+00:00 2018-04-28 21:48:54+00:00 asthmaf FAMILY COHORT: ASTHMA +64 Asthma 176718 phv00176718.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:48:59+00:00 2018-04-28 21:48:59+00:00 asthma5 ASTHMA: SELF-REPORT +64 Asthma 176719 phv00176719.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:49:06+00:00 2018-04-28 21:49:06+00:00 devlpyr5 FIRST ASTHMA SYMPTOMS: AGE +64 Asthma 176721 phv00176721.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:49:12+00:00 2018-04-28 21:49:12+00:00 diagyr5 DOCTOR DIAGNOSIS OF ASTHMA: AGE +64 Asthma 176725 phv00176725.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 21:49:18+00:00 2018-04-28 21:49:18+00:00 recuryr5 FIRST RECURRENCE OF ASTHMA SYMPTOMS: AGE +64 Asthma 125000 phv00125000.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:26:57+00:00 2018-06-08 15:26:57+00:00 AFUA7H 7h. Asthma +64 Asthma 125085 phv00125085.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:30:14+00:00 2018-06-08 16:30:14+00:00 AFUA7H 7h. Asthma +64 Asthma 125170 phv00125170.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:51:55+00:00 2018-06-08 16:51:55+00:00 AFUB7H 7h. Asthma +64 Asthma 125256 phv00125256.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:59:53+00:00 2018-06-08 16:59:53+00:00 AFUB7H 7h. Asthma +64 Asthma 125382 phv00125382.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:13:44+00:00 2018-06-08 17:13:44+00:00 AFUC20 20. Has a doctor ever said that you had asthma? +64 Asthma 125383 phv00125383.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:14:08+00:00 2018-06-08 17:14:08+00:00 AFUC20A 20a. Did the doctor sat that you have asthma since we last contacted you? +64 Asthma 125604 phv00125604.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:46:58+00:00 2018-06-08 19:46:58+00:00 AFUI7H DOCTOR - ASTHMA Q7H +64 Asthma 125692 phv00125692.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:55:27+00:00 2018-06-08 19:55:27+00:00 AFUJ7H DOCTOR - ASTHMA Q7H +64 Asthma 125516 phv00125516.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:09:33+00:00 2018-06-08 20:09:33+00:00 AFUI7H DOCTOR - ASTHMA Q7H +64 Asthma 125780 phv00125780.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:14:44+00:00 2018-06-08 20:14:44+00:00 AFUK7H DOCTOR - ASTHMA Q7H +64 Asthma 128344 phv00128344.v1.p1 pht001973.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:56:59+00:00 2018-06-20 16:56:59+00:00 RPAA13 13: Have you ever had asthma? +64 Asthma 128345 phv00128345.v1.p1 pht001973.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:58:38+00:00 2018-06-20 16:58:38+00:00 RPAA14 14: Was it confirmed by a doctor? +64 Asthma 128346 phv00128346.v1.p1 pht001973.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:58:55+00:00 2018-06-20 16:58:55+00:00 RPAA16 16: Do you still have asthma? +64 Asthma 128353 phv00128353.v1.p1 pht001973.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:59:15+00:00 2018-06-20 16:59:15+00:00 RPAA15 15: What age did your asthma start? +64 Asthma 128354 phv00128354.v1.p1 pht001973.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:59:27+00:00 2018-06-20 16:59:27+00:00 RPAA17 17: What age did asthma stop? +64 Asthma 128103 phv00128103.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:21:13+00:00 2018-06-20 18:21:13+00:00 PFHA10A 10a: Has doctor said you have Asthma? +64 Asthma 128104 phv00128104.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:22:54+00:00 2018-06-20 18:22:54+00:00 PFHA10B 10b: Age when told this +64 Asthma 159701 phv00159701.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:51:20+00:00 2018-08-10 20:51:20+00:00 Asthma Asthma: have you ever had asthma Collection Interval: Collected in Exam 1 +64 Asthma 159702 phv00159702.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:51:31+00:00 2018-08-10 20:51:31+00:00 AsthmaAge Asthma: at about what age did asthma start Collection Interval: Collected in Exam 1 +64 Asthma 159703 phv00159703.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:51:43+00:00 2018-08-10 20:51:43+00:00 AsthmaAgeDK Asthma: asthma as a child; age not known Collection Interval: Collected in Exam 1 +64 Asthma 159704 phv00159704.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:52:15+00:00 2018-08-10 20:52:15+00:00 AsthmaDxByDr Asthma: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1 +64 Asthma 159705 phv00159705.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:52:22+00:00 2018-08-10 20:52:22+00:00 AsthmaStillHave Asthma: do you still have asthma Collection Interval: Collected in Exam 1 +64 Asthma 159706 phv00159706.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:52:29+00:00 2018-08-10 20:52:29+00:00 AsthmaAgeStop Asthma: if you no longer have asthma at what age did it stop Collection Interval: Collected in Exam 1 +64 Asthma 159707 phv00159707.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:52:43+00:00 2018-08-10 20:52:43+00:00 AsthmaStopChild Asthma: asthma stopped as a child; age not known Collection Interval: Collected in Exam 1 +64 Asthma 122253 phv00122253.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:56:23+00:00 2018-08-14 20:56:23+00:00 ASTHMA Asthma (AC) +64 Asthma 122254 phv00122254.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:56:37+00:00 2018-08-14 20:56:37+00:00 ASTDIAG Asthma diagnosed by doctor (AC) +64 Asthma 122255 phv00122255.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:57:07+00:00 2018-08-14 20:57:07+00:00 ASTAGE Age when asthma noted (AC) +64 Asthma 122256 phv00122256.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:57:18+00:00 2018-08-14 20:57:18+00:00 ASTPRES Asthma still present (AC) +64 Asthma 124265 phv00124265.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:58:17+00:00 2018-08-14 20:58:17+00:00 ASTDIADAY Days from visit date - Diagnosed Asthma +64 Asthma 123024 phv00123024.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:58:28+00:00 2018-08-14 20:58:28+00:00 activeasthma Asthma: MD dx of Asthma and on Asthma meds in past 3 days +64 Asthma 113388 phv00113388.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:54:15+00:00 2018-08-17 20:54:15+00:00 A12ASSTP AGE WHEN ASTHMA STOPPED +64 Asthma 113387 phv00113387.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:54:23+00:00 2018-08-17 20:54:23+00:00 A12ASAGE AGE WHEN ASTHMA STARTED +64 Asthma 113386 phv00113386.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:54:30+00:00 2018-08-17 20:54:30+00:00 A12ASDOC WAS ASTHMA CONFIRMED BY A DOCTOR +64 Asthma 226252 phv00226252.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:09:04+00:00 2018-08-22 21:09:04+00:00 ASTHMA_EVER Ever asthma +64 Asthma 114604 phv00114604.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:23:48+00:00 2018-08-22 23:23:48+00:00 B12ASSTP AGE ASTHMA SYMPTOMS STOPPED. Q 7E +64 Asthma 114603 phv00114603.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:23:56+00:00 2018-08-22 23:23:56+00:00 B12ASAGE AGE OF ONSET OF ASTHMA. Q 7D +64 Asthma 114602 phv00114602.v2.p2 pht001626.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:24:03+00:00 2018-08-22 23:24:03+00:00 B12ASDOC ASTHMA CONFIRMED BY MD. Q 7C +64 Asthma 117046 phv00117046.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:20:11+00:00 2018-08-24 00:20:11+00:00 D08ASTAG AGE FIRST DIAGNOSED WITH ASTHMA. Q 14 +64 Asthma 226387 phv00226387.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:28:45+00:00 2018-08-24 16:28:45+00:00 RSEA32 Asthma: ever (RSEA32) +64 Asthma 226388 phv00226388.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:28:52+00:00 2018-08-24 16:28:52+00:00 RSEA34 Asthma diagnosed by doctor (RSEA34) +64 Asthma 226389 phv00226389.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:28:57+00:00 2018-08-24 16:28:57+00:00 RSEA35 Asthma: now (RSEA35) +64 Asthma 258081 phv00258081.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:03:25+00:00 2018-08-24 17:03:25+00:00 RSEA33 Age started: asthma (RSEA33) +64 Asthma 118521 phv00118521.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:45:28+00:00 2018-08-28 22:45:28+00:00 E08ASTYR HAD ASTHMA IN THE PAST YEAR? Q 14 +64 Asthma 118520 phv00118520.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:45:34+00:00 2018-08-28 22:45:34+00:00 E08ASTAG AGE DIAGNOSED-ASTHMA. Q 14 +64 Asthma 119905 phv00119905.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:12:26+00:00 2018-08-29 21:12:26+00:00 F08ASTYR HAD ASTHMA IN THE PAST YEAR? Q 14 +64 Asthma 119904 phv00119904.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:12:34+00:00 2018-08-29 21:12:34+00:00 F08ASTAG AGE DIAGNOSED-ASTHMA. Q 14 +64 Asthma 119892 phv00119892.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:12:40+00:00 2018-08-29 21:12:40+00:00 F08ASTH ASTHMA? Q 14 +64 Asthma 121272 phv00121272.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:26:03+00:00 2018-08-30 00:26:03+00:00 Y01ASTEP ENDPT - ASTHMA +64 Asthma 121364 phv00121364.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:33:52+00:00 2018-08-30 00:33:52+00:00 Y01ASTHM ASTHMA +64 Asthma 121468 phv00121468.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:47:27+00:00 2018-08-30 19:47:27+00:00 Y00ASTHM DISCHG DIAG - ASTHMA +64 Asthma 121488 phv00121488.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:48:54+00:00 2018-08-30 19:48:54+00:00 Y01ASTEP ENDPT - ASTHMA +64 Asthma 121583 phv00121583.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:55:22+00:00 2018-08-30 19:55:22+00:00 Y01ASTHM ASTHMA +64 Asthma 258652 phv00258652.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:11:42+00:00 2018-09-06 13:11:42+00:00 asthma Subject have asthma +64 Asthma 77634 phv00077634.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:26:22+00:00 2018-09-21 17:26:22+00:00 ASTHMA_3 Asthma +64 Asthma 77759 phv00077759.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:26:29+00:00 2018-09-21 17:26:29+00:00 ASTHMA_4 Asthma +64 Asthma 77869 phv00077869.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:26:35+00:00 2018-09-21 17:26:35+00:00 ASTHMA_5 Asthma +64 Asthma 78033 phv00078033.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:26:40+00:00 2018-09-21 17:26:40+00:00 ASTHMA_6 Asthma +64 Asthma 78173 phv00078173.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:26:45+00:00 2018-09-21 17:26:45+00:00 ASTHMA_7 Asthma +64 Asthma 78314 phv00078314.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:26:52+00:00 2018-09-21 17:26:52+00:00 ASTHMA_8 Asthma +64 Asthma 78512 phv00078512.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:26:57+00:00 2018-09-21 17:26:57+00:00 ASTHMA Asthma ever +64 Asthma 283509 phv00283509.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:27:03+00:00 2018-09-21 17:27:03+00:00 ASTHMAHX F136 History of asthma +64 Asthma 101661 phv00101661.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:35:03+00:00 2018-09-27 16:35:03+00:00 ASTHMA59 HAD ASTHMA +64 Asthma 102854 phv00102854.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:35:19+00:00 2018-09-27 16:35:19+00:00 ASTHMA59 HAD ASTHMA +64 Asthma 103164 phv00103164.v1.p1 pht001476.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:35:31+00:00 2018-09-27 16:35:31+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103217 phv00103217.v1.p1 pht001477.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:35:45+00:00 2018-09-27 16:35:45+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103269 phv00103269.v1.p1 pht001478.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:35:57+00:00 2018-09-27 16:35:57+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103322 phv00103322.v1.p1 pht001479.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:36:16+00:00 2018-09-27 16:36:16+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103374 phv00103374.v1.p1 pht001480.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:36:29+00:00 2018-09-27 16:36:29+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103427 phv00103427.v1.p1 pht001481.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:36:44+00:00 2018-09-27 16:36:44+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103479 phv00103479.v1.p1 pht001482.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:36:55+00:00 2018-09-27 16:36:55+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103532 phv00103532.v1.p1 pht001483.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:37:06+00:00 2018-09-27 16:37:06+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103584 phv00103584.v1.p1 pht001484.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:37:16+00:00 2018-09-27 16:37:16+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103637 phv00103637.v1.p1 pht001485.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:37:28+00:00 2018-09-27 16:37:28+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103689 phv00103689.v1.p1 pht001486.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:37:40+00:00 2018-09-27 16:37:40+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 103740 phv00103740.v1.p1 pht001487.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:37:56+00:00 2018-09-27 16:37:56+00:00 ASTHMA32 TOLD BY MD YOU HAD ASTHMA +64 Asthma 105885 phv00105885.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:38:10+00:00 2018-09-27 16:38:10+00:00 ASTHMA ASTHMA CONF BY DOCTOR +64 Asthma 107849 phv00107849.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:38:23+00:00 2018-09-27 16:38:23+00:00 ASTHMA56 EVER HAD ASTHMA +64 Asthma 108215 phv00108215.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:38:39+00:00 2018-09-27 16:38:39+00:00 ASTHMA Ever asthma confirmed by a doctor +64 Asthma 110173 phv00110173.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:38:55+00:00 2018-09-27 16:38:55+00:00 ASTHMA59 HAD ASTHMA +64 Asthma 197463 phv00197463.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:39:10+00:00 2018-09-27 16:39:10+00:00 asthma15 MD said pt had asthma? +64 Asthma 99466 phv00099466.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:40:34+00:00 2018-09-27 16:40:34+00:00 ASTHCUR CURRENT ASTHMA DX BY DOC +64 Asthma 100442 phv00100442.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:40:49+00:00 2018-09-27 16:40:49+00:00 ASTHCUR CURRENT ASTHMA DX BY DOC +64 Asthma 106023 phv00106023.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:41:32+00:00 2018-09-27 16:41:32+00:00 ASTHH57 DO YOU STILL HAVE IT +64 Asthma 106024 phv00106024.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:41:47+00:00 2018-09-27 16:41:47+00:00 ASTHDR57 WAS IT CONFIRMED BY A DOCTOR +64 Asthma 106025 phv00106025.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:42:10+00:00 2018-09-27 16:42:10+00:00 ASTHAG57 AT WHAT AGE DID IT START +64 Asthma 106026 phv00106026.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:42:21+00:00 2018-09-27 16:42:21+00:00 ASTHST57 AT WHAT AGE DID IT STOP +64 Asthma 106407 phv00106407.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:42:38+00:00 2018-09-27 16:42:38+00:00 ASTHCUR CURRENT ASTHMA DX BY DOC +64 Asthma 197464 phv00197464.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:43:11+00:00 2018-09-27 16:43:11+00:00 asth1215 Pt had attack of asthma in last 12 months? +64 Asthma 99087 phv00099087.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:43:40+00:00 2018-09-27 16:43:40+00:00 ATH07 ASTHMA +64 Asthma 99088 phv00099088.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:44:24+00:00 2018-09-27 16:44:24+00:00 ATHH07 DO YOU STILL HAVE IT +64 Asthma 99089 phv00099089.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:44:42+00:00 2018-09-27 16:44:42+00:00 ATHDR07 WAS IT CONFIRMED BY A DOCTOR +64 Asthma 99090 phv00099090.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:44:54+00:00 2018-09-27 16:44:54+00:00 ATHT07 AT WHAT AGE DID IT START +64 Asthma 104144 phv00104144.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:45:17+00:00 2018-09-27 16:45:17+00:00 ATH37 ASTHMA +64 Asthma 107851 phv00107851.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:46:17+00:00 2018-09-27 16:46:17+00:00 ASDR56 ASTHMA CONFIRMED BY DOCTOR +64 Asthma 107850 phv00107850.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:46:54+00:00 2018-09-27 16:46:54+00:00 ASSTIL56 STILL HAVE ASTHMA +64 Asthma 107853 phv00107853.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:47:07+00:00 2018-09-27 16:47:07+00:00 ASSTOP56 AT WHAT AGE DID ASTHMA STOP +64 Asthma 107852 phv00107852.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:47:56+00:00 2018-09-27 16:47:56+00:00 ASLAST56 WHAT AGE WAS LAST EPISODE OF ASTHMA +64 Asthma 55304 phv00055304.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:42:24+00:00 2018-10-04 15:42:24+00:00 ASTHMA15 MD said pt had asthma? +64 Asthma 4065 phv00004065.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 FL475 CDI: ASTHMA +64 Asthma 4487 phv00004487.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 FM502 CLINICAL DIAGNOSTIC IMPRESSION: ASTHMA +64 Asthma 4923 phv00004923.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 FN473 CDI-ASTHMA +64 Asthma 5285 phv00005285.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 FO489 CLINICAL DIAGNOSTIC IMPRESSION: ASTHMA +64 Asthma 5665 phv00005665.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 FP146 ASTHMA IN INTERIM +64 Asthma 7778 phv00007778.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 B128 ASTHMA +64 Asthma 8701 phv00008701.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 C374 CDI: ASTHMA +64 Asthma 9088 phv00009088.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 D360 CDI: ASTHMA +64 Asthma 9543 phv00009543.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 E646 CDI-ASTHMA +64 Asthma 10057 phv00010057.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 F641 CDI: ASTHMA +64 Asthma 250709 phv00250709.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 e646 Clinical Diagnostic Impressions - Part III: Non Cardiovascular Diagnoses - Asthma Collection Interval: Exam 1 +64 Asthma 276870 phv00276870.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:44:47+00:00 2018-10-04 15:44:47+00:00 CHF071 Asthma +64 Asthma 5912 phv00005912.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FP455 CLINICAL DIAGNOSTIC IMPRESSION- ASTHMA +64 Asthma 6529 phv00006529.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FR256 RESPIRATORY SYMPTOMS - HAVE YOU HAD ASTHMA IN THE INTERIM? +64 Asthma 6650 phv00006650.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FR425 NON-CARDIOVASCULAR - ASTHMA +64 Asthma 6960 phv00006960.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FS351 HAVE YOU HAD ASTHMA IN THE INTERIM? +64 Asthma 7085 phv00007085.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FS525 1ST EXAMINER OPINIONS: ASTHMA +64 Asthma 7392 phv00007392.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FT353 HAVE YOU HAD ASTHMA IN THE INTERIM? +64 Asthma 7519 phv00007519.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FT530 NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS - ASTHMA +64 Asthma 70545 phv00070545.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FU242 NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS: ASTHMA +64 Asthma 254754 phv00254754.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 fv244 Clinical Diagnostic Impression: Non Cardiovascular Diagnoses First Examiner Opinions: Asthma Collection Interval: Exam 29 +64 Asthma 255145 phv00255145.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 fw286 Clinical Diagnostic Impression - Asthma Collection Interval: Original Cohort Exam 30 +64 Asthma 274870 phv00274870.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 FX286 Clinical Diagnostic Impression - Asthma Collection Interval: Original Cohort Exam 31 +64 Asthma 275228 phv00275228.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:46:46+00:00 2018-10-04 15:46:46+00:00 fy286 Clinical Diagnostic Impression - Asthma Collection Interval: Original Cohort Exam 32 +64 Asthma 10270 phv00010270.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 G127 HAVE YOU HAD ASTHMA IN THE INTERIM? +64 Asthma 21205 phv00021205.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 G3A407 CDI - ASTHMA +64 Asthma 21292 phv00021292.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 G3A539 HAVE YOU EVER HAD ASTHMA? +64 Asthma 21293 phv00021293.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 G3A540 ASTHMA: DO YOU STILL HAVE IT? +64 Asthma 21294 phv00021294.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 G3A541 ASTHMA: WAS IT DIAGNOSED BY A DOCTOR OR OTHER HEALTH PROFESSIONAL? +64 Asthma 21295 phv00021295.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 G3A542 ASTHMA: AT WHAT AGE DID IT START? (AGE IN YEARS) +64 Asthma 21296 phv00021296.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 G3A543 ASTHMA: IF YOU NO LONGER HAVE IT, AT WHAT AGE DID IT STOP? (AGE IN YEARS) +64 Asthma 250838 phv00250838.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g127 Medical History - Respiratory and Heart: Have you had asthma in the interim Collection Interval: Exam 2 +64 Asthma 274028 phv00274028.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a407 CDI - Asthma Collection Interval: Exam 1 +64 Asthma 274119 phv00274119.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a539 Have you ever had asthma? Collection Interval: Exam 1 +64 Asthma 274120 phv00274120.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a540 Asthma: Do you still have it? Collection Interval: Exam 1 +64 Asthma 274121 phv00274121.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a541 Asthma: Was it diagnosed by a doctor or other health professional? Collection Interval: Exam 1 +64 Asthma 274122 phv00274122.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a542 Asthma: At what age did it start? Collection Interval: Exam 1 +64 Asthma 274123 phv00274123.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a543 Asthma: If you no longer have it, at what age did it stop? Collection Interval: Exam 1 +64 Asthma 274521 phv00274521.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a407 CDI - Asthma +64 Asthma 274610 phv00274610.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a539 Have you ever had asthma? +64 Asthma 274611 phv00274611.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a540 Asthma: Do you still have it? +64 Asthma 274612 phv00274612.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a541 Asthma: Was it diagnosed by a doctor or other health professional? +64 Asthma 274613 phv00274613.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a542 Asthma: At what age did it start? +64 Asthma 274614 phv00274614.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:58:52+00:00 2018-10-04 15:58:52+00:00 g3a543 Asthma: If you no longer have it, at what age did it stop? +64 Asthma 10489 phv00010489.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:36+00:00 2018-10-04 16:00:36+00:00 G418 CDI: ASTHMA +64 Asthma 10661 phv00010661.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:36+00:00 2018-10-04 16:00:36+00:00 G670 RESPIRATORY: HAVE YOU EVER HAD ASTHMA? +64 Asthma 177516 phv00177516.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:37+00:00 2018-10-04 16:00:37+00:00 g3b0431 Clinical Diagnostic Impression: Asthma +64 Asthma 177565 phv00177565.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:37+00:00 2018-10-04 16:00:37+00:00 g3b0591 Respiratory Disease Questionnaire-Technician administered: Since your last exam have you had asthma? +64 Asthma 177566 phv00177566.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:37+00:00 2018-10-04 16:00:37+00:00 g3b0592 Respiratory Disease Questionnaire-Technician administered: Do you still have it? +64 Asthma 177567 phv00177567.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:37+00:00 2018-10-04 16:00:37+00:00 g3b0593 Respiratory Disease Questionnaire-Technician administered: Was it diagnosed by a doctor or other health care professional? +64 Asthma 177568 phv00177568.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:37+00:00 2018-10-04 16:00:37+00:00 g3b0594 Respiratory Disease Questionnaire-Technician administered: If it started since your last exam, at what age did it start? +64 Asthma 177569 phv00177569.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:37+00:00 2018-10-04 16:00:37+00:00 g3b0595 Respiratory Disease Questionnaire-Technician administered: If you no longer have it, at what age did it stop? +64 Asthma 251049 phv00251049.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:37+00:00 2018-10-04 16:00:37+00:00 g418 Clinical Diagnostic Impression - Part III - Non Cardiovascular Diagnoses First Examiner Opinions: Asthma Collection Interval: Exam 2 +64 Asthma 251235 phv00251235.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:00:37+00:00 2018-10-04 16:00:37+00:00 g670 Respiratory Questionnaire - Asthma: Have you even had asthma? Collection Interval: Exam 2 +64 Asthma 72313 phv00072313.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:01:33+00:00 2018-10-04 16:01:33+00:00 H359 CLINICAL DIAGNOSTIC IMPRESSION: ASTHMA +64 Asthma 72488 phv00072488.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:01:33+00:00 2018-10-04 16:01:33+00:00 H647 SINCE YOUR LAST EXAM HAVE YOU HAD ASTHMA? +64 Asthma 251510 phv00251510.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:01:33+00:00 2018-10-04 16:01:33+00:00 h359 Clinical Diagnostic Impression - Part II: Non Cardiovascular Diagnoses First Examiner Opinions: Pulmonary: Asthma Collection Interval: Exam 3 +64 Asthma 251703 phv00251703.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 16:01:33+00:00 2018-10-04 16:01:33+00:00 h647 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had asthma? Collection Interval: Exam 3 +64 Asthma 56803 phv00056803.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 hi201d Asthma: has a doctor ever told you that you have asthma? +64 Asthma 56804 phv00056804.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 hi201e Current asthma: if hi201d= 1 (yes), do you still have asthma? +64 Asthma 72489 phv00072489.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 H648 ASTHMA: DO YOU STILL HAVE IT? +64 Asthma 72490 phv00072490.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 H649 ASTHMA: WAS IT DIAGNOSED BY A DOCTOR OR OTHER HEALTH PROFESSIONAL? +64 Asthma 72509 phv00072509.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 H650 ASTHMA: AT WHAT AGE DID IT START? +64 Asthma 72510 phv00072510.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 H651 ASTHMA: IF YOU NO LONGER HAVE IT, AT WHAT AGE DID IT STOP? +64 Asthma 251704 phv00251704.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 h648 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Do you still have it? Collection Interval: Exam 3 +64 Asthma 251705 phv00251705.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 h649 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Was it diagnosed by a doctor or other health professional? Collection Interval: Exam 3 +64 Asthma 251706 phv00251706.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 h650 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: At what age did it start? Collection Interval: Exam 3 +64 Asthma 251707 phv00251707.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:33:46+00:00 2018-10-04 17:33:46+00:00 h651 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: If you no longer have it, at what age did it stop? Collection Interval: Exam 3 +64 Asthma 484 phv00000484.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:36:12+00:00 2018-10-04 17:36:12+00:00 MF10 HISTORY OF ALLERGY OR ASTHMA, EXAM 1 +64 Asthma 701 phv00000701.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:36:12+00:00 2018-10-04 17:36:12+00:00 MF246 INTERIM HISTORY OF ALLERGIES: ASTHMA, EXAM 4 +64 Asthma 789 phv00000789.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:36:12+00:00 2018-10-04 17:36:12+00:00 MF339 LIFETIME HISTORY OF HAY FEVER AND ASTHMA, EXAM 5 (IF BOTH PRESENT, ONLY ASTHMA IS CODED) +64 Asthma 22715 phv00022715.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:36:12+00:00 2018-10-04 17:36:12+00:00 RQ014 EVER HAD ASTHMA +64 Asthma 254260 phv00254260.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:36:12+00:00 2018-10-04 17:36:12+00:00 j421 Clinical Diagnostic Impression-Part II-Pulmonary: Asthma +64 Asthma 254489 phv00254489.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:36:12+00:00 2018-10-04 17:36:12+00:00 j832 Respiratory Disease Questionnaire Part 1-Tech administered: Respiratory Diagnosis: Have you ever had asthma? +64 Asthma 254492 phv00254492.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:36:12+00:00 2018-10-04 17:36:12+00:00 j835 Respiratory Disease Questionnaire Part 1-Tech administered: Respiratory Diagnosis: At what age did it start? +64 Asthma 254493 phv00254493.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:36:12+00:00 2018-10-04 17:36:12+00:00 j836 Respiratory Disease Questionnaire Part 1-Tech administered: Respiratory Diagnosis: If you no longer have it, at what age did it stop? +64 Asthma 8468 phv00008468.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:16:21+00:00 2018-10-05 18:16:21+00:00 C93 WHEEZING OR ASTHMA +64 Asthma 8881 phv00008881.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:16:21+00:00 2018-10-05 18:16:21+00:00 D117 WHEEZING OR ASTHMA +64 Asthma 603 phv00000603.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 MF135 LIFETIME HISTORY OF ALLERGIES: HIVES, HAY FEVER, ASTHMA, EXAM 2 +64 Asthma 3399 phv00003399.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 FK151 RESPIRATORY: WHEEZING OR ASTHMA +64 Asthma 3856 phv00003856.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 FL212 WHEEZING OR ASTHMA +64 Asthma 4292 phv00004292.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 FM256 WHEEZING OR ASTHMA +64 Asthma 4694 phv00004694.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 FN197 WHEEZING OR ASTHMA +64 Asthma 4695 phv00004695.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 FN198 TYPE OF WHEEZING OR ASTHMA +64 Asthma 5045 phv00005045.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 FO192 WHEEZING OR ASTHMA +64 Asthma 5046 phv00005046.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 FO193 WHEEZING OR ASTHMA - TYPE +64 Asthma 6183 phv00006183.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 FQ198 WHEEZING OR ASTHMA +64 Asthma 9292 phv00009292.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 E339 WHEEZING OR ASTHMA +64 Asthma 9293 phv00009293.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 E340 TYPE OF WHEEZING OR ASTHMA +64 Asthma 9799 phv00009799.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 F309 WHEEZING OR ASTHMA +64 Asthma 250472 phv00250472.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 e339 Medical History - Respiratory: Wheezing or asthma Collection Interval: Exam 1 +64 Asthma 250473 phv00250473.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 18:19:35+00:00 2018-10-05 18:19:35+00:00 e340 Medical History - Respiratory: Type of wheezing or asthma Collection Interval: Exam 1 +65 Asthma severity 83121 phv00083121.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:24:34+00:00 2018-04-28 22:24:34+00:00 istrd1c INHALED STEROIDS FOR ASTHMA +65 Asthma severity 83134 phv00083134.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:24:54+00:00 2018-04-28 22:24:54+00:00 oaia1c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 85366 phv00085366.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:25:00+00:00 2018-04-28 22:25:00+00:00 istrd1c INHALED STEROIDS FOR ASTHMA +65 Asthma severity 85379 phv00085379.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:25:09+00:00 2018-04-28 22:25:09+00:00 oaia1c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 86047 phv00086047.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:44:02+00:00 2018-04-28 22:44:02+00:00 istrd2c INHALED STEROIDS FOR ASTHMA +65 Asthma severity 86058 phv00086058.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:44:10+00:00 2018-04-28 22:44:10+00:00 oaia2c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 86529 phv00086529.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:44:15+00:00 2018-04-28 22:44:15+00:00 istrd3c INHALED STEROIDS FOR ASTHMA +65 Asthma severity 86540 phv00086540.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:44:21+00:00 2018-04-28 22:44:21+00:00 oaia3c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 86966 phv00086966.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:44:27+00:00 2018-04-28 22:44:27+00:00 istrd4c INHALED STEROIDS FOR ASTHMA +65 Asthma severity 86977 phv00086977.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:44:48+00:00 2018-04-28 22:44:48+00:00 oaia4c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 87342 phv00087342.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:44:54+00:00 2018-04-28 22:44:54+00:00 istrdfc INHALED STEROIDS FOR ASTHMA +65 Asthma severity 87355 phv00087355.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:45:29+00:00 2018-04-28 22:45:29+00:00 oaiafc ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 175368 phv00175368.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:45:36+00:00 2018-04-28 22:45:36+00:00 istrd5c INHALED STEROIDS FOR ASTHMA +65 Asthma severity 175381 phv00175381.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:45:46+00:00 2018-04-28 22:45:46+00:00 oaia5c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 175874 phv00175874.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:45:52+00:00 2018-04-28 22:45:52+00:00 istrd1c INHALED STEROIDS FOR ASTHMA +65 Asthma severity 175958 phv00175958.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:45:59+00:00 2018-04-28 22:45:59+00:00 istrdfc FAMILY COHORT: INHALED STEROIDS FOR ASTHMA +65 Asthma severity 175959 phv00175959.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:47:53+00:00 2018-04-28 22:47:53+00:00 oaiafc FAMILY COHORT: ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 176791 phv00176791.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:48:00+00:00 2018-04-28 22:48:00+00:00 istrd5c INHALED STEROIDS FOR ASTHMA +65 Asthma severity 176804 phv00176804.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 22:48:10+00:00 2018-04-28 22:48:10+00:00 oaia5c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +65 Asthma severity 159708 phv00159708.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:54:40+00:00 2018-08-10 20:54:40+00:00 AsthmaTreat Asthma: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1 +65 Asthma severity 1099 phv00001099.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 FA80 HOSPITALIZED SINCE LAST EXAM FOR ASTHMA +65 Asthma severity 1118 phv00001118.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 FA107 UNDER MEDICAL CARE BUT NOT HOSPITALIZED SINCE LAST EXAM FOR ASTHMA +65 Asthma severity 3014 phv00003014.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 FJ71 RESPIRATORY SYMPTOMS & CHF COMPLAINTS: ASTHMA-LONG DURATION +65 Asthma severity 3015 phv00003015.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 FJ72 RESPIRATORY SYMPTOMS & CHF COMPLAINTS: ASTHMA-SEASONAL +65 Asthma severity 3016 phv00003016.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 FJ73 RESPIRATORY SYMPTOMS & CHF COMPLAINTS: ASTHMA-WITH RESPIRATORY INFECTION +65 Asthma severity 21297 phv00021297.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 G3A544 ASTHMA: HAVE YOU RECEIVED MEDICAL TREATMENT FOR THIS IN THE PAST 12 MONTHS? +65 Asthma severity 55305 phv00055305.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 ASTH1215 Pt had attack of asthma in last 12 months? +65 Asthma severity 274124 phv00274124.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 g3a544 Asthma: Have you received medical treatment for this in the past 12 months? Collection Interval: Exam 1 +65 Asthma severity 274615 phv00274615.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:52:23+00:00 2018-10-04 14:52:23+00:00 g3a544 Asthma: Have you received medical treatment for this in the past 12 months? +65 Asthma severity 10662 phv00010662.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:53:51+00:00 2018-10-04 14:53:51+00:00 G671 RESPIRATORY: HAVE YOU HAD AN ATTACK OF ASTHMA AT ANY TIME IN THE LAST 12 MONTHS? +65 Asthma severity 10663 phv00010663.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:53:51+00:00 2018-10-04 14:53:51+00:00 G672 RESPIRATORY: ARE YOU CURRENTLY TAKING ANY MEDICATIONS (INCLUDING INHALERS, AEROSOLS, OR TABLETS) FOR ASTHMA? +65 Asthma severity 251236 phv00251236.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:53:51+00:00 2018-10-04 14:53:51+00:00 g671 Respiratory Questionnaire - Asthma: Have you had an attack of asthma at any time in the last 12 months? Collection Interval: Exam 2 +65 Asthma severity 251237 phv00251237.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 14:53:51+00:00 2018-10-04 14:53:51+00:00 g672 Respiratory Questionnaire - Asthma: Are you currently taking any medicines (including inhalers, aerosols, or tablets) for asthma? Collection Interval: Exam 2 +65 Asthma severity 22716 phv00022716.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:12:10+00:00 2018-10-04 15:12:10+00:00 RQ015 HAD AN ATTACK OF ASTHMA AT ANY TIME IN THE LAST 12 MONTHS +65 Asthma severity 22717 phv00022717.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:12:10+00:00 2018-10-04 15:12:10+00:00 RQ016 CURRENTLY TAKING ANY MEDICINES (INC. INHALERS, AEROSOLS, OR TABLETS) FOR ASTHMA +65 Asthma severity 55372 phv00055372.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:12:10+00:00 2018-10-04 15:12:10+00:00 ISTRD1 Inhaled steroids for asthma +65 Asthma severity 56964 phv00056964.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:12:10+00:00 2018-10-04 15:12:10+00:00 ISTRD2 Inhaled steroids for asthma +65 Asthma severity 72491 phv00072491.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:12:10+00:00 2018-10-04 15:12:10+00:00 H652 ASTHMA: HAVE YOU RECEIVED MEDICAL TREATMENT FOR THIS IN THE PAST 12 MONTHS? +65 Asthma severity 251708 phv00251708.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 15:12:11+00:00 2018-10-04 15:12:11+00:00 h652 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Have you received medical treatment for this in the past 12 months? Collection Interval: Exam 3 +65 Asthma severity 2713 phv00002713.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 FI61 INTERIM HISTORY OF RESPIRATORY SYMPTOMS AND CHF COMPLAINTS: TROUBLED WITH WHEEZING-ASTHMA +65 Asthma severity 3013 phv00003013.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 FJ70 RESPIRATORY SYMPTOMS & CHF COMPLAINTS: TROUBLE WITH WHEEZING-ASTHMA +65 Asthma severity 4293 phv00004293.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 FM257 WHEEZING OR ASTHMA IS OF LONG DURATION? +65 Asthma severity 4294 phv00004294.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 FM258 WHEEZING OR ASTHMA IS SEASONAL? +65 Asthma severity 4295 phv00004295.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 FM259 WHEEZING OR ASTHMA WITH RESPIRATORY INFECTION? +65 Asthma severity 8469 phv00008469.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 C94 WHEEZING OR ASTHMA - OF LONG DURATION +65 Asthma severity 8470 phv00008470.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 C95 WHEEZING OR ASTHMA - SEASONAL +65 Asthma severity 8471 phv00008471.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 C96 WHEEZING OR ASTHMA - WITH RESPIRATORY INFECTIONS +65 Asthma severity 8882 phv00008882.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 D118 WHEEZING OR ASTHMA IS OF LONG DURATION? +65 Asthma severity 8883 phv00008883.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 D119 WHEEZING OR ASTHMA IS SEASONAL? +65 Asthma severity 8884 phv00008884.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 17:54:10+00:00 2018-10-05 17:54:10+00:00 D120 WHEEZING OR ASTHMA COMES WITH RESPIRATORY INFECTION? +65 Asthma severity 115478 phv00115478.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-12 23:48:45+00:00 2018-12-12 23:48:45+00:00 C08ASMA CURRENTLY TAKING ASTHMA MEDICATION. Q 12 +65 Asthma severity 114364 phv00114364.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-12 23:49:07+00:00 2018-12-12 23:49:07+00:00 B08ASMA TAKE MEDICINE FOR ASTHMA. Q 6 +65 Asthma severity 113016 phv00113016.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-12 23:49:15+00:00 2018-12-12 23:49:15+00:00 A08ASMA TAKE MEDICINE FOR ASTHMA +65 Asthma severity 119935 phv00119935.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-12 23:51:14+00:00 2018-12-12 23:51:14+00:00 F08ASMA CURRENTLY TAKING MEDS FOR ASTHMA. Q 29 +65 Asthma severity 121748 phv00121748.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-12 23:51:28+00:00 2018-12-12 23:51:28+00:00 B09ASLUS TIME SINCE LAST USED ASTHMA MED. Q 4.04B +65 Asthma severity 121750 phv00121750.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-12 23:52:07+00:00 2018-12-12 23:52:07+00:00 B09ASTMO DURATION OF ASTHMA MED USE: MONTHS. Q 4.04C +65 Asthma severity 121749 phv00121749.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-12 23:52:23+00:00 2018-12-12 23:52:23+00:00 B09ASTYR DURATION OF ASTHMA MED USE: YEARS. Q 4.04C +65 Asthma severity 121740 phv00121740.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-12 23:52:27+00:00 2018-12-12 23:52:27+00:00 B09ASTUS TOTAL DURATION OF ASTHMA MED USE: MONTHS +65 Asthma severity 122123 phv00122123.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ASTPLNOW Still take asthma spray +65 Asthma severity 122124 phv00122124.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ASTHSPY Ever take asthma spray (AC) +65 Asthma severity 226253 phv00226253.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ASTHMA_MEDS Asthma Med Use - self/scanned (current asthma by MD diagnosis) +65 Asthma severity 226316 phv00226316.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 MED_ANTIASTHMATICS Antiasthmatic or bronchodilator agents +65 Asthma severity 117066 phv00117066.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 D08ASMA CURRENTLY TAKING MEDS FOR ASTHMA. Q 24 +65 Asthma severity 258083 phv00258083.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 RSEA37 Medical treatment: asthma in 12 months (RSEA37) +65 Asthma severity 118546 phv00118546.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 E08ASMA CURRENTLY TAKING MEDS FOR ASTHMA. Q 26 +65 Asthma severity 56977 phv00056977.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA2 Oral anti-inflammatory asthma drugs (leukotriene receptor antagonists and inhibitors of lipo-oxygenase) +65 Asthma severity 99614 phv00099614.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 99627 phv00099627.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 100553 phv00100553.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 100566 phv00100566.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 104422 phv00104422.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 104435 phv00104435.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 105052 phv00105052.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 105065 phv00105065.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 106473 phv00106473.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 106486 phv00106486.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 107398 phv00107398.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 107411 phv00107411.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 108259 phv00108259.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 108272 phv00108272.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 109013 phv00109013.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 109026 phv00109026.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 109724 phv00109724.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 109737 phv00109737.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 110679 phv00110679.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 102131 phv00102131.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 ISTRD06 Inhaled steroids for asthma +65 Asthma severity 102144 phv00102144.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 103117 phv00103117.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +65 Asthma severity 197547 phv00197547.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 istrd Inhaled steroids for asthma +65 Asthma severity 199069 phv00199069.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 istrd2 Inhaled steroids for asthma +65 Asthma severity 199082 phv00199082.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-12-27 02:07:35+00:00 2018-12-27 02:07:35+00:00 oaia2 Oral Anti-inflammatory asthma drugs (leukotriene receptor antagonists and inhibitor) +66 COPD 83483 phv00083483.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:12:42+00:00 2018-04-28 23:12:42+00:00 cpmesaa4 COPD - MESA +66 COPD 83484 phv00083484.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:12:51+00:00 2018-04-28 23:12:51+00:00 cpgolda4 COPD - GOLD +66 COPD 83485 phv00083485.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:13:02+00:00 2018-04-28 23:13:02+00:00 cp2005a4 COPD - 2005 PFT +66 COPD 83545 phv00083545.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:13:09+00:00 2018-04-28 23:13:09+00:00 qcopda4 COPD +66 COPD 83546 phv00083546.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:13:36+00:00 2018-04-28 23:13:36+00:00 qcopdaa4 AGE WITH COPD +66 COPD 83620 phv00083620.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:13:43+00:00 2018-04-28 23:13:43+00:00 copdlla4 COPD- 2005 DEFINITION +66 COPD 83718 phv00083718.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:14:00+00:00 2018-04-28 23:14:00+00:00 cpmesaa4 COPD - MESA +66 COPD 83719 phv00083719.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:14:07+00:00 2018-04-28 23:14:07+00:00 cpgolda4 COPD - GOLD +66 COPD 83720 phv00083720.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:14:13+00:00 2018-04-28 23:14:13+00:00 cp2005a4 COPD - 2005 PFT +66 COPD 83780 phv00083780.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:14:28+00:00 2018-04-28 23:14:28+00:00 qcopda4 COPD +66 COPD 83781 phv00083781.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:14:34+00:00 2018-04-28 23:14:34+00:00 qcopdaa4 AGE WITH COPD +66 COPD 83850 phv00083850.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:14:41+00:00 2018-04-28 23:14:41+00:00 copdlla4 COPD- 2005 DEFINITION +66 COPD 87709 phv00087709.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:14:56+00:00 2018-04-28 23:14:56+00:00 cpmesaa4 COPD - MESA +66 COPD 87710 phv00087710.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:15:03+00:00 2018-04-28 23:15:03+00:00 cpgolda4 COPD - GOLD +66 COPD 87711 phv00087711.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:15:09+00:00 2018-04-28 23:15:09+00:00 cp2005a4 COPD - 2005 PFT +66 COPD 87771 phv00087771.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:15:22+00:00 2018-04-28 23:15:22+00:00 qcopda4 COPD +66 COPD 87772 phv00087772.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:15:28+00:00 2018-04-28 23:15:28+00:00 qcopdaa4 AGE WITH COPD +66 COPD 87846 phv00087846.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:15:35+00:00 2018-04-28 23:15:35+00:00 copdlla4 COPD - 2005 DEFINITION +66 COPD 175294 phv00175294.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:15:48+00:00 2018-04-28 23:15:48+00:00 emphys5 EMPHYSEMA OR COPD: SELF-REPORT +66 COPD 176717 phv00176717.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:16:01+00:00 2018-04-28 23:16:01+00:00 emphys5 EMPHYSEMA OR COPD: SELF-REPORT +66 COPD 206784 phv00206784.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:34:36+00:00 2018-05-03 16:34:36+00:00 HFAA10B [Medical history]. Q10b - Chronic bronchitis/COPD [Heart Failure Hospital Record Abstraction Form, HFA] +66 COPD 214106 phv00214106.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 16:34:57+00:00 2018-05-03 16:34:57+00:00 COPD15 MD said pt had COPD? +66 COPD 159734 phv00159734.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:14:43+00:00 2018-08-10 21:14:43+00:00 CopdStillHave COPD: do you still have COPD Collection Interval: Collected in Exam 1 +66 COPD 159733 phv00159733.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:14:51+00:00 2018-08-10 21:14:51+00:00 CopdAge COPD: at about what age did COPD start Collection Interval: Collected in Exam 1 +66 COPD 159732 phv00159732.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:14:59+00:00 2018-08-10 21:14:59+00:00 CopdDxByDr COPD: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1 +66 COPD 159731 phv00159731.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:15:07+00:00 2018-08-10 21:15:07+00:00 COPD COPD: have you ever had COPD Collection Interval: Collected in Exam 1 +66 COPD 308100 phv00308100.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:22:01+00:00 2018-08-16 00:22:01+00:00 LUNGAGE In what year or how old were you when this condition was first diagnosed? - age Collection Interval: 2000-2004 +66 COPD 308099 phv00308099.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:22:09+00:00 2018-08-16 00:22:09+00:00 LUNGYR In what year or how old were you when this condition was first diagnosed? - year Collection Interval: 2000-2004 +66 COPD 308098 phv00308098.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:22:16+00:00 2018-08-16 00:22:16+00:00 LUNG Have you ever been told by a physician that you had emphysema/chronic bronchitis/or obstructive lung disease? Collection Interval: 2000-2004 +66 COPD 277907 phv00277907.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:29:09+00:00 2018-08-16 00:29:09+00:00 LUNGAGE In what year or how old were you when this condition was first diagnosed? - age Collection Interval: 2000-2004 +66 COPD 277906 phv00277906.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:29:17+00:00 2018-08-16 00:29:17+00:00 LUNGYR In what year or how old were you when this condition was first diagnosed? - year Collection Interval: 2000-2004 +66 COPD 277905 phv00277905.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:29:25+00:00 2018-08-16 00:29:25+00:00 LUNG Have you ever been told by a physician that you had emphysema/chronic bronchitis/or obstructive lung disease? Collection Interval: 2000-2004 +66 COPD 258042 phv00258042.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:56:05+00:00 2018-08-24 16:56:05+00:00 COPD_BY_BD COPD by BD test (for all valid PRE_BD) +66 COPD 169348 phv00169348.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:45:14+00:00 2018-09-10 17:45:14+00:00 EmphStillHave Emphysema: do you still have it Collection Interval: Collected in Exam 1 +66 COPD 169347 phv00169347.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:45:21+00:00 2018-09-10 17:45:21+00:00 EmphAge Emphysema: at about what age did it start Collection Interval: Collected in Exam 1 +66 COPD 159730 phv00159730.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:45:28+00:00 2018-09-10 17:45:28+00:00 EmphDxByDr Emphysema: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1 +66 COPD 159729 phv00159729.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:45:36+00:00 2018-09-10 17:45:36+00:00 Emphysema Emphysema: have you ever had emphysema Collection Interval: Collected in Exam 1 +66 COPD 119923 phv00119923.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:00+00:00 2018-09-10 17:47:00+00:00 F08EMPYR HAD EMPHYSEMA IN THE PAST YEAR? Q 20 +66 COPD 119922 phv00119922.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:07+00:00 2018-09-10 17:47:07+00:00 F08EMPAG AGE DIAGNOSED-EMPHYSEMA. Q 20 +66 COPD 119914 phv00119914.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:14+00:00 2018-09-10 17:47:14+00:00 F08EMPH EMPHYSEMA? Q 20 +66 COPD 118535 phv00118535.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:21+00:00 2018-09-10 17:47:21+00:00 E08EMPAG AGE DIAGNOSED-EMPHYSEMA. Q 19 +66 COPD 118534 phv00118534.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:28+00:00 2018-09-10 17:47:28+00:00 E08EMPH EMPHYSEMA? Q 19 +66 COPD 117055 phv00117055.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:36+00:00 2018-09-10 17:47:36+00:00 D08EMPAG AGE FIRST DIAGNOSED WITH EMPHYSEMA. Q 17 +66 COPD 117054 phv00117054.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:43+00:00 2018-09-10 17:47:43+00:00 D08EMPH EMPHYSEMA. Q 17 +66 COPD 113383 phv00113383.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:51+00:00 2018-09-10 17:47:51+00:00 A12EMAGE AGE WHEN EMPHYSEMA STARTED +66 COPD 113382 phv00113382.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:47:57+00:00 2018-09-10 17:47:57+00:00 A12EMDOC WAS EMPHYSEMA CONFIRMED BY A DOCTOR +66 COPD 113381 phv00113381.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:48:05+00:00 2018-09-10 17:48:05+00:00 A12EMSTL DOES SUBJECT STILL HAVE EMPHYSEMA +66 COPD 113380 phv00113380.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:48:21+00:00 2018-09-10 17:48:21+00:00 A12EMPH EVER HAD EMPHYSEMA +66 COPD 159845 phv00159845.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:50:16+00:00 2018-09-10 17:50:16+00:00 Chronic_Bronchitis Chronic bronchitis calc. from cough/phlegm ques Collection Interval: Collected in Exam 1 +66 COPD 159728 phv00159728.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:50:24+00:00 2018-09-10 17:50:24+00:00 ChronBroncDxByDr Chronic bronchitis: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1 +66 COPD 159727 phv00159727.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:50:32+00:00 2018-09-10 17:50:32+00:00 ChronBronch Chronic bronchitis: have you ever had chronic bronchitis Collection Interval: Collected in Exam 1 +66 COPD 169345 phv00169345.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:50:42+00:00 2018-09-10 17:50:42+00:00 ChronBrncStillHv Chronic bronchitis: do you still have it Collection Interval: Collected in Exam 1 +66 COPD 169344 phv00169344.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-09-10 17:50:49+00:00 2018-09-10 17:50:49+00:00 ChronBroncAge Chronic bronchitis: at about what age did it start Collection Interval: Collected in Exam 1 +66 COPD 119915 phv00119915.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:51:56+00:00 2018-09-10 17:51:56+00:00 F08BRON CHRONIC BRONCHITIS? Q 21 +66 COPD 118536 phv00118536.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:52:02+00:00 2018-09-10 17:52:02+00:00 E08BRON CHRONIC BRONCHITIS? Q 20 +66 COPD 117056 phv00117056.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:52:09+00:00 2018-09-10 17:52:09+00:00 D08BRON CHRONIC BRONCHITIS. Q 18 +66 COPD 113379 phv00113379.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:52:16+00:00 2018-09-10 17:52:16+00:00 A12CBAGE AGE WHEN CHRONIC BRONCHITIS STARTED +66 COPD 113378 phv00113378.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:52:23+00:00 2018-09-10 17:52:23+00:00 A12CBDOC CHRONIC BRONCHITIS CONFIRMED BY A DOCTOR +66 COPD 113377 phv00113377.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:52:35+00:00 2018-09-10 17:52:35+00:00 A12CBSTL DOES PT STILL HAVE CHRONIC BRONCHITIS +66 COPD 113376 phv00113376.v2.p2 pht001575.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-09-10 17:52:43+00:00 2018-09-10 17:52:43+00:00 A12CBRON EVER HAD ATTACKS OF CHRONIC BRONCHITIS +66 COPD 5909 phv00005909.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:16:22+00:00 2018-09-19 22:16:22+00:00 FP452 CLINICAL DIAGNOSTIC IMPRESSION- EMPHYSEMA +66 COPD 5282 phv00005282.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:16:29+00:00 2018-09-19 22:16:29+00:00 FO486 CLINICAL DIAGNOSTIC IMPRESSION: EMPHYSEMA +66 COPD 4920 phv00004920.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:16:36+00:00 2018-09-19 22:16:36+00:00 FN470 CDI-EMPHYSEMA +66 COPD 4484 phv00004484.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:16:44+00:00 2018-09-19 22:16:44+00:00 FM499 CLINICAL DIAGNOSTIC IMPRESSION: EMPHYSEMA +66 COPD 4062 phv00004062.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:16:51+00:00 2018-09-19 22:16:51+00:00 FL472 CDI: EMPHYSEMA +66 COPD 2196 phv00002196.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:16:58+00:00 2018-09-19 22:16:58+00:00 FF277 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, EMPHYSEMA +66 COPD 2012 phv00002012.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:17:05+00:00 2018-09-19 22:17:05+00:00 FE343 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, EMPHYSEMA +66 COPD 1783 phv00001783.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:17:12+00:00 2018-09-19 22:17:12+00:00 FD287 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, EMPHYSEMA +66 COPD 21203 phv00021203.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:17:41+00:00 2018-09-19 22:17:41+00:00 G3A405 CDI - EMPHYSEMA +66 COPD 10486 phv00010486.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:17:48+00:00 2018-09-19 22:17:48+00:00 G415 CDI: EMPHYSEMA +66 COPD 10054 phv00010054.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:17:55+00:00 2018-09-19 22:17:55+00:00 F638 CDI: EMPHYSEMA +66 COPD 9540 phv00009540.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:18:01+00:00 2018-09-19 22:18:01+00:00 E643 CDI-EMPHYSEMA +66 COPD 9085 phv00009085.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:18:09+00:00 2018-09-19 22:18:09+00:00 D357 CDI: EMPHYSEMA +66 COPD 8697 phv00008697.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:18:17+00:00 2018-09-19 22:18:17+00:00 C370 CDI: EMPHYSEMA +66 COPD 7516 phv00007516.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:18:24+00:00 2018-09-19 22:18:24+00:00 FT527 NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS - EMPHYSEMA +66 COPD 7082 phv00007082.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:18:31+00:00 2018-09-19 22:18:31+00:00 FS522 1ST EXAMINER OPINIONS: EMPHYSEMA +66 COPD 6647 phv00006647.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:18:38+00:00 2018-09-19 22:18:38+00:00 FR422 NON-CARDIOVASCULAR - EMPHYSEMA +66 COPD 6316 phv00006316.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:18:46+00:00 2018-09-19 22:18:46+00:00 FQ389 EMPHYSEMA IN INTERIM +66 COPD 70542 phv00070542.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:19:15+00:00 2018-09-19 22:19:15+00:00 FU239 NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS: EMPHYSEMA +66 COPD 56800 phv00056800.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:19:22+00:00 2018-09-19 22:19:22+00:00 hi201a Emphysema: has a doctor ever told you that you have emphysema? +66 COPD 55301 phv00055301.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:19:30+00:00 2018-09-19 22:19:30+00:00 EMPHYS15 MD said pt had emphysema? +66 COPD 21306 phv00021306.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:19:37+00:00 2018-09-19 22:19:37+00:00 G3A553 EMPHYSEMA: AGE CONDITION BEGAN +66 COPD 21305 phv00021305.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:19:44+00:00 2018-09-19 22:19:44+00:00 G3A552 EMPHYSEMA: HEALTH PROFESSIONAL DX? +66 COPD 21304 phv00021304.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:19:50+00:00 2018-09-19 22:19:50+00:00 G3A551 HAVE YOU EVER HAD EMPHYSEMA? +66 COPD 251714 phv00251714.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:21:21+00:00 2018-09-19 22:21:21+00:00 h658 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had emphysema? Collection Interval: Exam 3 +66 COPD 251508 phv00251508.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:21:30+00:00 2018-09-19 22:21:30+00:00 h357 Clinical Diagnostic Impression - Part II: Non Cardiovascular Diagnoses First Examiner Opinions: Pulmonary: Emphysema Collection Interval: Exam 3 +66 COPD 251046 phv00251046.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:21:37+00:00 2018-09-19 22:21:37+00:00 g415 Clinical Diagnostic Impression - Part III - Non Cardiovascular Diagnoses First Examiner Opinions: Emphysema Collection Interval: Exam 2 +66 COPD 250706 phv00250706.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:21:45+00:00 2018-09-19 22:21:45+00:00 e643 Clinical Diagnostic Impressions - Part III: Non Cardiovascular Diagnoses - Emphysema Collection Interval: Exam 1 +66 COPD 177573 phv00177573.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:21:52+00:00 2018-09-19 22:21:52+00:00 g3b0599 Respiratory Disease Questionnaire-Technician administered: Have you had the following condition diagnosed by a doctor or other health care professional? Emphysema +66 COPD 177514 phv00177514.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:21:59+00:00 2018-09-19 22:21:59+00:00 g3b0429 Clinical Diagnostic Impression: Emphysema +66 COPD 72499 phv00072499.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:22:07+00:00 2018-09-19 22:22:07+00:00 H660 SINCE YOUR LAST EXAM HAVE YOU HAD ...EMPHYSEMA: AGE CONDITION BEGAN +66 COPD 72498 phv00072498.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:22:14+00:00 2018-09-19 22:22:14+00:00 H659 SINCE YOUR LAST EXAM HAVE YOU HAD ...EMPHYSEMA: HEALTH PROFESSIONAL DIAGNOSIS? +66 COPD 72497 phv00072497.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:22:21+00:00 2018-09-19 22:22:21+00:00 H658 SINCE YOUR LAST EXAM HAVE YOU HAD ... EMPHYSEMA: CONDITION? +66 COPD 72311 phv00072311.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:22:29+00:00 2018-09-19 22:22:29+00:00 H357 CLINICAL DIAGNOSTIC IMPRESSION: EMPHYSEMA +66 COPD 257608 phv00257608.v1.p10 pht005155.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:24:09+00:00 2018-09-19 22:24:09+00:00 classification Emphysema subtypes based upon pattern of involvement in the secondary pulmonary lobule +66 COPD 257607 phv00257607.v1.p10 pht005155.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:24:19+00:00 2018-09-19 22:24:19+00:00 emphysema_cor Absence (=0) or presence (=1) of emphysema by visual determination +66 COPD 255329 phv00255329.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:26:14+00:00 2018-09-19 22:26:14+00:00 fw601 Respiratory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Emphysema Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +66 COPD 255142 phv00255142.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:26:21+00:00 2018-09-19 22:26:21+00:00 fw283 Clinical Diagnostic Impression - Emphysema Collection Interval: Original Cohort Exam 30 +66 COPD 254751 phv00254751.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:26:29+00:00 2018-09-19 22:26:29+00:00 fv241 Clinical Diagnostic Impression: Non Cardiovascular Diagnoses First Examiner Opinions: Emphysema Collection Interval: Exam 29 +66 COPD 254498 phv00254498.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:26:36+00:00 2018-09-19 22:26:36+00:00 j841 Respiratory Disease Questionnaire Part 1-Tech administered: Have you ever had the following condition diagnosed by a doctor or health care professional: Emphysema +66 COPD 254258 phv00254258.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:26:43+00:00 2018-09-19 22:26:43+00:00 j419 Clinical Diagnostic Impression-Part II-Pulmonary: Emphysema +66 COPD 251716 phv00251716.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:26:50+00:00 2018-09-19 22:26:50+00:00 h660 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Age condition began - Emphysema Collection Interval: Exam 3 +66 COPD 251715 phv00251715.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:26:57+00:00 2018-09-19 22:26:57+00:00 h659 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Health professional diagnosis - Emphysema Collection Interval: Exam 3 +66 COPD 275388 phv00275388.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:28:50+00:00 2018-09-19 22:28:50+00:00 fy601 Respiratory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for emphysema? Collection Interval: Original Cohort Exam 32 +66 COPD 275225 phv00275225.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:28:57+00:00 2018-09-19 22:28:57+00:00 fy283 Clinical Diagnostic Impression - Emphysema Collection Interval: Original Cohort Exam 32 +66 COPD 275054 phv00275054.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:29:05+00:00 2018-09-19 22:29:05+00:00 FX601 Respiratory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for emphysema? Collection Interval: Original Cohort Exam 31 +66 COPD 274867 phv00274867.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:29:12+00:00 2018-09-19 22:29:12+00:00 FX283 Clinical Diagnostic Impression - Emphysema Collection Interval: Original Cohort Exam 31 +66 COPD 274624 phv00274624.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:29:19+00:00 2018-09-19 22:29:19+00:00 g3a553 Emphysema: Age condition began +66 COPD 274623 phv00274623.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:29:26+00:00 2018-09-19 22:29:26+00:00 g3a552 Emphysema: Health professional dx? +66 COPD 274622 phv00274622.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:29:34+00:00 2018-09-19 22:29:34+00:00 g3a551 Have you ever had emphysema? +66 COPD 274519 phv00274519.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:29:41+00:00 2018-09-19 22:29:41+00:00 g3a405 CDI - Emphysema +66 COPD 274133 phv00274133.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:29:48+00:00 2018-09-19 22:29:48+00:00 g3a553 Emphysema: Age condition began Collection Interval: Exam 1 +66 COPD 274132 phv00274132.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:29:55+00:00 2018-09-19 22:29:55+00:00 g3a552 Emphysema: Health professional dx? Collection Interval: Exam 1 +66 COPD 274131 phv00274131.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:30:03+00:00 2018-09-19 22:30:03+00:00 g3a551 Have you ever had emphysema? Collection Interval: Exam 1 +66 COPD 274026 phv00274026.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-19 22:30:11+00:00 2018-09-19 22:30:11+00:00 g3a405 CDI - Emphysema Collection Interval: Exam 1 +66 COPD 82974 phv00082974.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:34:03+00:00 2018-09-19 22:34:03+00:00 emphys1 EMPHYSEMA: SELF-REPORT +66 COPD 78513 phv00078513.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-19 22:34:11+00:00 2018-09-19 22:34:11+00:00 EMPHYSEM Emphysema ever +66 COPD 78315 phv00078315.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-19 22:34:19+00:00 2018-09-19 22:34:19+00:00 EMPHYSEM_8 Emphysema / chronic bronchitis +66 COPD 78174 phv00078174.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-19 22:34:27+00:00 2018-09-19 22:34:27+00:00 EMPHYSEM_7 Emphysema / chronic bronchitis +66 COPD 78034 phv00078034.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-19 22:34:35+00:00 2018-09-19 22:34:35+00:00 EMPHYSEM_6 Emphysema / chronic bronchitis +66 COPD 77870 phv00077870.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-19 22:34:42+00:00 2018-09-19 22:34:42+00:00 EMPHYSEM_5 Emphysema / chronic bronchitis +66 COPD 77760 phv00077760.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-19 22:34:49+00:00 2018-09-19 22:34:49+00:00 EMPHYSEM_4 Emphysema / chronic bronchitis +66 COPD 77635 phv00077635.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-19 22:34:58+00:00 2018-09-19 22:34:58+00:00 EMPHYSEM_3 Emphysema / chronic bronchitis +66 COPD 87118 phv00087118.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:36:33+00:00 2018-09-19 22:36:33+00:00 emphysf EMPHYSEMA +66 COPD 86869 phv00086869.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:36:41+00:00 2018-09-19 22:36:41+00:00 emphys4 EMPHYSEMA: SELF-REPORT +66 COPD 86417 phv00086417.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:36:48+00:00 2018-09-19 22:36:48+00:00 emphys3 EMPHYSEMA: SELF-REPORT +66 COPD 85935 phv00085935.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:36:56+00:00 2018-09-19 22:36:56+00:00 emphys2 EMPHYSEMA: SELF-REPORT +66 COPD 85210 phv00085210.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:37:03+00:00 2018-09-19 22:37:03+00:00 emphys1 EMPHYSEMA: SELF-REPORT +66 COPD 104143 phv00104143.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:39:57+00:00 2018-09-19 22:39:57+00:00 EPH37 EMPHYSEMA +66 COPD 103744 phv00103744.v1.p1 pht001487.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:40:03+00:00 2018-09-19 22:40:03+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103693 phv00103693.v1.p1 pht001486.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:40:11+00:00 2018-09-19 22:40:11+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103641 phv00103641.v1.p1 pht001485.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:40:19+00:00 2018-09-19 22:40:19+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103588 phv00103588.v1.p1 pht001484.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:40:27+00:00 2018-09-19 22:40:27+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103536 phv00103536.v1.p1 pht001483.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:40:34+00:00 2018-09-19 22:40:34+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103483 phv00103483.v1.p1 pht001482.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:40:40+00:00 2018-09-19 22:40:40+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103431 phv00103431.v1.p1 pht001481.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:40:47+00:00 2018-09-19 22:40:47+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103378 phv00103378.v1.p1 pht001480.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:40:54+00:00 2018-09-19 22:40:54+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103326 phv00103326.v1.p1 pht001479.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:41:01+00:00 2018-09-19 22:41:01+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103273 phv00103273.v1.p1 pht001478.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:41:07+00:00 2018-09-19 22:41:07+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 198889 phv00198889.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:41:50+00:00 2018-09-19 22:41:50+00:00 hi201a 1a emphysema +66 COPD 197460 phv00197460.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:41:57+00:00 2018-09-19 22:41:57+00:00 emphys15 MD said pt had emphysema? +66 COPD 110172 phv00110172.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:42:04+00:00 2018-09-19 22:42:04+00:00 EMPHYS59 HAD EMPHYSEMA +66 COPD 106018 phv00106018.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:42:10+00:00 2018-09-19 22:42:10+00:00 EMPH57 EMPHYSEMA +66 COPD 105884 phv00105884.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:42:17+00:00 2018-09-19 22:42:17+00:00 EMPHYSEM EMPHYSEMA DX BY DOCTOR +66 COPD 105130 phv00105130.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:42:27+00:00 2018-09-19 22:42:27+00:00 LUNG01 LUNG DISEASE, EMPHYSEMA, OR BRONCHITIS +66 COPD 124286 phv00124286.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-09-19 22:45:18+00:00 2018-09-19 22:45:18+00:00 EMPDIADAY Days from visit date - Diagnosed Emphysema +66 COPD 103221 phv00103221.v1.p1 pht001477.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:46:02+00:00 2018-09-19 22:46:02+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 103168 phv00103168.v1.p1 pht001476.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:46:09+00:00 2018-09-19 22:46:09+00:00 EMPHYS32 TOLD BY MD YOU HAD EMPHYSEMA +66 COPD 102853 phv00102853.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:46:17+00:00 2018-09-19 22:46:17+00:00 EMPHYS59 HAD EMPHYSEMA +66 COPD 101660 phv00101660.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:46:24+00:00 2018-09-19 22:46:24+00:00 EMPHYS59 HAD EMPHYSEMA +66 COPD 100319 phv00100319.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:46:31+00:00 2018-09-19 22:46:31+00:00 EMPHYSEM EMPHYSEMA DX BY DOCTOR +66 COPD 99464 phv00099464.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:46:38+00:00 2018-09-19 22:46:38+00:00 EMPHYSEM EMPHYSEMA DX BY DOCTOR +66 COPD 99083 phv00099083.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:46:44+00:00 2018-09-19 22:46:44+00:00 EPH07 EMPHYSEMA +66 COPD 98813 phv00098813.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-19 22:46:51+00:00 2018-09-19 22:46:51+00:00 LUNG01 LUNG DISEASE, EMPHYSEMA, OR BRONCHITIS +66 COPD 125373 phv00125373.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-09-19 22:46:59+00:00 2018-09-19 22:46:59+00:00 AFUC18A 18a. Has a doctor ever said that you had chronic lung disease, such as bronchitis or emphysema? +66 COPD 125255 phv00125255.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-09-19 22:47:06+00:00 2018-09-19 22:47:06+00:00 AFUB7G 7g. Chronic lung disease such as bronchitis or emphysema +66 COPD 125169 phv00125169.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-09-19 22:47:13+00:00 2018-09-19 22:47:13+00:00 AFUB7G 7g. Chronic lung disease such as bronchitis or emphysema +66 COPD 125084 phv00125084.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-09-19 22:47:21+00:00 2018-09-19 22:47:21+00:00 AFUA7G 7g. Chronic lung disease such as bronchitis or emphysema +66 COPD 124999 phv00124999.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-09-19 22:47:29+00:00 2018-09-19 22:47:29+00:00 AFUA7G 7g. Chronic lung disease such as bronchitis or emphysema +66 COPD 209066 phv00209066.v1.p1 pht004146.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:48:27+00:00 2018-09-19 22:48:27+00:00 PHXB6D [Medical care]. Has a doctor ever said you had any of the following? Chronic lung disease, such as bronchitis, or emphysema. Q6d [Personal History form, exam 4] +66 COPD 208975 phv00208975.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:48:38+00:00 2018-09-19 22:48:38+00:00 PHXA8L [Medical care]. Chronic lung disease, such as bronchitis, or emphysema? Q8l [Personal History Form, exam 3] +66 COPD 207317 phv00207317.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:48:46+00:00 2018-09-19 22:48:46+00:00 HOM10G Has a doctor ever said that you had any of the following: chronic lung disease, such as chronic bronchitis, or emphysema? Q10g [Home Interview, exam 1] +66 COPD 207068 phv00207068.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:48:52+00:00 2018-09-19 22:48:52+00:00 HHXB05E [Medical care]. Has a doctor ever said you had any of the following: (read each disease name and code N if No or Never Tested). Q5. Chronic lung disease, such as chronic bronchitis, or emphysema. Q5E [Health/Medical History, exam 2] +66 COPD 202932 phv00202932.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:48:59+00:00 2018-09-19 22:48:59+00:00 AFUcomp7g_G [General health]. Has a doctor ever said you had any of the following? Chronic lung disease, such as bronchitis or emphysema [Annual Follow-up Questionnaire Form, AFUG] +66 COPD 175953 phv00175953.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:49:10+00:00 2018-09-19 22:49:10+00:00 emphysf FAMILY COHORT: EMPHYSEMA +66 COPD 175894 phv00175894.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:49:17+00:00 2018-09-19 22:49:17+00:00 emphysema EMPHYSEMA +66 COPD 175871 phv00175871.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 22:49:24+00:00 2018-09-19 22:49:24+00:00 emphys1 EMPHYSEMA: SELF-REPORT +66 COPD 122252 phv00122252.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-09-19 22:50:07+00:00 2018-09-19 22:50:07+00:00 EMPPRES Emphysema still present (A) +66 COPD 122251 phv00122251.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-09-19 22:50:14+00:00 2018-09-19 22:50:14+00:00 EMPAGE Age when emphysema noted (A) +66 COPD 122250 phv00122250.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-09-19 22:50:21+00:00 2018-09-19 22:50:21+00:00 EMPDIAG Emphysema diagnosed by doctor (A) +66 COPD 122249 phv00122249.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-09-19 22:50:29+00:00 2018-09-19 22:50:29+00:00 EMPHYSEM Emphysema (A) +66 COPD 214104 phv00214104.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:50:35+00:00 2018-09-19 22:50:35+00:00 EMPHYS15 MD said pt had emphysema? +66 COPD 209713 phv00209713.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:50:42+00:00 2018-09-19 22:50:42+00:00 RPAA34 [Bronchitis]. Age emphysema started. Q34 [Respiratory Symptoms and Physical Activity Form, exam 1] +66 COPD 209712 phv00209712.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:50:49+00:00 2018-09-19 22:50:49+00:00 RPAA33 [Bronchitis]. Was emphysema confirmed by a doctor? Q33 [Respiratory Symptoms and Physical Activity Form, exam 1] +66 COPD 209711 phv00209711.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:50:56+00:00 2018-09-19 22:50:56+00:00 RPAA32 [Bronchitis]. Still have emphysema? Q32 [Respiratory Symptoms and Physical Activity Form, exam 1] +66 COPD 209710 phv00209710.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-19 22:51:02+00:00 2018-09-19 22:51:02+00:00 RPAA31 [Emphysema]. Ever had emphysema? Q31 [Respiratory Symptoms and Physical Activity Form, exam 1] +66 COPD 83726 phv00083726.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 23:42:56+00:00 2018-09-19 23:42:56+00:00 mrcbrna4 MRC DEFINED BRONCHITIS +66 COPD 83491 phv00083491.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 23:43:28+00:00 2018-09-19 23:43:28+00:00 mrcbrna4 MRC DEFINED BRONCHITIS +66 COPD 87717 phv00087717.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-09-19 23:47:46+00:00 2018-09-19 23:47:46+00:00 mrcbrna4 MRC DEFINED BRONCHITIS +66 COPD 4063 phv00004063.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:04:13+00:00 2018-09-20 21:04:13+00:00 FL473 CDI: CHRONIC BRONCHITIS +66 COPD 3656 phv00003656.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:04:20+00:00 2018-09-20 21:04:20+00:00 FK445 NON-CARDIOVASCULAR DISEASE: CHRONIC BRONCHITIS +66 COPD 3237 phv00003237.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:04:27+00:00 2018-09-20 21:04:27+00:00 FJ349 NON-CARDIOVASCULAR DIAGNOSIS: CHRONIC BRONCHITIS +66 COPD 2838 phv00002838.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:04:33+00:00 2018-09-20 21:04:33+00:00 FI218 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS +66 COPD 2632 phv00002632.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:04:40+00:00 2018-09-20 21:04:40+00:00 FH307 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS +66 COPD 2394 phv00002394.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:04:47+00:00 2018-09-20 21:04:47+00:00 FG288 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS +66 COPD 2197 phv00002197.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:04:54+00:00 2018-09-20 21:04:54+00:00 FF278 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS +66 COPD 2013 phv00002013.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:05:00+00:00 2018-09-20 21:05:00+00:00 FE344 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS +66 COPD 1784 phv00001784.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:05:08+00:00 2018-09-20 21:05:08+00:00 FD288 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC BRONCHITIS +66 COPD 6648 phv00006648.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:05:51+00:00 2018-09-20 21:05:51+00:00 FR423 NON-CARDIOVASCULAR - CHRONIC BRONCHITIS +66 COPD 6539 phv00006539.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:05:58+00:00 2018-09-20 21:05:58+00:00 FR267 RESPIRATORY EXAMINER'S OPINIONS - CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTNUM AT LEAST 3 MONTHS IN PAST 12 MONTHS) +66 COPD 6317 phv00006317.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:06:06+00:00 2018-09-20 21:06:06+00:00 FQ390 CHRONIC BRONCHITIS IN INTERIM (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MONTHS) +66 COPD 5910 phv00005910.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:06:13+00:00 2018-09-20 21:06:13+00:00 FP453 CLINICAL DIAGNOSTIC IMPRESSION- CHRONIC BRONCHITIS +66 COPD 5672 phv00005672.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:06:20+00:00 2018-09-20 21:06:20+00:00 FP154 1ST EXAMINER BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN THE PAST 12 MONTHS) +66 COPD 5283 phv00005283.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:06:27+00:00 2018-09-20 21:06:27+00:00 FO487 CLINICAL DIAGNOSTIC IMPRESSION: CHRONIC BRONCHITIS +66 COPD 5052 phv00005052.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:06:35+00:00 2018-09-20 21:06:35+00:00 FO200 1ST EXAMINER BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN THE PAST 12 MONTHS) +66 COPD 4921 phv00004921.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:06:41+00:00 2018-09-20 21:06:41+00:00 FN471 CDI-CHRONIC BRONCHITIS +66 COPD 4701 phv00004701.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:06:48+00:00 2018-09-20 21:06:48+00:00 FN205 1ST EXAMINER BELIEVES CHRONIC BRONCHITIS +66 COPD 4485 phv00004485.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:06:55+00:00 2018-09-20 21:06:55+00:00 FM500 CLINICAL DIAGNOSTIC IMPRESSION: CHRONIC BRONCHITIS +66 COPD 21303 phv00021303.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:07:54+00:00 2018-09-20 21:07:54+00:00 G3A550 CHRONIC BRONCHITIS: AGE CONDITION BEGAN +66 COPD 21302 phv00021302.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:08:01+00:00 2018-09-20 21:08:01+00:00 G3A549 CHRONIC BRONCHITIS: HEALTH PROFESSIONAL DX? +66 COPD 21301 phv00021301.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:08:07+00:00 2018-09-20 21:08:07+00:00 G3A548 HAVE YOU EVER HAD CHRONIC BRONCHITIS? +66 COPD 10487 phv00010487.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:08:14+00:00 2018-09-20 21:08:14+00:00 G416 CDI: CHRONIC BRONCHITIS +66 COPD 10280 phv00010280.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:08:21+00:00 2018-09-20 21:08:21+00:00 G138 1ST EXAMINER OPINIONS - BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MONTHS) +66 COPD 10055 phv00010055.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:08:28+00:00 2018-09-20 21:08:28+00:00 F639 CDI: CHRONIC BRONCHITIS +66 COPD 9805 phv00009805.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:08:36+00:00 2018-09-20 21:08:36+00:00 F316 1ST EXAMINER OPINIONS - BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MONTHS) +66 COPD 9541 phv00009541.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:08:43+00:00 2018-09-20 21:08:43+00:00 E644 CDI-CHRONIC BRONCHITIS +66 COPD 9300 phv00009300.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:08:55+00:00 2018-09-20 21:08:55+00:00 E347 1ST EXAMINER BELIEVES CHRONIC BRONCHITIS +66 COPD 9086 phv00009086.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:09:01+00:00 2018-09-20 21:09:01+00:00 D358 CDI: CHRONIC BRONCHITIS +66 COPD 8698 phv00008698.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:09:08+00:00 2018-09-20 21:09:08+00:00 C371 CDI: CHRONIC BRONCHITIS +66 COPD 7945 phv00007945.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:09:14+00:00 2018-09-20 21:09:14+00:00 B326 CHRONIC BRONCHITIS +66 COPD 7517 phv00007517.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:09:21+00:00 2018-09-20 21:09:21+00:00 FT528 NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS - CHRONIC BRONCHITIS +66 COPD 7402 phv00007402.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:09:28+00:00 2018-09-20 21:09:28+00:00 FT364 RESPIRATORY 1ST OPINIONS: 1ST EXAMINER BELIEVES CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MONTHS) +66 COPD 7083 phv00007083.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:09:35+00:00 2018-09-20 21:09:35+00:00 FS523 1ST EXAMINER OPINIONS: CHRONIC BRONCHITIS +66 COPD 6970 phv00006970.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:09:42+00:00 2018-09-20 21:09:42+00:00 FS362 1ST EXAMINER OPINIONS: CHRONIC BRONCHITIS (COUGH THAT PRODUCES SPUTUM AT LEAST 3 MONTHS IN PAST 12 MOS) +66 COPD 251711 phv00251711.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:12:25+00:00 2018-09-20 21:12:25+00:00 h655 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had chronic bronchitis? Collection Interval: Exam 3 +66 COPD 251047 phv00251047.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:12:32+00:00 2018-09-20 21:12:32+00:00 g416 Clinical Diagnostic Impression - Part III - Non Cardiovascular Diagnoses First Examiner Opinions: Chronic bronchitis Collection Interval: Exam 2 +66 COPD 250847 phv00250847.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:12:39+00:00 2018-09-20 21:12:39+00:00 g138 Medical History - Respiratory and Heart: 1st examiner believes Chronic Bronchitis (Cough that produces sputum at least 3 months in past 12 months) Collection Interval: Exam 2 +66 COPD 250707 phv00250707.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:12:47+00:00 2018-09-20 21:12:47+00:00 e644 Clinical Diagnostic Impressions - Part III: Non Cardiovascular Diagnoses - Chronic bronchitis Collection Interval: Exam 1 +66 COPD 250479 phv00250479.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:12:54+00:00 2018-09-20 21:12:54+00:00 e347 Medical History - Respiratory: 1st Examiner believes chronic bronchitis Collection Interval: Exam 1 +66 COPD 177572 phv00177572.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:13:01+00:00 2018-09-20 21:13:01+00:00 g3b0598 Respiratory Disease Questionnaire-Technician administered: Have you had the following condition diagnosed by a doctor or other health care professional? Chronic bronchitis +66 COPD 72496 phv00072496.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:13:08+00:00 2018-09-20 21:13:08+00:00 H657 SINCE YOUR LAST EXAM HAVE YOU HAD ...CHRONIC BRONCHITIS: AGE CONDITION BEGAN +66 COPD 72495 phv00072495.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:13:15+00:00 2018-09-20 21:13:15+00:00 H656 SINCE YOUR LAST EXAM HAVE YOU HAD ... CHRONIC BRONCHITIS: HEALTH PROFESSIONAL DIAGNOSIS? +66 COPD 72494 phv00072494.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:13:22+00:00 2018-09-20 21:13:22+00:00 H655 SINCE YOUR LAST EXAM HAVE YOU HAD ... CHRONIC BRONCHITIS: CONDITION? +66 COPD 70543 phv00070543.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:13:30+00:00 2018-09-20 21:13:30+00:00 FU240 NON CARDIOVASCULAR DIAGNOSTIC 1ST EXAMINER OPINIONS: CHRONIC BRONCHITIS +66 COPD 56801 phv00056801.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:13:37+00:00 2018-09-20 21:13:37+00:00 hi201b Chronic bronchitis: has a doctor ever told you that you have chronic bronchitis? +66 COPD 55302 phv00055302.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:13:43+00:00 2018-09-20 21:13:43+00:00 CRBRON15 MD said pt had chronic bronchitis? +66 COPD 274868 phv00274868.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:14:37+00:00 2018-09-20 21:14:37+00:00 FX284 Clinical Diagnostic Impression - Chronic bronchitis Collection Interval: Original Cohort Exam 31 +66 COPD 274621 phv00274621.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:14:43+00:00 2018-09-20 21:14:43+00:00 g3a550 Chronic bronchitis: Age condition began +66 COPD 274620 phv00274620.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:14:50+00:00 2018-09-20 21:14:50+00:00 g3a549 Chronic bronchitis: Health professional dx? +66 COPD 274619 phv00274619.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:14:57+00:00 2018-09-20 21:14:57+00:00 g3a548 Have you ever had chronic bronchitis? +66 COPD 274130 phv00274130.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:15:03+00:00 2018-09-20 21:15:03+00:00 g3a550 Chronic bronchitis: Age condition began Collection Interval: Exam 1 +66 COPD 274129 phv00274129.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:15:10+00:00 2018-09-20 21:15:10+00:00 g3a549 Chronic bronchitis: Health professional dx? Collection Interval: Exam 1 +66 COPD 274128 phv00274128.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:15:17+00:00 2018-09-20 21:15:17+00:00 g3a548 Have you ever had chronic bronchitis? Collection Interval: Exam 1 +66 COPD 255328 phv00255328.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:15:25+00:00 2018-09-20 21:15:25+00:00 fw600 Respiratory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Chronic Bronchitis Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +66 COPD 255143 phv00255143.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:15:33+00:00 2018-09-20 21:15:33+00:00 fw284 Clinical Diagnostic Impression - Chronic bronchitis Collection Interval: Original Cohort Exam 30 +66 COPD 254752 phv00254752.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:15:40+00:00 2018-09-20 21:15:40+00:00 fv242 Clinical Diagnostic Impression: Non Cardiovascular Diagnoses First Examiner Opinions: Chronic bronchitis Collection Interval: Exam 29 +66 COPD 254497 phv00254497.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:15:47+00:00 2018-09-20 21:15:47+00:00 j840 Respiratory Disease Questionnaire Part 1-Tech administered: Have you ever had the following condition diagnosed by a doctor or health care professional: Chronic Bronchitis +66 COPD 251713 phv00251713.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:15:53+00:00 2018-09-20 21:15:53+00:00 h657 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Age condition began - Chronic Bronchitis Collection Interval: Exam 3 +66 COPD 251712 phv00251712.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:16:00+00:00 2018-09-20 21:16:00+00:00 h656 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Health professional diagnosis - Chronic Bronchitis Collection Interval: Exam 3 +66 COPD 275387 phv00275387.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:18:08+00:00 2018-09-20 21:18:08+00:00 fy600 Respiratory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for chronic bronchitis? Collection Interval: Original Cohort Exam 32 +66 COPD 275226 phv00275226.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:18:14+00:00 2018-09-20 21:18:14+00:00 fy284 Clinical Diagnostic Impression - Chronic bronchitis Collection Interval: Original Cohort Exam 32 +66 COPD 275053 phv00275053.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-20 21:18:21+00:00 2018-09-20 21:18:21+00:00 FX600 Respiratory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for chronic bronchitis? Collection Interval: Original Cohort Exam 31 +66 COPD 283510 phv00283510.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-20 21:18:51+00:00 2018-09-20 21:18:51+00:00 BRONCHITISHX F136 History of chronic bronchitis/COPD +66 COPD 214105 phv00214105.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-20 21:22:19+00:00 2018-09-20 21:22:19+00:00 CRBRON15 MD said pt had chronic bronchitis? +66 COPD 209709 phv00209709.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-20 21:22:32+00:00 2018-09-20 21:22:32+00:00 RPAA30 [Bronchitis]. Age chronic bronchitis started. Q30 [Respiratory Symptoms and Physical Activity Form, exam 1] +66 COPD 209708 phv00209708.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-20 21:22:40+00:00 2018-09-20 21:22:40+00:00 RPAA29 [Bronchitis]. Was chronic bronchitis confirmed by a doctor? Q29 [Respiratory Symptoms and Physical Activity Form, exam 1] +66 COPD 209707 phv00209707.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-20 21:22:48+00:00 2018-09-20 21:22:48+00:00 RPAA28 [Bronchitis]. Still have chronic bronchitis? Q28 [Respiratory Symptoms and Physical Activity Form, exam 1] +66 COPD 209706 phv00209706.v1.p1 pht004161.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-09-20 21:22:55+00:00 2018-09-20 21:22:55+00:00 RPAA27 [Bronchitis]. Ever had chronic bronchitis? Q27 [Respiratory Symptoms and Physical Activity Form, exam 1] +66 COPD 124267 phv00124267.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-09-20 21:25:43+00:00 2018-09-20 21:25:43+00:00 BRODIADAY Days from visit date - Diagnosed Chronic Bronchitis +66 COPD 198890 phv00198890.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-20 21:36:27+00:00 2018-09-20 21:36:27+00:00 hi201b 1b chronic bronchitis +66 COPD 197461 phv00197461.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-20 21:36:35+00:00 2018-09-20 21:36:35+00:00 crbron15 MD said pt had chronic bronchitis? +66 COPD 106008 phv00106008.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-20 21:36:42+00:00 2018-09-20 21:36:42+00:00 CBRN57 CHRONIC BRONCHITIS +66 COPD 104142 phv00104142.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-20 21:36:52+00:00 2018-09-20 21:36:52+00:00 CRNC37 CHRONIC BRONCHITIS +66 COPD 99073 phv00099073.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-20 21:36:59+00:00 2018-09-20 21:36:59+00:00 CRNC07 CHRONIC BRONCHITIS +66 COPD 193631 phv00193631.v3.p3 pht003413.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:22:19+00:00 2018-09-21 17:22:19+00:00 F33COPD F33 COPD +66 COPD 193632 phv00193632.v3.p3 pht003413.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:22:27+00:00 2018-09-21 17:22:27+00:00 F33COPDDY Days enrollment to F33 COPD +66 COPD 193741 phv00193741.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:22:41+00:00 2018-09-21 17:22:41+00:00 F33COPD F33 COPD +66 COPD 193742 phv00193742.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:22:50+00:00 2018-09-21 17:22:50+00:00 F33COPDDY Days enrollment to F33 COPD +66 COPD 100497 phv00100497.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:48:49+00:00 2018-09-27 16:48:49+00:00 COPDBL COPD at baseline +66 COPD 197462 phv00197462.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:49:11+00:00 2018-09-27 16:49:11+00:00 copd15 MD said pt had COPD? +66 COPD 2393 phv00002393.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 FG287 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC OBSTRUCTIVE LUNG DISEASE +66 COPD 2631 phv00002631.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 FH306 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC OBSTRUCTIVE LUNG DISEASE +66 COPD 2837 phv00002837.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 FI217 CLINICAL DIAGNOSTIC IMPRESSION: NON-CVD, CHRONIC OBSTRUCTIVE LUNG DISEASE +66 COPD 3236 phv00003236.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 FJ348 NON-CARDIOVASCULAR DIAGNOSIS: CHRONIC OBSTRUCTIVE LUNG DISEASE +66 COPD 3655 phv00003655.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 FK444 NON-CARDIOVASCULAR DISEASE: CHRONIC OBSTRUCTIVE LUNG DISEASE +66 COPD 7944 phv00007944.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 B325 CHRONIC OBSTRUCTIVE LUNG DISEASE +66 COPD 21307 phv00021307.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 G3A554 HAVE YOU EVER HAD COPD? +66 COPD 21308 phv00021308.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 G3A555 COPD: HEALTH PROFESSIONAL DX? +66 COPD 55303 phv00055303.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 COPD15 MD said pt had COPD? +66 COPD 255330 phv00255330.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 fw602 Respiratory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: COPD (Chronic Obstructive Pulmonary Disease) Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +66 COPD 274134 phv00274134.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 g3a554 Have you ever had COPD? Collection Interval: Exam 1 +66 COPD 274135 phv00274135.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 g3a555 COPD: Health professional dx? Collection Interval: Exam 1 +66 COPD 274625 phv00274625.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 g3a554 Have you ever had COPD? +66 COPD 274626 phv00274626.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 g3a555 COPD: Health professional dx? +66 COPD 275055 phv00275055.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 FX602 Respiratory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for COPD (Chronic Obstructive Pulmonary Disease)? Collection Interval: Original Cohort Exam 31 +66 COPD 275389 phv00275389.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 fy602 Respiratory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for COPD (Chronic Obstructive Pulmonary Disease)? Collection Interval: Original Cohort Exam 32 +66 COPD 276871 phv00276871.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 CHF072 COPD, regular bronchodilator or steroid user - not PRN +66 COPD 276872 phv00276872.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:07:19+00:00 2018-09-28 17:07:19+00:00 CHF073 COPD, PRN user of bronchodilator or steroids +66 COPD 21309 phv00021309.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 G3A556 COPD: AGE CONDITION BEGAN +66 COPD 56802 phv00056802.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 hi201c COPD: has a doctor ever told you that you have COPD (chronic obstructive pulmonary disease)? +66 COPD 72500 phv00072500.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 H661 SINCE YOUR LAST EXAM HAVE YOU HAD ...COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE): CONDITION? +66 COPD 72501 phv00072501.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 H662 SINCE YOUR LAST EXAM HAVE YOU HAD ...COPD: HEALTH PROFESSIONAL DIAGNOSIS? +66 COPD 72502 phv00072502.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 H663 SINCE YOUR LAST EXAM HAVE YOU HAD ...COPD: AGE CONDITION BEGAN +66 COPD 177574 phv00177574.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 g3b0600 Respiratory Disease Questionnaire-Technician administered: Have you had the following condition diagnosed by a doctor or other health care professional? COPD (Chronic obstructive pulmonary disease) +66 COPD 251717 phv00251717.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 h661 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had COPD (Chronic obstructive pulmonary disease)? Collection Interval: Exam 3 +66 COPD 251718 phv00251718.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 h662 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Health professional diagnosis - COPD (Chronic obstructive pulmonary disease) Collection Interval: Exam 3 +66 COPD 251719 phv00251719.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 h663 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Age condition began - COPD (Chronic obstructive pulmonary disease) Collection Interval: Exam 3 +66 COPD 254499 phv00254499.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 j842 Respiratory Disease Questionnaire Part 1-Tech administered: Have you ever had the following condition diagnosed by a doctor or health care professional: COPD +66 COPD 274136 phv00274136.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 g3a556 COPD: Age condition began Collection Interval: Exam 1 +66 COPD 274627 phv00274627.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 17:08:39+00:00 2018-09-28 17:08:39+00:00 g3a556 COPD: Age condition began +66 COPD 1120 phv00001120.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 17:14:17+00:00 2018-10-04 17:14:17+00:00 FA109 UNDER MEDICAL CARE BUT NOT HOSPITALIZED SINCE LAST EXAM FOR EMPHYSEMA OR FIBROSIS +67 Sleep apnea 83431 phv00083431.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:30:44+00:00 2018-04-28 23:30:44+00:00 apnea1 SLEEP APNEA DIAGNOSIS BY DOCTOR +67 Sleep apnea 86249 phv00086249.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:30:51+00:00 2018-04-28 23:30:51+00:00 apnea2 HAVE YOU EVER BEEN TOLD BY DOCTOR YOU HAVE SLEEP APNEA +67 Sleep apnea 87066 phv00087066.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-28 23:30:59+00:00 2018-04-28 23:30:59+00:00 apnea4 SLEEP APNEA DIAGNOSIS +67 Sleep apnea 206788 phv00206788.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:54:42+00:00 2018-05-10 14:54:42+00:00 HFAA10F [Medical history]. Q10f - f. Sleep apnea [Heart Failure Hospital Record Abstraction Form, HFA] +67 Sleep apnea 214103 phv00214103.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:55:05+00:00 2018-05-10 14:55:05+00:00 SA15 MD said pt had sleep apnea? +67 Sleep apnea 214292 phv00214292.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-10 14:55:41+00:00 2018-05-10 14:55:41+00:00 MDSA02 Have you ever been told by a doctor that you have sleep apnea? +67 Sleep apnea 159736 phv00159736.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:46:39+00:00 2018-08-10 20:46:39+00:00 SleepApnea Sleep apnea: have you ever had sleep apnea Collection Interval: Collected in Exam 1 +67 Sleep apnea 159737 phv00159737.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:46:51+00:00 2018-08-10 20:46:51+00:00 SleepApDxByDr Sleep apnea: diagnosed by doctor or other health professional Collection Interval: Collected in Exam 1 +67 Sleep apnea 159738 phv00159738.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:47:01+00:00 2018-08-10 20:47:01+00:00 SleepApAge Sleep apnea: at about what age did sleep apnea start Collection Interval: Collected in Exam 1 +67 Sleep apnea 159739 phv00159739.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 20:47:10+00:00 2018-08-10 20:47:10+00:00 SleepApStillHav Sleep apnea: do you still have sleep apnea Collection Interval: Collected in Exam 1 +67 Sleep apnea 122392 phv00122392.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:35:52+00:00 2018-08-16 23:35:52+00:00 DIAAPN Ever been diagnosed w/ sleep apnea +67 Sleep apnea 122393 phv00122393.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:36:09+00:00 2018-08-16 23:36:09+00:00 YRDIAGN Year diagnosed with sleep apnea +67 Sleep apnea 122504 phv00122504.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:44:48+00:00 2018-08-16 23:44:48+00:00 CHAPN Since last visit diagnosed OSA (sleep apnea) +67 Sleep apnea 123476 phv00123476.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:36:57+00:00 2018-08-21 17:36:57+00:00 SLAPNDIA 95 Sleep Apnea +67 Sleep apnea 123477 phv00123477.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:39:07+00:00 2018-08-21 17:39:07+00:00 AGEDIAAP 95 Age Diagnosed - Sleep Apnea +67 Sleep apnea 124264 phv00124264.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 19:00:30+00:00 2018-08-21 19:00:30+00:00 APNDIADAY Days from visit date - Diagnosed Sleep Apnea +67 Sleep apnea 283514 phv00283514.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 17:20:45+00:00 2018-09-21 17:20:45+00:00 SLEEPAPNEAHX F136 History of sleep apnea +67 Sleep apnea 197459 phv00197459.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:56:59+00:00 2018-09-27 16:56:59+00:00 sa15 MD said pt had sleep apnea? +67 Sleep apnea 197677 phv00197677.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 16:58:43+00:00 2018-09-27 16:58:43+00:00 mdsa02 Have you ever been told by a doctor that you have sleep apnea? +67 Sleep apnea 21310 phv00021310.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 G3A557 HAVE YOU EVER HAD SLEEP APNEA +67 Sleep apnea 21311 phv00021311.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 G3A558 SLEEP APNEA: HEALTH PROFESSIONAL DX? +67 Sleep apnea 21312 phv00021312.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 G3A559 SLEEP APNEA: AGE CONDITION BEGAN +67 Sleep apnea 72503 phv00072503.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 H664 SINCE YOUR LAST EXAM HAVE YOU HAD ... SLEEP APNEA: CONDITION? +67 Sleep apnea 72504 phv00072504.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 H665 SINCE YOUR LAST EXAM HAVE YOU HAD ...SLEEP APNEA: HEALTH PROFESSIONAL DIAGNOSIS? +67 Sleep apnea 177575 phv00177575.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 g3b0601 Respiratory Disease Questionnaire-Technician administered: Have you had the following condition diagnosed by a doctor or other health care professional? Sleep apnea +67 Sleep apnea 251720 phv00251720.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 h664 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Since your last exam have you had sleep apnea? Collection Interval: Exam 3 +67 Sleep apnea 251721 phv00251721.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 h665 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Health professional diagnosis - Sleep Apnea Collection Interval: Exam 3 +67 Sleep apnea 255331 phv00255331.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 fw603 Respiratory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Sleep Apnea Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +67 Sleep apnea 274137 phv00274137.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 g3a557 Have you ever had sleep apnea Collection Interval: Exam 1 +67 Sleep apnea 274138 phv00274138.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 g3a558 Sleep apnea: Health professional dx? Collection Interval: Exam 1 +67 Sleep apnea 274139 phv00274139.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 g3a559 Sleep apnea: Age condition began Collection Interval: Exam 1 +67 Sleep apnea 274628 phv00274628.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 g3a557 Have you ever had sleep apnea +67 Sleep apnea 274629 phv00274629.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 g3a558 Sleep apnea: Health professional dx? +67 Sleep apnea 274630 phv00274630.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 g3a559 Sleep apnea: Age condition began +67 Sleep apnea 275056 phv00275056.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 FX603 Respiratory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for sleep apnea? Collection Interval: Original Cohort Exam 31 +67 Sleep apnea 275390 phv00275390.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:33:08+00:00 2018-09-28 13:33:08+00:00 fy603 Respiratory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for sleep apnea? Collection Interval: Original Cohort Exam 32 +67 Sleep apnea 55489 phv00055489.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:34:54+00:00 2018-09-28 13:34:54+00:00 MDSA02 Have you ever been told by a doctor that you have sleep apnea? +67 Sleep apnea 56675 phv00056675.v2.p10 pht000396.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:34:54+00:00 2018-09-28 13:34:54+00:00 sleepApnea Told by doctor that you had sleep apnea +67 Sleep apnea 72505 phv00072505.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:34:54+00:00 2018-09-28 13:34:54+00:00 H666 SINCE YOUR LAST EXAM HAVE YOU HAD ...SLEEP APNEA: AGE CONDITION BEGAN +67 Sleep apnea 72574 phv00072574.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:34:54+00:00 2018-09-28 13:34:54+00:00 H744 HAVE YOU EVER BEEN TOLD BY A DOCTOR OR OTHER HEALTH PROFESSIONAL THAT YOU HAVE SLEEP APNEA? +67 Sleep apnea 251722 phv00251722.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:34:54+00:00 2018-09-28 13:34:54+00:00 h666 Respiratory Disease Questionnaire - Technician Administered: Respiratory Diagnoses: Age condition began - Sleep Apnea Collection Interval: Exam 3 +67 Sleep apnea 251789 phv00251789.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:34:54+00:00 2018-09-28 13:34:54+00:00 h744 Sleep Questionnaire - Part 2 - Self-administered: Have you ever been told by a doctor or other health professional that you have sleep apnea or obstructive sleep apnea? Collection Interval: Exam 3 +67 Sleep apnea 254500 phv00254500.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:34:54+00:00 2018-09-28 13:34:54+00:00 j843 Respiratory Disease Questionnaire Part 1-Tech administered: Have you ever had the following condition diagnosed by a doctor or health care professional: Sleep Apnea +67 Sleep apnea 254589 phv00254589.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:34:54+00:00 2018-09-28 13:34:54+00:00 j942 Sleep Questionnaire Part 3-Self administered: Have you ever been told by a doctor or other health care professional that you have: Sleep apnea or obstructive sleep apnea? +68 AHI 214356 phv00214356.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-28 14:18:57+00:00 2018-03-28 14:18:57+00:00 OAHI Obstructive (all desats) apnea hypopnea (4% desat) Index) +68 AHI 122638 phv00122638.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:45:36+00:00 2018-08-14 20:45:36+00:00 ahi Apnea hypapnea index +68 AHI 124212 phv00124212.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:45:58+00:00 2018-08-14 20:45:58+00:00 oahi Calculated - Obstructive apnea (all desats) Hypopnea (4% desat) Index +68 AHI 124213 phv00124213.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:46:19+00:00 2018-08-14 20:46:19+00:00 oahi3 Calculated - Obstructive apnea (all desats) Hypopnea (3% desat) Index +68 AHI 226392 phv00226392.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:30:05+00:00 2018-08-24 16:30:05+00:00 SLPA54 Apnea/hypopnea index (3% desat) (SLPA54) +68 AHI 197745 phv00197745.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:57:10+00:00 2018-09-27 17:57:10+00:00 oahi Obstructive (all desats) apnea Hypopnea (4% desat) Index) +68 AHI 200047 phv00200047.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:57:40+00:00 2018-09-27 17:57:40+00:00 oahi Calculated - obstructive apnea (all desats) hypopnea (4% desat) index +68 AHI 55553 phv00055553.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 20:57:58+00:00 2018-10-04 20:57:58+00:00 oahi Obstructive (all desats) apnea Hypopnea (4% desat) Index) +68 AHI 57941 phv00057941.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 21:01:08+00:00 2018-10-04 21:01:08+00:00 oahi Obstructive (all desats) apnea Hypopnea (4% desat) Index) +68 AHI 55564 phv00055564.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:03:45+00:00 2018-10-04 23:03:45+00:00 oai0p Obstructive Apnea Index all desats +68 AHI 55565 phv00055565.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:08:29+00:00 2018-10-04 23:08:29+00:00 oai4p Obstructive Apnea Index 4% desats +68 AHI 55566 phv00055566.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:08:50+00:00 2018-10-04 23:08:50+00:00 oai4pa Obstructive Apnea Index 4% or arousal +68 AHI 55567 phv00055567.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:08:57+00:00 2018-10-04 23:08:57+00:00 cai0p Central Apnea Index all desats +68 AHI 55568 phv00055568.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:09:03+00:00 2018-10-04 23:09:03+00:00 cai4p Central Apnea Index 4% desats +68 AHI 55569 phv00055569.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:09:12+00:00 2018-10-04 23:09:12+00:00 cai4pa Central Apnea Index 4% or arousal +68 AHI 57952 phv00057952.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:09:20+00:00 2018-10-04 23:09:20+00:00 oai0p Obstructive Apnea Index all desats +68 AHI 57953 phv00057953.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:09:26+00:00 2018-10-04 23:09:26+00:00 oai4p Obstructive Apnea Index 4% desats +68 AHI 57954 phv00057954.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:09:32+00:00 2018-10-04 23:09:32+00:00 oai4pa Obstructive Apnea Index 4% or arousal +68 AHI 57955 phv00057955.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:09:39+00:00 2018-10-04 23:09:39+00:00 cai0p Central Apnea Index all desats +68 AHI 57956 phv00057956.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:09:46+00:00 2018-10-04 23:09:46+00:00 cai4p Central Apnea Index 4% desats +68 AHI 57957 phv00057957.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-04 23:09:52+00:00 2018-10-04 23:09:52+00:00 cai4pa Central Apnea Index 4% or arousal +68 AHI 214367 phv00214367.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-10-04 23:10:22+00:00 2018-10-04 23:10:22+00:00 OAI0P Obstructive apnea index all desats +68 AHI 214368 phv00214368.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-10-04 23:10:29+00:00 2018-10-04 23:10:29+00:00 OAI4P Obstructive apnea index 4% desats +68 AHI 214369 phv00214369.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-10-04 23:10:36+00:00 2018-10-04 23:10:36+00:00 OAI4PA Obstructive apnea index 4% or arousal +68 AHI 214370 phv00214370.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-10-04 23:10:42+00:00 2018-10-04 23:10:42+00:00 CAI0P Central apnea index all desats +68 AHI 214371 phv00214371.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-10-04 23:10:51+00:00 2018-10-04 23:10:51+00:00 CAI4P Central apnea index 4% desats +68 AHI 214372 phv00214372.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-10-04 23:10:57+00:00 2018-10-04 23:10:57+00:00 CAI4PA Central apnea index 4% or arousal +68 AHI 124218 phv00124218.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-10-04 23:11:04+00:00 2018-10-04 23:11:04+00:00 oai0p Calculated - Obstructive Apnea Index all desats +68 AHI 124219 phv00124219.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-10-04 23:11:34+00:00 2018-10-04 23:11:34+00:00 oai4p Calculated - Obstructive Apnea Index 4% desats +68 AHI 124220 phv00124220.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-10-04 23:11:40+00:00 2018-10-04 23:11:40+00:00 cai0p Calculated - Central Apnea Index all desats +68 AHI 124221 phv00124221.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-10-04 23:11:45+00:00 2018-10-04 23:11:45+00:00 cai4p Calculated - Central Apnea Index 4% desats +68 AHI 197756 phv00197756.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-04 23:11:52+00:00 2018-10-04 23:11:52+00:00 oai0p Obstructive Apnea Index all desats +68 AHI 197757 phv00197757.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-04 23:11:57+00:00 2018-10-04 23:11:57+00:00 oai4p Obstructive Apnea Index 4% desats +68 AHI 197758 phv00197758.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-04 23:12:02+00:00 2018-10-04 23:12:02+00:00 oai4pa Obstructive Apnea Index 4% or arousal +68 AHI 197759 phv00197759.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-04 23:12:08+00:00 2018-10-04 23:12:08+00:00 cai0p Central Apnea Index all desats +68 AHI 197760 phv00197760.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-04 23:12:13+00:00 2018-10-04 23:12:13+00:00 cai4p Central Apnea Index 4% desats +68 AHI 197761 phv00197761.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-04 23:12:17+00:00 2018-10-04 23:12:17+00:00 cai4pa Central Apnea Index 4% or arousal +68 AHI 55759 phv00055759.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBP Central Apnea RDI in NREM (Back position) overall +68 AHI 55831 phv00055831.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBA Central Apnea RDI in NREM (Back position) associated with arousal +68 AHI 55927 phv00055927.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBP2 Central Apnea RDI in NREM (Back position) 2% desaturation +68 AHI 55999 phv00055999.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBA2 Central Apnea RDI in NREM (Back position) 2% desaturation or arousal +68 AHI 56071 phv00056071.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBP3 Central Apnea RDI in NREM (Back position) 3% desaturation +68 AHI 56143 phv00056143.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBA3 Central Apnea RDI in NREM (Back position) 3% desaturation or arousal +68 AHI 56215 phv00056215.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBP4 Central Apnea RDI in NREM (Back position) 4% desaturation +68 AHI 56287 phv00056287.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBA4 Central Apnea RDI in NREM (Back position) 4% desaturation or arousal +68 AHI 56359 phv00056359.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBP5 Central Apnea RDI in NREM (Back position) 5% desaturation +68 AHI 56431 phv00056431.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 CARDNBA5 Central Apnea RDI in NREM (Back position) 5% desaturation or arousal +68 AHI 57719 phv00057719.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnbp Central Apnea RDI in NREM (Back position) overall +68 AHI 57731 phv00057731.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnba Central Apnea RDI in NREM (Back position) associated with arousal +68 AHI 57743 phv00057743.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnbp2 Central Apnea RDI in NREM (Back position) 2% desaturation +68 AHI 57755 phv00057755.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnba2 Central Apnea RDI in NREM (Back position) 2% desaturation or arousal +68 AHI 57767 phv00057767.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnbp3 Central Apnea RDI in NREM (Back position) 3% desaturation +68 AHI 57779 phv00057779.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnba3 Central Apnea RDI in NREM (Back position) 3% desaturation or arousal +68 AHI 57791 phv00057791.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnbp4 Central Apnea RDI in NREM (Back position) 4% desaturation +68 AHI 57803 phv00057803.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnba4 Central Apnea RDI in NREM (Back position) 4% desaturation or arousal +68 AHI 57815 phv00057815.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnbp5 Central Apnea RDI in NREM (Back position) 5% desaturation +68 AHI 57827 phv00057827.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:44:37+00:00 2018-12-06 18:05:54+00:00 cardnba5 Central Apnea RDI in NREM (Back position) 5% desaturation or arousal +68 AHI 55764 phv00055764.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOP Central Apnea RDI in NREM (Other position) overall +68 AHI 55836 phv00055836.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOA Central Apnea RDI in NREM (Other position) associated with arousal +68 AHI 55932 phv00055932.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOP2 Central Apnea RDI in NREM (Other position) 2% desaturation +68 AHI 56004 phv00056004.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOA2 Central Apnea RDI in NREM (Other position) 2% desaturation or arousal +68 AHI 56076 phv00056076.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOP3 Central Apnea RDI in NREM (Other position) 3% desaturation +68 AHI 56148 phv00056148.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOA3 Central Apnea RDI in NREM (Other position) 3% desaturation or arousal +68 AHI 56220 phv00056220.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOP4 Central Apnea RDI in NREM (Other position) 4% desaturation +68 AHI 56292 phv00056292.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOA4 Central Apnea RDI in NREM (Other position) 4% desaturation or arousal +68 AHI 56364 phv00056364.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOP5 Central Apnea RDI in NREM (Other position) 5% desaturation +68 AHI 56436 phv00056436.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 CARDNOA5 Central Apnea RDI in NREM (Other position) 5% desaturation or arousal +68 AHI 57720 phv00057720.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnop Central Apnea RDI in NREM (Other position) overall +68 AHI 57732 phv00057732.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnoa Central Apnea RDI in NREM (Other position) associated with arousal +68 AHI 57744 phv00057744.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnop2 Central Apnea RDI in NREM (Other position) 2% desaturation +68 AHI 57756 phv00057756.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnoa2 Central Apnea RDI in NREM (Other position) 2% desaturation or arousal +68 AHI 57768 phv00057768.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnop3 Central Apnea RDI in NREM (Other position) 3% desaturation +68 AHI 57780 phv00057780.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnoa3 Central Apnea RDI in NREM (Other position) 3% desaturation or arousal +68 AHI 57792 phv00057792.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnop4 Central Apnea RDI in NREM (Other position) 4% desaturation +68 AHI 57804 phv00057804.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnoa4 Central Apnea RDI in NREM (Other position) 4% desaturation or arousal +68 AHI 57816 phv00057816.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnop5 Central Apnea RDI in NREM (Other position) 5% desaturation +68 AHI 57828 phv00057828.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:46:45+00:00 2018-12-06 18:05:54+00:00 cardnoa5 Central Apnea RDI in NREM (Other position) 5% desaturation or arousal +68 AHI 55749 phv00055749.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBP Central Apnea RDI in REM (Back position) overall +68 AHI 55821 phv00055821.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBA Central Apnea RDI in REM (Back position) associated with arousal +68 AHI 55917 phv00055917.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBP2 Central Apnea RDI in REM (Back position) 2% desaturation +68 AHI 55989 phv00055989.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBA2 Central Apnea RDI in REM (Back position) 2% desaturation or arousal +68 AHI 56061 phv00056061.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBP3 Central Apnea RDI in REM (Back position) 3% desaturation +68 AHI 56133 phv00056133.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBA3 Central Apnea RDI in REM (Back position) 3% desaturation or arousal +68 AHI 56205 phv00056205.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBP4 Central Apnea RDI in REM (Back position) 4% desaturation +68 AHI 56277 phv00056277.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBA4 Central Apnea RDI in REM (Back position) 4% desaturation or arousal +68 AHI 56349 phv00056349.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBP5 Central Apnea RDI in REM (Back position) 5% desaturation +68 AHI 56421 phv00056421.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 CARDRBA5 Central Apnea RDI in REM (Back position) 5% desaturation or arousal +68 AHI 57717 phv00057717.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrbp Central Apnea RDI in REM (Back position) overall +68 AHI 57729 phv00057729.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrba Central Apnea RDI in REM (Back position) associated with arousal +68 AHI 57741 phv00057741.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrbp2 Central Apnea RDI in REM (Back position) 2% desaturation +68 AHI 57753 phv00057753.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrba2 Central Apnea RDI in REM (Back position) 2% desaturation or arousal +68 AHI 57765 phv00057765.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrbp3 Central Apnea RDI in REM (Back position) 3% desaturation +68 AHI 57777 phv00057777.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrba3 Central Apnea RDI in REM (Back position) 3% desaturation or arousal +68 AHI 57789 phv00057789.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrbp4 Central Apnea RDI in REM (Back position) 4% desaturation +68 AHI 57801 phv00057801.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrba4 Central Apnea RDI in REM (Back position) 4% desaturation or arousal +68 AHI 57813 phv00057813.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrbp5 Central Apnea RDI in REM (Back position) 5% desaturation +68 AHI 57825 phv00057825.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:48:10+00:00 2018-12-06 18:05:54+00:00 cardrba5 Central Apnea RDI in REM (Back position) 5% desaturation or arousal +68 AHI 55754 phv00055754.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROP Central Apnea RDI in REM (Other position) overall +68 AHI 55826 phv00055826.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROA Central Apnea RDI in REM (Other position) associated with arousal +68 AHI 55922 phv00055922.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROP2 Central Apnea RDI in REM (Other position) 2% desaturation +68 AHI 55994 phv00055994.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROA2 Central Apnea RDI in REM (Other position) 2% desaturation or arousal +68 AHI 56066 phv00056066.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROP3 Central Apnea RDI in REM (Other position) 3% desaturation +68 AHI 56138 phv00056138.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROA3 Central Apnea RDI in REM (Other position) 3% desaturation or arousal +68 AHI 56210 phv00056210.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROP4 Central Apnea RDI in REM (Other position) 4% desaturation +68 AHI 56282 phv00056282.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROA4 Central Apnea RDI in REM (Other position) 4% desaturation or arousal +68 AHI 56354 phv00056354.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROP5 Central Apnea RDI in REM (Other position) 5% desaturation +68 AHI 56426 phv00056426.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 CARDROA5 Central Apnea RDI in REM (Other position) 5% desaturation or arousal +68 AHI 57718 phv00057718.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardrop Central Apnea RDI in REM (Other position) overall +68 AHI 57730 phv00057730.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardroa Central Apnea RDI in REM (Other position) associated with arousal +68 AHI 57742 phv00057742.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardrop2 Central Apnea RDI in REM (Other position) 2% desaturation +68 AHI 57754 phv00057754.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardroa2 Central Apnea RDI in REM (Other position) 2% desaturation or arousal +68 AHI 57766 phv00057766.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardrop3 Central Apnea RDI in REM (Other position) 3% desaturation +68 AHI 57778 phv00057778.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardroa3 Central Apnea RDI in REM (Other position) 3% desaturation or arousal +68 AHI 57790 phv00057790.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardrop4 Central Apnea RDI in REM (Other position) 4% desaturation +68 AHI 57802 phv00057802.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardroa4 Central Apnea RDI in REM (Other position) 4% desaturation or arousal +68 AHI 57814 phv00057814.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardrop5 Central Apnea RDI in REM (Other position) 5% desaturation +68 AHI 57826 phv00057826.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 12:50:12+00:00 2018-12-06 18:05:54+00:00 cardroa5 Central Apnea RDI in REM (Other position) 5% desaturation or arousal +68 AHI 55779 phv00055779.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBP Obstructive Apnea RDI in NREM (Back position) overall +68 AHI 55851 phv00055851.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBA Obstructive Apnea RDI in NREM (Back position) associated with arousal +68 AHI 55947 phv00055947.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBP2 Obstructive Apnea RDI in NREM (Back position) 2% desaturation +68 AHI 56019 phv00056019.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBA2 Obstructive Apnea RDI in NREM (Back position) 2% desaturation or arousal +68 AHI 56091 phv00056091.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBP3 Obstructive Apnea RDI in NREM (Back position) 3% desaturation +68 AHI 56163 phv00056163.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBA3 Obstructive Apnea RDI in NREM (Back position) 3% desaturation or arousal +68 AHI 56235 phv00056235.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBP4 Obstructive Apnea RDI in NREM (Back position) 4% desaturation +68 AHI 56307 phv00056307.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBA4 Obstructive Apnea RDI in NREM (Back position) 4% desaturation or arousal +68 AHI 56379 phv00056379.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBP5 Obstructive Apnea RDI in NREM (Back position) 5% desaturation +68 AHI 56451 phv00056451.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 OARDNBA5 Obstructive Apnea RDI in NREM (Back position) 5% desaturation or arousal +68 AHI 57723 phv00057723.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnbp Obstructive Apnea RDI in NREM (Back position) overall +68 AHI 57735 phv00057735.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnba Obstructive Apnea RDI in NREM (Back position) associated with arousal +68 AHI 57747 phv00057747.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnbp2 Obstructive Apnea RDI in NREM (Back position) 2% desaturation +68 AHI 57759 phv00057759.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnba2 Obstructive Apnea RDI in NREM (Back position) 2% desaturation or arousal +68 AHI 57771 phv00057771.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnbp3 Obstructive Apnea RDI in NREM (Back position) 3% desaturation +68 AHI 57783 phv00057783.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnba3 Obstructive Apnea RDI in NREM (Back position) 3% desaturation or arousal +68 AHI 57795 phv00057795.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnbp4 Obstructive Apnea RDI in NREM (Back position) 4% desaturation +68 AHI 57807 phv00057807.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnba4 Obstructive Apnea RDI in NREM (Back position) 4% desaturation or arousal +68 AHI 57819 phv00057819.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnbp5 Obstructive Apnea RDI in NREM (Back position) 5% desaturation +68 AHI 57831 phv00057831.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:16:14+00:00 2018-12-06 18:05:54+00:00 oardnba5 Obstructive Apnea RDI in NREM (Back position) 5% desaturation or arousal +68 AHI 55784 phv00055784.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOP Obstructive Apnea RDI in NREM (Other position) overall +68 AHI 55856 phv00055856.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOA Obstructive Apnea RDI in NREM (Other position) associated with arousal +68 AHI 55952 phv00055952.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOP2 Obstructive Apnea RDI in NREM (Other position) 2% desaturation +68 AHI 56024 phv00056024.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOA2 Obstructive Apnea RDI in NREM (Other position) 2% desaturation or arousal +68 AHI 56096 phv00056096.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOP3 Obstructive Apnea RDI in NREM (Other position) 3% desaturation +68 AHI 56168 phv00056168.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOA3 Obstructive Apnea RDI in NREM (Other position) 3% desaturation or arousal +68 AHI 56240 phv00056240.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOP4 Obstructive Apnea RDI in NREM (Other position) 4% desaturation +68 AHI 56312 phv00056312.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOA4 Obstructive Apnea RDI in NREM (Other position) 4% desaturation or arousal +68 AHI 56384 phv00056384.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOP5 Obstructive Apnea RDI in NREM (Other position) 5% desaturation +68 AHI 56456 phv00056456.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 OARDNOA5 Obstructive Apnea RDI in NREM (Other position) 5% desaturation or arousal +68 AHI 57724 phv00057724.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnop Obstructive Apnea RDI in NREM (Other position) overall +68 AHI 57736 phv00057736.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnoa Obstructive Apnea RDI in NREM (Other position) associated with arousal +68 AHI 57748 phv00057748.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnop2 Obstructive Apnea RDI in NREM (Other position) 2% desaturation +68 AHI 57760 phv00057760.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnoa2 Obstructive Apnea RDI in NREM (Other position) 2% desaturation or arousal +68 AHI 57772 phv00057772.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnop3 Obstructive Apnea RDI in NREM (Other position) 3% desaturation +68 AHI 57784 phv00057784.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnoa3 Obstructive Apnea RDI in NREM (Other position) 3% desaturation or arousal +68 AHI 57796 phv00057796.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnop4 Obstructive Apnea RDI in NREM (Other position) 4% desaturation +68 AHI 57808 phv00057808.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnoa4 Obstructive Apnea RDI in NREM (Other position) 4% desaturation or arousal +68 AHI 57820 phv00057820.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnop5 Obstructive Apnea RDI in NREM (Other position) 5% desaturation +68 AHI 57832 phv00057832.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:19:46+00:00 2018-12-06 18:05:54+00:00 oardnoa5 Obstructive Apnea RDI in NREM (Other position) 5% desaturation or arousal +68 AHI 55769 phv00055769.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBP Obstructive Apnea RDI in REM (Back position) overall +68 AHI 55841 phv00055841.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBA Obstructive Apnea RDI in REM (Back position) associated with arousal +68 AHI 55937 phv00055937.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBP2 Obstructive Apnea RDI in REM (Back position) 2% desaturation +68 AHI 56009 phv00056009.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBA2 Obstructive Apnea RDI in REM (Back position) 2% desaturation or arousal +68 AHI 56081 phv00056081.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBP3 Obstructive Apnea RDI in REM (Back position) 3% desaturation +68 AHI 56153 phv00056153.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBA3 Obstructive Apnea RDI in REM (Back position) 3% desaturation or arousal +68 AHI 56225 phv00056225.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBP4 Obstructive Apnea RDI in REM (Back position) 4% desaturation +68 AHI 56297 phv00056297.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBA4 Obstructive Apnea RDI in REM (Back position) 4% desaturation or arousal +68 AHI 56369 phv00056369.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBP5 Obstructive Apnea RDI in REM (Back position) 5% desaturation +68 AHI 56441 phv00056441.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 OARDRBA5 Obstructive Apnea RDI in REM (Back position) 5% desaturation or arousal +68 AHI 57721 phv00057721.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrbp Obstructive Apnea RDI in REM (Back position) overall +68 AHI 57733 phv00057733.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrba Obstructive Apnea RDI in REM (Back position) associated with arousal +68 AHI 57745 phv00057745.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrbp2 Obstructive Apnea RDI in REM (Back position) 2% desaturation +68 AHI 57757 phv00057757.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrba2 Obstructive Apnea RDI in REM (Back position) 2% desaturation or arousal +68 AHI 57769 phv00057769.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrbp3 Obstructive Apnea RDI in REM (Back position) 3% desaturation +68 AHI 57781 phv00057781.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrba3 Obstructive Apnea RDI in REM (Back position) 3% desaturation or arousal +68 AHI 57793 phv00057793.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrbp4 Obstructive Apnea RDI in REM (Back position) 4% desaturation +68 AHI 57805 phv00057805.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrba4 Obstructive Apnea RDI in REM (Back position) 4% desaturation or arousal +68 AHI 57817 phv00057817.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrbp5 Obstructive Apnea RDI in REM (Back position) 5% desaturation +68 AHI 57829 phv00057829.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:25:15+00:00 2018-12-06 18:05:54+00:00 oardrba5 Obstructive Apnea RDI in REM (Back position) 5% desaturation or arousal +68 AHI 55774 phv00055774.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROP Obstructive Apnea RDI in REM (Other position) overall +68 AHI 55846 phv00055846.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROA Obstructive Apnea RDI in REM (Other position) associated with arousal +68 AHI 55942 phv00055942.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROP2 Obstructive Apnea RDI in REM (Other position) 2% desaturation +68 AHI 56014 phv00056014.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROA2 Obstructive Apnea RDI in REM (Other position) 2% desaturation or arousal +68 AHI 56086 phv00056086.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROP3 Obstructive Apnea RDI in REM (Other position) 3% desaturation +68 AHI 56158 phv00056158.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROA3 Obstructive Apnea RDI in REM (Other position) 3% desaturation or arousal +68 AHI 56230 phv00056230.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROP4 Obstructive Apnea RDI in REM (Other position) 4% desaturation +68 AHI 56302 phv00056302.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROA4 Obstructive Apnea RDI in REM (Other position) 4% desaturation or arousal +68 AHI 56374 phv00056374.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROP5 Obstructive Apnea RDI in REM (Other position) 5% desaturation +68 AHI 56446 phv00056446.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 OARDROA5 Obstructive Apnea RDI in REM (Other position) 5% desaturation or arousal +68 AHI 57722 phv00057722.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardrop Obstructive Apnea RDI in REM (Other position) overall +68 AHI 57734 phv00057734.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardroa Obstructive Apnea RDI in REM (Other position) associated with arousal +68 AHI 57746 phv00057746.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardrop2 Obstructive Apnea RDI in REM (Other position) 2% desaturation +68 AHI 57758 phv00057758.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardroa2 Obstructive Apnea RDI in REM (Other position) 2% desaturation or arousal +68 AHI 57770 phv00057770.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardrop3 Obstructive Apnea RDI in REM (Other position) 3% desaturation +68 AHI 57782 phv00057782.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardroa3 Obstructive Apnea RDI in REM (Other position) 3% desaturation or arousal +68 AHI 57794 phv00057794.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardrop4 Obstructive Apnea RDI in REM (Other position) 4% desaturation +68 AHI 57806 phv00057806.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardroa4 Obstructive Apnea RDI in REM (Other position) 4% desaturation or arousal +68 AHI 57818 phv00057818.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardrop5 Obstructive Apnea RDI in REM (Other position) 5% desaturation +68 AHI 57830 phv00057830.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:27:21+00:00 2018-12-06 18:05:54+00:00 oardroa5 Obstructive Apnea RDI in REM (Other position) 5% desaturation or arousal +68 AHI 55811 phv00055811.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:09+00:00 2018-12-06 18:05:54+00:00 RDINBA Hypopnea RDI in NREM (Back position) associated with arousal +68 AHI 55979 phv00055979.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:09+00:00 2018-12-06 18:05:54+00:00 RDINBA2 Hypopnea RDI in NREM (Back position) 2% desaturation or arousal +68 AHI 56123 phv00056123.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:10+00:00 2018-12-06 18:05:54+00:00 RDINBA3 Hypopnea RDI in NREM (Back position) 3% desaturation or arousal +68 AHI 56267 phv00056267.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:10+00:00 2018-12-06 18:05:54+00:00 RDINBA4 Hypopnea RDI in NREM (Back position) 4% desaturation or arousal +68 AHI 56411 phv00056411.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:10+00:00 2018-12-06 18:05:54+00:00 RDINBA5 Hypopnea RDI in NREM (Back position) 5% desaturation or arousal +68 AHI 57727 phv00057727.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:10+00:00 2018-12-06 18:05:54+00:00 rdinba Hypopnea RDI in NREM (Back position) associated with arousal +68 AHI 57751 phv00057751.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:10+00:00 2018-12-06 18:05:54+00:00 rdinba2 Hypopnea RDI in NREM (Back position) 2% desaturation or arousal +68 AHI 57775 phv00057775.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:10+00:00 2018-12-06 18:05:54+00:00 rdinba3 Hypopnea RDI in NREM (Back position) 3% desaturation or arousal +68 AHI 57799 phv00057799.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:10+00:00 2018-12-06 18:05:54+00:00 rdinba4 Hypopnea RDI in NREM (Back position) 4% desaturation or arousal +68 AHI 57823 phv00057823.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:38:10+00:00 2018-12-06 18:05:54+00:00 rdinba5 Hypopnea RDI in NREM (Back position) 5% desaturation or arousal +68 AHI 55739 phv00055739.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINBP Hypopnea RDI in NREM (Back position) overall +68 AHI 55816 phv00055816.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINOA Hypopnea RDI in NREM (Other position) associated with arousal +68 AHI 55907 phv00055907.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINBP2 Hypopnea RDI in NREM (Back position) 2% desaturation +68 AHI 55984 phv00055984.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINOA2 Hypopnea RDI in NREM (Other position) 2% desaturation or arousal +68 AHI 56051 phv00056051.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINBP3 Hypopnea RDI in NREM (Back position) 3% desaturation +68 AHI 56128 phv00056128.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINOA3 Hypopnea RDI in NREM (Other position) 3% desaturation or arousal +68 AHI 56195 phv00056195.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINBP4 Hypopnea RDI in NREM (Back position) 4% desaturation +68 AHI 56272 phv00056272.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINOA4 Hypopnea RDI in NREM (Other position) 4% desaturation or arousal +68 AHI 56339 phv00056339.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINBP5 Hypopnea RDI in NREM (Back position) 5% desaturation +68 AHI 56416 phv00056416.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 RDINOA5 Hypopnea RDI in NREM (Other position) 5% desaturation or arousal +68 AHI 57715 phv00057715.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinbp Hypopnea RDI in NREM (Back position) overall +68 AHI 57728 phv00057728.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinoa Hypopnea RDI in NREM (Other position) associated with arousal +68 AHI 57739 phv00057739.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinbp2 Hypopnea RDI in NREM (Back position) 2% desaturation +68 AHI 57752 phv00057752.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinoa2 Hypopnea RDI in NREM (Other position) 2% desaturation or arousal +68 AHI 57763 phv00057763.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinbp3 Hypopnea RDI in NREM (Back position) 3% desaturation +68 AHI 57776 phv00057776.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinoa3 Hypopnea RDI in NREM (Other position) 3% desaturation or arousal +68 AHI 57787 phv00057787.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinbp4 Hypopnea RDI in NREM (Back position) 4% desaturation +68 AHI 57800 phv00057800.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinoa4 Hypopnea RDI in NREM (Other position) 4% desaturation or arousal +68 AHI 57811 phv00057811.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinbp5 Hypopnea RDI in NREM (Back position) 5% desaturation +68 AHI 57824 phv00057824.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:44:36+00:00 2018-12-06 18:05:54+00:00 rdinoa5 Hypopnea RDI in NREM (Other position) 5% desaturation or arousal +68 AHI 55744 phv00055744.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDINOP Hypopnea RDI in NREM (Other position) overall +68 AHI 55801 phv00055801.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDIRBA Hypopnea RDI in REM (Back position) associated with arousal +68 AHI 55912 phv00055912.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDINOP2 Hypopnea RDI in NREM (Other position) 2% desaturation +68 AHI 55969 phv00055969.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDIRBA2 Hypopnea RDI in REM (Back position) 2% desaturation or arousal +68 AHI 56056 phv00056056.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDINOP3 Hypopnea RDI in NREM (Other position) 3% desaturation +68 AHI 56113 phv00056113.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDIRBA3 Hypopnea RDI in REM (Back position) 3% desaturation or arousal +68 AHI 56200 phv00056200.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDINOP4 Hypopnea RDI in NREM (Other position) 4% desaturation +68 AHI 56257 phv00056257.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDIRBA4 Hypopnea RDI in REM (Back position) 4% desaturation or arousal +68 AHI 56344 phv00056344.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDINOP5 Hypopnea RDI in NREM (Other position) 5% desaturation +68 AHI 56401 phv00056401.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 RDIRBA5 Hypopnea RDI in REM (Back position) 5% desaturation or arousal +68 AHI 57716 phv00057716.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 rdinop Hypopnea RDI in NREM (Other position) overall +68 AHI 57725 phv00057725.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 rdirba Hypopnea RDI in REM (Back position) associated with arousal +68 AHI 57740 phv00057740.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 rdinop2 Hypopnea RDI in NREM (Other position) 2% desaturation +68 AHI 57749 phv00057749.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 rdirba2 Hypopnea RDI in REM (Back position) 2% desaturation or arousal +68 AHI 57764 phv00057764.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:36+00:00 2018-12-06 18:05:54+00:00 rdinop3 Hypopnea RDI in NREM (Other position) 3% desaturation +68 AHI 57773 phv00057773.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:37+00:00 2018-12-06 18:05:54+00:00 rdirba3 Hypopnea RDI in REM (Back position) 3% desaturation or arousal +68 AHI 57788 phv00057788.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:37+00:00 2018-12-06 18:05:54+00:00 rdinop4 Hypopnea RDI in NREM (Other position) 4% desaturation +68 AHI 57797 phv00057797.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:37+00:00 2018-12-06 18:05:54+00:00 rdirba4 Hypopnea RDI in REM (Back position) 4% desaturation or arousal +68 AHI 57812 phv00057812.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:37+00:00 2018-12-06 18:05:54+00:00 rdinop5 Hypopnea RDI in NREM (Other position) 5% desaturation +68 AHI 57821 phv00057821.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:51:37+00:00 2018-12-06 18:05:54+00:00 rdirba5 Hypopnea RDI in REM (Back position) 5% desaturation or arousal +68 AHI 55729 phv00055729.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIRBP Hypopnea RDI in REM (Back position) overall +68 AHI 55806 phv00055806.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIROA Hypopnea RDI in REM (Other position) associated with arousal +68 AHI 55897 phv00055897.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIRBP2 Hypopnea RDI in REM (Back position) 2% desaturation +68 AHI 55974 phv00055974.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIROA2 Hypopnea RDI in REM (Other position) 2% desaturation or arousal +68 AHI 56041 phv00056041.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIRBP3 Hypopnea RDI in REM (Back position) 3% desaturation +68 AHI 56118 phv00056118.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIROA3 Hypopnea RDI in REM (Other position) 3% desaturation or arousal +68 AHI 56185 phv00056185.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIRBP4 Hypopnea RDI in REM (Back position) 4% desaturation +68 AHI 56262 phv00056262.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIROA4 Hypopnea RDI in REM (Other position) 4% desaturation or arousal +68 AHI 56329 phv00056329.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIRBP5 Hypopnea RDI in REM (Back position) 5% desaturation +68 AHI 56406 phv00056406.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:36+00:00 2018-12-06 18:05:54+00:00 RDIROA5 Hypopnea RDI in REM (Other position) 5% desaturation or arousal +68 AHI 57713 phv00057713.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdirbp Hypopnea RDI in REM (Back position) overall +68 AHI 57726 phv00057726.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdiroa Hypopnea RDI in REM (Other position) associated with arousal +68 AHI 57737 phv00057737.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdirbp2 Hypopnea RDI in REM (Back position) 2% desaturation +68 AHI 57750 phv00057750.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdiroa2 Hypopnea RDI in REM (Other position) 2% desaturation or arousal +68 AHI 57761 phv00057761.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdirbp3 Hypopnea RDI in REM (Back position) 3% desaturation +68 AHI 57774 phv00057774.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdiroa3 Hypopnea RDI in REM (Other position) 3% desaturation or arousal +68 AHI 57785 phv00057785.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdirbp4 Hypopnea RDI in REM (Back position) 4% desaturation +68 AHI 57798 phv00057798.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdiroa4 Hypopnea RDI in REM (Other position) 4% desaturation or arousal +68 AHI 57809 phv00057809.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdirbp5 Hypopnea RDI in REM (Back position) 5% desaturation +68 AHI 57822 phv00057822.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 13:53:37+00:00 2018-12-06 18:05:54+00:00 rdiroa5 Hypopnea RDI in REM (Other position) 5% desaturation or arousal +68 AHI 55734 phv00055734.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 RDIROP Hypopnea RDI in REM (Other position) overall +68 AHI 55902 phv00055902.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 RDIROP2 Hypopnea RDI in REM (Other position) 2% desaturation +68 AHI 56046 phv00056046.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 RDIROP3 Hypopnea RDI in REM (Other position) 3% desaturation +68 AHI 56190 phv00056190.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 RDIROP4 Hypopnea RDI in REM (Other position) 4% desaturation +68 AHI 56334 phv00056334.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 RDIROP5 Hypopnea RDI in REM (Other position) 5% desaturation +68 AHI 57714 phv00057714.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 rdirop Hypopnea RDI in REM (Other position) overall +68 AHI 57738 phv00057738.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 rdirop2 Hypopnea RDI in REM (Other position) 2% desaturation +68 AHI 57762 phv00057762.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 rdirop3 Hypopnea RDI in REM (Other position) 3% desaturation +68 AHI 57786 phv00057786.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 rdirop4 Hypopnea RDI in REM (Other position) 4% desaturation +68 AHI 57810 phv00057810.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-10 14:04:40+00:00 2018-12-06 18:05:54+00:00 rdirop5 Hypopnea RDI in REM (Other position) 5% desaturation +69 Cigarette smoking 226257 phv00226257.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:56:03+00:00 2018-03-14 21:56:03+00:00 CIGARETTE_PACK_YEARS Cigarette Pack Years +69 Cigarette smoking 226258 phv00226258.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:56:17+00:00 2018-03-14 21:56:17+00:00 CIGARETTE_USE Cigarette use (1-Never,2=Former,3=Current) +69 Cigarette smoking 258106 phv00258106.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:00:13+00:00 2018-03-14 22:00:13+00:00 TBEA1 Smoke at least 100 cigs in lifetime (TBEA1) +69 Cigarette smoking 258107 phv00258107.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:00:29+00:00 2018-03-14 22:00:29+00:00 TBEA3 Present smoking status (TBEA3) +69 Cigarette smoking 258108 phv00258108.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:00:37+00:00 2018-03-14 22:00:37+00:00 TBEA4 Daily: cigs per day - present (TBEA4) +69 Cigarette smoking 258109 phv00258109.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:00:47+00:00 2018-03-14 22:00:47+00:00 TBEA5 Some: number of days you smoked during past 30 days - original desc: some: past 30 days - smoke cigs (TBEA5) +69 Cigarette smoking 258110 phv00258110.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:00:57+00:00 2018-03-14 22:00:57+00:00 TBEA5A Some: cigarettes per day on days you smoked during past 30 days - original desc: some: past 30 days - quit smoking 6 months or longer (TBEA5A) +69 Cigarette smoking 258111 phv00258111.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 22:01:08+00:00 2018-03-14 22:01:08+00:00 TBEA9 Average Cigs per day - entire time (TBEA9) +69 Cigarette smoking 204655 phv00204655.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:05:22+00:00 2018-03-27 14:05:22+00:00 CIGT21 Visit 2, cigarette smoking status [Cohort, Exam 2] +69 Cigarette smoking 204713 phv00204713.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:05:40+00:00 2018-03-27 14:05:40+00:00 CIGT01 Cigarette smoking status [Cohort, Exam 1] +69 Cigarette smoking 204714 phv00204714.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:06:01+00:00 2018-03-27 14:06:01+00:00 CIGTYR01 Cigarette years of smoking [Cohort, Exam 1] +69 Cigarette smoking 204756 phv00204756.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:06:26+00:00 2018-03-27 14:06:26+00:00 CURSMK01 Current cigarette smoker [Cohort, Exam 1] +69 Cigarette smoking 204757 phv00204757.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:06:47+00:00 2018-03-27 14:06:47+00:00 FORSMK01 Former cigarette smoker [Cohort, Exam 1] +69 Cigarette smoking 204758 phv00204758.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:07:10+00:00 2018-03-27 14:07:10+00:00 EVRSMK01 Ever smoked cigarettes [Cohort, Exam 1] +69 Cigarette smoking 204859 phv00204859.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:07:33+00:00 2018-03-27 14:07:33+00:00 CIGT31 Version 3, cigarette smoking status [Cohort, Exam 3] +69 Cigarette smoking 204971 phv00204971.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:07:59+00:00 2018-03-27 14:07:59+00:00 CIGT41 Cigarette smoking status [Cohort, Exam 4] +69 Cigarette smoking 204972 phv00204972.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:08:22+00:00 2018-03-27 14:08:22+00:00 CURSMK41 Current cigarette smoker [Cohort, Exam 4] +69 Cigarette smoking 204973 phv00204973.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:08:41+00:00 2018-03-27 14:08:41+00:00 FORSMK41 Former cigarette smoker [Cohort, Exam 4] +69 Cigarette smoking 204974 phv00204974.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:09:18+00:00 2018-03-27 14:09:18+00:00 EVRSMK41 Ever smoked cigarettes [Cohort, Exam 4] +69 Cigarette smoking 207119 phv00207119.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:10:21+00:00 2018-03-27 14:10:21+00:00 HHXB44 [Smoking]. Have you ever smoked cigarettes? [Code No if less than 400 cigarettes in a lifetime]. Q44 [Health/Medical History, exam 2] +69 Cigarette smoking 207120 phv00207120.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:10:45+00:00 2018-03-27 14:10:45+00:00 HHXB45 [Smoking]. Do you now smoke cigarettes? Q45 [Health/Medical History, exam 2] +69 Cigarette smoking 207121 phv00207121.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:11:08+00:00 2018-03-27 14:11:08+00:00 HHXB46 [Smoking]. When did you smoke your last cigarette? Q46 [Health/Medical History, exam 2] +69 Cigarette smoking 207122 phv00207122.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:11:25+00:00 2018-03-27 14:11:25+00:00 HHXB47 [Smoking]. Prior to quitting, how many cigarettes did you usually smoke per day? [Code 00 if less than one per day]. Q47 [Health/Medical History, exam 2] +69 Cigarette smoking 207123 phv00207123.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:11:45+00:00 2018-03-27 14:11:45+00:00 HHXB48 [Smoking]. How many cigarettes do you smoke per day now? [Code 00 if less than one per day]. Q48 [Health/Medical History, exam 2] +69 Cigarette smoking 207124 phv00207124.v1.p1 pht004103.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:12:40+00:00 2018-03-27 14:12:40+00:00 HHXB49 [Smoking]. Do/did you inhale the cigarette smoke? Q49 [Health/Medical History, exam 2] +69 Cigarette smoking 207368 phv00207368.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:13:09+00:00 2018-03-27 14:13:09+00:00 HOM28 Have you ever smoked cigarettes? Q28 [Home Interview, exam 1] +69 Cigarette smoking 207369 phv00207369.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:13:30+00:00 2018-03-27 14:13:30+00:00 HOM29 How old were you when you first started regular cigarette smoking? Q29 [Home Interview, exam 1] +69 Cigarette smoking 207370 phv00207370.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:13:55+00:00 2018-03-27 14:13:55+00:00 HOM30 Do you now smoke cigarettes? Q30 [Home Interview, exam 1] +69 Cigarette smoking 207371 phv00207371.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:14:12+00:00 2018-03-27 14:14:12+00:00 HOM31 Age stopped smoking cigarettes Q31 [Home Interview, exam 1] +69 Cigarette smoking 207372 phv00207372.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:14:28+00:00 2018-03-27 14:14:28+00:00 HOM32 Number of cigarettes smoked per day. Q32 [Home Interview, exam 1] +69 Cigarette smoking 207373 phv00207373.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:15:12+00:00 2018-03-27 14:15:12+00:00 HOM33 During the years that you have not smoked, was there ever a period of one year or more that you did not smoke cigarettes? Q33 [Home Interview, exam 1] +69 Cigarette smoking 207374 phv00207374.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:15:36+00:00 2018-03-27 14:15:36+00:00 HOM34 How many years did you not smoke cigarettes? Q34 [Home Interview, exam 1] +69 Cigarette smoking 207375 phv00207375.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:15:52+00:00 2018-03-27 14:15:52+00:00 HOM35 On the average of the entire time you smoked, how many cigarettes did you usually smoke per day? Q35 [Home Interview, exam 1] +69 Cigarette smoking 207376 phv00207376.v1.p1 pht004111.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 14:16:17+00:00 2018-03-27 14:16:17+00:00 HOM36 (Do/did) you inhale the cigarette smoke? Q36 [Home Interview, exam 1] +69 Cigarette smoking 208996 phv00208996.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:00:35+00:00 2018-03-27 15:00:35+00:00 PHXA25 [Smoking]. Have you ever smoked cigarettes? Q25 [Personal History Form, exam 3] +69 Cigarette smoking 208998 phv00208998.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:00:52+00:00 2018-03-27 15:00:52+00:00 PHXA27 [Smoking]. Do you now smoke cigarettes? Q27 [Personal History Form, exam 3] +69 Cigarette smoking 208999 phv00208999.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:01:09+00:00 2018-03-27 15:01:09+00:00 PHXA28 [Smoking]. When did you smoke your last cigarette? Q28 [Personal History Form, exam 3] +69 Cigarette smoking 209000 phv00209000.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:01:30+00:00 2018-03-27 15:01:30+00:00 PHXA31 [Smoking]. Do (did) you inhale the cigarette smoke? Q31 [Personal History Form, exam 3] +69 Cigarette smoking 209026 phv00209026.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:02:26+00:00 2018-03-27 15:02:26+00:00 PHXA30 [Smoking]. How many cigarettes do you smoke per day now? Q30 [Personal History Form, exam 3] +69 Cigarette smoking 209034 phv00209034.v1.p1 pht004145.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:02:45+00:00 2018-03-27 15:02:45+00:00 PHXA29 [Smoking]. Prior to quitting, how many cigarettes did you usually smoke per day? Q29 [Personal History Form, exam 3] +69 Cigarette smoking 209072 phv00209072.v1.p1 pht004146.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:03:13+00:00 2018-03-27 15:03:13+00:00 PHXB7 [Smoking]. Have you ever smoked cigarettes? Q7 [Personal History form, exam 4] +69 Cigarette smoking 209073 phv00209073.v1.p1 pht004146.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:03:33+00:00 2018-03-27 15:03:33+00:00 PHXB8 [Smoking]. Do you now smoke cigarettes? Q8 [Personal History form, exam 4] +69 Cigarette smoking 209086 phv00209086.v1.p1 pht004146.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:05:34+00:00 2018-03-27 15:05:34+00:00 PHXB11 [Smoking]. How many cigarettes do you usually smoke per day now? Q11 [Personal History form, exam 4] +69 Cigarette smoking 209085 phv00209085.v1.p1 pht004146.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:05:55+00:00 2018-03-27 15:05:55+00:00 PHXB10 [Smoking]. Prior to quitting, how many cigarettes did you usually smoke per day? Q10 [Personal History form, exam 4] +69 Cigarette smoking 209074 phv00209074.v1.p1 pht004146.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:06:19+00:00 2018-03-27 15:06:19+00:00 PHXB9 [Smoking]. When did you smoke your last cigarette? Q9 [Personal History form, exam 4] +69 Cigarette smoking 214056 phv00214056.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:06:57+00:00 2018-03-27 15:06:57+00:00 CGPKYR Lifetime cigarette smoking: pack years +69 Cigarette smoking 214118 phv00214118.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:07:16+00:00 2018-03-27 15:07:16+00:00 EVSMOK15 Have you ever smoked cigarettes (ever = at least 20 packs in lifetime)? +69 Cigarette smoking 214119 phv00214119.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:07:41+00:00 2018-03-27 15:07:41+00:00 SMKNOW15 Do you now smoke cigarettes? +69 Cigarette smoking 214122 phv00214122.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:07:57+00:00 2018-03-27 15:07:57+00:00 CIGDAY15 If yes to [SMKNOW15]: How many cigarettes do you smoke per day now? +69 Cigarette smoking 202966 phv00202966.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:09:07+00:00 2018-03-27 15:09:07+00:00 AFUcomp30_G [Other items]. Do you now smoke cigarettes? [Annual Follow-up Questionnaire Form, AFUG] +69 Cigarette smoking 204312 phv00204312.v1.p1 pht004054.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:10:02+00:00 2018-03-27 15:10:02+00:00 IFIA19B [History]. Did he/she have a history of cigarette smoking? Q19b [Informant Interview Form, IFI] +69 Cigarette smoking 204413 phv00204413.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:10:24+00:00 2018-03-27 15:10:24+00:00 PHQA03M [Medical history]. Did the decedent have a history of any of the following? Cigarette smoking. Q3m [Physician Questionnaire Form, exam 1] +69 Cigarette smoking 214120 phv00214120.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:14:55+00:00 2018-03-27 15:14:55+00:00 MOSTOP15 If no to [SMKNOW15]: month stopped smoking? +69 Cigarette smoking 214121 phv00214121.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:15:13+00:00 2018-03-27 15:15:13+00:00 YRSTOP15 If no to [SMKNOW15]: year stopped smoking? +69 Cigarette smoking 215390 phv00215390.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:15:45+00:00 2018-03-27 15:15:45+00:00 SMOKSTAT_S1 Smoking status (never=0, current=1, former=2) +69 Cigarette smoking 214117 phv00214117.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:16:18+00:00 2018-03-27 15:16:18+00:00 WHENSM15 Data on smoking collected when? +69 Cigarette smoking 203798 phv00203798.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:17:28+00:00 2018-03-27 15:17:28+00:00 CORA22B Is there a history of smoking? Q22b [Coroner / Medical Examiner Form] +69 Cigarette smoking 203911 phv00203911.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-27 15:17:49+00:00 2018-03-27 15:17:49+00:00 HRAA21D [Second transfer]. Smoking status. Q21d [Hospital Abstraction Form] +69 Cigarette smoking 83241 phv00083241.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:01:06+00:00 2018-04-29 00:01:06+00:00 cig1c CIGARETTE SMOKING STATUS +69 Cigarette smoking 83247 phv00083247.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:01:54+00:00 2018-04-29 00:01:54+00:00 cigsday1 CIGARETTES: AVERAGE # SMOKED PER DAY +69 Cigarette smoking 83613 phv00083613.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:02:07+00:00 2018-04-29 00:02:07+00:00 cig1ca4 CIGARETTE SMOKING STATUS +69 Cigarette smoking 83843 phv00083843.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:02:15+00:00 2018-04-29 00:02:15+00:00 cig1ca4 CIGARETTE SMOKING STATUS +69 Cigarette smoking 85545 phv00085545.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:02:20+00:00 2018-04-29 00:02:20+00:00 cig1c CIGARETTE SMOKING STATUS +69 Cigarette smoking 85574 phv00085574.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:02:25+00:00 2018-04-29 00:02:25+00:00 cigsday1 CIGARETTES: AVERAGE # SMOKED PER DAY +69 Cigarette smoking 86098 phv00086098.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:02:37+00:00 2018-04-29 00:02:37+00:00 cigsday2 CIGARETTES: AVERAGE # SMOKED PER DAY +69 Cigarette smoking 86102 phv00086102.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:02:42+00:00 2018-04-29 00:02:42+00:00 cig2c CIGARRETTE SMOKING STATUS, EXAM 2 +69 Cigarette smoking 86582 phv00086582.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:02:48+00:00 2018-04-29 00:02:48+00:00 cigsday3 CIGARETTES: AVERAGE # SMOKED PER DAY +69 Cigarette smoking 86586 phv00086586.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:02:53+00:00 2018-04-29 00:02:53+00:00 cig3c CIGARRETTE SMOKING STATUS, EXAM 3 +69 Cigarette smoking 87014 phv00087014.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:00+00:00 2018-04-29 00:03:00+00:00 cigsday4 AVERAGE CIGARETTES SMOKED PER DAY +69 Cigarette smoking 87017 phv00087017.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:08+00:00 2018-04-29 00:03:08+00:00 cig4c CIGARETTE SMOKING STATUS, EXAM 4 +69 Cigarette smoking 87082 phv00087082.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:13+00:00 2018-04-29 00:03:13+00:00 cigfc CIGARETTE SMOKING STATUS +69 Cigarette smoking 87256 phv00087256.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:22+00:00 2018-04-29 00:03:22+00:00 cigsdayf AVERAGE NUMBER OF CIGARETTES SMOKED PER DAY +69 Cigarette smoking 87839 phv00087839.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:35+00:00 2018-04-29 00:03:35+00:00 cig1ca4 CIGARETTE SMOKING STATUS +69 Cigarette smoking 175433 phv00175433.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:42+00:00 2018-04-29 00:03:42+00:00 cigsday5 AVERAGE CIGARETTES SMOKED PER DAY +69 Cigarette smoking 175450 phv00175450.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:47+00:00 2018-04-29 00:03:47+00:00 cig5c CIGARETTE SMOKING STATUS, EXAM 5 +69 Cigarette smoking 175860 phv00175860.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:52+00:00 2018-04-29 00:03:52+00:00 cig1c CIGARETTE SMOKING STATUS +69 Cigarette smoking 175945 phv00175945.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:03:58+00:00 2018-04-29 00:03:58+00:00 cigfc FAMILY COHORT: CIGARETTE SMOKING STATUS +69 Cigarette smoking 176867 phv00176867.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:04:04+00:00 2018-04-29 00:04:04+00:00 cigsday5 AVERAGE CIGARETTES SMOKED PER DAY +69 Cigarette smoking 176884 phv00176884.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:04:09+00:00 2018-04-29 00:04:09+00:00 cig5c CIGARETTE SMOKING STATUS, EXAM 5 +69 Cigarette smoking 83242 phv00083242.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:10:34+00:00 2018-04-29 00:10:34+00:00 pkyrs1c PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 83243 phv00083243.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:10:43+00:00 2018-04-29 00:10:43+00:00 evsmk1 SMOKED AT LEAST 100 CIGARETTES IN LIFETIME +69 Cigarette smoking 83244 phv00083244.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:10:49+00:00 2018-04-29 00:10:49+00:00 agesmk1 CIGARETTES: AGE STARTED SMOKING +69 Cigarette smoking 83245 phv00083245.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:10:56+00:00 2018-04-29 00:10:56+00:00 cursmk1 CIGARETTES: SMOKED IN LAST 30 DAYS +69 Cigarette smoking 83246 phv00083246.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:11:02+00:00 2018-04-29 00:11:02+00:00 agequit1 CIGARETTES: AGE QUIT SMOKING +69 Cigarette smoking 83473 phv00083473.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:11:10+00:00 2018-04-29 00:11:10+00:00 lsmoksa4 SMOKING STATUS +69 Cigarette smoking 83496 phv00083496.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:11:18+00:00 2018-04-29 00:11:18+00:00 spsmka4 SMOKE IN PAST 2 HRS +69 Cigarette smoking 83582 phv00083582.v1.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:11:28+00:00 2018-04-29 00:11:28+00:00 qsmokea4 SMOKE CIGARETTES +69 Cigarette smoking 83614 phv00083614.v2.p3 pht001112.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:11:34+00:00 2018-04-29 00:11:34+00:00 lpya4 PACK-YEARS OF CIGARETTE SMOKING IN SPIROMETRY EXAM +69 Cigarette smoking 83708 phv00083708.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:11:44+00:00 2018-04-29 00:11:44+00:00 lsmoksa4 SMOKING STATUS +69 Cigarette smoking 83731 phv00083731.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:11:50+00:00 2018-04-29 00:11:50+00:00 spsmka4 SMOKE IN PAST 2 HRS +69 Cigarette smoking 83844 phv00083844.v2.p3 pht001114.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:11:59+00:00 2018-04-29 00:11:59+00:00 lpya4 PACK-YEARS OF CIGARETTE SMOKING IN SPIROMETRY EXAM +69 Cigarette smoking 85544 phv00085544.v3.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:12:05+00:00 2018-04-29 00:12:05+00:00 pkyrs1c PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 85570 phv00085570.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:12:11+00:00 2018-04-29 00:12:11+00:00 evsmk1 SMOKED AT LEAST 100 CIGARETTES IN LIFETIME +69 Cigarette smoking 85571 phv00085571.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:12:21+00:00 2018-04-29 00:12:21+00:00 agesmk1 CIGARETTES: AGE STARTED SMOKING +69 Cigarette smoking 85572 phv00085572.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:12:27+00:00 2018-04-29 00:12:27+00:00 cursmk1 CIGARETTES: SMOKED IN LAST 30 DAYS +69 Cigarette smoking 85573 phv00085573.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:12:38+00:00 2018-04-29 00:12:38+00:00 agequit1 CIGARETTES: AGE QUIT SMOKING +69 Cigarette smoking 86096 phv00086096.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:12:44+00:00 2018-04-29 00:12:44+00:00 smkstat2 SMOKING STATUS +69 Cigarette smoking 86097 phv00086097.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:12:49+00:00 2018-04-29 00:12:49+00:00 cursmk2 CIGARETTES: SMOKED IN LAST 30 DAYS +69 Cigarette smoking 142658 phv00142658.v3.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:12:55+00:00 2018-04-29 00:12:55+00:00 pkyrs2c PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 86580 phv00086580.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:00+00:00 2018-04-29 00:13:00+00:00 smkstat3 SMOKING STATUS +69 Cigarette smoking 86581 phv00086581.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:06+00:00 2018-04-29 00:13:06+00:00 cursmk3 CIGARETTES: SMOKED IN LAST 30 DAYS +69 Cigarette smoking 142659 phv00142659.v4.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:11+00:00 2018-04-29 00:13:11+00:00 pkyrs3c PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 87012 phv00087012.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:17+00:00 2018-04-29 00:13:17+00:00 smkstat4 CURRENT SMOKING STATUS +69 Cigarette smoking 87013 phv00087013.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:22+00:00 2018-04-29 00:13:22+00:00 cursmk4 SMOKED CIGARETTES: LAST 30 DAYS +69 Cigarette smoking 163138 phv00163138.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:28+00:00 2018-04-29 00:13:28+00:00 pkyrs4c PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 87083 phv00087083.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:33+00:00 2018-04-29 00:13:33+00:00 pkyrsfc PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 87252 phv00087252.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:39+00:00 2018-04-29 00:13:39+00:00 evsmkf SMOKED 100+ CIGARETTES IN LIFETIME +69 Cigarette smoking 87253 phv00087253.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:45+00:00 2018-04-29 00:13:45+00:00 agesmkf AGE FIRST STARTED SMOKING CIGARETTES +69 Cigarette smoking 87254 phv00087254.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:51+00:00 2018-04-29 00:13:51+00:00 cursmkf SMOKED CIGARETTES IN THE LAST 30 DAYS +69 Cigarette smoking 87255 phv00087255.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:13:56+00:00 2018-04-29 00:13:56+00:00 agequitf AGE QUIT SMOKING CIGARETTES +69 Cigarette smoking 87699 phv00087699.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:03+00:00 2018-04-29 00:14:03+00:00 lsmoksa4 SMOKING STATUS +69 Cigarette smoking 87722 phv00087722.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:08+00:00 2018-04-29 00:14:08+00:00 spsmka4 SMOKE IN PAST 2 HRS +69 Cigarette smoking 87808 phv00087808.v1.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:14+00:00 2018-04-29 00:14:14+00:00 qsmokea4 SMOKE CIGARETTES +69 Cigarette smoking 87840 phv00087840.v2.p3 pht001122.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:20+00:00 2018-04-29 00:14:20+00:00 lpya4 PACK-YEARS OF CIGARETTE SMOKING IN SPIROMETRY EXAM +69 Cigarette smoking 175428 phv00175428.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:25+00:00 2018-04-29 00:14:25+00:00 smkstat5 CURRENT SMOKING STATUS +69 Cigarette smoking 175429 phv00175429.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:34+00:00 2018-04-29 00:14:34+00:00 avcday5 CIGARETTES SMOKED PER DAY +69 Cigarette smoking 175432 phv00175432.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:40+00:00 2018-04-29 00:14:40+00:00 cursmk5 SMOKED CIGARETTES: LAST 30 DAYS +69 Cigarette smoking 175451 phv00175451.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:46+00:00 2018-04-29 00:14:46+00:00 pkyrs5c EXAM 5 PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 175861 phv00175861.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:14:53+00:00 2018-04-29 00:14:53+00:00 pkyrs1c PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 175891 phv00175891.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:15:03+00:00 2018-04-29 00:15:03+00:00 smoke_stat SMOKE_STAT +69 Cigarette smoking 175946 phv00175946.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:15:10+00:00 2018-04-29 00:15:10+00:00 pkyrsfc FAMILY COHORT: PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 176862 phv00176862.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:15:16+00:00 2018-04-29 00:15:16+00:00 smkstat5 CURRENT SMOKING STATUS +69 Cigarette smoking 176863 phv00176863.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:15:33+00:00 2018-04-29 00:15:33+00:00 avcday5 CIGARETTES SMOKED PER DAY +69 Cigarette smoking 176866 phv00176866.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:15:40+00:00 2018-04-29 00:15:40+00:00 cursmk5 SMOKED CIGARETTES: LAST 30 DAYS +69 Cigarette smoking 176885 phv00176885.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:15:45+00:00 2018-04-29 00:15:45+00:00 pkyrs5c EXAM 5 PACK-YEARS OF CIGARETTE SMOKING +69 Cigarette smoking 204864 phv00204864.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:42:07+00:00 2018-05-03 20:42:07+00:00 CURSMK31 Current smoker [Cohort, Exam 3] +69 Cigarette smoking 204865 phv00204865.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:42:32+00:00 2018-05-03 20:42:32+00:00 FORSMK31 Former smoker [Cohort, Exam 3] +69 Cigarette smoking 204866 phv00204866.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-05-03 20:42:51+00:00 2018-05-03 20:42:51+00:00 EVRSMK31 Ever smoker [Cohort, Exam 3] +69 Cigarette smoking 125054 phv00125054.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:19:34+00:00 2018-06-08 16:19:34+00:00 AFUA30 30. Do you now smoke cigarettes? +69 Cigarette smoking 125139 phv00125139.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:40:53+00:00 2018-06-08 16:40:53+00:00 AFUA30 30. Do you now smoke cigarettes? +69 Cigarette smoking 125225 phv00125225.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:55:36+00:00 2018-06-08 16:55:36+00:00 AFUB30 30. Do you now smoke cigarettes? +69 Cigarette smoking 125311 phv00125311.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:01:55+00:00 2018-06-08 17:01:55+00:00 AFUB30 30. Do you now smoke cigarettes? +69 Cigarette smoking 125492 phv00125492.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:17:36+00:00 2018-06-08 17:17:36+00:00 AFUC50 50. Do you now smoke cigarettes? +69 Cigarette smoking 125654 phv00125654.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 19:49:46+00:00 2018-06-08 19:49:46+00:00 AFUI30 SMOKE CIGARRETES Q30 +69 Cigarette smoking 125743 phv00125743.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:02:33+00:00 2018-06-08 20:02:33+00:00 AFUJ30 SMOKE CIGARRETES Q30 +69 Cigarette smoking 125565 phv00125565.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:11:52+00:00 2018-06-08 20:11:52+00:00 AFUI30 SMOKE CIGARRETES Q30 +69 Cigarette smoking 125830 phv00125830.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 20:18:41+00:00 2018-06-08 20:18:41+00:00 AFUK30 SMOKE CIGARRETES Q30 +69 Cigarette smoking 126091 phv00126091.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:27:11+00:00 2018-06-12 01:27:11+00:00 SMK01 Cigarette smoking only +69 Cigarette smoking 128496 phv00128496.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:31:31+00:00 2018-06-17 18:31:31+00:00 TOBA1 1: Smoked at least 400 cigarettes +69 Cigarette smoking 128497 phv00128497.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:31:48+00:00 2018-06-17 18:31:48+00:00 TOBA2 2: Age when first smoke cigarettes +69 Cigarette smoking 128498 phv00128498.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:32:30+00:00 2018-06-17 18:32:30+00:00 TOBA3 3: Do you now smoke cigarettes +69 Cigarette smoking 128499 phv00128499.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:33:32+00:00 2018-06-17 18:33:32+00:00 TOBA4A 4a: Since you last smoked (months) +69 Cigarette smoking 128500 phv00128500.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:33:51+00:00 2018-06-17 18:33:51+00:00 TOBA4B 4b: Since you last smoked (years) +69 Cigarette smoking 128501 phv00128501.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:34:11+00:00 2018-06-17 18:34:11+00:00 TOBA5 5: Cigarettes you smoke per day +69 Cigarette smoking 128502 phv00128502.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:34:37+00:00 2018-06-17 18:34:37+00:00 TOBA6 6: Smoke more first few hrs after wake +69 Cigarette smoking 128503 phv00128503.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:36:06+00:00 2018-06-17 18:36:06+00:00 TOBA7 7: How soon do you smoke? +69 Cigarette smoking 128504 phv00128504.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:36:58+00:00 2018-06-17 18:36:58+00:00 TOBA8 8: Which cigarette hate to give up? +69 Cigarette smoking 128505 phv00128505.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:40:25+00:00 2018-06-17 18:40:25+00:00 TOBA9 9: Difficult to refrain from smoking +69 Cigarette smoking 128506 phv00128506.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:40:44+00:00 2018-06-17 18:40:44+00:00 TOBA10 10: Smoke when ill? +69 Cigarette smoking 128507 phv00128507.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:41:01+00:00 2018-06-17 18:41:01+00:00 TOBA11 11: Cigarettes smoke usually per day +69 Cigarette smoking 128508 phv00128508.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:41:27+00:00 2018-06-17 18:41:27+00:00 TOBA12 12: Years off cigarettes? +69 Cigarette smoking 128509 phv00128509.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:45:00+00:00 2018-06-17 18:45:00+00:00 TOBA13 13: How deeply do you inhale? +69 Cigarette smoking 159641 phv00159641.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:01:50+00:00 2018-08-10 21:01:50+00:00 SmokeMenthol Do you now or did you smoke menthol cigarettes Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159747 phv00159747.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:01:59+00:00 2018-08-10 21:01:59+00:00 EverSmokedCig Have you ever smoked cigarettes? Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159748 phv00159748.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:02:07+00:00 2018-08-10 21:02:07+00:00 SmokStartAge How old were you when you first started cigarette smoking? [Years old] Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159749 phv00159749.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:02:15+00:00 2018-08-10 21:02:15+00:00 SmokCigNow Do you now smoke cigarettes [as of one month ago]? Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159636 phv00159636.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:02:26+00:00 2018-08-10 21:02:26+00:00 HowSoonSmoke How soon after waking do you smoke first cigarette Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159637 phv00159637.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:02:35+00:00 2018-08-10 21:02:35+00:00 SmokeMore2hrs Smoke more during first 2 hours of day than rest of day Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159640 phv00159640.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:02:43+00:00 2018-08-10 21:02:43+00:00 SmokeSickBed Smoke when so ill you are in bed most of day Collection Interval: Collected in Exam 1 +69 Cigarette smoking 169389 phv00169389.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:05:58+00:00 2018-08-10 21:05:58+00:00 YearsSinceQuit Years since quit smoking Collection Interval: Collected in Exam 1 +69 Cigarette smoking 169388 phv00169388.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:06:08+00:00 2018-08-10 21:06:08+00:00 Duration_Smoking Duration of smoking [yrs] Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159756 phv00159756.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:06:42+00:00 2018-08-10 21:06:42+00:00 CigSmokHalfHr How many cigarettes have you smoked in the past half hour [cigarettes] Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159755 phv00159755.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:06:51+00:00 2018-08-10 21:06:51+00:00 CigSmok2hrs How many cigarettes have you smoked in the past 2 hours [cigarettes] Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159754 phv00159754.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:07:00+00:00 2018-08-10 21:07:00+00:00 CigSmok24hrs How many cigarettes have you smoked in the past 24 hours [cigarettes] Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159753 phv00159753.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:07:10+00:00 2018-08-10 21:07:10+00:00 CigSmok24hrs_NA Cigarettes smoked past 24 hours - does not apply Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159752 phv00159752.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:07:21+00:00 2018-08-10 21:07:21+00:00 CigPerDaySmokAvg Average for entire time how many cigarettes smoked per day [cigarettes/day] Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159751 phv00159751.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:07:30+00:00 2018-08-10 21:07:30+00:00 SmokStopAge How old were you when you completely stopped smoking? [Years old] Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159750 phv00159750.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:07:39+00:00 2018-08-10 21:07:39+00:00 CigPerDaySmokNow How many cigarettes do you smoke per day now? [Cigarettes/day] Collection Interval: Collected in Exam 1 +69 Cigarette smoking 159842 phv00159842.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:12:14+00:00 2018-08-10 21:12:14+00:00 ATS_PackYears Pack years (ATS) Collection Interval: Collected in Exam 1 +69 Cigarette smoking 277459 phv00277459.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:34:28+00:00 2018-08-14 22:34:28+00:00 SMOKE100 Smoked more than 100 cigarettes in life? Collection Interval: 2009-2011 +69 Cigarette smoking 277465 phv00277465.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:34:49+00:00 2018-08-14 22:34:49+00:00 AVGCIGDY Average number of cigarettes per day Collection Interval: 2009-2011 +69 Cigarette smoking 277464 phv00277464.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:34:56+00:00 2018-08-14 22:34:56+00:00 LSMK_AGE Age at which last quit smoking Collection Interval: 2009-2011 +69 Cigarette smoking 277463 phv00277463.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:35:03+00:00 2018-08-14 22:35:03+00:00 LSMK_YR Year last quit smoking Collection Interval: 2009-2011 +69 Cigarette smoking 277462 phv00277462.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:35:11+00:00 2018-08-14 22:35:11+00:00 CIGARETT Smoke cigarettes now? Collection Interval: 2009-2011 +69 Cigarette smoking 277461 phv00277461.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:35:18+00:00 2018-08-14 22:35:18+00:00 FSMK_AGE Age at which first started smoking Collection Interval: 2009-2011 +69 Cigarette smoking 277460 phv00277460.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:35:25+00:00 2018-08-14 22:35:25+00:00 FSMK_YR Year first started smoking Collection Interval: 2009-2011 +69 Cigarette smoking 277624 phv00277624.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:55:08+00:00 2018-08-14 22:55:08+00:00 AVGCIGDY On average how many cigarettes per day do/did you usually smoke? Collection Interval: 1996-2000 +69 Cigarette smoking 277623 phv00277623.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:55:17+00:00 2018-08-14 22:55:17+00:00 LSMK_AGE In what year or how old were you when you last quit smoking? - age Collection Interval: 1996-2000 +69 Cigarette smoking 277622 phv00277622.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:55:25+00:00 2018-08-14 22:55:25+00:00 LSMK_YR In what year or how old were you when you last quit smoking? - year Collection Interval: 1996-2000 +69 Cigarette smoking 277621 phv00277621.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:55:32+00:00 2018-08-14 22:55:32+00:00 CIGARETT Do you now smoke cigarettes? Collection Interval: 1996-2000 +69 Cigarette smoking 277620 phv00277620.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:55:39+00:00 2018-08-14 22:55:39+00:00 FSMK_AGE In what year or how old were you when you first started smoking? - age Collection Interval: 1996-2000 +69 Cigarette smoking 277619 phv00277619.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:55:46+00:00 2018-08-14 22:55:46+00:00 FSMK_YR In what year or how old were you when you first started smoking? - year Collection Interval: 1996-2000 +69 Cigarette smoking 277618 phv00277618.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:55:53+00:00 2018-08-14 22:55:53+00:00 SMOKE100 Have you smoked more than 100 cigarettes in your entire life? Collection Interval: 1996-2000 +69 Cigarette smoking 277925 phv00277925.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:19:48+00:00 2018-08-14 23:19:48+00:00 AVGCIGDY On average; how many cigarettes per day do/did you usually smoke? Collection Interval: 2000-2004 +69 Cigarette smoking 277924 phv00277924.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:19:54+00:00 2018-08-14 23:19:54+00:00 LSMK_AGE In what year or how old were you when you last quit smoking? - age Collection Interval: 2000-2004 +69 Cigarette smoking 277923 phv00277923.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:20:02+00:00 2018-08-14 23:20:02+00:00 LSMK_YR In what year or how old were you when you last quit smoking? - year Collection Interval: 2000-2004 +69 Cigarette smoking 277922 phv00277922.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:20:09+00:00 2018-08-14 23:20:09+00:00 CIGARETT Do you now smoke cigarettes? Collection Interval: 2000-2004 +69 Cigarette smoking 277921 phv00277921.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:20:16+00:00 2018-08-14 23:20:16+00:00 FSMK_AGE In what year or how old were you when you first started smoking? - age Collection Interval: 2000-2004 +69 Cigarette smoking 277920 phv00277920.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:20:26+00:00 2018-08-14 23:20:26+00:00 FSMK_YR In what year or how old were you when you first started smoking? - year Collection Interval: 2000-2004 +69 Cigarette smoking 277919 phv00277919.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:20:34+00:00 2018-08-14 23:20:34+00:00 SMOKE100 Have you smoked more than 100 cigarettes in your entire life? Collection Interval: 2000-2004 +69 Cigarette smoking 307905 phv00307905.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:04:59+00:00 2018-08-16 00:04:59+00:00 AVGCIGDY On average how many cigarettes per day do/did you usually smoke? Collection Interval: 1996-2000 +69 Cigarette smoking 307904 phv00307904.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:05:06+00:00 2018-08-16 00:05:06+00:00 LSMK_AGE In what year or how old were you when you last quit smoking? - age Collection Interval: 1996-2000 +69 Cigarette smoking 307903 phv00307903.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:05:14+00:00 2018-08-16 00:05:14+00:00 LSMK_YR In what year or how old were you when you last quit smoking? - year Collection Interval: 1996-2000 +69 Cigarette smoking 307902 phv00307902.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:05:24+00:00 2018-08-16 00:05:24+00:00 CIGARETT Do you now smoke cigarettes? Collection Interval: 1996-2000 +69 Cigarette smoking 307901 phv00307901.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:05:32+00:00 2018-08-16 00:05:32+00:00 FSMK_AGE In what year or how old were you when you first started smoking? - age Collection Interval: 1996-2000 +69 Cigarette smoking 307900 phv00307900.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:05:40+00:00 2018-08-16 00:05:40+00:00 FSMK_YR In what year or how old were you when you first started smoking? - year Collection Interval: 1996-2000 +69 Cigarette smoking 307899 phv00307899.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:05:47+00:00 2018-08-16 00:05:47+00:00 SMOKE100 Have you smoked more than 100 cigarettes in your entire life? Collection Interval: 1996-2000 +69 Cigarette smoking 308118 phv00308118.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:23:13+00:00 2018-08-16 00:23:13+00:00 AVGCIGDY On average; how many cigarettes per day do/did you usually smoke? Collection Interval: 2000-2004 +69 Cigarette smoking 308117 phv00308117.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:23:20+00:00 2018-08-16 00:23:20+00:00 LSMK_AGE In what year or how old were you when you last quit smoking? - age Collection Interval: 2000-2004 +69 Cigarette smoking 308116 phv00308116.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:23:27+00:00 2018-08-16 00:23:27+00:00 LSMK_YR In what year or how old were you when you last quit smoking? - year Collection Interval: 2000-2004 +69 Cigarette smoking 308115 phv00308115.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:23:33+00:00 2018-08-16 00:23:33+00:00 CIGARETT Do you now smoke cigarettes? Collection Interval: 2000-2004 +69 Cigarette smoking 308114 phv00308114.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:23:40+00:00 2018-08-16 00:23:40+00:00 FSMK_AGE In what year or how old were you when you first started smoking? - age Collection Interval: 2000-2004 +69 Cigarette smoking 308113 phv00308113.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:23:48+00:00 2018-08-16 00:23:48+00:00 FSMK_YR In what year or how old were you when you first started smoking? - year Collection Interval: 2000-2004 +69 Cigarette smoking 308112 phv00308112.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:23:55+00:00 2018-08-16 00:23:55+00:00 SMOKE100 Have you smoked more than 100 cigarettes in your entire life? Collection Interval: 2000-2004 +69 Cigarette smoking 112438 phv00112438.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-16 22:34:39+00:00 2018-08-16 22:34:39+00:00 A01WQUIT IF EX-SMOKER, WHEN QUIT +69 Cigarette smoking 112437 phv00112437.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-16 22:34:46+00:00 2018-08-16 22:34:46+00:00 A01TQUIT PT TRIED TO STOP SMOKING W/I PAST 2 YRS +69 Cigarette smoking 112436 phv00112436.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-16 22:34:54+00:00 2018-08-16 22:34:54+00:00 A01SMNUM # CIGARETTES SMOKED PER DAY +69 Cigarette smoking 112435 phv00112435.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-16 22:35:01+00:00 2018-08-16 22:35:01+00:00 A01SMNOW CURRENT SMOKER? +69 Cigarette smoking 112434 phv00112434.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-16 22:35:09+00:00 2018-08-16 22:35:09+00:00 A01SM100 LIFETIME CIGARETTE COMSUMPTION > 99 +69 Cigarette smoking 122542 phv00122542.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:45:53+00:00 2018-08-16 23:45:53+00:00 CIGADY Smoke >= 1 cigarette/day (C) +69 Cigarette smoking 122543 phv00122543.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:45:58+00:00 2018-08-16 23:45:58+00:00 CIGAWK Smoke >= 1 cigarette/week (C) +69 Cigarette smoking 122544 phv00122544.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:46:03+00:00 2018-08-16 23:46:03+00:00 EVERCIG Smoke >= 1 cigarette/week for a month (C) +69 Cigarette smoking 122545 phv00122545.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:46:09+00:00 2018-08-16 23:46:09+00:00 MOSSMOK Number of months have been smoking (C) +69 Cigarette smoking 122546 phv00122546.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:46:14+00:00 2018-08-16 23:46:14+00:00 NOCIGS Average number of cigarettes smoked/day (C) +69 Cigarette smoking 113174 phv00113174.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:39:01+00:00 2018-08-17 18:39:01+00:00 A09CGTDY CIGARETTES, # SMOKED/DAY. Q 2.05 +69 Cigarette smoking 113173 phv00113173.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:39:08+00:00 2018-08-17 18:39:08+00:00 A09SLS3M NEW SMOKER: STILL SMOKES? Q 2.04A +69 Cigarette smoking 113172 phv00113172.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:39:17+00:00 2018-08-17 18:39:17+00:00 A09STS3M STARTED SMOKING, PAST 3 MOS.? Q 2.04 +69 Cigarette smoking 113171 phv00113171.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:39:25+00:00 2018-08-17 18:39:25+00:00 A09SMKYR HOW MANY YRS SMOKED CIGS REG.? Q 2.03 +69 Cigarette smoking 113170 phv00113170.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:39:34+00:00 2018-08-17 18:39:34+00:00 A09SMKAG HOW OLD WHEN STARTED SMOKING? Q 2.02 +69 Cigarette smoking 113169 phv00113169.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:39:42+00:00 2018-08-17 18:39:42+00:00 A09YRSQT EX-SMOKER: HOW LONG AGO QUIT SMOKING? Q 2.01 +69 Cigarette smoking 113168 phv00113168.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:39:49+00:00 2018-08-17 18:39:49+00:00 A09SMKNW STILL SMOKES CIGARETTES REGULARLY? Q 2.01 +69 Cigarette smoking 113179 phv00113179.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:40:21+00:00 2018-08-17 18:40:21+00:00 A09CMENT CURR BRAND: MENTHOLATED/NONMENTHOLATED. Q 2.06 +69 Cigarette smoking 113178 phv00113178.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:40:29+00:00 2018-08-17 18:40:29+00:00 A09CSIZE CURR BRAND: REGULAR/KING SIZE/LONG. Q 2.06 +69 Cigarette smoking 113177 phv00113177.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:40:37+00:00 2018-08-17 18:40:37+00:00 A09CPACK CURR BRAND: SOFT/HARD PACK. Q 2.06 +69 Cigarette smoking 113176 phv00113176.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:40:46+00:00 2018-08-17 18:40:46+00:00 A09CFILT CURR BRAND: FILTERED/UNFILTERED. Q 2.06 +69 Cigarette smoking 113175 phv00113175.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:40:55+00:00 2018-08-17 18:40:55+00:00 A09CBRND CURR BRAND: NAME. Q 2.06 +69 Cigarette smoking 113189 phv00113189.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:41:30+00:00 2018-08-17 18:41:30+00:00 A09XMEN2 OLD BRAND 2: MENTHOLATED/NONMENTHOLATED. Q 2.07 +69 Cigarette smoking 113188 phv00113188.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:41:37+00:00 2018-08-17 18:41:37+00:00 A09XSIZ2 OLD BRAND 2: REGULAR/KING SIZE/LONG. Q 2.07 +69 Cigarette smoking 113187 phv00113187.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:41:45+00:00 2018-08-17 18:41:45+00:00 A09XPAC2 OLD BRAND 2: SOFT/HARD PACK. Q 2.07 +69 Cigarette smoking 113186 phv00113186.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:41:52+00:00 2018-08-17 18:41:52+00:00 A09XFIL2 OLD BRAND 2: FILTERED/UNFILTERED. Q 2.07 +69 Cigarette smoking 113185 phv00113185.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:41:59+00:00 2018-08-17 18:41:59+00:00 A09XBRN2 OLD BRAND 2: NAME. Q 2.07 +69 Cigarette smoking 113184 phv00113184.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:42:06+00:00 2018-08-17 18:42:06+00:00 A09XMEN1 OLD BRAND 1: MENTHOLATED/NONMENTHOLATED. Q 2.07 +69 Cigarette smoking 113183 phv00113183.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:42:13+00:00 2018-08-17 18:42:13+00:00 A09XSIZ1 OLD BRAND 1: REGULAR/KING SIZE/LONG. Q 2.07 +69 Cigarette smoking 113182 phv00113182.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:42:21+00:00 2018-08-17 18:42:21+00:00 A09XPAC1 OLD BRAND 1: SOFT/HARD PACK. Q 2.07 +69 Cigarette smoking 113181 phv00113181.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:42:29+00:00 2018-08-17 18:42:29+00:00 A09XFIL1 OLD BRAND 1: FILTERED/UNFILTERED. Q 2.07 +69 Cigarette smoking 113180 phv00113180.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:42:36+00:00 2018-08-17 18:42:36+00:00 A09XBRN1 OLD BRAND 1: NAME. Q 2.07 +69 Cigarette smoking 113199 phv00113199.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:43:04+00:00 2018-08-17 18:43:04+00:00 A09XMEN4 OLD BRAND 4: MENTHOLATED/NONMENTHOLATED. Q 2.07 +69 Cigarette smoking 113198 phv00113198.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:43:11+00:00 2018-08-17 18:43:11+00:00 A09XSIZ4 OLD BRAND 4: REGULAR/KING SIZE/LONG. Q 2.07 +69 Cigarette smoking 113197 phv00113197.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:43:21+00:00 2018-08-17 18:43:21+00:00 A09XPAC4 OLD BRAND 4: SOFT/HARD PACK. Q 2.07 +69 Cigarette smoking 113196 phv00113196.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:43:28+00:00 2018-08-17 18:43:28+00:00 A09XFIL4 OLD BRAND 4: FILTERED/UNFILTERED. Q 2.07 +69 Cigarette smoking 113195 phv00113195.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:43:35+00:00 2018-08-17 18:43:35+00:00 A09XBRN4 OLD BRAND 4: NAME. Q 2.07 +69 Cigarette smoking 113194 phv00113194.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:43:43+00:00 2018-08-17 18:43:43+00:00 A09XMEN3 OLD BRAND 3: MENTHOLATED/NONMENTHOLATED. Q 2.07 +69 Cigarette smoking 113193 phv00113193.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:43:50+00:00 2018-08-17 18:43:50+00:00 A09XSIZ3 OLD BRAND 3: REGULAR/KING SIZE/LONG. Q 2.07 +69 Cigarette smoking 113192 phv00113192.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:43:57+00:00 2018-08-17 18:43:57+00:00 A09XPAC3 OLD BRAND 3: SOFT/HARD PACK. Q 2.07 +69 Cigarette smoking 113191 phv00113191.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:44:06+00:00 2018-08-17 18:44:06+00:00 A09XFIL3 OLD BRAND 3: FILTERED/UNFILTERED. Q 2.07 +69 Cigarette smoking 113190 phv00113190.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:44:14+00:00 2018-08-17 18:44:14+00:00 A09XBRN3 OLD BRAND 3: NAME. Q 2.07 +69 Cigarette smoking 113202 phv00113202.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:46:05+00:00 2018-08-17 18:46:05+00:00 A09SMK5Y EXPECTS TO SMOKE IN 5 YRS? Q 2.10 +69 Cigarette smoking 113201 phv00113201.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:46:12+00:00 2018-08-17 18:46:12+00:00 A09TRYQT TRIED TO STOP SMOKING, PAST 2 YRS? Q 2.09 +69 Cigarette smoking 113210 phv00113210.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:46:39+00:00 2018-08-17 18:46:39+00:00 A09CO 1985 FTC CARBON MONOXIDE OF CURRENT BRD +69 Cigarette smoking 113209 phv00113209.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:46:46+00:00 2018-08-17 18:46:46+00:00 A09TAR 1985 FTC TAR OF CURRENT BRAND +69 Cigarette smoking 113208 phv00113208.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:46:53+00:00 2018-08-17 18:46:53+00:00 A09NIC 1985 FTC NICOTINE OF CURRENT BRAND +69 Cigarette smoking 113200 phv00113200.v2.p2 pht001572.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:49:04+00:00 2018-08-17 18:49:04+00:00 A09INHAL HOW OFTEN SMOKE INHALED? Q 2.08 +69 Cigarette smoking 123025 phv00123025.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:55:41+00:00 2018-08-17 19:55:41+00:00 smokerx Smoking: Smoker Status +69 Cigarette smoking 123026 phv00123026.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:55:49+00:00 2018-08-17 19:55:49+00:00 yrssmoke Smoking: Years smoked +69 Cigarette smoking 123027 phv00123027.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:55:59+00:00 2018-08-17 19:55:59+00:00 packyr Smoking: Average packs smoked/year +69 Cigarette smoking 113224 phv00113224.v2.p2 pht001573.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:44:53+00:00 2018-08-17 20:44:53+00:00 A10SMOKE CIGARETTE SMOKING STATUS +69 Cigarette smoking 113213 phv00113213.v2.p2 pht001573.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 20:45:02+00:00 2018-08-17 20:45:02+00:00 A10CIGS SUBJECT HAS SMOKED CIGARETTES. Q 2 +69 Cigarette smoking 114071 phv00114071.v2.p2 pht001594.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:29:33+00:00 2018-08-17 21:29:33+00:00 FY012SMK # CIGS/DAY - MON 12 +69 Cigarette smoking 114100 phv00114100.v2.p2 pht001596.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:36:06+00:00 2018-08-17 21:36:06+00:00 B02SMOKE SMOKES, DOESN'T REMEMBER, DOESN'T SMOKE. Q 1 +69 Cigarette smoking 114372 phv00114372.v2.p2 pht001602.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:54:45+00:00 2018-08-17 21:54:45+00:00 B09MENTH MENTHOLATED/NONMENTHOLATED +69 Cigarette smoking 114371 phv00114371.v2.p2 pht001602.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:54:53+00:00 2018-08-17 21:54:53+00:00 B09LNGTH REGULAR/KING-SIZE/LONG +69 Cigarette smoking 114370 phv00114370.v2.p2 pht001602.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:55:00+00:00 2018-08-17 21:55:00+00:00 B09PAKSZ SOFT/HARD PACK +69 Cigarette smoking 114369 phv00114369.v2.p2 pht001602.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:55:08+00:00 2018-08-17 21:55:08+00:00 B09FILTR FILTERED/UNFILTERED +69 Cigarette smoking 114368 phv00114368.v2.p2 pht001602.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:55:15+00:00 2018-08-17 21:55:15+00:00 B09BRAND CIGARETTE BRAND NAME +69 Cigarette smoking 226277 phv00226277.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:35:46+00:00 2018-08-22 21:35:46+00:00 EXPOSURE_YEAR Adjusted years smoked +69 Cigarette smoking 114546 phv00114546.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:14:20+00:00 2018-08-22 23:14:20+00:00 B09SLS3M BEGINNER, STILL SMOKES? Q 2.04a +69 Cigarette smoking 114545 phv00114545.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:14:27+00:00 2018-08-22 23:14:27+00:00 B09STS3M STARTED SMOKING, PAST 3 MOS.? Q 2.04 +69 Cigarette smoking 114544 phv00114544.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:14:34+00:00 2018-08-22 23:14:34+00:00 B09SMKYR HOW MANY YRS SMOKED REGULARLY? Q 2.03 +69 Cigarette smoking 114543 phv00114543.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:14:41+00:00 2018-08-22 23:14:41+00:00 B09SMKAG HOW OLD WHEN STARTED? Q 2.02 +69 Cigarette smoking 114542 phv00114542.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:14:49+00:00 2018-08-22 23:14:49+00:00 B09YRSQT IF NOT, HOW LONG QUIT? Q 2.01 +69 Cigarette smoking 114541 phv00114541.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:14:56+00:00 2018-08-22 23:14:56+00:00 B09SMKNW STILL SMOKE? Q 2.01 +69 Cigarette smoking 114550 phv00114550.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:15:26+00:00 2018-08-22 23:15:26+00:00 B09SMK5Y DO YOU EXPECT TO SMOKE IN 5 YRS? Q 2.10 +69 Cigarette smoking 114549 phv00114549.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:15:33+00:00 2018-08-22 23:15:33+00:00 B09TRYQT HAVE YOU TRIED TO STOP, PAST 2 YRS? Q 2.10 +69 Cigarette smoking 114548 phv00114548.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:15:40+00:00 2018-08-22 23:15:40+00:00 B09INHAL HOW OFTEN SMOKE INHALED? Q 2.08 +69 Cigarette smoking 114547 phv00114547.v2.p2 pht001621.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:15:47+00:00 2018-08-22 23:15:47+00:00 B09CGTDY CIGARETTES, # SMOKED/DAY. Q 2.05 +69 Cigarette smoking 114582 phv00114582.v2.p2 pht001625.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:20:42+00:00 2018-08-22 23:20:42+00:00 B10SMOKE SMOKING STATUS +69 Cigarette smoking 114581 phv00114581.v2.p2 pht001625.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:20:50+00:00 2018-08-22 23:20:50+00:00 B10EXLRG HRS/WK EXP TO SMK IN LG AREA. Q 11 +69 Cigarette smoking 114580 phv00114580.v2.p2 pht001625.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:20:57+00:00 2018-08-22 23:20:57+00:00 B10EXSML HRS/WK EXP TO SMK IN SMALL AREA. Q 10 +69 Cigarette smoking 114579 phv00114579.v2.p2 pht001625.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:21:07+00:00 2018-08-22 23:21:07+00:00 B10EXHME HRS/WK EXP TO SMK IN HOME. Q 9 +69 Cigarette smoking 114572 phv00114572.v2.p2 pht001625.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:21:15+00:00 2018-08-22 23:21:15+00:00 B10CIGS HAS SMOKED CIGARETTES. Q 2 +69 Cigarette smoking 115079 phv00115079.v2.p2 pht001640.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:47:58+00:00 2018-08-22 23:47:58+00:00 B09P_SMK SMOKE >= 10 CIG. A DAY FOR >= 1 MONTH. Q 12 +69 Cigarette smoking 115156 phv00115156.v2.p2 pht001646.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:53:54+00:00 2018-08-22 23:53:54+00:00 FY048SMK # OF CIGS/DAY - MON 48 +69 Cigarette smoking 115149 phv00115149.v2.p2 pht001646.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:54:00+00:00 2018-08-22 23:54:00+00:00 FY036SMK # OF CIGS/DAY - MON 36 +69 Cigarette smoking 115317 phv00115317.v2.p2 pht001652.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:59:41+00:00 2018-08-22 23:59:41+00:00 C02SMOKE SMOKES, DOESN'T REMEMBER, DOESN'T SMOKE. Q 1 +69 Cigarette smoking 115544 phv00115544.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:17:58+00:00 2018-08-23 17:17:58+00:00 C09UPC CIGARETTES USED - UPC CODE +69 Cigarette smoking 115551 phv00115551.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:18:05+00:00 2018-08-23 17:18:05+00:00 C09SLS3M BEGINNER, STILL SMOKES? Q Q 2.04a +69 Cigarette smoking 115550 phv00115550.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:18:12+00:00 2018-08-23 17:18:12+00:00 C09STS3M STARTED SMOKING, PAST 3 MOS.? Q 2.04 +69 Cigarette smoking 115549 phv00115549.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:18:20+00:00 2018-08-23 17:18:20+00:00 C09SMKYR HOW MANY YRS SMOKED REGULARLY? Q 2.03 +69 Cigarette smoking 115548 phv00115548.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:18:27+00:00 2018-08-23 17:18:27+00:00 C09SMKAG HOW OLD WHEN STARTED? Q 2.02 +69 Cigarette smoking 115547 phv00115547.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:18:35+00:00 2018-08-23 17:18:35+00:00 C09YRSQT IF NOT, HOW LONG QUIT? Q 2.01a +69 Cigarette smoking 115546 phv00115546.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:18:43+00:00 2018-08-23 17:18:43+00:00 C09SMKNW STILL SMOKE? Q 2.01 +69 Cigarette smoking 115545 phv00115545.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:18:51+00:00 2018-08-23 17:18:51+00:00 C09BRAND CIGARETTE BRAND NAME +69 Cigarette smoking 115558 phv00115558.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:19:28+00:00 2018-08-23 17:19:28+00:00 C09BURNW PORTION OF CIGARETTE THAT IS UNSMOKED. Q 2.08 +69 Cigarette smoking 115557 phv00115557.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:19:35+00:00 2018-08-23 17:19:35+00:00 C09BURN HOW FAR DO YOU LET CIGARETTE BURN. Q 2.07 +69 Cigarette smoking 115556 phv00115556.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:19:42+00:00 2018-08-23 17:19:42+00:00 C09MENTH MENTHOLATED/NONMENTHOLATED. Q 2.06e +69 Cigarette smoking 115555 phv00115555.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:19:49+00:00 2018-08-23 17:19:49+00:00 C09LNGTH REGULAR/KING-SIZE/LONG. Q 2.06d +69 Cigarette smoking 115554 phv00115554.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:19:56+00:00 2018-08-23 17:19:56+00:00 C09PAKSZ SOFT/HARD PACK. Q 2.06c +69 Cigarette smoking 115553 phv00115553.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:20:04+00:00 2018-08-23 17:20:04+00:00 C09FILTR FILTERED/UNFILTERED. Q 2.06b +69 Cigarette smoking 115552 phv00115552.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:20:11+00:00 2018-08-23 17:20:11+00:00 C09CGTDY CIGARETTES, # SMOKED/DAY. Q 2.05 +69 Cigarette smoking 115566 phv00115566.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:20:51+00:00 2018-08-23 17:20:51+00:00 C09OTHER QUIT ATTEMPT: OTHER. Q 2.12 +69 Cigarette smoking 115565 phv00115565.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:20:58+00:00 2018-08-23 17:20:58+00:00 C09COLDT QUIT ATTEMPT: COLD TURKEY. Q 2.12 +69 Cigarette smoking 115564 phv00115564.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:21:04+00:00 2018-08-23 17:21:04+00:00 C09HELP QUIT ATTEMPT: SOUGHT PROFESSIONAL HELP. Q 2.12 +69 Cigarette smoking 115563 phv00115563.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:21:11+00:00 2018-08-23 17:21:11+00:00 C09CUTDN QUIT ATTEMPT: REDUCED # OF CIGS SMOKED. Q 2.12 +69 Cigarette smoking 115562 phv00115562.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:21:18+00:00 2018-08-23 17:21:18+00:00 C09LONG LONGEST ATTEMPT TO QUIT. Q 2.11 +69 Cigarette smoking 115561 phv00115561.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:21:26+00:00 2018-08-23 17:21:26+00:00 C09ATTMP HOW MANY ATTEMPTS TO QUIT >= 48 HRS. Q 2.10 +69 Cigarette smoking 115560 phv00115560.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:21:32+00:00 2018-08-23 17:21:32+00:00 C09TRYQT TRIED TO QUIT IN LAST 3 YEARS. Q 2.10 +69 Cigarette smoking 115559 phv00115559.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:21:39+00:00 2018-08-23 17:21:39+00:00 C09FSTCG HOW SOON SMOKE AFTER WAKING. Q 2.09 +69 Cigarette smoking 115573 phv00115573.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:22:14+00:00 2018-08-23 17:22:14+00:00 C09WORK REASON QUIT -WORK POLICY. Q 2.13g +69 Cigarette smoking 115572 phv00115572.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:22:21+00:00 2018-08-23 17:22:21+00:00 C09EXPEN REASON QUIT -EXPENSE OF HABIT. Q 2.13f +69 Cigarette smoking 115571 phv00115571.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:22:28+00:00 2018-08-23 17:22:28+00:00 C09TIRED REASON QUIT -TIRED OF HABIT. Q 2.13e +69 Cigarette smoking 115570 phv00115570.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:22:34+00:00 2018-08-23 17:22:34+00:00 C09FAMIL REASON QUIT -FAMILY/FRIENDS SUGGESTED. Q 2.13d +69 Cigarette smoking 115569 phv00115569.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:22:41+00:00 2018-08-23 17:22:41+00:00 C09PREGN REASON QUIT -PREG OR RECENT BIRTH. Q 2.13c +69 Cigarette smoking 115568 phv00115568.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:22:48+00:00 2018-08-23 17:22:48+00:00 C09CONCE REASON QUIT -HEALTH CONCERN. Q 2.13b +69 Cigarette smoking 115567 phv00115567.v2.p2 pht001664.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:22:55+00:00 2018-08-23 17:22:55+00:00 C09DOCTR REASON QUIT -MD RECOMMENDED. Q 2.13a +69 Cigarette smoking 115592 phv00115592.v2.p2 pht001665.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:25:51+00:00 2018-08-23 17:25:51+00:00 C10SMOKE SMOKING STATUS +69 Cigarette smoking 115582 phv00115582.v2.p2 pht001665.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:25:58+00:00 2018-08-23 17:25:58+00:00 C10CIGS HAS SMOKED CIGARETTES. Q 2 +69 Cigarette smoking 116285 phv00116285.v2.p2 pht001686.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 18:56:48+00:00 2018-08-23 18:56:48+00:00 C42BSMOK SMOKED SINCE LAST CUFF INFLATION? +69 Cigarette smoking 116413 phv00116413.v2.p2 pht001701.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:20:40+00:00 2018-08-23 19:20:40+00:00 FY072SMK # OF CIGS/DAY - MON 72 +69 Cigarette smoking 116540 phv00116540.v2.p2 pht001707.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 21:37:16+00:00 2018-08-23 21:37:16+00:00 D02SMOKE SMOKES, DOESN'T REMEMBER, DOESN'T SMOKE. Q 1 +69 Cigarette smoking 117147 phv00117147.v2.p2 pht001717.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:25:04+00:00 2018-08-24 00:25:04+00:00 D10SMOKE SMOKING STATUS +69 Cigarette smoking 117136 phv00117136.v2.p2 pht001717.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:25:11+00:00 2018-08-24 00:25:11+00:00 D10CIGS HAS SMOKED CIGARETTES. Q 2 +69 Cigarette smoking 252990 phv00252990.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:13:52+00:00 2018-08-24 17:13:52+00:00 current_smoker_baseline Current smoking status of participant at baseline visit +69 Cigarette smoking 117533 phv00117533.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:46:47+00:00 2018-08-24 22:46:47+00:00 D09PAKSZ SOFT/HARD PACK. Q 2.04c +69 Cigarette smoking 117532 phv00117532.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:46:53+00:00 2018-08-24 22:46:53+00:00 D09FILTR FILTERED/UNFILTERED. Q 2.04b +69 Cigarette smoking 117531 phv00117531.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:47:00+00:00 2018-08-24 22:47:00+00:00 D09CGTDY CIGARETTES, # SMOKED/DAY. Q 2.03 +69 Cigarette smoking 117530 phv00117530.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:47:08+00:00 2018-08-24 22:47:08+00:00 D09SLS3M BEGINNER, STILL SMOKES? Q 2.02a +69 Cigarette smoking 117529 phv00117529.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:47:15+00:00 2018-08-24 22:47:15+00:00 D09STS3M STARTED SMOKING, PAST 3 MOS.? Q 2.02 +69 Cigarette smoking 117528 phv00117528.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:47:23+00:00 2018-08-24 22:47:23+00:00 D09SMKNW STILL SMOKE? Q 1.01 +69 Cigarette smoking 117527 phv00117527.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:47:30+00:00 2018-08-24 22:47:30+00:00 D09BRAND CIGARETTE BRAND NAME +69 Cigarette smoking 117526 phv00117526.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:47:37+00:00 2018-08-24 22:47:37+00:00 D09UPC CIGARETTES USED - UPC CODE +69 Cigarette smoking 117537 phv00117537.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:50:46+00:00 2018-08-24 22:50:46+00:00 D09ATTMP HOW MANY ATTEMPTS TO QUIT >= 48 HRS. Q 2.05 +69 Cigarette smoking 117536 phv00117536.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:50:55+00:00 2018-08-24 22:50:55+00:00 D09TRYQT TRIED TO QUIT IN LAST 2 YEARS. Q 2.05 +69 Cigarette smoking 117535 phv00117535.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:51:02+00:00 2018-08-24 22:51:02+00:00 D09MENTH MENTHOLATED/NONMENTHOLATED. Q 2.04e +69 Cigarette smoking 117534 phv00117534.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:51:10+00:00 2018-08-24 22:51:10+00:00 D09LNGTH REGULAR/KING-SIZE/LONG. Q 2.04d +69 Cigarette smoking 117545 phv00117545.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:51:20+00:00 2018-08-24 22:51:20+00:00 D09SPEND EVER SPENT MONEY TO QUIT SMOKING. Q 2.09 +69 Cigarette smoking 117544 phv00117544.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:51:27+00:00 2018-08-24 22:51:27+00:00 D09ATTND EVER PARTICIPATED IN CESSATION PROGRAM. Q 2.08 +69 Cigarette smoking 117925 phv00117925.v2.p2 pht001749.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-27 23:09:55+00:00 2018-08-27 23:09:55+00:00 FY096SMK # OF CIGS/DAY - MON 96 +69 Cigarette smoking 118268 phv00118268.v2.p2 pht001757.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:38:07+00:00 2018-08-28 22:38:07+00:00 E02SMOKE SMOKED IN PAST 24 HOURS? Q 1 +69 Cigarette smoking 118744 phv00118744.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:26:02+00:00 2018-08-28 23:26:02+00:00 E09STS3M STARTED SMOKING, PAST 3 MOS? Q 2.02 +69 Cigarette smoking 118743 phv00118743.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:26:09+00:00 2018-08-28 23:26:09+00:00 E09QTFRQ HOW LONG SINCE SMOKED REG - UNIT. Q 2.01a +69 Cigarette smoking 118742 phv00118742.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:26:16+00:00 2018-08-28 23:26:16+00:00 E09QTNUM HOW LONG SINCE SMOKED REG - NUMBER. Q 2.01a +69 Cigarette smoking 118741 phv00118741.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:26:22+00:00 2018-08-28 23:26:22+00:00 E09SMKNW STILL SMOKE? Q 2.01 +69 Cigarette smoking 118740 phv00118740.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:26:28+00:00 2018-08-28 23:26:28+00:00 E09BRAND CIGARETTE BRAND NAME +69 Cigarette smoking 118739 phv00118739.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:26:34+00:00 2018-08-28 23:26:34+00:00 E09UPC CIGARETTES USED - UPC CODE +69 Cigarette smoking 118758 phv00118758.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:27:55+00:00 2018-08-28 23:27:55+00:00 E09QUIT HOW INTERESTED IN QUITTING SMOKING. Q 2.08 +69 Cigarette smoking 118753 phv00118753.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:02+00:00 2018-08-28 23:28:02+00:00 E09ATTMP HOW MANY ATTEMPTS TO QUIT >= 48 HRS. Q 206 +69 Cigarette smoking 118752 phv00118752.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:09+00:00 2018-08-28 23:28:09+00:00 E09TRYQT TRIED TO QUIT IN PAST 3 YRS. Q 2.06 +69 Cigarette smoking 118751 phv00118751.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:16+00:00 2018-08-28 23:28:16+00:00 E09MENTH MENTHOLATED/NONMENTHOLATED. Q 2.05e +69 Cigarette smoking 118750 phv00118750.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:23+00:00 2018-08-28 23:28:23+00:00 E09LNGTH REGULAR/KING-SIZE/LONG. Q 2.05d +69 Cigarette smoking 118749 phv00118749.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:30+00:00 2018-08-28 23:28:30+00:00 E09PAKSZ SOFT/HARD PACK. Q 2.05c +69 Cigarette smoking 118748 phv00118748.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:36+00:00 2018-08-28 23:28:36+00:00 E09FILTR FILTERED/UNFILTERED. Q 2.05b +69 Cigarette smoking 118747 phv00118747.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:44+00:00 2018-08-28 23:28:44+00:00 E09SMKDY SMOKE EVERY DAY. Q 2.04 +69 Cigarette smoking 118746 phv00118746.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:51+00:00 2018-08-28 23:28:51+00:00 E09CGTDY CIGARETTES, # SMOKED/DAY. Q 2.03 +69 Cigarette smoking 118745 phv00118745.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:28:58+00:00 2018-08-28 23:28:58+00:00 E09SLS3M BEGINNER, STILL SMOKES? Q 2.02a +69 Cigarette smoking 118765 phv00118765.v2.p2 pht001778.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:32:45+00:00 2018-08-28 23:32:45+00:00 E10CIGS HAS SMOKED CIGARETTES. Q 2 +69 Cigarette smoking 118780 phv00118780.v2.p2 pht001778.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:33:07+00:00 2018-08-28 23:33:07+00:00 E10SMOKE SMOKING STATUS +69 Cigarette smoking 118757 phv00118757.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:15:49+00:00 2018-08-29 20:15:49+00:00 E09CHGOT PLAN TO MAKE OTHER CHANGES IN NEXT 6 MOS. Q 2.07 +69 Cigarette smoking 118756 phv00118756.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:15:56+00:00 2018-08-29 20:15:56+00:00 E09CHGLO PLAN TO CHANGE TO LOW TAR IN NEXT 6 MOS. Q 2.07 +69 Cigarette smoking 118755 phv00118755.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:16:04+00:00 2018-08-29 20:16:04+00:00 E09CHGNO PLAN TO CUT DOWN IN NEXT 6 MOS. Q 2.07 +69 Cigarette smoking 118754 phv00118754.v2.p2 pht001777.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:16:11+00:00 2018-08-29 20:16:11+00:00 E09CHGQT PLAN TO QUIT SMOKING IN NEXT 6 MOS. Q 2.07 +69 Cigarette smoking 117543 phv00117543.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:16:53+00:00 2018-08-29 20:16:53+00:00 D09AWARE AWARE OF CESSATION PGMS IN COMMUNITY. Q 2.08 +69 Cigarette smoking 117542 phv00117542.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:17:00+00:00 2018-08-29 20:17:00+00:00 D09QUIT HOW INTERESTED IN QUITTING SMOKING. 2,07 +69 Cigarette smoking 117541 phv00117541.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:17:07+00:00 2018-08-29 20:17:07+00:00 D09CHGOT PLAN TO MAKE OTHER CHANGES IN NEXT 6 MOS. Q 2.06 +69 Cigarette smoking 117540 phv00117540.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:17:15+00:00 2018-08-29 20:17:15+00:00 D09CHGLO PLAN TO CHANGE TO LOW TAR IN NEXT 6 MOS. Q 2.06 +69 Cigarette smoking 117539 phv00117539.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:17:22+00:00 2018-08-29 20:17:22+00:00 D09CHGNO PLAN TO CUT DOWN IN NEXT 6 MOS. Q 2.06 +69 Cigarette smoking 117538 phv00117538.v2.p2 pht001735.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:17:30+00:00 2018-08-29 20:17:30+00:00 D09CHGQT PLAN TO QUIT SMOKING IN NEXT 6 MOS. Q 2.06 +69 Cigarette smoking 119523 phv00119523.v2.p2 pht001795.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:58:22+00:00 2018-08-29 20:58:22+00:00 E53CIGN # OF CIGS IN PAST 24 HRS +69 Cigarette smoking 119522 phv00119522.v2.p2 pht001795.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:58:30+00:00 2018-08-29 20:58:30+00:00 E53CIG24 SMOKED IN PAST 24 HRS? +69 Cigarette smoking 119694 phv00119694.v2.p2 pht001808.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:05:14+00:00 2018-08-29 21:05:14+00:00 F02SMOKE SMOKED IN PAST 24 HOURS? Q 1 +69 Cigarette smoking 120046 phv00120046.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:25:58+00:00 2018-08-29 21:25:58+00:00 F09FILTR FILTERED/UNFILTERED. Q 2.05 +69 Cigarette smoking 120045 phv00120045.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:26:05+00:00 2018-08-29 21:26:05+00:00 F09SMKDY SMOKE EVERY DAY. Q 2.04 +69 Cigarette smoking 120044 phv00120044.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:26:11+00:00 2018-08-29 21:26:11+00:00 F09SLS3M BEGINNER, STILL SMOKES? Q 2.02a +69 Cigarette smoking 120043 phv00120043.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:26:17+00:00 2018-08-29 21:26:17+00:00 F09QTFRQ HOW LONG SINCE SMOKED REG - UNIT. q 2.01a +69 Cigarette smoking 120042 phv00120042.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:26:23+00:00 2018-08-29 21:26:23+00:00 F09QTNUM HOW LONG SINCE SMOKED REG - NUMBER. Q 2.01a +69 Cigarette smoking 120041 phv00120041.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:26:31+00:00 2018-08-29 21:26:31+00:00 F09CGTDY CIGARETTES, # SMOKED/DAY. Q 2.03 +69 Cigarette smoking 120040 phv00120040.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:26:37+00:00 2018-08-29 21:26:37+00:00 F09STS3M STARTED SMOKING, PAST 3 MOS? Q 2.02 +69 Cigarette smoking 120039 phv00120039.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:26:44+00:00 2018-08-29 21:26:44+00:00 F09SMKNW STILL SMOKE? Q 2.01 +69 Cigarette smoking 120062 phv00120062.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:27:31+00:00 2018-08-29 21:27:31+00:00 F09CHNGS SPECIFIED OTHER PLANNED CHANGES. Q 2.07 +69 Cigarette smoking 120057 phv00120057.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:27:38+00:00 2018-08-29 21:27:38+00:00 F09QUIT HOW INTERESTED IN QUITTING SMOKING. Q 2.08 +69 Cigarette smoking 120056 phv00120056.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:27:44+00:00 2018-08-29 21:27:44+00:00 F09CHGOT PLAN TO MAKE OTHER CHANGES. Q 2.07 +69 Cigarette smoking 120055 phv00120055.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:27:51+00:00 2018-08-29 21:27:51+00:00 F09CHGLO PLAN TO CHANGE TO LOW TAR CIGARETTE. Q 2.07 +69 Cigarette smoking 120054 phv00120054.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:27:58+00:00 2018-08-29 21:27:58+00:00 F09CHGNO PLAN TO CUT DOWN NUMBER OF CIGARET. Q 2.07 +69 Cigarette smoking 120053 phv00120053.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:28:05+00:00 2018-08-29 21:28:05+00:00 F09CHGQT PLAN TO QUIT SMOKING COMPLETELY. Q 2.07 +69 Cigarette smoking 120052 phv00120052.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:28:12+00:00 2018-08-29 21:28:12+00:00 F09CIGDY ON SMOKE DAYS, HOW MANY CIGARETTES. Q 2.04b +69 Cigarette smoking 120051 phv00120051.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:28:19+00:00 2018-08-29 21:28:19+00:00 F09SMK30 SMOKED ON HOW MANY DAYS IN PAST 30. Q 2.04a +69 Cigarette smoking 120050 phv00120050.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:28:25+00:00 2018-08-29 21:28:25+00:00 F09ATTMP HOW MANY ATTEMPTS TO QUIT >= 48 HRS +69 Cigarette smoking 120049 phv00120049.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:28:32+00:00 2018-08-29 21:28:32+00:00 F09TRYQT TRIED TO QUIT IN PAST 5 YRS. Q 2.06 +69 Cigarette smoking 120048 phv00120048.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:28:40+00:00 2018-08-29 21:28:40+00:00 F09MENTH MENTHOLATED/NONMENTHOLATED. Q 2.05c +69 Cigarette smoking 120047 phv00120047.v2.p2 pht001817.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:28:47+00:00 2018-08-29 21:28:47+00:00 F09LNGTH REGULAR/KING-SIZE/LONG. Q 2.05b +69 Cigarette smoking 120080 phv00120080.v2.p2 pht001818.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:29:58+00:00 2018-08-29 22:29:58+00:00 F10SMOKE SMOKING STATUS +69 Cigarette smoking 120065 phv00120065.v2.p2 pht001818.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:30:14+00:00 2018-08-29 22:30:14+00:00 F10CIGS HAS SMOKED CIGARETTES. Q 2 +69 Cigarette smoking 120700 phv00120700.v2.p2 pht001850.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:11:25+00:00 2018-08-29 23:11:25+00:00 FHL111A NUMBER OF CIGARETTES +69 Cigarette smoking 120699 phv00120699.v2.p2 pht001850.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:11:31+00:00 2018-08-29 23:11:31+00:00 FHL111 DID YOU SMOKE CIGARETTES +69 Cigarette smoking 121173 phv00121173.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:20:04+00:00 2018-08-30 00:20:04+00:00 py15 Pack-years @year 15 +69 Cigarette smoking 121172 phv00121172.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:20:11+00:00 2018-08-30 00:20:11+00:00 py10 Pack-years @year 10 +69 Cigarette smoking 121171 phv00121171.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:20:17+00:00 2018-08-30 00:20:17+00:00 py7 Pack-years @year 7 +69 Cigarette smoking 121170 phv00121170.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:20:24+00:00 2018-08-30 00:20:24+00:00 py5 Pack-years @year 5 +69 Cigarette smoking 121169 phv00121169.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:20:31+00:00 2018-08-30 00:20:31+00:00 py2 Pack-years @year 2 +69 Cigarette smoking 121168 phv00121168.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:20:37+00:00 2018-08-30 00:20:37+00:00 py0 Pack-years @year 0 +69 Cigarette smoking 121179 phv00121179.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:20:53+00:00 2018-08-30 00:20:53+00:00 ltsmk15 Lifetime pack-years of cigarettes smoked @year 15 +69 Cigarette smoking 121178 phv00121178.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:21:00+00:00 2018-08-30 00:21:00+00:00 ltsmk10 Lifetime pack-years of cigarettes smoked @year 10 +69 Cigarette smoking 121177 phv00121177.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:21:06+00:00 2018-08-30 00:21:06+00:00 ltsmk7 Lifetime pack-years of cigarettes smoked @year 7 +69 Cigarette smoking 121176 phv00121176.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:21:13+00:00 2018-08-30 00:21:13+00:00 ltsmk5 Lifetime pack-years of cigarettes smoked @year 5 +69 Cigarette smoking 121175 phv00121175.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:21:20+00:00 2018-08-30 00:21:20+00:00 ltsmk2 Lifetime pack-years of cigarettes smoked @year 2 +69 Cigarette smoking 121174 phv00121174.v2.p2 pht001866.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:21:27+00:00 2018-08-30 00:21:27+00:00 ltsmk0 Lifetime pack-years of cigarettes smoked @year 0 +69 Cigarette smoking 121256 phv00121256.v2.p2 pht001868.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:23:28+00:00 2018-08-30 00:23:28+00:00 ltsmk0 Lifetime pack-years of cigarettes smoked @year 0 +69 Cigarette smoking 258705 phv00258705.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:35:29+00:00 2018-09-06 12:35:29+00:00 Current_smoke Current Smoker +69 Cigarette smoking 258706 phv00258706.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:36:13+00:00 2018-09-06 12:36:13+00:00 Age_smoking Age Started Smoking (years) +69 Cigarette smoking 258707 phv00258707.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:37:11+00:00 2018-09-06 12:37:11+00:00 Length_sm_years Length of time smoking (years) +69 Cigarette smoking 258708 phv00258708.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:37:27+00:00 2018-09-06 12:37:27+00:00 Length_sm_months Length of time smoking (months) +69 Cigarette smoking 258709 phv00258709.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:38:22+00:00 2018-09-06 12:38:22+00:00 Man_cigarettes Number of manufactured cigarettes per day +69 Cigarette smoking 258710 phv00258710.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:38:35+00:00 2018-09-06 12:38:35+00:00 Hand_cigarettes Number of hand-rolled cigarettes per day +69 Cigarette smoking 258713 phv00258713.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:38:49+00:00 2018-09-06 12:38:49+00:00 Past_smoker Past Smoker +69 Cigarette smoking 258714 phv00258714.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:39:03+00:00 2018-09-06 12:39:03+00:00 Age_Quit Age Quit Smoking +69 Cigarette smoking 258715 phv00258715.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:42:12+00:00 2018-09-06 12:42:12+00:00 Length_Quit_Years Length of time since Quitting (years) +69 Cigarette smoking 258716 phv00258716.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:42:25+00:00 2018-09-06 12:42:25+00:00 Length_Quit_Months Length of time since Quitting (months) +69 Cigarette smoking 267374 phv00267374.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:13:13+00:00 2018-09-06 13:13:13+00:00 ever_Smoker Ever smoked +69 Cigarette smoking 267375 phv00267375.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:13:37+00:00 2018-09-06 13:13:37+00:00 Current_Smoker Current smoking status +69 Cigarette smoking 267376 phv00267376.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:13:47+00:00 2018-09-06 13:13:47+00:00 former_Smoker Former smoking status +69 Cigarette smoking 267377 phv00267377.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:13:56+00:00 2018-09-06 13:13:56+00:00 packyrs Packs of cigarettes smoked per day multiplied by years of cigarette smoking, calculated at specified visit +69 Cigarette smoking 267378 phv00267378.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:14:05+00:00 2018-09-06 13:14:05+00:00 cigsperday Number of cigarettes smoked per day +69 Cigarette smoking 267379 phv00267379.v2.p1 pht005248.v2.p1 phs000988.v2.p1 NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica 988 2 2018-09-06 13:14:16+00:00 2018-09-06 13:14:16+00:00 cigsperday_average Number of cigarettes smoked per day, averaged over all years of smoking +69 Cigarette smoking 259394 phv00259394.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-09-06 13:25:24+00:00 2018-09-06 13:25:24+00:00 smoke Smoking status at index date +69 Cigarette smoking 121874 phv00121874.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:57:07+00:00 2018-09-07 15:57:07+00:00 smoking Ever smoked (never, former, current) +69 Cigarette smoking 77460 phv00077460.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:08:05+00:00 2018-09-21 16:08:05+00:00 LWPSMKNG_3 Smoking to lose weight +69 Cigarette smoking 77918 phv00077918.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:08:22+00:00 2018-09-21 16:08:22+00:00 LWPSMKNG_6 5lbs on purpose/Started, increased smoking +69 Cigarette smoking 79571 phv00079571.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:08:59+00:00 2018-09-21 16:08:59+00:00 LWGTSMK Lost weight by increasing smoking +69 Cigarette smoking 78775 phv00078775.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:09:25+00:00 2018-09-21 16:09:25+00:00 SMOKAGE Age started smoking cigarettes regularly +69 Cigarette smoking 78777 phv00078777.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:09:49+00:00 2018-09-21 16:09:49+00:00 QSMOKAGE Age quit smoking regularly +69 Cigarette smoking 78778 phv00078778.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:10:28+00:00 2018-09-21 16:10:28+00:00 QSMOKHP Quit smoking because of health problems +69 Cigarette smoking 78825 phv00078825.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:11:07+00:00 2018-09-21 16:11:07+00:00 SMOKING Smoking status +69 Cigarette smoking 282910 phv00282910.v1.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:11:34+00:00 2018-09-21 16:11:34+00:00 PACKYRS Pack years of smoking +69 Cigarette smoking 282911 phv00282911.v1.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:11:41+00:00 2018-09-21 16:11:41+00:00 PACKYRSC Pack years of smoking (categorical) +69 Cigarette smoking 77559 phv00077559.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:13:02+00:00 2018-09-21 16:13:02+00:00 SMOKENW_3 Smoke cigarettes now +69 Cigarette smoking 77704 phv00077704.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:13:12+00:00 2018-09-21 16:13:12+00:00 SMOKENW_4 Smoke cigarettes now +69 Cigarette smoking 77811 phv00077811.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:13:20+00:00 2018-09-21 16:13:20+00:00 SMOKENW_5 Smoke cigarettes now +69 Cigarette smoking 77961 phv00077961.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:13:30+00:00 2018-09-21 16:13:30+00:00 SMOKENW_6 Smoke cigarettes now +69 Cigarette smoking 78123 phv00078123.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:13:39+00:00 2018-09-21 16:13:39+00:00 SMOKENW_7 Smoke cigarettes now +69 Cigarette smoking 78247 phv00078247.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:13:48+00:00 2018-09-21 16:13:48+00:00 SMOKENW_8 Smoke cigarettes now +69 Cigarette smoking 78774 phv00078774.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:13:56+00:00 2018-09-21 16:13:56+00:00 SMOKEVR Smoked at least 100 cigarettes ever +69 Cigarette smoking 79634 phv00079634.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:14:05+00:00 2018-09-21 16:14:05+00:00 SMOKENW Smoke cigarettes now +69 Cigarette smoking 283507 phv00283507.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:14:13+00:00 2018-09-21 16:14:13+00:00 SMOKERHX F136 History of current smoker +69 Cigarette smoking 77560 phv00077560.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:15:03+00:00 2018-09-21 16:15:03+00:00 CIGSDAY_3 How many cigarettes/day +69 Cigarette smoking 77705 phv00077705.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:15:10+00:00 2018-09-21 16:15:10+00:00 CIGSDAY_4 Cigarettes per day +69 Cigarette smoking 77812 phv00077812.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:15:19+00:00 2018-09-21 16:15:19+00:00 CIGSDAY_5 Cigarettes per day +69 Cigarette smoking 77962 phv00077962.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:15:30+00:00 2018-09-21 16:15:30+00:00 CIGSDAY_6 How many cigarette per day +69 Cigarette smoking 78124 phv00078124.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:15:39+00:00 2018-09-21 16:15:39+00:00 CIGSDAY_7 How many cigarette per day +69 Cigarette smoking 78248 phv00078248.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:15:48+00:00 2018-09-21 16:15:48+00:00 CIGSDAY_8 Cigarettes per day +69 Cigarette smoking 78779 phv00078779.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:15:57+00:00 2018-09-21 16:15:57+00:00 CIGSDAY Smoke or smoked, cigarettes/day +69 Cigarette smoking 78848 phv00078848.v6.p3 pht001004.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:16:07+00:00 2018-09-21 16:16:07+00:00 CIGSDAY How many cigarettes per day +69 Cigarette smoking 79635 phv00079635.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:16:15+00:00 2018-09-21 16:16:15+00:00 CIGSDAY Smoke, cigs/day +69 Cigarette smoking 282993 phv00282993.v1.p3 pht006214.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:16:25+00:00 2018-09-21 16:16:25+00:00 CIGSDAY Cigarettes per day +69 Cigarette smoking 79636 phv00079636.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:51:23+00:00 2018-09-21 16:51:23+00:00 CIGFILTR Type of filter on cigarette +69 Cigarette smoking 79637 phv00079637.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:51:47+00:00 2018-09-21 16:51:47+00:00 CIGTAR Type of tar and nicotine cigarette +69 Cigarette smoking 79638 phv00079638.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:52:41+00:00 2018-09-21 16:52:41+00:00 CIGSIZE Size cigarette usually smoked +69 Cigarette smoking 78781 phv00078781.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:53:52+00:00 2018-09-21 16:53:52+00:00 SMOKWGT Smoked to lose weight +69 Cigarette smoking 78780 phv00078780.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 16:58:24+00:00 2018-09-21 16:58:24+00:00 SMOKYRS Years a regular smoker +69 Cigarette smoking 78776 phv00078776.v6.p3 pht001003.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:04:48+00:00 2018-09-21 23:04:48+00:00 SMOKNOW Smoke cigarettes now +69 Cigarette smoking 98844 phv00098844.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:28:19+00:00 2018-09-27 17:28:19+00:00 SMOKE101 SMOKED IN LIFETIME +69 Cigarette smoking 98845 phv00098845.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:28:30+00:00 2018-09-27 17:28:30+00:00 SMOKE201 SMOKED CIGARETTES LAST 30 DAYS +69 Cigarette smoking 99155 phv00099155.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:28:40+00:00 2018-09-27 17:28:40+00:00 SMOKE08 EVER SMOKED MORE THAN 100 CIGARETTES +69 Cigarette smoking 99445 phv00099445.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:28:51+00:00 2018-09-27 17:28:51+00:00 SMOKE SMOKING STATUS +69 Cigarette smoking 100466 phv00100466.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:29:04+00:00 2018-09-27 17:29:04+00:00 SMOKE SMOKING STATUS +69 Cigarette smoking 101622 phv00101622.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:29:32+00:00 2018-09-27 17:29:32+00:00 SMOKE59 CURRENT SMOKING STATUS +69 Cigarette smoking 102802 phv00102802.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:29:45+00:00 2018-09-27 17:29:45+00:00 SMOKE59 CURRENT SMOKING STATUS +69 Cigarette smoking 104378 phv00104378.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:29:57+00:00 2018-09-27 17:29:57+00:00 SMOKE Smoking status +69 Cigarette smoking 105010 phv00105010.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:30:20+00:00 2018-09-27 17:30:20+00:00 SMOKE Calculated smoking status at year 4 +69 Cigarette smoking 105143 phv00105143.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:30:32+00:00 2018-09-27 17:30:32+00:00 SMOKE101 SMOKED IN LIFETIME +69 Cigarette smoking 105144 phv00105144.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:30:42+00:00 2018-09-27 17:30:42+00:00 SMOKE201 SMOKED CIGARETTES LAST 30 DAYS +69 Cigarette smoking 105886 phv00105886.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:30:56+00:00 2018-09-27 17:30:56+00:00 SMOKE SMOKING STATUS +69 Cigarette smoking 106196 phv00106196.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:31:06+00:00 2018-09-27 17:31:06+00:00 SMOKE58 EVER SMOKED MORE THAN 100 CIGARETTES +69 Cigarette smoking 107229 phv00107229.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:31:31+00:00 2018-09-27 17:31:31+00:00 SMOKE29 CURRENT SMOKING STATUS +69 Cigarette smoking 108097 phv00108097.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:31:50+00:00 2018-09-27 17:31:50+00:00 SMOKE59 CURRENT SMOKING STATUS +69 Cigarette smoking 108732 phv00108732.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:32:00+00:00 2018-09-27 17:32:00+00:00 SMOKE59 CURRENT SMOKING STATUS +69 Cigarette smoking 109464 phv00109464.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:32:14+00:00 2018-09-27 17:32:14+00:00 SMOKE59 CURRENT SMOKING STATUS +69 Cigarette smoking 110131 phv00110131.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:32:25+00:00 2018-09-27 17:32:25+00:00 SMOKE59 CURRENT SMOKING STATUS +69 Cigarette smoking 99446 phv00099446.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:32:59+00:00 2018-09-27 17:32:59+00:00 PKYRS PACK YEARS SMOKED +69 Cigarette smoking 100467 phv00100467.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:33:08+00:00 2018-09-27 17:33:08+00:00 PKYRS PACK YEARS SMOKED +69 Cigarette smoking 105892 phv00105892.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:33:17+00:00 2018-09-27 17:33:17+00:00 PKYRS PACK YEARS SMOKED +69 Cigarette smoking 99159 phv00099159.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:33:41+00:00 2018-09-27 17:33:41+00:00 AMOUNT08 HOW MANY DID YOU SMOKE PER DAY ON AVER (99=UNKNOWN) +69 Cigarette smoking 100341 phv00100341.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:33:50+00:00 2018-09-27 17:33:50+00:00 AMOUNT CIGS SMOKED/DAY +69 Cigarette smoking 106200 phv00106200.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:34:01+00:00 2018-09-27 17:34:01+00:00 AMOUNT58 HOW MANY DID YOU SMOKE PER DAY ON AVER. +69 Cigarette smoking 101621 phv00101621.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:37:16+00:00 2018-09-27 17:37:16+00:00 NUMCIG59 NUMBER CIGARETTES SMOKED PER DAY +69 Cigarette smoking 102801 phv00102801.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:37:25+00:00 2018-09-27 17:37:25+00:00 NUMCIG59 NUMBER CIGARETTES SMOKED PER DAY +69 Cigarette smoking 104871 phv00104871.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:37:33+00:00 2018-09-27 17:37:33+00:00 NUMCIG39 NUMBER OF CIGARETTES/DAY +69 Cigarette smoking 107228 phv00107228.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:37:45+00:00 2018-09-27 17:37:45+00:00 NUMCIG29 NUMBER CIGARETTES SMOKED PER DAY +69 Cigarette smoking 108096 phv00108096.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:37:53+00:00 2018-09-27 17:37:53+00:00 NUMCIG59 NUMBER CIGARETTES SMOKED PER DAY +69 Cigarette smoking 108731 phv00108731.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:38:07+00:00 2018-09-27 17:38:07+00:00 NUMCIG59 NUMBER CIGARETTES SMOKED PER DAY +69 Cigarette smoking 109463 phv00109463.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:38:17+00:00 2018-09-27 17:38:17+00:00 NUMCIG59 NUMBER CIGARETTES SMOKED PER DAY +69 Cigarette smoking 110130 phv00110130.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:38:26+00:00 2018-09-27 17:38:26+00:00 NUMCIG59 NUMBER CIGARETTES SMOKED PER DAY +69 Cigarette smoking 99156 phv00099156.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:43:41+00:00 2018-09-27 17:43:41+00:00 SMK3008 HAVE YOU SMOKED IN LAST 30 DAYS +69 Cigarette smoking 99157 phv00099157.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:43:51+00:00 2018-09-27 17:43:51+00:00 SMKAGE08 HOW OLD WHEN YOU STARTED TO SMOKE +69 Cigarette smoking 99334 phv00099334.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:44:01+00:00 2018-09-27 17:44:01+00:00 SMKHR11 SMOKE DURING THE PAST HOUR +69 Cigarette smoking 99477 phv00099477.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:44:11+00:00 2018-09-27 17:44:11+00:00 SMKAMT SMOKE AMOUNT +69 Cigarette smoking 100373 phv00100373.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:44:21+00:00 2018-09-27 17:44:21+00:00 SMKAMT SMOKE AMOUNT +69 Cigarette smoking 101620 phv00101620.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:44:33+00:00 2018-09-27 17:44:33+00:00 SMK3059 SMOKED CIGARETTES DURING LAST 30 DAYS +69 Cigarette smoking 102800 phv00102800.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:44:44+00:00 2018-09-27 17:44:44+00:00 SMK3059 SMOKED CIGARETTES DURING LAST 30 DAYS +69 Cigarette smoking 104287 phv00104287.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:44:56+00:00 2018-09-27 17:44:56+00:00 SMK38 SMOKED MORE THAN 100 CIGARETTES +69 Cigarette smoking 104288 phv00104288.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:45:11+00:00 2018-09-27 17:45:11+00:00 SMK3038 SMOKED CIGARETTES DURING LAST 30 DAYS +69 Cigarette smoking 104872 phv00104872.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:46:10+00:00 2018-09-27 17:46:10+00:00 SMKQIT39 QUIT SMOKING IN LAST YEAR +69 Cigarette smoking 105890 phv00105890.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:46:47+00:00 2018-09-27 17:46:47+00:00 SMKAMT SMOKE AMOUNT +69 Cigarette smoking 106197 phv00106197.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:46:57+00:00 2018-09-27 17:46:57+00:00 SMK3058 HAVE YOU SMOKED IN LAST 30 DAYS +69 Cigarette smoking 106198 phv00106198.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:47:08+00:00 2018-09-27 17:47:08+00:00 SMKAGE58 HOW OLD WHEN YOU STARTED TO SMOKE +69 Cigarette smoking 107227 phv00107227.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:47:44+00:00 2018-09-27 17:47:44+00:00 SMK3029 SMOKED CIGARETTES DURING LAST 30 DAYS +69 Cigarette smoking 108095 phv00108095.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:48:11+00:00 2018-09-27 17:48:11+00:00 SMK3059 SMOKED CIGARETTES DURING LAST 30 DAYS +69 Cigarette smoking 108730 phv00108730.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:48:32+00:00 2018-09-27 17:48:32+00:00 SMK3059 SMOKED CIGARETTES DURING LAST 30 DAYS +69 Cigarette smoking 109462 phv00109462.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:48:44+00:00 2018-09-27 17:48:44+00:00 SMK3059 SMOKED CIGARETTES DURING LAST 30 DAYS +69 Cigarette smoking 110129 phv00110129.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:48:54+00:00 2018-09-27 17:48:54+00:00 SMK3059 SMOKED CIGARETTES DURING LAST 30 DAYS +69 Cigarette smoking 197475 phv00197475.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:49:04+00:00 2018-09-27 17:49:04+00:00 agesmk15 Age started smoking? (years) +69 Cigarette smoking 197478 phv00197478.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:49:15+00:00 2018-09-27 17:49:15+00:00 smknow15 Do you now smoke cigarettes? +69 Cigarette smoking 197482 phv00197482.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:49:26+00:00 2018-09-27 17:49:26+00:00 avesmk15 How many cigarettes per day did you average over all the time you smoked? +69 Cigarette smoking 99158 phv00099158.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:49:49+00:00 2018-09-27 17:49:49+00:00 STOP08 HOW OLD WERE WHEN YOU STOPPED SMOKING (99=UNKNOWN) +69 Cigarette smoking 106199 phv00106199.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:50:30+00:00 2018-09-27 17:50:30+00:00 STOP58 HOW OLD WERE WHEN YOU STOPPED SMOKING +69 Cigarette smoking 7612 phv00007612.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 A99 SMOKES CIGARETTES +69 Cigarette smoking 7613 phv00007613.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 A100 AGE STARTED SMOKING CIGARETTES REGULARLY +69 Cigarette smoking 7614 phv00007614.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 A101 IF STOPPED, AGE STOPPED +69 Cigarette smoking 7615 phv00007615.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 A102 USUAL # OF CIGARETTES SMOKED, NOW OR EVER +69 Cigarette smoking 7736 phv00007736.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B86 SMOKING NOW +69 Cigarette smoking 7737 phv00007737.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B87 SMOKING LAST YEAR(NOT SMOKING NOW) +69 Cigarette smoking 7738 phv00007738.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B88 NO. OF CIGARETTES PER DAY +69 Cigarette smoking 7742 phv00007742.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B92 INHALES CIGARETTES +69 Cigarette smoking 7746 phv00007746.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B96 SMOKING TIME PATTERN +69 Cigarette smoking 7747 phv00007747.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B97 AGE START CIGARETTE SMOKING +69 Cigarette smoking 7748 phv00007748.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B98 MAX NO. CIGARETTES PER DAY +69 Cigarette smoking 7749 phv00007749.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B99 STOP SMOKING CIGARETTE LAST YEAR OR LONGER +69 Cigarette smoking 7750 phv00007750.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B100 NO. YEARS STOPPED SMOKING CIGARETTE +69 Cigarette smoking 7752 phv00007752.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B102 CIGARETTE RANK +69 Cigarette smoking 7994 phv00007994.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B376 EVER SMOKED CIGARETTES REGULARLY +69 Cigarette smoking 7995 phv00007995.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B377 NUMBER OF CIGARETTES SMOKED +69 Cigarette smoking 7996 phv00007996.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:04:00+00:00 2018-10-03 13:04:00+00:00 B379 CURRENT CIGARETTE SMOKING +69 Cigarette smoking 21635 phv00021635.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:05:53+00:00 2018-10-03 13:05:53+00:00 BW34 LIVE-BIRTH PREGNANCY #1: SMOKED CIGARETTES DURING THE PREGNANCY? +69 Cigarette smoking 21647 phv00021647.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:05:53+00:00 2018-10-03 13:05:53+00:00 BW47 LIVE-BIRTH PREGNANCY #2: SMOKED CIGARETTES DURING THE PREGNANCY +69 Cigarette smoking 21659 phv00021659.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:05:53+00:00 2018-10-03 13:05:53+00:00 BW60 LIVE-BIRTH PREGNANCY #3: SMOKED CIGARETTES DURING THE PREGNANCY? +69 Cigarette smoking 21671 phv00021671.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:05:53+00:00 2018-10-03 13:05:53+00:00 BW73 LIVE-BIRTH PREGNANCY #4: SMOKED CIGARETTES DURING THE PREGNANCY +69 Cigarette smoking 21683 phv00021683.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:05:53+00:00 2018-10-03 13:05:53+00:00 BW86 LIVE-BIRTH PREGNANCY #5: SMOKED CIGARETTES DURING THE PREGNANCY? +69 Cigarette smoking 24398 phv00024398.v4.p10 pht000194.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:05:53+00:00 2018-10-03 13:05:53+00:00 BR25 HAVE YOU SMOKED CIGARETTES IN THE LAST 6 HOURS? +69 Cigarette smoking 24399 phv00024399.v4.p10 pht000194.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:05:53+00:00 2018-10-03 13:05:53+00:00 BR26 IF SMOKED IN LAST 6 HOURS, HOW MANY HOURS SINCE YOUR LAST CIGARETTE? (NOTE: FOR TIME SINCE LAST CIGARETTE, BOTH BR26 AND BR27 NEED TO BE USED.) +69 Cigarette smoking 24400 phv00024400.v4.p10 pht000194.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:05:53+00:00 2018-10-03 13:05:53+00:00 BR27 IF SMOKED IN LAST 6 HOURS, HOW MANY MINUTES SINCE YOUR LAST CIGARETTE? (NOTE: FOR TIME SINCE LAST CIGARETTE, BOTH BR26 AND BR27 NEED TO BE USED.) +69 Cigarette smoking 8442 phv00008442.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:44+00:00 2018-10-03 13:07:44+00:00 C67 SMOKED CIGARETTES REGULARLY IN LAST YEAR +69 Cigarette smoking 8443 phv00008443.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:44+00:00 2018-10-03 13:07:44+00:00 C68 CIGARETTES SMOKED PER DAY +69 Cigarette smoking 8444 phv00008444.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:44+00:00 2018-10-03 13:07:44+00:00 C69 INHALED CIGARETTES +69 Cigarette smoking 8445 phv00008445.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:44+00:00 2018-10-03 13:07:44+00:00 C70 STRENGTH OF CIGARETTE +69 Cigarette smoking 8446 phv00008446.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:44+00:00 2018-10-03 13:07:44+00:00 C71 TYPE CIGARETTE +69 Cigarette smoking 8447 phv00008447.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:44+00:00 2018-10-03 13:07:44+00:00 C72 FILTER CIGARETTE +69 Cigarette smoking 8448 phv00008448.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:44+00:00 2018-10-03 13:07:44+00:00 C73 LENGTH OF CIGARETTE +69 Cigarette smoking 8449 phv00008449.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:45+00:00 2018-10-03 13:07:45+00:00 C74 HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 55254 phv00055254.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:45+00:00 2018-10-03 13:07:45+00:00 CgPkYr Lifetime cigarette smoking: pack years +69 Cigarette smoking 55319 phv00055319.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:45+00:00 2018-10-03 13:07:45+00:00 CIGDAY15 If yes to [SMKNOW15]: How many cigarettes do you smoke per day now? +69 Cigarette smoking 55405 phv00055405.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:45+00:00 2018-10-03 13:07:45+00:00 CGRTTS10 How many cigarettes 4 hours before going to sleep last night? +69 Cigarette smoking 56609 phv00056609.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:07:45+00:00 2018-10-03 13:07:45+00:00 cgpkyrdt Lifetime cigarette smoking Date +69 Cigarette smoking 277028 phv00277028.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD1 Number of cigarettes smoked per day, Exam 1 +69 Cigarette smoking 277029 phv00277029.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD2 Number of cigarettes smoked per day, Exam 2 +69 Cigarette smoking 277113 phv00277113.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD1 Number of cigarettes smoked per day, Exam 1 +69 Cigarette smoking 277114 phv00277114.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD2 Number of cigarettes smoked per day, Exam 2 +69 Cigarette smoking 277115 phv00277115.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD3 Number of cigarettes smoked per day, Exam 3 +69 Cigarette smoking 277116 phv00277116.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD4 Number of cigarettes smoked per day, Exam 4 +69 Cigarette smoking 277117 phv00277117.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD5 Number of cigarettes smoked per day, Exam 5 +69 Cigarette smoking 277118 phv00277118.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD6 Number of cigarettes smoked per day, Exam 6 +69 Cigarette smoking 277119 phv00277119.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD7 Number of cigarettes smoked per day, Exam 7 +69 Cigarette smoking 277120 phv00277120.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD8 Number of cigarettes smoked per day, Exam 8 +69 Cigarette smoking 277121 phv00277121.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:09:17+00:00 2018-10-03 13:09:17+00:00 CPD9 Number of cigarettes smoked per day, Exam 9 +69 Cigarette smoking 277032 phv00277032.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:22+00:00 2018-10-03 13:10:22+00:00 CURRSMK1 Current smoking status, Exam 1 +69 Cigarette smoking 277033 phv00277033.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:22+00:00 2018-10-03 13:10:22+00:00 CURRSMK2 Current smoking status, Exam 2 +69 Cigarette smoking 277128 phv00277128.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:22+00:00 2018-10-03 13:10:22+00:00 CURRSMK1 Current smoking status, Exam 1 +69 Cigarette smoking 277129 phv00277129.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:23+00:00 2018-10-03 13:10:23+00:00 CURRSMK2 Current smoking status, Exam 2 +69 Cigarette smoking 277130 phv00277130.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:23+00:00 2018-10-03 13:10:23+00:00 CURRSMK3 Current smoking status, Exam 3 +69 Cigarette smoking 277131 phv00277131.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:23+00:00 2018-10-03 13:10:23+00:00 CURRSMK4 Current smoking status, Exam 4 +69 Cigarette smoking 277132 phv00277132.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:23+00:00 2018-10-03 13:10:23+00:00 CURRSMK5 Current smoking status, Exam 5 +69 Cigarette smoking 277133 phv00277133.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:23+00:00 2018-10-03 13:10:23+00:00 CURRSMK6 Current smoking status, Exam 6 +69 Cigarette smoking 277134 phv00277134.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:23+00:00 2018-10-03 13:10:23+00:00 CURRSMK7 Current smoking status, Exam 7 +69 Cigarette smoking 277135 phv00277135.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:23+00:00 2018-10-03 13:10:23+00:00 CURRSMK8 Current smoking status, Exam 8 +69 Cigarette smoking 277136 phv00277136.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:10:23+00:00 2018-10-03 13:10:23+00:00 CURRSMK9 Current smoking status, Exam 9 +69 Cigarette smoking 8762 phv00008762.v6.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:11:32+00:00 2018-10-03 13:11:32+00:00 D096 BRAND OF CIGARETTE XXXXXXXX (FIRST EIGHT LETTERS OF CIGARETTE BRAND) +69 Cigarette smoking 8862 phv00008862.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:11:32+00:00 2018-10-03 13:11:32+00:00 D093 SMOKED CIGARETTES REGULARLY IN PAST YEAR +69 Cigarette smoking 8863 phv00008863.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:11:32+00:00 2018-10-03 13:11:32+00:00 D094 HOW MANY CIGARETTES DO/DID YOU SMOKE PER DAY +69 Cigarette smoking 8865 phv00008865.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:11:32+00:00 2018-10-03 13:11:32+00:00 D097 STRENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 8866 phv00008866.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:11:32+00:00 2018-10-03 13:11:32+00:00 D098 TYPE OF CIGARETTES SMOKED +69 Cigarette smoking 8867 phv00008867.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:11:32+00:00 2018-10-03 13:11:32+00:00 D099 FILTER OF CIGARETTES SMOKED +69 Cigarette smoking 8868 phv00008868.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:11:32+00:00 2018-10-03 13:11:32+00:00 D100 LENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 8869 phv00008869.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:11:32+00:00 2018-10-03 13:11:32+00:00 D101 NUMBER OF HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 9272 phv00009272.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E319 SMOKED CIGARETTES REGULARLY IN LAST YEAR +69 Cigarette smoking 9273 phv00009273.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E320 HOW MANY CIGARETTES SMOKED PER DAY +69 Cigarette smoking 9274 phv00009274.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E321 CIGARETTES - DO YOU INHALE? +69 Cigarette smoking 9275 phv00009275.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E322 CIGARETTE BRAND XXXXXXXX (FIRST EIGHT LETTERS OF CIGARETTE BRAND) +69 Cigarette smoking 9276 phv00009276.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E323 CIGARETTE-STRENGTH +69 Cigarette smoking 9277 phv00009277.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E324 CIGARETTE-TYPE +69 Cigarette smoking 9278 phv00009278.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E325 CIGARETTE-FILTER +69 Cigarette smoking 9279 phv00009279.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E326 CIGARETTE-LENGTH +69 Cigarette smoking 9280 phv00009280.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 E327 HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 250452 phv00250452.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e319 Medical History - Smoking: Smoked cigarettes regularly in last year? Collection Interval: Exam 1 +69 Cigarette smoking 250453 phv00250453.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e320 Medical History - Smoking: How many cigarettes do/did you smoke per day? Collection Interval: Exam 1 +69 Cigarette smoking 250454 phv00250454.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e321 Medical History - Smoking: Do you inhale? Collection Interval: Exam 1 +69 Cigarette smoking 250455 phv00250455.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e322 Medical History - Smoking: Cigarette brand Collection Interval: Exam 1 +69 Cigarette smoking 250456 phv00250456.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e323 Medical History - Smoking: Cigarette-strength Collection Interval: Exam 1 +69 Cigarette smoking 250457 phv00250457.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e324 Medical History - Smoking: Cigarette-type Collection Interval: Exam 1 +69 Cigarette smoking 250458 phv00250458.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e325 Medical History - Smoking: Cigarette-filter Collection Interval: Exam 1 +69 Cigarette smoking 250459 phv00250459.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e326 Medical History - Smoking: Cigarette-length Collection Interval: Exam 1 +69 Cigarette smoking 250460 phv00250460.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:16:04+00:00 2018-10-03 13:16:04+00:00 e327 Medical History - Smoking: How many hours since last cigarette? Collection Interval: Exam 1 +69 Cigarette smoking 1143 phv00001143.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 FA137 SMOKING HISTORY: SMOKES CIGARETTES NOW (1 YEAR OR MORE DURING INTERIM) +69 Cigarette smoking 1144 phv00001144.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 FA138 SMOKING HISTORY: USES FILTER +69 Cigarette smoking 1145 phv00001145.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 FA139 SMOKING HISTORY: INHALES +69 Cigarette smoking 1146 phv00001146.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 FA140 SMOKING HISTORY: PROPORTION OF CIGARETTE SMOKED +69 Cigarette smoking 9778 phv00009778.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 F288 SMOKED CIGARETTES REGULARLY IN LAST YEAR +69 Cigarette smoking 9779 phv00009779.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 F289 HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY +69 Cigarette smoking 9781 phv00009781.v6.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 F291 CIGARETTE BRAND XXXXXXXX (FIRST 8 LETTERS OF BRAND) +69 Cigarette smoking 9782 phv00009782.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 F292 STRENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 9783 phv00009783.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 F293 TYPE OF CIGARETTES SMOKED +69 Cigarette smoking 9784 phv00009784.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 F294 FILTER OF CIGARETTES SMOKED +69 Cigarette smoking 9785 phv00009785.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 F295 LENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 9786 phv00009786.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 F296 HOW MANY HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 24446 phv00024446.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 EF09 IF YES (TO EF08), HOW MANY HOURS SINCE YOUR LAST CIGARETTE? +69 Cigarette smoking 24447 phv00024447.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 EF10 IF YES (TO EF08), HOW MANY MINUTES SINCE YOUR LAST CIGARETTE? +69 Cigarette smoking 55315 phv00055315.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:18:07+00:00 2018-10-03 13:18:07+00:00 EVSMOK15 Have you ever smoked cigarettes ('ever' = at least 20 packs in lifetime)? +69 Cigarette smoking 1258 phv00001258.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FB86 INTERIM HISTORY OF SMOKING: SMOKES CIGARETTES +69 Cigarette smoking 1259 phv00001259.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FB87 INTERIM HISTORY OF SMOKING: NUMBER CIGARETTES/DAY +69 Cigarette smoking 1260 phv00001260.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FB88 INTERIM HISTORY OF SMOKING: PORTION OF CIGARETTE SMOKED +69 Cigarette smoking 1261 phv00001261.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FB89 INTERIM HISTORY OF SMOKING: USES FILTER +69 Cigarette smoking 1262 phv00001262.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FB90 INTERIM HISTORY OF SMOKING: INHALES +69 Cigarette smoking 1452 phv00001452.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FC102 INTERIM HISTORY OF SMOKING: SMOKES CIGARETTES +69 Cigarette smoking 1453 phv00001453.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FC103 INTERIM HISTORY OF SMOKING: NO. OF CIGARETTES PER DAY +69 Cigarette smoking 1454 phv00001454.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FC104 INTERIM HISTORY OF SMOKING: PORTION OF CIGARETTE SMOKED +69 Cigarette smoking 1455 phv00001455.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FC105 INTERIM HISTORY OF SMOKING: USES FILTER ON CIGARETTE +69 Cigarette smoking 1456 phv00001456.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FC106 INTERIM HISTORY OF SMOKING: INHALES CIGARETTE +69 Cigarette smoking 1636 phv00001636.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FD95 INTERIM HISTORY OF SMOKING: SMOKES CIGARETTES +69 Cigarette smoking 1637 phv00001637.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FD96 INTERIM HISTORY OF SMOKING: NUMBER OF CIGARETTES PER DAY +69 Cigarette smoking 1638 phv00001638.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FD97 INTERIM HISTORY OF SMOKING: PORTION OF CIGARETTE SMOKED +69 Cigarette smoking 1639 phv00001639.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FD98 INTERIM HISTORY OF SMOKING: USES FILTER ON CIGARETTE +69 Cigarette smoking 1640 phv00001640.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:20:29+00:00 2018-10-03 13:20:29+00:00 FD99 INTERIM HISTORY OF SMOKING: INHALES CIGARETTE +69 Cigarette smoking 1838 phv00001838.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FE108 INTERIM HISTORY OF SMOKING: AMOUNT SMOKED: CIGARETTES/DAY +69 Cigarette smoking 1843 phv00001843.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FE113 CIGARETTE SMOKING ONLY: MAXIMUM NO. OF CIGARETTES/DAY EVER SMOKED REGULARLY FOR AS LONG AS ONE YEAR +69 Cigarette smoking 1844 phv00001844.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FE114 CIGARETTE SMOKING ONLY: STOPPED SMOKING CIGARETTES FOR LAST YEAR OR LONGER +69 Cigarette smoking 1845 phv00001845.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FE115 CIGARETTE SMOKING ONLY: YEARS SINCE STOPPED SMOKING CIGARETTES +69 Cigarette smoking 1846 phv00001846.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FE116 CIGARETTE SMOKING ONLY: REASON FOR STOPPING +69 Cigarette smoking 1847 phv00001847.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FE117 CIGARETTE SMOKING ONLY: IF NOW SMOKING: PORTION OF CIGARETTE SMOKED +69 Cigarette smoking 1848 phv00001848.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FE118 CIGARETTE SMOKING ONLY: IF NOW SMOKING: USES FILTER CIGARETTES +69 Cigarette smoking 1849 phv00001849.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FE119 CIGARETTE SMOKING ONLY: IF NOW SMOKING: INHALES CIGARETTES +69 Cigarette smoking 2055 phv00002055.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FF108 INTERIM HISTORY OF SMOKING: EVER SMOKED +69 Cigarette smoking 2056 phv00002056.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FF109 INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YR. IN LAST TWO YRS. +69 Cigarette smoking 2057 phv00002057.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FF110 INTERIM HISTORY OF SMOKING: AMOUNT SMOKED: CIGARETTES/DAY +69 Cigarette smoking 2061 phv00002061.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FF114 CIGARETTE SMOKING ONLY: STOPPED SMOKING CIGARETTES FOR LAST YEAR OR LONGER +69 Cigarette smoking 2062 phv00002062.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FF115 CIGARETTE SMOKING ONLY: IF NOW SMOKING: PORTION OF CIGARETTE SMOKED +69 Cigarette smoking 2063 phv00002063.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FF116 CIGARETTE SMOKING ONLY: IF NOW SMOKING: USES FILTER CIGARETTES +69 Cigarette smoking 2064 phv00002064.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FF117 CIGARETTE SMOKING ONLY: IF NOW SMOKING: INHALES CIGARETTES +69 Cigarette smoking 2238 phv00002238.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FG104 INTERIM HISTORY OF SMOKING: AMOUNT SMOKED: CIGARETTES/DAY +69 Cigarette smoking 2242 phv00002242.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FG108 CIGARETTE SMOKING ONLY: IF NOW SMOKING: USES FILTER CIGARETTES +69 Cigarette smoking 2243 phv00002243.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:25:22+00:00 2018-10-03 13:25:22+00:00 FG109 CIGARETTE SMOKING ONLY: IF NOW SMOKING: INHALES CIGARETTES +69 Cigarette smoking 2459 phv00002459.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FH102 INTERIM HISTORY OF SMOKING: AMOUNT SMOKED: CIGARETTES/DAY +69 Cigarette smoking 2463 phv00002463.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FH106 CIGARETTE SMOKING ONLY: IF NOW SMOKING: USES FILTER CIGARETTES +69 Cigarette smoking 2464 phv00002464.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FH107 CIGARETTE SMOKING ONLY: IF NOW SMOKING: INHALES CIGARETTES +69 Cigarette smoking 2981 phv00002981.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ38 SMOKING HISTORY: EVER SMOKED CIGARETTES REGULARLY +69 Cigarette smoking 2982 phv00002982.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ39 SMOKING HISTORY: FOR CURRENT & FORMER SMOKERS: CIGARETTES/DAY SMOKED DURING MOST OF SMOKING LIFETIME +69 Cigarette smoking 2983 phv00002983.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ40 SMOKING HISTORY: NO. CIGARETTES/DAY +69 Cigarette smoking 2984 phv00002984.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ41 SMOKING HISTORY: AGE STOPPED SMOKING +69 Cigarette smoking 2985 phv00002985.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ42 SMOKING HISTORY: AGE STARTED +69 Cigarette smoking 2986 phv00002986.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ43 SMOKING HISTORY: YEARS STOPPED DURING SMOKING PERIOD +69 Cigarette smoking 2987 phv00002987.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ44 SMOKING HISTORY: INHALE +69 Cigarette smoking 2988 phv00002988.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ45 SMOKING HISTORY: USE FILTER +69 Cigarette smoking 2989 phv00002989.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ46 SMOKING HISTORY: WHAT BRAND LAST SMOKED +69 Cigarette smoking 2990 phv00002990.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ47 CODE FOR CIGARETTE CARD EDITION +69 Cigarette smoking 2991 phv00002991.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FJ48 SMOKING HISTORY: HOW MANY HOURS SINCE YOUR LAST CIGARETTE +69 Cigarette smoking 3379 phv00003379.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FK131 SMOKING HISTORY: NUMBER OF CIGARETTES SMOKED PER DAY +69 Cigarette smoking 3380 phv00003380.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FK132 SMOKING HISTORY: DOES PATIENT INHALE +69 Cigarette smoking 3381 phv00003381.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FK133 SMOKING HISTORY: WHAT BRAND DID PATIENT SMOKE +69 Cigarette smoking 3382 phv00003382.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FK134 SMOKING HISTORY: CODE BRAND +69 Cigarette smoking 3383 phv00003383.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:28:22+00:00 2018-10-03 13:28:22+00:00 FK135 SMOKING HISTORY: NUMBER OF HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 3830 phv00003830.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FL186 SMOKE CIGARETTES REGULARLY IN PAST YEAR +69 Cigarette smoking 3831 phv00003831.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FL187 HOW MANY CIGARETTES DO/DID YOU SMOKE PER DAY +69 Cigarette smoking 3833 phv00003833.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FL189 STRENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 3834 phv00003834.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FL190 TYPE OF CIGARETTES SMOKED +69 Cigarette smoking 3835 phv00003835.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FL191 FILTER OF CIGARETTES SMOKED +69 Cigarette smoking 3836 phv00003836.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FL192 LENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 3837 phv00003837.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FL193 NUMBER OF HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 4095 phv00004095.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FM235 BRAND OF CIGARETTE +69 Cigarette smoking 4273 phv00004273.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FM232 SMOKED CIGARETTES REGULARLY IN LAST YEAR +69 Cigarette smoking 4274 phv00004274.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FM233 HOW MANY CIGARETTES DO/DID YOU SMOKE PER DAY? +69 Cigarette smoking 4276 phv00004276.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FM236 STRENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 4277 phv00004277.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FM237 TYPE OF CIGARETTES SMOKED +69 Cigarette smoking 4278 phv00004278.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FM238 FILTER OF CIGARETTES SMOKED +69 Cigarette smoking 4279 phv00004279.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FM239 LENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 4280 phv00004280.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FM240 NUMBER OF HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 4537 phv00004537.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FN188 CIGARETTE BRAND XXXXXXXX FIRST EIGHT LETTERS OF CIGARETTE BRAND +69 Cigarette smoking 4683 phv00004683.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FN185 SMOKED CIGARETTES REGULARLY IN LAST YEAR +69 Cigarette smoking 4684 phv00004684.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FN186 HOW MANY CIGARETTES SMOKED PER DAY +69 Cigarette smoking 4685 phv00004685.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:30:58+00:00 2018-10-03 13:30:58+00:00 FN187 CIGARETTES - DO YOU INHALE? +69 Cigarette smoking 4686 phv00004686.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FN189 CIGARETTE-STRENGTH +69 Cigarette smoking 4687 phv00004687.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FN190 CIGARETTE-TYPE +69 Cigarette smoking 4688 phv00004688.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FN191 CIGARETTE-FILTER +69 Cigarette smoking 4689 phv00004689.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FN192 CIGARETTE-LENGTH +69 Cigarette smoking 4690 phv00004690.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FN193 HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 5033 phv00005033.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO180 SMOKED CIGARETTES REGULARLY IN LAST YEAR? +69 Cigarette smoking 5034 phv00005034.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO181 CIGARETTES - HOW MANY CIGARETTES DO/DID YOU SMOKE PER DAY? +69 Cigarette smoking 5035 phv00005035.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO182 CIGARETTES - DO YOU INHALE? +69 Cigarette smoking 5037 phv00005037.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO184 CIGARETTE-STRENGTH +69 Cigarette smoking 5038 phv00005038.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO185 CIGARETTE-TYPE +69 Cigarette smoking 5039 phv00005039.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO186 CIGARETTE-FILTER +69 Cigarette smoking 5040 phv00005040.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO187 CIGARETTE-LENGTH +69 Cigarette smoking 5041 phv00005041.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO188 HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 5036 phv00005036.v2.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:51:22+00:00 2018-10-03 13:51:22+00:00 FO183 CIGARETTE BRAND XXXXXXXX FIRST EIGHT LETTERS OF CIGARETTE BRAND +69 Cigarette smoking 5652 phv00005652.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP133 SMOKED CIGARETTES REGULARLY IN LAST YEAR +69 Cigarette smoking 5653 phv00005653.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP134 HOW MANY CIGARETTES SMOKED PER DAY +69 Cigarette smoking 5654 phv00005654.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP135 CIGARETTES - DO YOU INHALE? +69 Cigarette smoking 5655 phv00005655.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP136 CIGARETTE BRAND XXXXXXXX FIRST EIGHT LETTERS OF CIGARETTE BRAND +69 Cigarette smoking 5656 phv00005656.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP137 CIGARETTE-STRENGTH +69 Cigarette smoking 5657 phv00005657.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP138 CIGARETTE-TYPE +69 Cigarette smoking 5658 phv00005658.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP139 CIGARETTE-FILTER +69 Cigarette smoking 5659 phv00005659.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP140 CIGARETTE-LENGTH +69 Cigarette smoking 5660 phv00005660.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FP141 HOURS SINCE LAST CIGARETTE +69 Cigarette smoking 6179 phv00006179.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FQ194 SMOKED CIGARETTES REGULARLY IN LAST YEAR? +69 Cigarette smoking 6180 phv00006180.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FQ195 IF YES (TO FQ194), HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY? +69 Cigarette smoking 6525 phv00006525.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FR252 SMOKING HISTORY SMOKED CIGARETTES REGULARLY IN THE LAST YEAR? +69 Cigarette smoking 6526 phv00006526.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FR253 SMOKING HISTORY HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY? +69 Cigarette smoking 6956 phv00006956.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FS347 SMOKING: SMOKED CIGARETTES REGULARLY IN THE LAST YEAR? +69 Cigarette smoking 6957 phv00006957.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FS348 SMOKING: HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY? +69 Cigarette smoking 7388 phv00007388.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FT349 SMOKING: SMOKED CIGARETTES REGULARLY IN THE LAST YEAR? +69 Cigarette smoking 7389 phv00007389.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FT350 SMOKING: HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY? +69 Cigarette smoking 70406 phv00070406.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FU050 SMOKING: SMOKED CIGARETTES REGULARLY SINCE YOUR LAST EXAM? +69 Cigarette smoking 70407 phv00070407.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:54:21+00:00 2018-10-03 13:54:21+00:00 FU051 SMOKING: HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY? +69 Cigarette smoking 10259 phv00010259.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 G116 SMOKED CIGARETTES REGULARLY IN LAST YEAR +69 Cigarette smoking 10260 phv00010260.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 G117 HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY +69 Cigarette smoking 250827 phv00250827.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 g116 Medical History - Smoking: Smoked cigarettes regularly in the last year Collection Interval: Exam 2 +69 Cigarette smoking 250828 phv00250828.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 g117 Medical History - Smoking: How many cigarettes do/did you smoke a day Collection Interval: Exam 2 +69 Cigarette smoking 254617 phv00254617.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 fv026 Medical History - Smoking: Have you smoked cigarettes regularly since your last exam? Collection Interval: Exam 29 +69 Cigarette smoking 254618 phv00254618.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 fv027 Medical History - Smoking: How many cigarettes do/did you smoke a day? Collection Interval: Exam 29 +69 Cigarette smoking 255005 phv00255005.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 fw025 Medical History - Smoking: Do you smoke cigarettes regularly since last exam? Collection Interval: Original Cohort Exam 30 +69 Cigarette smoking 255006 phv00255006.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 fw026 Medical History - Smoking: How many cigarettes do you smoke a day? Collection Interval: Original Cohort Exam 30 +69 Cigarette smoking 274725 phv00274725.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 FX025 Medical History - Smoking: Have you smoked cigarettes regularly since last exam? Collection Interval: Original Cohort Exam 31 +69 Cigarette smoking 274726 phv00274726.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 FX026 Medical History - Smoking: How many cigarettes do/did you smoke a day? Collection Interval: Original Cohort Exam 31 +69 Cigarette smoking 275082 phv00275082.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 fy025 Medical History - Smoking: Have you smoked cigarettes regularly since last exam? Collection Interval: Original Cohort Exam 32 +69 Cigarette smoking 275083 phv00275083.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 13:56:29+00:00 2018-10-03 13:56:29+00:00 fy026 Medical History - Smoking: How many cigarettes do/did you smoke a day? Collection Interval: Original Cohort Exam 32 +69 Cigarette smoking 10262 phv00010262.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 G119 CIGARETTE BRAND XXXXXXXX (FIRST 8 LETTERS OF BRAND) +69 Cigarette smoking 10263 phv00010263.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 G120 STRENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 10264 phv00010264.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 G121 TYPE OF CIGARETTES SMOKED +69 Cigarette smoking 10265 phv00010265.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 G122 FILTER OF CIGARETTES SMOKED +69 Cigarette smoking 10266 phv00010266.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 G123 LENGTH OF CIGARETTES SMOKED +69 Cigarette smoking 10267 phv00010267.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 G124 HOW MANY HOURS SINCE LAST CIGARETTE? +69 Cigarette smoking 20925 phv00020925.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 G3A070 HAVE YOU EVER SMOKED CIGARETTES REGULARLY? (NO MEANS LESS THAN +69 Cigarette smoking 20926 phv00020926.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 G3A071 IF EVER SMOKED CIGS REGULARLY: HAVE YOU SMOKED CIGARETTES REGULARLY IN THE LAST YEAR? +69 Cigarette smoking 250829 phv00250829.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 g118 Medical History - Smoking: Do you inhale Collection Interval: Exam 2 +69 Cigarette smoking 250830 phv00250830.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 g119 Medical History - Smoking: Cigarette brand Collection Interval: Exam 2 +69 Cigarette smoking 250831 phv00250831.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 g120 Medical History - Smoking: Strength Collection Interval: Exam 2 +69 Cigarette smoking 250832 phv00250832.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 g121 Medical History - Smoking: Type Collection Interval: Exam 2 +69 Cigarette smoking 250833 phv00250833.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 g122 Medical History - Smoking: Filter Collection Interval: Exam 2 +69 Cigarette smoking 250834 phv00250834.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 g123 Medical History - Smoking: Length Collection Interval: Exam 2 +69 Cigarette smoking 250835 phv00250835.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:03+00:00 2018-10-03 14:23:03+00:00 g124 Medical History - Smoking: How many hours since last cigarette Collection Interval: Exam 2 +69 Cigarette smoking 273759 phv00273759.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:04+00:00 2018-10-03 14:23:04+00:00 g3a070 Have you ever smoked cigarettes regularly? (no means less than 20 packs of cigarettes or 12 oz. of tobacco in a lifetime or less than 1 cigarette a day for a year.) Collection Interval: Exam 1 +69 Cigarette smoking 273760 phv00273760.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:04+00:00 2018-10-03 14:23:04+00:00 g3a071 If ever smoked cigarettes regularly: Have you smoked cigarettes regularly in the last year? Collection Interval: Exam 1 +69 Cigarette smoking 274252 phv00274252.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:04+00:00 2018-10-03 14:23:04+00:00 g3a070 Have you ever smoked cigarettes regularly? (no means less than 20 packs of cigarettes or 12 oz. of tobacco in a lifetime or less than 1 cigarette a day for a year.) +69 Cigarette smoking 274253 phv00274253.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:23:04+00:00 2018-10-03 14:23:04+00:00 g3a071 If ever smoked cigarettes regularly: Have you smoked cigarettes regularly in the last year? +69 Cigarette smoking 20927 phv00020927.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 G3A072 IF EVER SMOKED CIGS REGULARLY: DO YOU NOW SMOKE CIGARETTS (AS OF 1 MONTH AGO)? +69 Cigarette smoking 20928 phv00020928.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 G3A073 IF EVER SMOKED CIGS REGULARLY: HOW MANY CIGARETTES DO YOU SMOKE PER DAY NOW? +69 Cigarette smoking 20929 phv00020929.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 G3A074 IF EVER SMOKED CIGS REGULARLY: ON THE AVERAGE OF THE ENTIRE TIME YOU SMOKED, HOW MANY CIGARETTES DID YOU SMOKE PER DAY? +69 Cigarette smoking 20930 phv00020930.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 G3A075 IF EVER SMOKED CIGS REGULARLY: HOW OLD WERE YOU WHEN YOU FIRST STARTED REGULAR CIGARETTE SMOKING? +69 Cigarette smoking 273761 phv00273761.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 g3a072 If ever smoked cigarettes regularly: Do you now smoke cigarettes (as of 1 month ago)? Collection Interval: Exam 1 +69 Cigarette smoking 273762 phv00273762.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 g3a073 If ever smoked cigarettes regularly: How many cigarettes do you smoke per day now? Collection Interval: Exam 1 +69 Cigarette smoking 273763 phv00273763.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 g3a074 If ever smoked cigarettes regularly: On the average of the entire time you smoked, how many cigarettes did you smoke per day? Collection Interval: Exam 1 +69 Cigarette smoking 273764 phv00273764.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 g3a075 If ever smoked cigarettes regularly: How old were you when you first started regular cigarette smoking? Collection Interval: Exam 1 +69 Cigarette smoking 274254 phv00274254.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 g3a072 If ever smoked cigarettes regularly: Do you now smoke cigarettes (as of 1 month ago)? +69 Cigarette smoking 274255 phv00274255.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 g3a073 If ever smoked cigarettes regularly: How many cigarettes do you smoke per day now? +69 Cigarette smoking 274256 phv00274256.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 g3a074 If ever smoked cigarettes regularly: On the average of the entire time you smoked, how many cigarettes did you smoke per day? +69 Cigarette smoking 274257 phv00274257.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:24:33+00:00 2018-10-03 14:24:33+00:00 g3a075 If ever smoked cigarettes regularly: How old were you when you first started regular cigarette smoking? +69 Cigarette smoking 20931 phv00020931.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 G3A076 IF EVER SMOKED CIGS REGULARLY AND THEN STOPPED SMOKING CIGARETTES COMPLETELY, HOW OLD WERE YOU WHEN YOU STOPPED? +69 Cigarette smoking 20932 phv00020932.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 G3A077 IF EVER SMOKED CIGS REGULARLY: WHEN YOU WERE SMOKING, DID YOU EVER STOP SMOKING FOR > 6 MONTHS? +69 Cigarette smoking 20933 phv00020933.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 G3A078 IF EVER STOPPED FOR > 6 MONTHS: FOR HOW MANY YEARS IN TOTAL DID YOU STOP SMOKING CIGARETTS? +69 Cigarette smoking 177301 phv00177301.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0091 Medical History-Smoking: Since your last exam have you smoked cigarettes regularly? +69 Cigarette smoking 177302 phv00177302.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0092 Medical History-Smoking: Have you smoked cigarettes regularly in the last year? +69 Cigarette smoking 177303 phv00177303.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0093 Medical History-Smoking: Do you now smoke cigarettes (as of 1 month ago)? +69 Cigarette smoking 177304 phv00177304.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0094 Medical History-Smoking: How many cigarettes do you smoke per day now? +69 Cigarette smoking 177305 phv00177305.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0095 "Medical History-Smoking: Question refers to ""whole lifetime"". On the average of the entire time you smoked, how many cigarettes did you smoke per day?" +69 Cigarette smoking 177306 phv00177306.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0096 "Medical History-Smoking: Question refers to ""whole lifetime"". How old were you when you first started regular cigarette smoking?" +69 Cigarette smoking 177307 phv00177307.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0097 "Medical History-Smoking: Question refers to ""whole lifetime"". If you have stopped smoking cigarettes completely, how old were you when you stopped?" +69 Cigarette smoking 177308 phv00177308.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0098 "Medical History-Smoking: Question refers to ""whole lifetime"". When you were smoking, did you ever stop smoking for >6 months?" +69 Cigarette smoking 177309 phv00177309.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3b0099 "Medical History-Smoking: Question refers to ""whole lifetime"". For how many years in total did you stop smoking cigarettes?" +69 Cigarette smoking 273765 phv00273765.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3a076 If ever smoked cigarettes regularly and then stopped smoking cigarettes completely, how old were you when you stopped? Collection Interval: Exam 1 +69 Cigarette smoking 273766 phv00273766.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3a077 If ever smoked cigarettes regularly: When you were smoking, did you ever stop smoking for > 6 months? Collection Interval: Exam 1 +69 Cigarette smoking 273767 phv00273767.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3a078 If ever stopped for > 6 months: For how many years in total did you stop smoking cigarettes? Collection Interval: Exam 1 +69 Cigarette smoking 274258 phv00274258.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3a076 If ever smoked cigarettes regularly and then stopped smoking cigarettes completely, how old were you when you stopped? +69 Cigarette smoking 274259 phv00274259.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3a077 If ever smoked cigarettes regularly: When you were smoking, did you ever stop smoking for > 6 months? +69 Cigarette smoking 274260 phv00274260.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:26:40+00:00 2018-10-03 14:26:40+00:00 g3a078 If ever stopped for > 6 months: For how many years in total did you stop smoking cigarettes? +69 Cigarette smoking 10665 phv00010665.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:27:58+00:00 2018-10-03 14:27:58+00:00 G674 RESPIRATORY: DO YOU NOW SMOKE CIGARETTES (I.E. WITHIN THE LAST WEEK)? +69 Cigarette smoking 10666 phv00010666.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:27:58+00:00 2018-10-03 14:27:58+00:00 G675 RESPIRATORY: HAVE YOU EVER SMOKED CIGARETTES FOR AS LONG AS A YEAR? +69 Cigarette smoking 251239 phv00251239.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:27:58+00:00 2018-10-03 14:27:58+00:00 g674 Respiratory Questionnaire - Smoking: Do you now smoke cigarettes? (i.e. within the last week) Collection Interval: Exam 2 +69 Cigarette smoking 251240 phv00251240.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:27:58+00:00 2018-10-03 14:27:58+00:00 g675 Respiratory Questionnaire - Smoking: Have you ever smoked cigarettes for as long as a year? Collection Interval: Exam 2 +69 Cigarette smoking 10668 phv00010668.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 G677 RESPIRATORY: HOW MANY CIGARETTES DO/DID YOU SMOKE A DAY? +69 Cigarette smoking 72088 phv00072088.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 H060 SINCE YOUR LAST EXAM HAVE YOU SMOKED CIGARETTES REGULARLY? (NO MEANS LESS THAN 1 CIGARETTE A DAY FOR 1 YEAR) +69 Cigarette smoking 72089 phv00072089.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 H061 HAVE YOU SMOKED CIGARETTES REGULARLY IN THE LAST YEAR? +69 Cigarette smoking 72090 phv00072090.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 H062 DO YOU NOW SMOKE CIGARETTES (AS OF 1 MONTH AGO)? +69 Cigarette smoking 72091 phv00072091.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 H063 HOW MANY CIGARETTES DO YOU SMOKE PER DAY NOW? +69 Cigarette smoking 72092 phv00072092.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 H064 ON AVERAGE, SINCE YOUR LAST EXAM, HOW MANY CIGARETTES DID YOU SMOKE PER DAY? +69 Cigarette smoking 72093 phv00072093.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 H065 HOW OLD WERE YOU WHEN YOU FIRST STARTED REGULAR CIGARETTE SMOKING? +69 Cigarette smoking 72094 phv00072094.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 H066 IF YOU HAVE STOPPED SMOKING CIGARETTES COMPLETELY, HOW OLD WERE YOU WHEN YOU STOPPED? +69 Cigarette smoking 251241 phv00251241.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 g676 Respiratory Questionnaire - Smoking: How many years have you smoked/did you smoke? Collection Interval: Exam 2 +69 Cigarette smoking 251242 phv00251242.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 g677 Respiratory Questionnaire - Smoking: How many cigarette do/did you smoke a day? Collection Interval: Exam 2 +69 Cigarette smoking 251243 phv00251243.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 g678 Respiratory Questionnaire - Smoking: If you no longer smoke, when did you quit? Collection Interval: Exam 2 +69 Cigarette smoking 251295 phv00251295.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 h060 Medical History - Smoking - Cigarettes: Since your last exam have you smoked cigarettes regularly? Collection Interval: Exam 3 +69 Cigarette smoking 251296 phv00251296.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 h061 Medical History - Smoking - Cigarettes: Have you smoked cigarettes regularly in the last year? Collection Interval: Exam 3 +69 Cigarette smoking 251297 phv00251297.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 h062 Medical History - Smoking - Cigarettes: Do you now smoke cigarettes (as of 1 month ago)? Collection Interval: Exam 3 +69 Cigarette smoking 251298 phv00251298.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 h063 Medical History - Smoking - Cigarettes: How many cigarettes do you smoke per day now? Collection Interval: Exam 3 +69 Cigarette smoking 251299 phv00251299.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 h064 Medical History - Smoking - Cigarettes: On average, since your last exam, how many cigarettes did you smoke per day? Collection Interval: Exam 3 +69 Cigarette smoking 251300 phv00251300.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 h065 Medical History - Smoking - Cigarettes: How old were you when you first started regular cigarette smoking? Collection Interval: Exam 3 +69 Cigarette smoking 251301 phv00251301.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:46:35+00:00 2018-10-03 14:46:35+00:00 h066 Medical History - Smoking - Cigarettes: If you have stopped smoking cigarettes completely, how old were you when you stopped? Collection Interval: Exam 3 +69 Cigarette smoking 781 phv00000781.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 MF331 HISTORY OF SMOKING: NUMBER OF CIGARETTES/DAY SMOKED NOW, EXAM 5 +69 Cigarette smoking 977 phv00000977.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 MF537 PRESENT HISTORY OF SMOKING: NUMBER OF CIGARETTES/DAY, EXAM 7 +69 Cigarette smoking 72095 phv00072095.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 H067 DURING THE TIME YOU WERE SMOKING SINCE YOUR LAST EXAM, DID YOU EVER STOP SMOKING FOR > 6 MONTHS? +69 Cigarette smoking 72096 phv00072096.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 H068 DURING THE TIME SINCE YOUR LAST EXAM, FOR HOW MANY YEARS IN TOTAL DID YOU STOP SMOKING CIGARETTES? +69 Cigarette smoking 251302 phv00251302.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 h067 Medical History - Smoking - Cigarettes: During the time you were smoking since your last exam, did you ever stop smoking for > 6 months? Collection Interval: Exam 3 +69 Cigarette smoking 251303 phv00251303.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 h068 Medical History - Smoking - Cigarettes: During the time since your last exam, for how many years in total did you stop smoking cigarettes? Collection Interval: Exam 3 +69 Cigarette smoking 254041 phv00254041.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 j062 Medical History - Smoking-Cigarettes: Since your last exam have you smoked cigarettes regularly? +69 Cigarette smoking 254042 phv00254042.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 j063 Medical History - Smoking-Cigarettes: Have you smoked cigarettes regularly in the last year? +69 Cigarette smoking 254043 phv00254043.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 j064 Medical History - Smoking-Cigarettes: Do you now smoke cigarettes (as of 1 month ago)? +69 Cigarette smoking 254044 phv00254044.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 j065 Medical History - Smoking-Cigarettes: How many cigarettes do you smoke per day now? +69 Cigarette smoking 254045 phv00254045.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 j066 "Medical History - Smoking-Cigarettes: Question refers to ""since your last exam"": During the time you were smoking, on average how many cigarettes per day did you smoke?" +69 Cigarette smoking 254046 phv00254046.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 j067 "Medical History - Smoking-Cigarettes: Question refers to ""since your last exam"": If you have stopped smoking cigarettes completely, how old were you when you stopped?" +69 Cigarette smoking 254047 phv00254047.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 j068 "Medical History - Smoking-Cigarettes: Question refers to ""since your last exam"": When you were smoking, did you ever stop smoking for >6 months?" +69 Cigarette smoking 254048 phv00254048.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:49:36+00:00 2018-10-03 14:49:36+00:00 j069 "Medical History - Smoking-Cigarettes: Question refers to ""since your last exam"": For how many years in total did you stop smoking cigarettes?" +69 Cigarette smoking 546 phv00000546.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 MF74 CIGARETTES SMOKED PER DAY +69 Cigarette smoking 980 phv00000980.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 MF540 PRESENT HISTORY OF SMOKING: USES CIGARETTE WITH FILTER, EXAM 7 +69 Cigarette smoking 981 phv00000981.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 MF541 PRESENT HISTORY OF SMOKING: INHALES CIGARETTES, EXAM 7 +69 Cigarette smoking 982 phv00000982.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 MF542 PRESENT HISTORY OF SMOKING: PORTION OF CIGARETTE SMOKED, EXAM 7 +69 Cigarette smoking 22719 phv00022719.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 RQ018 NOW SMOKE CIGARETTES (WITHIN THE LAST WEEK) +69 Cigarette smoking 22720 phv00022720.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 RQ019 EVER SMOKED CIGARETTES FOR AS LONG AS A YEAR (IF YES, ANSWER RQ020-RQ022) +69 Cigarette smoking 22722 phv00022722.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 RQ021 NUMBER OF CIGARETTES SMOKE(D) A DAY +69 Cigarette smoking 55317 phv00055317.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 MOSTOP15 If no to [SMKNOW15]: month stopped smoking? +69 Cigarette smoking 56741 phv00056741.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 sh320 Have you smoked as many as 20 packs of cigarettes in your whole lifetime? +69 Cigarette smoking 56742 phv00056742.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 sh321 If sh320=1, how many years ago did you START smoking? +69 Cigarette smoking 56828 phv00056828.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 ms211a How much did you smoke during the 4 hours before you went to sleep last night? Number of cigarettes +69 Cigarette smoking 72628 phv00072628.v4.p10 pht000748.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 PCIG6HR Have you smoked cigarettes in the last 6 hours? +69 Cigarette smoking 72629 phv00072629.v4.p10 pht000748.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 PCIGHR "If ""yes"" to PICG6HR: How many hours and minutes since your last cigarette?" +69 Cigarette smoking 72630 phv00072630.v4.p10 pht000748.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 14:56:00+00:00 2018-10-03 14:56:00+00:00 PCIGMIN "If ""yes"" to PICG6HR: How many hours and minutes since your last cigarette?" +69 Cigarette smoking 24445 phv00024445.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 smoke6hr HAVE YOU SMOKED CIGARETTES IN THE LAST 6 HOURS? (RENAMED FROM EF08) +69 Cigarette smoking 24886 phv00024886.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 SMOKE6HR HAVE YOU SMOKED CIGARETTES IN THE LAST 6 HOURS? (RENAMED FROM TM05) +69 Cigarette smoking 24887 phv00024887.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 TM06 IF YES (TO TM05), HOW MANY HOURS SINCE YOUR LAST CIGARETTE? +69 Cigarette smoking 24888 phv00024888.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 TM07 IF YES (TO TM05), HOW MANY MINUTES SINCE YOUR LAST CIGARETTE? +69 Cigarette smoking 55316 phv00055316.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 SMKNOW15 Do you now smoke cigarettes? +69 Cigarette smoking 56589 phv00056589.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 smokstat_s1 Smoking Status +69 Cigarette smoking 55318 phv00055318.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 yrstop15 If no to [SMKNOW15]: year stopped smoking? +69 Cigarette smoking 56725 phv00056725.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 smokstat_s2 Smoking status (never=0, current=1, former=2) +69 Cigarette smoking 56743 phv00056743.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 sh322 Since you began smoking, was there ever a period of one year or more that you did NOT smoke? +69 Cigarette smoking 56744 phv00056744.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 sh323 Are you currently still smoking? +69 Cigarette smoking 56745 phv00056745.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 sh324 On average, during the entire time you smoked, how many cigarettes did you usually smoke per day? +69 Cigarette smoking 56780 phv00056780.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:00:07+00:00 2018-10-03 15:00:07+00:00 sh323a If sh323=0, how many years ago did you STOP smoking? +69 Cigarette smoking 7998 phv00007998.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:37:57+00:00 2018-10-03 15:37:57+00:00 B381 CURRENT SMOKING-REG LAST 2 YRS +69 Cigarette smoking 7745 phv00007745.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 15:42:15+00:00 2018-10-03 15:42:15+00:00 B95 NO. OF CIGARETTES SMOKED THIS MORNING +69 Cigarette smoking 1836 phv00001836.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 FE106 INTERIM HISTORY OF SMOKING: EVER SMOKED +69 Cigarette smoking 1837 phv00001837.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 FE107 INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YR. IN LAST TWO YRS. +69 Cigarette smoking 3832 phv00003832.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 FL188 DOES PATIENT INHALE +69 Cigarette smoking 4275 phv00004275.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 FM234 DOES PATIENT INHALE +69 Cigarette smoking 7617 phv00007617.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 A104 INHALES +69 Cigarette smoking 7735 phv00007735.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 B85 EVER SMOKED +69 Cigarette smoking 8864 phv00008864.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 D095 DOES PATIENT INHALE +69 Cigarette smoking 9780 phv00009780.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 F290 DO YOU INHALE +69 Cigarette smoking 21636 phv00021636.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 BW35 LIVE-BIRTH PREGNANCY #1: IF YES TO BW34, WRITE IN NUMBER SMOKED PER DAY +69 Cigarette smoking 21648 phv00021648.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 BW48 LIVE-BIRTH PREGNANCY #2: IF YES TO BW47, WRITE IN NUMBER SMOKED PER DAY +69 Cigarette smoking 21660 phv00021660.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 BW61 LIVE-BIRTH PREGNANCY #3: IF YES TO BW60, WRITE IN NUMBER SMOKED PER DAY +69 Cigarette smoking 21672 phv00021672.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 BW74 LIVE-BIRTH PREGNANCY #4: IF YES TO BW73, WRITE IN NUMBER SMOKED PER DAY +69 Cigarette smoking 21684 phv00021684.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:10:49+00:00 2018-10-05 15:10:49+00:00 BW87 LIVE-BIRTH PREGNANCY #5: IF YES TO BW86, WRITE IN NUMBER SMOKED PER DAY +69 Cigarette smoking 10261 phv00010261.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:13:35+00:00 2018-10-05 15:13:35+00:00 G118 DO YOU INHALE? +69 Cigarette smoking 10667 phv00010667.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:13:35+00:00 2018-10-05 15:13:35+00:00 G676 RESPIRATORY: HOW MANY YEARS HAVE YOU SMOKED/DID YOU SMOKE? +69 Cigarette smoking 10669 phv00010669.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:13:35+00:00 2018-10-05 15:13:35+00:00 G678 RESPIRATORY: IF YOU NO LONGER SMOKE, WHEN DID YOU QUIT? +69 Cigarette smoking 22721 phv00022721.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:13:35+00:00 2018-10-05 15:13:35+00:00 RQ020 HOW MANY YEARS HAVE YOU SMOKED / DID YOU SMOKE +69 Cigarette smoking 22723 phv00022723.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:13:35+00:00 2018-10-05 15:13:35+00:00 RQ022 IF NO LONGER SMOKE, WHEN QUIT +69 Cigarette smoking 56779 phv00056779.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-05 15:13:35+00:00 2018-10-05 15:13:35+00:00 sh322a "If sh322=1, If 'Yes"" (there was a period of one year or more that you did not smoke,) how many years did you NOT smoke?" +69 Cigarette smoking 707 phv00000707.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-09 17:12:57+00:00 2018-10-09 17:12:57+00:00 MF252 INTERIM HISTORY OF TOBACCO USAGE, EXAM 4 +69 Cigarette smoking 7616 phv00007616.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-09 17:13:52+00:00 2018-10-09 17:13:52+00:00 A103 USES FILTER +69 Cigarette smoking 7751 phv00007751.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-09 17:14:40+00:00 2018-10-09 17:14:40+00:00 B101 REASON FOR STOPPING +69 Cigarette smoking 7609 phv00007609.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:26:12+00:00 2018-10-17 17:26:12+00:00 A96 SMOKED AT LEAST 1 YEAR +69 Cigarette smoking 7753 phv00007753.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:26:40+00:00 2018-10-17 17:26:40+00:00 B103 CARD CODE +69 Cigarette smoking 1255 phv00001255.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:28:39+00:00 2018-10-17 17:28:39+00:00 FB83 INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YEAR IN LAST TWO YEARS +69 Cigarette smoking 1449 phv00001449.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:29:08+00:00 2018-10-17 17:29:08+00:00 FC99 INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YEAR IN LAST TWO YEARS +69 Cigarette smoking 1633 phv00001633.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:29:33+00:00 2018-10-17 17:29:33+00:00 FD92 INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YEAR IN LAST TWO YEARS +69 Cigarette smoking 1842 phv00001842.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:30:37+00:00 2018-10-17 17:30:37+00:00 FE112 INTERIM HISTORY OF SMOKING: TIME PATTERN: +69 Cigarette smoking 2237 phv00002237.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:31:54+00:00 2018-10-17 17:31:54+00:00 FG103 INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YR. IN LAST TWO YRS. +69 Cigarette smoking 2458 phv00002458.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:32:46+00:00 2018-10-17 17:32:46+00:00 FH101 INTERIM HISTORY OF SMOKING: SMOKED AT LEAST ONE YR. IN LAST TWO YRS. +69 Cigarette smoking 780 phv00000780.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:33:54+00:00 2018-10-17 17:33:54+00:00 MF330 HISTORY OF SMOKING: PRESENT HABIT, EXAM 5 +69 Cigarette smoking 784 phv00000784.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:34:26+00:00 2018-10-17 17:34:26+00:00 MF334 HISTORY OF SMOKING: CHANGE IN HABIT IN PAST TWO YEARS, EXAM 5 +69 Cigarette smoking 543 phv00000543.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:34:49+00:00 2018-10-17 17:34:49+00:00 MF71 "TOBACCO USED ""NOW"" OR ""EVER""" +69 Cigarette smoking 544 phv00000544.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:35:12+00:00 2018-10-17 17:35:12+00:00 MF72 "DURATION OF TOBACCO USE (WHEN SMOKING ""NOW"")" +69 Cigarette smoking 545 phv00000545.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-17 17:35:28+00:00 2018-10-17 17:35:28+00:00 MF73 "PERIOD OF LAPSE IN TOBACCO USE (WHEN NOT SMOKING ""NOW"")" +70 Subcohort 176003 phv00176003.v1.p3 pht003090.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:55:38+00:00 2018-04-29 00:55:38+00:00 group3 GROUP 3 COHORT INDICATOR +70 Subcohort 176005 phv00176005.v1.p3 pht003090.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:55:48+00:00 2018-04-29 00:55:48+00:00 casecohdes CASE-COHORT DESIGNATION +70 Subcohort 165066 phv00165066.v1.p3 pht002515.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 00:55:54+00:00 2018-04-29 00:55:54+00:00 cachrt1a RANDOM COHORT AND CASES NOT IN COHORT +70 Subcohort 1035 phv00001035.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:04:37+00:00 2018-05-15 17:04:37+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 1186 phv00001186.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:05:08+00:00 2018-05-15 17:05:08+00:00 idtype COHORT IDENTIFIER +70 Subcohort 1362 phv00001362.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:05:23+00:00 2018-05-15 17:05:23+00:00 idtype COHORT IDENTIFIER +70 Subcohort 1558 phv00001558.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:05:44+00:00 2018-05-15 17:05:44+00:00 idtype COHORT IDENTIFIER +70 Subcohort 1802 phv00001802.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:06:06+00:00 2018-05-15 17:06:06+00:00 idtype COHORT IDENTIFIER +70 Subcohort 2019 phv00002019.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:06:28+00:00 2018-05-15 17:06:28+00:00 idtype COHORT IDENTIFIER +70 Subcohort 2203 phv00002203.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:06:46+00:00 2018-05-15 17:06:46+00:00 idtype COHORT IDENTIFIER +70 Subcohort 2424 phv00002424.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:07:07+00:00 2018-05-15 17:07:07+00:00 idtype COHORT IDENTIFIER +70 Subcohort 2667 phv00002667.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:07:25+00:00 2018-05-15 17:07:25+00:00 idtype COHORT IDENTIFIER +70 Subcohort 2945 phv00002945.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:07:42+00:00 2018-05-15 17:07:42+00:00 idtype COHORT IDENTIFIER +70 Subcohort 3260 phv00003260.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:08:36+00:00 2018-05-15 17:08:36+00:00 idtype COHORT IDENTIFIER +70 Subcohort 3666 phv00003666.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:08:51+00:00 2018-05-15 17:08:51+00:00 idtype COHORT IDENTIFIER +70 Subcohort 4082 phv00004082.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:09:06+00:00 2018-05-15 17:09:06+00:00 idtype COHORT IDENTIFIER +70 Subcohort 4524 phv00004524.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:09:22+00:00 2018-05-15 17:09:22+00:00 idtype COHORT IDENTIFIER +70 Subcohort 4938 phv00004938.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:09:40+00:00 2018-05-15 17:09:40+00:00 idtype COHORT IDENTIFIER +70 Subcohort 4940 phv00004940.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:09:55+00:00 2018-05-15 17:09:55+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 5558 phv00005558.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:10:15+00:00 2018-05-15 17:10:15+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 6031 phv00006031.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:10:35+00:00 2018-05-15 17:10:35+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 6326 phv00006326.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:10:55+00:00 2018-05-15 17:10:55+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 6664 phv00006664.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:11:15+00:00 2018-05-15 17:11:15+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 7096 phv00007096.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:11:39+00:00 2018-05-15 17:11:39+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 7674 phv00007674.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:12:20+00:00 2018-05-15 17:12:20+00:00 idtype COHORT IDENTIFIER +70 Subcohort 8378 phv00008378.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:12:36+00:00 2018-05-15 17:12:36+00:00 idtype COHORT IDENTIFIER +70 Subcohort 8742 phv00008742.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:13:34+00:00 2018-05-15 17:13:34+00:00 idtype COHORT IDENTIFIER +70 Subcohort 9126 phv00009126.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:14:16+00:00 2018-05-15 17:14:16+00:00 idtype COHORT IDENTIFIER +70 Subcohort 9129 phv00009129.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:15:17+00:00 2018-05-15 17:15:17+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 9580 phv00009580.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:15:36+00:00 2018-05-15 17:15:36+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 10139 phv00010139.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:15:53+00:00 2018-05-15 17:15:53+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 10767 phv00010767.v10.p10 pht000039.v11.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:16:38+00:00 2018-05-15 17:16:38+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 10782 phv00010782.v2.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:17:02+00:00 2018-05-15 17:17:02+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Exam 1 - Exam 28 +70 Subcohort 10803 phv00010803.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:17:43+00:00 2018-05-15 17:17:43+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 11014 phv00011014.v1.p10 pht000042.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:17:58+00:00 2018-05-15 17:17:58+00:00 IDTYPE Framingham cohort identifier +70 Subcohort 11073 phv00011073.v6.p10 pht000043.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:18:14+00:00 2018-05-15 17:18:14+00:00 IDTYPE Framingham cohort identifier +70 Subcohort 11079 phv00011079.v1.p10 pht000044.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:18:36+00:00 2018-05-15 17:18:36+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21398 phv00021398.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:19:02+00:00 2018-05-15 17:19:02+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21569 phv00021569.v5.p10 pht000076.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:19:14+00:00 2018-05-15 17:19:14+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21588 phv00021588.v5.p10 pht000077.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:19:24+00:00 2018-05-15 17:19:24+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21607 phv00021607.v5.p10 pht000078.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:19:34+00:00 2018-05-15 17:19:34+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21686 phv00021686.v5.p10 pht000079.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:20:16+00:00 2018-05-15 17:20:16+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21689 phv00021689.v5.p10 pht000080.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:20:28+00:00 2018-05-15 17:20:28+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21694 phv00021694.v5.p10 pht000081.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:20:39+00:00 2018-05-15 17:20:39+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21696 phv00021696.v5.p10 pht000082.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:20:50+00:00 2018-05-15 17:20:50+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21699 phv00021699.v5.p10 pht000083.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:21:02+00:00 2018-05-15 17:21:02+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21739 phv00021739.v5.p10 pht000084.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:21:17+00:00 2018-05-15 17:21:17+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21742 phv00021742.v5.p10 pht000085.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:21:32+00:00 2018-05-15 17:21:32+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21749 phv00021749.v1.p10 pht000086.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:21:48+00:00 2018-05-15 17:21:48+00:00 idtype COHORT IDENTIFIER +70 Subcohort 21753 phv00021753.v5.p10 pht000087.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:22:00+00:00 2018-05-15 17:22:00+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21756 phv00021756.v4.p10 pht000088.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:22:17+00:00 2018-05-15 17:22:17+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21822 phv00021822.v4.p10 pht000089.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:22:37+00:00 2018-05-15 17:22:37+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21874 phv00021874.v1.p10 pht000090.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:23:05+00:00 2018-05-15 17:23:05+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21930 phv00021930.v5.p10 pht000091.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:24:49+00:00 2018-05-15 17:24:49+00:00 idtype COHORT IDENTIFIER +70 Subcohort 21932 phv00021932.v5.p10 pht000092.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:25:05+00:00 2018-05-15 17:25:05+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21938 phv00021938.v5.p10 pht000093.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:25:15+00:00 2018-05-15 17:25:15+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21960 phv00021960.v1.p10 pht000094.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:25:28+00:00 2018-05-15 17:25:28+00:00 idtype COHORT IDENTIFIER +70 Subcohort 21962 phv00021962.v5.p10 pht000095.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:25:41+00:00 2018-05-15 17:25:41+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21965 phv00021965.v5.p10 pht000096.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:25:57+00:00 2018-05-15 17:25:57+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 21984 phv00021984.v1.p10 pht000097.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:26:12+00:00 2018-05-15 17:26:12+00:00 idtype COHORT IDENTIFIER +70 Subcohort 21986 phv00021986.v5.p10 pht000098.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:26:26+00:00 2018-05-15 17:26:26+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22306 phv00022306.v5.p10 pht000099.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:26:48+00:00 2018-05-15 17:26:48+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22552 phv00022552.v5.p10 pht000100.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:27:44+00:00 2018-05-15 17:27:44+00:00 idtype COHORT IDENTIFIER +70 Subcohort 22554 phv00022554.v5.p10 pht000101.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:27:54+00:00 2018-05-15 17:27:54+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22567 phv00022567.v4.p10 pht000102.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:28:11+00:00 2018-05-15 17:28:11+00:00 idtype COHORT IDENTIFIER +70 Subcohort 22580 phv00022580.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:28:29+00:00 2018-05-15 17:28:29+00:00 idtype COHORT IDENTIFIER +70 Subcohort 22673 phv00022673.v5.p10 pht000104.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:28:44+00:00 2018-05-15 17:28:44+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22676 phv00022676.v5.p10 pht000105.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:29:11+00:00 2018-05-15 17:29:11+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22698 phv00022698.v5.p10 pht000106.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:29:23+00:00 2018-05-15 17:29:23+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22701 phv00022701.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:29:46+00:00 2018-05-15 17:29:46+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22728 phv00022728.v1.p10 pht000108.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:30:05+00:00 2018-05-15 17:30:05+00:00 idtype COHORT IDENTIFIER +70 Subcohort 22730 phv00022730.v5.p10 pht000109.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:30:19+00:00 2018-05-15 17:30:19+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22768 phv00022768.v5.p10 pht000110.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:30:31+00:00 2018-05-15 17:30:31+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22780 phv00022780.v4.p10 pht000111.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:30:48+00:00 2018-05-15 17:30:48+00:00 idtype COHORT IDENTIFIER +70 Subcohort 22787 phv00022787.v5.p10 pht000112.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:31:46+00:00 2018-05-15 17:31:46+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 22791 phv00022791.v5.p10 pht000113.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:32:05+00:00 2018-05-15 17:32:05+00:00 idtype COHORT IDENTIFIER +70 Subcohort 23128 phv00023128.v1.p10 pht000138.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:32:51+00:00 2018-05-15 17:32:51+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23149 phv00023149.v3.p10 pht000139.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:33:08+00:00 2018-05-15 17:33:08+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23158 phv00023158.v3.p10 pht000140.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:34:25+00:00 2018-05-15 17:34:25+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23169 phv00023169.v4.p10 pht000141.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:34:39+00:00 2018-05-15 17:34:39+00:00 idtype COHORT IDENTIFIER +70 Subcohort 23193 phv00023193.v3.p10 pht000144.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:35:13+00:00 2018-05-15 17:35:13+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23199 phv00023199.v3.p10 pht000145.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:35:37+00:00 2018-05-15 17:35:37+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23205 phv00023205.v5.p10 pht000146.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:36:02+00:00 2018-05-15 17:36:02+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23210 phv00023210.v3.p10 pht000147.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:36:17+00:00 2018-05-15 17:36:17+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23253 phv00023253.v5.p10 pht000149.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:37:24+00:00 2018-05-15 17:37:24+00:00 idtype COHORT IDENTIFIER +70 Subcohort 23495 phv00023495.v5.p10 pht000150.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:37:35+00:00 2018-05-15 17:37:35+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23556 phv00023556.v5.p10 pht000151.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:38:00+00:00 2018-05-15 17:38:00+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23560 phv00023560.v5.p10 pht000152.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:38:14+00:00 2018-05-15 17:38:14+00:00 idtype COHORT IDENTIFIER +70 Subcohort 23626 phv00023626.v1.p10 pht000155.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:38:41+00:00 2018-05-15 17:38:41+00:00 idtype COHORT IDENTIFIER +70 Subcohort 23631 phv00023631.v5.p10 pht000156.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:38:54+00:00 2018-05-15 17:38:54+00:00 idtype COHORT IDENTIFIER +70 Subcohort 23711 phv00023711.v1.p10 pht000158.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:39:16+00:00 2018-05-15 17:39:16+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23788 phv00023788.v1.p10 pht000160.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:39:31+00:00 2018-05-15 17:39:31+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23795 phv00023795.v5.p10 pht000161.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:39:45+00:00 2018-05-15 17:39:45+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23798 phv00023798.v5.p10 pht000162.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:40:29+00:00 2018-05-15 17:40:29+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23805 phv00023805.v5.p10 pht000163.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:40:38+00:00 2018-05-15 17:40:38+00:00 idtype COHORT IDENTIFIER +70 Subcohort 23807 phv00023807.v5.p10 pht000164.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:40:49+00:00 2018-05-15 17:40:49+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23810 phv00023810.v5.p10 pht000165.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:41:07+00:00 2018-05-15 17:41:07+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23852 phv00023852.v5.p10 pht000167.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:41:19+00:00 2018-05-15 17:41:19+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23873 phv00023873.v1.p10 pht000168.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:41:30+00:00 2018-05-15 17:41:30+00:00 IDTYPE Framingham Cohort Identifier Collection Interval: Exams 20, 22, 24 +70 Subcohort 23884 phv00023884.v4.p10 pht000169.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:41:43+00:00 2018-05-15 17:41:43+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 23889 phv00023889.v3.p10 pht000170.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:41:59+00:00 2018-05-15 17:41:59+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23891 phv00023891.v5.p10 pht000171.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:42:12+00:00 2018-05-15 17:42:12+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 23912 phv00023912.v5.p10 pht000175.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:43:04+00:00 2018-05-15 17:43:04+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24059 phv00024059.v5.p10 pht000182.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:43:15+00:00 2018-05-15 17:43:15+00:00 idtype Refers to the Framingham cohort the sample comes from, useful to identify which files phenotypes will be found +70 Subcohort 24361 phv00024361.v4.p10 pht000191.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:43:29+00:00 2018-05-15 17:43:29+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24366 phv00024366.v5.p10 pht000192.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:43:43+00:00 2018-05-15 17:43:43+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24368 phv00024368.v5.p10 pht000193.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:44:04+00:00 2018-05-15 17:44:04+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24372 phv00024372.v4.p10 pht000194.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:44:22+00:00 2018-05-15 17:44:22+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24438 phv00024438.v5.p10 pht000195.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:44:37+00:00 2018-05-15 17:44:37+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24511 phv00024511.v3.p10 pht000196.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:44:50+00:00 2018-05-15 17:44:50+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24555 phv00024555.v5.p10 pht000197.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:45:02+00:00 2018-05-15 17:45:02+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24559 phv00024559.v5.p10 pht000198.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:45:58+00:00 2018-05-15 17:45:58+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24586 phv00024586.v2.p10 pht000200.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:46:08+00:00 2018-05-15 17:46:08+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24646 phv00024646.v1.p10 pht000201.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:46:17+00:00 2018-05-15 17:46:17+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24656 phv00024656.v5.p10 pht000202.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:46:28+00:00 2018-05-15 17:46:28+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24669 phv00024669.v5.p10 pht000203.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:46:42+00:00 2018-05-15 17:46:42+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24679 phv00024679.v5.p10 pht000204.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:46:56+00:00 2018-05-15 17:46:56+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24681 phv00024681.v5.p10 pht000205.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:47:13+00:00 2018-05-15 17:47:13+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24720 phv00024720.v1.p10 pht000206.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:47:29+00:00 2018-05-15 17:47:29+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24722 phv00024722.v4.p10 pht000207.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:47:46+00:00 2018-05-15 17:47:46+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24757 phv00024757.v3.p10 pht000208.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:47:58+00:00 2018-05-15 17:47:58+00:00 idtype COHORT IDENTIFIER +70 Subcohort 24759 phv00024759.v5.p10 pht000209.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:48:11+00:00 2018-05-15 17:48:11+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24803 phv00024803.v4.p10 pht000210.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:48:33+00:00 2018-05-15 17:48:33+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 24847 phv00024847.v1.p10 pht000211.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:48:50+00:00 2018-05-15 17:48:50+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 36219 phv00036219.v5.p10 pht000293.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:49:11+00:00 2018-05-15 17:49:11+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36250 phv00036250.v1.p10 pht000294.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:49:33+00:00 2018-05-15 17:49:33+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36318 phv00036318.v3.p10 pht000295.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:49:55+00:00 2018-05-15 17:49:55+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36345 phv00036345.v3.p10 pht000298.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:54:15+00:00 2018-05-15 17:54:15+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36348 phv00036348.v8.p10 pht000299.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:54:25+00:00 2018-05-15 17:54:25+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36380 phv00036380.v5.p10 pht000300.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:54:34+00:00 2018-05-15 17:54:34+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 36400 phv00036400.v5.p10 pht000301.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:54:42+00:00 2018-05-15 17:54:42+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36403 phv00036403.v1.p10 pht000302.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:54:52+00:00 2018-05-15 17:54:52+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36406 phv00036406.v3.p10 pht000303.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:55:03+00:00 2018-05-15 17:55:03+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 36409 phv00036409.v3.p10 pht000304.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:55:11+00:00 2018-05-15 17:55:11+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36412 phv00036412.v3.p10 pht000305.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:55:20+00:00 2018-05-15 17:55:20+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36416 phv00036416.v3.p10 pht000306.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:55:29+00:00 2018-05-15 17:55:29+00:00 idtype COHORT IDENTIFIER +70 Subcohort 36418 phv00036418.v5.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:55:38+00:00 2018-05-15 17:55:38+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 36458 phv00036458.v5.p10 pht000308.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:55:47+00:00 2018-05-15 17:55:47+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 36470 phv00036470.v11.p10 pht000309.v12.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:55:56+00:00 2018-05-15 17:55:56+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Events reviewed through 12/2015 +70 Subcohort 36492 phv00036492.v4.p10 pht000313.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:56:05+00:00 2018-05-15 17:56:05+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 51865 phv00051865.v4.p10 pht000366.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:56:22+00:00 2018-05-15 17:56:22+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 54650 phv00054650.v1.p10 pht000386.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:56:33+00:00 2018-05-15 17:56:33+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 54661 phv00054661.v2.p10 pht000387.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:56:42+00:00 2018-05-15 17:56:42+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 54676 phv00054676.v3.p10 pht000388.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:56:54+00:00 2018-05-15 17:56:54+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 54693 phv00054693.v7.p10 pht000389.v9.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:57:04+00:00 2018-05-15 17:57:04+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 55021 phv00055021.v1.p10 pht000390.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:57:14+00:00 2018-05-15 17:57:14+00:00 idtype COHORT IDENTIFIER +70 Subcohort 55087 phv00055087.v1.p10 pht000391.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:57:24+00:00 2018-05-15 17:57:24+00:00 idtype COHORT IDENTIFIER +70 Subcohort 55154 phv00055154.v4.p10 pht000392.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:57:35+00:00 2018-05-15 17:57:35+00:00 idtype COHORT IDENTIFIER +70 Subcohort 55162 phv00055162.v5.p10 pht000393.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:57:44+00:00 2018-05-15 17:57:44+00:00 idtype COHORT IDENTIFIER +70 Subcohort 55164 phv00055164.v4.p10 pht000394.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:57:56+00:00 2018-05-15 17:57:56+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 56607 phv00056607.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:58:08+00:00 2018-05-15 17:58:08+00:00 idtype Framingham Cohort Identifier +70 Subcohort 56716 phv00056716.v2.p10 pht000396.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:58:22+00:00 2018-05-15 17:58:22+00:00 idtype Framingham Cohort Identifier +70 Subcohort 57968 phv00057968.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:58:46+00:00 2018-05-15 17:58:46+00:00 idtype Framingham Cohort Identifier +70 Subcohort 64580 phv00064580.v1.p10 pht000602.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:58:56+00:00 2018-05-15 17:58:56+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 64595 phv00064595.v1.p10 pht000603.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:59:04+00:00 2018-05-15 17:59:04+00:00 idtype COHORT IDENTIFIER +70 Subcohort 64600 phv00064600.v2.p10 pht000604.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:59:12+00:00 2018-05-15 17:59:12+00:00 idtype COHORT IDENTIFIER +70 Subcohort 64602 phv00064602.v2.p10 pht000605.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:59:20+00:00 2018-05-15 17:59:20+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 64608 phv00064608.v2.p10 pht000606.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:59:28+00:00 2018-05-15 17:59:28+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 65174 phv00065174.v2.p10 pht000607.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:59:37+00:00 2018-05-15 17:59:37+00:00 idtype COHORT IDENTIFIER +70 Subcohort 65287 phv00065287.v1.p10 pht000608.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:59:46+00:00 2018-05-15 17:59:46+00:00 idtype COHORT IDENTIFIER +70 Subcohort 65291 phv00065291.v2.p10 pht000609.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 17:59:55+00:00 2018-05-15 17:59:55+00:00 IDtype COHORT IDENTIFIER +70 Subcohort 65396 phv00065396.v2.p10 pht000610.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:00:03+00:00 2018-05-15 18:00:03+00:00 idtype COHORT IDENTIFIER +70 Subcohort 65450 phv00065450.v4.p10 pht000611.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:00:13+00:00 2018-05-15 18:00:13+00:00 idtype COHORT IDENTIFIER +70 Subcohort 65453 phv00065453.v4.p10 pht000612.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:00:24+00:00 2018-05-15 18:00:24+00:00 idtype COHORT IDENTIFIER +70 Subcohort 66665 phv00066665.v4.p10 pht000670.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:00:33+00:00 2018-05-15 18:00:33+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Offspring Exam 8 and Omni 1 Exam 3 +70 Subcohort 66687 phv00066687.v4.p10 pht000671.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:00:43+00:00 2018-05-15 18:00:43+00:00 idtype COHORT IDENTIFIER +70 Subcohort 66692 phv00066692.v4.p10 pht000672.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:00:54+00:00 2018-05-15 18:00:54+00:00 idtype COHORT IDENTIFIER +70 Subcohort 66749 phv00066749.v4.p10 pht000673.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:01:07+00:00 2018-05-15 18:01:07+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 66766 phv00066766.v4.p10 pht000674.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:01:19+00:00 2018-05-15 18:01:19+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 66817 phv00066817.v2.p10 pht000675.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:01:28+00:00 2018-05-15 18:01:28+00:00 IDTYPE FRAMINGHAM COHORT IDENTIFIER +70 Subcohort 66832 phv00066832.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:01:37+00:00 2018-05-15 18:01:37+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 68240 phv00068240.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:01:50+00:00 2018-05-15 18:01:50+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 68707 phv00068707.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:02:00+00:00 2018-05-15 18:02:00+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 69161 phv00069161.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:02:09+00:00 2018-05-15 18:02:09+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 70890 phv00070890.v4.p10 pht000683.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:02:18+00:00 2018-05-15 18:02:18+00:00 idtype COHORT IDENTIFIER +70 Subcohort 69659 phv00069659.v4.p10 pht000684.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:02:28+00:00 2018-05-15 18:02:28+00:00 idtype COHORT IDENTIFIER +70 Subcohort 69667 phv00069667.v1.p10 pht000685.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:02:40+00:00 2018-05-15 18:02:40+00:00 idtype COHORT IDENTIFIER +70 Subcohort 69669 phv00069669.v4.p10 pht000686.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:03:07+00:00 2018-05-15 18:03:07+00:00 idtype COHORT IDENTIFIER +70 Subcohort 69677 phv00069677.v4.p10 pht000687.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:03:15+00:00 2018-05-15 18:03:15+00:00 idtype COHORT IDENTIFIER +70 Subcohort 69682 phv00069682.v3.p10 pht000688.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:03:23+00:00 2018-05-15 18:03:23+00:00 idtype COHORT IDENTIFIER +70 Subcohort 70889 phv00070889.v4.p10 pht000689.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:03:30+00:00 2018-05-15 18:03:30+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 69841 phv00069841.v10.p10 pht000690.v11.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:03:38+00:00 2018-05-15 18:03:38+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 69847 phv00069847.v10.p10 pht000691.v11.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:03:46+00:00 2018-05-15 18:03:46+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 70364 phv00070364.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:03:56+00:00 2018-05-15 18:03:56+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 70742 phv00070742.v2.p10 pht000693.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:04:04+00:00 2018-05-15 18:04:04+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 70904 phv00070904.v3.p10 pht000694.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:04:15+00:00 2018-05-15 18:04:15+00:00 idtype COHORT IDENTIFIER +70 Subcohort 71880 phv00071880.v6.p10 pht000740.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:04:27+00:00 2018-05-15 18:04:27+00:00 idtype Framingham Cohort Identifier +70 Subcohort 71883 phv00071883.v3.p10 pht000741.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:04:37+00:00 2018-05-15 18:04:37+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Cases reviewed through Feb 2011 +70 Subcohort 71888 phv00071888.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:04:50+00:00 2018-05-15 18:04:50+00:00 IDTYPE Framingham cohort identifier +70 Subcohort 71900 phv00071900.v3.p10 pht000743.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:04:59+00:00 2018-05-15 18:04:59+00:00 idtype Framingham cohort identifier Collection Interval: Through 2005 +70 Subcohort 71908 phv00071908.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:05:08+00:00 2018-05-15 18:05:08+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +70 Subcohort 72013 phv00072013.v2.p10 pht000745.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:05:17+00:00 2018-05-15 18:05:17+00:00 idtype Framingham cohort identifier Collection Interval: 1998-2003 +70 Subcohort 72019 phv00072019.v4.p10 pht000746.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:05:29+00:00 2018-05-15 18:05:29+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 72044 phv00072044.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:05:41+00:00 2018-05-15 18:05:41+00:00 IDTYPE FRAMINGHAM COHORT IDENTIFIER +70 Subcohort 72619 phv00072619.v4.p10 pht000748.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:05:49+00:00 2018-05-15 18:05:49+00:00 idtype Framingham Cohort Identifier +70 Subcohort 73718 phv00073718.v4.p10 pht000820.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:06:02+00:00 2018-05-15 18:06:02+00:00 idtype Framingham Cohort Identifier +70 Subcohort 73721 phv00073721.v2.p10 pht000821.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:06:13+00:00 2018-05-15 18:06:13+00:00 idtype Framingham Cohort Identifier +70 Subcohort 73725 phv00073725.v2.p10 pht000822.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:06:24+00:00 2018-05-15 18:06:24+00:00 idtype Framingham Cohort Identifier +70 Subcohort 73728 phv00073728.v2.p10 pht000823.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:07:11+00:00 2018-05-15 18:07:11+00:00 idtype Framingham Cohort Identifier +70 Subcohort 73734 phv00073734.v4.p10 pht000824.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:07:23+00:00 2018-05-15 18:07:23+00:00 idtype Framingham Cohort Identifier +70 Subcohort 73737 phv00073737.v2.p10 pht000825.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:07:33+00:00 2018-05-15 18:07:33+00:00 idtype Framingham Cohort Identifier +70 Subcohort 73740 phv00073740.v2.p10 pht000826.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:07:57+00:00 2018-05-15 18:07:57+00:00 idtype Framingham Cohort Identifier +70 Subcohort 73754 phv00073754.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:09:35+00:00 2018-05-15 18:09:35+00:00 IDTYPE Framingham Cohort Identifier Collection Interval: Exam 28 +70 Subcohort 73785 phv00073785.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:09:43+00:00 2018-05-15 18:09:43+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 73817 phv00073817.v1.p10 pht000830.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:09:50+00:00 2018-05-15 18:09:50+00:00 idtype Framingham Cohort Identifier Collection Interval: Exam 20 +70 Subcohort 73827 phv00073827.v4.p10 pht000832.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:10:29+00:00 2018-05-15 18:10:29+00:00 idtype Framingham Cohort Identifier +70 Subcohort 76324 phv00076324.v2.p10 pht000903.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:10:37+00:00 2018-05-15 18:10:37+00:00 idtype Framingham Cohort Identifier Collection Interval: 2002-2005 +70 Subcohort 76336 phv00076336.v3.p10 pht000904.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:10:46+00:00 2018-05-15 18:10:46+00:00 idtype Framingham Cohort Identifier +70 Subcohort 76348 phv00076348.v2.p10 pht000905.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:10:55+00:00 2018-05-15 18:10:55+00:00 IDTYPE Framingham Cohort Identifier Collection Interval: 2002-2005 +70 Subcohort 76359 phv00076359.v3.p10 pht000906.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:11:11+00:00 2018-05-15 18:11:11+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 76365 phv00076365.v4.p10 pht000907.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:12:02+00:00 2018-05-15 18:12:02+00:00 IDTYPE Framingham cohort identifier +70 Subcohort 76381 phv00076381.v6.p10 pht000908.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:12:14+00:00 2018-05-15 18:12:14+00:00 IDTYPE Framingham Heart Study Cohort Identifier +70 Subcohort 76395 phv00076395.v3.p10 pht000909.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:12:26+00:00 2018-05-15 18:12:26+00:00 idtype Framingham Cohort Identifier +70 Subcohort 76398 phv00076398.v4.p10 pht000910.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:12:34+00:00 2018-05-15 18:12:34+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 80750 phv00080750.v2.p10 pht001039.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:12:45+00:00 2018-05-15 18:12:45+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 80762 phv00080762.v2.p10 pht001040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:12:56+00:00 2018-05-15 18:12:56+00:00 idtype Framingham Cohort Identifier +70 Subcohort 80764 phv00080764.v4.p10 pht001041.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:13:06+00:00 2018-05-15 18:13:06+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 80769 phv00080769.v2.p10 pht001042.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:13:17+00:00 2018-05-15 18:13:17+00:00 idtype Framingham Cohort Identifier +70 Subcohort 80998 phv00080998.v2.p10 pht001043.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:13:26+00:00 2018-05-15 18:13:26+00:00 idtype Framingham Cohort Identifier +70 Subcohort 81009 phv00081009.v5.p10 pht001044.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:13:35+00:00 2018-05-15 18:13:35+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 81012 phv00081012.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:13:43+00:00 2018-05-15 18:13:43+00:00 IDTYPE Framingham Cohort Identifier Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +70 Subcohort 89301 phv00089301.v6.p10 pht001177.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:13:52+00:00 2018-05-15 18:13:52+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 89306 phv00089306.v6.p10 pht001178.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:14:03+00:00 2018-05-15 18:14:03+00:00 idtype Framingham Cohort Identifier +70 Subcohort 89333 phv00089333.v1.p10 pht001179.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:14:13+00:00 2018-05-15 18:14:13+00:00 IDTYPE Framingham Cohort Identifier Collection Interval: Exams 17 - 21 +70 Subcohort 89412 phv00089412.v2.p10 pht001182.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:14:23+00:00 2018-05-15 18:14:23+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 89417 phv00089417.v2.p10 pht001183.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:14:36+00:00 2018-05-15 18:14:36+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Cases reviewed through July 2012 +70 Subcohort 90344 phv00090344.v2.p10 pht001224.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:14:47+00:00 2018-05-15 18:14:47+00:00 idtype Framingham Cohort Identifier Collection Interval: 2002-2005 +70 Subcohort 90347 phv00090347.v2.p10 pht001225.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:15:15+00:00 2018-05-15 18:15:15+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 90353 phv00090353.v2.p10 pht001226.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:15:23+00:00 2018-05-15 18:15:23+00:00 IDTYPE Framingham Cohort Identifier Collection Interval: 2002-2005 +70 Subcohort 90357 phv00090357.v2.p10 pht001227.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:15:30+00:00 2018-05-15 18:15:30+00:00 IDTYPE Framingham Cohort Identifier +70 Subcohort 90363 phv00090363.v2.p10 pht001228.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:15:38+00:00 2018-05-15 18:15:38+00:00 idtype Framingham Cohort Identifier Collection Interval: Exam 7 +70 Subcohort 121941 phv00121941.v2.p10 pht001892.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:15:50+00:00 2018-05-15 18:15:50+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 121954 phv00121954.v3.p10 pht001893.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:15:59+00:00 2018-05-15 18:15:59+00:00 IDtype Framingham Cohort Identifier +70 Subcohort 121970 phv00121970.v2.p10 pht001894.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:16:07+00:00 2018-05-15 18:16:07+00:00 IDtype Framingham Cohort Identifier +70 Subcohort 141867 phv00141867.v4.p10 pht002072.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:16:15+00:00 2018-05-15 18:16:15+00:00 IDTYPE Framingham Heart Study cohort group +70 Subcohort 141874 phv00141874.v3.p10 pht002073.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:16:25+00:00 2018-05-15 18:16:25+00:00 idtype Framingham Cohort Identifier Collection Interval: Test performed 1995-1998 +70 Subcohort 141914 phv00141914.v2.p10 pht002074.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:16:34+00:00 2018-05-15 18:16:34+00:00 idtype FHS Cohort Identifier +70 Subcohort 142045 phv00142045.v2.p10 pht002075.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:16:47+00:00 2018-05-15 18:16:47+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Cases reviewed through 4/2012 +70 Subcohort 142053 phv00142053.v4.p10 pht002076.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:26:42+00:00 2018-05-15 18:26:42+00:00 idtype Framingham Heart Study cohort group +70 Subcohort 142393 phv00142393.v4.p10 pht002077.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:26:51+00:00 2018-05-15 18:26:51+00:00 idtype FHS Cohort Identifier +70 Subcohort 142423 phv00142423.v4.p10 pht002078.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:27:00+00:00 2018-05-15 18:27:00+00:00 idtype Framingham Heart Study cohort group +70 Subcohort 142461 phv00142461.v1.p10 pht002080.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:27:08+00:00 2018-05-15 18:27:08+00:00 idtype FHS Cohort Identifier Collection Interval: Exams 10, 14, and 22 +70 Subcohort 156629 phv00156629.v4.p10 pht002141.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:27:16+00:00 2018-05-15 18:27:16+00:00 idtype Framingham Cohort Identifier +70 Subcohort 156638 phv00156638.v4.p10 pht002142.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:27:24+00:00 2018-05-15 18:27:24+00:00 idtype Framingham Cohort Identifier +70 Subcohort 156647 phv00156647.v4.p10 pht002143.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:27:33+00:00 2018-05-15 18:27:33+00:00 idtype Framingham Cohort Identifier +70 Subcohort 156664 phv00156664.v3.p10 pht002144.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:27:41+00:00 2018-05-15 18:27:41+00:00 idtype Framingham Cohort Identifier +70 Subcohort 156676 phv00156676.v3.p10 pht002145.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:27:50+00:00 2018-05-15 18:27:50+00:00 idtype Framingham Cohort Identifier +70 Subcohort 156684 phv00156684.v4.p10 pht002146.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:27:58+00:00 2018-05-15 18:27:58+00:00 idtype Framingham Cohort Identifier +70 Subcohort 156709 phv00156709.v1.p10 pht002147.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:28:06+00:00 2018-05-15 18:28:06+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Scan done 2002 - 2005 +70 Subcohort 156741 phv00156741.v2.p10 pht002148.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:28:15+00:00 2018-05-15 18:28:15+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 156750 phv00156750.v2.p10 pht002149.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:28:23+00:00 2018-05-15 18:28:23+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 157295 phv00157295.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:28:30+00:00 2018-05-15 18:28:30+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 157770 phv00157770.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:28:43+00:00 2018-05-15 18:28:43+00:00 idtype COHORT IDENTIFIER +70 Subcohort 158090 phv00158090.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:28:50+00:00 2018-05-15 18:28:50+00:00 idtype COHORT IDENTIFIER +70 Subcohort 158539 phv00158539.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:28:58+00:00 2018-05-15 18:28:58+00:00 idtype COHORT IDENTIFIER +70 Subcohort 158542 phv00158542.v3.p10 pht002154.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:29:05+00:00 2018-05-15 18:29:05+00:00 idtype Framingham Cohort Identifier +70 Subcohort 158551 phv00158551.v3.p10 pht002155.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:29:13+00:00 2018-05-15 18:29:13+00:00 idtype Framingham Cohort Identifier +70 Subcohort 159486 phv00159486.v4.p10 pht002232.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:29:21+00:00 2018-05-15 18:29:21+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 159493 phv00159493.v4.p10 pht002233.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:29:30+00:00 2018-05-15 18:29:30+00:00 IDTYPE Framingham Heart Study cohort group +70 Subcohort 159549 phv00159549.v4.p10 pht002234.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:29:38+00:00 2018-05-15 18:29:38+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 159552 phv00159552.v4.p10 pht002235.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:29:47+00:00 2018-05-15 18:29:47+00:00 IDTYPE Framingham Heart Study cohort group +70 Subcohort 159554 phv00159554.v3.p10 pht002236.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:29:58+00:00 2018-05-15 18:29:58+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Exam dates from 12/2000 to 6/2008 +70 Subcohort 161912 phv00161912.v3.p10 pht002343.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:30:07+00:00 2018-05-15 18:30:07+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 161914 phv00161914.v4.p10 pht002344.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:30:15+00:00 2018-05-15 18:30:15+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 162080 phv00162080.v1.p10 pht002346.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:30:23+00:00 2018-05-15 18:30:23+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test done at Generation 3 Exam 2 between April 2010 and March 2011 +70 Subcohort 162092 phv00162092.v1.p10 pht002347.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:30:31+00:00 2018-05-15 18:30:31+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: CT scans done between 2002-2005 +70 Subcohort 162100 phv00162100.v2.p10 pht002348.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:30:39+00:00 2018-05-15 18:30:39+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test done 1995 - 1998 +70 Subcohort 162110 phv00162110.v1.p10 pht002349.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:30:47+00:00 2018-05-15 18:30:47+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test done at Generation 3 Exam 2 between September 2010 to March 2011 +70 Subcohort 162673 phv00162673.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:30:56+00:00 2018-05-15 18:30:56+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 163417 phv00163417.v4.p10 pht002424.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:31:05+00:00 2018-05-15 18:31:05+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 163438 phv00163438.v2.p10 pht002425.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:31:13+00:00 2018-05-15 18:31:13+00:00 IDTYPE Framingham Heart Study cohort group Collection Interval: Exam 8 +70 Subcohort 163440 phv00163440.v2.p10 pht002426.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:31:21+00:00 2018-05-15 18:31:21+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 163449 phv00163449.v3.p10 pht002427.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:31:29+00:00 2018-05-15 18:31:29+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 163453 phv00163453.v1.p10 pht002428.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:31:45+00:00 2018-05-15 18:31:45+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Exams 8, 9, 10 +70 Subcohort 163455 phv00163455.v1.p10 pht002429.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:31:53+00:00 2018-05-15 18:31:53+00:00 idtype Participant Cohort Group Collection Interval: Original Cohort Exam 11 and Offspring Exam 1 +70 Subcohort 163498 phv00163498.v1.p10 pht002430.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:32:01+00:00 2018-05-15 18:32:01+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 163501 phv00163501.v3.p10 pht002431.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:32:10+00:00 2018-05-15 18:32:10+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Original Cohort Exams 27 and 28, Offspring Exam 8 +70 Subcohort 163511 phv00163511.v1.p10 pht002432.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:32:26+00:00 2018-05-15 18:32:26+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 166709 phv00166709.v4.p10 pht002564.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:32:34+00:00 2018-05-15 18:32:34+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 166776 phv00166776.v4.p10 pht002565.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:32:42+00:00 2018-05-15 18:32:42+00:00 idtype Framingham cohort identifier +70 Subcohort 166831 phv00166831.v3.p10 pht002566.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:32:49+00:00 2018-05-15 18:32:49+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 166938 phv00166938.v3.p10 pht002567.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:32:57+00:00 2018-05-15 18:32:57+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 166940 phv00166940.v5.p10 pht002568.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:33:04+00:00 2018-05-15 18:33:04+00:00 IDTYPE Framingham cohort identifier +70 Subcohort 166964 phv00166964.v4.p10 pht002569.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:33:12+00:00 2018-05-15 18:33:12+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 166970 phv00166970.v1.p10 pht002570.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:33:24+00:00 2018-05-15 18:33:24+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 166997 phv00166997.v1.p10 pht002571.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:33:35+00:00 2018-05-15 18:33:35+00:00 idtype Framingham cohort identifier Collection Interval: Scans done between 2002-2005 +70 Subcohort 167000 phv00167000.v5.p10 pht002572.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:33:44+00:00 2018-05-15 18:33:44+00:00 IDTYPE FRAMINGHAM HEART STUDY COHORT IDENTIFIER +70 Subcohort 167132 phv00167132.v1.p10 pht002573.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:33:51+00:00 2018-05-15 18:33:51+00:00 IDTYPE FRAMINGHAM HEART STUDY COHORT IDENTIFIER +70 Subcohort 171859 phv00171859.v5.p10 pht002851.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:33:59+00:00 2018-05-15 18:33:59+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 171862 phv00171862.v2.p10 pht002852.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:34:07+00:00 2018-05-15 18:34:07+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 171872 phv00171872.v4.p10 pht002853.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:34:16+00:00 2018-05-15 18:34:16+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 171878 phv00171878.v1.p10 pht002854.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:34:25+00:00 2018-05-15 18:34:25+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 172157 phv00172157.v4.p10 pht002888.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:34:32+00:00 2018-05-15 18:34:32+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172160 phv00172160.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:34:41+00:00 2018-05-15 18:34:41+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 172211 phv00172211.v4.p10 pht002890.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:34:49+00:00 2018-05-15 18:34:49+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172219 phv00172219.v4.p10 pht002891.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:35:01+00:00 2018-05-15 18:35:01+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172231 phv00172231.v4.p10 pht002892.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:35:10+00:00 2018-05-15 18:35:10+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172241 phv00172241.v4.p10 pht002893.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:35:20+00:00 2018-05-15 18:35:20+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172303 phv00172303.v1.p10 pht002894.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:35:28+00:00 2018-05-15 18:35:28+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Exam 5 +70 Subcohort 172357 phv00172357.v1.p10 pht002895.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:35:36+00:00 2018-05-15 18:35:36+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172360 phv00172360.v4.p10 pht002896.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:35:45+00:00 2018-05-15 18:35:45+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172368 phv00172368.v4.p10 pht002897.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:35:56+00:00 2018-05-15 18:35:56+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172382 phv00172382.v2.p10 pht002898.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:36:11+00:00 2018-05-15 18:36:11+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 172387 phv00172387.v4.p10 pht002899.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:36:18+00:00 2018-05-15 18:36:18+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 173095 phv00173095.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:36:25+00:00 2018-05-15 18:36:25+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 177238 phv00177238.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:36:33+00:00 2018-05-15 18:36:33+00:00 idtype Framingham Heart Study participant cohort identifier +70 Subcohort 177785 phv00177785.v1.p10 pht003095.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:36:41+00:00 2018-05-15 18:36:41+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 177804 phv00177804.v2.p10 pht003096.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:36:50+00:00 2018-05-15 18:36:50+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Scans done from January 2002 through July 2008 +70 Subcohort 177810 phv00177810.v3.p10 pht003097.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:36:58+00:00 2018-05-15 18:36:58+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 177893 phv00177893.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:37:07+00:00 2018-05-15 18:37:07+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 177928 phv00177928.v4.p10 pht003099.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:37:16+00:00 2018-05-15 18:37:16+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 190689 phv00190689.v3.p10 pht003309.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:37:24+00:00 2018-05-15 18:37:24+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 190761 phv00190761.v2.p10 pht003310.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:37:34+00:00 2018-05-15 18:37:34+00:00 idtype Framingham participant IDTYPE +70 Subcohort 190764 phv00190764.v2.p10 pht003311.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:37:42+00:00 2018-05-15 18:37:42+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Tests performed between 1995 and 1998 +70 Subcohort 190767 phv00190767.v1.p10 pht003312.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:37:50+00:00 2018-05-15 18:37:50+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Exam 5 +70 Subcohort 190791 phv00190791.v2.p10 pht003313.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:37:59+00:00 2018-05-15 18:37:59+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: 12/2000 - 6/2009 +70 Subcohort 190811 phv00190811.v3.p10 pht003315.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:38:09+00:00 2018-05-15 18:38:09+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 190815 phv00190815.v4.p10 pht003316.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:38:19+00:00 2018-05-15 18:38:19+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 190828 phv00190828.v3.p10 pht003317.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:38:29+00:00 2018-05-15 18:38:29+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 190975 phv00190975.v3.p10 pht003334.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:38:39+00:00 2018-05-15 18:38:39+00:00 IDTYPE Framingham Heart Study Cohort Identifier Collection Interval: Cases reviewed 1/1949 - 12/2012 +70 Subcohort 190980 phv00190980.v5.p10 pht003335.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:39:29+00:00 2018-05-15 18:39:29+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 195382 phv00195382.v1.p10 pht003459.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:39:37+00:00 2018-05-15 18:39:37+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 195489 phv00195489.v1.p10 pht003462.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:39:47+00:00 2018-05-15 18:39:47+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 195497 phv00195497.v1.p10 pht003463.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:39:57+00:00 2018-05-15 18:39:57+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 196511 phv00196511.v2.p10 pht003628.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:40:06+00:00 2018-05-15 18:40:06+00:00 IDTYPE FHS cohort identifier +70 Subcohort 196515 phv00196515.v1.p10 pht003629.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:40:19+00:00 2018-05-15 18:40:19+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 196519 phv00196519.v3.p10 pht003630.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:40:33+00:00 2018-05-15 18:40:33+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 196531 phv00196531.v2.p10 pht003631.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:40:55+00:00 2018-05-15 18:40:55+00:00 idtype Idtype +70 Subcohort 196547 phv00196547.v2.p10 pht003632.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:41:05+00:00 2018-05-15 18:41:05+00:00 idtype Study Group Identifier +70 Subcohort 196564 phv00196564.v2.p10 pht003633.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:41:14+00:00 2018-05-15 18:41:14+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 196581 phv00196581.v2.p10 pht003634.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:41:21+00:00 2018-05-15 18:41:21+00:00 idtype Framingham Heart Study cohort identifier, Albuterol Collection Interval: Offspring Exam 8, Omni 1 Exam 3 +70 Subcohort 201100 phv00201100.v1.p10 pht003782.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:41:29+00:00 2018-05-15 18:41:29+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Cases Reviewed Through 2013 +70 Subcohort 201990 phv00201990.v2.p10 pht003901.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:41:38+00:00 2018-05-15 18:41:38+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 201994 phv00201994.v2.p10 pht003902.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:41:46+00:00 2018-05-15 18:41:46+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 201998 phv00201998.v2.p10 pht003903.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:41:55+00:00 2018-05-15 18:41:55+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 202013 phv00202013.v2.p10 pht003904.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:42:02+00:00 2018-05-15 18:42:02+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 202019 phv00202019.v3.p10 pht003905.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:42:11+00:00 2018-05-15 18:42:11+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 202022 phv00202022.v4.p10 pht003906.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:42:19+00:00 2018-05-15 18:42:19+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 202066 phv00202066.v3.p10 pht003910.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:42:29+00:00 2018-05-15 18:42:29+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 219225 phv00219225.v2.p10 pht004361.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:42:39+00:00 2018-05-15 18:42:39+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 219233 phv00219233.v1.p10 pht004362.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:42:50+00:00 2018-05-15 18:42:50+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Offspring Exam 6 +70 Subcohort 219545 phv00219545.v2.p10 pht004363.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:43:08+00:00 2018-05-15 18:43:08+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 219551 phv00219551.v1.p10 pht004364.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:43:17+00:00 2018-05-15 18:43:17+00:00 idtype Framingham Heart Study participant cohort identifier Collection Interval: 2005-2010 +70 Subcohort 220689 phv00220689.v3.p10 pht004365.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:43:32+00:00 2018-05-15 18:43:32+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Brain MRI Scans Dates 3/1999 to 8/2011 +70 Subcohort 220703 phv00220703.v3.p10 pht004366.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:43:40+00:00 2018-05-15 18:43:40+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 220740 phv00220740.v1.p10 pht004367.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:43:47+00:00 2018-05-15 18:43:47+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: 1999-2005 +70 Subcohort 220744 phv00220744.v2.p10 pht004368.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:43:55+00:00 2018-05-15 18:43:55+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 220750 phv00220750.v1.p10 pht004369.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:44:05+00:00 2018-05-15 18:44:05+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 220756 phv00220756.v1.p10 pht004370.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:44:14+00:00 2018-05-15 18:44:14+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 220822 phv00220822.v3.p10 pht004374.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:44:26+00:00 2018-05-15 18:44:26+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 220864 phv00220864.v2.p10 pht004375.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:44:35+00:00 2018-05-15 18:44:35+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Questionnaire administered at Original cohort Exams 14 and 15 +70 Subcohort 227010 phv00227010.v1.p10 pht004800.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:44:58+00:00 2018-05-15 18:44:58+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 227013 phv00227013.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:45:15+00:00 2018-05-15 18:45:15+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Exam 1 +70 Subcohort 227024 phv00227024.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:45:22+00:00 2018-05-15 18:45:22+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 227074 phv00227074.v1.p10 pht004803.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:45:30+00:00 2018-05-15 18:45:30+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 227081 phv00227081.v1.p10 pht004804.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:45:37+00:00 2018-05-15 18:45:37+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 227083 phv00227083.v1.p10 pht004805.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:45:45+00:00 2018-05-15 18:45:45+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 227088 phv00227088.v1.p10 pht004806.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:45:57+00:00 2018-05-15 18:45:57+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Exam 1 +70 Subcohort 227158 phv00227158.v1.p10 pht004807.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:46:09+00:00 2018-05-15 18:46:09+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 227163 phv00227163.v1.p10 pht004808.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:46:18+00:00 2018-05-15 18:46:18+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 227262 phv00227262.v1.p10 pht004809.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:46:29+00:00 2018-05-15 18:46:29+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test performed at Offspring Exam9 and Omni 1 Exam 4 +70 Subcohort 227293 phv00227293.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:46:39+00:00 2018-05-15 18:46:39+00:00 idtype Framingham Heart Study participant identifier within cohort (counts are observations, not participants) +70 Subcohort 227329 phv00227329.v1.p10 pht004811.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:46:47+00:00 2018-05-15 18:46:47+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 238808 phv00238808.v1.p10 pht004812.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:46:55+00:00 2018-05-15 18:46:55+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 250283 phv00250283.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:47:03+00:00 2018-05-15 18:47:03+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Exam 1 +70 Subcohort 250719 phv00250719.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:47:10+00:00 2018-05-15 18:47:10+00:00 idtype Framingham Heart Study participant cohort identifier Collection Interval: Exam 2 +70 Subcohort 251263 phv00251263.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:47:19+00:00 2018-05-15 18:47:19+00:00 idtype Framingham Heart Study participant cohort identifier Collection Interval: Exam 3 +70 Subcohort 254011 phv00254011.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:47:29+00:00 2018-05-15 18:47:29+00:00 idtype Framingham Heart Study participant cohort identifier +70 Subcohort 254597 phv00254597.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:47:37+00:00 2018-05-15 18:47:37+00:00 idtype Framingham Heart Study participant cohort identifier Collection Interval: Exam 29 +70 Subcohort 254990 phv00254990.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:47:46+00:00 2018-05-15 18:47:46+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Original Cohort Exam 30 +70 Subcohort 255340 phv00255340.v1.p10 pht005143.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:47:55+00:00 2018-05-15 18:47:55+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 255417 phv00255417.v1.p10 pht005144.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:48:03+00:00 2018-05-15 18:48:03+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 255435 phv00255435.v1.p10 pht005145.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:48:11+00:00 2018-05-15 18:48:11+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 255462 phv00255462.v1.p10 pht005146.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:48:18+00:00 2018-05-15 18:48:18+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 256865 phv00256865.v1.p10 pht005147.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:48:26+00:00 2018-05-15 18:48:26+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Exam 8 +70 Subcohort 256868 phv00256868.v1.p10 pht005148.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:48:34+00:00 2018-05-15 18:48:34+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257537 phv00257537.v1.p10 pht005149.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:48:42+00:00 2018-05-15 18:48:42+00:00 IDTYPE Framingham Heart Study participant cohort identifier +70 Subcohort 257556 phv00257556.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:48:56+00:00 2018-05-15 18:48:56+00:00 idtype Framingham Heart Study participant cohort identifier +70 Subcohort 257577 phv00257577.v1.p10 pht005151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:49:03+00:00 2018-05-15 18:49:03+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test performed at Exam 2 +70 Subcohort 257589 phv00257589.v1.p10 pht005152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:49:17+00:00 2018-05-15 18:49:17+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257593 phv00257593.v1.p10 pht005153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:49:25+00:00 2018-05-15 18:49:25+00:00 IDTYPE FRAMINGHAM HEART STUDY COHORT IDENTIFIER +70 Subcohort 257600 phv00257600.v1.p10 pht005154.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:49:33+00:00 2018-05-15 18:49:33+00:00 IDTYPE FRAMINGHAM HEART STUDY COHORT IDENTIFIER +70 Subcohort 257606 phv00257606.v1.p10 pht005155.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:49:41+00:00 2018-05-15 18:49:41+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257612 phv00257612.v1.p10 pht005156.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:49:49+00:00 2018-05-15 18:49:49+00:00 IDTYPE Framingham Heart Study cohort group Collection Interval: 2002 - 2005 +70 Subcohort 257628 phv00257628.v1.p10 pht005157.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:49:57+00:00 2018-05-15 18:49:57+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257641 phv00257641.v1.p10 pht005158.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:50:06+00:00 2018-05-15 18:50:06+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257660 phv00257660.v1.p10 pht005159.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:50:13+00:00 2018-05-15 18:50:13+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257665 phv00257665.v1.p10 pht005160.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:50:22+00:00 2018-05-15 18:50:22+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257669 phv00257669.v1.p10 pht005161.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:50:30+00:00 2018-05-15 18:50:30+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257674 phv00257674.v1.p10 pht005162.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:50:40+00:00 2018-05-15 18:50:40+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257678 phv00257678.v1.p10 pht005163.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:50:47+00:00 2018-05-15 18:50:47+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257684 phv00257684.v1.p10 pht005164.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:50:55+00:00 2018-05-15 18:50:55+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 257716 phv00257716.v1.p10 pht005165.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:51:06+00:00 2018-05-15 18:51:06+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 257783 phv00257783.v1.p10 pht005166.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:51:16+00:00 2018-05-15 18:51:16+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 257798 phv00257798.v1.p10 pht005167.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:51:28+00:00 2018-05-15 18:51:28+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Omni 1 Exam 3 +70 Subcohort 257814 phv00257814.v1.p10 pht005168.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:51:37+00:00 2018-05-15 18:51:37+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +70 Subcohort 257830 phv00257830.v1.p10 pht005169.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:51:45+00:00 2018-05-15 18:51:45+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +70 Subcohort 257848 phv00257848.v1.p10 pht005170.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:51:55+00:00 2018-05-15 18:51:55+00:00 idtype Study Group Identifier +70 Subcohort 257864 phv00257864.v1.p10 pht005171.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:52:03+00:00 2018-05-15 18:52:03+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test performed at Offspring Exam 9 and Omni 1 Exam 4 +70 Subcohort 257881 phv00257881.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:52:12+00:00 2018-05-15 18:52:12+00:00 idtype Framingham Heart Study cohort identifier (counts are observations, not participants) +70 Subcohort 257913 phv00257913.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:52:20+00:00 2018-05-15 18:52:20+00:00 idtype Framingham Heart Study cohort identifier (counts are observations, not participants) Collection Interval: Original Cohort Exams 29, 30 and 31 +70 Subcohort 257947 phv00257947.v1.p10 pht005174.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:52:37+00:00 2018-05-15 18:52:37+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 257969 phv00257969.v1.p10 pht005175.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:52:53+00:00 2018-05-15 18:52:53+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Exam performed at Exam 17 through Exam 32 +70 Subcohort 261077 phv00261077.v1.p10 pht005389.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:53:01+00:00 2018-05-15 18:53:01+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 273701 phv00273701.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:53:09+00:00 2018-05-15 18:53:09+00:00 idtype Framingham Heart Study cohort identifier within a cohort Collection Interval: Exam 1 +70 Subcohort 274194 phv00274194.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:53:16+00:00 2018-05-15 18:53:16+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 274709 phv00274709.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:53:24+00:00 2018-05-15 18:53:24+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Original Cohort Exam 31 +70 Subcohort 275064 phv00275064.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:53:32+00:00 2018-05-15 18:53:32+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Original Cohort Exam 32 +70 Subcohort 275398 phv00275398.v1.p10 pht006009.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:53:40+00:00 2018-05-15 18:53:40+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 275401 phv00275401.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:53:48+00:00 2018-05-15 18:53:48+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Exam 2 +70 Subcohort 275411 phv00275411.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:53:58+00:00 2018-05-15 18:53:58+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Omni 1 Exam 3 +70 Subcohort 275423 phv00275423.v1.p10 pht006012.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:54:07+00:00 2018-05-15 18:54:07+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 275428 phv00275428.v1.p10 pht006013.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:54:14+00:00 2018-05-15 18:54:14+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 276559 phv00276559.v1.p10 pht006014.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:54:22+00:00 2018-05-15 18:54:22+00:00 idtype Framingham Heart Study cohort identifier Collection Interval: Test Performed after Offspring Exam 9 +70 Subcohort 276584 phv00276584.v1.p10 pht006015.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:54:31+00:00 2018-05-15 18:54:31+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 276642 phv00276642.v1.p10 pht006016.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:54:40+00:00 2018-05-15 18:54:40+00:00 idtype Framingham Heart Study cohort identifier +70 Subcohort 276649 phv00276649.v1.p10 pht006017.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:54:49+00:00 2018-05-15 18:54:49+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Original cohort: Baseline 1967-1969 Original cohort: Follow-up 1992 - 1993 Offsp +70 Subcohort 276845 phv00276845.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:54:57+00:00 2018-05-15 18:54:57+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 276909 phv00276909.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:55:08+00:00 2018-05-15 18:55:08+00:00 IDTYPE Framingham Heart Study participant identifier within cohort (counts are observations, not participants) Collection Interval: Exam 3 +70 Subcohort 276928 phv00276928.v1.p10 pht006020.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:55:17+00:00 2018-05-15 18:55:17+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Cumulative through Exam 2 +70 Subcohort 276939 phv00276939.v1.p10 pht006021.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:55:26+00:00 2018-05-15 18:55:26+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Cumulative through Exam 2 +70 Subcohort 276950 phv00276950.v1.p10 pht006022.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:55:34+00:00 2018-05-15 18:55:34+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: Cases reviewed through Exam 3 +70 Subcohort 276964 phv00276964.v1.p10 pht006023.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:55:44+00:00 2018-05-15 18:55:44+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 276970 phv00276970.v1.p10 pht006024.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:55:52+00:00 2018-05-15 18:55:52+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 276976 phv00276976.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:56:00+00:00 2018-05-15 18:56:00+00:00 IDTYPE Framingham Heart Study cohort identifier Collection Interval: 1975 through 2014 +70 Subcohort 277016 phv00277016.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:56:22+00:00 2018-05-15 18:56:22+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 277066 phv00277066.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-15 18:56:40+00:00 2018-05-15 18:56:40+00:00 IDTYPE Framingham Heart Study cohort identifier +70 Subcohort 23894 phv00023894.v1.p10 pht000172.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-05-16 12:33:08+00:00 2018-05-16 12:33:08+00:00 IDTYPE COHORT IDENTIFIER +70 Subcohort 126148 phv00126148.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:31:36+00:00 2018-06-12 01:31:36+00:00 PLKA1 Participant type +70 Subcohort 100290 phv00100290.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 21:57:09+00:00 2018-06-27 21:57:09+00:00 PERSTAT COHORT +70 Subcohort 100682 phv00100682.v1.p1 pht001456.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 21:57:47+00:00 2018-06-27 21:57:47+00:00 PERSTAT Cohort +70 Subcohort 100809 phv00100809.v1.p1 pht001466.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 21:58:23+00:00 2018-06-27 21:58:23+00:00 PERSTAT COHORT +70 Subcohort 100867 phv00100867.v1.p1 pht001469.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 21:58:43+00:00 2018-06-27 21:58:43+00:00 PERSTAT Cohort +70 Subcohort 101122 phv00101122.v1.p1 pht001470.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 21:59:02+00:00 2018-06-27 21:59:02+00:00 PERSTAT COHORT +70 Subcohort 101232 phv00101232.v1.p1 pht001472.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 21:59:18+00:00 2018-06-27 21:59:18+00:00 PERSTAT COHORT +70 Subcohort 101234 phv00101234.v1.p1 pht001473.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 21:59:32+00:00 2018-06-27 21:59:32+00:00 PERSTAT COHORT +70 Subcohort 101949 phv00101949.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 21:59:46+00:00 2018-06-27 21:59:46+00:00 PERSTAT COHORT +70 Subcohort 102584 phv00102584.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:01:05+00:00 2018-06-27 22:01:05+00:00 PERSTAT COHORT +70 Subcohort 106430 phv00106430.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:01:20+00:00 2018-06-27 22:01:20+00:00 PERSTAT COHORT +70 Subcohort 107355 phv00107355.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:01:35+00:00 2018-06-27 22:01:35+00:00 PERSTAT COHORT +70 Subcohort 107781 phv00107781.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:01:50+00:00 2018-06-27 22:01:50+00:00 PERSTAT COHORT +70 Subcohort 108392 phv00108392.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:02:06+00:00 2018-06-27 22:02:06+00:00 PERSTAT COHORT +70 Subcohort 109143 phv00109143.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:02:19+00:00 2018-06-27 22:02:19+00:00 PERSTAT COHORT +70 Subcohort 109856 phv00109856.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:02:31+00:00 2018-06-27 22:02:31+00:00 PERSTAT COHORT +70 Subcohort 80424 phv00080424.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:07:26+00:00 2018-06-28 22:07:26+00:00 CTFLAG CT Participant +70 Subcohort 80425 phv00080425.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:07:59+00:00 2018-06-28 22:07:59+00:00 OSFLAG OS Participant +70 Subcohort 80426 phv00080426.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:08:12+00:00 2018-06-28 22:08:12+00:00 HRTFLAG HRT Participant +70 Subcohort 80427 phv00080427.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:08:25+00:00 2018-06-28 22:08:25+00:00 DMFLAG DM Participant +70 Subcohort 80428 phv00080428.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:08:45+00:00 2018-06-28 22:08:45+00:00 CADFLAG CAD Participant +70 Subcohort 80429 phv00080429.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:08:57+00:00 2018-06-28 22:08:57+00:00 HRTARM HRT Arm +70 Subcohort 80430 phv00080430.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:09:18+00:00 2018-06-28 22:09:18+00:00 DMARM DM Arm +70 Subcohort 80431 phv00080431.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:09:31+00:00 2018-06-28 22:09:31+00:00 CADARM CaD Arm +70 Subcohort 80433 phv00080433.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:09:43+00:00 2018-06-28 22:09:43+00:00 BMDFLAG Rand to BMD +70 Subcohort 192297 phv00192297.v3.p3 pht003395.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:11:41+00:00 2018-06-28 22:11:41+00:00 EXTFLAG Enrolled in WHI Extension 1 +70 Subcohort 192300 phv00192300.v3.p3 pht003395.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:12:00+00:00 2018-06-28 22:12:00+00:00 EXT2FLAG Enrolled in WHI Extension 2 +70 Subcohort 192302 phv00192302.v3.p3 pht003395.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:12:15+00:00 2018-06-28 22:12:15+00:00 EXT2MRC Extension 2 MRC Participant +70 Subcohort 192303 phv00192303.v3.p3 pht003395.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-28 22:12:26+00:00 2018-06-28 22:12:26+00:00 EXT2SRC Extension 2 SRC Participant +71 Clinic visit 127610 phv00127610.v1.p1 pht001959.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:43:40+00:00 2018-03-16 01:43:40+00:00 VISIT CONTACT OCCASION +71 Clinic visit 125926 phv00125926.v1.p1 pht001945.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-16 01:53:16+00:00 2018-03-16 01:53:16+00:00 VISIT CONTACT OCCASION +71 Clinic visit 124550 phv00124550.v1.p1 pht001921.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-20 09:49:43+00:00 2018-03-20 09:49:43+00:00 VISIT CONTACT OCCASION [visit 1] +71 Clinic visit 124605 phv00124605.v1.p1 pht001922.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-20 09:49:43+00:00 2018-03-20 09:49:43+00:00 VISIT CONTACT OCCASION +71 Clinic visit 124615 phv00124615.v1.p1 pht001923.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-20 09:49:43+00:00 2018-03-20 09:49:43+00:00 VISIT CONTACT OCCASION +71 Clinic visit 124637 phv00124637.v1.p1 pht001924.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-20 09:49:43+00:00 2018-03-20 09:49:43+00:00 VISIT CONTACT OCCASION +71 Clinic visit 124668 phv00124668.v1.p1 pht001926.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-20 09:49:43+00:00 2018-03-20 09:49:43+00:00 VISIT CONTACT OCCASION +71 Clinic visit 124676 phv00124676.v1.p1 pht001927.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-20 09:49:43+00:00 2018-03-20 09:49:43+00:00 VISIT CONTACT OCCASION +71 Clinic visit 124710 phv00124710.v1.p1 pht001928.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-20 09:49:43+00:00 2018-03-20 09:49:43+00:00 VISIT CONTACT OCCASION +71 Clinic visit 127523 phv00127523.v1.p1 pht001956.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION +71 Clinic visit 127578 phv00127578.v1.p1 pht001957.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION +71 Clinic visit 127592 phv00127592.v1.p1 pht001958.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION +71 Clinic visit 127669 phv00127669.v1.p1 pht001962.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION +71 Clinic visit 127671 phv00127671.v1.p1 pht001963.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION +71 Clinic visit 127754 phv00127754.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION +71 Clinic visit 127985 phv00127985.v1.p1 pht001965.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION [visit 1] +71 Clinic visit 128027 phv00128027.v1.p1 pht001966.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128604 phv00128604.v1.p1 pht001982.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-03-22 21:33:29+00:00 2018-03-22 21:33:29+00:00 VISIT CONTACT OCCASION +71 Clinic visit 21570 phv00021570.v5.p10 pht000076.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 16:58:30+00:00 2018-06-04 16:58:30+00:00 EXAM EXAM CYCLE 7 (N=3257) +71 Clinic visit 21589 phv00021589.v5.p10 pht000077.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 16:59:24+00:00 2018-06-04 16:59:24+00:00 EXAM EXAM CYCLE 6 +71 Clinic visit 21987 phv00021987.v5.p10 pht000098.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:00:02+00:00 2018-06-04 17:00:02+00:00 EXAM EXAM CYCLE NUMBER +71 Clinic visit 23129 phv00023129.v1.p10 pht000138.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:00:27+00:00 2018-06-04 17:00:27+00:00 EXAM EXAM CYCLE 23 +71 Clinic visit 24716 phv00024716.v1.p10 pht000206.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:00:46+00:00 2018-06-04 17:00:46+00:00 EXAM EXAM MEASURED (9-11, 21-23) +71 Clinic visit 80751 phv00080751.v2.p10 pht001039.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:01:21+00:00 2018-06-04 17:01:21+00:00 EXAM FHS Exam number corresponding to the sample +71 Clinic visit 23206 phv00023206.v5.p10 pht000146.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:01:40+00:00 2018-06-04 17:01:40+00:00 EXAM EXAM CYCLE 7 +71 Clinic visit 36344 phv00036344.v3.p10 pht000298.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:01:57+00:00 2018-06-04 17:01:57+00:00 exam EXAM CYCLE: 1 +71 Clinic visit 23554 phv00023554.v5.p10 pht000151.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:02:19+00:00 2018-06-04 17:02:19+00:00 EXAM EXAM 3-4 (PREDOMINANTLY EXAM 3, N=10 FOR EXAM 4) +71 Clinic visit 73733 phv00073733.v4.p10 pht000824.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:02:41+00:00 2018-06-04 17:02:41+00:00 exam Exam cycle of pain questionnaire +71 Clinic visit 24556 phv00024556.v5.p10 pht000197.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:04:00+00:00 2018-06-04 17:04:00+00:00 hrv_exam FHS EXAM NUMBER +71 Clinic visit 36251 phv00036251.v1.p10 pht000294.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:04:41+00:00 2018-06-04 17:04:41+00:00 Exam EXAM NUMBER +71 Clinic visit 36220 phv00036220.v5.p10 pht000293.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:05:02+00:00 2018-06-04 17:05:02+00:00 Exam EXAM NUMBER 6 - 7 +71 Clinic visit 227020 phv00227020.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:05:32+00:00 2018-06-04 17:05:32+00:00 EXAM Exam number Collection Interval: Exam 1 +71 Clinic visit 275406 phv00275406.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:05:50+00:00 2018-06-04 17:05:50+00:00 EXAM Exam number Collection Interval: Exam 2 +71 Clinic visit 275424 phv00275424.v1.p10 pht006012.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:06:09+00:00 2018-06-04 17:06:09+00:00 EXAM Exam number +71 Clinic visit 227084 phv00227084.v1.p10 pht004805.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:06:28+00:00 2018-06-04 17:06:28+00:00 EXAM Framingham Heart Study cohort exam number +71 Clinic visit 172230 phv00172230.v4.p10 pht002892.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:20:51+00:00 2018-06-04 17:20:51+00:00 exam Exam Number +71 Clinic visit 227161 phv00227161.v1.p10 pht004807.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:21:16+00:00 2018-06-04 17:21:16+00:00 EXAM Framingham Heart Study cohort exam number +71 Clinic visit 219546 phv00219546.v2.p10 pht004363.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:22:04+00:00 2018-06-04 17:22:04+00:00 EXAM Framingham Heart Study exam number +71 Clinic visit 81047 phv00081047.v1.p10 pht001045.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:22:39+00:00 2018-06-04 17:22:39+00:00 exam Cohort exam corresponding to sample Collection Interval: Exam 20 (n=1279) and Exam 21 (n=38) +71 Clinic visit 36317 phv00036317.v3.p10 pht000295.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:23:13+00:00 2018-06-04 17:23:13+00:00 exam EXAM INDICATOR WHEN XRAY WAS OBTAINED +71 Clinic visit 70899 phv00070899.v1.p10 pht000685.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:23:33+00:00 2018-06-04 17:23:33+00:00 exam EXAM CYCLE: 7 +71 Clinic visit 22649 phv00022649.v1.p10 pht000103.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:23:59+00:00 2018-06-04 17:23:59+00:00 EXAM EXAM CYCLE OF TEST +71 Clinic visit 22702 phv00022702.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:24:17+00:00 2018-06-04 17:24:17+00:00 EXAM FRAMINGHAM EXAM CYCLE 5-6 +71 Clinic visit 22727 phv00022727.v1.p10 pht000108.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:24:55+00:00 2018-06-04 17:24:55+00:00 RHDEXAM EXAM OF FIRST RHEUMATIC HEART DISEASE +71 Clinic visit 167002 phv00167002.v5.p10 pht002572.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:25:37+00:00 2018-06-04 17:25:37+00:00 EXAM EXAM NUMBER +71 Clinic visit 167134 phv00167134.v1.p10 pht002573.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:25:56+00:00 2018-06-04 17:25:56+00:00 EXAM EXAM NUMBER +71 Clinic visit 156740 phv00156740.v2.p10 pht002148.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:26:13+00:00 2018-06-04 17:26:13+00:00 EXAM Exam number +71 Clinic visit 163456 phv00163456.v1.p10 pht002429.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:26:45+00:00 2018-06-04 17:26:45+00:00 exam_number Number of Exam Collection Interval: Original Cohort Exam 11 and Offspring Exam 1 +71 Clinic visit 159556 phv00159556.v3.p10 pht002236.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:50:32+00:00 2018-06-04 17:50:32+00:00 exam Closest Framingham exam cycle Collection Interval: Exam dates from 12/2000 to 6/2008 +71 Clinic visit 163502 phv00163502.v3.p10 pht002431.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:50:56+00:00 2018-06-04 17:50:56+00:00 exam Exam number Collection Interval: Original Cohort Exams 27 and 28, Offspring Exam 8 +71 Clinic visit 227327 phv00227327.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:51:29+00:00 2018-06-04 17:51:29+00:00 exam Exam number (counts are observations, not participants) +71 Clinic visit 257914 phv00257914.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:52:38+00:00 2018-06-04 17:52:38+00:00 exam Exam number (counts are observations, not participants) Collection Interval: Original Cohort Exams 29, 30 and 31 +71 Clinic visit 257948 phv00257948.v1.p10 pht005174.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:54:58+00:00 2018-06-04 17:54:58+00:00 exam EXAM NUMBER +71 Clinic visit 257970 phv00257970.v1.p10 pht005175.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 17:55:24+00:00 2018-06-04 17:55:24+00:00 exam EXAM NUMBER Collection Interval: Exam performed at Exam 17 through Exam 32 +71 Clinic visit 55165 phv00055165.v4.p10 pht000394.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-04 18:10:45+00:00 2018-06-04 18:10:45+00:00 EXAM EXAM CYCLE 7 +71 Clinic visit 124739 phv00124739.v1.p1 pht001929.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 14:56:56+00:00 2018-06-08 14:56:56+00:00 VISIT CONTACT OCCASION [visit 1] +71 Clinic visit 124863 phv00124863.v1.p1 pht001930.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:02:45+00:00 2018-06-08 15:02:45+00:00 VISIT CONTACT OCCASION +71 Clinic visit 124987 phv00124987.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 15:11:40+00:00 2018-06-08 15:11:40+00:00 VISIT CONTACT OCCASION +71 Clinic visit 125072 phv00125072.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:28:42+00:00 2018-06-08 16:28:42+00:00 VISIT CONTACT OCCASION +71 Clinic visit 125157 phv00125157.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:44:42+00:00 2018-06-08 16:44:42+00:00 VISIT CONTACT OCCASION +71 Clinic visit 125243 phv00125243.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 16:58:26+00:00 2018-06-08 16:58:26+00:00 VISIT CONTACT OCCASION +71 Clinic visit 125329 phv00125329.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-08 17:05:06+00:00 2018-06-08 17:05:06+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128495 phv00128495.v1.p1 pht001977.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-17 18:29:41+00:00 2018-06-17 18:29:41+00:00 VISIT CONTACT OCCASION +71 Clinic visit 127121 phv00127121.v1.p1 pht001954.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:40:40+00:00 2018-06-20 01:40:40+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128172 phv00128172.v1.p1 pht001968.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:38:54+00:00 2018-06-20 16:38:54+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128245 phv00128245.v1.p1 pht001970.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:40:10+00:00 2018-06-20 16:40:10+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128382 phv00128382.v1.p1 pht001975.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:45:34+00:00 2018-06-20 16:45:34+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128578 phv00128578.v1.p1 pht001979.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:55:38+00:00 2018-06-20 16:55:38+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128587 phv00128587.v1.p1 pht001980.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:55:55+00:00 2018-06-20 16:55:55+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128331 phv00128331.v1.p1 pht001973.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:56:44+00:00 2018-06-20 16:56:44+00:00 VISIT CONTACT OCCASION +71 Clinic visit 128085 phv00128085.v1.p1 pht001967.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:16:32+00:00 2018-06-20 18:16:32+00:00 VISIT CONTACT OCCASION +71 Clinic visit 100772 phv00100772.v1.p1 pht001463.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 23:54:19+00:00 2018-06-27 23:54:19+00:00 SampleYear Year sample taken +71 Clinic visit 99570 phv00099570.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:28:35+00:00 2018-06-29 16:28:35+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 100283 phv00100283.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:28:47+00:00 2018-06-29 16:28:47+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 100692 phv00100692.v1.p1 pht001459.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:29:21+00:00 2018-06-29 16:29:21+00:00 YEAR Year CAC was measured +71 Clinic visit 101404 phv00101404.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:29:43+00:00 2018-06-29 16:29:43+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 102282 phv00102282.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:29:58+00:00 2018-06-29 16:29:58+00:00 YEAR NUMBER OF YEARS SINCE BASELINE +71 Clinic visit 103855 phv00103855.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:30:12+00:00 2018-06-29 16:30:12+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 104543 phv00104543.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:30:24+00:00 2018-06-29 16:30:24+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 105620 phv00105620.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:30:34+00:00 2018-06-29 16:30:34+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 107591 phv00107591.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:30:47+00:00 2018-06-29 16:30:47+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 108391 phv00108391.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:30:57+00:00 2018-06-29 16:30:57+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 109142 phv00109142.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:31:08+00:00 2018-06-29 16:31:08+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 110524 phv00110524.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-29 16:31:27+00:00 2018-06-29 16:31:27+00:00 YEAR Number of YEARS SINCE BASELINE +71 Clinic visit 77317 phv00077317.v6.p3 pht000983.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:24:20+00:00 2018-06-29 22:24:20+00:00 HIPVTYP Hip scan visit type +71 Clinic visit 77318 phv00077318.v6.p3 pht000983.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:24:20+00:00 2018-06-29 22:24:20+00:00 HIPVY Hip scan visit year +71 Clinic visit 77330 phv00077330.v6.p3 pht000984.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:25:21+00:00 2018-06-29 22:25:21+00:00 SPNVTYP Spine scan visit type +71 Clinic visit 77331 phv00077331.v6.p3 pht000984.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:25:21+00:00 2018-06-29 22:25:21+00:00 SPNVY Spine scan visit year +71 Clinic visit 283349 phv00283349.v1.p3 pht006218.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:25:21+00:00 2018-06-29 22:25:21+00:00 VTYP Visit Type +71 Clinic visit 283350 phv00283350.v1.p3 pht006218.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:26:00+00:00 2018-06-29 22:26:00+00:00 VISITYR Visit Year +71 Clinic visit 77339 phv00077339.v6.p3 pht000985.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:26:48+00:00 2018-06-29 22:26:48+00:00 WBVTYP Whole body scan visit type +71 Clinic visit 77340 phv00077340.v6.p3 pht000985.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:26:48+00:00 2018-06-29 22:26:48+00:00 WBVY Whole body visit year +71 Clinic visit 77361 phv00077361.v6.p3 pht000986.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:27:19+00:00 2018-06-29 22:27:19+00:00 CBCVTYP CBC Visit type +71 Clinic visit 77362 phv00077362.v6.p3 pht000986.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:27:19+00:00 2018-06-29 22:27:19+00:00 CBCVY CBC Visit year +71 Clinic visit 77370 phv00077370.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:28:16+00:00 2018-06-29 22:28:16+00:00 COREVTYP Visit Type +71 Clinic visit 77371 phv00077371.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:28:16+00:00 2018-06-29 22:28:16+00:00 COREVY Visit year +71 Clinic visit 77442 phv00077442.v6.p3 pht000989.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:29:18+00:00 2018-06-29 22:29:18+00:00 ECGFUVTYP Follow-up ECG visit type +71 Clinic visit 77443 phv00077443.v6.p3 pht000989.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:29:18+00:00 2018-06-29 22:29:18+00:00 ECGFUVY Follow-up ECG visit year +71 Clinic visit 78829 phv00078829.v6.p3 pht001004.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:34+00:00 2018-06-29 22:49:34+00:00 F35VTYP Visit Type +71 Clinic visit 78830 phv00078830.v6.p3 pht001004.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:34+00:00 2018-06-29 22:49:34+00:00 F35VY Visit year +71 Clinic visit 79313 phv00079313.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:34+00:00 2018-06-29 22:49:34+00:00 F41VTYP Visit Type +71 Clinic visit 79314 phv00079314.v6.p3 pht001009.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:34+00:00 2018-06-29 22:49:34+00:00 F41VY Visit year +71 Clinic visit 79850 phv00079850.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:34+00:00 2018-06-29 22:49:34+00:00 F80VTYP Visit Type +71 Clinic visit 79851 phv00079851.v6.p3 pht001019.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:34+00:00 2018-06-29 22:49:34+00:00 F80VY Visit year +71 Clinic visit 111655 phv00111655.v6.p3 pht001517.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:34+00:00 2018-06-29 22:49:34+00:00 F60VTYP F60 Visit type +71 Clinic visit 111656 phv00111656.v6.p3 pht001517.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:34+00:00 2018-06-29 22:49:34+00:00 F60VY F60 Visit year +71 Clinic visit 156380 phv00156380.v5.p3 pht002125.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:35+00:00 2018-06-29 22:49:35+00:00 F60VTYP Visit Type +71 Clinic visit 156381 phv00156381.v5.p3 pht002125.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:49:35+00:00 2018-06-29 22:49:35+00:00 F60VY Visit year +71 Clinic visit 78868 phv00078868.v6.p3 pht001005.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F37VTYP Visit Type +71 Clinic visit 78869 phv00078869.v6.p3 pht001005.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F37VY Visit year +71 Clinic visit 79086 phv00079086.v6.p3 pht001006.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F38VTYP Visit Type +71 Clinic visit 79087 phv00079087.v6.p3 pht001006.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F38VY Visit year +71 Clinic visit 79229 phv00079229.v6.p3 pht001007.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F39VTYP Visit Type +71 Clinic visit 79230 phv00079230.v6.p3 pht001007.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F39VY Visit year +71 Clinic visit 79305 phv00079305.v6.p3 pht001008.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F40VTYP F40 Visit type +71 Clinic visit 79306 phv00079306.v6.p3 pht001008.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F40VY F40 Visit year +71 Clinic visit 79871 phv00079871.v6.p3 pht001020.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F81VTYP Visit Type +71 Clinic visit 79872 phv00079872.v6.p3 pht001020.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F81VY Visit year +71 Clinic visit 79908 phv00079908.v6.p3 pht001021.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F82VTYP Visit Type +71 Clinic visit 79909 phv00079909.v6.p3 pht001021.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F82VY Visit year +71 Clinic visit 79923 phv00079923.v6.p3 pht001022.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F83VTYP Visit Type +71 Clinic visit 79924 phv00079924.v6.p3 pht001022.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F83VY Visit year +71 Clinic visit 79943 phv00079943.v6.p3 pht001023.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F84VTYP Visit Type +71 Clinic visit 79944 phv00079944.v6.p3 pht001023.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:53:35+00:00 2018-06-29 22:53:35+00:00 F84VY Visit year +71 Clinic visit 79982 phv00079982.v6.p3 pht001025.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F90VTYP Visit Type +71 Clinic visit 79983 phv00079983.v6.p3 pht001025.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F90VY Visit year +71 Clinic visit 79997 phv00079997.v6.p3 pht001026.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F92VTYP Visit Type +71 Clinic visit 79998 phv00079998.v6.p3 pht001026.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F92VY Visit year +71 Clinic visit 154926 phv00154926.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 ECGVTYP ECG visit type +71 Clinic visit 154927 phv00154927.v5.p3 pht002118.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 ECGVY ECG visit year +71 Clinic visit 155605 phv00155605.v5.p3 pht002120.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F85VTYP Visit Type +71 Clinic visit 155606 phv00155606.v5.p3 pht002120.v5.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F85VY Visit year +71 Clinic visit 169399 phv00169399.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F150VTYP Visit Type +71 Clinic visit 169400 phv00169400.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F150VY Visit Year +71 Clinic visit 169507 phv00169507.v4.p3 pht002750.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F153VTYP F153 Visit type +71 Clinic visit 169508 phv00169508.v4.p3 pht002750.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F153VY F153 Visit year +71 Clinic visit 169545 phv00169545.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F154VTYP Visit Type +71 Clinic visit 169546 phv00169546.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:55:12+00:00 2018-06-29 22:55:12+00:00 F154VY Visit Year +71 Clinic visit 169603 phv00169603.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 F44VTYP Visit Type +71 Clinic visit 169604 phv00169604.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 F44VY F44 Visit year or number +71 Clinic visit 192305 phv00192305.v3.p3 pht003396.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 F151VTYP Visit Type +71 Clinic visit 192306 phv00192306.v3.p3 pht003396.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 F151VY Visit Year +71 Clinic visit 192334 phv00192334.v3.p3 pht003397.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 F33VTYP Visit Type +71 Clinic visit 192335 phv00192335.v3.p3 pht003397.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 F33VY Visit year +71 Clinic visit 192360 phv00192360.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 F45VTYP Visit Type +71 Clinic visit 192361 phv00192361.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 F45VY Visit year +71 Clinic visit 193847 phv00193847.v3.p3 pht003418.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 DRAWVTYP Visit Type +71 Clinic visit 193848 phv00193848.v3.p3 pht003418.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:36+00:00 2018-06-29 22:56:36+00:00 DRAWVY Specimen Draw Visit Year +71 Clinic visit 282952 phv00282952.v1.p3 pht006212.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:55+00:00 2018-06-29 22:56:55+00:00 ADHVTYP Visit type for CaD adherence period +71 Clinic visit 282953 phv00282953.v1.p3 pht006212.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:55+00:00 2018-06-29 22:56:55+00:00 ADHVY Visit year for CaD adherence period +71 Clinic visit 282965 phv00282965.v1.p3 pht006213.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:55+00:00 2018-06-29 22:56:55+00:00 ADHVTYP Visit type for HRT adherence period +71 Clinic visit 282966 phv00282966.v1.p3 pht006213.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:56:56+00:00 2018-06-29 22:56:56+00:00 ADHVY Visit year for HRT adherence period +71 Clinic visit 282979 phv00282979.v1.p3 pht006214.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F155VTYP Visit type +71 Clinic visit 282980 phv00282980.v1.p3 pht006214.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F155VY Visit year +71 Clinic visit 283184 phv00283184.v1.p3 pht006215.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F156VTYP Visit Type +71 Clinic visit 283185 phv00283185.v1.p3 pht006215.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F156VY Visit Year +71 Clinic visit 283186 phv00283186.v1.p3 pht006215.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F156X2VY Extension 2 visit year +71 Clinic visit 283252 phv00283252.v1.p3 pht006216.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F157VTYP Visit Type +71 Clinic visit 283253 phv00283253.v1.p3 pht006216.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F157VY Visit Year +71 Clinic visit 283254 phv00283254.v1.p3 pht006216.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F157X2VY Extension 2 visit year +71 Clinic visit 283287 phv00283287.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F301VTYP Visit Type +71 Clinic visit 283288 phv00283288.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-06-29 22:58:16+00:00 2018-06-29 22:58:16+00:00 F301VY Visit Year +71 Clinic visit 125664 phv00125664.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:06:14+00:00 2018-07-09 20:06:14+00:00 visit CONTACT YEAR +71 Clinic visit 125575 phv00125575.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:08:28+00:00 2018-07-09 20:08:28+00:00 visit CONTACT YEAR +71 Clinic visit 125753 phv00125753.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:17:37+00:00 2018-07-09 20:17:37+00:00 VISIT CONTACT YEAR +71 Clinic visit 125840 phv00125840.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 20:32:08+00:00 2018-07-09 20:32:08+00:00 VISIT CONTACT YEAR +71 Clinic visit 127458 phv00127458.v1.p1 pht001955.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-10 16:45:09+00:00 2018-07-10 16:45:09+00:00 VISIT CONTACT OCCASION +71 Clinic visit 278175 phv00278175.v1.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:12:52+00:00 2018-08-10 21:12:52+00:00 Visit_Year Year of visit, to use for longitudinal analysis Collection Interval: Collected in Exam 1 +71 Clinic visit 278174 phv00278174.v1.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 21:14:31+00:00 2018-08-10 21:14:31+00:00 Study_Phase Phase of COPDGene study: baseline, phase 2 Collection Interval: Collected in Exam 1 +71 Clinic visit 210894 phv00210894.v1.p1 pht004204.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-13 19:07:18+00:00 2018-08-13 19:07:18+00:00 TIAECY Contact year [10] [TIA/Stroke Form, Cohort Visit 4] +71 Clinic visit 210963 phv00210963.v1.p1 pht004205.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-13 19:07:27+00:00 2018-08-13 19:07:27+00:00 TIBECY Administrative information. Contact Year [10]. [TIA/Stroke Form, Cohort Visit 4] +71 Clinic visit 210596 phv00210596.v1.p1 pht004202.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-13 19:07:35+00:00 2018-08-13 19:07:35+00:00 TIACCY Contact year [4] [TIA/Stroke, exam 2] +71 Clinic visit 210470 phv00210470.v1.p1 pht004201.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-13 19:07:43+00:00 2018-08-13 19:07:43+00:00 TIABCY Contact year [1] [TIA/Stroke, exam 1] +71 Clinic visit 210785 phv00210785.v1.p1 pht004203.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-13 19:07:50+00:00 2018-08-13 19:07:50+00:00 TIADCY Contact year [7] [TIA/Stroke, exam 3] +71 Clinic visit 277281 phv00277281.v1.p1 pht006030.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:06:28+00:00 2018-08-14 22:06:28+00:00 EXAMYEAR Year of examination Collection Interval: 2007-2009 +71 Clinic visit 277328 phv00277328.v1.p1 pht006034.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:11:56+00:00 2018-08-14 22:11:56+00:00 EXAMYEAR Year of examination Collection Interval: 2009-2011 +71 Clinic visit 277508 phv00277508.v1.p1 pht006039.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:40:36+00:00 2018-08-14 22:40:36+00:00 EXAMYEAR Year of examination Collection Interval: 1996-2000 +71 Clinic visit 277655 phv00277655.v1.p1 pht006044.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:57:13+00:00 2018-08-14 22:57:13+00:00 EXAMYEAR_MR Year of MR scan Collection Interval: 2002-2006 +71 Clinic visit 277759 phv00277759.v1.p1 pht006046.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:07:23+00:00 2018-08-14 23:07:23+00:00 EXAMYEAR Year of examination Collection Interval: 2000-2004 +71 Clinic visit 307741 phv00307741.v1.p1 pht006649.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:51:23+00:00 2018-08-15 23:51:23+00:00 EXAMYEAR Year of examination Collection Interval: 2006-2011 +71 Clinic visit 307789 phv00307789.v1.p1 pht006653.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:54:48+00:00 2018-08-15 23:54:48+00:00 EXAMYEAR Year of examination Collection Interval: 1996-2000 +71 Clinic visit 307936 phv00307936.v1.p1 pht006658.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:06:51+00:00 2018-08-16 00:06:51+00:00 EXAMYEAR_MR Year of MR scan Collection Interval: 2002-2006 +71 Clinic visit 307950 phv00307950.v1.p1 pht006659.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:08:51+00:00 2018-08-16 00:08:51+00:00 EXAMYEAR Year of examination Collection Interval: 2000-2004 +71 Clinic visit 124330 phv00124330.v1.p1 pht001903.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:01:28+00:00 2018-08-16 23:01:28+00:00 rectype Visit +71 Clinic visit 122012 phv00122012.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:01:53+00:00 2018-08-16 23:01:53+00:00 visit Visit Number +71 Clinic visit 253221 phv00253221.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:32:37+00:00 2018-08-24 16:32:37+00:00 CLINDATE_YR Year of baseline clinic visit +71 Clinic visit 258036 phv00258036.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:54:48+00:00 2018-08-24 16:54:48+00:00 CLINDATE Date of clinic visit +71 Clinic visit 121453 phv00121453.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-18 19:29:07+00:00 2018-12-18 19:29:07+00:00 YTCNT CONTACT PERIOD +71 Clinic visit 121677 phv00121677.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-18 19:29:46+00:00 2018-12-18 19:29:46+00:00 YTCNT CONTACT PERIOD +71 Clinic visit 121472 phv00121472.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-18 19:30:04+00:00 2018-12-18 19:30:04+00:00 YTCNT CONTACT PERIOD +71 Clinic visit 121181 phv00121181.v2.p2 pht001867.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-12-18 19:33:08+00:00 2018-12-18 19:33:08+00:00 YTCNT CONTACT CODE +71 Clinic visit 259377 phv00259377.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:41:47+00:00 2018-12-20 19:41:47+00:00 indexy Index Year +72 Fasting 253225 phv00253225.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:59:57+00:00 2018-03-14 21:59:57+00:00 FASTTIME Time fasting prior to blood draw +72 Fasting 204681 phv00204681.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 15:59:50+00:00 2018-03-19 15:59:50+00:00 FAST0823 Visit 2, fast 8 hrs. or more, definition 2 [Cohort, Exam 2] +72 Fasting 204682 phv00204682.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:00:14+00:00 2018-03-19 16:00:14+00:00 FAST1223 Visit 2, fast 12 hrs. or more, definition 2 [Cohort, Exam 2] +72 Fasting 204732 phv00204732.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:00:38+00:00 2018-03-19 16:00:38+00:00 FAST0802 Fasting time of 8 hours or more [Cohort, Exam 1] +72 Fasting 204733 phv00204733.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:01:04+00:00 2018-03-19 16:01:04+00:00 FAST1202 Fasting time of 12 hours or more [Cohort, Exam 1] +72 Fasting 204902 phv00204902.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:01:21+00:00 2018-03-19 16:01:21+00:00 FAST0834 Fasting time of 8 hours or more [Cohort, Exam 3] +72 Fasting 204903 phv00204903.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:02:07+00:00 2018-03-19 16:02:07+00:00 FAST1234 Fasting time of 12 hours or more [Cohort, Exam 3] +72 Fasting 204956 phv00204956.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:02:42+00:00 2018-03-19 16:02:42+00:00 FAST0841 Fasting time of 8 hours or more [Cohort, Exam 4] +72 Fasting 204957 phv00204957.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:03:10+00:00 2018-03-19 16:03:10+00:00 FAST1241 Fasting time of 12 hours or more [Cohort, Exam 4] +72 Fasting 206629 phv00206629.v1.p1 pht004096.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:12:58+00:00 2018-03-19 16:12:58+00:00 GTSA3 Has participant fasted at least 12 hours? Q3 [Oral Glucose Tolerance Screening Form, exam 4] +72 Fasting 206637 phv00206637.v1.p1 pht004097.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-19 16:13:53+00:00 2018-03-19 16:13:53+00:00 GTSB3 Has participant fasted at least 10 hours? Q3 [Oral Glucose Tolerance Screening Version B, exam 4] +72 Fasting 112660 phv00112660.v2.p2 pht001563.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 A05FSTMN NUMBER OF MINUTES FASTING +72 Fasting 112661 phv00112661.v2.p2 pht001563.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 A05FAST 12 HR FAST BEFORE BLOOD DRAWN +72 Fasting 114299 phv00114299.v2.p2 pht001599.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 B05FSTMN NUMBER OF MINUTES FASTING +72 Fasting 114300 phv00114300.v2.p2 pht001599.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 B05FAST 12 HR FAST BEFORE BLOOD DRAWN +72 Fasting 115407 phv00115407.v2.p2 pht001654.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 C05FSTMN NUMBER OF MINUTES FASTING +72 Fasting 115408 phv00115408.v2.p2 pht001654.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 C05FAST 12 HR FAST BEFORE BLOOD DRAWN +72 Fasting 116645 phv00116645.v2.p2 pht001709.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 D05FSTMN NUMBER OF MINUTES FASTING +72 Fasting 116646 phv00116646.v2.p2 pht001709.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 D05FAST 12 HR FAST BEFORE BLOOD DRAWN +72 Fasting 118414 phv00118414.v2.p2 pht001759.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 E05FSTMN NUMBER OF MINUTES FASTING +72 Fasting 118415 phv00118415.v2.p2 pht001759.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 E05FAST 12 HR FAST BEFORE BLOOD DRAW? +72 Fasting 119786 phv00119786.v2.p2 pht001809.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 F05FSTMN NUMBER OF MINUTES FASTING +72 Fasting 119787 phv00119787.v2.p2 pht001809.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-04-17 20:12:40+00:00 2018-04-17 20:12:40+00:00 F05FAST 12 HR FAST BEFORE BLOOD DRAW? +72 Fasting 83303 phv00083303.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:02:58+00:00 2018-04-29 01:02:58+00:00 lastdrk1 HOW LONG AGO LAST DRINK OR EAT? (HRS) +72 Fasting 84980 phv00084980.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:03:07+00:00 2018-04-29 01:03:07+00:00 lastdrk1 HOW LONG AGO LAST DRINK OR EAT? (HRS) +72 Fasting 86410 phv00086410.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:03:14+00:00 2018-04-29 01:03:14+00:00 lastdrk3 HOW LONG AGO LAST EAT OR DRINK? (hrs) +72 Fasting 85927 phv00085927.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:03:22+00:00 2018-04-29 01:03:22+00:00 lastdrk2 HOW LONG AGO LAST EAT OR DRINK? (HRS) +72 Fasting 86842 phv00086842.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:03:29+00:00 2018-04-29 01:03:29+00:00 lastdrk4 HOW LONG AGO LAST EAT OR DRINK? (Hrs) +72 Fasting 87524 phv00087524.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:03:35+00:00 2018-04-29 01:03:35+00:00 lastdrkf HOW LONG AGO LAST DRINK OR EAT? (hrs) +72 Fasting 82696 phv00082696.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:03:42+00:00 2018-04-29 01:03:42+00:00 ecgfst1 PARTICIPANT FASTING? +72 Fasting 82697 phv00082697.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:03:54+00:00 2018-04-29 01:03:54+00:00 eceattm1 TIME LAST ATE OR DRANK +72 Fasting 227071 phv00227071.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:11:34+00:00 2018-06-05 15:11:34+00:00 FAST_H Number of hours fasting +72 Fasting 71889 phv00071889.v4.p10 pht000742.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:13:17+00:00 2018-06-05 15:13:17+00:00 FASTING Fasting 8 hours +72 Fasting 172200 phv00172200.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:13:45+00:00 2018-06-05 15:13:45+00:00 fasting Fasting at least 10 hours +72 Fasting 227021 phv00227021.v1.p10 pht004801.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:14:08+00:00 2018-06-05 15:14:08+00:00 FASTING Number of hours fasting Collection Interval: Exam 1 +72 Fasting 227070 phv00227070.v1.p10 pht004802.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:14:33+00:00 2018-06-05 15:14:33+00:00 FASTING Fasting status +72 Fasting 255347 phv00255347.v1.p10 pht005143.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:14:58+00:00 2018-06-05 15:14:58+00:00 FASTING Fasting at least 8 hours +72 Fasting 275407 phv00275407.v1.p10 pht006010.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:15:22+00:00 2018-06-05 15:15:22+00:00 FASTING Fasting status Collection Interval: Exam 2 +72 Fasting 275412 phv00275412.v1.p10 pht006011.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:15:49+00:00 2018-06-05 15:15:49+00:00 FASTING Fasting 8 hours Collection Interval: Omni 1 Exam 3 +72 Fasting 172199 phv00172199.v2.p10 pht002889.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-05 15:42:43+00:00 2018-06-05 15:42:43+00:00 hrs_fasting Number of hours fasting +72 Fasting 126016 phv00126016.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:06:41+00:00 2018-06-12 01:06:41+00:00 GLF01ST Glucose fasting status +72 Fasting 126044 phv00126044.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:20:45+00:00 2018-06-12 01:20:45+00:00 LPF01 Fasting and non-fasting status for lipid profile +72 Fasting 126129 phv00126129.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:42:14+00:00 2018-06-20 17:42:14+00:00 FST01TM FST01TM +72 Fasting 126130 phv00126130.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:42:14+00:00 2018-06-20 17:42:14+00:00 FST01HR FST01HR +72 Fasting 277396 phv00277396.v1.p1 pht006036.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:41:36+00:00 2018-08-02 18:41:36+00:00 FAST10HR Is the participant fasting at least 10 hours? Collection Interval: 2009-2011 +72 Fasting 277572 phv00277572.v1.p1 pht006041.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:41:46+00:00 2018-08-02 18:41:46+00:00 FAST10HR Compute length of time fasting: Is the participant fasting at least 10 hours? Collection Interval: 1996-2000 +72 Fasting 277840 phv00277840.v1.p1 pht006048.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:41:53+00:00 2018-08-02 18:41:53+00:00 FAST10HR Compute length of time fasting: Is the participant fasting at least 10 hours? Collection Interval: 2000-2004 +72 Fasting 307853 phv00307853.v1.p1 pht006655.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:42:01+00:00 2018-08-02 18:42:01+00:00 FAST10HR Compute length of time fasting: Is the participant fasting at least 10 hours? Collection Interval: 1996-2000 +72 Fasting 308033 phv00308033.v1.p1 pht006661.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-02 18:42:10+00:00 2018-08-02 18:42:10+00:00 FAST10HR Compute length of time fasting: Is the participant fasting at least 10 hours? Collection Interval: 2000-2004 +72 Fasting 118384 phv00118384.v2.p2 pht001759.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:42:31+00:00 2018-08-28 22:42:31+00:00 E05FST8H PARTICIPANT FAST FOR AT LEAST 8 HOURS? Q 13 +72 Fasting 258726 phv00258726.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 12:48:53+00:00 2018-09-06 12:48:53+00:00 Fasting Fasting Status +72 Fasting 77373 phv00077373.v6.p3 pht000987.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-20 22:12:41+00:00 2018-09-20 22:12:41+00:00 FASTHRS Fasting hours +72 Fasting 193854 phv00193854.v3.p3 pht003418.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-20 22:13:05+00:00 2018-09-20 22:13:05+00:00 FASTHRS Fasting hours +72 Fasting 283302 phv00283302.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-20 22:13:34+00:00 2018-09-20 22:13:34+00:00 FASTHRS Fasting hours +72 Fasting 99347 phv00099347.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:52:27+00:00 2018-09-27 17:52:27+00:00 FAST12 FASTING +72 Fasting 99923 phv00099923.v1.p1 pht001451.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:52:39+00:00 2018-09-27 17:52:39+00:00 FAST30 HOURS SINCE LAST ATE OR DRANK +72 Fasting 101781 phv00101781.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:53:35+00:00 2018-09-27 17:53:35+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 102469 phv00102469.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:53:45+00:00 2018-09-27 17:53:45+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 104027 phv00104027.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:53:54+00:00 2018-09-27 17:53:54+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 104693 phv00104693.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:54:04+00:00 2018-09-27 17:54:04+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 105431 phv00105431.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:54:12+00:00 2018-09-27 17:54:12+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 106793 phv00106793.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:54:21+00:00 2018-09-27 17:54:21+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 107761 phv00107761.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:54:31+00:00 2018-09-27 17:54:31+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 108492 phv00108492.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:54:39+00:00 2018-09-27 17:54:39+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 110276 phv00110276.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:54:47+00:00 2018-09-27 17:54:47+00:00 TIMEAT14 HOURS SINCE LAST EATEN +72 Fasting 102449 phv00102449.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:55:09+00:00 2018-09-27 17:55:09+00:00 TIMATE12 HOURS SINCE EATEN +72 Fasting 105411 phv00105411.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:55:17+00:00 2018-09-27 17:55:17+00:00 TIMATE12 HOURS SINCE EATEN +72 Fasting 106774 phv00106774.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:55:26+00:00 2018-09-27 17:55:26+00:00 TIMATE12 HOURS SINCE EATEN +72 Fasting 107745 phv00107745.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:55:35+00:00 2018-09-27 17:55:35+00:00 TIMATE12 HOURS SINCE EATEN +72 Fasting 108479 phv00108479.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:55:48+00:00 2018-09-27 17:55:48+00:00 TIMATE12 HOURS SINCE EATEN +72 Fasting 109241 phv00109241.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:56:01+00:00 2018-09-27 17:56:01+00:00 TIMATE12 HOURS SINCE EATEN +72 Fasting 110349 phv00110349.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 17:56:09+00:00 2018-09-27 17:56:09+00:00 TIMATE12 HOURS SINCE EATEN +72 Fasting 1049 phv00001049.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FA15 BLOOD ANALYSIS: FASTING +72 Fasting 1201 phv00001201.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FB24 BLOOD ANALYSIS: FASTING +72 Fasting 1378 phv00001378.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FC20 BLOOD ANALYSIS: FASTING +72 Fasting 1391 phv00001391.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FC35 GLUCOSE CHALLENGE: TIME OF LAST EATING, AM OR PM +72 Fasting 1392 phv00001392.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FC36 GLUCOSE CHALLENGE: TIME OF LAST EATING. HOUR +72 Fasting 1393 phv00001393.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FC37 GLUCOSE CHALLENGE: TIME OF LAST EATING, MINUTE +72 Fasting 1573 phv00001573.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FD28 GLUCOSE CHALLENGE: TIME OF LAST EATING, AM OR PM +72 Fasting 1574 phv00001574.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FD29 GLUCOSE CHALLENGE: TIME OF LAST EATING, HOUR +72 Fasting 1575 phv00001575.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:13+00:00 2018-10-03 17:37:13+00:00 FD30 GLUCOSE CHALLENGE: TIME OF LAST EATING, MINUTE +72 Fasting 1797 phv00001797.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:14+00:00 2018-10-03 17:37:14+00:00 FD301 BLOOD ANALYSIS - FASTING 12 HOURS OR MORE +72 Fasting 7550 phv00007550.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:14+00:00 2018-10-03 17:37:14+00:00 A23 FASTING 12 HRS. OR MORE +72 Fasting 7986 phv00007986.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:14+00:00 2018-10-03 17:37:14+00:00 B368 BLOOD ANALYSIS-FASTING LIPIDS: FASTING 12 HRS. OR MORE +72 Fasting 8773 phv00008773.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:14+00:00 2018-10-03 17:37:14+00:00 D418 NUMBER OF HOURS FASTING +72 Fasting 9562 phv00009562.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:14+00:00 2018-10-03 17:37:14+00:00 E040 NUMBER OF HOURS FASTING +72 Fasting 10117 phv00010117.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:14+00:00 2018-10-03 17:37:14+00:00 F021 NUMBER OF HOURS FASTING +72 Fasting 10137 phv00010137.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:14+00:00 2018-10-03 17:37:14+00:00 F728 BLOOD ANALYSIS - FASTING +72 Fasting 250297 phv00250297.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:37:14+00:00 2018-10-03 17:37:14+00:00 e040 Numerical Data - Part I: Number of hours fasting Collection Interval: Exam 1 +72 Fasting 932 phv00000932.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:38:20+00:00 2018-10-03 17:38:20+00:00 MF490 BLOOD ANALYSIS: FASTING BLOOD, EXAM 7 +72 Fasting 10145 phv00010145.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:38:20+00:00 2018-10-03 17:38:20+00:00 G707 FASTING STATUS +72 Fasting 10504 phv00010504.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:38:20+00:00 2018-10-03 17:38:20+00:00 G447 REGIONAL ANTHROPOMETRY - NUMBER OF HOURS FASTING +72 Fasting 21237 phv00021237.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:38:20+00:00 2018-10-03 17:38:20+00:00 G3A453 NUMBER OF HOURS FASTING +72 Fasting 251067 phv00251067.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:38:20+00:00 2018-10-03 17:38:20+00:00 g447 Numerical Data - Part I - Regional Anthropometry: Number of hours fasting Collection Interval: Exam 2 +72 Fasting 251544 phv00251544.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:38:20+00:00 2018-10-03 17:38:20+00:00 h409 Numerical Data - Part I: Regional Anthropometry: Are you fasting >= than 8 hours? Collection Interval: Exam 3 +72 Fasting 274059 phv00274059.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:38:20+00:00 2018-10-03 17:38:20+00:00 g3a453 Number of hours fasting Collection Interval: Exam 1 +72 Fasting 274550 phv00274550.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-10-03 17:38:20+00:00 2018-10-03 17:38:20+00:00 g3a453 Number of hours fasting +73 Geographic site 226256 phv00226256.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-03-14 21:55:48+00:00 2018-03-14 21:55:48+00:00 CENTER Center +73 Geographic site 204692 phv00204692.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:01:55+00:00 2018-03-15 15:01:55+00:00 CENTERID Recoded Center ID [Cohort, Exam 2] +73 Geographic site 204813 phv00204813.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:02:21+00:00 2018-03-15 15:02:21+00:00 CENTERID Recoded Center ID [Cohort, Exam 1] +73 Geographic site 204920 phv00204920.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:02:48+00:00 2018-03-15 15:02:48+00:00 CENTERID Recoded center ID [Cohort, Exam 3] +73 Geographic site 205016 phv00205016.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-03-15 15:03:19+00:00 2018-03-15 15:03:19+00:00 CENTERID Recoded Center ID [Cohort, Exam 4] +73 Geographic site 82644 phv00082644.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:11:50+00:00 2018-04-29 01:11:50+00:00 site1c SITE +73 Geographic site 84447 phv00084447.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:11:56+00:00 2018-04-29 01:11:56+00:00 site1c SITE +73 Geographic site 85783 phv00085783.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:12:02+00:00 2018-04-29 01:12:02+00:00 site2c SITE AT EXAM 2 +73 Geographic site 86269 phv00086269.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:12:08+00:00 2018-04-29 01:12:08+00:00 site3c SITE AT EXAM3 +73 Geographic site 86737 phv00086737.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:12:14+00:00 2018-04-29 01:12:14+00:00 site4c SITE AT EXAM 4 +73 Geographic site 87075 phv00087075.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:12:21+00:00 2018-04-29 01:12:21+00:00 sitefc FIELD CENTER WHERE EXAMINED +73 Geographic site 142679 phv00142679.v4.p3 pht002100.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:12:27+00:00 2018-04-29 01:12:27+00:00 site SITE +73 Geographic site 150533 phv00150533.v1.p3 pht002108.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:12:33+00:00 2018-04-29 01:12:33+00:00 site SITE +73 Geographic site 152531 phv00152531.v2.p3 pht002109.v2.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:12:38+00:00 2018-04-29 01:12:38+00:00 site SITE +73 Geographic site 174587 phv00174587.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:12:44+00:00 2018-04-29 01:12:44+00:00 site5c SITE AT EXAM 5 +73 Geographic site 175857 phv00175857.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:13:22+00:00 2018-04-29 01:13:22+00:00 site1c SITE +73 Geographic site 175880 phv00175880.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:13:27+00:00 2018-04-29 01:13:27+00:00 site SITE +73 Geographic site 175942 phv00175942.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:13:33+00:00 2018-04-29 01:13:33+00:00 sitefc FAMILY COHORT: FIELD CENTER WHERE EXAMINED +73 Geographic site 176010 phv00176010.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:13:39+00:00 2018-04-29 01:13:39+00:00 site5c SITE AT EXAM 5 +73 Geographic site 219023 phv00219023.v1.p3 pht004326.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-04-29 01:13:45+00:00 2018-04-29 01:13:45+00:00 sitesc SITE AT STRESS EXAM +73 Geographic site 250284 phv00250284.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:42:51+00:00 2018-06-14 18:42:51+00:00 e020 Numerical Data - Part I: Site of exam Collection Interval: Exam 1 +73 Geographic site 251057 phv00251057.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:43:12+00:00 2018-06-14 18:43:12+00:00 g436 Numerical Data - Part I - Basic Information: Site of exam Collection Interval: Exam 2 +73 Geographic site 251531 phv00251531.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:43:34+00:00 2018-06-14 18:43:34+00:00 h392 Numerical Data - Part I: Basic Information: Site of Exam Collection Interval: Exam 3 +73 Geographic site 254283 phv00254283.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:44:15+00:00 2018-06-14 18:44:15+00:00 j469 Numerical Data/Anthropometry: Basic Information - Site of Exam +73 Geographic site 254761 phv00254761.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:44:49+00:00 2018-06-14 18:44:49+00:00 fv251 Numerical Data (Anthropometry) - Basic Information: Site of Exam Collection Interval: Exam 29 +73 Geographic site 255154 phv00255154.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:45:34+00:00 2018-06-14 18:45:34+00:00 fw297 Numerical Data: Basic Information - Site of Exam Collection Interval: Original Cohort Exam 30 +73 Geographic site 274879 phv00274879.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:45:55+00:00 2018-06-14 18:45:55+00:00 FX297 Numerical Data: Basic Information - Site of Exam Collection Interval: Original Cohort Exam 31 +73 Geographic site 275237 phv00275237.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-06-14 18:46:13+00:00 2018-06-14 18:46:13+00:00 fy297 Numerical Data: Basic Information - Site of Exam Collection Interval: Original Cohort Exam 32 +73 Geographic site 99453 phv00099453.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:16:01+00:00 2018-06-27 22:16:01+00:00 CLINIC CHS SITE +73 Geographic site 100291 phv00100291.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:16:39+00:00 2018-06-27 22:16:39+00:00 CLINIC CHS CLINIC +73 Geographic site 100696 phv00100696.v1.p1 pht001460.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:16:55+00:00 2018-06-27 22:16:55+00:00 CLINIC No description provided +73 Geographic site 102623 phv00102623.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:17:08+00:00 2018-06-27 22:17:08+00:00 CLINIC CHS SITE +73 Geographic site 105114 phv00105114.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:17:22+00:00 2018-06-27 22:17:22+00:00 CLINIC CLINIC +73 Geographic site 108814 phv00108814.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:17:45+00:00 2018-06-27 22:17:45+00:00 CLINIC CHS SITE +73 Geographic site 106546 phv00106546.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:18:04+00:00 2018-06-27 22:18:04+00:00 CLINIC CLINIC +73 Geographic site 109510 phv00109510.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:18:20+00:00 2018-06-27 22:18:20+00:00 CLINIC CHS SITE +73 Geographic site 198806 phv00198806.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-06-27 22:18:32+00:00 2018-06-27 22:18:32+00:00 clinic Clinic identification number +73 Geographic site 80435 phv00080435.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-07-02 20:56:59+00:00 2018-07-02 20:56:59+00:00 REGION U. S. Region +73 Geographic site 126005 phv00126005.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-02 21:54:32+00:00 2018-08-02 21:54:32+00:00 COUNTY COUNTY +73 Geographic site 202105 phv00202105.v2.p1 pht003918.v2.p1 phs000741.v2.p1 GOLDN 741 2 2018-08-02 21:56:00+00:00 2018-08-02 21:56:00+00:00 center Recruitment center +73 Geographic site 159569 phv00159569.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-02 21:56:10+00:00 2018-08-02 21:56:10+00:00 deid_center De-identified site code Collection Interval: Collected in Exam 1 +73 Geographic site 258677 phv00258677.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-08-02 21:56:41+00:00 2018-08-02 21:56:41+00:00 Census_Region Census Region of Samoa +73 Geographic site 121847 phv00121847.v1.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-08-02 21:57:00+00:00 2018-08-02 21:57:00+00:00 state_enroll State of residence at current appt date +73 Geographic site 112418 phv00112418.v2.p2 pht001559.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-16 22:33:03+00:00 2018-08-16 22:33:03+00:00 A01LCEN A01LCEN +73 Geographic site 116398 phv00116398.v2.p2 pht001700.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:12:28+00:00 2018-08-23 19:12:28+00:00 CENTER_CARE CENTER FOR CARE PROJECT +74 Medication/supplement use 126136 phv00126136.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:32:31+00:00 2018-06-12 01:32:31+00:00 HRM01 Current female hormone use +74 Medication/supplement use 126055 phv00126055.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:37:59+00:00 2018-06-12 01:37:59+00:00 CLM01 Anti-hypercholesterolemic medication status +74 Medication/supplement use 126023 phv00126023.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:39:44+00:00 2018-06-12 01:39:44+00:00 DMM01T Antidiabetic medication type +74 Medication/supplement use 126024 phv00126024.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:39:59+00:00 2018-06-12 01:39:59+00:00 DMM01 Antidiabetic medication status +74 Medication/supplement use 126026 phv00126026.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:40:16+00:00 2018-06-12 01:40:16+00:00 SRMED Self-reported anti-diabetic medication +74 Medication/supplement use 126053 phv00126053.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:41:00+00:00 2018-06-12 01:41:00+00:00 LPM01 Anti-hyperlipidemic medication status +74 Medication/supplement use 126054 phv00126054.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-12 01:41:15+00:00 2018-06-12 01:41:15+00:00 TRM01 Anti-hypertriglyceridemic medication status +74 Medication/supplement use 123029 phv00123029.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-06-18 19:17:08+00:00 2018-06-18 19:17:08+00:00 xbpmeds Meds: On specified BP medication +74 Medication/supplement use 126299 phv00126299.v1.p1 pht001951.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:33:51+00:00 2018-06-20 01:33:51+00:00 DITA138 Use supplements (y/n) +74 Medication/supplement use 126304 phv00126304.v1.p1 pht001952.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:34:21+00:00 2018-06-20 01:34:21+00:00 lffq_supp_use LFFQ: use of supplements indicated +74 Medication/supplement use 126444 phv00126444.v1.p1 pht001952.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:35:04+00:00 2018-06-20 01:35:04+00:00 ravg_supp_use 0/1 supplement user +74 Medication/supplement use 126574 phv00126574.v1.p1 pht001952.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:36:06+00:00 2018-06-20 01:36:06+00:00 sffq_supp_use SFFQ: use of supplements indicated +74 Medication/supplement use 126712 phv00126712.v1.p1 pht001953.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:37:24+00:00 2018-06-20 01:37:24+00:00 lffq_supp_use LFFQ: use of supplements indicated +74 Medication/supplement use 126853 phv00126853.v1.p1 pht001953.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:38:07+00:00 2018-06-20 01:38:07+00:00 ravg_supp_use 0/1 supplement user +74 Medication/supplement use 126983 phv00126983.v1.p1 pht001953.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 01:38:50+00:00 2018-06-20 01:38:50+00:00 sffq_supp_use SFFQ: use of supplements indicated +74 Medication/supplement use 127668 phv00127668.v1.p1 pht001962.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 14:08:12+00:00 2018-06-20 14:08:12+00:00 ahfscode Msrahfscode +74 Medication/supplement use 127664 phv00127664.v2.p1 pht001962.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 14:08:25+00:00 2018-06-20 14:08:25+00:00 medconc Medconc +74 Medication/supplement use 127665 phv00127665.v2.p1 pht001962.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 14:08:37+00:00 2018-06-20 14:08:37+00:00 gpicode Msragpicode +74 Medication/supplement use 127666 phv00127666.v2.p1 pht001962.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 14:08:50+00:00 2018-06-20 14:08:50+00:00 tccode Msratccode +74 Medication/supplement use 127667 phv00127667.v1.p1 pht001962.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 14:09:09+00:00 2018-06-20 14:09:09+00:00 tcname Msratcname +74 Medication/supplement use 125033 phv00125033.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:57:41+00:00 2018-06-20 15:57:41+00:00 AFUA17 17. Are you now taking aspirin or a medicine containing aspirin on a regular basis? +74 Medication/supplement use 125118 phv00125118.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:57:55+00:00 2018-06-20 15:57:55+00:00 AFUA17 17. Are you now taking aspirin or a medicine containing aspirin on a regular basis? +74 Medication/supplement use 125204 phv00125204.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:58:07+00:00 2018-06-20 15:58:07+00:00 AFUB17 17. Are you now taking aspirin or a medicine containing aspirin on a regular basis? +74 Medication/supplement use 125290 phv00125290.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:58:17+00:00 2018-06-20 15:58:17+00:00 AFUB17 17. Are you now taking aspirin or a medicine containing aspirin on a regular basis? +74 Medication/supplement use 125491 phv00125491.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:58:28+00:00 2018-06-20 15:58:28+00:00 AFUC49 49. Are you now taking aspirin, or a medicine containing aspirin on a regular basis? +74 Medication/supplement use 125545 phv00125545.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 15:58:45+00:00 2018-06-20 15:58:45+00:00 AFUI17 TAKING ASPRIN REGULARLY Q17 +74 Medication/supplement use 125634 phv00125634.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:02:02+00:00 2018-06-20 16:02:02+00:00 AFUI17 TAKING ASPRIN REGULARLY Q17 +74 Medication/supplement use 125723 phv00125723.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:02:19+00:00 2018-06-20 16:02:19+00:00 AFUJ17 TAKING ASPRIN REGULARLY Q17 +74 Medication/supplement use 125810 phv00125810.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:02:34+00:00 2018-06-20 16:02:34+00:00 AFUK17 TAKING ASPRIN REGULARLY Q17 +74 Medication/supplement use 128271 phv00128271.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:32:03+00:00 2018-06-20 16:32:03+00:00 RHXA13 13:Age start taking birth control pills? +74 Medication/supplement use 128272 phv00128272.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:32:21+00:00 2018-06-20 16:32:21+00:00 RHXA14 14:Currently taking birth control pills? +74 Medication/supplement use 128273 phv00128273.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:32:45+00:00 2018-06-20 16:32:45+00:00 RHXA15 15:Age stop taking birth control pills? +74 Medication/supplement use 128329 phv00128329.v1.p1 pht001972.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:41:45+00:00 2018-06-20 16:41:45+00:00 ahfscode Ahfscode +74 Medication/supplement use 128325 phv00128325.v1.p1 pht001972.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:43:10+00:00 2018-06-20 16:43:10+00:00 medconc Medconc +74 Medication/supplement use 128326 phv00128326.v1.p1 pht001972.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:43:10+00:00 2018-06-20 16:43:10+00:00 gpicode Gpicode +74 Medication/supplement use 128327 phv00128327.v1.p1 pht001972.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:43:10+00:00 2018-06-20 16:43:10+00:00 tcname Tcname +74 Medication/supplement use 128328 phv00128328.v1.p1 pht001972.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 16:43:10+00:00 2018-06-20 16:43:10+00:00 tccode Tccode +74 Medication/supplement use 126038 phv00126038.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:45:20+00:00 2018-06-20 17:45:20+00:00 BPM01 Antihypertensive medication +74 Medication/supplement use 126058 phv00126058.v1.p1 pht001949.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 17:48:32+00:00 2018-06-20 17:48:32+00:00 MED01CT Medication accountability +74 Medication/supplement use 124762 phv00124762.v1.p1 pht001929.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:26:23+00:00 2018-06-20 18:26:23+00:00 AFOV1C 1c. What medication did you take for your heart condition? +74 Medication/supplement use 124743 phv00124743.v1.p1 pht001929.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:28:16+00:00 2018-06-20 18:28:16+00:00 AFOV1B 1b. Other heart condition, such as congestive heart failure +74 Medication/supplement use 124742 phv00124742.v1.p1 pht001929.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:28:31+00:00 2018-06-20 18:28:31+00:00 AFOV1A 1a. Chest pain or angina +74 Medication/supplement use 124866 phv00124866.v1.p1 pht001930.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:29:32+00:00 2018-06-20 18:29:32+00:00 AFOV1A 1a. Chest pain or angina +74 Medication/supplement use 124867 phv00124867.v1.p1 pht001930.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:29:45+00:00 2018-06-20 18:29:45+00:00 AFOV1B 1b. Other heart condition, such as congestive heart failure +74 Medication/supplement use 124886 phv00124886.v1.p1 pht001930.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-06-20 18:30:07+00:00 2018-06-20 18:30:07+00:00 AFOV1C 1c. What medication did you take for your heart condition? +74 Medication/supplement use 125122 phv00125122.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:30:13+00:00 2018-07-09 19:30:13+00:00 AFUA19B 19b. Since your JHS visit, have you taken or used any female hormone pills, skin patches, shots or implants? +74 Medication/supplement use 125123 phv00125123.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:31:00+00:00 2018-07-09 19:31:00+00:00 AFUA19C 19c. Name 1 +74 Medication/supplement use 125124 phv00125124.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:31:16+00:00 2018-07-09 19:31:16+00:00 AFUA20 20. Code 1 +74 Medication/supplement use 125121 phv00125121.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-09 19:37:23+00:00 2018-07-09 19:37:23+00:00 AFUA19A 19a. Since we last contacted you, have you taken or used any female hormone pills, skin patches, shots or implants? +74 Medication/supplement use 125040 phv00125040.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:08:17+00:00 2018-07-12 18:08:17+00:00 AFUA21 21. Have you also used a second female hormone since we last contacted you? +74 Medication/supplement use 125041 phv00125041.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:08:17+00:00 2018-07-12 18:08:17+00:00 AFUA21A 21a. Name 2 +74 Medication/supplement use 125042 phv00125042.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:08:17+00:00 2018-07-12 18:08:17+00:00 AFUA22 22. Code 2 +74 Medication/supplement use 125125 phv00125125.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:08:17+00:00 2018-07-12 18:08:17+00:00 AFUA21 21. Have you also used a second female hormone since we last contacted you? +74 Medication/supplement use 125126 phv00125126.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:08:17+00:00 2018-07-12 18:08:17+00:00 AFUA21A 21a. Name 2 +74 Medication/supplement use 125127 phv00125127.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:08:17+00:00 2018-07-12 18:08:17+00:00 AFUA22 22. Code 2 +74 Medication/supplement use 125201 phv00125201.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB16A 16a. High blood pressure +74 Medication/supplement use 125202 phv00125202.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB16B 16b. High blood cholesterol +74 Medication/supplement use 125203 phv00125203.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB16C 16c. Diabetes or high blood sugar +74 Medication/supplement use 125207 phv00125207.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB19A 19a. Since we last contacted you, have you taken or used any female hormone pills, skin patches, shots or implants? +74 Medication/supplement use 125208 phv00125208.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB19B 19b. Since your JHS visit, have you taken or used any female hormone pills, skin patches, shots or implants? +74 Medication/supplement use 125209 phv00125209.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB19C 19c. Name 1 +74 Medication/supplement use 125287 phv00125287.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB16A 16a. High blood pressure +74 Medication/supplement use 125288 phv00125288.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB16B 16b. High blood cholesterol +74 Medication/supplement use 125289 phv00125289.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB16C 16c. Diabetes or high blood sugar +74 Medication/supplement use 125293 phv00125293.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB19A 19a. Since we last contacted you, have you taken or used any female hormone pills, skin patches, shots or implants? +74 Medication/supplement use 125294 phv00125294.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB19B 19b. Since your JHS visit, have you taken or used any female hormone pills, skin patches, shots or implants? +74 Medication/supplement use 125295 phv00125295.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:10:34+00:00 2018-07-12 18:10:34+00:00 AFUB19C 19c. Name 1 +74 Medication/supplement use 125210 phv00125210.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:12:45+00:00 2018-07-12 18:12:45+00:00 AFUB20 20. Code 1 +74 Medication/supplement use 125211 phv00125211.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:12:45+00:00 2018-07-12 18:12:45+00:00 AFUB21 21. Have you also used a second female hormone since we last contacted you? +74 Medication/supplement use 125212 phv00125212.v1.p1 pht001933.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:12:45+00:00 2018-07-12 18:12:45+00:00 AFUB21A 21a. Name 2 +74 Medication/supplement use 125296 phv00125296.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:12:45+00:00 2018-07-12 18:12:45+00:00 AFUB20 20. Code 1 +74 Medication/supplement use 125297 phv00125297.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:12:45+00:00 2018-07-12 18:12:45+00:00 AFUB21 21. Have you also used a second female hormone since we last contacted you? +74 Medication/supplement use 125298 phv00125298.v1.p1 pht001934.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:12:45+00:00 2018-07-12 18:12:45+00:00 AFUB21A 21a. Name 2 +74 Medication/supplement use 125030 phv00125030.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:15:16+00:00 2018-07-12 18:15:16+00:00 AFUA16A 16a. High blood pressure +74 Medication/supplement use 125031 phv00125031.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:15:16+00:00 2018-07-12 18:15:16+00:00 AFUA16B 16b. High blood cholesterol +74 Medication/supplement use 125032 phv00125032.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:15:16+00:00 2018-07-12 18:15:16+00:00 AFUA16C 16c. Diabetes or high blood sugar +74 Medication/supplement use 125115 phv00125115.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:15:16+00:00 2018-07-12 18:15:16+00:00 AFUA16A 16a. High blood pressure +74 Medication/supplement use 125116 phv00125116.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:15:16+00:00 2018-07-12 18:15:16+00:00 AFUA16B 16b. High blood cholesterol +74 Medication/supplement use 125117 phv00125117.v1.p1 pht001932.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:15:16+00:00 2018-07-12 18:15:16+00:00 AFUA16C 16c. Diabetes or high blood sugar +74 Medication/supplement use 125036 phv00125036.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:17:00+00:00 2018-07-12 18:17:00+00:00 AFUA19A 19a. Since we last contacted you, have you taken or used any female hormone pills, skin patches, shots or implants? +74 Medication/supplement use 125037 phv00125037.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:18:28+00:00 2018-07-12 18:18:28+00:00 AFUA19B 19b. Since your JHS visit, have you taken or used any female hormone pills, skin patches, shots or implants? +74 Medication/supplement use 125038 phv00125038.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:18:28+00:00 2018-07-12 18:18:28+00:00 AFUA19C 19c. Name 1 +74 Medication/supplement use 125039 phv00125039.v1.p1 pht001931.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-12 18:19:04+00:00 2018-07-12 18:19:04+00:00 AFUA20 20. Code 1 +74 Medication/supplement use 204685 phv00204685.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:06:19+00:00 2018-07-19 15:06:19+00:00 HYPTMDCODE21 Hypertension lowering medication within past 2 weeks (visit 2) [Cohort, Exam 2] +74 Medication/supplement use 204689 phv00204689.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:06:47+00:00 2018-07-19 15:06:47+00:00 CHOLMDCODE21 Cholesterol lowering medication W/in 2 wks.: using 2004 Med. code, visit 2 [Cohort, Exam 2] +74 Medication/supplement use 204690 phv00204690.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:09:14+00:00 2018-07-19 15:09:14+00:00 CHOLMDCODE22 Medications which secondarily affect cholesterol: using 2004 Med. Code, visit 2 [Cohort, Exam 2] +74 Medication/supplement use 204607 phv00204607.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:21:23+00:00 2018-07-19 15:21:23+00:00 ASPIRINCODE21 Used aspirin-containing analgesics (at visit 2) in last 2 weeks (0=no, 1=yes), based on 2004 Med. code [Cohort, Exam 2] +74 Medication/supplement use 204694 phv00204694.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:21:42+00:00 2018-07-19 15:21:42+00:00 ASPIRINCODE01 Used aspirin-containing analgesics (at visit 1) in last 2 weeks (0=no, 1=yes), based on 2004 Med code [Cohort, Exam 1] +74 Medication/supplement use 204825 phv00204825.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:22:04+00:00 2018-07-19 15:22:04+00:00 ASPIRINCODE31 Used aspirin-containing analgesics (at visit 3) in last 2 weeks (0=no, 1=yes), based on 2004 Med. code [Cohort, Exam 3] +74 Medication/supplement use 204929 phv00204929.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:22:22+00:00 2018-07-19 15:22:22+00:00 ASPIRINCODE41 Used aspirin-containing analgesics (at visit 4) in last 2 weeks (0=no, 1=yes), based on 2004 med code [Cohort, Exam 4] +74 Medication/supplement use 204608 phv00204608.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:22:56+00:00 2018-07-19 15:22:56+00:00 STATINCODE21 Used statin (at visit 2) last 2weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 2] +74 Medication/supplement use 204695 phv00204695.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:23:15+00:00 2018-07-19 15:23:15+00:00 STATINCODE01 Statin use in the past 2 weeks based on 2004 medication codes [Cohort, Exam 1] +74 Medication/supplement use 204826 phv00204826.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:23:35+00:00 2018-07-19 15:23:35+00:00 STATINCODE31 Used statin (at visit 3) last 2 weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 3] +74 Medication/supplement use 204930 phv00204930.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:23:52+00:00 2018-07-19 15:23:52+00:00 STATINCODE41 Used statin (at visit 4) last 2 weeks (0=no, 1=yes) based on 2004 med code [Cohort, Exam 4] +74 Medication/supplement use 204658 phv00204658.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:55:41+00:00 2018-07-19 15:55:41+00:00 HYPTMD21 Hypertension Meds (self reported) [Cohort, Exam 2] +74 Medication/supplement use 204754 phv00204754.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:56:16+00:00 2018-07-19 15:56:16+00:00 HYPTMD01 Blood pressure lowering medications in the past 2 weeks [Cohort, Exam 1] +74 Medication/supplement use 204798 phv00204798.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:56:35+00:00 2018-07-19 15:56:35+00:00 HYPTMDCODE01 Hypertension lowering medication within past 2 weeks [Cohort, Exam 1] +74 Medication/supplement use 204858 phv00204858.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:56:58+00:00 2018-07-19 15:56:58+00:00 HYPTMD31 Visit 3, hypertension medications, definition 1 [Cohort, Exam 3] +74 Medication/supplement use 204913 phv00204913.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:57:33+00:00 2018-07-19 15:57:33+00:00 HYPTMDCODE31 Hypertension lowering medication within past 2 weeks (visit 3) [Cohort, Exam 3] +74 Medication/supplement use 204961 phv00204961.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:57:53+00:00 2018-07-19 15:57:53+00:00 HYPTMD41 Visit 3, hypertension medications, definition 1 [Cohort, Exam 4] +74 Medication/supplement use 205008 phv00205008.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 15:58:23+00:00 2018-07-19 15:58:23+00:00 HYPTMDCODE41 Hypertension lowering medication within past 2 weeks (visit 4) [Cohort, Exam 4] +74 Medication/supplement use 204802 phv00204802.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:01:56+00:00 2018-07-19 16:01:56+00:00 CHOLMDCODE01 Cholesterol lowering medication in past 2 weeks: using 2004 Med. code, visit 1 [Cohort, Exam 1] +74 Medication/supplement use 204803 phv00204803.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:02:14+00:00 2018-07-19 16:02:14+00:00 CHOLMDCODE02 Medications which secondarily affect cholesterol: using 2004 Med. Code, visit 1 [Cohort, Exam 1] +74 Medication/supplement use 204917 phv00204917.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:02:30+00:00 2018-07-19 16:02:30+00:00 CHOLMDCODE31 Cholesterol lowering medication within 2 wks.: using 2004 Med. Code, visit 3 [Cohort, Exam 3] +74 Medication/supplement use 204918 phv00204918.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:02:51+00:00 2018-07-19 16:02:51+00:00 CHOLMDCODE32 Medications which secondarily affect cholesterol: using 2004 Med. code, visit 3 [Cohort, Exam 3] +74 Medication/supplement use 205012 phv00205012.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:03:19+00:00 2018-07-19 16:03:19+00:00 CHOLMDCODE41 Cholesterol lowering medication within 2wks: using 2004 med code -visit 3 [Cohort, Exam 4] +74 Medication/supplement use 205013 phv00205013.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:03:58+00:00 2018-07-19 16:03:58+00:00 CHOLMDCODE42 Medications which secondarily affect cholesterol: using 2004 med code -visit 4 [Cohort, Exam 4] +74 Medication/supplement use 204609 phv00204609.v1.p1 pht004062.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:07:36+00:00 2018-07-19 16:07:36+00:00 ANTICOAGCODE21 Used anticoagulants (at visit 2) last 2 weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 2] +74 Medication/supplement use 204696 phv00204696.v1.p1 pht004063.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:08:05+00:00 2018-07-19 16:08:05+00:00 ANTICOAGCODE01 Used anticoagulants (at visit 1) last 2 weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 1] +74 Medication/supplement use 204827 phv00204827.v1.p1 pht004064.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:08:24+00:00 2018-07-19 16:08:24+00:00 ANTICOAGCODE31 Used anticoagulants (at visit 3) last 2 weeks (0=no, 1=yes) based on 2004 Med. code [Cohort, Exam 3] +74 Medication/supplement use 204931 phv00204931.v1.p1 pht004065.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:09:04+00:00 2018-07-19 16:09:04+00:00 ANTICOAGCODE41 Used anticoagulants (at visit 4) last 2 weeks (0=no, 1=yes) based on 2004 med code [Cohort, Exam 4] +74 Medication/supplement use 202953 phv00202953.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:24:28+00:00 2018-07-19 16:24:28+00:00 AFUcomp16a_G [Interview]. Did you take any medications during the past two weeks for high blood pressure [Annual Follow-up Questionnaire Form, AFUG] +74 Medication/supplement use 202954 phv00202954.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:24:45+00:00 2018-07-19 16:24:45+00:00 AFUcomp16b_G [Interview]. Did you take any medications during the past two weeks for high blood cholesterol [Annual Follow-up Questionnaire Form, AFUG] +74 Medication/supplement use 202955 phv00202955.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:25:12+00:00 2018-07-19 16:25:12+00:00 AFUcomp16c_G [Interview]. Did you take any medications during the past two weeks for high blood sugar [Annual Follow-up Questionnaire Form, AFUG] +74 Medication/supplement use 203007 phv00203007.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:25:30+00:00 2018-07-19 16:25:30+00:00 AFUcomp46d_L [Interview]. Did you take any medications during the past two weeks for heart failure? [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203008 phv00203008.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:26:15+00:00 2018-07-19 16:26:15+00:00 AFUcomp47_L [Interview]. Does the participant have medications to report? [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203009 phv00203009.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:26:41+00:00 2018-07-19 16:26:41+00:00 AFUcomp48a_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203010 phv00203010.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:27:01+00:00 2018-07-19 16:27:01+00:00 AFUcomp48b_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203011 phv00203011.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:27:18+00:00 2018-07-19 16:27:18+00:00 AFUcomp48c_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203012 phv00203012.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:27:34+00:00 2018-07-19 16:27:34+00:00 AFUcomp48d_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203013 phv00203013.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:27:51+00:00 2018-07-19 16:27:51+00:00 AFUcomp48e_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203014 phv00203014.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:28:09+00:00 2018-07-19 16:28:09+00:00 AFUcomp48f_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203015 phv00203015.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:28:26+00:00 2018-07-19 16:28:26+00:00 AFUcomp48g_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203016 phv00203016.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:28:47+00:00 2018-07-19 16:28:47+00:00 AFUcomp48h_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203017 phv00203017.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:29:06+00:00 2018-07-19 16:29:06+00:00 AFUcomp48i_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203018 phv00203018.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:29:25+00:00 2018-07-19 16:29:25+00:00 AFUcomp48j_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203019 phv00203019.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:29:45+00:00 2018-07-19 16:29:45+00:00 AFUcomp48k_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203020 phv00203020.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:30:03+00:00 2018-07-19 16:30:03+00:00 AFUcomp48l_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203021 phv00203021.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:30:20+00:00 2018-07-19 16:30:20+00:00 AFUcomp48m_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203022 phv00203022.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:30:38+00:00 2018-07-19 16:30:38+00:00 AFUcomp48n_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203023 phv00203023.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:30:55+00:00 2018-07-19 16:30:55+00:00 AFUcomp48o_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203024 phv00203024.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:31:22+00:00 2018-07-19 16:31:22+00:00 AFUcomp48p_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203025 phv00203025.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:31:38+00:00 2018-07-19 16:31:38+00:00 AFUcomp48q_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203026 phv00203026.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:31:53+00:00 2018-07-19 16:31:53+00:00 AFUcomp48r_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203027 phv00203027.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:32:10+00:00 2018-07-19 16:32:10+00:00 AFUcomp48s_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUL] +74 Medication/supplement use 203028 phv00203028.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:32:28+00:00 2018-07-19 16:32:28+00:00 AFUcomp48t_L [Interview]. Does the participant have medications to report? Medication name [Annual Follow-up Questionnaire Form, AFUM] +74 Medication/supplement use 214282 phv00214282.v1.p1 pht004228.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:46:40+00:00 2018-07-19 16:46:40+00:00 TKPILL02 How often do you take sleeping pills or other medication to help you sleep? +74 Medication/supplement use 209382 phv00209382.v1.p1 pht004156.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:47:18+00:00 2018-07-19 16:47:18+00:00 RHXC23A Medication name. Q23a [Hormone Names and Codes, exam 4] +74 Medication/supplement use 209381 phv00209381.v1.p1 pht004156.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:47:38+00:00 2018-07-19 16:47:38+00:00 RHXC11A Medication name. Q11a [Hormone Names and Codes, exam 4] +74 Medication/supplement use 209380 phv00209380.v1.p1 pht004156.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:48:04+00:00 2018-07-19 16:48:04+00:00 AHF24 Medication code (AHF code). Q24 [Hormone Names and Codes, exam 4] +74 Medication/supplement use 209379 phv00209379.v1.p1 pht004156.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:48:26+00:00 2018-07-19 16:48:26+00:00 AHF12 Medication code (AHF code). Q12 [Hormone Names and Codes, exam 4] +74 Medication/supplement use 209369 phv00209369.v1.p1 pht004154.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:48:44+00:00 2018-07-19 16:48:44+00:00 AHF38 6 Digit medication (AHF code). Q-38 [Hormone Names and Codes, exam 1] +74 Medication/supplement use 209368 phv00209368.v1.p1 pht004154.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:49:01+00:00 2018-07-19 16:49:01+00:00 AHF31 6 Digit medication code (AHF code). Q-31 [Hormone Names and Codes, exam 1] +74 Medication/supplement use 209367 phv00209367.v1.p1 pht004154.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:49:17+00:00 2018-07-19 16:49:17+00:00 AHF24 6 Digit medication code (AHF code). Q-24 [Hormone Names and Codes, exam 1] +74 Medication/supplement use 209366 phv00209366.v1.p1 pht004154.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:49:35+00:00 2018-07-19 16:49:35+00:00 AHF17 6 Digit medication code (AHF code). Q-17 [Hormone Names and Codes, exam 1] +74 Medication/supplement use 208324 phv00208324.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:50:02+00:00 2018-07-19 16:50:02+00:00 MSRD30DMONTHS Months of started taking nasaid since exam 1 [Medication Survey Form, exam 4] +74 Medication/supplement use 208323 phv00208323.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:50:20+00:00 2018-07-19 16:50:20+00:00 MSRD29EMONTHS Months of started taking aspirin since exam 1 [Medication Survey Form, exam 4] +74 Medication/supplement use 203058 phv00203058.v1.p1 pht004031.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:51:37+00:00 2018-07-19 16:51:37+00:00 AMHA11 Please think back about the time when you FIRST came to the ARIC clinic on [date]. At that time, were you taking a nonsteroidal anti-inflammatory or arthritis medication on a regular basis? Q11 [AFU Medical History Form, AMH] +74 Medication/supplement use 203062 phv00203062.v1.p1 pht004031.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:52:13+00:00 2018-07-19 16:52:13+00:00 AMHA12 Are you now taking a nonsteroidal anti-inflammatory or arthritis medication on a regular basis? Q12 [AFU Medical History Form, AMH] +74 Medication/supplement use 203185 phv00203185.v1.p1 pht004035.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:53:09+00:00 2018-07-19 16:53:09+00:00 ANTD7 [History of hair loss]. Have you ever received or used any treatment for baldness, such as hair implantation or a medication prescribed by a doctor? Q7 [Anthropometry Form, ANTD, exam 4] +74 Medication/supplement use 203799 phv00203799.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:54:01+00:00 2018-07-19 16:54:01+00:00 CORA23A Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Nitrates? Q23a [Coroner / Medical Examiner Form] +74 Medication/supplement use 203800 phv00203800.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:54:17+00:00 2018-07-19 16:54:17+00:00 CORA23B Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Calcium channel blockers. 23b [Coroner / Medical Examiner Form] +74 Medication/supplement use 203801 phv00203801.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:54:34+00:00 2018-07-19 16:54:34+00:00 CORA23C Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Beta-blockers. Q23c [Coroner / Medical Examiner Form] +74 Medication/supplement use 203802 phv00203802.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:54:51+00:00 2018-07-19 16:54:51+00:00 CORA23D Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Digitalis. Q23d [Coroner / Medical Examiner Form] +74 Medication/supplement use 203803 phv00203803.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:55:10+00:00 2018-07-19 16:55:10+00:00 CORA23E Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? ACE or angiotensin II inhibitors. Q23e [Coroner / Medical Examiner Form] +74 Medication/supplement use 203804 phv00203804.v1.p1 pht004047.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:55:26+00:00 2018-07-19 16:55:26+00:00 CORA23F Was the decedent taking any of the following medications as an outpatient within the four weeks prior to death? Aspirin. Q23f [Coroner / Medical Examiner Form] +74 Medication/supplement use 204156 phv00204156.v1.p1 pht004053.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:55:56+00:00 2018-07-19 16:55:56+00:00 HRAA31L [Second transfer]. Were any of the following drugs given during this hospitalization or at discharge? Lipid lowering medications (Statins, Niacin, Other). Q31l [Hospital Abstraction Form] +74 Medication/supplement use 204414 phv00204414.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:56:22+00:00 2018-07-19 16:56:22+00:00 PHQA04A [Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Nitrates. Q4a [Physician Questionnaire Form, exam 1] +74 Medication/supplement use 204415 phv00204415.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:56:37+00:00 2018-07-19 16:56:37+00:00 PHQA04B [Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Calcium channel blockers. Q4b [Physician Questionnaire Form, exam 1] +74 Medication/supplement use 204416 phv00204416.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:56:51+00:00 2018-07-19 16:56:51+00:00 PHQA04C [Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Digitalis. Q4c [Physician Questionnaire Form, exam 1] +74 Medication/supplement use 204417 phv00204417.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:57:16+00:00 2018-07-19 16:57:16+00:00 PHQA04D [Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Beta-blockers. Q4d [Physician Questionnaire Form, exam 1] +74 Medication/supplement use 204418 phv00204418.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:57:36+00:00 2018-07-19 16:57:36+00:00 PHQA04D1 [Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Aspirin. Q4d1 [Physician Questionnaire Form, exam 1] +74 Medication/supplement use 204419 phv00204419.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:57:58+00:00 2018-07-19 16:57:58+00:00 PHQA04D2 [Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? ACE or angiotensin II inhibitors. Q4d2 [Physician Questionnaire Form, exam 1] +74 Medication/supplement use 204420 phv00204420.v1.p1 pht004059.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:58:17+00:00 2018-07-19 16:58:17+00:00 PHQA04E [Medical history]. Was the decedent taking any of the following medications within four weeks prior to death? Other cardiovascular drugs. Q4e [Physician Questionnaire Form, exam 1] +74 Medication/supplement use 205052 phv00205052.v1.p1 pht004067.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:58:49+00:00 2018-07-19 16:58:49+00:00 DSRA14 Are you taking prednisone or an immunosuppressive medication? Q14 [Dental Screening Form, exam 4] +74 Medication/supplement use 206628 phv00206628.v1.p1 pht004096.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:59:07+00:00 2018-07-19 16:59:07+00:00 GTSA2 Do you regularly take medication to control diabetes? Q2 [Oral Glucose Tolerance Screening Form, exam 4] +74 Medication/supplement use 206636 phv00206636.v1.p1 pht004097.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 16:59:22+00:00 2018-07-19 16:59:22+00:00 GTSB2 Do you regularly take medication to control diabetes (high blood sugar)? Q2 [Oral Glucose Tolerance Screening Version B, exam 4] +74 Medication/supplement use 206919 phv00206919.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:00:06+00:00 2018-07-19 17:00:06+00:00 HFAA59 [Medication]. Q59 - Ace inhibitors prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206920 phv00206920.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:00:35+00:00 2018-07-19 17:00:35+00:00 HFAA59A [Medication]. Q59a - Ace inhibitors at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206921 phv00206921.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:00:58+00:00 2018-07-19 17:00:58+00:00 HFAA60 [Medication]. Q60 - Angiotensin II receptor blockers prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206964 phv00206964.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:01:14+00:00 2018-07-19 17:01:14+00:00 HFAA60A [Medication]. Q60a - Angiotensin II reception blockers at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206965 phv00206965.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:01:30+00:00 2018-07-19 17:01:30+00:00 HFAA61A [Medication]. Q61a - Antiarrhythmic: amiodarone prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206966 phv00206966.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:01:50+00:00 2018-07-19 17:01:50+00:00 HFAA61A1 [Medication]. Q61a1- Antiarrhythmic: amiodarone at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206967 phv00206967.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:02:08+00:00 2018-07-19 17:02:08+00:00 HFAA61B [Medication]. Q61b - Antiarrhythmic: other prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206968 phv00206968.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:02:23+00:00 2018-07-19 17:02:23+00:00 HFAA61B1 [Medication]. Q61b1- Antiarrhythmic: other at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206969 phv00206969.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:02:38+00:00 2018-07-19 17:02:38+00:00 HFAA62 [Medication]. Q62 - Anticoagulants prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206970 phv00206970.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:02:54+00:00 2018-07-19 17:02:54+00:00 HFAA62A [Medication]. Q62a - Anticoagulants at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206971 phv00206971.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:03:10+00:00 2018-07-19 17:03:10+00:00 HFAA63 [Medication]. Q63 - Anti-inflammatory prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206972 phv00206972.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:03:26+00:00 2018-07-19 17:03:26+00:00 HFAA63A [Medication]. Q63a - Anti-inflammatory at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206973 phv00206973.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:03:48+00:00 2018-07-19 17:03:48+00:00 HFAA64A [Medication]. Q64a - Antiplatelets: aspirin prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206974 phv00206974.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:04:04+00:00 2018-07-19 17:04:04+00:00 HFAA64A1 [Medication]. Q64a1- Antiplatelets: aspirin at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206975 phv00206975.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:04:40+00:00 2018-07-19 17:04:40+00:00 HFAA64B [Medication]. Q64b - Antiplatelets: other prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206976 phv00206976.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:05:28+00:00 2018-07-19 17:05:28+00:00 HFAA64B1 [Medication]. Q64b1- Antiplatelets: other at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206977 phv00206977.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:06:12+00:00 2018-07-19 17:06:12+00:00 HFAA65 [Medication]. Q65 - Beta blockers prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206978 phv00206978.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:06:50+00:00 2018-07-19 17:06:50+00:00 HFAA65A [Medication]. Q65a - Beta blockers at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206979 phv00206979.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:07:06+00:00 2018-07-19 17:07:06+00:00 HFAA66 [Medication]. Q66 - Calcium channel blockers prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206980 phv00206980.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:07:36+00:00 2018-07-19 17:07:36+00:00 HFAA66A [Medication]. Q66a - Calcium channel blockers at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206981 phv00206981.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:07:54+00:00 2018-07-19 17:07:54+00:00 HFAA67 [Medication]. Q67 - Digitalis prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206982 phv00206982.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:08:14+00:00 2018-07-19 17:08:14+00:00 HFAA67A [Medication]. Q67a - Digitalis at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206983 phv00206983.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:08:30+00:00 2018-07-19 17:08:30+00:00 HFAA68 [Medication]. Q68 - Diuretics prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206984 phv00206984.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:08:51+00:00 2018-07-19 17:08:51+00:00 HFAA68A [Medication]. Q68a - Diuretics at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206985 phv00206985.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:09:08+00:00 2018-07-19 17:09:08+00:00 HFAA69 [Medication]. Q69 - Aldosterone blocker prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206986 phv00206986.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:09:24+00:00 2018-07-19 17:09:24+00:00 HFAA69A [Medication]. Q69a - Aldosterone blocker at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206987 phv00206987.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:09:47+00:00 2018-07-19 17:09:47+00:00 HFAA70A [Medication]. Q70a - Lipid lowering statins prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206988 phv00206988.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:10:04+00:00 2018-07-19 17:10:04+00:00 HFAA70A1 [Medication]. Q70a1- Lipid lowering statins at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206989 phv00206989.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:10:21+00:00 2018-07-19 17:10:21+00:00 HFAA70B [Medication]. Q70b - Lipid lowering other prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206990 phv00206990.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:10:39+00:00 2018-07-19 17:10:39+00:00 HFAA70B1 [Medication]. Q70b1- Lipid lowering other at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206991 phv00206991.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:11:00+00:00 2018-07-19 17:11:00+00:00 HFAA71 [Medication]. Q71 - Nitrates prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206992 phv00206992.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:11:21+00:00 2018-07-19 17:11:21+00:00 HFAA71A [Medication]. Q71a - Nitrates at hospital discharge [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206993 phv00206993.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:11:54+00:00 2018-07-19 17:11:54+00:00 HFAA72 [Medication]. Q72 - Hydralazine prior to hospitalization or progression in hospital [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206994 phv00206994.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:12:16+00:00 2018-07-19 17:12:16+00:00 HFAA72A [Medication]. Q72a - Hydralazine [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206995 phv00206995.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:12:38+00:00 2018-07-19 17:12:38+00:00 HFAA73A [Medication]. Q73a - IV inotropes [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 206996 phv00206996.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:13:27+00:00 2018-07-19 17:13:27+00:00 HFAA73B [Medication]. Q73b - IV diuretics [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 207048 phv00207048.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:13:57+00:00 2018-07-19 17:13:57+00:00 HFAA73C [Medication]. Q73c - IV vasodilators (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 207049 phv00207049.v1.p1 pht004102.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:14:17+00:00 2018-07-19 17:14:17+00:00 HFAA73D [Medication]. Q73d - IV antiarrythmics (removed from current form version) [Heart Failure Hospital Record Abstraction Form, HFA] +74 Medication/supplement use 207842 phv00207842.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:29:52+00:00 2018-07-19 17:29:52+00:00 MSRA04AA [Medication records]. Medication name & concentration. Q4aa [Medication Survey Form, exam 1] +74 Medication/supplement use 207843 phv00207843.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 17:30:27+00:00 2018-07-19 17:30:27+00:00 MSRA04AB [Medication records]. Medication code No. Q4ab [Medication Survey Form, exam 1] +74 Medication/supplement use 207846 phv00207846.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 19:59:09+00:00 2018-07-19 19:59:09+00:00 MSRA04BA [Medication records]. Medication name & concentration.Q4ba [Medication Survey Form, exam 1] +74 Medication/supplement use 207847 phv00207847.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 19:59:31+00:00 2018-07-19 19:59:31+00:00 MSRA04BB [Medication records]. Medication Code No. Q4bb [Medication Survey Form, exam 1] +74 Medication/supplement use 207850 phv00207850.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:00:31+00:00 2018-07-19 20:00:31+00:00 MSRA04CA [Medication records]. Medication name & concentration. Q4ca [Medication Survey Form, exam 1] +74 Medication/supplement use 207851 phv00207851.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:00:53+00:00 2018-07-19 20:00:53+00:00 MSRA04CB [Medication records]. Medication code No. Q4cb [Medication Survey Form, exam 1] +74 Medication/supplement use 207854 phv00207854.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:01:39+00:00 2018-07-19 20:01:39+00:00 MSRA04DA [Medication records]. Medication name & concentration. Q4da [Medication Survey Form, exam 1] +74 Medication/supplement use 207855 phv00207855.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:01:59+00:00 2018-07-19 20:01:59+00:00 MSRA04DB [Medication records]. Medication code No. Q4db [Medication Survey Form, exam 1] +74 Medication/supplement use 207858 phv00207858.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:02:24+00:00 2018-07-19 20:02:24+00:00 MSRA04EA [Medication records]. Medication name & concentration. Q4ea [Medication Survey Form, exam 1] +74 Medication/supplement use 207859 phv00207859.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:02:46+00:00 2018-07-19 20:02:46+00:00 MSRA04EB [Medication records]. Medication code No. Q4eb [Medication Survey Form, exam 1] +74 Medication/supplement use 207862 phv00207862.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:05:51+00:00 2018-07-19 20:05:51+00:00 MSRA04FA [Medication records]. Medication name & concentration. Q4fa [Medication Survey Form, exam 1] +74 Medication/supplement use 207863 phv00207863.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:07:37+00:00 2018-07-19 20:07:37+00:00 MSRA04FB [Medication records]. Medication code No. Q4fb [Medication Survey Form, exam 1] +74 Medication/supplement use 207866 phv00207866.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:17:44+00:00 2018-07-19 20:17:44+00:00 MSRA04GA [Medication records]. Medication name & concentration. Q4ga [Medication Survey Form, exam 1] +74 Medication/supplement use 207867 phv00207867.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:18:02+00:00 2018-07-19 20:18:02+00:00 MSRA04GB [Medication records]. Medication code No. Q4gb [Medication Survey Form, exam 1] +74 Medication/supplement use 207870 phv00207870.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:18:20+00:00 2018-07-19 20:18:20+00:00 MSRA04HA [Medication records]. Medication name & concentration. Q4ha [Medication Survey Form, exam 1] +74 Medication/supplement use 207871 phv00207871.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:18:42+00:00 2018-07-19 20:18:42+00:00 MSRA04HB [Medication records]. Medication code No. Q4hb [Medication Survey Form, exam 1] +74 Medication/supplement use 207874 phv00207874.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:19:22+00:00 2018-07-19 20:19:22+00:00 MSRA04IA [Medication records]. Medication name & concentration. Q4ia [Medication Survey Form, exam 1] +74 Medication/supplement use 207875 phv00207875.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:19:42+00:00 2018-07-19 20:19:42+00:00 MSRA04IB [Medication records]. Medication code No. Q4ib [Medication Survey Form, exam 1] +74 Medication/supplement use 207878 phv00207878.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:20:02+00:00 2018-07-19 20:20:02+00:00 MSRA04JA [Medication records]. Medication name & concentration. Q4ja [Medication Survey Form, exam 1] +74 Medication/supplement use 207879 phv00207879.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:20:20+00:00 2018-07-19 20:20:20+00:00 MSRA04JB Medication code No. Q4jb [Medication Survey Form, exam 1] +74 Medication/supplement use 207882 phv00207882.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:20:39+00:00 2018-07-19 20:20:39+00:00 MSRA04KA [Medication records]. Medication name & concentration. Q4ka [Medication Survey Form, exam 1] +74 Medication/supplement use 207883 phv00207883.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:21:00+00:00 2018-07-19 20:21:00+00:00 MSRA04KB [Medication records]. Medication code No. Q4kb [Medication Survey Form, exam 1] +74 Medication/supplement use 207886 phv00207886.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:21:19+00:00 2018-07-19 20:21:19+00:00 MSRA04LA [Medication records]. Medication name & concentration. Q4la [Medication Survey Form, exam 1] +74 Medication/supplement use 207887 phv00207887.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:21:43+00:00 2018-07-19 20:21:43+00:00 MSRA04LB [Medication records]. Medication code No. Q4lb [Medication Survey Form, exam 1] +74 Medication/supplement use 207890 phv00207890.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:22:04+00:00 2018-07-19 20:22:04+00:00 MSRA04MA [Medication records]. Medication name & concentration. Q4ma [Medication Survey Form, exam 1] +74 Medication/supplement use 207891 phv00207891.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:22:25+00:00 2018-07-19 20:22:25+00:00 MSRA04MB [Medication records]. Medication code No. Q4mb [Medication Survey Form, exam 1] +74 Medication/supplement use 207894 phv00207894.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:22:43+00:00 2018-07-19 20:22:43+00:00 MSRA04NA [Medication records]. Medication name & concentration. Q4na [Medication Survey Form, exam 1] +74 Medication/supplement use 207895 phv00207895.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:23:02+00:00 2018-07-19 20:23:02+00:00 MSRA04NB [Medication records]. Medication code No. Q4nb [Medication Survey Form, exam 1] +74 Medication/supplement use 207898 phv00207898.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:23:20+00:00 2018-07-19 20:23:20+00:00 MSRA04OA [Medication records]. Medication name & concentration. Q4oa [Medication Survey Form, exam 1] +74 Medication/supplement use 207899 phv00207899.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:23:41+00:00 2018-07-19 20:23:41+00:00 MSRA04OB [Medication records]. Medication code No. Q4ob [Medication Survey Form, exam 1] +74 Medication/supplement use 207902 phv00207902.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:24:02+00:00 2018-07-19 20:24:02+00:00 MSRA04PA [Medication records]. Medication name & concentration. Q4pa [Medication Survey Form, exam 1] +74 Medication/supplement use 207903 phv00207903.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:24:19+00:00 2018-07-19 20:24:19+00:00 MSRA04PB [Medication records]. Medication code No. Q4pb [Medication Survey Form, exam 1] +74 Medication/supplement use 207906 phv00207906.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:24:41+00:00 2018-07-19 20:24:41+00:00 MSRA04QA [Medication records]. Medication name & concentration. Q4qa [Medication Survey Form, exam 1] +74 Medication/supplement use 207907 phv00207907.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:25:07+00:00 2018-07-19 20:25:07+00:00 MSRA04QB [Medication records]. Medication code No. Q4qb [Medication Survey Form, exam 1] +74 Medication/supplement use 207913 phv00207913.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:26:40+00:00 2018-07-19 20:26:40+00:00 MSRA08A [Interview]. Were any of the medications you took during the past two weeks for: High blood pressure? Q8a [Medication Survey Form, exam 1] +74 Medication/supplement use 207914 phv00207914.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:27:16+00:00 2018-07-19 20:27:16+00:00 MSRA08B [Interview]. Were any of the medications you took during the past two weeks for: angina or chest pain? Q8b [Medication Survey Form, exam 1] +74 Medication/supplement use 207915 phv00207915.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:27:36+00:00 2018-07-19 20:27:36+00:00 MSRA08C [Interview]. Were any of the medications you took during the past two weeks for: control of heart rhythm? Q8c [Medication Survey Form, exam 1] +74 Medication/supplement use 207916 phv00207916.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:27:56+00:00 2018-07-19 20:27:56+00:00 MSRA08D [Interview]. Were any of the medications you took during the past two weeks for: heart failure? Q8d [Medication Survey Form, exam 1] +74 Medication/supplement use 207917 phv00207917.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:28:16+00:00 2018-07-19 20:28:16+00:00 MSRA08E [Interview]. Were any of the medications you took during the past two weeks for: blood thinning? Q8e [Medication Survey Form, exam 1] +74 Medication/supplement use 207918 phv00207918.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:28:40+00:00 2018-07-19 20:28:40+00:00 MSRA08F [Interview]. Were any of the medications you took during the past two weeks for: diabetes or high blood sugar? Q8f [Medication Survey Form, exam 1] +74 Medication/supplement use 207919 phv00207919.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:28:58+00:00 2018-07-19 20:28:58+00:00 MSRA08G [Interview]. Were any of the medications you took during the past two weeks for: stroke? Q8g [Medication Survey Form, exam 1] +74 Medication/supplement use 207920 phv00207920.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:29:26+00:00 2018-07-19 20:29:26+00:00 MSRA08H [Interview]. Were any of the medications you took during the past two weeks for: leg pain when walking? Q8h [Medication Survey Form, exam 1] +74 Medication/supplement use 207921 phv00207921.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:29:48+00:00 2018-07-19 20:29:48+00:00 MSRA09 [Interview]. During the past two weeks, did you take any Aspirin, Alka-Seltzer, a cold medicine, or a headache powder? Q9 [Medication Survey Form, exam 1] +74 Medication/supplement use 207922 phv00207922.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 20:30:11+00:00 2018-07-19 20:30:11+00:00 MSRA10 [Interview]. During the past two weeks, did you take any (other) medication for arthritis, fever, or muscle aches and pains, (or menstrual cramps)? Q10 [Medication Survey Form, exam 1] +74 Medication/supplement use 207929 phv00207929.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:31:09+00:00 2018-07-19 21:31:09+00:00 MSRB04A [Medication records]. Medication name and concentration. Q4A [Medication Survey Form, exam 2] +74 Medication/supplement use 207930 phv00207930.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:31:27+00:00 2018-07-19 21:31:27+00:00 MSRB04B [Medication records]. Medication code number. Q4B [Medication Survey Form, exam 2] +74 Medication/supplement use 207933 phv00207933.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:31:52+00:00 2018-07-19 21:31:52+00:00 MSRB05A [Medication records]. Medication name and concentration Q5A [Medication Survey Form, exam 2] +74 Medication/supplement use 207934 phv00207934.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:32:17+00:00 2018-07-19 21:32:17+00:00 MSRB05B [Medication records]. Medication code number. Q5B [Medication Survey Form, exam 2] +74 Medication/supplement use 207937 phv00207937.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:32:56+00:00 2018-07-19 21:32:56+00:00 MSRB06A [Medication records]. Medication name and concentration. Q6A [Medication Survey Form, exam 2] +74 Medication/supplement use 207938 phv00207938.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:33:29+00:00 2018-07-19 21:33:29+00:00 MSRB06B [Medication records]. Medication code number. Q6B [Medication Survey Form, exam 2] +74 Medication/supplement use 207941 phv00207941.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:33:56+00:00 2018-07-19 21:33:56+00:00 MSRB07A [Medication records]. Medication name and concentration. Q7A [Medication Survey Form, exam 2] +74 Medication/supplement use 207942 phv00207942.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:34:28+00:00 2018-07-19 21:34:28+00:00 MSRB07B [Medication records]. Medication code number. Q7B [Medication Survey Form, exam 2] +74 Medication/supplement use 207945 phv00207945.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:34:53+00:00 2018-07-19 21:34:53+00:00 MSRB08A [Medication records]. Medication name and concentration. Q8A [Medication Survey Form, exam 2] +74 Medication/supplement use 207946 phv00207946.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:35:17+00:00 2018-07-19 21:35:17+00:00 MSRB08B [Medication records]. Medication code number. Q8B [Medication Survey Form, exam 2] +74 Medication/supplement use 207949 phv00207949.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:35:56+00:00 2018-07-19 21:35:56+00:00 MSRB09A [Medication records]. Medication name and concentration. Q9A [Medication Survey Form, exam 2] +74 Medication/supplement use 207950 phv00207950.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:36:13+00:00 2018-07-19 21:36:13+00:00 MSRB09B [Medication records]. Medication code number. Q9B [Medication Survey Form, exam 2] +74 Medication/supplement use 207953 phv00207953.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:36:33+00:00 2018-07-19 21:36:33+00:00 MSRB10A [Medication records]. Medication name and concentration. Q10A [Medication Survey Form, exam 2] +74 Medication/supplement use 207954 phv00207954.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:36:50+00:00 2018-07-19 21:36:50+00:00 MSRB10B [Medication records]. Medication code number. Q10B [Medication Survey Form, exam 2] +74 Medication/supplement use 207957 phv00207957.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:37:10+00:00 2018-07-19 21:37:10+00:00 MSRB11A [Medication records]. Medication name and concentration. Q11A [Medication Survey Form, exam 2] +74 Medication/supplement use 207958 phv00207958.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:37:29+00:00 2018-07-19 21:37:29+00:00 MSRB11B [Medication records]. Medication code number. Q11B [Medication Survey Form, exam 2] +74 Medication/supplement use 207961 phv00207961.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:37:49+00:00 2018-07-19 21:37:49+00:00 MSRB12A [Medication records]. Medication name and concentration. Q12A [Medication Survey Form, exam 2] +74 Medication/supplement use 207962 phv00207962.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:38:06+00:00 2018-07-19 21:38:06+00:00 MSRB12B [Medication records]. Medication code number. Q12B [Medication Survey Form, exam 2] +74 Medication/supplement use 207965 phv00207965.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:40:31+00:00 2018-07-19 21:40:31+00:00 MSRB13A [Medication records]. Medication name and concentration. Q13A [Medication Survey Form, exam 2] +74 Medication/supplement use 207966 phv00207966.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:40:49+00:00 2018-07-19 21:40:49+00:00 MSRB13B [Medication records]. Medication code number. Q13B [Medication Survey Form, exam 2] +74 Medication/supplement use 207969 phv00207969.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:41:17+00:00 2018-07-19 21:41:17+00:00 MSRB14A [Medication records]. Medication name and concentration. Q14A [Medication Survey Form, exam 2] +74 Medication/supplement use 207970 phv00207970.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:41:35+00:00 2018-07-19 21:41:35+00:00 MSRB14B [Medication records]. Medication code number. Q14B [Medication Survey Form, exam 2] +74 Medication/supplement use 207973 phv00207973.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:42:01+00:00 2018-07-19 21:42:01+00:00 MSRB15A [Medication records]. Medication name and concentration. Q15A [Medication Survey Form, exam 2] +74 Medication/supplement use 207974 phv00207974.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:42:25+00:00 2018-07-19 21:42:25+00:00 MSRB15B [Medication records]. Medication code number. Q15B [Medication Survey Form, exam 2] +74 Medication/supplement use 207978 phv00207978.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:43:18+00:00 2018-07-19 21:43:18+00:00 MSRB16B [Medication records]. Medication code number. Q16B [Medication Survey Form, exam 2] +74 Medication/supplement use 207977 phv00207977.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:43:38+00:00 2018-07-19 21:43:38+00:00 MSRB16A [Medication records]. Medication name and concentration. Q16A [Medication Survey Form, exam 2] +74 Medication/supplement use 207981 phv00207981.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:44:12+00:00 2018-07-19 21:44:12+00:00 MSRB17A [Medication records]. Medication name and concentration. Q17A [Medication Survey Form, exam 2] +74 Medication/supplement use 207982 phv00207982.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:44:33+00:00 2018-07-19 21:44:33+00:00 MSRB17B [Medication records]. Medication code number. Q17B [Medication Survey Form, exam 2] +74 Medication/supplement use 207985 phv00207985.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:44:56+00:00 2018-07-19 21:44:56+00:00 MSRB18A [Medication records]. Medication name and concentration. Q18A [Medication Survey Form, exam 2] +74 Medication/supplement use 207986 phv00207986.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:45:14+00:00 2018-07-19 21:45:14+00:00 MSRB18B [Medication records]. Medication code number. Q18B [Medication Survey Form, exam 2] +74 Medication/supplement use 207989 phv00207989.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:45:51+00:00 2018-07-19 21:45:51+00:00 MSRB19A [Medication records]. Medication name and concentration. Q19A [Medication Survey Form, exam 2] +74 Medication/supplement use 207990 phv00207990.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:46:08+00:00 2018-07-19 21:46:08+00:00 MSRB19B [Medication records]. Medication code number. Q19B [Medication Survey Form, exam 2] +74 Medication/supplement use 207993 phv00207993.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:46:25+00:00 2018-07-19 21:46:25+00:00 MSRB20A [Medication records]. Medication name and concentration. Q20A [Medication Survey Form, exam 2] +74 Medication/supplement use 207994 phv00207994.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:46:44+00:00 2018-07-19 21:46:44+00:00 MSRB20B [Medication records]. Medication code number. Q20B [Medication Survey Form, exam 2] +74 Medication/supplement use 208001 phv00208001.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:48:44+00:00 2018-07-19 21:48:44+00:00 MSRB24A [Interview]. Were any of the medications you took during the past two weeks for: high blood pressure. Q24A [Medication Survey Form, exam 2] +74 Medication/supplement use 208002 phv00208002.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:49:06+00:00 2018-07-19 21:49:06+00:00 MSRB24B [Interview]. Were any of the medications you took during the past two weeks for: angina or chest pain. Q24B [Medication Survey Form, exam 2] +74 Medication/supplement use 208003 phv00208003.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:49:25+00:00 2018-07-19 21:49:25+00:00 MSRB24C [Interview]. Were any of the medications you took during the past two weeks for: control of heart rhythm. Q24C [Medication Survey Form, exam 2] +74 Medication/supplement use 208004 phv00208004.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:49:45+00:00 2018-07-19 21:49:45+00:00 MSRB24D [Interview]. Were any of the medications you took during the past two weeks for: heart failure. Q24D [Medication Survey Form, exam 2] +74 Medication/supplement use 208005 phv00208005.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:50:07+00:00 2018-07-19 21:50:07+00:00 MSRB24E [Interview]. Were any of the medications you took during the past two weeks for: blood thinning. Q24E [Medication Survey Form, exam 2] +74 Medication/supplement use 208006 phv00208006.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:50:26+00:00 2018-07-19 21:50:26+00:00 MSRB24F [Interview]. Were any of the medications you took during the past two weeks for: diabetes or high blood sugar. Q24F [Medication Survey Form, exam 2] +74 Medication/supplement use 208007 phv00208007.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:50:47+00:00 2018-07-19 21:50:47+00:00 MSRB24G [Interview]. Were any of the medications you took during the past two weeks for: stroke. Q24G [Medication Survey Form, exam 2] +74 Medication/supplement use 208008 phv00208008.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:51:15+00:00 2018-07-19 21:51:15+00:00 MSRB24H [Interview]. Were any of the medications you took during the past two weeks for: leg pain when walking. Q24H [Medication Survey Form, exam 2] +74 Medication/supplement use 208009 phv00208009.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:51:37+00:00 2018-07-19 21:51:37+00:00 MSRB25 [Interview]. During the past two weeks, did you take any aspirin, Alka-Seltzer, cold medicine, or headache powder? Q25 [Medication Survey Form, exam 2] +74 Medication/supplement use 208010 phv00208010.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-07-19 21:51:56+00:00 2018-07-19 21:51:56+00:00 MSRB26 [Interview]. During the Past two weeks, did you take any [other] medication for arthritis, fever, or muscle aches and pains, (or menstrual cramps)? Q26 [Medication Survey Form, exam 2] +74 Medication/supplement use 125479 phv00125479.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:17:46+00:00 2018-07-30 14:17:46+00:00 AFUC48I 48i. Medication name +74 Medication/supplement use 125480 phv00125480.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:17:46+00:00 2018-07-30 14:17:46+00:00 AFUC48J 48j. Medication name +74 Medication/supplement use 125481 phv00125481.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:17:46+00:00 2018-07-30 14:17:46+00:00 AFUC48K 48k. Medication name +74 Medication/supplement use 125482 phv00125482.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:17:46+00:00 2018-07-30 14:17:46+00:00 AFUC48L 48l. Medication name +74 Medication/supplement use 125483 phv00125483.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:17:46+00:00 2018-07-30 14:17:46+00:00 AFUC48M 48m. Medication name +74 Medication/supplement use 125484 phv00125484.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:17:46+00:00 2018-07-30 14:17:46+00:00 AFUC48N 48n. Medication name +74 Medication/supplement use 125485 phv00125485.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:17:46+00:00 2018-07-30 14:17:46+00:00 AFUC48O 48o. Medication name +74 Medication/supplement use 125486 phv00125486.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:20:15+00:00 2018-07-30 14:20:15+00:00 AFUC48P 48p. Medication name +74 Medication/supplement use 125487 phv00125487.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:20:15+00:00 2018-07-30 14:20:15+00:00 AFUC48Q 48q. Medication name +74 Medication/supplement use 125488 phv00125488.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:20:15+00:00 2018-07-30 14:20:15+00:00 AFUC48R 48r. Medication name +74 Medication/supplement use 125489 phv00125489.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:20:15+00:00 2018-07-30 14:20:15+00:00 AFUC48S 48s. Medication name +74 Medication/supplement use 125490 phv00125490.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:20:15+00:00 2018-07-30 14:20:15+00:00 AFUC48T 48t. Medication name +74 Medication/supplement use 125470 phv00125470.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:26:50+00:00 2018-07-30 14:26:50+00:00 AFUC47 47. Does the participant have medications to report +74 Medication/supplement use 125471 phv00125471.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:26:50+00:00 2018-07-30 14:26:50+00:00 AFUC48A 48a. Medication name +74 Medication/supplement use 125472 phv00125472.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:26:50+00:00 2018-07-30 14:26:50+00:00 AFUC48B 48b. Medication name +74 Medication/supplement use 125473 phv00125473.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:26:50+00:00 2018-07-30 14:26:50+00:00 AFUC48C 48c. Medication name +74 Medication/supplement use 125474 phv00125474.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:26:50+00:00 2018-07-30 14:26:50+00:00 AFUC48D 48d. Medication name +74 Medication/supplement use 125475 phv00125475.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:26:50+00:00 2018-07-30 14:26:50+00:00 AFUC48E 48e. Medication name +74 Medication/supplement use 125476 phv00125476.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:26:50+00:00 2018-07-30 14:26:50+00:00 AFUC48F 48f. Medication name +74 Medication/supplement use 125477 phv00125477.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:26:50+00:00 2018-07-30 14:26:50+00:00 AFUC48G 48g. Medication name +74 Medication/supplement use 125466 phv00125466.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:35:25+00:00 2018-07-30 14:35:25+00:00 AFUC46A 46a. High blood pressure +74 Medication/supplement use 125467 phv00125467.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:35:25+00:00 2018-07-30 14:35:25+00:00 AFUC46B 46b. High blood cholesterol +74 Medication/supplement use 125468 phv00125468.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:35:25+00:00 2018-07-30 14:35:25+00:00 AFUC46C 46c. Diabetes or high blood sugar +74 Medication/supplement use 125469 phv00125469.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:35:25+00:00 2018-07-30 14:35:25+00:00 AFUC46D 46d. Heart failure +74 Medication/supplement use 125478 phv00125478.v1.p1 pht001935.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:35:25+00:00 2018-07-30 14:35:25+00:00 AFUC48H 48h. Medication name +74 Medication/supplement use 125547 phv00125547.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:36:16+00:00 2018-07-30 14:36:16+00:00 AFUI19A FEMALE HORMONE SINCE LAST CONTACT Q19A +74 Medication/supplement use 125548 phv00125548.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:36:16+00:00 2018-07-30 14:36:16+00:00 AFUI19B FEMALE HORMONE SINCE LAST VISIT Q19B +74 Medication/supplement use 125549 phv00125549.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:36:16+00:00 2018-07-30 14:36:16+00:00 AFUI19C NAME OF FEMALE HORMONES Q19C +74 Medication/supplement use 125636 phv00125636.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:36:16+00:00 2018-07-30 14:36:16+00:00 AFUI19A FEMALE HORMONE SINCE LAST CONTACT Q19A +74 Medication/supplement use 125637 phv00125637.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:36:16+00:00 2018-07-30 14:36:16+00:00 AFUI19B FEMALE HORMONE SINCE LAST VISIT Q19B +74 Medication/supplement use 125638 phv00125638.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:36:16+00:00 2018-07-30 14:36:16+00:00 AFUI19C NAME OF FEMALE HORMONES Q19C +74 Medication/supplement use 125550 phv00125550.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:56:06+00:00 2018-07-30 14:56:06+00:00 AFUI19D NAME OF FEMALE HORMONES Q19D +74 Medication/supplement use 125551 phv00125551.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:56:06+00:00 2018-07-30 14:56:06+00:00 AFUI20 FEMALE HORMONE CODE 1 Q20 +74 Medication/supplement use 125552 phv00125552.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:56:06+00:00 2018-07-30 14:56:06+00:00 AFUI21 USE OF SECOND FEMALE HORMONE Q21 +74 Medication/supplement use 125553 phv00125553.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:56:06+00:00 2018-07-30 14:56:06+00:00 AFUI21A NAME 2 OF FEMALE HORMONE Q21A +74 Medication/supplement use 125639 phv00125639.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:56:06+00:00 2018-07-30 14:56:06+00:00 AFUI19D NAME OF FEMALE HORMONES Q19D +74 Medication/supplement use 125640 phv00125640.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:56:06+00:00 2018-07-30 14:56:06+00:00 AFUI20 FEMALE HORMONE CODE 1 Q20 +74 Medication/supplement use 125641 phv00125641.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:56:06+00:00 2018-07-30 14:56:06+00:00 AFUI21 USE OF SECOND FEMALE HORMONE Q21 +74 Medication/supplement use 125642 phv00125642.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:56:06+00:00 2018-07-30 14:56:06+00:00 AFUI21A NAME 2 OF FEMALE HORMONE Q21A +74 Medication/supplement use 125542 phv00125542.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI16A MEDS FOR HIGH BP IN LAST 2 WKS Q16A +74 Medication/supplement use 125543 phv00125543.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI16B MEDS FOR HIGH CHOL IN LAST 2 WKS Q16B +74 Medication/supplement use 125544 phv00125544.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI16C MEDS FOR DIAB, BLOOD SUGAR IN 2WK Q16C +74 Medication/supplement use 125554 phv00125554.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI21B NAME 2 OF FEMALE HORMONE Q21B +74 Medication/supplement use 125555 phv00125555.v1.p1 pht001936.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI22 FEMALE HORMONE CODE 2 Q22 +74 Medication/supplement use 125631 phv00125631.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI16A MEDS FOR HIGH BP IN LAST 2 WKS Q16A +74 Medication/supplement use 125632 phv00125632.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI16B MEDS FOR HIGH CHOL IN LAST 2 WKS Q16B +74 Medication/supplement use 125633 phv00125633.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI16C MEDS FOR DIAB, BLOOD SUGAR IN 2WK Q16C +74 Medication/supplement use 125643 phv00125643.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI21B NAME 2 OF FEMALE HORMONE Q21B +74 Medication/supplement use 125644 phv00125644.v1.p1 pht001937.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 14:59:26+00:00 2018-07-30 14:59:26+00:00 AFUI22 FEMALE HORMONE CODE 2 Q22 +74 Medication/supplement use 125720 phv00125720.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:02:55+00:00 2018-07-30 15:02:55+00:00 AFUJ16A MEDS FOR HIGH BP IN LAST 2 WKS Q16A +74 Medication/supplement use 125721 phv00125721.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:02:55+00:00 2018-07-30 15:02:55+00:00 AFUJ16B MEDS FOR HIGH CHOL IN LAST 2 WKS Q16B +74 Medication/supplement use 125722 phv00125722.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:02:55+00:00 2018-07-30 15:02:55+00:00 AFUJ16C MEDS FOR DIAB, BLOOD SUGAR IN 2WK Q16C +74 Medication/supplement use 125725 phv00125725.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:02:55+00:00 2018-07-30 15:02:55+00:00 AFUJ19A FEMALE HORMONE SINCE LAST CONTACT Q19A +74 Medication/supplement use 125726 phv00125726.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:02:55+00:00 2018-07-30 15:02:55+00:00 AFUJ19B FEMALE HORMONE SINCE LAST VISIT Q19B +74 Medication/supplement use 125727 phv00125727.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:02:55+00:00 2018-07-30 15:02:55+00:00 AFUJ19C NAME OF FEMALE HORMONES Q19C +74 Medication/supplement use 125728 phv00125728.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:02:55+00:00 2018-07-30 15:02:55+00:00 AFUJ19D NAME OF FEMALE HORMONES Q19D +74 Medication/supplement use 125729 phv00125729.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUJ20 FEMALE HORMONE CODE 1 Q20 +74 Medication/supplement use 125730 phv00125730.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUJ21 USE OF SECOND FEMALE HORMONE Q21 +74 Medication/supplement use 125731 phv00125731.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUJ21A NAME 2 OF FEMALE HORMONE Q21A +74 Medication/supplement use 125732 phv00125732.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUJ21B NAME 2 OF FEMALE HORMONE Q21B +74 Medication/supplement use 125733 phv00125733.v1.p1 pht001938.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUJ22 FEMALE HORMONE CODE 2 Q22 +74 Medication/supplement use 125812 phv00125812.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUK19A FEMALE HORMONE SINCE LAST CONTACT Q19A +74 Medication/supplement use 125813 phv00125813.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUK19B FEMALE HORMONE SINCE LAST VISIT Q19B +74 Medication/supplement use 125814 phv00125814.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUK19C NAME OF FEMALE HORMONES Q19C +74 Medication/supplement use 125815 phv00125815.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUK19D NAME OF FEMALE HORMONES Q19D +74 Medication/supplement use 125816 phv00125816.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:07:02+00:00 2018-07-30 15:07:02+00:00 AFUK20 FEMALE HORMONE CODE 1 Q20 +74 Medication/supplement use 125807 phv00125807.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:10:07+00:00 2018-07-30 15:10:07+00:00 AFUK16A MEDS FOR HIGH BP IN LAST 2 WKS Q16A +74 Medication/supplement use 125808 phv00125808.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:10:07+00:00 2018-07-30 15:10:07+00:00 AFUK16B MEDS FOR HIGH CHOL IN LAST 2 WKS Q16B +74 Medication/supplement use 125809 phv00125809.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:10:07+00:00 2018-07-30 15:10:07+00:00 AFUK16C MEDS FOR DIAB, BLOOD SUGAR IN 2WK Q16C +74 Medication/supplement use 125817 phv00125817.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:10:07+00:00 2018-07-30 15:10:07+00:00 AFUK21 USE OF SECOND FEMALE HORMONE Q21 +74 Medication/supplement use 125818 phv00125818.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:10:07+00:00 2018-07-30 15:10:07+00:00 AFUK21A NAME 2 OF FEMALE HORMONE Q21A +74 Medication/supplement use 125819 phv00125819.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:10:07+00:00 2018-07-30 15:10:07+00:00 AFUK21B NAME 2 OF FEMALE HORMONE Q21B +74 Medication/supplement use 125820 phv00125820.v1.p1 pht001939.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:10:07+00:00 2018-07-30 15:10:07+00:00 AFUK22 FEMALE HORMONE CODE 2 Q22 +74 Medication/supplement use 128270 phv00128270.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA12 12: Ever taken birth control pills? +74 Medication/supplement use 128274 phv00128274.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA16 16: Years you have used birth control? +74 Medication/supplement use 128275 phv00128275.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA17 17: Taken female hormone pills, etc.? +74 Medication/supplement use 128276 phv00128276.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA18A 18a: Name 1 +74 Medication/supplement use 128277 phv00128277.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA18B 18b: Concentration 1 (mg or mcg) +74 Medication/supplement use 128278 phv00128278.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA18C 18c: Second hormone (mg or mcg) +74 Medication/supplement use 128279 phv00128279.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA18D 18d: Code1 +74 Medication/supplement use 128280 phv00128280.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA19 19: Age start taking this hormone? +74 Medication/supplement use 128281 phv00128281.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:16:10+00:00 2018-07-30 15:16:10+00:00 RHXA20 20: Currently taking this hormone? +74 Medication/supplement use 128282 phv00128282.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:17:53+00:00 2018-07-30 15:17:53+00:00 RHXA21 21: Age stop taking this hormone? +74 Medication/supplement use 128283 phv00128283.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:17:53+00:00 2018-07-30 15:17:53+00:00 RHXA22A 22a: How long used this hormone (years) +74 Medication/supplement use 128284 phv00128284.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:17:53+00:00 2018-07-30 15:17:53+00:00 RHXA22B 22b: How long used this hormone (months) +74 Medication/supplement use 128285 phv00128285.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:17:53+00:00 2018-07-30 15:17:53+00:00 RHXA23 23:Days took this hormone in 4 wk period +74 Medication/supplement use 128286 phv00128286.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:17:53+00:00 2018-07-30 15:17:53+00:00 RHXA24A 24a: Used a second female hormone? +74 Medication/supplement use 128287 phv00128287.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:17:53+00:00 2018-07-30 15:17:53+00:00 RHXA24B 24b: Name 2 +74 Medication/supplement use 128288 phv00128288.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:17:53+00:00 2018-07-30 15:17:53+00:00 RHXA24C 24c: Concentration 2 (mg or mcg) +74 Medication/supplement use 128289 phv00128289.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:17:53+00:00 2018-07-30 15:17:53+00:00 RHXA24D 24d: Second hormone (mg or mcg) +74 Medication/supplement use 128290 phv00128290.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA25 25: Age start taking this hormone? +74 Medication/supplement use 128291 phv00128291.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA26 26: Currenlty taking this hormone? +74 Medication/supplement use 128292 phv00128292.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA27 27: Age stop taking this hormone +74 Medication/supplement use 128293 phv00128293.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA28A 28a: How long used this hormone (years) +74 Medication/supplement use 128294 phv00128294.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA28B 28b: How long used this hormone (months) +74 Medication/supplement use 128295 phv00128295.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA29 29:Days took this hormone in 4 wk period +74 Medication/supplement use 128296 phv00128296.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA24E 24e: Code 2 +74 Medication/supplement use 128297 phv00128297.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA30A 30a: Used a third female hormone? +74 Medication/supplement use 128298 phv00128298.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA30B 30b: Name 3 +74 Medication/supplement use 128299 phv00128299.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA30C 30c: Concentration 3 (mg or mcg units) +74 Medication/supplement use 128300 phv00128300.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA30D 30d: Second hormone (mg or mcg) +74 Medication/supplement use 128301 phv00128301.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA30E 30e: Code 3 +74 Medication/supplement use 128302 phv00128302.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA31 31: Age first start taking hormone +74 Medication/supplement use 128303 phv00128303.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA32 32: Currently taking this hormone +74 Medication/supplement use 128304 phv00128304.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA33 33: Age stop taking this hormone +74 Medication/supplement use 128305 phv00128305.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA34A 34a: How long used this hormone (years) +74 Medication/supplement use 128306 phv00128306.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA34B 34b: How long used this hormone (months) +74 Medication/supplement use 128307 phv00128307.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA35 35:Days took this hormone in 4 wk period +74 Medication/supplement use 128308 phv00128308.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:25:06+00:00 2018-07-30 15:25:06+00:00 RHXA36A 36a: How you used a fourth hormone? +74 Medication/supplement use 128309 phv00128309.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA36B 36b: Name 4: +74 Medication/supplement use 128310 phv00128310.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA36C 36c: Concentration 4 (mg or mcg) +74 Medication/supplement use 128311 phv00128311.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA36D 36d: Second hormone (mg or mcg) +74 Medication/supplement use 128312 phv00128312.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA36E 36e: Code 4 +74 Medication/supplement use 128313 phv00128313.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA37 37: Age start taking this hormone +74 Medication/supplement use 128314 phv00128314.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA38 38: Currently taking this hormone? +74 Medication/supplement use 128315 phv00128315.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA39 39: Age stop taking this hormone +74 Medication/supplement use 128316 phv00128316.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA40A 40a: How long used this hormone (years) +74 Medication/supplement use 128317 phv00128317.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:28:00+00:00 2018-07-30 15:28:00+00:00 RHXA40B 40b: How long used this hormone (months) +74 Medication/supplement use 127755 phv00127755.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA1 1: Bring in all medications used? +74 Medication/supplement use 127756 phv00127756.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA2 2: Because you forgot medications? +74 Medication/supplement use 127762 phv00127762.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA4D MSRA4D +74 Medication/supplement use 127759 phv00127759.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA4A MSRA4A +74 Medication/supplement use 127760 phv00127760.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA4B MSRA4B +74 Medication/supplement use 127761 phv00127761.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA4C MSRA4C +74 Medication/supplement use 127764 phv00127764.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA5A MSRA5A +74 Medication/supplement use 127765 phv00127765.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA5B MSRA5B +74 Medication/supplement use 127766 phv00127766.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 MSRA5C MSRA5C +74 Medication/supplement use 128318 phv00128318.v1.p1 pht001971.v1.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-07-30 15:31:40+00:00 2018-07-30 15:31:40+00:00 RHXA41 41:Days took this hormone in 4 wk period +74 Medication/supplement use 208016 phv00208016.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:25:46+00:00 2018-08-02 12:25:46+00:00 MSRC4A [Medication records]. Medication name and concentration. Q4a [Medication Survey Form, exam 3] +74 Medication/supplement use 208017 phv00208017.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:26:11+00:00 2018-08-02 12:26:11+00:00 MSRC4B [Medication records]. Medication code number. Q4b [Medication Survey Form, exam 3] +74 Medication/supplement use 208019 phv00208019.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:27:04+00:00 2018-08-02 12:27:04+00:00 MSRC5A [Medication records]. Medication name and concentration. Q5a [Medication Survey Form, exam 3] +74 Medication/supplement use 208020 phv00208020.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:27:32+00:00 2018-08-02 12:27:32+00:00 MSRC5B [Medication records]. Medication code number. Q5b [Medication Survey Form, exam 3] +74 Medication/supplement use 208022 phv00208022.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:28:04+00:00 2018-08-02 12:28:04+00:00 MSRC6A [Medication records]. Medication name and concentration. Q6a [Medication Survey Form, exam 3] +74 Medication/supplement use 208023 phv00208023.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:31:34+00:00 2018-08-02 12:31:34+00:00 MSRC6B [Medication records]. Medication code number. Q6b [Medication Survey Form, exam 3] +74 Medication/supplement use 208025 phv00208025.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:33:17+00:00 2018-08-02 12:33:17+00:00 MSRC7A [Medication records]. Medication name and concentration. Q7a [Medication Survey Form, exam 3] +74 Medication/supplement use 208026 phv00208026.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:33:42+00:00 2018-08-02 12:33:42+00:00 MSRC7B [Medication records]. Medication code number. Q7b [Medication Survey Form, exam 3] +74 Medication/supplement use 208028 phv00208028.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC8A [Medication records]. Medication name and concentration. Q8a [Medication Survey Form, exam 3] +74 Medication/supplement use 208029 phv00208029.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC8B [Medication records]. Medication code number. Q8b [Medication Survey Form, exam 3] +74 Medication/supplement use 208031 phv00208031.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC9A [Medication records]. Medication name and concentration. Q9a [Medication Survey Form, exam 3] +74 Medication/supplement use 208032 phv00208032.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC9B [Medication records]. Medication code number. Q9b [Medication Survey Form, exam 3] +74 Medication/supplement use 208034 phv00208034.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC10A [Medication records]. Medication name and concentration. Q10a [Medication Survey Form, exam 3] +74 Medication/supplement use 208035 phv00208035.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC10B [Medication records]. Medication code number. Q10b [Medication Survey Form, exam 3] +74 Medication/supplement use 208037 phv00208037.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC11A [Medication records]. Medication name and concentration. Q11a [Medication Survey Form, exam 3] +74 Medication/supplement use 208038 phv00208038.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC11B [Medication records]. Medication code number. Q11b [Medication Survey Form, exam 3] +74 Medication/supplement use 208040 phv00208040.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC12A [Medication records]. Medication name and concentration. Q12a [Medication Survey Form, exam 3] +74 Medication/supplement use 208041 phv00208041.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC12B [Medication records]. Medication code number. Q12b [Medication Survey Form, exam 3] +74 Medication/supplement use 208043 phv00208043.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC13A [Medication records]. Medication name and concentration. Q13a [Medication Survey Form, exam 3] +74 Medication/supplement use 208044 phv00208044.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC13B [Medication records]. Medication code number. Q13b [Medication Survey Form, exam 3] +74 Medication/supplement use 208046 phv00208046.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC14A [Medication records]. Medication name and concentration. Q14a [Medication Survey Form, exam 3] +74 Medication/supplement use 208047 phv00208047.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC14B [Medication records]. Medication code number. Q14b [Medication Survey Form, exam 3] +74 Medication/supplement use 208049 phv00208049.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC15A [Medication records]. Medication name and concentration. Q15a [Medication Survey Form, exam 3] +74 Medication/supplement use 208050 phv00208050.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC15B [Medication records]. Medication code number. Q15b [Medication Survey Form, exam 3] +74 Medication/supplement use 208052 phv00208052.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC16A [Medication records]. Medication name and concentration. Q16a [Medication Survey Form, exam 3] +74 Medication/supplement use 208053 phv00208053.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC16B [Medication records]. Medication code number. Q16b [Medication Survey Form, exam 3] +74 Medication/supplement use 208055 phv00208055.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC17A [Medication records]. Medication name and concentration. Q17a [Medication Survey Form, exam 3] +74 Medication/supplement use 208056 phv00208056.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC17B [Medication records]. Medication code number. Q17b [Medication Survey Form, exam 3] +74 Medication/supplement use 208058 phv00208058.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC18A [Medication records]. Medication name and concentration. Q18a [Medication Survey Form, exam 3] +74 Medication/supplement use 208059 phv00208059.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC18B [Medication records]. Medication code number. Q18b [Medication Survey Form, exam 3] +74 Medication/supplement use 208061 phv00208061.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC19A [Medication records]. Medication name and concentration. Q19a [Medication Survey Form, exam 3] +74 Medication/supplement use 208062 phv00208062.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC19B [Medication records]. Medication code number. Q19b [Medication Survey Form, exam 3] +74 Medication/supplement use 208064 phv00208064.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC20A [Medication records]. Medication name and concentration. Q20a [Medication Survey Form, exam 3] +74 Medication/supplement use 208065 phv00208065.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:41:22+00:00 2018-08-02 12:41:22+00:00 MSRC20B [Medication records]. Medication code number. Q20b [Medication Survey Form, exam 3] +74 Medication/supplement use 208067 phv00208067.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:42:35+00:00 2018-08-02 12:42:35+00:00 MSRC24A [Interview]. Were any of the medications you took during the past two weeks for: high blood pressure. Q24a [Medication Survey Form, exam 3] +74 Medication/supplement use 208068 phv00208068.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:43:11+00:00 2018-08-02 12:43:11+00:00 MSRC24F [Interview]. Were any of the medications you took during the past two weeks for: blood thinning. Q24f [Medication Survey Form, exam 3] +74 Medication/supplement use 208069 phv00208069.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:44:12+00:00 2018-08-02 12:44:12+00:00 MSRC24B [Interview]. Were any of the medications you took during the past two weeks for: high blood cholesterol. Q24b [Medication Survey Form, exam 3] +74 Medication/supplement use 208070 phv00208070.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:44:34+00:00 2018-08-02 12:44:34+00:00 MSRC24G [Interview]. Were any of the medications you took during the past two weeks for: diabetes or high blood sugar. Q24g [Medication Survey Form, exam 3] +74 Medication/supplement use 208071 phv00208071.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:45:01+00:00 2018-08-02 12:45:01+00:00 MSRC24C [Interview]. Were any of the medications you took during the past two weeks for: angina or chest pain. Q24c [Medication Survey Form, exam 3] +74 Medication/supplement use 208072 phv00208072.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:45:25+00:00 2018-08-02 12:45:25+00:00 MSRC24H [Interview]. Were any of the medications you took during the past two weeks for: stroke Q24h [Medication Survey Form, exam 3] +74 Medication/supplement use 208073 phv00208073.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:45:50+00:00 2018-08-02 12:45:50+00:00 MSRC24D [Interview]. Were any of the medications you took during the past two weeks for: control of heart rhythm. Q24d [Medication Survey Form, exam 3] +74 Medication/supplement use 208074 phv00208074.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:46:13+00:00 2018-08-02 12:46:13+00:00 MSRC24I [Interview]. Were any of the medications you took during the past two weeks for: leg pain when walking. Q24i [Medication Survey Form, exam 3] +74 Medication/supplement use 208075 phv00208075.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:46:36+00:00 2018-08-02 12:46:36+00:00 MSRC24E [Interview]. Were any of the medications you took during the past two weeks for: heart failure. Q24e [Medication Survey Form, exam 3] +74 Medication/supplement use 208076 phv00208076.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:47:53+00:00 2018-08-02 12:47:53+00:00 MSRC25 [Interview]. During the past two weeks, did you take any aspirin, Alka-Seltzer, cold medicine or headache powder? Q25 [Medication Survey Form, exam 3] +74 Medication/supplement use 208078 phv00208078.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:48:26+00:00 2018-08-02 12:48:26+00:00 MSRC28 [Interview]. During the past two weeks, did you take any [other] medication for arthritis, fever, or muscle aches and pains, (or menstrual cramps)? Q28 [Medication Survey Form, exam 3] +74 Medication/supplement use 208081 phv00208081.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:49:13+00:00 2018-08-02 12:49:13+00:00 MSRC26 [Interview]. How many days during the last two weeks did you take aspirin, or a medication that contains aspirin? Q26 [Medication Survey Form, exam 3] +74 Medication/supplement use 208085 phv00208085.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 12:57:11+00:00 2018-08-02 12:57:11+00:00 MSRA04AA Medication and concentration. Q4m01a [Medication Codes, exam 1] +74 Medication/supplement use 208086 phv00208086.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:05:00+00:00 2018-08-02 19:05:00+00:00 MSRA04BA Medication and concentration. Q4m02a [Medication Codes, exam 1] +74 Medication/supplement use 208087 phv00208087.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:05:27+00:00 2018-08-02 19:05:27+00:00 MSRA04CA Medication and concentration. Q4m03a [Medication Codes, exam 1] +74 Medication/supplement use 208088 phv00208088.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:05:45+00:00 2018-08-02 19:05:45+00:00 MSRA04DA Medication and concentration. Q4m04a [Medication Codes, exam 1] +74 Medication/supplement use 208089 phv00208089.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:06:10+00:00 2018-08-02 19:06:10+00:00 MSRA04EA Medication and concentration. Q4m05a [Medication Codes, exam 1] +74 Medication/supplement use 208090 phv00208090.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:06:30+00:00 2018-08-02 19:06:30+00:00 MSRA04FA Medication and concentration. Q4m06a [Medication Codes, exam 1] +74 Medication/supplement use 208091 phv00208091.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04GA Medication and concentration. Q4m07a [Medication Codes, exam 1] +74 Medication/supplement use 208092 phv00208092.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04HA Medication and concentration. Q4m08a [Medication Codes, exam 1] +74 Medication/supplement use 208093 phv00208093.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04IA Medication and concentration. Q4m09a [Medication Codes, exam 1] +74 Medication/supplement use 208094 phv00208094.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04JA Medication and concentration. Q4m10a [Medication Codes, exam 1] +74 Medication/supplement use 208095 phv00208095.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04KA Medication and concentration. Q4m11a [Medication Codes, exam 1] +74 Medication/supplement use 208096 phv00208096.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04LA Medication and concentration. Q4m12a [Medication Codes, exam 1] +74 Medication/supplement use 208097 phv00208097.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04MA Medication and concentration. Q4m13a [Medication Codes, exam 1] +74 Medication/supplement use 208098 phv00208098.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04NA Medication and concentration. Q4m14a [Medication Codes, exam 1] +74 Medication/supplement use 208099 phv00208099.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04OA Medication and concentration. Q4m15a [Medication Codes, exam 1] +74 Medication/supplement use 208100 phv00208100.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04PA Medication and concentration. Q4m16a [Medication Codes, exam 1] +74 Medication/supplement use 208101 phv00208101.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:11:04+00:00 2018-08-02 19:11:04+00:00 MSRA04QA Medication and concentration. Q4m17a [Medication Codes, exam 1] +74 Medication/supplement use 208102 phv00208102.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE1 2004 drug code. Q4m01b [Medication Codes, exam 1] +74 Medication/supplement use 208103 phv00208103.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE2 2004 drug code. Q4m02b [Medication Codes, exam 1] +74 Medication/supplement use 208104 phv00208104.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE3 2004 drug code. Q4m03b [Medication Codes, exam 1] +74 Medication/supplement use 208105 phv00208105.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE4 2004 drug code. Q4m04b [Medication Codes, exam 1] +74 Medication/supplement use 208106 phv00208106.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE5 2004 drug code. Q4m05b [Medication Codes, exam 1] +74 Medication/supplement use 208107 phv00208107.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE6 2004 drug code. Q4m06b [Medication Codes, exam 1] +74 Medication/supplement use 208110 phv00208110.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE9 2004 drug code. Q4m09b [Medication Codes, exam 1] +74 Medication/supplement use 208111 phv00208111.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE10 2004 drug code. Q4m10b [Medication Codes, exam 1] +74 Medication/supplement use 208112 phv00208112.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE11 2004 drug code. Q4m11b [Medication Codes, exam 1] +74 Medication/supplement use 208113 phv00208113.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE12 2004 drug code. Q4m12b [Medication Codes, exam 1] +74 Medication/supplement use 208114 phv00208114.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE13 2004 drug code. Q4m13b [Medication Codes, exam 1] +74 Medication/supplement use 208115 phv00208115.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE14 2004 drug code. Q4m14b [Medication Codes, exam 1] +74 Medication/supplement use 208116 phv00208116.v1.p1 pht004132.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE15 2004 drug code. Q4m15b [Medication Codes, exam 1] +74 Medication/supplement use 208222 phv00208222.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE16 2004 drug code. Q19b [Medication Codes, exam 4] +74 Medication/supplement use 208223 phv00208223.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:15:03+00:00 2018-08-02 19:15:03+00:00 CODE17 2004 drug code. Q20b [Medication Codes, exam 4] +74 Medication/supplement use 208120 phv00208120.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB04A Medication name and concentration. Q4a [Medication Codes, exam 2] +74 Medication/supplement use 208121 phv00208121.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB05A Medication name and concentration. Q5a [Medication Codes, exam 2] +74 Medication/supplement use 208122 phv00208122.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB06A Medication name and concentration. Q6a [Medication Codes, exam 2] +74 Medication/supplement use 208123 phv00208123.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB07A Medication name and concentration. Q7a [Medication Codes, exam 2] +74 Medication/supplement use 208124 phv00208124.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB08A Medication name and concentration. Q8a [Medication Codes, exam 2] +74 Medication/supplement use 208125 phv00208125.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB09A Medication name and concentration. Q9a [Medication Codes, exam 2] +74 Medication/supplement use 208126 phv00208126.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB10A Medication name and concentration. Q10a [Medication Codes, exam 2] +74 Medication/supplement use 208127 phv00208127.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB11A Medication name and concentration. Q11a [Medication Codes, exam 2] +74 Medication/supplement use 208128 phv00208128.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB12A Medication name and concentration. Q12a [Medication Codes, exam 2] +74 Medication/supplement use 208129 phv00208129.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB13A Medication name and concentration. Q13a [Medication Codes, exam 2] +74 Medication/supplement use 208130 phv00208130.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB14A Medication name and concentration. Q14a [Medication Codes, exam 2] +74 Medication/supplement use 208131 phv00208131.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB15A Medication name and concentration. Q15a [Medication Codes, exam 2] +74 Medication/supplement use 208132 phv00208132.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB16A Medication name and concentration. Q16a [Medication Codes, exam 2] +74 Medication/supplement use 208133 phv00208133.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB17A Medication name and concentration. Q17a [Medication Codes, exam 2] +74 Medication/supplement use 208134 phv00208134.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB18A Medication name and concentration. Q18a [Medication Codes, exam 2] +74 Medication/supplement use 208135 phv00208135.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB19A Medication name and concentration. Q19a [Medication Codes, exam 2] +74 Medication/supplement use 208136 phv00208136.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:21:59+00:00 2018-08-02 19:21:59+00:00 MSRB20A Medication name and concentration. Q20a [Medication Codes, exam 2] +74 Medication/supplement use 208137 phv00208137.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE1 2004 drug code. Q04b [Medication Codes, exam 2] +74 Medication/supplement use 208138 phv00208138.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE2 2004 drug code. Q05b [Medication Codes, exam 2] +74 Medication/supplement use 208139 phv00208139.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE3 2004 drug code. Q06b [Medication Codes, exam 2] +74 Medication/supplement use 208140 phv00208140.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE4 2004 drug code. Q07b [Medication Codes, exam 2] +74 Medication/supplement use 208141 phv00208141.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE5 2004 drug code. Q08b [Medication Codes, exam 2] +74 Medication/supplement use 208142 phv00208142.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE6 2004 drug code. Q09b [Medication Codes, exam 2] +74 Medication/supplement use 208143 phv00208143.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE7 2004 drug code. Q10b [Medication Codes, exam 2] +74 Medication/supplement use 208144 phv00208144.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE8 2004 drug code. Q11b [Medication Codes, exam 2] +74 Medication/supplement use 208145 phv00208145.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE9 2004 drug code. Q12b [Medication Codes, exam 2] +74 Medication/supplement use 208146 phv00208146.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE10 2004 drug code. Q13b [Medication Codes, exam 2] +74 Medication/supplement use 208147 phv00208147.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE11 2004 drug code. Q14b [Medication Codes, exam 2] +74 Medication/supplement use 208148 phv00208148.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE12 2004 drug code. Q15b [Medication Codes, exam 2] +74 Medication/supplement use 208149 phv00208149.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE13 2004 drug code. Q16b [Medication Codes, exam 2] +74 Medication/supplement use 208150 phv00208150.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE14 2004 drug code. Q17b [Medication Codes, exam 2] +74 Medication/supplement use 208151 phv00208151.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE15 2004 drug code. Q18b [Medication Codes, exam 2] +74 Medication/supplement use 208152 phv00208152.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE16 2004 drug code. Q19b [Medication Codes, exam 2] +74 Medication/supplement use 208153 phv00208153.v1.p1 pht004133.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:45:28+00:00 2018-08-02 19:45:28+00:00 CODE17 2004 drug code. Q20b [Medication Codes, exam 2] +74 Medication/supplement use 208155 phv00208155.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC4A Medication name and concentration. Q4 A [Medication Codes, exam 3] +74 Medication/supplement use 208156 phv00208156.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC5A Medication name and concentration. Q5 A [Medication Codes, exam 3] +74 Medication/supplement use 208157 phv00208157.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC6A Medication name and concentration. Q6 A [Medication Codes, exam 3] +74 Medication/supplement use 208158 phv00208158.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC7A Medication name and concentration. Q7 A [Medication Codes, exam 3] +74 Medication/supplement use 208159 phv00208159.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC8A Medication name and concentration. Q8 A [Medication Codes, exam 3] +74 Medication/supplement use 208160 phv00208160.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC9A Medication name and concentration. Q9 A [Medication Codes, exam 3] +74 Medication/supplement use 208161 phv00208161.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC10A Medication name and concentration Q10 A [Medication Codes, exam 3] +74 Medication/supplement use 208162 phv00208162.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC11A Medication name and concentration. Q11 A [Medication Codes, exam 3] +74 Medication/supplement use 208163 phv00208163.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC12A Medication name and concentration. Q12 A [Medication Codes, exam 3] +74 Medication/supplement use 208164 phv00208164.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC13A Medication name and concentration. Q13 A [Medication Codes, exam 3] +74 Medication/supplement use 208165 phv00208165.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC14A Medication name and concentration. Q14 A [Medication Codes, exam 3] +74 Medication/supplement use 208166 phv00208166.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC15A Medication name and concentration. Q15 A [Medication Codes, exam 3] +74 Medication/supplement use 208167 phv00208167.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC16A Medication name and concentration. Q16 A [Medication Codes, exam 3] +74 Medication/supplement use 208168 phv00208168.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC17A Medication name and concentration. Q17 A [Medication Codes, exam 3] +74 Medication/supplement use 208169 phv00208169.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC18A Medication name and concentration. Q18 A [Medication Codes, exam 3] +74 Medication/supplement use 208170 phv00208170.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC19A Medication name and concentration. Q19 A [Medication Codes, exam 3] +74 Medication/supplement use 208171 phv00208171.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 MSRC20A Medication name and concentration. Q20 A [Medication Codes, exam 3] +74 Medication/supplement use 208172 phv00208172.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE1 2004 drug code. Q04b [Medication Codes, exam 3] +74 Medication/supplement use 208173 phv00208173.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE2 2004 drug code. Q05b [Medication Codes, exam 3] +74 Medication/supplement use 208174 phv00208174.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE3 2004 drug code. Q06b [Medication Codes, exam 3] +74 Medication/supplement use 208175 phv00208175.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE4 2004 drug code. Q07b [Medication Codes, exam 3] +74 Medication/supplement use 208176 phv00208176.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE5 2004 drug code. Q08b [Medication Codes, exam 3] +74 Medication/supplement use 208177 phv00208177.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE6 2004 drug code. Q09b [Medication Codes, exam 3] +74 Medication/supplement use 208178 phv00208178.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE7 2004 drug code. Q10b [Medication Codes, exam 3] +74 Medication/supplement use 208179 phv00208179.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE8 2004 drug code. Q11b [Medication Codes, exam 3] +74 Medication/supplement use 208180 phv00208180.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE9 2004 drug code. Q12b [Medication Codes, exam 3] +74 Medication/supplement use 208181 phv00208181.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE10 2004 drug code. Q13b [Medication Codes, exam 3] +74 Medication/supplement use 208182 phv00208182.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE11 2004 drug code. Q14b [Medication Codes, exam 3] +74 Medication/supplement use 208183 phv00208183.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE12 2004 drug code. Q15b [Medication Codes, exam 3] +74 Medication/supplement use 208184 phv00208184.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE13 2004 drug code. Q16b [Medication Codes, exam 3] +74 Medication/supplement use 208185 phv00208185.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE14 2004 drug code. Q17b [Medication Codes, exam 3] +74 Medication/supplement use 208186 phv00208186.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE15 2004 drug code. Q18b [Medication Codes, exam 3] +74 Medication/supplement use 208187 phv00208187.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE16 2004 drug code. Q19b [Medication Codes, exam 3] +74 Medication/supplement use 208188 phv00208188.v1.p1 pht004134.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:51:20+00:00 2018-08-02 19:51:20+00:00 CODE17 2004 drug code. Q20b [Medication Codes, exam 3] +74 Medication/supplement use 208190 phv00208190.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD4A Medication name. Q4a [Medication Codes, exam 4] +74 Medication/supplement use 208191 phv00208191.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD5A Medication name. Q5a [Medication Codes, exam 4] +74 Medication/supplement use 208192 phv00208192.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD6A Medication name. Q6a [Medication Codes, exam 4] +74 Medication/supplement use 208193 phv00208193.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD7A Medication name. Q7a [Medication Codes, exam 4] +74 Medication/supplement use 208194 phv00208194.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD8A Medication name. Q8a [Medication Codes, exam 4] +74 Medication/supplement use 208195 phv00208195.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD9A Medication name. Q9a [Medication Codes, exam 4] +74 Medication/supplement use 208196 phv00208196.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD10A Medication name. Q10a [Medication Codes, exam 4] +74 Medication/supplement use 208197 phv00208197.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD11A Medication name. Q11a [Medication Codes, exam 4] +74 Medication/supplement use 208198 phv00208198.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD12A Medication name. Q12a [Medication Codes, exam 4] +74 Medication/supplement use 208199 phv00208199.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD13A Medication name. Q13a [Medication Codes, exam 4] +74 Medication/supplement use 208200 phv00208200.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD14A Medication name. Q14a [Medication Codes, exam 4] +74 Medication/supplement use 208201 phv00208201.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD15A Medication name. Q15a [Medication Codes, exam 4] +74 Medication/supplement use 208202 phv00208202.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD16A Medication name. Q16a [Medication Codes, exam 4] +74 Medication/supplement use 208203 phv00208203.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD17A Medication name. Q17a [Medication Codes, exam 4] +74 Medication/supplement use 208204 phv00208204.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD18A Medication name. Q18a [Medication Codes, exam 4] +74 Medication/supplement use 208205 phv00208205.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD19A Medication name. Q19a [Medication Codes, exam 4] +74 Medication/supplement use 208206 phv00208206.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:55:51+00:00 2018-08-02 19:55:51+00:00 MSRD20A Medication name. Q20a [Medication Codes, exam 4] +74 Medication/supplement use 208207 phv00208207.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE1 2004 drug code. Q04b [Medication Codes, exam 4] +74 Medication/supplement use 208208 phv00208208.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE2 2004 drug code. Q05b [Medication Codes, exam 4] +74 Medication/supplement use 208209 phv00208209.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE3 2004 drug code. Q06b [Medication Codes, exam 4] +74 Medication/supplement use 208210 phv00208210.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE4 2004 drug code. Q07b [Medication Codes, exam 4] +74 Medication/supplement use 208211 phv00208211.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE5 2004 drug code. Q08b [Medication Codes, exam 4] +74 Medication/supplement use 208212 phv00208212.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE6 2004 drug code. Q09b [Medication Codes, exam 4] +74 Medication/supplement use 208213 phv00208213.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE7 2004 drug code. Q10b [Medication Codes, exam 4] +74 Medication/supplement use 208214 phv00208214.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE8 2004 drug code. Q11b [Medication Codes, exam 4] +74 Medication/supplement use 208215 phv00208215.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE9 2004 drug code. Q12b [Medication Codes, exam 4] +74 Medication/supplement use 208216 phv00208216.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE10 2004 drug code. Q13b [Medication Codes, exam 4] +74 Medication/supplement use 208217 phv00208217.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE11 2004 drug code. Q14b [Medication Codes, exam 4] +74 Medication/supplement use 208218 phv00208218.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE12 2004 drug code. Q15b [Medication Codes, exam 4] +74 Medication/supplement use 208219 phv00208219.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE13 2004 drug code. Q16b [Medication Codes, exam 4] +74 Medication/supplement use 208220 phv00208220.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE14 2004 drug code. Q17b [Medication Codes, exam 4] +74 Medication/supplement use 208221 phv00208221.v1.p1 pht004135.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 19:59:38+00:00 2018-08-02 19:59:38+00:00 CODE15 2004 drug code. Q18b [Medication Codes, exam 4] +74 Medication/supplement use 208228 phv00208228.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD4A [Medication records]. Medication A name. Q4a [Medication Survey Form, exam 4] +74 Medication/supplement use 208232 phv00208232.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD5A [Medication records]. Medication B name. Q5a [Medication Survey Form, exam 4] +74 Medication/supplement use 208236 phv00208236.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD6A [Medication records]. Medication C name. Q6a [Medication Survey Form, exam 4] +74 Medication/supplement use 208240 phv00208240.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD7A [Medication records]. Medication D name. Q7a [Medication Survey Form, exam 4] +74 Medication/supplement use 208244 phv00208244.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD8A [Medication records]. Medication E name. Q8a [Medication Survey Form, exam 4] +74 Medication/supplement use 208248 phv00208248.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD9A [Medication records]. Medication F name. Q9a [Medication Survey Form, exam 4] +74 Medication/supplement use 208252 phv00208252.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD10A [Medication records]. Medication G name. Q10a [Medication Survey Form, exam 4] +74 Medication/supplement use 208256 phv00208256.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD11A [Medication records]. Medication H name. Q11a [Medication Survey Form, exam 4] +74 Medication/supplement use 208260 phv00208260.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD12A [Medication records]. Medication I name. Q12a [Medication Survey Form, exam 4] +74 Medication/supplement use 208264 phv00208264.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD13A [Medication records]. Medication J name. Q13a [Medication Survey Form, exam 4] +74 Medication/supplement use 208268 phv00208268.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD14A [Medication records]. Medication K name. Q14a [Medication Survey Form, exam 4] +74 Medication/supplement use 208272 phv00208272.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD15A [Medication records]. Medication L name. Q15a [Medication Survey Form, exam 4] +74 Medication/supplement use 208276 phv00208276.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD16A [Medication records]. Medication M name. Q16a [Medication Survey Form, exam 4] +74 Medication/supplement use 208280 phv00208280.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD17A [Medication records]. Medication N name. Q17a [Medication Survey Form, exam 4] +74 Medication/supplement use 208284 phv00208284.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD18A [Medication records]. Medication O name. Q18a [Medication Survey Form, exam 4] +74 Medication/supplement use 208288 phv00208288.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD19A [Medication records]. Medication P name. Q19a [Medication Survey Form, exam 4] +74 Medication/supplement use 208292 phv00208292.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:10:56+00:00 2018-08-02 20:10:56+00:00 MSRD20A [Medication records]. Medication Q name Q20a [Medication Survey Form, exam 4] +74 Medication/supplement use 208229 phv00208229.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD4B [Medication records]. Medication A concentration. Q4b [Medication Survey Form, exam 4] +74 Medication/supplement use 208233 phv00208233.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD5B [Medication records]. Medication B concentration. Q5b [Medication Survey Form, exam 4] +74 Medication/supplement use 208237 phv00208237.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD6B [Medication records]. Medication C concentration. Q6b [Medication Survey Form, exam 4] +74 Medication/supplement use 208241 phv00208241.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD7B [Medication records]. Medication D concentration. Q7b [Medication Survey Form, exam 4] +74 Medication/supplement use 208245 phv00208245.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD8B [Medication records]. Medication E concentration. Q8b [Medication Survey Form, exam 4] +74 Medication/supplement use 208249 phv00208249.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD9B [Medication records]. Medication F concentration. Q9b [Medication Survey Form, exam 4] +74 Medication/supplement use 208253 phv00208253.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD10B [Medication records]. Medication G concentration. Q10b [Medication Survey Form, exam 4] +74 Medication/supplement use 208257 phv00208257.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD11B [Medication records]. Medication H concentration. Q11b [Medication Survey Form, exam 4] +74 Medication/supplement use 208261 phv00208261.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD12B [Medication records]. Medication I concentration. Q12b [Medication Survey Form, exam 4] +74 Medication/supplement use 208265 phv00208265.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD13B [Medication records]. Medication J concentration. Q13b [Medication Survey Form, exam 4] +74 Medication/supplement use 208269 phv00208269.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD14B [Medication records]. Medication K concentration. Q14b [Medication Survey Form, exam 4] +74 Medication/supplement use 208273 phv00208273.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD15B [Medication records]. Medication L concentration. Q15b [Medication Survey Form, exam 4] +74 Medication/supplement use 208277 phv00208277.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD16B [Medication records]. Medication M concentration. Q16b [Medication Survey Form, exam 4] +74 Medication/supplement use 208281 phv00208281.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD17B [Medication records]. Medication N concentration. Q17b [Medication Survey Form, exam 4] +74 Medication/supplement use 208285 phv00208285.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD18B [Medication records]. Medication O concentration. Q18b [Medication Survey Form, exam 4] +74 Medication/supplement use 208289 phv00208289.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD19B [Medication records]. Medication P concentration. Q19b [Medication Survey Form, exam 4] +74 Medication/supplement use 208293 phv00208293.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:14:39+00:00 2018-08-02 20:14:39+00:00 MSRD20B [Medication records]. Medication Q concentration. Q20b [Medication Survey Form, exam 4] +74 Medication/supplement use 208230 phv00208230.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD4C [Medication records]. Medication A code number. Q4c [Medication Survey Form, exam 4] +74 Medication/supplement use 208234 phv00208234.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD5C [Medication records]. Medication B code number. Q5c [Medication Survey Form, exam 4] +74 Medication/supplement use 208238 phv00208238.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD6C [Medication records]. Medication C code number. Q6c [Medication Survey Form, exam 4] +74 Medication/supplement use 208242 phv00208242.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD7C [Medication records]. Medication D code number. Q7c [Medication Survey Form, exam 4] +74 Medication/supplement use 208246 phv00208246.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD8C [Medication records]. Medication E code number. Q8c [Medication Survey Form, exam 4] +74 Medication/supplement use 208250 phv00208250.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD9C [Medication records]. Medication F code number. Q9c [Medication Survey Form, exam 4] +74 Medication/supplement use 208254 phv00208254.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD10C [Medication records]. Medication G code number. Q10c [Medication Survey Form, exam 4] +74 Medication/supplement use 208258 phv00208258.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD11C [Medication records]. Medication H code number. Q11c [Medication Survey Form, exam 4] +74 Medication/supplement use 208262 phv00208262.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD12C [Medication records]. Medication I code number. Q12c [Medication Survey Form, exam 4] +74 Medication/supplement use 208266 phv00208266.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD13C [Medication records]. Medication J code number. Q13c [Medication Survey Form, exam 4] +74 Medication/supplement use 208270 phv00208270.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD14C [Medication records]. Medication K code number. Q14c [Medication Survey Form, exam 4] +74 Medication/supplement use 208274 phv00208274.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD15C [Medication records]. Medication L code number. Q15c [Medication Survey Form, exam 4] +74 Medication/supplement use 208278 phv00208278.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD16C [Medication records]. Medication M code number. Q16c [Medication Survey Form, exam 4] +74 Medication/supplement use 208282 phv00208282.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD17C [Medication records]. Medication N code number. Q17c [Medication Survey Form, exam 4] +74 Medication/supplement use 208286 phv00208286.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD18C [Medication records]. Medication O code number. Q18c [Medication Survey Form, exam 4] +74 Medication/supplement use 208290 phv00208290.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD19C [Medication records]. Medication P code number. Q19c [Medication Survey Form, exam 4] +74 Medication/supplement use 208294 phv00208294.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:04+00:00 2018-08-02 20:18:04+00:00 MSRD20C [Medication records]. Medication Q code number. Q20c [Medication Survey Form, exam 4] +74 Medication/supplement use 208296 phv00208296.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:18:34+00:00 2018-08-02 20:18:34+00:00 MSRD24A [Interview]. Were any of the medications you took during the past two weeks for: high blood pressure. Q24a [Medication Survey Form, exam 4] +74 Medication/supplement use 208297 phv00208297.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:19:02+00:00 2018-08-02 20:19:02+00:00 MSRD24B [Interview]. Were any of the medications you took during the past two weeks for: high blood cholesterol. Q24b [Medication Survey Form, exam 4] +74 Medication/supplement use 208298 phv00208298.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:19:26+00:00 2018-08-02 20:19:26+00:00 MSRD24C [Interview]. Were any of the medications you took during the past two weeks for: angina or chest pain. Q24c [Medication Survey Form, exam 4] +74 Medication/supplement use 208299 phv00208299.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:19:49+00:00 2018-08-02 20:19:49+00:00 MSRD24D [Interview]. Were any of the medications you took during the past two weeks for: control of heart rhythm. Q24d [Medication Survey Form, exam 4] +74 Medication/supplement use 208300 phv00208300.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:20:35+00:00 2018-08-02 20:20:35+00:00 MSRD24E [Interview]. Were any of the medications you took during the past two weeks for: heart failure. Q24e [Medication Survey Form, exam 4] +74 Medication/supplement use 208316 phv00208316.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:22:00+00:00 2018-08-02 20:22:00+00:00 MSRD26 [Interview]. How many days during the last two weeks did you take aspirin, or a medication that contains aspirin? Q26 [Medication Survey Form, exam 4] +74 Medication/supplement use 208313 phv00208313.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:22:30+00:00 2018-08-02 20:22:30+00:00 MSRD30B [Interview]. Except for aspirin or Tylenol, are you NOW taking other non-steroidal anti-inflammatory drugs or arthritis medicines on a regular basis? Examples include Ibuprofen, Advil, Nuprin, Motrin, Naprosyn, Feldene and Clinoril. What is the brand name of the medicine? If Other, specify? Q30b [Medication Survey Form, exam 4] +74 Medication/supplement use 208312 phv00208312.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:23:15+00:00 2018-08-02 20:23:15+00:00 MSRD30A [Interview]. Except for aspirin or Tylenol, are you NOW taking other non-steroidal anti-inflammatory drugs or arthritis medicines on a regular basis? Examples include Ibuprofen, Advil, Nuprin, Motrin, Naprosyn, Feldene and Clinoril. What is the brand name of the medicine? [Medication Survey Form, exam 4] +74 Medication/supplement use 208311 phv00208311.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:23:50+00:00 2018-08-02 20:23:50+00:00 MSRD30 [Interview]. Except for aspirin or Tylenol, are you NOW taking other non-steroidal anti-inflammatory drugs or arthritis medicines on a regular basis? Examples include Ibuprofen, Advil, Nuprin, Motrin, Naprosyn, Feldene and Clinoril. Q30 [Medication Survey Form, exam 4] +74 Medication/supplement use 208309 phv00208309.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:24:20+00:00 2018-08-02 20:24:20+00:00 MSRD29A [Interview]. What is the strength of aspirin in the pill? Q29a [Medication Survey Form, exam 4] +74 Medication/supplement use 208308 phv00208308.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:24:44+00:00 2018-08-02 20:24:44+00:00 MSRD29 [Interview]. Are you NOW taking aspirin, or a medicine containing aspirin, on a regular basis? This does not include Tylenol nor Advil. Q29 [Medication Survey Form, exam 4] +74 Medication/supplement use 208307 phv00208307.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:25:26+00:00 2018-08-02 20:25:26+00:00 MSRD28 [Interview]. During the past two weeks, did you take any [other] medication for arthritis, fever, or muscle aches and pains, (or menstrual cramps)? Q28 [Medication Survey Form, exam 4] +74 Medication/supplement use 208305 phv00208305.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:25:48+00:00 2018-08-02 20:25:48+00:00 MSRD25 [Interview]. During the past two weeks, did you take any aspirin, Alka-Seltzer, cold medicine or headache powder? Q25 [Medication Survey Form, exam 4] +74 Medication/supplement use 208304 phv00208304.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:26:11+00:00 2018-08-02 20:26:11+00:00 MSRD24I [Interview]. Were any of the medications you took during the past two weeks for: leg pain when walking. Q24i [Medication Survey Form, exam 4] +74 Medication/supplement use 208303 phv00208303.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:26:33+00:00 2018-08-02 20:26:33+00:00 MSRD24H [Interview]. Were any of the medications you took during the past two weeks for: stroke. Q24h [Medication Survey Form, exam 4] +74 Medication/supplement use 208302 phv00208302.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:26:57+00:00 2018-08-02 20:26:57+00:00 MSRD24G [Interview]. Were any of the medications you took during the past two weeks for: diabetes or high blood sugar. Q24g [Medication Survey Form, exam 4] +74 Medication/supplement use 208301 phv00208301.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-02 20:27:18+00:00 2018-08-02 20:27:18+00:00 MSRD24F [Interview]. Were any of the medications you took during the past two weeks for: blood thinning. Q24f [Medication Survey Form, exam 4] +74 Medication/supplement use 127767 phv00127767.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 14:36:28+00:00 2018-08-06 14:36:28+00:00 MSRA5D MSRA5D +74 Medication/supplement use 127772 phv00127772.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 14:36:28+00:00 2018-08-06 14:36:28+00:00 MSRA6D MSRA6D +74 Medication/supplement use 127769 phv00127769.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 14:36:28+00:00 2018-08-06 14:36:28+00:00 MSRA6A MSRA6A +74 Medication/supplement use 127770 phv00127770.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 14:36:28+00:00 2018-08-06 14:36:28+00:00 MSRA6B MSRA6B +74 Medication/supplement use 127771 phv00127771.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 14:36:28+00:00 2018-08-06 14:36:28+00:00 MSRA6C MSRA6C +74 Medication/supplement use 127776 phv00127776.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA7C MSRA7C +74 Medication/supplement use 127777 phv00127777.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA7D MSRA7D +74 Medication/supplement use 127781 phv00127781.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA8C MSRA8C +74 Medication/supplement use 127782 phv00127782.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA8D MSRA8D +74 Medication/supplement use 127797 phv00127797.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA9D MSRA9D +74 Medication/supplement use 127799 phv00127799.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA10A MSRA10A +74 Medication/supplement use 127801 phv00127801.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA10C MSRA10C +74 Medication/supplement use 127802 phv00127802.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA10D MSRA10D +74 Medication/supplement use 127806 phv00127806.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA11C MSRA11C +74 Medication/supplement use 127807 phv00127807.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA11D MSRA11D +74 Medication/supplement use 127809 phv00127809.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA12A MSRA12A +74 Medication/supplement use 127811 phv00127811.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA12C MSRA12C +74 Medication/supplement use 127812 phv00127812.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA12D MSRA12D +74 Medication/supplement use 127814 phv00127814.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA13A MSRA13A +74 Medication/supplement use 127816 phv00127816.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA13C MSRA13C +74 Medication/supplement use 127817 phv00127817.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA13D MSRA13D +74 Medication/supplement use 127774 phv00127774.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA7A MSRA7A +74 Medication/supplement use 127775 phv00127775.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA7B MSRA7B +74 Medication/supplement use 127779 phv00127779.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:08+00:00 2018-08-06 15:18:08+00:00 MSRA8A MSRA8A +74 Medication/supplement use 127780 phv00127780.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA8B MSRA8B +74 Medication/supplement use 127794 phv00127794.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA9A MSRA9A +74 Medication/supplement use 127795 phv00127795.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA9B MSRA9B +74 Medication/supplement use 127796 phv00127796.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA9C MSRA9C +74 Medication/supplement use 127800 phv00127800.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA10B MSRA10B +74 Medication/supplement use 127804 phv00127804.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA11A MSRA11A +74 Medication/supplement use 127805 phv00127805.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA11B MSRA11B +74 Medication/supplement use 127810 phv00127810.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA12B MSRA12B +74 Medication/supplement use 127815 phv00127815.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:18:09+00:00 2018-08-06 15:18:09+00:00 MSRA13B MSRA13B +74 Medication/supplement use 127829 phv00127829.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA14A MSRA14A +74 Medication/supplement use 127831 phv00127831.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA14C MSRA14C +74 Medication/supplement use 127832 phv00127832.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA14D MSRA14D +74 Medication/supplement use 127834 phv00127834.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA15A MSRA15A +74 Medication/supplement use 127836 phv00127836.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA15C MSRA15C +74 Medication/supplement use 127837 phv00127837.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA15D MSRA15D +74 Medication/supplement use 127839 phv00127839.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA16A MSRA16A +74 Medication/supplement use 127841 phv00127841.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA16C MSRA16C +74 Medication/supplement use 127842 phv00127842.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA16D MSRA16D +74 Medication/supplement use 127844 phv00127844.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA17A MSRA17A +74 Medication/supplement use 127846 phv00127846.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA17C MSRA17C +74 Medication/supplement use 127847 phv00127847.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA17D MSRA17D +74 Medication/supplement use 127849 phv00127849.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA18A MSRA18A +74 Medication/supplement use 127850 phv00127850.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA18B MSRA18B +74 Medication/supplement use 127851 phv00127851.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA18C MSRA18C +74 Medication/supplement use 127852 phv00127852.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA18D MSRA18D +74 Medication/supplement use 127864 phv00127864.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA19A MSRA19A +74 Medication/supplement use 127865 phv00127865.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA19B MSRA19B +74 Medication/supplement use 127866 phv00127866.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA19C MSRA19C +74 Medication/supplement use 127867 phv00127867.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA19D MSRA19D +74 Medication/supplement use 127830 phv00127830.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA14B MSRA14B +74 Medication/supplement use 127835 phv00127835.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA15B MSRA15B +74 Medication/supplement use 127840 phv00127840.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA16B MSRA16B +74 Medication/supplement use 127845 phv00127845.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:20:53+00:00 2018-08-06 15:20:53+00:00 MSRA17B MSRA17B +74 Medication/supplement use 127869 phv00127869.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA20A MSRA20A +74 Medication/supplement use 127870 phv00127870.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA20B MSRA20B +74 Medication/supplement use 127871 phv00127871.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA20C MSRA20C +74 Medication/supplement use 127872 phv00127872.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA20D MSRA20D +74 Medication/supplement use 127874 phv00127874.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA21A MSRA21A +74 Medication/supplement use 127875 phv00127875.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA21B MSRA21B +74 Medication/supplement use 127876 phv00127876.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA21C MSRA21C +74 Medication/supplement use 127877 phv00127877.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA21D MSRA21D +74 Medication/supplement use 127879 phv00127879.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA22A MSRA22A +74 Medication/supplement use 127880 phv00127880.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA22B MSRA22B +74 Medication/supplement use 127881 phv00127881.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA22C MSRA22C +74 Medication/supplement use 127882 phv00127882.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA22D MSRA22D +74 Medication/supplement use 127884 phv00127884.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA23A MSRA23A +74 Medication/supplement use 127886 phv00127886.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA23C MSRA23C +74 Medication/supplement use 127887 phv00127887.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA23D MSRA23D +74 Medication/supplement use 127885 phv00127885.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:22:31+00:00 2018-08-06 15:22:31+00:00 MSRA23B MSRA23B +74 Medication/supplement use 127899 phv00127899.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA24A MSRA24A +74 Medication/supplement use 127900 phv00127900.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA24B MSRA24B +74 Medication/supplement use 127901 phv00127901.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA24C MSRA24C +74 Medication/supplement use 127902 phv00127902.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA24D MSRA24D +74 Medication/supplement use 127904 phv00127904.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA25A MSRA25A +74 Medication/supplement use 127905 phv00127905.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA25B MSRA25B +74 Medication/supplement use 127906 phv00127906.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA25C MSRA25C +74 Medication/supplement use 127907 phv00127907.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA25D MSRA25D +74 Medication/supplement use 127909 phv00127909.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA26A MSRA26A +74 Medication/supplement use 127910 phv00127910.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA26B MSRA26B +74 Medication/supplement use 127911 phv00127911.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA26C MSRA26C +74 Medication/supplement use 127912 phv00127912.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:23:38+00:00 2018-08-06 15:23:38+00:00 MSRA26D MSRA26D +74 Medication/supplement use 127914 phv00127914.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA27 27: Total number of medicatons in bag. +74 Medication/supplement use 127915 phv00127915.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA28 28: Medications unable to transcribe. +74 Medication/supplement use 127922 phv00127922.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30A 30a: Past 2 wks took high blood pressure medications? +74 Medication/supplement use 127923 phv00127923.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30B 30b: Past 2 wks took high blood cholesterol? +74 Medication/supplement use 127924 phv00127924.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30C 30c: Past 2 wks took angina/chest pain medications? +74 Medication/supplement use 127925 phv00127925.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30D 30d: Past 2 wks took control of heart rhythm medications? +74 Medication/supplement use 127926 phv00127926.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30E 30e: Took medications for heart failure? +74 Medication/supplement use 127927 phv00127927.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30F 30f: Took medications for blood thinning? +74 Medication/supplement use 127928 phv00127928.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30G 30g: Took medications for diabetes/high blood sugar? +74 Medication/supplement use 127929 phv00127929.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30H 30h: Took medications for stroke +74 Medication/supplement use 127930 phv00127930.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA30I 30i: Took medications for leg pain when walking? +74 Medication/supplement use 127931 phv00127931.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31A 30a: In a hurry, too busy, forgot to take medications +74 Medication/supplement use 127932 phv00127932.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31B 31b: Medication was inconvenient to take +74 Medication/supplement use 127933 phv00127933.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31C 31c: Medication wouldn't do any good-did not take +74 Medication/supplement use 127934 phv00127934.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31D 31d: Medication made you feel bad-did not take +74 Medication/supplement use 127935 phv00127935.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31E 31e: Can't carry out normal activities-did not take medications +74 Medication/supplement use 127936 phv00127936.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31F 31f: Thought you might become addicted-did not take medications +74 Medication/supplement use 127937 phv00127937.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31G 31g: Don't like to take medicine +74 Medication/supplement use 127938 phv00127938.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31H 31h: Trying to do without taking medications +74 Medication/supplement use 127939 phv00127939.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31I 31i: No money to purchase medication +74 Medication/supplement use 127940 phv00127940.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31J 31j: Did not have medication available +74 Medication/supplement use 127941 phv00127941.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31K 31k: Other reasons for not taking a medication +74 Medication/supplement use 127942 phv00127942.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:29:47+00:00 2018-08-06 15:29:47+00:00 MSRA31L 31l: Specify why not taking medication +74 Medication/supplement use 127943 phv00127943.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA32 32: Past 2 weeks, take any aspirin? +74 Medication/supplement use 127944 phv00127944.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA33 33: Now taking aspirin? +74 Medication/supplement use 127945 phv00127945.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA34A 34a: Strength of aspirin in the pill +74 Medication/supplement use 127946 phv00127946.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA34B 34b: How may days a week, taking medication? +74 Medication/supplement use 127947 phv00127947.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA34C 34c: Pills taking per week, on average? +74 Medication/supplement use 127948 phv00127948.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA34D 34d: Purpose for taking this medication? +74 Medication/supplement use 127950 phv00127950.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA35A 35a: Now taking other non-steroidal drugs? +74 Medication/supplement use 127951 phv00127951.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA35B 35b: Brand name of medication? +74 Medication/supplement use 127952 phv00127952.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA35C 35c: If 'Other', specify +74 Medication/supplement use 127953 phv00127953.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA35D 35d: Average pills per week you are taking? +74 Medication/supplement use 127955 phv00127955.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA36A 36a: Have you used vinegar? +74 Medication/supplement use 127956 phv00127956.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA36B 36b: How many days during past 2 weeks did you used vinegar? +74 Medication/supplement use 127957 phv00127957.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA36C 36c: For what purpose did you used vinegar? +74 Medication/supplement use 127958 phv00127958.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA37A 37a: Past 2 weeks have you used epsom salts? +74 Medication/supplement use 127959 phv00127959.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA37B 37b: How many days during past 2 weeks did you use epsom salts? +74 Medication/supplement use 127960 phv00127960.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA37C 37c: For what purpose did you use epsom salts? +74 Medication/supplement use 127962 phv00127962.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA38B 38b: How many days during the past 2 weeks did you use lemon/juice? +74 Medication/supplement use 127963 phv00127963.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA38C 38c: For what purpose did you used lemon/lemon juice? +74 Medication/supplement use 127964 phv00127964.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA39A 39a: Past 2 weeks have you used garlic? +74 Medication/supplement use 127965 phv00127965.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA39B 39b: How many days during the past 2 weeks did you use garlic? +74 Medication/supplement use 127966 phv00127966.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA39C 39c: For what purpose did you used garlic? +74 Medication/supplement use 127967 phv00127967.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA40A 40a: Past 2 weeks did you use Teas? +74 Medication/supplement use 127968 phv00127968.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA40B 40b: How many days past 2 weeks used teas? +74 Medication/supplement use 127969 phv00127969.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA40C 40c: For what purpose did you used teas? +74 Medication/supplement use 127970 phv00127970.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA40D 40d: Specify type of teas +74 Medication/supplement use 127949 phv00127949.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA34E 34e: When did you start taking aspirin (mm/yyyy)? +74 Medication/supplement use 127954 phv00127954.v2.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:37:53+00:00 2018-08-06 15:37:53+00:00 MSRA35E 35e: When did you start taking (mm/yy)? +74 Medication/supplement use 127961 phv00127961.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:38:11+00:00 2018-08-06 15:38:11+00:00 MSRA38A 38a: Lemon juice or lemon? +74 Medication/supplement use 127971 phv00127971.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA41A 41a: Past 2 weeks did you use roots? +74 Medication/supplement use 127972 phv00127972.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA41B 41b: How many days the past 2 wks did you use roots? +74 Medication/supplement use 127973 phv00127973.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA41C 41c: Purpose you use roots? +74 Medication/supplement use 127974 phv00127974.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA41D 41d: Specify type of roots used +74 Medication/supplement use 127975 phv00127975.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA42A 42a: Any other home remedies used (2 weeks)? +74 Medication/supplement use 127976 phv00127976.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA42B 42b: How many days for past 2 wks took remedies? +74 Medication/supplement use 127977 phv00127977.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA42C 42c: What purpose took home remedies? +74 Medication/supplement use 127978 phv00127978.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA42D 42d: Specify type of home remedie +74 Medication/supplement use 127979 phv00127979.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA43A 43a: Any other home remedies? +74 Medication/supplement use 127980 phv00127980.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA43B 43b: Home remedies for your heart or other symptoms? +74 Medication/supplement use 127981 phv00127981.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA43C 43c: What other symptoms? +74 Medication/supplement use 127982 phv00127982.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRA43D 43d: How often have you used home remedies? +74 Medication/supplement use 127983 phv00127983.v1.p1 pht001964.v2.p1 phs000286.v5.p1 Jackson Heart Study 286 5 2018-08-06 15:41:15+00:00 2018-08-06 15:41:15+00:00 MSRAflag Data record present: Yes/No +74 Medication/supplement use 159648 phv00159648.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:14:21+00:00 2018-08-10 22:14:21+00:00 CurrentMedUse Currently do you use medications to treat breathing problem Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159647 phv00159647.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:14:30+00:00 2018-08-10 22:14:30+00:00 CortsterOral Oral corticosteroids Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159646 phv00159646.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:14:38+00:00 2018-08-10 22:14:38+00:00 Cortsterinhal Inhaled corticosteroids Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159645 phv00159645.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:14:47+00:00 2018-08-10 22:14:47+00:00 combivent Combination short-acting medication Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159644 phv00159644.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:14:55+00:00 2018-08-10 22:14:55+00:00 CombcCSBagon Combination inhaled corticosteroid and beta-agonist Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159643 phv00159643.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:15:04+00:00 2018-08-10 22:15:04+00:00 bagonistlongact Long-acting beta-agonist Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159642 phv00159642.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:15:12+00:00 2018-08-10 22:15:12+00:00 bagonist Inhaled short-acting beta-agonist Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159653 phv00159653.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:16:14+00:00 2018-08-10 22:16:14+00:00 tiotrop Tiotroprium bromide Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159652 phv00159652.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:16:20+00:00 2018-08-10 22:16:20+00:00 theoph Theophylline Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159651 phv00159651.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:16:28+00:00 2018-08-10 22:16:28+00:00 nebulizer Nebulizer for an inhaled medication Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159649 phv00159649.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:16:36+00:00 2018-08-10 22:16:36+00:00 ipratrop Ipratropium bromide Collection Interval: Collected in Exam 1 +74 Medication/supplement use 169343 phv00169343.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:18:50+00:00 2018-08-10 22:18:50+00:00 TreatSteroiTimes If yes how many times Collection Interval: Collected in Exam 1 +74 Medication/supplement use 169342 phv00169342.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:18:56+00:00 2018-08-10 22:18:56+00:00 TreatSteroids Been treated with steroid pills or injections Collection Interval: Collected in Exam 1 +74 Medication/supplement use 169341 phv00169341.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:19:04+00:00 2018-08-10 22:19:04+00:00 TreatChestTimes How many times treated with antibiotics for chest illness Collection Interval: Collected in Exam 1 +74 Medication/supplement use 169340 phv00169340.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:19:11+00:00 2018-08-10 22:19:11+00:00 TreatChestIll Have you been to treated with antibiotics for chest illness Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159676 phv00159676.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:20:52+00:00 2018-08-10 22:20:52+00:00 MedorTreatAttack Have you ever required medicine/treatment for attacks Collection Interval: Collected in Exam 1 +74 Medication/supplement use 169351 phv00169351.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:20:59+00:00 2018-08-10 22:20:59+00:00 COPDExac_NewRx_Antib_Ster Episodes past year: number of times doctor new prescription [antibiotics or steroids] Collection Interval: Collected in Exam 1 +74 Medication/supplement use 169350 phv00169350.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:21:05+00:00 2018-08-10 22:21:05+00:00 COPDExac_Antib_Ster_Home Episodes past year: number of times antibiotics or steroids at home Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159799 phv00159799.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:21:13+00:00 2018-08-10 22:21:13+00:00 COPDExac_UsualMed "Episodes past year: number of times ""Increased usual medication"" Collection Interval: Collected in Exam 1" +74 Medication/supplement use 159740 phv00159740.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:22:48+00:00 2018-08-10 22:22:48+00:00 SleepApTreat Sleep apnea: in past 12 months have you received any treatment for sleep apnea Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159735 phv00159735.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:22:55+00:00 2018-08-10 22:22:55+00:00 CopdTreat COPD: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1 +74 Medication/supplement use 169349 phv00169349.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:23:03+00:00 2018-08-10 22:23:03+00:00 EmphTreat Emphysema: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1 +74 Medication/supplement use 169346 phv00169346.v3.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:23:11+00:00 2018-08-10 22:23:11+00:00 ChronBroncTreat Chronic bronchitis: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159716 phv00159716.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:23:20+00:00 2018-08-10 22:23:20+00:00 HayFevTreat Hayfever: received medical treatment or used medications/nasal spray Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159708 phv00159708.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-10 22:23:29+00:00 2018-08-10 22:23:29+00:00 AsthmaTreat Asthma: received medical treatment or used medications/inhaler Collection Interval: Collected in Exam 1 +74 Medication/supplement use 123024 phv00123024.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-14 20:58:39+00:00 2018-08-14 20:58:39+00:00 activeasthma Asthma: MD dx of Asthma and on Asthma meds in past 3 days +74 Medication/supplement use 277317 phv00277317.v1.p1 pht006032.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:10:55+00:00 2018-08-14 22:10:55+00:00 MEDS_URICACID Taking Medication That Affect Uric Acid? Collection Interval: 2007-2009 +74 Medication/supplement use 277316 phv00277316.v1.p1 pht006032.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:11:03+00:00 2018-08-14 22:11:03+00:00 MEDS_LIPIDS Taking any Lipid Lowering Medication? Collection Interval: 2007-2009 +74 Medication/supplement use 277315 phv00277315.v1.p1 pht006032.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:11:10+00:00 2018-08-14 22:11:10+00:00 MEDS_HYT Taking any Anti-Hypertension Medication? Collection Interval: 2007-2009 +74 Medication/supplement use 277314 phv00277314.v1.p1 pht006032.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:11:19+00:00 2018-08-14 22:11:19+00:00 MEDS_DIABETES Taking any Anti-Diabetic Medication? Collection Interval: 2007-2009 +74 Medication/supplement use 277409 phv00277409.v1.p1 pht006037.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:24:22+00:00 2018-08-14 22:24:22+00:00 ASPIRIN1 In the last month, have you been regularly taking aspirin -- I mean daily or every other day? Collection Interval: 2009-2011 +74 Medication/supplement use 277410 phv00277410.v1.p1 pht006037.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:24:47+00:00 2018-08-14 22:24:47+00:00 ASPIRIN2 Do you take aspirin because your physician recommended it, or on your own? Collection Interval: 2009-2011 +74 Medication/supplement use 277416 phv00277416.v1.p1 pht006037.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:25:16+00:00 2018-08-14 22:25:16+00:00 meds_NUTRIENTS Taking any Nutritional Supplement? Collection Interval: 2009-2011 +74 Medication/supplement use 277415 phv00277415.v1.p1 pht006037.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:25:24+00:00 2018-08-14 22:25:24+00:00 meds_UricAcid Taking Medication That Affect Uric Acid? Collection Interval: 2009-2011 +74 Medication/supplement use 277414 phv00277414.v1.p1 pht006037.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:25:32+00:00 2018-08-14 22:25:32+00:00 meds_BRAIN Taking Medication that Affects the Brain? Collection Interval: 2009-2011 +74 Medication/supplement use 277413 phv00277413.v1.p1 pht006037.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:25:40+00:00 2018-08-14 22:25:40+00:00 meds_DIABETES Taking any Anti-Diabetic Medication? Collection Interval: 2009-2011 +74 Medication/supplement use 277412 phv00277412.v1.p1 pht006037.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:25:47+00:00 2018-08-14 22:25:47+00:00 meds_LIPIDS Taking any Lipid Lowering Medication? Collection Interval: 2009-2011 +74 Medication/supplement use 277411 phv00277411.v1.p1 pht006037.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:25:54+00:00 2018-08-14 22:25:54+00:00 meds_HYT Taking any Anti-Hypertension Medication? Collection Interval: 2009-2011 +74 Medication/supplement use 277426 phv00277426.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:27:45+00:00 2018-08-14 22:27:45+00:00 HYT_RXAGE In what year or how old were you when you last took prescription medication to lower your bp? -age Collection Interval: 2009-2011 +74 Medication/supplement use 277425 phv00277425.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:27:52+00:00 2018-08-14 22:27:52+00:00 HYT_RXYR In what year or how old were you when you last took prescription medication to lower your bp? -year Collection Interval: 2009-2011 +74 Medication/supplement use 277424 phv00277424.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:27:59+00:00 2018-08-14 22:27:59+00:00 HYT_RX Are you currently taking prescription medication to lower your blood pressure? Collection Interval: 2009-2011 +74 Medication/supplement use 277423 phv00277423.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:28:06+00:00 2018-08-14 22:28:06+00:00 HMED_AGE In what year or how old were you when medication was first prescribed? - age Collection Interval: 2009-2011 +74 Medication/supplement use 277422 phv00277422.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:28:13+00:00 2018-08-14 22:28:13+00:00 HMED_YR In what year or how old were you when medication was first prescribed? - year Collection Interval: 2009-2011 +74 Medication/supplement use 277421 phv00277421.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:28:20+00:00 2018-08-14 22:28:20+00:00 HYT_MED Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 2009-2011 +74 Medication/supplement use 277451 phv00277451.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:32:58+00:00 2018-08-14 22:32:58+00:00 HBS_INS Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2009-2011 +74 Medication/supplement use 277450 phv00277450.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:33:05+00:00 2018-08-14 22:33:05+00:00 HBS_MED Has oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2009-2011 +74 Medication/supplement use 277495 phv00277495.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:37:14+00:00 2018-08-14 22:37:14+00:00 BIRTHC In the last month have you taken or used any oral contraceptives/shots/or implants for birth control? Collection Interval: 2009-2011 +74 Medication/supplement use 277492 phv00277492.v1.p1 pht006038.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:37:21+00:00 2018-08-14 22:37:21+00:00 HOR_EST In the last month have you taken or used any pills/skin patches/or shots for hormone or estrogen therapy? Collection Interval: 2009-2011 +74 Medication/supplement use 277590 phv00277590.v1.p1 pht006042.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:45:44+00:00 2018-08-14 22:45:44+00:00 meds_NUTRIENTS Taking any Nutritional Supplement? Collection Interval: 1996-2000 +74 Medication/supplement use 277589 phv00277589.v1.p1 pht006042.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:45:51+00:00 2018-08-14 22:45:51+00:00 meds_UricAcid Taking Medication That Affect Uric Acid? Collection Interval: 1996-2000 +74 Medication/supplement use 277588 phv00277588.v1.p1 pht006042.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:45:58+00:00 2018-08-14 22:45:58+00:00 meds_BRAIN Taking Medication that Affects the Brain? Collection Interval: 1996-2000 +74 Medication/supplement use 277587 phv00277587.v1.p1 pht006042.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:46:05+00:00 2018-08-14 22:46:05+00:00 meds_DIABETES Taking any Anti-Diabetic Medication? Collection Interval: 1996-2000 +74 Medication/supplement use 277586 phv00277586.v1.p1 pht006042.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:46:13+00:00 2018-08-14 22:46:13+00:00 meds_LIPIDS Taking any Lipid Lowering Medication? Collection Interval: 1996-2000 +74 Medication/supplement use 277585 phv00277585.v1.p1 pht006042.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:46:20+00:00 2018-08-14 22:46:20+00:00 meds_HYT Taking any Anti-Hypertension Medication? Collection Interval: 1996-2000 +74 Medication/supplement use 277584 phv00277584.v1.p1 pht006042.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:46:28+00:00 2018-08-14 22:46:28+00:00 ASPIRIN In the last month, have you taken aspirin on a daily basis? Collection Interval: 1996-2000 +74 Medication/supplement use 277597 phv00277597.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:46:49+00:00 2018-08-14 22:46:49+00:00 HMED_AGE In what year or how old were you when medication was first prescribed? - age Collection Interval: 1996-2000 +74 Medication/supplement use 277596 phv00277596.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:46:56+00:00 2018-08-14 22:46:56+00:00 HMED_YR In what year or how old were you when medication was first prescribed? - year Collection Interval: 1996-2000 +74 Medication/supplement use 277595 phv00277595.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:47:03+00:00 2018-08-14 22:47:03+00:00 HYT_MED Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 1996-2000 +74 Medication/supplement use 277617 phv00277617.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:53:29+00:00 2018-08-14 22:53:29+00:00 IN_AGE In what year or how old were you when insulin was first prescribed? - age Collection Interval: 1996-2000 +74 Medication/supplement use 277616 phv00277616.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:53:37+00:00 2018-08-14 22:53:37+00:00 IN_YR In what year or how old were you when insulin was first prescribed? - year Collection Interval: 1996-2000 +74 Medication/supplement use 277615 phv00277615.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:53:44+00:00 2018-08-14 22:53:44+00:00 hbs_ins Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 1996-2000 +74 Medication/supplement use 277614 phv00277614.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:53:52+00:00 2018-08-14 22:53:52+00:00 HBSMED_A In what year or how old were you when it was first prescribed? - age Collection Interval: 1996-2000 +74 Medication/supplement use 277613 phv00277613.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:53:59+00:00 2018-08-14 22:53:59+00:00 HBSMED_Y In what year or how old were you when it was first prescribed? - year Collection Interval: 1996-2000 +74 Medication/supplement use 277612 phv00277612.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:54:08+00:00 2018-08-14 22:54:08+00:00 HBS_MED Has an oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 1996-2000 +74 Medication/supplement use 277652 phv00277652.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:56:48+00:00 2018-08-14 22:56:48+00:00 BIRTHC In the last month; have you taken or used any oral contraceptives; shots; or implants for birth control? Collection Interval: 1996-2000 +74 Medication/supplement use 277649 phv00277649.v1.p1 pht006043.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 22:56:55+00:00 2018-08-14 22:56:55+00:00 HOR_EST In the last month have you taken or used any pills/skin patches/shots for hormone/estrogen replacement therapy? Collection Interval: 1996-2000 +74 Medication/supplement use 277865 phv00277865.v1.p1 pht006049.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:12:14+00:00 2018-08-14 23:12:14+00:00 meds_NUTRIENTS Taking any Nutritional Supplement? Collection Interval: 2000-2004 +74 Medication/supplement use 277864 phv00277864.v1.p1 pht006049.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:12:21+00:00 2018-08-14 23:12:21+00:00 meds_UricAcid Taking Medication That Affect Uric Acid? Collection Interval: 2000-2004 +74 Medication/supplement use 277863 phv00277863.v1.p1 pht006049.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:12:28+00:00 2018-08-14 23:12:28+00:00 meds_BRAIN Taking Medication that Affects the Brain? Collection Interval: 2000-2004 +74 Medication/supplement use 277862 phv00277862.v1.p1 pht006049.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:12:35+00:00 2018-08-14 23:12:35+00:00 meds_DIABETES Taking any Anti-Diabetic Medication? Collection Interval: 2000-2004 +74 Medication/supplement use 277861 phv00277861.v1.p1 pht006049.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:12:43+00:00 2018-08-14 23:12:43+00:00 meds_LIPIDS Taking any Lipid Lowering Medication? Collection Interval: 2000-2004 +74 Medication/supplement use 277860 phv00277860.v1.p1 pht006049.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:12:51+00:00 2018-08-14 23:12:51+00:00 meds_HYT Taking any Anti-Hypertension Medication? Collection Interval: 2000-2004 +74 Medication/supplement use 277859 phv00277859.v1.p1 pht006049.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:12:59+00:00 2018-08-14 23:12:59+00:00 ASPIRIN2 Do you take aspirin because your physician recommended it, or on your own? Collection Interval: 2000-2004 +74 Medication/supplement use 277858 phv00277858.v1.p1 pht006049.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:13:06+00:00 2018-08-14 23:13:06+00:00 ASPIRIN1 In the last month, have you been regularly taking aspirin -- I mean daily or every other day? Collection Interval: 2000-2004 +74 Medication/supplement use 277875 phv00277875.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:13:43+00:00 2018-08-14 23:13:43+00:00 HYT_RXAGE In what year or how old were you when you last took prescription medication to lower your bp? -age Collection Interval: 2000-2004 +74 Medication/supplement use 277874 phv00277874.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:13:50+00:00 2018-08-14 23:13:50+00:00 HYT_RXYR In what year or how old were you when you last took prescription medication to lower your bp? -year Collection Interval: 2000-2004 +74 Medication/supplement use 277873 phv00277873.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:13:56+00:00 2018-08-14 23:13:56+00:00 HYT_RX Are you currently taking prescription medication to lower your blood pressure? Collection Interval: 2000-2004 +74 Medication/supplement use 277872 phv00277872.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:14:02+00:00 2018-08-14 23:14:02+00:00 HMED_AGE In what year or how old were you when medication was first prescribed? - age Collection Interval: 2000-2004 +74 Medication/supplement use 277871 phv00277871.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:14:09+00:00 2018-08-14 23:14:09+00:00 HMED_YR In what year or how old were you when medication was first prescribed? - year Collection Interval: 2000-2004 +74 Medication/supplement use 277870 phv00277870.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:14:16+00:00 2018-08-14 23:14:16+00:00 HYT_MED Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 2000-2004 +74 Medication/supplement use 277904 phv00277904.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:17:45+00:00 2018-08-14 23:17:45+00:00 IN_AGE In what year or how old were you when insulin was first prescribed? - age Collection Interval: 2000-2004 +74 Medication/supplement use 277903 phv00277903.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:17:52+00:00 2018-08-14 23:17:52+00:00 IN_YR In what year or how old were you when insulin was first prescribed? - year Collection Interval: 2000-2004 +74 Medication/supplement use 277902 phv00277902.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:17:59+00:00 2018-08-14 23:17:59+00:00 hbs_ins Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2000-2004 +74 Medication/supplement use 277901 phv00277901.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:18:05+00:00 2018-08-14 23:18:05+00:00 HBSMED_A In what year or how old were you when it was first prescribed? - age Collection Interval: 2000-2004 +74 Medication/supplement use 277900 phv00277900.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:18:12+00:00 2018-08-14 23:18:12+00:00 HBSMED_Y In what year or how old were you when it was first prescribed? - year Collection Interval: 2000-2004 +74 Medication/supplement use 277899 phv00277899.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-14 23:18:18+00:00 2018-08-14 23:18:18+00:00 HBS_MED Has oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2000-2004 +74 Medication/supplement use 277956 phv00277956.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:50:25+00:00 2018-08-15 23:50:25+00:00 BIRTHC In the last month have you taken or used any oral contraceptives/shots/or implants for birth control? Collection Interval: 2000-2004 +74 Medication/supplement use 277953 phv00277953.v1.p1 pht006050.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:50:32+00:00 2018-08-15 23:50:32+00:00 HOR_EST In the last month have you taken or used any pills/skin patches/or shots for hormone or estrogen therapy? Collection Interval: 2000-2004 +74 Medication/supplement use 307777 phv00307777.v1.p1 pht006651.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:53:57+00:00 2018-08-15 23:53:57+00:00 MEDS_URICACID Taking Medication That Affect Uric Acid? Collection Interval: 2006-2011 +74 Medication/supplement use 307776 phv00307776.v1.p1 pht006651.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:54:05+00:00 2018-08-15 23:54:05+00:00 MEDS_LIPIDS Taking any Lipid Lowering Medication? Collection Interval: 2006-2011 +74 Medication/supplement use 307775 phv00307775.v1.p1 pht006651.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:54:12+00:00 2018-08-15 23:54:12+00:00 MEDS_HYT Taking any Anti-Hypertension Medication? Collection Interval: 2006-2011 +74 Medication/supplement use 307774 phv00307774.v1.p1 pht006651.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:54:19+00:00 2018-08-15 23:54:19+00:00 MEDS_DIABETES Taking any Anti-Diabetic Medication? Collection Interval: 2006-2011 +74 Medication/supplement use 307871 phv00307871.v1.p1 pht006656.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:58:24+00:00 2018-08-15 23:58:24+00:00 meds_NUTRIENTS Taking any Nutritional Supplement? Collection Interval: 1996-2000 +74 Medication/supplement use 307870 phv00307870.v1.p1 pht006656.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:58:32+00:00 2018-08-15 23:58:32+00:00 meds_UricAcid Taking Medication That Affect Uric Acid? Collection Interval: 1996-2000 +74 Medication/supplement use 307869 phv00307869.v1.p1 pht006656.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:58:39+00:00 2018-08-15 23:58:39+00:00 meds_BRAIN Taking Medication that Affects the Brain? Collection Interval: 1996-2000 +74 Medication/supplement use 307868 phv00307868.v1.p1 pht006656.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:58:48+00:00 2018-08-15 23:58:48+00:00 meds_DIABETES Taking any Anti-Diabetic Medication? Collection Interval: 1996-2000 +74 Medication/supplement use 307867 phv00307867.v1.p1 pht006656.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:58:55+00:00 2018-08-15 23:58:55+00:00 meds_LIPIDS Taking any Lipid Lowering Medication? Collection Interval: 1996-2000 +74 Medication/supplement use 307866 phv00307866.v1.p1 pht006656.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:59:03+00:00 2018-08-15 23:59:03+00:00 meds_HYT Taking any Anti-Hypertension Medication? Collection Interval: 1996-2000 +74 Medication/supplement use 307865 phv00307865.v1.p1 pht006656.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:59:11+00:00 2018-08-15 23:59:11+00:00 ASPIRIN In the last month, have you taken aspirin on a daily basis? Collection Interval: 1996-2000 +74 Medication/supplement use 307878 phv00307878.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:59:37+00:00 2018-08-15 23:59:37+00:00 HMED_AGE In what year or how old were you when medication was first prescribed? - age Collection Interval: 1996-2000 +74 Medication/supplement use 307877 phv00307877.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:59:43+00:00 2018-08-15 23:59:43+00:00 HMED_YR In what year or how old were you when medication was first prescribed? - year Collection Interval: 1996-2000 +74 Medication/supplement use 307876 phv00307876.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-15 23:59:51+00:00 2018-08-15 23:59:51+00:00 HYT_MED Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 1996-2000 +74 Medication/supplement use 307898 phv00307898.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:02:54+00:00 2018-08-16 00:02:54+00:00 IN_AGE In what year or how old were you when insulin was first prescribed? - age Collection Interval: 1996-2000 +74 Medication/supplement use 307897 phv00307897.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:03:02+00:00 2018-08-16 00:03:02+00:00 IN_YR In what year or how old were you when insulin was first prescribed? - year Collection Interval: 1996-2000 +74 Medication/supplement use 307896 phv00307896.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:03:12+00:00 2018-08-16 00:03:12+00:00 hbs_ins Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 1996-2000 +74 Medication/supplement use 307895 phv00307895.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:03:26+00:00 2018-08-16 00:03:26+00:00 HBSMED_A In what year or how old were you when it was first prescribed? - age Collection Interval: 1996-2000 +74 Medication/supplement use 307894 phv00307894.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:03:34+00:00 2018-08-16 00:03:34+00:00 HBSMED_Y In what year or how old were you when it was first prescribed? - year Collection Interval: 1996-2000 +74 Medication/supplement use 307893 phv00307893.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:03:42+00:00 2018-08-16 00:03:42+00:00 HBS_MED Has an oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 1996-2000 +74 Medication/supplement use 307933 phv00307933.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:06:19+00:00 2018-08-16 00:06:19+00:00 BIRTHC In the last month; have you taken or used any oral contraceptives; shots; or implants for birth control? Collection Interval: 1996-2000 +74 Medication/supplement use 307930 phv00307930.v1.p1 pht006657.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:06:26+00:00 2018-08-16 00:06:26+00:00 HOR_EST In the last month have you taken or used any pills/skin patches/shots for hormone/estrogen replacement therapy? Collection Interval: 1996-2000 +74 Medication/supplement use 308058 phv00308058.v1.p1 pht006662.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:13:15+00:00 2018-08-16 00:13:15+00:00 meds_NUTRIENTS Taking any Nutritional Supplement? Collection Interval: 2000-2004 +74 Medication/supplement use 308057 phv00308057.v1.p1 pht006662.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:13:22+00:00 2018-08-16 00:13:22+00:00 meds_UricAcid Taking Medication That Affect Uric Acid? Collection Interval: 2000-2004 +74 Medication/supplement use 308056 phv00308056.v1.p1 pht006662.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:13:29+00:00 2018-08-16 00:13:29+00:00 meds_BRAIN Taking Medication that Affects the Brain? Collection Interval: 2000-2004 +74 Medication/supplement use 308055 phv00308055.v1.p1 pht006662.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:13:36+00:00 2018-08-16 00:13:36+00:00 meds_DIABETES Taking any Anti-Diabetic Medication? Collection Interval: 2000-2004 +74 Medication/supplement use 308054 phv00308054.v1.p1 pht006662.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:13:44+00:00 2018-08-16 00:13:44+00:00 meds_LIPIDS Taking any Lipid Lowering Medication? Collection Interval: 2000-2004 +74 Medication/supplement use 308053 phv00308053.v1.p1 pht006662.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:13:51+00:00 2018-08-16 00:13:51+00:00 meds_HYT Taking any Anti-Hypertension Medication? Collection Interval: 2000-2004 +74 Medication/supplement use 308052 phv00308052.v1.p1 pht006662.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:14:00+00:00 2018-08-16 00:14:00+00:00 ASPIRIN2 Do you take aspirin because your physician recommended it, or on your own? Collection Interval: 2000-2004 +74 Medication/supplement use 308051 phv00308051.v1.p1 pht006662.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:14:08+00:00 2018-08-16 00:14:08+00:00 ASPIRIN1 In the last month, have you been regularly taking aspirin -- I mean daily or every other day? Collection Interval: 2000-2004 +74 Medication/supplement use 308068 phv00308068.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:14:38+00:00 2018-08-16 00:14:38+00:00 HYT_RXAGE In what year or how old were you when you last took prescription medication to lower your bp? -age Collection Interval: 2000-2004 +74 Medication/supplement use 308067 phv00308067.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:14:45+00:00 2018-08-16 00:14:45+00:00 HYT_RXYR In what year or how old were you when you last took prescription medication to lower your bp? -year Collection Interval: 2000-2004 +74 Medication/supplement use 308066 phv00308066.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:14:51+00:00 2018-08-16 00:14:51+00:00 HYT_RX Are you currently taking prescription medication to lower your blood pressure? Collection Interval: 2000-2004 +74 Medication/supplement use 308065 phv00308065.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:15:00+00:00 2018-08-16 00:15:00+00:00 HMED_AGE In what year or how old were you when medication was first prescribed? - age Collection Interval: 2000-2004 +74 Medication/supplement use 308064 phv00308064.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:15:07+00:00 2018-08-16 00:15:07+00:00 HMED_YR In what year or how old were you when medication was first prescribed? - year Collection Interval: 2000-2004 +74 Medication/supplement use 308063 phv00308063.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:15:15+00:00 2018-08-16 00:15:15+00:00 HYT_MED Has medication ever been prescribed by a physician to lower your blood pressure? Collection Interval: 2000-2004 +74 Medication/supplement use 308097 phv00308097.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:20:29+00:00 2018-08-16 00:20:29+00:00 IN_AGE In what year or how old were you when insulin was first prescribed? - age Collection Interval: 2000-2004 +74 Medication/supplement use 308096 phv00308096.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:20:37+00:00 2018-08-16 00:20:37+00:00 IN_YR In what year or how old were you when insulin was first prescribed? - year Collection Interval: 2000-2004 +74 Medication/supplement use 308095 phv00308095.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:20:44+00:00 2018-08-16 00:20:44+00:00 hbs_ins Has insulin ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2000-2004 +74 Medication/supplement use 308094 phv00308094.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:20:51+00:00 2018-08-16 00:20:51+00:00 HBSMED_A In what year or how old were you when it was first prescribed? - age Collection Interval: 2000-2004 +74 Medication/supplement use 308093 phv00308093.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:20:58+00:00 2018-08-16 00:20:58+00:00 HBSMED_Y In what year or how old were you when it was first prescribed? - year Collection Interval: 2000-2004 +74 Medication/supplement use 308092 phv00308092.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:21:07+00:00 2018-08-16 00:21:07+00:00 HBS_MED Has oral medication ever been prescribed by a physician for treatment of your diabetes or high blood sugar? Collection Interval: 2000-2004 +74 Medication/supplement use 308149 phv00308149.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:24:47+00:00 2018-08-16 00:24:47+00:00 BIRTHC In the last month have you taken or used any oral contraceptives/shots/or implants for birth control? Collection Interval: 2000-2004 +74 Medication/supplement use 308146 phv00308146.v1.p1 pht006663.v1.p1 phs001238.v1.p1 Genetic Epidemiology Network of Arteriopathy (GENOA) 1238 1 2018-08-16 00:24:55+00:00 2018-08-16 00:24:55+00:00 HOR_EST In the last month have you taken or used any pills/skin patches/or shots for hormone or estrogen therapy? Collection Interval: 2000-2004 +74 Medication/supplement use 159576 phv00159576.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-16 17:01:29+00:00 2018-08-16 17:01:29+00:00 O2_suppl_6MW Supplemental O2 used during 6-min walk L/min Collection Interval: Collected in Exam 1 +74 Medication/supplement use 160267 phv00160267.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-16 17:01:35+00:00 2018-08-16 17:01:35+00:00 O2use_sleep Oxygen use: sleep Collection Interval: Collected in Exam 1 +74 Medication/supplement use 160266 phv00160266.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-16 17:01:45+00:00 2018-08-16 17:01:45+00:00 O2use_exercise Oxygen use: exercise Collection Interval: Collected in Exam 1 +74 Medication/supplement use 160265 phv00160265.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-16 17:01:52+00:00 2018-08-16 17:01:52+00:00 O2use_rest Oxygen use: at rest Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159588 phv00159588.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-16 17:01:59+00:00 2018-08-16 17:01:59+00:00 O2_Years How long have they used supplemental 02 [years] Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159586 phv00159586.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-16 17:02:07+00:00 2018-08-16 17:02:07+00:00 O2_Therapy Does subject use supplemental 02 therapy Collection Interval: Collected in Exam 1 +74 Medication/supplement use 159585 phv00159585.v4.p2 pht002239.v4.p2 phs000179.v5.p2 COPDGene 179 5 2018-08-16 17:02:15+00:00 2018-08-16 17:02:15+00:00 O2_Hours_Day On typical 24-hour day how many hours supplemental 02 used [hours] Collection Interval: Collected in Exam 1 +74 Medication/supplement use 122120 phv00122120.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:06:36+00:00 2018-08-16 23:06:36+00:00 BPMED Ever take blood pressure medicine (A) +74 Medication/supplement use 122121 phv00122121.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:06:48+00:00 2018-08-16 23:06:48+00:00 BPMEDNOW Still take blood pressure medicine (A) +74 Medication/supplement use 122122 phv00122122.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:07:00+00:00 2018-08-16 23:07:00+00:00 ASTHPIL Ever take breathing medicine (AC) +74 Medication/supplement use 122123 phv00122123.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:07:17+00:00 2018-08-16 23:07:17+00:00 ASTPLNOW Still take asthma spray +74 Medication/supplement use 122124 phv00122124.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:07:27+00:00 2018-08-16 23:07:27+00:00 ASTHSPY Ever take asthma spray (AC) +74 Medication/supplement use 122126 phv00122126.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:07:37+00:00 2018-08-16 23:07:37+00:00 HRTPIL Ever take heart pills (A) +74 Medication/supplement use 122127 phv00122127.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:07:46+00:00 2018-08-16 23:07:46+00:00 HRTPLNOW Still take heart pill (A) +74 Medication/supplement use 122128 phv00122128.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:07:57+00:00 2018-08-16 23:07:57+00:00 H2OPIL Ever take water pills (A) +74 Medication/supplement use 122129 phv00122129.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:08:09+00:00 2018-08-16 23:08:09+00:00 H2OPLNOW Still take water pill (A) +74 Medication/supplement use 122130 phv00122130.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:08:41+00:00 2018-08-16 23:08:41+00:00 SLPPIL Ever take sleeping pills (A) +74 Medication/supplement use 122131 phv00122131.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:08:47+00:00 2018-08-16 23:08:47+00:00 SLPPLNOW Still take sleeping pills (A) +74 Medication/supplement use 122132 phv00122132.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:08:54+00:00 2018-08-16 23:08:54+00:00 NASDEC Ever take antihistamine (AC) +74 Medication/supplement use 122133 phv00122133.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:09:00+00:00 2018-08-16 23:09:00+00:00 NASDCNOW Still take antihistamines (A) +74 Medication/supplement use 122134 phv00122134.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:09:07+00:00 2018-08-16 23:09:07+00:00 THYRMED Ever take thyroid medicine (AC) +74 Medication/supplement use 122135 phv00122135.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:09:14+00:00 2018-08-16 23:09:14+00:00 THYRMNOW Still take thyroid medicine (A) +74 Medication/supplement use 122136 phv00122136.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:09:20+00:00 2018-08-16 23:09:20+00:00 TRANQUIL Ever take tranquilizers (AC) +74 Medication/supplement use 122137 phv00122137.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:09:26+00:00 2018-08-16 23:09:26+00:00 TRANQNOW Still take tranquilizers (A) +74 Medication/supplement use 122138 phv00122138.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:09:33+00:00 2018-08-16 23:09:33+00:00 PROG Ever take progesterone/hormones etc (A) +74 Medication/supplement use 122139 phv00122139.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:09:39+00:00 2018-08-16 23:09:39+00:00 PROGNOW Still take progesterone/hormones etc (A) +74 Medication/supplement use 122394 phv00122394.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:42:56+00:00 2018-08-16 23:42:56+00:00 CPAP Recommended or prescribed CPAP (Continuous Positive Airway Pressure) +74 Medication/supplement use 122558 phv00122558.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:47:58+00:00 2018-08-16 23:47:58+00:00 TYPETX Type of sleep apnea treatment +74 Medication/supplement use 122559 phv00122559.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:48:28+00:00 2018-08-16 23:48:28+00:00 TXOTHER Other type of treatment for sleep apnea +74 Medication/supplement use 122626 phv00122626.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:52:34+00:00 2018-08-16 23:52:34+00:00 MEDICN Took medications on day of study (AC) +74 Medication/supplement use 122627 phv00122627.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:52:57+00:00 2018-08-16 23:52:57+00:00 SEDATIVE Took sedatives on day of study (AC) +74 Medication/supplement use 122628 phv00122628.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:53:05+00:00 2018-08-16 23:53:05+00:00 STIMULAN Took stimulants on day of study (AC) +74 Medication/supplement use 122629 phv00122629.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:53:11+00:00 2018-08-16 23:53:11+00:00 ANTIHIST Took antihistamines on day of study (AC) +74 Medication/supplement use 122630 phv00122630.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:53:18+00:00 2018-08-16 23:53:18+00:00 BRONCHIO Took bronchodilators on day of study (AC) +74 Medication/supplement use 122631 phv00122631.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:53:24+00:00 2018-08-16 23:53:24+00:00 DIURETIC Took diuretics on day of study (AC) +74 Medication/supplement use 122633 phv00122633.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:53:32+00:00 2018-08-16 23:53:32+00:00 OTHER List of other medications taken day of study +74 Medication/supplement use 122906 phv00122906.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:55:52+00:00 2018-08-16 23:55:52+00:00 OTHER1 Meds: list of other medications taken day of study +74 Medication/supplement use 122907 phv00122907.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:55:58+00:00 2018-08-16 23:55:58+00:00 OTHER2 Meds: list of other medications taken day of study +74 Medication/supplement use 122908 phv00122908.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:56:03+00:00 2018-08-16 23:56:03+00:00 ACETAMIN Meds: Acetaminophen +74 Medication/supplement use 122909 phv00122909.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:56:09+00:00 2018-08-16 23:56:09+00:00 BABYASPR Meds: Baby aspirin +74 Medication/supplement use 122910 phv00122910.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:56:15+00:00 2018-08-16 23:56:15+00:00 IBUPROFE Meds: Ibuprofen +74 Medication/supplement use 122911 phv00122911.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:56:21+00:00 2018-08-16 23:56:21+00:00 ANTIINFL Meds: Other anti-inflammatory analgesics, 2+ times/week +74 Medication/supplement use 122912 phv00122912.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:56:27+00:00 2018-08-16 23:56:27+00:00 CELEVIOX Meds: Celebrex or Vioxx +74 Medication/supplement use 122913 phv00122913.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:56:33+00:00 2018-08-16 23:56:33+00:00 THIAZIDE Meds: Thiazide diuretic +74 Medication/supplement use 122914 phv00122914.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:56:39+00:00 2018-08-16 23:56:39+00:00 LASIX Meds: Lasix +74 Medication/supplement use 122915 phv00122915.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:56:47+00:00 2018-08-16 23:56:47+00:00 CALCBLOC Meds: Calcium blocker +74 Medication/supplement use 122916 phv00122916.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:57:33+00:00 2018-08-16 23:57:33+00:00 BETBLOC Meds: Beta-blocker +74 Medication/supplement use 122917 phv00122917.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:57:41+00:00 2018-08-16 23:57:41+00:00 ACEINHIB Meds: ACE Inhibitors +74 Medication/supplement use 122918 phv00122918.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:57:46+00:00 2018-08-16 23:57:46+00:00 ANTIHYPE Meds: Other antihypertensive +74 Medication/supplement use 122919 phv00122919.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:57:52+00:00 2018-08-16 23:57:52+00:00 ORALSTER Meds: Steroids taken orally +74 Medication/supplement use 122920 phv00122920.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:57:58+00:00 2018-08-16 23:57:58+00:00 INSTEROI Meds: Inhaled steroids +74 Medication/supplement use 122921 phv00122921.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:58:05+00:00 2018-08-16 23:58:05+00:00 INBRONCH Meds: Inhaled bronchodilator +74 Medication/supplement use 122922 phv00122922.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:58:12+00:00 2018-08-16 23:58:12+00:00 DIGOXIN Meds: Digoxin +74 Medication/supplement use 122923 phv00122923.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:58:55+00:00 2018-08-16 23:58:55+00:00 ANTIARRH Meds: Antiarrhythmic +74 Medication/supplement use 122924 phv00122924.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:59:00+00:00 2018-08-16 23:59:00+00:00 BLODTHIN Meds: Coumadin (blood thinner) +74 Medication/supplement use 122925 phv00122925.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:59:07+00:00 2018-08-16 23:59:07+00:00 CHOLLOWD Meds: Cholesterol lowering drugs +74 Medication/supplement use 122926 phv00122926.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:59:13+00:00 2018-08-16 23:59:13+00:00 CHOLYRS Meds: If yes, Number of years used +74 Medication/supplement use 122927 phv00122927.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:59:19+00:00 2018-08-16 23:59:19+00:00 OTHCHLDR Meds: Other cholesterol lowering drug +74 Medication/supplement use 122928 phv00122928.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:59:26+00:00 2018-08-16 23:59:26+00:00 CIMETIDI Meds: Cimetidine +74 Medication/supplement use 122929 phv00122929.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:59:32+00:00 2018-08-16 23:59:32+00:00 H2BLOC Meds: Other H2 Blocker +74 Medication/supplement use 122930 phv00122930.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:59:42+00:00 2018-08-16 23:59:42+00:00 PRILPREV Meds: Prilosec or Prevacid +74 Medication/supplement use 122931 phv00122931.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-16 23:59:49+00:00 2018-08-16 23:59:49+00:00 INSULIN Meds: Insulin +74 Medication/supplement use 122932 phv00122932.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:01:10+00:00 2018-08-17 00:01:10+00:00 ORALGLUC Meds: Oral Hypoglycemic +74 Medication/supplement use 122933 phv00122933.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:01:18+00:00 2018-08-17 00:01:18+00:00 ANTIDEPR Meds: Anti depressant +74 Medication/supplement use 122934 phv00122934.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:01:25+00:00 2018-08-17 00:01:25+00:00 PROZAC Meds: Prozac +74 Medication/supplement use 122935 phv00122935.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:01:33+00:00 2018-08-17 00:01:33+00:00 ZOLOFT Meds: Zoloft +74 Medication/supplement use 122936 phv00122936.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:01:40+00:00 2018-08-17 00:01:40+00:00 PAXIL Meds: Paxil +74 Medication/supplement use 122937 phv00122937.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:01:48+00:00 2018-08-17 00:01:48+00:00 CELEXA Meds: Celexa +74 Medication/supplement use 122938 phv00122938.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:01:56+00:00 2018-08-17 00:01:56+00:00 OTHANTID Meds: Other antidepressants +74 Medication/supplement use 122939 phv00122939.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:02:03+00:00 2018-08-17 00:02:03+00:00 TQUILIZE Meds: Tranquilizers +74 Medication/supplement use 122940 phv00122940.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:02:11+00:00 2018-08-17 00:02:11+00:00 MERIDIA Meds: Meridia +74 Medication/supplement use 122941 phv00122941.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:02:18+00:00 2018-08-17 00:02:18+00:00 PHENTERM Meds: Phentermine +74 Medication/supplement use 122942 phv00122942.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:02:56+00:00 2018-08-17 00:02:56+00:00 XENICAL Meds: Xenical +74 Medication/supplement use 122943 phv00122943.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:03:03+00:00 2018-08-17 00:03:03+00:00 THRYD Meds: Thyroid +74 Medication/supplement use 122944 phv00122944.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:03:10+00:00 2018-08-17 00:03:10+00:00 DEMENTIA Meds: Dementia +74 Medication/supplement use 122945 phv00122945.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:03:17+00:00 2018-08-17 00:03:17+00:00 SLEEPMED Meds: Sleeping medicine +74 Medication/supplement use 122946 phv00122946.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:03:24+00:00 2018-08-17 00:03:24+00:00 ANTIHIS Meds: Antihistamine +74 Medication/supplement use 122947 phv00122947.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:03:31+00:00 2018-08-17 00:03:31+00:00 NITRATES Meds: Nitrates +74 Medication/supplement use 122948 phv00122948.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:03:38+00:00 2018-08-17 00:03:38+00:00 NITROGLY Meds: Nitroglycerin +74 Medication/supplement use 122949 phv00122949.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:03:46+00:00 2018-08-17 00:03:46+00:00 THEOPHYL Meds: Theophylline +74 Medication/supplement use 122950 phv00122950.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:03:53+00:00 2018-08-17 00:03:53+00:00 ADHDMED Meds: ADHD (Adderall, Ritalin, Stratera) +74 Medication/supplement use 122951 phv00122951.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:04:01+00:00 2018-08-17 00:04:01+00:00 REGMEDOT Meds: Other regular medicine +74 Medication/supplement use 122952 phv00122952.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:04:38+00:00 2018-08-17 00:04:38+00:00 OTHREG1 Meds: specify other medication (1) +74 Medication/supplement use 122953 phv00122953.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:04:48+00:00 2018-08-17 00:04:48+00:00 OTHREG2 Meds: specify other medication (2) +74 Medication/supplement use 122954 phv00122954.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:04:56+00:00 2018-08-17 00:04:56+00:00 OTHREG3 Meds: specify other medication (3) +74 Medication/supplement use 122955 phv00122955.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:05:02+00:00 2018-08-17 00:05:02+00:00 OTHREG4 Meds: specify other medication (4) +74 Medication/supplement use 122956 phv00122956.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:05:08+00:00 2018-08-17 00:05:08+00:00 MULTIVIT Meds: Do you currently take a multi-vitamin? +74 Medication/supplement use 122957 phv00122957.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:05:15+00:00 2018-08-17 00:05:15+00:00 PSYCHO Meds: Anti-psychotic medicines (Serex, Lithium, Sericol) +74 Medication/supplement use 122958 phv00122958.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:05:22+00:00 2018-08-17 00:05:22+00:00 ALLOPURI Meds: Allopurinol (Zyloprin) +74 Medication/supplement use 122959 phv00122959.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:05:29+00:00 2018-08-17 00:05:29+00:00 BCONTROL Meds: Birth Control +74 Medication/supplement use 122960 phv00122960.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:05:36+00:00 2018-08-17 00:05:36+00:00 PREMARIN Meds: Premarin +74 Medication/supplement use 122961 phv00122961.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:05:42+00:00 2018-08-17 00:05:42+00:00 PREMPRO Meds: Prempro +74 Medication/supplement use 122962 phv00122962.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:06:00+00:00 2018-08-17 00:06:00+00:00 ESTRACE Meds: Estrace +74 Medication/supplement use 122963 phv00122963.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:06:06+00:00 2018-08-17 00:06:06+00:00 ESTRATE Meds: Estratest +74 Medication/supplement use 122964 phv00122964.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:06:12+00:00 2018-08-17 00:06:12+00:00 OTHHPILL Meds: Other hormones or birth control pills? +74 Medication/supplement use 122965 phv00122965.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 00:06:19+00:00 2018-08-17 00:06:19+00:00 OTHPILSP Meds: specify other hormones or birth control pills +74 Medication/supplement use 113017 phv00113017.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:15:05+00:00 2018-08-17 18:15:05+00:00 A08OTMED TAKING ANY OTHER PRESCRIPTION DRUGS +74 Medication/supplement use 113016 phv00113016.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:15:13+00:00 2018-08-17 18:15:13+00:00 A08ASMA TAKE MEDICINE FOR ASTHMA +74 Medication/supplement use 113015 phv00113015.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:15:20+00:00 2018-08-17 18:15:20+00:00 A08HORMN EVER TAKEN HORMONES, EXCLUDING BC +74 Medication/supplement use 113014 phv00113014.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:15:29+00:00 2018-08-17 18:15:29+00:00 A08BRTHC EVER TAKEN BIRTH CONTROL PILLS +74 Medication/supplement use 113013 phv00113013.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:15:36+00:00 2018-08-17 18:15:36+00:00 A08HRMED EVER TAKEN MEDS FOR A HEART CONDITION +74 Medication/supplement use 113012 phv00113012.v2.p2 pht001569.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:15:43+00:00 2018-08-17 18:15:43+00:00 A08BPMED EVER TAKEN MEDS FOR HIGH BLOOD PRESSURE +74 Medication/supplement use 113154 phv00113154.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:24:07+00:00 2018-08-17 18:24:07+00:00 A09MDTYP MEDIC'N FOLL'UP PAGE NAME (MED TYPE) +74 Medication/supplement use 113155 phv00113155.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:25:39+00:00 2018-08-17 18:25:39+00:00 A09MDNOW TAKING MED NOW? +74 Medication/supplement use 113157 phv00113157.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:25:51+00:00 2018-08-17 18:25:51+00:00 A09MDNM NAME OF MEDICATION +74 Medication/supplement use 113161 phv00113161.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:34:25+00:00 2018-08-17 18:34:25+00:00 A09MDCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 113160 phv00113160.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:34:31+00:00 2018-08-17 18:34:31+00:00 A09MDCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 113159 phv00113159.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:34:38+00:00 2018-08-17 18:34:38+00:00 A09MDCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 113158 phv00113158.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:34:46+00:00 2018-08-17 18:34:46+00:00 A09MDCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 113166 phv00113166.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:35:15+00:00 2018-08-17 18:35:15+00:00 A09MDTUS TOTAL TIME USED MEDICATION, MONTHS +74 Medication/supplement use 113165 phv00113165.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:35:22+00:00 2018-08-17 18:35:22+00:00 A09MDRSN REASON FOR USE (ASTH & OTHER MEDS ONLY) +74 Medication/supplement use 113164 phv00113164.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:35:28+00:00 2018-08-17 18:35:28+00:00 A09MDTMO MONTHS USED MEDICATION +74 Medication/supplement use 113163 phv00113163.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:35:36+00:00 2018-08-17 18:35:36+00:00 A09MDTYR YEARS USED MEDICATION +74 Medication/supplement use 113162 phv00113162.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 18:35:43+00:00 2018-08-17 18:35:43+00:00 A09MDLUS TIME SINCE LAST USED MEDICATION +74 Medication/supplement use 123028 phv00123028.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:56:35+00:00 2018-08-17 19:56:35+00:00 bpmedx Meds: Self-report of BP medication use or on specified BP medication +74 Medication/supplement use 123030 phv00123030.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:56:44+00:00 2018-08-17 19:56:44+00:00 statins Meds: Use of cholesterol lowering drugs (chollowd, othchldr) +74 Medication/supplement use 123031 phv00123031.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:56:51+00:00 2018-08-17 19:56:51+00:00 aspirintherapy Meds: aspirin 4-7 days/wk +74 Medication/supplement use 123032 phv00123032.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:56:58+00:00 2018-08-17 19:56:58+00:00 inflmed Meds: anti-inflammatory meds (ibubrofen, celebrex, oral steroids) +74 Medication/supplement use 123033 phv00123033.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:57:06+00:00 2018-08-17 19:57:06+00:00 othregmd Specify other regular medicine +74 Medication/supplement use 123034 phv00123034.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:57:13+00:00 2018-08-17 19:57:13+00:00 psychmeds Meds: Anit-depressant or anti-anxiety medications +74 Medication/supplement use 123035 phv00123035.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:57:20+00:00 2018-08-17 19:57:20+00:00 hrtx Meds: Hormone Replacement Therapy +74 Medication/supplement use 123036 phv00123036.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:57:51+00:00 2018-08-17 19:57:51+00:00 prescpap Ever prescribed CPAP +74 Medication/supplement use 123037 phv00123037.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 19:57:58+00:00 2018-08-17 19:57:58+00:00 regcpap Current regular use of CPAP (at least 50% of time) +74 Medication/supplement use 123157 phv00123157.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:05:25+00:00 2018-08-17 20:05:25+00:00 BPMEDYR 73 Blood pressure medicine in last year (L) +74 Medication/supplement use 123158 phv00123158.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:05:31+00:00 2018-08-17 20:05:31+00:00 BPMED3DY 73 Blood pressure meds in last 3 days (L) +74 Medication/supplement use 123159 phv00123159.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:05:37+00:00 2018-08-17 20:05:37+00:00 ASTHPLYR 73 Breathing pills in last yr (L) +74 Medication/supplement use 123160 phv00123160.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:05:44+00:00 2018-08-17 20:05:44+00:00 ASTPL3DY 73 Breathing pills in last 3 days (L) +74 Medication/supplement use 123161 phv00123161.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:05:50+00:00 2018-08-17 20:05:50+00:00 ASTHSPYR 73 Breathing sprays in last yr (L) +74 Medication/supplement use 123162 phv00123162.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:06:29+00:00 2018-08-17 20:06:29+00:00 ASTSP3DY 73 Breathing spray in last 3 days (L) +74 Medication/supplement use 123163 phv00123163.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:06:36+00:00 2018-08-17 20:06:36+00:00 HRTPLYR 73 Heart pills in last yr (L) +74 Medication/supplement use 123164 phv00123164.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:06:42+00:00 2018-08-17 20:06:42+00:00 HRTPL3DY 73 Heart pills in last 3 days (L) +74 Medication/supplement use 123165 phv00123165.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:13:33+00:00 2018-08-17 20:13:33+00:00 H2OPILYR 73 Water pills in last yr (L) +74 Medication/supplement use 123166 phv00123166.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:13:38+00:00 2018-08-17 20:13:38+00:00 H2OPL3DY 73 Water pills in last 3 days (L) +74 Medication/supplement use 123167 phv00123167.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:13:44+00:00 2018-08-17 20:13:44+00:00 SLPPILYR 73 Sleeping pills in last yr (L) +74 Medication/supplement use 123168 phv00123168.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:13:51+00:00 2018-08-17 20:13:51+00:00 SLPPL3DY 73 Sleep pills in last 3 days (L) +74 Medication/supplement use 123169 phv00123169.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:14:01+00:00 2018-08-17 20:14:01+00:00 NASDECYR 73 Antihistamines in last yr (L) +74 Medication/supplement use 123170 phv00123170.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:14:08+00:00 2018-08-17 20:14:08+00:00 NASDC3DY 73 Antihistamines in last 3 days (L) +74 Medication/supplement use 123171 phv00123171.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 20:14:15+00:00 2018-08-17 20:14:15+00:00 THYRMDYR 73 Thyroid medicines in last yr (L) +74 Medication/supplement use 113670 phv00113670.v2.p2 pht001584.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:05:35+00:00 2018-08-17 21:05:35+00:00 A21MED PT USES CARDIOVASCULAR MEDICATIONS. Q 6 +74 Medication/supplement use 123172 phv00123172.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:42:43+00:00 2018-08-17 21:42:43+00:00 THYRM3DY 73 Thyroid meds in last 3 days (L) +74 Medication/supplement use 123173 phv00123173.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:42:49+00:00 2018-08-17 21:42:49+00:00 TRANQUYR 73 Tranquilizers in last yr (L) +74 Medication/supplement use 123174 phv00123174.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:42:56+00:00 2018-08-17 21:42:56+00:00 TRANQ3DY 73 Tranquilizers in last 3 days (L) +74 Medication/supplement use 123175 phv00123175.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:44:46+00:00 2018-08-17 21:44:46+00:00 PROGYR 73 Progesterone in last yr (L) +74 Medication/supplement use 123176 phv00123176.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:44:51+00:00 2018-08-17 21:44:51+00:00 PROG3DY 73 Progesterone in last 3 days (L) +74 Medication/supplement use 123177 phv00123177.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:44:57+00:00 2018-08-17 21:44:57+00:00 STIMYR 73 Stimulants in last yr (L) +74 Medication/supplement use 123178 phv00123178.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:45:03+00:00 2018-08-17 21:45:03+00:00 STIM3DY 73 Stimulants in last 3 days (L) +74 Medication/supplement use 123179 phv00123179.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:45:08+00:00 2018-08-17 21:45:08+00:00 ACETAMON 74 Last month have you used acetaminophen +74 Medication/supplement use 123180 phv00123180.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:45:14+00:00 2018-08-17 21:45:14+00:00 ACETADAY 74 How many days per week do you take acetaminophen +74 Medication/supplement use 123181 phv00123181.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:45:20+00:00 2018-08-17 21:45:20+00:00 ACETAMNO 74 On average, how many tablets acetaminophen taken +74 Medication/supplement use 123182 phv00123182.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:45:52+00:00 2018-08-17 21:45:52+00:00 BABYAMON 74 Last month have you taken baby aspirin +74 Medication/supplement use 123183 phv00123183.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:45:59+00:00 2018-08-17 21:45:59+00:00 BABYADAY 74 How many days per week taken baby aspirin +74 Medication/supplement use 123184 phv00123184.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:46:05+00:00 2018-08-17 21:46:05+00:00 BABYASNO 74 On average how many baby aspirin taken +74 Medication/supplement use 123185 phv00123185.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:46:12+00:00 2018-08-17 21:46:12+00:00 ASPIRMON 74 Last month have you used aspirin +74 Medication/supplement use 123186 phv00123186.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:46:18+00:00 2018-08-17 21:46:18+00:00 ASPIRDAY 74 How many days per week do you take aspirin +74 Medication/supplement use 123187 phv00123187.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:46:23+00:00 2018-08-17 21:46:23+00:00 ASPRINNO 74 On average how many aspirin taken +74 Medication/supplement use 123188 phv00123188.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:46:29+00:00 2018-08-17 21:46:29+00:00 IBUPRMON 74 Last month have you used ibuprofen +74 Medication/supplement use 123189 phv00123189.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:46:35+00:00 2018-08-17 21:46:35+00:00 IBUPRDAY 74 Days per week ibuprofen taken +74 Medication/supplement use 123190 phv00123190.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:46:41+00:00 2018-08-17 21:46:41+00:00 IBUPRONO 74 On average how many ibuprofen taken +74 Medication/supplement use 123191 phv00123191.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:46:46+00:00 2018-08-17 21:46:46+00:00 NOMULVIT 74 How many multi-vitamins do you take per week? +74 Medication/supplement use 123192 phv00123192.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:07+00:00 2018-08-17 21:47:07+00:00 ALLBEEC 74 Mult Vit: Allbee + C +74 Medication/supplement use 123193 phv00123193.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:13+00:00 2018-08-17 21:47:13+00:00 CENTSENT 74 Mult Vit: Centrum, Century, Sentury +74 Medication/supplement use 123194 phv00123194.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:19+00:00 2018-08-17 21:47:19+00:00 ONEADAYE 74 Mult Vit: One A Day Essential +74 Medication/supplement use 123195 phv00123195.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:24+00:00 2018-08-17 21:47:24+00:00 THERAGRM 74 Mult Vit: Theragran +74 Medication/supplement use 123196 phv00123196.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:33+00:00 2018-08-17 21:47:33+00:00 CALIT600 74 Mult Vit: Calitrate 600 +74 Medication/supplement use 123197 phv00123197.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:38+00:00 2018-08-17 21:47:38+00:00 CENTSILV 74 Mult Vit: Centrum Silver +74 Medication/supplement use 123198 phv00123198.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:44+00:00 2018-08-17 21:47:44+00:00 ONEADAYM 74 Mult Vit: One A Day Maximum +74 Medication/supplement use 123199 phv00123199.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:49+00:00 2018-08-17 21:47:49+00:00 THERAGMM 74 Mult Vit: Theragram M +74 Medication/supplement use 123200 phv00123200.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:47:55+00:00 2018-08-17 21:47:55+00:00 CVSDAILY 74 Mult Vit: VS Daily +74 Medication/supplement use 123201 phv00123201.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:48:01+00:00 2018-08-17 21:48:01+00:00 FORNU100 74 Mult Vit: Formula 100, Nutri-100 +74 Medication/supplement use 123202 phv00123202.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:48:42+00:00 2018-08-17 21:48:42+00:00 ONEADAYW 74 Mult Vit: One A Day Womens +74 Medication/supplement use 123203 phv00123203.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:48:47+00:00 2018-08-17 21:48:47+00:00 UNICAP 74 Mult Vit: Unicap +74 Medication/supplement use 123204 phv00123204.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:48:54+00:00 2018-08-17 21:48:54+00:00 CVSMINER 74 Mult Vit: CVS Daily w Minerals +74 Medication/supplement use 123205 phv00123205.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:48:59+00:00 2018-08-17 21:48:59+00:00 HEALTPAC 74 Mult Vit: Health Balance Daily Pack +74 Medication/supplement use 123206 phv00123206.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:49:04+00:00 2018-08-17 21:49:04+00:00 PROTEGRA 74 Mult Vit: Protegra +74 Medication/supplement use 123207 phv00123207.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:49:09+00:00 2018-08-17 21:49:09+00:00 UNICAPM 74 Mult Vit: Unicap-M +74 Medication/supplement use 123208 phv00123208.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:49:14+00:00 2018-08-17 21:49:14+00:00 CVSPROVI 74 Mult Vit: CVS Pro-Vite +74 Medication/supplement use 123209 phv00123209.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:49:19+00:00 2018-08-17 21:49:19+00:00 HDFORWPL 74 Mult Vit: Healthy Direction Forward Plus +74 Medication/supplement use 123210 phv00123210.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:49:25+00:00 2018-08-17 21:49:25+00:00 SHAKLEE 74 Mult Vit: Shaklee Vita-Lea +74 Medication/supplement use 123211 phv00123211.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:49:31+00:00 2018-08-17 21:49:31+00:00 UNICAPSR 74 Mult Vit: Unicap Senior +74 Medication/supplement use 123229 phv00123229.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:05+00:00 2018-08-17 21:50:05+00:00 FOLDOSDY 74 Folic acid dose per day +74 Medication/supplement use 123228 phv00123228.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:11+00:00 2018-08-17 21:50:11+00:00 FOLICACD 74 Do you take Folic Acid? +74 Medication/supplement use 123227 phv00123227.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:17+00:00 2018-08-17 21:50:17+00:00 YOUVITIR 74 Does your multivitamin include iron? +74 Medication/supplement use 123226 phv00123226.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:23+00:00 2018-08-17 21:50:23+00:00 YOURVITA 74 Mult Vit: specify +74 Medication/supplement use 123225 phv00123225.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:28+00:00 2018-08-17 21:50:28+00:00 ONEDAYAP 74 Mult Vit: One A Day Antioxidant Plus +74 Medication/supplement use 123224 phv00123224.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:34+00:00 2018-08-17 21:50:34+00:00 CENTVITS 74 Mult Vit: Central Vite Select +74 Medication/supplement use 123223 phv00123223.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:41+00:00 2018-08-17 21:50:41+00:00 OCUVITPL 74 Mult Vit: Ocuvite Plus +74 Medication/supplement use 123222 phv00123222.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:46+00:00 2018-08-17 21:50:46+00:00 ZBEC 74 Mult Vit: Z-Bec +74 Medication/supplement use 123221 phv00123221.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:51+00:00 2018-08-17 21:50:51+00:00 SURBEXT 74 Mult Vit: Surbex T +74 Medication/supplement use 123220 phv00123220.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:50:56+00:00 2018-08-17 21:50:56+00:00 CENVITPL 74 Mult Vit: Central Vite Plus +74 Medication/supplement use 123219 phv00123219.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:51:01+00:00 2018-08-17 21:51:01+00:00 OCUVITE 74 Mult Vit: Ocuvite +74 Medication/supplement use 123218 phv00123218.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:51:06+00:00 2018-08-17 21:51:06+00:00 STRESSTB 74 Mult Vit: Stresstabs +74 Medication/supplement use 123217 phv00123217.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:51:11+00:00 2018-08-17 21:51:11+00:00 WOMPOWPK 74 Mult Vit: Women Power Pack +74 Medication/supplement use 123216 phv00123216.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:51:17+00:00 2018-08-17 21:51:17+00:00 CENTRALV 74 Mult Vit: Central Vite +74 Medication/supplement use 123215 phv00123215.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:51:29+00:00 2018-08-17 21:51:29+00:00 VIMIN75 74 Mult Vit: VI-MIN 75 +74 Medication/supplement use 123214 phv00123214.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:51:34+00:00 2018-08-17 21:51:34+00:00 SOLOTRON 74 Mult Vit: Solotron for Women +74 Medication/supplement use 123213 phv00123213.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:51:39+00:00 2018-08-17 21:51:39+00:00 NUSKINPK 74 Mult Vit: Nuskin Life Pack +74 Medication/supplement use 123212 phv00123212.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:51:45+00:00 2018-08-17 21:51:45+00:00 CVSMEGML 74 Mult Vit: CVS Mega Multi +74 Medication/supplement use 114365 phv00114365.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:52:19+00:00 2018-08-17 21:52:19+00:00 B08OTMED TAKING OTHER PRESCRIPTION DRUGS. Q 6 +74 Medication/supplement use 114364 phv00114364.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:52:25+00:00 2018-08-17 21:52:25+00:00 B08ASMA TAKE MEDICINE FOR ASTHMA. Q 6 +74 Medication/supplement use 114363 phv00114363.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:52:33+00:00 2018-08-17 21:52:33+00:00 B08HORMN EVER TAKEN HORMONES EXCLUDING BCP? Q 6 +74 Medication/supplement use 114362 phv00114362.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:52:40+00:00 2018-08-17 21:52:40+00:00 B08BRTHC EVER TAKEN BC PILLS? +74 Medication/supplement use 114361 phv00114361.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:52:47+00:00 2018-08-17 21:52:47+00:00 B08HRMED EVER TAKEN MEDS FOR HEART. Q 6 +74 Medication/supplement use 114360 phv00114360.v2.p2 pht001601.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-17 21:52:55+00:00 2018-08-17 21:52:55+00:00 B08BPMED EVER TAKEN MEDS FOR HBP. Q 6 +74 Medication/supplement use 123241 phv00123241.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:58:18+00:00 2018-08-17 21:58:18+00:00 HORMONES 76 Ever use prescription female hormones? +74 Medication/supplement use 123243 phv00123243.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:58:23+00:00 2018-08-17 21:58:23+00:00 PATCHEST 76 Ever use - patch estrogen +74 Medication/supplement use 123244 phv00123244.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:58:28+00:00 2018-08-17 21:58:28+00:00 VAGESTRO 76 Ever use - vaginal estrogen +74 Medication/supplement use 123245 phv00123245.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:58:34+00:00 2018-08-17 21:58:34+00:00 OGEN 76 Ever use - Ogen +74 Medication/supplement use 123246 phv00123246.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:58:40+00:00 2018-08-17 21:58:40+00:00 OTHESTRO 76 Ever use - Other Estrogen +74 Medication/supplement use 123247 phv00123247.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:58:46+00:00 2018-08-17 21:58:46+00:00 SPECEST 76 Ever use - Specify hormone +74 Medication/supplement use 123248 phv00123248.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:58:51+00:00 2018-08-17 21:58:51+00:00 PROCYCMP 76 Ever use - Provera/Cycrin/MPA +74 Medication/supplement use 123249 phv00123249.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:58:57+00:00 2018-08-17 21:58:57+00:00 VAGINAL 76 Ever use - Vaginal +74 Medication/supplement use 123250 phv00123250.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:59:10+00:00 2018-08-17 21:59:10+00:00 MICRONIZ 76 Ever use - Micronized (e.g. Prometrium) +74 Medication/supplement use 123251 phv00123251.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:59:15+00:00 2018-08-17 21:59:15+00:00 OTHPROG 76 Ever use - Other Progesterone +74 Medication/supplement use 123252 phv00123252.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:59:20+00:00 2018-08-17 21:59:20+00:00 SPECPROG 76 Ever use - specify progesterone +74 Medication/supplement use 123253 phv00123253.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:59:26+00:00 2018-08-17 21:59:26+00:00 PREMPROP 76 Ever use - Prempro (pink) +74 Medication/supplement use 123254 phv00123254.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:59:30+00:00 2018-08-17 21:59:30+00:00 PREMPROB 76 Ever use - Prempro (blue) +74 Medication/supplement use 123255 phv00123255.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:59:35+00:00 2018-08-17 21:59:35+00:00 PREMPHAS 76 Ever use - Premphase +74 Medication/supplement use 123256 phv00123256.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:59:41+00:00 2018-08-17 21:59:41+00:00 COMBIPAT 76 Ever use - Combipatch +74 Medication/supplement use 123257 phv00123257.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-17 21:59:46+00:00 2018-08-17 21:59:46+00:00 FEMHRT 76 Ever use - FemHRT +74 Medication/supplement use 123811 phv00123811.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:08+00:00 2018-08-21 17:56:08+00:00 LANYMED PreSleep: Have you taken any medication today? +74 Medication/supplement use 123812 phv00123812.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:12+00:00 2018-08-21 17:56:12+00:00 LSEDS PreSleep: Sedatives today? +74 Medication/supplement use 123813 phv00123813.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:17+00:00 2018-08-21 17:56:17+00:00 LSTIM PreSleep: Stimulants today? +74 Medication/supplement use 123814 phv00123814.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:21+00:00 2018-08-21 17:56:21+00:00 LANTI PreSleep: Antihistamines today? +74 Medication/supplement use 123815 phv00123815.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:26+00:00 2018-08-21 17:56:26+00:00 LBRON PreSleep: Bronchodilators today? +74 Medication/supplement use 123816 phv00123816.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:30+00:00 2018-08-21 17:56:30+00:00 LSPLPIL PreSleep: Sleeping Pill today? +74 Medication/supplement use 123817 phv00123817.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:35+00:00 2018-08-21 17:56:35+00:00 LDECON PreSleep: Decongestant today? +74 Medication/supplement use 123818 phv00123818.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:39+00:00 2018-08-21 17:56:39+00:00 LABOTHMD PreSleep: Other medication(s) today? +74 Medication/supplement use 123819 phv00123819.v1.p1 pht001902.v1.p1 phs000284.v1.p1 Cleveland Family Study 284 1 2018-08-21 17:56:45+00:00 2018-08-21 17:56:45+00:00 LOMED PreSleep: Specify other medication(s) today +74 Medication/supplement use 226253 phv00226253.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:09:18+00:00 2018-08-22 21:09:18+00:00 ASTHMA_MEDS Asthma Med Use - self/scanned (current asthma by MD diagnosis) +74 Medication/supplement use 226260 phv00226260.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:20:57+00:00 2018-08-22 21:20:57+00:00 COPD_MEDS COPD Med Use - self/scanned (ever COPD by MD diagnosis) +74 Medication/supplement use 114452 phv00114452.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:28:48+00:00 2018-08-22 21:28:48+00:00 B09BCCD3 MED CLASSIFICATION CODE 3 OF 3 +74 Medication/supplement use 114451 phv00114451.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:29:05+00:00 2018-08-22 21:29:05+00:00 B09BCCD2 MED CLASSIFICATION CODE 2 OF 3 +74 Medication/supplement use 114450 phv00114450.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:29:20+00:00 2018-08-22 21:29:20+00:00 B09BCCD1 MED CLASSIFICATION CODE 1 OF 3 +74 Medication/supplement use 114449 phv00114449.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:29:40+00:00 2018-08-22 21:29:40+00:00 B09BCN BRAND OF BIRTH CONTROL PILL +74 Medication/supplement use 114448 phv00114448.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:29:56+00:00 2018-08-22 21:29:56+00:00 B09ST_DT DATE LAST STOPPED BCP'S +74 Medication/supplement use 114458 phv00114458.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:32:17+00:00 2018-08-22 21:32:17+00:00 B09BCTMO DURATION OF BCP USE, MONTHS +74 Medication/supplement use 114457 phv00114457.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:32:42+00:00 2018-08-22 21:32:42+00:00 B09BCTYR DURATION OF BCP USE, YEARS +74 Medication/supplement use 114456 phv00114456.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:33:01+00:00 2018-08-22 21:33:01+00:00 B09BCTM1 DURATION OF BCP USE: EX-USERS, MONTHS +74 Medication/supplement use 114455 phv00114455.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:33:16+00:00 2018-08-22 21:33:16+00:00 B09BCTY1 DURATION OF BCP USE: EX-USERS, YEARS +74 Medication/supplement use 114454 phv00114454.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:33:52+00:00 2018-08-22 21:33:52+00:00 B09BCXD DATE LAST STOPPED BCP'S EXACT/APPX? +74 Medication/supplement use 114453 phv00114453.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:34:20+00:00 2018-08-22 21:34:20+00:00 B09BCNOW TAKING BCP MED NOW? +74 Medication/supplement use 114460 phv00114460.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:34:46+00:00 2018-08-22 21:34:46+00:00 B09BCCUS DURATION OF BCP USE, SINCE LAST STARTED +74 Medication/supplement use 114459 phv00114459.v2.p2 pht001611.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:36:57+00:00 2018-08-22 21:36:57+00:00 B09BCTUS B09BCTUS +74 Medication/supplement use 114464 phv00114464.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:39:40+00:00 2018-08-22 21:39:40+00:00 B09HBNM NAME OF HBP MED +74 Medication/supplement use 114462 phv00114462.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:40:46+00:00 2018-08-22 21:40:46+00:00 B09HBTUS TOTAL DURATION, HBP MED USE, MONTHS +74 Medication/supplement use 114468 phv00114468.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:40:59+00:00 2018-08-22 21:40:59+00:00 B09HBCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 114467 phv00114467.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:41:10+00:00 2018-08-22 21:41:10+00:00 B09HBCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 114466 phv00114466.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:41:28+00:00 2018-08-22 21:41:28+00:00 B09HBCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 114465 phv00114465.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:41:44+00:00 2018-08-22 21:41:44+00:00 B09HBCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 114463 phv00114463.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:42:15+00:00 2018-08-22 21:42:15+00:00 B09HBNUM MEDICATION NUMBER: HBP MED +74 Medication/supplement use 114472 phv00114472.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:43:25+00:00 2018-08-22 21:43:25+00:00 B09HBTMO DURATION OF HBP MED USE: MONTHS +74 Medication/supplement use 114471 phv00114471.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:44:00+00:00 2018-08-22 21:44:00+00:00 B09HBTYR DURATION OF HBP MED USE: YEARS +74 Medication/supplement use 114470 phv00114470.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:44:15+00:00 2018-08-22 21:44:15+00:00 B09HBLUS TIME SINCE LAST USED HBP MED +74 Medication/supplement use 114469 phv00114469.v2.p2 pht001612.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:44:27+00:00 2018-08-22 21:44:27+00:00 B09HBNOW TAKING HBP MED NOW? +74 Medication/supplement use 113156 phv00113156.v2.p2 pht001571.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:50:54+00:00 2018-08-22 21:50:54+00:00 A09MDNBR SEQUENCE NR FOR THIS MED TYPE +74 Medication/supplement use 226313 phv00226313.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:53:01+00:00 2018-08-22 21:53:01+00:00 MED_ANTIANGINAL Antianginals +74 Medication/supplement use 226314 phv00226314.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:53:18+00:00 2018-08-22 21:53:18+00:00 MED_ANTIANXI Antianxiety agents +74 Medication/supplement use 226315 phv00226315.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:53:26+00:00 2018-08-22 21:53:26+00:00 MED_ANTIARRHYTHMICS Antiarrhythmics +74 Medication/supplement use 226316 phv00226316.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:53:33+00:00 2018-08-22 21:53:33+00:00 MED_ANTIASTHMATICS Antiasthmatic or bronchodilator agents +74 Medication/supplement use 114480 phv00114480.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:53:35+00:00 2018-08-22 21:53:35+00:00 B09HMCD4 MED CLASSIFICATION CODE 4 OF 4. Q 4.03A +74 Medication/supplement use 226317 phv00226317.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:53:41+00:00 2018-08-22 21:53:41+00:00 MED_ANTICOAG Anticoagulants +74 Medication/supplement use 114479 phv00114479.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:53:47+00:00 2018-08-22 21:53:47+00:00 B09HMCD3 MED CLASSIFICATION CODE 3 OF 4. Q 4.03A +74 Medication/supplement use 226318 phv00226318.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:53:49+00:00 2018-08-22 21:53:49+00:00 MED_ANTICOAG_COUMARIN Coumarin anticoagulants +74 Medication/supplement use 114478 phv00114478.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:53:58+00:00 2018-08-22 21:53:58+00:00 B09HMCD2 MED CLASSIFICATION CODE 2 OF 4. Q 4.03A +74 Medication/supplement use 226319 phv00226319.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:53:58+00:00 2018-08-22 21:53:58+00:00 MED_ANTICOAG_HEPARIN Heparin anticoagulants +74 Medication/supplement use 226320 phv00226320.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:54:08+00:00 2018-08-22 21:54:08+00:00 MED_ANTIDEPRESS Antidepressants +74 Medication/supplement use 114477 phv00114477.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:54:10+00:00 2018-08-22 21:54:10+00:00 B09HMCD1 MED CLASSIFICATION CODE 1 OF 4. Q 4.03A +74 Medication/supplement use 114476 phv00114476.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:54:22+00:00 2018-08-22 21:54:22+00:00 B09HMNM NAME OF MED. Q 4.03A +74 Medication/supplement use 226321 phv00226321.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:54:22+00:00 2018-08-22 21:54:22+00:00 MED_ANTIDEPRE_SSRI Antidepressants - selective serotonin re-uptake inhibitors +74 Medication/supplement use 226322 phv00226322.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:54:30+00:00 2018-08-22 21:54:30+00:00 MED_ANTIDEPRE_TRICYC Antidepressants tricyclic antidepressants +74 Medication/supplement use 114475 phv00114475.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:54:35+00:00 2018-08-22 21:54:35+00:00 B09HMNUM MEDICATION NUMBER. Q 4.03A +74 Medication/supplement use 114474 phv00114474.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:54:49+00:00 2018-08-22 21:54:49+00:00 B09HMTUS TOTAL DURATION OF HORMONE USE, MONTHS +74 Medication/supplement use 226323 phv00226323.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:04+00:00 2018-08-22 21:55:04+00:00 MED_ANTIDIAB Antidiabetics +74 Medication/supplement use 226324 phv00226324.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:11+00:00 2018-08-22 21:55:11+00:00 MED_ANTIHYPERT Antihypertensives +74 Medication/supplement use 114485 phv00114485.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:55:16+00:00 2018-08-22 21:55:16+00:00 B09RESO REASON MEDICATION TAKEN +74 Medication/supplement use 226325 phv00226325.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:18+00:00 2018-08-22 21:55:18+00:00 MED_ANTIHYPERT_ACEI ACE inhibitors +74 Medication/supplement use 226326 phv00226326.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:25+00:00 2018-08-22 21:55:25+00:00 MED_ANTIHYPERT_AT2RAS Angiotensin II receptor antagonists +74 Medication/supplement use 114484 phv00114484.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:55:29+00:00 2018-08-22 21:55:29+00:00 B09HMTMO MOS USED MED. Q 4.03C +74 Medication/supplement use 226327 phv00226327.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:32+00:00 2018-08-22 21:55:32+00:00 MED_ANTIPLATELET Antiplatelets +74 Medication/supplement use 226328 phv00226328.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:39+00:00 2018-08-22 21:55:39+00:00 MED_ANTIPSYCHO Antipsychotics +74 Medication/supplement use 114483 phv00114483.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:55:43+00:00 2018-08-22 21:55:43+00:00 B09HMTYR YRS USED MED. Q 4.03C +74 Medication/supplement use 226329 phv00226329.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:46+00:00 2018-08-22 21:55:46+00:00 MED_ASPIRIN Aspirin-containing analgesics +74 Medication/supplement use 226330 phv00226330.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:52+00:00 2018-08-22 21:55:52+00:00 MED_BB Beta blockers +74 Medication/supplement use 114482 phv00114482.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:55:59+00:00 2018-08-22 21:55:59+00:00 B09HMLUS TIME SINCE LAST USED MED. Q 4.03B +74 Medication/supplement use 226331 phv00226331.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-22 21:55:59+00:00 2018-08-22 21:55:59+00:00 MED_BB_OPHTHALMIC Ophthalmic beta blockers +74 Medication/supplement use 114481 phv00114481.v2.p2 pht001613.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 21:56:10+00:00 2018-08-22 21:56:10+00:00 B09HMNOW TAKING MED NOW? Q 4.03A +74 Medication/supplement use 114497 phv00114497.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:23:31+00:00 2018-08-22 22:23:31+00:00 B09HTTMO DURATION OF HEART MED USE: MONTHS. Q 4.01C +74 Medication/supplement use 114496 phv00114496.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:23:39+00:00 2018-08-22 22:23:39+00:00 B09HTTYR DURATION OF HEART MED USE: YEARS. Q 4.01C +74 Medication/supplement use 114495 phv00114495.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:23:47+00:00 2018-08-22 22:23:47+00:00 B09HTLUS TIME SINCE LAST USED HEART MED. Q 4.01B +74 Medication/supplement use 114494 phv00114494.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:23:54+00:00 2018-08-22 22:23:54+00:00 B09HTNOW TAKING HEART MED NOW? Q 4.01A +74 Medication/supplement use 114493 phv00114493.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:24:02+00:00 2018-08-22 22:24:02+00:00 B09HTCD4 MED CLASSIFICATION CODE 4 OF 4. Q 4.01A +74 Medication/supplement use 114492 phv00114492.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:24:09+00:00 2018-08-22 22:24:09+00:00 B09HTCD3 MED CLASSIFICATION CODE 3 OF 4. Q 4.01A +74 Medication/supplement use 114491 phv00114491.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:24:15+00:00 2018-08-22 22:24:15+00:00 B09HTCD2 MED CLASSIFICATION CODE 2 OF 4. Q 4.01A +74 Medication/supplement use 114490 phv00114490.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:24:23+00:00 2018-08-22 22:24:23+00:00 B09HTCD1 MED CLASSIFICATION CODE 1 OF 4. Q 4.01A +74 Medication/supplement use 114489 phv00114489.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:24:30+00:00 2018-08-22 22:24:30+00:00 B09HTNM NAME OF HEART MED +74 Medication/supplement use 114488 phv00114488.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:24:37+00:00 2018-08-22 22:24:37+00:00 B09HTNUM MEDICATION NUMBER: HEART MED +74 Medication/supplement use 114487 phv00114487.v2.p2 pht001614.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:24:44+00:00 2018-08-22 22:24:44+00:00 B09HTTUS TOTAL DURATION, HEART MED USE, MONTHS +74 Medication/supplement use 114509 phv00114509.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:32:45+00:00 2018-08-22 22:32:45+00:00 B09OTTMO DURATION OF OTHER MED USE: MONTHS +74 Medication/supplement use 114508 phv00114508.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:32:54+00:00 2018-08-22 22:32:54+00:00 B09OTTYR DURATION OF OTHER MED USE: YEARS +74 Medication/supplement use 114507 phv00114507.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:33:01+00:00 2018-08-22 22:33:01+00:00 B09OTLUS TIME SINCE LAST USED THIS MED +74 Medication/supplement use 114506 phv00114506.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:33:10+00:00 2018-08-22 22:33:10+00:00 B09OTNOW TAKING OTHER MED NOW? +74 Medication/supplement use 114505 phv00114505.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:33:17+00:00 2018-08-22 22:33:17+00:00 B09OTCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 114504 phv00114504.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:33:24+00:00 2018-08-22 22:33:24+00:00 B09OTCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 114503 phv00114503.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:33:32+00:00 2018-08-22 22:33:32+00:00 B09OTCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 114502 phv00114502.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:33:40+00:00 2018-08-22 22:33:40+00:00 B09OTCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 114501 phv00114501.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:33:47+00:00 2018-08-22 22:33:47+00:00 B09OTNM NAME OF MED +74 Medication/supplement use 114500 phv00114500.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:33:55+00:00 2018-08-22 22:33:55+00:00 B09OTNUM MEDICATION NUMBER - PRESCRIPTION +74 Medication/supplement use 114499 phv00114499.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:34:02+00:00 2018-08-22 22:34:02+00:00 B09OTTUS TOTAL DURATION, OTHER MED USE, MONTHS +74 Medication/supplement use 114510 phv00114510.v2.p2 pht001615.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 22:36:11+00:00 2018-08-22 22:36:11+00:00 B09RESO B09RESO +74 Medication/supplement use 114997 phv00114997.v2.p2 pht001635.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:44:50+00:00 2018-08-22 23:44:50+00:00 B30LENGB LENGTH OF USE, IN DAYS, MED#2. Q 4 +74 Medication/supplement use 114996 phv00114996.v2.p2 pht001635.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:44:56+00:00 2018-08-22 23:44:56+00:00 B30NAMEB NAME OF MEDICATION #2. Q 4 +74 Medication/supplement use 114995 phv00114995.v2.p2 pht001635.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:45:05+00:00 2018-08-22 23:45:05+00:00 B30LENGA LENGTH OF USE, IN DAYS, MED #1. Q 4 +74 Medication/supplement use 114994 phv00114994.v2.p2 pht001635.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:45:12+00:00 2018-08-22 23:45:12+00:00 B30NAMEA NAME OF MED #1. Q 4 +74 Medication/supplement use 114993 phv00114993.v2.p2 pht001635.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-22 23:45:18+00:00 2018-08-22 23:45:18+00:00 B30APLMD APPLIED MED? Q 4 +74 Medication/supplement use 207844 phv00207844.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:52:39+00:00 2018-08-23 14:52:39+00:00 MSRA04AC [Medication records]. Medication A prescription type. Q4ac [Medication Survey Form, exam 1] +74 Medication/supplement use 207845 phv00207845.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:53:09+00:00 2018-08-23 14:53:09+00:00 MSRA04AD [Medication records]. Take medication A in past 24 hrs? Q4ad [Medication Survey Form, exam 1] +74 Medication/supplement use 207908 phv00207908.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:54:05+00:00 2018-08-23 14:54:05+00:00 MSRA04QC [Medication records]. Medication Q prescription type. Q4qc [Medication Survey Form, exam 1] +74 Medication/supplement use 207848 phv00207848.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:54:59+00:00 2018-08-23 14:54:59+00:00 MSRA04BC [Medication records]. Medication B prescription type. Q4bc [Medication Survey Form, exam 1] +74 Medication/supplement use 207849 phv00207849.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:55:19+00:00 2018-08-23 14:55:19+00:00 MSRA04BD [Medication records]. Take medication B in past 24 hrs? Q4bd [Medication Survey Form, exam 1] +74 Medication/supplement use 207852 phv00207852.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:55:42+00:00 2018-08-23 14:55:42+00:00 MSRA04CC [Medication records]. Medication C prescription type. Q4cc [Medication Survey Form, exam 1] +74 Medication/supplement use 207853 phv00207853.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:56:01+00:00 2018-08-23 14:56:01+00:00 MSRA04CD [Medication records]. Take medication C in past 24 hrs? Q4cd [Medication Survey Form, exam 1] +74 Medication/supplement use 207856 phv00207856.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:56:33+00:00 2018-08-23 14:56:33+00:00 MSRA04DC [Medication records]. Medication D prescription type. Q4dc [Medication Survey Form, exam 1] +74 Medication/supplement use 207857 phv00207857.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:56:57+00:00 2018-08-23 14:56:57+00:00 MSRA04DD [Medication records]. Take medication D in past 24 hrs? Q4dd [Medication Survey Form, exam 1] +74 Medication/supplement use 207860 phv00207860.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:57:23+00:00 2018-08-23 14:57:23+00:00 MSRA04EC [Medication records]. Medication E prescription type. Q4ec [Medication Survey Form, exam 1] +74 Medication/supplement use 207861 phv00207861.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 14:57:53+00:00 2018-08-23 14:57:53+00:00 MSRA04ED [Medication records]. Take medication E in past 24 hrs? Q4ed [Medication Survey Form, exam 1] +74 Medication/supplement use 207864 phv00207864.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:19:21+00:00 2018-08-23 15:19:21+00:00 MSRA04FC [Medication records]. Medication F prescription type. Q4fc [Medication Survey Form, exam 1] +74 Medication/supplement use 207865 phv00207865.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:19:37+00:00 2018-08-23 15:19:37+00:00 MSRA04FD [Medication records]. Take medication F in past 24 hrs? Q4fd [Medication Survey Form, exam 1] +74 Medication/supplement use 207868 phv00207868.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:21:18+00:00 2018-08-23 15:21:18+00:00 MSRA04GC [Medication records]. Medication G prescription type. Q4gc [Medication Survey Form, exam 1] +74 Medication/supplement use 207869 phv00207869.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:21:36+00:00 2018-08-23 15:21:36+00:00 MSRA04GD [Medication records]. Take medication G in past 24 hrs? Q4gd [Medication Survey Form, exam 1] +74 Medication/supplement use 207872 phv00207872.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:22:00+00:00 2018-08-23 15:22:00+00:00 MSRA04HC [Medication records]. Medication H prescription type. Q4hc [Medication Survey Form, exam 1] +74 Medication/supplement use 207873 phv00207873.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:22:15+00:00 2018-08-23 15:22:15+00:00 MSRA04HD [Medication records]. Take medication H in past 24 hrs? Q4hd [Medication Survey Form, exam 1] +74 Medication/supplement use 207876 phv00207876.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:22:31+00:00 2018-08-23 15:22:31+00:00 MSRA04IC [Medication records]. Medication I prescription type. Q4ic [Medication Survey Form, exam 1] +74 Medication/supplement use 207877 phv00207877.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:22:48+00:00 2018-08-23 15:22:48+00:00 MSRA04ID [Medication records]. Take medication I in past 24 hrs? Q4id [Medication Survey Form, exam 1] +74 Medication/supplement use 207880 phv00207880.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:23:07+00:00 2018-08-23 15:23:07+00:00 MSRA04JC [Medication records]. Medication J prescription type. Q4jc [Medication Survey Form, exam 1] +74 Medication/supplement use 207881 phv00207881.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:23:23+00:00 2018-08-23 15:23:23+00:00 MSRA04JD [Medication records]. Take medication J in past 24 hrs? Q4jd [Medication Survey Form, exam 1] +74 Medication/supplement use 207884 phv00207884.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:23:42+00:00 2018-08-23 15:23:42+00:00 MSRA04KC [Medication records]. Medication K prescription type. Q4kc [Medication Survey Form, exam 1] +74 Medication/supplement use 207885 phv00207885.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:24:00+00:00 2018-08-23 15:24:00+00:00 MSRA04KD [Medication records]. Take medication K in past 24 hrs? Q4kd [Medication Survey Form, exam 1] +74 Medication/supplement use 207888 phv00207888.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:24:33+00:00 2018-08-23 15:24:33+00:00 MSRA04LC [Medication records]. Medication L prescription type. Q4lc [Medication Survey Form, exam 1] +74 Medication/supplement use 207889 phv00207889.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:27:57+00:00 2018-08-23 15:27:57+00:00 MSRA04LD [Medication records]. Take medication L in past 24 hrs? Q4ld [Medication Survey Form, exam 1] +74 Medication/supplement use 207892 phv00207892.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:28:17+00:00 2018-08-23 15:28:17+00:00 MSRA04MC [Medication records]. Medication M prescription type. Q4mc [Medication Survey Form, exam 1] +74 Medication/supplement use 207893 phv00207893.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:28:41+00:00 2018-08-23 15:28:41+00:00 MSRA04MD [Medication records]. Take medication M in past 24 hrs? Q4md [Medication Survey Form, exam 1] +74 Medication/supplement use 207896 phv00207896.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:28:58+00:00 2018-08-23 15:28:58+00:00 MSRA04NC [Medication records]. Medication N prescription type. Q4nc [Medication Survey Form, exam 1] +74 Medication/supplement use 207897 phv00207897.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:29:16+00:00 2018-08-23 15:29:16+00:00 MSRA04ND [Medication records]. Take medication N in past 24 hrs? Q4nd [Medication Survey Form, exam 1] +74 Medication/supplement use 207900 phv00207900.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:29:35+00:00 2018-08-23 15:29:35+00:00 MSRA04OC [Medication records]. Medication O prescription type. Q4oc [Medication Survey Form, exam 1] +74 Medication/supplement use 207901 phv00207901.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:29:54+00:00 2018-08-23 15:29:54+00:00 MSRA04OD [Medication records]. Take medication O in past 24 hrs? Q4od [Medication Survey Form, exam 1] +74 Medication/supplement use 207904 phv00207904.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:30:13+00:00 2018-08-23 15:30:13+00:00 MSRA04PC [Medication records]. Medication P prescription type. Q4pc [Medication Survey Form, exam 1] +74 Medication/supplement use 207905 phv00207905.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:30:30+00:00 2018-08-23 15:30:30+00:00 MSRA04PD [Medication records]. Take medication P in past 24 hrs? Q4pd [Medication Survey Form, exam 1] +74 Medication/supplement use 207909 phv00207909.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:31:01+00:00 2018-08-23 15:31:01+00:00 MSRA04QD [Medication records]. Take medication Q in past 24 hrs? Q4qd [Medication Survey Form, exam 1] +74 Medication/supplement use 207931 phv00207931.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:34:59+00:00 2018-08-23 15:34:59+00:00 MSRB04C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q4C [Medication Survey Form, exam 2] +74 Medication/supplement use 207932 phv00207932.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:35:15+00:00 2018-08-23 15:35:15+00:00 MSRB04D [Medication records]. Did you take this medication in the past 24 hours? Q4D [Medication Survey Form, exam 2] +74 Medication/supplement use 207935 phv00207935.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:35:38+00:00 2018-08-23 15:35:38+00:00 MSRB05C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q5C [Medication Survey Form, exam 2] +74 Medication/supplement use 207936 phv00207936.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:36:01+00:00 2018-08-23 15:36:01+00:00 MSRB05D [Medication records]. Did you take this medication in the past 24 hours? Q5D [Medication Survey Form, exam 2] +74 Medication/supplement use 207939 phv00207939.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:36:43+00:00 2018-08-23 15:36:43+00:00 MSRB06C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q6C [Medication Survey Form, exam 2] +74 Medication/supplement use 207940 phv00207940.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:37:00+00:00 2018-08-23 15:37:00+00:00 MSRB06D [Medication records]. Did you take this medication in the past 24 hours? Q6D [Medication Survey Form, exam 2] +74 Medication/supplement use 207943 phv00207943.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:37:17+00:00 2018-08-23 15:37:17+00:00 MSRB07C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q7C [Medication Survey Form, exam 2] +74 Medication/supplement use 207944 phv00207944.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:37:34+00:00 2018-08-23 15:37:34+00:00 MSRB07D [Medication records]. Did you take this medication in the past 24 hours? Q7D [Medication Survey Form, exam 2] +74 Medication/supplement use 207947 phv00207947.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:37:51+00:00 2018-08-23 15:37:51+00:00 MSRB08C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q8C [Medication Survey Form, exam 2] +74 Medication/supplement use 207948 phv00207948.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:38:09+00:00 2018-08-23 15:38:09+00:00 MSRB08D [Medication records]. Did you take this medication in the past 24 hours? Q8D [Medication Survey Form, exam 2] +74 Medication/supplement use 207951 phv00207951.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:38:42+00:00 2018-08-23 15:38:42+00:00 MSRB09C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q9C [Medication Survey Form, exam 2] +74 Medication/supplement use 207952 phv00207952.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:39:00+00:00 2018-08-23 15:39:00+00:00 MSRB09D [Medication records]. Did you take this medication in the past 24 hours? Q9D [Medication Survey Form, exam 2] +74 Medication/supplement use 207955 phv00207955.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:39:19+00:00 2018-08-23 15:39:19+00:00 MSRB10C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q10C [Medication Survey Form, exam 2] +74 Medication/supplement use 207956 phv00207956.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:39:38+00:00 2018-08-23 15:39:38+00:00 MSRB10D [Medication records]. Did you take this medication in the past 24 hours? Q10D [Medication Survey Form, exam 2] +74 Medication/supplement use 207959 phv00207959.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:39:55+00:00 2018-08-23 15:39:55+00:00 MSRB11C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q11C [Medication Survey Form, exam 2] +74 Medication/supplement use 207960 phv00207960.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:40:11+00:00 2018-08-23 15:40:11+00:00 MSRB11D [Medication records]. Did you take this medication in the past 24 hours? Q11D [Medication Survey Form, exam 2] +74 Medication/supplement use 207963 phv00207963.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:40:28+00:00 2018-08-23 15:40:28+00:00 MSRB12C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q12C [Medication Survey Form, exam 2] +74 Medication/supplement use 207964 phv00207964.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:40:49+00:00 2018-08-23 15:40:49+00:00 MSRB12D [Medication records]. Did you take this medication in the past 24 hours? Q12D [Medication Survey Form, exam 2] +74 Medication/supplement use 207967 phv00207967.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:41:16+00:00 2018-08-23 15:41:16+00:00 MSRB13C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q13C [Medication Survey Form, exam 2] +74 Medication/supplement use 207968 phv00207968.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:41:31+00:00 2018-08-23 15:41:31+00:00 MSRB13D [Medication records]. Did you take this medication in the past 24 hours? Q13D [Medication Survey Form, exam 2] +74 Medication/supplement use 207971 phv00207971.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:41:50+00:00 2018-08-23 15:41:50+00:00 MSRB14C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q14C [Medication Survey Form, exam 2] +74 Medication/supplement use 207972 phv00207972.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:42:12+00:00 2018-08-23 15:42:12+00:00 MSRB14D [Medication records]. Did you take this medication in the past 24 hours? Q14D [Medication Survey Form, exam 2] +74 Medication/supplement use 207975 phv00207975.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:42:43+00:00 2018-08-23 15:42:43+00:00 MSRB15C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q15C [Medication Survey Form, exam 2] +74 Medication/supplement use 207976 phv00207976.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:42:58+00:00 2018-08-23 15:42:58+00:00 MSRB15D [Medication records]. Did you take this medication in the past 24 hours? Q15D [Medication Survey Form, exam 2] +74 Medication/supplement use 207979 phv00207979.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:43:15+00:00 2018-08-23 15:43:15+00:00 MSRB16C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q16C [Medication Survey Form, exam 2] +74 Medication/supplement use 207980 phv00207980.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:43:33+00:00 2018-08-23 15:43:33+00:00 MSRB16D [Medication records]. Did you take this medication in the past 24 hours? Q16D [Medication Survey Form, exam 2] +74 Medication/supplement use 207983 phv00207983.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:44:00+00:00 2018-08-23 15:44:00+00:00 MSRB17C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q17C [Medication Survey Form, exam 2] +74 Medication/supplement use 207984 phv00207984.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:44:16+00:00 2018-08-23 15:44:16+00:00 MSRB17D [Medication records]. Did you take this medication in the past 24 hours? Q17D [Medication Survey Form, exam 2] +74 Medication/supplement use 207987 phv00207987.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:44:33+00:00 2018-08-23 15:44:33+00:00 MSRB18C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q18C [Medication Survey Form, exam 2] +74 Medication/supplement use 207988 phv00207988.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:44:48+00:00 2018-08-23 15:44:48+00:00 MSRB18D [Medication records]. Did you take this medication in the past 24 hours? Q18D [Medication Survey Form, exam 2] +74 Medication/supplement use 207991 phv00207991.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:45:03+00:00 2018-08-23 15:45:03+00:00 MSRB19C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q19C [Medication Survey Form, exam 2] +74 Medication/supplement use 207992 phv00207992.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:45:17+00:00 2018-08-23 15:45:17+00:00 MSRB19D [Medication records]. Did you take this medication in the past 24 hours? Q19D [Medication Survey Form, exam 2] +74 Medication/supplement use 207995 phv00207995.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:45:35+00:00 2018-08-23 15:45:35+00:00 MSRB20C [Medication records]. Was this medication prescribed for you, over-the-counter, or shared? Q20C [Medication Survey Form, exam 2] +74 Medication/supplement use 207996 phv00207996.v1.p1 pht004130.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:45:52+00:00 2018-08-23 15:45:52+00:00 MSRB20D [Medication records]. Did you take this medication in the past 24 hours? Q20D [Medication Survey Form, exam 2] +74 Medication/supplement use 208018 phv00208018.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:47:03+00:00 2018-08-23 15:47:03+00:00 MSRC4D [Medication records]. Did you take this medication in the past 24 hours? Q4d [Medication Survey Form, exam 3] +74 Medication/supplement use 208021 phv00208021.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:48:15+00:00 2018-08-23 15:48:15+00:00 MSRC5D [Medication records]. Did you take this medication in the past 24 hours? Q5d [Medication Survey Form, exam 3] +74 Medication/supplement use 208024 phv00208024.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:48:28+00:00 2018-08-23 15:48:28+00:00 MSRC6D [Medication records]. Did you take this medication in the past 24 hours? Q6d [Medication Survey Form, exam 3] +74 Medication/supplement use 208027 phv00208027.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:49:12+00:00 2018-08-23 15:49:12+00:00 MSRC7D [Medication records]. Did you take this medication in the past 24 hours? Q7d [Medication Survey Form, exam 3] +74 Medication/supplement use 208030 phv00208030.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:49:32+00:00 2018-08-23 15:49:32+00:00 MSRC8D [Medication records]. Did you take this medication in the past 24 hours? Q8d [Medication Survey Form, exam 3] +74 Medication/supplement use 208033 phv00208033.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:49:47+00:00 2018-08-23 15:49:47+00:00 MSRC9D [Medication records]. Did you take this medication in the past 24 hours? Q9d [Medication Survey Form, exam 3] +74 Medication/supplement use 208036 phv00208036.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:50:01+00:00 2018-08-23 15:50:01+00:00 MSRC10D [Medication records]. Did you take this medication in the past 24 hours? Q10d [Medication Survey Form, exam 3] +74 Medication/supplement use 208039 phv00208039.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:55:04+00:00 2018-08-23 15:55:04+00:00 MSRC11D [Medication records]. Did you take this medication in the past 24 hours? Q11d [Medication Survey Form, exam 3] +74 Medication/supplement use 208042 phv00208042.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:55:23+00:00 2018-08-23 15:55:23+00:00 MSRC12D [Medication records]. Did you take this medication in the past 24 hours? Q12d [Medication Survey Form, exam 3] +74 Medication/supplement use 208045 phv00208045.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:55:41+00:00 2018-08-23 15:55:41+00:00 MSRC13D [Medication records]. Did you take this medication in the past 24 hours? Q13d [Medication Survey Form, exam 3] +74 Medication/supplement use 208048 phv00208048.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 15:56:07+00:00 2018-08-23 15:56:07+00:00 MSRC14D [Medication records]. Did you take this medication in the past 24 hours? Q14d [Medication Survey Form, exam 3] +74 Medication/supplement use 208051 phv00208051.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:29:11+00:00 2018-08-23 16:29:11+00:00 MSRC15D [Medication records]. Did you take this medication in the past 24 hours? Q15d [Medication Survey Form, exam 3] +74 Medication/supplement use 208054 phv00208054.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:29:28+00:00 2018-08-23 16:29:28+00:00 MSRC16D [Medication records]. Did you take this medication in the past 24 hours? Q16d [Medication Survey Form, exam 3] +74 Medication/supplement use 208057 phv00208057.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:29:47+00:00 2018-08-23 16:29:47+00:00 MSRC17D [Medication records]. Did you take this medication in the past 24 hours? Q17d [Medication Survey Form, exam 3] +74 Medication/supplement use 208060 phv00208060.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:30:10+00:00 2018-08-23 16:30:10+00:00 MSRC18D [Medication records]. Did you take this medication in the past 24 hours? Q18d [Medication Survey Form, exam 3] +74 Medication/supplement use 208063 phv00208063.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:30:32+00:00 2018-08-23 16:30:32+00:00 MSRC19D [Medication records]. Did you take this medication in the past 24 hours? Q19d [Medication Survey Form, exam 3] +74 Medication/supplement use 208066 phv00208066.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:30:54+00:00 2018-08-23 16:30:54+00:00 MSRC20D [Medication records]. Did you take this medication in the past 24 hours? Q20d [Medication Survey Form, exam 3] +74 Medication/supplement use 208077 phv00208077.v1.p1 pht004131.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:32:04+00:00 2018-08-23 16:32:04+00:00 MSRC27 [Interview]. For what purpose are you taking aspirin? Q27 [Medication Survey Form, exam 3] +74 Medication/supplement use 208231 phv00208231.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:33:42+00:00 2018-08-23 16:33:42+00:00 MSRD4D [Medication records]. Did you take this medication in the past 24 hours? Q4d [Medication Survey Form, exam 4] +74 Medication/supplement use 208235 phv00208235.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:34:05+00:00 2018-08-23 16:34:05+00:00 MSRD5D [Medication records]. Did you take this medication in the past 24 hours? Q5d [Medication Survey Form, exam 4] +74 Medication/supplement use 208239 phv00208239.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:34:22+00:00 2018-08-23 16:34:22+00:00 MSRD6D [Medication records]. Did you take this medication in the past 24 hours? Q6d [Medication Survey Form, exam 4] +74 Medication/supplement use 208243 phv00208243.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:36:58+00:00 2018-08-23 16:36:58+00:00 MSRD7D [Medication records]. Did you take this medication in the past 24 hours? Q7d [Medication Survey Form, exam 4] +74 Medication/supplement use 208247 phv00208247.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:37:16+00:00 2018-08-23 16:37:16+00:00 MSRD8D [Medication records]. Did you take this medication in the past 24 hours? Q8d [Medication Survey Form, exam 4] +74 Medication/supplement use 208251 phv00208251.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:37:43+00:00 2018-08-23 16:37:43+00:00 MSRD9D [Medication records]. Did you take this medication in the past 24 hours? Q9d [Medication Survey Form, exam 4] +74 Medication/supplement use 208255 phv00208255.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:38:08+00:00 2018-08-23 16:38:08+00:00 MSRD10D [Medication records]. Did you take this medication in the past 24 hours? Q10d [Medication Survey Form, exam 4] +74 Medication/supplement use 208259 phv00208259.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:38:28+00:00 2018-08-23 16:38:28+00:00 MSRD11D [Medication records]. Did you take this medication in the past 24 hours? Q11d [Medication Survey Form, exam 4] +74 Medication/supplement use 208263 phv00208263.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:38:46+00:00 2018-08-23 16:38:46+00:00 MSRD12D [Medication records]. Did you take this medication in the past 24 hours? Q12d [Medication Survey Form, exam 4] +74 Medication/supplement use 208267 phv00208267.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:39:10+00:00 2018-08-23 16:39:10+00:00 MSRD13D [Medication records]. Did you take this medication in the past 24 hours? Q13d [Medication Survey Form, exam 4] +74 Medication/supplement use 208271 phv00208271.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:39:25+00:00 2018-08-23 16:39:25+00:00 MSRD14D [Medication records]. Did you take this medication in the past 24 hours? Q14d [Medication Survey Form, exam 4] +74 Medication/supplement use 208275 phv00208275.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:39:41+00:00 2018-08-23 16:39:41+00:00 MSRD15D [Medication records]. Did you take this medication in the past 24 hours? Q15d [Medication Survey Form, exam 4] +74 Medication/supplement use 208279 phv00208279.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:39:57+00:00 2018-08-23 16:39:57+00:00 MSRD16D [Medication records]. Did you take this medication in the past 24 hours? Q16d [Medication Survey Form, exam 4] +74 Medication/supplement use 208283 phv00208283.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:40:12+00:00 2018-08-23 16:40:12+00:00 MSRD17D [Medication records]. Did you take this medication in the past 24 hours? Q17d [Medication Survey Form, exam 4] +74 Medication/supplement use 208287 phv00208287.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:40:28+00:00 2018-08-23 16:40:28+00:00 MSRD18D [Medication records]. Did you take this medication in the past 24 hours? Q18d [Medication Survey Form, exam 4] +74 Medication/supplement use 208291 phv00208291.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:40:45+00:00 2018-08-23 16:40:45+00:00 MSRD19D [Medication records]. Did you take this medication in the past 24 hours? Q19d [Medication Survey Form, exam 4] +74 Medication/supplement use 208295 phv00208295.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:41:16+00:00 2018-08-23 16:41:16+00:00 MSRD20D [Medication records]. Did you take this medication in the past 24 hours? Q20d [Medication Survey Form, exam 4] +74 Medication/supplement use 208306 phv00208306.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:41:54+00:00 2018-08-23 16:41:54+00:00 MSRD27 [Interview]. For what purpose are you taking aspirin? Q27 [Medication Survey Form, exam 4] +74 Medication/supplement use 208310 phv00208310.v1.p1 pht004136.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-08-23 16:42:26+00:00 2018-08-23 16:42:26+00:00 MSRD29D [Interview]. For what purpose are you taking this medication? Q29d [Medication Survey Form, exam 4] +74 Medication/supplement use 115487 phv00115487.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 16:59:45+00:00 2018-08-23 16:59:45+00:00 C08HMNOW TAKING HORMONES OTHER THAN BCP. Q 17 +74 Medication/supplement use 115486 phv00115486.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 16:59:52+00:00 2018-08-23 16:59:52+00:00 C08BCNOW CURRENTLY USING BCP. Q 16 +74 Medication/supplement use 115479 phv00115479.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:00:00+00:00 2018-08-23 17:00:00+00:00 C08OTMED CURRENTLY TAKING OTHER PRSCR MEDICATION. Q 13 +74 Medication/supplement use 115478 phv00115478.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:00:07+00:00 2018-08-23 17:00:07+00:00 C08ASMA CURRENTLY TAKING ASTHMA MEDICATION. Q 12 +74 Medication/supplement use 115477 phv00115477.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:00:13+00:00 2018-08-23 17:00:13+00:00 C08CHNOW CURRENTLY TAKING CHOLESTEROL MEDICATION. Q 11 +74 Medication/supplement use 115476 phv00115476.v2.p2 pht001656.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:00:21+00:00 2018-08-23 17:00:21+00:00 C08HBNOW CURRENTLY TAKING HBP MEDICATION. Q 10 +74 Medication/supplement use 115495 phv00115495.v2.p2 pht001657.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:10:06+00:00 2018-08-23 17:10:06+00:00 C09ASCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 115494 phv00115494.v2.p2 pht001657.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:10:12+00:00 2018-08-23 17:10:12+00:00 C09ASCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 115493 phv00115493.v2.p2 pht001657.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:10:19+00:00 2018-08-23 17:10:19+00:00 C09ASCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 115492 phv00115492.v2.p2 pht001657.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:10:26+00:00 2018-08-23 17:10:26+00:00 C09ASCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 115491 phv00115491.v2.p2 pht001657.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:10:33+00:00 2018-08-23 17:10:33+00:00 C09ASNM NAME OF ASTHMA MEDICATION +74 Medication/supplement use 115490 phv00115490.v2.p2 pht001657.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:10:40+00:00 2018-08-23 17:10:40+00:00 C09ASNUM MEDICATION NUMBER :ASTHMA +74 Medication/supplement use 115506 phv00115506.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:11:20+00:00 2018-08-23 17:11:20+00:00 C09BCCUS DURATION OF BCP USE, SINCE LAST STARTED +74 Medication/supplement use 115505 phv00115505.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:11:27+00:00 2018-08-23 17:11:27+00:00 C09BCTUS DURATION OF BCP USE, SINCE FIRST STARTED +74 Medication/supplement use 115504 phv00115504.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:11:34+00:00 2018-08-23 17:11:34+00:00 C09BCTMO DURATION OF BCP USE, MONTHS +74 Medication/supplement use 115503 phv00115503.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:11:42+00:00 2018-08-23 17:11:42+00:00 C09BCTYR DURATION OF BCP USE, YEARS +74 Medication/supplement use 115502 phv00115502.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:11:50+00:00 2018-08-23 17:11:50+00:00 C09BCTM1 DURATION OF BCP USE: EX-USERS, MONTHS +74 Medication/supplement use 115501 phv00115501.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:11:57+00:00 2018-08-23 17:11:57+00:00 C09BCTY1 DURATION OF BCP USE: EX-USERS, YEARS +74 Medication/supplement use 115500 phv00115500.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:12:05+00:00 2018-08-23 17:12:05+00:00 C09BCCD3 MED CLASSIFICATION CODE 3 OF 3 +74 Medication/supplement use 115499 phv00115499.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:12:13+00:00 2018-08-23 17:12:13+00:00 C09BCCD2 MED CLASSIFICATION CODE 2 OF 3 +74 Medication/supplement use 115498 phv00115498.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:12:20+00:00 2018-08-23 17:12:20+00:00 C09BCCD1 MED CLASSIFICATION CODE 1 OF 3 +74 Medication/supplement use 115497 phv00115497.v2.p2 pht001658.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:12:27+00:00 2018-08-23 17:12:27+00:00 C09BCNAM BRAND OF BIRTH CONTROL PILL +74 Medication/supplement use 115514 phv00115514.v1.p2 pht001659.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:12:57+00:00 2018-08-23 17:12:57+00:00 C09CHCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 115513 phv00115513.v1.p2 pht001659.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:13:04+00:00 2018-08-23 17:13:04+00:00 C09CHCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 115512 phv00115512.v1.p2 pht001659.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:13:13+00:00 2018-08-23 17:13:13+00:00 C09CHCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 115511 phv00115511.v1.p2 pht001659.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:13:20+00:00 2018-08-23 17:13:20+00:00 C09CHCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 115510 phv00115510.v1.p2 pht001659.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:13:27+00:00 2018-08-23 17:13:27+00:00 C09CHNM NAME OF CHOL LOWERING MEDICATION. Q 11a +74 Medication/supplement use 115509 phv00115509.v1.p2 pht001659.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:13:34+00:00 2018-08-23 17:13:34+00:00 C09CHNUM MEDICATION NUMBER: CHOL LOWERING MED +74 Medication/supplement use 115522 phv00115522.v2.p2 pht001660.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:13:59+00:00 2018-08-23 17:13:59+00:00 C09HBCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 115521 phv00115521.v2.p2 pht001660.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:14:06+00:00 2018-08-23 17:14:06+00:00 C09HBCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 115520 phv00115520.v2.p2 pht001660.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:14:13+00:00 2018-08-23 17:14:13+00:00 C09HBCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 115519 phv00115519.v2.p2 pht001660.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:14:21+00:00 2018-08-23 17:14:21+00:00 C09HBCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 115518 phv00115518.v2.p2 pht001660.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:14:28+00:00 2018-08-23 17:14:28+00:00 C09HBNM NAME OF HBP MEDICATION. Q 10a +74 Medication/supplement use 115517 phv00115517.v2.p2 pht001660.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:14:36+00:00 2018-08-23 17:14:36+00:00 C09HBNUM MEDICATION NUMBER: HBP MED +74 Medication/supplement use 115530 phv00115530.v1.p2 pht001661.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:15:00+00:00 2018-08-23 17:15:00+00:00 C09HMCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 115529 phv00115529.v1.p2 pht001661.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:15:08+00:00 2018-08-23 17:15:08+00:00 C09HMCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 115528 phv00115528.v1.p2 pht001661.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:15:16+00:00 2018-08-23 17:15:16+00:00 C09HMCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 115527 phv00115527.v1.p2 pht001661.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:15:23+00:00 2018-08-23 17:15:23+00:00 C09HMCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 115526 phv00115526.v1.p2 pht001661.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:15:30+00:00 2018-08-23 17:15:30+00:00 C09HMNM NAME OF HORMONE MEDICATION. Q 17a +74 Medication/supplement use 115525 phv00115525.v1.p2 pht001661.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:15:38+00:00 2018-08-23 17:15:38+00:00 C09HMNUM MEDICATION NUMBER: HORMONES +74 Medication/supplement use 115538 phv00115538.v2.p2 pht001662.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:16:10+00:00 2018-08-23 17:16:10+00:00 C09OTCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 115537 phv00115537.v2.p2 pht001662.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:16:18+00:00 2018-08-23 17:16:18+00:00 C09OTCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 115536 phv00115536.v2.p2 pht001662.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:16:25+00:00 2018-08-23 17:16:25+00:00 C09OTCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 115535 phv00115535.v2.p2 pht001662.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:16:33+00:00 2018-08-23 17:16:33+00:00 C09OTCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 115534 phv00115534.v2.p2 pht001662.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:16:41+00:00 2018-08-23 17:16:41+00:00 C09OTNM NAME OF 'OTHER'MEDICATION. Q 13a +74 Medication/supplement use 115533 phv00115533.v2.p2 pht001662.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 17:16:52+00:00 2018-08-23 17:16:52+00:00 C09OTNUM MEDICATION NUMBER - PRESCRIPTION +74 Medication/supplement use 116463 phv00116463.v2.p2 pht001704.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:23:55+00:00 2018-08-23 19:23:55+00:00 D47Q10A Q10A: MEDICATION 1 +74 Medication/supplement use 116448 phv00116448.v2.p2 pht001704.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:24:01+00:00 2018-08-23 19:24:01+00:00 D47Q10 Q10: TAKE MEDICATION DURING COLLECTION? +74 Medication/supplement use 116468 phv00116468.v2.p2 pht001704.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:24:17+00:00 2018-08-23 19:24:17+00:00 D47Q10F Q10F: MEDICATION 6 +74 Medication/supplement use 116467 phv00116467.v2.p2 pht001704.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:24:24+00:00 2018-08-23 19:24:24+00:00 D47Q10E Q10E: MEDICATION 5 +74 Medication/supplement use 116466 phv00116466.v2.p2 pht001704.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:24:31+00:00 2018-08-23 19:24:31+00:00 D47Q10D Q10D: MEDICATION 4 +74 Medication/supplement use 116465 phv00116465.v2.p2 pht001704.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:24:38+00:00 2018-08-23 19:24:38+00:00 D47Q10C Q10C: MEDICATION 3 +74 Medication/supplement use 116464 phv00116464.v2.p2 pht001704.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-23 19:24:44+00:00 2018-08-23 19:24:44+00:00 D47Q10B Q10B: MEDICATION 2 +74 Medication/supplement use 117068 phv00117068.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:22:05+00:00 2018-08-24 00:22:05+00:00 D08ASP TAKE ASPIRIN 3 TIMES/WK? Q 26 +74 Medication/supplement use 117067 phv00117067.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:22:12+00:00 2018-08-24 00:22:12+00:00 D08OTMED CURRENTLY TAKING ANY OTHER MEDS. Q 25 +74 Medication/supplement use 117066 phv00117066.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:22:19+00:00 2018-08-24 00:22:19+00:00 D08ASMA CURRENTLY TAKING MEDS FOR ASTHMA. Q 24 +74 Medication/supplement use 117065 phv00117065.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:22:26+00:00 2018-08-24 00:22:26+00:00 D08CHNOW CURRENTLY TAKING MEDS TO LOWER CHOLEST. Q 23 +74 Medication/supplement use 117064 phv00117064.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:22:33+00:00 2018-08-24 00:22:33+00:00 D08HBNOW CURRENTLY TAKING MEDS FOR HBP. Q 22 +74 Medication/supplement use 117106 phv00117106.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:23:48+00:00 2018-08-24 00:23:48+00:00 D08HMNOW CURRENTLY TAKING HORMONES EXCLUDING BCP? Q 43 +74 Medication/supplement use 117105 phv00117105.v2.p2 pht001715.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:23:55+00:00 2018-08-24 00:23:55+00:00 D08BCNOW CURRENTLY TAKING BC PILLS? Q 42 +74 Medication/supplement use 117141 phv00117141.v2.p2 pht001717.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:40:55+00:00 2018-08-24 00:40:55+00:00 D10PATCH NOW USING A NICOTINE PATCH? Q 7 +74 Medication/supplement use 120070 phv00120070.v2.p2 pht001818.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:41:02+00:00 2018-08-24 00:41:02+00:00 F10GUMWK USED NICOTINE GUM IN PAST WEEK. Q 6 +74 Medication/supplement use 120069 phv00120069.v2.p2 pht001818.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:41:09+00:00 2018-08-24 00:41:09+00:00 F10GUMEV EVER USED NICOTINE GUM? Q 6 +74 Medication/supplement use 118770 phv00118770.v2.p2 pht001778.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:41:16+00:00 2018-08-24 00:41:16+00:00 E10GUMWK USED NICOTINE GUM IN PAST WEEK. Q 6 +74 Medication/supplement use 118769 phv00118769.v2.p2 pht001778.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:41:23+00:00 2018-08-24 00:41:23+00:00 E10GUMEV EVER USED NICOTINE GUM? Q 6 +74 Medication/supplement use 117140 phv00117140.v2.p2 pht001717.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:41:30+00:00 2018-08-24 00:41:30+00:00 D10GUM CURRENTLY USES NICOTINE GUM. Q 6 +74 Medication/supplement use 115586 phv00115586.v2.p2 pht001665.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:41:38+00:00 2018-08-24 00:41:38+00:00 C10GUM CURRENTLY USES NICOTINE GUM. Q 6 +74 Medication/supplement use 114576 phv00114576.v2.p2 pht001625.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:41:44+00:00 2018-08-24 00:41:44+00:00 B10GUM HAS USED NICOTINE GUM. Q 6 +74 Medication/supplement use 113217 phv00113217.v2.p2 pht001573.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:41:53+00:00 2018-08-24 00:41:53+00:00 A10GUM SUBJECT HAS USED NICOTINE GUM. Q 6 +74 Medication/supplement use 120078 phv00120078.v2.p2 pht001818.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:42:40+00:00 2018-08-24 00:42:40+00:00 F10PATWK USED NICOTINE PATCH IN PAST WEEK +74 Medication/supplement use 120071 phv00120071.v2.p2 pht001818.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:42:47+00:00 2018-08-24 00:42:47+00:00 F10PATEV EVER USED NICOTINE PATCH? Q 7 +74 Medication/supplement use 118772 phv00118772.v2.p2 pht001778.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:42:54+00:00 2018-08-24 00:42:54+00:00 E10PATWK USED NICOTINE PATCH IN PAST WEEK. Q 7 +74 Medication/supplement use 118771 phv00118771.v2.p2 pht001778.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 00:43:00+00:00 2018-08-24 00:43:00+00:00 E10PATEV EVER USED NICOTINE PATCH? Q 7 +74 Medication/supplement use 226332 phv00226332.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:21:51+00:00 2018-08-24 16:21:51+00:00 MED_CACB Calcium channel blockers +74 Medication/supplement use 226333 phv00226333.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:21:59+00:00 2018-08-24 16:21:59+00:00 MED_CARDIACGLYCOSIDES Cardiac glycosides +74 Medication/supplement use 226334 phv00226334.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:22:06+00:00 2018-08-24 16:22:06+00:00 MED_CHEMO Chemotherapy +74 Medication/supplement use 226335 phv00226335.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:22:12+00:00 2018-08-24 16:22:12+00:00 MED_CLOPID Clopidogrel (Plavix) +74 Medication/supplement use 226336 phv00226336.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:22:19+00:00 2018-08-24 16:22:19+00:00 MED_CONTRACEPTIVES Contraceptives +74 Medication/supplement use 226337 phv00226337.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:22:25+00:00 2018-08-24 16:22:25+00:00 MED_COX2 COX-2 inhibitors +74 Medication/supplement use 226338 phv00226338.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:22:31+00:00 2018-08-24 16:22:31+00:00 MED_CURRENT_HRT Any hormone repl. therapy +74 Medication/supplement use 226339 phv00226339.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:22:37+00:00 2018-08-24 16:22:37+00:00 MED_DIURETIC Diuretics +74 Medication/supplement use 226340 phv00226340.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:22:44+00:00 2018-08-24 16:22:44+00:00 MED_DIURETIC_THIAZIDE Thiazide diuretics +74 Medication/supplement use 226341 phv00226341.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:22:50+00:00 2018-08-24 16:22:50+00:00 MED_ESTROGENS Estrogens +74 Medication/supplement use 226342 phv00226342.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:08+00:00 2018-08-24 16:23:08+00:00 MED_ESTROGEN_COMBO Estrogens - combinations only +74 Medication/supplement use 226343 phv00226343.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:14+00:00 2018-08-24 16:23:14+00:00 MED_FERTILITY_REG Fertility regulators +74 Medication/supplement use 226344 phv00226344.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:22+00:00 2018-08-24 16:23:22+00:00 MED_FIBARES_NICOACID Fibric/nicotinic acids (trt of TG and HDL) +74 Medication/supplement use 226345 phv00226345.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:28+00:00 2018-08-24 16:23:28+00:00 MED_INSULIN Insulins +74 Medication/supplement use 226346 phv00226346.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:34+00:00 2018-08-24 16:23:34+00:00 MED_LHRH LHRH/GnRH only +74 Medication/supplement use 226347 phv00226347.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:40+00:00 2018-08-24 16:23:40+00:00 MED_LHRH_AG LHRH/GnRH agonist analog +74 Medication/supplement use 226348 phv00226348.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:46+00:00 2018-08-24 16:23:46+00:00 MED_LHRH_ANT LHRH/GnRH antagonists +74 Medication/supplement use 226349 phv00226349.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:52+00:00 2018-08-24 16:23:52+00:00 MED_LLD Lipid lowering drugs/antihyperlipidemics (LLD) +74 Medication/supplement use 226350 phv00226350.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:23:57+00:00 2018-08-24 16:23:57+00:00 MED_METFORMIN Metformins +74 Medication/supplement use 226351 phv00226351.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:24:17+00:00 2018-08-24 16:24:17+00:00 MED_NSAID NSAIDs +74 Medication/supplement use 226352 phv00226352.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:24:22+00:00 2018-08-24 16:24:22+00:00 MED_OI_STEROID Oral/inhalantable glucocorticorsteroids +74 Medication/supplement use 226353 phv00226353.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:24:28+00:00 2018-08-24 16:24:28+00:00 MED_PROGESTINS Progestins +74 Medication/supplement use 226354 phv00226354.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:24:34+00:00 2018-08-24 16:24:34+00:00 MED_PULMONARY Pulmonary medication +74 Medication/supplement use 226355 phv00226355.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:24:40+00:00 2018-08-24 16:24:40+00:00 MED_SERM Selective estrogen receptor modulators +74 Medication/supplement use 226356 phv00226356.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:24:48+00:00 2018-08-24 16:24:48+00:00 MED_STATIN Statins +74 Medication/supplement use 226361 phv00226361.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:25:59+00:00 2018-08-24 16:25:59+00:00 MHEA16D Diabetes - insulin Trt for diabetes self (MHEA16D) +74 Medication/supplement use 226360 phv00226360.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:26:30+00:00 2018-08-24 16:26:30+00:00 MHEA16C Diabetes - insulin TrtSelf (MHEA16C) +74 Medication/supplement use 258039 phv00258039.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:55:04+00:00 2018-08-24 16:55:04+00:00 HYPERT_TREATMENT Treatment of hypertension - NHANES +74 Medication/supplement use 258052 phv00258052.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:56:55+00:00 2018-08-24 16:56:55+00:00 ELEVATED_BP_PLUSMEDS Elevated blood pressure or antihypert med use +74 Medication/supplement use 258053 phv00258053.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:57:17+00:00 2018-08-24 16:57:17+00:00 HIGH_TRIG_PLUSMEDS High triglycerides or fibares nicoacid med use +74 Medication/supplement use 258054 phv00258054.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:57:23+00:00 2018-08-24 16:57:23+00:00 LOW_HDL_PLUSMEDS Low HDL or fibares nicoacid med use +74 Medication/supplement use 258055 phv00258055.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 16:57:29+00:00 2018-08-24 16:57:29+00:00 ELEVATED_BP_SELFMEDS Elevated blood pressure or self-reported antihypert med use +74 Medication/supplement use 258083 phv00258083.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:03:57+00:00 2018-08-24 17:03:57+00:00 RSEA37 Medical treatment: asthma in 12 months (RSEA37) +74 Medication/supplement use 258104 phv00258104.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:05:24+00:00 2018-08-24 17:05:24+00:00 SLEA8 Take sleeping pills (SLEA8) +74 Medication/supplement use 258117 phv00258117.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:08:18+00:00 2018-08-24 17:08:18+00:00 THIAZIDE Thiazide diuretic: 1=Reported taking thiazide diuretic, 0=Not exposed +74 Medication/supplement use 258118 phv00258118.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:08:23+00:00 2018-08-24 17:08:23+00:00 TCA Tri & tetracyclic antidepressant: 1=Reported taking tri & tetracyclic antidepressant, 0=Not exposed +74 Medication/supplement use 258119 phv00258119.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:08:33+00:00 2018-08-24 17:08:33+00:00 SULFON Sulfonylurea: 1=Reported taking sulfonylurea, 0=Not exposed +74 Medication/supplement use 258120 phv00258120.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:08:40+00:00 2018-08-24 17:08:40+00:00 ORAL_BB Oral/parental beta blockers: 1=Reported taking oral/parental beta blockers, 0=Not exposed +74 Medication/supplement use 258121 phv00258121.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:08:47+00:00 2018-08-24 17:08:47+00:00 DILTIAZEM Diltiazem: 1=Reported taking diltiazem, 0=Not Exposed +74 Medication/supplement use 258122 phv00258122.v1.p1 pht004715.v1.p1 phs000810.v1.p1 Hispanic Community Health Study /Study of Latinos (HCHS/SOL) 810 1 2018-08-24 17:08:52+00:00 2018-08-24 17:08:52+00:00 VERAPAMIL Verapamil: 1=Reported taking verapamil, 0=Not exposed +74 Medication/supplement use 252997 phv00252997.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:15:17+00:00 2018-08-24 17:15:17+00:00 htn_med_baseline Taking medication for hypertension at baseline visit +74 Medication/supplement use 252999 phv00252999.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:15:38+00:00 2018-08-24 17:15:38+00:00 t2d_med_baseline Taking medication for type 2 diabetes at baseline visit +74 Medication/supplement use 253021 phv00253021.v1.p1 pht005002.v1.p1 phs000956.v2.p1 Genetics of Cardiometabolic Health in the Amish 956 2 2018-08-24 17:22:34+00:00 2018-08-24 17:22:34+00:00 lipid_med_baseline Taking medication for hypercholesterolemia at baseline visit +74 Medication/supplement use 117455 phv00117455.v2.p2 pht001726.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:35:15+00:00 2018-08-24 22:35:15+00:00 D09ASSOR SOURCE OF ASTHMA MEDICATION. Q 24b +74 Medication/supplement use 117454 phv00117454.v2.p2 pht001726.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:35:24+00:00 2018-08-24 22:35:24+00:00 D09ASCD4 MED CLASSIFICATION CODE 4 OF 4. Q 24a +74 Medication/supplement use 117453 phv00117453.v2.p2 pht001726.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:35:31+00:00 2018-08-24 22:35:31+00:00 D09ASCD3 MED CLASSIFICATION CODE 3 OF 4. Q 24a +74 Medication/supplement use 117452 phv00117452.v2.p2 pht001726.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:35:38+00:00 2018-08-24 22:35:38+00:00 D09ASCD2 MED CLASSIFICATION CODE 2 OF 4. Q 24a +74 Medication/supplement use 117451 phv00117451.v2.p2 pht001726.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:35:46+00:00 2018-08-24 22:35:46+00:00 D09ASCD1 MED CLASSIFICATION CODE 1 OF 4. Q 24a +74 Medication/supplement use 117450 phv00117450.v2.p2 pht001726.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:35:54+00:00 2018-08-24 22:35:54+00:00 D09ASNM NAME OF ASTHMA MEDICATION. Q 24a +74 Medication/supplement use 117449 phv00117449.v2.p2 pht001726.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:36:01+00:00 2018-08-24 22:36:01+00:00 D09ASNUM MEDICATION NUMBER: ASTHMA MED +74 Medication/supplement use 117467 phv00117467.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:36:35+00:00 2018-08-24 22:36:35+00:00 D09BCCUS DURATION OF BCP USE, SINCE LAST STARTED +74 Medication/supplement use 117466 phv00117466.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:36:42+00:00 2018-08-24 22:36:42+00:00 D09BCTUS DURATION OF BCP USE, SINCE FIRST STARTED +74 Medication/supplement use 117465 phv00117465.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:36:49+00:00 2018-08-24 22:36:49+00:00 D09BCSOR SOURCE OF MEDICATION NAME +74 Medication/supplement use 117464 phv00117464.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:36:56+00:00 2018-08-24 22:36:56+00:00 D09BCTMO DURATION OF BCP USE: CURRENT, MONTHS +74 Medication/supplement use 117463 phv00117463.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:37:03+00:00 2018-08-24 22:37:03+00:00 D09BCTYR DURATION OF BCP USE: CURRENT, YEARS +74 Medication/supplement use 117462 phv00117462.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:37:13+00:00 2018-08-24 22:37:13+00:00 D09BCTM1 DURATION OF BCP USE: TOTAL, MONTHS +74 Medication/supplement use 117461 phv00117461.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:37:20+00:00 2018-08-24 22:37:20+00:00 D09BCTY1 DURATION OF BCP USE: TOTAL, YEARS +74 Medication/supplement use 117460 phv00117460.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:37:27+00:00 2018-08-24 22:37:27+00:00 D09BCCD3 MED CLASSIFICATION CODE 3 OF 3 +74 Medication/supplement use 117459 phv00117459.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:37:34+00:00 2018-08-24 22:37:34+00:00 D09BCCD2 MED CLASSIFICATION CODE 2 OF 3 +74 Medication/supplement use 117458 phv00117458.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:37:40+00:00 2018-08-24 22:37:40+00:00 D09BCCD1 MED CLASSIFICATION CODE 1 OF 3 +74 Medication/supplement use 117457 phv00117457.v2.p2 pht001727.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:37:47+00:00 2018-08-24 22:37:47+00:00 D09BCNAM BRAND OF BIRTH CONTROL PILL +74 Medication/supplement use 117476 phv00117476.v1.p2 pht001728.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:38:11+00:00 2018-08-24 22:38:11+00:00 D09CHSOR SOURCE OF CHOLESTEROL MEDICATION. Q 23b +74 Medication/supplement use 117475 phv00117475.v1.p2 pht001728.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:38:17+00:00 2018-08-24 22:38:17+00:00 D09CHCD4 MED CLASSIFICATION CODE 4 OF 4. Q 23a +74 Medication/supplement use 117474 phv00117474.v1.p2 pht001728.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:38:25+00:00 2018-08-24 22:38:25+00:00 D09CHCD3 MED CLASSIFICATION CODE 3 OF 4. Q 23a +74 Medication/supplement use 117473 phv00117473.v1.p2 pht001728.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:38:32+00:00 2018-08-24 22:38:32+00:00 D09CHCD2 MED CLASSIFICATION CODE 2 OF 4. Q 23a +74 Medication/supplement use 117472 phv00117472.v1.p2 pht001728.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:38:40+00:00 2018-08-24 22:38:40+00:00 D09CHCD1 MED CLASSIFICATION CODE 1 OF 4. Q 23a +74 Medication/supplement use 117471 phv00117471.v1.p2 pht001728.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:38:47+00:00 2018-08-24 22:38:47+00:00 D09CHNM NAME OF CHOL LOWERING MEDICATION. Q 23a +74 Medication/supplement use 117470 phv00117470.v1.p2 pht001728.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:38:54+00:00 2018-08-24 22:38:54+00:00 D09CHNUM MEDICATION NUMBER: CHOL LOWERING MED +74 Medication/supplement use 117485 phv00117485.v2.p2 pht001729.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:39:17+00:00 2018-08-24 22:39:17+00:00 D09HBSOR SOURCE OF HBP MEDICATION. Q 22b +74 Medication/supplement use 117484 phv00117484.v2.p2 pht001729.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:39:24+00:00 2018-08-24 22:39:24+00:00 D09HBCD4 MED CLASSIFICATION CODE 4 OF 4. Q 22a +74 Medication/supplement use 117483 phv00117483.v2.p2 pht001729.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:39:32+00:00 2018-08-24 22:39:32+00:00 D09HBCD3 MED CLASSIFICATION CODE 3 OF 4. Q 22a +74 Medication/supplement use 117482 phv00117482.v2.p2 pht001729.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:39:39+00:00 2018-08-24 22:39:39+00:00 D09HBCD2 MED CLASSIFICATION CODE 2 OF 4. Q 22a +74 Medication/supplement use 117481 phv00117481.v2.p2 pht001729.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:42:32+00:00 2018-08-24 22:42:32+00:00 D09HBCD1 MED CLASSIFICATION CODE 1 OF 4. Q 22a +74 Medication/supplement use 117480 phv00117480.v2.p2 pht001729.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:42:39+00:00 2018-08-24 22:42:39+00:00 D09HBNM NAME OF HBP MEDICATION. Q 22a +74 Medication/supplement use 117479 phv00117479.v2.p2 pht001729.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:42:45+00:00 2018-08-24 22:42:45+00:00 D09HBNUM MEDICATION NUMBER: HBP MED +74 Medication/supplement use 117494 phv00117494.v2.p2 pht001730.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:43:09+00:00 2018-08-24 22:43:09+00:00 D09HMSOR SOURCE OF HORMONE MEDICATION. Q 43b +74 Medication/supplement use 117493 phv00117493.v2.p2 pht001730.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:43:15+00:00 2018-08-24 22:43:15+00:00 D09HMCD4 MED CLASSIFICATION CODE 4 OF 4. Q 43a +74 Medication/supplement use 117492 phv00117492.v2.p2 pht001730.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:43:21+00:00 2018-08-24 22:43:21+00:00 D09HMCD3 MED CLASSIFICATION CODE 3 OF 4. Q 43a +74 Medication/supplement use 117491 phv00117491.v2.p2 pht001730.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:43:28+00:00 2018-08-24 22:43:28+00:00 D09HMCD2 MED CLASSIFICATION CODE 2 OF 4. Q 43a +74 Medication/supplement use 117490 phv00117490.v2.p2 pht001730.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:43:34+00:00 2018-08-24 22:43:34+00:00 D09HMCD1 MED CLASSIFICATION CODE 1 OF 4. Q 43a +74 Medication/supplement use 117489 phv00117489.v2.p2 pht001730.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:43:41+00:00 2018-08-24 22:43:41+00:00 D09HMNM NAME OF HORMONE MEDICATION. Q 43a +74 Medication/supplement use 117488 phv00117488.v2.p2 pht001730.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:43:47+00:00 2018-08-24 22:43:47+00:00 D09HMNUM MEDICATION NUMBER: HORMONES +74 Medication/supplement use 117504 phv00117504.v2.p2 pht001731.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:44:14+00:00 2018-08-24 22:44:14+00:00 D09RESO REASON FOR TAKING MEDICATION +74 Medication/supplement use 117503 phv00117503.v2.p2 pht001731.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:44:20+00:00 2018-08-24 22:44:20+00:00 D09OTNUM MEDICATION NUMBER: 'OTHER' MED +74 Medication/supplement use 117502 phv00117502.v2.p2 pht001731.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:44:27+00:00 2018-08-24 22:44:27+00:00 D09OTSOR SOURCE OF 'OTHER' MEDICATION. Q 25c +74 Medication/supplement use 117501 phv00117501.v2.p2 pht001731.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:44:34+00:00 2018-08-24 22:44:34+00:00 D09OTCD4 MED CLASSIFICATION CODE 4 OF 4. Q 25 +74 Medication/supplement use 117500 phv00117500.v2.p2 pht001731.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:44:40+00:00 2018-08-24 22:44:40+00:00 D09OTCD3 MED CLASSIFICATION CODE 3 OF 4. Q 25 +74 Medication/supplement use 117499 phv00117499.v2.p2 pht001731.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:44:48+00:00 2018-08-24 22:44:48+00:00 D09OTCD2 MED CLASSIFICATION CODE 2 OF 4. Q 25 +74 Medication/supplement use 117498 phv00117498.v2.p2 pht001731.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:44:55+00:00 2018-08-24 22:44:55+00:00 D09OTCD1 MED CLASSIFICATION CODE 1 OF 4. Q 25 +74 Medication/supplement use 117497 phv00117497.v2.p2 pht001731.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-24 22:45:02+00:00 2018-08-24 22:45:02+00:00 D09OTNM NAME OF 'OTHER' MEDICATION. Q 25a +74 Medication/supplement use 118387 phv00118387.v2.p2 pht001759.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:42:04+00:00 2018-08-28 22:42:04+00:00 E05STERD USING STEROIDS? Q 15 +74 Medication/supplement use 118386 phv00118386.v2.p2 pht001759.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 22:42:11+00:00 2018-08-28 22:42:11+00:00 E05INSUL CURRENTLY TAKING INSULIN OR ORAL DRUGS? Q 14 +74 Medication/supplement use 118579 phv00118579.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:00:31+00:00 2018-08-28 23:00:31+00:00 E08BRTHC EVER TAKEN BIRTH CONTROL PILLS? Q 42 +74 Medication/supplement use 118548 phv00118548.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:00:38+00:00 2018-08-28 23:00:38+00:00 E08ASP TAKE ASPIRIN 3 TIMES/WK? Q 28 +74 Medication/supplement use 118547 phv00118547.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:00:46+00:00 2018-08-28 23:00:46+00:00 E08OTMED CURRENTLY TAKING ANY OTHER MEDS. Q 27 +74 Medication/supplement use 118546 phv00118546.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:00:53+00:00 2018-08-28 23:00:53+00:00 E08ASMA CURRENTLY TAKING MEDS FOR ASTHMA. Q 26 +74 Medication/supplement use 118545 phv00118545.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:01:02+00:00 2018-08-28 23:01:02+00:00 E08CHNOW CURRENTLY TAKING MEDS TO LOWER CHOLEST. Q 25 +74 Medication/supplement use 118544 phv00118544.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:01:12+00:00 2018-08-28 23:01:12+00:00 E08HBNOW CURRENTLY TAKING MEDS FOR HBP. Q 24 +74 Medication/supplement use 118581 phv00118581.v2.p2 pht001761.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:01:42+00:00 2018-08-28 23:01:42+00:00 E08HMNOW CURRENTLY TAKING HORMONES EXCLUDING BCP? Q 44 +74 Medication/supplement use 118633 phv00118633.v2.p2 pht001762.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:02:33+00:00 2018-08-28 23:02:33+00:00 E08CPMED CHEST PAIN/PRESSURE, ANGINA MEDICATIONS. Q 14 +74 Medication/supplement use 118649 phv00118649.v2.p2 pht001765.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:03:55+00:00 2018-08-28 23:03:55+00:00 E09MDOTH MISS TAKING PILLS FOR ANY REASON? +74 Medication/supplement use 118648 phv00118648.v2.p2 pht001765.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:04:02+00:00 2018-08-28 23:04:02+00:00 E09MDSCK MISS TAKING PILLS WHEN FEELING SICK? +74 Medication/supplement use 118647 phv00118647.v2.p2 pht001765.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:04:09+00:00 2018-08-28 23:04:09+00:00 E09MDBTR MISS TAKING PILLS WHEN FEELING BETTER? +74 Medication/supplement use 118646 phv00118646.v2.p2 pht001765.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:04:15+00:00 2018-08-28 23:04:15+00:00 E09MDCLS EVER CARELESS IN TAKING PILLS? +74 Medication/supplement use 118645 phv00118645.v2.p2 pht001765.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:04:22+00:00 2018-08-28 23:04:22+00:00 E09MDFGT EVER FORGET TO TAKE PILLS? +74 Medication/supplement use 118653 phv00118653.v2.p2 pht001766.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:05:42+00:00 2018-08-28 23:05:42+00:00 E09ASPRS PURPOSE FOR TAKING ASPIRIN. Q 28b +74 Medication/supplement use 118652 phv00118652.v2.p2 pht001766.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:05:49+00:00 2018-08-28 23:05:49+00:00 E09ASPNO NUMBER OF ASPIRIN TAKEN PER WEEK. Q 28a +74 Medication/supplement use 118663 phv00118663.v2.p2 pht001767.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:06:22+00:00 2018-08-28 23:06:22+00:00 E09ASNM NAME OF ASTHMA MEDICATION. Q 26a +74 Medication/supplement use 118662 phv00118662.v2.p2 pht001767.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:06:28+00:00 2018-08-28 23:06:28+00:00 E09ASSOR SOURCE OF ASTHMA MEDICATION NAME. Q 26b +74 Medication/supplement use 118661 phv00118661.v2.p2 pht001767.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:06:34+00:00 2018-08-28 23:06:34+00:00 E09ASCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 118660 phv00118660.v2.p2 pht001767.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:06:41+00:00 2018-08-28 23:06:41+00:00 E09ASCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 118659 phv00118659.v2.p2 pht001767.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:06:49+00:00 2018-08-28 23:06:49+00:00 E09ASCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 118658 phv00118658.v2.p2 pht001767.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:06:56+00:00 2018-08-28 23:06:56+00:00 E09ASCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 118657 phv00118657.v2.p2 pht001767.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:07:02+00:00 2018-08-28 23:07:02+00:00 E09ASNUM MEDICATION NUMBER: ASTHMA MED +74 Medication/supplement use 118672 phv00118672.v1.p2 pht001768.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:07:28+00:00 2018-08-28 23:07:28+00:00 E09CHNM NAME OF CHOL LOWERING MED. Q 25a +74 Medication/supplement use 118671 phv00118671.v1.p2 pht001768.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:07:35+00:00 2018-08-28 23:07:35+00:00 E09CHSOR SOURCE OF CHOLESTEROL MED NAME. Q 25b +74 Medication/supplement use 118670 phv00118670.v1.p2 pht001768.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:07:42+00:00 2018-08-28 23:07:42+00:00 E09CHCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 118669 phv00118669.v1.p2 pht001768.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:07:49+00:00 2018-08-28 23:07:49+00:00 E09CHCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 118668 phv00118668.v1.p2 pht001768.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:07:56+00:00 2018-08-28 23:07:56+00:00 E09CHCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 118667 phv00118667.v1.p2 pht001768.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:08:03+00:00 2018-08-28 23:08:03+00:00 E09CHCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 118666 phv00118666.v1.p2 pht001768.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:08:09+00:00 2018-08-28 23:08:09+00:00 E09CHNUM MEDICATION NUMBER: CHOL LOWERING MED +74 Medication/supplement use 118681 phv00118681.v1.p2 pht001769.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:08:33+00:00 2018-08-28 23:08:33+00:00 E09CPNM NAME OF ANTI-ANGINAL MED +74 Medication/supplement use 118680 phv00118680.v1.p2 pht001769.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:08:40+00:00 2018-08-28 23:08:40+00:00 E09CPSOR SOURCE OF ANTI-ANGINAL MED NAME +74 Medication/supplement use 118679 phv00118679.v1.p2 pht001769.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:08:46+00:00 2018-08-28 23:08:46+00:00 E09CPCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 118678 phv00118678.v1.p2 pht001769.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:08:52+00:00 2018-08-28 23:08:52+00:00 E09CPCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 118677 phv00118677.v1.p2 pht001769.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:08:59+00:00 2018-08-28 23:08:59+00:00 E09CPCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 118676 phv00118676.v1.p2 pht001769.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:09:05+00:00 2018-08-28 23:09:05+00:00 E09CPCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 118675 phv00118675.v1.p2 pht001769.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:09:13+00:00 2018-08-28 23:09:13+00:00 E09CPNUM MEDICATION NUMBER: ANTI-ANGINAL MED +74 Medication/supplement use 118690 phv00118690.v2.p2 pht001770.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:09:35+00:00 2018-08-28 23:09:35+00:00 E09HBNM NAME OF HBP MEDICATION +74 Medication/supplement use 118689 phv00118689.v2.p2 pht001770.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:09:42+00:00 2018-08-28 23:09:42+00:00 E09HBSOR SOURCE OF HBP MED NAME. Q 24b +74 Medication/supplement use 118688 phv00118688.v2.p2 pht001770.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:09:50+00:00 2018-08-28 23:09:50+00:00 E09HBCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 118687 phv00118687.v2.p2 pht001770.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:09:57+00:00 2018-08-28 23:09:57+00:00 E09HBCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 118686 phv00118686.v2.p2 pht001770.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:10:05+00:00 2018-08-28 23:10:05+00:00 E09HBCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 118685 phv00118685.v2.p2 pht001770.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:10:13+00:00 2018-08-28 23:10:13+00:00 E09HBCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 118684 phv00118684.v2.p2 pht001770.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:10:25+00:00 2018-08-28 23:10:25+00:00 E09HBNUM MEDICATION NUMBER: HBP MED. Q 24a +74 Medication/supplement use 118699 phv00118699.v2.p2 pht001771.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:10:51+00:00 2018-08-28 23:10:51+00:00 E09HMNM NAME OF HORMONE MEDICATION. Q 44a +74 Medication/supplement use 118698 phv00118698.v2.p2 pht001771.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:10:58+00:00 2018-08-28 23:10:58+00:00 E09HMSOR SOURCE OF HORMONE MED NAME. Q 44b +74 Medication/supplement use 118697 phv00118697.v2.p2 pht001771.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:11:05+00:00 2018-08-28 23:11:05+00:00 E09HMCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 118696 phv00118696.v2.p2 pht001771.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:11:13+00:00 2018-08-28 23:11:13+00:00 E09HMCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 118695 phv00118695.v2.p2 pht001771.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:11:20+00:00 2018-08-28 23:11:20+00:00 E09HMCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 118694 phv00118694.v2.p2 pht001771.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:11:26+00:00 2018-08-28 23:11:26+00:00 E09HMCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 118693 phv00118693.v2.p2 pht001771.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:11:33+00:00 2018-08-28 23:11:33+00:00 E09HMNUM MEDICATION NUMBER: HORMONE MED +74 Medication/supplement use 118709 phv00118709.v2.p2 pht001772.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:21:56+00:00 2018-08-28 23:21:56+00:00 E09OCCD PAST/CURRENT: CODE OF MOST RECENT OC USED +74 Medication/supplement use 118708 phv00118708.v2.p2 pht001772.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:22:02+00:00 2018-08-28 23:22:02+00:00 E09OCCUR CURRENT USER: MOS OF MOST RECENT USE +74 Medication/supplement use 118707 phv00118707.v2.p2 pht001772.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:22:09+00:00 2018-08-28 23:22:09+00:00 E09OCLST PAST USER: MOS SINCE LAST EPISODE OF USE +74 Medication/supplement use 118706 phv00118706.v2.p2 pht001772.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:22:15+00:00 2018-08-28 23:22:15+00:00 E09OC3MO USED OC IN 3 MOS BEFORE EXAM DATE +74 Medication/supplement use 118705 phv00118705.v2.p2 pht001772.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:22:22+00:00 2018-08-28 23:22:22+00:00 E09OCLNG LONGEST CONT INTERVAL OF OC USE (MONTHS) +74 Medication/supplement use 118704 phv00118704.v2.p2 pht001772.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:22:29+00:00 2018-08-28 23:22:29+00:00 E09OCYR YEAR BEGAN TO USE OC +74 Medication/supplement use 118703 phv00118703.v2.p2 pht001772.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:22:36+00:00 2018-08-28 23:22:36+00:00 E09OCTOT TOTAL # OF MONTHS OF OC USE +74 Medication/supplement use 118702 phv00118702.v2.p2 pht001772.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:22:42+00:00 2018-08-28 23:22:42+00:00 E09OCNOW OC STATUS AS OF EXAM DATE +74 Medication/supplement use 118714 phv00118714.v2.p2 pht001773.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:23:45+00:00 2018-08-28 23:23:45+00:00 E09OTNUM MEDICATION NUMBER: OTHER PRESCRIP MED +74 Medication/supplement use 118721 phv00118721.v2.p2 pht001773.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:23:51+00:00 2018-08-28 23:23:51+00:00 E09RESO REASON FOR TAKING OTHER PRESCRIPTION MED. Q 27b +74 Medication/supplement use 118720 phv00118720.v2.p2 pht001773.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:23:58+00:00 2018-08-28 23:23:58+00:00 E09OTNM NAME OF OTHER PRESCRIPTION MED. Q 27a +74 Medication/supplement use 118719 phv00118719.v2.p2 pht001773.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:24:04+00:00 2018-08-28 23:24:04+00:00 E09OTSOR SOURCE OF OTHER PRESCRIPTION MED NAME. Q 27c +74 Medication/supplement use 118718 phv00118718.v2.p2 pht001773.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:24:10+00:00 2018-08-28 23:24:10+00:00 E09OTCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 118717 phv00118717.v2.p2 pht001773.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:24:16+00:00 2018-08-28 23:24:16+00:00 E09OTCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 118716 phv00118716.v2.p2 pht001773.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:24:23+00:00 2018-08-28 23:24:23+00:00 E09OTCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 118715 phv00118715.v2.p2 pht001773.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-28 23:24:29+00:00 2018-08-28 23:24:29+00:00 E09OTCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 119289 phv00119289.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:38:43+00:00 2018-08-29 20:38:43+00:00 E48STABF FREQ (DAY/WEEK/MONTH) TAKEN (STRESS-TAB). Q 4 +74 Medication/supplement use 119288 phv00119288.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:38:50+00:00 2018-08-29 20:38:50+00:00 E48STABN NUMBER TAKEN (STRESS-TAB). Q 4 +74 Medication/supplement use 119287 phv00119287.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:38:57+00:00 2018-08-29 20:38:57+00:00 E48STAB TAKEN STRESS-TAB MULTIPLE VITAMIN? Q 4 +74 Medication/supplement use 119286 phv00119286.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:39:04+00:00 2018-08-29 20:39:04+00:00 E481DAYF FREQ (DAY/WEEK/MONTH) TAKEN (ONE-A-DAY). Q 4 +74 Medication/supplement use 119285 phv00119285.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:39:11+00:00 2018-08-29 20:39:11+00:00 E481DAYN NUMBER TAKEN (ONE-A-DAY). Q 4 +74 Medication/supplement use 119284 phv00119284.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:39:18+00:00 2018-08-29 20:39:18+00:00 E481DAY TAKEN ONE-A-DAY MULTIPLE VITAMINS? Q 4 +74 Medication/supplement use 119283 phv00119283.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:39:25+00:00 2018-08-29 20:39:25+00:00 E48VIT TAKEN VITAMINS OR MINERALS IN PAST YEAR? Q 4 +74 Medication/supplement use 119298 phv00119298.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:39:48+00:00 2018-08-29 20:39:48+00:00 E48VITBF FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN B). Q4 +74 Medication/supplement use 119297 phv00119297.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:39:55+00:00 2018-08-29 20:39:55+00:00 E48VITBN NUMBER TAKEN (VITAMIN B). Q 4 +74 Medication/supplement use 119296 phv00119296.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:40:02+00:00 2018-08-29 20:40:02+00:00 E48VITB TAKEN VITAMIN B? Q 4 +74 Medication/supplement use 119295 phv00119295.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:40:09+00:00 2018-08-29 20:40:09+00:00 E48VITAF FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN A). Q 4 +74 Medication/supplement use 119294 phv00119294.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:40:15+00:00 2018-08-29 20:40:15+00:00 E48VITAN NUMBER TAKEN (VITAMIN A). Q 4 +74 Medication/supplement use 119293 phv00119293.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:40:22+00:00 2018-08-29 20:40:22+00:00 E48VITA TAKEN VITAMIN A? Q 4 +74 Medication/supplement use 119292 phv00119292.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:40:30+00:00 2018-08-29 20:40:30+00:00 E48THERF FREQ (DAY/WEEK/MONTH) TAKEN (THERAP). Q4 +74 Medication/supplement use 119291 phv00119291.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:40:37+00:00 2018-08-29 20:40:37+00:00 E48THERN NUMBER TAKEN (THERAP/THERAGRAN TYPE). Q 4 +74 Medication/supplement use 119290 phv00119290.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:40:43+00:00 2018-08-29 20:40:43+00:00 E48THER TAKEN THERAPEUTIC/THERAGRAN TYPE VITS? Q 4 +74 Medication/supplement use 119307 phv00119307.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:41:13+00:00 2018-08-29 20:41:13+00:00 E48BCARF FREQ (DAY/WEEK/MONTH) TAKEN (BETA-CAROT). Q 4 +74 Medication/supplement use 119306 phv00119306.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:41:19+00:00 2018-08-29 20:41:19+00:00 E48BCARN NUMBER TAKEN (BETA-CAROTENE). Q 4 +74 Medication/supplement use 119305 phv00119305.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:41:26+00:00 2018-08-29 20:41:26+00:00 E48BCAR TAKEN BETA-CAROTENE? Q 4 +74 Medication/supplement use 119304 phv00119304.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:41:32+00:00 2018-08-29 20:41:32+00:00 E48VITEF FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN E). Q4 +74 Medication/supplement use 119303 phv00119303.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:41:38+00:00 2018-08-29 20:41:38+00:00 E48VITEN NUMBER TAKEN (VITAMIN E). Q 4 +74 Medication/supplement use 119302 phv00119302.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:41:44+00:00 2018-08-29 20:41:44+00:00 E48VITE TAKEN VITAMIN E? Q 4 +74 Medication/supplement use 119301 phv00119301.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:41:51+00:00 2018-08-29 20:41:51+00:00 E48VITCF FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN C). Q4 +74 Medication/supplement use 119300 phv00119300.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:41:57+00:00 2018-08-29 20:41:57+00:00 E48VITCN NUMBER TAKEN (VITAMIN C). Q4 +74 Medication/supplement use 119299 phv00119299.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:42:03+00:00 2018-08-29 20:42:03+00:00 E48VITC TAKEN VITAMIN C? Q 4 +74 Medication/supplement use 119316 phv00119316.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:42:32+00:00 2018-08-29 20:42:32+00:00 E48NIACF FREQ (DAY/WEEK/MONTH) TAKEN (NIACIN). Q 4 +74 Medication/supplement use 119315 phv00119315.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:42:38+00:00 2018-08-29 20:42:38+00:00 E48NIACN NUMBER TAKEN (NIACIN). Q 4 +74 Medication/supplement use 119314 phv00119314.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:42:45+00:00 2018-08-29 20:42:45+00:00 E48NIAC TAKEN NIACIN? Q 4 +74 Medication/supplement use 119313 phv00119313.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:42:51+00:00 2018-08-29 20:42:51+00:00 E48FISHF FREQ (DAY/WEEK/MONTH) TAKEN (FISH OIL). Q 4 +74 Medication/supplement use 119312 phv00119312.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:42:58+00:00 2018-08-29 20:42:58+00:00 E48FISHN NUMBER TAKEN (FISH OIL). Q 4 +74 Medication/supplement use 119311 phv00119311.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:43:05+00:00 2018-08-29 20:43:05+00:00 E48FISH TAKEN FISH OIL? Q 4 +74 Medication/supplement use 119310 phv00119310.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:43:12+00:00 2018-08-29 20:43:12+00:00 E48ANTIF FREQ (DAY/WEEK/MONTH) TAKEN (ANTIOX). Q 4 +74 Medication/supplement use 119309 phv00119309.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:43:18+00:00 2018-08-29 20:43:18+00:00 E48ANTIN NUMBER TAKEN (ANTIOXIDANT). Q 4 +74 Medication/supplement use 119308 phv00119308.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:43:25+00:00 2018-08-29 20:43:25+00:00 E48ANTI TAKEN ANTIOXIDANT COMBINATION? Q 4 +74 Medication/supplement use 119325 phv00119325.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:44:06+00:00 2018-08-29 20:44:06+00:00 E48IRONF FREQ (DAY/WEEK/MONTH) TAKEN (IRON). Q 4 +74 Medication/supplement use 119324 phv00119324.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:44:12+00:00 2018-08-29 20:44:12+00:00 E48IRONN NUMBER TAKEN (IRON). Q 4 +74 Medication/supplement use 119323 phv00119323.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:44:19+00:00 2018-08-29 20:44:19+00:00 E48IRON TAKEN IRON? Q 4 +74 Medication/supplement use 119322 phv00119322.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:44:26+00:00 2018-08-29 20:44:26+00:00 E48CALCF FREQ (DAY/WEEK/MONTH) TAKEN (CALCIUM). Q 4 +74 Medication/supplement use 119321 phv00119321.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:44:32+00:00 2018-08-29 20:44:32+00:00 E48CALCN NUMBER TAKEN (CALCIUM). Q 4 +74 Medication/supplement use 119320 phv00119320.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:44:39+00:00 2018-08-29 20:44:39+00:00 E48CALC TAKEN CALCIUM? Q 4 +74 Medication/supplement use 119319 phv00119319.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:44:45+00:00 2018-08-29 20:44:45+00:00 E48SELEF FREQ (DAY/WEEK/MONTH) TAKEN (SELENIUM). Q 4 +74 Medication/supplement use 119318 phv00119318.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:44:54+00:00 2018-08-29 20:44:54+00:00 E48SELEN NUMBER TAKEN (SELENIUM). Q 4 +74 Medication/supplement use 119317 phv00119317.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:45:00+00:00 2018-08-29 20:45:00+00:00 E48SELE TAKEN SELENIUM? Q 4 +74 Medication/supplement use 119334 phv00119334.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:45:33+00:00 2018-08-29 20:45:33+00:00 E48CODF FREQ (DAY/WEEK/MONTH) TAKEN (COD LV OIL). Q 4 +74 Medication/supplement use 119333 phv00119333.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:45:42+00:00 2018-08-29 20:45:42+00:00 E48CODN NUMBER TAKEN (COD LIVER OIL). Q4 +74 Medication/supplement use 119332 phv00119332.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:45:49+00:00 2018-08-29 20:45:49+00:00 E48COD TAKEN COD LIVER OIL? Q 4 +74 Medication/supplement use 119331 phv00119331.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:45:57+00:00 2018-08-29 20:45:57+00:00 E48BREWF "FREQ (DAY/WK/MO) TAKEN (BREWER""S YEAST). Q 4" +74 Medication/supplement use 119330 phv00119330.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:46:04+00:00 2018-08-29 20:46:04+00:00 E48BREWN "NUMBER TAKEN (BREWER""S YEAST). Q 4" +74 Medication/supplement use 119329 phv00119329.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:46:13+00:00 2018-08-29 20:46:13+00:00 E48BREW "TAKEN BREWER""S YEAST? Q 4" +74 Medication/supplement use 119328 phv00119328.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:46:20+00:00 2018-08-29 20:46:20+00:00 E48ZINCF FREQ (DAY/WEEK/MONTH) TAKEN (ZINC). Q 4 +74 Medication/supplement use 119327 phv00119327.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:46:28+00:00 2018-08-29 20:46:28+00:00 E48ZINCN NUMBER TAKEN (ZINC). Q 4 +74 Medication/supplement use 119326 phv00119326.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:46:34+00:00 2018-08-29 20:46:34+00:00 E48ZINC TAKEN ZINC? Q 4 +74 Medication/supplement use 119340 phv00119340.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:48:16+00:00 2018-08-29 20:48:16+00:00 E48OTHVF FREQ (DAY/WEEK/MONTH) TAKEN (OTHER VIT). Q 4 +74 Medication/supplement use 119339 phv00119339.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:48:23+00:00 2018-08-29 20:48:23+00:00 E48OTHVN NUMBER TAKEN (OTHER VITAMINS). Q 4 +74 Medication/supplement use 119338 phv00119338.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:48:30+00:00 2018-08-29 20:48:30+00:00 E48OTHV TAKEN OTHER VITAMINS? Q 4 +74 Medication/supplement use 119337 phv00119337.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:48:37+00:00 2018-08-29 20:48:37+00:00 E48GARLF FREQ (DAY/WEEK/MONTH) TAKEN (GARLIC). Q 4 +74 Medication/supplement use 119336 phv00119336.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:48:43+00:00 2018-08-29 20:48:43+00:00 E48GARLN NUMBER TAKEN (GARLIC). Q 4 +74 Medication/supplement use 119335 phv00119335.v2.p2 pht001791.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:48:50+00:00 2018-08-29 20:48:50+00:00 E48GARL TAKEN GARLIC? Q 4 +74 Medication/supplement use 119431 phv00119431.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:51:14+00:00 2018-08-29 20:51:14+00:00 E50TWDFR HOW OFTEN DOUBLE DIET PILLS. Q 16 +74 Medication/supplement use 119430 phv00119430.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:51:21+00:00 2018-08-29 20:51:21+00:00 E50TWDP DOUBLE DIET PILLS TO LOSE WEIGHT. Q 16 +74 Medication/supplement use 119429 phv00119429.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:51:28+00:00 2018-08-29 20:51:28+00:00 E50DPFR HOW OFTEN DIET PILLS. Q 15 +74 Medication/supplement use 119428 phv00119428.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:51:35+00:00 2018-08-29 20:51:35+00:00 E50USEDP DIET PILLS TO LOSE WEIGHT. Q 15 +74 Medication/supplement use 119423 phv00119423.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:51:41+00:00 2018-08-29 20:51:41+00:00 E50DIUFR HOW OFTEN DOUBLE DIURETICS. Q 12 +74 Medication/supplement use 119422 phv00119422.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:51:49+00:00 2018-08-29 20:51:49+00:00 E50DIUR DOUBLE DIURETICS TO LOSE WEIGHT. Q 12 +74 Medication/supplement use 119421 phv00119421.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:51:55+00:00 2018-08-29 20:51:55+00:00 E50LAXFR HOW OFTEN DOUBLE LAXATIVES. Q 11 +74 Medication/supplement use 119420 phv00119420.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:52:02+00:00 2018-08-29 20:52:02+00:00 E50LAX DOUBLE LAXATIVES TO LOSE WEIGHT. Q 11 +74 Medication/supplement use 119433 phv00119433.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:53:49+00:00 2018-08-29 20:53:49+00:00 E50MLRFR HOW OFTEN DIETARY PRODUCTS. Q 17 +74 Medication/supplement use 119432 phv00119432.v2.p2 pht001793.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:53:55+00:00 2018-08-29 20:53:55+00:00 E50MEALR DIETARY PRODUCTS TO LOSE WEIGHT. Q 17 +74 Medication/supplement use 119508 phv00119508.v2.p2 pht001795.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:58:54+00:00 2018-08-29 20:58:54+00:00 E53MEDS TAKE MEDS? +74 Medication/supplement use 119474 phv00119474.v2.p2 pht001795.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 20:59:40+00:00 2018-08-29 20:59:40+00:00 E53MEDSX TAKE MEDS-COMMENT +74 Medication/supplement use 119943 phv00119943.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:13:26+00:00 2018-08-29 21:13:26+00:00 F08ASP TAKE ASPIRIN 3 TIMES/WK? Q 32 +74 Medication/supplement use 119942 phv00119942.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:13:33+00:00 2018-08-29 21:13:33+00:00 F08OTMED CURRENTLY TAKING ANY OTHER MEDS. Q 31 +74 Medication/supplement use 119936 phv00119936.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:13:40+00:00 2018-08-29 21:13:40+00:00 F08DEPMD CURRENTLY TAKING MEDS FOR DEPRESSION. Q 30 +74 Medication/supplement use 119935 phv00119935.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:13:46+00:00 2018-08-29 21:13:46+00:00 F08ASMA CURRENTLY TAKING MEDS FOR ASTHMA. Q 29 +74 Medication/supplement use 119934 phv00119934.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:13:53+00:00 2018-08-29 21:13:53+00:00 F08CHNOW CURRENTLY TAKING MEDS TO LOWER CHOLEST. Q 28 +74 Medication/supplement use 119933 phv00119933.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:14:00+00:00 2018-08-29 21:14:00+00:00 F08HBNOW CURRENTLY TAKING MEDS FOR HBP. Q 27 +74 Medication/supplement use 119972 phv00119972.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:15:16+00:00 2018-08-29 21:15:16+00:00 F08MEDS3 MED FOR INFERTILITY,POLYCYSTIC OVARIAN. Q 39b +74 Medication/supplement use 119971 phv00119971.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:15:22+00:00 2018-08-29 21:15:22+00:00 F08MEDS2 MED FOR IRREGUL PERIODS,POLYCYSTIC OVAR. Q 39b +74 Medication/supplement use 119970 phv00119970.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:15:29+00:00 2018-08-29 21:15:29+00:00 F08MEDS1 MED FOR HAIR GROWTH/ACNE,POLYCYSTIC OV. Q 39b +74 Medication/supplement use 119966 phv00119966.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:15:35+00:00 2018-08-29 21:15:35+00:00 F08HMNOW CURRENTLY TAKING HORMONES EXCLUDING BCP? Q 42 +74 Medication/supplement use 119965 phv00119965.v2.p2 pht001811.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:15:41+00:00 2018-08-29 21:15:41+00:00 F08BRTHC EVER TAKEN BIRTH CONTROL PILLS? Q 41 +74 Medication/supplement use 119992 phv00119992.v2.p2 pht001812.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:16:17+00:00 2018-08-29 21:16:17+00:00 F09ASPRS PURPOSE FOR TAKING ASPIRIN. Q 32b +74 Medication/supplement use 119991 phv00119991.v2.p2 pht001812.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:16:23+00:00 2018-08-29 21:16:23+00:00 F09ASPNO NUMBER OF ASPIRINS TAKEN PER WEEK. Q 32a +74 Medication/supplement use 120006 phv00120006.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:17:13+00:00 2018-08-29 21:17:13+00:00 F09BCNUM MEDICATION NUMBER. Q 41a +74 Medication/supplement use 120005 phv00120005.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:18:54+00:00 2018-08-29 21:18:54+00:00 F09BCXD STOP DATE: EXACT/APPROXIMATE. Q 41b.2 +74 Medication/supplement use 120004 phv00120004.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:19:01+00:00 2018-08-29 21:19:01+00:00 F09BCTM1 MONTHS SINCE LAST STARTED BCP. Q 41b.1 +74 Medication/supplement use 120003 phv00120003.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:19:17+00:00 2018-08-29 21:19:17+00:00 F09BCTY1 YEARS SINCE LAST STARTED BCP. Q 41b.1 +74 Medication/supplement use 120002 phv00120002.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:19:24+00:00 2018-08-29 21:19:24+00:00 F09BCTMO MONTHS OF BCP ALTOGETHER. Q 41c +74 Medication/supplement use 120001 phv00120001.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:19:30+00:00 2018-08-29 21:19:30+00:00 F09BCTYR YEARS OF BCP ALTOGETHER. Q 41c +74 Medication/supplement use 120000 phv00120000.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:19:36+00:00 2018-08-29 21:19:36+00:00 F09BCNOW CURRENTLY TAKING BIRTH CONTROL PILLS? Q 41b +74 Medication/supplement use 119999 phv00119999.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:19:43+00:00 2018-08-29 21:19:43+00:00 F09BCCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 119998 phv00119998.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:19:50+00:00 2018-08-29 21:19:50+00:00 F09BCCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 119997 phv00119997.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:19:57+00:00 2018-08-29 21:19:57+00:00 F09BCCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 119996 phv00119996.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:20:03+00:00 2018-08-29 21:20:03+00:00 F09BCCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 120012 phv00120012.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:20:32+00:00 2018-08-29 21:20:32+00:00 F09ST_DT DATE STOPPED TAKING BCP. Q 41b.2 +74 Medication/supplement use 120010 phv00120010.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:20:37+00:00 2018-08-29 21:20:37+00:00 F09BCNAM MEDICATION NAME +74 Medication/supplement use 120009 phv00120009.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:20:53+00:00 2018-08-29 21:20:53+00:00 F09STPDT DATE STOPPED TAKING BCP +74 Medication/supplement use 120008 phv00120008.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:20:59+00:00 2018-08-29 21:20:59+00:00 F09STPMO MONTH STOPPED TAKING BCP +74 Medication/supplement use 120007 phv00120007.v2.p2 pht001813.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:21:05+00:00 2018-08-29 21:21:05+00:00 F09STPYR YEAR STOPPED TAKING BCP +74 Medication/supplement use 120014 phv00120014.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:23:16+00:00 2018-08-29 21:23:16+00:00 F09MFUIT FOLLOW-UP FOR WHICH ITEM ON FORM 8. Q 1 +74 Medication/supplement use 120022 phv00120022.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:23:36+00:00 2018-08-29 21:23:36+00:00 F09RESO REASON FOR THIS MEDICATION. Q 3 +74 Medication/supplement use 120021 phv00120021.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:23:42+00:00 2018-08-29 21:23:42+00:00 F09MDSOR SOURCE OF MEDICATION NAME. Q 4 +74 Medication/supplement use 120020 phv00120020.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:23:48+00:00 2018-08-29 21:23:48+00:00 F09MDCD4 MED CLASSIFICATION CODE 4 OF 4 +74 Medication/supplement use 120019 phv00120019.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:23:54+00:00 2018-08-29 21:23:54+00:00 F09MDCD3 MED CLASSIFICATION CODE 3 OF 4 +74 Medication/supplement use 120018 phv00120018.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:24:02+00:00 2018-08-29 21:24:02+00:00 F09MDCD2 MED CLASSIFICATION CODE 2 OF 4 +74 Medication/supplement use 120017 phv00120017.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:24:09+00:00 2018-08-29 21:24:09+00:00 F09MDCD1 MED CLASSIFICATION CODE 1 OF 4 +74 Medication/supplement use 120016 phv00120016.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:24:17+00:00 2018-08-29 21:24:17+00:00 F09MDNM MEDICATION NAME. Q 2 +74 Medication/supplement use 120015 phv00120015.v2.p2 pht001814.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 21:24:23+00:00 2018-08-29 21:24:23+00:00 F09MDNUM MEDICATION NUMBER. Q 1 +74 Medication/supplement use 120334 phv00120334.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:37:50+00:00 2018-08-29 22:37:50+00:00 F48VITE TAKEN VITAMIN E? Q 2 +74 Medication/supplement use 120333 phv00120333.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:37:57+00:00 2018-08-29 22:37:57+00:00 F48VITC TAKEN VITAMIN C? Q 2 +74 Medication/supplement use 120332 phv00120332.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:38:05+00:00 2018-08-29 22:38:05+00:00 F48VITB TAKEN VITAMIN B? Q 2 +74 Medication/supplement use 120331 phv00120331.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:38:12+00:00 2018-08-29 22:38:12+00:00 F48VITA TAKEN VITAMIN A? Q 2 +74 Medication/supplement use 120330 phv00120330.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:38:19+00:00 2018-08-29 22:38:19+00:00 F48THER TAKEN THERAPEUTIC/THERAGRAN TYPE VITS? Q 2 +74 Medication/supplement use 120329 phv00120329.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:38:27+00:00 2018-08-29 22:38:27+00:00 F48STAB TAKEN STRESS-TAB MULTIPLE VITAMIN? Q 2 +74 Medication/supplement use 120328 phv00120328.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:38:34+00:00 2018-08-29 22:38:34+00:00 F481DAY TAKEN ONE-A-DAY MULTIPLE VITAMINS? Q 2 +74 Medication/supplement use 120327 phv00120327.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:38:41+00:00 2018-08-29 22:38:41+00:00 F48VIT TAKEN VITAMINS OR MINERALS IN PAST YEAR? Q 2 +74 Medication/supplement use 120342 phv00120342.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:39:07+00:00 2018-08-29 22:39:07+00:00 F48ZINC TAKEN ZINC? Q 2 +74 Medication/supplement use 120341 phv00120341.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:39:13+00:00 2018-08-29 22:39:13+00:00 F48IRON TAKEN IRON? Q 2 +74 Medication/supplement use 120340 phv00120340.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:39:21+00:00 2018-08-29 22:39:21+00:00 F48CALC TAKEN CALCIUM? Q 2 +74 Medication/supplement use 120339 phv00120339.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:39:28+00:00 2018-08-29 22:39:28+00:00 F48SELE TAKEN SELENIUM? Q 2 +74 Medication/supplement use 120338 phv00120338.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:39:35+00:00 2018-08-29 22:39:35+00:00 F48NIAC TAKEN NIACIN? Q 2 +74 Medication/supplement use 120337 phv00120337.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:39:41+00:00 2018-08-29 22:39:41+00:00 F48FISH TAKEN FISH OIL? Q 2 +74 Medication/supplement use 120336 phv00120336.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:39:48+00:00 2018-08-29 22:39:48+00:00 F48ANTI TAKEN ANTIOXIDANT COMBINATION? Q 2 +74 Medication/supplement use 120335 phv00120335.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:39:54+00:00 2018-08-29 22:39:54+00:00 F48BCAR TAKEN BETA-CAROTENE? Q 2 +74 Medication/supplement use 120352 phv00120352.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:40:23+00:00 2018-08-29 22:40:23+00:00 F48THERF FREQ (DAY/WEEK/MONTH) TAKEN (THERAP). Q 2 +74 Medication/supplement use 120351 phv00120351.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:40:30+00:00 2018-08-29 22:40:30+00:00 F48THERN NUMBER TAKEN (THERAP/THERAGRAN TYPE). Q 2 +74 Medication/supplement use 120350 phv00120350.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:40:37+00:00 2018-08-29 22:40:37+00:00 F48STABF FREQ (DAY/WEEK/MONTH) TAKEN (STRESS-TAB). Q 2 +74 Medication/supplement use 120349 phv00120349.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:40:44+00:00 2018-08-29 22:40:44+00:00 F48STABN NUMBER TAKEN (STRESS-TAB). Q 2 +74 Medication/supplement use 120348 phv00120348.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:40:53+00:00 2018-08-29 22:40:53+00:00 F481DAYF FREQ (DAY/WEEK/MONTH) TAKEN (ONE-A-DAY). Q 2 +74 Medication/supplement use 120347 phv00120347.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:41:00+00:00 2018-08-29 22:41:00+00:00 F481DAYN NUMBER TAKEN (ONE-A-DAY). Q 2 +74 Medication/supplement use 120346 phv00120346.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:41:07+00:00 2018-08-29 22:41:07+00:00 F48OTHV TAKEN OTHER VITAMINS? Q 2 +74 Medication/supplement use 120345 phv00120345.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:41:15+00:00 2018-08-29 22:41:15+00:00 F48GARL TAKEN GARLIC? Q 2 +74 Medication/supplement use 120344 phv00120344.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:41:23+00:00 2018-08-29 22:41:23+00:00 F48COD TAKEN COD LIVER OIL? Q 2 +74 Medication/supplement use 120343 phv00120343.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:41:29+00:00 2018-08-29 22:41:29+00:00 F48BREW "TAKEN BREWER""S YEAST? Q 2" +74 Medication/supplement use 120362 phv00120362.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:41:56+00:00 2018-08-29 22:41:56+00:00 F48BCARF FREQ (DAY/WEEK/MONTH) TAKEN (BETA-CAROT). Q 2 +74 Medication/supplement use 120361 phv00120361.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:42:02+00:00 2018-08-29 22:42:02+00:00 F48BCARN NUMBER TAKEN (BETA-CAROTENE). Q 2 +74 Medication/supplement use 120360 phv00120360.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:42:08+00:00 2018-08-29 22:42:08+00:00 F48VITEF FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN E). Q 2 +74 Medication/supplement use 120359 phv00120359.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:42:15+00:00 2018-08-29 22:42:15+00:00 F48VITEN NUMBER TAKEN (VITAMIN E). Q 2 +74 Medication/supplement use 120358 phv00120358.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:42:23+00:00 2018-08-29 22:42:23+00:00 F48VITCF FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN C). Q 2 +74 Medication/supplement use 120357 phv00120357.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:42:30+00:00 2018-08-29 22:42:30+00:00 F48VITCN NUMBER TAKEN (VITAMIN C). Q 2 +74 Medication/supplement use 120356 phv00120356.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:42:39+00:00 2018-08-29 22:42:39+00:00 F48VITBF FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN B). Q 2 +74 Medication/supplement use 120355 phv00120355.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:42:45+00:00 2018-08-29 22:42:45+00:00 F48VITBN NUMBER TAKEN (VITAMIN B). Q 2 +74 Medication/supplement use 120354 phv00120354.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:42:53+00:00 2018-08-29 22:42:53+00:00 F48VITAF FREQ (DAY/WEEK/MONTH) TAKEN (VITAMIN A). Q 2 +74 Medication/supplement use 120353 phv00120353.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:43:02+00:00 2018-08-29 22:43:02+00:00 F48VITAN NUMBER TAKEN (VITAMIN A). Q 2 +74 Medication/supplement use 120376 phv00120376.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:43:34+00:00 2018-08-29 22:43:34+00:00 F48ZINCF FREQ (DAY/WEEK/MONTH) TAKEN (ZINC). Q 2 +74 Medication/supplement use 120375 phv00120375.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:43:40+00:00 2018-08-29 22:43:40+00:00 F48ZINCN NUMBER TAKEN (ZINC). Q 2 +74 Medication/supplement use 120374 phv00120374.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:43:47+00:00 2018-08-29 22:43:47+00:00 F48IRONF FREQ (DAY/WEEK/MONTH) TAKEN (IRON). Q 2 +74 Medication/supplement use 120373 phv00120373.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:43:54+00:00 2018-08-29 22:43:54+00:00 F48IRONN NUMBER TAKEN (IRON). Q 2 +74 Medication/supplement use 120372 phv00120372.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:01+00:00 2018-08-29 22:44:01+00:00 F48CALCF FREQ (DAY/WEEK/MONTH) TAKEN (CALCIUM). Q 2 +74 Medication/supplement use 120371 phv00120371.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:08+00:00 2018-08-29 22:44:08+00:00 F48CALCN NUMBER TAKEN (CALCIUM). Q 2 +74 Medication/supplement use 120370 phv00120370.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:15+00:00 2018-08-29 22:44:15+00:00 F48SELEF FREQ (DAY/WEEK/MONTH) TAKEN (SELENIUM). Q 2 +74 Medication/supplement use 120369 phv00120369.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:22+00:00 2018-08-29 22:44:22+00:00 F48SELEN NUMBER TAKEN (SELENIUM). Q 2 +74 Medication/supplement use 120368 phv00120368.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:29+00:00 2018-08-29 22:44:29+00:00 F48NIACF FREQ (DAY/WEEK/MONTH) TAKEN (NIACIN). Q 2 +74 Medication/supplement use 120367 phv00120367.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:36+00:00 2018-08-29 22:44:36+00:00 F48NIACN NUMBER TAKEN (NIACIN). Q 2 +74 Medication/supplement use 120366 phv00120366.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:42+00:00 2018-08-29 22:44:42+00:00 F48FISHF FREQ (DAY/WEEK/MONTH) TAKEN (FISH OIL). Q 2 +74 Medication/supplement use 120365 phv00120365.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:49+00:00 2018-08-29 22:44:49+00:00 F48FISHN NUMBER TAKEN (FISH OIL). Q 2 +74 Medication/supplement use 120364 phv00120364.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:44:56+00:00 2018-08-29 22:44:56+00:00 F48ANTIF FREQ (DAY/WEEK/MONTH) TAKEN (ANTIOX). Q 2 +74 Medication/supplement use 120363 phv00120363.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:45:02+00:00 2018-08-29 22:45:02+00:00 F48ANTIN NUMBER TAKEN (ANTIOXIDANT). Q 2 +74 Medication/supplement use 120398 phv00120398.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:46:09+00:00 2018-08-29 22:46:09+00:00 F48OTVTX TEXT RESPONSE - OTHER VITAMINS TAKEN. Q 2 +74 Medication/supplement use 120384 phv00120384.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:46:16+00:00 2018-08-29 22:46:16+00:00 F48OTHVF FREQ (DAY/WEEK/MONTH) TAKEN (OTHER VIT). Q 2 +74 Medication/supplement use 120383 phv00120383.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:46:24+00:00 2018-08-29 22:46:24+00:00 F48OTHVN NUMBER TAKEN (OTHER VITAMINS). Q 2 +74 Medication/supplement use 120382 phv00120382.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:46:31+00:00 2018-08-29 22:46:31+00:00 F48GARLF FREQ (DAY/WEEK/MONTH) TAKEN (GARLIC). Q 2 +74 Medication/supplement use 120381 phv00120381.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:46:39+00:00 2018-08-29 22:46:39+00:00 F48GARLN NUMBER TAKEN (GARLIC). Q 2 +74 Medication/supplement use 120380 phv00120380.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:46:46+00:00 2018-08-29 22:46:46+00:00 F48CODF FREQ (DAY/WEEK/MONTH) TAKEN (COD LV OIL). Q 2 +74 Medication/supplement use 120379 phv00120379.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:46:53+00:00 2018-08-29 22:46:53+00:00 F48CODN NUMBER TAKEN (COD LIVER OIL). Q 2 +74 Medication/supplement use 120378 phv00120378.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:47:02+00:00 2018-08-29 22:47:02+00:00 F48BREWF "FREQ (DAY/WK/MO) TAKEN (BREWER""S YEAST). Q 2" +74 Medication/supplement use 120377 phv00120377.v2.p2 pht001825.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:47:09+00:00 2018-08-29 22:47:09+00:00 F48BREWN "NUMBER TAKEN (BREWER""S YEAST). Q 2" +74 Medication/supplement use 120550 phv00120550.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:58:59+00:00 2018-08-29 22:58:59+00:00 F68OTHR USED BC FOR OTH REASON, AGE 20-30. Q 5 +74 Medication/supplement use 120549 phv00120549.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:59:06+00:00 2018-08-29 22:59:06+00:00 F68VAGBL USED BC FOR VAGINAL BLEED, AGE 20-30. Q 5 +74 Medication/supplement use 120548 phv00120548.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:59:12+00:00 2018-08-29 22:59:12+00:00 F68PAIN USED BC FOR PAINFUL OVUL, AGE 20-30. Q 5 +74 Medication/supplement use 120547 phv00120547.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:59:18+00:00 2018-08-29 22:59:18+00:00 F68REGPD USED BC TO REGULATE PERIOD, AGE 20-30. Q 5 +74 Medication/supplement use 120546 phv00120546.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:59:25+00:00 2018-08-29 22:59:25+00:00 F68CRMPS USED BC TO CONTROL CRAMPS, AGE 20-30. Q 5 +74 Medication/supplement use 120545 phv00120545.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:59:32+00:00 2018-08-29 22:59:32+00:00 F68ACNE USED BC TO CONTROL ACNE, AGE 20-30. Q 5 +74 Medication/supplement use 120544 phv00120544.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 22:59:39+00:00 2018-08-29 22:59:39+00:00 F68BC USED BC FOR BIRTH CONTROL, AGE 20-30. Q 5 +74 Medication/supplement use 120575 phv00120575.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:01:26+00:00 2018-08-29 23:01:26+00:00 F68YOTHR USED BC FOR OTHER REASON, PAST 12 MOS. Q16 +74 Medication/supplement use 120574 phv00120574.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:01:33+00:00 2018-08-29 23:01:33+00:00 F68YVAGB USED BC FOR VAGINAL BLEED, PAST 12 MOS. Q 16 +74 Medication/supplement use 120573 phv00120573.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:01:39+00:00 2018-08-29 23:01:39+00:00 F68YPAIN USED BC FOR PAINFUL OVUL, PAST 12 MOS. Q16 +74 Medication/supplement use 120572 phv00120572.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:01:46+00:00 2018-08-29 23:01:46+00:00 F68YRGPD USED BC TO REGULATE PERIOD, PAST 12 MOS. Q 16 +74 Medication/supplement use 120571 phv00120571.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:01:53+00:00 2018-08-29 23:01:53+00:00 F68YCRMP USED BC TO CONTROL CRAMPS, PAST 12 MOS. Q 16 +74 Medication/supplement use 120570 phv00120570.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:02:00+00:00 2018-08-29 23:02:00+00:00 F68YACNE USED BC TO CONTROL ACNE, PAST 12 MOS. Q 16 +74 Medication/supplement use 120569 phv00120569.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:02:06+00:00 2018-08-29 23:02:06+00:00 F68YBC USED BC FOR BIRTH CONTROL, PAST 12 MOS. Q 16 +74 Medication/supplement use 120613 phv00120613.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:03:48+00:00 2018-08-29 23:03:48+00:00 F68OTMED TEXT-OTH NON-PRESCRIP Rx, LAST 12 MOS. Q 25 +74 Medication/supplement use 120612 phv00120612.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:03:56+00:00 2018-08-29 23:03:56+00:00 F68YOTHT TEXT-OTH REAS FOR BC, PAST 12 MOS. Q 16 +74 Medication/supplement use 120611 phv00120611.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:04:02+00:00 2018-08-29 23:04:02+00:00 F68OTHTC TEXT - OTH REASON FOR BC, AGE 20-30. Q 5 +74 Medication/supplement use 120589 phv00120589.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:04:08+00:00 2018-08-29 23:04:08+00:00 F68HORMN PRESCRIBED HORMONES FOR HOT FLASHES? Q 23a +74 Medication/supplement use 120609 phv00120609.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:07+00:00 2018-08-29 23:06:07+00:00 F68NONE TOOK NO NONPRESCRIP Rx, LAST 12 MOS. Q 25 +74 Medication/supplement use 120608 phv00120608.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:13+00:00 2018-08-29 23:06:13+00:00 F68OTHER MEDICINALLY TOOK OTH TREAT, LST 12 MOS. Q 25 +74 Medication/supplement use 120607 phv00120607.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:19+00:00 2018-08-29 23:06:19+00:00 F68BVIT MEDICINALLY TOOK VIT B, LAST 12 MOS. Q 25 +74 Medication/supplement use 120606 phv00120606.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:25+00:00 2018-08-29 23:06:25+00:00 F68GNSNG MEDICINALLY TOOK GINS, LAST 12 MOS. Q 25 +74 Medication/supplement use 120605 phv00120605.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:31+00:00 2018-08-29 23:06:31+00:00 F68SJWRT MEDICINALLY TOOK STJOHNS WRT, LST 12MOS. Q 25 +74 Medication/supplement use 120604 phv00120604.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:38+00:00 2018-08-29 23:06:38+00:00 F68COHOS MEDICINALLY TOOK BLK COHSH, LAST 12 MOS. Q 25 +74 Medication/supplement use 120603 phv00120603.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:44+00:00 2018-08-29 23:06:44+00:00 F68PHYTE MEDICINALLY TOOK PHYTOEST, LAST 12 MOS. Q 25 +74 Medication/supplement use 120602 phv00120602.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:50+00:00 2018-08-29 23:06:50+00:00 F68DHEA MEDICINALLY TOOK DHEA , LAST 12 MOS. Q 25 +74 Medication/supplement use 120601 phv00120601.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:06:57+00:00 2018-08-29 23:06:57+00:00 F68PROGS MEDICINALLY TOOK PROGESTER, LAST 12 MOS. Q 25 +74 Medication/supplement use 120600 phv00120600.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:07:06+00:00 2018-08-29 23:07:06+00:00 F68WDYAM MEDICINALLY TOOK WILD YAMS, LAST 12 MOS. Q 25 +74 Medication/supplement use 120576 phv00120576.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:07:44+00:00 2018-08-29 23:07:44+00:00 F68YNOBC DID NOT USE BC, PAST 12 MONTHS. Q16 +74 Medication/supplement use 120551 phv00120551.v2.p2 pht001840.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:07:51+00:00 2018-08-29 23:07:51+00:00 F68NOBCP DID NOT USE BIRTH CONTROL, AGE 20-30. Q 5 +74 Medication/supplement use 120716 phv00120716.v2.p2 pht001850.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:13:13+00:00 2018-08-29 23:13:13+00:00 FHL196 6) ANY MEDS OVER COUNTER +74 Medication/supplement use 120715 phv00120715.v2.p2 pht001850.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:13:19+00:00 2018-08-29 23:13:19+00:00 FHL195 5) ANY MEDS OVER COUNTER +74 Medication/supplement use 120714 phv00120714.v2.p2 pht001850.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:13:25+00:00 2018-08-29 23:13:25+00:00 FHL194 4) ANY MEDS OVER COUNTER +74 Medication/supplement use 120713 phv00120713.v2.p2 pht001850.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:13:32+00:00 2018-08-29 23:13:32+00:00 FHL193 3) ANY MEDS OVER COUNTER +74 Medication/supplement use 120712 phv00120712.v2.p2 pht001850.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:13:38+00:00 2018-08-29 23:13:38+00:00 FHL192 2) ANY MEDS OVER COUNTER +74 Medication/supplement use 120711 phv00120711.v2.p2 pht001850.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:13:44+00:00 2018-08-29 23:13:44+00:00 FHL191 1) ANY MEDS OVER COUNTER +74 Medication/supplement use 120747 phv00120747.v2.p2 pht001851.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-29 23:15:59+00:00 2018-08-29 23:15:59+00:00 FDIABMED TAKING DIABETES MEDS (1=NO,2=YES) +74 Medication/supplement use 120990 phv00120990.v2.p2 pht001856.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:03:31+00:00 2018-08-30 00:03:31+00:00 F09MDSCK MISS TAKING PILLS WHEN FEELING SICK? +74 Medication/supplement use 120989 phv00120989.v2.p2 pht001856.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:03:39+00:00 2018-08-30 00:03:39+00:00 F09MDBTR MISS TAKING PILLS WHEN FEELING BETTER? +74 Medication/supplement use 120988 phv00120988.v2.p2 pht001856.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:03:45+00:00 2018-08-30 00:03:45+00:00 F09MDCLS EVER CARELESS IN TAKING PILLS? +74 Medication/supplement use 120987 phv00120987.v2.p2 pht001856.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:03:54+00:00 2018-08-30 00:03:54+00:00 F09MDFGT EVER FORGET TO TAKE PILLS? +74 Medication/supplement use 120991 phv00120991.v2.p2 pht001856.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:04:03+00:00 2018-08-30 00:04:03+00:00 F09MDOTH MISS TAKING PILLS FOR ANY REASON? +74 Medication/supplement use 121750 phv00121750.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:15:16+00:00 2018-08-30 20:15:16+00:00 B09ASTMO DURATION OF ASTHMA MED USE: MONTHS. Q 4.04C +74 Medication/supplement use 121749 phv00121749.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:15:23+00:00 2018-08-30 20:15:23+00:00 B09ASTYR DURATION OF ASTHMA MED USE: YEARS. Q 4.04C +74 Medication/supplement use 121748 phv00121748.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:15:30+00:00 2018-08-30 20:15:30+00:00 B09ASLUS TIME SINCE LAST USED ASTHMA MED. Q 4.04B +74 Medication/supplement use 121747 phv00121747.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:15:36+00:00 2018-08-30 20:15:36+00:00 B09ASNOW TAKING MED NOW? Q 4.04A +74 Medication/supplement use 121746 phv00121746.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:15:43+00:00 2018-08-30 20:15:43+00:00 B09ASCD4 MED CLASSIFICATION CODE 4 OF 4. Q 4.04A +74 Medication/supplement use 121745 phv00121745.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:15:49+00:00 2018-08-30 20:15:49+00:00 B09ASCD3 MED CLASSIFICATION CODE 3 OF 4. Q 4.04A +74 Medication/supplement use 121744 phv00121744.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:15:56+00:00 2018-08-30 20:15:56+00:00 B09ASCD2 MED CLASSIFICATION CODE 2 OF 4. Q 4.04A +74 Medication/supplement use 121743 phv00121743.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:16:03+00:00 2018-08-30 20:16:03+00:00 B09ASCD1 MED CLASSIFICATION CODE 1 OF 4. Q 4.04A +74 Medication/supplement use 121742 phv00121742.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:16:10+00:00 2018-08-30 20:16:10+00:00 B09ASNM NAME OF MED. Q 4.04A +74 Medication/supplement use 121741 phv00121741.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:16:16+00:00 2018-08-30 20:16:16+00:00 B09ASNUM MEDICATION NUMBER :ASTHMA +74 Medication/supplement use 121740 phv00121740.v2.p2 pht001875.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:16:22+00:00 2018-08-30 20:16:22+00:00 B09ASTUS TOTAL DURATION OF ASTHMA MED USE: MONTHS +74 Medication/supplement use 258772 phv00258772.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:05:59+00:00 2018-09-06 13:05:59+00:00 Hd_meds_name Name of heart disease meds +74 Medication/supplement use 258774 phv00258774.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:06:36+00:00 2018-09-06 13:06:36+00:00 Past_hd_meds Have you taken heart diseasemeds in the past? +74 Medication/supplement use 258777 phv00258777.v1.p1 pht005253.v1.p1 phs000914.v1.p1 GWAS of Adiposity in Samoans 914 1 2018-09-06 13:08:04+00:00 2018-09-06 13:08:04+00:00 Hd_traditional_meds Are you taking traditional remedies for heart disease? +74 Medication/supplement use 121863 phv00121863.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:51:52+00:00 2018-09-07 15:51:52+00:00 OC_clot Taking oral contraceptives in the three months prior to first clot +74 Medication/supplement use 169606 phv00169606.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:46:06+00:00 2018-09-21 18:46:06+00:00 MEDSEQ F44 Medication sequence id within visit +74 Medication/supplement use 169607 phv00169607.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:46:23+00:00 2018-09-21 18:46:23+00:00 MEDNDC F44 Medication National Drug Code (NDC) +74 Medication/supplement use 169608 phv00169608.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:46:34+00:00 2018-09-21 18:46:34+00:00 ADULTDY F44 Adult duration of medication use (days) +74 Medication/supplement use 169609 phv00169609.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:46:48+00:00 2018-09-21 18:46:48+00:00 ADULTY F44 Adult duration of medication use (years) +74 Medication/supplement use 169610 phv00169610.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:49:41+00:00 2018-09-21 18:49:41+00:00 CORT F44 Oral daily use of a glucocorticosteroid +74 Medication/supplement use 169611 phv00169611.v4.p3 pht002754.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:49:51+00:00 2018-09-21 18:49:51+00:00 TCCODE F44 Medication Therapeutic Class Code +74 Medication/supplement use 169535 phv00169535.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:51:49+00:00 2018-09-21 18:51:49+00:00 F153SEQ F153 Medication sequence id within form +74 Medication/supplement use 169536 phv00169536.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:52:21+00:00 2018-09-21 18:52:21+00:00 F153MEDTYPE F153 Form section - medication type +74 Medication/supplement use 169537 phv00169537.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:52:29+00:00 2018-09-21 18:52:29+00:00 F153TAKEMED F153 Taking this medication +74 Medication/supplement use 169538 phv00169538.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:52:38+00:00 2018-09-21 18:52:38+00:00 F153MEDNDC F153 Medication National Drug Code (NDC) +74 Medication/supplement use 169539 phv00169539.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:52:45+00:00 2018-09-21 18:52:45+00:00 F153MEDNDCVER F153 Medication National Drug Code (NDC) Version +74 Medication/supplement use 169540 phv00169540.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:52:54+00:00 2018-09-21 18:52:54+00:00 F153FREQ F153 How often taking this medication +74 Medication/supplement use 169541 phv00169541.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:53:03+00:00 2018-09-21 18:53:03+00:00 F153DUR F153 How long taking this medication +74 Medication/supplement use 169542 phv00169542.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:53:16+00:00 2018-09-21 18:53:16+00:00 F153ADULTY F153 Adult years taking this medication +74 Medication/supplement use 169543 phv00169543.v4.p3 pht002751.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 18:53:29+00:00 2018-09-21 18:53:29+00:00 F153TCCODE F153 Medication Therapeutic Class Code +74 Medication/supplement use 192363 phv00192363.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45VITA Supplemental Vitamin A, mcg RE +74 Medication/supplement use 192364 phv00192364.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45VITE Supplemental Alpha-tocopherol, IU +74 Medication/supplement use 192365 phv00192365.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45VITB1 Supplemental Vitamin B1 (Thiamine), mg +74 Medication/supplement use 192366 phv00192366.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45VTB12 Supplemental Vitamin B12, mcg +74 Medication/supplement use 192367 phv00192367.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45VITB2 Supplemental Vitamin B2 (Riboflavin), mg +74 Medication/supplement use 192368 phv00192368.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45VITB6 Supplemental Vitamin B6, mg +74 Medication/supplement use 192369 phv00192369.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45BETA Supplemental Beta-carotene, mcg +74 Medication/supplement use 192370 phv00192370.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45BIOT Supplemental Biotin, mcg +74 Medication/supplement use 192371 phv00192371.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45VITC Supplemental Vitamin C, mg +74 Medication/supplement use 192372 phv00192372.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45CALC Supplemental Calcium, mg +74 Medication/supplement use 192373 phv00192373.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45CHROM Supplemental Chromium, mcg +74 Medication/supplement use 192374 phv00192374.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45COPP Supplemental Copper, mg +74 Medication/supplement use 192375 phv00192375.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45VITD Supplemental Vitamin D, mcg +74 Medication/supplement use 192376 phv00192376.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45FOLIC Supplemental Folic Acid, mcg +74 Medication/supplement use 192377 phv00192377.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45IRON Supplemental Iron, mg +74 Medication/supplement use 192378 phv00192378.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45MAGN Supplemental Magnesium, mg +74 Medication/supplement use 192379 phv00192379.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45MANG Supplemental Manganese, mg +74 Medication/supplement use 192380 phv00192380.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45MOLYB Supplemental Molybdenum, mcg +74 Medication/supplement use 192381 phv00192381.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45NIAC Supplemental Niacin, mg +74 Medication/supplement use 192382 phv00192382.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45PANTO Supplemental Pantothenic Acid, mg +74 Medication/supplement use 192383 phv00192383.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45RETIN Supplemental Retinol, mcg +74 Medication/supplement use 192384 phv00192384.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45SELEN Supplemental Selenium, mcg +74 Medication/supplement use 192385 phv00192385.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45ZINC Supplemental Zinc, mg +74 Medication/supplement use 192386 phv00192386.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45MULTI Multivitamin without Minerals +74 Medication/supplement use 192387 phv00192387.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45MVMIN Multivitamin with Minerals +74 Medication/supplement use 192388 phv00192388.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45STRES Stress Formula Pills +74 Medication/supplement use 192389 phv00192389.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45OTHCM Other Comb Pill (not multivit/stress) +74 Medication/supplement use 192390 phv00192390.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:00:42+00:00 2018-09-21 19:00:42+00:00 F45COMBP Any Combination Pill +74 Medication/supplement use 192391 phv00192391.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKVITA F45 Taking vitamin A from single sup +74 Medication/supplement use 192392 phv00192392.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKVITE F45 Taking alpha-toco from single sup +74 Medication/supplement use 192393 phv00192393.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKVITB1 F45 Taking vitamin B1 from single sup +74 Medication/supplement use 192394 phv00192394.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKVITB12 F45 Taking vitamin B12 from single sup +74 Medication/supplement use 192395 phv00192395.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKVITB2 F45 Taking vitamin B2 from single sup +74 Medication/supplement use 192396 phv00192396.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKVITB6 F45 Taking vitamin B6 from single sup +74 Medication/supplement use 192397 phv00192397.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKBETA F45 Taking beta-carotene from single sup +74 Medication/supplement use 192398 phv00192398.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKBIOT F45 Taking biotin from single sup +74 Medication/supplement use 192399 phv00192399.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKVITC F45 Taking vitamin C from single sup +74 Medication/supplement use 192400 phv00192400.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKCALC F45 Taking calcium from single sup +74 Medication/supplement use 192401 phv00192401.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKCHROM F45 Taking chromium from single sup +74 Medication/supplement use 192402 phv00192402.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKCOPP F45 Taking copper from single sup +74 Medication/supplement use 192403 phv00192403.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKVITD F45 Taking vitamin D from single sup +74 Medication/supplement use 192404 phv00192404.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKFOLIC F45 Taking folic acid from single sup +74 Medication/supplement use 192405 phv00192405.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKIRON F45 Taking iron from single sup +74 Medication/supplement use 192406 phv00192406.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKMAGN F45 Taking magnesium from single sup +74 Medication/supplement use 192407 phv00192407.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKMANG F45 Taking manganese from single sup +74 Medication/supplement use 192408 phv00192408.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKMOLYB F45 Taking molybdenum from single sup +74 Medication/supplement use 192409 phv00192409.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 19:04:51+00:00 2018-09-21 19:04:51+00:00 TKNIAC F45 Taking niacin from single sup +74 Medication/supplement use 192410 phv00192410.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 TKPANTO F45 Taking pantothenic acid from single sup +74 Medication/supplement use 192411 phv00192411.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 TKRETIN F45 Taking retinol from single sup +74 Medication/supplement use 192412 phv00192412.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 TKSELEN F45 Taking selenium from single sup +74 Medication/supplement use 192413 phv00192413.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 TKZINC F45 Taking zinc from single sup +74 Medication/supplement use 192414 phv00192414.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 F45MVYR Multivitamin without Minerals adult years taken +74 Medication/supplement use 192415 phv00192415.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 F45MVMYR Multivitamin with Minerals adult years taken +74 Medication/supplement use 192416 phv00192416.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 F45STRYR Stress Formula Pills adult years taken +74 Medication/supplement use 192417 phv00192417.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 F45OTHYR Other Comb Pill (not multivit/stress) adult years taken +74 Medication/supplement use 192418 phv00192418.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 F45CALCY Calcium adult years taken +74 Medication/supplement use 192419 phv00192419.v3.p3 pht003398.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:12:53+00:00 2018-09-21 20:12:53+00:00 F45VITDY Vitamin D adult years taken +74 Medication/supplement use 78511 phv00078511.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:19:00+00:00 2018-09-21 20:19:00+00:00 HICHOLRP High cholesterol requiring pills ever +74 Medication/supplement use 78558 phv00078558.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:21:15+00:00 2018-09-21 20:21:15+00:00 HYPTPILL Pills for hypertension ever +74 Medication/supplement use 78559 phv00078559.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:21:23+00:00 2018-09-21 20:21:23+00:00 HYPTPILN Pills for hypertension now +74 Medication/supplement use 78561 phv00078561.v6.p3 pht000999.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:21:34+00:00 2018-09-21 20:21:34+00:00 ANGNPILN Pills for angina now +74 Medication/supplement use 78470 phv00078470.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:36:40+00:00 2018-09-21 20:36:40+00:00 DIABPILL Pills for diabetes ever +74 Medication/supplement use 78469 phv00078469.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:36:54+00:00 2018-09-21 20:36:54+00:00 INSULINW Insulin shots now +74 Medication/supplement use 78468 phv00078468.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:37:15+00:00 2018-09-21 20:37:15+00:00 INSULIN Insulin shots ever +74 Medication/supplement use 78505 phv00078505.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:38:00+00:00 2018-09-21 20:38:00+00:00 DIABTRT Diabetes treated (pills or shots) +74 Medication/supplement use 77996 phv00077996.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:39:47+00:00 2018-09-21 20:39:47+00:00 OSTPL_6 Used prescription osteoporosis medication +74 Medication/supplement use 78272 phv00078272.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:39:55+00:00 2018-09-21 20:39:55+00:00 OSTPL_8 Used prescription osteoporosis medication +74 Medication/supplement use 169402 phv00169402.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:40:02+00:00 2018-09-21 20:40:02+00:00 OSTPL_X Used prescription osteoporosis meds +74 Medication/supplement use 77999 phv00077999.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:40:40+00:00 2018-09-21 20:40:40+00:00 OSTUNTK_6 Don't know what kind of osteoporosis medication +74 Medication/supplement use 78280 phv00078280.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:40:48+00:00 2018-09-21 20:40:48+00:00 OSTUNTK_8 Don't know what kind of osteoporosis medication +74 Medication/supplement use 78128 phv00078128.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:41:24+00:00 2018-09-21 20:41:24+00:00 WTLOTHER_7 Other prescription weight loss meds +74 Medication/supplement use 78252 phv00078252.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:41:36+00:00 2018-09-21 20:41:36+00:00 WTLOTHER_8 Other prescription weight loss meds +74 Medication/supplement use 78376 phv00078376.v6.p3 pht000996.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:41:46+00:00 2018-09-21 20:41:46+00:00 WTLOTHER_9 Other weight loss rx meds +74 Medication/supplement use 79641 phv00079641.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:42:45+00:00 2018-09-21 20:42:45+00:00 ESTROGEN Estrogen past year +74 Medication/supplement use 170619 phv00170619.v4.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:42:54+00:00 2018-09-21 20:42:54+00:00 F33ESTROGEN F33 Estrogen or Estrogen Combination Pills +74 Medication/supplement use 170701 phv00170701.v4.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:43:02+00:00 2018-09-21 20:43:02+00:00 F33ESTROGEN F33 Estrogen or Estrogen Combination Pills +74 Medication/supplement use 79651 phv00079651.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:43:40+00:00 2018-09-21 20:43:40+00:00 PROGEST Progesterone past year +74 Medication/supplement use 193130 phv00193130.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:44:16+00:00 2018-09-21 20:44:16+00:00 AFMEDRATE Rate control with meds +74 Medication/supplement use 193131 phv00193131.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:44:23+00:00 2018-09-21 20:44:23+00:00 AFMEDRYTHM Rhythm control with meds +74 Medication/supplement use 193132 phv00193132.v3.p3 pht003406.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:44:48+00:00 2018-09-21 20:44:48+00:00 AFANTICOAG Anticoagulation meds +74 Medication/supplement use 79032 phv00079032.v6.p3 pht001005.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:45:19+00:00 2018-09-21 20:45:19+00:00 MEDSLEEP Take medication for sleep +74 Medication/supplement use 79184 phv00079184.v6.p3 pht001006.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:45:26+00:00 2018-09-21 20:45:26+00:00 MEDSLEEP Did you take medication for sleep +74 Medication/supplement use 283085 phv00283085.v1.p3 pht006214.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:45:34+00:00 2018-09-21 20:45:34+00:00 MEDSLEEP Did you take medication or alcohol to sleep +74 Medication/supplement use 283303 phv00283303.v1.p3 pht006217.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:45:52+00:00 2018-09-21 20:45:52+00:00 DIABMEDS Diabetes meds taken +74 Medication/supplement use 77712 phv00077712.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:47:55+00:00 2018-09-21 20:47:55+00:00 OESTRANW_4 Olestra/past year +74 Medication/supplement use 79482 phv00079482.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:48:42+00:00 2018-09-21 20:48:42+00:00 ESTR Estratest use +74 Medication/supplement use 79483 phv00079483.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:48:51+00:00 2018-09-21 20:48:51+00:00 ESTRMIN Age first used estratest +74 Medication/supplement use 79484 phv00079484.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:49:05+00:00 2018-09-21 20:49:05+00:00 ESTRMAX Age last used estratest +74 Medication/supplement use 79485 phv00079485.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:49:16+00:00 2018-09-21 20:49:16+00:00 ESTRSTAT Estratest usage status +74 Medication/supplement use 79486 phv00079486.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:49:26+00:00 2018-09-21 20:49:26+00:00 ESTRTIME Estratest duration (years) +74 Medication/supplement use 79642 phv00079642.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:49:39+00:00 2018-09-21 20:49:39+00:00 ESTR_M Months used estrogen past year +74 Medication/supplement use 79643 phv00079643.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:49:48+00:00 2018-09-21 20:49:48+00:00 ESTR_T Type of estrogen used the longest +74 Medication/supplement use 79644 phv00079644.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:49:57+00:00 2018-09-21 20:49:57+00:00 ESTR_P Estrogen pill past year +74 Medication/supplement use 79645 phv00079645.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:50:06+00:00 2018-09-21 20:50:06+00:00 ESTR_PD Estrogen pills used, days/month +74 Medication/supplement use 79646 phv00079646.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:50:15+00:00 2018-09-21 20:50:15+00:00 ESTR_PL Type estrogen pill used longest +74 Medication/supplement use 79647 phv00079647.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:50:25+00:00 2018-09-21 20:50:25+00:00 ESTR_DD Dose of estrogen pill taken each day +74 Medication/supplement use 79648 phv00079648.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:50:35+00:00 2018-09-21 20:50:35+00:00 ESTR_SP Estrogen skin patch past year +74 Medication/supplement use 79649 phv00079649.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:50:43+00:00 2018-09-21 20:50:43+00:00 ESTR_SPD Dose of estrogen skin patch +74 Medication/supplement use 79650 phv00079650.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:50:52+00:00 2018-09-21 20:50:52+00:00 ESTR_SPN Times/week changed estrogen skin patch +74 Medication/supplement use 79468 phv00079468.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TOTPSTAT Estrogen + progesterone usage status +74 Medication/supplement use 79469 phv00079469.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TOTPTIME Lifetime estrogen + progest duration +74 Medication/supplement use 79470 phv00079470.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TOTH HRT use ever +74 Medication/supplement use 79471 phv00079471.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TOTHCAT HRT duration by category +74 Medication/supplement use 79472 phv00079472.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TOTHMIN Age first used HRT +74 Medication/supplement use 79473 phv00079473.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TOTHMAX Age last used HRT +74 Medication/supplement use 79474 phv00079474.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TOTHSTAT HRT usage status +74 Medication/supplement use 79475 phv00079475.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TOTHTIME Lifetime HRT duration +74 Medication/supplement use 79477 phv00079477.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TEST Testosterone or other male hormone use +74 Medication/supplement use 79478 phv00079478.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TESTMIN Age first used testosterone +74 Medication/supplement use 79479 phv00079479.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TESTMAX Age last used testosterone +74 Medication/supplement use 79480 phv00079480.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TESTSTAT Testosterone or other male hormone status +74 Medication/supplement use 79481 phv00079481.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:58:04+00:00 2018-09-21 20:58:04+00:00 TESTTIME Testosterone or other male hormone duration (years) +74 Medication/supplement use 79458 phv00079458.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTE Unopposed estrogen use ever +74 Medication/supplement use 79459 phv00079459.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTECAT Unopposed estrogen duration by category +74 Medication/supplement use 79460 phv00079460.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTEMIN Age first used unopposed estrogen +74 Medication/supplement use 79461 phv00079461.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTEMAX Age last used unopposed estrogen +74 Medication/supplement use 79462 phv00079462.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTESTAT Unopposed estrogen usage status +74 Medication/supplement use 79463 phv00079463.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTETIME Lifetime unopposed estrogen duration +74 Medication/supplement use 79464 phv00079464.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTP Estrogen + progesterone use ever +74 Medication/supplement use 79465 phv00079465.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTPCAT Estrogen + progesterone duration by category +74 Medication/supplement use 79466 phv00079466.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTPMIN Age first used estrogen + progesterone +74 Medication/supplement use 79467 phv00079467.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 20:59:24+00:00 2018-09-21 20:59:24+00:00 TOTPMAX Age last used estrogen + progesterone +74 Medication/supplement use 79442 phv00079442.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 OC Oral contraceptive use ever +74 Medication/supplement use 79443 phv00079443.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 OCAGEMIN Age first used OC +74 Medication/supplement use 79444 phv00079444.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 OCAGEMAX Age last used OC +74 Medication/supplement use 79445 phv00079445.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 OCTIME OC duration (years) +74 Medication/supplement use 79446 phv00079446.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 OCBPREG OC use before first term pregnancy +74 Medication/supplement use 79447 phv00079447.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 OCBPTIME OC use before first term preg duration (years) +74 Medication/supplement use 79448 phv00079448.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DES DES (diethylstilbestrol) use ever +74 Medication/supplement use 79449 phv00079449.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DESAGEMIN Age started DES +74 Medication/supplement use 79450 phv00079450.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DESAGEMAX Age stopped DES +74 Medication/supplement use 79451 phv00079451.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DESTIME DES Duration (years) +74 Medication/supplement use 79452 phv00079452.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DMPA DMPA (depo-provera) use ever +74 Medication/supplement use 79453 phv00079453.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DMPAGEMIN Age first used DMPA +74 Medication/supplement use 79454 phv00079454.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DMPAGEMAX Age last used DMPA +74 Medication/supplement use 79455 phv00079455.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DMPATIME DMPA duration (years) +74 Medication/supplement use 79456 phv00079456.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DMPAFREQ DMPA frequency of use +74 Medication/supplement use 79457 phv00079457.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:01:58+00:00 2018-09-21 21:01:58+00:00 DMPAUOM DMPA frequency UOM +74 Medication/supplement use 169555 phv00169555.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:03:49+00:00 2018-09-21 21:03:49+00:00 BCANASTDUR How long taken anastrozole +74 Medication/supplement use 169556 phv00169556.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:03:49+00:00 2018-09-21 21:03:49+00:00 BCEXEME Ever taken exemestane +74 Medication/supplement use 169557 phv00169557.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:03:49+00:00 2018-09-21 21:03:49+00:00 BCEXEMEDUR How long taken exemestane +74 Medication/supplement use 169558 phv00169558.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:03:49+00:00 2018-09-21 21:03:49+00:00 BCLETRO Ever taken letrozole +74 Medication/supplement use 169559 phv00169559.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:03:49+00:00 2018-09-21 21:03:49+00:00 BCLETRODUR How long taken letrozole +74 Medication/supplement use 169560 phv00169560.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:03:49+00:00 2018-09-21 21:03:49+00:00 BCSERM Ever taken other SERM or aromatase inhibitor +74 Medication/supplement use 169561 phv00169561.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:03:49+00:00 2018-09-21 21:03:49+00:00 BCSERMDUR How long taken this other SERM or aromatase inhibitor +74 Medication/supplement use 169548 phv00169548.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:05:28+00:00 2018-09-21 21:05:28+00:00 BCTAMOX Ever taken tamoxifen +74 Medication/supplement use 169549 phv00169549.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:05:28+00:00 2018-09-21 21:05:28+00:00 BCTAMOXDUR How long taken tamoxifen +74 Medication/supplement use 169550 phv00169550.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:05:28+00:00 2018-09-21 21:05:28+00:00 BCRALOX Ever taken raloxifene +74 Medication/supplement use 169551 phv00169551.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:05:28+00:00 2018-09-21 21:05:28+00:00 BCRALOXDUR How long taken raloxifene +74 Medication/supplement use 169552 phv00169552.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:05:28+00:00 2018-09-21 21:05:28+00:00 BCTOREM Ever taken toremifene +74 Medication/supplement use 169553 phv00169553.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:05:28+00:00 2018-09-21 21:05:28+00:00 BCTOREMDUR How long taken toremifene +74 Medication/supplement use 169554 phv00169554.v4.p3 pht002752.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:05:28+00:00 2018-09-21 21:05:28+00:00 BCANAST Ever taken anastrozole +74 Medication/supplement use 169466 phv00169466.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PCRM_X Used Progesterone skin cream +74 Medication/supplement use 169467 phv00169467.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PCRMDUR_X Months used Progesterone skin cream +74 Medication/supplement use 169468 phv00169468.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PSHT_X Had Progesterone shots +74 Medication/supplement use 169469 phv00169469.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PSHTDUR_X Months had Progesterone shots +74 Medication/supplement use 169470 phv00169470.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PVAG_X Used Progesterone vaginal cream +74 Medication/supplement use 169471 phv00169471.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PVAGDUR_X Months used Progesterone vaginal cream +74 Medication/supplement use 169472 phv00169472.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PIUD_X Used intrauterine Progestin device (IUD) +74 Medication/supplement use 169473 phv00169473.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PIUDDUR_X Months used Progestin IUD +74 Medication/supplement use 169474 phv00169474.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 EST_X Estrogen use last year +74 Medication/supplement use 169475 phv00169475.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 PRG_X Progesterone use last year +74 Medication/supplement use 169476 phv00169476.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:14:33+00:00 2018-09-21 21:14:33+00:00 HRT_X Hormone use last year (estrogen or progesterone) +74 Medication/supplement use 169456 phv00169456.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 ECRMDUR_X Months used Estrogen skin cream +74 Medication/supplement use 169457 phv00169457.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 ESHT_X Had Estrogen shots +74 Medication/supplement use 169458 phv00169458.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 ESHTDUR_X Months had Estrogen shots +74 Medication/supplement use 169459 phv00169459.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 EVAG_X Used Estrogen vaginal cream, ring, capsule +74 Medication/supplement use 169460 phv00169460.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 EVAGDUR_X Months used vaginal forms of Estrogen +74 Medication/supplement use 169461 phv00169461.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 P_X Used prescription Progesterone +74 Medication/supplement use 169462 phv00169462.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 PPL_X Used Progesterone pill +74 Medication/supplement use 169463 phv00169463.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 PPLDUR_X Months used Progesterone pill +74 Medication/supplement use 169465 phv00169465.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:15:52+00:00 2018-09-21 21:15:52+00:00 PPLDAY_X Days per month used Progesterone pill +74 Medication/supplement use 169446 phv00169446.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 ETPL_X Used prescription Estrogen+Testosterone pills +74 Medication/supplement use 169447 phv00169447.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 ETDUR_X Months used Estrogen+Testosterone pills +74 Medication/supplement use 169448 phv00169448.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 ETTYPE_X Type of Estrogen+Testosterone pills used longest +74 Medication/supplement use 169449 phv00169449.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 E_X Used prescription Estrogen +74 Medication/supplement use 169450 phv00169450.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 EPL_X Used oral Estrogen pill +74 Medication/supplement use 169451 phv00169451.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 EPLDUR_X Months used oral Estrogen pills +74 Medication/supplement use 169452 phv00169452.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 EPLTYPE_X Kind of Oral Estrogen pills taken +74 Medication/supplement use 169453 phv00169453.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 EPCH_X Used Estrogen skin patch +74 Medication/supplement use 169454 phv00169454.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 EPCHDUR_X Months used Estrogen skin patch +74 Medication/supplement use 169455 phv00169455.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:18:22+00:00 2018-09-21 21:18:22+00:00 ECRM_X Used Estrogen skin cream +74 Medication/supplement use 169436 phv00169436.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 HRTEST_X Estrogen or Progesterone - Results from test +74 Medication/supplement use 169437 phv00169437.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 HRMEDIA_X Estrogen or Progesterone - Info in media +74 Medication/supplement use 169438 phv00169438.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 HROTH_X Estrogen or Progesterone - Other reason +74 Medication/supplement use 169439 phv00169439.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 EPPLPA_X Used prescription Estrogen+Progesterone +74 Medication/supplement use 169440 phv00169440.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 EPPL_X Used Estrogen+Progesterone pill combination +74 Medication/supplement use 169441 phv00169441.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 EPPLDUR_X Months used Estrogen+Progesterone pill combo +74 Medication/supplement use 169442 phv00169442.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 EPPA_X Used Estrogen+Progesterone patch combination +74 Medication/supplement use 169443 phv00169443.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 EPPADUR_X Months used Estrogen+Progesterone patch combo +74 Medication/supplement use 169444 phv00169444.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 EPOTH_X Used Estrogen+Progesterone other combination +74 Medication/supplement use 169445 phv00169445.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:51:47+00:00 2018-09-21 21:51:47+00:00 EPOTHDUR_X Months used Estrogen+Progesterone other combo +74 Medication/supplement use 169416 phv00169416.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 NATHOR_X Used non-prescription natural hormones +74 Medication/supplement use 169417 phv00169417.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 YAMCRM_X Natural - Wild yam cream +74 Medication/supplement use 169418 phv00169418.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 YAMPLS_X Natural - Wild yam pills +74 Medication/supplement use 169419 phv00169419.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 PRGCRM_X Natural - Progesterone cream +74 Medication/supplement use 169420 phv00169420.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 PRGSUP_X Natural - Progesterone suppositories +74 Medication/supplement use 169421 phv00169421.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 DHEAPL_X Natural - DHEA pills +74 Medication/supplement use 169422 phv00169422.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 PHYPLS_X Natural - Phytoestrogen pills or powder +74 Medication/supplement use 169423 phv00169423.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 PHYCRM_X Natural - Phytoestrogen creams +74 Medication/supplement use 169424 phv00169424.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 PHYFDS_X Natural - Phytoestrogen-enriched foods +74 Medication/supplement use 169425 phv00169425.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 NTOTHR_X Natural - Other +74 Medication/supplement use 169426 phv00169426.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 NTDNTK_X Natural - Don't know +74 Medication/supplement use 169427 phv00169427.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:57:01+00:00 2018-09-21 21:57:01+00:00 HRPST1YR_X Used prescription Estrogen or Progesterone +74 Medication/supplement use 169406 phv00169406.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 OSTPAMID_X Osteoporosis - Pamidronate (Aredia) +74 Medication/supplement use 169407 phv00169407.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 OSTZOLEN_X Osteoporosis - Zolendronate (Zometa) +74 Medication/supplement use 169408 phv00169408.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 OSTPTH_X Osteoporosis - Parathyroid hormone (PTH,Forteo) +74 Medication/supplement use 169409 phv00169409.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 OSTOTHER_X Osteoporosis - Other medication +74 Medication/supplement use 169410 phv00169410.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 OSTDNTK_X Osteoporosis - Don't know medication +74 Medication/supplement use 169411 phv00169411.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 SRM_X Used SERMs +74 Medication/supplement use 169412 phv00169412.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 SRMEVST_X SERMs - Raloxifene (Evista) +74 Medication/supplement use 169413 phv00169413.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 SRMNOLV_X SERMs - Tamoxifen (Nolvadex ) +74 Medication/supplement use 169414 phv00169414.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 SRMOTHR_X SERMS - Other +74 Medication/supplement use 169415 phv00169415.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 21:59:09+00:00 2018-09-21 21:59:09+00:00 SRMDNTK_X SERMs - Don't know +74 Medication/supplement use 77997 phv00077997.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:01:11+00:00 2018-09-21 22:01:11+00:00 OSTALND_6 Alendronate (Fosamax) +74 Medication/supplement use 77998 phv00077998.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:01:11+00:00 2018-09-21 22:01:11+00:00 OSTCALC_6 Calcitonin (Miacalcin) +74 Medication/supplement use 78273 phv00078273.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:01:11+00:00 2018-09-21 22:01:11+00:00 OSTALND_8 Alendronate (Fosamax) +74 Medication/supplement use 78274 phv00078274.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:01:11+00:00 2018-09-21 22:01:11+00:00 OSTCALC_8 Calcitonin (Miacalcin) +74 Medication/supplement use 169403 phv00169403.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:01:11+00:00 2018-09-21 22:01:11+00:00 OSTALND_X Osteoporosis - Alendronate (Fosamax) +74 Medication/supplement use 169404 phv00169404.v3.p3 pht002748.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:01:11+00:00 2018-09-21 22:01:11+00:00 OSTCALC_X Osteoporosis - Calcitonin (Miacalcin) +74 Medication/supplement use 77722 phv00077722.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:04:47+00:00 2018-09-21 22:04:47+00:00 NATHOR_4 Natural hormones in past year +74 Medication/supplement use 77723 phv00077723.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:04:54+00:00 2018-09-21 22:04:54+00:00 YAMCRM_4 Natural/wild yam or prog cream +74 Medication/supplement use 77724 phv00077724.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:05:02+00:00 2018-09-21 22:05:02+00:00 YAMPLS_4 Natural/wild yam pills +74 Medication/supplement use 77725 phv00077725.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:05:09+00:00 2018-09-21 22:05:09+00:00 PRGSUP_4 Natural/Progest suppositories +74 Medication/supplement use 77726 phv00077726.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:05:25+00:00 2018-09-21 22:05:25+00:00 DHEAPL_4 Natural/DHEA pills +74 Medication/supplement use 77727 phv00077727.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:05:33+00:00 2018-09-21 22:05:33+00:00 PHYPLS_4 Natural/Phytoestrogen pills +74 Medication/supplement use 77728 phv00077728.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:05:40+00:00 2018-09-21 22:05:40+00:00 PHYCRM_4 Natural/Phytoestrogen creams +74 Medication/supplement use 77729 phv00077729.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:05:48+00:00 2018-09-21 22:05:48+00:00 PHYFDS_4 Natural/Phytoestrogen foods +74 Medication/supplement use 77730 phv00077730.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:05:56+00:00 2018-09-21 22:05:56+00:00 NTOTHR_4 Natural/Other +74 Medication/supplement use 77731 phv00077731.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:06:03+00:00 2018-09-21 22:06:03+00:00 NTDNTK_4 Natural/Don't know +74 Medication/supplement use 77732 phv00077732.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:06:12+00:00 2018-09-21 22:06:12+00:00 HRPST1YR_4 Used female hormones in past year +74 Medication/supplement use 77733 phv00077733.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:06:56+00:00 2018-09-21 22:06:56+00:00 EPPL_4 Combined estr/progest pills +74 Medication/supplement use 77734 phv00077734.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:07:03+00:00 2018-09-21 22:07:03+00:00 EPDUR_4 Months used estr/progest pills +74 Medication/supplement use 77735 phv00077735.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:07:10+00:00 2018-09-21 22:07:10+00:00 ETPL_4 Combined estr/testost pills +74 Medication/supplement use 77736 phv00077736.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:07:18+00:00 2018-09-21 22:07:18+00:00 ETDUR_4 Months used estr/testost pills +74 Medication/supplement use 77737 phv00077737.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:07:26+00:00 2018-09-21 22:07:26+00:00 ETTYPE_4 Estr/testost pill used longest +74 Medication/supplement use 77738 phv00077738.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:07:35+00:00 2018-09-21 22:07:35+00:00 EPL_4 Used estrogen pills +74 Medication/supplement use 77739 phv00077739.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:07:42+00:00 2018-09-21 22:07:42+00:00 EPLDUR_4 Months used estrogen pills +74 Medication/supplement use 77741 phv00077741.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:07:49+00:00 2018-09-21 22:07:49+00:00 EPLTYPE_4 Estrogen pills used longest +74 Medication/supplement use 77742 phv00077742.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:07:56+00:00 2018-09-21 22:07:56+00:00 EPLDOSE_4 Estrogen pill dose per day +74 Medication/supplement use 77743 phv00077743.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:08:54+00:00 2018-09-21 22:08:54+00:00 ESHT_4 Took estrogen shots +74 Medication/supplement use 77744 phv00077744.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:09:01+00:00 2018-09-21 22:09:01+00:00 ESHTDUR_4 Months took estrogen shots +74 Medication/supplement use 77745 phv00077745.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:09:08+00:00 2018-09-21 22:09:08+00:00 ECRM_4 Used estrogen vaginally +74 Medication/supplement use 77746 phv00077746.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:09:15+00:00 2018-09-21 22:09:15+00:00 ECRMDUR_4 Months used vaginal estrogen +74 Medication/supplement use 77747 phv00077747.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:09:22+00:00 2018-09-21 22:09:22+00:00 EPCH_4 Used estrogen skin patch +74 Medication/supplement use 77748 phv00077748.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:09:29+00:00 2018-09-21 22:09:29+00:00 EPCHDUR_4 Months used skin patch +74 Medication/supplement use 77749 phv00077749.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:09:37+00:00 2018-09-21 22:09:37+00:00 EPCHTYPE_4 Skin patch used longest +74 Medication/supplement use 77750 phv00077750.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:09:45+00:00 2018-09-21 22:09:45+00:00 EPCHDOSE_4 Skin patch dose +74 Medication/supplement use 77751 phv00077751.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:09:52+00:00 2018-09-21 22:09:52+00:00 EPCHCHNG_4 Skin patch changed per week +74 Medication/supplement use 77752 phv00077752.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:10:00+00:00 2018-09-21 22:10:00+00:00 PPL_4 Used progesterone pills +74 Medication/supplement use 77753 phv00077753.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:10:08+00:00 2018-09-21 22:10:08+00:00 PPLDUR_4 Months used progest pills +74 Medication/supplement use 77754 phv00077754.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:10:16+00:00 2018-09-21 22:10:16+00:00 PPLDAY_4 Progest pills days per month +74 Medication/supplement use 77755 phv00077755.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:10:23+00:00 2018-09-21 22:10:23+00:00 PPLTYPE_4 Progest pills used longest +74 Medication/supplement use 77756 phv00077756.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:10:31+00:00 2018-09-21 22:10:31+00:00 PPLDOSE_4 Progest pill dose per day +74 Medication/supplement use 77794 phv00077794.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:11:15+00:00 2018-09-21 22:11:15+00:00 EST_4 Estrogen use last year +74 Medication/supplement use 77795 phv00077795.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:11:22+00:00 2018-09-21 22:11:22+00:00 PRG_4 Progesterone use last year +74 Medication/supplement use 77796 phv00077796.v6.p3 pht000991.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:11:28+00:00 2018-09-21 22:11:28+00:00 HRT_4 Hormone use last year (estrogen or progesterone) +74 Medication/supplement use 77597 phv00077597.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:13:30+00:00 2018-09-21 22:13:30+00:00 NATHOR2_3 Past 2 years used 'Natural' hormones +74 Medication/supplement use 77598 phv00077598.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:13:37+00:00 2018-09-21 22:13:37+00:00 YAMCRM2_3 Used wild yam or progesterone creams +74 Medication/supplement use 77599 phv00077599.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:13:44+00:00 2018-09-21 22:13:44+00:00 YAMPLS2_3 Used wild yam pills +74 Medication/supplement use 77600 phv00077600.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:13:51+00:00 2018-09-21 22:13:51+00:00 PRGSUP2_3 Used progsterone suppositories +74 Medication/supplement use 77601 phv00077601.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:14:29+00:00 2018-09-21 22:14:29+00:00 DHEAPL2_3 Used DHEA (dehydroepiandosterone) pills +74 Medication/supplement use 77602 phv00077602.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:14:36+00:00 2018-09-21 22:14:36+00:00 PHYPLS2_3 Used Phytoestrogen pills (soy or flax) +74 Medication/supplement use 77603 phv00077603.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:14:45+00:00 2018-09-21 22:14:45+00:00 PHYCRM2_3 Used Phystoestrogen creams (soy or flax) +74 Medication/supplement use 77604 phv00077604.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:14:53+00:00 2018-09-21 22:14:53+00:00 PHYFDS2_3 Used Phytoestrogen containing foods (tofu, soybeans) +74 Medication/supplement use 77605 phv00077605.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:15:02+00:00 2018-09-21 22:15:02+00:00 NTOTHR2_3 Used other natural hormones +74 Medication/supplement use 77606 phv00077606.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:15:12+00:00 2018-09-21 22:15:12+00:00 NTDNTK2_3 Used unknown natural hormone +74 Medication/supplement use 77607 phv00077607.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:15:22+00:00 2018-09-21 22:15:22+00:00 HRPST2YR_3 Past 2 years used prescribed female hormones +74 Medication/supplement use 77608 phv00077608.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:16:22+00:00 2018-09-21 22:16:22+00:00 EPPL_3 Used Estrogen and Progestin pills +74 Medication/supplement use 77609 phv00077609.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:16:31+00:00 2018-09-21 22:16:31+00:00 EPDUR_3 Used Estrogen and Progestin - how many months +74 Medication/supplement use 77610 phv00077610.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:16:38+00:00 2018-09-21 22:16:38+00:00 ETPL_3 Used Estrogen and Testosterone pills +74 Medication/supplement use 77611 phv00077611.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:16:45+00:00 2018-09-21 22:16:45+00:00 ETDUR_3 Used Estrogen and Testosterone pills - how many months +74 Medication/supplement use 77612 phv00077612.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:16:54+00:00 2018-09-21 22:16:54+00:00 ETTYPE_3 Used Estrogen and Testosterone - what type +74 Medication/supplement use 77613 phv00077613.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:17:01+00:00 2018-09-21 22:17:01+00:00 EPL_3 Used Estrogen pills +74 Medication/supplement use 77614 phv00077614.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:17:09+00:00 2018-09-21 22:17:09+00:00 EPLDUR_3 Used Estrogen pills - how many months +74 Medication/supplement use 77615 phv00077615.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:17:17+00:00 2018-09-21 22:17:17+00:00 EPLDAYS_3 Used Estrogen pills - average number of days +74 Medication/supplement use 77616 phv00077616.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:17:24+00:00 2018-09-21 22:17:24+00:00 EPLTYPE_3 Estrogen pills used longest +74 Medication/supplement use 77617 phv00077617.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:17:33+00:00 2018-09-21 22:17:33+00:00 EPLDOSE_3 Estrogen pills - dosage +74 Medication/supplement use 77618 phv00077618.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:17:40+00:00 2018-09-21 22:17:40+00:00 ESHT_3 Used Estrogen shots +74 Medication/supplement use 77619 phv00077619.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:17:48+00:00 2018-09-21 22:17:48+00:00 ESHTDUR_3 Used Estrogen shots - how many months +74 Medication/supplement use 77620 phv00077620.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:17:55+00:00 2018-09-21 22:17:55+00:00 ECRM_3 Used Estrogen vaginal cream or suppository +74 Medication/supplement use 77621 phv00077621.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:18:03+00:00 2018-09-21 22:18:03+00:00 ECRMDUR_3 Estrogen vaginal cream or suppository - how many months +74 Medication/supplement use 77622 phv00077622.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:18:12+00:00 2018-09-21 22:18:12+00:00 EPCH_3 Used Estrogen skin patch containing +74 Medication/supplement use 77623 phv00077623.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:18:19+00:00 2018-09-21 22:18:19+00:00 EPCHDUR_3 Used Estrogen skin patch - how many months +74 Medication/supplement use 77624 phv00077624.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:18:27+00:00 2018-09-21 22:18:27+00:00 EPCHTYPE_3 Used Estrogen Skin patch - what type +74 Medication/supplement use 77625 phv00077625.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:18:35+00:00 2018-09-21 22:18:35+00:00 EPCHDOSE_3 Estrogen skin patch - dosage +74 Medication/supplement use 77626 phv00077626.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:18:42+00:00 2018-09-21 22:18:42+00:00 EPCHCHNG_3 Estrogen skin patch - times changed per week +74 Medication/supplement use 77627 phv00077627.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:19:07+00:00 2018-09-21 22:19:07+00:00 PPL_3 Used Progesterone +74 Medication/supplement use 77628 phv00077628.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:19:16+00:00 2018-09-21 22:19:16+00:00 PPLDUR_3 Used Progesterone - how many months +74 Medication/supplement use 77629 phv00077629.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:19:23+00:00 2018-09-21 22:19:23+00:00 PPLDAY_3 Used Progesterone - average number days per month +74 Medication/supplement use 77630 phv00077630.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:19:32+00:00 2018-09-21 22:19:32+00:00 PPLTYPE_3 Used Progesterone - what type +74 Medication/supplement use 77631 phv00077631.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:19:40+00:00 2018-09-21 22:19:40+00:00 PPLDOSE_3 Progesterone - dosage +74 Medication/supplement use 77668 phv00077668.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:20:05+00:00 2018-09-21 22:20:05+00:00 ELST2YR_3 Estrogen use last 2 years +74 Medication/supplement use 77669 phv00077669.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:20:12+00:00 2018-09-21 22:20:12+00:00 PLST2YR_3 Progesterone use last 2 years +74 Medication/supplement use 77670 phv00077670.v6.p3 pht000990.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:20:19+00:00 2018-09-21 22:20:19+00:00 HLST2YR_3 Hormone use last 2 years (estrogen or progesterone) +74 Medication/supplement use 77832 phv00077832.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:21:59+00:00 2018-09-21 22:21:59+00:00 NATHOR_5 Natural hormones in past year +74 Medication/supplement use 77833 phv00077833.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:24:42+00:00 2018-09-21 22:24:42+00:00 YAMCRM_5 Natural/wild yam or prog cream +74 Medication/supplement use 77834 phv00077834.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:24:49+00:00 2018-09-21 22:24:49+00:00 YAMPLS_5 Natural/wild yam pills +74 Medication/supplement use 77835 phv00077835.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:24:56+00:00 2018-09-21 22:24:56+00:00 PRGSUP_5 Natural/Progest suppositories +74 Medication/supplement use 77836 phv00077836.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:25:02+00:00 2018-09-21 22:25:02+00:00 DHEAPL_5 Natural/DHEA pills +74 Medication/supplement use 77837 phv00077837.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:25:10+00:00 2018-09-21 22:25:10+00:00 PHYPLS_5 Natural/Phytoestrogen pills +74 Medication/supplement use 77838 phv00077838.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:25:18+00:00 2018-09-21 22:25:18+00:00 PHYCRM_5 Natural/Phytoestrogen creams +74 Medication/supplement use 77839 phv00077839.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:00+00:00 2018-09-21 22:26:00+00:00 PHYFDS_5 Natural/Phytoestrogen foods +74 Medication/supplement use 77840 phv00077840.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:08+00:00 2018-09-21 22:26:08+00:00 NTOTHR_5 Natural/Other +74 Medication/supplement use 77841 phv00077841.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:14+00:00 2018-09-21 22:26:14+00:00 NTDNTK_5 Natural/Don't know +74 Medication/supplement use 77842 phv00077842.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:22+00:00 2018-09-21 22:26:22+00:00 HRPST1YR_5 Used female hormones/past year +74 Medication/supplement use 77843 phv00077843.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:28+00:00 2018-09-21 22:26:28+00:00 EPPL_5 Combined estr/progest pills +74 Medication/supplement use 77844 phv00077844.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:37+00:00 2018-09-21 22:26:37+00:00 EPDUR_5 Months used estr/progest pills +74 Medication/supplement use 77845 phv00077845.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:44+00:00 2018-09-21 22:26:44+00:00 ETPL_5 Combined estr/testost pills +74 Medication/supplement use 77846 phv00077846.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:51+00:00 2018-09-21 22:26:51+00:00 ETDUR_5 Months used estr/testost pills +74 Medication/supplement use 77847 phv00077847.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:26:59+00:00 2018-09-21 22:26:59+00:00 ETTYPE_5 Estr/testost pill used longest +74 Medication/supplement use 77848 phv00077848.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:27:42+00:00 2018-09-21 22:27:42+00:00 EPL_5 Used estrogen pills +74 Medication/supplement use 77849 phv00077849.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:27:49+00:00 2018-09-21 22:27:49+00:00 EPLDUR_5 Months used estrogen pills +74 Medication/supplement use 77850 phv00077850.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:27:56+00:00 2018-09-21 22:27:56+00:00 EPLDAYS_5 Estrogen pills days per month +74 Medication/supplement use 77851 phv00077851.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:03+00:00 2018-09-21 22:28:03+00:00 EPLTYPE_5 Estrogen pills used longest +74 Medication/supplement use 77852 phv00077852.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:10+00:00 2018-09-21 22:28:10+00:00 EPLDOSE_5 Estrogen pill dose per day +74 Medication/supplement use 77853 phv00077853.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:16+00:00 2018-09-21 22:28:16+00:00 ESHT_5 Took estrogen shots +74 Medication/supplement use 77854 phv00077854.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:24+00:00 2018-09-21 22:28:24+00:00 ESHTDUR_5 Months took estrogen shots +74 Medication/supplement use 77855 phv00077855.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:31+00:00 2018-09-21 22:28:31+00:00 ECRM_5 Used estrogen vaginally +74 Medication/supplement use 77856 phv00077856.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:38+00:00 2018-09-21 22:28:38+00:00 ECRMDUR_5 Months used vaginal estrogen +74 Medication/supplement use 77857 phv00077857.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:44+00:00 2018-09-21 22:28:44+00:00 EPCH_5 Used estrogen skin patch +74 Medication/supplement use 77858 phv00077858.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:50+00:00 2018-09-21 22:28:50+00:00 EPCHDUR_5 Months used skin patch +74 Medication/supplement use 77859 phv00077859.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:28:57+00:00 2018-09-21 22:28:57+00:00 EPCHTYPE_5 Skin patch used longest +74 Medication/supplement use 77860 phv00077860.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:29:04+00:00 2018-09-21 22:29:04+00:00 EPCHDOSE_5 Skin patch dose +74 Medication/supplement use 77861 phv00077861.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:29:10+00:00 2018-09-21 22:29:10+00:00 EPCHCHNG_5 Skin patch changed per week +74 Medication/supplement use 77866 phv00077866.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:29:44+00:00 2018-09-21 22:29:44+00:00 PPLDOSE_5 Progest pill dose per day +74 Medication/supplement use 77865 phv00077865.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:29:51+00:00 2018-09-21 22:29:51+00:00 PPLTYPE_5 Progest pills used longest +74 Medication/supplement use 77864 phv00077864.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:30:02+00:00 2018-09-21 22:30:02+00:00 PPLDAY_5 Progest pills days per month +74 Medication/supplement use 77863 phv00077863.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:30:11+00:00 2018-09-21 22:30:11+00:00 PPLDUR_5 Months used progest pills +74 Medication/supplement use 77862 phv00077862.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:30:21+00:00 2018-09-21 22:30:21+00:00 PPL_5 Used progesterone pills +74 Medication/supplement use 77904 phv00077904.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:30:42+00:00 2018-09-21 22:30:42+00:00 EST_5 Estrogen use last year +74 Medication/supplement use 77905 phv00077905.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:30:48+00:00 2018-09-21 22:30:48+00:00 PRG_5 Progesterone use last year +74 Medication/supplement use 77906 phv00077906.v6.p3 pht000992.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:30:54+00:00 2018-09-21 22:30:54+00:00 HRT_5 Hormone use last year (estrogen or progesterone) +74 Medication/supplement use 77985 phv00077985.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:32:15+00:00 2018-09-21 22:32:15+00:00 NATHOR_6 Natural hormones in past year +74 Medication/supplement use 77986 phv00077986.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:32:23+00:00 2018-09-21 22:32:23+00:00 YAMCRM_6 Natural/wild yam cream +74 Medication/supplement use 77987 phv00077987.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:32:29+00:00 2018-09-21 22:32:29+00:00 YAMPLS_6 Natural/Wild yam pills +74 Medication/supplement use 77988 phv00077988.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:32:38+00:00 2018-09-21 22:32:38+00:00 PRGCRM_6 Natural/Progesterone cream +74 Medication/supplement use 77989 phv00077989.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:32:45+00:00 2018-09-21 22:32:45+00:00 PRGSUP_6 Natural/Progest suppositories +74 Medication/supplement use 77990 phv00077990.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:32:53+00:00 2018-09-21 22:32:53+00:00 DHEAPL_6 Natural/DHEA pills +74 Medication/supplement use 77991 phv00077991.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:33:00+00:00 2018-09-21 22:33:00+00:00 PHYPLS_6 Natural/Phytoest pills/powder +74 Medication/supplement use 77992 phv00077992.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:33:06+00:00 2018-09-21 22:33:06+00:00 PHYCRM_6 Natural/Phytoestrogen creams +74 Medication/supplement use 77993 phv00077993.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:33:13+00:00 2018-09-21 22:33:13+00:00 PHYFDS_6 Natural/Phytoestrogen foods +74 Medication/supplement use 77994 phv00077994.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:33:20+00:00 2018-09-21 22:33:20+00:00 NTOTHR_6 Natural/Other +74 Medication/supplement use 77995 phv00077995.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:33:27+00:00 2018-09-21 22:33:27+00:00 NTDNTK_6 Natural/Don't know +74 Medication/supplement use 78000 phv00078000.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:34:06+00:00 2018-09-21 22:34:06+00:00 SRM_6 Use non-estrogen prescription +74 Medication/supplement use 78001 phv00078001.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:34:14+00:00 2018-09-21 22:34:14+00:00 SRMEVST_6 Non-estrogen rx/Evista (Raloxifene) +74 Medication/supplement use 78002 phv00078002.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:34:22+00:00 2018-09-21 22:34:22+00:00 SRMNOLU_6 Non-estrogen rx/Nolvadex (Tamoxifen) +74 Medication/supplement use 78003 phv00078003.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:34:29+00:00 2018-09-21 22:34:29+00:00 SRMOTHR_6 Non-estrogen rx/Other +74 Medication/supplement use 78004 phv00078004.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:34:35+00:00 2018-09-21 22:34:35+00:00 SRMDNTK_6 Non-estrogen rx/Don't know +74 Medication/supplement use 78005 phv00078005.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:34:43+00:00 2018-09-21 22:34:43+00:00 HRPST1YR_6 Used female hormones/past year +74 Medication/supplement use 78006 phv00078006.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:34:50+00:00 2018-09-21 22:34:50+00:00 EPPLPA_6 Comb estr/progest pills/patch +74 Medication/supplement use 78007 phv00078007.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:34:57+00:00 2018-09-21 22:34:57+00:00 EPDUR_6 Months comb estr/progesterone +74 Medication/supplement use 78008 phv00078008.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:35:46+00:00 2018-09-21 22:35:46+00:00 EPTYPE_6 Which estr/progest combination +74 Medication/supplement use 78009 phv00078009.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:35:53+00:00 2018-09-21 22:35:53+00:00 ETPL_6 Combined estr/testost pills +74 Medication/supplement use 78010 phv00078010.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:35:59+00:00 2018-09-21 22:35:59+00:00 ETDUR_6 Months used estr/testost pills +74 Medication/supplement use 78011 phv00078011.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:36:06+00:00 2018-09-21 22:36:06+00:00 ETTYPE_6 Estr/testost pill used longest +74 Medication/supplement use 78012 phv00078012.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:36:14+00:00 2018-09-21 22:36:14+00:00 E_6 Estrogen pill,patch,cream,shot +74 Medication/supplement use 78013 phv00078013.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:36:20+00:00 2018-09-21 22:36:20+00:00 EPL_6 Did you use any Estrogen pill +74 Medication/supplement use 78014 phv00078014.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:36:27+00:00 2018-09-21 22:36:27+00:00 EPLDUR_6 Months used estrogen pills +74 Medication/supplement use 78015 phv00078015.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:36:33+00:00 2018-09-21 22:36:33+00:00 EPLTYPE_6 Kind of estrogen pills +74 Medication/supplement use 78016 phv00078016.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:36:40+00:00 2018-09-21 22:36:40+00:00 EPCH_6 Did you use an estrogen patch? +74 Medication/supplement use 78017 phv00078017.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:36:47+00:00 2018-09-21 22:36:47+00:00 EPCHDUR_6 How many months used patch? +74 Medication/supplement use 78018 phv00078018.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:36:55+00:00 2018-09-21 22:36:55+00:00 ECRM_6 Did you use an estrogen cream? +74 Medication/supplement use 78019 phv00078019.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:37:01+00:00 2018-09-21 22:37:01+00:00 ECRMDUR_6 How many months used cream? +74 Medication/supplement use 78020 phv00078020.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:37:08+00:00 2018-09-21 22:37:08+00:00 ESHT_6 Estrogen shots +74 Medication/supplement use 78021 phv00078021.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:37:15+00:00 2018-09-21 22:37:15+00:00 ESHTDUR_6 Months took estrogen shots +74 Medication/supplement use 78022 phv00078022.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:37:45+00:00 2018-09-21 22:37:45+00:00 P_6 Progesterone pill, cream shot +74 Medication/supplement use 78023 phv00078023.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:37:51+00:00 2018-09-21 22:37:51+00:00 PPL_6 Progesterone pill or capsule +74 Medication/supplement use 78024 phv00078024.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:37:58+00:00 2018-09-21 22:37:58+00:00 PPLDUR_6 Months progesterone pill/ caps +74 Medication/supplement use 78025 phv00078025.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:38:07+00:00 2018-09-21 22:38:07+00:00 PPLTYPE_6 Kind of progesterone +74 Medication/supplement use 78026 phv00078026.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:38:14+00:00 2018-09-21 22:38:14+00:00 PPLDAY_6 Progest pills days per month +74 Medication/supplement use 78027 phv00078027.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:38:20+00:00 2018-09-21 22:38:20+00:00 PCRM_6 Progesterone/Progestin cream +74 Medication/supplement use 78028 phv00078028.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:38:27+00:00 2018-09-21 22:38:27+00:00 PCRMDUR_6 Months used progesterone cream +74 Medication/supplement use 78029 phv00078029.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:38:33+00:00 2018-09-21 22:38:33+00:00 PSHT_6 Have progesterone shots +74 Medication/supplement use 78030 phv00078030.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:38:40+00:00 2018-09-21 22:38:40+00:00 PSHTDUR_6 Months used progesterone shots +74 Medication/supplement use 78108 phv00078108.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:39:14+00:00 2018-09-21 22:39:14+00:00 HRT_6 Hormone use last year (estrogen or progesterone) +74 Medication/supplement use 78106 phv00078106.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:39:20+00:00 2018-09-21 22:39:20+00:00 EST_6 Estrogen use last year +74 Medication/supplement use 78107 phv00078107.v6.p3 pht000993.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:39:28+00:00 2018-09-21 22:39:28+00:00 PRG_6 Progesterone use last year +74 Medication/supplement use 78129 phv00078129.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:40:13+00:00 2018-09-21 22:40:13+00:00 NATHOR_7 Natural hormones in past year +74 Medication/supplement use 78130 phv00078130.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:40:20+00:00 2018-09-21 22:40:20+00:00 YAMCRM_7 Natural/wild yam cream +74 Medication/supplement use 78131 phv00078131.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:40:26+00:00 2018-09-21 22:40:26+00:00 YAMPLS_7 Natural/Wild yam pills +74 Medication/supplement use 78132 phv00078132.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:40:37+00:00 2018-09-21 22:40:37+00:00 PRGCRM_7 Natural/Progesterone cream +74 Medication/supplement use 78133 phv00078133.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:40:44+00:00 2018-09-21 22:40:44+00:00 PRGSUP_7 Natural/Progest suppositories +74 Medication/supplement use 78134 phv00078134.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:40:51+00:00 2018-09-21 22:40:51+00:00 DHEAPL_7 Natural/DHEA pills +74 Medication/supplement use 78135 phv00078135.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:40:59+00:00 2018-09-21 22:40:59+00:00 PHYPLS_7 Natural/Phytoest pills/powder +74 Medication/supplement use 78136 phv00078136.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:41:06+00:00 2018-09-21 22:41:06+00:00 PHYCRM_7 Natural/Phytoestrogen creams +74 Medication/supplement use 78137 phv00078137.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:41:14+00:00 2018-09-21 22:41:14+00:00 PHYFDS_7 Natural/Phytoestrogen foods +74 Medication/supplement use 78138 phv00078138.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:41:24+00:00 2018-09-21 22:41:24+00:00 NTOTHR_7 Natural/Other +74 Medication/supplement use 78139 phv00078139.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:41:31+00:00 2018-09-21 22:41:31+00:00 NTDNTK_7 Natural/Don't know +74 Medication/supplement use 78140 phv00078140.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:42:08+00:00 2018-09-21 22:42:08+00:00 SRM_7 Use non-estrogen prescription? +74 Medication/supplement use 78141 phv00078141.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:42:15+00:00 2018-09-21 22:42:15+00:00 SRMEVST_7 Evista (Raloxifene) +74 Medication/supplement use 78142 phv00078142.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:42:21+00:00 2018-09-21 22:42:21+00:00 SRMNOLU_7 Nolvadex (Tamoxifen) +74 Medication/supplement use 78143 phv00078143.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:42:27+00:00 2018-09-21 22:42:27+00:00 SRMOTHR_7 Other/ non-estrogen +74 Medication/supplement use 78144 phv00078144.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:42:34+00:00 2018-09-21 22:42:34+00:00 SRMDNTK_7 Don't know/non-estrogen +74 Medication/supplement use 78145 phv00078145.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:42:40+00:00 2018-09-21 22:42:40+00:00 HRPST1YR_7 Used female hormones/past year +74 Medication/supplement use 78146 phv00078146.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:42:47+00:00 2018-09-21 22:42:47+00:00 EPPLPA_7 Comb estr/progest pills/patch +74 Medication/supplement use 78147 phv00078147.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:42:54+00:00 2018-09-21 22:42:54+00:00 EPDUR_7 Months comb estr/progesterone +74 Medication/supplement use 78148 phv00078148.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:43:00+00:00 2018-09-21 22:43:00+00:00 EPTYPE_7 Which estr/progest combination +74 Medication/supplement use 78149 phv00078149.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:43:07+00:00 2018-09-21 22:43:07+00:00 ETPL_7 Combined estr/testost pills +74 Medication/supplement use 78150 phv00078150.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:43:14+00:00 2018-09-21 22:43:14+00:00 ETDUR_7 Months used estr/testost pills +74 Medication/supplement use 78151 phv00078151.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:43:21+00:00 2018-09-21 22:43:21+00:00 ETTYPE_7 Estr/testost pill used longest +74 Medication/supplement use 78152 phv00078152.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:43:29+00:00 2018-09-21 22:43:29+00:00 E_7 Estrogen pill,patch,cream,shot +74 Medication/supplement use 78153 phv00078153.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:43:36+00:00 2018-09-21 22:43:36+00:00 EPL_7 Did you use any Estrogen pill +74 Medication/supplement use 78154 phv00078154.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:43:58+00:00 2018-09-21 22:43:58+00:00 EPLDUR_7 Months used estrogen pills +74 Medication/supplement use 78155 phv00078155.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:44:05+00:00 2018-09-21 22:44:05+00:00 EPLTYPE_7 Kind of estrogen pills +74 Medication/supplement use 78156 phv00078156.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:44:11+00:00 2018-09-21 22:44:11+00:00 EPCH_7 Did you use an estrogen patch? +74 Medication/supplement use 78157 phv00078157.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:44:17+00:00 2018-09-21 22:44:17+00:00 EPCHDUR_7 How many months used patch? +74 Medication/supplement use 78158 phv00078158.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:44:24+00:00 2018-09-21 22:44:24+00:00 ECRM_7 Did you use an estrogen cream? +74 Medication/supplement use 78159 phv00078159.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:44:30+00:00 2018-09-21 22:44:30+00:00 ECRMDUR_7 How many months used cream? +74 Medication/supplement use 78160 phv00078160.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:02+00:00 2018-09-21 22:45:02+00:00 ESHT_7 Estrogen shots +74 Medication/supplement use 78161 phv00078161.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:08+00:00 2018-09-21 22:45:08+00:00 ESHTDUR_7 Months took estrogen shots +74 Medication/supplement use 78162 phv00078162.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:14+00:00 2018-09-21 22:45:14+00:00 P_7 Progesterone pill, cream shot +74 Medication/supplement use 78163 phv00078163.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:23+00:00 2018-09-21 22:45:23+00:00 PPL_7 Progesterone pill or capsule +74 Medication/supplement use 78164 phv00078164.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:29+00:00 2018-09-21 22:45:29+00:00 PPLDUR_7 Months progesterone pill/ caps +74 Medication/supplement use 78165 phv00078165.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:35+00:00 2018-09-21 22:45:35+00:00 PPLTYPE_7 Kind of progesterone +74 Medication/supplement use 78166 phv00078166.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:42+00:00 2018-09-21 22:45:42+00:00 PPLDAY_7 Progest pills days per month +74 Medication/supplement use 78167 phv00078167.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:49+00:00 2018-09-21 22:45:49+00:00 PCRM_7 Progesterone/Progestin cream +74 Medication/supplement use 78168 phv00078168.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:45:57+00:00 2018-09-21 22:45:57+00:00 PCRMDUR_7 Months used progesterone cream +74 Medication/supplement use 78169 phv00078169.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:46:05+00:00 2018-09-21 22:46:05+00:00 PSHT_7 Have progesterone shots +74 Medication/supplement use 78170 phv00078170.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:46:13+00:00 2018-09-21 22:46:13+00:00 PSHTDUR_7 Months used progesterone shots +74 Medication/supplement use 78230 phv00078230.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:46:46+00:00 2018-09-21 22:46:46+00:00 EST_7 Estrogen use last year +74 Medication/supplement use 78231 phv00078231.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:46:53+00:00 2018-09-21 22:46:53+00:00 PRG_7 Progesterone use last year +74 Medication/supplement use 78232 phv00078232.v6.p3 pht000994.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:47:01+00:00 2018-09-21 22:47:01+00:00 HRT_7 Hormone use last year (estrogen or progesterone) +74 Medication/supplement use 78261 phv00078261.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 NATHOR_8 Natural hormones in past year +74 Medication/supplement use 78262 phv00078262.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 YAMCRM_8 Natural/wild yam cream +74 Medication/supplement use 78263 phv00078263.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 YAMPLS_8 Natural/wild yam pills +74 Medication/supplement use 78264 phv00078264.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 PRGCRM_8 Natural/Progesterone cream +74 Medication/supplement use 78265 phv00078265.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 PRGSUP_8 Natural/Progest suppositories +74 Medication/supplement use 78266 phv00078266.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 DHEAPL_8 Natural/DHEA pills +74 Medication/supplement use 78267 phv00078267.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 PHYPLS_8 Natural/Phytoest pills/powder +74 Medication/supplement use 78270 phv00078270.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 NTOTHR_8 Natural/Other +74 Medication/supplement use 78271 phv00078271.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 NTDNTK_8 Natural/Don't know +74 Medication/supplement use 78275 phv00078275.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 OSTRISED_8 Risedronate (Actonel) +74 Medication/supplement use 78276 phv00078276.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 OSTPAMID_8 Pamidronate (Aredia) +74 Medication/supplement use 78278 phv00078278.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 OSTPTH_8 Parathyroid hormone (PTH) (Forteo) +74 Medication/supplement use 78279 phv00078279.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 OSTOTHER_8 Other specified prescription osteoporosis medication +74 Medication/supplement use 78281 phv00078281.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 SRM_8 Use non-estrogen prescription +74 Medication/supplement use 78282 phv00078282.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 SRMEVST_8 Non-estrogen rx/Evista (Raloxifene) +74 Medication/supplement use 78283 phv00078283.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:53:15+00:00 2018-09-21 22:53:15+00:00 SRMNOLU_8 Non-estrogen rx/Nolvadex (Tamoxifen) +74 Medication/supplement use 78284 phv00078284.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 SRMOTHR_8 Non-estrogen rx/Other +74 Medication/supplement use 78285 phv00078285.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 SRMDNTK_8 Non-estrogen rx/Don't know +74 Medication/supplement use 78286 phv00078286.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 HRPST1YR_8 Used female hormones/past year +74 Medication/supplement use 78287 phv00078287.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 EPPLPA_8 Comb estr/progest pills/patch +74 Medication/supplement use 78288 phv00078288.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 EPDUR_8 Months comb estr/progesterone +74 Medication/supplement use 78289 phv00078289.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 EPTYPE_8 Which estr/progest combination +74 Medication/supplement use 78290 phv00078290.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 ETPL_8 Combined estr/testost pills +74 Medication/supplement use 78291 phv00078291.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 ETDUR_8 Months used estr/testost pills +74 Medication/supplement use 78292 phv00078292.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 ETTYPE_8 Estr/testost pill used longest +74 Medication/supplement use 78293 phv00078293.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 E_8 Estrogen pill,patch,cream,shot +74 Medication/supplement use 78294 phv00078294.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 EPL_8 Did you use any Estrogen pill +74 Medication/supplement use 78295 phv00078295.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 EPLDUR_8 Months used estrogen pills +74 Medication/supplement use 78296 phv00078296.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 EPLTYPE_8 Kind of estrogen pills +74 Medication/supplement use 78297 phv00078297.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 EPCH_8 Did you use an estrogen patch? +74 Medication/supplement use 78298 phv00078298.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 EPCHDUR_8 How many months used patch? +74 Medication/supplement use 78301 phv00078301.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 ESHT_8 Estrogen shots +74 Medication/supplement use 78302 phv00078302.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 ESHTDUR_8 Months took estrogen shots +74 Medication/supplement use 78303 phv00078303.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 P_8 Progesterone pill, cream shot +74 Medication/supplement use 78304 phv00078304.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 PPL_8 Progesterone pill or capsule +74 Medication/supplement use 78305 phv00078305.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 PPLDUR_8 Months progesterone pill/ caps +74 Medication/supplement use 78306 phv00078306.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 PPLTYPE_8 Kind of progesterone +74 Medication/supplement use 78307 phv00078307.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 22:56:31+00:00 2018-09-21 22:56:31+00:00 PPLDAY_8 Progest pills days per month +74 Medication/supplement use 78308 phv00078308.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:01:07+00:00 2018-09-21 23:01:07+00:00 PCRM_8 Progesterone/Progestin cream +74 Medication/supplement use 78309 phv00078309.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:01:13+00:00 2018-09-21 23:01:13+00:00 PCRMDUR_8 Months used progesterone cream +74 Medication/supplement use 78310 phv00078310.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:01:20+00:00 2018-09-21 23:01:20+00:00 PSHT_8 Have progesterone shots +74 Medication/supplement use 78311 phv00078311.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:01:25+00:00 2018-09-21 23:01:25+00:00 PSHTDUR_8 Months used progesterone shots +74 Medication/supplement use 78354 phv00078354.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:01:32+00:00 2018-09-21 23:01:32+00:00 EST_8 Estrogen use last year +74 Medication/supplement use 78355 phv00078355.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:01:39+00:00 2018-09-21 23:01:39+00:00 PRG_8 Progesterone use last year +74 Medication/supplement use 78356 phv00078356.v6.p3 pht000995.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:01:46+00:00 2018-09-21 23:01:46+00:00 HRT_8 Hormone use last year (estrogen or progesterone) +74 Medication/supplement use 78503 phv00078503.v6.p3 pht000998.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:03:59+00:00 2018-09-21 23:03:59+00:00 HORMSTAT HRT use ever +74 Medication/supplement use 79639 phv00079639.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:07:45+00:00 2018-09-21 23:07:45+00:00 HRTCMBP Combined HRT same pill past year +74 Medication/supplement use 79640 phv00079640.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:07:51+00:00 2018-09-21 23:07:51+00:00 HRTCMBPM Combined HRT same pill months/past year +74 Medication/supplement use 79652 phv00079652.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:08:54+00:00 2018-09-21 23:08:54+00:00 PROG_M Months used progesterone past year +74 Medication/supplement use 79653 phv00079653.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:09:01+00:00 2018-09-21 23:09:01+00:00 PROG_T Type of progesterone past year +74 Medication/supplement use 79654 phv00079654.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:09:13+00:00 2018-09-21 23:09:13+00:00 PROG_P Progesterone pill past year +74 Medication/supplement use 79655 phv00079655.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:09:20+00:00 2018-09-21 23:09:20+00:00 PROG_PD Progesterone pills used, days/month +74 Medication/supplement use 79656 phv00079656.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:09:43+00:00 2018-09-21 23:09:43+00:00 PROVERA Provera/Cycrin/Amen past year +74 Medication/supplement use 79657 phv00079657.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:10:27+00:00 2018-09-21 23:10:27+00:00 PROVERAD Provera/Cycrin/Amen dose past year +74 Medication/supplement use 79658 phv00079658.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:10:33+00:00 2018-09-21 23:10:33+00:00 MICRPROG Micronized progesterone past year +74 Medication/supplement use 79683 phv00079683.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:10:58+00:00 2018-09-21 23:10:58+00:00 ELSTYR Estrogen use in last year +74 Medication/supplement use 79684 phv00079684.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:11:04+00:00 2018-09-21 23:11:04+00:00 PLSTYR Progesterone use in last year +74 Medication/supplement use 79685 phv00079685.v6.p3 pht001014.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:11:10+00:00 2018-09-21 23:11:10+00:00 HLSTYR Hormone use in last year (estr or prog) +74 Medication/supplement use 79476 phv00079476.v6.p3 pht001011.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:12:31+00:00 2018-09-21 23:12:31+00:00 PCYCLE Progesterone cycle during last PERT use +74 Medication/supplement use 80429 phv00080429.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:13:12+00:00 2018-09-21 23:13:12+00:00 HRTARM HRT Arm +74 Medication/supplement use 80430 phv00080430.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:13:18+00:00 2018-09-21 23:13:18+00:00 DMARM DM Arm +74 Medication/supplement use 80431 phv00080431.v6.p3 pht001031.v6.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:13:24+00:00 2018-09-21 23:13:24+00:00 CADARM CaD Arm +74 Medication/supplement use 193669 phv00193669.v3.p3 pht003413.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:14:49+00:00 2018-09-21 23:14:49+00:00 F33DIABTX F33 Diabetes Treated +74 Medication/supplement use 193781 phv00193781.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:14:55+00:00 2018-09-21 23:14:55+00:00 F33DIABTX F33 Diabetes Treated +74 Medication/supplement use 170685 phv00170685.v4.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:15:01+00:00 2018-09-21 23:15:01+00:00 F33DIABTX F33 Diabetes Treated +74 Medication/supplement use 170603 phv00170603.v4.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:15:08+00:00 2018-09-21 23:15:08+00:00 F33DIABTX F33 Diabetes Treated +74 Medication/supplement use 282990 phv00282990.v1.p3 pht006214.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:16:21+00:00 2018-09-21 23:16:21+00:00 HRPST1YR Used female hormones in past year +74 Medication/supplement use 283206 phv00283206.v1.p3 pht006215.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:16:45+00:00 2018-09-21 23:16:45+00:00 PNEUMONIASHOT Ever had a pneumonia shot +74 Medication/supplement use 283205 phv00283205.v1.p3 pht006215.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:17:03+00:00 2018-09-21 23:17:03+00:00 FLUSHOT Flu shot in the past 12 months +74 Medication/supplement use 170599 phv00170599.v4.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:23:27+00:00 2018-09-21 23:23:27+00:00 F33DIABPILLS F33 Diabetes Pills +74 Medication/supplement use 170681 phv00170681.v4.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:23:37+00:00 2018-09-21 23:23:37+00:00 F33DIABPILLS F33 Diabetes Pills +74 Medication/supplement use 193673 phv00193673.v3.p3 pht003413.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:23:44+00:00 2018-09-21 23:23:44+00:00 F33DIABPILLS F33 Diabetes Pills +74 Medication/supplement use 193785 phv00193785.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:23:51+00:00 2018-09-21 23:23:51+00:00 F33DIABPILLS F33 Diabetes Pills +74 Medication/supplement use 170607 phv00170607.v4.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:27:37+00:00 2018-09-21 23:27:37+00:00 F33PILLSHYP F33 Pills For Hypertension +74 Medication/supplement use 170689 phv00170689.v4.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:27:43+00:00 2018-09-21 23:27:43+00:00 F33PILLSHYP F33 Pills For Hypertension +74 Medication/supplement use 193667 phv00193667.v3.p3 pht003413.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:27:49+00:00 2018-09-21 23:27:49+00:00 F33PILLSHYP F33 Pills for Hypertension +74 Medication/supplement use 193779 phv00193779.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:27:57+00:00 2018-09-21 23:27:57+00:00 F33PILLSHYP F33 Pills For Hypertension +74 Medication/supplement use 170613 phv00170613.v4.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:29:00+00:00 2018-09-21 23:29:00+00:00 F33OSTEOPILLS F33 Osteoporosis Pills +74 Medication/supplement use 170695 phv00170695.v4.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:29:06+00:00 2018-09-21 23:29:06+00:00 F33OSTEOPILLS F33 Osteoporosis Pills +74 Medication/supplement use 170617 phv00170617.v4.p3 pht002769.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:29:31+00:00 2018-09-21 23:29:31+00:00 F33CHOLESPILLS F33 Cholesterol Pills +74 Medication/supplement use 170699 phv00170699.v4.p3 pht002770.v4.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:29:37+00:00 2018-09-21 23:29:37+00:00 F33CHOLESPILLS F33 Cholesterol Pills +74 Medication/supplement use 283685 phv00283685.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:31:48+00:00 2018-09-21 23:31:48+00:00 STATINPRIOR F136 Statins prior +74 Medication/supplement use 283686 phv00283686.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:31:54+00:00 2018-09-21 23:31:54+00:00 STATINDSCH F136 Statins discharge +74 Medication/supplement use 283687 phv00283687.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:32:48+00:00 2018-09-21 23:32:48+00:00 LIPIDOTHPRIOR F136 Other lipid lowering agents prior +74 Medication/supplement use 283688 phv00283688.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:32:54+00:00 2018-09-21 23:32:54+00:00 LIPIDOTHDSCH F136 Other lipid lowering agents discharge +74 Medication/supplement use 283681 phv00283681.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:34:13+00:00 2018-09-21 23:34:13+00:00 DIURETICPRIOR F136 Diuretics prior +74 Medication/supplement use 283682 phv00283682.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:34:19+00:00 2018-09-21 23:34:19+00:00 DIURETICDSCH F136 Diuretics discharge +74 Medication/supplement use 283683 phv00283683.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:34:27+00:00 2018-09-21 23:34:27+00:00 ALDOSTPRIOR F136 Aldosterone blocker prior +74 Medication/supplement use 283684 phv00283684.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:34:33+00:00 2018-09-21 23:34:33+00:00 ALDOSTDSCH F136 Aldosterone blocker discharge +74 Medication/supplement use 283689 phv00283689.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:34:40+00:00 2018-09-21 23:34:40+00:00 NITRATESPRIOR F136 Nitrates prior +74 Medication/supplement use 283690 phv00283690.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:34:46+00:00 2018-09-21 23:34:46+00:00 NITRATESDSCH F136 Nitrates discharge +74 Medication/supplement use 283691 phv00283691.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:34:52+00:00 2018-09-21 23:34:52+00:00 HYDRALAZINEPRIOR F136 Hydralazine prior +74 Medication/supplement use 283692 phv00283692.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:34:59+00:00 2018-09-21 23:34:59+00:00 HYDRALAZINEDSCH F136 Hydralazine discharge +74 Medication/supplement use 283693 phv00283693.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:35:06+00:00 2018-09-21 23:35:06+00:00 IVINOTROP F136 IV Inotropes +74 Medication/supplement use 283694 phv00283694.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:35:12+00:00 2018-09-21 23:35:12+00:00 IVDIURETICS F136 IV Diuretics +74 Medication/supplement use 283678 phv00283678.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:36:46+00:00 2018-09-21 23:36:46+00:00 BETABDSCH F136 Beta blockers discharge +74 Medication/supplement use 283677 phv00283677.v1.p3 pht006223.v1.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-09-21 23:36:52+00:00 2018-09-21 23:36:52+00:00 BETABPRIOR F136 Beta blockers prior +74 Medication/supplement use 80818 phv00080818.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:20:46+00:00 2018-09-24 11:20:46+00:00 RX1 CURRENT TREATMENT FOR DIABETES EXAM 1 +74 Medication/supplement use 80827 phv00080827.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:21:02+00:00 2018-09-24 11:21:02+00:00 RX10 CURRENT TREATMENT FOR DIABETES EXAM 10 +74 Medication/supplement use 80828 phv00080828.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:21:13+00:00 2018-09-24 11:21:13+00:00 RX11 CURRENT TREATMENT FOR DIABETES EXAM 11 +74 Medication/supplement use 80802 phv00080802.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:21:22+00:00 2018-09-24 11:21:22+00:00 RX12 CURRENT TREATMENT FOR DIABETES EXAM 12 +74 Medication/supplement use 80803 phv00080803.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:21:40+00:00 2018-09-24 11:21:40+00:00 RX13 CURRENT TREATMENT FOR DIABETES EXAM 13 +74 Medication/supplement use 80804 phv00080804.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:21:52+00:00 2018-09-24 11:21:52+00:00 RX14 CURRENT TREATMENT FOR DIABETES EXAM 14 +74 Medication/supplement use 80805 phv00080805.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:22:02+00:00 2018-09-24 11:22:02+00:00 RX15 CURRENT TREATMENT FOR DIABETES EXAM 15 +74 Medication/supplement use 80806 phv00080806.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:22:12+00:00 2018-09-24 11:22:12+00:00 RX16 CURRENT TREATMENT FOR DIABETES EXAM 16 +74 Medication/supplement use 80807 phv00080807.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:22:23+00:00 2018-09-24 11:22:23+00:00 RX17 CURRENT TREATMENT FOR DIABETES EXAM 17 +74 Medication/supplement use 80808 phv00080808.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:22:33+00:00 2018-09-24 11:22:33+00:00 RX18 CURRENT TREATMENT FOR DIABETES EXAM 18 +74 Medication/supplement use 80809 phv00080809.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:22:43+00:00 2018-09-24 11:22:43+00:00 RX19 CURRENT TREATMENT FOR DIABETES EXAM 19 +74 Medication/supplement use 80819 phv00080819.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:22:54+00:00 2018-09-24 11:22:54+00:00 RX2 CURRENT TREATMENT FOR DIABETES EXAM 2 +74 Medication/supplement use 80810 phv00080810.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:23:04+00:00 2018-09-24 11:23:04+00:00 RX20 CURRENT TREATMENT FOR DIABETES EXAM 20 +74 Medication/supplement use 80811 phv00080811.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:23:15+00:00 2018-09-24 11:23:15+00:00 RX21 CURRENT TREATMENT FOR DIABETES EXAM 21 +74 Medication/supplement use 80812 phv00080812.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:23:24+00:00 2018-09-24 11:23:24+00:00 RX22 CURRENT TREATMENT FOR DIABETES EXAM 22 +74 Medication/supplement use 80813 phv00080813.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:23:34+00:00 2018-09-24 11:23:34+00:00 RX23 CURRENT TREATMENT FOR DIABETES EXAM 23 +74 Medication/supplement use 80814 phv00080814.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:23:48+00:00 2018-09-24 11:23:48+00:00 RX24 CURRENT TREATMENT FOR DIABETES EXAM 24 +74 Medication/supplement use 80815 phv00080815.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:23:57+00:00 2018-09-24 11:23:57+00:00 RX25 CURRENT TREATMENT FOR DIABETES EXAM 25 +74 Medication/supplement use 80816 phv00080816.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:24:08+00:00 2018-09-24 11:24:08+00:00 RX26 CURRENT TREATMENT FOR DIABETES EXAM 26 +74 Medication/supplement use 80817 phv00080817.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:24:18+00:00 2018-09-24 11:24:18+00:00 RX27 CURRENT TREATMENT FOR DIABETES EXAM 27 +74 Medication/supplement use 80820 phv00080820.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:24:28+00:00 2018-09-24 11:24:28+00:00 RX3 CURRENT TREATMENT FOR DIABETES EXAM 3 +74 Medication/supplement use 80821 phv00080821.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:24:38+00:00 2018-09-24 11:24:38+00:00 RX4 CURRENT TREATMENT FOR DIABETES EXAM 4 +74 Medication/supplement use 80822 phv00080822.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:24:47+00:00 2018-09-24 11:24:47+00:00 RX5 CURRENT TREATMENT FOR DIABETES EXAM 5 +74 Medication/supplement use 80823 phv00080823.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:24:57+00:00 2018-09-24 11:24:57+00:00 RX6 CURRENT TREATMENT FOR DIABETES EXAM 6 +74 Medication/supplement use 80824 phv00080824.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:25:07+00:00 2018-09-24 11:25:07+00:00 RX7 CURRENT TREATMENT FOR DIABETES EXAM 7 +74 Medication/supplement use 80825 phv00080825.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:25:28+00:00 2018-09-24 11:25:28+00:00 RX8 CURRENT TREATMENT FOR DIABETES EXAM 8 +74 Medication/supplement use 80826 phv00080826.v1.p10 pht000040.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:25:38+00:00 2018-09-24 11:25:38+00:00 RX9 CURRENT TREATMENT FOR DIABETES EXAM 9 +74 Medication/supplement use 10784 phv00010784.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:28:06+00:00 2018-09-24 11:28:06+00:00 DMRX1 UNDER TREATMENT FOR DIABETES EXAM 1 (SOURCE: A84 (EXAM 1 - CALCULATED)) +74 Medication/supplement use 10785 phv00010785.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:28:16+00:00 2018-09-24 11:28:16+00:00 DMRX2 UNDER TREATMENT FOR DIABETES EXAM 2 (SOURCE: B65/B68 (EXAM 2 - CALCULATED)) +74 Medication/supplement use 10786 phv00010786.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:28:25+00:00 2018-09-24 11:28:25+00:00 DMRX3 UNDER TREATMENT FOR DIABETES EXAM 3 (SOURCE: C29/C30 (EXAM 3 - CALCULATED)) +74 Medication/supplement use 10787 phv00010787.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:28:33+00:00 2018-09-24 11:28:33+00:00 DMRX4 UNDER TREATMENT FOR DIABETES EXAM 4 (SOURCE: D035/D037 (EXAM 4 - CALCULATED)) +74 Medication/supplement use 10788 phv00010788.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:28:41+00:00 2018-09-24 11:28:41+00:00 DMRX5 UNDER TREATMENT FOR DIABETES EXAM 5 (SOURCE: E254/E256 (EXAM 5 - CALCUALTED)) +74 Medication/supplement use 10789 phv00010789.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:28:50+00:00 2018-09-24 11:28:50+00:00 DMRX6 UNDER TREATMENT FOR DIABETES EXAM 6 (SOURCE: F218/F220 (EXAM 6 - CALCULATED)) +74 Medication/supplement use 10790 phv00010790.v5.p10 pht000041.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:28:58+00:00 2018-09-24 11:28:58+00:00 DMRX7 UNDER TREATMENT FOR DIABETES EXAM 7 (SOURCE: G050 G052-059 (EXAM 7 - CALCULATED)) +74 Medication/supplement use 177245 phv00177245.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:31:01+00:00 2018-09-24 11:31:01+00:00 g3b0009 Medical History - Medications: Do you take aspirin regularly? +74 Medication/supplement use 177246 phv00177246.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:31:13+00:00 2018-09-24 11:31:13+00:00 g3b0010 Medical History - Medications: Number of aspirins taken regularly +74 Medication/supplement use 177247 phv00177247.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:31:26+00:00 2018-09-24 11:31:26+00:00 g3b0011 Medical History - Medications: Aspirin frequency per +74 Medication/supplement use 177248 phv00177248.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:31:39+00:00 2018-09-24 11:31:39+00:00 g3b0012 Medical History - Medications: Usual dose of aspirin +74 Medication/supplement use 177250 phv00177250.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:31:53+00:00 2018-09-24 11:31:53+00:00 g3b0014 Medical History - Medications: Since your last exam have you taken medication for high blood pressure of hypertension? +74 Medication/supplement use 177252 phv00177252.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:32:05+00:00 2018-09-24 11:32:05+00:00 g3b0016 Medical History - Medications: Since your last exam have you taken medication for high blood cholesterol or high triglycerides? +74 Medication/supplement use 177254 phv00177254.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:32:24+00:00 2018-09-24 11:32:24+00:00 g3b0018 Medical History - Medications: Since your last exam have you taken medication for high blood sugar or diabetes? +74 Medication/supplement use 177255 phv00177255.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:32:35+00:00 2018-09-24 11:32:35+00:00 g3b0019 Medical History - Medications: Since your last exam have you taken medication for cardiovascular disease? (example: angina/chest pain, heart failure, atrial fibrillation/heart rhythm abnormality, stroke, leg pain when walking, peripheral artery disease) +74 Medication/supplement use 177258 phv00177258.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:32:49+00:00 2018-09-24 11:32:49+00:00 g3b0029 Medical History-Female Reproductive History: Since your last exam have you taken or used birth control pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)? +74 Medication/supplement use 177577 phv00177577.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:35:18+00:00 2018-09-24 11:35:18+00:00 g3b0603 Respiratory Disease Questionnaire-Technician administered: Do you take inhalers or bronchodilators? +74 Medication/supplement use 177578 phv00177578.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:35:33+00:00 2018-09-24 11:35:33+00:00 g3b0604 Respiratory Disease Questionnaire-Technician administered: Do you use any of these medications - albuterol, atrovent, proventin, combivent, maxair, volmax, xopenex, bronkometer, preo-air, pirbuterol, levalbuterol, metaproterenol, or ipratropium +74 Medication/supplement use 177579 phv00177579.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:35:45+00:00 2018-09-24 11:35:45+00:00 g3b0605 Respiratory Disease Questionnaire-Technician administered: How many hours ago did you last use the medication, either by inhaler or nebulizer? +74 Medication/supplement use 177580 phv00177580.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:36:19+00:00 2018-09-24 11:36:19+00:00 g3b0606 Respiratory Disease Questionnaire-Technician administered: Do you take any of the following inhalers - serevent, advair, foradil, salmeterol, formoterol, spiriva, symbicort, brovana, arformoterol, or tiotropium +74 Medication/supplement use 177581 phv00177581.v2.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:36:45+00:00 2018-09-24 11:36:45+00:00 g3b0607 Respiratory Disease Questionnaire-Technician administered: How many hours ago did you last use the medication? +74 Medication/supplement use 253878 phv00253878.v1.p10 pht003094.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:39:39+00:00 2018-09-24 11:39:39+00:00 g3b0083 Medical History - Female Reproductive History: Have you since your last exam taken hormone replacement therapy (estrogen/progesterone) or a selective estrogen receptor modulator (such as evista or raloxifene)? +74 Medication/supplement use 273707 phv00273707.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:41:16+00:00 2018-09-24 11:41:16+00:00 g3a008 Take aspirin regularly? Collection Interval: Exam 1 +74 Medication/supplement use 273708 phv00273708.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:41:34+00:00 2018-09-24 11:41:34+00:00 g3a009 If take aspirin regularly: Number aspirins taken Collection Interval: Exam 1 +74 Medication/supplement use 273709 phv00273709.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:41:43+00:00 2018-09-24 11:41:43+00:00 g3a010 If take aspirin regularly: Frequency per Collection Interval: Exam 1 +74 Medication/supplement use 273710 phv00273710.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:41:54+00:00 2018-09-24 11:41:54+00:00 g3a011 If take aspirin regularly: Usual dose Collection Interval: Exam 1 +74 Medication/supplement use 273711 phv00273711.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:42:05+00:00 2018-09-24 11:42:05+00:00 g3a012 Have you ever taken medication for hypertension/high blood pressure? Collection Interval: Exam 1 +74 Medication/supplement use 273712 phv00273712.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:42:38+00:00 2018-09-24 11:42:38+00:00 g3a013 If yes to G3A012, at what age did you begin Collection Interval: Exam 1 +74 Medication/supplement use 273713 phv00273713.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:42:51+00:00 2018-09-24 11:42:51+00:00 g3a014 Have you ever taken medication for high blood cholesterol? Collection Interval: Exam 1 +74 Medication/supplement use 273714 phv00273714.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:43:07+00:00 2018-09-24 11:43:07+00:00 g3a015 If yes to G3A014, at what age did you begin taking medication for high blood cholesterol? Collection Interval: Exam 1 +74 Medication/supplement use 273715 phv00273715.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:43:26+00:00 2018-09-24 11:43:26+00:00 g3a016 Have you ever taken medication for high blood sugar or diabetes? Collection Interval: Exam 1 +74 Medication/supplement use 273716 phv00273716.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:43:41+00:00 2018-09-24 11:43:41+00:00 g3a017 If yes to G3A016, at what age did you begin Collection Interval: Exam 1 +74 Medication/supplement use 273717 phv00273717.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:43:55+00:00 2018-09-24 11:43:55+00:00 g3a018 If yes to G3A016, was insulin your first diabetes medication? Collection Interval: Exam 1 +74 Medication/supplement use 273719 phv00273719.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:44:21+00:00 2018-09-24 11:44:21+00:00 g3a020 Have you ever taken medication for cardiovascular disease (for example angina/chest pain, heart failure, atrial fibrillation/heart rhythm abnormality, stroke, leg pain when walking?) Collection Interval: Exam 1 +74 Medication/supplement use 273720 phv00273720.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:44:34+00:00 2018-09-24 11:44:34+00:00 g3a021 If yes to G3A020, at what age did you begin Collection Interval: Exam 1 +74 Medication/supplement use 273722 phv00273722.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:46:36+00:00 2018-09-24 11:46:36+00:00 g3a024 Have you ever taken or used oral contraceptive pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)? Collection Interval: Exam 1 +74 Medication/supplement use 273723 phv00273723.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:46:50+00:00 2018-09-24 11:46:50+00:00 g3a025 If OCP use, what is the name of the current or most recent oral contraceptive, shot or implant used? Collection Interval: Exam 1 +74 Medication/supplement use 273724 phv00273724.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:47:00+00:00 2018-09-24 11:47:00+00:00 g3a026 If OCP use, strength Collection Interval: Exam 1 +74 Medication/supplement use 273725 phv00273725.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:47:10+00:00 2018-09-24 11:47:10+00:00 g3a027 If OCP use, form Collection Interval: Exam 1 +74 Medication/supplement use 273726 phv00273726.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:47:30+00:00 2018-09-24 11:47:30+00:00 g3a032 If OCP use, what is the total number of years over your lifetime that you used oral contraceptives pills, shots, or hormone implants? Collection Interval: Exam 1 +74 Medication/supplement use 273742 phv00273742.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:47:50+00:00 2018-09-24 11:47:50+00:00 g3a053 If periods stopped: Have you ever taken hormone replacement therapy (estrogen/progesterone)? Collection Interval: Exam 1 +74 Medication/supplement use 273743 phv00273743.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:48:11+00:00 2018-09-24 11:48:11+00:00 g3a054 If taken HRT: What age did you begin hormone replacement therapy? Collection Interval: Exam 1 +74 Medication/supplement use 273744 phv00273744.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:48:20+00:00 2018-09-24 11:48:20+00:00 g3a055 If taken HRT: For how long did you take hormones (years)? Collection Interval: Exam 1 +74 Medication/supplement use 273745 phv00273745.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:48:29+00:00 2018-09-24 11:48:29+00:00 g3a056 If taken HRT: For how long did you take hormones (months)? Collection Interval: Exam 1 +74 Medication/supplement use 273746 phv00273746.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:48:40+00:00 2018-09-24 11:48:40+00:00 g3a057 If taken HRT: Estrogen use ever? Collection Interval: Exam 1 +74 Medication/supplement use 273747 phv00273747.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:48:51+00:00 2018-09-24 11:48:51+00:00 g3a058 If estrogen use ever: Name of most recent estrogen preparation Collection Interval: Exam 1 +74 Medication/supplement use 273748 phv00273748.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:49:01+00:00 2018-09-24 11:49:01+00:00 g3a059 If estrogen use ever: The strength of estrogen Collection Interval: Exam 1 +74 Medication/supplement use 273749 phv00273749.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:49:11+00:00 2018-09-24 11:49:11+00:00 g3a060 If estrogen use ever: Number of days per month taken Collection Interval: Exam 1 +74 Medication/supplement use 273750 phv00273750.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:49:26+00:00 2018-09-24 11:49:26+00:00 g3a061 If taken HRT: Progesterone use ever? Collection Interval: Exam 1 +74 Medication/supplement use 273751 phv00273751.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:49:34+00:00 2018-09-24 11:49:34+00:00 g3a062 If progesterone use ever: Name of most recent progesterone preparation Collection Interval: Exam 1 +74 Medication/supplement use 273752 phv00273752.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:49:47+00:00 2018-09-24 11:49:47+00:00 g3a063 If progesterone use ever: The strength of progesterone Collection Interval: Exam 1 +74 Medication/supplement use 273753 phv00273753.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:49:56+00:00 2018-09-24 11:49:56+00:00 g3a064 If progesterone use ever: Number of days per month taken Collection Interval: Exam 1 +74 Medication/supplement use 273754 phv00273754.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:50:06+00:00 2018-09-24 11:50:06+00:00 g3a065 If periods stopped: Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? Collection Interval: Exam 1 +74 Medication/supplement use 273755 phv00273755.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:50:14+00:00 2018-09-24 11:50:14+00:00 g3a066 If used SERMs: Number of months used? Collection Interval: Exam 1 +74 Medication/supplement use 273756 phv00273756.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:50:27+00:00 2018-09-24 11:50:27+00:00 g3a067 If use SERMs: Current use? Collection Interval: Exam 1 +74 Medication/supplement use 273757 phv00273757.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:51:03+00:00 2018-09-24 11:51:03+00:00 g3a068 If periods stopped: Do you take over-the-counter alternative, herbal, or natural soy-based preparations to treat menopausal symptoms? Collection Interval: Exam 1 +74 Medication/supplement use 273758 phv00273758.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 11:51:16+00:00 2018-09-24 11:51:16+00:00 g3a069 If yes to G3A068: Specify preparation Collection Interval: Exam 1 +74 Medication/supplement use 250298 phv00250298.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:23:04+00:00 2018-09-24 12:23:04+00:00 e041 Numerical Data - Part I: Number of days since last dose of aspirin Collection Interval: Exam 1 +74 Medication/supplement use 250355 phv00250355.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:23:29+00:00 2018-09-24 12:23:29+00:00 e218 Medical History - Cardiovascular Medications: Number of aspirins Collection Interval: Exam 1 +74 Medication/supplement use 250356 phv00250356.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:23:40+00:00 2018-09-24 12:23:40+00:00 e219 Medical History - Cardiovascular Medications: Time interval for aspirin taken Collection Interval: Exam 1 +74 Medication/supplement use 250357 phv00250357.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:26:48+00:00 2018-09-24 12:26:48+00:00 e220 Medical History - Cardiovascular Medications: Any of the cardiovascular medications below Collection Interval: Exam 1 +74 Medication/supplement use 250358 phv00250358.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:26:58+00:00 2018-09-24 12:26:58+00:00 e221 Medical History - Cardiovascular Medications: Currently receiving medication for the treatment of hypertension? Collection Interval: Exam 1 +74 Medication/supplement use 250359 phv00250359.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:27:06+00:00 2018-09-24 12:27:06+00:00 e222 Medical History - Cardiovascular Medications: Cardiac Glycosides Collection Interval: Exam 1 +74 Medication/supplement use 250360 phv00250360.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:27:15+00:00 2018-09-24 12:27:15+00:00 e223 Medical History - Cardiovascular Medications: Nitroglycerine Collection Interval: Exam 1 +74 Medication/supplement use 250361 phv00250361.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:27:23+00:00 2018-09-24 12:27:23+00:00 e224 Medical History - Cardiovascular Medications: Longer acting nitrates (Isordil, Cardilate, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250362 phv00250362.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:27:32+00:00 2018-09-24 12:27:32+00:00 e225 Medical History - Cardiovascular Medications: Calcium Channel Blockers (Nifedipine, Verapamil, Diltiazem) Collection Interval: Exam 1 +74 Medication/supplement use 250363 phv00250363.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:27:40+00:00 2018-09-24 12:27:40+00:00 e226 Medical History - Cardiovascular Medications: Beta Blockers Collection Interval: Exam 1 +74 Medication/supplement use 250364 phv00250364.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:27:48+00:00 2018-09-24 12:27:48+00:00 e227 Medical History - Cardiovascular Medications: Beta Blockers Group Collection Interval: Exam 1 +74 Medication/supplement use 250365 phv00250365.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:27:55+00:00 2018-09-24 12:27:55+00:00 e228 Medical History - Cardiovascular Medications: Beta Blockers dose Collection Interval: Exam 1 +74 Medication/supplement use 250366 phv00250366.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:28:02+00:00 2018-09-24 12:28:02+00:00 e229 Medical History - Cardiovascular Medications: Loop diuretics (Lasix, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250367 phv00250367.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:28:21+00:00 2018-09-24 12:28:21+00:00 e230 Medical History - Cardiovascular Medications: Thiazide/K-sparing diuretics (Dyazide, Maxide, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250368 phv00250368.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:28:33+00:00 2018-09-24 12:28:33+00:00 e231 Medical History - Cardiovascular Medications: Thiazide diuretics Collection Interval: Exam 1 +74 Medication/supplement use 250369 phv00250369.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:28:42+00:00 2018-09-24 12:28:42+00:00 e232 Medical History - Cardiovascular Medications: K-sparing diuretics (Aldactone, Triamterene) Collection Interval: Exam 1 +74 Medication/supplement use 250370 phv00250370.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:28:50+00:00 2018-09-24 12:28:50+00:00 e233 Medical History - Cardiovascular Medications: Potassium supplements Collection Interval: Exam 1 +74 Medication/supplement use 250371 phv00250371.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:28:59+00:00 2018-09-24 12:28:59+00:00 e234 Medical History - Cardiovascular Medications: Reserpine derivatives Collection Interval: Exam 1 +74 Medication/supplement use 250372 phv00250372.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:29:07+00:00 2018-09-24 12:29:07+00:00 e235 Medical History - Cardiovascular Medications: Methyldopa (Aldomet) Collection Interval: Exam 1 +74 Medication/supplement use 250373 phv00250373.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:29:22+00:00 2018-09-24 12:29:22+00:00 e236 Medical History - Cardiovascular Medications: Alpha-1 agonist (Clonidine, Wytensin, Guanabenz) Collection Interval: Exam 1 +74 Medication/supplement use 250374 phv00250374.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:29:29+00:00 2018-09-24 12:29:29+00:00 e237 Medical History - Cardiovascular Medications: Alpha-2 blockers (Prazosin, Terazosin, Doxazosin) Collection Interval: Exam 1 +74 Medication/supplement use 250375 phv00250375.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:29:39+00:00 2018-09-24 12:29:39+00:00 e238 Medical History - Cardiovascular Medications: Renin-angiotensin blocking drugs (Captopril, Enalapril, Lisinopril) Collection Interval: Exam 1 +74 Medication/supplement use 250376 phv00250376.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:29:47+00:00 2018-09-24 12:29:47+00:00 e239 Medical History - Cardiovascular Medications: Peripheral vasodilators (Hydralazine, Minoxidil, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250377 phv00250377.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:29:57+00:00 2018-09-24 12:29:57+00:00 e240 Medical History - Cardiovascular Medications: Other anti-hypertensives Collection Interval: Exam 1 +74 Medication/supplement use 250378 phv00250378.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:30:06+00:00 2018-09-24 12:30:06+00:00 e241 Medical History - Cardiovascular Medications: Antiarrhythmics (Quinidine, Procainamide, Norpace, Disopyramide, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250379 phv00250379.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:30:15+00:00 2018-09-24 12:30:15+00:00 e242 Medical History - Cardiovascular Medications: Antiplatelet (Anturane, Persantine, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250380 phv00250380.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:30:25+00:00 2018-09-24 12:30:25+00:00 e243 Medical History - Cardiovascular Medications: Anticoagulants (Coudmadin, Warfarin, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250381 phv00250381.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:30:34+00:00 2018-09-24 12:30:34+00:00 e244 Medical History - Cardiovascular Medications: Other cardiac medication Collection Interval: Exam 1 +74 Medication/supplement use 250382 phv00250382.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:30:44+00:00 2018-09-24 12:30:44+00:00 e245 Medical History - Other Medications: Anti cholesterol drugs (Resins, e.g. Questran, Colestid) Collection Interval: Exam 1 +74 Medication/supplement use 250383 phv00250383.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:30:52+00:00 2018-09-24 12:30:52+00:00 e246 Medical History - Other Medications: Anti cholesterol drugs (Niacin or Nicotinic Acid) Collection Interval: Exam 1 +74 Medication/supplement use 250384 phv00250384.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:31:31+00:00 2018-09-24 12:31:31+00:00 e247 Medical History - Other Medications: Anti cholesterol drugs (Fibrates, e.g. Gemfibrozil) Collection Interval: Exam 1 +74 Medication/supplement use 250385 phv00250385.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:31:40+00:00 2018-09-24 12:31:40+00:00 e248 Medical History - Other Medications: Anti cholesterol drugs (Statins, e.g. Lovastatin, Pravastatin) Collection Interval: Exam 1 +74 Medication/supplement use 250386 phv00250386.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:31:50+00:00 2018-09-24 12:31:50+00:00 e249 Medical History - Other Medications: Anti cholesterol drugs (Other) Collection Interval: Exam 1 +74 Medication/supplement use 250387 phv00250387.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:32:00+00:00 2018-09-24 12:32:00+00:00 e250 Medical History - Other Medications: Antigout--uric acid lowering (Allopurinol, Probenecid etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250388 phv00250388.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:32:09+00:00 2018-09-24 12:32:09+00:00 e251 Medical History - Other Medications: Antigout (Colchicine) Collection Interval: Exam 1 +74 Medication/supplement use 250389 phv00250389.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:32:20+00:00 2018-09-24 12:32:20+00:00 e252 Medical History - Other Medications: Thyroid extract (Dessicated thyroid) Collection Interval: Exam 1 +74 Medication/supplement use 250390 phv00250390.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:32:29+00:00 2018-09-24 12:32:29+00:00 e253 Medical History - Other Medications: Thyroxine (Synthroid etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250391 phv00250391.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:32:38+00:00 2018-09-24 12:32:38+00:00 e254 Medical History - Other Medications: Insulin Collection Interval: Exam 1 +74 Medication/supplement use 250392 phv00250392.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:32:46+00:00 2018-09-24 12:32:46+00:00 e255 Medical History - Other Medications: Total units of insulin per day Collection Interval: Exam 1 +74 Medication/supplement use 250393 phv00250393.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:32:54+00:00 2018-09-24 12:32:54+00:00 e256 Medical History - Other Medications: Oral hypoglycemics Collection Interval: Exam 1 +74 Medication/supplement use 250394 phv00250394.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:33:03+00:00 2018-09-24 12:33:03+00:00 e257 Medical History - Other Medications: Oral/patch estrogen Collection Interval: Exam 1 +74 Medication/supplement use 250395 phv00250395.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:33:14+00:00 2018-09-24 12:33:14+00:00 e258 Medical History - Other Medications: Oral glucocorticoids (Prednisone, Cortisone, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250396 phv00250396.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:33:23+00:00 2018-09-24 12:33:23+00:00 e259 Medical History - Other Medications: Non-steroidal anti-inflammatory agents (Motrin, Ibuprofen, Naprosyn, Indocin, Clinoril) Collection Interval: Exam 1 +74 Medication/supplement use 250397 phv00250397.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:33:32+00:00 2018-09-24 12:33:32+00:00 e260 Medical History - Other Medications: Analgesic-narcotics (Demerol, Codeine, Dilaudid, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250398 phv00250398.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:33:41+00:00 2018-09-24 12:33:41+00:00 e261 Medical History - Other Medications: Analgesic-non-narcotics (Acetaminophen, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250399 phv00250399.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:33:50+00:00 2018-09-24 12:33:50+00:00 e262 Medical History - Other Medications: Bronchodilators, Aerosols, etc. Collection Interval: Exam 1 +74 Medication/supplement use 250400 phv00250400.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:33:59+00:00 2018-09-24 12:33:59+00:00 e263 Medical History - Other Medications: Antihistamines Collection Interval: Exam 1 +74 Medication/supplement use 250401 phv00250401.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:34:09+00:00 2018-09-24 12:34:09+00:00 e264 Medical History - Other Medications: Antiulcer (Tagamet, Ranitidine, Probanthine, H ion inhibitors) Collection Interval: Exam 1 +74 Medication/supplement use 250402 phv00250402.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:34:17+00:00 2018-09-24 12:34:17+00:00 e265 Medical History - Other Medications: Anti-anxiety, Sedative/Hypnotics etc. (Librium, Valium, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250403 phv00250403.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:34:26+00:00 2018-09-24 12:34:26+00:00 e266 Medical History - Other Medications: Sleeping pills Collection Interval: Exam 1 +74 Medication/supplement use 250404 phv00250404.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:34:36+00:00 2018-09-24 12:34:36+00:00 e267 Medical History - Other Medications: Anti-depressants Collection Interval: Exam 1 +74 Medication/supplement use 250405 phv00250405.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:34:44+00:00 2018-09-24 12:34:44+00:00 e268 Medical History - Other Medications: Eye drops Collection Interval: Exam 1 +74 Medication/supplement use 250406 phv00250406.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:34:54+00:00 2018-09-24 12:34:54+00:00 e269 Medical History - Other Medications: Antibiotics Collection Interval: Exam 1 +74 Medication/supplement use 250407 phv00250407.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:35:02+00:00 2018-09-24 12:35:02+00:00 e270 Medical History - Other Medications: Anti-parkinson drugs (Sinemet, L-Dopa, Symmetrel, Cogentin, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250408 phv00250408.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:35:11+00:00 2018-09-24 12:35:11+00:00 e271 Medical History - Other Medications: Anticonvulsants (Dilantin, Phenobarb, Tegretol, Mysoline, etc.) Collection Interval: Exam 1 +74 Medication/supplement use 250409 phv00250409.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:35:20+00:00 2018-09-24 12:35:20+00:00 e272 Medical History - Other Medications: Others Collection Interval: Exam 1 +74 Medication/supplement use 250413 phv00250413.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:35:51+00:00 2018-09-24 12:35:51+00:00 e280 Medical History - Female Genitourinary Disease: Oral contraceptives in interim Collection Interval: Exam 1 +74 Medication/supplement use 250414 phv00250414.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:35:59+00:00 2018-09-24 12:35:59+00:00 e281 Medical History - Female Genitourinary Disease: Conjugated estrogen use in interim (e.g. Premarin) Collection Interval: Exam 1 +74 Medication/supplement use 250415 phv00250415.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:36:09+00:00 2018-09-24 12:36:09+00:00 e282 Medical History - Female Genitourinary Disease: Oral dose per day of premarin or conjugated Estrogens Collection Interval: Exam 1 +74 Medication/supplement use 250416 phv00250416.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:36:18+00:00 2018-09-24 12:36:18+00:00 e283 Medical History - Female Genitourinary Disease: Patch dose per day of estrogen Collection Interval: Exam 1 +74 Medication/supplement use 250417 phv00250417.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:36:29+00:00 2018-09-24 12:36:29+00:00 e284 Medical History - Female Genitourinary Disease: Number of days per month taking estrogens Collection Interval: Exam 1 +74 Medication/supplement use 250418 phv00250418.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:36:39+00:00 2018-09-24 12:36:39+00:00 e285 Medical History - Female Genitourinary Disease: Estrogen cream use in interim Collection Interval: Exam 1 +74 Medication/supplement use 250419 phv00250419.v1.p10 pht004813.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:37:06+00:00 2018-09-24 12:37:06+00:00 e286 Medical History - Female Genitourinary Disease: Progesterone use in interim Collection Interval: Exam 1 +74 Medication/supplement use 274200 phv00274200.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:46:46+00:00 2018-09-24 12:46:46+00:00 g3a008 Take aspirin regularly? +74 Medication/supplement use 274201 phv00274201.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:46:57+00:00 2018-09-24 12:46:57+00:00 g3a009 If take aspirin regularly: Number aspirins taken +74 Medication/supplement use 274202 phv00274202.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:47:08+00:00 2018-09-24 12:47:08+00:00 g3a010 If take aspirin regularly: Frequency per +74 Medication/supplement use 274203 phv00274203.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:47:18+00:00 2018-09-24 12:47:18+00:00 g3a011 If take aspirin regularly: Usual dose +74 Medication/supplement use 274204 phv00274204.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:47:30+00:00 2018-09-24 12:47:30+00:00 g3a012 Have you ever taken medication for hypertension/high blood pressure? +74 Medication/supplement use 274205 phv00274205.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:47:40+00:00 2018-09-24 12:47:40+00:00 g3a013 If yes to G3A012, at what age did you begin +74 Medication/supplement use 274206 phv00274206.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:47:48+00:00 2018-09-24 12:47:48+00:00 g3a014 Have you ever taken medication for high blood cholesterol? +74 Medication/supplement use 274207 phv00274207.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:47:59+00:00 2018-09-24 12:47:59+00:00 g3a015 If yes to G3A014, at what age did you begin taking medication for this? +74 Medication/supplement use 274208 phv00274208.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:48:08+00:00 2018-09-24 12:48:08+00:00 g3a016 Have you ever taken medication for high blood sugar or diabetes? +74 Medication/supplement use 274209 phv00274209.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:48:18+00:00 2018-09-24 12:48:18+00:00 g3a017 If yes to G3A016, at what age did you begin +74 Medication/supplement use 274210 phv00274210.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:48:27+00:00 2018-09-24 12:48:27+00:00 g3a018 If yes to G3A016, was insulin your first diabetes medication? +74 Medication/supplement use 274212 phv00274212.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:48:52+00:00 2018-09-24 12:48:52+00:00 g3a020 Have you ever taken medication for cardiovascular disease (for example angina/chest pain, heart failure, atrial fibrillation/heart rhythm abnormality, stroke, leg pain when walking?) +74 Medication/supplement use 274213 phv00274213.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:49:03+00:00 2018-09-24 12:49:03+00:00 g3a021 If yes to G3A020, at what age did you begin +74 Medication/supplement use 274215 phv00274215.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:49:13+00:00 2018-09-24 12:49:13+00:00 g3a024 Have you ever taken or used oral contraceptive pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)? +74 Medication/supplement use 274216 phv00274216.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:49:23+00:00 2018-09-24 12:49:23+00:00 g3a025 If OCP use, what is the name of the current or most recent oral contraceptive, shot or implant used? +74 Medication/supplement use 274217 phv00274217.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:49:32+00:00 2018-09-24 12:49:32+00:00 g3a026 If OCP use, strength +74 Medication/supplement use 274218 phv00274218.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:49:41+00:00 2018-09-24 12:49:41+00:00 g3a027 If OCP use, form +74 Medication/supplement use 274219 phv00274219.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:49:57+00:00 2018-09-24 12:49:57+00:00 g3a032 If OCP use, what is the total number of years over your lifetime that you used oral contraceptives pills, shots, or hormone implants? +74 Medication/supplement use 274235 phv00274235.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:50:12+00:00 2018-09-24 12:50:12+00:00 g3a053 If periods stopped: Have you ever taken hormone replacement therapy (estrogen/progesterone)? +74 Medication/supplement use 274236 phv00274236.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:50:23+00:00 2018-09-24 12:50:23+00:00 g3a054 If taken HRT: What age did you begin hormone replacement therapy? +74 Medication/supplement use 274237 phv00274237.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:50:33+00:00 2018-09-24 12:50:33+00:00 g3a055 If taken HRT: For how long did you take hormones (years)? +74 Medication/supplement use 274238 phv00274238.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:50:44+00:00 2018-09-24 12:50:44+00:00 g3a056 If taken HRT: For how long did you take hormones (months)? +74 Medication/supplement use 274239 phv00274239.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:50:55+00:00 2018-09-24 12:50:55+00:00 g3a057 If taken HRT: Estrogen use ever? +74 Medication/supplement use 274240 phv00274240.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:51:08+00:00 2018-09-24 12:51:08+00:00 g3a058 If estrogen use ever: Name of most recent estrogen preparation +74 Medication/supplement use 274241 phv00274241.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:51:16+00:00 2018-09-24 12:51:16+00:00 g3a059 If estrogen use ever: The strength of estrogen +74 Medication/supplement use 274242 phv00274242.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:51:24+00:00 2018-09-24 12:51:24+00:00 g3a060 If estrogen use ever: Number of days per month taken +74 Medication/supplement use 274243 phv00274243.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:51:34+00:00 2018-09-24 12:51:34+00:00 g3a061 If taken HRT: Progesterone use ever? +74 Medication/supplement use 274244 phv00274244.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:51:42+00:00 2018-09-24 12:51:42+00:00 g3a062 If progesterone use ever: Name of most recent progesterone preparation +74 Medication/supplement use 274245 phv00274245.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:51:57+00:00 2018-09-24 12:51:57+00:00 g3a063 If progesterone use ever: The strength of progesterone +74 Medication/supplement use 274246 phv00274246.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:52:06+00:00 2018-09-24 12:52:06+00:00 g3a064 If progesterone use ever: Number of days per month taken +74 Medication/supplement use 274247 phv00274247.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:52:15+00:00 2018-09-24 12:52:15+00:00 g3a065 If periods stopped: Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? +74 Medication/supplement use 274248 phv00274248.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:52:24+00:00 2018-09-24 12:52:24+00:00 g3a066 If used SERMs: Number of months used? +74 Medication/supplement use 274249 phv00274249.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:52:52+00:00 2018-09-24 12:52:52+00:00 g3a067 If use SERMs: Current use? +74 Medication/supplement use 274250 phv00274250.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:53:07+00:00 2018-09-24 12:53:07+00:00 g3a068 If periods stopped: Do you take over-the-counter alternative, herbal, or natural soy-based preparations to treat menopausal symptoms? +74 Medication/supplement use 274251 phv00274251.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 12:53:19+00:00 2018-09-24 12:53:19+00:00 g3a069 If yes to G3A068: Specify OTC menopausal symptom preparation +74 Medication/supplement use 250725 phv00250725.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:08:54+00:00 2018-09-24 13:08:54+00:00 g008 Medical History - Cardiovascular Medications: In the interim have you taken medication for the treatment of hypertension? Collection Interval: Exam 2 +74 Medication/supplement use 250726 phv00250726.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:09:04+00:00 2018-09-24 13:09:04+00:00 g009 Medical History - Cardiovascular Medications: Any of the cardiovascular medications in the following section, if yes, continue Collection Interval: Exam 2 +74 Medication/supplement use 250727 phv00250727.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:09:14+00:00 2018-09-24 13:09:14+00:00 g010 Medical History - Cardiovascular Medications: Cardiac glycosides Collection Interval: Exam 2 +74 Medication/supplement use 250728 phv00250728.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:09:24+00:00 2018-09-24 13:09:24+00:00 g011 Medical History - Cardiovascular Medications: Nitroglycerine Collection Interval: Exam 2 +74 Medication/supplement use 250729 phv00250729.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:09:34+00:00 2018-09-24 13:09:34+00:00 g012 Medical History - Cardiovascular Medications: Longer acting nitrates Collection Interval: Exam 2 +74 Medication/supplement use 250730 phv00250730.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:09:45+00:00 2018-09-24 13:09:45+00:00 g013 Medical History - Cardiovascular Medications: Calcium channel blockers (specify) Collection Interval: Exam 2 +74 Medication/supplement use 250731 phv00250731.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:09:55+00:00 2018-09-24 13:09:55+00:00 g014 Medical History - Cardiovascular Medications: Calcium channel blocker group Collection Interval: Exam 2 +74 Medication/supplement use 250732 phv00250732.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:10:14+00:00 2018-09-24 13:10:14+00:00 g015 Medical History - Cardiovascular Medications: Tablet size of calcium channel broker Collection Interval: Exam 2 +74 Medication/supplement use 250733 phv00250733.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:10:23+00:00 2018-09-24 13:10:23+00:00 g016 Medical History - Cardiovascular Medications: Number of times calcium channel blocker taken per day Collection Interval: Exam 2 +74 Medication/supplement use 250734 phv00250734.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:10:34+00:00 2018-09-24 13:10:34+00:00 g017 Medical History - Cardiovascular Medications: Beta blockers (specify) Collection Interval: Exam 2 +74 Medication/supplement use 250735 phv00250735.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:10:43+00:00 2018-09-24 13:10:43+00:00 g018 Medical History - Cardiovascular Medications: Beta blocker group Collection Interval: Exam 2 +74 Medication/supplement use 250736 phv00250736.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:10:52+00:00 2018-09-24 13:10:52+00:00 g019 Medical History - Cardiovascular Medications: Dose of beta blocker Collection Interval: Exam 2 +74 Medication/supplement use 250737 phv00250737.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:11:01+00:00 2018-09-24 13:11:01+00:00 g020 Medical History - Cardiovascular Medications: Loop diuretics (Lasix, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250738 phv00250738.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:11:10+00:00 2018-09-24 13:11:10+00:00 g021 Medical History - Cardiovascular Medications: Thiazide/K-sparing diuretics (Dyazide, Maxide, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250739 phv00250739.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:11:20+00:00 2018-09-24 13:11:20+00:00 g022 Medical History - Cardiovascular Medications: Thiazide diuretics Collection Interval: Exam 2 +74 Medication/supplement use 250740 phv00250740.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:11:28+00:00 2018-09-24 13:11:28+00:00 g023 Medical History - Cardiovascular Medications: K-sparing diuretics (Aldactone, Triamterene) Collection Interval: Exam 2 +74 Medication/supplement use 250741 phv00250741.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:11:41+00:00 2018-09-24 13:11:41+00:00 g024 Medical History - Cardiovascular Medications: Potassium supplements Collection Interval: Exam 2 +74 Medication/supplement use 250742 phv00250742.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:11:52+00:00 2018-09-24 13:11:52+00:00 g025 Medical History - Cardiovascular Medications: Reserpine derivatives Collection Interval: Exam 2 +74 Medication/supplement use 250743 phv00250743.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:12:04+00:00 2018-09-24 13:12:04+00:00 g026 Medical History - Cardiovascular Medications: Methyldopa (Aldomet) Collection Interval: Exam 2 +74 Medication/supplement use 250744 phv00250744.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:12:13+00:00 2018-09-24 13:12:13+00:00 g027 Medical History - Cardiovascular Medications: Alpha-1 agonist (Clonidine, Wytensin, Guanabenz) Collection Interval: Exam 2 +74 Medication/supplement use 250745 phv00250745.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:12:23+00:00 2018-09-24 13:12:23+00:00 g028 Medical History - Cardiovascular Medications: Alpha-2 blockers (Prazosin, Terazosin, Doxazosin) Collection Interval: Exam 2 +74 Medication/supplement use 250746 phv00250746.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:12:33+00:00 2018-09-24 13:12:33+00:00 g029 Medical History - Cardiovascular Medications: Renin-angiotensin blocking drugs (ACE) (Captopril, Enalapril, Lisinopril) Collection Interval: Exam 2 +74 Medication/supplement use 250747 phv00250747.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:12:43+00:00 2018-09-24 13:12:43+00:00 g030 Medical History - Cardiovascular Medications: Peripheral vasodilators (Hydralazine, Minoxidil, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250748 phv00250748.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:12:54+00:00 2018-09-24 13:12:54+00:00 g031 Medical History - Cardiovascular Medications: Angiotensin II antagonists (Losartan etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250749 phv00250749.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:13:05+00:00 2018-09-24 13:13:05+00:00 g032 Medical History - Cardiovascular Medications: Other anti-hypertensives (Losartan etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250750 phv00250750.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:13:13+00:00 2018-09-24 13:13:13+00:00 g033 Medical History - Cardiovascular Medications: Antiarrhythmics (Quinidine, Procainamide, Amiodarone, Sotalol, Disopyramide, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250751 phv00250751.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:13:24+00:00 2018-09-24 13:13:24+00:00 g034 Medical History - Cardiovascular Medications: Antiplatelet (Anturane, Persantine, Ticlopidine), specify Collection Interval: Exam 2 +74 Medication/supplement use 250752 phv00250752.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:13:33+00:00 2018-09-24 13:13:33+00:00 g035 Medical History - Cardiovascular Medications: Anticoagulants (Coumadin, Warfarin, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250753 phv00250753.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:13:41+00:00 2018-09-24 13:13:41+00:00 g036 Medical History - Cardiovascular Medications: Other cardiac medication (specify) Collection Interval: Exam 2 +74 Medication/supplement use 250754 phv00250754.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:13:49+00:00 2018-09-24 13:13:49+00:00 g037 Medical History - Aspirin: Take aspirin regularly? Collection Interval: Exam 2 +74 Medication/supplement use 250755 phv00250755.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:13:58+00:00 2018-09-24 13:13:58+00:00 g038 Medical History - Aspirin: Number aspirin taken regularly Collection Interval: Exam 2 +74 Medication/supplement use 250756 phv00250756.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:14:20+00:00 2018-09-24 13:14:20+00:00 g039 Medical History - Aspirin: Aspirin frequency - number taken regularly Collection Interval: Exam 2 +74 Medication/supplement use 250757 phv00250757.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:15:32+00:00 2018-09-24 13:15:32+00:00 g040 Medical History - Aspirin: Usual aspirin dose for above Collection Interval: Exam 2 +74 Medication/supplement use 250758 phv00250758.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:15:40+00:00 2018-09-24 13:15:40+00:00 g041 Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Resins-e.g. Questran, Colestid) Collection Interval: Exam 2 +74 Medication/supplement use 250759 phv00250759.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:15:48+00:00 2018-09-24 13:15:48+00:00 g042 Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Niacin or Nicotinic acid) Collection Interval: Exam 2 +74 Medication/supplement use 250760 phv00250760.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:15:56+00:00 2018-09-24 13:15:56+00:00 g043 Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Fibrates-e.g. Gemfibrozil) Collection Interval: Exam 2 +74 Medication/supplement use 250761 phv00250761.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:16:05+00:00 2018-09-24 13:16:05+00:00 g044 Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Statins-e.g. Lovastatin, Pravastatin) Collection Interval: Exam 2 +74 Medication/supplement use 250762 phv00250762.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:16:13+00:00 2018-09-24 13:16:13+00:00 g045 Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (other-specify) Collection Interval: Exam 2 +74 Medication/supplement use 250763 phv00250763.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:16:29+00:00 2018-09-24 13:16:29+00:00 g046 Medical History - Interim Non-cardiovascular Medications I: Antigout-uric acid lowering (Allopurinol, Probenecid ect) Collection Interval: Exam 2 +74 Medication/supplement use 250764 phv00250764.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:16:38+00:00 2018-09-24 13:16:38+00:00 g047 Medical History - Interim Non-cardiovascular Medications I: Antigout - (Colchicine) Collection Interval: Exam 2 +74 Medication/supplement use 250765 phv00250765.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:16:50+00:00 2018-09-24 13:16:50+00:00 g048 Medical History - Interim Non-cardiovascular Medications I: Thyroid extract (Dessicated Thyroid) Collection Interval: Exam 2 +74 Medication/supplement use 250766 phv00250766.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:16:58+00:00 2018-09-24 13:16:58+00:00 g049 Medical History - Interim Non-cardiovascular Medications I: Thyroixine (Synthroid etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250767 phv00250767.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:17:07+00:00 2018-09-24 13:17:07+00:00 g050 Medical History - Interim Non-cardiovascular Medications I: Insulin Collection Interval: Exam 2 +74 Medication/supplement use 250768 phv00250768.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:17:19+00:00 2018-09-24 13:17:19+00:00 g051 Medical History - Interim Non-cardiovascular Medications I: Total units of insulin a day Collection Interval: Exam 2 +74 Medication/supplement use 250769 phv00250769.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:17:28+00:00 2018-09-24 13:17:28+00:00 g052 Medical History - Interim Non-cardiovascular Medications I: Oral hypoglycemics Collection Interval: Exam 2 +74 Medication/supplement use 250770 phv00250770.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:17:50+00:00 2018-09-24 13:17:50+00:00 g053 Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Metformin Collection Interval: Exam 2 +74 Medication/supplement use 250771 phv00250771.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:18:06+00:00 2018-09-24 13:18:06+00:00 g054 Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Triglitazone Collection Interval: Exam 2 +74 Medication/supplement use 250772 phv00250772.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:18:16+00:00 2018-09-24 13:18:16+00:00 g055 Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Glipizide Collection Interval: Exam 2 +74 Medication/supplement use 250773 phv00250773.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:18:26+00:00 2018-09-24 13:18:26+00:00 g056 Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Glyburide Collection Interval: Exam 2 +74 Medication/supplement use 250774 phv00250774.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:18:35+00:00 2018-09-24 13:18:35+00:00 g057 Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Chlorpropamide Collection Interval: Exam 2 +74 Medication/supplement use 250775 phv00250775.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:18:44+00:00 2018-09-24 13:18:44+00:00 g058 Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Other (specify) Collection Interval: Exam 2 +74 Medication/supplement use 250776 phv00250776.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:18:52+00:00 2018-09-24 13:18:52+00:00 g059 Medical History - Interim Non-cardiovascular Medications I: Oral Hypoglycemic: Unknown Collection Interval: Exam 2 +74 Medication/supplement use 250777 phv00250777.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:19:02+00:00 2018-09-24 13:19:02+00:00 g060 Medical History - Interim Non-cardiovascular Medications I: Oral/patch estrogen (for women users also see estrogen section G088-G096) Collection Interval: Exam 2 +74 Medication/supplement use 250778 phv00250778.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:19:11+00:00 2018-09-24 13:19:11+00:00 g061 Medical History - Interim Non-cardiovascular Medications I: Oral glucocorticoids (Prednisone, Cortisone, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250779 phv00250779.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:19:19+00:00 2018-09-24 13:19:19+00:00 g062 Medical History - Non-cardiovascular Medications II - Interim Medications: Non-steroidal anti-inflammatory agents (NSAIDS) (Motrin, Ibuprofen, Naprosyn, Indocin, Cliinoril) Collection Interval: Exam 2 +74 Medication/supplement use 250780 phv00250780.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:19:28+00:00 2018-09-24 13:19:28+00:00 g063 Medical History - Non-cardiovascular Medications II - Interim Medications: Analgesic-narcotics (Demerol, Codeline, Dilaudid, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250781 phv00250781.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:19:36+00:00 2018-09-24 13:19:36+00:00 g064 Medical History - Non-cardiovascular Medications II - Interim Medications: Analgesic-non-narcotics (Acetaminophen etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250782 phv00250782.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:19:46+00:00 2018-09-24 13:19:46+00:00 g065 Medical History - Non-cardiovascular Medications II - Interim Medications: Antihistamines Collection Interval: Exam 2 +74 Medication/supplement use 250783 phv00250783.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:19:54+00:00 2018-09-24 13:19:54+00:00 g066 Medical History - Non-cardiovascular Medications II - Interim Medications: Antiulcer (Tagamet, Ranitidine, Probanthine, H ion inhibitors) Collection Interval: Exam 2 +74 Medication/supplement use 250784 phv00250784.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:20:01+00:00 2018-09-24 13:20:01+00:00 g067 Medical History - Non-cardiovascular Medications II - Interim Medications: Anti-anxiety, Sedative/Hypnotics etc. (Librium, Valium, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250785 phv00250785.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:20:09+00:00 2018-09-24 13:20:09+00:00 g068 Medical History - Non-cardiovascular Medications II - Interim Medications: Sleeping pills Collection Interval: Exam 2 +74 Medication/supplement use 250786 phv00250786.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:20:17+00:00 2018-09-24 13:20:17+00:00 g069 Medical History - Non-cardiovascular Medications II - Interim Medications: Anti-depressants Collection Interval: Exam 2 +74 Medication/supplement use 250787 phv00250787.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:20:26+00:00 2018-09-24 13:20:26+00:00 g070 Medical History - Non-cardiovascular Medications II - Interim Medications: Eyedrops Collection Interval: Exam 2 +74 Medication/supplement use 250788 phv00250788.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:20:36+00:00 2018-09-24 13:20:36+00:00 g071 Medical History - Non-cardiovascular Medications II - Interim Medications: Antibiotics Collection Interval: Exam 2 +74 Medication/supplement use 250789 phv00250789.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:21:08+00:00 2018-09-24 13:21:08+00:00 g072 Medical History - Non-cardiovascular Medications II - Interim Medications: Anti-parkinson drugs (Sinemet, L-dopa, Symmetrel, Cogentin, etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250790 phv00250790.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:21:20+00:00 2018-09-24 13:21:20+00:00 g073 Medical History - Non-cardiovascular Medications II - Interim Medications: Anticonvulsants (Dilantin, Phenobarbital, Tegretol, Mysoline etc.) Collection Interval: Exam 2 +74 Medication/supplement use 250791 phv00250791.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:21:29+00:00 2018-09-24 13:21:29+00:00 g074 Medical History - Non-cardiovascular Medications II - Interim Medications: Bronchodilators and aerosols Collection Interval: Exam 2 +74 Medication/supplement use 250792 phv00250792.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:21:42+00:00 2018-09-24 13:21:42+00:00 g075 Medical History - Non-cardiovascular Medications II - Interim Medications: Osteroporosis medications Collection Interval: Exam 2 +74 Medication/supplement use 250793 phv00250793.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:21:54+00:00 2018-09-24 13:21:54+00:00 g076 Medical History - Non-cardiovascular Medications II - Interim Medications: Others specify Collection Interval: Exam 2 +74 Medication/supplement use 250798 phv00250798.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:22:20+00:00 2018-09-24 13:22:20+00:00 g087 Medical History - Female Genitourinary Disease 1: Oral contraceptives in interim Collection Interval: Exam 2 +74 Medication/supplement use 250799 phv00250799.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:22:29+00:00 2018-09-24 13:22:29+00:00 g088 Medical History - Female Genitourinary Disease 2: Estrogen replacement in interim Collection Interval: Exam 2 +74 Medication/supplement use 250800 phv00250800.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:22:37+00:00 2018-09-24 13:22:37+00:00 g089 Medical History - Female Genitourinary Disease 2: Dose/day of premarin conjugated estrogens, or other oral estrogen Collection Interval: Exam 2 +74 Medication/supplement use 250801 phv00250801.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:22:46+00:00 2018-09-24 13:22:46+00:00 g090 Medical History - Female Genitourinary Disease 2: Patch dose of estrogen Collection Interval: Exam 2 +74 Medication/supplement use 250802 phv00250802.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:22:56+00:00 2018-09-24 13:22:56+00:00 g091 Medical History - Female Genitourinary Disease 2: Number of days a month taking estrogens Collection Interval: Exam 2 +74 Medication/supplement use 250803 phv00250803.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:23:07+00:00 2018-09-24 13:23:07+00:00 g092 Medical History - Female Genitourinary Disease 2: Number of years on estrogen Collection Interval: Exam 2 +74 Medication/supplement use 250804 phv00250804.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:23:17+00:00 2018-09-24 13:23:17+00:00 g093 Medical History - Female Genitourinary Disease 2: Estrogen cream use in interim Collection Interval: Exam 2 +74 Medication/supplement use 250805 phv00250805.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:23:25+00:00 2018-09-24 13:23:25+00:00 g094 Medical History - Female Genitourinary Disease 2: Progestin replacement in interim Collection Interval: Exam 2 +74 Medication/supplement use 250806 phv00250806.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:23:35+00:00 2018-09-24 13:23:35+00:00 g095 Medical History - Female Genitourinary Disease 2: Dose/day of progestin Collection Interval: Exam 2 +74 Medication/supplement use 250807 phv00250807.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:23:43+00:00 2018-09-24 13:23:43+00:00 g096 Medical History - Female Genitourinary Disease 2: Number of days a month taking progestins Collection Interval: Exam 2 +74 Medication/supplement use 251237 phv00251237.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:25:37+00:00 2018-09-24 13:25:37+00:00 g672 Respiratory Questionnaire - Asthma: Are you currently taking any medicines (including inhalers, aerosols, or tablets) for asthma? Collection Interval: Exam 2 +74 Medication/supplement use 251244 phv00251244.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:25:55+00:00 2018-09-24 13:25:55+00:00 g679 Respiratory Questionnaire - Steroid Medications: Are you currently taking any steroid medications? Collection Interval: Exam 2 +74 Medication/supplement use 251245 phv00251245.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:26:07+00:00 2018-09-24 13:26:07+00:00 g680 Respiratory Questionnaire - Smoking: If yes, by what route - Oral Collection Interval: Exam 2 +74 Medication/supplement use 251248 phv00251248.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:27:23+00:00 2018-09-24 13:27:23+00:00 g683 Respiratory Questionnaire: If yes, by what route - Nasal Collection Interval: Exam 2 +74 Medication/supplement use 251271 phv00251271.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:29:40+00:00 2018-09-24 13:29:40+00:00 h010 Medical History - Medications: Do you take aspirin regularly? Collection Interval: Exam 3 +74 Medication/supplement use 251272 phv00251272.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:29:53+00:00 2018-09-24 13:29:53+00:00 h011 Medical History - Medications: Number of aspirins taken regularly Collection Interval: Exam 3 +74 Medication/supplement use 251273 phv00251273.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:30:00+00:00 2018-09-24 13:30:00+00:00 h012 Medical History - Medications: Aspirin frequency per Collection Interval: Exam 3 +74 Medication/supplement use 251274 phv00251274.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:30:08+00:00 2018-09-24 13:30:08+00:00 h013 Medical History - Medications: Usual dose of aspirin Collection Interval: Exam 3 +74 Medication/supplement use 251275 phv00251275.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:30:16+00:00 2018-09-24 13:30:16+00:00 h014 Medical History - Medications: Since your last exam have you taken medication for high blood pressure or hypertension? Collection Interval: Exam 3 +74 Medication/supplement use 251276 phv00251276.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:30:23+00:00 2018-09-24 13:30:23+00:00 h015 Medical History - Medications: Since your last exam have you taken medication for high blood cholesterol or high triglycerides? Collection Interval: Exam 3 +74 Medication/supplement use 251277 phv00251277.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:30:30+00:00 2018-09-24 13:30:30+00:00 h016 Medical History - Medications: Since your last exam have you been told by a doctor you have high blood sugar or diabetes? Collection Interval: Exam 3 +74 Medication/supplement use 251278 phv00251278.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:30:49+00:00 2018-09-24 13:30:49+00:00 h017 Medical History - Medications: Since your last exam have you taken medication for cardiovascular disease? Collection Interval: Exam 3 +74 Medication/supplement use 251279 phv00251279.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:31:03+00:00 2018-09-24 13:31:03+00:00 h024 Medical History - Female Reproductive History - Part 1: Since your last exam have you taken or used oral contraceptive pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)? Collection Interval: Exam 3 +74 Medication/supplement use 251280 phv00251280.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:31:18+00:00 2018-09-24 13:31:18+00:00 h027 Medical History - Female Reproductive History - Part 1: What is the form of the current or most recent oral contraceptive, shot or implant used? Collection Interval: Exam 3 +74 Medication/supplement use 251284 phv00251284.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:31:31+00:00 2018-09-24 13:31:31+00:00 h045 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Since your last exam have you taken hormone replacement therapy? (estrogen/progesterone) Collection Interval: Exam 3 +74 Medication/supplement use 251285 phv00251285.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:31:42+00:00 2018-09-24 13:31:42+00:00 h046 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - At what age did you begin hormone replacement therapy? Collection Interval: Exam 3 +74 Medication/supplement use 251286 phv00251286.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:31:53+00:00 2018-09-24 13:31:53+00:00 h047 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - For how long did you take hormones? - years Collection Interval: Exam 3 +74 Medication/supplement use 251287 phv00251287.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:32:02+00:00 2018-09-24 13:32:02+00:00 h048 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - For how long did you take hormones? - months Collection Interval: Exam 3 +74 Medication/supplement use 251288 phv00251288.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:32:13+00:00 2018-09-24 13:32:13+00:00 h049 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Estrogen use? Collection Interval: Exam 3 +74 Medication/supplement use 251289 phv00251289.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:32:23+00:00 2018-09-24 13:32:23+00:00 h052 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Number of days per month estrogen was taken Collection Interval: Exam 3 +74 Medication/supplement use 251290 phv00251290.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:32:34+00:00 2018-09-24 13:32:34+00:00 h053 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Progesterone use? Collection Interval: Exam 3 +74 Medication/supplement use 251291 phv00251291.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:32:46+00:00 2018-09-24 13:32:46+00:00 h056 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Number of days per month progesterone was taken Collection Interval: Exam 3 +74 Medication/supplement use 251292 phv00251292.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:32:57+00:00 2018-09-24 13:32:57+00:00 h057 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? Collection Interval: Exam 3 +74 Medication/supplement use 251293 phv00251293.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:33:35+00:00 2018-09-24 13:33:35+00:00 h058 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? - Number of months used Collection Interval: Exam 3 +74 Medication/supplement use 251294 phv00251294.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:34:19+00:00 2018-09-24 13:34:19+00:00 h059 Medical History - Female Reproductive History - Part 2: IF PERIODS STOPPED - Have you used Evista (raloxifene) or Nolvadex (tamoxifen) or other selective estrogen receptor modulator (SERM)? - Current use Collection Interval: Exam 3 +74 Medication/supplement use 251726 phv00251726.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:35:37+00:00 2018-09-24 13:35:37+00:00 h670 Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: Do you take inhalers or bronchodilators? Collection Interval: Exam 3 +74 Medication/supplement use 251727 phv00251727.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:35:48+00:00 2018-09-24 13:35:48+00:00 h671 Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: Do you use any of these medications - Albuterol, Proventil, Ventolin, Combivent, Maxari, Volmax, Xopenex, Bronkoometer, pirubuterol, levalbuterol, or metaproterenol? Collection Interval: Exam 3 +74 Medication/supplement use 251729 phv00251729.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 13:36:13+00:00 2018-09-24 13:36:13+00:00 h673 Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: Do you take any of the following inhalers - Serevent, Advair, Foradil, salmeterol, or formoterol? Collection Interval: Exam 3 +74 Medication/supplement use 254019 phv00254019.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:17:20+00:00 2018-09-24 14:17:20+00:00 j010 Medical History - Medications: Do you take aspirin regularly? +74 Medication/supplement use 254020 phv00254020.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:17:35+00:00 2018-09-24 14:17:35+00:00 j011 Medical History - Medications: Number of aspirins taken regularly +74 Medication/supplement use 254021 phv00254021.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:17:47+00:00 2018-09-24 14:17:47+00:00 j012 Medical History - Medications: Aspirin frequency per (day, week, month, year) +74 Medication/supplement use 254022 phv00254022.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:17:58+00:00 2018-09-24 14:17:58+00:00 j013 Medical History - Medications: Usual dose of aspirin +74 Medication/supplement use 254024 phv00254024.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:18:15+00:00 2018-09-24 14:18:15+00:00 j015 Medical History - Medications: Since your last exam have you taken medication for high blood pressure of hypertension? +74 Medication/supplement use 254026 phv00254026.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:18:28+00:00 2018-09-24 14:18:28+00:00 j017 Medical History - Medications: Since your last exam have you taken medication for high blood cholesterol or high triglycerides? +74 Medication/supplement use 254028 phv00254028.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:18:39+00:00 2018-09-24 14:18:39+00:00 j019 Medical History - Medications: Since your last exam have you taken medication for high blood sugar or diabetes? +74 Medication/supplement use 254029 phv00254029.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:18:51+00:00 2018-09-24 14:18:51+00:00 j020 Medical History - Medications: Since your last exam have you taken medication for cardiovascular disease? (example: angina/chest pain, heart failure, atrial fibrillation/heart rhythm abnormality, stroke, leg pain when walking, peripheral artery disease) +74 Medication/supplement use 254032 phv00254032.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:19:08+00:00 2018-09-24 14:19:08+00:00 j032 Medical History - Female Reproductive History, Part 1: Since your last exam have you taken or used birth control pills, shots, or hormone implants for birth control or medical indications (not post menopausal hormone replacement)? +74 Medication/supplement use 254502 phv00254502.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:20:19+00:00 2018-09-24 14:20:19+00:00 j845 Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: Do you take inhalers or bronchodilators? +74 Medication/supplement use 254503 phv00254503.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:20:30+00:00 2018-09-24 14:20:30+00:00 j846 Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: Do you take any of the inhaled medications? +74 Medication/supplement use 254504 phv00254504.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:20:38+00:00 2018-09-24 14:20:38+00:00 j847 Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: How many hours ago did you last use the medication, either by inhaler or nebulizer? +74 Medication/supplement use 254505 phv00254505.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:20:47+00:00 2018-09-24 14:20:47+00:00 j848 Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: Do you take any of the following inhaled medications? +74 Medication/supplement use 254506 phv00254506.v1.p10 pht005140.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:20:56+00:00 2018-09-24 14:20:56+00:00 j849 Respiratory Disease Questionnaire Part 1-Tech administered: Inhaler use: How many hours ago did you last use the medication, either by inhaler or nebulizer? +74 Medication/supplement use 254605 phv00254605.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:43:15+00:00 2018-09-24 14:43:15+00:00 fv010 Medical History - Medications: Since your last exam have you taken medication for the treatment of hypertension? (high blood pressure) Collection Interval: Exam 29 +74 Medication/supplement use 254606 phv00254606.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:43:28+00:00 2018-09-24 14:43:28+00:00 fv011 Medical History - Medications: Take aspirin regularly? Collection Interval: Exam 29 +74 Medication/supplement use 254607 phv00254607.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:43:43+00:00 2018-09-24 14:43:43+00:00 fv012 Medical History - Medications: Number aspirins taken regularly Collection Interval: Exam 29 +74 Medication/supplement use 254608 phv00254608.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:50:27+00:00 2018-09-24 14:50:27+00:00 fv013 Medical History - Medications: Aspirin frequency, number taken regularly Collection Interval: Exam 29 +74 Medication/supplement use 254609 phv00254609.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:50:39+00:00 2018-09-24 14:50:39+00:00 fv014 Medical History - Medications: Usual aspirin dose Collection Interval: Exam 29 +74 Medication/supplement use 254827 phv00254827.v1.p10 pht005141.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:51:41+00:00 2018-09-24 14:51:41+00:00 fv371 Instrumental Activities of Daily Living (Lawton IADL): Do you take medicines or use any medications? Collection Interval: Exam 29 +74 Medication/supplement use 254996 phv00254996.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:56:37+00:00 2018-09-24 14:56:37+00:00 fw008 Medical History - Medications - Hypertension: Have you taken medication for the treatment of hypertension since last exam? Collection Interval: Original Cohort Exam 30 +74 Medication/supplement use 254997 phv00254997.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:56:46+00:00 2018-09-24 14:56:46+00:00 fw009 Medical History - Medications : Do you take aspirin regularly? Collection Interval: Original Cohort Exam 30 +74 Medication/supplement use 254998 phv00254998.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:56:54+00:00 2018-09-24 14:56:54+00:00 fw010 Medical History - Medications : Number of aspirin taken regularly Collection Interval: Original Cohort Exam 30 +74 Medication/supplement use 254999 phv00254999.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:57:03+00:00 2018-09-24 14:57:03+00:00 fw011 Medical History - Medications: Aspirin frequency per Collection Interval: Original Cohort Exam 30 +74 Medication/supplement use 255000 phv00255000.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:57:12+00:00 2018-09-24 14:57:12+00:00 fw012 Medical History - Medications: Usual dose of aspirin Collection Interval: Original Cohort Exam 30 +74 Medication/supplement use 255214 phv00255214.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 14:58:12+00:00 2018-09-24 14:58:12+00:00 fw429 LAWTON - Do you take medicines or use any medications? Collection Interval: Original Cohort Exam 30 +74 Medication/supplement use 274716 phv00274716.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:00:09+00:00 2018-09-24 15:00:09+00:00 FX008 Medical History - Medications - Hypertension: Have you taken medication for the treatment of hypertension since last exam? Collection Interval: Original Cohort Exam 31 +74 Medication/supplement use 274717 phv00274717.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:00:17+00:00 2018-09-24 15:00:17+00:00 FX009 Medical History - Medications : Do you take aspirin regularly? Collection Interval: Original Cohort Exam 31 +74 Medication/supplement use 274718 phv00274718.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:00:26+00:00 2018-09-24 15:00:26+00:00 FX010 Medical History - Medications : Number of aspirin taken regularly Collection Interval: Original Cohort Exam 31 +74 Medication/supplement use 274719 phv00274719.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:00:35+00:00 2018-09-24 15:00:35+00:00 FX011 Medical History - Medications: Aspirin frequency per Collection Interval: Original Cohort Exam 31 +74 Medication/supplement use 274720 phv00274720.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:00:44+00:00 2018-09-24 15:00:44+00:00 FX012 Medical History - Medications: Usual dose of aspirin Collection Interval: Original Cohort Exam 31 +74 Medication/supplement use 274939 phv00274939.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:01:29+00:00 2018-09-24 15:01:29+00:00 FX429 LAWTON - Do you take medicines or use any medications? Collection Interval: Original Cohort Exam 31 +74 Medication/supplement use 275071 phv00275071.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:07:48+00:00 2018-09-24 15:07:48+00:00 fy008 Medical History - Medications : Have you taken medication for the treatment of hypertension since last exam? Collection Interval: Original Cohort Exam 32 +74 Medication/supplement use 275074 phv00275074.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:08:02+00:00 2018-09-24 15:08:02+00:00 fy009 Medical History - Medications : Do you take aspirin regularly? Collection Interval: Original Cohort Exam 32 +74 Medication/supplement use 275075 phv00275075.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:08:12+00:00 2018-09-24 15:08:12+00:00 fy010 Medical History - Medications : Number of aspirin taken regularly Collection Interval: Original Cohort Exam 32 +74 Medication/supplement use 275076 phv00275076.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:08:28+00:00 2018-09-24 15:08:28+00:00 fy011 Medical History - Medications: Aspirin frequency per Collection Interval: Original Cohort Exam 32 +74 Medication/supplement use 275077 phv00275077.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:08:37+00:00 2018-09-24 15:08:37+00:00 fy012 Medical History - Medications: Usual dose of aspirin Collection Interval: Original Cohort Exam 32 +74 Medication/supplement use 275297 phv00275297.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:09:45+00:00 2018-09-24 15:09:45+00:00 fy429 LAWTON - Do you take medicines or use any medications? Collection Interval: Original Cohort Exam 32 +74 Medication/supplement use 275072 phv00275072.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:10:15+00:00 2018-09-24 15:10:15+00:00 fy620 Medical History - Medications : Have you taken medication for the treatment of high blood cholesterol or high triglycerides? Collection Interval: Original Cohort Exam 32 +74 Medication/supplement use 275073 phv00275073.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:10:24+00:00 2018-09-24 15:10:24+00:00 fy621 Medical History - Medications : Have you taken medication for the treatment of high blood sugar or diabetes? Collection Interval: Original Cohort Exam 32 +74 Medication/supplement use 1539 phv00001539.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:15:50+00:00 2018-09-24 15:15:50+00:00 FC205 ECG: TAKING DIGITALIS OR QUINIDINE +74 Medication/supplement use 1541 phv00001541.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:16:04+00:00 2018-09-24 15:16:04+00:00 FC209 CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 1436 phv00001436.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:16:26+00:00 2018-09-24 15:16:26+00:00 FC82 INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES +74 Medication/supplement use 1437 phv00001437.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:16:44+00:00 2018-09-24 15:16:44+00:00 FC83 INTERIM HISTORY OF MEDICINE USED: NITRITES +74 Medication/supplement use 1438 phv00001438.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:16:53+00:00 2018-09-24 15:16:53+00:00 FC84 INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE) +74 Medication/supplement use 1439 phv00001439.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:17:20+00:00 2018-09-24 15:17:20+00:00 FC85 INTERIM HISTORY OF MEDICINE USED: DIURETICS +74 Medication/supplement use 1440 phv00001440.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:17:29+00:00 2018-09-24 15:17:29+00:00 FC86 INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES +74 Medication/supplement use 1441 phv00001441.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:17:37+00:00 2018-09-24 15:17:37+00:00 FC87 INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS +74 Medication/supplement use 1442 phv00001442.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:17:46+00:00 2018-09-24 15:17:46+00:00 FC88 INTERIM HISTORY OF MEDICINE USED: THYROID +74 Medication/supplement use 1443 phv00001443.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:18:29+00:00 2018-09-24 15:18:29+00:00 FC89 INTERIM HISTORY OF MEDICINE USED: ANTITHYROID +74 Medication/supplement use 1444 phv00001444.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:18:40+00:00 2018-09-24 15:18:40+00:00 FC90 INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS +74 Medication/supplement use 1445 phv00001445.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:19:23+00:00 2018-09-24 15:19:23+00:00 FC91 INTERIM HISTORY OF MEDICINE USED: HYPOGLYCEMIC AGENTS +74 Medication/supplement use 1446 phv00001446.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:19:35+00:00 2018-09-24 15:19:35+00:00 FC92 INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS +74 Medication/supplement use 1447 phv00001447.v1.p10 pht000012.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:19:45+00:00 2018-09-24 15:19:45+00:00 FC96 MENOPAUSE: HORMONE THERAPY +74 Medication/supplement use 1730 phv00001730.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:21:13+00:00 2018-09-24 15:21:13+00:00 FD201 ECG: TAKING DIGITALIS OR QUINIDINE +74 Medication/supplement use 1768 phv00001768.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:21:33+00:00 2018-09-24 15:21:33+00:00 FD259 CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 1619 phv00001619.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:21:57+00:00 2018-09-24 15:21:57+00:00 FD74 INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES +74 Medication/supplement use 1620 phv00001620.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:22:16+00:00 2018-09-24 15:22:16+00:00 FD75 INTERIM HISTORY OF MEDICINE USED: NITRITES +74 Medication/supplement use 1621 phv00001621.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:22:27+00:00 2018-09-24 15:22:27+00:00 FD76 INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE) +74 Medication/supplement use 1622 phv00001622.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:26:15+00:00 2018-09-24 15:26:15+00:00 FD77 INTERIM HISTORY OF MEDICINE USED: DIURETICS +74 Medication/supplement use 1623 phv00001623.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:26:25+00:00 2018-09-24 15:26:25+00:00 FD78 INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS) +74 Medication/supplement use 1624 phv00001624.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:26:36+00:00 2018-09-24 15:26:36+00:00 FD79 INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS +74 Medication/supplement use 1625 phv00001625.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:26:43+00:00 2018-09-24 15:26:43+00:00 FD80 INTERIM HISTORY OF MEDICINE USED: THYROID +74 Medication/supplement use 1626 phv00001626.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:26:51+00:00 2018-09-24 15:26:51+00:00 FD81 INTERIM HISTORY OF MEDICINE USED: ANTITHYROID +74 Medication/supplement use 1627 phv00001627.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:26:58+00:00 2018-09-24 15:26:58+00:00 FD82 INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS +74 Medication/supplement use 1628 phv00001628.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:27:05+00:00 2018-09-24 15:27:05+00:00 FD83 INTERIM HISTORY OF MEDICINE USED: HYPOGLYCEMIC AGENTS +74 Medication/supplement use 1629 phv00001629.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:27:13+00:00 2018-09-24 15:27:13+00:00 FD84 INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS +74 Medication/supplement use 1630 phv00001630.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:27:20+00:00 2018-09-24 15:27:20+00:00 FD85 INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL +74 Medication/supplement use 1631 phv00001631.v1.p10 pht000013.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:27:31+00:00 2018-09-24 15:27:31+00:00 FD86 INTERIM HISTORY OF MEDICINE USED: HORMONE THERAPY +74 Medication/supplement use 1834 phv00001834.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:29:00+00:00 2018-09-24 15:29:00+00:00 FE100 INTERIM HISTORY OF MEDICINE USED: ASPIRIN - TABS/DAY +74 Medication/supplement use 1994 phv00001994.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:29:31+00:00 2018-09-24 15:29:31+00:00 FE281 ECG: TAKING DIGITALIS OR QUINIDINE +74 Medication/supplement use 2000 phv00002000.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:29:42+00:00 2018-09-24 15:29:42+00:00 FE318 CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 1819 phv00001819.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:30:11+00:00 2018-09-24 15:30:11+00:00 FE85 INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES +74 Medication/supplement use 1820 phv00001820.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:30:20+00:00 2018-09-24 15:30:20+00:00 FE86 INTERIM HISTORY OF MEDICINE USED: NITRITES +74 Medication/supplement use 1821 phv00001821.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:30:27+00:00 2018-09-24 15:30:27+00:00 FE87 INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE) +74 Medication/supplement use 1822 phv00001822.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:30:36+00:00 2018-09-24 15:30:36+00:00 FE88 INTERIM HISTORY OF MEDICINE USED: DIURETICS +74 Medication/supplement use 1823 phv00001823.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:30:49+00:00 2018-09-24 15:30:49+00:00 FE89 INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS) +74 Medication/supplement use 1824 phv00001824.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:30:56+00:00 2018-09-24 15:30:56+00:00 FE90 INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS +74 Medication/supplement use 1825 phv00001825.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:31:08+00:00 2018-09-24 15:31:08+00:00 FE91 INTERIM HISTORY OF MEDICINE USED: THYROID +74 Medication/supplement use 1826 phv00001826.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:31:15+00:00 2018-09-24 15:31:15+00:00 FE92 INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS +74 Medication/supplement use 1827 phv00001827.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:31:24+00:00 2018-09-24 15:31:24+00:00 FE93 INTERIM HISTORY OF MEDICINE USED: INSULIN +74 Medication/supplement use 1828 phv00001828.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:31:32+00:00 2018-09-24 15:31:32+00:00 FE94 INTERIM HISTORY OF MEDICINE USED: ORINASE +74 Medication/supplement use 1829 phv00001829.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:31:40+00:00 2018-09-24 15:31:40+00:00 FE95 INTERIM HISTORY OF MEDICINE USED: OTHER HYPOGLYCEMIC AGENTS +74 Medication/supplement use 1830 phv00001830.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:31:48+00:00 2018-09-24 15:31:48+00:00 FE96 INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS +74 Medication/supplement use 1831 phv00001831.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:31:57+00:00 2018-09-24 15:31:57+00:00 FE97 INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL +74 Medication/supplement use 1832 phv00001832.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:32:05+00:00 2018-09-24 15:32:05+00:00 FE98 INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES +74 Medication/supplement use 1833 phv00001833.v1.p10 pht000014.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:32:13+00:00 2018-09-24 15:32:13+00:00 FE99 INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT +74 Medication/supplement use 2051 phv00002051.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:34:42+00:00 2018-09-24 15:34:42+00:00 FF100 INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES +74 Medication/supplement use 2052 phv00002052.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:34:51+00:00 2018-09-24 15:34:51+00:00 FF101 INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT +74 Medication/supplement use 2053 phv00002053.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:35:00+00:00 2018-09-24 15:35:00+00:00 FF102 INTERIM HISTORY OF MEDICINE USED: ASPIRIN - TABS/WEEK +74 Medication/supplement use 2174 phv00002174.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:35:22+00:00 2018-09-24 15:35:22+00:00 FF244 ECG: TAKING DIGITALIS OR QUINIDINE +74 Medication/supplement use 2181 phv00002181.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:35:37+00:00 2018-09-24 15:35:37+00:00 FF251 CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 2038 phv00002038.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:36:03+00:00 2018-09-24 15:36:03+00:00 FF87 INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES +74 Medication/supplement use 2039 phv00002039.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:36:10+00:00 2018-09-24 15:36:10+00:00 FF88 INTERIM HISTORY OF MEDICINE USED: NITRITES +74 Medication/supplement use 2040 phv00002040.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:36:18+00:00 2018-09-24 15:36:18+00:00 FF89 INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE) +74 Medication/supplement use 2041 phv00002041.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:36:26+00:00 2018-09-24 15:36:26+00:00 FF90 INTERIM HISTORY OF MEDICINE USED: DIURETICS +74 Medication/supplement use 2042 phv00002042.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:36:33+00:00 2018-09-24 15:36:33+00:00 FF91 INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS) +74 Medication/supplement use 2043 phv00002043.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:36:41+00:00 2018-09-24 15:36:41+00:00 FF92 INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS +74 Medication/supplement use 2044 phv00002044.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:36:49+00:00 2018-09-24 15:36:49+00:00 FF93 INTERIM HISTORY OF MEDICINE USED: THYROID +74 Medication/supplement use 2045 phv00002045.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:36:57+00:00 2018-09-24 15:36:57+00:00 FF94 INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS +74 Medication/supplement use 2046 phv00002046.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:37:04+00:00 2018-09-24 15:37:04+00:00 FF95 INTERIM HISTORY OF MEDICINE USED: INSULIN +74 Medication/supplement use 2047 phv00002047.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:37:12+00:00 2018-09-24 15:37:12+00:00 FF96 INTERIM HISTORY OF MEDICINE USED: ORINASE +74 Medication/supplement use 2048 phv00002048.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:37:26+00:00 2018-09-24 15:37:26+00:00 FF97 INTERIM HISTORY OF MEDICINE USED: OTHER HYPOGLYCEMIC AGENTS +74 Medication/supplement use 2049 phv00002049.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:37:34+00:00 2018-09-24 15:37:34+00:00 FF98 INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS +74 Medication/supplement use 2050 phv00002050.v1.p10 pht000015.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:37:42+00:00 2018-09-24 15:37:42+00:00 FF99 INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL +74 Medication/supplement use 2235 phv00002235.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:39:16+00:00 2018-09-24 15:39:16+00:00 FG100 INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT +74 Medication/supplement use 2369 phv00002369.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:39:45+00:00 2018-09-24 15:39:45+00:00 FG252 ECG: TAKING DIGITALIS OR QUINIDINE +74 Medication/supplement use 2376 phv00002376.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:39:58+00:00 2018-09-24 15:39:58+00:00 FG259 CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 2219 phv00002219.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:40:25+00:00 2018-09-24 15:40:25+00:00 FG84 INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES +74 Medication/supplement use 2220 phv00002220.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:40:34+00:00 2018-09-24 15:40:34+00:00 FG85 INTERIM HISTORY OF MEDICINE USED: NITRITES +74 Medication/supplement use 2221 phv00002221.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:40:41+00:00 2018-09-24 15:40:41+00:00 FG86 INTERIM HISTORY OF MEDICINE USE: PROPRANOLOL +74 Medication/supplement use 2222 phv00002222.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:40:49+00:00 2018-09-24 15:40:49+00:00 FG87 INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE) +74 Medication/supplement use 2223 phv00002223.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:40:56+00:00 2018-09-24 15:40:56+00:00 FG88 INTERIM HISTORY OF MEDICINE USED: DIURETICS-HYPERTENSION +74 Medication/supplement use 2224 phv00002224.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:41:04+00:00 2018-09-24 15:41:04+00:00 FG89 INTERIM HISTORY OF MEDICINE USED: DIURETICS-OTHER +74 Medication/supplement use 2225 phv00002225.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:41:12+00:00 2018-09-24 15:41:12+00:00 FG90 INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS) +74 Medication/supplement use 2226 phv00002226.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:41:19+00:00 2018-09-24 15:41:19+00:00 FG91 INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS +74 Medication/supplement use 2227 phv00002227.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:41:27+00:00 2018-09-24 15:41:27+00:00 FG92 INTERIM HISTORY OF MEDICINE USED: THYROID +74 Medication/supplement use 2228 phv00002228.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:41:34+00:00 2018-09-24 15:41:34+00:00 FG93 INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS +74 Medication/supplement use 2229 phv00002229.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:41:42+00:00 2018-09-24 15:41:42+00:00 FG94 INTERIM HISTORY OF MEDICINE USED: INSULIN +74 Medication/supplement use 2230 phv00002230.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:41:51+00:00 2018-09-24 15:41:51+00:00 FG95 INTERIM HISTORY OF MEDICINE USED: ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 2231 phv00002231.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:41:59+00:00 2018-09-24 15:41:59+00:00 FG96 INTERIM HISTORY OF MEDICINE USED: SLEEPING PILLS +74 Medication/supplement use 2232 phv00002232.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:42:07+00:00 2018-09-24 15:42:07+00:00 FG97 INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS +74 Medication/supplement use 2233 phv00002233.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:42:16+00:00 2018-09-24 15:42:16+00:00 FG98 INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL +74 Medication/supplement use 2234 phv00002234.v1.p10 pht000016.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:42:25+00:00 2018-09-24 15:42:25+00:00 FG99 INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES +74 Medication/supplement use 2457 phv00002457.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:43:34+00:00 2018-09-24 15:43:34+00:00 FH100 INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES +74 Medication/supplement use 2609 phv00002609.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:44:04+00:00 2018-09-24 15:44:04+00:00 FH269 ECG: TAKING DIGITALIS OR QUINIDINE +74 Medication/supplement use 2615 phv00002615.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:44:18+00:00 2018-09-24 15:44:18+00:00 FH276 CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 2439 phv00002439.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:44:45+00:00 2018-09-24 15:44:45+00:00 FH82 INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES +74 Medication/supplement use 2440 phv00002440.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:44:53+00:00 2018-09-24 15:44:53+00:00 FH83 INTERIM HISTORY OF MEDICINE USED: NITRITES +74 Medication/supplement use 2441 phv00002441.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:45:02+00:00 2018-09-24 15:45:02+00:00 FH84 INTERIM HISTORY OF MEDICINE USE: PROPRANOLOL +74 Medication/supplement use 2442 phv00002442.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:45:11+00:00 2018-09-24 15:45:11+00:00 FH85 INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE) +74 Medication/supplement use 2443 phv00002443.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:45:20+00:00 2018-09-24 15:45:20+00:00 FH86 INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS) +74 Medication/supplement use 2444 phv00002444.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:45:29+00:00 2018-09-24 15:45:29+00:00 FH87 INTERIM HISTORY OF MEDICINE USED: ALDOMET +74 Medication/supplement use 2445 phv00002445.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:45:36+00:00 2018-09-24 15:45:36+00:00 FH88 INTERIM HISTORY OF MEDICINE USED: SPIRONOLACTONE +74 Medication/supplement use 2446 phv00002446.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:45:45+00:00 2018-09-24 15:45:45+00:00 FH89 INTERIM HISTORY OF MEDICINE USED: DIURETICS-HYPERTENSION +74 Medication/supplement use 2447 phv00002447.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:45:54+00:00 2018-09-24 15:45:54+00:00 FH90 INTERIM HISTORY OF MEDICINE USED: DIURETICS-OTHER +74 Medication/supplement use 2448 phv00002448.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:46:03+00:00 2018-09-24 15:46:03+00:00 FH91 INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS +74 Medication/supplement use 2449 phv00002449.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:46:10+00:00 2018-09-24 15:46:10+00:00 FH92 INTERIM HISTORY OF MEDICINE USED: THYROID +74 Medication/supplement use 2450 phv00002450.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:46:20+00:00 2018-09-24 15:46:20+00:00 FH93 INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS +74 Medication/supplement use 2451 phv00002451.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:46:28+00:00 2018-09-24 15:46:28+00:00 FH94 INTERIM HISTORY OF MEDICINE USED: INSULIN +74 Medication/supplement use 2452 phv00002452.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:46:35+00:00 2018-09-24 15:46:35+00:00 FH95 INTERIM HISTORY OF MEDICINE USED: ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 2453 phv00002453.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:46:44+00:00 2018-09-24 15:46:44+00:00 FH96 INTERIM HISTORY OF MEDICINE USED: SLEEPING PILLS +74 Medication/supplement use 2454 phv00002454.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:46:52+00:00 2018-09-24 15:46:52+00:00 FH97 INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS +74 Medication/supplement use 2455 phv00002455.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:47:03+00:00 2018-09-24 15:47:03+00:00 FH98 INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL +74 Medication/supplement use 2456 phv00002456.v1.p10 pht000017.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:47:14+00:00 2018-09-24 15:47:14+00:00 FH99 INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT +74 Medication/supplement use 2821 phv00002821.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:48:49+00:00 2018-09-24 15:48:49+00:00 FI187 CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 2693 phv00002693.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:49:28+00:00 2018-09-24 15:49:28+00:00 FI41 INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES +74 Medication/supplement use 2694 phv00002694.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:49:35+00:00 2018-09-24 15:49:35+00:00 FI42 INTERIM HISTORY OF MEDICINE USED: NITRITES +74 Medication/supplement use 2695 phv00002695.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:49:43+00:00 2018-09-24 15:49:43+00:00 FI43 INTERIM HISTORY OF MEDICINE USE: PROPRANOLOL +74 Medication/supplement use 2696 phv00002696.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:49:50+00:00 2018-09-24 15:49:50+00:00 FI44 INTERIM HISTORY OF MEDICINE USED: QUINIDINE (OR PROCAINAMIDE) +74 Medication/supplement use 2697 phv00002697.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:49:58+00:00 2018-09-24 15:49:58+00:00 FI45 INTERIM HISTORY OF MEDICINE USED: HYPOTENSIVES (EXCLUDE DIURETICS) +74 Medication/supplement use 2698 phv00002698.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:50:06+00:00 2018-09-24 15:50:06+00:00 FI46 INTERIM HISTORY OF MEDICINE USED: ALDOMET +74 Medication/supplement use 2699 phv00002699.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:50:14+00:00 2018-09-24 15:50:14+00:00 FI47 INTERIM HISTORY OF MEDICINE USED: SPIRONOLACTONE +74 Medication/supplement use 2700 phv00002700.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:50:22+00:00 2018-09-24 15:50:22+00:00 FI48 INTERIM HISTORY OF MEDICINE USED: DIURETICS-HYPERTENSION +74 Medication/supplement use 2701 phv00002701.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:50:30+00:00 2018-09-24 15:50:30+00:00 FI49 INTERIM HISTORY OF MEDICINE USED: DIURETICS-OTHER +74 Medication/supplement use 2702 phv00002702.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:50:39+00:00 2018-09-24 15:50:39+00:00 FI50 INTERIM HISTORY OF MEDICINE USED: ANTI-CHOLESTEROL AGENTS +74 Medication/supplement use 2703 phv00002703.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:50:50+00:00 2018-09-24 15:50:50+00:00 FI51 INTERIM HISTORY OF MEDICINE USED: THYROID +74 Medication/supplement use 2704 phv00002704.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:51:04+00:00 2018-09-24 15:51:04+00:00 FI52 INTERIM HISTORY OF MEDICINE USED: ANTICOAGULANTS +74 Medication/supplement use 2705 phv00002705.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:51:12+00:00 2018-09-24 15:51:12+00:00 FI53 INTERIM HISTORY OF MEDICINE USED: INSULIN +74 Medication/supplement use 2706 phv00002706.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:51:19+00:00 2018-09-24 15:51:19+00:00 FI54 INTERIM HISTORY OF MEDICINE USED: ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 2707 phv00002707.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:51:31+00:00 2018-09-24 15:51:31+00:00 FI55 INTERIM HISTORY OF MEDICINE USED: SLEEPING PILLS +74 Medication/supplement use 2708 phv00002708.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:51:39+00:00 2018-09-24 15:51:39+00:00 FI56 INTERIM HISTORY OF MEDICINE USED: TRANQUILIZERS +74 Medication/supplement use 2709 phv00002709.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:51:48+00:00 2018-09-24 15:51:48+00:00 FI57 INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR OR AEROSOL +74 Medication/supplement use 2710 phv00002710.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:51:56+00:00 2018-09-24 15:51:56+00:00 FI58 INTERIM HISTORY OF MEDICINE USED: HORMONE TREATMENT +74 Medication/supplement use 2711 phv00002711.v1.p10 pht000018.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:52:07+00:00 2018-09-24 15:52:07+00:00 FI59 INTERIM HISTORY OF MEDICINE USED: OTHER MEDICINES +74 Medication/supplement use 2953 phv00002953.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:53:43+00:00 2018-09-24 15:53:43+00:00 FJ10 INTERIM HISTORY OF MEDICINE USE: LONGER ACTING NITRATES +74 Medication/supplement use 2954 phv00002954.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:54:02+00:00 2018-09-24 15:54:02+00:00 FJ11 INTERIM HISTORY OF MEDICINE USED: CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 2955 phv00002955.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:54:14+00:00 2018-09-24 15:54:14+00:00 FJ12 INTERIM HISTORY OF MEDICINE USED: BETA BLOCKER +74 Medication/supplement use 2956 phv00002956.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:54:26+00:00 2018-09-24 15:54:26+00:00 FJ13 INTERIM HISTORY OF MEDICINE USED: ANTIARRHYTHMICS +74 Medication/supplement use 3062 phv00003062.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:54:38+00:00 2018-09-24 15:54:38+00:00 FJ134 THYROID DISEASE: EVER TAKEN THYROID MEDICATION +74 Medication/supplement use 2957 phv00002957.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:54:49+00:00 2018-09-24 15:54:49+00:00 FJ14 INTERIM HISTORY OF MEDICINE USED: ANTIPLATELET +74 Medication/supplement use 2958 phv00002958.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:55:01+00:00 2018-09-24 15:55:01+00:00 FJ15 INTERIM HISTORY OF MEDICINE USED: DIURETICS +74 Medication/supplement use 2959 phv00002959.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:55:11+00:00 2018-09-24 15:55:11+00:00 FJ16 INTERIM HISTORY OF MEDICINE USED: K-SPARING DIURETICS +74 Medication/supplement use 2960 phv00002960.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:55:22+00:00 2018-09-24 15:55:22+00:00 FJ17 INTERIM HISTORY OF MEDICINE USED: RESERPINE DERIVATIVES +74 Medication/supplement use 2961 phv00002961.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:55:37+00:00 2018-09-24 15:55:37+00:00 FJ18 INTERIM HISTORY OF MEDICINE USED: METHYLDOPA +74 Medication/supplement use 2962 phv00002962.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:55:47+00:00 2018-09-24 15:55:47+00:00 FJ19 INTERIM HISTORY OF MEDICINE USED: CLONIDINE +74 Medication/supplement use 2963 phv00002963.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:55:59+00:00 2018-09-24 15:55:59+00:00 FJ20 INTERIM HISTORY OF MEDICINE USED: GANGLIONIC BLOCKERS +74 Medication/supplement use 2964 phv00002964.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:56:12+00:00 2018-09-24 15:56:12+00:00 FJ21 INTERIM HISTORY OF MEDICINE USED: PERIPHERAL VASODILATORS +74 Medication/supplement use 2965 phv00002965.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:56:25+00:00 2018-09-24 15:56:25+00:00 FJ22 INTERIM HISTORY OF MEDICINE USED: UNKNOWN HYPERTENSIVE MEDICATIONS +74 Medication/supplement use 2966 phv00002966.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:56:39+00:00 2018-09-24 15:56:39+00:00 FJ23 INTERIM HISTORY OF MEDICINE USED: ANTICHOLESTEROL DRUGS +74 Medication/supplement use 2967 phv00002967.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:56:51+00:00 2018-09-24 15:56:51+00:00 FJ24 INTERIM HISTORY OF MEDICINE USED: ANTIGOUT +74 Medication/supplement use 2968 phv00002968.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:57:06+00:00 2018-09-24 15:57:06+00:00 FJ25 INTERIM HISTORY OF MEDICINE USED: THYROID +74 Medication/supplement use 2969 phv00002969.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:57:23+00:00 2018-09-24 15:57:23+00:00 FJ26 INTERIM HISTORY OF MEDICINE USED: ORAL HYPOGLYCEMICS +74 Medication/supplement use 2970 phv00002970.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:57:42+00:00 2018-09-24 15:57:42+00:00 FJ27 INTERIM HISTORY OF MEDICINE USED: INSULIN +74 Medication/supplement use 2971 phv00002971.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:57:53+00:00 2018-09-24 15:57:53+00:00 FJ28 INTERIM HISTORY OF MEDICINE USED: ESTROGEN +74 Medication/supplement use 2972 phv00002972.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:58:09+00:00 2018-09-24 15:58:09+00:00 FJ29 INTERIM HISTORY OF MEDICINE USED: STEROIDS +74 Medication/supplement use 3198 phv00003198.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:58:23+00:00 2018-09-24 15:58:23+00:00 FJ296 ECG: TAKING DIGITALIS +74 Medication/supplement use 2973 phv00002973.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:58:34+00:00 2018-09-24 15:58:34+00:00 FJ30 INTERIM HISTORY OF MEDICINE USED: BRONCHODILATOR, AEROSOLS, ETC. +74 Medication/supplement use 2974 phv00002974.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:58:47+00:00 2018-09-24 15:58:47+00:00 FJ31 INTERIM HISTORY OF MEDICINE USED: ANTIHISTAMINES +74 Medication/supplement use 3219 phv00003219.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:59:13+00:00 2018-09-24 15:59:13+00:00 FJ318 HEART: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 2975 phv00002975.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:59:29+00:00 2018-09-24 15:59:29+00:00 FJ32 INTERIM HISTORY OF MEDICINE USED: SLEEPING PILLS +74 Medication/supplement use 2976 phv00002976.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:59:39+00:00 2018-09-24 15:59:39+00:00 FJ33 INTERIM HISTORY OF MEDICINE USED: SEDATIVE/HYPNOTIC +74 Medication/supplement use 2977 phv00002977.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 15:59:51+00:00 2018-09-24 15:59:51+00:00 FJ34 INTERIM HISTORY OF MEDICINE USED: ANTIDEPRESSANTS +74 Medication/supplement use 2978 phv00002978.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:00:19+00:00 2018-09-24 16:00:19+00:00 FJ35 INTERIM HISTORY OF MEDICINE USED: POTASSIUM SUPPLEMENT +74 Medication/supplement use 2979 phv00002979.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:00:27+00:00 2018-09-24 16:00:27+00:00 FJ36 INTERIM HISTORY OF MEDICINE USED: OTHER +74 Medication/supplement use 2980 phv00002980.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:00:37+00:00 2018-09-24 16:00:37+00:00 FJ37 INTERIM HISTORY OF MEDICINE USED: NO OF TABS, ASPIRIN/WEEK +74 Medication/supplement use 2951 phv00002951.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:01:09+00:00 2018-09-24 16:01:09+00:00 FJ8 INTERIM HISTORY OF MEDICINE USED: CARDIAC GLYCOSIDES +74 Medication/supplement use 2952 phv00002952.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:01:27+00:00 2018-09-24 16:01:27+00:00 FJ9 INTERIM HISTORY OF MEDICINE USED: NITROGLYCERINE +74 Medication/supplement use 3035 phv00003035.v1.p10 pht000019.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:01:41+00:00 2018-09-24 16:01:41+00:00 FJ95 CHEST DISCOMFORT: RELIEVED BY NITROGLYCERINE +74 Medication/supplement use 3348 phv00003348.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:40:23+00:00 2018-09-24 16:40:23+00:00 FK100 MEDICINE USE: HYPERTENSIVE MEDICATIONS +74 Medication/supplement use 3349 phv00003349.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:40:59+00:00 2018-09-24 16:40:59+00:00 FK101 TYPE OF HYPERTENSIVE MEDICATIONS +74 Medication/supplement use 3350 phv00003350.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:41:08+00:00 2018-09-24 16:41:08+00:00 FK102 MEDICINE USE: ANTICHOLESTEROL DRUG +74 Medication/supplement use 3351 phv00003351.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:41:15+00:00 2018-09-24 16:41:15+00:00 FK103 TYPE OF ANTICHOLESTEROL DRUG +74 Medication/supplement use 3352 phv00003352.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:41:23+00:00 2018-09-24 16:41:23+00:00 FK104 MEDICINE USE: ANTIGOUT +74 Medication/supplement use 3353 phv00003353.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:41:35+00:00 2018-09-24 16:41:35+00:00 FK105 TYPE OF ANTIGOUT MEDICINE +74 Medication/supplement use 3354 phv00003354.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:43:08+00:00 2018-09-24 16:43:08+00:00 FK106 MEDICINE USE: THYROID +74 Medication/supplement use 3355 phv00003355.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:43:15+00:00 2018-09-24 16:43:15+00:00 FK107 TYPE OF THYROID +74 Medication/supplement use 3356 phv00003356.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:43:35+00:00 2018-09-24 16:43:35+00:00 FK108 MEDICINE USE: ORAL HYPOGLYCEMICS +74 Medication/supplement use 3357 phv00003357.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:43:43+00:00 2018-09-24 16:43:43+00:00 FK109 TYPE OF ORAL HYPOGLYCEMICS +74 Medication/supplement use 3358 phv00003358.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:43:51+00:00 2018-09-24 16:43:51+00:00 FK110 MEDICINE USE: INSULIN +74 Medication/supplement use 3359 phv00003359.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:43:58+00:00 2018-09-24 16:43:58+00:00 FK111 TYPE OF INSULIN +74 Medication/supplement use 3360 phv00003360.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:44:05+00:00 2018-09-24 16:44:05+00:00 FK112 MEDICINE USE: ESTROGEN +74 Medication/supplement use 3361 phv00003361.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:44:12+00:00 2018-09-24 16:44:12+00:00 FK113 TYPE OF ESTROGEN +74 Medication/supplement use 3362 phv00003362.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:44:19+00:00 2018-09-24 16:44:19+00:00 FK114 MEDICINE USE: STEROIDS +74 Medication/supplement use 3363 phv00003363.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:44:27+00:00 2018-09-24 16:44:27+00:00 FK115 TYPE OF STEROIDS +74 Medication/supplement use 3364 phv00003364.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:44:36+00:00 2018-09-24 16:44:36+00:00 FK116 MEDICINE USE: BRONCHODILATOR, AEROSOLS +74 Medication/supplement use 3365 phv00003365.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:44:43+00:00 2018-09-24 16:44:43+00:00 FK117 TYPE OF BRONCHODILATOR, AEROSOLS +74 Medication/supplement use 3366 phv00003366.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:44:55+00:00 2018-09-24 16:44:55+00:00 FK118 MEDICINE USE: ANTIHISTAMINES +74 Medication/supplement use 3367 phv00003367.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:45:11+00:00 2018-09-24 16:45:11+00:00 FK119 TYPE OF ANTIHISTAMINES +74 Medication/supplement use 3368 phv00003368.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:45:19+00:00 2018-09-24 16:45:19+00:00 FK120 MEDICINE USE: SLEEPING PILLS +74 Medication/supplement use 3369 phv00003369.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:45:26+00:00 2018-09-24 16:45:26+00:00 FK121 TYPE OF SLEEPING PILLS +74 Medication/supplement use 3370 phv00003370.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:45:33+00:00 2018-09-24 16:45:33+00:00 FK122 MEDICINE USE: SEDATIVE/HYPNOTIC +74 Medication/supplement use 3371 phv00003371.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:45:42+00:00 2018-09-24 16:45:42+00:00 FK123 TYPE OF SEDATIVE/HYPNOTIC +74 Medication/supplement use 3372 phv00003372.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:45:50+00:00 2018-09-24 16:45:50+00:00 FK124 MEDICINE USE: ANTIDEPRESSANTS +74 Medication/supplement use 3373 phv00003373.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:45:57+00:00 2018-09-24 16:45:57+00:00 FK125 TYPE OF ANTIDEPRESSANTS +74 Medication/supplement use 3374 phv00003374.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:46:05+00:00 2018-09-24 16:46:05+00:00 FK126 MEDICINE USE: POTASSIUM SUPPLEMENT +74 Medication/supplement use 3376 phv00003376.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:46:37+00:00 2018-09-24 16:46:37+00:00 FK128 MEDICINE USE: OTHER DRUG +74 Medication/supplement use 3377 phv00003377.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:46:48+00:00 2018-09-24 16:46:48+00:00 FK129 TYPE OF OTHER DRUG +74 Medication/supplement use 3378 phv00003378.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:46:56+00:00 2018-09-24 16:46:56+00:00 FK130 MEDICINE USE: # OF ASPIRIN TABLETS PER WEEK +74 Medication/supplement use 3421 phv00003421.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:47:15+00:00 2018-09-24 16:47:15+00:00 FK176 PAIN RELIEVED BY NITROGLYCERINE +74 Medication/supplement use 3448 phv00003448.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:47:52+00:00 2018-09-24 16:47:52+00:00 FK215 THYROID DISEASE: THYROID MEDICATION IN INTERIM +74 Medication/supplement use 3613 phv00003613.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:48:33+00:00 2018-09-24 16:48:33+00:00 FK391 ECG: TAKING DIGITALIS +74 Medication/supplement use 3635 phv00003635.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:48:52+00:00 2018-09-24 16:48:52+00:00 FK413 HEART: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 3320 phv00003320.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:49:15+00:00 2018-09-24 16:49:15+00:00 FK72 MEDICINE USE: CARDIAC GLYCOSIDES +74 Medication/supplement use 3321 phv00003321.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:49:22+00:00 2018-09-24 16:49:22+00:00 FK73 TYPE OF CARDIAC GLYCOSIDES +74 Medication/supplement use 3322 phv00003322.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:50:25+00:00 2018-09-24 16:50:25+00:00 FK74 MEDICINE USE: NITROGLYCERINE +74 Medication/supplement use 3323 phv00003323.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:50:33+00:00 2018-09-24 16:50:33+00:00 FK75 TYPE OF NITROGLYCERINE +74 Medication/supplement use 3324 phv00003324.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:50:40+00:00 2018-09-24 16:50:40+00:00 FK76 MEDICINE USE: LONGER ACTING NITRATES +74 Medication/supplement use 3325 phv00003325.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:50:47+00:00 2018-09-24 16:50:47+00:00 FK77 TYPE OF LONGER ACTING NITRATES +74 Medication/supplement use 3326 phv00003326.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:50:54+00:00 2018-09-24 16:50:54+00:00 FK78 MEDICINE USE: CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 3327 phv00003327.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:51:02+00:00 2018-09-24 16:51:02+00:00 FK79 TYPE OF CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 3328 phv00003328.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:51:09+00:00 2018-09-24 16:51:09+00:00 FK80 MEDICINE USE: BETA BLOCKERS +74 Medication/supplement use 3329 phv00003329.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:51:18+00:00 2018-09-24 16:51:18+00:00 FK81 TYPE OF BETA BLOCKERS +74 Medication/supplement use 3330 phv00003330.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:51:26+00:00 2018-09-24 16:51:26+00:00 FK82 MEDICINE USE: ANTIARRHYTHMICS +74 Medication/supplement use 3331 phv00003331.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:51:33+00:00 2018-09-24 16:51:33+00:00 FK83 TYPE OF ANTIARRHYTHMICS +74 Medication/supplement use 3332 phv00003332.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:51:41+00:00 2018-09-24 16:51:41+00:00 FK84 MEDICINE USE: ANTIPLATELET +74 Medication/supplement use 3333 phv00003333.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:51:54+00:00 2018-09-24 16:51:54+00:00 FK85 TYPE OF ANTIPLATELET +74 Medication/supplement use 3334 phv00003334.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:52:01+00:00 2018-09-24 16:52:01+00:00 FK86 MEDICINE USE: DIURETICS +74 Medication/supplement use 3335 phv00003335.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:52:09+00:00 2018-09-24 16:52:09+00:00 FK87 TYPE OF DIURETICS +74 Medication/supplement use 3336 phv00003336.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:52:19+00:00 2018-09-24 16:52:19+00:00 FK88 MEDICINE USE: K-SPARING DIURETICS +74 Medication/supplement use 3337 phv00003337.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:52:28+00:00 2018-09-24 16:52:28+00:00 FK89 TYPE OF K-SPARING DIURETICS +74 Medication/supplement use 3338 phv00003338.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:52:37+00:00 2018-09-24 16:52:37+00:00 FK90 MEDICINE USE: RESERPINE DERIVATIVES +74 Medication/supplement use 3339 phv00003339.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:52:49+00:00 2018-09-24 16:52:49+00:00 FK91 TYPE OF RESERPINE DERIVATIVES +74 Medication/supplement use 3340 phv00003340.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:52:58+00:00 2018-09-24 16:52:58+00:00 FK92 MEDICINE USE: METHYLDOPA +74 Medication/supplement use 3341 phv00003341.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:53:07+00:00 2018-09-24 16:53:07+00:00 FK93 TYPE OF METHYLDOPA +74 Medication/supplement use 3342 phv00003342.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:53:15+00:00 2018-09-24 16:53:15+00:00 FK94 MEDICINE USE: CLONIDINE +74 Medication/supplement use 3343 phv00003343.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:53:24+00:00 2018-09-24 16:53:24+00:00 FK95 TYPE OF CLONIDINE +74 Medication/supplement use 3344 phv00003344.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:53:33+00:00 2018-09-24 16:53:33+00:00 FK96 MEDICINE USE: GANGLIONIC BLOCKERS +74 Medication/supplement use 3345 phv00003345.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:53:42+00:00 2018-09-24 16:53:42+00:00 FK97 TYPE OF GANGLIONIC BLOCKERS +74 Medication/supplement use 3346 phv00003346.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:53:51+00:00 2018-09-24 16:53:51+00:00 FK98 MEDICINE USE: PERIPHERAL VASODILATORS +74 Medication/supplement use 3347 phv00003347.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:54:00+00:00 2018-09-24 16:54:00+00:00 FK99 TYPE OF PERIPHERAL VASODILATORS +74 Medication/supplement use 3764 phv00003764.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:58:22+00:00 2018-09-24 16:58:22+00:00 FL119 CARDIAC GLYCOSIDES +74 Medication/supplement use 3765 phv00003765.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:59:26+00:00 2018-09-24 16:59:26+00:00 FL120 NITROGLYCERINE +74 Medication/supplement use 3766 phv00003766.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:59:33+00:00 2018-09-24 16:59:33+00:00 FL121 LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.) +74 Medication/supplement use 3767 phv00003767.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:59:41+00:00 2018-09-24 16:59:41+00:00 FL122 CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 3768 phv00003768.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:59:49+00:00 2018-09-24 16:59:49+00:00 FL123 BETA BLOCKERS +74 Medication/supplement use 3769 phv00003769.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 16:59:56+00:00 2018-09-24 16:59:56+00:00 FL124 ANTIARRHYTHMICS (QUINIDINE, PROCAINE, NORPACE, ETC.) +74 Medication/supplement use 3770 phv00003770.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:00:04+00:00 2018-09-24 17:00:04+00:00 FL125 ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 3771 phv00003771.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:00:14+00:00 2018-09-24 17:00:14+00:00 FL126 ANTICOAGULANTS (COUMADIN, ETC.) +74 Medication/supplement use 3772 phv00003772.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:02:17+00:00 2018-09-24 17:02:17+00:00 FL127 THIAZIDE DIURETICS +74 Medication/supplement use 3773 phv00003773.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:02:25+00:00 2018-09-24 17:02:25+00:00 FL128 LOOP DIURETICS (LASIX, ETC.) +74 Medication/supplement use 3774 phv00003774.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:02:32+00:00 2018-09-24 17:02:32+00:00 FL129 K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 3775 phv00003775.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:02:40+00:00 2018-09-24 17:02:40+00:00 FL130 RESERPINE DERIVATIVES +74 Medication/supplement use 3776 phv00003776.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:02:47+00:00 2018-09-24 17:02:47+00:00 FL131 METHYLDOPA (ALDOMET) +74 Medication/supplement use 3777 phv00003777.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:02:55+00:00 2018-09-24 17:02:55+00:00 FL132 CLONIDINE (CATAPRES) +74 Medication/supplement use 3778 phv00003778.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:03:01+00:00 2018-09-24 17:03:01+00:00 FL133 WYTENSIN +74 Medication/supplement use 3779 phv00003779.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:03:08+00:00 2018-09-24 17:03:08+00:00 FL134 GANGLIONIC BLOCKERS +74 Medication/supplement use 3780 phv00003780.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:03:15+00:00 2018-09-24 17:03:15+00:00 FL135 RENIN-AGIOTENSIN BLOCKING DRUGS (CAPTOPRIL) +74 Medication/supplement use 3782 phv00003782.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:03:39+00:00 2018-09-24 17:03:39+00:00 FL137 OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 3783 phv00003783.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:03:45+00:00 2018-09-24 17:03:45+00:00 FL138 OTHER CARDIAC MEDICATION +74 Medication/supplement use 3784 phv00003784.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:03:56+00:00 2018-09-24 17:03:56+00:00 FL139 ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.) +74 Medication/supplement use 3785 phv00003785.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:04:03+00:00 2018-09-24 17:04:03+00:00 FL140 ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 3786 phv00003786.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:04:12+00:00 2018-09-24 17:04:12+00:00 FL141 ANTIGOUT - COLCHICINE +74 Medication/supplement use 3787 phv00003787.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:04:20+00:00 2018-09-24 17:04:20+00:00 FL142 THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 3788 phv00003788.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:04:27+00:00 2018-09-24 17:04:27+00:00 FL143 THYROXINE (SYNTHROID ETC.) +74 Medication/supplement use 3789 phv00003789.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:04:37+00:00 2018-09-24 17:04:37+00:00 FL144 INSULIN +74 Medication/supplement use 3680 phv00003680.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:04:44+00:00 2018-09-24 17:04:44+00:00 FL145 TOTAL UNITS OF INSULIN PER DAY +74 Medication/supplement use 3790 phv00003790.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:04:52+00:00 2018-09-24 17:04:52+00:00 FL146 ORAL HYPOGLYCEMICS +74 Medication/supplement use 3791 phv00003791.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:05:00+00:00 2018-09-24 17:05:00+00:00 FL147 ORAL ESTROGEN +74 Medication/supplement use 3792 phv00003792.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:05:08+00:00 2018-09-24 17:05:08+00:00 FL148 ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 3793 phv00003793.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:05:17+00:00 2018-09-24 17:05:17+00:00 FL149 NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 3794 phv00003794.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:05:26+00:00 2018-09-24 17:05:26+00:00 FL150 ANALGESIC - NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 3795 phv00003795.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:06:08+00:00 2018-09-24 17:06:08+00:00 FL151 ANALGESIC - NON-NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 3796 phv00003796.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:06:19+00:00 2018-09-24 17:06:19+00:00 FL152 BRONCHODILATOR, AEROSOLS +74 Medication/supplement use 3797 phv00003797.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:06:27+00:00 2018-09-24 17:06:27+00:00 FL153 ANTIHISTAMINES +74 Medication/supplement use 3798 phv00003798.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:06:34+00:00 2018-09-24 17:06:34+00:00 FL154 ANTIULCER (TAGMET, PROBANTHINE, H-ION INHIBITORS) +74 Medication/supplement use 3799 phv00003799.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:06:43+00:00 2018-09-24 17:06:43+00:00 FL155 ANTI-ANXIETY, SEDATIVE/HYPNOTICS, ETC. (LIBRIUM, VALIUM, ETC.) +74 Medication/supplement use 3800 phv00003800.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:06:51+00:00 2018-09-24 17:06:51+00:00 FL156 SLEEPING PILLS +74 Medication/supplement use 3801 phv00003801.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:06:58+00:00 2018-09-24 17:06:58+00:00 FL157 ANTI-DEPRESSANTS +74 Medication/supplement use 3802 phv00003802.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:07:08+00:00 2018-09-24 17:07:08+00:00 FL158 EYE DROPS +74 Medication/supplement use 3803 phv00003803.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:07:16+00:00 2018-09-24 17:07:16+00:00 FL159 POTASSIUM SUPPLEMENT +74 Medication/supplement use 3804 phv00003804.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:07:23+00:00 2018-09-24 17:07:23+00:00 FL160 ANTIBIOTICS +74 Medication/supplement use 3805 phv00003805.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:07:32+00:00 2018-09-24 17:07:32+00:00 FL161 OTHER DRUG +74 Medication/supplement use 3806 phv00003806.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:07:48+00:00 2018-09-24 17:07:48+00:00 FL162 # OF ASPIRIN PER WEEK +74 Medication/supplement use 3807 phv00003807.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:07:55+00:00 2018-09-24 17:07:55+00:00 FL163 # OF MULTIVITAMINS PER WEEK +74 Medication/supplement use 3808 phv00003808.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:08:03+00:00 2018-09-24 17:08:03+00:00 FL164 # OF VITAMIN C TABS PER WEEK +74 Medication/supplement use 3809 phv00003809.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:08:11+00:00 2018-09-24 17:08:11+00:00 FL165 # OF VITAMIN D TABS PER WEEK +74 Medication/supplement use 3810 phv00003810.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:08:19+00:00 2018-09-24 17:08:19+00:00 FL166 # OF CALCIUM SUPPLEMENT TABS PER WEEK +74 Medication/supplement use 3811 phv00003811.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:08:28+00:00 2018-09-24 17:08:28+00:00 FL167 # OF ANTACID TABS PER WEEK +74 Medication/supplement use 3812 phv00003812.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:08:36+00:00 2018-09-24 17:08:36+00:00 FL168 # OF ANTACID TABLESPOONS PER WEEK +74 Medication/supplement use 3818 phv00003818.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:08:54+00:00 2018-09-24 17:08:54+00:00 FL174 CONJUGATED ESTROGEN USE IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 3819 phv00003819.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:09:04+00:00 2018-09-24 17:09:04+00:00 FL175 DOSE/DAY PREMARIN OR CONJ ESTROGEN +74 Medication/supplement use 3820 phv00003820.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:09:11+00:00 2018-09-24 17:09:11+00:00 FL176 DAYS/MONTH TAKING PREMARIN +74 Medication/supplement use 3821 phv00003821.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:09:18+00:00 2018-09-24 17:09:18+00:00 FL177 PROGESTERONE USE DURING INTERIM +74 Medication/supplement use 4078 phv00004078.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:10:30+00:00 2018-09-24 17:10:30+00:00 FL519 TREATMENT FOR BLOOD PRESSURE, EXAM19 +74 Medication/supplement use 4186 phv00004186.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:12:57+00:00 2018-09-24 17:12:57+00:00 FM135 ARE YOU PRESENTLY UNDER TREATMENT FOR RHEUMATOID ARTHRITIS? +74 Medication/supplement use 4197 phv00004197.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:13:10+00:00 2018-09-24 17:13:10+00:00 FM155 # OF ASPIRIN PER WEEK +74 Medication/supplement use 4198 phv00004198.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:13:21+00:00 2018-09-24 17:13:21+00:00 FM156 ANY CARDIOVASCULAR MEDICATIONS? +74 Medication/supplement use 4199 phv00004199.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:13:31+00:00 2018-09-24 17:13:31+00:00 FM157 MEDICINE USE: CARDIAC GLYCOSIDES +74 Medication/supplement use 4200 phv00004200.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:14:17+00:00 2018-09-24 17:14:17+00:00 FM158 MEDICINE USE: NITROGLYCERINE +74 Medication/supplement use 4201 phv00004201.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:14:26+00:00 2018-09-24 17:14:26+00:00 FM159 MEDICINE USE: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.) +74 Medication/supplement use 4202 phv00004202.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:14:34+00:00 2018-09-24 17:14:34+00:00 FM160 MEDICINE USE: CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 4203 phv00004203.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:14:41+00:00 2018-09-24 17:14:41+00:00 FM161 MEDICINE USE: BETA BLOCKERS +74 Medication/supplement use 4204 phv00004204.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:14:49+00:00 2018-09-24 17:14:49+00:00 FM162 MEDICINE USE: ANTIARRHYTHMICS (QUINIDINE, PROCAINE, NORPACE, ETC.) +74 Medication/supplement use 4205 phv00004205.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:14:57+00:00 2018-09-24 17:14:57+00:00 FM163 MEDICINE USE: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 4206 phv00004206.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:15:05+00:00 2018-09-24 17:15:05+00:00 FM164 MEDICINE USE: ANTICOAGULANTS (COUMADIN, ETC.) +74 Medication/supplement use 4207 phv00004207.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:15:12+00:00 2018-09-24 17:15:12+00:00 FM165 MEDICINE USE: THIAZIDE DIURETICS +74 Medication/supplement use 4208 phv00004208.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:15:21+00:00 2018-09-24 17:15:21+00:00 FM166 MEDICINE USE: LOOP DIURETICS (LASIX, ETC.) +74 Medication/supplement use 4209 phv00004209.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:15:28+00:00 2018-09-24 17:15:28+00:00 FM167 MEDICINE USE: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 4210 phv00004210.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:15:40+00:00 2018-09-24 17:15:40+00:00 FM168 MEDICINE USE: RESERPINE DERIVATIVES +74 Medication/supplement use 4211 phv00004211.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:15:52+00:00 2018-09-24 17:15:52+00:00 FM169 MEDICINE USE: METHYLDOPA (ALDOMET) +74 Medication/supplement use 4212 phv00004212.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:16:00+00:00 2018-09-24 17:16:00+00:00 FM170 MEDICINE USE: CLONIDINE (CATAPRES) +74 Medication/supplement use 4213 phv00004213.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:16:27+00:00 2018-09-24 17:16:27+00:00 FM171 MEDICINE USE: WYTENSIN +74 Medication/supplement use 4214 phv00004214.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:16:34+00:00 2018-09-24 17:16:34+00:00 FM172 MEDICINE USE: GANGLIONIC BLOCKERS +74 Medication/supplement use 4215 phv00004215.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:16:42+00:00 2018-09-24 17:16:42+00:00 FM173 MEDICINE USE: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL) +74 Medication/supplement use 4216 phv00004216.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:16:50+00:00 2018-09-24 17:16:50+00:00 FM174 MEDICINE USE: PERIPHERAL VASODILATORS (HYDRALAZINE, MINIPRES, MINOXIDIL, ETC.) +74 Medication/supplement use 4217 phv00004217.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:17:00+00:00 2018-09-24 17:17:00+00:00 FM175 MEDICINE USE: OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 4218 phv00004218.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:17:07+00:00 2018-09-24 17:17:07+00:00 FM176 MEDICINE USE: OTHER CARDIAC MEDICATION +74 Medication/supplement use 4219 phv00004219.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:17:15+00:00 2018-09-24 17:17:15+00:00 FM177 MEDICINE USE: ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.) +74 Medication/supplement use 4220 phv00004220.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:17:23+00:00 2018-09-24 17:17:23+00:00 FM178 MEDICINE USE: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 4221 phv00004221.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:17:33+00:00 2018-09-24 17:17:33+00:00 FM179 MEDICINE USE: ANTIGOUT - (COLCHICINE) +74 Medication/supplement use 4222 phv00004222.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:17:42+00:00 2018-09-24 17:17:42+00:00 FM180 MEDICINE USE: THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 4223 phv00004223.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:17:55+00:00 2018-09-24 17:17:55+00:00 FM181 MEDICINE USE: THYROXINE (SYNTHROID ETC.) +74 Medication/supplement use 4224 phv00004224.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:18:03+00:00 2018-09-24 17:18:03+00:00 FM182 MEDICINE USE: INSULIN +74 Medication/supplement use 4094 phv00004094.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:18:44+00:00 2018-09-24 17:18:44+00:00 FM183 MEDICINE USE: TOTAL UNITS OF INSULIN PER DAY +74 Medication/supplement use 4225 phv00004225.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:18:51+00:00 2018-09-24 17:18:51+00:00 FM184 MEDICINE USE: ORAL HYPOGLYCEMICS +74 Medication/supplement use 4226 phv00004226.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:18:59+00:00 2018-09-24 17:18:59+00:00 FM185 MEDICINE USE: ORAL ESTROGEN +74 Medication/supplement use 4227 phv00004227.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:19:08+00:00 2018-09-24 17:19:08+00:00 FM186 MEDICINE USE: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 4228 phv00004228.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:19:16+00:00 2018-09-24 17:19:16+00:00 FM187 MEDICINE USE: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 4229 phv00004229.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:19:25+00:00 2018-09-24 17:19:25+00:00 FM188 MEDICINE USE: ANALGESIC - NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 4230 phv00004230.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:19:33+00:00 2018-09-24 17:19:33+00:00 FM189 MEDICINE USE: ANALGESIC - NON-NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 4231 phv00004231.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:19:41+00:00 2018-09-24 17:19:41+00:00 FM190 MEDICINE USE: BRONCHODILATOR, AEROSOLS +74 Medication/supplement use 4232 phv00004232.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:19:54+00:00 2018-09-24 17:19:54+00:00 FM191 MEDICINE USE: ANTIHISTAMINES +74 Medication/supplement use 4233 phv00004233.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:20:02+00:00 2018-09-24 17:20:02+00:00 FM192 MEDICINE USE: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS) +74 Medication/supplement use 4234 phv00004234.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:20:13+00:00 2018-09-24 17:20:13+00:00 FM193 MEDICINE USE: ANTI-ANXIETY, SEDATIVE/HYPNOTICS, ETC. (LIBRIUM, VALIUM, ETC.) +74 Medication/supplement use 4235 phv00004235.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:20:22+00:00 2018-09-24 17:20:22+00:00 FM194 MEDICINE USE: SLEEPING PILLS +74 Medication/supplement use 4236 phv00004236.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:20:31+00:00 2018-09-24 17:20:31+00:00 FM195 MEDICINE USE: ANTI-DEPRESSANTS +74 Medication/supplement use 4237 phv00004237.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:20:39+00:00 2018-09-24 17:20:39+00:00 FM196 MEDICINE USE: EYEDROPS +74 Medication/supplement use 4238 phv00004238.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:20:49+00:00 2018-09-24 17:20:49+00:00 FM197 MEDICINE USE: POTASSIUM SUPPLEMENTS +74 Medication/supplement use 4239 phv00004239.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:20:57+00:00 2018-09-24 17:20:57+00:00 FM198 MEDICINE USE: ANTIBIOTICS +74 Medication/supplement use 4240 phv00004240.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:22:49+00:00 2018-09-24 17:22:49+00:00 FM199 MEDICINE USE: OTHER DRUG +74 Medication/supplement use 4243 phv00004243.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:23:10+00:00 2018-09-24 17:23:10+00:00 FM202 CONJUGATED ESTROGEN USE IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 4244 phv00004244.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:23:18+00:00 2018-09-24 17:23:18+00:00 FM203 DOSE/DAY PREMARIN OR CONJ. ESTROGENS +74 Medication/supplement use 4245 phv00004245.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:23:24+00:00 2018-09-24 17:23:24+00:00 FM204 DAYS PER MONTH TAKING PREMARIN +74 Medication/supplement use 4246 phv00004246.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:23:32+00:00 2018-09-24 17:23:32+00:00 FM205 ESTROGEN CREAM USE DURING INTERIM +74 Medication/supplement use 4247 phv00004247.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:23:42+00:00 2018-09-24 17:23:42+00:00 FM206 PROGESTERONE USE DURING INTERIM +74 Medication/supplement use 4520 phv00004520.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:24:51+00:00 2018-09-24 17:24:51+00:00 FM474A CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 4522 phv00004522.v1.p10 pht000022.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:25:10+00:00 2018-09-24 17:25:10+00:00 FM539 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 4599 phv00004599.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:27:42+00:00 2018-09-24 17:27:42+00:00 FN100 LOOP DIURETICS (LASIX, ETC.) +74 Medication/supplement use 4600 phv00004600.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:27:49+00:00 2018-09-24 17:27:49+00:00 FN101 THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.) +74 Medication/supplement use 4601 phv00004601.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:27:56+00:00 2018-09-24 17:27:56+00:00 FN102 THIAZIDE DIURETICS +74 Medication/supplement use 4602 phv00004602.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:28:03+00:00 2018-09-24 17:28:03+00:00 FN103 K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE, AMILORIDE) +74 Medication/supplement use 4603 phv00004603.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:28:11+00:00 2018-09-24 17:28:11+00:00 FN104 POTASSIUM SUPPLEMENTS +74 Medication/supplement use 4604 phv00004604.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:28:20+00:00 2018-09-24 17:28:20+00:00 FN105 RESERPINE DERIVATIVES +74 Medication/supplement use 4605 phv00004605.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:28:31+00:00 2018-09-24 17:28:31+00:00 FN106 METHYLDOPA (ALDOMET) +74 Medication/supplement use 4606 phv00004606.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:28:40+00:00 2018-09-24 17:28:40+00:00 FN107 ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 4607 phv00004607.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:28:47+00:00 2018-09-24 17:28:47+00:00 FN108 ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN) +74 Medication/supplement use 4608 phv00004608.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:28:55+00:00 2018-09-24 17:28:55+00:00 FN109 RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 4609 phv00004609.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:29:03+00:00 2018-09-24 17:29:03+00:00 FN110 PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC.) +74 Medication/supplement use 4610 phv00004610.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:29:10+00:00 2018-09-24 17:29:10+00:00 FN111 OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 4611 phv00004611.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:29:18+00:00 2018-09-24 17:29:18+00:00 FN112 ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.) +74 Medication/supplement use 4612 phv00004612.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:29:26+00:00 2018-09-24 17:29:26+00:00 FN113 ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 4613 phv00004613.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:29:37+00:00 2018-09-24 17:29:37+00:00 FN114 ANITCOAGULANTS (COUMADIN, WARFARIN, ETC.) +74 Medication/supplement use 4614 phv00004614.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:29:45+00:00 2018-09-24 17:29:45+00:00 FN115 OTHER CARDIAC MEDICATION +74 Medication/supplement use 4615 phv00004615.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:29:52+00:00 2018-09-24 17:29:52+00:00 FN116 ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, LOVASTATIN, ETC.) +74 Medication/supplement use 4616 phv00004616.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:30:01+00:00 2018-09-24 17:30:01+00:00 FN117 ANTIGOUT--URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 4617 phv00004617.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:30:08+00:00 2018-09-24 17:30:08+00:00 FN118 ANTIGOUT (COLCHICINE) +74 Medication/supplement use 4618 phv00004618.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:30:15+00:00 2018-09-24 17:30:15+00:00 FN119 THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 4619 phv00004619.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:30:23+00:00 2018-09-24 17:30:23+00:00 FN120 THYROXINE (SYNTHROID, ETC.) +74 Medication/supplement use 4620 phv00004620.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:30:49+00:00 2018-09-24 17:30:49+00:00 FN121 INSULIN +74 Medication/supplement use 4536 phv00004536.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:30:57+00:00 2018-09-24 17:30:57+00:00 FN122 INSULIN/TOTAL UNITS PER DAY +74 Medication/supplement use 4621 phv00004621.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:31:05+00:00 2018-09-24 17:31:05+00:00 FN123 ORAL HYPOGLYCEMICS +74 Medication/supplement use 4622 phv00004622.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:31:12+00:00 2018-09-24 17:31:12+00:00 FN124 ORAL ESTROGEN +74 Medication/supplement use 4623 phv00004623.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:31:21+00:00 2018-09-24 17:31:21+00:00 FN125 ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 4624 phv00004624.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:31:28+00:00 2018-09-24 17:31:28+00:00 FN126 NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 4625 phv00004625.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:31:37+00:00 2018-09-24 17:31:37+00:00 FN127 ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 4626 phv00004626.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:31:45+00:00 2018-09-24 17:31:45+00:00 FN128 ANALGESIC-NON-NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 4627 phv00004627.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:31:55+00:00 2018-09-24 17:31:55+00:00 FN129 BRONCHODILATORS, AEROSOLS, ETC. +74 Medication/supplement use 4628 phv00004628.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:32:02+00:00 2018-09-24 17:32:02+00:00 FN130 ANTIHISTAMINES +74 Medication/supplement use 4629 phv00004629.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:32:11+00:00 2018-09-24 17:32:11+00:00 FN131 ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H-ION INHIBITORS) +74 Medication/supplement use 4630 phv00004630.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:32:19+00:00 2018-09-24 17:32:19+00:00 FN132 ANTI-ANXIETY, SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM, ETC.) +74 Medication/supplement use 4631 phv00004631.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:32:28+00:00 2018-09-24 17:32:28+00:00 FN133 SLEEPING PILLS +74 Medication/supplement use 4632 phv00004632.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:32:35+00:00 2018-09-24 17:32:35+00:00 FN134 ANTI-DEPRESSANTS +74 Medication/supplement use 4633 phv00004633.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:32:42+00:00 2018-09-24 17:32:42+00:00 FN135 EYEDROPS +74 Medication/supplement use 4634 phv00004634.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:32:50+00:00 2018-09-24 17:32:50+00:00 FN136 ANTIBIOTICS +74 Medication/supplement use 4635 phv00004635.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:32:59+00:00 2018-09-24 17:32:59+00:00 FN137 ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.) +74 Medication/supplement use 4636 phv00004636.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:33:06+00:00 2018-09-24 17:33:06+00:00 FN138 ANTICONVULSANTS (DILANTIN, PHENOBARB, TEGRETOL, MYSOLINE, ETC.) +74 Medication/supplement use 4637 phv00004637.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:33:15+00:00 2018-09-24 17:33:15+00:00 FN139 MEDICATIONS - OTHERS +74 Medication/supplement use 4650 phv00004650.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:33:38+00:00 2018-09-24 17:33:38+00:00 FN152 CONJUGATED ESTROGEN USE IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 4651 phv00004651.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:33:50+00:00 2018-09-24 17:33:50+00:00 FN153 ORAL DOSE/DAY OF PREMARIN OR CONJ. ESTROGEN +74 Medication/supplement use 4652 phv00004652.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:33:57+00:00 2018-09-24 17:33:57+00:00 FN154 NUMBER OF DAYS/MONTH TAKING PREMARIN - FEMALE +74 Medication/supplement use 4653 phv00004653.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:34:05+00:00 2018-09-24 17:34:05+00:00 FN155 ESTROGEN CREAM USE IN INTERIM +74 Medication/supplement use 4654 phv00004654.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:34:13+00:00 2018-09-24 17:34:13+00:00 FN156 PROGESTERONE USE IN INTERIM +74 Medication/supplement use 4934 phv00004934.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:36:10+00:00 2018-09-24 17:36:10+00:00 FN507 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 4592 phv00004592.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:36:46+00:00 2018-09-24 17:36:46+00:00 FN93 NUMBER OF ASPIRINS PER WEEK +74 Medication/supplement use 4593 phv00004593.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:36:54+00:00 2018-09-24 17:36:54+00:00 FN94 TAKING ANY CARDIOVASCULAR MEDS BELOW? +74 Medication/supplement use 4594 phv00004594.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:37:02+00:00 2018-09-24 17:37:02+00:00 FN95 CARDIAC GLYCOSIDES +74 Medication/supplement use 4595 phv00004595.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:37:10+00:00 2018-09-24 17:37:10+00:00 FN96 NITROGLYCERINE +74 Medication/supplement use 4596 phv00004596.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:37:18+00:00 2018-09-24 17:37:18+00:00 FN97 LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.) +74 Medication/supplement use 4597 phv00004597.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:37:26+00:00 2018-09-24 17:37:26+00:00 FN98 CALCIUM CHANNEL BLOCKERS (NIFEDIPINE, VERAPAMIL, DILTIAZEM) +74 Medication/supplement use 4598 phv00004598.v1.p10 pht000023.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 17:37:35+00:00 2018-09-24 17:37:35+00:00 FN99 BETA BLOCKERS +74 Medication/supplement use 4944 phv00004944.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:24:19+00:00 2018-09-24 18:24:19+00:00 FO091 NUMBER OF ASPIRINS PER TIME INTERVAL +74 Medication/supplement use 4945 phv00004945.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:24:26+00:00 2018-09-24 18:24:26+00:00 FO092 TIME INTERVAL FOR ASPIRIN TAKEN +74 Medication/supplement use 4946 phv00004946.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:24:33+00:00 2018-09-24 18:24:33+00:00 FO093 CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION? +74 Medication/supplement use 4947 phv00004947.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:24:40+00:00 2018-09-24 18:24:40+00:00 FO094 (TAKING) ANY CARDIOVASCULAR MEDICATIONS BELOW? +74 Medication/supplement use 4948 phv00004948.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:24:47+00:00 2018-09-24 18:24:47+00:00 FO095 MEDICATION USE: CARDIAC GLYCOSIDES +74 Medication/supplement use 4949 phv00004949.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:24:54+00:00 2018-09-24 18:24:54+00:00 FO096 MEDICATION USE: NITROGLYCERINE +74 Medication/supplement use 4950 phv00004950.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:25:01+00:00 2018-09-24 18:25:01+00:00 FO097 MEDICATION USE: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.) +74 Medication/supplement use 4951 phv00004951.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:25:07+00:00 2018-09-24 18:25:07+00:00 FO098 MEDICATION USE: CALCIUM CHANNEL BLOCKERS (NIFIDIPINE, VERAPAMIL, DILTIAZEM) +74 Medication/supplement use 4952 phv00004952.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:25:14+00:00 2018-09-24 18:25:14+00:00 FO099 MEDICATION USE: BETA BLOCKERS +74 Medication/supplement use 4953 phv00004953.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:25:26+00:00 2018-09-24 18:25:26+00:00 FO100 MEDICATION USE: BETA BLOCKERS GROUP +74 Medication/supplement use 4954 phv00004954.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:25:32+00:00 2018-09-24 18:25:32+00:00 FO101 MEDICATION USE: BETA BLOCKERS DOSE (MG/DAY) +74 Medication/supplement use 4955 phv00004955.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:25:40+00:00 2018-09-24 18:25:40+00:00 FO102 MEDICATION USE: LOOP DIURETICS (LASIX, ETC.) +74 Medication/supplement use 4956 phv00004956.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:25:46+00:00 2018-09-24 18:25:46+00:00 FO103 MEDICATION USE: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.) +74 Medication/supplement use 4957 phv00004957.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:25:54+00:00 2018-09-24 18:25:54+00:00 FO104 MEDICATION USE: THIAZIDE DIURETICS +74 Medication/supplement use 4958 phv00004958.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:26:01+00:00 2018-09-24 18:26:01+00:00 FO105 MEDICATION USE: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE, AMILORIDE) +74 Medication/supplement use 4959 phv00004959.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:26:09+00:00 2018-09-24 18:26:09+00:00 FO106 MEDICATION USE: POTASSIUM SUPPLEMENTS +74 Medication/supplement use 4960 phv00004960.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:26:18+00:00 2018-09-24 18:26:18+00:00 FO107 MEDICATION USE: RESERPINE DERIVATIVES +74 Medication/supplement use 4961 phv00004961.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:26:25+00:00 2018-09-24 18:26:25+00:00 FO108 MEDICATION USE: METHYLDOPA (ALDOMET) +74 Medication/supplement use 4962 phv00004962.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:26:35+00:00 2018-09-24 18:26:35+00:00 FO109 MEDICATION USE: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 4963 phv00004963.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:27:23+00:00 2018-09-24 18:27:23+00:00 FO110 MEDICATION USE: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN) +74 Medication/supplement use 4964 phv00004964.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:27:31+00:00 2018-09-24 18:27:31+00:00 FO111 MEDICATION USE: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 4965 phv00004965.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:27:39+00:00 2018-09-24 18:27:39+00:00 FO112 MEDICATION USE: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC.) +74 Medication/supplement use 4966 phv00004966.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:27:47+00:00 2018-09-24 18:27:47+00:00 FO113 MEDICATION USE: OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 4967 phv00004967.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:27:56+00:00 2018-09-24 18:27:56+00:00 FO114 MEDICATION USE: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.) +74 Medication/supplement use 4968 phv00004968.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:28:04+00:00 2018-09-24 18:28:04+00:00 FO115 MEDICATION USE: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 4969 phv00004969.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:28:11+00:00 2018-09-24 18:28:11+00:00 FO116 MEDICATION USE: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.) +74 Medication/supplement use 4970 phv00004970.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:28:19+00:00 2018-09-24 18:28:19+00:00 FO117 MEDICATION USE: OTHER CARDIAC MEDICATION +74 Medication/supplement use 4971 phv00004971.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:28:27+00:00 2018-09-24 18:28:27+00:00 FO118 "(TAKING) ANY OF THE ""NON-CARDIOVASCULAR MEDICATIONS"" BELOW?" +74 Medication/supplement use 4972 phv00004972.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:28:35+00:00 2018-09-24 18:28:35+00:00 FO119 MEDICATION USE: ANTI CHOLESTEROL DRUGS (RESINS -- E.G. QUESTRAN, COLESTID) +74 Medication/supplement use 4973 phv00004973.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:28:43+00:00 2018-09-24 18:28:43+00:00 FO120 MEDICATION USE: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID) +74 Medication/supplement use 4974 phv00004974.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:29:09+00:00 2018-09-24 18:29:09+00:00 FO121 MEDICATION USE: ANTI CHOLESTEROL DRUGS (FIBRATES -- E.G. GEMFIBROZIL) +74 Medication/supplement use 4975 phv00004975.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:29:20+00:00 2018-09-24 18:29:20+00:00 FO122 MEDICATION USE: ANTI CHOLESTEROL DRUGS (STATINS -- E.G. LOVASTATIN, PRAVASTATIN) +74 Medication/supplement use 4976 phv00004976.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:29:27+00:00 2018-09-24 18:29:27+00:00 FO123 MEDICATION USE: ANTI CHOLESTEROL DRUGS (OTHER) +74 Medication/supplement use 4977 phv00004977.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:29:34+00:00 2018-09-24 18:29:34+00:00 FO124 MEDICATION USE: ANTIGOUT--URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 4978 phv00004978.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:29:41+00:00 2018-09-24 18:29:41+00:00 FO125 MEDICATION USE: ANTIGOUT (COLCHICINE) +74 Medication/supplement use 4979 phv00004979.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:29:49+00:00 2018-09-24 18:29:49+00:00 FO126 MEDICATION USE: THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 4980 phv00004980.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:29:56+00:00 2018-09-24 18:29:56+00:00 FO127 MEDICATION USE: THYROXINE (SYNTHROID, ETC.) +74 Medication/supplement use 4981 phv00004981.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:30:12+00:00 2018-09-24 18:30:12+00:00 FO128 MEDICATION USE: INSULIN +74 Medication/supplement use 4982 phv00004982.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:30:19+00:00 2018-09-24 18:30:19+00:00 FO129 MEDICATION USE: TOTAL UNITS OF INSULIN PER DAY +74 Medication/supplement use 4983 phv00004983.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:30:29+00:00 2018-09-24 18:30:29+00:00 FO130 MEDICATION USE: ORAL HYPOGLYCEMICS +74 Medication/supplement use 4984 phv00004984.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:30:36+00:00 2018-09-24 18:30:36+00:00 FO131 MEDICATION USE: ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION) +74 Medication/supplement use 4985 phv00004985.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:30:45+00:00 2018-09-24 18:30:45+00:00 FO132 MEDICATION USE: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 4986 phv00004986.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:30:55+00:00 2018-09-24 18:30:55+00:00 FO133 MEDICATION USE: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 4987 phv00004987.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:31:02+00:00 2018-09-24 18:31:02+00:00 FO134 MEDICATION USE: IF TAKING NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, DO YOU TAKE THEM EVERY DAY? +74 Medication/supplement use 4988 phv00004988.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:31:09+00:00 2018-09-24 18:31:09+00:00 FO135 MEDICATION USE: ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 4989 phv00004989.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:31:17+00:00 2018-09-24 18:31:17+00:00 FO136 MEDICATION USE: ANALGESIC-NON-NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 4990 phv00004990.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:31:25+00:00 2018-09-24 18:31:25+00:00 FO137 MEDICATION USE: BRONCHODILATORS, AEROSOLS, ETC +74 Medication/supplement use 4991 phv00004991.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:31:34+00:00 2018-09-24 18:31:34+00:00 FO138 MEDICATION USE: ANTIHISTAMINES +74 Medication/supplement use 4992 phv00004992.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:31:42+00:00 2018-09-24 18:31:42+00:00 FO139 MEDICATION USE: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H-ION INHIBITORS) +74 Medication/supplement use 4993 phv00004993.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:31:56+00:00 2018-09-24 18:31:56+00:00 FO140 MEDICATION USE: ANTI-ANXIETY,SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM, ETC.) +74 Medication/supplement use 4994 phv00004994.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:32:08+00:00 2018-09-24 18:32:08+00:00 FO141 MEDICATION USE: SLEEPING PILLS +74 Medication/supplement use 4995 phv00004995.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:32:18+00:00 2018-09-24 18:32:18+00:00 FO142 MEDICATION USE: ANTI-DEPRESSANTS +74 Medication/supplement use 4996 phv00004996.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:32:26+00:00 2018-09-24 18:32:26+00:00 FO143 MEDICATION USE: EYEDROPS +74 Medication/supplement use 4997 phv00004997.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:32:34+00:00 2018-09-24 18:32:34+00:00 FO144 MEDICATION USE: ANTIBIOTICS +74 Medication/supplement use 4998 phv00004998.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:32:42+00:00 2018-09-24 18:32:42+00:00 FO145 MEDICATION USE: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.) +74 Medication/supplement use 4999 phv00004999.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:32:58+00:00 2018-09-24 18:32:58+00:00 FO146 MEDICATION USE: ANTICONVULSANTS (DILANTIN, PHENOBARB, TEGRETOL, MYSOLINE, ETC.) +74 Medication/supplement use 5000 phv00005000.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:33:07+00:00 2018-09-24 18:33:07+00:00 FO147 MEDICATION USE: NON-CARDIOVASCULAR MEDICATION - OTHER +74 Medication/supplement use 5004 phv00005004.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:33:35+00:00 2018-09-24 18:33:35+00:00 FO151 CONJUGATED ESTROGEN USE IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 5005 phv00005005.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:33:43+00:00 2018-09-24 18:33:43+00:00 FO152 ORAL DOSE/DAY OF PREMARIN OR CONJ. ESTROGEN - FEMALE +74 Medication/supplement use 5006 phv00005006.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:33:51+00:00 2018-09-24 18:33:51+00:00 FO153 PATCH DOSE/DAY OF ESTROGEN - FEMALE +74 Medication/supplement use 5007 phv00005007.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:34:00+00:00 2018-09-24 18:34:00+00:00 FO154 NUMBER OF DAYS/MONTH TAKING ESTROGENS - FEMALE +74 Medication/supplement use 5008 phv00005008.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:34:08+00:00 2018-09-24 18:34:08+00:00 FO155 ESTROGEN CREAM USE IN INTERIM - FEMALE +74 Medication/supplement use 5009 phv00005009.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:34:16+00:00 2018-09-24 18:34:16+00:00 FO156 PROGESTERONE USE IN INTERIM - FEMALE +74 Medication/supplement use 5456 phv00005456.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:35:20+00:00 2018-09-24 18:35:20+00:00 FO643 ARTHRITIS B - DO YOU TAKE MEDICATION DAILY FOR YOUR JOINT PAIN, ACHING OR STIFFNESS? +74 Medication/supplement use 5457 phv00005457.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:35:32+00:00 2018-09-24 18:35:32+00:00 FO644 ARTHRITIS B - IF YES (TO FO643), WHAT IS THE NAME OF THE MEDICATION? +74 Medication/supplement use 5555 phv00005555.v1.p10 pht000024.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:35:58+00:00 2018-09-24 18:35:58+00:00 FO728 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 5563 phv00005563.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:40:49+00:00 2018-09-24 18:40:49+00:00 FP044 NUMBER OF ASPIRINS PER TIME INTERVAL +74 Medication/supplement use 5564 phv00005564.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:41:01+00:00 2018-09-24 18:41:01+00:00 FP045 TIME INTERVAL FOR ASPIRIN TAKEN +74 Medication/supplement use 5565 phv00005565.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:41:09+00:00 2018-09-24 18:41:09+00:00 FP046 USUAL ASPIRIN DOSE FOR ABOVE (FP045) +74 Medication/supplement use 5566 phv00005566.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:41:16+00:00 2018-09-24 18:41:16+00:00 FP047 CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION? +74 Medication/supplement use 5567 phv00005567.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:41:24+00:00 2018-09-24 18:41:24+00:00 FP048 ANY CARDIOVASCULAR MEDICATIONS BELOW TAKEN IN INTERIM? +74 Medication/supplement use 5568 phv00005568.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:41:32+00:00 2018-09-24 18:41:32+00:00 FP049 MEDICATION USE: CARDIAC GLYCOSIDES +74 Medication/supplement use 5569 phv00005569.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:41:39+00:00 2018-09-24 18:41:39+00:00 FP050 MEDICATION USE: NITROGLYCERINE +74 Medication/supplement use 5570 phv00005570.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:41:47+00:00 2018-09-24 18:41:47+00:00 FP051 MEDICATION USE: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.) +74 Medication/supplement use 5571 phv00005571.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:41:55+00:00 2018-09-24 18:41:55+00:00 FP052 MEDICATION USE: CALCIUM CHANNEL BLOCKERS (NIFIDIPINE, VERAPAMIL, DILTIAZEM) +74 Medication/supplement use 5572 phv00005572.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:42:03+00:00 2018-09-24 18:42:03+00:00 FP053 MEDICATION USE: BETA BLOCKERS +74 Medication/supplement use 5573 phv00005573.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:42:10+00:00 2018-09-24 18:42:10+00:00 FP054 MEDICATION USE: BETA BLOCKERS GROUP +74 Medication/supplement use 5574 phv00005574.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:42:19+00:00 2018-09-24 18:42:19+00:00 FP055 MEDICATION USE: BETA BLOCKERS DOSE (MG/DAY) +74 Medication/supplement use 5575 phv00005575.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:42:27+00:00 2018-09-24 18:42:27+00:00 FP056 MEDICATION USE: LOOP DIURETICS (LASIX, ETC.) +74 Medication/supplement use 5576 phv00005576.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:42:34+00:00 2018-09-24 18:42:34+00:00 FP057 MEDICATION USE: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.) +74 Medication/supplement use 5577 phv00005577.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:42:42+00:00 2018-09-24 18:42:42+00:00 FP058 MEDICATION USE: THIAZIDE DIURETICS +74 Medication/supplement use 5578 phv00005578.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:42:49+00:00 2018-09-24 18:42:49+00:00 FP059 MEDICATION USE: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE, AMILORIDE) +74 Medication/supplement use 5579 phv00005579.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:42:56+00:00 2018-09-24 18:42:56+00:00 FP060 MEDICATION USE: POTASSIUM SUPPLEMENTS +74 Medication/supplement use 5580 phv00005580.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:43:13+00:00 2018-09-24 18:43:13+00:00 FP061 MEDICATION USE: RESERPINE DERIVATIVES +74 Medication/supplement use 5581 phv00005581.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:43:20+00:00 2018-09-24 18:43:20+00:00 FP062 MEDICATION USE: METHYLDOPA (ALDOMET) +74 Medication/supplement use 5582 phv00005582.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:43:28+00:00 2018-09-24 18:43:28+00:00 FP063 MEDICATION USE: ALPHA AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 5583 phv00005583.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:43:35+00:00 2018-09-24 18:43:35+00:00 FP064 MEDICATION USE: ALPHA BLOCKERS (PRAZOSIN, TERAZOSIN) +74 Medication/supplement use 5584 phv00005584.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:43:43+00:00 2018-09-24 18:43:43+00:00 FP065 MEDICATION USE: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 5585 phv00005585.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:43:54+00:00 2018-09-24 18:43:54+00:00 FP066 MEDICATION USE: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC.) +74 Medication/supplement use 5586 phv00005586.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:44:01+00:00 2018-09-24 18:44:01+00:00 FP067 MEDICATION USE: OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 5587 phv00005587.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:44:08+00:00 2018-09-24 18:44:08+00:00 FP068 MEDICATION USE: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.) +74 Medication/supplement use 5588 phv00005588.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:44:17+00:00 2018-09-24 18:44:17+00:00 FP069 MEDICATION USE: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 5589 phv00005589.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:44:24+00:00 2018-09-24 18:44:24+00:00 FP070 MEDICATION USE: ANITCOAGULANTS (COUMADIN, WARFARIN, ETC.) +74 Medication/supplement use 5590 phv00005590.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:44:34+00:00 2018-09-24 18:44:34+00:00 FP071 MEDICATION USE: OTHER CARDIAC MEDICATION +74 Medication/supplement use 5591 phv00005591.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:44:42+00:00 2018-09-24 18:44:42+00:00 FP072 ANY OF THE NON-CARDIOVASCULAR MEDICATIONS BELOW TAKEN IN INTERIM? +74 Medication/supplement use 5592 phv00005592.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:44:50+00:00 2018-09-24 18:44:50+00:00 FP073 MEDICATION USE: ANTI CHOLESTEROL DRUGS (RESINS--E.G. QUESTRAN, COLESTID) +74 Medication/supplement use 5593 phv00005593.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:45:03+00:00 2018-09-24 18:45:03+00:00 FP074 MEDICATION USE: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID) +74 Medication/supplement use 5594 phv00005594.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:45:12+00:00 2018-09-24 18:45:12+00:00 FP075 MEDICATION USE: ANTI CHOLESTEROL DRUGS (FIBRATES--E.G. GEMFIBROZIL) +74 Medication/supplement use 5595 phv00005595.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:45:19+00:00 2018-09-24 18:45:19+00:00 FP076 MEDICATION USE: ANTI CHOLESTEROL DRUGS (STATINS--E.G. LOVASTATIN, PRAVASTATIN) +74 Medication/supplement use 5596 phv00005596.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:45:27+00:00 2018-09-24 18:45:27+00:00 FP077 MEDICATION USE: ANTI CHOLESTEROL DRUGS--OTHER +74 Medication/supplement use 5597 phv00005597.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:45:34+00:00 2018-09-24 18:45:34+00:00 FP078 MEDICATION USE: ANTIGOUT--URIC ACID LOWERING (ALLOPURINOL, PROBENECID ETC.) +74 Medication/supplement use 5598 phv00005598.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:45:42+00:00 2018-09-24 18:45:42+00:00 FP079 MEDICATION USE: ANTIGOUT--(COLCHICINE) +74 Medication/supplement use 5599 phv00005599.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:45:50+00:00 2018-09-24 18:45:50+00:00 FP080 MEDICATION USE: THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 5600 phv00005600.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:46:24+00:00 2018-09-24 18:46:24+00:00 FP081 MEDICATION USE: THYROXINE (SYNTHROID ETC.) +74 Medication/supplement use 5601 phv00005601.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:46:32+00:00 2018-09-24 18:46:32+00:00 FP082 MEDICATION USE: INSULIN +74 Medication/supplement use 5602 phv00005602.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:46:40+00:00 2018-09-24 18:46:40+00:00 FP083 MEDICATION USE: INSULIN/TOTAL UNITS PER DAY +74 Medication/supplement use 5603 phv00005603.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:46:47+00:00 2018-09-24 18:46:47+00:00 FP084 MEDICATION USE: ORAL HYPOGLYCEMICS +74 Medication/supplement use 5604 phv00005604.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:46:54+00:00 2018-09-24 18:46:54+00:00 FP085 MEDICATION USE: ORAL/PATCH ESTROGEN +74 Medication/supplement use 5605 phv00005605.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:47:02+00:00 2018-09-24 18:47:02+00:00 FP086 MEDICATION USE: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 5606 phv00005606.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:47:10+00:00 2018-09-24 18:47:10+00:00 FP087 MEDICATION USE: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 5607 phv00005607.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:47:17+00:00 2018-09-24 18:47:17+00:00 FP088 MEDICATION USE: IF TAKING NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, DO YOU TAKE THEM EVERY DAY? +74 Medication/supplement use 5608 phv00005608.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:47:24+00:00 2018-09-24 18:47:24+00:00 FP089 MEDICATION USE: ANALGESIC--NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 5609 phv00005609.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:47:32+00:00 2018-09-24 18:47:32+00:00 FP090 MEDICATION USE: ANALGESIC--NON-NARCOTICS (ACETAMINOPHEN ETC.) +74 Medication/supplement use 5610 phv00005610.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:47:39+00:00 2018-09-24 18:47:39+00:00 FP091 MEDICATION USE: BRONCHODILATORS, AEROSOLS, ETC +74 Medication/supplement use 5611 phv00005611.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:47:47+00:00 2018-09-24 18:47:47+00:00 FP092 MEDICATION USE: ANTIHISTAMINES +74 Medication/supplement use 5612 phv00005612.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:48:26+00:00 2018-09-24 18:48:26+00:00 FP093 MEDICATION USE: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS) +74 Medication/supplement use 5613 phv00005613.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:48:34+00:00 2018-09-24 18:48:34+00:00 FP094 MEDICATION USE: ANTI-ANXIETY,SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM ETC.) +74 Medication/supplement use 5614 phv00005614.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:48:42+00:00 2018-09-24 18:48:42+00:00 FP095 MEDICATION USE: SLEEPING PILLS +74 Medication/supplement use 5615 phv00005615.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:48:50+00:00 2018-09-24 18:48:50+00:00 FP096 MEDICATION USE: ANTI-DEPRESSANTS +74 Medication/supplement use 5616 phv00005616.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:48:57+00:00 2018-09-24 18:48:57+00:00 FP097 MEDICATION USE: EYEDROPS +74 Medication/supplement use 5617 phv00005617.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:49:05+00:00 2018-09-24 18:49:05+00:00 FP098 MEDICATION USE: ANTIBIOTICS +74 Medication/supplement use 5618 phv00005618.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:49:14+00:00 2018-09-24 18:49:14+00:00 FP099 MEDICATION USE: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.) +74 Medication/supplement use 5619 phv00005619.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:49:22+00:00 2018-09-24 18:49:22+00:00 FP100 MEDICATION USE: ANTICONVULSANTS (DILANTIN, PHENOBARB, TEGRETOL, MYSOLINE ETC.) +74 Medication/supplement use 5620 phv00005620.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:49:30+00:00 2018-09-24 18:49:30+00:00 FP101 MEDICATION USE: MEDICATIONS - OTHERS (INCLUDING VITAMINS) +74 Medication/supplement use 5640 phv00005640.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:57:23+00:00 2018-09-24 18:57:23+00:00 FP121 USING FEMALE HORMONES IN INTERIM +74 Medication/supplement use 5641 phv00005641.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:57:40+00:00 2018-09-24 18:57:40+00:00 FP122 SYSTEMIC ESTROGEN IN INTERIM +74 Medication/supplement use 5642 phv00005642.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:57:49+00:00 2018-09-24 18:57:49+00:00 FP123 ORAL DOSE/DAY OF PREMARIN OR CONJ. ESTROGEN - FEMALE +74 Medication/supplement use 5643 phv00005643.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:58:00+00:00 2018-09-24 18:58:00+00:00 FP124 PATCH DOSE/DAY OF ESTROGEN - FEMALE +74 Medication/supplement use 5644 phv00005644.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:58:08+00:00 2018-09-24 18:58:08+00:00 FP125 NUMBER OF DAYS/MONTH TAKING ESTROGEN - FEMALE +74 Medication/supplement use 5645 phv00005645.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:58:18+00:00 2018-09-24 18:58:18+00:00 FP126 ESTROGEN CREAM USE IN INTERIM - FEMALE +74 Medication/supplement use 5646 phv00005646.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:58:28+00:00 2018-09-24 18:58:28+00:00 FP127 PROGESTERONE USE IN INTERIM - FEMALE +74 Medication/supplement use 5683 phv00005683.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:58:46+00:00 2018-09-24 18:58:46+00:00 FP167 CHEST DISCOMFORT -- NITROGLYCERINE TRIED FOR RELIEF +74 Medication/supplement use 6020 phv00006020.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:59:44+00:00 2018-09-24 18:59:44+00:00 FP587 ARTHRITIS - DO YOU TAKE MEDICATION FOR YOUR JOINT PAIN, ACHING OR STIFNESS? +74 Medication/supplement use 6021 phv00006021.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 18:59:56+00:00 2018-09-24 18:59:56+00:00 FP588 ARTHRITIS - IF YES (TO FP587), WHAT IS THE NAME OF THE MEDICATION? +74 Medication/supplement use 6024 phv00006024.v1.p10 pht000025.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-24 19:00:09+00:00 2018-09-24 19:00:09+00:00 FP592 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 6113 phv00006113.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:24:51+00:00 2018-09-25 11:24:51+00:00 FQ128 TAKE ASPIRIN REGULARLY +74 Medication/supplement use 6114 phv00006114.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:25:03+00:00 2018-09-25 11:25:03+00:00 FQ129 NUMBER OF ASPIRINS TAKEN REGULARLY +74 Medication/supplement use 6115 phv00006115.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:25:10+00:00 2018-09-25 11:25:10+00:00 FQ130 ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY +74 Medication/supplement use 6116 phv00006116.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:25:17+00:00 2018-09-25 11:25:17+00:00 FQ131 USUAL ASPIRIN DOSE FOR ABOVE +74 Medication/supplement use 6117 phv00006117.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:25:25+00:00 2018-09-25 11:25:25+00:00 FQ132 CURRENTLY RECEIVING MEDICATION FOR HYPERTENSION? +74 Medication/supplement use 6118 phv00006118.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:25:33+00:00 2018-09-25 11:25:33+00:00 FQ133 TAKING ANY OF THE CARDIOVASCULAR MEDICATION ON THIS PAGE? (PAGE INCLUDES FQ134 - FQ157) +74 Medication/supplement use 6119 phv00006119.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:25:40+00:00 2018-09-25 11:25:40+00:00 FQ134 MEDICATION USE - CARDIAC GLYCOSIDES +74 Medication/supplement use 6120 phv00006120.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:25:47+00:00 2018-09-25 11:25:47+00:00 FQ135 MEDICATION USE - NITROGLYCERINE +74 Medication/supplement use 6121 phv00006121.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:25:55+00:00 2018-09-25 11:25:55+00:00 FQ136 MEDICATION USE - LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC) +74 Medication/supplement use 6122 phv00006122.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:26:03+00:00 2018-09-25 11:26:03+00:00 FQ137 MEDICATION USE - CALCIUM CHANNEL BLOCKERS (NIFEDIPINE, VERAPAMIL, DILTIAZEM) +74 Medication/supplement use 6123 phv00006123.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:26:12+00:00 2018-09-25 11:26:12+00:00 FQ138 MEDICATION USE - SHORT OR LONG ACTING CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 6124 phv00006124.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:26:21+00:00 2018-09-25 11:26:21+00:00 FQ139 MEDICATION USE - BETA BLOCKERS +74 Medication/supplement use 6125 phv00006125.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:26:28+00:00 2018-09-25 11:26:28+00:00 FQ140 MEDICATION USE - BETA BLOCKER GROUP +74 Medication/supplement use 6126 phv00006126.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:26:36+00:00 2018-09-25 11:26:36+00:00 FQ141 MEDICATION USE - DOSE OF BETA BLOCKER +74 Medication/supplement use 6127 phv00006127.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:26:44+00:00 2018-09-25 11:26:44+00:00 FQ142 MEDICATION USE - LOOP DIURECTICS (LASIX) +74 Medication/supplement use 6128 phv00006128.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:26:51+00:00 2018-09-25 11:26:51+00:00 FQ143 MEDICATION USE - THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE) +74 Medication/supplement use 6129 phv00006129.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:26:59+00:00 2018-09-25 11:26:59+00:00 FQ144 MEDICATION USE - THIAZIDE DIURETICS +74 Medication/supplement use 6130 phv00006130.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:27:06+00:00 2018-09-25 11:27:06+00:00 FQ145 MEDICATION USE - K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 6131 phv00006131.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:27:16+00:00 2018-09-25 11:27:16+00:00 FQ146 MEDICATION USE - POTASSIUM SUPPLEMENTS +74 Medication/supplement use 6132 phv00006132.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:27:28+00:00 2018-09-25 11:27:28+00:00 FQ147 MEDICATION USE - RESERPINE DERIVATIVES +74 Medication/supplement use 6133 phv00006133.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:27:40+00:00 2018-09-25 11:27:40+00:00 FQ148 MEDICATION USE - METHYLDOPA (ALDOMET) +74 Medication/supplement use 6134 phv00006134.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:27:48+00:00 2018-09-25 11:27:48+00:00 FQ149 MEDICATION USE - ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 6135 phv00006135.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:27:55+00:00 2018-09-25 11:27:55+00:00 FQ150 MEDICATION USE - ALPHA-2 AGONIST (PRAZOSIN, TERAZOSIN, DOXAZOSIN) +74 Medication/supplement use 6136 phv00006136.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:28:09+00:00 2018-09-25 11:28:09+00:00 FQ151 MEDICATION USE - RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 6137 phv00006137.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:28:17+00:00 2018-09-25 11:28:17+00:00 FQ152 MEDICATION USE - PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC) +74 Medication/supplement use 6138 phv00006138.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:28:24+00:00 2018-09-25 11:28:24+00:00 FQ153 MEDICATION USE - OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 6139 phv00006139.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:28:34+00:00 2018-09-25 11:28:34+00:00 FQ154 MEDICATION USE - ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE) +74 Medication/supplement use 6140 phv00006140.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:28:43+00:00 2018-09-25 11:28:43+00:00 FQ155 MEDICATION USE - ANTIPLATELET (ANTURANE, PERSANTINE) +74 Medication/supplement use 6141 phv00006141.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:28:51+00:00 2018-09-25 11:28:51+00:00 FQ156 MEDICATION USE - ANTICOAGUALANTS (COUMADIN, WARFARIN) +74 Medication/supplement use 6142 phv00006142.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:28:59+00:00 2018-09-25 11:28:59+00:00 FQ157 MEDICATION USE - OTHER CARDIAC MEDICATION +74 Medication/supplement use 6143 phv00006143.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:29:07+00:00 2018-09-25 11:29:07+00:00 FQ158 MEDICATION USE - ANTI CHOLESTEROL DRUGS, (RESINS - E.G. QUESTRAN, COLESTID) +74 Medication/supplement use 6144 phv00006144.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:29:17+00:00 2018-09-25 11:29:17+00:00 FQ159 MEDICATION USE - ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID) +74 Medication/supplement use 6145 phv00006145.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:29:26+00:00 2018-09-25 11:29:26+00:00 FQ160 MEDICATION USE - ANTI CHOLESTEROL DRUGS, (FILBRATES- E.G. GEMFIBROZIL) +74 Medication/supplement use 6146 phv00006146.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:29:52+00:00 2018-09-25 11:29:52+00:00 FQ161 MEDICATION USE - ANTI CHOLESTEROL DRUGS, (STATINS - E.G. LOVASTATIN, PRAVASTATIN) +74 Medication/supplement use 6147 phv00006147.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:29:59+00:00 2018-09-25 11:29:59+00:00 FQ162 MEDICATION USE - ANTI CHOLESTEROL DRUGS (OTHER) +74 Medication/supplement use 6148 phv00006148.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:30:07+00:00 2018-09-25 11:30:07+00:00 FQ163 MEDICATION USE - ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC) +74 Medication/supplement use 6149 phv00006149.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:30:14+00:00 2018-09-25 11:30:14+00:00 FQ164 MEDICATION USE - ANTIGOUT (COLCHICINE) +74 Medication/supplement use 6150 phv00006150.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:30:22+00:00 2018-09-25 11:30:22+00:00 FQ165 MEDICATION USE - THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 6151 phv00006151.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:30:30+00:00 2018-09-25 11:30:30+00:00 FQ166 MEDICATION USE - THYROXINE (SYNTHROID, ETC) +74 Medication/supplement use 6152 phv00006152.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:30:38+00:00 2018-09-25 11:30:38+00:00 FQ167 MEDICATION USE - INSULIN +74 Medication/supplement use 6153 phv00006153.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:30:45+00:00 2018-09-25 11:30:45+00:00 FQ168 MEDICATION USE - IF YES (TO FQ167), HOW MANY UNITS OF INSULIN / DAY +74 Medication/supplement use 6154 phv00006154.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:30:52+00:00 2018-09-25 11:30:52+00:00 FQ169 MEDICATION USE - ORAL HYPOGLYCEMICS +74 Medication/supplement use 6155 phv00006155.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:30:59+00:00 2018-09-25 11:30:59+00:00 FQ170 MEDICATION USE - ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION) +74 Medication/supplement use 6156 phv00006156.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:31:07+00:00 2018-09-25 11:31:07+00:00 FQ171 MEDICATION USE - ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC) +74 Medication/supplement use 6157 phv00006157.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:31:15+00:00 2018-09-25 11:31:15+00:00 FQ172 MEDICATION USE - NON-STERIODAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 6158 phv00006158.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:31:24+00:00 2018-09-25 11:31:24+00:00 FQ173 MEDICATION USE - ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC) +74 Medication/supplement use 6159 phv00006159.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:31:34+00:00 2018-09-25 11:31:34+00:00 FQ174 MEDICATION USE - ANALGESTIC-NON-NARCOTICS (ACETAMINOPHEN, ETC) +74 Medication/supplement use 6160 phv00006160.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:31:42+00:00 2018-09-25 11:31:42+00:00 FQ175 MEDICATION USE - ANTIHISTAMINES +74 Medication/supplement use 6161 phv00006161.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:31:49+00:00 2018-09-25 11:31:49+00:00 FQ176 MEDICATION USE - ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS) +74 Medication/supplement use 6162 phv00006162.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:31:56+00:00 2018-09-25 11:31:56+00:00 FQ177 MEDICATION USE - ANTI-ANXIETY, SEDATIVE/HYPNOTICS (LIBRIUM, VALIUM, ETC) +74 Medication/supplement use 6163 phv00006163.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:32:04+00:00 2018-09-25 11:32:04+00:00 FQ178 MEDICATION USE - SLEEPING PILLS +74 Medication/supplement use 6164 phv00006164.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:32:12+00:00 2018-09-25 11:32:12+00:00 FQ179 MEDICATION USE - ANTI-DEPRESSANTS +74 Medication/supplement use 6165 phv00006165.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:32:19+00:00 2018-09-25 11:32:19+00:00 FQ180 MEDICATION USE - EYEDROPS +74 Medication/supplement use 6166 phv00006166.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:32:26+00:00 2018-09-25 11:32:26+00:00 FQ181 MEDICATION USE - ANTIBIOTICS +74 Medication/supplement use 6167 phv00006167.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:32:35+00:00 2018-09-25 11:32:35+00:00 FQ182 MEDICATION USE - ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMETREL, COGENTIN, ETC) +74 Medication/supplement use 6168 phv00006168.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:32:42+00:00 2018-09-25 11:32:42+00:00 FQ183 MEDICATION USE - ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC) +74 Medication/supplement use 6169 phv00006169.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:32:50+00:00 2018-09-25 11:32:50+00:00 FQ184 MEDICATION USE - BRONCHODILATORS & AEROSOLS +74 Medication/supplement use 6170 phv00006170.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:32:58+00:00 2018-09-25 11:32:58+00:00 FQ185 MEDICATIONS USE - OTHER +74 Medication/supplement use 6171 phv00006171.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:33:08+00:00 2018-09-25 11:33:08+00:00 FQ186 ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 6172 phv00006172.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:33:16+00:00 2018-09-25 11:33:16+00:00 FQ187 DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS OR OTHER ORAL ESTROGENS +74 Medication/supplement use 6173 phv00006173.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:33:25+00:00 2018-09-25 11:33:25+00:00 FQ188 PATCH DOSE OF ESTROGEN +74 Medication/supplement use 6174 phv00006174.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:33:34+00:00 2018-09-25 11:33:34+00:00 FQ189 NUMBER OF DAYS A MONTH TAKING ESTROGENS +74 Medication/supplement use 6175 phv00006175.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:33:41+00:00 2018-09-25 11:33:41+00:00 FQ190 PROGESTERONE USE INTERIM +74 Medication/supplement use 6324 phv00006324.v1.p10 pht000026.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 11:34:43+00:00 2018-09-25 11:34:43+00:00 FQ394 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 6453 phv00006453.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:21:52+00:00 2018-09-25 13:21:52+00:00 FR180 TAKE ASPIRIN REGULARLY +74 Medication/supplement use 6454 phv00006454.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:22:06+00:00 2018-09-25 13:22:06+00:00 FR181 IF YES TO FR180, NUMBER OF ASPIRIN TAKEN REGULARLY +74 Medication/supplement use 6455 phv00006455.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:22:13+00:00 2018-09-25 13:22:13+00:00 FR182 IF YES TO FR180, ASPIRIN FREQUENCY +74 Medication/supplement use 6456 phv00006456.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:22:20+00:00 2018-09-25 13:22:20+00:00 FR183 IF YES TO FR180, USUAL ASPIRIN DOSE +74 Medication/supplement use 6457 phv00006457.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:22:28+00:00 2018-09-25 13:22:28+00:00 FR184 CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION? +74 Medication/supplement use 6458 phv00006458.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:22:37+00:00 2018-09-25 13:22:37+00:00 FR185 ANY OF THE CARDIOVASCULAR MEDICATIONS BELOW ON THIS PAGE? +74 Medication/supplement use 6459 phv00006459.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:22:45+00:00 2018-09-25 13:22:45+00:00 FR186 CARDIOVASCULAR MEDICATIONS - CARDIAC GLYCOSIDES +74 Medication/supplement use 6460 phv00006460.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:23:03+00:00 2018-09-25 13:23:03+00:00 FR187 CARDIOVASCULAR MEDICATIONS - NITROGLYCERINE +74 Medication/supplement use 6461 phv00006461.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:23:10+00:00 2018-09-25 13:23:10+00:00 FR188 CARDIOVASCULAR MEDICATIONS - LONGER ACTING NITRATES (ISORDIL, CARDILATE) +74 Medication/supplement use 6462 phv00006462.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:23:17+00:00 2018-09-25 13:23:17+00:00 FR189 CARDIOVASCULAR MEDICATIONS - CALCIUM CHANNEL BLOCKERS (SPECIFY) +74 Medication/supplement use 6463 phv00006463.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:23:25+00:00 2018-09-25 13:23:25+00:00 FR190 CARDIOVASCULAR MEDICATIONS - CALCIUM CHANNEL BLOCKER GROUP +74 Medication/supplement use 6464 phv00006464.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:23:33+00:00 2018-09-25 13:23:33+00:00 FR191 CARDIOVASCULAR MEDICATIONS - TABLET SIZE OF CALCIUM CHANNEL BLOCKER (MG) +74 Medication/supplement use 6465 phv00006465.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:23:41+00:00 2018-09-25 13:23:41+00:00 FR192 CARDIOVASCULAR MEDICATIONS - NUMBER OF TIMES CALCIUM CHANNEL BLOCKER TAKEN PER DAY +74 Medication/supplement use 6466 phv00006466.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:23:50+00:00 2018-09-25 13:23:50+00:00 FR193 CARDIOVASCULAR MEDICATIONS - BETA BLOCKERS (SPECIFY) +74 Medication/supplement use 6467 phv00006467.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:24:01+00:00 2018-09-25 13:24:01+00:00 FR194 CARDIOVASCULAR MEDICATIONS - BETA BLOCKER GROUP +74 Medication/supplement use 6468 phv00006468.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:24:09+00:00 2018-09-25 13:24:09+00:00 FR195 CARDIOVASCULAR MEDICATIONS - DOSE OF BETA BLOCKER +74 Medication/supplement use 6469 phv00006469.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:24:17+00:00 2018-09-25 13:24:17+00:00 FR196 CARDIOVASCULAR MEDICATIONS - LOOP DIURETICS (LASIX, ETC) +74 Medication/supplement use 6470 phv00006470.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:24:24+00:00 2018-09-25 13:24:24+00:00 FR197 CARDIOVASCULAR MEDICATIONS - THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.) +74 Medication/supplement use 6471 phv00006471.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:24:33+00:00 2018-09-25 13:24:33+00:00 FR198 CARDIOVASCULAR MEDICATIONS - THIAZIDE DIURETICS +74 Medication/supplement use 6472 phv00006472.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:24:41+00:00 2018-09-25 13:24:41+00:00 FR199 CARDIOVASCULAR MEDICATIONS - K-SPARING DIURECTICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 6473 phv00006473.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:24:50+00:00 2018-09-25 13:24:50+00:00 FR200 CARDIOVASCULAR MEDICATIONS - POTASSIUM SUPPLEMENTS +74 Medication/supplement use 6474 phv00006474.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:25:13+00:00 2018-09-25 13:25:13+00:00 FR201 CARDIOVASCULAR MEDICATIONS - ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 6475 phv00006475.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:25:22+00:00 2018-09-25 13:25:22+00:00 FR202 CARDIOVASCULAR MEDICATIONS - ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN) +74 Medication/supplement use 6476 phv00006476.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:25:29+00:00 2018-09-25 13:25:29+00:00 FR203 CARDIOVASCULAR MEDICATIONS - RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 6477 phv00006477.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:25:36+00:00 2018-09-25 13:25:36+00:00 FR204 CARDIOVASCULAR MEDICATIONS - PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL,ETC) +74 Medication/supplement use 6478 phv00006478.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:25:50+00:00 2018-09-25 13:25:50+00:00 FR205 CARDIOVASCULAR MEDICATIONS - OTHER ANTI-HYPERTENSIVES (SPECIFY) +74 Medication/supplement use 6479 phv00006479.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:25:58+00:00 2018-09-25 13:25:58+00:00 FR206 CARDIOVASCULAR MEDICATIONS - ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE NORPACE, DISOPYRAMIDE, ETC.) +74 Medication/supplement use 6480 phv00006480.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:26:05+00:00 2018-09-25 13:26:05+00:00 FR207 CARDIOVASCULAR MEDICATIONS - ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 6481 phv00006481.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:26:15+00:00 2018-09-25 13:26:15+00:00 FR208 CARDIOVASCULAR MEDICATIONS - ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.) +74 Medication/supplement use 6482 phv00006482.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:26:23+00:00 2018-09-25 13:26:23+00:00 FR209 CARDIOVASCULAR MEDICATIONS - OTHER CARDIAC MEDICATIONS (SPECIFY) +74 Medication/supplement use 6483 phv00006483.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:26:30+00:00 2018-09-25 13:26:30+00:00 FR210 OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (RESINS -- E.G. QUESTRAN, COLESTID) +74 Medication/supplement use 6484 phv00006484.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:26:38+00:00 2018-09-25 13:26:38+00:00 FR211 OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIS ACID) +74 Medication/supplement use 6485 phv00006485.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:26:46+00:00 2018-09-25 13:26:46+00:00 FR212 OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (FIBRATES -- E.G. GEMFIBROZIL) +74 Medication/supplement use 6486 phv00006486.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:26:55+00:00 2018-09-25 13:26:55+00:00 FR213 OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (STATINS -- E.G. LOVASTATIN, PRAVASTATIN) +74 Medication/supplement use 6487 phv00006487.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:27:03+00:00 2018-09-25 13:27:03+00:00 FR214 OTHER MEDICATIONS - ANTI CHOLESTEROL DRUGS (OTHER-SPECIFY) +74 Medication/supplement use 6488 phv00006488.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:27:11+00:00 2018-09-25 13:27:11+00:00 FR215 OTHER MEDICATIONS - ANTIGOUT -- URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 6489 phv00006489.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:27:19+00:00 2018-09-25 13:27:19+00:00 FR216 OTHER MEDICATIONS - ANTIGOUT - (COLCHICINE) +74 Medication/supplement use 6490 phv00006490.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:27:29+00:00 2018-09-25 13:27:29+00:00 FR217 OTHER MEDICATIONS - THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 6491 phv00006491.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:27:41+00:00 2018-09-25 13:27:41+00:00 FR218 OTHER MEDICATIONS - THYROXINE (SYNTHROID, ETC) +74 Medication/supplement use 6492 phv00006492.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:27:50+00:00 2018-09-25 13:27:50+00:00 FR219 OTHER MEDICATIONS - INSULIN +74 Medication/supplement use 6493 phv00006493.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:27:58+00:00 2018-09-25 13:27:58+00:00 FR220 OTHER MEDICATIONS - TOTAL UNITS OF INSULIN A DAY +74 Medication/supplement use 6494 phv00006494.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:28:11+00:00 2018-09-25 13:28:11+00:00 FR221 OTHER MEDICATIONS - ORAL HYPOGLYCEMICS (SPECIFY BRAND) +74 Medication/supplement use 6495 phv00006495.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:28:20+00:00 2018-09-25 13:28:20+00:00 FR222 OTHER MEDICATIONS - ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION) +74 Medication/supplement use 6496 phv00006496.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:28:28+00:00 2018-09-25 13:28:28+00:00 FR223 OTHER MEDICATIONS - ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 6497 phv00006497.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:28:35+00:00 2018-09-25 13:28:35+00:00 FR224 OTHER MEDICATIONS - NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 6498 phv00006498.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:28:43+00:00 2018-09-25 13:28:43+00:00 FR225 OTHER MEDICATIONS - ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 6499 phv00006499.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:28:51+00:00 2018-09-25 13:28:51+00:00 FR226 OTHER MEDICATIONS - ANALGESIC-NON NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 6500 phv00006500.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:29:00+00:00 2018-09-25 13:29:00+00:00 FR227 OTHER MEDICATIONS - ANTIHISTAMINES +74 Medication/supplement use 6501 phv00006501.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:29:09+00:00 2018-09-25 13:29:09+00:00 FR228 OTHER MEDICATIONS - ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE H-ION INHIBITORS) +74 Medication/supplement use 6502 phv00006502.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:29:17+00:00 2018-09-25 13:29:17+00:00 FR229 OTHER MEDICATIONS - ANTI-ANXIETY, SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM ETC) +74 Medication/supplement use 6503 phv00006503.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:29:25+00:00 2018-09-25 13:29:25+00:00 FR230 OTHER MEDICATIONS - SLEEPING PILLS +74 Medication/supplement use 6504 phv00006504.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:29:45+00:00 2018-09-25 13:29:45+00:00 FR231 OTHER MEDICATIONS - ANTI-DEPRESSANTS +74 Medication/supplement use 6505 phv00006505.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:29:52+00:00 2018-09-25 13:29:52+00:00 FR232 OTHER MEDICATIONS - EYE DROPS +74 Medication/supplement use 6506 phv00006506.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:35:11+00:00 2018-09-25 13:35:11+00:00 FR233 OTHER MEDICATIONS - ANTIBIOTICS +74 Medication/supplement use 6507 phv00006507.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:35:22+00:00 2018-09-25 13:35:22+00:00 FR234 OTHER MEDICATIONS - ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.) +74 Medication/supplement use 6508 phv00006508.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:35:39+00:00 2018-09-25 13:35:39+00:00 FR235 OTHER MEDICATIONS - ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC.) +74 Medication/supplement use 6509 phv00006509.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:35:46+00:00 2018-09-25 13:35:46+00:00 FR236 OTHER MEDICATIONS - BRONCHODILATORS AND AEROSOLS +74 Medication/supplement use 6510 phv00006510.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:35:53+00:00 2018-09-25 13:35:53+00:00 FR237 OTHER MEDICATIONS - OSTEOPOROSIS MEDICATIONS (ALENDRONATE (FOSAMAX), CALCITONIN, ETIDRONATE, EVISTA (RALOXIFERE)) +74 Medication/supplement use 6511 phv00006511.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:36:02+00:00 2018-09-25 13:36:02+00:00 FR238 OTHER MEDICATIONS - OTHERS SPECIFY (INCLUDE VITAMINS) +74 Medication/supplement use 6514 phv00006514.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:36:27+00:00 2018-09-25 13:36:27+00:00 FR241 FEMALE GENITOURINARY ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 6515 phv00006515.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:36:40+00:00 2018-09-25 13:36:40+00:00 FR242 FEMALE GENITOURINARY DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN +74 Medication/supplement use 6516 phv00006516.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:36:48+00:00 2018-09-25 13:36:48+00:00 FR243 FEMALE GENITOURINARY PATCH DOSE OF ESTROGEN +74 Medication/supplement use 6517 phv00006517.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:36:56+00:00 2018-09-25 13:36:56+00:00 FR244 FEMALE GENITOURINARY NUMBER OF DAYS A MONTH TAKING ESTROGEN +74 Medication/supplement use 6518 phv00006518.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:37:04+00:00 2018-09-25 13:37:04+00:00 FR245 FEMALE GENITOURINARY ESTROGEN CREAM USE IN INTERIM +74 Medication/supplement use 6519 phv00006519.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:37:14+00:00 2018-09-25 13:37:14+00:00 FR246 FEMALE GENITOURINARY PROGESTIN REPLACEMENT IN INTERIM (E.G. PROVERA) +74 Medication/supplement use 6520 phv00006520.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:37:21+00:00 2018-09-25 13:37:21+00:00 FR247 FEMALE GENITOURINARY DOSE/DAY OF PROGESTIN +74 Medication/supplement use 6521 phv00006521.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:37:29+00:00 2018-09-25 13:37:29+00:00 FR248 FEMALE GENITOURINARY NUMBER OF DAYS PER MONTH TAKING PROGESTINS +74 Medication/supplement use 6658 phv00006658.v1.p10 pht000027.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:38:18+00:00 2018-09-25 13:38:18+00:00 FR434 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 6845 phv00006845.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:59:25+00:00 2018-09-25 13:59:25+00:00 FS236 CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION? +74 Medication/supplement use 6846 phv00006846.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 13:59:56+00:00 2018-09-25 13:59:56+00:00 FS237 ANY OF THE CARDIOVASCULAR MEDICATIONS BELOW ON THIS PAGE? +74 Medication/supplement use 6847 phv00006847.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:00:08+00:00 2018-09-25 14:00:08+00:00 FS238 CARDIOVASCULAR MEDICATIONS: CARDIAC GLYCOSIDES +74 Medication/supplement use 6848 phv00006848.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:00:16+00:00 2018-09-25 14:00:16+00:00 FS239 CARDIOVASCULAR MEDICATIONS: NITROGLYCERINE +74 Medication/supplement use 6849 phv00006849.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:00:24+00:00 2018-09-25 14:00:24+00:00 FS240 CARDIOVASCULAR MEDICATIONS: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC) +74 Medication/supplement use 6850 phv00006850.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:00:32+00:00 2018-09-25 14:00:32+00:00 FS241 CARDIOVASCULAR MEDICATIONS: CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 6851 phv00006851.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:00:40+00:00 2018-09-25 14:00:40+00:00 FS242 CALCIUM CHANNEL BLOCKER GROUP +74 Medication/supplement use 6852 phv00006852.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:00:47+00:00 2018-09-25 14:00:47+00:00 FS243 CALCIUM CHANNEL BLOCKER: TABLET SIZE OF CALCIUM CHANNEL BLOCKER (MG) +74 Medication/supplement use 6853 phv00006853.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:00:55+00:00 2018-09-25 14:00:55+00:00 FS244 CALCIUM CHANNEL BLOCKER: NUMBER OF TIMES CALCIUM CHANNEL BLOCKER TAKEN PER DAY +74 Medication/supplement use 6854 phv00006854.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:01:03+00:00 2018-09-25 14:01:03+00:00 FS245 CARDIOVASCULAR MEDICATIONS: BETA BLOCKERS +74 Medication/supplement use 6855 phv00006855.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:01:16+00:00 2018-09-25 14:01:16+00:00 FS246 BETA BLOCKER GROUP +74 Medication/supplement use 6856 phv00006856.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:01:27+00:00 2018-09-25 14:01:27+00:00 FS247 BETA BLOCKER: DOSE (MG/DAY) OF BETA BLOCKERS +74 Medication/supplement use 6857 phv00006857.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:01:37+00:00 2018-09-25 14:01:37+00:00 FS248 CARDIOVASCULAR MEDICATIONS: LOOP DIURETICS (LASIX, ETC) +74 Medication/supplement use 6858 phv00006858.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:01:49+00:00 2018-09-25 14:01:49+00:00 FS249 CARDIOVASCULAR MEDICATIONS: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC) +74 Medication/supplement use 6859 phv00006859.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:01:58+00:00 2018-09-25 14:01:58+00:00 FS250 CARDIOVASCULAR MEDICATIONS: THIAZIDE DIURETICS +74 Medication/supplement use 6860 phv00006860.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:02:10+00:00 2018-09-25 14:02:10+00:00 FS251 CARDIOVASCULAR MEDICATIONS: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 6861 phv00006861.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:02:19+00:00 2018-09-25 14:02:19+00:00 FS252 CARDIOVASCULAR MEDICATIONS: POTASSIUM SUPPLEMENTS +74 Medication/supplement use 6862 phv00006862.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:02:27+00:00 2018-09-25 14:02:27+00:00 FS253 CARDIOVASCULAR MEDICATIONS: RESERPINE DERIVATIVES +74 Medication/supplement use 6863 phv00006863.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:02:38+00:00 2018-09-25 14:02:38+00:00 FS254 CARDIOVASCULAR MEDICATIONS: METHYLDOPA (ALDOMET) +74 Medication/supplement use 6864 phv00006864.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:02:58+00:00 2018-09-25 14:02:58+00:00 FS255 CARDIOVASCULAR MEDICATIONS: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 6865 phv00006865.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:03:45+00:00 2018-09-25 14:03:45+00:00 FS256 CARDIOVASCULAR MEDICATIONS: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN) +74 Medication/supplement use 6866 phv00006866.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:03:53+00:00 2018-09-25 14:03:53+00:00 FS257 CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 6867 phv00006867.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:04:02+00:00 2018-09-25 14:04:02+00:00 FS258 CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC) +74 Medication/supplement use 6868 phv00006868.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:04:10+00:00 2018-09-25 14:04:10+00:00 FS259 CARDIOVASCULAR MEDICATIONS: ANGIOTENSIN II ANTAGONISTS (LOSARTAN, ETC) +74 Medication/supplement use 6869 phv00006869.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:04:18+00:00 2018-09-25 14:04:18+00:00 FS260 CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 6870 phv00006870.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:04:54+00:00 2018-09-25 14:04:54+00:00 FS261 CARDIOVASCULAR MEDICATIONS: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.) +74 Medication/supplement use 6871 phv00006871.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:05:05+00:00 2018-09-25 14:05:05+00:00 FS262 CARDIOVASCULAR MEDICATIONS: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 6872 phv00006872.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:05:13+00:00 2018-09-25 14:05:13+00:00 FS263 CARDIOVASCULAR MEDICATIONS: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.) +74 Medication/supplement use 6873 phv00006873.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:05:20+00:00 2018-09-25 14:05:20+00:00 FS264 CARDIOVASCULAR MEDICATIONS: OTHER CARDIAC MEDICATION +74 Medication/supplement use 6874 phv00006874.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:05:28+00:00 2018-09-25 14:05:28+00:00 FS265 TAKE ASPIRIN REGULARLY? +74 Medication/supplement use 6875 phv00006875.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:05:36+00:00 2018-09-25 14:05:36+00:00 FS266 ASPIRIN: NUMBER ASPIRINS TAKEN REGULARLY +74 Medication/supplement use 6876 phv00006876.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:05:45+00:00 2018-09-25 14:05:45+00:00 FS267 ASPIRIN: ASPIRIN FREQUENCY +74 Medication/supplement use 6877 phv00006877.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:05:55+00:00 2018-09-25 14:05:55+00:00 FS268 ASPIRIN: USUAL ASPIRIN DOSE +74 Medication/supplement use 6878 phv00006878.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:06:03+00:00 2018-09-25 14:06:03+00:00 FS269 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID) +74 Medication/supplement use 6879 phv00006879.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:06:10+00:00 2018-09-25 14:06:10+00:00 FS270 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID) +74 Medication/supplement use 6880 phv00006880.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:06:19+00:00 2018-09-25 14:06:19+00:00 FS271 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL) +74 Medication/supplement use 6881 phv00006881.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:06:27+00:00 2018-09-25 14:06:27+00:00 FS272 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN) +74 Medication/supplement use 6882 phv00006882.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:06:34+00:00 2018-09-25 14:06:34+00:00 FS273 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (OTHER) +74 Medication/supplement use 6883 phv00006883.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:06:44+00:00 2018-09-25 14:06:44+00:00 FS274 NONCARDIOVASCULAR MEDICATIONS: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 6884 phv00006884.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:06:52+00:00 2018-09-25 14:06:52+00:00 FS275 NONCARDIOVASCULAR MEDICATIONS: ANTIGOUT (COLCHICINE) +74 Medication/supplement use 6885 phv00006885.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:07:01+00:00 2018-09-25 14:07:01+00:00 FS276 NONCARDIOVASCULAR MEDICATIONS: THYROID EXTRACT (DESICCATED THYROID) +74 Medication/supplement use 6886 phv00006886.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:07:11+00:00 2018-09-25 14:07:11+00:00 FS277 NONCARDIOVASCULAR MEDICATIONS: THYROXINE (SYNTHROID, ETC.) +74 Medication/supplement use 6887 phv00006887.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:07:20+00:00 2018-09-25 14:07:20+00:00 FS278 NONCARDIOVASCULAR MEDICATIONS: INSULIN +74 Medication/supplement use 6888 phv00006888.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:07:29+00:00 2018-09-25 14:07:29+00:00 FS279 INSULIN: TOTAL UNITS A DAY +74 Medication/supplement use 6889 phv00006889.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:07:40+00:00 2018-09-25 14:07:40+00:00 FS280 NONCARDIOVASCULAR MEDICATIONS: ORAL HYPOGLYCEMICS +74 Medication/supplement use 6890 phv00006890.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:08:04+00:00 2018-09-25 14:08:04+00:00 FS281 ORAL HYPOGLYCEMICS: METFORMIN +74 Medication/supplement use 6891 phv00006891.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:08:11+00:00 2018-09-25 14:08:11+00:00 FS282 ORAL HYPOGLYCEMICS: ROSIGLITAZONE +74 Medication/supplement use 6892 phv00006892.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:08:19+00:00 2018-09-25 14:08:19+00:00 FS283 ORAL HYPOGLYCEMICS: GLIPIZIDE +74 Medication/supplement use 6893 phv00006893.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:08:28+00:00 2018-09-25 14:08:28+00:00 FS284 ORAL HYPOGLYCEMICS: GLYBURIDE +74 Medication/supplement use 6894 phv00006894.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:08:36+00:00 2018-09-25 14:08:36+00:00 FS285 ORAL HYPOGLYCEMICS: CHLORPROPAMIDE +74 Medication/supplement use 6895 phv00006895.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:08:47+00:00 2018-09-25 14:08:47+00:00 FS286 ORAL HYPOGLYCEMICS: REPAGLINIDE +74 Medication/supplement use 6896 phv00006896.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:08:56+00:00 2018-09-25 14:08:56+00:00 FS287 ORAL HYPOGLYCEMICS: GLIMEPRIRIDE +74 Medication/supplement use 6897 phv00006897.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:09:04+00:00 2018-09-25 14:09:04+00:00 FS288 ORAL HYPOGLYCEMICS: OTHER +74 Medication/supplement use 6898 phv00006898.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:09:12+00:00 2018-09-25 14:09:12+00:00 FS289 ORAL HYPOGLYCEMICS: UNKNOWN +74 Medication/supplement use 6899 phv00006899.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:09:20+00:00 2018-09-25 14:09:20+00:00 FS290 NONCARDIOVASCULAR MEDICATIONS: ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION) +74 Medication/supplement use 6900 phv00006900.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:09:29+00:00 2018-09-25 14:09:29+00:00 FS291 NONCARDIOVASCULAR MEDICATIONS: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 6901 phv00006901.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:09:37+00:00 2018-09-25 14:09:37+00:00 FS292 NONCARDIOVASCULAR MEDICATIONS: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 6902 phv00006902.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:09:46+00:00 2018-09-25 14:09:46+00:00 FS293 NONCARDIOVASCULAR MEDICATIONS: ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 6903 phv00006903.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:09:55+00:00 2018-09-25 14:09:55+00:00 FS294 NONCARDIOVASCULAR MEDICATIONS: ANALGESIC NON-NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 6904 phv00006904.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:10:02+00:00 2018-09-25 14:10:02+00:00 FS295 NONCARDIOVASCULAR MEDICATIONS: ANTIHISTAMINES +74 Medication/supplement use 6905 phv00006905.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:10:10+00:00 2018-09-25 14:10:10+00:00 FS296 NONCARDIOVASCULAR MEDICATIONS: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS) +74 Medication/supplement use 6906 phv00006906.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:10:17+00:00 2018-09-25 14:10:17+00:00 FS297 NONCARDIOVASCULAR MEDICATIONS: ANTI-ANXIETY, SEDATIVE/HYPNOTICS (LIBRIUM, VALIUM, ETC.) +74 Medication/supplement use 6907 phv00006907.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:10:26+00:00 2018-09-25 14:10:26+00:00 FS298 NONCARDIOVASCULAR MEDICATIONS: SLEEPING PILLS +74 Medication/supplement use 6908 phv00006908.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:10:35+00:00 2018-09-25 14:10:35+00:00 FS299 NONCARDIOVASCULAR MEDICATIONS: ANTI-DEPRESSANTS +74 Medication/supplement use 6909 phv00006909.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:10:43+00:00 2018-09-25 14:10:43+00:00 FS300 NONCARDIOVASCULAR MEDICATIONS: EYE DROPS +74 Medication/supplement use 6910 phv00006910.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:11:04+00:00 2018-09-25 14:11:04+00:00 FS301 NONCARDIOVASCULAR MEDICATIONS: ANTIBIOTICS +74 Medication/supplement use 6911 phv00006911.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:11:11+00:00 2018-09-25 14:11:11+00:00 FS302 NONCARDIOVASCULAR MEDICATIONS: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.) +74 Medication/supplement use 6912 phv00006912.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:11:19+00:00 2018-09-25 14:11:19+00:00 FS303 NONCARDIOVASCULAR MEDICATIONS: ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC.) +74 Medication/supplement use 6913 phv00006913.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:11:29+00:00 2018-09-25 14:11:29+00:00 FS304 NONCARDIOVASCULAR MEDICATIONS: MEDICATIONS FOR MEMORY LOSS OR DEMENTIA (TACRINE, DONEPAZIL) +74 Medication/supplement use 6914 phv00006914.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:11:37+00:00 2018-09-25 14:11:37+00:00 FS305 NONCARDIOVASCULAR MEDICATIONS: BRONCHODILATORS AND AEROSOLS +74 Medication/supplement use 6915 phv00006915.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:11:46+00:00 2018-09-25 14:11:46+00:00 FS306 NONCARDIOVASCULAR MEDICATIONS: OSTEOPOROSIS MEDICATIONS +74 Medication/supplement use 6916 phv00006916.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:11:54+00:00 2018-09-25 14:11:54+00:00 FS307 OSTEOPOROSIS MEDICATIONS: BISPHOSPHORATES (ALENDRONATE, (FOSAMAX), ETIDRONATE) +74 Medication/supplement use 6917 phv00006917.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:12:04+00:00 2018-09-25 14:12:04+00:00 FS308 OSTEOPOROSIS MEDICATIONS: CALCITONIN +74 Medication/supplement use 6918 phv00006918.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:12:12+00:00 2018-09-25 14:12:12+00:00 FS309 OSTEOPOROSIS MEDICATIONS: SERMS, EVISTA (RALOXIFENE) +74 Medication/supplement use 6919 phv00006919.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:12:21+00:00 2018-09-25 14:12:21+00:00 FS310 OSTEOPOROSIS MEDICATIONS: OTHER +74 Medication/supplement use 6920 phv00006920.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:12:32+00:00 2018-09-25 14:12:32+00:00 FS311 NONCARDIOVASCULAR MEDICATIONS: OTHERS (INCLUDING VITAMINS) +74 Medication/supplement use 6923 phv00006923.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:18:13+00:00 2018-09-25 14:18:13+00:00 FS314 FEMALE HORMONE REPLACEMENT: ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 6924 phv00006924.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:18:27+00:00 2018-09-25 14:18:27+00:00 FS315 FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN +74 Medication/supplement use 6926 phv00006926.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:18:48+00:00 2018-09-25 14:18:48+00:00 FS317 FEMALE HORMONE REPLACEMENT: NUMBER OF DAYS A MONTH TAKING ESTROGENS +74 Medication/supplement use 6927 phv00006927.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:18:58+00:00 2018-09-25 14:18:58+00:00 FS318 FEMALE HORMONE REPLACEMENT: ESTROGEN CREAM USE IN INTERIM +74 Medication/supplement use 6928 phv00006928.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:19:21+00:00 2018-09-25 14:19:21+00:00 FS319 FEMALE HORMONE REPLACEMENT: PROGESTIN REPLACEMENT IN INTERIM (E.G. PROVERA) +74 Medication/supplement use 6929 phv00006929.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:19:33+00:00 2018-09-25 14:19:33+00:00 FS320 FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PROGESTIN +74 Medication/supplement use 6930 phv00006930.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:19:41+00:00 2018-09-25 14:19:41+00:00 FS321 FEMALE HORMONE REPLACEMENT: NUMBER OF DAYS A MONTH TAKING PROGESTINS +74 Medication/supplement use 7093 phv00007093.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:20:26+00:00 2018-09-25 14:20:26+00:00 FS539 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 7282 phv00007282.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:43:11+00:00 2018-09-25 14:43:11+00:00 FT243 IN THE INTERIM HAVE YOU TAKEN MEDICATION FOR THE TREATMENT OF HYPERTENSION? +74 Medication/supplement use 7283 phv00007283.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:43:34+00:00 2018-09-25 14:43:34+00:00 FT244 ANY OF THE CARDIOVASCULAR MEDICATIONS IN THE FOLLOWING SECTION? +74 Medication/supplement use 7284 phv00007284.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:43:41+00:00 2018-09-25 14:43:41+00:00 FT245 CARDIOVASCULAR MEDICATIONS: CARDIAC GLYCOSIDES +74 Medication/supplement use 7285 phv00007285.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:43:47+00:00 2018-09-25 14:43:47+00:00 FT246 CARDIOVASCULAR MEDICATIONS: NITROGLYCERINE +74 Medication/supplement use 7286 phv00007286.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:43:54+00:00 2018-09-25 14:43:54+00:00 FT247 CARDIOVASCULAR MEDICATIONS: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC) +74 Medication/supplement use 7287 phv00007287.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:01+00:00 2018-09-25 14:44:01+00:00 FT248 CARDIOVASCULAR MEDICATIONS: CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 7288 phv00007288.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:08+00:00 2018-09-25 14:44:08+00:00 FT249 CALCIUM CHANNEL BLOCKER GROUP +74 Medication/supplement use 7289 phv00007289.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:15+00:00 2018-09-25 14:44:15+00:00 FT250 CALCIUM CHANNEL BLOCKER: TABLET SIZE OF CALCIUM CHANNEL BLOCKER (MG) +74 Medication/supplement use 7290 phv00007290.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:22+00:00 2018-09-25 14:44:22+00:00 FT251 CALCIUM CHANNEL BLOCKER: NUMBER OF TIMES CALCIUM CHANNEL BLOCKER TAKEN PER DAY +74 Medication/supplement use 7291 phv00007291.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:29+00:00 2018-09-25 14:44:29+00:00 FT252 CARDIOVASCULAR MEDICATIONS: BETA BLOCKERS +74 Medication/supplement use 7292 phv00007292.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:38+00:00 2018-09-25 14:44:38+00:00 FT253 BETA BLOCKER GROUP +74 Medication/supplement use 7293 phv00007293.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:45+00:00 2018-09-25 14:44:45+00:00 FT254 BETA BLOCKER: DOSE (MG/DAY) OF BETA BLOCKERS +74 Medication/supplement use 7294 phv00007294.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:52+00:00 2018-09-25 14:44:52+00:00 FT255 CARDIOVASCULAR MEDICATIONS: LOOP DIURETICS (LASIX, ETC) +74 Medication/supplement use 7295 phv00007295.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:44:59+00:00 2018-09-25 14:44:59+00:00 FT256 CARDIOVASCULAR MEDICATIONS: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC) +74 Medication/supplement use 7296 phv00007296.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:45:07+00:00 2018-09-25 14:45:07+00:00 FT257 CARDIOVASCULAR MEDICATIONS: THIAZIDE DIURETICS +74 Medication/supplement use 7297 phv00007297.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:45:15+00:00 2018-09-25 14:45:15+00:00 FT258 CARDIOVASCULAR MEDICATIONS: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 7298 phv00007298.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:45:26+00:00 2018-09-25 14:45:26+00:00 FT259 CARDIOVASCULAR MEDICATIONS: POTASSIUM SUPPLEMENTS +74 Medication/supplement use 7299 phv00007299.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:45:33+00:00 2018-09-25 14:45:33+00:00 FT260 CARDIOVASCULAR MEDICATIONS: RESERPINE DERIVATIVES +74 Medication/supplement use 7300 phv00007300.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:45:40+00:00 2018-09-25 14:45:40+00:00 FT261 CARDIOVASCULAR MEDICATIONS: METHYLDOPA (ALDOMET) +74 Medication/supplement use 7301 phv00007301.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:45:47+00:00 2018-09-25 14:45:47+00:00 FT262 CARDIOVASCULAR MEDICATIONS: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 7302 phv00007302.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:45:54+00:00 2018-09-25 14:45:54+00:00 FT263 CARDIOVASCULAR MEDICATIONS: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN) +74 Medication/supplement use 7303 phv00007303.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:46:01+00:00 2018-09-25 14:46:01+00:00 FT264 CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 7304 phv00007304.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:46:09+00:00 2018-09-25 14:46:09+00:00 FT265 CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC) +74 Medication/supplement use 7305 phv00007305.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:46:16+00:00 2018-09-25 14:46:16+00:00 FT266 CARDIOVASCULAR MEDICATIONS: ANGIOTENSIN II ANTAGONISTS (LOSARTAN, ETC) +74 Medication/supplement use 7306 phv00007306.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:46:23+00:00 2018-09-25 14:46:23+00:00 FT267 CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 7307 phv00007307.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:46:34+00:00 2018-09-25 14:46:34+00:00 FT268 CARDIOVASCULAR MEDICATIONS: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC.) +74 Medication/supplement use 7308 phv00007308.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:46:41+00:00 2018-09-25 14:46:41+00:00 FT269 CARDIOVASCULAR MEDICATIONS: ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 7309 phv00007309.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:46:47+00:00 2018-09-25 14:46:47+00:00 FT270 CARDIOVASCULAR MEDICATIONS: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.) +74 Medication/supplement use 7310 phv00007310.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:47:17+00:00 2018-09-25 14:47:17+00:00 FT271 CARDIOVASCULAR MEDICATIONS: OTHER CARDIAC MEDICATION +74 Medication/supplement use 7311 phv00007311.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:47:25+00:00 2018-09-25 14:47:25+00:00 FT272 TAKE ASPIRIN REGULARLY? +74 Medication/supplement use 7312 phv00007312.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:47:32+00:00 2018-09-25 14:47:32+00:00 FT273 ASPIRIN: NUMBER ASPIRINS TAKEN REGULARLY +74 Medication/supplement use 7313 phv00007313.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:47:39+00:00 2018-09-25 14:47:39+00:00 FT274 ASPIRIN: ASPIRIN FREQUENCY +74 Medication/supplement use 7314 phv00007314.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:47:47+00:00 2018-09-25 14:47:47+00:00 FT275 ASPIRIN: USUAL ASPIRIN DOSE +74 Medication/supplement use 7315 phv00007315.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:47:56+00:00 2018-09-25 14:47:56+00:00 FT276 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID) +74 Medication/supplement use 7316 phv00007316.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:48:04+00:00 2018-09-25 14:48:04+00:00 FT277 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID) +74 Medication/supplement use 7317 phv00007317.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:48:12+00:00 2018-09-25 14:48:12+00:00 FT278 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL) +74 Medication/supplement use 7318 phv00007318.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:48:19+00:00 2018-09-25 14:48:19+00:00 FT279 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN) +74 Medication/supplement use 7319 phv00007319.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:48:28+00:00 2018-09-25 14:48:28+00:00 FT280 NONCARDIOVASCULAR MEDICATIONS: ANTI CHOLESTEROL DRUGS (OTHER) +74 Medication/supplement use 7320 phv00007320.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:48:36+00:00 2018-09-25 14:48:36+00:00 FT281 NONCARDIOVASCULAR MEDICATIONS: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 7321 phv00007321.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:48:43+00:00 2018-09-25 14:48:43+00:00 FT282 NONCARDIOVASCULAR MEDICATIONS: ANTIGOUT (COLCHICINE) +74 Medication/supplement use 7322 phv00007322.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:48:50+00:00 2018-09-25 14:48:50+00:00 FT283 NONCARDIOVASCULAR MEDICATIONS: THYROID EXTRACT (DESICCATED THYROID) +74 Medication/supplement use 7323 phv00007323.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:48:58+00:00 2018-09-25 14:48:58+00:00 FT284 NONCARDIOVASCULAR MEDICATIONS: THYROXINE (SYNTHROID, ETC.) +74 Medication/supplement use 7324 phv00007324.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:49:06+00:00 2018-09-25 14:49:06+00:00 FT285 NONCARDIOVASCULAR MEDICATIONS: INSULIN +74 Medication/supplement use 7325 phv00007325.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:49:14+00:00 2018-09-25 14:49:14+00:00 FT286 INSULIN: TOTAL UNITS A DAY +74 Medication/supplement use 7326 phv00007326.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:49:21+00:00 2018-09-25 14:49:21+00:00 FT287 NONCARDIOVASCULAR MEDICATIONS: ORAL HYPOGLYCEMICS +74 Medication/supplement use 7327 phv00007327.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:49:29+00:00 2018-09-25 14:49:29+00:00 FT288 ORAL HYPOGLYCEMICS: METFORMIN +74 Medication/supplement use 7328 phv00007328.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:49:37+00:00 2018-09-25 14:49:37+00:00 FT289 ORAL HYPOGLYCEMICS: ROSIGLITAZONE +74 Medication/supplement use 7329 phv00007329.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:49:45+00:00 2018-09-25 14:49:45+00:00 FT290 ORAL HYPOGLYCEMICS: GLIPIZIDE +74 Medication/supplement use 7330 phv00007330.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:49:55+00:00 2018-09-25 14:49:55+00:00 FT291 ORAL HYPOGLYCEMICS: GLYBURIDE +74 Medication/supplement use 7331 phv00007331.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:50:04+00:00 2018-09-25 14:50:04+00:00 FT292 ORAL HYPOGLYCEMICS: REPAGLINIDE +74 Medication/supplement use 7332 phv00007332.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:50:11+00:00 2018-09-25 14:50:11+00:00 FT293 ORAL HYPOGLYCEMICS: GLIMEPRIRIDE +74 Medication/supplement use 7333 phv00007333.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:50:20+00:00 2018-09-25 14:50:20+00:00 FT294 HYPOGLYCEMICS: CHLORPROPAMIDE +74 Medication/supplement use 7334 phv00007334.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:50:33+00:00 2018-09-25 14:50:33+00:00 FT295 ORAL HYPOGLYCEMICS: OTHER +74 Medication/supplement use 7335 phv00007335.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:50:40+00:00 2018-09-25 14:50:40+00:00 FT296 ORAL HYPOGLYCEMICS: UNKNOWN +74 Medication/supplement use 7336 phv00007336.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:50:48+00:00 2018-09-25 14:50:48+00:00 FT297 NONCARDIOVASCULAR MEDICATIONS: ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION) +74 Medication/supplement use 7337 phv00007337.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:50:56+00:00 2018-09-25 14:50:56+00:00 FT298 NONCARDIOVASCULAR MEDICATIONS: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 7338 phv00007338.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:51:04+00:00 2018-09-25 14:51:04+00:00 FT299 NONCARDIOVASCULAR MEDICATIONS: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 7339 phv00007339.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:51:13+00:00 2018-09-25 14:51:13+00:00 FT300 NONCARDIOVASCULAR MEDICATIONS: ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 7340 phv00007340.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:51:37+00:00 2018-09-25 14:51:37+00:00 FT301 NONCARDIOVASCULAR MEDICATIONS: ANALGESIC NON-NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 7341 phv00007341.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:51:44+00:00 2018-09-25 14:51:44+00:00 FT302 NONCARDIOVASCULAR MEDICATIONS: ANTIHISTAMINES +74 Medication/supplement use 7342 phv00007342.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:51:52+00:00 2018-09-25 14:51:52+00:00 FT303 NONCARDIOVASCULAR MEDICATIONS: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS) +74 Medication/supplement use 7343 phv00007343.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:52:01+00:00 2018-09-25 14:52:01+00:00 FT304 NONCARDIOVASCULAR MEDICATIONS: ANTI-ANXIETY, SEDATIVE/HYPNOTICS (LIBRIUM, VALIUM, ETC.) +74 Medication/supplement use 7344 phv00007344.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:52:08+00:00 2018-09-25 14:52:08+00:00 FT305 NONCARDIOVASCULAR MEDICATIONS: SLEEPING PILLS +74 Medication/supplement use 7345 phv00007345.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:52:16+00:00 2018-09-25 14:52:16+00:00 FT306 NONCARDIOVASCULAR MEDICATIONS: ANTI-DEPRESSANTS +74 Medication/supplement use 7346 phv00007346.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:52:27+00:00 2018-09-25 14:52:27+00:00 FT307 NONCARDIOVASCULAR MEDICATIONS: EYE DROPS +74 Medication/supplement use 7347 phv00007347.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:52:35+00:00 2018-09-25 14:52:35+00:00 FT308 NONCARDIOVASCULAR MEDICATIONS: ANTIBIOTICS +74 Medication/supplement use 7348 phv00007348.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:52:47+00:00 2018-09-25 14:52:47+00:00 FT309 NONCARDIOVASCULAR MEDICATIONS: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.) +74 Medication/supplement use 7349 phv00007349.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:53:00+00:00 2018-09-25 14:53:00+00:00 FT310 NONCARDIOVASCULAR MEDICATIONS: MEDICATIONS FOR MEMORY LOSS OR DEMENTIA (TACRINE, DONEPAZIL) +74 Medication/supplement use 7350 phv00007350.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:53:09+00:00 2018-09-25 14:53:09+00:00 FT311 NONCARDIOVASCULAR MEDICATIONS: ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC.) +74 Medication/supplement use 7351 phv00007351.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:53:16+00:00 2018-09-25 14:53:16+00:00 FT312 NONCARDIOVASCULAR MEDICATIONS: BRONCHODILATORS AND AEROSOLS +74 Medication/supplement use 7352 phv00007352.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:53:24+00:00 2018-09-25 14:53:24+00:00 FT313 NONCARDIOVASCULAR MEDICATIONS: OSTEOPOROSIS MEDICATIONS +74 Medication/supplement use 7353 phv00007353.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:53:31+00:00 2018-09-25 14:53:31+00:00 FT314 OSTEOPOROSIS MEDICATIONS: BISPHOSPHORATES (ALENDRONATE, (FOSAMAX), ETIDRONATE) +74 Medication/supplement use 7354 phv00007354.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:53:39+00:00 2018-09-25 14:53:39+00:00 FT315 OSTEOPOROSIS MEDICATIONS: CALCITONIN +74 Medication/supplement use 7355 phv00007355.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:53:47+00:00 2018-09-25 14:53:47+00:00 FT316 OSTEOPOROSIS MEDICATIONS: SERMS, EVISTA (RALOXIFENE) +74 Medication/supplement use 7356 phv00007356.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:53:55+00:00 2018-09-25 14:53:55+00:00 FT317 OSTEOPOROSIS MEDICATIONS: OTHER +74 Medication/supplement use 7357 phv00007357.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:54:04+00:00 2018-09-25 14:54:04+00:00 FT318 NONCARDIOVASCULAR MEDICATIONS: OTHERS (INCLUDING VITAMINS) +74 Medication/supplement use 7362 phv00007362.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:54:28+00:00 2018-09-25 14:54:28+00:00 FT323 FEMALE HORMONE REPLACEMENT: ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 7363 phv00007363.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:54:42+00:00 2018-09-25 14:54:42+00:00 FT324 FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN +74 Medication/supplement use 7364 phv00007364.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:54:55+00:00 2018-09-25 14:54:55+00:00 FT325 FEMALE HORMONE REPLACEMENT: PATCH DOSE OF ESTROGEN +74 Medication/supplement use 7365 phv00007365.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:55:04+00:00 2018-09-25 14:55:04+00:00 FT326 FEMALE HORMONE REPLACEMENT: NUMBER OF DAYS A MONTH TAKING ESTROGENS +74 Medication/supplement use 7366 phv00007366.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:56:34+00:00 2018-09-25 14:56:34+00:00 FT327 FEMALE HORMONE REPLACEMENT: ESTROGEN CREAM USE IN INTERIM +74 Medication/supplement use 7367 phv00007367.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:56:44+00:00 2018-09-25 14:56:44+00:00 FT328 FEMALE HORMONE REPLACEMENT: PROGESTIN REPLACEMENT IN INTERIM (E.G. PROVERA) +74 Medication/supplement use 7368 phv00007368.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:56:52+00:00 2018-09-25 14:56:52+00:00 FT329 FEMALE HORMONE REPLACEMENT: DOSE/DAY OF PROGESTIN +74 Medication/supplement use 7369 phv00007369.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:57:00+00:00 2018-09-25 14:57:00+00:00 FT330 FEMALE HORMONE REPLACEMENT: NUMBER OF DAYS A MONTH TAKING PROGESTINS +74 Medication/supplement use 7532 phv00007532.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 14:57:52+00:00 2018-09-25 14:57:52+00:00 FT539 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 70370 phv00070370.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:08:05+00:00 2018-09-25 15:08:05+00:00 FU009 HYPERTENSION: SINCE YOUR LAST EXAM HAVE YOU TAKEN MEDICATION FOR THE TREATMENT OF HYPERTENSION? (HIGH BLOOD PRESSURE) +74 Medication/supplement use 70371 phv00070371.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:08:16+00:00 2018-09-25 15:08:16+00:00 FU010 ASPIRIN: TAKE ASPIRIN REGULARLY? +74 Medication/supplement use 70372 phv00070372.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:08:24+00:00 2018-09-25 15:08:24+00:00 FU011 ASPIRIN: NUMBER ASPIRINS TAKEN REGULARLY +74 Medication/supplement use 70373 phv00070373.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:08:32+00:00 2018-09-25 15:08:32+00:00 FU012 ASPIRIN: ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY +74 Medication/supplement use 70374 phv00070374.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:08:42+00:00 2018-09-25 15:08:42+00:00 FU013 ASPIRIN: USUAL ASPIRIN DOSE FOR ABOVE +74 Medication/supplement use 70379 phv00070379.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:09:01+00:00 2018-09-25 15:09:01+00:00 FU023 FEMALE HORMONE REPLACEMENT: ESTROGEN USE SINCE YOUR LAST EXAM? +74 Medication/supplement use 70380 phv00070380.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:09:12+00:00 2018-09-25 15:09:12+00:00 FU024 FEMALE HORMONE REPLACEMENT: NAME OF MOST RECENT ESTROGEN PREPARATION - CHARACTER VARIABLE; (BLANK) = UNKNOWN, OR NO ESTROGEN PREPARATION USE (197) +74 Medication/supplement use 70381 phv00070381.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:09:19+00:00 2018-09-25 15:09:19+00:00 FU025 FEMALE HORMONE REPLACEMENT: ESTROGEN PREPARATION: STRENGTH CHARACTER VARIABLE; (BLANK) = UNKNOWN, OR NO ESTROGEN PREPARATION USE (199) +74 Medication/supplement use 70382 phv00070382.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:09:26+00:00 2018-09-25 15:09:26+00:00 FU026 FEMALE HORMONE REPLACEMENT: ESTROGEN PREPARATION: NUMBER OF DAYS PER MONTH TAKEN +74 Medication/supplement use 70383 phv00070383.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:09:33+00:00 2018-09-25 15:09:33+00:00 FU027 FEMALE HORMONE REPLACEMENT: ESTROGEN CREAM USE SINCE LAST EXAM +74 Medication/supplement use 70384 phv00070384.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:09:40+00:00 2018-09-25 15:09:40+00:00 FU028 FEMALE HORMONE REPLACEMENT: PROGESTERONE USE SINCE YOUR LAST EXAM? +74 Medication/supplement use 70385 phv00070385.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:09:47+00:00 2018-09-25 15:09:47+00:00 FU029 FEMALE HORMONE REPLACEMENT: NAME OF MOST RECENT PROGESTERONE PREPARATION - CHARACTER VARIABLE; (BLANK) = UNKNOWN, OR NO PROGESTERONE PREPARATION USE (207) +74 Medication/supplement use 70386 phv00070386.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:09:54+00:00 2018-09-25 15:09:54+00:00 FU030 FEMALE HORMONE REPLACEMENT: PROGESERONE PREPARATION: STRENGTH CHARACTER VARIABLE; (BLANK) = UNKNOWN, OR NO PROGESTERONE PREPARATION USE (207) +74 Medication/supplement use 70387 phv00070387.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:10:02+00:00 2018-09-25 15:10:02+00:00 FU031 FEMALE HORMONE REPLACEMENT: PROGESTERONE PREPARATION: NUMBER OF DAYS PER MONTH TAKEN +74 Medication/supplement use 597 phv00000597.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 15:34:30+00:00 2018-09-25 15:34:30+00:00 MF129 INTERIM HISTORY OF DRUGS TAKEN: DIGITALIS, EXAM 2 +74 Medication/supplement use 598 phv00000598.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:49:04+00:00 2018-09-25 17:49:04+00:00 MF130 INTERIM HISTORY OF DRUGS TAKEN: HORMONES, EXAM 2 +74 Medication/supplement use 496 phv00000496.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:49:30+00:00 2018-09-25 17:49:30+00:00 MF22 HISTORY OF DRUGS TAKEN: DIGITALIS OR NITRITES, EXAM 1 +74 Medication/supplement use 704 phv00000704.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:49:49+00:00 2018-09-25 17:49:49+00:00 MF249 INTERIM HISTORY OF DRUGS TAKEN: DIGITALIS, EXAM 4 +74 Medication/supplement use 705 phv00000705.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:50:00+00:00 2018-09-25 17:50:00+00:00 MF250 INTERIM HISTORY OF DRUGS TAKEN: HYPOTENSIVES, EXAM 4 +74 Medication/supplement use 778 phv00000778.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:50:19+00:00 2018-09-25 17:50:19+00:00 MF328 LIFETIME HISTORY OF HORMONE THERAPY, EXAM 5 +74 Medication/supplement use 866 phv00000866.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:50:40+00:00 2018-09-25 17:50:40+00:00 MF417 INTERIM HISTORY OF DRUGS TAKEN: HYPOTENSIVE, EXAM 6 +74 Medication/supplement use 951 phv00000951.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:51:00+00:00 2018-09-25 17:51:00+00:00 MF509 INTERIM HISTORY OF DRUGS TAKEN: DIGITALIS, EXAM 7 +74 Medication/supplement use 953 phv00000953.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:51:11+00:00 2018-09-25 17:51:11+00:00 MF511 INTERIM HISTORY OF DRUGS TAKEN: HYPOTENSIVE, EXAM 7 +74 Medication/supplement use 954 phv00000954.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:51:37+00:00 2018-09-25 17:51:37+00:00 MF512 INTERIM HISTORY OF DRUGS TAKEN: HYPOCHOLESTEROL, EXAM 7 +74 Medication/supplement use 958 phv00000958.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:51:57+00:00 2018-09-25 17:51:57+00:00 MF516 INTERIM HISTORY OF DIET FOLLOWED: HYPOCHOLESTEROL, EXAM 7 +74 Medication/supplement use 965 phv00000965.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:52:11+00:00 2018-09-25 17:52:11+00:00 MF523 LIFETIME HISTORY OF DIABETES: TREATMENT OF DIABETES, EXAM 7 +74 Medication/supplement use 975 phv00000975.v1.p10 pht000009.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:52:28+00:00 2018-09-25 17:52:28+00:00 MF535 LIFETIME HISTORY OF MENOPAUSE: HORMONE THERAPY, EXAM 7 +74 Medication/supplement use 1127 phv00001127.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:55:59+00:00 2018-09-25 17:55:59+00:00 FA116 MEDICINE TAKEN DURING INTERIM: DIGITALIS +74 Medication/supplement use 1128 phv00001128.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:56:12+00:00 2018-09-25 17:56:12+00:00 FA117 MEDICINE TAKEN DURING INTERIM: NITRITES +74 Medication/supplement use 1129 phv00001129.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:56:19+00:00 2018-09-25 17:56:19+00:00 FA118 MEDICINE TAKEN DURING INTERIM: QUINIDINE +74 Medication/supplement use 1130 phv00001130.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:56:26+00:00 2018-09-25 17:56:26+00:00 FA119 MEDICINE TAKEN DURING INTERIM: DIURETIC +74 Medication/supplement use 1131 phv00001131.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:56:38+00:00 2018-09-25 17:56:38+00:00 FA120 MEDICINE TAKEN DURING INTERIM: HYPOTENSIVE +74 Medication/supplement use 1132 phv00001132.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:56:45+00:00 2018-09-25 17:56:45+00:00 FA121 MEDICINE TAKEN DURING INTERIM: HYPOCHOLESTEROL +74 Medication/supplement use 1133 phv00001133.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:56:52+00:00 2018-09-25 17:56:52+00:00 FA122 MEDICINE TAKEN DURING INTERIM: ANTICOAGULANT +74 Medication/supplement use 1134 phv00001134.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:56:59+00:00 2018-09-25 17:56:59+00:00 FA123 MEDICINE TAKEN DURING INTERIM: THYROID +74 Medication/supplement use 1135 phv00001135.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:57:07+00:00 2018-09-25 17:57:07+00:00 FA124 MEDICINE TAKEN DURING INTERIM: ANTIBACTERIAL +74 Medication/supplement use 1141 phv00001141.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:57:26+00:00 2018-09-25 17:57:26+00:00 FA135 MENOPAUSE: HORMONE THERAPY, PRESENT USE +74 Medication/supplement use 1142 phv00001142.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:57:34+00:00 2018-09-25 17:57:34+00:00 FA136 MENOPAUSE: HORMONE THERAPY, PAST USE +74 Medication/supplement use 1183 phv00001183.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:57:57+00:00 2018-09-25 17:57:57+00:00 FA188 FDI: STATUS & TREATMENT OF BLOOD PRESSURE DURING INTERIM BEFORE EXAM 8 +74 Medication/supplement use 1344 phv00001344.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:59:06+00:00 2018-09-25 17:59:06+00:00 FB196 ECG: TAKING DIGITALIS OR QUINIDINE +74 Medication/supplement use 1346 phv00001346.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:59:20+00:00 2018-09-25 17:59:20+00:00 FB221 CLINICAL DIAGNOSTIC IMPRESSION: UNDER TREATMENT FOR HYPERTENSION +74 Medication/supplement use 1242 phv00001242.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:59:40+00:00 2018-09-25 17:59:40+00:00 FB65 INTERIM HISTORY OF MEDICINE: DIGITALIS +74 Medication/supplement use 1243 phv00001243.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:59:48+00:00 2018-09-25 17:59:48+00:00 FB66 INTERIM HISTORY OF MEDICINE: NITRITES +74 Medication/supplement use 1244 phv00001244.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 17:59:55+00:00 2018-09-25 17:59:55+00:00 FB67 INTERIM HISTORY OF MEDICINE: QUINIDINE (OR PROCAINAMIDE) +74 Medication/supplement use 1245 phv00001245.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:00:03+00:00 2018-09-25 18:00:03+00:00 FB68 INTERIM HISTORY OF MEDICINE: DIURETICS +74 Medication/supplement use 1246 phv00001246.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:00:12+00:00 2018-09-25 18:00:12+00:00 FB69 INTERIM HISTORY OF MEDICINE: HYPOTENSIVES +74 Medication/supplement use 1247 phv00001247.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:00:20+00:00 2018-09-25 18:00:20+00:00 FB70 INTERIM HISTORY OF MEDICINE: HYPOCHOLESTEROL +74 Medication/supplement use 1248 phv00001248.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:00:30+00:00 2018-09-25 18:00:30+00:00 FB71 INTERIM HISTORY OF MEDICINE: THYROID +74 Medication/supplement use 1249 phv00001249.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:00:38+00:00 2018-09-25 18:00:38+00:00 FB72 INTERIM HISTORY OF MEDICINE: ANTITHYROID +74 Medication/supplement use 1250 phv00001250.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:00:49+00:00 2018-09-25 18:00:49+00:00 FB73 INTERIM HISTORY OF MEDICINE: ANTICOAGULANTS +74 Medication/supplement use 1251 phv00001251.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:00:57+00:00 2018-09-25 18:00:57+00:00 FB74 INTERIM HISTORY OF MEDICINE: ANTIBACTERIAL +74 Medication/supplement use 1252 phv00001252.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:01:05+00:00 2018-09-25 18:01:05+00:00 FB75 INTERIM HISTORY OF MEDICINE: TRANQUILIZERS +74 Medication/supplement use 1253 phv00001253.v1.p10 pht000011.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:01:20+00:00 2018-09-25 18:01:20+00:00 FB80 INTERIM HISTORY OF MENOPAUSE: HORMONE THERAPY +74 Medication/supplement use 7664 phv00007664.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:02:53+00:00 2018-09-25 18:02:53+00:00 A162 TAKING DIGITALIS OR QUINIDINE +74 Medication/supplement use 7587 phv00007587.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:03:16+00:00 2018-09-25 18:03:16+00:00 A74 CARDIAC GLYCOSIDES +74 Medication/supplement use 7588 phv00007588.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:03:24+00:00 2018-09-25 18:03:24+00:00 A75 NITRITES +74 Medication/supplement use 7589 phv00007589.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:03:31+00:00 2018-09-25 18:03:31+00:00 A76 QUINIDINE +74 Medication/supplement use 7590 phv00007590.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:03:39+00:00 2018-09-25 18:03:39+00:00 A77 DIURETICS FOR FLUID RETENTION +74 Medication/supplement use 7591 phv00007591.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:03:46+00:00 2018-09-25 18:03:46+00:00 A78 DIURETICS FOR BLOOD PRESSURE +74 Medication/supplement use 7592 phv00007592.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:03:53+00:00 2018-09-25 18:03:53+00:00 A79 HYPOTENSIVES (EXCLUDING DIURETICS) +74 Medication/supplement use 7593 phv00007593.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:04:07+00:00 2018-09-25 18:04:07+00:00 A80 ANTI-CHOLESTEROL AGENTS +74 Medication/supplement use 7594 phv00007594.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:04:14+00:00 2018-09-25 18:04:14+00:00 A81 THYROID +74 Medication/supplement use 7595 phv00007595.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:04:21+00:00 2018-09-25 18:04:21+00:00 A82 ANTI-THYROID +74 Medication/supplement use 7596 phv00007596.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:04:29+00:00 2018-09-25 18:04:29+00:00 A83 ANTI-COAGULANTS +74 Medication/supplement use 7597 phv00007597.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:04:37+00:00 2018-09-25 18:04:37+00:00 A84 HYPOGLYCEMIC AGENTS (SPECIFY) +74 Medication/supplement use 7598 phv00007598.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:04:46+00:00 2018-09-25 18:04:46+00:00 A85 TRANQUILIZERS +74 Medication/supplement use 7599 phv00007599.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:04:57+00:00 2018-09-25 18:04:57+00:00 A86 BRONCHODILATOR OR AEROSOL +74 Medication/supplement use 7600 phv00007600.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:05:05+00:00 2018-09-25 18:05:05+00:00 A87 OTHER (C-V DRUGS) +74 Medication/supplement use 7606 phv00007606.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:05:21+00:00 2018-09-25 18:05:21+00:00 A93 ORAL CONTRACEPTIVE +74 Medication/supplement use 7607 phv00007607.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:05:30+00:00 2018-09-25 18:05:30+00:00 A94 PREMARIN +74 Medication/supplement use 7608 phv00007608.v5.p10 pht000030.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:05:42+00:00 2018-09-25 18:05:42+00:00 A95 OTHER (SPECIFY) +74 Medication/supplement use 7927 phv00007927.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:07:56+00:00 2018-09-25 18:07:56+00:00 B295 TREATMENT FOR HYPERTENSION +74 Medication/supplement use 7985 phv00007985.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:08:29+00:00 2018-09-25 18:08:29+00:00 B367 BLOOD ANALYSIS-FASTING LIPIDS: CREAM AFTER 12 HRS. OR MORE +74 Medication/supplement use 7992 phv00007992.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:08:45+00:00 2018-09-25 18:08:45+00:00 B374 CURRENTLY TAKING MEDICATION FOR HYPERTENSION +74 Medication/supplement use 7702 phv00007702.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:09:13+00:00 2018-09-25 18:09:13+00:00 B52 CARDIAC GLYCOSIDES +74 Medication/supplement use 7703 phv00007703.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:09:26+00:00 2018-09-25 18:09:26+00:00 B53 NITRITES +74 Medication/supplement use 7704 phv00007704.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:09:52+00:00 2018-09-25 18:09:52+00:00 B54 PROPRANOLOL +74 Medication/supplement use 7705 phv00007705.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:10:05+00:00 2018-09-25 18:10:05+00:00 B55 QUINIDINE +74 Medication/supplement use 7706 phv00007706.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:10:19+00:00 2018-09-25 18:10:19+00:00 B56 HYPOTENSIVE (EXCLUDING DIURETICS) +74 Medication/supplement use 7707 phv00007707.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:10:40+00:00 2018-09-25 18:10:40+00:00 B57 ALDOMET +74 Medication/supplement use 7708 phv00007708.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:10:51+00:00 2018-09-25 18:10:51+00:00 B58 SPIRONOLACTONE +74 Medication/supplement use 7709 phv00007709.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:11:03+00:00 2018-09-25 18:11:03+00:00 B59 DIURETICS-HYPERTENSION +74 Medication/supplement use 7710 phv00007710.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:11:16+00:00 2018-09-25 18:11:16+00:00 B60 DIURETICS-OTHER +74 Medication/supplement use 7711 phv00007711.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:11:29+00:00 2018-09-25 18:11:29+00:00 B61 ANTI-CHOLESTEROL AGENT +74 Medication/supplement use 7712 phv00007712.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:11:50+00:00 2018-09-25 18:11:50+00:00 B62 THYROID +74 Medication/supplement use 7713 phv00007713.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:11:58+00:00 2018-09-25 18:11:58+00:00 B63 ANTI-COAGULANTS +74 Medication/supplement use 7714 phv00007714.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:12:08+00:00 2018-09-25 18:12:08+00:00 B64 BRONCHODILATOR OR AEROSOL +74 Medication/supplement use 7715 phv00007715.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:12:18+00:00 2018-09-25 18:12:18+00:00 B65 ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 7716 phv00007716.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:13:20+00:00 2018-09-25 18:13:20+00:00 B66 SLEEPING PILLS +74 Medication/supplement use 7717 phv00007717.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:13:31+00:00 2018-09-25 18:13:31+00:00 B67 TRANQUILIZERS +74 Medication/supplement use 7718 phv00007718.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:13:43+00:00 2018-09-25 18:13:43+00:00 B68 INSULIN +74 Medication/supplement use 7719 phv00007719.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:13:57+00:00 2018-09-25 18:13:57+00:00 B69 ASPIRIN TABS/DAY +74 Medication/supplement use 7728 phv00007728.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:14:31+00:00 2018-09-25 18:14:31+00:00 B78 MENOPAUSE: ORAL CONTRACEPTIVE +74 Medication/supplement use 7729 phv00007729.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:14:39+00:00 2018-09-25 18:14:39+00:00 B79 MENOPAUSE: CODE # OF BRAND & DOSAGE +74 Medication/supplement use 7730 phv00007730.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:14:52+00:00 2018-09-25 18:14:52+00:00 B80 MENOPAUSE: TOTAL # OF YEARS OC MEDICATION TAKEN +74 Medication/supplement use 7731 phv00007731.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:15:00+00:00 2018-09-25 18:15:00+00:00 B81 MENOPAUSE: EVER TAKEN PREMARIN +74 Medication/supplement use 7732 phv00007732.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:15:10+00:00 2018-09-25 18:15:10+00:00 B82 MENOPAUSE: TOTAL # OF YEARS PREMARIN TAKEN +74 Medication/supplement use 7733 phv00007733.v5.p10 pht000031.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:15:23+00:00 2018-09-25 18:15:23+00:00 B83 NO. OF PILLS TAKEN PER MONTH +74 Medication/supplement use 8385 phv00008385.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:17:35+00:00 2018-09-25 18:17:35+00:00 C10 LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.) +74 Medication/supplement use 8386 phv00008386.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:17:43+00:00 2018-09-25 18:17:43+00:00 C11 CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 8387 phv00008387.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:18:09+00:00 2018-09-25 18:18:09+00:00 C12 BETA BLOCKERS +74 Medication/supplement use 8388 phv00008388.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:18:21+00:00 2018-09-25 18:18:21+00:00 C13 ANTI-ARRHYTHMICS (QUINIDINE, PROCAINE, NORPACE, ETC.) +74 Medication/supplement use 8389 phv00008389.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:18:30+00:00 2018-09-25 18:18:30+00:00 C14 PERIPHERAL VASODILATORS (HYDRALZINE, MINIPRES, MONOXIDIL, ETC.) +74 Medication/supplement use 8390 phv00008390.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:18:44+00:00 2018-09-25 18:18:44+00:00 C15 ANTI-PLATELET DRUGS (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 8391 phv00008391.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:18:57+00:00 2018-09-25 18:18:57+00:00 C16 OTHER ANTI-HYPERTENSIVE DRUGS +74 Medication/supplement use 8392 phv00008392.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:19:18+00:00 2018-09-25 18:19:18+00:00 C17 DIURETICS (THIAZIDES, LASIX, ETC.) +74 Medication/supplement use 8393 phv00008393.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:19:31+00:00 2018-09-25 18:19:31+00:00 C18 OTHER CARDIAC MEDICATION +74 Medication/supplement use 8394 phv00008394.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:19:42+00:00 2018-09-25 18:19:42+00:00 C19 POTASSIUM SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 8395 phv00008395.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:19:52+00:00 2018-09-25 18:19:52+00:00 C20 RESERPINE DERIVATIVES +74 Medication/supplement use 8396 phv00008396.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:20:09+00:00 2018-09-25 18:20:09+00:00 C21 METHYLDOPA (ALDOMET) +74 Medication/supplement use 8397 phv00008397.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:20:26+00:00 2018-09-25 18:20:26+00:00 C22 CLONIDINE (CATAPRES) +74 Medication/supplement use 8398 phv00008398.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:20:33+00:00 2018-09-25 18:20:33+00:00 C23 WYTENSIN +74 Medication/supplement use 8399 phv00008399.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:20:45+00:00 2018-09-25 18:20:45+00:00 C24 GANGLIONIC BLOCKERS +74 Medication/supplement use 8400 phv00008400.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:21:03+00:00 2018-09-25 18:21:03+00:00 C25 RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL) +74 Medication/supplement use 8401 phv00008401.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:21:17+00:00 2018-09-25 18:21:17+00:00 C26 ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.) +74 Medication/supplement use 8402 phv00008402.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:21:39+00:00 2018-09-25 18:21:39+00:00 C27 ANTIGOUT +74 Medication/supplement use 8403 phv00008403.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:21:52+00:00 2018-09-25 18:21:52+00:00 C28 THYROID +74 Medication/supplement use 8404 phv00008404.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:22:02+00:00 2018-09-25 18:22:02+00:00 C29 INSULIN +74 Medication/supplement use 8405 phv00008405.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:22:25+00:00 2018-09-25 18:22:25+00:00 C30 ORAL HYPOGLYCEMICS +74 Medication/supplement use 8406 phv00008406.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:22:48+00:00 2018-09-25 18:22:48+00:00 C31 ESTROGEN +74 Medication/supplement use 8407 phv00008407.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:22:56+00:00 2018-09-25 18:22:56+00:00 C32 STEROIDS +74 Medication/supplement use 8408 phv00008408.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:23:06+00:00 2018-09-25 18:23:06+00:00 C33 NON-STEROIDAL ANTI-INFLAMMATORY (MOTRIN, IBUPROFEN ETC.) +74 Medication/supplement use 8409 phv00008409.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:23:28+00:00 2018-09-25 18:23:28+00:00 C34 ANALGESIC-NARCOTIC (DEMEROL, CODEINE, DILAUDID ETC.) +74 Medication/supplement use 8410 phv00008410.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:23:37+00:00 2018-09-25 18:23:37+00:00 C35 ANALGESIC-NON-NARCOTIC (ACETAMINOPHEN ETC.) +74 Medication/supplement use 8411 phv00008411.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:23:49+00:00 2018-09-25 18:23:49+00:00 C36 BRONCHODILATORS, AEROSOLS,ETC +74 Medication/supplement use 8412 phv00008412.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:24:04+00:00 2018-09-25 18:24:04+00:00 C37 ANTIHISTAMINES +74 Medication/supplement use 8413 phv00008413.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:24:38+00:00 2018-09-25 18:24:38+00:00 C38 ANTI-ACID MEDICATIONS +74 Medication/supplement use 8414 phv00008414.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:24:51+00:00 2018-09-25 18:24:51+00:00 C39 ANTIULCER (TAGAMET, PROBANTHINE, H-ION INHIBITORS) +74 Medication/supplement use 8415 phv00008415.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:25:19+00:00 2018-09-25 18:25:19+00:00 C40 ANTI-ANXIETY, SEDATIVE/HYPNOTICS ETC. (LIBRIUM, VALIUM ETC.) +74 Medication/supplement use 8416 phv00008416.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:25:37+00:00 2018-09-25 18:25:37+00:00 C41 SLEEPING PILLS +74 Medication/supplement use 8417 phv00008417.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:25:54+00:00 2018-09-25 18:25:54+00:00 C42 ANTI-DEPRESSANTS +74 Medication/supplement use 8418 phv00008418.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:26:13+00:00 2018-09-25 18:26:13+00:00 C43 EYEDROPS +74 Medication/supplement use 8419 phv00008419.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:26:26+00:00 2018-09-25 18:26:26+00:00 C44 POTASSIUM SUPPLEMENT +74 Medication/supplement use 8420 phv00008420.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:26:49+00:00 2018-09-25 18:26:49+00:00 C45 ANTIBIOTICS +74 Medication/supplement use 8734 phv00008734.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:27:26+00:00 2018-09-25 18:27:26+00:00 C450 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 8421 phv00008421.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:27:40+00:00 2018-09-25 18:27:40+00:00 C46 OTHERS (SPECIFY BELOW) +74 Medication/supplement use 8429 phv00008429.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:27:53+00:00 2018-09-25 18:27:53+00:00 C54 MENOPAUSE: ORAL CONTRACEPTIVES IN INTERIM +74 Medication/supplement use 8430 phv00008430.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:28:15+00:00 2018-09-25 18:28:15+00:00 C55 MENOPAUSE: PREMARIN USE IN INTERIM +74 Medication/supplement use 8431 phv00008431.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:28:30+00:00 2018-09-25 18:28:30+00:00 C56 MENOPAUSE: NUMBER OF PREMARIN PILLS (0.625 MG) TAKEN PER MONTH +74 Medication/supplement use 8382 phv00008382.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:28:47+00:00 2018-09-25 18:28:47+00:00 C7 # OF ASPIRINS PER WEEK +74 Medication/supplement use 8383 phv00008383.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:29:00+00:00 2018-09-25 18:29:00+00:00 C8 CARDIAC GLYCOSIDES +74 Medication/supplement use 8384 phv00008384.v5.p10 pht000032.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:29:22+00:00 2018-09-25 18:29:22+00:00 C9 NITROGLYCERIN +74 Medication/supplement use 8778 phv00008778.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:34:50+00:00 2018-09-25 18:34:50+00:00 D008 NUMBER OF ASPIRIN PER WEEK +74 Medication/supplement use 8779 phv00008779.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:35:11+00:00 2018-09-25 18:35:11+00:00 D009 ANY CARDIOVASCULAR MEDICATIONS? +74 Medication/supplement use 8780 phv00008780.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:35:19+00:00 2018-09-25 18:35:19+00:00 D010 CARDIAC GLYCOSIDES +74 Medication/supplement use 8781 phv00008781.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:35:26+00:00 2018-09-25 18:35:26+00:00 D011 NITROGLYCERINE +74 Medication/supplement use 8782 phv00008782.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:35:33+00:00 2018-09-25 18:35:33+00:00 D012 LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.) +74 Medication/supplement use 8783 phv00008783.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:35:40+00:00 2018-09-25 18:35:40+00:00 D013 CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 8784 phv00008784.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:35:47+00:00 2018-09-25 18:35:47+00:00 D014 BETA BLOCKERS +74 Medication/supplement use 8785 phv00008785.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:35:55+00:00 2018-09-25 18:35:55+00:00 D015 ANTIARRHYTHMICS (QUINIDINE, PROCAINE, NORPACE, ETC.) +74 Medication/supplement use 8786 phv00008786.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:36:05+00:00 2018-09-25 18:36:05+00:00 D016 ANTIPLATELET (ANTURANE, PERSANTINE, ETC.) +74 Medication/supplement use 8787 phv00008787.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:36:12+00:00 2018-09-25 18:36:12+00:00 D017 ANTICOAGULANTS (COUMADIN, ETC.) +74 Medication/supplement use 8788 phv00008788.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:36:19+00:00 2018-09-25 18:36:19+00:00 D018 THIAZIDE DIURETICS +74 Medication/supplement use 8789 phv00008789.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:36:26+00:00 2018-09-25 18:36:26+00:00 D019 LOOP DIURETICS (LASIX, ETC.) +74 Medication/supplement use 8790 phv00008790.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:36:33+00:00 2018-09-25 18:36:33+00:00 D020 K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 8791 phv00008791.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:36:42+00:00 2018-09-25 18:36:42+00:00 D021 RESERPINE DERIVATIVES +74 Medication/supplement use 8792 phv00008792.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:36:49+00:00 2018-09-25 18:36:49+00:00 D022 METHYLDOPA (ALDOMET) +74 Medication/supplement use 8793 phv00008793.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:36:56+00:00 2018-09-25 18:36:56+00:00 D023 CLONIDINE (CATAPRES) +74 Medication/supplement use 8794 phv00008794.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:37:05+00:00 2018-09-25 18:37:05+00:00 D024 WYTENSIN +74 Medication/supplement use 8795 phv00008795.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:37:13+00:00 2018-09-25 18:37:13+00:00 D025 GANGLIONIC BLOCKERS +74 Medication/supplement use 8796 phv00008796.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:37:21+00:00 2018-09-25 18:37:21+00:00 D026 RENIN-ANGIOTENSIN BLOCKING DRUGS (CAPTOPRIL) +74 Medication/supplement use 8797 phv00008797.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:37:30+00:00 2018-09-25 18:37:30+00:00 D027 PERIPHERAL VASODILATORS (HYDRALAZINE, MINIPRES, MINOXIDIL, ETC.) +74 Medication/supplement use 8798 phv00008798.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:37:37+00:00 2018-09-25 18:37:37+00:00 D028 OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 8799 phv00008799.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:37:44+00:00 2018-09-25 18:37:44+00:00 D029 OTHER CARDIAC MEDICATION +74 Medication/supplement use 8800 phv00008800.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:37:52+00:00 2018-09-25 18:37:52+00:00 D030 ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.) +74 Medication/supplement use 8801 phv00008801.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:38:02+00:00 2018-09-25 18:38:02+00:00 D031 ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 8802 phv00008802.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:38:09+00:00 2018-09-25 18:38:09+00:00 D032 ANTIGOUT (COLCHICINE) +74 Medication/supplement use 8803 phv00008803.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:38:16+00:00 2018-09-25 18:38:16+00:00 D033 THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 8804 phv00008804.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:38:25+00:00 2018-09-25 18:38:25+00:00 D034 THYROXINE (SYNTHROID ETC.) +74 Medication/supplement use 8805 phv00008805.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:38:31+00:00 2018-09-25 18:38:31+00:00 D035 INSULIN +74 Medication/supplement use 8744 phv00008744.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:38:42+00:00 2018-09-25 18:38:42+00:00 D036 TOTAL UNITS OF INSULIN PER DAY +74 Medication/supplement use 8806 phv00008806.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:38:50+00:00 2018-09-25 18:38:50+00:00 D037 ORAL HYPOGLYCEMICS +74 Medication/supplement use 8807 phv00008807.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:38:57+00:00 2018-09-25 18:38:57+00:00 D038 ORAL ESTROGEN +74 Medication/supplement use 8808 phv00008808.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:39:06+00:00 2018-09-25 18:39:06+00:00 D039 ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 8809 phv00008809.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:39:13+00:00 2018-09-25 18:39:13+00:00 D040 NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 8810 phv00008810.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:39:35+00:00 2018-09-25 18:39:35+00:00 D041 ANALGESIC - NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 8811 phv00008811.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:39:44+00:00 2018-09-25 18:39:44+00:00 D042 ANALGESIC - NON-NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 8812 phv00008812.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:39:51+00:00 2018-09-25 18:39:51+00:00 D043 BRONCHODILATORS, AEROSOLS, ETC. +74 Medication/supplement use 8813 phv00008813.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:40:00+00:00 2018-09-25 18:40:00+00:00 D044 ANTIHISTAMINES +74 Medication/supplement use 8814 phv00008814.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:40:07+00:00 2018-09-25 18:40:07+00:00 D045 ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H-ION INHIBITORS) +74 Medication/supplement use 8815 phv00008815.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:40:15+00:00 2018-09-25 18:40:15+00:00 D046 ANTI-ANXIETY, SEDATIVE/HYPNOTICS, ETC (LIBRIUM, VALIUM, ETC.) +74 Medication/supplement use 8816 phv00008816.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:40:22+00:00 2018-09-25 18:40:22+00:00 D047 SLEEPING PILLS +74 Medication/supplement use 8817 phv00008817.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:40:31+00:00 2018-09-25 18:40:31+00:00 D048 ANTI-DEPRESSANTS +74 Medication/supplement use 8818 phv00008818.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:40:38+00:00 2018-09-25 18:40:38+00:00 D049 EYE DROPS +74 Medication/supplement use 8819 phv00008819.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:40:46+00:00 2018-09-25 18:40:46+00:00 D050 POTASSIUM SUPPLEMENTS +74 Medication/supplement use 8820 phv00008820.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:40:55+00:00 2018-09-25 18:40:55+00:00 D051 ANTIBIOTICS +74 Medication/supplement use 8821 phv00008821.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:41:05+00:00 2018-09-25 18:41:05+00:00 D052 OTHER DRUG +74 Medication/supplement use 8829 phv00008829.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:41:21+00:00 2018-09-25 18:41:21+00:00 D060 ORAL CONTRACEPTIVES IN INTERIM +74 Medication/supplement use 8830 phv00008830.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:41:30+00:00 2018-09-25 18:41:30+00:00 D061 CONJUGATED ESTROGEN USED IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 8831 phv00008831.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:41:38+00:00 2018-09-25 18:41:38+00:00 D062 DOSE/DAY PREMARIN OR CONJUGATED ESTROGEN +74 Medication/supplement use 8832 phv00008832.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:41:46+00:00 2018-09-25 18:41:46+00:00 D063 DAYS PER MONTH TAKING PREMARIN +74 Medication/supplement use 8833 phv00008833.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:41:53+00:00 2018-09-25 18:41:53+00:00 D064 ESTROGEN CREAM USE DURING INTERIM +74 Medication/supplement use 8834 phv00008834.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:42:01+00:00 2018-09-25 18:42:01+00:00 D065 PROGESTERONE USE DURING INTERIM +74 Medication/supplement use 9119 phv00009119.v5.p10 pht000033.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:42:53+00:00 2018-09-25 18:42:53+00:00 D445 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 9563 phv00009563.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:45:32+00:00 2018-09-25 18:45:32+00:00 E041 # OF DAYS SINCE LAST DOSE OF ASPIRIN +74 Medication/supplement use 9171 phv00009171.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:45:51+00:00 2018-09-25 18:45:51+00:00 E218 NUMBER OF ASPIRINS PER TIME INTERVAL +74 Medication/supplement use 9172 phv00009172.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:46:20+00:00 2018-09-25 18:46:20+00:00 E219 TIME INTERVAL FOR ASPIRIN TAKEN +74 Medication/supplement use 9173 phv00009173.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:46:26+00:00 2018-09-25 18:46:26+00:00 E220 TAKING ANY CARDIOVASCULAR MEDS BELOW? +74 Medication/supplement use 9174 phv00009174.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:46:35+00:00 2018-09-25 18:46:35+00:00 E221 CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION +74 Medication/supplement use 9175 phv00009175.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:46:44+00:00 2018-09-25 18:46:44+00:00 E222 CARDIAC GLYCOSIDES +74 Medication/supplement use 9176 phv00009176.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:46:51+00:00 2018-09-25 18:46:51+00:00 E223 NITROGLYCERINE +74 Medication/supplement use 9177 phv00009177.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:46:58+00:00 2018-09-25 18:46:58+00:00 E224 LONGER ACTING NITRATES +74 Medication/supplement use 9178 phv00009178.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:47:04+00:00 2018-09-25 18:47:04+00:00 E225 CALCIUM CHANNEL BLOCKERS +74 Medication/supplement use 9179 phv00009179.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:47:12+00:00 2018-09-25 18:47:12+00:00 E226 BETA BLOCKERS +74 Medication/supplement use 9180 phv00009180.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:47:18+00:00 2018-09-25 18:47:18+00:00 E227 BETA BLOCKERS GROUP +74 Medication/supplement use 9181 phv00009181.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:47:26+00:00 2018-09-25 18:47:26+00:00 E228 BETA BLOCKERS DOSE (MG/DAY) +74 Medication/supplement use 9182 phv00009182.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:47:34+00:00 2018-09-25 18:47:34+00:00 E229 LOOP DIURETICS +74 Medication/supplement use 9183 phv00009183.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:47:45+00:00 2018-09-25 18:47:45+00:00 E230 THIAZIDE/K-SPARING DIURETICS +74 Medication/supplement use 9184 phv00009184.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:47:52+00:00 2018-09-25 18:47:52+00:00 E231 THIAZIDE DIURETICS +74 Medication/supplement use 9185 phv00009185.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:48:02+00:00 2018-09-25 18:48:02+00:00 E232 K-SPARING DIURETICS +74 Medication/supplement use 9186 phv00009186.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:48:10+00:00 2018-09-25 18:48:10+00:00 E233 POTASSIUM SUPPLEMENTS +74 Medication/supplement use 9187 phv00009187.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:48:20+00:00 2018-09-25 18:48:20+00:00 E234 RESERPINE DERIVATIVES +74 Medication/supplement use 9188 phv00009188.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:48:27+00:00 2018-09-25 18:48:27+00:00 E235 METHYLDOPA +74 Medication/supplement use 9189 phv00009189.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:48:39+00:00 2018-09-25 18:48:39+00:00 E236 ALPHA-1 AGONIST +74 Medication/supplement use 9190 phv00009190.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:48:48+00:00 2018-09-25 18:48:48+00:00 E237 ALPHA-2 BLOCKERS +74 Medication/supplement use 9191 phv00009191.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:48:59+00:00 2018-09-25 18:48:59+00:00 E238 RENIN-ANGIOTENSIN BLOCKING DRUGS +74 Medication/supplement use 9192 phv00009192.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:49:07+00:00 2018-09-25 18:49:07+00:00 E239 PERIPHERAL VASODILATORS +74 Medication/supplement use 9193 phv00009193.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:49:20+00:00 2018-09-25 18:49:20+00:00 E240 OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 9194 phv00009194.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:49:28+00:00 2018-09-25 18:49:28+00:00 E241 ANTIARRHYTHMICS +74 Medication/supplement use 9195 phv00009195.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:49:34+00:00 2018-09-25 18:49:34+00:00 E242 ANTIPLATELET +74 Medication/supplement use 9196 phv00009196.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:49:41+00:00 2018-09-25 18:49:41+00:00 E243 ANITCOAGULANTS +74 Medication/supplement use 9197 phv00009197.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:49:49+00:00 2018-09-25 18:49:49+00:00 E244 OTHER CARDIAC MEDICATION +74 Medication/supplement use 9198 phv00009198.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:49:57+00:00 2018-09-25 18:49:57+00:00 E245 ANTI CHOLESTEROL DRUGS-RESINS +74 Medication/supplement use 9199 phv00009199.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:50:06+00:00 2018-09-25 18:50:06+00:00 E246 ANTI CHOLESTEROL DRUGS-NIACIN +74 Medication/supplement use 9200 phv00009200.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:50:20+00:00 2018-09-25 18:50:20+00:00 E247 ANTI CHOLESTEROL DRUGS-FIBRATES +74 Medication/supplement use 9201 phv00009201.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:50:31+00:00 2018-09-25 18:50:31+00:00 E248 ANTI CHOLESTEROL DRUGS-STATINS +74 Medication/supplement use 9202 phv00009202.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:50:39+00:00 2018-09-25 18:50:39+00:00 E249 ANTI CHOLESTEROL DRUGS-OTHER +74 Medication/supplement use 9203 phv00009203.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:52:27+00:00 2018-09-25 18:52:27+00:00 E250 ANTIGOUT--URIC ACID LOWERING +74 Medication/supplement use 9204 phv00009204.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:52:34+00:00 2018-09-25 18:52:34+00:00 E251 ANTIGOUT (COLCHICINE) +74 Medication/supplement use 9205 phv00009205.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:52:41+00:00 2018-09-25 18:52:41+00:00 E252 THYROID EXTRACT +74 Medication/supplement use 9206 phv00009206.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:52:48+00:00 2018-09-25 18:52:48+00:00 E253 THYROXINE +74 Medication/supplement use 9207 phv00009207.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:52:58+00:00 2018-09-25 18:52:58+00:00 E254 INSULIN +74 Medication/supplement use 9208 phv00009208.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:53:05+00:00 2018-09-25 18:53:05+00:00 E255 INSULIN/TOTAL UNITS PER DAY +74 Medication/supplement use 9209 phv00009209.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:53:12+00:00 2018-09-25 18:53:12+00:00 E256 ORAL HYPOGLYCEMICS +74 Medication/supplement use 9210 phv00009210.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:53:20+00:00 2018-09-25 18:53:20+00:00 E257 ORAL/PATCH ESTROGEN +74 Medication/supplement use 9211 phv00009211.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:53:36+00:00 2018-09-25 18:53:36+00:00 E258 ORAL GLUCOCORTICOIDS +74 Medication/supplement use 9212 phv00009212.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:53:44+00:00 2018-09-25 18:53:44+00:00 E259 NON-STEROIDAL ANTI-INFLAMMATORY AGENTS +74 Medication/supplement use 9213 phv00009213.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:53:51+00:00 2018-09-25 18:53:51+00:00 E260 ANALGESIC-NARCOTICS +74 Medication/supplement use 9214 phv00009214.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:53:58+00:00 2018-09-25 18:53:58+00:00 E261 ANALGESIC-NON-NARCOTICS +74 Medication/supplement use 9215 phv00009215.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:54:29+00:00 2018-09-25 18:54:29+00:00 E262 BRONCHODILATORS, AEROSOLS, ETC +74 Medication/supplement use 9216 phv00009216.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:54:36+00:00 2018-09-25 18:54:36+00:00 E263 ANTIHISTAMINES +74 Medication/supplement use 9217 phv00009217.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:54:44+00:00 2018-09-25 18:54:44+00:00 E264 ANTIULCER +74 Medication/supplement use 9218 phv00009218.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:54:51+00:00 2018-09-25 18:54:51+00:00 E265 ANTI-ANXIETY, SEDATIVE/HYPNOTICS, ETC +74 Medication/supplement use 9219 phv00009219.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:54:58+00:00 2018-09-25 18:54:58+00:00 E266 SLEEPING PILLS +74 Medication/supplement use 9220 phv00009220.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:55:05+00:00 2018-09-25 18:55:05+00:00 E267 ANTI-DEPRESSANTS +74 Medication/supplement use 9221 phv00009221.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:55:12+00:00 2018-09-25 18:55:12+00:00 E268 EYEDROPS +74 Medication/supplement use 9222 phv00009222.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:55:20+00:00 2018-09-25 18:55:20+00:00 E269 ANTIBIOTICS +74 Medication/supplement use 9223 phv00009223.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:55:28+00:00 2018-09-25 18:55:28+00:00 E270 ANTI-PARKINSON DRUGS +74 Medication/supplement use 9224 phv00009224.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:55:39+00:00 2018-09-25 18:55:39+00:00 E271 ANTICONVULSANTS +74 Medication/supplement use 9225 phv00009225.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:55:48+00:00 2018-09-25 18:55:48+00:00 E272 MEDICATIONS - OTHERS +74 Medication/supplement use 9233 phv00009233.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:56:08+00:00 2018-09-25 18:56:08+00:00 E280 ORAL CONTRACEPTIVES IN INTERIM - FEMALE +74 Medication/supplement use 9128 phv00009128.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:56:18+00:00 2018-09-25 18:56:18+00:00 E280A NAME OF ORAL CONTRCPTVE LAST USED - FEMALE XXXXXXXXXXXXXXXX - +74 Medication/supplement use 9234 phv00009234.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:56:31+00:00 2018-09-25 18:56:31+00:00 E281 CONJUGATED ESTROGEN USE IN INTERIM -FEMALE +74 Medication/supplement use 9235 phv00009235.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:56:40+00:00 2018-09-25 18:56:40+00:00 E282 ORAL DOSE/DAY OF PREMARIN OR CONJ. ESTROGEN - FEMALE +74 Medication/supplement use 9236 phv00009236.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:56:48+00:00 2018-09-25 18:56:48+00:00 E283 PATCH DOSE/DAY OF ESTROGEN - FEMALE +74 Medication/supplement use 9237 phv00009237.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:56:56+00:00 2018-09-25 18:56:56+00:00 E284 NUMBER OF DAYS/MONTH TAKING PREMARIN - FEMALE +74 Medication/supplement use 9238 phv00009238.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:57:04+00:00 2018-09-25 18:57:04+00:00 E285 ESTROGEN CREAM USE IN INTERIM - FEMALE +74 Medication/supplement use 9239 phv00009239.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:57:11+00:00 2018-09-25 18:57:11+00:00 E286 PROGESTERONE USE IN INTERIM - FEMALE +74 Medication/supplement use 9571 phv00009571.v5.p10 pht000034.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-25 18:59:10+00:00 2018-09-25 18:59:10+00:00 E664 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 10118 phv00010118.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:21:12+00:00 2018-09-26 11:21:12+00:00 F022 NUMBER OF DAYS SINCE LAST DOSE OF ASPIRIN (TYPICAL VALUE 1 TO 7 FOR USE IN PAST WEEK) +74 Medication/supplement use 9670 phv00009670.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:22:31+00:00 2018-09-26 11:22:31+00:00 F180 TAKE ASPIRIN REGULARLY +74 Medication/supplement use 9671 phv00009671.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:22:39+00:00 2018-09-26 11:22:39+00:00 F181 NUMBER OF ASPIRIN TAKEN REGULARLY +74 Medication/supplement use 9672 phv00009672.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:22:46+00:00 2018-09-26 11:22:46+00:00 F182 ASPIRIN FREQUENCY +74 Medication/supplement use 9673 phv00009673.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:22:53+00:00 2018-09-26 11:22:53+00:00 F183 USUAL ASPIRIN DOSE FOR ABOVE +74 Medication/supplement use 9674 phv00009674.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:23:01+00:00 2018-09-26 11:23:01+00:00 F184 CURRENTLY RECEIVING MEDICATION FOR THE TREATMENT OF HYPERTENSION +74 Medication/supplement use 9675 phv00009675.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:23:08+00:00 2018-09-26 11:23:08+00:00 F185 ANY OF THE CARDIOVASCULAR MEDICATIONS BELOW ON THIS PAGE +74 Medication/supplement use 9676 phv00009676.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:23:24+00:00 2018-09-26 11:23:24+00:00 F186 CARDIOVASCULAR MEDICATIONS : CARDIAC GLYCOSIDES +74 Medication/supplement use 9677 phv00009677.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:23:31+00:00 2018-09-26 11:23:31+00:00 F187 CARDIOVASCULAR MEDICATIONS : NITROGLYCERINE +74 Medication/supplement use 9678 phv00009678.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:23:39+00:00 2018-09-26 11:23:39+00:00 F188 CARDIOVASCULAR MEDICATIONS : LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC) +74 Medication/supplement use 9679 phv00009679.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:23:46+00:00 2018-09-26 11:23:46+00:00 F189 CARDIOVASCULAR MEDICATIONS : CALCIUM CHANNEL BLOCKERS (NIFEDIPINE, VERAPAMIL, DILTIAZEM) +74 Medication/supplement use 9680 phv00009680.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:23:53+00:00 2018-09-26 11:23:53+00:00 F190 CARDIOVASCULAR MEDICATIONS : BETA BLOCKERS +74 Medication/supplement use 9681 phv00009681.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:24:00+00:00 2018-09-26 11:24:00+00:00 F191 BETA BLOCKER GROUP +74 Medication/supplement use 9682 phv00009682.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:24:08+00:00 2018-09-26 11:24:08+00:00 F192 DOSE (MG/DAY) OF BETA BLOCKER +74 Medication/supplement use 9683 phv00009683.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:24:15+00:00 2018-09-26 11:24:15+00:00 F193 CARDIOVASCULAR MEDICATIONS: LOOP DIURECTICS (LASIX, ETC) +74 Medication/supplement use 9684 phv00009684.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:24:22+00:00 2018-09-26 11:24:22+00:00 F194 CARDIOVASCULAR MEDICATIONS: THIAZIDE/K-SPARING DIURECTICS (DYAZIDE, MAXIDE, ETC) +74 Medication/supplement use 9685 phv00009685.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:24:30+00:00 2018-09-26 11:24:30+00:00 F195 CARDIOVASCULAR MEDICATIONS: THIAZIDE DIURETICS +74 Medication/supplement use 9686 phv00009686.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:24:37+00:00 2018-09-26 11:24:37+00:00 F196 CARDIOVASCULAR MEDICATIONS: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 9687 phv00009687.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:24:46+00:00 2018-09-26 11:24:46+00:00 F197 CARDIOVASCULAR MEDICATIONS: POTASSIUM SUPPLEMENTS +74 Medication/supplement use 9688 phv00009688.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:24:54+00:00 2018-09-26 11:24:54+00:00 F198 CARDIOVASCULAR MEDICATIONS: RESERPINE DERIVATIVES +74 Medication/supplement use 9689 phv00009689.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:25:02+00:00 2018-09-26 11:25:02+00:00 F199 CARDIOVASCULAR MEDICATIONS: METHYLDOPA (ALDOMET) +74 Medication/supplement use 9690 phv00009690.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:25:09+00:00 2018-09-26 11:25:09+00:00 F200 CARDIOVASCULAR MEDICATIONS: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 9691 phv00009691.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:25:16+00:00 2018-09-26 11:25:16+00:00 F201 CARDIOVASCULAR MEDICATIONS: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN) +74 Medication/supplement use 9692 phv00009692.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:25:24+00:00 2018-09-26 11:25:24+00:00 F202 CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 9693 phv00009693.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:25:33+00:00 2018-09-26 11:25:33+00:00 F203 CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC) +74 Medication/supplement use 9694 phv00009694.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:25:42+00:00 2018-09-26 11:25:42+00:00 F204 CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 9695 phv00009695.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:25:50+00:00 2018-09-26 11:25:50+00:00 F205 CARDIOVASCULAR MEDICATIONS: ANTIARRHYTHMICS (QUINIDINE, PROCAINAMIDE, NORPACE, DISOPYRAMIDE, ETC) +74 Medication/supplement use 9696 phv00009696.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:25:57+00:00 2018-09-26 11:25:57+00:00 F206 CARDIOVASCULAR MEDICATIONS: ANTIPLATELET (ANTURANE, PERSANTINE, ETC) +74 Medication/supplement use 9697 phv00009697.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:26:05+00:00 2018-09-26 11:26:05+00:00 F207 CARDIOVASCULAR MEDICATIONS: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC) +74 Medication/supplement use 9698 phv00009698.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:26:13+00:00 2018-09-26 11:26:13+00:00 F208 CARDIOVASCULAR MEDICATIONS: OTHER CARDIAC MEDICATION +74 Medication/supplement use 9699 phv00009699.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:26:22+00:00 2018-09-26 11:26:22+00:00 F209 MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID) +74 Medication/supplement use 9700 phv00009700.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:26:30+00:00 2018-09-26 11:26:30+00:00 F210 MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID) +74 Medication/supplement use 9701 phv00009701.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:26:56+00:00 2018-09-26 11:26:56+00:00 F211 MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL) +74 Medication/supplement use 9702 phv00009702.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:27:04+00:00 2018-09-26 11:27:04+00:00 F212 MEDICATIONS: ANTI CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN) +74 Medication/supplement use 9703 phv00009703.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:27:12+00:00 2018-09-26 11:27:12+00:00 F213 MEDICATIONS: ANTI CHOLESTEROL DRUGS - OTHER +74 Medication/supplement use 9704 phv00009704.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:27:20+00:00 2018-09-26 11:27:20+00:00 F214 MEDICATIONS: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC) +74 Medication/supplement use 9705 phv00009705.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:27:28+00:00 2018-09-26 11:27:28+00:00 F215 MEDICATIONS: ANTIGOUT (COLCHICINE) +74 Medication/supplement use 9706 phv00009706.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:27:36+00:00 2018-09-26 11:27:36+00:00 F216 MEDICATIONS: THYROID EXTRACT (DESSICATED THYROID) +74 Medication/supplement use 9707 phv00009707.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:27:44+00:00 2018-09-26 11:27:44+00:00 F217 MEDICATIONS: THYROXINE (SYNTHROID, ETC) +74 Medication/supplement use 9708 phv00009708.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:27:55+00:00 2018-09-26 11:27:55+00:00 F218 MEDICATIONS: INSULIN +74 Medication/supplement use 9709 phv00009709.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:28:02+00:00 2018-09-26 11:28:02+00:00 F219 HOW MANY UNITS OF INSULIN/DAY +74 Medication/supplement use 9710 phv00009710.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:28:10+00:00 2018-09-26 11:28:10+00:00 F220 MEDICATIONS: ORAL HYPOGLYCEMICS +74 Medication/supplement use 9711 phv00009711.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:28:18+00:00 2018-09-26 11:28:18+00:00 F221 MEDICATIONS: ORAL/PATCH ESTROGEN (FOR WOMEN USERS ALSO SEE ESTROGEN SECTION) +74 Medication/supplement use 9712 phv00009712.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:28:26+00:00 2018-09-26 11:28:26+00:00 F222 MEDICATIONS: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE) +74 Medication/supplement use 9713 phv00009713.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:28:33+00:00 2018-09-26 11:28:33+00:00 F223 MEDICATIONS: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 9714 phv00009714.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:28:41+00:00 2018-09-26 11:28:41+00:00 F224 MEDICATIONS: ANALGESIC-NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC) +74 Medication/supplement use 9715 phv00009715.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:28:51+00:00 2018-09-26 11:28:51+00:00 F225 MEDICATIONS: ANALGESIC-NON-NARCOTICS (ACETAMINOPHEN, ETC) +74 Medication/supplement use 9716 phv00009716.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:29:00+00:00 2018-09-26 11:29:00+00:00 F226 MEDICATIONS: ANTIHISTAMINES +74 Medication/supplement use 9717 phv00009717.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:29:08+00:00 2018-09-26 11:29:08+00:00 F227 MEDICATIONS: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS) +74 Medication/supplement use 9718 phv00009718.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:29:15+00:00 2018-09-26 11:29:15+00:00 F228 MEDICATIONS: ANTI-ANXIETY, SEDATIVE/HYPNOTICS (LIBRIUM, VALIUM) +74 Medication/supplement use 9719 phv00009719.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:29:22+00:00 2018-09-26 11:29:22+00:00 F229 MEDICATIONS: SLEEPING PILLS +74 Medication/supplement use 9720 phv00009720.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:29:29+00:00 2018-09-26 11:29:29+00:00 F230 MEDICATIONS: ANTI-DEPRESSANTS +74 Medication/supplement use 9721 phv00009721.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:29:36+00:00 2018-09-26 11:29:36+00:00 F231 MEDICATIONS: EYEDROPS +74 Medication/supplement use 9722 phv00009722.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:29:44+00:00 2018-09-26 11:29:44+00:00 F232 MEDICATIONS: ANTIBIOTICS +74 Medication/supplement use 9723 phv00009723.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:29:52+00:00 2018-09-26 11:29:52+00:00 F233 MEDICATIONS: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC) +74 Medication/supplement use 9724 phv00009724.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:30:00+00:00 2018-09-26 11:30:00+00:00 F234 MEDICATIONS: ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC) +74 Medication/supplement use 9725 phv00009725.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:30:09+00:00 2018-09-26 11:30:09+00:00 F235 MEDICATIONS: BRONCHODILATORS AND AEROSOLS +74 Medication/supplement use 9726 phv00009726.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:30:17+00:00 2018-09-26 11:30:17+00:00 F236 MEDICATIONS: OTHER +74 Medication/supplement use 9736 phv00009736.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:30:34+00:00 2018-09-26 11:30:34+00:00 F246 ORAL CONTRACEPTIVES IN INTERIM +74 Medication/supplement use 9737 phv00009737.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:30:49+00:00 2018-09-26 11:30:49+00:00 F247 ESTROGEN REPLACEMENT IN INTERIM (E.G.PREMARIN) +74 Medication/supplement use 9738 phv00009738.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:30:56+00:00 2018-09-26 11:30:56+00:00 F248 DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN (PICK NEAREST DOSE) +74 Medication/supplement use 9739 phv00009739.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:31:06+00:00 2018-09-26 11:31:06+00:00 F249 PATCH DOSE OF ESTROGEN +74 Medication/supplement use 9740 phv00009740.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:31:13+00:00 2018-09-26 11:31:13+00:00 F250 NUMBER OF DAYS A MONTH TAKING ESTROGENS +74 Medication/supplement use 9741 phv00009741.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:31:21+00:00 2018-09-26 11:31:21+00:00 F251 ESTROGEN CREAM USE INTERIM +74 Medication/supplement use 9742 phv00009742.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:31:29+00:00 2018-09-26 11:31:29+00:00 F252 PROGESTERONE USE INTERIM +74 Medication/supplement use 9816 phv00009816.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:31:57+00:00 2018-09-26 11:31:57+00:00 F329 RELIEF BY NITROGLYCERINE IN LESS THAN 15 MIN +74 Medication/supplement use 10131 phv00010131.v5.p10 pht000035.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:32:33+00:00 2018-09-26 11:32:33+00:00 F721 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 10151 phv00010151.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:34:07+00:00 2018-09-26 11:34:07+00:00 G008 IN THE INTERIM HAVE YOU TAKEN MEDICATION FOR THE TREATMENT OF HYPERTENSION? +74 Medication/supplement use 10152 phv00010152.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:34:31+00:00 2018-09-26 11:34:31+00:00 G009 ANY OF THE CARDIOVASCULAR MEDICATIONS IN THE FOLLOWING SECTION? +74 Medication/supplement use 10153 phv00010153.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:34:40+00:00 2018-09-26 11:34:40+00:00 G010 CARDIOVASCULAR MEDICATIONS: CARDIAC GLYCOSIDES +74 Medication/supplement use 10154 phv00010154.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:34:48+00:00 2018-09-26 11:34:48+00:00 G011 CARDIOVASCULAR MEDICATIONS: NITROGLYCERINE +74 Medication/supplement use 10155 phv00010155.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:34:55+00:00 2018-09-26 11:34:55+00:00 G012 CARDIOVASCULAR MEDICATIONS: LONGER ACTING NITRATES (ISORDIL, CARDILATE, ETC.) +74 Medication/supplement use 10156 phv00010156.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:35:02+00:00 2018-09-26 11:35:02+00:00 G013 CARDIOVASCULAR MEDICATIONS: CALCIUM CHANNEL BLOCKERS (NIFEDIPINE, VERAPAMIL, DILTIAZEM) +74 Medication/supplement use 10157 phv00010157.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:35:09+00:00 2018-09-26 11:35:09+00:00 G014 CALCIUM CHANNEL BLOCKER GROUP +74 Medication/supplement use 10158 phv00010158.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:35:16+00:00 2018-09-26 11:35:16+00:00 G015 CALCIUM CHANNEL BLOCKER: TABLET SIZE OF CALCIUM CHANNEL BLOCKER (NUMBER OF MG) +74 Medication/supplement use 10159 phv00010159.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:35:23+00:00 2018-09-26 11:35:23+00:00 G016 CALCIUM CHANNEL BLOCKER: NUMBER OF TIMES CALCIUM CHANNEL BLOCKER TAKEN PER DAY +74 Medication/supplement use 10160 phv00010160.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:39:12+00:00 2018-09-26 11:39:12+00:00 G017 CARDIOVASCULAR MEDICATIONS: BETA BLOCKERS +74 Medication/supplement use 10161 phv00010161.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:39:20+00:00 2018-09-26 11:39:20+00:00 G018 BETA BLOCKER GROUP +74 Medication/supplement use 10162 phv00010162.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:39:27+00:00 2018-09-26 11:39:27+00:00 G019 BETA BLOCKER GROUP: DOSE (MG/DAY) OF BETA BLOCKER +74 Medication/supplement use 10163 phv00010163.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:39:34+00:00 2018-09-26 11:39:34+00:00 G020 CARDIOVASCULAR MEDICATIONS: LOOP DIURETICS (LASIX, ETC.) +74 Medication/supplement use 10164 phv00010164.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:39:41+00:00 2018-09-26 11:39:41+00:00 G021 CARDIOVASCULAR MEDICATIONS: THIAZIDE/K-SPARING DIURETICS (DYAZIDE, MAXIDE, ETC.) +74 Medication/supplement use 10165 phv00010165.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:39:50+00:00 2018-09-26 11:39:50+00:00 G022 CARDIOVASCULAR MEDICATIONS: THIAZIDE DIURETICS +74 Medication/supplement use 10166 phv00010166.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:39:58+00:00 2018-09-26 11:39:58+00:00 G023 CARDIOVASCULAR MEDICATIONS: K-SPARING DIURETICS (ALDACTONE, TRIAMTERENE) +74 Medication/supplement use 10167 phv00010167.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:40:05+00:00 2018-09-26 11:40:05+00:00 G024 CARDIOVASCULAR MEDICATIONS: POTASSIUM SUPPLEMENTS +74 Medication/supplement use 10168 phv00010168.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:40:12+00:00 2018-09-26 11:40:12+00:00 G025 CARDIOVASCULAR MEDICATIONS: RESERPINE DERIVATIVES +74 Medication/supplement use 10169 phv00010169.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:40:18+00:00 2018-09-26 11:40:18+00:00 G026 CARDIOVASCULAR MEDICATIONS: METHYLDOPA (ALDOMET) +74 Medication/supplement use 10170 phv00010170.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:40:25+00:00 2018-09-26 11:40:25+00:00 G027 CARDIOVASCULAR MEDICATIONS: ALPHA-1 AGONIST (CLONIDINE, WYTENSIN, GUANABENZ) +74 Medication/supplement use 10171 phv00010171.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:40:33+00:00 2018-09-26 11:40:33+00:00 G028 CARDIOVASCULAR MEDICATIONS: ALPHA-2 BLOCKERS (PRAZOSIN, TERAZOSIN, DOXAZOSIN) +74 Medication/supplement use 10172 phv00010172.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:40:40+00:00 2018-09-26 11:40:40+00:00 G029 CARDIOVASCULAR MEDICATIONS: RENIN-ANGIOTENSIN BLOCKING DRUGS (ACE) (CAPTOPRIL, ENALAPRIL, LISINOPRIL) +74 Medication/supplement use 10173 phv00010173.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:40:48+00:00 2018-09-26 11:40:48+00:00 G030 CARDIOVASCULAR MEDICATIONS: PERIPHERAL VASODILATORS (HYDRALAZINE, MINOXIDIL, ETC.) +74 Medication/supplement use 10174 phv00010174.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:40:55+00:00 2018-09-26 11:40:55+00:00 G031 CARDIOVASCULAR MEDICATIONS: ANGIOTENSIN II ANTAGONISTS (LOSARTAN, ETC.) +74 Medication/supplement use 10175 phv00010175.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:41:08+00:00 2018-09-26 11:41:08+00:00 G032 CARDIOVASCULAR MEDICATIONS: OTHER ANTI-HYPERTENSIVES +74 Medication/supplement use 10176 phv00010176.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:41:17+00:00 2018-09-26 11:41:17+00:00 G033 CARDIOVASCULAR MEDICATIONS: ANTI-ARRHYTHMICS (QUINIDINE, PROCAINAMIDE, AMIODARONE, SOTALOL DISOPYRAMIDE, ETC.) +74 Medication/supplement use 10177 phv00010177.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:41:23+00:00 2018-09-26 11:41:23+00:00 G034 CARDIOVASCULAR MEDICATIONS: ANTIPLATELET (ANTURANE, PERSANTINE, TICLOPIDINE) +74 Medication/supplement use 10178 phv00010178.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:41:31+00:00 2018-09-26 11:41:31+00:00 G035 CARDIOVASCULAR MEDICATIONS: ANTICOAGULANTS (COUMADIN, WARFARIN, ETC.) +74 Medication/supplement use 10179 phv00010179.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:41:38+00:00 2018-09-26 11:41:38+00:00 G036 CARDIOVASCULAR MEDICATIONS: OTHER CARDIAC MEDICATION +74 Medication/supplement use 10180 phv00010180.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:41:46+00:00 2018-09-26 11:41:46+00:00 G037 TAKE ASPIRIN REGULARLY? +74 Medication/supplement use 10181 phv00010181.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:41:53+00:00 2018-09-26 11:41:53+00:00 G038 ASPIRIN: NUMBER TAKEN REGULARLY +74 Medication/supplement use 10182 phv00010182.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:42:00+00:00 2018-09-26 11:42:00+00:00 G039 ASPIRIN: ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY +74 Medication/supplement use 10183 phv00010183.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:42:08+00:00 2018-09-26 11:42:08+00:00 G040 ASPIRIN: USUAL ASPIRIN DOSE FOR ABOVE +74 Medication/supplement use 10184 phv00010184.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:42:37+00:00 2018-09-26 11:42:37+00:00 G041 NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID) +74 Medication/supplement use 10185 phv00010185.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:42:44+00:00 2018-09-26 11:42:44+00:00 G042 NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID) +74 Medication/supplement use 10186 phv00010186.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:42:51+00:00 2018-09-26 11:42:51+00:00 G043 NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL) +74 Medication/supplement use 10187 phv00010187.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:42:58+00:00 2018-09-26 11:42:58+00:00 G044 NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (STATINS - E.G. LOVASTATIN, PRAVASTATIN) +74 Medication/supplement use 10188 phv00010188.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:43:05+00:00 2018-09-26 11:43:05+00:00 G045 NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (OTHER - SPECIFY) +74 Medication/supplement use 10189 phv00010189.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:43:12+00:00 2018-09-26 11:43:12+00:00 G046 NON-CARDIOVASCULAR MEDICATIONS: ANTIGOUT - URIC ACID LOWERING (ALLOPURINOL, PROBENECID, ETC.) +74 Medication/supplement use 10190 phv00010190.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:43:20+00:00 2018-09-26 11:43:20+00:00 G047 NON-CARDIOVASCULAR MEDICATIONS: ANTIGOUT (COLCHICINE) +74 Medication/supplement use 10191 phv00010191.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:43:27+00:00 2018-09-26 11:43:27+00:00 G048 NON-CARDIOVASCULAR MEDICATIONS: THYROID EXTRACT (DESICCATED THYROID) +74 Medication/supplement use 10192 phv00010192.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:43:34+00:00 2018-09-26 11:43:34+00:00 G049 NON-CARDIOVASCULAR MEDICATIONS: THYROXINE (SYNTHROID, ETC.) +74 Medication/supplement use 10193 phv00010193.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:43:42+00:00 2018-09-26 11:43:42+00:00 G050 NON-CARDIOVASCULAR MEDICATIONS: INSULIN +74 Medication/supplement use 10194 phv00010194.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:43:51+00:00 2018-09-26 11:43:51+00:00 G051 INSULIN: TOTAL UNITS A DAY +74 Medication/supplement use 10195 phv00010195.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:43:58+00:00 2018-09-26 11:43:58+00:00 G052 NON-CARDIOVASCULAR MEDICATIONS: ORAL HYPOGLYCEMICS +74 Medication/supplement use 10196 phv00010196.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:44:08+00:00 2018-09-26 11:44:08+00:00 G053 ORAL HYPOGLYCEMICS: METFORMIN +74 Medication/supplement use 10197 phv00010197.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:44:15+00:00 2018-09-26 11:44:15+00:00 G054 ORAL HYPOGLYCEMICS: TRIGLITAZONE +74 Medication/supplement use 10198 phv00010198.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:44:22+00:00 2018-09-26 11:44:22+00:00 G055 ORAL HYPOGLYCEMICS: GLIPIZIDE +74 Medication/supplement use 10199 phv00010199.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:44:29+00:00 2018-09-26 11:44:29+00:00 G056 ORAL HYPOGLYCEMICS: GLYBURIDE +74 Medication/supplement use 10200 phv00010200.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:44:37+00:00 2018-09-26 11:44:37+00:00 G057 ORAL HYPOGLYCEMICS: CHLORPROPAMIDE +74 Medication/supplement use 10201 phv00010201.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:44:44+00:00 2018-09-26 11:44:44+00:00 G058 ORAL HYPOGLYCEMICS: OTHER (SPECIFY) +74 Medication/supplement use 10202 phv00010202.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:44:51+00:00 2018-09-26 11:44:51+00:00 G059 ORAL HYPOGLYCEMICS: UNKNOWN +74 Medication/supplement use 10203 phv00010203.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:45:02+00:00 2018-09-26 11:45:02+00:00 G060 NON-CARDIOVASCULAR MEDICATIONS: ORAL/PATCH ESTROGEN +74 Medication/supplement use 10204 phv00010204.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:45:09+00:00 2018-09-26 11:45:09+00:00 G061 NON-CARDIOVASCULAR MEDICATIONS: ORAL GLUCOCORTICOIDS (PREDNISONE, CORTISONE, ETC.) +74 Medication/supplement use 10205 phv00010205.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:45:17+00:00 2018-09-26 11:45:17+00:00 G062 NON-CARDIOVASCULAR MEDICATIONS: NON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) (MOTRIN, IBUPROFEN, NAPROSYN, INDOCIN, CLINORIL) +74 Medication/supplement use 10206 phv00010206.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:45:23+00:00 2018-09-26 11:45:23+00:00 G063 NON-CARDIOVASCULAR MEDICATIONS: ANALGESIC NARCOTICS (DEMEROL, CODEINE, DILAUDID, ETC.) +74 Medication/supplement use 10207 phv00010207.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:45:32+00:00 2018-09-26 11:45:32+00:00 G064 NON-CARDIOVASCULAR MEDICATIONS: ANALGESIC NON-NARCOTICS (ACETAMINOPHEN, ETC.) +74 Medication/supplement use 10208 phv00010208.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:45:40+00:00 2018-09-26 11:45:40+00:00 G065 NON-CARDIOVASCULAR MEDICATIONS: ANTIHISTAMINES +74 Medication/supplement use 10209 phv00010209.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:45:47+00:00 2018-09-26 11:45:47+00:00 G066 NON-CARDIOVASCULAR MEDICATIONS: ANTIULCER (TAGAMET, RANITIDINE, PROBANTHINE, H ION INHIBITORS) +74 Medication/supplement use 10210 phv00010210.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:45:55+00:00 2018-09-26 11:45:55+00:00 G067 NON-CARDIOVASCULAR MEDICATIONS: ANTI-ANXIETY, SEDATIVE/ HYPNOTICS (LIBRIUM, VALIUM, ETC.) +74 Medication/supplement use 10211 phv00010211.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:46:03+00:00 2018-09-26 11:46:03+00:00 G068 NON-CARDIOVASCULAR MEDICATIONS: SLEEPING PILLS +74 Medication/supplement use 10212 phv00010212.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:46:10+00:00 2018-09-26 11:46:10+00:00 G069 NON-CARDIOVASCULAR MEDICATIONS: ANTI-DEPRESSANTS +74 Medication/supplement use 10213 phv00010213.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:46:18+00:00 2018-09-26 11:46:18+00:00 G070 NON-CARDIOVASCULAR MEDICATIONS: EYEDROPS +74 Medication/supplement use 10214 phv00010214.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:46:36+00:00 2018-09-26 11:46:36+00:00 G071 NON-CARDIOVASCULAR MEDICATIONS: ANTIBIOTICS +74 Medication/supplement use 10215 phv00010215.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:46:44+00:00 2018-09-26 11:46:44+00:00 G072 NON-CARDIOVASCULAR MEDICATIONS: ANTI-PARKINSON DRUGS (SINEMET, L-DOPA, SYMMETREL, COGENTIN, ETC.) +74 Medication/supplement use 10216 phv00010216.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:46:51+00:00 2018-09-26 11:46:51+00:00 G073 NON-CARDIOVASCULAR MEDICATIONS: ANTICONVULSANTS (DILANTIN, PHENOBARBITAL, TEGRETOL, MYSOLINE, ETC.) +74 Medication/supplement use 10217 phv00010217.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:46:59+00:00 2018-09-26 11:46:59+00:00 G074 NON-CARDIOVASCULAR MEDICATIONS: BRONCHODILATORS AND AEROSOLS +74 Medication/supplement use 10218 phv00010218.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:47:06+00:00 2018-09-26 11:47:06+00:00 G075 NON-CARDIOVASCULAR MEDICATIONS: OSTEOPOROSIS MEDICATIONS +74 Medication/supplement use 10219 phv00010219.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:47:14+00:00 2018-09-26 11:47:14+00:00 G076 NON-CARDIOVASCULAR MEDICATIONS: OTHERS +74 Medication/supplement use 10230 phv00010230.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:47:28+00:00 2018-09-26 11:47:28+00:00 G087 ORAL CONTRACEPTIVES IN INTERIM +74 Medication/supplement use 10231 phv00010231.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:47:44+00:00 2018-09-26 11:47:44+00:00 G088 ESTROGEN REPLACEMENT IN INTERIM (E.G. PREMARIN) +74 Medication/supplement use 10232 phv00010232.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:47:51+00:00 2018-09-26 11:47:51+00:00 G089 DOSE/DAY OF PREMARIN CONJUGATED ESTROGENS, OR OTHER ORAL ESTROGEN +74 Medication/supplement use 10233 phv00010233.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:47:58+00:00 2018-09-26 11:47:58+00:00 G090 PATCH DOSE OF ESTROGEN +74 Medication/supplement use 10234 phv00010234.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:48:07+00:00 2018-09-26 11:48:07+00:00 G091 NUMBER OF DAYS A MONTH TAKING ESTROGENS +74 Medication/supplement use 10235 phv00010235.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:48:15+00:00 2018-09-26 11:48:15+00:00 G092 NUMBER OF YEARS ON ESTROGEN +74 Medication/supplement use 10236 phv00010236.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:48:24+00:00 2018-09-26 11:48:24+00:00 G093 ESTROGEN CREAM USE IN INTERIM +74 Medication/supplement use 10237 phv00010237.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:48:32+00:00 2018-09-26 11:48:32+00:00 G094 PROGESTIN REPLACEMENT IN INTERIM +74 Medication/supplement use 10238 phv00010238.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:48:39+00:00 2018-09-26 11:48:39+00:00 G095 DOSE/DAY OF PROGESTIN +74 Medication/supplement use 10239 phv00010239.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:48:47+00:00 2018-09-26 11:48:47+00:00 G096 NUMBER OF DAYS A MONTH TAKING PROGESTINS +74 Medication/supplement use 10663 phv00010663.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:49:59+00:00 2018-09-26 11:49:59+00:00 G672 RESPIRATORY: ARE YOU CURRENTLY TAKING ANY MEDICATIONS (INCLUDING INHALERS, AEROSOLS, OR TABLETS) FOR ASTHMA? +74 Medication/supplement use 10670 phv00010670.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:50:11+00:00 2018-09-26 11:50:11+00:00 G679 RESPIRATORY: ARE YOU CURRENTLY TAKING ANY STEROID MEDICATIONS? +74 Medication/supplement use 10671 phv00010671.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:50:27+00:00 2018-09-26 11:50:27+00:00 G680 RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - ORAL (CHECK ALL THAT APPLY) +74 Medication/supplement use 10674 phv00010674.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:50:40+00:00 2018-09-26 11:50:40+00:00 G683 RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - NASAL (CHECK ALL THAT APPLY) +74 Medication/supplement use 10692 phv00010692.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 11:51:04+00:00 2018-09-26 11:51:04+00:00 G708 TREATMENT FOR BLOOD PRESSURE +74 Medication/supplement use 72053 phv00072053.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:04:39+00:00 2018-09-26 12:04:39+00:00 H010 TAKE ASPIRIN REGULARLY? +74 Medication/supplement use 72054 phv00072054.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:04:51+00:00 2018-09-26 12:04:51+00:00 H011 IF TAKING ASPIRIN, NUMBER OF ASPIRINS TAKEN REGULARLY +74 Medication/supplement use 72055 phv00072055.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:04:59+00:00 2018-09-26 12:04:59+00:00 H012 IF TAKING ASPIRIN, FREQUENCY PER +74 Medication/supplement use 72056 phv00072056.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:05:05+00:00 2018-09-26 12:05:05+00:00 H013 IF TAKING ASPIRIN, USUAL DOSE +74 Medication/supplement use 72052 phv00072052.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:05:14+00:00 2018-09-26 12:05:14+00:00 H014 SINCE YOUR LAST EXAM HAVE YOU TAKEN MEDICATION FOR HYPERTENSION/HIGH BLOOD PRESSURE? +74 Medication/supplement use 72057 phv00072057.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:05:31+00:00 2018-09-26 12:05:31+00:00 H015 SINCE YOUR LAST EXAM HAVE YOU TAKEN MEDICATION FOR HIGH BLOOD CHOLESTEROL OR HIGH TRIGLYCERIDES? +74 Medication/supplement use 72058 phv00072058.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:05:48+00:00 2018-09-26 12:05:48+00:00 H017 SINCE YOUR LAST EXAM HAVE YOU TAKEN MEDICATION FOR CARDIOVASCULAR DISEASE (FOR EXAMPLE ANGINA/CHEST PAIN, HEART FAILURE, ATRIAL FIBRILLATION/HEART RHYTHM ABNORMALITY, STROKE, LEG PAIN WHEN WALKING?) +74 Medication/supplement use 72061 phv00072061.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:05:59+00:00 2018-09-26 12:05:59+00:00 H024 SINCE YOUR LAST EXAM HAVE YOU TAKEN OR USED ORAL CONTRACEPTIVE PILLS, SHOTS, OR HORMONE IMPLANTS FOR BIRTH CONTROL OR MEDICAL INDICATIONS (NOT POST MENOPAUSAL HORMONE REPLACEMENT)? +74 Medication/supplement use 72062 phv00072062.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:06:13+00:00 2018-09-26 12:06:13+00:00 H025 WHAT IS THE NAME OF THE CURRENT OR MOST RECENT ORAL CONTRACEPTIVE, SHOT OR IMPLANT USED? - NAME +74 Medication/supplement use 72068 phv00072068.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:06:20+00:00 2018-09-26 12:06:20+00:00 H026 WHAT IS THE NAME OF THE CURRENT OR MOST RECENT ORAL CONTRACEPTIVE, SHOT OR IMPLANT USED? - STRENGTH +74 Medication/supplement use 72063 phv00072063.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:06:28+00:00 2018-09-26 12:06:28+00:00 H027 WHAT IS THE NAME OF THE CURRENT OR MOST RECENT ORAL CONTRACEPTIVE, SHOT OR IMPLANT USED? - FORM +74 Medication/supplement use 72074 phv00072074.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:07:10+00:00 2018-09-26 12:07:10+00:00 H046 WHAT AGE DID YOU BEGIN HORMONE REPLACEMENT THERAPY? +74 Medication/supplement use 72075 phv00072075.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:07:20+00:00 2018-09-26 12:07:20+00:00 H047 "FOR HOW LONG DID YOU TAKE HORMONES? - ""YEAR"" PART OF DURATION" +74 Medication/supplement use 72076 phv00072076.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:07:27+00:00 2018-09-26 12:07:27+00:00 H048 "FOR HOW LONG DID YOU TAKE HORMONES? - ""MONTH"" PART OF DURATION" +74 Medication/supplement use 72077 phv00072077.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:07:34+00:00 2018-09-26 12:07:34+00:00 H049 ESTROGEN USE? +74 Medication/supplement use 72078 phv00072078.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:07:41+00:00 2018-09-26 12:07:41+00:00 H050 NAME OF MOST RECENT ESTROGEN PREPARATION +74 Medication/supplement use 72079 phv00072079.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:07:49+00:00 2018-09-26 12:07:49+00:00 H051 STRENGTH OF MOST RECENT ESTROGEN PREPARATION +74 Medication/supplement use 72087 phv00072087.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:08:01+00:00 2018-09-26 12:08:01+00:00 H052 NUMBER OF DAYS PER MONTH ESTROGEN TAKEN +74 Medication/supplement use 72080 phv00072080.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:08:09+00:00 2018-09-26 12:08:09+00:00 H053 PROGESTERONE USE? +74 Medication/supplement use 72081 phv00072081.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:08:17+00:00 2018-09-26 12:08:17+00:00 H054 NAME OF MOST RECENT PROGESTERONE PREPARATION +74 Medication/supplement use 72082 phv00072082.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:08:24+00:00 2018-09-26 12:08:24+00:00 H055 STRENGTH OF MOST RECENT PROGESTERONE PREPARATION +74 Medication/supplement use 72083 phv00072083.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:08:31+00:00 2018-09-26 12:08:31+00:00 H056 NUMBER OF DAYS PER MONTH PREGESTERONE TAKEN +74 Medication/supplement use 72084 phv00072084.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:08:44+00:00 2018-09-26 12:08:44+00:00 H057 IF PERIODS HAVE STOPPED, HAVE YOU USED EVISTA (RALOXIFENE) OR NOLVADEX (TAMOXIFEN) OR OTHER SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)? +74 Medication/supplement use 72085 phv00072085.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:08:57+00:00 2018-09-26 12:08:57+00:00 H058 NUMBER OF MONTHS SERMS USED +74 Medication/supplement use 72086 phv00072086.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:09:06+00:00 2018-09-26 12:09:06+00:00 H059 CURRENT SERMS USE? +74 Medication/supplement use 72511 phv00072511.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:10:31+00:00 2018-09-26 12:10:31+00:00 H670 DO YOU TAKE INHALERS OR BRONCHODILATORS? +74 Medication/supplement use 72512 phv00072512.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:10:42+00:00 2018-09-26 12:10:42+00:00 H671 DO YOU USE ANY OF THESE MEDICATIONS - ALBUTEROL, PROVENTIL, VENTOLIN, COMBIVENT, MAXAIR, VOLMAX, XOPENEX, BRONKOOMETER, PIRBUTEROL, LEVALBUTEROL, OR METAPROTERENOL? +74 Medication/supplement use 72513 phv00072513.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:10:50+00:00 2018-09-26 12:10:50+00:00 H672 HOW MANY HOURS AGO DID YOU LAST USE THE MEDICATION, EITHER BY INHALER OR NEBULIZER? +74 Medication/supplement use 72514 phv00072514.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:10:58+00:00 2018-09-26 12:10:58+00:00 H673 DO YOU TAKE ANY OF THE FOLLOWING INHALERS? SEREVENT, ADVAIR, FORADIL, SALMETEROL, OR FORMOTEROL +74 Medication/supplement use 72515 phv00072515.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:11:08+00:00 2018-09-26 12:11:08+00:00 H674 HOW MANY HOURS AGO DID YOU LAST USE THE MEDICATION? +74 Medication/supplement use 20873 phv00020873.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:13:29+00:00 2018-09-26 12:13:29+00:00 G3A008 TAKE ASPIRIN REGULARLY? +74 Medication/supplement use 20874 phv00020874.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:13:44+00:00 2018-09-26 12:13:44+00:00 G3A009 IF TAKE ASPIRIN REGULARLY: NUMBER ASPIRINS TAKEN +74 Medication/supplement use 20875 phv00020875.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:13:51+00:00 2018-09-26 12:13:51+00:00 G3A010 IF TAKE ASPIRIN REGULARLY: FREQUENCY PER +74 Medication/supplement use 20876 phv00020876.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:13:59+00:00 2018-09-26 12:13:59+00:00 G3A011 IF TAKE ASPIRIN REGULARLY: USUAL DOSE +74 Medication/supplement use 20877 phv00020877.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:14:06+00:00 2018-09-26 12:14:06+00:00 G3A012 HAVE YOU EVER TAKEN MEDICATION FOR HYPERTENSION/HIGH BLOOD PRESSURE? +74 Medication/supplement use 20878 phv00020878.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:14:13+00:00 2018-09-26 12:14:13+00:00 G3A013 IF YES TO G3A012, AT WHAT AGE DID YOU BEGIN +74 Medication/supplement use 20879 phv00020879.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:14:20+00:00 2018-09-26 12:14:20+00:00 G3A014 HAVE YOU EVER TAKEN MEDICATION FOR HIGH BLOOD CHOLESTEROL? +74 Medication/supplement use 20880 phv00020880.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:14:28+00:00 2018-09-26 12:14:28+00:00 G3A015 IF YES TO G3A014, AT WHAT AGE DID YOU BEGIN +74 Medication/supplement use 20881 phv00020881.v5.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:14:36+00:00 2018-09-26 12:14:36+00:00 G3A016 HAVE YOU EVER TAKEN MEDICATION FOR HIGH BLOOD SUGAR OR DIABETES? +74 Medication/supplement use 20882 phv00020882.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:14:44+00:00 2018-09-26 12:14:44+00:00 G3A017 IF YES TO G3A016, AT WHAT AGE DID YOU BEGIN +74 Medication/supplement use 20883 phv00020883.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:14:51+00:00 2018-09-26 12:14:51+00:00 G3A018 IF YES TO G3A016, WAS INSULIN YOUR FIRST DIABETES MEDICATION? +74 Medication/supplement use 20885 phv00020885.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:16:06+00:00 2018-09-26 12:16:06+00:00 G3A020 HAVE YOU EVER TAKEN MEDICATION FOR CARDIOVASCULAR DISEASE (FOR EXAMPLE ANGINA/CHEST PAIN, HEART FAILURE, ARTIAL FIBRILLATION/ HEART RHYTHM ABNORMALITY, STROKE, LEG PAIN WHEN WALKING?) +74 Medication/supplement use 20886 phv00020886.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:16:17+00:00 2018-09-26 12:16:17+00:00 G3A021 IF YES TO G3A020, AT WHAT AGE DID YOU BEGIN +74 Medication/supplement use 20888 phv00020888.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:16:30+00:00 2018-09-26 12:16:30+00:00 G3A024 HAVE YOU EVER TAKEN OR USED ORAL CONTRACEPTIVE PILLS, SHOTS, OR HORMONE IMPLANTS FOR BIRTH CONTROL OR MEDICAL INDICATIONS (NOT POST MENOPAUSAL HORMONE REPLACEMENT)? +74 Medication/supplement use 20889 phv00020889.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:16:41+00:00 2018-09-26 12:16:41+00:00 G3A025 IF OCP USE, WHAT IS THE NAME OF THE CURRENT OR MOST RECENT ORAL CONTRACEPTIVE, SHOT OR IMPLANT USED? +74 Medication/supplement use 20890 phv00020890.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:16:48+00:00 2018-09-26 12:16:48+00:00 G3A026 IF OCP USE, STRENGTH +74 Medication/supplement use 20891 phv00020891.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:16:55+00:00 2018-09-26 12:16:55+00:00 G3A027 IF OCP USE, FORM +74 Medication/supplement use 20892 phv00020892.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:17:14+00:00 2018-09-26 12:17:14+00:00 G3A032 IF OCP USE, WHAT IS THE TOTAL NUMBER OF YEARS OVER YOUR LIFETIME THAT YOU USED ORAL CONTRACEPTIVES PILLS, SHOTS, OR HORMONE IMPLANTS? +74 Medication/supplement use 20908 phv00020908.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:17:32+00:00 2018-09-26 12:17:32+00:00 G3A053 IF PERIODS STOPPED: HAVE YOU EVER TAKEN HORMONE REPLACEMENT THERAPY (ESTROGEN/PROGESTERONE)? +74 Medication/supplement use 20909 phv00020909.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:17:47+00:00 2018-09-26 12:17:47+00:00 G3A054 IF TAKEN HRT: WHAT AGE DID YOU BEGIN HORMONE REPLACEMENT THERAPY? +74 Medication/supplement use 20910 phv00020910.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:17:55+00:00 2018-09-26 12:17:55+00:00 G3A055 IF TAKEN HRT: FOR HOW LONG DID YOU TAKE HORMONES (YEARS)? +74 Medication/supplement use 20911 phv00020911.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:18:03+00:00 2018-09-26 12:18:03+00:00 G3A056 IF TAKEN HRT: FOR HOW LONG DID YOU TAKE HORMONES (MONTHS)? +74 Medication/supplement use 20912 phv00020912.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:18:12+00:00 2018-09-26 12:18:12+00:00 G3A057 IF TAKEN HRT: ESTROGEN USE EVER? +74 Medication/supplement use 20913 phv00020913.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:18:21+00:00 2018-09-26 12:18:21+00:00 G3A058 IF ESTROGEN USE EVER: NAME OF MOST RECENT ESTROGEN PREPARATION +74 Medication/supplement use 20914 phv00020914.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:18:30+00:00 2018-09-26 12:18:30+00:00 G3A059 IF ESTROGEN USE EVER: THE STRENGTH OF ESTROGEN +74 Medication/supplement use 20915 phv00020915.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:18:42+00:00 2018-09-26 12:18:42+00:00 G3A060 IF ESTROGEN USE EVER: NUMBER OF DAYS PER MONTH TAKEN +74 Medication/supplement use 20916 phv00020916.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:19:03+00:00 2018-09-26 12:19:03+00:00 G3A061 IF TAKEN HRT: PROGESTERONE USE EVER? +74 Medication/supplement use 20917 phv00020917.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:19:15+00:00 2018-09-26 12:19:15+00:00 G3A062 IF PROGESTERONE USE EVER: NAME OF MOST RECENT PROGESTERONE PREPARATION +74 Medication/supplement use 20918 phv00020918.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:19:23+00:00 2018-09-26 12:19:23+00:00 G3A063 IF PROGESTERONE USE EVER: THE STRENGTH OF PROGESTERONE +74 Medication/supplement use 20919 phv00020919.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:19:30+00:00 2018-09-26 12:19:30+00:00 G3A064 IF PROGESTERONE USE EVER: NUMBER OF DAYS PER MONTH TAKEN +74 Medication/supplement use 20920 phv00020920.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:19:38+00:00 2018-09-26 12:19:38+00:00 G3A065 IF PERIODS STOPPED: HAVE YOU USED EVISTA (RALOXIFENE) OR NOLVADEX (TAMOXIFEN) OR OTHER SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)? +74 Medication/supplement use 20921 phv00020921.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:19:50+00:00 2018-09-26 12:19:50+00:00 G3A066 IF USED SERMS: NUMBER OF MONTHS USED? +74 Medication/supplement use 20922 phv00020922.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:19:57+00:00 2018-09-26 12:19:57+00:00 G3A067 IF USE SERMS: CURRENT USE? +74 Medication/supplement use 20923 phv00020923.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:20:11+00:00 2018-09-26 12:20:11+00:00 G3A068 IF PERIODS STOPPED: DO YOU TAKE OVER-THE-COUNTER ALTERNATIVE, HERBAL, OR NATURAL SOY-BASED PREPARATIONS TO TREAT MENOPAUSAL SYMPTOMS? +74 Medication/supplement use 20924 phv00020924.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:20:22+00:00 2018-09-26 12:20:22+00:00 G3A069 IF YES TO G3A068: SPECIFY PREPARATION +74 Medication/supplement use 69859 phv00069859.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:36:30+00:00 2018-09-26 12:36:30+00:00 ADUR FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68247 phv00068247.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:36:30+00:00 2018-09-26 12:36:30+00:00 ADUR FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68815 phv00068815.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:36:30+00:00 2018-09-26 12:36:30+00:00 ADUR FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 156758 phv00156758.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:36:30+00:00 2018-09-26 12:36:30+00:00 ADUR FFQ: VIT A SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157392 phv00157392.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:36:30+00:00 2018-09-26 12:36:30+00:00 ADUR FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157868 phv00157868.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:36:30+00:00 2018-09-26 12:36:30+00:00 ADUR FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 158185 phv00158185.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:36:30+00:00 2018-09-26 12:36:30+00:00 ADUR FFQ: VITAMIN A SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 162118 phv00162118.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:36:30+00:00 2018-09-26 12:36:30+00:00 ADUR FFQ: VIT A SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 69889 phv00069889.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:39:14+00:00 2018-09-26 12:39:14+00:00 B_Y FFQ: TAKE BREWER'S YEAST SUPPLEMENT +74 Medication/supplement use 68277 phv00068277.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:39:14+00:00 2018-09-26 12:39:14+00:00 B_Y FFQ: TAKE BREWER'S YEAST SUPPLEMENT +74 Medication/supplement use 68845 phv00068845.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:39:14+00:00 2018-09-26 12:39:14+00:00 B_Y FFQ: TAKE BREWER'S YEAST SUPPLEMENT +74 Medication/supplement use 156788 phv00156788.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:39:14+00:00 2018-09-26 12:39:14+00:00 B_Y FFQ: TAKE BREWER'S YEAST SUPPLEMENT +74 Medication/supplement use 157421 phv00157421.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:39:14+00:00 2018-09-26 12:39:14+00:00 B_Y FFQ: TAKE BREWER'S YEAST SUPPLEMENT +74 Medication/supplement use 157898 phv00157898.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:39:14+00:00 2018-09-26 12:39:14+00:00 B_Y FFQ: TAKE BREWER'S YEAST SUPPLEMENT +74 Medication/supplement use 158215 phv00158215.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:39:14+00:00 2018-09-26 12:39:14+00:00 B_Y FFQ: TAKE BREWER'S YEAST SUPPLEMENT +74 Medication/supplement use 162148 phv00162148.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:39:14+00:00 2018-09-26 12:39:14+00:00 B_Y FFQ: TAKE BREWER'S YEAST SUPPLEMENT +74 Medication/supplement use 69865 phv00069865.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6DUR FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 69866 phv00069866.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6D FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68253 phv00068253.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6DUR FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68254 phv00068254.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6D FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68821 phv00068821.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6DUR FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68822 phv00068822.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6D FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 156764 phv00156764.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6DUR FFQ: VIT B6 SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 156765 phv00156765.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6D FFQ: VIT B6 SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157398 phv00157398.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6DUR FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157399 phv00157399.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6D FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157874 phv00157874.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6DUR FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157875 phv00157875.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6D FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 158191 phv00158191.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6DUR FFQ: VITAMIN B6 SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 158192 phv00158192.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6D FFQ: VITAMIN B6 SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 162124 phv00162124.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6DUR FFQ: VIT B6 SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 162125 phv00162125.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:43:46+00:00 2018-09-26 12:43:46+00:00 B6D FFQ: VIT B6 SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 69890 phv00069890.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:45:23+00:00 2018-09-26 12:45:23+00:00 BCAROT FFQ: TAKE BETA-CAROTENE SUPPLEMENT +74 Medication/supplement use 68278 phv00068278.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:45:23+00:00 2018-09-26 12:45:23+00:00 BCAROT FFQ: TAKE BETA-CAROTENE SUPPLEMENT +74 Medication/supplement use 68846 phv00068846.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:45:23+00:00 2018-09-26 12:45:23+00:00 BCAROT FFQ: TAKE BETA-CAROTENE SUPPLEMENT +74 Medication/supplement use 156789 phv00156789.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:45:23+00:00 2018-09-26 12:45:23+00:00 BCAROT FFQ: TAKE BETA-CAROTENE SUPPLEMENT +74 Medication/supplement use 157422 phv00157422.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:45:23+00:00 2018-09-26 12:45:23+00:00 BCAROT FFQ: TAKE BETA-CAROTENE SUPPLEMENT +74 Medication/supplement use 157899 phv00157899.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:45:23+00:00 2018-09-26 12:45:23+00:00 BCAROT FFQ: TAKE BETA-CAROTENE SUPPLEMENT +74 Medication/supplement use 158216 phv00158216.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:45:23+00:00 2018-09-26 12:45:23+00:00 BCAROT FFQ: TAKE BETA-CAROTENE SUPPLEMENT +74 Medication/supplement use 162149 phv00162149.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:45:23+00:00 2018-09-26 12:45:23+00:00 BCAROT FFQ: TAKE BETA-CAROTENE SUPPLEMENT +74 Medication/supplement use 69880 phv00069880.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CADUR FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 69881 phv00069881.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CAD FFQ: CALCIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68268 phv00068268.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CADUR FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68269 phv00068269.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CAD FFQ: CALCIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68836 phv00068836.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CADUR FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68837 phv00068837.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CAD FFQ: CALCIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 156779 phv00156779.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CADUR FFQ: CALCIUM SUPPLEMENT YEARS OF DUR +74 Medication/supplement use 156780 phv00156780.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CAD FFQ: CALCIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157412 phv00157412.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CADUR FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157413 phv00157413.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CAD FFQ: CALCIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157889 phv00157889.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CADUR FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157890 phv00157890.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CAD FFQ: CALCIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 158206 phv00158206.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CADUR FFQ: CALCIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 158207 phv00158207.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CAD FFQ: CALCIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 162139 phv00162139.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CADUR FFQ: CALCIUM SUPPLEMENT YEARS OF DUR +74 Medication/supplement use 162140 phv00162140.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:47:40+00:00 2018-09-26 12:47:40+00:00 CAD FFQ: CALCIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 69862 phv00069862.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:49:22+00:00 2018-09-26 12:49:22+00:00 CDUR FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68250 phv00068250.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:49:22+00:00 2018-09-26 12:49:22+00:00 CDUR FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68818 phv00068818.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:49:22+00:00 2018-09-26 12:49:22+00:00 CDUR FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 156761 phv00156761.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:49:22+00:00 2018-09-26 12:49:22+00:00 CDUR FFQ: VIT C SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157395 phv00157395.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:49:22+00:00 2018-09-26 12:49:22+00:00 CDUR FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157871 phv00157871.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:49:22+00:00 2018-09-26 12:49:22+00:00 CDUR FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 158188 phv00158188.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:49:22+00:00 2018-09-26 12:49:22+00:00 CDUR FFQ: VITAMIN C SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 162121 phv00162121.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:49:22+00:00 2018-09-26 12:49:22+00:00 CDUR FFQ: VIT C SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 69885 phv00069885.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:50:38+00:00 2018-09-26 12:50:38+00:00 CODLIV FFQ: TAKE COD LIVER OIL SUPPLEMENT +74 Medication/supplement use 68273 phv00068273.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:50:38+00:00 2018-09-26 12:50:38+00:00 CODLIV FFQ: TAKE COD LIVER OIL SUPPLEMENT +74 Medication/supplement use 68841 phv00068841.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:50:38+00:00 2018-09-26 12:50:38+00:00 CODLIV FFQ: TAKE COD LIVER OIL SUPPLEMENT +74 Medication/supplement use 156784 phv00156784.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:50:38+00:00 2018-09-26 12:50:38+00:00 CODLIV FFQ: TAKE COD LIVER OIL SUPPLEMENT +74 Medication/supplement use 157417 phv00157417.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:50:38+00:00 2018-09-26 12:50:38+00:00 CODLIV FFQ: TAKE COD LIVER OIL SUPPLEMENT +74 Medication/supplement use 157894 phv00157894.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:50:38+00:00 2018-09-26 12:50:38+00:00 CODLIV FFQ: TAKE COD LIVER OIL SUPPLEMENT +74 Medication/supplement use 158211 phv00158211.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:50:38+00:00 2018-09-26 12:50:38+00:00 CODLIV FFQ: TAKE COD LIVER OIL SUPPLEMENT +74 Medication/supplement use 162144 phv00162144.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:50:38+00:00 2018-09-26 12:50:38+00:00 CODLIV FFQ: TAKE COD LIVER OIL SUPPLEMENT +74 Medication/supplement use 69868 phv00069868.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:52:07+00:00 2018-09-26 12:52:07+00:00 EDUR FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68256 phv00068256.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:52:07+00:00 2018-09-26 12:52:07+00:00 EDUR FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68824 phv00068824.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:52:07+00:00 2018-09-26 12:52:07+00:00 EDUR FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 156767 phv00156767.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:52:07+00:00 2018-09-26 12:52:07+00:00 EDUR FFQ: VIT E SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157401 phv00157401.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:52:07+00:00 2018-09-26 12:52:07+00:00 EDUR FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157877 phv00157877.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:52:07+00:00 2018-09-26 12:52:07+00:00 EDUR FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 158194 phv00158194.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:52:07+00:00 2018-09-26 12:52:07+00:00 EDUR FFQ: VITAMIN E SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 162127 phv00162127.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 12:52:07+00:00 2018-09-26 12:52:07+00:00 EDUR FFQ: VIT E SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 69874 phv00069874.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FEDUR FFQ: IRON SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 69875 phv00069875.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FED FFQ: IRON SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68262 phv00068262.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FEDUR FFQ: IRON SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68263 phv00068263.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FED FFQ: IRON SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68830 phv00068830.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FEDUR FFQ: IRON SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68831 phv00068831.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FED FFQ: IRON SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 156773 phv00156773.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FEDUR FFQ: IRON SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 156774 phv00156774.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FED FFQ: IRON SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157407 phv00157407.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FEDUR FFQ: IRON SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157408 phv00157408.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FED FFQ: IRON SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157883 phv00157883.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FEDUR FFQ: IRON SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157884 phv00157884.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FED FFQ: IRON SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 158200 phv00158200.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FEDUR FFQ: IRON SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 158201 phv00158201.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FED FFQ: IRON SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 162133 phv00162133.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FEDUR FFQ: IRON SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 162134 phv00162134.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:18:18+00:00 2018-09-26 14:18:18+00:00 FED FFQ: IRON SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 69887 phv00069887.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:20:08+00:00 2018-09-26 14:20:08+00:00 IODINE FFQ: TAKE IODINE SUPPLEMENT +74 Medication/supplement use 68275 phv00068275.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:20:08+00:00 2018-09-26 14:20:08+00:00 IODINE FFQ: TAKE IODINE SUPPLEMENT +74 Medication/supplement use 68843 phv00068843.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:20:08+00:00 2018-09-26 14:20:08+00:00 IODINE FFQ: TAKE IODINE SUPPLEMENT +74 Medication/supplement use 156786 phv00156786.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:20:08+00:00 2018-09-26 14:20:08+00:00 IODINE FFQ: TAKE IODINE SUPPLEMENT +74 Medication/supplement use 157419 phv00157419.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:20:08+00:00 2018-09-26 14:20:08+00:00 IODINE FFQ: TAKE IODINE SUPPLEMENT +74 Medication/supplement use 157896 phv00157896.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:20:08+00:00 2018-09-26 14:20:08+00:00 IODINE FFQ: TAKE IODINE SUPPLEMENT +74 Medication/supplement use 158213 phv00158213.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:20:08+00:00 2018-09-26 14:20:08+00:00 IODINE FFQ: TAKE IODINE SUPPLEMENT +74 Medication/supplement use 162146 phv00162146.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:20:08+00:00 2018-09-26 14:20:08+00:00 IODINE FFQ: TAKE IODINE SUPPLEMENT +74 Medication/supplement use 69891 phv00069891.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:21:24+00:00 2018-09-26 14:21:24+00:00 MG FFQ: TAKE MAGNESIUM SUPPLEMENT +74 Medication/supplement use 68279 phv00068279.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:21:24+00:00 2018-09-26 14:21:24+00:00 MG FFQ: TAKE MAGNESIUM SUPPLEMENT +74 Medication/supplement use 68847 phv00068847.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:21:24+00:00 2018-09-26 14:21:24+00:00 MG FFQ: TAKE MAGNESIUM SUPPLEMENT +74 Medication/supplement use 156790 phv00156790.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:21:24+00:00 2018-09-26 14:21:24+00:00 MG FFQ: TAKE MAGNESIUM SUPPLEMENT +74 Medication/supplement use 157423 phv00157423.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:21:24+00:00 2018-09-26 14:21:24+00:00 MG FFQ: TAKE MAGNESIUM SUPPLEMENT +74 Medication/supplement use 157900 phv00157900.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:21:24+00:00 2018-09-26 14:21:24+00:00 MG FFQ: TAKE MAGNESIUM SUPPLEMENT +74 Medication/supplement use 158217 phv00158217.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:21:24+00:00 2018-09-26 14:21:24+00:00 MG FFQ: TAKE MAGNESIUM SUPPLEMENT +74 Medication/supplement use 162150 phv00162150.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:21:24+00:00 2018-09-26 14:21:24+00:00 MG FFQ: TAKE MAGNESIUM SUPPLEMENT +74 Medication/supplement use 69886 phv00069886.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:27:20+00:00 2018-09-26 14:27:20+00:00 OMEGA3 FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT +74 Medication/supplement use 68274 phv00068274.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:27:20+00:00 2018-09-26 14:27:20+00:00 OMEGA3 FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT +74 Medication/supplement use 68842 phv00068842.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:27:20+00:00 2018-09-26 14:27:20+00:00 OMEGA3 FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT +74 Medication/supplement use 156785 phv00156785.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:27:20+00:00 2018-09-26 14:27:20+00:00 OMEGA3 FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT +74 Medication/supplement use 157418 phv00157418.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:27:20+00:00 2018-09-26 14:27:20+00:00 OMEGA3 FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT +74 Medication/supplement use 157895 phv00157895.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:27:20+00:00 2018-09-26 14:27:20+00:00 OMEGA3 FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT +74 Medication/supplement use 158212 phv00158212.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:27:20+00:00 2018-09-26 14:27:20+00:00 OMEGA3 FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT +74 Medication/supplement use 162145 phv00162145.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:27:20+00:00 2018-09-26 14:27:20+00:00 OMEGA3 FFQ: TAKE OMEGA-3 FATTY-ACIDS SUPPLEMENT +74 Medication/supplement use 69892 phv00069892.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:30:55+00:00 2018-09-26 14:30:55+00:00 OTHERS FFQ: TAKE OTHER SUPPLEMENT +74 Medication/supplement use 68280 phv00068280.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:30:55+00:00 2018-09-26 14:30:55+00:00 OTHERS FFQ: TAKE OTHER SUPPLEMENT +74 Medication/supplement use 68848 phv00068848.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:30:55+00:00 2018-09-26 14:30:55+00:00 OTHERS FFQ: TAKE OTHER SUPPLEMENT +74 Medication/supplement use 156791 phv00156791.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:30:55+00:00 2018-09-26 14:30:55+00:00 OTHERS FFQ: TAKE OTHER SUPPLEMENT +74 Medication/supplement use 157424 phv00157424.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:30:55+00:00 2018-09-26 14:30:55+00:00 OTHERS FFQ: TAKE OTHER SUPPLEMENT +74 Medication/supplement use 157901 phv00157901.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:30:55+00:00 2018-09-26 14:30:55+00:00 OTHERS FFQ: TAKE OTHER SUPPLEMENT +74 Medication/supplement use 158218 phv00158218.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:30:55+00:00 2018-09-26 14:30:55+00:00 OTHERS FFQ: TAKE OTHER SUPPLEMENT +74 Medication/supplement use 162151 phv00162151.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:30:55+00:00 2018-09-26 14:30:55+00:00 OTHERS FFQ: TAKE OTHER SUPPLEMENT +74 Medication/supplement use 69870 phv00069870.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SEL FFQ: TAKE SELENIUM SUPPLEMENT +74 Medication/supplement use 69871 phv00069871.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELDUR FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 69872 phv00069872.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELD FFQ: SELENIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68258 phv00068258.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SEL FFQ: TAKE SELENIUM SUPPLEMENT +74 Medication/supplement use 68259 phv00068259.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELDUR FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68260 phv00068260.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELD FFQ: SELENIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68826 phv00068826.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SEL FFQ: TAKE SELENIUM SUPPLEMENT +74 Medication/supplement use 68827 phv00068827.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELDUR FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68828 phv00068828.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELD FFQ: SELENIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 156769 phv00156769.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SEL FFQ: TAKE SELENIUM SUPPLEMENT +74 Medication/supplement use 156770 phv00156770.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELDUR FFQ: SELENIUM SUPPLEMENT YEARS OF DUR +74 Medication/supplement use 156771 phv00156771.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELD FFQ: SELENIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157403 phv00157403.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SEL FFQ: TAKE SELENIUM SUPPLEMENT +74 Medication/supplement use 157404 phv00157404.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELDUR FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157405 phv00157405.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELD FFQ: SELENIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157879 phv00157879.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SEL FFQ: TAKE SELENIUM SUPPLEMENT +74 Medication/supplement use 157880 phv00157880.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELDUR FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157881 phv00157881.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELD FFQ: SELENIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 158196 phv00158196.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SEL FFQ: TAKE SELENIUM SUPPLEMENT +74 Medication/supplement use 158197 phv00158197.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELDUR FFQ: SELENIUM SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 158198 phv00158198.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELD FFQ: SELENIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 162129 phv00162129.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SEL FFQ: TAKE SELENIUM SUPPLEMENT +74 Medication/supplement use 162130 phv00162130.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELDUR FFQ: SELENIUM SUPPLEMENT YEARS OF DUR +74 Medication/supplement use 162131 phv00162131.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:34:31+00:00 2018-09-26 14:34:31+00:00 SELD FFQ: SELENIUM SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 69884 phv00069884.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:35:44+00:00 2018-09-26 14:35:44+00:00 VB FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT +74 Medication/supplement use 68272 phv00068272.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:35:44+00:00 2018-09-26 14:35:44+00:00 VB FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT +74 Medication/supplement use 68840 phv00068840.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:35:44+00:00 2018-09-26 14:35:44+00:00 VB FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT +74 Medication/supplement use 156783 phv00156783.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:35:44+00:00 2018-09-26 14:35:44+00:00 VB FFQ: TAKE VIT B-COMPLEX SUPPLEMENT +74 Medication/supplement use 157416 phv00157416.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:35:44+00:00 2018-09-26 14:35:44+00:00 VB FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT +74 Medication/supplement use 157893 phv00157893.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:35:44+00:00 2018-09-26 14:35:44+00:00 VB FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT +74 Medication/supplement use 158210 phv00158210.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:35:44+00:00 2018-09-26 14:35:44+00:00 VB FFQ: TAKE VITAMIN B-COMPLEX SUPPLEMENT +74 Medication/supplement use 162143 phv00162143.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:35:44+00:00 2018-09-26 14:35:44+00:00 VB FFQ: TAKE VIT B-COMPLEX SUPPLEMENT +74 Medication/supplement use 69876 phv00069876.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZN FFQ: TAKE ZINC SUPPLEMENT +74 Medication/supplement use 69877 phv00069877.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZNDUR FFQ: ZINC SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 69878 phv00069878.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZND FFQ: ZINC SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68264 phv00068264.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZN FFQ: TAKE ZINC SUPPLEMENT +74 Medication/supplement use 68265 phv00068265.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZNDUR FFQ: ZINC SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68266 phv00068266.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZND FFQ: ZINC SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68832 phv00068832.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZN FFQ: TAKE ZINC SUPPLEMENT +74 Medication/supplement use 68833 phv00068833.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZNDUR FFQ: ZINC SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 68834 phv00068834.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZND FFQ: ZINC SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 156775 phv00156775.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZN FFQ: TAKE ZINC SUPPLEMENT +74 Medication/supplement use 156776 phv00156776.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZNDUR FFQ: ZINC SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 156777 phv00156777.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZND FFQ: ZINC SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157409 phv00157409.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZN FFQ: TAKE ZINC SUPPLEMENT +74 Medication/supplement use 157410 phv00157410.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZNDUR FFQ: ZINC SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157411 phv00157411.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZND FFQ: ZINC SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157885 phv00157885.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZN FFQ: TAKE ZINC SUPPLEMENT +74 Medication/supplement use 157886 phv00157886.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZNDUR FFQ: ZINC SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 157887 phv00157887.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZND FFQ: ZINC SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 158202 phv00158202.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZN FFQ: TAKE ZINC SUPPLEMENT +74 Medication/supplement use 158203 phv00158203.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZNDUR FFQ: ZINC SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 158204 phv00158204.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZND FFQ: ZINC SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 162135 phv00162135.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZN FFQ: TAKE ZINC SUPPLEMENT +74 Medication/supplement use 162136 phv00162136.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 zndur FFQ: ZINC SUPPLEMENT YEARS OF DURATION +74 Medication/supplement use 162137 phv00162137.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:39:48+00:00 2018-09-26 14:39:48+00:00 ZND FFQ: ZINC SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 69860 phv00069860.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:44:28+00:00 2018-09-26 14:44:28+00:00 AD FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68248 phv00068248.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:44:28+00:00 2018-09-26 14:44:28+00:00 AD FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68816 phv00068816.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:44:28+00:00 2018-09-26 14:44:28+00:00 AD FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 156759 phv00156759.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:44:28+00:00 2018-09-26 14:44:28+00:00 AD FFQ: VIT A SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157393 phv00157393.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:44:28+00:00 2018-09-26 14:44:28+00:00 AD FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157869 phv00157869.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:44:28+00:00 2018-09-26 14:44:28+00:00 AD FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 158186 phv00158186.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:44:28+00:00 2018-09-26 14:44:28+00:00 AD FFQ: VITAMIN A SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 162119 phv00162119.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:44:28+00:00 2018-09-26 14:44:28+00:00 AD FFQ: VIT A SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 69864 phv00069864.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:49:53+00:00 2018-09-26 14:49:53+00:00 B6 FFQ: TAKE VITAMIN B6 SUPPLEMENT +74 Medication/supplement use 68252 phv00068252.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:49:53+00:00 2018-09-26 14:49:53+00:00 B6 FFQ: TAKE VITAMIN B6 SUPPLEMENT +74 Medication/supplement use 68820 phv00068820.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:49:53+00:00 2018-09-26 14:49:53+00:00 B6 FFQ: TAKE VITAMIN B6 SUPPLEMENT +74 Medication/supplement use 156763 phv00156763.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:49:53+00:00 2018-09-26 14:49:53+00:00 B6 FFQ: TAKE VIT B6 SUPPLEMENT +74 Medication/supplement use 157397 phv00157397.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:49:53+00:00 2018-09-26 14:49:53+00:00 B6 FFQ: TAKE VITAMIN B6 SUPPLEMENT +74 Medication/supplement use 157873 phv00157873.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:49:53+00:00 2018-09-26 14:49:53+00:00 B6 FFQ: TAKE VITAMIN B6 SUPPLEMENT +74 Medication/supplement use 158190 phv00158190.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:49:53+00:00 2018-09-26 14:49:53+00:00 B6 FFQ: TAKE VITAMIN B6 SUPPLEMENT +74 Medication/supplement use 162123 phv00162123.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:49:53+00:00 2018-09-26 14:49:53+00:00 B6 FFQ: TAKE VIT B6 SUPPLEMENT +74 Medication/supplement use 69863 phv00069863.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:53:13+00:00 2018-09-26 14:53:13+00:00 CD FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68251 phv00068251.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:53:13+00:00 2018-09-26 14:53:13+00:00 CD FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68819 phv00068819.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:53:13+00:00 2018-09-26 14:53:13+00:00 CD FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 156762 phv00156762.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:53:13+00:00 2018-09-26 14:53:13+00:00 CD FFQ: VIT C SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157396 phv00157396.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:53:13+00:00 2018-09-26 14:53:13+00:00 CD FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157872 phv00157872.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:53:13+00:00 2018-09-26 14:53:13+00:00 CD FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 158189 phv00158189.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:53:13+00:00 2018-09-26 14:53:13+00:00 CD FFQ: VITAMIN C SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 162122 phv00162122.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:53:13+00:00 2018-09-26 14:53:13+00:00 CD FFQ: VIT C SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 69888 phv00069888.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:54:20+00:00 2018-09-26 14:54:20+00:00 CU FFQ: TAKE COPPER SUPPLEMENT +74 Medication/supplement use 68276 phv00068276.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:54:20+00:00 2018-09-26 14:54:20+00:00 CU FFQ: TAKE COPPER SUPPLEMENT +74 Medication/supplement use 68844 phv00068844.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:54:20+00:00 2018-09-26 14:54:20+00:00 CU FFQ: TAKE COPPER SUPPLEMENT +74 Medication/supplement use 156787 phv00156787.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:54:20+00:00 2018-09-26 14:54:20+00:00 CU FFQ: TAKE COPPER SUPPLEMENT +74 Medication/supplement use 157420 phv00157420.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:54:20+00:00 2018-09-26 14:54:20+00:00 CU FFQ: TAKE COPPER SUPPLEMENT +74 Medication/supplement use 157897 phv00157897.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:54:20+00:00 2018-09-26 14:54:20+00:00 CU FFQ: TAKE COPPER SUPPLEMENT +74 Medication/supplement use 158214 phv00158214.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:54:20+00:00 2018-09-26 14:54:20+00:00 CU FFQ: TAKE COPPER SUPPLEMENT +74 Medication/supplement use 162147 phv00162147.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:54:20+00:00 2018-09-26 14:54:20+00:00 CU FFQ: TAKE COPPER SUPPLEMENT +74 Medication/supplement use 69869 phv00069869.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:55:45+00:00 2018-09-26 14:55:45+00:00 ED FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68257 phv00068257.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:55:45+00:00 2018-09-26 14:55:45+00:00 ED FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 68825 phv00068825.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:55:45+00:00 2018-09-26 14:55:45+00:00 ED FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 156768 phv00156768.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:55:46+00:00 2018-09-26 14:55:46+00:00 ED FFQ: VIT E SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157402 phv00157402.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:55:46+00:00 2018-09-26 14:55:46+00:00 ED FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 157878 phv00157878.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:55:46+00:00 2018-09-26 14:55:46+00:00 ED FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 158195 phv00158195.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:55:46+00:00 2018-09-26 14:55:46+00:00 ED FFQ: VITAMIN E SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 162128 phv00162128.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:55:46+00:00 2018-09-26 14:55:46+00:00 ED FFQ: VIT E SUPPLEMENT DOSE PER DAY +74 Medication/supplement use 69858 phv00069858.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:57:13+00:00 2018-09-26 14:57:13+00:00 A FFQ: TAKE VITAMIN A SUPPLEMENT +74 Medication/supplement use 69861 phv00069861.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:59:31+00:00 2018-09-26 14:59:31+00:00 C FFQ: TAKE VITAMIN C SUPPLEMENT +74 Medication/supplement use 69879 phv00069879.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 14:59:51+00:00 2018-09-26 14:59:51+00:00 CA FFQ: TAKE CALCIUM SUPPLEMENT +74 Medication/supplement use 69883 phv00069883.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:00:48+00:00 2018-09-26 15:00:48+00:00 D FFQ: TAKE VITAMIN D SUPPLEMENT +74 Medication/supplement use 69867 phv00069867.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:01:02+00:00 2018-09-26 15:01:02+00:00 E FFQ: TAKE VITAMIN E SUPPLEMENT +74 Medication/supplement use 69882 phv00069882.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:01:20+00:00 2018-09-26 15:01:20+00:00 FA FFQ: TAKE FOLIC ACID SUPPLEMENT +74 Medication/supplement use 69873 phv00069873.v4.p10 pht000680.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:01:33+00:00 2018-09-26 15:01:33+00:00 FE FFQ: TAKE IRON SUPPLEMENT +74 Medication/supplement use 157391 phv00157391.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:03:42+00:00 2018-09-26 15:03:42+00:00 A FFQ: TAKE VITAMIN A SUPPLEMENT +74 Medication/supplement use 157394 phv00157394.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:03:56+00:00 2018-09-26 15:03:56+00:00 C FFQ: TAKE VITAMIN C SUPPLEMENT +74 Medication/supplement use 157736 phv00157736.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:04:06+00:00 2018-09-26 15:04:06+00:00 CA FFQ: TAKE CALCIUM SUPPLEMENT +74 Medication/supplement use 157415 phv00157415.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:04:24+00:00 2018-09-26 15:04:24+00:00 D FFQ: TAKE VITAMIN D SUPPLEMENT +74 Medication/supplement use 157400 phv00157400.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:04:34+00:00 2018-09-26 15:04:34+00:00 E FFQ: TAKE VITAMIN E SUPPLEMENT +74 Medication/supplement use 157414 phv00157414.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:04:46+00:00 2018-09-26 15:04:46+00:00 FA FFQ: TAKE FOLIC ACID SUPPLEMENT +74 Medication/supplement use 157406 phv00157406.v1.p10 pht002151.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:04:58+00:00 2018-09-26 15:04:58+00:00 FE FFQ: TAKE IRON SUPPLEMENT +74 Medication/supplement use 157867 phv00157867.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:06:44+00:00 2018-09-26 15:06:44+00:00 A FFQ: TAKE VITAMIN A SUPPLEMENT +74 Medication/supplement use 157870 phv00157870.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:07:02+00:00 2018-09-26 15:07:02+00:00 C FFQ: TAKE VITAMIN C SUPPLEMENT +74 Medication/supplement use 157888 phv00157888.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:07:13+00:00 2018-09-26 15:07:13+00:00 CA FFQ: TAKE CALCIUM SUPPLEMENT +74 Medication/supplement use 157892 phv00157892.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:07:31+00:00 2018-09-26 15:07:31+00:00 D FFQ: TAKE VITAMIN D SUPPLEMENT +74 Medication/supplement use 157876 phv00157876.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:07:43+00:00 2018-09-26 15:07:43+00:00 E FFQ: TAKE VITAMIN E SUPPLEMENT +74 Medication/supplement use 157891 phv00157891.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:07:57+00:00 2018-09-26 15:07:57+00:00 FA FFQ: TAKE FOLIC ACID SUPPLEMENT +74 Medication/supplement use 157882 phv00157882.v1.p10 pht002152.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:08:09+00:00 2018-09-26 15:08:09+00:00 FE FFQ: TAKE IRON SUPPLEMENT +74 Medication/supplement use 158184 phv00158184.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:09:54+00:00 2018-09-26 15:09:54+00:00 A FFQ: TAKE VITAMIN A SUPPLEMENT +74 Medication/supplement use 158187 phv00158187.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:10:10+00:00 2018-09-26 15:10:10+00:00 C FFQ: TAKE VITAMIN C SUPPLEMENT +74 Medication/supplement use 158205 phv00158205.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:10:26+00:00 2018-09-26 15:10:26+00:00 CA FFQ: TAKE CALCIUM SUPPLEMENT +74 Medication/supplement use 158209 phv00158209.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:10:51+00:00 2018-09-26 15:10:51+00:00 D FFQ: TAKE VITAMIN D SUPPLEMENT +74 Medication/supplement use 158193 phv00158193.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:11:04+00:00 2018-09-26 15:11:04+00:00 E FFQ: TAKE VITAMIN E SUPPLEMENT +74 Medication/supplement use 158208 phv00158208.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:11:19+00:00 2018-09-26 15:11:19+00:00 FA FFQ: TAKE FOLIC ACID SUPPLEMENT +74 Medication/supplement use 158199 phv00158199.v1.p10 pht002153.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:11:31+00:00 2018-09-26 15:11:31+00:00 FE FFQ: TAKE IRON SUPPLEMENT +74 Medication/supplement use 68246 phv00068246.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:15:39+00:00 2018-09-26 15:15:39+00:00 A FFQ: TAKE VITAMIN A SUPPLEMENT +74 Medication/supplement use 68249 phv00068249.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:15:53+00:00 2018-09-26 15:15:53+00:00 C FFQ: TAKE VITAMIN C SUPPLEMENT +74 Medication/supplement use 68267 phv00068267.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:16:04+00:00 2018-09-26 15:16:04+00:00 CA FFQ: TAKE CALCIUM SUPPLEMENT +74 Medication/supplement use 68271 phv00068271.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:16:24+00:00 2018-09-26 15:16:24+00:00 D FFQ: TAKE VITAMIN D SUPPLEMENT +74 Medication/supplement use 68255 phv00068255.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:17:04+00:00 2018-09-26 15:17:04+00:00 E FFQ: TAKE VITAMIN E SUPPLEMENT +74 Medication/supplement use 68270 phv00068270.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:17:16+00:00 2018-09-26 15:17:16+00:00 FA FFQ: TAKE FOLIC ACID SUPPLEMENT +74 Medication/supplement use 68261 phv00068261.v4.p10 pht000681.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:17:28+00:00 2018-09-26 15:17:28+00:00 FE FFQ: TAKE IRON SUPPLEMENT +74 Medication/supplement use 68814 phv00068814.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:19:20+00:00 2018-09-26 15:19:20+00:00 A FFQ: TAKE VITAMIN A SUPPLEMENT +74 Medication/supplement use 68817 phv00068817.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:19:43+00:00 2018-09-26 15:19:43+00:00 C FFQ: TAKE VITAMIN C SUPPLEMENT +74 Medication/supplement use 68835 phv00068835.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:19:56+00:00 2018-09-26 15:19:56+00:00 CA FFQ: TAKE CALCIUM SUPPLEMENT +74 Medication/supplement use 68839 phv00068839.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:20:11+00:00 2018-09-26 15:20:11+00:00 D FFQ: TAKE VITAMIN D SUPPLEMENT +74 Medication/supplement use 68823 phv00068823.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:20:22+00:00 2018-09-26 15:20:22+00:00 E FFQ: TAKE VITAMIN E SUPPLEMENT +74 Medication/supplement use 68838 phv00068838.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:20:36+00:00 2018-09-26 15:20:36+00:00 FA FFQ: TAKE FOLIC ACID SUPPLEMENT +74 Medication/supplement use 68829 phv00068829.v4.p10 pht000682.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:20:46+00:00 2018-09-26 15:20:46+00:00 FE FFQ: TAKE IRON SUPPLEMENT +74 Medication/supplement use 156757 phv00156757.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:22:46+00:00 2018-09-26 15:22:46+00:00 A FFQ: TAKE VIT A SUPPLEMENT +74 Medication/supplement use 156760 phv00156760.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:23:06+00:00 2018-09-26 15:23:06+00:00 C FFQ: TAKE VIT C SUPPLEMENT +74 Medication/supplement use 156778 phv00156778.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:23:18+00:00 2018-09-26 15:23:18+00:00 CA FFQ: TAKE CALCIUM SUPPLEMENT +74 Medication/supplement use 156782 phv00156782.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:23:37+00:00 2018-09-26 15:23:37+00:00 D FFQ: TAKE VIT D SUPPLEMENT +74 Medication/supplement use 156766 phv00156766.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:23:48+00:00 2018-09-26 15:23:48+00:00 E FFQ: TAKE VIT E SUPPLEMENT +74 Medication/supplement use 156781 phv00156781.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:24:00+00:00 2018-09-26 15:24:00+00:00 FA FFQ: TAKE FOLIC ACID SUPPLEMENT +74 Medication/supplement use 156772 phv00156772.v2.p10 pht002150.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:24:11+00:00 2018-09-26 15:24:11+00:00 FE FFQ: TAKE IRON SUPPLEMENT +74 Medication/supplement use 162117 phv00162117.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:26:40+00:00 2018-09-26 15:26:40+00:00 A FFQ: TAKE VIT A SUPPLEMENT +74 Medication/supplement use 162120 phv00162120.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:26:56+00:00 2018-09-26 15:26:56+00:00 C FFQ: TAKE VIT C SUPPLEMENT +74 Medication/supplement use 162138 phv00162138.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:27:09+00:00 2018-09-26 15:27:09+00:00 CA FFQ: TAKE CALCIUM SUPPLEMENT +74 Medication/supplement use 162142 phv00162142.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:27:26+00:00 2018-09-26 15:27:26+00:00 D FFQ: TAKE VIT D SUPPLEMENT +74 Medication/supplement use 162126 phv00162126.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:27:40+00:00 2018-09-26 15:27:40+00:00 E FFQ: TAKE VIT E SUPPLEMENT +74 Medication/supplement use 162141 phv00162141.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:27:53+00:00 2018-09-26 15:27:53+00:00 FA FFQ: TAKE FOLIC ACID SUPPLEMENT +74 Medication/supplement use 162132 phv00162132.v4.p10 pht002350.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:28:04+00:00 2018-09-26 15:28:04+00:00 FE FFQ: TAKE IRON SUPPLEMENT +74 Medication/supplement use 172407 phv00172407.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:32:45+00:00 2018-09-26 15:32:45+00:00 Q_AD FFQ: Vitamin A supplement dose per day +74 Medication/supplement use 172428 phv00172428.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:33:31+00:00 2018-09-26 15:33:31+00:00 Q_B12 FFQ: Take vitamin B12 supplement +74 Medication/supplement use 172412 phv00172412.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:33:55+00:00 2018-09-26 15:33:55+00:00 Q_B6 FFQ: Take vitamin B6 supplement +74 Medication/supplement use 172413 phv00172413.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:34:13+00:00 2018-09-26 15:34:13+00:00 Q_B6D FFQ: Vitamin B6 supplement dose per day +74 Medication/supplement use 172431 phv00172431.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:34:57+00:00 2018-09-26 15:34:57+00:00 Q_BCAR FFQ: Take beta-carotene supplement +74 Medication/supplement use 172440 phv00172440.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:35:11+00:00 2018-09-26 15:35:11+00:00 Q_BCOMPL FFQ: Take B-complex supplement +74 Medication/supplement use 172418 phv00172418.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:35:54+00:00 2018-09-26 15:35:54+00:00 Q_CAD FFQ: Calcium supplement dose per day +74 Medication/supplement use 172417 phv00172417.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:36:06+00:00 2018-09-26 15:36:06+00:00 Q_CALCIUM FFQ: Take calcium supplement +74 Medication/supplement use 172411 phv00172411.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:36:18+00:00 2018-09-26 15:36:18+00:00 Q_CD FFQ: Vitamin C supplement dose per day +74 Medication/supplement use 172438 phv00172438.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:36:33+00:00 2018-09-26 15:36:33+00:00 Q_CHOL FFQ: Take choline supplement +74 Medication/supplement use 172427 phv00172427.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:36:52+00:00 2018-09-26 15:36:52+00:00 Q_COD_LIV_OIL FFQ: Take cod liver oil supplement +74 Medication/supplement use 172437 phv00172437.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:37:07+00:00 2018-09-26 15:37:07+00:00 Q_COQ10 FFQ: Take coenzyme Q10 supplement +74 Medication/supplement use 172435 phv00172435.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:37:24+00:00 2018-09-26 15:37:24+00:00 Q_CR FFQ: Take chromium supplement +74 Medication/supplement use 172442 phv00172442.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:38:02+00:00 2018-09-26 15:38:02+00:00 Q_DHEA FFQ: Take DHEA supplement +74 Medication/supplement use 172415 phv00172415.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:38:34+00:00 2018-09-26 15:38:34+00:00 Q_ED FFQ: Vitamin E supplement dose per day +74 Medication/supplement use 172416 phv00172416.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:38:43+00:00 2018-09-26 15:38:43+00:00 Q_ETYPE FFQ: Type of vitamin E supplement +74 Medication/supplement use 172430 phv00172430.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:39:17+00:00 2018-09-26 15:39:17+00:00 Q_FLAX FFQ: Take flax seed supplement +74 Medication/supplement use 172439 phv00172439.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:39:27+00:00 2018-09-26 15:39:27+00:00 Q_FOLIC_ACID FFQ: Take folic acid supplement +74 Medication/supplement use 172443 phv00172443.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:39:57+00:00 2018-09-26 15:39:57+00:00 Q_IRON FFQ: Take iron supplement +74 Medication/supplement use 172429 phv00172429.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:40:19+00:00 2018-09-26 15:40:19+00:00 Q_LINSEED FFQ: Take flax seed oil supplement +74 Medication/supplement use 172436 phv00172436.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:40:35+00:00 2018-09-26 15:40:35+00:00 Q_LECITHIN FFQ: Take lecithin supplement +74 Medication/supplement use 172441 phv00172441.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:40:47+00:00 2018-09-26 15:40:47+00:00 Q_LYCO FFQ: Take lycopene supplement +74 Medication/supplement use 172432 phv00172432.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:41:29+00:00 2018-09-26 15:41:29+00:00 Q_MAGNESIUM FFQ: Take magnesium supplement +74 Medication/supplement use 172426 phv00172426.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:41:40+00:00 2018-09-26 15:41:40+00:00 Q_METAMUCIL FFQ: Take Metamucil/Citrucel supplement +74 Medication/supplement use 172434 phv00172434.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:42:09+00:00 2018-09-26 15:42:09+00:00 Q_NIACIN2 FFQ: Take niacin supplement +74 Medication/supplement use 172433 phv00172433.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:42:42+00:00 2018-09-26 15:42:42+00:00 Q_OMEGA_3_EPA FFQ: Take fish oil supplement +74 Medication/supplement use 172444 phv00172444.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:43:04+00:00 2018-09-26 15:43:04+00:00 Q_OTHERS FFQ: Take other supplement +74 Medication/supplement use 172419 phv00172419.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:43:32+00:00 2018-09-26 15:43:32+00:00 Q_SEL FFQ: Take selenium supplement +74 Medication/supplement use 172420 phv00172420.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:43:40+00:00 2018-09-26 15:43:40+00:00 Q_SELD FFQ: Selenium supplement dose per day +74 Medication/supplement use 172406 phv00172406.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:44:28+00:00 2018-09-26 15:44:28+00:00 Q_VITAMIN_A FFQ: Take vitamin A supplement +74 Medication/supplement use 172408 phv00172408.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:44:36+00:00 2018-09-26 15:44:36+00:00 Q_VITAMIN_K FFQ: Take potassium supplement +74 Medication/supplement use 172410 phv00172410.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:44:43+00:00 2018-09-26 15:44:43+00:00 Q_VITAMIN_C FFQ: Take vitamin C supplement +74 Medication/supplement use 172414 phv00172414.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:44:51+00:00 2018-09-26 15:44:51+00:00 Q_VITAMIN_E FFQ: Take vitamin E supplement +74 Medication/supplement use 172421 phv00172421.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:45:00+00:00 2018-09-26 15:45:00+00:00 Q_VITAMIN_D FFQ: Take vitamin D supplement +74 Medication/supplement use 172422 phv00172422.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:45:09+00:00 2018-09-26 15:45:09+00:00 Q_VITDD FFQ: Vitamin D supplement dose per day +74 Medication/supplement use 172423 phv00172423.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:45:42+00:00 2018-09-26 15:45:42+00:00 Q_ZINC FFQ: Take zinc supplement +74 Medication/supplement use 172424 phv00172424.v1.p10 pht002900.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:45:51+00:00 2018-09-26 15:45:51+00:00 Q_ZND FFQ: Zinc supplement dose per day +74 Medication/supplement use 36444 phv00036444.v5.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:54:40+00:00 2018-09-26 15:54:40+00:00 EST1 Current estrogen user at exam 1 +74 Medication/supplement use 70740 phv00070740.v3.p10 pht000693.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:54:50+00:00 2018-09-26 15:54:50+00:00 EST1 Estrogen Use At Exam 1 +74 Medication/supplement use 276932 phv00276932.v1.p10 pht006020.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:54:57+00:00 2018-09-26 15:54:57+00:00 EST1 Estrogen use at Exam 1 Collection Interval: Cumulative through Exam 2 +74 Medication/supplement use 276943 phv00276943.v1.p10 pht006021.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:55:06+00:00 2018-09-26 15:55:06+00:00 EST1 Estrogen use at Exam 1 Collection Interval: Cumulative through Exam 2 +74 Medication/supplement use 276954 phv00276954.v1.p10 pht006022.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:55:15+00:00 2018-09-26 15:55:15+00:00 EST1 Estrogen use at Exam 1 Collection Interval: Cases reviewed through Exam 3 +74 Medication/supplement use 36445 phv00036445.v5.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:57:11+00:00 2018-09-26 15:57:11+00:00 EST2 Current estrogen user at exam 2 +74 Medication/supplement use 172149 phv00172149.v1.p10 pht000693.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:57:11+00:00 2018-09-26 15:57:11+00:00 EST2 Estrogen Use At Exam 2 +74 Medication/supplement use 276933 phv00276933.v1.p10 pht006020.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:57:11+00:00 2018-09-26 15:57:11+00:00 EST2 Estrogen use at Exam 2 Collection Interval: Cumulative through Exam 2 +74 Medication/supplement use 276944 phv00276944.v1.p10 pht006021.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:57:11+00:00 2018-09-26 15:57:11+00:00 EST2 Estrogen use at Exam 2 Collection Interval: Cumulative through Exam 2 +74 Medication/supplement use 276955 phv00276955.v1.p10 pht006022.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:57:11+00:00 2018-09-26 15:57:11+00:00 EST2 Estrogen use at Exam 2 Collection Interval: Cases reviewed through Exam 3 +74 Medication/supplement use 36446 phv00036446.v6.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:57:58+00:00 2018-09-26 15:57:58+00:00 EST3 Current estrogen user at exam 3 +74 Medication/supplement use 276956 phv00276956.v1.p10 pht006022.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:57:58+00:00 2018-09-26 15:57:58+00:00 EST3 Estrogen use at Exam 3 Collection Interval: Cases reviewed through Exam 3 +74 Medication/supplement use 36443 phv00036443.v6.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:59:29+00:00 2018-09-26 15:59:29+00:00 EST7 Current estrogen user at exam 7 +74 Medication/supplement use 36447 phv00036447.v6.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:59:29+00:00 2018-09-26 15:59:29+00:00 EST4 Current estrogen user at exam 4 +74 Medication/supplement use 36448 phv00036448.v6.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:59:29+00:00 2018-09-26 15:59:29+00:00 EST5 Current estrogen user at exam 5 +74 Medication/supplement use 36449 phv00036449.v6.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:59:29+00:00 2018-09-26 15:59:29+00:00 EST6 Current estrogen user at exam 6 +74 Medication/supplement use 76390 phv00076390.v4.p10 pht000307.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 15:59:29+00:00 2018-09-26 15:59:29+00:00 EST8 Current estrogen user at exam 8 +74 Medication/supplement use 172150 phv00172150.v1.p10 pht000693.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM1 Selective Estrogen Receptor Modulator Use At Exam 1 +74 Medication/supplement use 172151 phv00172151.v1.p10 pht000693.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM2 Selective Estrogen Receptor Modulator Use At Exam 2 +74 Medication/supplement use 276934 phv00276934.v1.p10 pht006020.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM1 Selective Estrogen Receptor Modulators (SERMS) use at Exam 1 Collection Interval: Cumulative through Exam 2 +74 Medication/supplement use 276935 phv00276935.v1.p10 pht006020.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM2 Selective Estrogen Receptor Modulators (SERMs) use at Exam 2 Collection Interval: Cumulative through Exam 2 +74 Medication/supplement use 276945 phv00276945.v1.p10 pht006021.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM1 Selective Estrogen Receptor Modulators (SERMs) use at Exam 1 Collection Interval: Cumulative through Exam 2 +74 Medication/supplement use 276946 phv00276946.v1.p10 pht006021.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM2 Selective Estrogen Receptor Modulators (SERMs) use at Exam 2 Collection Interval: Cumulative through Exam 2 +74 Medication/supplement use 276957 phv00276957.v1.p10 pht006022.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM1 Selective Estrogen Receptor Modulators (SERMs) use at Exam 1 Collection Interval: Cases reviewed through Exam 3 +74 Medication/supplement use 276958 phv00276958.v1.p10 pht006022.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM2 Selective Estrogen Receptor Modulators (SERMs) use at Exam 2 Collection Interval: Cases reviewed through Exam 3 +74 Medication/supplement use 276959 phv00276959.v1.p10 pht006022.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:00:57+00:00 2018-09-26 17:00:57+00:00 SERM3 Selective Estrogen Receptor Modulators (SERMs) use at Exam 3 Collection Interval: Cases reviewed through Exam 3 +74 Medication/supplement use 22717 phv00022717.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:02:11+00:00 2018-09-26 17:02:11+00:00 RQ016 CURRENTLY TAKING ANY MEDICINES (INC. INHALERS, AEROSOLS, OR TABLETS) FOR ASTHMA +74 Medication/supplement use 22724 phv00022724.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:02:11+00:00 2018-09-26 17:02:11+00:00 RQ023 CURRENTLY TAKING ANY STEROID MEDICATIONS +74 Medication/supplement use 22725 phv00022725.v5.p10 pht000107.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:02:11+00:00 2018-09-26 17:02:11+00:00 RQ024 IF TAKING ANY STEROID MEDICATIONS, BY WHAT ROUTE (IF TAKEN BY MORE THAN ONE ROUTE, HIERARCHY OF ROUTES IS INJECTED, ORAL, INHALED, NASAL, SKIN...) +74 Medication/supplement use 55377 phv00055377.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:04:31+00:00 2018-09-26 17:04:31+00:00 ACE1 Ace inhibitors +74 Medication/supplement use 22770 phv00022770.v5.p10 pht000110.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:05:21+00:00 2018-09-26 17:05:21+00:00 E2 ESTROGEN (PG/ML) +74 Medication/supplement use 56924 phv00056924.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:07:45+00:00 2018-09-26 17:07:45+00:00 A2A2 Angiotensin type 2 antagonists +74 Medication/supplement use 55378 phv00055378.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:08:32+00:00 2018-09-26 17:08:32+00:00 ACED1 Ace inhibitors and diuretics +74 Medication/supplement use 56926 phv00056926.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:08:32+00:00 2018-09-26 17:08:32+00:00 ACE2 ACE inhibitors without diuretics +74 Medication/supplement use 56927 phv00056927.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:08:32+00:00 2018-09-26 17:08:32+00:00 ACED2 ACE inhibitors with diuretics +74 Medication/supplement use 56928 phv00056928.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:09:06+00:00 2018-09-26 17:09:06+00:00 ADPI2 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 55342 phv00055342.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ANAR1A1 Anti-arrhythmics, class 1A +74 Medication/supplement use 55363 phv00055363.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ALPHA1 Alpha-blockers w/o diuretics +74 Medication/supplement use 55364 phv00055364.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ALPHAD1 Alpha-blockers with diuretics +74 Medication/supplement use 55365 phv00055365.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ANAR1B1 Anti-arrhythmics, class 1b +74 Medication/supplement use 55366 phv00055366.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ANAR1C1 Anti-arrhythmics, class 1c +74 Medication/supplement use 55367 phv00055367.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ANAR31 Anti-arrhythmics, class 3 +74 Medication/supplement use 56929 phv00056929.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 AGDI2 Alpha-glucosidase inhibitors +74 Medication/supplement use 56930 phv00056930.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ALPHA2 Alpha-blockers without diuretics +74 Medication/supplement use 56931 phv00056931.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ALPHAD2 Alpha-blockers with diuretics +74 Medication/supplement use 56932 phv00056932.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ALZH2 Acetylcholine esterase inhibitors for alzh's +74 Medication/supplement use 56933 phv00056933.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 AMLOD2 Amlodipine +74 Medication/supplement use 56934 phv00056934.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ANAR1A2 Anti-arrhythmics, class 1A +74 Medication/supplement use 56935 phv00056935.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ANAR1B2 Anti-arrhythmics, class 1B +74 Medication/supplement use 56936 phv00056936.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ANAR1C2 Anti-arrhythmics, class 1C +74 Medication/supplement use 56937 phv00056937.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:11:46+00:00 2018-09-26 17:11:46+00:00 ANAR32 Anti-arrhythmics, class 3 +74 Medication/supplement use 55321 phv00055321.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 ASA15 In last two weeks, did you take any aspirin or aspirin containing meds? +74 Medication/supplement use 55322 phv00055322.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 ASALW15 How many days did you take aspirin or aspirin containing meds in last week? +74 Medication/supplement use 55350 phv00055350.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 ANTPSY1 Anti-psychotic +74 Medication/supplement use 55351 phv00055351.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 ASA1 Aspirin (anti-inflam agents) +74 Medication/supplement use 55353 phv00055353.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 BENZOD1 Benzodiazepines +74 Medication/supplement use 55369 phv00055369.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 BASQ1 Bile-acid sequestrants +74 Medication/supplement use 55374 phv00055374.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 BETA1 Beta blockers +74 Medication/supplement use 55375 phv00055375.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 BETAD1 Beta blockers and diuretics +74 Medication/supplement use 56702 phv00056702.v2.p10 pht000396.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 aspirin How often aspirin or aspirin-containing meds is taken +74 Medication/supplement use 56938 phv00056938.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 APSY2 Anti-psychotic medications +74 Medication/supplement use 56939 phv00056939.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 ASA2 Aspirin from 280804 (anti-inflam agents) +74 Medication/supplement use 56940 phv00056940.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 BASQ2 Bile-acid sequestrants +74 Medication/supplement use 56941 phv00056941.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 BENZOD2 Benzodiazepines +74 Medication/supplement use 56942 phv00056942.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 BETA2 Beta-blockers without diuretics +74 Medication/supplement use 56943 phv00056943.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:14:57+00:00 2018-09-26 17:14:57+00:00 BETAD2 Beta-blockers with diuretics +74 Medication/supplement use 55361 phv00055361.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 CCBIR1 All immediate-release CCB +74 Medication/supplement use 55362 phv00055362.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 CCBSR1 All slow-release CCB +74 Medication/supplement use 55376 phv00055376.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 CCB1 Any calcium channel blocker +74 Medication/supplement use 55382 phv00055382.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 DIG1 Digitalis +74 Medication/supplement use 56701 phv00056701.v2.p10 pht000396.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 bpmeds Treated for high blood pressure with meds since sleep study +74 Medication/supplement use 56944 phv00056944.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 BGND2 Biguanides +74 Medication/supplement use 56945 phv00056945.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 CCB2 Any calcium-channel blocker = CCIR or CCBSR or CCBT +74 Medication/supplement use 56946 phv00056946.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 CCBIR2 Immediate-release CCBS = NFIR or DIHIR or VERIR or DLTIR +74 Medication/supplement use 56947 phv00056947.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 CCBSR2 Slow-release CCBS = NIFSR or DIHSR or VERSR or DLTSR or AMLOD +74 Medication/supplement use 56948 phv00056948.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 CCBT2 T-type calcium-channel blocker +74 Medication/supplement use 56949 phv00056949.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 COX22 Cox-2 inhibitors (NSAID agents); separate from NSAID variable +74 Medication/supplement use 56950 phv00056950.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 DIG2 Digitalis preparations +74 Medication/supplement use 56951 phv00056951.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 DIHIR2 Immediate-release dihyroprydines other than nifedipine +74 Medication/supplement use 56952 phv00056952.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 DIHSR2 Slow-release dihydropyridines other than nifedipine or amlodipine +74 Medication/supplement use 56953 phv00056953.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 DLTIR2 Immediate-release diltiazem +74 Medication/supplement use 56954 phv00056954.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:18:17+00:00 2018-09-26 17:18:17+00:00 DLTSR2 Slow-release diltiazem +74 Medication/supplement use 55339 phv00055339.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 ESTRGN1 Estrogens +74 Medication/supplement use 55341 phv00055341.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 HTNMED1 Any hypertension meds +74 Medication/supplement use 55345 phv00055345.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 INSULN1 Insulin +74 Medication/supplement use 55359 phv00055359.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 HCTZ1 Thiazide diuretics w/o k-sparing +74 Medication/supplement use 55360 phv00055360.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 HCTZK1 Thiazide diuretics with k-sparing +74 Medication/supplement use 55372 phv00055372.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 ISTRD1 Inhaled steroids for asthma +74 Medication/supplement use 56788 phv00056788.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 hi202 Aspirin: the last two weeks, did you take any aspirin or aspirin-containing medicines such as Bufferin, Anacin, or Ascriptin +74 Medication/supplement use 56955 phv00056955.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 EDD2 Erectile dysfunction drugs +74 Medication/supplement use 56956 phv00056956.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 ESTRGN2 Estrogens, excluding vaginal creams +74 Medication/supplement use 56957 phv00056957.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 FIBR2 Fibrates +74 Medication/supplement use 56958 phv00056958.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 H2B2 H2 blockers +74 Medication/supplement use 56959 phv00056959.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 HCTZ2 Thiazide diuretics without k-sparing agents +74 Medication/supplement use 56960 phv00056960.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 HCTZK2 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 56961 phv00056961.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 HPRNS2 Heparins +74 Medication/supplement use 56962 phv00056962.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 INSLN2 Insulins +74 Medication/supplement use 56963 phv00056963.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 IPRTR2 Anticholinergics and combination with beta2-agonist +74 Medication/supplement use 56964 phv00056964.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 ISTRD2 Inhaled steroids for asthma +74 Medication/supplement use 57006 phv00057006.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:21:50+00:00 2018-09-26 17:21:50+00:00 HTNMED2 Any antihypertensive medication +74 Medication/supplement use 55343 phv00055343.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 LIPID1 Any lipid lowering med +74 Medication/supplement use 55348 phv00055348.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 MAOI1 Monoamine oxidase inhibitors +74 Medication/supplement use 55358 phv00055358.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 LOOP1 Loop diuretics +74 Medication/supplement use 56965 phv00056965.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 KBLKR2 K-channel blockers to enhance insulin secretion for diabetics +74 Medication/supplement use 56966 phv00056966.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 KCL2 Potassium supplements +74 Medication/supplement use 56967 phv00056967.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 KSPR2 Potassium-sparing agents alone +74 Medication/supplement use 56968 phv00056968.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 LOOP2 Loop diuretics +74 Medication/supplement use 56969 phv00056969.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 MAOI2 MAO inhibitors +74 Medication/supplement use 56970 phv00056970.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 MLPD2 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 57005 phv00057005.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:23:37+00:00 2018-09-26 17:23:37+00:00 LIPID2 Any lipid-lowering medication +74 Medication/supplement use 55324 phv00055324.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NITRO15 MD prescribed nitro in last year? +74 Medication/supplement use 55352 phv00055352.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NSAID1 Non-steroidal anti-inflam (no aspirin) +74 Medication/supplement use 55356 phv00055356.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NTCA1 Non-tricyclic antidepressants +74 Medication/supplement use 55370 phv00055370.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NIAC1 Niacin and nicotinic acid +74 Medication/supplement use 55383 phv00055383.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NTG1 Nitrates +74 Medication/supplement use 56971 phv00056971.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NIAC2 Niacin and nicotinic acid +74 Medication/supplement use 56972 phv00056972.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NIFIR2 Immediate-release nifedipine +74 Medication/supplement use 56973 phv00056973.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NIFSR2 Slow-release nifedipine +74 Medication/supplement use 56974 phv00056974.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NSAID2 Non-steroidal anti-inflammatory agents, excluding aspirin +74 Medication/supplement use 56975 phv00056975.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NTCA2 Non-tricyclic antidepressants other than MAOI +74 Medication/supplement use 56976 phv00056976.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 NTG2 Nitrates +74 Medication/supplement use 56977 phv00056977.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:25:36+00:00 2018-09-26 17:25:36+00:00 OAIA2 Oral anti-inflammatory asthma drugs (leukotriene receptor antagonists and inhibitors of lipo-oxygenase) +74 Medication/supplement use 55340 phv00055340.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PROGST1 Progestins +74 Medication/supplement use 55344 phv00055344.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 OHGA1 Oral hypogycemics +74 Medication/supplement use 55354 phv00055354.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PREMAR1 Premarin +74 Medication/supplement use 55355 phv00055355.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PDEI1 Phosphodiesterase inhibitors +74 Medication/supplement use 55368 phv00055368.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PVDL1 Peripheral vasodilators +74 Medication/supplement use 55373 phv00055373.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 OSTRD1 Oral steroids +74 Medication/supplement use 56978 phv00056978.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 OHGA2 Oral hypoglycemic agents +74 Medication/supplement use 56979 phv00056979.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 OSTRD2 Oral steroids +74 Medication/supplement use 56980 phv00056980.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 OTCH2B2 Over-the-counter h2-blockers +74 Medication/supplement use 56981 phv00056981.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PDEI2 Phosphodiesterase inhibitors +74 Medication/supplement use 56982 phv00056982.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PPI2 Proton pump inhibitors +74 Medication/supplement use 56983 phv00056983.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PRGSTN2 Progestins +74 Medication/supplement use 56984 phv00056984.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PRKNSN2 Drugs to treat parkinson's +74 Medication/supplement use 56985 phv00056985.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PRMRN2 Premarin (conjugated estrogens) +74 Medication/supplement use 56986 phv00056986.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PROB2 Probucol +74 Medication/supplement use 56987 phv00056987.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:28:38+00:00 2018-09-26 17:28:38+00:00 PVDL2 Peripheral vasodilators, exclude dipyridamole +74 Medication/supplement use 55323 phv00055323.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 SLPILL15 Do you take sleeping pills at least 1 day per week? +74 Medication/supplement use 55346 phv00055346.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 SYMPTH1 Sympathomimetic (adrenergic) agents +74 Medication/supplement use 55347 phv00055347.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 TCA1 Tri- and tetra- cyclic anti-depressants +74 Medication/supplement use 55349 phv00055349.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 TCAP1 Drug combination -- tricyclics and anti-psychotic +74 Medication/supplement use 55371 phv00055371.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 THRY1 Thyroid agents +74 Medication/supplement use 55380 phv00055380.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 VASOD1 Vasodilators and diuretics (including alphad) +74 Medication/supplement use 55479 phv00055479.v5.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 TkPill02 How often do you take sleeping pills or other medication to help you sleep? +74 Medication/supplement use 56660 phv00056660.v2.p10 pht000396.v4.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 sleepPills Take sleeping pills or other medication to aid in sleeping +74 Medication/supplement use 56762 phv00056762.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 sh308g Take sleeping pills or other medication to help you sleep (please indicate how often you experience this) +74 Medication/supplement use 56988 phv00056988.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 SLF12 First generation sulfonylureas +74 Medication/supplement use 56989 phv00056989.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 SLF22 Second generation sulfonylureas +74 Medication/supplement use 56990 phv00056990.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 STTN2 HMG COA reducatace inhibitors (statins) +74 Medication/supplement use 56991 phv00056991.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 SYMPTH2 Sympathomimetics, oral and inhaled +74 Medication/supplement use 56992 phv00056992.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 TCA2 Tri-cyclic antidepressants +74 Medication/supplement use 56993 phv00056993.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 TCAP2 Tri-cyclic antidepressants plus anti-psychotics combinations +74 Medication/supplement use 56994 phv00056994.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 THRY2 Thyroid agents +74 Medication/supplement use 56995 phv00056995.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 THZD2 Thiazolidinediones +74 Medication/supplement use 56996 phv00056996.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 URCOS2 Uricosurics +74 Medication/supplement use 56997 phv00056997.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 VASO2 Vasodilators, a mixed group +74 Medication/supplement use 56998 phv00056998.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:33:26+00:00 2018-09-26 17:33:26+00:00 VASOD2 Vasodilators with diuretics, a mixed group +74 Medication/supplement use 55357 phv00055357.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:34:35+00:00 2018-09-26 17:34:35+00:00 WARF1 Oral anticoagulants +74 Medication/supplement use 56999 phv00056999.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:34:35+00:00 2018-09-26 17:34:35+00:00 VERIR2 Immediate-release verapamil +74 Medication/supplement use 57000 phv00057000.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:34:35+00:00 2018-09-26 17:34:35+00:00 VERSR2 Slow-release verapamil +74 Medication/supplement use 57001 phv00057001.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:34:35+00:00 2018-09-26 17:34:35+00:00 WARF2 Oral anticoagulants including warfarin, coumadin, and anisindione +74 Medication/supplement use 57003 phv00057003.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:34:35+00:00 2018-09-26 17:34:35+00:00 XOI2 Xanthine oxidase inhibitors +74 Medication/supplement use 76376 phv00076376.v6.p10 pht000908.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:40:56+00:00 2018-09-26 17:40:56+00:00 ATHROMRX Discharge antithrombotics +74 Medication/supplement use 253890 phv00253890.v1.p10 pht003334.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:41:07+00:00 2018-09-26 17:41:07+00:00 ATHROMRX Discharge antithrombotics Collection Interval: Cases reviewed 1/1949 - 12/2012 +74 Medication/supplement use 76373 phv00076373.v6.p10 pht000908.v7.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:43:06+00:00 2018-09-26 17:43:06+00:00 CARVERRX Cardioversion medications, if CARVER=2 or 4 +74 Medication/supplement use 253896 phv00253896.v1.p10 pht003334.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:43:17+00:00 2018-09-26 17:43:17+00:00 CARVERRX Cardioversion medications, if CARVER=2 or 4 Collection Interval: Cases reviewed 1/1949 - 12/2012 +74 Medication/supplement use 276805 phv00276805.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF076 Discharge medication - ACEI +74 Medication/supplement use 276806 phv00276806.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF077 Discharge medication - Beta Blocker +74 Medication/supplement use 276807 phv00276807.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF078 Discharge medication - Furosemide +74 Medication/supplement use 276808 phv00276808.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF079 Discharge medication - Spironolactone +74 Medication/supplement use 276809 phv00276809.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF080 Discharge medication - Angiotensin Receptor Blocker +74 Medication/supplement use 276810 phv00276810.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF081 Discharge medication - Coumadin +74 Medication/supplement use 276811 phv00276811.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF082 Discharge medication - Hydralazine +74 Medication/supplement use 276812 phv00276812.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF083 Discharge medication - Statin +74 Medication/supplement use 276813 phv00276813.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF084 Discharge medication - Aspirin +74 Medication/supplement use 276814 phv00276814.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF085 Discharge medication - Digitalis +74 Medication/supplement use 276815 phv00276815.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF086 Discharge medication - NSAIDs +74 Medication/supplement use 276871 phv00276871.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF072 COPD, regular bronchodilator or steroid user - not PRN +74 Medication/supplement use 276872 phv00276872.v1.p10 pht006018.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:45:50+00:00 2018-09-26 17:45:50+00:00 CHF073 COPD, PRN user of bronchodilator or steroids +74 Medication/supplement use 66820 phv00066820.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod2 ATC code for second drug in compound +74 Medication/supplement use 66826 phv00066826.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod1 ATC code for medication or first drug in compound +74 Medication/supplement use 66838 phv00066838.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod3 ATC code for third drug in compound +74 Medication/supplement use 73742 phv00073742.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod2 ATC code for second drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73748 phv00073748.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod1 ATC code for medication or first drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73760 phv00073760.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod3 ATC code for third drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73773 phv00073773.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod2 ATC code for second drug in compound +74 Medication/supplement use 73779 phv00073779.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod1 ATC code for medication or first drug in compound +74 Medication/supplement use 73791 phv00073791.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod3 ATC code for third drug in compound +74 Medication/supplement use 177902 phv00177902.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod1 ATC code for medication or first drug in compound (character variable) +74 Medication/supplement use 177903 phv00177903.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod2 ATC code for second drug in compound (character variable) +74 Medication/supplement use 177904 phv00177904.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod3 ATC code for third drug in compound (character variable) +74 Medication/supplement use 227300 phv00227300.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod1 ATC code for medication or first drug in compound (character variable) +74 Medication/supplement use 227301 phv00227301.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod2 ATC code for second drug in compound (character variable) +74 Medication/supplement use 227302 phv00227302.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod3 ATC code for third drug in compound (character variable) +74 Medication/supplement use 257888 phv00257888.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod1 ATC code for medication or first drug in compound (character variable) +74 Medication/supplement use 257889 phv00257889.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod2 ATC code for second drug in compound (character variable) +74 Medication/supplement use 257890 phv00257890.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod3 ATC code for third drug in compound (character variable) +74 Medication/supplement use 257922 phv00257922.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod1 ATC code for medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257923 phv00257923.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod2 ATC code for second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257924 phv00257924.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod3 ATC code for third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276897 phv00276897.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod2 ATC code for second drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276903 phv00276903.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod1 ATC code for medication or first drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276915 phv00276915.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:50:19+00:00 2018-09-26 17:50:19+00:00 atc_cod3 ATC code for third drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66830 phv00066830.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 chem_gp1 Description/Label for chemical subgroup - medication or first drug in compound +74 Medication/supplement use 66839 phv00066839.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 atc_cod4 ATC code for fourth drug in compound +74 Medication/supplement use 73752 phv00073752.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 chem_gp1 Description/Label for chemical subgroup - medication or first drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73761 phv00073761.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 atc_cod4 ATC code for fourth drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73783 phv00073783.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 chem_gp1 Description/Label for chemical subgroup - medication or first drug in compound +74 Medication/supplement use 73792 phv00073792.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 atc_cod4 ATC code for fourth drug in compound +74 Medication/supplement use 177905 phv00177905.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 atc_cod4 ATC code for fourth drug in compound (character variable) +74 Medication/supplement use 177918 phv00177918.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 chem_gp1 Description/label for chemical subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 227303 phv00227303.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 atc_cod4 ATC code for fourth drug in compound (character variable) +74 Medication/supplement use 227316 phv00227316.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 chem_gp1 Description/label for chemical subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 257891 phv00257891.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 atc_cod4 ATC code for fourth drug in compound (character variable) +74 Medication/supplement use 257904 phv00257904.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 chem_gp1 Description/label for chemical subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 257925 phv00257925.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 atc_cod4 ATC code for fourth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257938 phv00257938.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 chem_gp1 Description/label for chemical subgroup - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276907 phv00276907.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 chem_gp1 Description/label for chemical subgroup - medication or first drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276916 phv00276916.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:51:38+00:00 2018-09-26 17:51:38+00:00 atc_cod4 ATC code for fourth drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66824 phv00066824.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp2 Description/Label for chemical subgroup - second drug in compound +74 Medication/supplement use 66843 phv00066843.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp3 Description/Label for chemical subgroup - third drug in compound +74 Medication/supplement use 66848 phv00066848.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp4 Description/Label for chemical subgroup - fourth drug in compound +74 Medication/supplement use 73746 phv00073746.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp2 Description/Label for chemical subgroup - second drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73765 phv00073765.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp3 Description/Label for chemical subgroup - third drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73770 phv00073770.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp4 Description/Label for chemical subgroup - fourth drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73777 phv00073777.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp2 Description/Label for chemical subgroup - second drug in compound +74 Medication/supplement use 73796 phv00073796.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp3 Description/Label for chemical subgroup - third drug in compound +74 Medication/supplement use 73801 phv00073801.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp4 Description/Label for chemical subgroup - fourth drug in compound +74 Medication/supplement use 177919 phv00177919.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp2 Description/label for chemical subgroup - second drug in compound (character variable) +74 Medication/supplement use 177920 phv00177920.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp3 Description/label for chemical subgroup - third drug in compound (character variable) +74 Medication/supplement use 177921 phv00177921.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp4 Description/label for chemical subgroup - forth drug in compound (character variable) +74 Medication/supplement use 227317 phv00227317.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp2 Description/label for chemical subgroup - second drug in compound (character variable) +74 Medication/supplement use 227318 phv00227318.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp3 Description/label for chemical subgroup - third drug in compound (character variable) +74 Medication/supplement use 227319 phv00227319.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp4 Description/label for chemical subgroup - forth drug in compound (character variable) +74 Medication/supplement use 257905 phv00257905.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp2 Description/label for chemical subgroup - second drug in compound (character variable) +74 Medication/supplement use 257906 phv00257906.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp3 Description/label for chemical subgroup - third drug in compound (character variable) +74 Medication/supplement use 257907 phv00257907.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp4 Description/label for chemical subgroup - forth drug in compound (character variable) +74 Medication/supplement use 257939 phv00257939.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp2 Description/label for chemical subgroup - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257940 phv00257940.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp3 Description/label for chemical subgroup - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257941 phv00257941.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp4 Description/label for chemical subgroup - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276901 phv00276901.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp2 Description/label for chemical subgroup - second drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276920 phv00276920.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp3 Description/label for chemical subgroup - third drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276925 phv00276925.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:53:28+00:00 2018-09-26 17:53:28+00:00 chem_gp4 Description/label for chemical subgroup - forth drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66825 phv00066825.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm2 Description/Label for chemical substance - second drug in compound +74 Medication/supplement use 66831 phv00066831.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm1 Description/Label for chemical substance - medication or first drug in compound +74 Medication/supplement use 66844 phv00066844.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm3 Description/Label for chemical substance - third drug in compound +74 Medication/supplement use 73747 phv00073747.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm2 Description/Label for chemical substance - second drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73753 phv00073753.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm1 Description/Label for chemical substance - medication or first drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73766 phv00073766.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm3 Description/Label for chemical substance - third drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73778 phv00073778.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm2 Description/Label for chemical substance - second drug in compound +74 Medication/supplement use 73784 phv00073784.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm1 Description/Label for chemical substance - medication or first drug in compound +74 Medication/supplement use 73797 phv00073797.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm3 Description/Label for chemical substance - third drug in compound +74 Medication/supplement use 177922 phv00177922.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm1 Description/label for chemical substance - medication or first drug in compound (character variable) +74 Medication/supplement use 177923 phv00177923.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm2 Description/label for chemical substance - second drug in compound (character variable) +74 Medication/supplement use 177924 phv00177924.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm3 Description/label for chemical substance - third drug in compound (character variable) +74 Medication/supplement use 227320 phv00227320.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm1 Description/label for chemical substance - medication or first drug in compound (character variable) +74 Medication/supplement use 227321 phv00227321.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm2 Description/label for chemical substance - second drug in compound (character variable) +74 Medication/supplement use 227322 phv00227322.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:17+00:00 2018-09-26 17:55:17+00:00 chem_nm3 Description/label for chemical substance - third drug in compound (character variable) +74 Medication/supplement use 257908 phv00257908.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:18+00:00 2018-09-26 17:55:18+00:00 chem_nm1 Description/label for chemical substance - medication or first drug in compound (character variable) +74 Medication/supplement use 257909 phv00257909.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:18+00:00 2018-09-26 17:55:18+00:00 chem_nm2 Description/label for chemical substance - second drug in compound (character variable) +74 Medication/supplement use 257942 phv00257942.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:18+00:00 2018-09-26 17:55:18+00:00 chem_nm1 Description/label for chemical substance - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257943 phv00257943.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:18+00:00 2018-09-26 17:55:18+00:00 chem_nm2 Description/label for chemical substance - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257944 phv00257944.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:18+00:00 2018-09-26 17:55:18+00:00 chem_nm3 Description/label for chemical substance - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276902 phv00276902.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:18+00:00 2018-09-26 17:55:18+00:00 chem_nm2 Description/label for chemical substance - second drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276908 phv00276908.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:55:18+00:00 2018-09-26 17:55:18+00:00 chem_nm1 Description/label for chemical substance - medication or first drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66833 phv00066833.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 MEDNAME Medication name +74 Medication/supplement use 66835 phv00066835.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 MEDNUM Number taken for a given period (medper) +74 Medication/supplement use 66849 phv00066849.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 chem_nm4 Description/Label for chemical substance - fourth drug in compound +74 Medication/supplement use 73755 phv00073755.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 MEDNAME Medication name Collection Interval: Exam 28 +74 Medication/supplement use 73757 phv00073757.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 MEDNUM Number taken for a given period (medper) Collection Interval: Exam 28 +74 Medication/supplement use 73771 phv00073771.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 chem_nm4 Description/Label for chemical substance - fourth drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73786 phv00073786.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 MEDNAME Medication name +74 Medication/supplement use 73788 phv00073788.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 MEDNUM Number taken for a given period (medper) +74 Medication/supplement use 73802 phv00073802.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 chem_nm4 Description/Label for chemical substance - fourth drug in compound +74 Medication/supplement use 177894 phv00177894.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 medname Medication name (character variable) +74 Medication/supplement use 177897 phv00177897.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 mednum Number taken for given period (MEDPER) +74 Medication/supplement use 177925 phv00177925.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 chem_nm4 Description/label for chemical substance - forth drug in compound (character variable) +74 Medication/supplement use 227294 phv00227294.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 medname Medication name (character variable) +74 Medication/supplement use 227296 phv00227296.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 mednum Number taken for given period (MEDPER) +74 Medication/supplement use 227323 phv00227323.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 chem_nm4 Description/label for chemical substance - forth drug in compound (character variable) +74 Medication/supplement use 257882 phv00257882.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 medname Medication name (character variable) +74 Medication/supplement use 257884 phv00257884.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 mednum Number taken for given period (MEDPER) +74 Medication/supplement use 257911 phv00257911.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 chem_nm4 Description/label for chemical substance - forth drug in compound (character variable) +74 Medication/supplement use 257915 phv00257915.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 medname Medication name (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257918 phv00257918.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 mednum Number taken for given period (MEDPER) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257945 phv00257945.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 chem_nm4 Description/label for chemical substance - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276910 phv00276910.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 MEDNAME Medication name (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276912 phv00276912.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 MEDNUM Number taken for given period Collection Interval: Exam 3 +74 Medication/supplement use 276926 phv00276926.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 17:58:46+00:00 2018-09-26 17:58:46+00:00 chem_nm4 Description/label for chemical substance - forth drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66834 phv00066834.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDSTREN Medication strength +74 Medication/supplement use 66836 phv00066836.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDPER Period range +74 Medication/supplement use 66837 phv00066837.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDPRN Medication taken as needed +74 Medication/supplement use 73756 phv00073756.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDSTREN Medication strength Collection Interval: Exam 28 +74 Medication/supplement use 73758 phv00073758.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDPER Period range Collection Interval: Exam 28 +74 Medication/supplement use 73759 phv00073759.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDPRN Medication taken as needed Collection Interval: Exam 28 +74 Medication/supplement use 73787 phv00073787.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDSTREN Medication strength +74 Medication/supplement use 73789 phv00073789.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDPER Period range +74 Medication/supplement use 73790 phv00073790.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDPRN Medication taken as needed +74 Medication/supplement use 177895 phv00177895.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medstren Medication strength (character variable) +74 Medication/supplement use 177898 phv00177898.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medper Period range +74 Medication/supplement use 177899 phv00177899.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medprn Medication taken as needed +74 Medication/supplement use 177900 phv00177900.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medotc CHECK if over the counter medication +74 Medication/supplement use 227295 phv00227295.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medstren Medication strength (character variable) +74 Medication/supplement use 227297 phv00227297.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medper Period range +74 Medication/supplement use 227298 phv00227298.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medprn Medication taken as needed +74 Medication/supplement use 227326 phv00227326.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medotc Medication over the counter +74 Medication/supplement use 257883 phv00257883.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medstren Medication strength (character variable) +74 Medication/supplement use 257885 phv00257885.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medper Period range medication taken +74 Medication/supplement use 257886 phv00257886.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medprn Medication taken as needed? +74 Medication/supplement use 257916 phv00257916.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medstren Medication strength (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257919 phv00257919.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medper Period range Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257920 phv00257920.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 medprn Medication taken as needed Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276911 phv00276911.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDSTREN Medication strength (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276913 phv00276913.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDPER Period range Collection Interval: Exam 3 +74 Medication/supplement use 276914 phv00276914.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:01:24+00:00 2018-09-26 18:01:24+00:00 MEDPRN Medication taken as needed Collection Interval: Exam 3 +74 Medication/supplement use 66823 phv00066823.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:46+00:00 2018-09-26 18:04:46+00:00 phrm_gp2 Description/Label for pharmacological subgroup - second drug in compound +74 Medication/supplement use 66829 phv00066829.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:46+00:00 2018-09-26 18:04:46+00:00 phrm_gp1 Description/Label for pharmacological subgroup - medication or first drug in compound +74 Medication/supplement use 66842 phv00066842.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:46+00:00 2018-09-26 18:04:46+00:00 phrm_gp3 Description/Label for pharmacological subgroup - third drug in compound +74 Medication/supplement use 66847 phv00066847.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:46+00:00 2018-09-26 18:04:46+00:00 phrm_gp4 Description/Label for pharmacological subgroup - fourth drug in compound +74 Medication/supplement use 73745 phv00073745.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:46+00:00 2018-09-26 18:04:46+00:00 phrm_gp2 Description/Label for pharmacological subgroup - second drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73751 phv00073751.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:46+00:00 2018-09-26 18:04:46+00:00 phrm_gp1 Description/Label for pharmacological subgroup - medication or first drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73764 phv00073764.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp3 Description/Label for pharmacological subgroup - third drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73769 phv00073769.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp4 Description/Label for pharmacological subgroup - fourth drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73776 phv00073776.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp2 Description/Label for pharmacological subgroup - second drug in compound +74 Medication/supplement use 73782 phv00073782.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp1 Description/Label for pharmacological subgroup - medication or first drug in compound +74 Medication/supplement use 73795 phv00073795.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp3 Description/Label for pharmacological subgroup - third drug in compound +74 Medication/supplement use 73800 phv00073800.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp4 Description/Label for pharmacological subgroup - fourth drug in compound +74 Medication/supplement use 177914 phv00177914.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp1 Description/label for pharmacological subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 177915 phv00177915.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp2 Description/label for pharmacological subgroup - second drug in compound (character variable) +74 Medication/supplement use 177916 phv00177916.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp3 Description/label for pharmacological subgroup - third drug in compound (character variable) +74 Medication/supplement use 177917 phv00177917.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp4 Description/label for pharmacological subgroup - forth drug in compound (character variable) +74 Medication/supplement use 227312 phv00227312.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp1 Description/label for pharmacological subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 227313 phv00227313.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp2 Description/label for pharmacological subgroup - second drug in compound (character variable) +74 Medication/supplement use 227314 phv00227314.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp3 Description/label for pharmacological subgroup - third drug in compound (character variable) +74 Medication/supplement use 227315 phv00227315.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp4 Description/label for pharmacological subgroup - forth drug in compound (character variable) +74 Medication/supplement use 257900 phv00257900.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp1 Description/label for pharmacological subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 257901 phv00257901.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp2 Description/label for pharmacological subgroup - second drug in compound (character variable) +74 Medication/supplement use 257902 phv00257902.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp3 Description/label for pharmacological subgroup - third drug in compound (character variable) +74 Medication/supplement use 257903 phv00257903.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp4 Description/label for pharmacological subgroup - forth drug in compound (character variable) +74 Medication/supplement use 257934 phv00257934.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp1 Description/label for pharmacological subgroup - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257935 phv00257935.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp2 Description/label for pharmacological subgroup - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257936 phv00257936.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp3 Description/label for pharmacological subgroup - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257937 phv00257937.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp4 Description/label for pharmacological subgroup - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276900 phv00276900.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp2 Description/label for pharmacological subgroup - second drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276906 phv00276906.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp1 Description/label for pharmacological subgroup - medication or first drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276919 phv00276919.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp3 Description/label for pharmacological subgroup - third drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276924 phv00276924.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:04:47+00:00 2018-09-26 18:04:47+00:00 phrm_gp4 Description/label for pharmacological subgroup - forth drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66821 phv00066821.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:23+00:00 2018-09-26 18:06:23+00:00 system2 Description/Label for anatomical main group - second drug in compound +74 Medication/supplement use 66827 phv00066827.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:23+00:00 2018-09-26 18:06:23+00:00 system1 Description/Label for anatomical main group - medication or first drug in compound +74 Medication/supplement use 73743 phv00073743.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system2 Description/Label for anatomical main group - second drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73749 phv00073749.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system1 Description/Label for anatomical main group - medication or first drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73774 phv00073774.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system2 Description/Label for anatomical main group - second drug in compound +74 Medication/supplement use 73780 phv00073780.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system1 Description/Label for anatomical main group - medication or first drug in compound +74 Medication/supplement use 177896 phv00177896.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 route Medication route +74 Medication/supplement use 177906 phv00177906.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system1 Description/label for anatomical main group - medication or first drug in compound (character variable) +74 Medication/supplement use 177907 phv00177907.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system2 Description/label for anatomical main group - second drug in compound (character variable) +74 Medication/supplement use 227304 phv00227304.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system1 Description/label for anatomical main group - medication or first drug in compound (character variable) +74 Medication/supplement use 227305 phv00227305.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system2 Description/label for anatomical main group - second drug in compound (character variable) +74 Medication/supplement use 227325 phv00227325.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 route Medication route +74 Medication/supplement use 257892 phv00257892.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system1 Description/label for anatomical main group - medication or first drug in compound (character variable) +74 Medication/supplement use 257893 phv00257893.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system2 Description/label for anatomical main group - second drug in compound (character variable) +74 Medication/supplement use 257917 phv00257917.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 route Medication route Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257926 phv00257926.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system1 Description/label for anatomical main group - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257927 phv00257927.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system2 Description/label for anatomical main group - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276898 phv00276898.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system2 Description/label for anatomical main group - second drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276904 phv00276904.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:06:24+00:00 2018-09-26 18:06:24+00:00 system1 Description/label for anatomical main group - medication or first drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66840 phv00066840.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system3 Description/Label for anatomical main group - third drug in compound +74 Medication/supplement use 66845 phv00066845.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system4 Description/Label for anatomical main group - fourth drug in compound +74 Medication/supplement use 73762 phv00073762.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system3 Description/Label for anatomical main group - third drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73767 phv00073767.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system4 Description/Label for anatomical main group - fourth drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73793 phv00073793.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system3 Description/Label for anatomical main group - third drug in compound +74 Medication/supplement use 73798 phv00073798.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system4 Description/Label for anatomical main group - fourth drug in compound +74 Medication/supplement use 177908 phv00177908.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system3 Description/label for anatomical main group - third drug in compound (character variable) +74 Medication/supplement use 177909 phv00177909.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system4 Description/label for anatomical main group - forth drug in compound (character variable) +74 Medication/supplement use 227306 phv00227306.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system3 Description/label for anatomical main group - third drug in compound (character variable) +74 Medication/supplement use 227307 phv00227307.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system4 Description/label for anatomical main group - forth drug in compound (character variable) +74 Medication/supplement use 257894 phv00257894.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system3 Description/label for anatomical main group - third drug in compound (character variable) +74 Medication/supplement use 257895 phv00257895.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system4 Description/label for anatomical main group - forth drug in compound (character variable) +74 Medication/supplement use 257928 phv00257928.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system3 Description/label for anatomical main group - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257929 phv00257929.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system4 Description/label for anatomical main group - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276917 phv00276917.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system3 Description/label for anatomical main group - third drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276922 phv00276922.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:07:31+00:00 2018-09-26 18:07:31+00:00 system4 Description/label for anatomical main group - forth drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66822 phv00066822.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp2 Description/Label for therapeutic subgroup - second drug in compound +74 Medication/supplement use 66828 phv00066828.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp1 Description/Label for therapeutic subgroup - medication or first drug in compound +74 Medication/supplement use 66841 phv00066841.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp3 Description/Label for therapeutic subgroup - third drug in compound +74 Medication/supplement use 73744 phv00073744.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp2 Description/Label for therapeutic subgroup - second drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73750 phv00073750.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp1 Description/Label for therapeutic subgroup - medication or first drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73763 phv00073763.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp3 Description/Label for therapeutic subgroup - third drug in compound Collection Interval: Exam 28 +74 Medication/supplement use 73775 phv00073775.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp2 Description/Label for therapeutic subgroup - second drug in compound +74 Medication/supplement use 73781 phv00073781.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp1 Description/Label for therapeutic subgroup - medication or first drug in compound +74 Medication/supplement use 73794 phv00073794.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp3 Description/Label for therapeutic subgroup - third drug in compound +74 Medication/supplement use 177910 phv00177910.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp1 Description/label for therapeutic subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 177911 phv00177911.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp2 Description/label for therapeutic subgroup - second drug in compound (character variable) +74 Medication/supplement use 177912 phv00177912.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp3 Description/label for therapeutic subgroup - third drug in compound (character variable) +74 Medication/supplement use 227308 phv00227308.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp1 Description/label for therapeutic subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 227309 phv00227309.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp2 Description/label for therapeutic subgroup - second drug in compound (character variable) +74 Medication/supplement use 227310 phv00227310.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp3 Description/label for therapeutic subgroup - third drug in compound (character variable) +74 Medication/supplement use 257896 phv00257896.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp1 Description/label for therapeutic subgroup - medication or first drug in compound (character variable) +74 Medication/supplement use 257897 phv00257897.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp2 Description/label for therapeutic subgroup - second drug in compound (character variable) +74 Medication/supplement use 257898 phv00257898.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp3 Description/label for therapeutic subgroup - third drug in compound (character variable) +74 Medication/supplement use 257930 phv00257930.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp1 Description/label for therapeutic subgroup - medication or first drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257931 phv00257931.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp2 Description/label for therapeutic subgroup - second drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 257932 phv00257932.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp3 Description/label for therapeutic subgroup - third drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276899 phv00276899.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp2 Description/label for therapeutic subgroup - second drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276905 phv00276905.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp1 Description/label for therapeutic subgroup - medication or first drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 276918 phv00276918.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:09:13+00:00 2018-09-26 18:09:13+00:00 ther_gp3 Description/label for therapeutic subgroup - third drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 66846 phv00066846.v5.p10 pht000676.v6.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ther_gp4 Description/Label for therapeutic subgroup - fourth drug in compoud +74 Medication/supplement use 73768 phv00073768.v1.p10 pht000827.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ther_gp4 Description/Label for therapeutic subgroup - fourth drug in compoud Collection Interval: Exam 28 +74 Medication/supplement use 73799 phv00073799.v4.p10 pht000828.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ther_gp4 Description/Label for therapeutic subgroup - fourth drug in compoud +74 Medication/supplement use 177913 phv00177913.v3.p10 pht003098.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ther_gp4 Description/label for therapeutic subgroup - forth drug in compound (character variable) +74 Medication/supplement use 227311 phv00227311.v1.p10 pht004810.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ther_gp4 Description/label for therapeutic subgroup - forth drug in compound (character variable) +74 Medication/supplement use 257899 phv00257899.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ther_gp4 Description/label for therapeutic subgroup - forth drug in compound (character variable) +74 Medication/supplement use 257933 phv00257933.v1.p10 pht005173.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ther_gp4 Description/label for therapeutic subgroup - forth drug in compound (character variable) Collection Interval: Original Cohort Exams 29, 30 and 31 +74 Medication/supplement use 276923 phv00276923.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ther_gp4 Description/label for therapeutic subgroup - forth drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 277000 phv00277000.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:11:04+00:00 2018-09-26 18:11:04+00:00 ORAL Oral contraceptive or hormone replacement Collection Interval: 1975 through 2014 +74 Medication/supplement use 277057 phv00277057.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX1 Treated for diabetes, Exam 1 +74 Medication/supplement use 277058 phv00277058.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX2 Treated for diabetes, Exam 2 +74 Medication/supplement use 277059 phv00277059.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX1 Treated for hypertension, Exam 1 +74 Medication/supplement use 277060 phv00277060.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX2 Treated for hypertension, Exam 2 +74 Medication/supplement use 277236 phv00277236.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX1 Treated for diabetes, Exam 1 +74 Medication/supplement use 277237 phv00277237.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX2 Treated for diabetes, Exam 2 +74 Medication/supplement use 277238 phv00277238.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX3 Treated for diabetes, Exam 3 +74 Medication/supplement use 277239 phv00277239.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX4 Treated for diabetes, Exam 4 +74 Medication/supplement use 277240 phv00277240.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX5 Treated for diabetes, Exam 5 +74 Medication/supplement use 277241 phv00277241.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX6 Treated for diabetes, Exam 6 +74 Medication/supplement use 277242 phv00277242.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX7 Treated for diabetes, Exam 7 +74 Medication/supplement use 277243 phv00277243.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX8 Treated for diabetes, Exam 8 +74 Medication/supplement use 277244 phv00277244.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 DMRX9 Treated for diabetes, Exam 9 +74 Medication/supplement use 277245 phv00277245.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX1 Treated for hypertension, Exam 1 +74 Medication/supplement use 277246 phv00277246.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX2 Treated for hypertension, Exam 2 +74 Medication/supplement use 277247 phv00277247.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX3 Treated for hypertension, Exam 3 +74 Medication/supplement use 277248 phv00277248.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX4 Treated for hypertension, Exam 4 +74 Medication/supplement use 277249 phv00277249.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX5 Treated for hypertension, Exam 5 +74 Medication/supplement use 277250 phv00277250.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX6 Treated for hypertension, Exam 6 +74 Medication/supplement use 277251 phv00277251.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX7 Treated for hypertension, Exam 7 +74 Medication/supplement use 277252 phv00277252.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX8 Treated for hypertension, Exam 8 +74 Medication/supplement use 277253 phv00277253.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:33:42+00:00 2018-09-26 18:33:42+00:00 HRX9 Treated for hypertension, Exam 9 +74 Medication/supplement use 277061 phv00277061.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX1 Treated for lipids, Exam 1 +74 Medication/supplement use 277062 phv00277062.v1.p10 pht006026.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX2 Treated for lipids, Exam 2 +74 Medication/supplement use 277254 phv00277254.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX1 Treated for lipids, Exam 1 +74 Medication/supplement use 277255 phv00277255.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX2 Treated for lipids, Exam 2 +74 Medication/supplement use 277256 phv00277256.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX3 Treated for lipids, Exam 3 +74 Medication/supplement use 277257 phv00277257.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX4 Treated for lipids, Exam 4 +74 Medication/supplement use 277258 phv00277258.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX5 Treated for lipids, Exam 5 +74 Medication/supplement use 277259 phv00277259.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX6 Treated for lipids, Exam 6 +74 Medication/supplement use 277260 phv00277260.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX7 Treated for lipids, Exam 7 +74 Medication/supplement use 277261 phv00277261.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX8 Treated for lipids, Exam 8 +74 Medication/supplement use 277262 phv00277262.v1.p10 pht006027.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-26 18:34:48+00:00 2018-09-26 18:34:48+00:00 LIPRX9 Treated for lipids, Exam 9 +74 Medication/supplement use 99346 phv00099346.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:25:02+00:00 2018-09-27 18:25:02+00:00 INSUL12 TAKE INSULIN +74 Medication/supplement use 99454 phv00099454.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:25:37+00:00 2018-09-27 18:25:37+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WKS +74 Medication/supplement use 99455 phv00099455.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:25:50+00:00 2018-09-27 18:25:50+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 99456 phv00099456.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:26:00+00:00 2018-09-27 18:26:00+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 99457 phv00099457.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:26:10+00:00 2018-09-27 18:26:10+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 99554 phv00099554.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:26:47+00:00 2018-09-27 18:26:47+00:00 TAKMED06 TAKE ANY MEDICATIONS +74 Medication/supplement use 99556 phv00099556.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:27:02+00:00 2018-09-27 18:27:02+00:00 ASPR06 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 99557 phv00099557.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:27:14+00:00 2018-09-27 18:27:14+00:00 DAYASP06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 99558 phv00099558.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:27:27+00:00 2018-09-27 18:27:27+00:00 FSHOIL06 CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS +74 Medication/supplement use 99559 phv00099559.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:27:39+00:00 2018-09-27 18:27:39+00:00 DAYFSH06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 99560 phv00099560.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:27:51+00:00 2018-09-27 18:27:51+00:00 ANTHST06 ANTIHISTAMINES (COLD PILLS, ALLERGY PILLS) +74 Medication/supplement use 99561 phv00099561.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:28:02+00:00 2018-09-27 18:28:02+00:00 SLPILL06 SLEEPING PILLS +74 Medication/supplement use 99563 phv00099563.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:28:13+00:00 2018-09-27 18:28:13+00:00 CALC06 CALCIUM SUPPLEMENTS +74 Medication/supplement use 99573 phv00099573.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:28:33+00:00 2018-09-27 18:28:33+00:00 NOMEDS06 Total Medications +74 Medication/supplement use 99574 phv00099574.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:28:43+00:00 2018-09-27 18:28:43+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 99575 phv00099575.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:29:05+00:00 2018-09-27 18:29:05+00:00 A2AD06 Combinations of angiotensin II antagonists +74 Medication/supplement use 99576 phv00099576.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:29:14+00:00 2018-09-27 18:29:14+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 99577 phv00099577.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:29:22+00:00 2018-09-27 18:29:22+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 99578 phv00099578.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:29:38+00:00 2018-09-27 18:29:38+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 99579 phv00099579.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:29:50+00:00 2018-09-27 18:29:50+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 99580 phv00099580.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:30:03+00:00 2018-09-27 18:30:03+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 99581 phv00099581.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:30:13+00:00 2018-09-27 18:30:13+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 99582 phv00099582.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:30:26+00:00 2018-09-27 18:30:26+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 99583 phv00099583.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:30:39+00:00 2018-09-27 18:30:39+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 99584 phv00099584.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:30:56+00:00 2018-09-27 18:30:56+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 99585 phv00099585.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:31:04+00:00 2018-09-27 18:31:04+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 99586 phv00099586.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:31:14+00:00 2018-09-27 18:31:14+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 99587 phv00099587.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:31:25+00:00 2018-09-27 18:31:25+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 56925 phv00056925.v2.p10 pht000397.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 18:45:10+00:00 2018-09-27 18:45:10+00:00 A2AD2 Combinations of angiotensin II antagonists plus diuretics +74 Medication/supplement use 251728 phv00251728.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 18:47:28+00:00 2018-09-27 18:47:28+00:00 h672 Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: How many hours ago did you last use the medication, either by inhaler or nebulizer? Collection Interval: Exam 3 +74 Medication/supplement use 251730 phv00251730.v1.p10 pht004815.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 18:47:46+00:00 2018-09-27 18:47:46+00:00 h674 Respiratory Disease Questionnaire - Technician Administered: Inhaler Use: How many hours ago did you last use the medication? Collection Interval: Exam 3 +74 Medication/supplement use 55379 phv00055379.v4.p10 pht000395.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-27 18:48:31+00:00 2018-09-27 18:48:31+00:00 VASO1 Vasodilators (including alpha) +74 Medication/supplement use 99588 phv00099588.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:49:34+00:00 2018-09-27 18:49:34+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 99589 phv00099589.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:49:46+00:00 2018-09-27 18:49:46+00:00 ASA06 Aspirin from 280804 (anti-inflam agents) +74 Medication/supplement use 99590 phv00099590.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:49:58+00:00 2018-09-27 18:49:58+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 99591 phv00099591.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:50:10+00:00 2018-09-27 18:50:10+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 99592 phv00099592.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:50:40+00:00 2018-09-27 18:50:40+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 99593 phv00099593.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:50:50+00:00 2018-09-27 18:50:50+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 99594 phv00099594.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:51:21+00:00 2018-09-27 18:51:21+00:00 BGND06 Biguanides +74 Medication/supplement use 99595 phv00099595.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:51:33+00:00 2018-09-27 18:51:33+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 99596 phv00099596.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:51:47+00:00 2018-09-27 18:51:47+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 99597 phv00099597.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:51:58+00:00 2018-09-27 18:51:58+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 99598 phv00099598.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:52:08+00:00 2018-09-27 18:52:08+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 99599 phv00099599.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:52:23+00:00 2018-09-27 18:52:23+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 99600 phv00099600.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:52:38+00:00 2018-09-27 18:52:38+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 99601 phv00099601.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:52:50+00:00 2018-09-27 18:52:50+00:00 DIHIR06 Immediate-release dihydropyridines other +74 Medication/supplement use 99602 phv00099602.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:52:59+00:00 2018-09-27 18:52:59+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 99603 phv00099603.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:53:09+00:00 2018-09-27 18:53:09+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 99604 phv00099604.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:53:21+00:00 2018-09-27 18:53:21+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 99605 phv00099605.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:53:31+00:00 2018-09-27 18:53:31+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 99606 phv00099606.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:53:38+00:00 2018-09-27 18:53:38+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 99607 phv00099607.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:53:47+00:00 2018-09-27 18:53:47+00:00 FIBR06 Fibrates +74 Medication/supplement use 99608 phv00099608.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:54:23+00:00 2018-09-27 18:54:23+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 99609 phv00099609.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:54:40+00:00 2018-09-27 18:54:40+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 99610 phv00099610.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:55:21+00:00 2018-09-27 18:55:21+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 99611 phv00099611.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:56:08+00:00 2018-09-27 18:56:08+00:00 HPRNS06 Heparins +74 Medication/supplement use 99621 phv00099621.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:56:23+00:00 2018-09-27 18:56:23+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 99620 phv00099620.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:56:33+00:00 2018-09-27 18:56:33+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 99619 phv00099619.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:56:41+00:00 2018-09-27 18:56:41+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 99618 phv00099618.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:56:51+00:00 2018-09-27 18:56:51+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 99617 phv00099617.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:57:00+00:00 2018-09-27 18:57:00+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 99616 phv00099616.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:57:09+00:00 2018-09-27 18:57:09+00:00 KCL06 Potassium supplements +74 Medication/supplement use 99615 phv00099615.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:57:19+00:00 2018-09-27 18:57:19+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 99614 phv00099614.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:57:30+00:00 2018-09-27 18:57:30+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 99613 phv00099613.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:57:40+00:00 2018-09-27 18:57:40+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 99612 phv00099612.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:57:53+00:00 2018-09-27 18:57:53+00:00 INSULN06 Insulins +74 Medication/supplement use 99622 phv00099622.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:58:14+00:00 2018-09-27 18:58:14+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 99623 phv00099623.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:58:25+00:00 2018-09-27 18:58:25+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 99624 phv00099624.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:58:33+00:00 2018-09-27 18:58:33+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 99625 phv00099625.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:58:42+00:00 2018-09-27 18:58:42+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 99626 phv00099626.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:58:53+00:00 2018-09-27 18:58:53+00:00 NTG06 Nitrates +74 Medication/supplement use 99627 phv00099627.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:59:02+00:00 2018-09-27 18:59:02+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 99628 phv00099628.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:59:10+00:00 2018-09-27 18:59:10+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 99629 phv00099629.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:59:19+00:00 2018-09-27 18:59:19+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 99630 phv00099630.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:59:29+00:00 2018-09-27 18:59:29+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers' +74 Medication/supplement use 99631 phv00099631.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 18:59:52+00:00 2018-09-27 18:59:52+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 99632 phv00099632.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:00:01+00:00 2018-09-27 19:00:01+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 99633 phv00099633.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:00:12+00:00 2018-09-27 19:00:12+00:00 PROGST06 Progestins +74 Medication/supplement use 99635 phv00099635.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:00:24+00:00 2018-09-27 19:00:24+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 99634 phv00099634.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:00:35+00:00 2018-09-27 19:00:35+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 99637 phv00099637.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:00:54+00:00 2018-09-27 19:00:54+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 99636 phv00099636.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:01:03+00:00 2018-09-27 19:01:03+00:00 PROB06 Probucol +74 Medication/supplement use 99638 phv00099638.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:01:17+00:00 2018-09-27 19:01:17+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 99639 phv00099639.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:01:26+00:00 2018-09-27 19:01:26+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 99640 phv00099640.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:01:35+00:00 2018-09-27 19:01:35+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 99641 phv00099641.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:01:46+00:00 2018-09-27 19:01:46+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 99642 phv00099642.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:01:55+00:00 2018-09-27 19:01:55+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 99643 phv00099643.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:02:05+00:00 2018-09-27 19:02:05+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 99644 phv00099644.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:02:13+00:00 2018-09-27 19:02:13+00:00 THRY06 Thyroid agents +74 Medication/supplement use 99645 phv00099645.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:02:23+00:00 2018-09-27 19:02:23+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 99646 phv00099646.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:02:41+00:00 2018-09-27 19:02:41+00:00 URCOS06 Uricosurics +74 Medication/supplement use 99647 phv00099647.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:02:57+00:00 2018-09-27 19:02:57+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 99649 phv00099649.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:03:07+00:00 2018-09-27 19:03:07+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 99648 phv00099648.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:03:18+00:00 2018-09-27 19:03:18+00:00 VASOD06 Vasodilators with diuretics, a mixed group +74 Medication/supplement use 99650 phv00099650.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:03:29+00:00 2018-09-27 19:03:29+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 99651 phv00099651.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:03:41+00:00 2018-09-27 19:03:41+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 99652 phv00099652.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:03:57+00:00 2018-09-27 19:03:57+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 99654 phv00099654.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:04:08+00:00 2018-09-27 19:04:08+00:00 DIURET06 Any diuretic +74 Medication/supplement use 99655 phv00099655.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:04:18+00:00 2018-09-27 19:04:18+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 99656 phv00099656.v1.p1 pht001450.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 19:04:30+00:00 2018-09-27 19:04:30+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 100437 phv00100437.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:52:00+00:00 2018-09-27 20:52:00+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WKS +74 Medication/supplement use 100438 phv00100438.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:52:11+00:00 2018-09-27 20:52:11+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 100439 phv00100439.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:52:20+00:00 2018-09-27 20:52:20+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 100440 phv00100440.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:52:31+00:00 2018-09-27 20:52:31+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 100441 phv00100441.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:52:43+00:00 2018-09-27 20:52:43+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 100468 phv00100468.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:53:10+00:00 2018-09-27 20:53:10+00:00 ESTBLNC Estrogen at baseline, no creams +74 Medication/supplement use 100472 phv00100472.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:53:38+00:00 2018-09-27 20:53:38+00:00 ASPR06 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 100473 phv00100473.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:53:49+00:00 2018-09-27 20:53:49+00:00 DAYASP06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 100474 phv00100474.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:54:00+00:00 2018-09-27 20:54:00+00:00 FSHOIL06 CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS +74 Medication/supplement use 100475 phv00100475.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:54:12+00:00 2018-09-27 20:54:12+00:00 DAYFSH06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 100476 phv00100476.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:54:26+00:00 2018-09-27 20:54:26+00:00 ANTHST06 ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS) +74 Medication/supplement use 100477 phv00100477.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:54:38+00:00 2018-09-27 20:54:38+00:00 SLPILL06 SLEEPING PILLS +74 Medication/supplement use 100478 phv00100478.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:54:45+00:00 2018-09-27 20:54:45+00:00 LAXATV06 LAXATIVES +74 Medication/supplement use 100479 phv00100479.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:54:54+00:00 2018-09-27 20:54:54+00:00 CALC06 CALCIUM SUPPLEMENTS +74 Medication/supplement use 100482 phv00100482.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:55:16+00:00 2018-09-27 20:55:16+00:00 NITRO06 PRESCRIBE NITROGLYCERIN IN THE LAST YEAR +74 Medication/supplement use 100511 phv00100511.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:55:41+00:00 2018-09-27 20:55:41+00:00 NOMEDS06 Number of medications +74 Medication/supplement use 100512 phv00100512.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:55:50+00:00 2018-09-27 20:55:50+00:00 TAKMED06 TAKE ANY MEDICATIONS +74 Medication/supplement use 100513 phv00100513.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:56:00+00:00 2018-09-27 20:56:00+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 100514 phv00100514.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:56:08+00:00 2018-09-27 20:56:08+00:00 A2AD06 Combinations of angiotensin II antagonis +74 Medication/supplement use 100515 phv00100515.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:56:20+00:00 2018-09-27 20:56:20+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 100516 phv00100516.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:56:36+00:00 2018-09-27 20:56:36+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 100517 phv00100517.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:56:49+00:00 2018-09-27 20:56:49+00:00 ADPI06 Inhibitors of ADP-induced platelet aggre +74 Medication/supplement use 100518 phv00100518.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:57:08+00:00 2018-09-27 20:57:08+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 100519 phv00100519.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:57:19+00:00 2018-09-27 20:57:19+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 100522 phv00100522.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:57:33+00:00 2018-09-27 20:57:33+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 100521 phv00100521.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:57:41+00:00 2018-09-27 20:57:41+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 100520 phv00100520.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:57:50+00:00 2018-09-27 20:57:50+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 100523 phv00100523.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:58:08+00:00 2018-09-27 20:58:08+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 100524 phv00100524.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:58:18+00:00 2018-09-27 20:58:18+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 100525 phv00100525.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:58:26+00:00 2018-09-27 20:58:26+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 100526 phv00100526.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:58:34+00:00 2018-09-27 20:58:34+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 100527 phv00100527.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:58:51+00:00 2018-09-27 20:58:51+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 100528 phv00100528.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:58:59+00:00 2018-09-27 20:58:59+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 100529 phv00100529.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:59:10+00:00 2018-09-27 20:59:10+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 100530 phv00100530.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:59:19+00:00 2018-09-27 20:59:19+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 100531 phv00100531.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:59:29+00:00 2018-09-27 20:59:29+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 100532 phv00100532.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:59:37+00:00 2018-09-27 20:59:37+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 100533 phv00100533.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:59:46+00:00 2018-09-27 20:59:46+00:00 BGND06 Biguanides +74 Medication/supplement use 100534 phv00100534.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 20:59:53+00:00 2018-09-27 20:59:53+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 100535 phv00100535.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:00:07+00:00 2018-09-27 21:00:07+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 100536 phv00100536.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:09:09+00:00 2018-09-27 21:09:09+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 100537 phv00100537.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:09:23+00:00 2018-09-27 21:09:23+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 100538 phv00100538.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:09:32+00:00 2018-09-27 21:09:32+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 100539 phv00100539.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:09:44+00:00 2018-09-27 21:09:44+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 100540 phv00100540.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:10:18+00:00 2018-09-27 21:10:18+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 100541 phv00100541.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:12:18+00:00 2018-09-27 21:12:18+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 100542 phv00100542.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:12:28+00:00 2018-09-27 21:12:28+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 100543 phv00100543.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:12:52+00:00 2018-09-27 21:12:52+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 100544 phv00100544.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:13:20+00:00 2018-09-27 21:13:20+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 100545 phv00100545.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:13:31+00:00 2018-09-27 21:13:31+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 100546 phv00100546.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:13:43+00:00 2018-09-27 21:13:43+00:00 FIBR06 Fibrates +74 Medication/supplement use 100547 phv00100547.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:13:53+00:00 2018-09-27 21:13:53+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 100548 phv00100548.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:14:09+00:00 2018-09-27 21:14:09+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 100549 phv00100549.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:14:21+00:00 2018-09-27 21:14:21+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 100550 phv00100550.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:14:32+00:00 2018-09-27 21:14:32+00:00 HPRNS06 Heparins +74 Medication/supplement use 100551 phv00100551.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:14:42+00:00 2018-09-27 21:14:42+00:00 INSULN06 Insulins +74 Medication/supplement use 100552 phv00100552.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:14:52+00:00 2018-09-27 21:14:52+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 100553 phv00100553.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:15:01+00:00 2018-09-27 21:15:01+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 100554 phv00100554.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:15:11+00:00 2018-09-27 21:15:11+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 100555 phv00100555.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:15:19+00:00 2018-09-27 21:15:19+00:00 KCL06 Potassium supplements +74 Medication/supplement use 100556 phv00100556.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:15:28+00:00 2018-09-27 21:15:28+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 100557 phv00100557.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:15:49+00:00 2018-09-27 21:15:49+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 100558 phv00100558.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:16:19+00:00 2018-09-27 21:16:19+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 100559 phv00100559.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:16:26+00:00 2018-09-27 21:16:26+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 100560 phv00100560.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:16:40+00:00 2018-09-27 21:16:40+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 100561 phv00100561.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:17:04+00:00 2018-09-27 21:17:04+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 100562 phv00100562.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:17:17+00:00 2018-09-27 21:17:17+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 100563 phv00100563.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:17:26+00:00 2018-09-27 21:17:26+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 100565 phv00100565.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:17:36+00:00 2018-09-27 21:17:36+00:00 NTG06 Nitrates +74 Medication/supplement use 100564 phv00100564.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:17:47+00:00 2018-09-27 21:17:47+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 100566 phv00100566.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:18:02+00:00 2018-09-27 21:18:02+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 100567 phv00100567.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:18:16+00:00 2018-09-27 21:18:16+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 100568 phv00100568.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:18:26+00:00 2018-09-27 21:18:26+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 100569 phv00100569.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:18:36+00:00 2018-09-27 21:18:36+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers +74 Medication/supplement use 100570 phv00100570.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:18:56+00:00 2018-09-27 21:18:56+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 100571 phv00100571.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:19:05+00:00 2018-09-27 21:19:05+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 100572 phv00100572.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:19:17+00:00 2018-09-27 21:19:17+00:00 PROGST06 Progestins +74 Medication/supplement use 100573 phv00100573.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:19:26+00:00 2018-09-27 21:19:26+00:00 PRKNSN06 Drugs used to treat Parkinson`s +74 Medication/supplement use 100574 phv00100574.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:19:36+00:00 2018-09-27 21:19:36+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 100575 phv00100575.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:19:44+00:00 2018-09-27 21:19:44+00:00 PROB06 Probucol +74 Medication/supplement use 100576 phv00100576.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:19:55+00:00 2018-09-27 21:19:55+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 100577 phv00100577.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:20:07+00:00 2018-09-27 21:20:07+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 100578 phv00100578.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:20:16+00:00 2018-09-27 21:20:16+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 100579 phv00100579.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:20:26+00:00 2018-09-27 21:20:26+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 100580 phv00100580.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:20:43+00:00 2018-09-27 21:20:43+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 100581 phv00100581.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:20:53+00:00 2018-09-27 21:20:53+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 100582 phv00100582.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:21:02+00:00 2018-09-27 21:21:02+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 100583 phv00100583.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:21:12+00:00 2018-09-27 21:21:12+00:00 THRY06 Thyroid agents +74 Medication/supplement use 100584 phv00100584.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:21:20+00:00 2018-09-27 21:21:20+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 100585 phv00100585.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:21:30+00:00 2018-09-27 21:21:30+00:00 URCOS06 Uricosurics +74 Medication/supplement use 100586 phv00100586.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:22:05+00:00 2018-09-27 21:22:05+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 100587 phv00100587.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:22:19+00:00 2018-09-27 21:22:19+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 100588 phv00100588.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:22:30+00:00 2018-09-27 21:22:30+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 100589 phv00100589.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:22:41+00:00 2018-09-27 21:22:41+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 100590 phv00100590.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:23:00+00:00 2018-09-27 21:23:00+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 100591 phv00100591.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:23:08+00:00 2018-09-27 21:23:08+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 100592 phv00100592.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:23:23+00:00 2018-09-27 21:23:23+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 100593 phv00100593.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:23:30+00:00 2018-09-27 21:23:30+00:00 DIURET06 Any diuretic +74 Medication/supplement use 100594 phv00100594.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:23:38+00:00 2018-09-27 21:23:38+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 100595 phv00100595.v1.p1 pht001452.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:23:50+00:00 2018-09-27 21:23:50+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 104304 phv00104304.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:28:14+00:00 2018-09-27 21:28:14+00:00 PREMAR38 TAKE PREMARIN FOR HOT FLASHES +74 Medication/supplement use 104305 phv00104305.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:28:27+00:00 2018-09-27 21:28:27+00:00 ESTROG38 TAKE ESTROGENS OR OTHER FEMALE HORMONES +74 Medication/supplement use 104306 phv00104306.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:28:37+00:00 2018-09-27 21:28:37+00:00 MED138 SPECIFY MEDICATION 1 +74 Medication/supplement use 104307 phv00104307.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:28:46+00:00 2018-09-27 21:28:46+00:00 MED238 SPECIFY MEDICATION 2 +74 Medication/supplement use 104308 phv00104308.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:28:54+00:00 2018-09-27 21:28:54+00:00 MED338 SPECIFY MEDICATION 3 +74 Medication/supplement use 104357 phv00104357.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:29:21+00:00 2018-09-27 21:29:21+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WKS +74 Medication/supplement use 104358 phv00104358.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:29:29+00:00 2018-09-27 21:29:29+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 104359 phv00104359.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:29:38+00:00 2018-09-27 21:29:38+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 104360 phv00104360.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:29:46+00:00 2018-09-27 21:29:46+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 104361 phv00104361.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:29:58+00:00 2018-09-27 21:29:58+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 104362 phv00104362.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:30:19+00:00 2018-09-27 21:30:19+00:00 TAKMED06 TAKE ANY MEDICATIONS +74 Medication/supplement use 104364 phv00104364.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:30:33+00:00 2018-09-27 21:30:33+00:00 ASPR06 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 104365 phv00104365.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:30:51+00:00 2018-09-27 21:30:51+00:00 DAYASP06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 104366 phv00104366.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:31:08+00:00 2018-09-27 21:31:08+00:00 FSHOIL06 CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS +74 Medication/supplement use 104367 phv00104367.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:31:17+00:00 2018-09-27 21:31:17+00:00 DAYFSH06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 104368 phv00104368.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:31:29+00:00 2018-09-27 21:31:29+00:00 ANTHST06 ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS) +74 Medication/supplement use 104369 phv00104369.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:31:41+00:00 2018-09-27 21:31:41+00:00 SLPILL06 SLEEPING PILLS +74 Medication/supplement use 104370 phv00104370.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:31:48+00:00 2018-09-27 21:31:48+00:00 LAXATV06 LAXATIVES +74 Medication/supplement use 104371 phv00104371.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:31:57+00:00 2018-09-27 21:31:57+00:00 CALC06 CALCIUM SUPPLEMENTS +74 Medication/supplement use 104374 phv00104374.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:32:11+00:00 2018-09-27 21:32:11+00:00 NITRO06 PRESCRIBE NITROGLYCERIN IN THE LAST YEAR +74 Medication/supplement use 104381 phv00104381.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:32:46+00:00 2018-09-27 21:32:46+00:00 NOMEDS06 Total Medications +74 Medication/supplement use 104382 phv00104382.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:32:59+00:00 2018-09-27 21:32:59+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 104383 phv00104383.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:33:07+00:00 2018-09-27 21:33:07+00:00 A2AD06 Combinations of angiotensin II antagonist +74 Medication/supplement use 104384 phv00104384.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:33:16+00:00 2018-09-27 21:33:16+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 104385 phv00104385.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:33:24+00:00 2018-09-27 21:33:24+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 104386 phv00104386.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:33:33+00:00 2018-09-27 21:33:33+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 104387 phv00104387.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:33:42+00:00 2018-09-27 21:33:42+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 104388 phv00104388.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:33:52+00:00 2018-09-27 21:33:52+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 104389 phv00104389.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:33:59+00:00 2018-09-27 21:33:59+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 104390 phv00104390.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:34:10+00:00 2018-09-27 21:34:10+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 104391 phv00104391.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:34:42+00:00 2018-09-27 21:34:42+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 104392 phv00104392.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:34:52+00:00 2018-09-27 21:34:52+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 104393 phv00104393.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:35:01+00:00 2018-09-27 21:35:01+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 104394 phv00104394.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:35:11+00:00 2018-09-27 21:35:11+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 104395 phv00104395.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:35:20+00:00 2018-09-27 21:35:20+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 104396 phv00104396.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:35:34+00:00 2018-09-27 21:35:34+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 104397 phv00104397.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:35:43+00:00 2018-09-27 21:35:43+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 104398 phv00104398.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:41:57+00:00 2018-09-27 21:41:57+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 104399 phv00104399.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:42:07+00:00 2018-09-27 21:42:07+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 104400 phv00104400.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:42:19+00:00 2018-09-27 21:42:19+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 104402 phv00104402.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:42:27+00:00 2018-09-27 21:42:27+00:00 BGND06 Biguanides +74 Medication/supplement use 104401 phv00104401.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:42:38+00:00 2018-09-27 21:42:38+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 104403 phv00104403.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:42:53+00:00 2018-09-27 21:42:53+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 104404 phv00104404.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:43:02+00:00 2018-09-27 21:43:02+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 104405 phv00104405.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:43:15+00:00 2018-09-27 21:43:15+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 104406 phv00104406.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:43:24+00:00 2018-09-27 21:43:24+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 104407 phv00104407.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:43:32+00:00 2018-09-27 21:43:32+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 104408 phv00104408.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:43:47+00:00 2018-09-27 21:43:47+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 104412 phv00104412.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:44:00+00:00 2018-09-27 21:44:00+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 104411 phv00104411.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:44:16+00:00 2018-09-27 21:44:16+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 104410 phv00104410.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:44:29+00:00 2018-09-27 21:44:29+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 104409 phv00104409.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:44:39+00:00 2018-09-27 21:44:39+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 104413 phv00104413.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:44:55+00:00 2018-09-27 21:44:55+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 104414 phv00104414.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:45:02+00:00 2018-09-27 21:45:02+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 104415 phv00104415.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:45:10+00:00 2018-09-27 21:45:10+00:00 FIBR06 Fibrates +74 Medication/supplement use 104416 phv00104416.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:45:24+00:00 2018-09-27 21:45:24+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 104418 phv00104418.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:45:35+00:00 2018-09-27 21:45:35+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 104417 phv00104417.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:45:44+00:00 2018-09-27 21:45:44+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 104419 phv00104419.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:45:52+00:00 2018-09-27 21:45:52+00:00 HPRNS06 Heparins +74 Medication/supplement use 104420 phv00104420.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:46:05+00:00 2018-09-27 21:46:05+00:00 INSULN06 Insulins +74 Medication/supplement use 104421 phv00104421.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:46:15+00:00 2018-09-27 21:46:15+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 104422 phv00104422.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:46:24+00:00 2018-09-27 21:46:24+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 104423 phv00104423.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:46:49+00:00 2018-09-27 21:46:49+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 104424 phv00104424.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:46:58+00:00 2018-09-27 21:46:58+00:00 KCL06 Potassium supplements +74 Medication/supplement use 104425 phv00104425.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:47:06+00:00 2018-09-27 21:47:06+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 104426 phv00104426.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:47:16+00:00 2018-09-27 21:47:16+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 104427 phv00104427.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:47:26+00:00 2018-09-27 21:47:26+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 104428 phv00104428.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:47:41+00:00 2018-09-27 21:47:41+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 104429 phv00104429.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:47:49+00:00 2018-09-27 21:47:49+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 104430 phv00104430.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:48:01+00:00 2018-09-27 21:48:01+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 104431 phv00104431.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:48:09+00:00 2018-09-27 21:48:09+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 104432 phv00104432.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:48:20+00:00 2018-09-27 21:48:20+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 104433 phv00104433.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:48:29+00:00 2018-09-27 21:48:29+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 104434 phv00104434.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:48:36+00:00 2018-09-27 21:48:36+00:00 NTG06 Nitrates +74 Medication/supplement use 104435 phv00104435.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:48:47+00:00 2018-09-27 21:48:47+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 104436 phv00104436.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:49:12+00:00 2018-09-27 21:49:12+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 104437 phv00104437.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:49:24+00:00 2018-09-27 21:49:24+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 104438 phv00104438.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:49:32+00:00 2018-09-27 21:49:32+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers' +74 Medication/supplement use 104439 phv00104439.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:49:40+00:00 2018-09-27 21:49:40+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 104440 phv00104440.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:49:49+00:00 2018-09-27 21:49:49+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 104441 phv00104441.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:49:56+00:00 2018-09-27 21:49:56+00:00 PROGST06 Progestins +74 Medication/supplement use 104445 phv00104445.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:50:07+00:00 2018-09-27 21:50:07+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 104444 phv00104444.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:50:20+00:00 2018-09-27 21:50:20+00:00 PROB06 Probucol +74 Medication/supplement use 104443 phv00104443.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:50:31+00:00 2018-09-27 21:50:31+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 104442 phv00104442.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:50:39+00:00 2018-09-27 21:50:39+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 104446 phv00104446.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:54:37+00:00 2018-09-27 21:54:37+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 104447 phv00104447.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:54:49+00:00 2018-09-27 21:54:49+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 104448 phv00104448.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:54:59+00:00 2018-09-27 21:54:59+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 104449 phv00104449.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:55:06+00:00 2018-09-27 21:55:06+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 104450 phv00104450.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:55:19+00:00 2018-09-27 21:55:19+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 104451 phv00104451.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:55:27+00:00 2018-09-27 21:55:27+00:00 TCAP06 Tricyclic anti-depressants plus anti-ps +74 Medication/supplement use 104452 phv00104452.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:55:37+00:00 2018-09-27 21:55:37+00:00 THRY06 Thyroid agents +74 Medication/supplement use 104453 phv00104453.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:55:45+00:00 2018-09-27 21:55:45+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 104454 phv00104454.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:55:54+00:00 2018-09-27 21:55:54+00:00 URCOS06 Uricosurics +74 Medication/supplement use 104455 phv00104455.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:56:14+00:00 2018-09-27 21:56:14+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 104456 phv00104456.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:56:24+00:00 2018-09-27 21:56:24+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 104457 phv00104457.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:56:32+00:00 2018-09-27 21:56:32+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 104458 phv00104458.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:56:48+00:00 2018-09-27 21:56:48+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 104459 phv00104459.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:56:57+00:00 2018-09-27 21:56:57+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 104460 phv00104460.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:57:07+00:00 2018-09-27 21:57:07+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 104461 phv00104461.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:57:19+00:00 2018-09-27 21:57:19+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 104462 phv00104462.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:57:27+00:00 2018-09-27 21:57:27+00:00 DIURET06 Any diuretic +74 Medication/supplement use 104463 phv00104463.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:57:35+00:00 2018-09-27 21:57:35+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 104464 phv00104464.v1.p1 pht001488.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:57:43+00:00 2018-09-27 21:57:43+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 104770 phv00104770.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:59:18+00:00 2018-09-27 21:59:18+00:00 ASPR06 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 104771 phv00104771.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:59:26+00:00 2018-09-27 21:59:26+00:00 DAYASP06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 104772 phv00104772.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:59:35+00:00 2018-09-27 21:59:35+00:00 FSHOIL06 CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS +74 Medication/supplement use 104773 phv00104773.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:59:45+00:00 2018-09-27 21:59:45+00:00 DAYFSH06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 104774 phv00104774.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 21:59:59+00:00 2018-09-27 21:59:59+00:00 ANTHST06 ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS) +74 Medication/supplement use 104775 phv00104775.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:00:08+00:00 2018-09-27 22:00:08+00:00 SLPILL06 SLEEPING PILLS +74 Medication/supplement use 104776 phv00104776.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:00:17+00:00 2018-09-27 22:00:17+00:00 LAXATV06 LAXATIVES +74 Medication/supplement use 104777 phv00104777.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:00:26+00:00 2018-09-27 22:00:26+00:00 CALC06 CALCIUM SUPPLEMENTS +74 Medication/supplement use 104780 phv00104780.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:00:36+00:00 2018-09-27 22:00:36+00:00 NITRO06 PRESCRIBE NITROGLYCERIN IN THE LAST YEAR +74 Medication/supplement use 104923 phv00104923.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:01:16+00:00 2018-09-27 22:01:16+00:00 ESTROC39 CURRENTLY TAKING ESTROGEN +74 Medication/supplement use 104924 phv00104924.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:01:25+00:00 2018-09-27 22:01:25+00:00 ECDAY39 CURRENT ESTROGEN DAYS/MONTH +74 Medication/supplement use 104925 phv00104925.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:01:39+00:00 2018-09-27 22:01:39+00:00 ECMO39 MONTHS CURRENTLY TAKING ESTROGEN +74 Medication/supplement use 104932 phv00104932.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:02:08+00:00 2018-09-27 22:02:08+00:00 ESTROP39 TOOK ESTROGEN IN THE PAST +74 Medication/supplement use 104933 phv00104933.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:02:20+00:00 2018-09-27 22:02:20+00:00 EPDAY39 PAST USE OF ESTROGEN DAYS/MONTH +74 Medication/supplement use 104934 phv00104934.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:02:38+00:00 2018-09-27 22:02:38+00:00 EYR39 YEAR STOPPED TAKING ESTROGEN +74 Medication/supplement use 104943 phv00104943.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:02:57+00:00 2018-09-27 22:02:57+00:00 PROGC39 CURRENTLY TAKING PROGESTIN +74 Medication/supplement use 104944 phv00104944.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:03:08+00:00 2018-09-27 22:03:08+00:00 PCDAY39 CURRENT PROGESTIN DAYS/MONTH +74 Medication/supplement use 105011 phv00105011.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:04:13+00:00 2018-09-27 22:04:13+00:00 NOMEDS06 Total Medications +74 Medication/supplement use 105012 phv00105012.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:04:25+00:00 2018-09-27 22:04:25+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 105013 phv00105013.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:04:36+00:00 2018-09-27 22:04:36+00:00 A2AD06 Combinations of angiotensin II antagonist +74 Medication/supplement use 105015 phv00105015.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:21:19+00:00 2018-09-27 22:21:19+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 105014 phv00105014.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:21:32+00:00 2018-09-27 22:21:32+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 105016 phv00105016.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:22:01+00:00 2018-09-27 22:22:01+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 105017 phv00105017.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:22:13+00:00 2018-09-27 22:22:13+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 105018 phv00105018.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:22:23+00:00 2018-09-27 22:22:23+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 105019 phv00105019.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:22:55+00:00 2018-09-27 22:22:55+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 105020 phv00105020.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:23:06+00:00 2018-09-27 22:23:06+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 105021 phv00105021.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:23:17+00:00 2018-09-27 22:23:17+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 105022 phv00105022.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:23:27+00:00 2018-09-27 22:23:27+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 105023 phv00105023.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:23:37+00:00 2018-09-27 22:23:37+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 105024 phv00105024.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:23:47+00:00 2018-09-27 22:23:47+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 105025 phv00105025.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:24:00+00:00 2018-09-27 22:24:00+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 105026 phv00105026.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:24:11+00:00 2018-09-27 22:24:11+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 105027 phv00105027.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:24:22+00:00 2018-09-27 22:24:22+00:00 ASA06 Aspirin from 280804 (anti-inflam agents) +74 Medication/supplement use 105028 phv00105028.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:24:38+00:00 2018-09-27 22:24:38+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 105029 phv00105029.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:24:52+00:00 2018-09-27 22:24:52+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 105030 phv00105030.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:25:09+00:00 2018-09-27 22:25:09+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 105031 phv00105031.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:25:25+00:00 2018-09-27 22:25:25+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 105032 phv00105032.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:25:35+00:00 2018-09-27 22:25:35+00:00 BGND06 Biguanides +74 Medication/supplement use 105033 phv00105033.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:25:44+00:00 2018-09-27 22:25:44+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 105034 phv00105034.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:25:54+00:00 2018-09-27 22:25:54+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 105035 phv00105035.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:26:05+00:00 2018-09-27 22:26:05+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 105036 phv00105036.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:26:25+00:00 2018-09-27 22:26:25+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 105037 phv00105037.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:26:34+00:00 2018-09-27 22:26:34+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 105038 phv00105038.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:26:47+00:00 2018-09-27 22:26:47+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 105039 phv00105039.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:26:59+00:00 2018-09-27 22:26:59+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 105040 phv00105040.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:27:16+00:00 2018-09-27 22:27:16+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 105041 phv00105041.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:27:29+00:00 2018-09-27 22:27:29+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 105042 phv00105042.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:27:45+00:00 2018-09-27 22:27:45+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 105043 phv00105043.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:27:55+00:00 2018-09-27 22:27:55+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 105046 phv00105046.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:28:07+00:00 2018-09-27 22:28:07+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 105047 phv00105047.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:28:17+00:00 2018-09-27 22:28:17+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 105048 phv00105048.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:28:29+00:00 2018-09-27 22:28:29+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 105049 phv00105049.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:28:47+00:00 2018-09-27 22:28:47+00:00 HPRNS06 Heparins +74 Medication/supplement use 105050 phv00105050.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:29:07+00:00 2018-09-27 22:29:07+00:00 INSULN06 Insulins +74 Medication/supplement use 105051 phv00105051.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:29:45+00:00 2018-09-27 22:29:45+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 105053 phv00105053.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:30:09+00:00 2018-09-27 22:30:09+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 105052 phv00105052.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:30:20+00:00 2018-09-27 22:30:20+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 105054 phv00105054.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:30:40+00:00 2018-09-27 22:30:40+00:00 KCL06 Potassium supplements +74 Medication/supplement use 105056 phv00105056.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:30:49+00:00 2018-09-27 22:30:49+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 105055 phv00105055.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:31:00+00:00 2018-09-27 22:31:00+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 105057 phv00105057.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:31:27+00:00 2018-09-27 22:31:27+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 105058 phv00105058.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:31:38+00:00 2018-09-27 22:31:38+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 105059 phv00105059.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:31:49+00:00 2018-09-27 22:31:49+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 105060 phv00105060.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:32:12+00:00 2018-09-27 22:32:12+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 105062 phv00105062.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:32:21+00:00 2018-09-27 22:32:21+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 105063 phv00105063.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:32:33+00:00 2018-09-27 22:32:33+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 105064 phv00105064.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:32:44+00:00 2018-09-27 22:32:44+00:00 NTG06 Nitrates +74 Medication/supplement use 105065 phv00105065.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:33:01+00:00 2018-09-27 22:33:01+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 105066 phv00105066.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:33:13+00:00 2018-09-27 22:33:13+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 105067 phv00105067.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:33:23+00:00 2018-09-27 22:33:23+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 105068 phv00105068.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:33:36+00:00 2018-09-27 22:33:36+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers' +74 Medication/supplement use 105069 phv00105069.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:34:09+00:00 2018-09-27 22:34:09+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 105070 phv00105070.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:34:18+00:00 2018-09-27 22:34:18+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 105071 phv00105071.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:34:29+00:00 2018-09-27 22:34:29+00:00 PROGST06 Progestins +74 Medication/supplement use 105072 phv00105072.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:34:38+00:00 2018-09-27 22:34:38+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 105073 phv00105073.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:34:53+00:00 2018-09-27 22:34:53+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 105074 phv00105074.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:35:06+00:00 2018-09-27 22:35:06+00:00 PROB06 Probucol +74 Medication/supplement use 105075 phv00105075.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:35:16+00:00 2018-09-27 22:35:16+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 105076 phv00105076.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:35:42+00:00 2018-09-27 22:35:42+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 105077 phv00105077.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:35:50+00:00 2018-09-27 22:35:50+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 105078 phv00105078.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:35:58+00:00 2018-09-27 22:35:58+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 105079 phv00105079.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:36:08+00:00 2018-09-27 22:36:08+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 105080 phv00105080.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:36:22+00:00 2018-09-27 22:36:22+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 105081 phv00105081.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:36:31+00:00 2018-09-27 22:36:31+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 105082 phv00105082.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:36:39+00:00 2018-09-27 22:36:39+00:00 THRY06 Thyroid agents +74 Medication/supplement use 105083 phv00105083.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:40:31+00:00 2018-09-27 22:40:31+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 105084 phv00105084.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:40:55+00:00 2018-09-27 22:40:55+00:00 URCOS06 Uricosurics +74 Medication/supplement use 105085 phv00105085.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:41:11+00:00 2018-09-27 22:41:11+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 105086 phv00105086.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:41:22+00:00 2018-09-27 22:41:22+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 105087 phv00105087.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:41:33+00:00 2018-09-27 22:41:33+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 105089 phv00105089.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:41:45+00:00 2018-09-27 22:41:45+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 105090 phv00105090.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:41:58+00:00 2018-09-27 22:41:58+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 105091 phv00105091.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:42:08+00:00 2018-09-27 22:42:08+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 105092 phv00105092.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:42:24+00:00 2018-09-27 22:42:24+00:00 DIURET06 Any diuretic +74 Medication/supplement use 105093 phv00105093.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:42:35+00:00 2018-09-27 22:42:35+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 105094 phv00105094.v1.p1 pht001489.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-27 22:42:49+00:00 2018-09-27 22:42:49+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 10672 phv00010672.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 12:39:01+00:00 2018-09-28 12:39:01+00:00 G681 RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - INJECTED (CHECK ALL THAT APPLY) +74 Medication/supplement use 251246 phv00251246.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 12:39:10+00:00 2018-09-28 12:39:10+00:00 g681 Respiratory Questionnaire: If yes, by what route - Injected Collection Interval: Exam 2 +74 Medication/supplement use 10673 phv00010673.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 12:39:30+00:00 2018-09-28 12:39:30+00:00 G682 RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - INHALED (CHECK ALL THAT APPLY) +74 Medication/supplement use 251247 phv00251247.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 12:39:39+00:00 2018-09-28 12:39:39+00:00 g682 Respiratory Questionnaire: If yes, by what route - Inhaled Collection Interval: Exam 2 +74 Medication/supplement use 10675 phv00010675.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 12:39:59+00:00 2018-09-28 12:39:59+00:00 G684 RESPIRATORY: IF YES TO G679, BY WHAT ROUTE - SKIN (CHECK ALL THAT APPLY) +74 Medication/supplement use 251249 phv00251249.v1.p10 pht004814.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 12:40:07+00:00 2018-09-28 12:40:07+00:00 g684 Respiratory Questionnaire: If yes, by what route - Skin Collection Interval: Exam 2 +74 Medication/supplement use 257910 phv00257910.v1.p10 pht005172.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:13:57+00:00 2018-09-28 13:13:57+00:00 chem_nm3 Description/label for chemical substance - third drug in compound (character variable) +74 Medication/supplement use 276921 phv00276921.v1.p10 pht006019.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:14:10+00:00 2018-09-28 13:14:10+00:00 chem_nm3 Description/label for chemical substance - third drug in compound (character variable) Collection Interval: Exam 3 +74 Medication/supplement use 3375 phv00003375.v1.p10 pht000020.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:17:27+00:00 2018-09-28 13:17:27+00:00 FK127 TYPE OF POTASSIUM SUPPLEMENT +74 Medication/supplement use 3781 phv00003781.v1.p10 pht000021.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:19:23+00:00 2018-09-28 13:19:23+00:00 FL136 PERIPHERAL VASODILATORS (HYDRALZINE, MINIPRES, MINOXIDIL, ETC.) +74 Medication/supplement use 6925 phv00006925.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:21:43+00:00 2018-09-28 13:21:43+00:00 FS316 FEMALE HORMONE REPLACEMENT: PATCH DOSE OF ESTROGEN +74 Medication/supplement use 72073 phv00072073.v4.p10 pht000747.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 13:23:23+00:00 2018-09-28 13:23:23+00:00 H045 IF PERIODS HAVE STOPPED, SINCE YOUR LAST EXAM HAVE YOU TAKEN HORMONE REPLACEMENT THERAPY? (ESTROGEN/PROGESTERONE) +74 Medication/supplement use 105623 phv00105623.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:36:47+00:00 2018-09-28 15:36:47+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WKS +74 Medication/supplement use 105624 phv00105624.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:36:58+00:00 2018-09-28 15:36:58+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 105625 phv00105625.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:37:12+00:00 2018-09-28 15:37:12+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 105626 phv00105626.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:37:24+00:00 2018-09-28 15:37:24+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 105627 phv00105627.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:37:35+00:00 2018-09-28 15:37:35+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 105632 phv00105632.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:37:52+00:00 2018-09-28 15:37:52+00:00 ASPR06 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 105633 phv00105633.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:38:01+00:00 2018-09-28 15:38:01+00:00 DAYASP06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 105634 phv00105634.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:38:11+00:00 2018-09-28 15:38:11+00:00 FSHOIL06 CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS +74 Medication/supplement use 105635 phv00105635.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:38:21+00:00 2018-09-28 15:38:21+00:00 DAYFSH06 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 105636 phv00105636.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:38:34+00:00 2018-09-28 15:38:34+00:00 ANTHST06 ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS) +74 Medication/supplement use 105637 phv00105637.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:38:46+00:00 2018-09-28 15:38:46+00:00 SLPILL06 SLEEPING PILLS +74 Medication/supplement use 105638 phv00105638.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:38:56+00:00 2018-09-28 15:38:56+00:00 LAXATV06 LAXATIVES +74 Medication/supplement use 105639 phv00105639.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:39:11+00:00 2018-09-28 15:39:11+00:00 CALC06 CALCIUM SUPPLEMENTS +74 Medication/supplement use 105642 phv00105642.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:39:40+00:00 2018-09-28 15:39:40+00:00 NITRO06 PRESCRIBE NITROGLYCERIN IN THE LAST YEAR +74 Medication/supplement use 106173 phv00106173.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:42:51+00:00 2018-09-28 15:42:51+00:00 VITAM58 DID YOU TAKE A VITAMIN SUPPLEMENT +74 Medication/supplement use 106175 phv00106175.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:44:39+00:00 2018-09-28 15:44:39+00:00 MDAYS58 DAYS TOOK A MULTIVITAMIN +74 Medication/supplement use 106176 phv00106176.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:44:48+00:00 2018-09-28 15:44:48+00:00 VITA58 DID YOU TAKE VITAMIN A +74 Medication/supplement use 106177 phv00106177.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:45:02+00:00 2018-09-28 15:45:02+00:00 ADAYS58 DAYS TOOK VITAMIN A +74 Medication/supplement use 106178 phv00106178.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:45:13+00:00 2018-09-28 15:45:13+00:00 VITC58 DID YOU TAKE VITAMIN C +74 Medication/supplement use 106179 phv00106179.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:45:22+00:00 2018-09-28 15:45:22+00:00 CDAYS58 DAYS TOOK VITAMIN C +74 Medication/supplement use 106180 phv00106180.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:45:33+00:00 2018-09-28 15:45:33+00:00 VITE58 DID YOU TAKE VITAMIN E +74 Medication/supplement use 106181 phv00106181.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:45:46+00:00 2018-09-28 15:45:46+00:00 EDAYS58 DAYS TOOK VITAMIN E +74 Medication/supplement use 106305 phv00106305.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:46:27+00:00 2018-09-28 15:46:27+00:00 ESTROC58 CURRENTLY TAKING ESTROGEN +74 Medication/supplement use 106306 phv00106306.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:46:39+00:00 2018-09-28 15:46:39+00:00 ECDAY58 CURRENT ESTROGEN DAYS/MONTH +74 Medication/supplement use 106307 phv00106307.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:46:55+00:00 2018-09-28 15:46:55+00:00 ECYR58 YEARS CURRENTLY TAKING ESTROGEN +74 Medication/supplement use 106316 phv00106316.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:47:10+00:00 2018-09-28 15:47:10+00:00 EPDAY58 PAST USE OF ESTROGEN DAYS/MONTH +74 Medication/supplement use 106327 phv00106327.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:47:26+00:00 2018-09-28 15:47:26+00:00 PROGC58 CURRENTLY TAKING PROGESTIN +74 Medication/supplement use 106330 phv00106330.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:47:38+00:00 2018-09-28 15:47:38+00:00 PROGP58 TOOK PROGESTIN IN THE PAST +74 Medication/supplement use 106431 phv00106431.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:48:19+00:00 2018-09-28 15:48:19+00:00 NOMEDS06 Number of medications +74 Medication/supplement use 106433 phv00106433.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:48:29+00:00 2018-09-28 15:48:29+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 106434 phv00106434.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:48:38+00:00 2018-09-28 15:48:38+00:00 A2AD06 Combinations of angiotensin II antagonist +74 Medication/supplement use 106435 phv00106435.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:48:46+00:00 2018-09-28 15:48:46+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 106436 phv00106436.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:48:54+00:00 2018-09-28 15:48:54+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 106437 phv00106437.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:49:11+00:00 2018-09-28 15:49:11+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 106438 phv00106438.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:49:23+00:00 2018-09-28 15:49:23+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 106439 phv00106439.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:49:35+00:00 2018-09-28 15:49:35+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 106440 phv00106440.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:49:46+00:00 2018-09-28 15:49:46+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 106441 phv00106441.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:49:56+00:00 2018-09-28 15:49:56+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 106442 phv00106442.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:50:05+00:00 2018-09-28 15:50:05+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 106443 phv00106443.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:50:26+00:00 2018-09-28 15:50:26+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 106444 phv00106444.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:50:34+00:00 2018-09-28 15:50:34+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 106445 phv00106445.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:50:43+00:00 2018-09-28 15:50:43+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 106446 phv00106446.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:50:52+00:00 2018-09-28 15:50:52+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 106447 phv00106447.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:51:00+00:00 2018-09-28 15:51:00+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 106448 phv00106448.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:51:09+00:00 2018-09-28 15:51:09+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 106449 phv00106449.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:51:17+00:00 2018-09-28 15:51:17+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 106450 phv00106450.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:51:29+00:00 2018-09-28 15:51:29+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 106451 phv00106451.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:51:38+00:00 2018-09-28 15:51:38+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 106452 phv00106452.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:51:46+00:00 2018-09-28 15:51:46+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 106453 phv00106453.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:51:56+00:00 2018-09-28 15:51:56+00:00 BGND06 Biguanides +74 Medication/supplement use 106454 phv00106454.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:52:07+00:00 2018-09-28 15:52:07+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 106455 phv00106455.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:52:15+00:00 2018-09-28 15:52:15+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 106456 phv00106456.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:52:28+00:00 2018-09-28 15:52:28+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 106457 phv00106457.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:52:37+00:00 2018-09-28 15:52:37+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 106458 phv00106458.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:52:46+00:00 2018-09-28 15:52:46+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 106459 phv00106459.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:52:57+00:00 2018-09-28 15:52:57+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 106460 phv00106460.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:53:05+00:00 2018-09-28 15:53:05+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 106461 phv00106461.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:53:13+00:00 2018-09-28 15:53:13+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 106462 phv00106462.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:53:23+00:00 2018-09-28 15:53:23+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 106463 phv00106463.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:53:37+00:00 2018-09-28 15:53:37+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 106464 phv00106464.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:53:47+00:00 2018-09-28 15:53:47+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 106465 phv00106465.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:53:55+00:00 2018-09-28 15:53:55+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 106466 phv00106466.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:54:01+00:00 2018-09-28 15:54:01+00:00 FIBR06 Fibrates +74 Medication/supplement use 106467 phv00106467.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:54:10+00:00 2018-09-28 15:54:10+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 106468 phv00106468.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:54:18+00:00 2018-09-28 15:54:18+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 106469 phv00106469.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:54:28+00:00 2018-09-28 15:54:28+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 106470 phv00106470.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:54:36+00:00 2018-09-28 15:54:36+00:00 HPRNS06 Heparins +74 Medication/supplement use 106471 phv00106471.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:54:51+00:00 2018-09-28 15:54:51+00:00 INSULN06 Insulins +74 Medication/supplement use 106472 phv00106472.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:55:03+00:00 2018-09-28 15:55:03+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 106473 phv00106473.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:55:11+00:00 2018-09-28 15:55:11+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 106474 phv00106474.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:55:19+00:00 2018-09-28 15:55:19+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 106475 phv00106475.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:55:28+00:00 2018-09-28 15:55:28+00:00 KCL06 Potassium supplements +74 Medication/supplement use 106476 phv00106476.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:55:40+00:00 2018-09-28 15:55:40+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 106477 phv00106477.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:55:48+00:00 2018-09-28 15:55:48+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 106478 phv00106478.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:56:01+00:00 2018-09-28 15:56:01+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 106479 phv00106479.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:56:10+00:00 2018-09-28 15:56:10+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 106480 phv00106480.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:56:27+00:00 2018-09-28 15:56:27+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 106481 phv00106481.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:56:35+00:00 2018-09-28 15:56:35+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 106482 phv00106482.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:56:49+00:00 2018-09-28 15:56:49+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 106483 phv00106483.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:57:01+00:00 2018-09-28 15:57:01+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 106484 phv00106484.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:57:15+00:00 2018-09-28 15:57:15+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 106485 phv00106485.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:57:26+00:00 2018-09-28 15:57:26+00:00 NTG06 Nitrates +74 Medication/supplement use 106486 phv00106486.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:57:35+00:00 2018-09-28 15:57:35+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 106487 phv00106487.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:57:43+00:00 2018-09-28 15:57:43+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 106488 phv00106488.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:57:52+00:00 2018-09-28 15:57:52+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 106489 phv00106489.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:58:04+00:00 2018-09-28 15:58:04+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers +74 Medication/supplement use 106490 phv00106490.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:58:15+00:00 2018-09-28 15:58:15+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 106491 phv00106491.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:58:24+00:00 2018-09-28 15:58:24+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 106492 phv00106492.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:58:34+00:00 2018-09-28 15:58:34+00:00 PROGST06 Progestins +74 Medication/supplement use 106493 phv00106493.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:58:44+00:00 2018-09-28 15:58:44+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 106494 phv00106494.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:58:51+00:00 2018-09-28 15:58:51+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 106495 phv00106495.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:59:00+00:00 2018-09-28 15:59:00+00:00 PROB06 Probucol +74 Medication/supplement use 106496 phv00106496.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:59:08+00:00 2018-09-28 15:59:08+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 106497 phv00106497.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:59:17+00:00 2018-09-28 15:59:17+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 106498 phv00106498.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:59:26+00:00 2018-09-28 15:59:26+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 106499 phv00106499.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:59:35+00:00 2018-09-28 15:59:35+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 106500 phv00106500.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:59:47+00:00 2018-09-28 15:59:47+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 106501 phv00106501.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 15:59:55+00:00 2018-09-28 15:59:55+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 106502 phv00106502.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:00:05+00:00 2018-09-28 16:00:05+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 106503 phv00106503.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:00:15+00:00 2018-09-28 16:00:15+00:00 THRY06 Thyroid agents +74 Medication/supplement use 106504 phv00106504.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:00:24+00:00 2018-09-28 16:00:24+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 106505 phv00106505.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:00:32+00:00 2018-09-28 16:00:32+00:00 URCOS06 Uricosurics +74 Medication/supplement use 106506 phv00106506.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:00:41+00:00 2018-09-28 16:00:41+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 106507 phv00106507.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:00:48+00:00 2018-09-28 16:00:48+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 106508 phv00106508.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:00:56+00:00 2018-09-28 16:00:56+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 106509 phv00106509.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:01:04+00:00 2018-09-28 16:01:04+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 106510 phv00106510.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:01:19+00:00 2018-09-28 16:01:19+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 106511 phv00106511.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:01:31+00:00 2018-09-28 16:01:31+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 106512 phv00106512.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:01:39+00:00 2018-09-28 16:01:39+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 106513 phv00106513.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:01:48+00:00 2018-09-28 16:01:48+00:00 DIURET06 Any diuretic +74 Medication/supplement use 106514 phv00106514.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:01:57+00:00 2018-09-28 16:01:57+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 106515 phv00106515.v1.p1 pht001490.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:02:05+00:00 2018-09-28 16:02:05+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 107204 phv00107204.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:29:51+00:00 2018-09-28 16:29:51+00:00 MLTVIT29 TAKEN MULTIPLE OR OTHER VITAMIN +74 Medication/supplement use 107205 phv00107205.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:30:03+00:00 2018-09-28 16:30:03+00:00 MULTI29 TOOK MULTIPLE VITAMIN +74 Medication/supplement use 107206 phv00107206.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:30:16+00:00 2018-09-28 16:30:16+00:00 MDAYS29 DAYS TOOK MULTIPLE VITAMIN +74 Medication/supplement use 107207 phv00107207.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:30:27+00:00 2018-09-28 16:30:27+00:00 VITA29 TOOK VITAMIN A +74 Medication/supplement use 107208 phv00107208.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:30:39+00:00 2018-09-28 16:30:39+00:00 ADAYS29 DAYS TOOK VITAMIN A +74 Medication/supplement use 107209 phv00107209.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:30:49+00:00 2018-09-28 16:30:49+00:00 VITC29 TOOK VITAMIN C +74 Medication/supplement use 107211 phv00107211.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:31:06+00:00 2018-09-28 16:31:06+00:00 VITE29 TOOK VITAMIN E +74 Medication/supplement use 107210 phv00107210.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:31:29+00:00 2018-09-28 16:31:29+00:00 CDAYS29 DAYS TOOK VITAMIN C +74 Medication/supplement use 107212 phv00107212.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:31:52+00:00 2018-09-28 16:31:52+00:00 EDAYS29 DAYS TOOK VITAMIN E +74 Medication/supplement use 107243 phv00107243.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:32:14+00:00 2018-09-28 16:32:14+00:00 ESTROC29 CURRENTLY TAKING ESTROGEN +74 Medication/supplement use 107244 phv00107244.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:32:25+00:00 2018-09-28 16:32:25+00:00 ECDAY29 DAYS PER MONTH TAKE ESTROGEN +74 Medication/supplement use 107265 phv00107265.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:32:43+00:00 2018-09-28 16:32:43+00:00 PROGC29 CURRENTLY TAKING PROGESTIN +74 Medication/supplement use 107266 phv00107266.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:32:54+00:00 2018-09-28 16:32:54+00:00 PCDAY29 DAYS PER MONTH TAKING PROGESTIN +74 Medication/supplement use 107348 phv00107348.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:34:07+00:00 2018-09-28 16:34:07+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WKS +74 Medication/supplement use 107356 phv00107356.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:34:17+00:00 2018-09-28 16:34:17+00:00 NOMEDS06 Number of medications +74 Medication/supplement use 107357 phv00107357.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:34:28+00:00 2018-09-28 16:34:28+00:00 TAKMED06 TAKE ANY MEDICATIONS +74 Medication/supplement use 107358 phv00107358.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:34:37+00:00 2018-09-28 16:34:37+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 107349 phv00107349.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:34:49+00:00 2018-09-28 16:34:49+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 107350 phv00107350.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:34:57+00:00 2018-09-28 16:34:57+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 107351 phv00107351.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:35:08+00:00 2018-09-28 16:35:08+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 107352 phv00107352.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:35:16+00:00 2018-09-28 16:35:16+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 107359 phv00107359.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:35:30+00:00 2018-09-28 16:35:30+00:00 A2AD06 Combinations of angiotensin II antagonist +74 Medication/supplement use 107360 phv00107360.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:35:38+00:00 2018-09-28 16:35:38+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 107361 phv00107361.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:35:46+00:00 2018-09-28 16:35:46+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 107362 phv00107362.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:35:55+00:00 2018-09-28 16:35:55+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 107363 phv00107363.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:36:04+00:00 2018-09-28 16:36:04+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 107364 phv00107364.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:36:12+00:00 2018-09-28 16:36:12+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 107365 phv00107365.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:36:22+00:00 2018-09-28 16:36:22+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 107366 phv00107366.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:36:31+00:00 2018-09-28 16:36:31+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 107367 phv00107367.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:36:41+00:00 2018-09-28 16:36:41+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 107368 phv00107368.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:36:49+00:00 2018-09-28 16:36:49+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 107369 phv00107369.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:36:57+00:00 2018-09-28 16:36:57+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 107370 phv00107370.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:37:04+00:00 2018-09-28 16:37:04+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 107371 phv00107371.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:37:15+00:00 2018-09-28 16:37:15+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 107372 phv00107372.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:37:27+00:00 2018-09-28 16:37:27+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 107373 phv00107373.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:37:35+00:00 2018-09-28 16:37:35+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 107374 phv00107374.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:37:48+00:00 2018-09-28 16:37:48+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 107375 phv00107375.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:37:55+00:00 2018-09-28 16:37:55+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 107376 phv00107376.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:38:04+00:00 2018-09-28 16:38:04+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 107377 phv00107377.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:38:13+00:00 2018-09-28 16:38:13+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 107378 phv00107378.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:38:21+00:00 2018-09-28 16:38:21+00:00 BGND06 Biguanides +74 Medication/supplement use 107379 phv00107379.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:38:29+00:00 2018-09-28 16:38:29+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 107380 phv00107380.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:38:36+00:00 2018-09-28 16:38:36+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 107381 phv00107381.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:38:45+00:00 2018-09-28 16:38:45+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 107382 phv00107382.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:38:54+00:00 2018-09-28 16:38:54+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 107383 phv00107383.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:39:02+00:00 2018-09-28 16:39:02+00:00 COX206 Cox-2 inhibitors (NSAID agents) ; seperat +74 Medication/supplement use 107384 phv00107384.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:39:11+00:00 2018-09-28 16:39:11+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 107385 phv00107385.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:39:20+00:00 2018-09-28 16:39:20+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 107386 phv00107386.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:39:27+00:00 2018-09-28 16:39:27+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 107387 phv00107387.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:39:35+00:00 2018-09-28 16:39:35+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 107389 phv00107389.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:39:46+00:00 2018-09-28 16:39:46+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 107390 phv00107390.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:39:56+00:00 2018-09-28 16:39:56+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 107391 phv00107391.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:40:04+00:00 2018-09-28 16:40:04+00:00 FIBR06 Fibrates +74 Medication/supplement use 107392 phv00107392.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:40:12+00:00 2018-09-28 16:40:12+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 107393 phv00107393.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:40:20+00:00 2018-09-28 16:40:20+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 107394 phv00107394.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:40:29+00:00 2018-09-28 16:40:29+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 107395 phv00107395.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:40:38+00:00 2018-09-28 16:40:38+00:00 HPRNS06 Heparins +74 Medication/supplement use 107396 phv00107396.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:40:47+00:00 2018-09-28 16:40:47+00:00 INSULN06 Insulins +74 Medication/supplement use 107397 phv00107397.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:40:55+00:00 2018-09-28 16:40:55+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 107398 phv00107398.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:41:04+00:00 2018-09-28 16:41:04+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 107399 phv00107399.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:41:13+00:00 2018-09-28 16:41:13+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 107400 phv00107400.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:41:22+00:00 2018-09-28 16:41:22+00:00 KCL06 Potassium supplements +74 Medication/supplement use 107401 phv00107401.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:41:31+00:00 2018-09-28 16:41:31+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 107402 phv00107402.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:41:41+00:00 2018-09-28 16:41:41+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 107403 phv00107403.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:41:50+00:00 2018-09-28 16:41:50+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 107404 phv00107404.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:41:58+00:00 2018-09-28 16:41:58+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 107405 phv00107405.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:42:08+00:00 2018-09-28 16:42:08+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 107406 phv00107406.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:42:20+00:00 2018-09-28 16:42:20+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 107407 phv00107407.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:42:28+00:00 2018-09-28 16:42:28+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 107408 phv00107408.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:42:39+00:00 2018-09-28 16:42:39+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 107409 phv00107409.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:42:47+00:00 2018-09-28 16:42:47+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 107410 phv00107410.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:42:57+00:00 2018-09-28 16:42:57+00:00 NTG06 Nitrates +74 Medication/supplement use 107411 phv00107411.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:43:06+00:00 2018-09-28 16:43:06+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 107412 phv00107412.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:43:15+00:00 2018-09-28 16:43:15+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 107413 phv00107413.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:43:23+00:00 2018-09-28 16:43:23+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 107414 phv00107414.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:43:32+00:00 2018-09-28 16:43:32+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers +74 Medication/supplement use 107415 phv00107415.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:43:40+00:00 2018-09-28 16:43:40+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 107416 phv00107416.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:43:48+00:00 2018-09-28 16:43:48+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 107417 phv00107417.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:43:57+00:00 2018-09-28 16:43:57+00:00 PROGST06 Progestins +74 Medication/supplement use 107418 phv00107418.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:44:05+00:00 2018-09-28 16:44:05+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 107419 phv00107419.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:44:12+00:00 2018-09-28 16:44:12+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 107420 phv00107420.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:44:20+00:00 2018-09-28 16:44:20+00:00 PROB06 Probucol +74 Medication/supplement use 107421 phv00107421.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:44:33+00:00 2018-09-28 16:44:33+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 107422 phv00107422.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:44:41+00:00 2018-09-28 16:44:41+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 107423 phv00107423.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:44:48+00:00 2018-09-28 16:44:48+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 107424 phv00107424.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:44:57+00:00 2018-09-28 16:44:57+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 107425 phv00107425.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:45:05+00:00 2018-09-28 16:45:05+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 107426 phv00107426.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:45:12+00:00 2018-09-28 16:45:12+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 107427 phv00107427.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:45:20+00:00 2018-09-28 16:45:20+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 107428 phv00107428.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:45:27+00:00 2018-09-28 16:45:27+00:00 THRY06 Thyroid agents +74 Medication/supplement use 107429 phv00107429.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:45:37+00:00 2018-09-28 16:45:37+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 107430 phv00107430.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:45:52+00:00 2018-09-28 16:45:52+00:00 URCOS06 Uricosurics +74 Medication/supplement use 107431 phv00107431.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:46:03+00:00 2018-09-28 16:46:03+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 107432 phv00107432.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:46:12+00:00 2018-09-28 16:46:12+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 107433 phv00107433.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:46:20+00:00 2018-09-28 16:46:20+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 107434 phv00107434.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:46:27+00:00 2018-09-28 16:46:27+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 107435 phv00107435.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:46:36+00:00 2018-09-28 16:46:36+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 107436 phv00107436.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:46:46+00:00 2018-09-28 16:46:46+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 107437 phv00107437.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:46:56+00:00 2018-09-28 16:46:56+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 107438 phv00107438.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:47:06+00:00 2018-09-28 16:47:06+00:00 DIURET06 Any diuretic +74 Medication/supplement use 107439 phv00107439.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:47:14+00:00 2018-09-28 16:47:14+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 107440 phv00107440.v1.p1 pht001491.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 16:47:24+00:00 2018-09-28 16:47:24+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 107782 phv00107782.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:27:31+00:00 2018-09-28 17:27:31+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 107783 phv00107783.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:27:40+00:00 2018-09-28 17:27:40+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 107784 phv00107784.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:27:50+00:00 2018-09-28 17:27:50+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 107785 phv00107785.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:27:58+00:00 2018-09-28 17:27:58+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 108064 phv00108064.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:29:08+00:00 2018-09-28 17:29:08+00:00 MLTVIT59 TAKEN MULTIPLE OR OTHER VITAMIN +74 Medication/supplement use 108066 phv00108066.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:29:18+00:00 2018-09-28 17:29:18+00:00 MDAYS59 DAYS TOOK MULTIPLE VITAMIN +74 Medication/supplement use 108065 phv00108065.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:29:27+00:00 2018-09-28 17:29:27+00:00 MULTI59 TOOK MULTIPLE VITAMIN +74 Medication/supplement use 108067 phv00108067.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:29:35+00:00 2018-09-28 17:29:35+00:00 VITA59 TOOK VITAMIN A +74 Medication/supplement use 108068 phv00108068.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:29:44+00:00 2018-09-28 17:29:44+00:00 ADAYS59 DAYS TOOK VITAMIN A +74 Medication/supplement use 108069 phv00108069.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:29:53+00:00 2018-09-28 17:29:53+00:00 VITC59 TOOK VITAMIN C +74 Medication/supplement use 108070 phv00108070.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:30:10+00:00 2018-09-28 17:30:10+00:00 CDAYS59 DAYS TOOK VITAMIN C +74 Medication/supplement use 108071 phv00108071.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:30:19+00:00 2018-09-28 17:30:19+00:00 VITE59 TOOK VITAMIN E +74 Medication/supplement use 108072 phv00108072.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:30:29+00:00 2018-09-28 17:30:29+00:00 EDAYS59 DAYS TOOK VITAMIN E +74 Medication/supplement use 108073 phv00108073.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:30:38+00:00 2018-09-28 17:30:38+00:00 ASPR59 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 108074 phv00108074.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:30:53+00:00 2018-09-28 17:30:53+00:00 DAYASP59 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 108075 phv00108075.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:31:03+00:00 2018-09-28 17:31:03+00:00 FSHOIL59 CODLIVER OIL/OTHER FISH-OIL SUPPLEMENTS +74 Medication/supplement use 108077 phv00108077.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:31:18+00:00 2018-09-28 17:31:18+00:00 ANTHST59 ANTIHISTAMINES(COLD PILLS, ALLERGY PILLS) +74 Medication/supplement use 108078 phv00108078.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:31:35+00:00 2018-09-28 17:31:35+00:00 SLPILL59 SLEEPING PILLS +74 Medication/supplement use 108079 phv00108079.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:31:45+00:00 2018-09-28 17:31:45+00:00 LAXATV59 LAXATIVES +74 Medication/supplement use 108080 phv00108080.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:31:55+00:00 2018-09-28 17:31:55+00:00 CALC59 CALCIUM SUPPLEMENTS +74 Medication/supplement use 108113 phv00108113.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:32:21+00:00 2018-09-28 17:32:21+00:00 ESTROC59 CURRENTLY TAKING ESTROGEN +74 Medication/supplement use 108114 phv00108114.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:32:31+00:00 2018-09-28 17:32:31+00:00 ECDAY59 DAYS PER MONTH TAKE ESTROGEN +74 Medication/supplement use 108135 phv00108135.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:32:42+00:00 2018-09-28 17:32:42+00:00 PROGC59 CURRENTLY TAKING PROGESTIN +74 Medication/supplement use 108136 phv00108136.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:32:54+00:00 2018-09-28 17:32:54+00:00 PCDAY59 DAYS PER MONTH TAKING PROGESTIN +74 Medication/supplement use 108213 phv00108213.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:33:18+00:00 2018-09-28 17:33:18+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WKS +74 Medication/supplement use 108218 phv00108218.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:33:31+00:00 2018-09-28 17:33:31+00:00 NOMEDS06 Total Medications +74 Medication/supplement use 108219 phv00108219.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:33:41+00:00 2018-09-28 17:33:41+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 108220 phv00108220.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:33:49+00:00 2018-09-28 17:33:49+00:00 A2AD06 Combinations of angiotensin II antagonists +74 Medication/supplement use 108221 phv00108221.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:34:00+00:00 2018-09-28 17:34:00+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 108222 phv00108222.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:34:09+00:00 2018-09-28 17:34:09+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 108223 phv00108223.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:34:18+00:00 2018-09-28 17:34:18+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 108224 phv00108224.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:34:26+00:00 2018-09-28 17:34:26+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 108225 phv00108225.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:34:33+00:00 2018-09-28 17:34:33+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 108226 phv00108226.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:34:46+00:00 2018-09-28 17:34:46+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 108227 phv00108227.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:34:57+00:00 2018-09-28 17:34:57+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 108228 phv00108228.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:35:10+00:00 2018-09-28 17:35:10+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 108229 phv00108229.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:35:19+00:00 2018-09-28 17:35:19+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 108230 phv00108230.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:35:32+00:00 2018-09-28 17:35:32+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 108231 phv00108231.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:35:48+00:00 2018-09-28 17:35:48+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 108232 phv00108232.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:35:57+00:00 2018-09-28 17:35:57+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 108233 phv00108233.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:36:11+00:00 2018-09-28 17:36:11+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 108234 phv00108234.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:36:20+00:00 2018-09-28 17:36:20+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 108235 phv00108235.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:36:29+00:00 2018-09-28 17:36:29+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 108236 phv00108236.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:36:43+00:00 2018-09-28 17:36:43+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 108237 phv00108237.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:36:53+00:00 2018-09-28 17:36:53+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 108238 phv00108238.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:37:01+00:00 2018-09-28 17:37:01+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 108239 phv00108239.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:37:09+00:00 2018-09-28 17:37:09+00:00 BGND06 Biguanides +74 Medication/supplement use 108240 phv00108240.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:37:25+00:00 2018-09-28 17:37:25+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 108241 phv00108241.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:37:40+00:00 2018-09-28 17:37:40+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 108242 phv00108242.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:37:48+00:00 2018-09-28 17:37:48+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 108243 phv00108243.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:37:58+00:00 2018-09-28 17:37:58+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 108244 phv00108244.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:48:11+00:00 2018-09-28 17:48:11+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 108245 phv00108245.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:48:20+00:00 2018-09-28 17:48:20+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 108246 phv00108246.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:48:31+00:00 2018-09-28 17:48:31+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 108247 phv00108247.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:48:41+00:00 2018-09-28 17:48:41+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 108248 phv00108248.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:48:51+00:00 2018-09-28 17:48:51+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 108249 phv00108249.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:49:00+00:00 2018-09-28 17:49:00+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 108250 phv00108250.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:53:13+00:00 2018-09-28 17:53:13+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 108251 phv00108251.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:53:24+00:00 2018-09-28 17:53:24+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 108252 phv00108252.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:53:37+00:00 2018-09-28 17:53:37+00:00 FIBR06 Fibrates +74 Medication/supplement use 108253 phv00108253.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:53:51+00:00 2018-09-28 17:53:51+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 108254 phv00108254.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:54:00+00:00 2018-09-28 17:54:00+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 108255 phv00108255.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:54:08+00:00 2018-09-28 17:54:08+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 108256 phv00108256.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:54:16+00:00 2018-09-28 17:54:16+00:00 HPRNS06 Heparins +74 Medication/supplement use 108257 phv00108257.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:54:24+00:00 2018-09-28 17:54:24+00:00 INSULN06 Insulins +74 Medication/supplement use 108258 phv00108258.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:54:33+00:00 2018-09-28 17:54:33+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 108259 phv00108259.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:54:43+00:00 2018-09-28 17:54:43+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 108260 phv00108260.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:54:54+00:00 2018-09-28 17:54:54+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 108261 phv00108261.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:55:06+00:00 2018-09-28 17:55:06+00:00 KCL06 Potassium supplements +74 Medication/supplement use 108262 phv00108262.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:55:16+00:00 2018-09-28 17:55:16+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 108263 phv00108263.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:55:57+00:00 2018-09-28 17:55:57+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 108264 phv00108264.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:56:06+00:00 2018-09-28 17:56:06+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 108265 phv00108265.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:56:15+00:00 2018-09-28 17:56:15+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 108266 phv00108266.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:56:26+00:00 2018-09-28 17:56:26+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 108267 phv00108267.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:56:34+00:00 2018-09-28 17:56:34+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 108268 phv00108268.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:56:42+00:00 2018-09-28 17:56:42+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 108269 phv00108269.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:56:50+00:00 2018-09-28 17:56:50+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 108270 phv00108270.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:56:58+00:00 2018-09-28 17:56:58+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 108271 phv00108271.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:57:08+00:00 2018-09-28 17:57:08+00:00 NTG06 Nitrates +74 Medication/supplement use 108272 phv00108272.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:57:19+00:00 2018-09-28 17:57:19+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 108273 phv00108273.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:57:28+00:00 2018-09-28 17:57:28+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 108274 phv00108274.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:57:35+00:00 2018-09-28 17:57:35+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 108275 phv00108275.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:57:49+00:00 2018-09-28 17:57:49+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers' +74 Medication/supplement use 108276 phv00108276.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:57:58+00:00 2018-09-28 17:57:58+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 108277 phv00108277.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:58:06+00:00 2018-09-28 17:58:06+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 108278 phv00108278.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:58:15+00:00 2018-09-28 17:58:15+00:00 PROGST06 Progestins +74 Medication/supplement use 108279 phv00108279.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:58:23+00:00 2018-09-28 17:58:23+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 108280 phv00108280.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:58:37+00:00 2018-09-28 17:58:37+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 108281 phv00108281.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:58:45+00:00 2018-09-28 17:58:45+00:00 PROB06 Probucol +74 Medication/supplement use 108282 phv00108282.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:58:53+00:00 2018-09-28 17:58:53+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 108283 phv00108283.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:59:01+00:00 2018-09-28 17:59:01+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 108284 phv00108284.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:59:26+00:00 2018-09-28 17:59:26+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 108285 phv00108285.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:59:35+00:00 2018-09-28 17:59:35+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 108286 phv00108286.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:59:44+00:00 2018-09-28 17:59:44+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 108287 phv00108287.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 17:59:53+00:00 2018-09-28 17:59:53+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 108288 phv00108288.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:00:01+00:00 2018-09-28 18:00:01+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 108289 phv00108289.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:00:11+00:00 2018-09-28 18:00:11+00:00 THRY06 Thyroid agents +74 Medication/supplement use 108290 phv00108290.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:00:23+00:00 2018-09-28 18:00:23+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 108291 phv00108291.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:00:30+00:00 2018-09-28 18:00:30+00:00 URCOS06 Uricosurics +74 Medication/supplement use 108292 phv00108292.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:00:37+00:00 2018-09-28 18:00:37+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 108293 phv00108293.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:00:44+00:00 2018-09-28 18:00:44+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 108294 phv00108294.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:00:56+00:00 2018-09-28 18:00:56+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 108295 phv00108295.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:01:05+00:00 2018-09-28 18:01:05+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 108296 phv00108296.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:01:13+00:00 2018-09-28 18:01:13+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 108297 phv00108297.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:01:21+00:00 2018-09-28 18:01:21+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 108298 phv00108298.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:01:29+00:00 2018-09-28 18:01:29+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 108299 phv00108299.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:01:39+00:00 2018-09-28 18:01:39+00:00 DIURET06 Any diuretic +74 Medication/supplement use 108300 phv00108300.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:01:47+00:00 2018-09-28 18:01:47+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 108301 phv00108301.v1.p1 pht001492.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 18:01:58+00:00 2018-09-28 18:01:58+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 108747 phv00108747.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:00:49+00:00 2018-09-28 20:00:49+00:00 ESTROC59 CURRENTLY TAKING ESTROGEN +74 Medication/supplement use 108748 phv00108748.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:00:59+00:00 2018-09-28 20:00:59+00:00 ECDAY59 DAYS PER MONTH TAKE ESTROGEN +74 Medication/supplement use 108755 phv00108755.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:01:12+00:00 2018-09-28 20:01:12+00:00 PROGC59 CURRENTLY TAKING PROGESTIN +74 Medication/supplement use 108756 phv00108756.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:01:21+00:00 2018-09-28 20:01:21+00:00 PCDAY59 DAYS PER MONTH TAKING PROGESTIN +74 Medication/supplement use 108841 phv00108841.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:01:48+00:00 2018-09-28 20:01:48+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 108842 phv00108842.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:01:55+00:00 2018-09-28 20:01:55+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 108843 phv00108843.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:02:05+00:00 2018-09-28 20:02:05+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 108844 phv00108844.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:02:15+00:00 2018-09-28 20:02:15+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 108845 phv00108845.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:02:24+00:00 2018-09-28 20:02:24+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WEEKS +74 Medication/supplement use 108972 phv00108972.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:03:08+00:00 2018-09-28 20:03:08+00:00 NOMEDS06 Total Medications +74 Medication/supplement use 108973 phv00108973.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:03:17+00:00 2018-09-28 20:03:17+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 108974 phv00108974.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:03:25+00:00 2018-09-28 20:03:25+00:00 A2AD06 Combinations of angiotensin II antagonists +74 Medication/supplement use 108975 phv00108975.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:03:33+00:00 2018-09-28 20:03:33+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 108976 phv00108976.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:03:41+00:00 2018-09-28 20:03:41+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 108977 phv00108977.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:03:56+00:00 2018-09-28 20:03:56+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 108978 phv00108978.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:04:08+00:00 2018-09-28 20:04:08+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 108979 phv00108979.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:04:17+00:00 2018-09-28 20:04:17+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 108980 phv00108980.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:04:30+00:00 2018-09-28 20:04:30+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 108981 phv00108981.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:04:38+00:00 2018-09-28 20:04:38+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 108982 phv00108982.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:04:52+00:00 2018-09-28 20:04:52+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 108983 phv00108983.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:05:02+00:00 2018-09-28 20:05:02+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 108984 phv00108984.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:05:10+00:00 2018-09-28 20:05:10+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 108985 phv00108985.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:05:17+00:00 2018-09-28 20:05:17+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 108986 phv00108986.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:05:25+00:00 2018-09-28 20:05:25+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 108987 phv00108987.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:05:38+00:00 2018-09-28 20:05:38+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 108988 phv00108988.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:05:47+00:00 2018-09-28 20:05:47+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 108989 phv00108989.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:05:55+00:00 2018-09-28 20:05:55+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 108990 phv00108990.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:06:04+00:00 2018-09-28 20:06:04+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 108991 phv00108991.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:06:13+00:00 2018-09-28 20:06:13+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 108992 phv00108992.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:06:25+00:00 2018-09-28 20:06:25+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 108993 phv00108993.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:06:32+00:00 2018-09-28 20:06:32+00:00 BGND06 Biguanides +74 Medication/supplement use 108994 phv00108994.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:06:41+00:00 2018-09-28 20:06:41+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 108998 phv00108998.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:06:49+00:00 2018-09-28 20:06:49+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 108999 phv00108999.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:06:57+00:00 2018-09-28 20:06:57+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 109000 phv00109000.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:07:08+00:00 2018-09-28 20:07:08+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 109001 phv00109001.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:07:16+00:00 2018-09-28 20:07:16+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 109002 phv00109002.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:07:24+00:00 2018-09-28 20:07:24+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 109003 phv00109003.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:07:32+00:00 2018-09-28 20:07:32+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 109004 phv00109004.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:07:43+00:00 2018-09-28 20:07:43+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 109005 phv00109005.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:07:53+00:00 2018-09-28 20:07:53+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 109006 phv00109006.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:08:00+00:00 2018-09-28 20:08:00+00:00 FIBR06 Fibrates +74 Medication/supplement use 109007 phv00109007.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:08:08+00:00 2018-09-28 20:08:08+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 109008 phv00109008.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:08:16+00:00 2018-09-28 20:08:16+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 109009 phv00109009.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:08:26+00:00 2018-09-28 20:08:26+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 109010 phv00109010.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:08:52+00:00 2018-09-28 20:08:52+00:00 HPRNS06 Heparins +74 Medication/supplement use 109011 phv00109011.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:08:59+00:00 2018-09-28 20:08:59+00:00 INSULN06 Insulins +74 Medication/supplement use 109012 phv00109012.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:09:07+00:00 2018-09-28 20:09:07+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 109013 phv00109013.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:09:15+00:00 2018-09-28 20:09:15+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 109014 phv00109014.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:09:23+00:00 2018-09-28 20:09:23+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 109015 phv00109015.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:09:32+00:00 2018-09-28 20:09:32+00:00 KCL06 Potassium supplements +74 Medication/supplement use 109016 phv00109016.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:09:46+00:00 2018-09-28 20:09:46+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 109017 phv00109017.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:10:00+00:00 2018-09-28 20:10:00+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 109018 phv00109018.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:10:09+00:00 2018-09-28 20:10:09+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 109019 phv00109019.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:10:34+00:00 2018-09-28 20:10:34+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 109020 phv00109020.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:10:46+00:00 2018-09-28 20:10:46+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 109021 phv00109021.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:11:03+00:00 2018-09-28 20:11:03+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 109022 phv00109022.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:11:12+00:00 2018-09-28 20:11:12+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 109023 phv00109023.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:11:21+00:00 2018-09-28 20:11:21+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 109024 phv00109024.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:11:31+00:00 2018-09-28 20:11:31+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 109025 phv00109025.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:11:38+00:00 2018-09-28 20:11:38+00:00 NTG06 Nitrates +74 Medication/supplement use 109026 phv00109026.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:11:46+00:00 2018-09-28 20:11:46+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 109027 phv00109027.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:11:53+00:00 2018-09-28 20:11:53+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 109028 phv00109028.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:12:01+00:00 2018-09-28 20:12:01+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 109029 phv00109029.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:12:09+00:00 2018-09-28 20:12:09+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers' +74 Medication/supplement use 109030 phv00109030.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:12:17+00:00 2018-09-28 20:12:17+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 109031 phv00109031.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:12:25+00:00 2018-09-28 20:12:25+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 109032 phv00109032.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:12:34+00:00 2018-09-28 20:12:34+00:00 PROGST06 Progestins +74 Medication/supplement use 109033 phv00109033.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:12:44+00:00 2018-09-28 20:12:44+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 109034 phv00109034.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:12:52+00:00 2018-09-28 20:12:52+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 109035 phv00109035.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:12:59+00:00 2018-09-28 20:12:59+00:00 PROB06 Probucol +74 Medication/supplement use 109036 phv00109036.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:13:06+00:00 2018-09-28 20:13:06+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 109037 phv00109037.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:13:15+00:00 2018-09-28 20:13:15+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 109038 phv00109038.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:13:25+00:00 2018-09-28 20:13:25+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 109039 phv00109039.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:13:34+00:00 2018-09-28 20:13:34+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 109040 phv00109040.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:13:41+00:00 2018-09-28 20:13:41+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 109041 phv00109041.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:13:51+00:00 2018-09-28 20:13:51+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 109042 phv00109042.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:13:58+00:00 2018-09-28 20:13:58+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 109043 phv00109043.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:14:06+00:00 2018-09-28 20:14:06+00:00 THRY06 Thyroid agents +74 Medication/supplement use 109044 phv00109044.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:14:19+00:00 2018-09-28 20:14:19+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 109045 phv00109045.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:14:29+00:00 2018-09-28 20:14:29+00:00 URCOS06 Uricosurics +74 Medication/supplement use 109046 phv00109046.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:14:37+00:00 2018-09-28 20:14:37+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 109047 phv00109047.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:14:46+00:00 2018-09-28 20:14:46+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 109048 phv00109048.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:14:53+00:00 2018-09-28 20:14:53+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 109049 phv00109049.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:15:01+00:00 2018-09-28 20:15:01+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 109050 phv00109050.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:15:10+00:00 2018-09-28 20:15:10+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 109051 phv00109051.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:15:17+00:00 2018-09-28 20:15:17+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 109052 phv00109052.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:15:25+00:00 2018-09-28 20:15:25+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 109053 phv00109053.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:15:34+00:00 2018-09-28 20:15:34+00:00 DIURET06 Any diuretic +74 Medication/supplement use 109054 phv00109054.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:15:45+00:00 2018-09-28 20:15:45+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 109055 phv00109055.v1.p1 pht001493.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:15:54+00:00 2018-09-28 20:15:54+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 109457 phv00109457.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:53:48+00:00 2018-09-28 20:53:48+00:00 ASPR59 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 109458 phv00109458.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:53:58+00:00 2018-09-28 20:53:58+00:00 DAYASP59 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 109461 phv00109461.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:54:16+00:00 2018-09-28 20:54:16+00:00 NITRO59 PRESCRIBE NITROGLYCERIN IN THE LAST YEAR +74 Medication/supplement use 109504 phv00109504.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:54:46+00:00 2018-09-28 20:54:46+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WKS +74 Medication/supplement use 109505 phv00109505.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:54:55+00:00 2018-09-28 20:54:55+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 109506 phv00109506.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:55:03+00:00 2018-09-28 20:55:03+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 109507 phv00109507.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:55:14+00:00 2018-09-28 20:55:14+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 109508 phv00109508.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:55:22+00:00 2018-09-28 20:55:22+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 109683 phv00109683.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:58:31+00:00 2018-09-28 20:58:31+00:00 NOMEDS06 Total Medications +74 Medication/supplement use 109684 phv00109684.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:58:42+00:00 2018-09-28 20:58:42+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 109685 phv00109685.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:58:49+00:00 2018-09-28 20:58:49+00:00 A2AD06 Combinations of angiotensin II antagonists +74 Medication/supplement use 109686 phv00109686.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:58:58+00:00 2018-09-28 20:58:58+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 109687 phv00109687.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:59:06+00:00 2018-09-28 20:59:06+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 109688 phv00109688.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:59:16+00:00 2018-09-28 20:59:16+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 109689 phv00109689.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:59:27+00:00 2018-09-28 20:59:27+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 109690 phv00109690.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:59:34+00:00 2018-09-28 20:59:34+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 109691 phv00109691.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:59:43+00:00 2018-09-28 20:59:43+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 109692 phv00109692.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 20:59:50+00:00 2018-09-28 20:59:50+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 109693 phv00109693.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:00:00+00:00 2018-09-28 21:00:00+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 109694 phv00109694.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:00:10+00:00 2018-09-28 21:00:10+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 109695 phv00109695.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:00:17+00:00 2018-09-28 21:00:17+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 109696 phv00109696.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:00:26+00:00 2018-09-28 21:00:26+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 109697 phv00109697.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:00:33+00:00 2018-09-28 21:00:33+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 109698 phv00109698.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:00:41+00:00 2018-09-28 21:00:41+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 109699 phv00109699.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:00:49+00:00 2018-09-28 21:00:49+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 109700 phv00109700.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:00:58+00:00 2018-09-28 21:00:58+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 109701 phv00109701.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:01:06+00:00 2018-09-28 21:01:06+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 109702 phv00109702.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:01:16+00:00 2018-09-28 21:01:16+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 109703 phv00109703.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:01:25+00:00 2018-09-28 21:01:25+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 109704 phv00109704.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:01:33+00:00 2018-09-28 21:01:33+00:00 BGND06 Biguanides +74 Medication/supplement use 109705 phv00109705.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:01:42+00:00 2018-09-28 21:01:42+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 109706 phv00109706.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:01:56+00:00 2018-09-28 21:01:56+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 109707 phv00109707.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:02:18+00:00 2018-09-28 21:02:18+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 109708 phv00109708.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:02:25+00:00 2018-09-28 21:02:25+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 109709 phv00109709.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:02:33+00:00 2018-09-28 21:02:33+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 109710 phv00109710.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:02:41+00:00 2018-09-28 21:02:41+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 109711 phv00109711.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:02:49+00:00 2018-09-28 21:02:49+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 109712 phv00109712.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:02:57+00:00 2018-09-28 21:02:57+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 109713 phv00109713.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:03:05+00:00 2018-09-28 21:03:05+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 109714 phv00109714.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:03:14+00:00 2018-09-28 21:03:14+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 109715 phv00109715.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:03:22+00:00 2018-09-28 21:03:22+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 109716 phv00109716.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:03:30+00:00 2018-09-28 21:03:30+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 109717 phv00109717.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:03:38+00:00 2018-09-28 21:03:38+00:00 FIBR06 Fibrates +74 Medication/supplement use 109718 phv00109718.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:03:46+00:00 2018-09-28 21:03:46+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 109719 phv00109719.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:03:55+00:00 2018-09-28 21:03:55+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 109720 phv00109720.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:04:06+00:00 2018-09-28 21:04:06+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 109721 phv00109721.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:04:16+00:00 2018-09-28 21:04:16+00:00 HPRNS06 Heparins +74 Medication/supplement use 109722 phv00109722.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:04:23+00:00 2018-09-28 21:04:23+00:00 INSULN06 Insulins +74 Medication/supplement use 109723 phv00109723.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:04:33+00:00 2018-09-28 21:04:33+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 109724 phv00109724.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:04:43+00:00 2018-09-28 21:04:43+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 109725 phv00109725.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:04:53+00:00 2018-09-28 21:04:53+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 109726 phv00109726.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:05:02+00:00 2018-09-28 21:05:02+00:00 KCL06 Potassium supplements +74 Medication/supplement use 109727 phv00109727.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:05:11+00:00 2018-09-28 21:05:11+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 109728 phv00109728.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:05:21+00:00 2018-09-28 21:05:21+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 109729 phv00109729.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:05:32+00:00 2018-09-28 21:05:32+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 109730 phv00109730.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:05:42+00:00 2018-09-28 21:05:42+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 109731 phv00109731.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:05:50+00:00 2018-09-28 21:05:50+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 109732 phv00109732.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:06:01+00:00 2018-09-28 21:06:01+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 109733 phv00109733.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:06:12+00:00 2018-09-28 21:06:12+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 109734 phv00109734.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:06:19+00:00 2018-09-28 21:06:19+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 109735 phv00109735.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:06:26+00:00 2018-09-28 21:06:26+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 109736 phv00109736.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:06:36+00:00 2018-09-28 21:06:36+00:00 NTG06 Nitrates +74 Medication/supplement use 109737 phv00109737.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:06:44+00:00 2018-09-28 21:06:44+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 109738 phv00109738.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:06:51+00:00 2018-09-28 21:06:51+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 109739 phv00109739.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:06:59+00:00 2018-09-28 21:06:59+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 109740 phv00109740.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:07:08+00:00 2018-09-28 21:07:08+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers' +74 Medication/supplement use 109741 phv00109741.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:07:17+00:00 2018-09-28 21:07:17+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 109742 phv00109742.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:07:25+00:00 2018-09-28 21:07:25+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 109743 phv00109743.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:07:32+00:00 2018-09-28 21:07:32+00:00 PROGST06 Progestins +74 Medication/supplement use 109744 phv00109744.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:07:41+00:00 2018-09-28 21:07:41+00:00 PRKNSN06 Drugs used to treat Parkinson`s +74 Medication/supplement use 109745 phv00109745.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:07:52+00:00 2018-09-28 21:07:52+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 109746 phv00109746.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:08:03+00:00 2018-09-28 21:08:03+00:00 PROB06 Probucol +74 Medication/supplement use 109747 phv00109747.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:08:11+00:00 2018-09-28 21:08:11+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 109748 phv00109748.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:08:19+00:00 2018-09-28 21:08:19+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 109749 phv00109749.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:08:29+00:00 2018-09-28 21:08:29+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 109750 phv00109750.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:08:38+00:00 2018-09-28 21:08:38+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 109751 phv00109751.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:08:48+00:00 2018-09-28 21:08:48+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 109752 phv00109752.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:08:57+00:00 2018-09-28 21:08:57+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 109753 phv00109753.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:09:08+00:00 2018-09-28 21:09:08+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 109754 phv00109754.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:09:15+00:00 2018-09-28 21:09:15+00:00 THRY06 Thyroid agents +74 Medication/supplement use 109755 phv00109755.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:09:24+00:00 2018-09-28 21:09:24+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 109756 phv00109756.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:09:32+00:00 2018-09-28 21:09:32+00:00 URCOS06 Uricosurics +74 Medication/supplement use 109757 phv00109757.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:09:49+00:00 2018-09-28 21:09:49+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 109758 phv00109758.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:09:57+00:00 2018-09-28 21:09:57+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 109759 phv00109759.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:10:05+00:00 2018-09-28 21:10:05+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 109760 phv00109760.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:10:13+00:00 2018-09-28 21:10:13+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 109761 phv00109761.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:10:22+00:00 2018-09-28 21:10:22+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 109762 phv00109762.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:10:31+00:00 2018-09-28 21:10:31+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 109763 phv00109763.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:10:40+00:00 2018-09-28 21:10:40+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 109764 phv00109764.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:10:48+00:00 2018-09-28 21:10:48+00:00 DIURET06 Any diuretic +74 Medication/supplement use 109765 phv00109765.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:10:57+00:00 2018-09-28 21:10:57+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 109766 phv00109766.v1.p1 pht001494.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-09-28 21:11:04+00:00 2018-09-28 21:11:04+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 110185 phv00110185.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:39:16+00:00 2018-10-01 15:39:16+00:00 ASPIRIN ASPIRIN USE > 2 DAYS IN 2 WKS +74 Medication/supplement use 110186 phv00110186.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:39:29+00:00 2018-10-01 15:39:29+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 110187 phv00110187.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:39:40+00:00 2018-10-01 15:39:40+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 110188 phv00110188.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:39:48+00:00 2018-10-01 15:39:48+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 110189 phv00110189.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:39:56+00:00 2018-10-01 15:39:56+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 110625 phv00110625.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:41:32+00:00 2018-10-01 15:41:32+00:00 NOMEDS06 Total Medications +74 Medication/supplement use 110626 phv00110626.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:41:44+00:00 2018-10-01 15:41:44+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 110627 phv00110627.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:41:52+00:00 2018-10-01 15:41:52+00:00 A2AD06 Combinations of angiotensin II antagonists +74 Medication/supplement use 110628 phv00110628.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:42:03+00:00 2018-10-01 15:42:03+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 110629 phv00110629.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:42:11+00:00 2018-10-01 15:42:11+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 110630 phv00110630.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:42:22+00:00 2018-10-01 15:42:22+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 110631 phv00110631.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:42:31+00:00 2018-10-01 15:42:31+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 110632 phv00110632.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:42:39+00:00 2018-10-01 15:42:39+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 110633 phv00110633.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:42:48+00:00 2018-10-01 15:42:48+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 110634 phv00110634.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:42:57+00:00 2018-10-01 15:42:57+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 110635 phv00110635.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:43:04+00:00 2018-10-01 15:43:04+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 110636 phv00110636.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:43:13+00:00 2018-10-01 15:43:13+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 110637 phv00110637.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:43:20+00:00 2018-10-01 15:43:20+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 110638 phv00110638.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:43:29+00:00 2018-10-01 15:43:29+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 110639 phv00110639.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:43:38+00:00 2018-10-01 15:43:38+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 110640 phv00110640.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:43:49+00:00 2018-10-01 15:43:49+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 110641 phv00110641.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:43:57+00:00 2018-10-01 15:43:57+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 110642 phv00110642.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:44:06+00:00 2018-10-01 15:44:06+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 110643 phv00110643.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:44:15+00:00 2018-10-01 15:44:15+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 110644 phv00110644.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:44:24+00:00 2018-10-01 15:44:24+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 110645 phv00110645.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:44:35+00:00 2018-10-01 15:44:35+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 110646 phv00110646.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:44:44+00:00 2018-10-01 15:44:44+00:00 BGND06 Biguanides +74 Medication/supplement use 110647 phv00110647.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:44:53+00:00 2018-10-01 15:44:53+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 110648 phv00110648.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:45:00+00:00 2018-10-01 15:45:00+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 110649 phv00110649.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:45:09+00:00 2018-10-01 15:45:09+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 110650 phv00110650.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:45:18+00:00 2018-10-01 15:45:18+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 110651 phv00110651.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:45:27+00:00 2018-10-01 15:45:27+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 110652 phv00110652.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:45:37+00:00 2018-10-01 15:45:37+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 110653 phv00110653.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:45:48+00:00 2018-10-01 15:45:48+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 110654 phv00110654.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:45:55+00:00 2018-10-01 15:45:55+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 110655 phv00110655.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:46:05+00:00 2018-10-01 15:46:05+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 110656 phv00110656.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:46:18+00:00 2018-10-01 15:46:18+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 110657 phv00110657.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:46:27+00:00 2018-10-01 15:46:27+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 110658 phv00110658.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:46:35+00:00 2018-10-01 15:46:35+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 110659 phv00110659.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:46:44+00:00 2018-10-01 15:46:44+00:00 FIBR06 Fibrates +74 Medication/supplement use 110660 phv00110660.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:46:54+00:00 2018-10-01 15:46:54+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 110661 phv00110661.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:47:04+00:00 2018-10-01 15:47:04+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 110663 phv00110663.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:47:13+00:00 2018-10-01 15:47:13+00:00 HPRNS06 Heparins +74 Medication/supplement use 110664 phv00110664.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:47:21+00:00 2018-10-01 15:47:21+00:00 INSULN06 Insulins +74 Medication/supplement use 110665 phv00110665.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:47:34+00:00 2018-10-01 15:47:34+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 110667 phv00110667.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:47:43+00:00 2018-10-01 15:47:43+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 110668 phv00110668.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:47:52+00:00 2018-10-01 15:47:52+00:00 KCL06 Potassium supplements +74 Medication/supplement use 110669 phv00110669.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:48:05+00:00 2018-10-01 15:48:05+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 110670 phv00110670.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:48:13+00:00 2018-10-01 15:48:13+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 110671 phv00110671.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:48:21+00:00 2018-10-01 15:48:21+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 110672 phv00110672.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:48:30+00:00 2018-10-01 15:48:30+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 110673 phv00110673.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:48:40+00:00 2018-10-01 15:48:40+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 110674 phv00110674.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:48:49+00:00 2018-10-01 15:48:49+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 110675 phv00110675.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:48:58+00:00 2018-10-01 15:48:58+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 110676 phv00110676.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:49:06+00:00 2018-10-01 15:49:06+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 110677 phv00110677.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:49:17+00:00 2018-10-01 15:49:17+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 110678 phv00110678.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:49:48+00:00 2018-10-01 15:49:48+00:00 NTG06 Nitrates +74 Medication/supplement use 110679 phv00110679.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:50:02+00:00 2018-10-01 15:50:02+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 110680 phv00110680.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:50:13+00:00 2018-10-01 15:50:13+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 110681 phv00110681.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:50:22+00:00 2018-10-01 15:50:22+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 110682 phv00110682.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:50:31+00:00 2018-10-01 15:50:31+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers' +74 Medication/supplement use 110683 phv00110683.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:50:39+00:00 2018-10-01 15:50:39+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 110684 phv00110684.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:50:47+00:00 2018-10-01 15:50:47+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 110685 phv00110685.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:50:54+00:00 2018-10-01 15:50:54+00:00 PROGST06 Progestins +74 Medication/supplement use 110686 phv00110686.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:51:03+00:00 2018-10-01 15:51:03+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 110687 phv00110687.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:51:11+00:00 2018-10-01 15:51:11+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 110688 phv00110688.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:51:21+00:00 2018-10-01 15:51:21+00:00 PROB06 Probucol +74 Medication/supplement use 110689 phv00110689.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:51:30+00:00 2018-10-01 15:51:30+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 110690 phv00110690.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:51:38+00:00 2018-10-01 15:51:38+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 110691 phv00110691.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:51:46+00:00 2018-10-01 15:51:46+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 110692 phv00110692.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:51:54+00:00 2018-10-01 15:51:54+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 110693 phv00110693.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:52:01+00:00 2018-10-01 15:52:01+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 110694 phv00110694.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:52:08+00:00 2018-10-01 15:52:08+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 110695 phv00110695.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:52:17+00:00 2018-10-01 15:52:17+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 110696 phv00110696.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:52:25+00:00 2018-10-01 15:52:25+00:00 THRY06 Thyroid agents +74 Medication/supplement use 110697 phv00110697.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:52:33+00:00 2018-10-01 15:52:33+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 110698 phv00110698.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:52:46+00:00 2018-10-01 15:52:46+00:00 URCOS06 Uricosurics +74 Medication/supplement use 110699 phv00110699.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:52:57+00:00 2018-10-01 15:52:57+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 110700 phv00110700.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:53:11+00:00 2018-10-01 15:53:11+00:00 VASOD06 Vasodilators with diuretics, a mixed gro +74 Medication/supplement use 110701 phv00110701.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:53:20+00:00 2018-10-01 15:53:20+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 110702 phv00110702.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:53:28+00:00 2018-10-01 15:53:28+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 110703 phv00110703.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:53:37+00:00 2018-10-01 15:53:37+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 110704 phv00110704.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:53:44+00:00 2018-10-01 15:53:44+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 110705 phv00110705.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:53:54+00:00 2018-10-01 15:53:54+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 110706 phv00110706.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:54:02+00:00 2018-10-01 15:54:02+00:00 DIURET06 Any diuretic +74 Medication/supplement use 110707 phv00110707.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:54:11+00:00 2018-10-01 15:54:11+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 110708 phv00110708.v1.p1 pht001495.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:54:21+00:00 2018-10-01 15:54:21+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 101600 phv00101600.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:58:19+00:00 2018-10-01 15:58:19+00:00 MLTVIT59 TAKEN MULTIPLE OR OTHER VITAMIN +74 Medication/supplement use 101601 phv00101601.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:58:29+00:00 2018-10-01 15:58:29+00:00 MULTI59 TOOK MULTIPLE VITAMIN +74 Medication/supplement use 101602 phv00101602.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:58:37+00:00 2018-10-01 15:58:37+00:00 MDAYS59 DAYS TOOK MULTIPLE VITAMIN +74 Medication/supplement use 101603 phv00101603.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:58:47+00:00 2018-10-01 15:58:47+00:00 VITA59 TOOK VITAMIN A +74 Medication/supplement use 101604 phv00101604.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:58:54+00:00 2018-10-01 15:58:54+00:00 ADAYS59 DAYS TOOK VITAMIN A +74 Medication/supplement use 101605 phv00101605.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:59:05+00:00 2018-10-01 15:59:05+00:00 VITC59 TOOK VITAMIN C +74 Medication/supplement use 101607 phv00101607.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:59:16+00:00 2018-10-01 15:59:16+00:00 VITE59 TOOK VITAMIN E +74 Medication/supplement use 101608 phv00101608.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:59:24+00:00 2018-10-01 15:59:24+00:00 EDAYS59 DAYS TOOK VITAMIN E +74 Medication/supplement use 101609 phv00101609.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 15:59:33+00:00 2018-10-01 15:59:33+00:00 ASPR59 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 101999 phv00101999.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:00:46+00:00 2018-10-01 16:00:46+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 102000 phv00102000.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:00:54+00:00 2018-10-01 16:00:54+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 102001 phv00102001.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:01:02+00:00 2018-10-01 16:01:02+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 102002 phv00102002.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:01:10+00:00 2018-10-01 16:01:10+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 102005 phv00102005.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:01:22+00:00 2018-10-01 16:01:22+00:00 ASPIRIN Aspirin use > 2 days in last 2 weeks +74 Medication/supplement use 102004 phv00102004.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:01:39+00:00 2018-10-01 16:01:39+00:00 DAYASP59 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 102089 phv00102089.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:02:04+00:00 2018-10-01 16:02:04+00:00 NOMEDS06 Number of medications +74 Medication/supplement use 102090 phv00102090.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:02:13+00:00 2018-10-01 16:02:13+00:00 TAKMED06 TAKE ANY MEDICATIONS +74 Medication/supplement use 102091 phv00102091.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:02:22+00:00 2018-10-01 16:02:22+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 102092 phv00102092.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:02:31+00:00 2018-10-01 16:02:31+00:00 A2AD06 Combinations of angiotensin II antagonists +74 Medication/supplement use 102093 phv00102093.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:02:39+00:00 2018-10-01 16:02:39+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 102094 phv00102094.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:02:46+00:00 2018-10-01 16:02:46+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 102095 phv00102095.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:02:55+00:00 2018-10-01 16:02:55+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 102096 phv00102096.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:03:05+00:00 2018-10-01 16:03:05+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 102097 phv00102097.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:03:18+00:00 2018-10-01 16:03:18+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 102098 phv00102098.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:03:26+00:00 2018-10-01 16:03:26+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 102099 phv00102099.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:03:34+00:00 2018-10-01 16:03:34+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 102100 phv00102100.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:03:41+00:00 2018-10-01 16:03:41+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 102101 phv00102101.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:03:49+00:00 2018-10-01 16:03:49+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 102102 phv00102102.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:03:56+00:00 2018-10-01 16:03:56+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 102103 phv00102103.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:04:04+00:00 2018-10-01 16:04:04+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 102104 phv00102104.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:04:11+00:00 2018-10-01 16:04:11+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 102105 phv00102105.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:04:20+00:00 2018-10-01 16:04:20+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 102107 phv00102107.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:05:09+00:00 2018-10-01 16:05:09+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 102106 phv00102106.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:05:18+00:00 2018-10-01 16:05:18+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 102108 phv00102108.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:05:33+00:00 2018-10-01 16:05:33+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 102109 phv00102109.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:05:49+00:00 2018-10-01 16:05:49+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 102110 phv00102110.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:06:02+00:00 2018-10-01 16:06:02+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 102111 phv00102111.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:06:10+00:00 2018-10-01 16:06:10+00:00 BGND06 Biguanides +74 Medication/supplement use 102112 phv00102112.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:06:20+00:00 2018-10-01 16:06:20+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 102113 phv00102113.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:06:31+00:00 2018-10-01 16:06:31+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 102114 phv00102114.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:06:40+00:00 2018-10-01 16:06:40+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 102115 phv00102115.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:06:49+00:00 2018-10-01 16:06:49+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 102116 phv00102116.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:06:57+00:00 2018-10-01 16:06:57+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 102117 phv00102117.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:07:06+00:00 2018-10-01 16:07:06+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 102118 phv00102118.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:07:15+00:00 2018-10-01 16:07:15+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 102119 phv00102119.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:07:23+00:00 2018-10-01 16:07:23+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 102120 phv00102120.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:07:31+00:00 2018-10-01 16:07:31+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 102121 phv00102121.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:08:00+00:00 2018-10-01 16:08:00+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 102122 phv00102122.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:08:16+00:00 2018-10-01 16:08:16+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 102123 phv00102123.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:08:25+00:00 2018-10-01 16:08:25+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 102124 phv00102124.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:08:33+00:00 2018-10-01 16:08:33+00:00 FIBR06 Fibrates +74 Medication/supplement use 102125 phv00102125.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:08:42+00:00 2018-10-01 16:08:42+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 102126 phv00102126.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:08:52+00:00 2018-10-01 16:08:52+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 102127 phv00102127.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:08:59+00:00 2018-10-01 16:08:59+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 102128 phv00102128.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:09:07+00:00 2018-10-01 16:09:07+00:00 HPRNS06 Heparins +74 Medication/supplement use 102129 phv00102129.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:09:14+00:00 2018-10-01 16:09:14+00:00 INSULN06 Insulins +74 Medication/supplement use 102130 phv00102130.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:09:22+00:00 2018-10-01 16:09:22+00:00 IPRTR06 Anticholinergics + combination with beta +74 Medication/supplement use 102131 phv00102131.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:09:30+00:00 2018-10-01 16:09:30+00:00 ISTRD06 Inhaled steroids for asthma +74 Medication/supplement use 102132 phv00102132.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:09:38+00:00 2018-10-01 16:09:38+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 102133 phv00102133.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:09:47+00:00 2018-10-01 16:09:47+00:00 KCL06 Potassium supplements +74 Medication/supplement use 102134 phv00102134.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:09:56+00:00 2018-10-01 16:09:56+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 102135 phv00102135.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:10:05+00:00 2018-10-01 16:10:05+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 102136 phv00102136.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:10:14+00:00 2018-10-01 16:10:14+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 102137 phv00102137.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:10:21+00:00 2018-10-01 16:10:21+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 102138 phv00102138.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:10:32+00:00 2018-10-01 16:10:32+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 102139 phv00102139.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:10:41+00:00 2018-10-01 16:10:41+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 102140 phv00102140.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:10:52+00:00 2018-10-01 16:10:52+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 102141 phv00102141.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:11:01+00:00 2018-10-01 16:11:01+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 102142 phv00102142.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:11:13+00:00 2018-10-01 16:11:13+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 102143 phv00102143.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 16:11:23+00:00 2018-10-01 16:11:23+00:00 NTG06 Nitrates +74 Medication/supplement use 102144 phv00102144.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:19:32+00:00 2018-10-01 18:19:32+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 102145 phv00102145.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:19:40+00:00 2018-10-01 18:19:40+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 102146 phv00102146.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:19:48+00:00 2018-10-01 18:19:48+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 102147 phv00102147.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:19:56+00:00 2018-10-01 18:19:56+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers +74 Medication/supplement use 102148 phv00102148.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:20:06+00:00 2018-10-01 18:20:06+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 102149 phv00102149.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:20:15+00:00 2018-10-01 18:20:15+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 102150 phv00102150.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:20:25+00:00 2018-10-01 18:20:25+00:00 PROGST06 Progestins +74 Medication/supplement use 102151 phv00102151.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:20:35+00:00 2018-10-01 18:20:35+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 102152 phv00102152.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:20:44+00:00 2018-10-01 18:20:44+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 102153 phv00102153.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:20:53+00:00 2018-10-01 18:20:53+00:00 PROB06 Probucol +74 Medication/supplement use 102154 phv00102154.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:21:02+00:00 2018-10-01 18:21:02+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 102155 phv00102155.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:21:21+00:00 2018-10-01 18:21:21+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 102156 phv00102156.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:21:30+00:00 2018-10-01 18:21:30+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 102157 phv00102157.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:21:39+00:00 2018-10-01 18:21:39+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 102158 phv00102158.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:21:49+00:00 2018-10-01 18:21:49+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 102159 phv00102159.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:21:57+00:00 2018-10-01 18:21:57+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 102160 phv00102160.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:22:05+00:00 2018-10-01 18:22:05+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 102161 phv00102161.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:22:13+00:00 2018-10-01 18:22:13+00:00 THRY06 Thyroid agents +74 Medication/supplement use 102162 phv00102162.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:22:22+00:00 2018-10-01 18:22:22+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 102163 phv00102163.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:22:33+00:00 2018-10-01 18:22:33+00:00 URCOS06 Uricosurics +74 Medication/supplement use 102164 phv00102164.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:22:41+00:00 2018-10-01 18:22:41+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 102165 phv00102165.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:22:50+00:00 2018-10-01 18:22:50+00:00 VASOD06 Vasodilators with diuretics, a mixed group +74 Medication/supplement use 102166 phv00102166.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:23:00+00:00 2018-10-01 18:23:00+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 102167 phv00102167.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:23:08+00:00 2018-10-01 18:23:08+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 102168 phv00102168.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:23:17+00:00 2018-10-01 18:23:17+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 102169 phv00102169.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:23:27+00:00 2018-10-01 18:23:27+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 102170 phv00102170.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:23:34+00:00 2018-10-01 18:23:34+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 102171 phv00102171.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:23:41+00:00 2018-10-01 18:23:41+00:00 DIURET06 Any diuretic +74 Medication/supplement use 102172 phv00102172.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:23:48+00:00 2018-10-01 18:23:48+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 102173 phv00102173.v1.p1 pht001474.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:23:55+00:00 2018-10-01 18:23:55+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 102627 phv00102627.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:25:55+00:00 2018-10-01 18:25:55+00:00 ANYACE ANY ACE INHIBITOR +74 Medication/supplement use 102628 phv00102628.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:26:03+00:00 2018-10-01 18:26:03+00:00 ANYBETA ANY BETA BLOCKER +74 Medication/supplement use 102629 phv00102629.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:26:11+00:00 2018-10-01 18:26:11+00:00 ANYVASO ANY VASO DILATOR +74 Medication/supplement use 102630 phv00102630.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:26:20+00:00 2018-10-01 18:26:20+00:00 ANYDIUR ANY DIURETIC +74 Medication/supplement use 102779 phv00102779.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:26:55+00:00 2018-10-01 18:26:55+00:00 MLTVIT59 TAKEN MULTIPLE OR OTHER VITAMIN +74 Medication/supplement use 102780 phv00102780.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:27:07+00:00 2018-10-01 18:27:07+00:00 MULTI59 TOOK MULTIPLE VITAMIN +74 Medication/supplement use 102781 phv00102781.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:27:15+00:00 2018-10-01 18:27:15+00:00 MDAYS59 DAYS TOOK MULTIPLE VITAMIN +74 Medication/supplement use 102782 phv00102782.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:27:27+00:00 2018-10-01 18:27:27+00:00 VITA59 TOOK VITAMIN A +74 Medication/supplement use 102783 phv00102783.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:27:38+00:00 2018-10-01 18:27:38+00:00 ADAYS59 DAYS TOOK VITAMIN A +74 Medication/supplement use 102784 phv00102784.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:27:47+00:00 2018-10-01 18:27:47+00:00 VITC59 TOOK VITAMIN C +74 Medication/supplement use 102785 phv00102785.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:27:56+00:00 2018-10-01 18:27:56+00:00 CDAYS59 DAYS TOOK VITAMIN C +74 Medication/supplement use 102786 phv00102786.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:28:09+00:00 2018-10-01 18:28:09+00:00 VITE59 TOOK VITAMIN E +74 Medication/supplement use 102787 phv00102787.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:28:17+00:00 2018-10-01 18:28:17+00:00 EDAYS59 DAYS TOOK VITAMIN E +74 Medication/supplement use 102788 phv00102788.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:28:28+00:00 2018-10-01 18:28:28+00:00 ASPR59 ASPIRIN/ASPIRIN-CONTAINING MEDICINES +74 Medication/supplement use 102789 phv00102789.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:28:36+00:00 2018-10-01 18:28:36+00:00 DAYASP59 DAYS TOOK THIS MEDICINE IN LAST TWO WEEK +74 Medication/supplement use 102817 phv00102817.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:28:54+00:00 2018-10-01 18:28:54+00:00 ESTROC59 CURRENTLY TAKING ESTROGEN +74 Medication/supplement use 102818 phv00102818.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:29:04+00:00 2018-10-01 18:29:04+00:00 ECDAY59 DAYS PER MONTH TAKE ESTROGEN +74 Medication/supplement use 102826 phv00102826.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:29:23+00:00 2018-10-01 18:29:23+00:00 PROGC59 CURRENTLY TAKING PROGESTIN +74 Medication/supplement use 102827 phv00102827.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:29:34+00:00 2018-10-01 18:29:34+00:00 PCDAY59 DAYS PER MONTH TAKING PROGESTIN +74 Medication/supplement use 102968 phv00102968.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:30:21+00:00 2018-10-01 18:30:21+00:00 ASPIRIN ASPIRIN USE >2 DAYS IN 2 WEEKS +74 Medication/supplement use 103062 phv00103062.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:30:46+00:00 2018-10-01 18:30:46+00:00 NOMEDS06 Number of medications +74 Medication/supplement use 103063 phv00103063.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:30:54+00:00 2018-10-01 18:30:54+00:00 TAKMED06 TAKE ANY MEDICATIONS +74 Medication/supplement use 103064 phv00103064.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:31:02+00:00 2018-10-01 18:31:02+00:00 A2A06 Angiotensin type 2 antagonists +74 Medication/supplement use 103065 phv00103065.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:31:08+00:00 2018-10-01 18:31:08+00:00 A2AD06 Combinations of angiotensin II antagonists +74 Medication/supplement use 103066 phv00103066.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:31:16+00:00 2018-10-01 18:31:16+00:00 ACE06 ACE Inhibitors without diuretics +74 Medication/supplement use 103067 phv00103067.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:31:27+00:00 2018-10-01 18:31:27+00:00 ACED06 ACE Inhibitors with diuretics +74 Medication/supplement use 103068 phv00103068.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:31:35+00:00 2018-10-01 18:31:35+00:00 ADPI06 Inhibitors of ADP-induced platelet aggregation +74 Medication/supplement use 103069 phv00103069.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:31:43+00:00 2018-10-01 18:31:43+00:00 AGDI06 Alpha-Glucosidase Inhibitors +74 Medication/supplement use 103070 phv00103070.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:31:51+00:00 2018-10-01 18:31:51+00:00 ALPHA06 Alpha-blockers without diuretics +74 Medication/supplement use 103071 phv00103071.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:31:59+00:00 2018-10-01 18:31:59+00:00 ALPHAD06 Alpha-blockers with diuretics +74 Medication/supplement use 103072 phv00103072.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:32:07+00:00 2018-10-01 18:32:07+00:00 ALZH06 Acetylcholine esterase inhibitors for Al +74 Medication/supplement use 103073 phv00103073.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:32:14+00:00 2018-10-01 18:32:14+00:00 AMLOD06 Amlodipine +74 Medication/supplement use 103074 phv00103074.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:32:21+00:00 2018-10-01 18:32:21+00:00 ANAR1A06 Anti-arrhythmics, class 1A +74 Medication/supplement use 103075 phv00103075.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:36:54+00:00 2018-10-01 18:36:54+00:00 ANAR1B06 Anti-arrhythmics, class 1B +74 Medication/supplement use 103076 phv00103076.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:37:04+00:00 2018-10-01 18:37:04+00:00 ANAR1C06 Anti-arrhythmics, class 1C +74 Medication/supplement use 103077 phv00103077.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:37:11+00:00 2018-10-01 18:37:11+00:00 ANAR306 Anti-arrhythmics, class 3 +74 Medication/supplement use 103078 phv00103078.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:37:21+00:00 2018-10-01 18:37:21+00:00 ANTPSY06 Anti-psychotic medications +74 Medication/supplement use 103079 phv00103079.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:37:29+00:00 2018-10-01 18:37:29+00:00 ASA06 Aspirin from 280804 (anti-inflammatory agents) +74 Medication/supplement use 103080 phv00103080.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:37:37+00:00 2018-10-01 18:37:37+00:00 BASQ06 Bile-acid sequestrants +74 Medication/supplement use 103081 phv00103081.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:37:44+00:00 2018-10-01 18:37:44+00:00 BENZOD06 Benzodiazepines +74 Medication/supplement use 103082 phv00103082.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:37:51+00:00 2018-10-01 18:37:51+00:00 BETA06 Beta-blockers without diuretics +74 Medication/supplement use 103083 phv00103083.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:38:01+00:00 2018-10-01 18:38:01+00:00 BETAD06 Beta-blockers with diuretics +74 Medication/supplement use 103084 phv00103084.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:38:09+00:00 2018-10-01 18:38:09+00:00 BGND06 Biguanides +74 Medication/supplement use 103085 phv00103085.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:38:17+00:00 2018-10-01 18:38:17+00:00 CCB06 Any calcium-channel blocker = CCIR or CC +74 Medication/supplement use 103086 phv00103086.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:38:24+00:00 2018-10-01 18:38:24+00:00 CCBIR06 Immediate-release CCBs = NIFIR or DIHIR +74 Medication/supplement use 103087 phv00103087.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:38:35+00:00 2018-10-01 18:38:35+00:00 CCBSR06 Slow-release CCBs = NIFSR or DIHSR or VE +74 Medication/supplement use 103088 phv00103088.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:38:52+00:00 2018-10-01 18:38:52+00:00 CCBT06 T-type calcium-channel blocker +74 Medication/supplement use 103089 phv00103089.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:39:04+00:00 2018-10-01 18:39:04+00:00 COX206 Cox-2 inhibitors (NSAID agents); seperat +74 Medication/supplement use 103090 phv00103090.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:39:13+00:00 2018-10-01 18:39:13+00:00 DIG06 Digitalis preparations +74 Medication/supplement use 103091 phv00103091.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:39:21+00:00 2018-10-01 18:39:21+00:00 DIHIR06 Immediate-release dihyropyridines other +74 Medication/supplement use 103092 phv00103092.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:39:28+00:00 2018-10-01 18:39:28+00:00 DIHSR06 Slow-release dihydropyridines other than +74 Medication/supplement use 103093 phv00103093.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:39:35+00:00 2018-10-01 18:39:35+00:00 DLTIR06 Immediate-release diltiazem +74 Medication/supplement use 103094 phv00103094.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:39:48+00:00 2018-10-01 18:39:48+00:00 DLTSR06 Slow-release diltiazem +74 Medication/supplement use 103095 phv00103095.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:40:00+00:00 2018-10-01 18:40:00+00:00 EDD06 Erectile dysfunction drugs +74 Medication/supplement use 103096 phv00103096.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:40:09+00:00 2018-10-01 18:40:09+00:00 ESTRGN06 Estrogens, excluding vaginal creams +74 Medication/supplement use 103097 phv00103097.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:40:17+00:00 2018-10-01 18:40:17+00:00 FIBR06 Fibrates +74 Medication/supplement use 103098 phv00103098.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:40:26+00:00 2018-10-01 18:40:26+00:00 H2B06 H-2 Blockers +74 Medication/supplement use 103099 phv00103099.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:40:34+00:00 2018-10-01 18:40:34+00:00 HCTZ06 Thiazide diuretics without k-sparing age +74 Medication/supplement use 103100 phv00103100.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:40:44+00:00 2018-10-01 18:40:44+00:00 HCTZK06 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 103101 phv00103101.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:40:52+00:00 2018-10-01 18:40:52+00:00 HPRNS06 Heparins +74 Medication/supplement use 103102 phv00103102.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:41:01+00:00 2018-10-01 18:41:01+00:00 INSULN06 Insulins +74 Medication/supplement use 103105 phv00103105.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:41:12+00:00 2018-10-01 18:41:12+00:00 KBLKR06 K-channel blockers to enhance insulin se +74 Medication/supplement use 103106 phv00103106.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:41:21+00:00 2018-10-01 18:41:21+00:00 KCL06 Potassium supplements +74 Medication/supplement use 103107 phv00103107.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:41:29+00:00 2018-10-01 18:41:29+00:00 KSPR06 Potassium-sparing agents alone +74 Medication/supplement use 103108 phv00103108.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:41:37+00:00 2018-10-01 18:41:37+00:00 LOOP06 Loop diuretics +74 Medication/supplement use 103109 phv00103109.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:41:45+00:00 2018-10-01 18:41:45+00:00 MAOI06 MAO Inhibitors +74 Medication/supplement use 103110 phv00103110.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:41:53+00:00 2018-10-01 18:41:53+00:00 MLPD06 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 103111 phv00103111.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:42:02+00:00 2018-10-01 18:42:02+00:00 NIAC06 Niacin and nicotinic acid +74 Medication/supplement use 103112 phv00103112.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:42:11+00:00 2018-10-01 18:42:11+00:00 NIFIR06 Immediate-release nifedipine +74 Medication/supplement use 103113 phv00103113.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:42:20+00:00 2018-10-01 18:42:20+00:00 NIFSR06 Slow-release nifedipine +74 Medication/supplement use 103114 phv00103114.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:42:27+00:00 2018-10-01 18:42:27+00:00 NSAID06 Non-steroidal anti-inflammatory agents, +74 Medication/supplement use 103115 phv00103115.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:42:37+00:00 2018-10-01 18:42:37+00:00 NTCA06 Non-tricyclic antidepressants other than +74 Medication/supplement use 103116 phv00103116.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:42:46+00:00 2018-10-01 18:42:46+00:00 NTG06 Nitrates +74 Medication/supplement use 103117 phv00103117.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:42:55+00:00 2018-10-01 18:42:55+00:00 OAIA06 Oral anti-inflammatory asthma drugs leuk +74 Medication/supplement use 103118 phv00103118.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:43:02+00:00 2018-10-01 18:43:02+00:00 OHGA06 Oral hypoglycemic agents +74 Medication/supplement use 103119 phv00103119.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:43:10+00:00 2018-10-01 18:43:10+00:00 OSTRD06 Oral steroids +74 Medication/supplement use 103120 phv00103120.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:43:18+00:00 2018-10-01 18:43:18+00:00 OTCH2B06 ('60) Over-the-counter H-2 blockers +74 Medication/supplement use 103121 phv00103121.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:43:27+00:00 2018-10-01 18:43:27+00:00 PDEI06 Phosphodiesterase inhibitors +74 Medication/supplement use 103122 phv00103122.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:43:37+00:00 2018-10-01 18:43:37+00:00 PPI06 Proton pump inhibitors +74 Medication/supplement use 103123 phv00103123.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:43:44+00:00 2018-10-01 18:43:44+00:00 PROGST06 Progestins +74 Medication/supplement use 103124 phv00103124.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:43:51+00:00 2018-10-01 18:43:51+00:00 PRKNSN06 Drugs used to treat Parkinson s +74 Medication/supplement use 103125 phv00103125.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:44:01+00:00 2018-10-01 18:44:01+00:00 PREMAR06 Premarin (conjugated estrogens) +74 Medication/supplement use 103126 phv00103126.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:44:09+00:00 2018-10-01 18:44:09+00:00 PROB06 Probucol +74 Medication/supplement use 103127 phv00103127.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:44:19+00:00 2018-10-01 18:44:19+00:00 PVDL06 Peripheral vasodilators, exclude dipyrid +74 Medication/supplement use 103128 phv00103128.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:44:27+00:00 2018-10-01 18:44:27+00:00 SLF106 First generation sulfonylureas +74 Medication/supplement use 103129 phv00103129.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:44:35+00:00 2018-10-01 18:44:35+00:00 SLF206 Second generation sulfonylureas +74 Medication/supplement use 103130 phv00103130.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:44:43+00:00 2018-10-01 18:44:43+00:00 STTN06 HMG-CoA reductase inhibitors +74 Medication/supplement use 103131 phv00103131.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:44:51+00:00 2018-10-01 18:44:51+00:00 SYMPTH06 Sympathomimetics, oral and inhaled +74 Medication/supplement use 103132 phv00103132.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:45:00+00:00 2018-10-01 18:45:00+00:00 TCA06 Tricyclic anti-depressants +74 Medication/supplement use 103133 phv00103133.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:45:10+00:00 2018-10-01 18:45:10+00:00 TCAP06 Tri-cyclic anti-depressants plus anti-ps +74 Medication/supplement use 103134 phv00103134.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:45:17+00:00 2018-10-01 18:45:17+00:00 THRY06 Thyroid agents +74 Medication/supplement use 103135 phv00103135.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:45:25+00:00 2018-10-01 18:45:25+00:00 THZD06 Thiazolidinediones +74 Medication/supplement use 103136 phv00103136.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:45:33+00:00 2018-10-01 18:45:33+00:00 URCOS06 Uricosurics +74 Medication/supplement use 103137 phv00103137.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:45:41+00:00 2018-10-01 18:45:41+00:00 VASO06 Vasodilators, a mixed group +74 Medication/supplement use 103138 phv00103138.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:45:49+00:00 2018-10-01 18:45:49+00:00 VASOD06 Vasodilators with diuretics, a mixed group +74 Medication/supplement use 103139 phv00103139.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:45:57+00:00 2018-10-01 18:45:57+00:00 VERIR06 Immediate-release verapamil +74 Medication/supplement use 103140 phv00103140.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:46:05+00:00 2018-10-01 18:46:05+00:00 VERSR06 Slow-release verapamil +74 Medication/supplement use 103141 phv00103141.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:46:13+00:00 2018-10-01 18:46:13+00:00 WARF06 Oral anticoagulants +74 Medication/supplement use 103142 phv00103142.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:46:20+00:00 2018-10-01 18:46:20+00:00 WTLS06 Weight loss drugs +74 Medication/supplement use 103143 phv00103143.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:46:28+00:00 2018-10-01 18:46:28+00:00 XOI06 Xanthine oxidase inhibitors +74 Medication/supplement use 103144 phv00103144.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:46:36+00:00 2018-10-01 18:46:36+00:00 DIURET06 Any diuretic +74 Medication/supplement use 103145 phv00103145.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:46:44+00:00 2018-10-01 18:46:44+00:00 LIPID06 Any lipid-lowering medication +74 Medication/supplement use 103146 phv00103146.v1.p1 pht001475.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 18:46:52+00:00 2018-10-01 18:46:52+00:00 HTNMED06 Any hypertension medication +74 Medication/supplement use 197514 phv00197514.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:09:26+00:00 2018-10-01 20:09:26+00:00 estrgn Estrogens +74 Medication/supplement use 197515 phv00197515.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:09:39+00:00 2018-10-01 20:09:39+00:00 progst Progestins +74 Medication/supplement use 197516 phv00197516.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:09:47+00:00 2018-10-01 20:09:47+00:00 htnmed Any hypertension meds +74 Medication/supplement use 197517 phv00197517.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:10:00+00:00 2018-10-01 20:10:00+00:00 anar1a Class 1a anti-arrhythmics +74 Medication/supplement use 197518 phv00197518.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:10:08+00:00 2018-10-01 20:10:08+00:00 lipid Any lipid lowering med +74 Medication/supplement use 197519 phv00197519.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:10:25+00:00 2018-10-01 20:10:25+00:00 ohga Oral hypoglycemics +74 Medication/supplement use 197520 phv00197520.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:10:33+00:00 2018-10-01 20:10:33+00:00 insuln Insulin +74 Medication/supplement use 197521 phv00197521.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:10:42+00:00 2018-10-01 20:10:42+00:00 sympth Sympathomimetic (adrenergic) agents +74 Medication/supplement use 197522 phv00197522.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:10:50+00:00 2018-10-01 20:10:50+00:00 tca Tri- and tetra- cyclic anti-depressants +74 Medication/supplement use 197523 phv00197523.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:14:36+00:00 2018-10-01 20:14:36+00:00 maoi Monoamine oxidase inhibitors +74 Medication/supplement use 197524 phv00197524.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:14:58+00:00 2018-10-01 20:14:58+00:00 tcap Drug combination -- tricyclics and anti-psychotic +74 Medication/supplement use 197525 phv00197525.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:15:09+00:00 2018-10-01 20:15:09+00:00 antpsy Anti-psychotic +74 Medication/supplement use 197526 phv00197526.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:15:17+00:00 2018-10-01 20:15:17+00:00 asa Aspirin (anti-inflam agents) +74 Medication/supplement use 197527 phv00197527.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:15:28+00:00 2018-10-01 20:15:28+00:00 nsaid Non-steroidal anti-inflam (no aspirin) +74 Medication/supplement use 197528 phv00197528.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:15:43+00:00 2018-10-01 20:15:43+00:00 benzod Benzodiazepines +74 Medication/supplement use 197529 phv00197529.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:15:52+00:00 2018-10-01 20:15:52+00:00 premar Premarin +74 Medication/supplement use 197530 phv00197530.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:16:01+00:00 2018-10-01 20:16:01+00:00 pdei Phosphodiesterase inhibitors +74 Medication/supplement use 197531 phv00197531.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:16:11+00:00 2018-10-01 20:16:11+00:00 ntca Non-tricyclic antidepressants +74 Medication/supplement use 197532 phv00197532.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:16:20+00:00 2018-10-01 20:16:20+00:00 warf Oral anticoagulants +74 Medication/supplement use 197533 phv00197533.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:16:33+00:00 2018-10-01 20:16:33+00:00 loop Loop diuretics +74 Medication/supplement use 197534 phv00197534.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:16:43+00:00 2018-10-01 20:16:43+00:00 hctz Thiazide diuretics w-o K-sparing +74 Medication/supplement use 197535 phv00197535.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:16:52+00:00 2018-10-01 20:16:52+00:00 hctzk Thiazide diuretics with K-sparing +74 Medication/supplement use 197536 phv00197536.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:17:00+00:00 2018-10-01 20:17:00+00:00 ccbir All immediate-release CCB +74 Medication/supplement use 197537 phv00197537.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:17:08+00:00 2018-10-01 20:17:08+00:00 ccbsr All slow-release CCB +74 Medication/supplement use 197538 phv00197538.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:17:15+00:00 2018-10-01 20:17:15+00:00 alpha Alpha-blockers w-o diuretics +74 Medication/supplement use 197539 phv00197539.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:17:23+00:00 2018-10-01 20:17:23+00:00 alphad Alpha-blockers with diuretics +74 Medication/supplement use 197540 phv00197540.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:17:32+00:00 2018-10-01 20:17:32+00:00 anar1b Anti-arrhythmics, class 1b +74 Medication/supplement use 197541 phv00197541.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:17:39+00:00 2018-10-01 20:17:39+00:00 anar1c Anti-arrhythmics, class 1c +74 Medication/supplement use 197542 phv00197542.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:17:47+00:00 2018-10-01 20:17:47+00:00 anar3 Anti-arrhythmics, class 3 +74 Medication/supplement use 197543 phv00197543.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:17:55+00:00 2018-10-01 20:17:55+00:00 pvdl Peripheral vasodilators +74 Medication/supplement use 197544 phv00197544.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:18:02+00:00 2018-10-01 20:18:02+00:00 basq Bile-acid sequestrants +74 Medication/supplement use 197545 phv00197545.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:18:10+00:00 2018-10-01 20:18:10+00:00 niac Niacin and nicotinic acid +74 Medication/supplement use 197546 phv00197546.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:18:18+00:00 2018-10-01 20:18:18+00:00 thry Thyroid agents +74 Medication/supplement use 197547 phv00197547.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:18:33+00:00 2018-10-01 20:18:33+00:00 istrd Inhaled steroids for asthma +74 Medication/supplement use 197548 phv00197548.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:18:40+00:00 2018-10-01 20:18:40+00:00 ostrd Oral steroids +74 Medication/supplement use 197549 phv00197549.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:18:48+00:00 2018-10-01 20:18:48+00:00 beta Beta blockers +74 Medication/supplement use 197550 phv00197550.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:18:58+00:00 2018-10-01 20:18:58+00:00 betad Beta blockers and diuretics +74 Medication/supplement use 197551 phv00197551.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:19:05+00:00 2018-10-01 20:19:05+00:00 ccb Any calcium channel blocker +74 Medication/supplement use 197552 phv00197552.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:19:14+00:00 2018-10-01 20:19:14+00:00 ace Ace inhibitors +74 Medication/supplement use 197553 phv00197553.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:19:21+00:00 2018-10-01 20:19:21+00:00 aced Ace inhibitors and diuretics +74 Medication/supplement use 197554 phv00197554.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:19:28+00:00 2018-10-01 20:19:28+00:00 vaso Vasodilators (including alpha) +74 Medication/supplement use 197555 phv00197555.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:19:36+00:00 2018-10-01 20:19:36+00:00 vasod Vasodilators and diuretics (including alphad) +74 Medication/supplement use 197556 phv00197556.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:19:45+00:00 2018-10-01 20:19:45+00:00 diuret Any diuretic +74 Medication/supplement use 197557 phv00197557.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:19:56+00:00 2018-10-01 20:19:56+00:00 dig Digitalis +74 Medication/supplement use 197558 phv00197558.v1.p1 pht003699.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:20:06+00:00 2018-10-01 20:20:06+00:00 ntg Nitrates +74 Medication/supplement use 199029 phv00199029.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:21:18+00:00 2018-10-01 20:21:18+00:00 a2a2 Angiotensin type 2 antagonists +74 Medication/supplement use 199030 phv00199030.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:21:28+00:00 2018-10-01 20:21:28+00:00 a2ad2 Combinations of angiotensin ii antagonists plus diuretics +74 Medication/supplement use 199031 phv00199031.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:21:37+00:00 2018-10-01 20:21:37+00:00 ace2 Ace inhibitors without diuretics +74 Medication/supplement use 199033 phv00199033.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:21:44+00:00 2018-10-01 20:21:44+00:00 adpi2 Inhibitors of adp-induced platelet aggregation +74 Medication/supplement use 199034 phv00199034.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:21:54+00:00 2018-10-01 20:21:54+00:00 agdi2 Alpha-glucosidase inhibitors +74 Medication/supplement use 199035 phv00199035.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:22:03+00:00 2018-10-01 20:22:03+00:00 alpha2 Alpha-blockers without diuretics +74 Medication/supplement use 199036 phv00199036.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:22:11+00:00 2018-10-01 20:22:11+00:00 alphad2 Alpha-blockers with diuretics +74 Medication/supplement use 199037 phv00199037.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:22:18+00:00 2018-10-01 20:22:18+00:00 alzh2 Acetylcholine esterase inhibitors for alzh's +74 Medication/supplement use 199038 phv00199038.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:22:27+00:00 2018-10-01 20:22:27+00:00 amlod2 Amlodipine +74 Medication/supplement use 199039 phv00199039.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:22:34+00:00 2018-10-01 20:22:34+00:00 anar1a2 Anti-arrhythmics, class 1a +74 Medication/supplement use 199040 phv00199040.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:22:41+00:00 2018-10-01 20:22:41+00:00 anar1b2 Anti-arrhythmics, class 1b +74 Medication/supplement use 199041 phv00199041.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:22:48+00:00 2018-10-01 20:22:48+00:00 anar1c2 Anti-arrhythmics, class 1c +74 Medication/supplement use 199042 phv00199042.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:22:57+00:00 2018-10-01 20:22:57+00:00 anar32 Anti-arrhythmics, class 3 +74 Medication/supplement use 199043 phv00199043.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:23:05+00:00 2018-10-01 20:23:05+00:00 apsy2 Anti-psychotic medications +74 Medication/supplement use 199044 phv00199044.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:23:15+00:00 2018-10-01 20:23:15+00:00 asa2 Aspirin from 280804 (Anti-inflam agents) +74 Medication/supplement use 199045 phv00199045.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:23:23+00:00 2018-10-01 20:23:23+00:00 basq2 Bile-acid sequestrants +74 Medication/supplement use 199046 phv00199046.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:23:30+00:00 2018-10-01 20:23:30+00:00 benzod2 Benzodiazepines +74 Medication/supplement use 199047 phv00199047.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:23:38+00:00 2018-10-01 20:23:38+00:00 beta2 Beta-blockers without diuretics +74 Medication/supplement use 199048 phv00199048.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:23:46+00:00 2018-10-01 20:23:46+00:00 betad2 Beta-blockers with diuretics +74 Medication/supplement use 199049 phv00199049.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:23:56+00:00 2018-10-01 20:23:56+00:00 bgnd2 Biguanides +74 Medication/supplement use 199050 phv00199050.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:24:07+00:00 2018-10-01 20:24:07+00:00 ccb2 Any calcium-channel blocker = ccir or ccbsr or ccbt +74 Medication/supplement use 199051 phv00199051.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:24:17+00:00 2018-10-01 20:24:17+00:00 ccbir2 Immediate-release ccbs = nifir or dihir or verir or dltir +74 Medication/supplement use 199052 phv00199052.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:24:26+00:00 2018-10-01 20:24:26+00:00 ccbsr2 Slow-release ccbs = nifsr or dihsr or versr or dltsr or amlod +74 Medication/supplement use 199053 phv00199053.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:24:34+00:00 2018-10-01 20:24:34+00:00 ccbt2 T-type calcium-channel blocker +74 Medication/supplement use 199054 phv00199054.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:24:42+00:00 2018-10-01 20:24:42+00:00 cox22 Cox-2 inhibitors (nsaid agents); separate from nsaid variable +74 Medication/supplement use 199055 phv00199055.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:24:49+00:00 2018-10-01 20:24:49+00:00 dig2 Digitalis preparations +74 Medication/supplement use 199056 phv00199056.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:25:01+00:00 2018-10-01 20:25:01+00:00 dihir2 Immediate-release dihyropryidines other than nifedipine +74 Medication/supplement use 199057 phv00199057.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:25:09+00:00 2018-10-01 20:25:09+00:00 dihsr2 Slow-release dihydropyridines other than nifedipine or amlopidine +74 Medication/supplement use 199058 phv00199058.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:25:18+00:00 2018-10-01 20:25:18+00:00 dltir2 Immediate-release diltiazem +74 Medication/supplement use 199059 phv00199059.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:25:31+00:00 2018-10-01 20:25:31+00:00 dltsr2 Slow-release diltiazem +74 Medication/supplement use 199060 phv00199060.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:25:41+00:00 2018-10-01 20:25:41+00:00 edd2 Erectile dysfunction drugs +74 Medication/supplement use 199061 phv00199061.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:25:49+00:00 2018-10-01 20:25:49+00:00 estrgn2 Estrogens, excluding vaginal creams +74 Medication/supplement use 199062 phv00199062.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:25:58+00:00 2018-10-01 20:25:58+00:00 fibr2 Fibrates +74 Medication/supplement use 199063 phv00199063.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:26:05+00:00 2018-10-01 20:26:05+00:00 h2b2 H-2 blockers +74 Medication/supplement use 199064 phv00199064.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:26:14+00:00 2018-10-01 20:26:14+00:00 hctz2 Thiazide diuretics without k-sparing agents +74 Medication/supplement use 199065 phv00199065.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:26:22+00:00 2018-10-01 20:26:22+00:00 hctzk2 Thiazide diuretics with k-sparing agents +74 Medication/supplement use 199066 phv00199066.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:26:35+00:00 2018-10-01 20:26:35+00:00 hprns2 Heparins +74 Medication/supplement use 199067 phv00199067.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:26:46+00:00 2018-10-01 20:26:46+00:00 insln2 Insulins +74 Medication/supplement use 199068 phv00199068.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:26:59+00:00 2018-10-01 20:26:59+00:00 iprtr2 Anticholinergics + combination with beta2-agonist +74 Medication/supplement use 199069 phv00199069.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:27:08+00:00 2018-10-01 20:27:08+00:00 istrd2 Inhaled steroids for asthma +74 Medication/supplement use 199070 phv00199070.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:27:17+00:00 2018-10-01 20:27:17+00:00 kblkr2 K-channel blockers to enhance insulin secretion for diabetics +74 Medication/supplement use 199071 phv00199071.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:27:26+00:00 2018-10-01 20:27:26+00:00 kcl2 Potassium supplements +74 Medication/supplement use 199072 phv00199072.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:27:33+00:00 2018-10-01 20:27:33+00:00 kspr2 Potassium-sparing agents alone +74 Medication/supplement use 199073 phv00199073.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:29:45+00:00 2018-10-01 20:29:45+00:00 loop2 Loop diuretics +74 Medication/supplement use 199074 phv00199074.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:29:56+00:00 2018-10-01 20:29:56+00:00 maoi2 MAO inhibitors +74 Medication/supplement use 199075 phv00199075.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:30:04+00:00 2018-10-01 20:30:04+00:00 mlpd2 Miscellaneous lipid-lowering drugs +74 Medication/supplement use 199076 phv00199076.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:30:12+00:00 2018-10-01 20:30:12+00:00 niac2 Niacin and nicotinic acid +74 Medication/supplement use 199077 phv00199077.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:30:20+00:00 2018-10-01 20:30:20+00:00 nifir2 Immediate-release nifedipine +74 Medication/supplement use 199078 phv00199078.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:30:29+00:00 2018-10-01 20:30:29+00:00 nifsr2 Slow-release nifedipine +74 Medication/supplement use 199079 phv00199079.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:30:37+00:00 2018-10-01 20:30:37+00:00 nsaid2 Non-steroidal Anti-inflammatory agents, excluding aspirin +74 Medication/supplement use 199080 phv00199080.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:30:48+00:00 2018-10-01 20:30:48+00:00 ntca2 Non-tricyclic antidepressants other than MAO inhibitors +74 Medication/supplement use 199081 phv00199081.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:30:57+00:00 2018-10-01 20:30:57+00:00 ntg2 Nitrates +74 Medication/supplement use 199082 phv00199082.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:31:05+00:00 2018-10-01 20:31:05+00:00 oaia2 Oral Anti-inflammatory asthma drugs (leukotriene receptor antagonists and inhibitor) +74 Medication/supplement use 199083 phv00199083.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:31:13+00:00 2018-10-01 20:31:13+00:00 ohga2 Oral hypoglycemic agents +74 Medication/supplement use 199084 phv00199084.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:31:21+00:00 2018-10-01 20:31:21+00:00 ostrd2 Oral steroids +74 Medication/supplement use 199085 phv00199085.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:31:30+00:00 2018-10-01 20:31:30+00:00 otch2b2 Over-the-counter H-2 blockers +74 Medication/supplement use 199086 phv00199086.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:31:39+00:00 2018-10-01 20:31:39+00:00 pdei2 Phosphodiesterase inhibitors +74 Medication/supplement use 199087 phv00199087.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:31:47+00:00 2018-10-01 20:31:47+00:00 ppi2 Proton pump inhibitors +74 Medication/supplement use 199088 phv00199088.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:31:55+00:00 2018-10-01 20:31:55+00:00 prgstn2 Progestins +74 Medication/supplement use 199089 phv00199089.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:32:03+00:00 2018-10-01 20:32:03+00:00 prknsn2 Drugs used to treat Parkinson's +74 Medication/supplement use 199090 phv00199090.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:32:12+00:00 2018-10-01 20:32:12+00:00 prmrn2 Premarin (conjugated estrogens) +74 Medication/supplement use 199091 phv00199091.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:32:19+00:00 2018-10-01 20:32:19+00:00 prob2 Probucol +74 Medication/supplement use 199092 phv00199092.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:32:27+00:00 2018-10-01 20:32:27+00:00 pvdl2 Peripheral vasodilators, exclude dipyridamole +74 Medication/supplement use 199093 phv00199093.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:32:36+00:00 2018-10-01 20:32:36+00:00 slf12 First generation sulfonylureas +74 Medication/supplement use 199094 phv00199094.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:32:44+00:00 2018-10-01 20:32:44+00:00 slf22 Second generation sulfonylureas +74 Medication/supplement use 199095 phv00199095.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:32:53+00:00 2018-10-01 20:32:53+00:00 sttn2 HMG CoA reductase inhibitors (statins) +74 Medication/supplement use 199096 phv00199096.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:33:00+00:00 2018-10-01 20:33:00+00:00 sympth2 Sympathomimetics, oral and inhaled +74 Medication/supplement use 199097 phv00199097.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:33:12+00:00 2018-10-01 20:33:12+00:00 tca2 Tricylic Anti-depressants +74 Medication/supplement use 199098 phv00199098.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:33:19+00:00 2018-10-01 20:33:19+00:00 tcap2 Tri-cyclic Anti-depressants plus Anti-psychotics combinations +74 Medication/supplement use 199099 phv00199099.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:33:26+00:00 2018-10-01 20:33:26+00:00 thry2 Thyroid agents +74 Medication/supplement use 199100 phv00199100.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:33:34+00:00 2018-10-01 20:33:34+00:00 thzd2 Thiazolidinediones +74 Medication/supplement use 199101 phv00199101.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:33:42+00:00 2018-10-01 20:33:42+00:00 urcos2 Uricosurics +74 Medication/supplement use 199102 phv00199102.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:33:49+00:00 2018-10-01 20:33:49+00:00 vaso2 Vasodilators, a mixed group +74 Medication/supplement use 199103 phv00199103.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:33:57+00:00 2018-10-01 20:33:57+00:00 vasod2 Vasodilators with diuretics, a mixed group +74 Medication/supplement use 199104 phv00199104.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:34:07+00:00 2018-10-01 20:34:07+00:00 verir2 Immediate-release verapamil +74 Medication/supplement use 199105 phv00199105.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:34:15+00:00 2018-10-01 20:34:15+00:00 versr2 Slow-release verapamil +74 Medication/supplement use 199106 phv00199106.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:34:27+00:00 2018-10-01 20:34:27+00:00 warf2 Oral anticoagulants including warfarin, coumadin, and anisindione +74 Medication/supplement use 199107 phv00199107.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:34:35+00:00 2018-10-01 20:34:35+00:00 wtls2 Weight loss drugs +74 Medication/supplement use 199108 phv00199108.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:34:42+00:00 2018-10-01 20:34:42+00:00 xoi2 Xanthine oxidase inhibitors +74 Medication/supplement use 199109 phv00199109.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:34:50+00:00 2018-10-01 20:34:50+00:00 diur2 Any diuretic +74 Medication/supplement use 199110 phv00199110.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:34:59+00:00 2018-10-01 20:34:59+00:00 lipid2 Any lipid-lowering medication +74 Medication/supplement use 199111 phv00199111.v1.p1 pht003700.v2.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-10-01 20:35:08+00:00 2018-10-01 20:35:08+00:00 htnmed2 Any Anti-hypertensive medication +74 Medication/supplement use 83081 phv00083081.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:02:14+00:00 2018-10-21 23:02:14+00:00 a2a1c ANGIOTENSIN TYPE 2 ANTAGONISTS +74 Medication/supplement use 83082 phv00083082.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:02:58+00:00 2018-10-21 23:02:58+00:00 a2ad1c COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS +74 Medication/supplement use 85326 phv00085326.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:03:05+00:00 2018-10-21 23:03:05+00:00 a2a1c ANGIOTENSIN TYPE 2 ANTAGONISTS +74 Medication/supplement use 85327 phv00085327.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:03:14+00:00 2018-10-21 23:03:14+00:00 a2ad1c COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS +74 Medication/supplement use 86015 phv00086015.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:03:21+00:00 2018-10-21 23:03:21+00:00 a2a2c ANGIOTENSIN TYPE 2 ANTAGONISTS +74 Medication/supplement use 86016 phv00086016.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:03:30+00:00 2018-10-21 23:03:30+00:00 a2ad2c COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS +74 Medication/supplement use 86497 phv00086497.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:03:38+00:00 2018-10-21 23:03:38+00:00 a2a3c ANGIOTENSIN TYPE 2 ANTAGONISTS +74 Medication/supplement use 86498 phv00086498.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:03:45+00:00 2018-10-21 23:03:45+00:00 a2ad3c COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS +74 Medication/supplement use 86934 phv00086934.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:03:51+00:00 2018-10-21 23:03:51+00:00 a2a4c ANGIOTENSIN TYPE 2 ANTAGONISTS +74 Medication/supplement use 86935 phv00086935.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:03:58+00:00 2018-10-21 23:03:58+00:00 a2ad4c COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS +74 Medication/supplement use 87302 phv00087302.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:04:05+00:00 2018-10-21 23:04:05+00:00 a2afc ANGIOTENSIN TYPE 2 ANTAGONISTS +74 Medication/supplement use 87303 phv00087303.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:04:15+00:00 2018-10-21 23:04:15+00:00 a2adfc COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS +74 Medication/supplement use 175327 phv00175327.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:04:21+00:00 2018-10-21 23:04:21+00:00 a2a5c ANGIOTENSIN TYPE 2 ANTAGONISTS +74 Medication/supplement use 175328 phv00175328.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:04:29+00:00 2018-10-21 23:04:29+00:00 a2ad5c COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS +74 Medication/supplement use 176750 phv00176750.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:04:36+00:00 2018-10-21 23:04:36+00:00 a2a5c ANGIOTENSIN TYPE 2 ANTAGONISTS +74 Medication/supplement use 176751 phv00176751.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:04:42+00:00 2018-10-21 23:04:42+00:00 a2ad5c COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS +74 Medication/supplement use 83083 phv00083083.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:06:10+00:00 2018-10-21 23:06:10+00:00 ace1c ACE INHIBITORS WITHOUT DIURETICS +74 Medication/supplement use 83084 phv00083084.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:06:18+00:00 2018-10-21 23:06:18+00:00 aced1c ACE INHIBITORS WITH DIURETICS +74 Medication/supplement use 85328 phv00085328.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:06:26+00:00 2018-10-21 23:06:26+00:00 ace1c ACE INHIBITORS WITHOUT DIURETICS +74 Medication/supplement use 85329 phv00085329.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:06:34+00:00 2018-10-21 23:06:34+00:00 aced1c ACE INHIBITORS WITH DIURETICS +74 Medication/supplement use 86001 phv00086001.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:06:42+00:00 2018-10-21 23:06:42+00:00 ace2c ACE INHIBITORS WITHOUT DIURETICS +74 Medication/supplement use 86002 phv00086002.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:06:53+00:00 2018-10-21 23:06:53+00:00 aced2c ACE INHIBITORS WITH DIURETICS +74 Medication/supplement use 86483 phv00086483.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:06:59+00:00 2018-10-21 23:06:59+00:00 ace3c ACE INHIBITORS WITHOUT DIURETICS +74 Medication/supplement use 86484 phv00086484.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:07:07+00:00 2018-10-21 23:07:07+00:00 aced3c ACE INHIBITORS WITH DIURETICS +74 Medication/supplement use 86920 phv00086920.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:07:14+00:00 2018-10-21 23:07:14+00:00 ace4c ACE INHIBITORS WITHOUT DIURETICS +74 Medication/supplement use 86921 phv00086921.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:07:20+00:00 2018-10-21 23:07:20+00:00 aced4c ACE INHIBITORS WITH DIURETICS +74 Medication/supplement use 87304 phv00087304.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:07:26+00:00 2018-10-21 23:07:26+00:00 acefc ACE INHIBITORS WITHOUT DIURETICS +74 Medication/supplement use 87305 phv00087305.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:07:34+00:00 2018-10-21 23:07:34+00:00 acedfc ACE INHIBITORS WITH DIURETICS +74 Medication/supplement use 175329 phv00175329.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:07:49+00:00 2018-10-21 23:07:49+00:00 ace5c ACE INHIBITORS WITHOUT DIURETICS +74 Medication/supplement use 175330 phv00175330.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:07:56+00:00 2018-10-21 23:07:56+00:00 aced5c ACE INHIBITORS WITH DIURETICS +74 Medication/supplement use 176752 phv00176752.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:08:04+00:00 2018-10-21 23:08:04+00:00 ace5c ACE INHIBITORS WITHOUT DIURETICS +74 Medication/supplement use 176753 phv00176753.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:08:12+00:00 2018-10-21 23:08:12+00:00 aced5c ACE INHIBITORS WITH DIURETICS +74 Medication/supplement use 83085 phv00083085.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:19:01+00:00 2018-10-21 23:19:01+00:00 adpi1c INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION +74 Medication/supplement use 85330 phv00085330.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:19:11+00:00 2018-10-21 23:19:11+00:00 adpi1c INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION +74 Medication/supplement use 86017 phv00086017.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:19:17+00:00 2018-10-21 23:19:17+00:00 adpi2c INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION +74 Medication/supplement use 86499 phv00086499.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:19:28+00:00 2018-10-21 23:19:28+00:00 adpi3c INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION +74 Medication/supplement use 86936 phv00086936.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:19:37+00:00 2018-10-21 23:19:37+00:00 adpi4c INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION +74 Medication/supplement use 87306 phv00087306.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:19:44+00:00 2018-10-21 23:19:44+00:00 adpifc INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION +74 Medication/supplement use 175331 phv00175331.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:19:51+00:00 2018-10-21 23:19:51+00:00 adpi5c INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION +74 Medication/supplement use 176754 phv00176754.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:20:13+00:00 2018-10-21 23:20:13+00:00 adpi5c INHIBITORS OF ADP-INDUCED PLATELET AGGREGATION +74 Medication/supplement use 83086 phv00083086.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:21:38+00:00 2018-10-21 23:21:38+00:00 agdi1c ALPHA-GLUCOSIDASE INHIBITORS +74 Medication/supplement use 85331 phv00085331.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:21:44+00:00 2018-10-21 23:21:44+00:00 agdi1c ALPHA-GLUCOSIDASE INHIBITORS +74 Medication/supplement use 86018 phv00086018.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:21:52+00:00 2018-10-21 23:21:52+00:00 agdi2c ALPHA-GLUCOSIDASE INHIBITORS +74 Medication/supplement use 86500 phv00086500.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:21:58+00:00 2018-10-21 23:21:58+00:00 agdi3c ALPHA-GLUCOSIDASE INHIBITORS +74 Medication/supplement use 86937 phv00086937.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:22:04+00:00 2018-10-21 23:22:04+00:00 agdi4c ALPHA-GLUCOSIDASE INHIBITORS +74 Medication/supplement use 87307 phv00087307.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:22:23+00:00 2018-10-21 23:22:23+00:00 agdifc ALPHA-GLUCOSIDASE INHIBITORS +74 Medication/supplement use 175332 phv00175332.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:22:30+00:00 2018-10-21 23:22:30+00:00 agdi5c ALPHA-GLUCOSIDASE INHIBITORS +74 Medication/supplement use 176755 phv00176755.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:22:38+00:00 2018-10-21 23:22:38+00:00 agdi5c ALPHA-GLUCOSIDASE INHIBITORS +74 Medication/supplement use 175333 phv00175333.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:26:19+00:00 2018-10-21 23:26:19+00:00 alpha5c ALPHA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 175334 phv00175334.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:26:28+00:00 2018-10-21 23:26:28+00:00 alphad5c ALPHA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 176756 phv00176756.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:26:35+00:00 2018-10-21 23:26:35+00:00 alpha5c ALPHA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 176757 phv00176757.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:26:41+00:00 2018-10-21 23:26:41+00:00 alphad5c ALPHA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 83087 phv00083087.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:26:49+00:00 2018-10-21 23:26:49+00:00 alpha1c ALPHA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 83088 phv00083088.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:27:03+00:00 2018-10-21 23:27:03+00:00 alphad1c ALPHA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 85332 phv00085332.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:27:10+00:00 2018-10-21 23:27:10+00:00 alpha1c ALPHA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 85333 phv00085333.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:27:20+00:00 2018-10-21 23:27:20+00:00 alphad1c ALPHA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 86019 phv00086019.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:28:32+00:00 2018-10-21 23:28:32+00:00 alpha2c ALPHA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 86020 phv00086020.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:28:54+00:00 2018-10-21 23:28:54+00:00 alphad2c ALPHA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 86501 phv00086501.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:30:29+00:00 2018-10-21 23:30:29+00:00 alpha3c ALPHA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 86502 phv00086502.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:30:38+00:00 2018-10-21 23:30:38+00:00 alphad3c ALPHA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 86938 phv00086938.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:30:45+00:00 2018-10-21 23:30:45+00:00 alpha4c ALPHA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 86939 phv00086939.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:30:53+00:00 2018-10-21 23:30:53+00:00 alphad4c ALPHA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 87308 phv00087308.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:31:01+00:00 2018-10-21 23:31:01+00:00 alphafc ALPHA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 87309 phv00087309.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:31:11+00:00 2018-10-21 23:31:11+00:00 alphadfc ALPHA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 83089 phv00083089.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:32:28+00:00 2018-10-21 23:32:28+00:00 alzh1c ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S +74 Medication/supplement use 85334 phv00085334.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:32:36+00:00 2018-10-21 23:32:36+00:00 alzh1c ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH' +74 Medication/supplement use 86021 phv00086021.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:32:46+00:00 2018-10-21 23:32:46+00:00 alzh2c ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S +74 Medication/supplement use 86503 phv00086503.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:32:56+00:00 2018-10-21 23:32:56+00:00 alzh3c ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S +74 Medication/supplement use 86940 phv00086940.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:33:03+00:00 2018-10-21 23:33:03+00:00 alzh4c ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZH'S +74 Medication/supplement use 87310 phv00087310.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:33:11+00:00 2018-10-21 23:33:11+00:00 alzhfc ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZHEIMER'S +74 Medication/supplement use 175335 phv00175335.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:33:17+00:00 2018-10-21 23:33:17+00:00 alzh5c ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZHEIMERS +74 Medication/supplement use 176758 phv00176758.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:33:23+00:00 2018-10-21 23:33:23+00:00 alzh5c ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZHEIMERS +74 Medication/supplement use 83090 phv00083090.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:54:45+00:00 2018-10-21 23:54:45+00:00 amlod1c AMLODIPINE +74 Medication/supplement use 85335 phv00085335.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:54:52+00:00 2018-10-21 23:54:52+00:00 amlod1c AMLODIPINE +74 Medication/supplement use 86022 phv00086022.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:54:59+00:00 2018-10-21 23:54:59+00:00 amlod2c AMLODIPINE +74 Medication/supplement use 86504 phv00086504.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:55:06+00:00 2018-10-21 23:55:06+00:00 amlod3c AMLODIPINE +74 Medication/supplement use 86941 phv00086941.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:55:15+00:00 2018-10-21 23:55:15+00:00 amlod4c AMLODIPINE +74 Medication/supplement use 87311 phv00087311.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:55:22+00:00 2018-10-21 23:55:22+00:00 amlodfc AMLODIPINE +74 Medication/supplement use 175336 phv00175336.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:55:29+00:00 2018-10-21 23:55:29+00:00 amlod5c AMLODIPINE +74 Medication/supplement use 176759 phv00176759.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:55:36+00:00 2018-10-21 23:55:36+00:00 amlod5c AMLODIPINE +74 Medication/supplement use 83091 phv00083091.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:56:54+00:00 2018-10-21 23:56:54+00:00 anar1a1c ANTI-ARRHYTHMICS, CLASS 1A +74 Medication/supplement use 83092 phv00083092.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:57:01+00:00 2018-10-21 23:57:01+00:00 anar1b1c ANTI-ARRHYTHMICS, CLASS 1B +74 Medication/supplement use 83093 phv00083093.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:57:09+00:00 2018-10-21 23:57:09+00:00 anar1c1c ANTI-ARRHYTHMICS, CLASS 1C +74 Medication/supplement use 85336 phv00085336.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:57:16+00:00 2018-10-21 23:57:16+00:00 anar1a1c ANTI-ARRHYTHMICS, CLASS 1A +74 Medication/supplement use 85337 phv00085337.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:57:24+00:00 2018-10-21 23:57:24+00:00 anar1b1c ANTI-ARRHYTHMICS, CLASS 1B +74 Medication/supplement use 85338 phv00085338.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:57:38+00:00 2018-10-21 23:57:38+00:00 anar1c1c ANTI-ARRHYTHMICS, CLASS 1C +74 Medication/supplement use 86023 phv00086023.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:57:45+00:00 2018-10-21 23:57:45+00:00 anar1a2c ANTI-ARRHYTHMICS, CLASS 1A +74 Medication/supplement use 86024 phv00086024.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:57:52+00:00 2018-10-21 23:57:52+00:00 anar1b2c ANTI-ARRHYTHMICS, CLASS 1B +74 Medication/supplement use 86025 phv00086025.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:57:58+00:00 2018-10-21 23:57:58+00:00 anar1c2c ANTI-ARRHYTHMICS, CLASS 1C +74 Medication/supplement use 86505 phv00086505.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:58:04+00:00 2018-10-21 23:58:04+00:00 anar1a3c ANTI-ARRHYTHMICS, CLASS 1A +74 Medication/supplement use 86506 phv00086506.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:58:10+00:00 2018-10-21 23:58:10+00:00 anar1b3c ANTI-ARRHYTHMICS, CLASS 1B +74 Medication/supplement use 86507 phv00086507.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:58:17+00:00 2018-10-21 23:58:17+00:00 anar1c3c ANTI-ARRHYTHMICS, CLASS 1C +74 Medication/supplement use 86942 phv00086942.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:58:23+00:00 2018-10-21 23:58:23+00:00 anar1a4c ANTI-ARRHYTHMICS, CLASS 1A +74 Medication/supplement use 86943 phv00086943.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:58:29+00:00 2018-10-21 23:58:29+00:00 anar1b4c ANTI-ARRHYTHMICS, CLASS 1B +74 Medication/supplement use 86944 phv00086944.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:58:36+00:00 2018-10-21 23:58:36+00:00 anar1c4c ANTI-ARRHYTHMICS, CLASS 1C +74 Medication/supplement use 87312 phv00087312.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:58:43+00:00 2018-10-21 23:58:43+00:00 anar1afc ANTI-ARRHYTHMICS, CLASS 1A +74 Medication/supplement use 87313 phv00087313.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:58:51+00:00 2018-10-21 23:58:51+00:00 anar1bfc ANTI-ARRHYTHMICS, CLASS 1B +74 Medication/supplement use 87314 phv00087314.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:59:00+00:00 2018-10-21 23:59:00+00:00 anar1cfc ANTI-ARRHYTHMICS, CLASS 1C +74 Medication/supplement use 175337 phv00175337.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:59:06+00:00 2018-10-21 23:59:06+00:00 anar1a5c ANTI-ARRHYTHMICS, CLASS 1A +74 Medication/supplement use 175338 phv00175338.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:59:13+00:00 2018-10-21 23:59:13+00:00 anar1b5c ANTI-ARRHYTHMICS, CLASS 1B +74 Medication/supplement use 175339 phv00175339.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:59:20+00:00 2018-10-21 23:59:20+00:00 anar1c5c ANTI-ARRHYTHMICS, CLASS 1C +74 Medication/supplement use 176760 phv00176760.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:59:26+00:00 2018-10-21 23:59:26+00:00 anar1a5c ANTI-ARRHYTHMICS, CLASS 1A +74 Medication/supplement use 176761 phv00176761.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:59:32+00:00 2018-10-21 23:59:32+00:00 anar1b5c ANTI-ARRHYTHMICS, CLASS 1B +74 Medication/supplement use 176762 phv00176762.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-21 23:59:54+00:00 2018-10-21 23:59:54+00:00 anar1c5c ANTI-ARRHYTHMICS, CLASS 1C +74 Medication/supplement use 83094 phv00083094.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:00:51+00:00 2018-10-22 00:00:51+00:00 anar31c ANTI-ARRHYTHMICS, CLASS 3 +74 Medication/supplement use 85339 phv00085339.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:00:57+00:00 2018-10-22 00:00:57+00:00 anar31c ANTI-ARRHYTHMICS, CLASS 3 +74 Medication/supplement use 86026 phv00086026.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:01:06+00:00 2018-10-22 00:01:06+00:00 anar32c ANTI-ARRHYTHMICS, CLASS 3 +74 Medication/supplement use 86508 phv00086508.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:01:17+00:00 2018-10-22 00:01:17+00:00 anar33c ANTI-ARRHYTHMICS, CLASS 3 +74 Medication/supplement use 86945 phv00086945.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:01:24+00:00 2018-10-22 00:01:24+00:00 anar34c ANTI-ARRHYTHMICS, CLASS 3 +74 Medication/supplement use 87315 phv00087315.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:01:31+00:00 2018-10-22 00:01:31+00:00 anar3fc ANTI-ARRHYTHMICS, CLASS 3 +74 Medication/supplement use 175340 phv00175340.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:01:37+00:00 2018-10-22 00:01:37+00:00 anar35c ANTI-ARRHYTHMICS, CLASS 3 +74 Medication/supplement use 176763 phv00176763.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:01:45+00:00 2018-10-22 00:01:45+00:00 anar35c ANTI-ARRHYTHMICS, CLASS 3 +74 Medication/supplement use 83095 phv00083095.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:02:40+00:00 2018-10-22 00:02:40+00:00 apsy1c ANTI-PSYCHOTIC MEDICATIONS +74 Medication/supplement use 85340 phv00085340.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:02:47+00:00 2018-10-22 00:02:47+00:00 apsy1c ANTI-PSYCHOTIC MEDICATIONS +74 Medication/supplement use 86027 phv00086027.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:02:53+00:00 2018-10-22 00:02:53+00:00 apsy2c ANTI-PSYCHOTIC MEDICATIONS +74 Medication/supplement use 86509 phv00086509.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:02:59+00:00 2018-10-22 00:02:59+00:00 apsy3c ANTI-PSYCHOTIC MEDICATIONS +74 Medication/supplement use 86946 phv00086946.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:03:06+00:00 2018-10-22 00:03:06+00:00 apsy4c ANTI-PSYCHOTIC MEDICATIONS +74 Medication/supplement use 87316 phv00087316.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:03:12+00:00 2018-10-22 00:03:12+00:00 apsyfc ANTI-PSYCHOTIC MEDICATIONS +74 Medication/supplement use 175341 phv00175341.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:03:20+00:00 2018-10-22 00:03:20+00:00 apsy5c ANTI-PSYCHOTIC MEDICATIONS +74 Medication/supplement use 176764 phv00176764.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:03:28+00:00 2018-10-22 00:03:28+00:00 apsy5c ANTI-PSYCHOTIC MEDICATIONS +74 Medication/supplement use 83072 phv00083072.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:19:04+00:00 2018-10-22 00:19:04+00:00 asacat1c CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK AT BASELINE) +74 Medication/supplement use 83096 phv00083096.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:19:12+00:00 2018-10-22 00:19:12+00:00 asa1c ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) +74 Medication/supplement use 85323 phv00085323.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:19:20+00:00 2018-10-22 00:19:20+00:00 asacat1c CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK AT BASELINE) +74 Medication/supplement use 85341 phv00085341.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:19:28+00:00 2018-10-22 00:19:28+00:00 asa1c ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) +74 Medication/supplement use 85973 phv00085973.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:19:36+00:00 2018-10-22 00:19:36+00:00 asacat2c CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK AT EXAM 2) +74 Medication/supplement use 86003 phv00086003.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:19:44+00:00 2018-10-22 00:19:44+00:00 asa2c ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) +74 Medication/supplement use 86455 phv00086455.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:19:53+00:00 2018-10-22 00:19:53+00:00 asacat3C CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK) +74 Medication/supplement use 86485 phv00086485.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:20:02+00:00 2018-10-22 00:20:02+00:00 asa3c ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) +74 Medication/supplement use 86899 phv00086899.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:20:11+00:00 2018-10-22 00:20:11+00:00 asacat4c CURRENT ASPIRIN USE (TAKING ASPIRIN AT LEAST 3 DAYS PER WEEK) +74 Medication/supplement use 86922 phv00086922.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:20:20+00:00 2018-10-22 00:20:20+00:00 asa4c ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) +74 Medication/supplement use 87317 phv00087317.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:20:28+00:00 2018-10-22 00:20:28+00:00 asafc ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) +74 Medication/supplement use 175342 phv00175342.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:20:36+00:00 2018-10-22 00:20:36+00:00 asa5c ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) +74 Medication/supplement use 176765 phv00176765.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:20:46+00:00 2018-10-22 00:20:46+00:00 asa5c ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) +74 Medication/supplement use 83097 phv00083097.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:22:03+00:00 2018-10-22 00:22:03+00:00 basq1c BILE-ACID SEQUESTRANTS +74 Medication/supplement use 85342 phv00085342.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:22:19+00:00 2018-10-22 00:22:19+00:00 basq1c BILE-ACID SEQUESTRANTS +74 Medication/supplement use 86028 phv00086028.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:22:28+00:00 2018-10-22 00:22:28+00:00 basq2c BILE-ACID SEQUESTRANTS +74 Medication/supplement use 86510 phv00086510.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:22:37+00:00 2018-10-22 00:22:37+00:00 basq3c BILE-ACID SEQUESTRANTS +74 Medication/supplement use 86947 phv00086947.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:23:05+00:00 2018-10-22 00:23:05+00:00 basq4c BILE-ACID SEQUESTRANTS +74 Medication/supplement use 87318 phv00087318.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:23:16+00:00 2018-10-22 00:23:16+00:00 basqfc BILE-ACID SEQUESTRANTS +74 Medication/supplement use 175343 phv00175343.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:23:28+00:00 2018-10-22 00:23:28+00:00 basq5c BILE-ACID SEQUESTRANTS +74 Medication/supplement use 176766 phv00176766.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:23:44+00:00 2018-10-22 00:23:44+00:00 basq5c BILE-ACID SEQUESTRANTS +74 Medication/supplement use 83098 phv00083098.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:44:07+00:00 2018-10-22 00:44:07+00:00 benzod1c BENZODIAZEPINES +74 Medication/supplement use 85343 phv00085343.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:44:15+00:00 2018-10-22 00:44:15+00:00 benzod1c BENZODIAZEPINES +74 Medication/supplement use 86029 phv00086029.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:44:41+00:00 2018-10-22 00:44:41+00:00 benzod2c BENZODIAZEPINES +74 Medication/supplement use 86511 phv00086511.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:45:01+00:00 2018-10-22 00:45:01+00:00 benzod3c BENZODIAZEPINES +74 Medication/supplement use 86948 phv00086948.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:45:15+00:00 2018-10-22 00:45:15+00:00 benzod4c BENZODIAZEPINES +74 Medication/supplement use 87319 phv00087319.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:45:33+00:00 2018-10-22 00:45:33+00:00 benzodfc BENZODIAZEPINES +74 Medication/supplement use 175344 phv00175344.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:45:40+00:00 2018-10-22 00:45:40+00:00 benzod5c BENZODIAZEPINES +74 Medication/supplement use 176767 phv00176767.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:45:46+00:00 2018-10-22 00:45:46+00:00 benzod5c BENZODIAZEPINES +74 Medication/supplement use 83099 phv00083099.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:46:46+00:00 2018-10-22 00:46:46+00:00 beta1c BETA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 83100 phv00083100.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:46:54+00:00 2018-10-22 00:46:54+00:00 betad1c BETA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 85344 phv00085344.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:47:01+00:00 2018-10-22 00:47:01+00:00 beta1c BETA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 85345 phv00085345.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:47:07+00:00 2018-10-22 00:47:07+00:00 betad1c BETA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 86004 phv00086004.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:47:21+00:00 2018-10-22 00:47:21+00:00 beta2c BETA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 86005 phv00086005.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:47:27+00:00 2018-10-22 00:47:27+00:00 betad2c BETA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 86486 phv00086486.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:47:34+00:00 2018-10-22 00:47:34+00:00 beta3c BETA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 86487 phv00086487.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:47:41+00:00 2018-10-22 00:47:41+00:00 betad3c BETA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 86923 phv00086923.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:47:48+00:00 2018-10-22 00:47:48+00:00 beta4c BETA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 86924 phv00086924.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:47:54+00:00 2018-10-22 00:47:54+00:00 betad4c BETA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 87320 phv00087320.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:48:03+00:00 2018-10-22 00:48:03+00:00 betafc BETA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 87321 phv00087321.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:48:10+00:00 2018-10-22 00:48:10+00:00 betadfc BETA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 175345 phv00175345.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:48:18+00:00 2018-10-22 00:48:18+00:00 beta5c BETA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 175346 phv00175346.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:48:27+00:00 2018-10-22 00:48:27+00:00 betad5c BETA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 176768 phv00176768.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:48:39+00:00 2018-10-22 00:48:39+00:00 beta5c BETA-BLOCKERS WITHOUT DIURETICS +74 Medication/supplement use 176769 phv00176769.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:48:51+00:00 2018-10-22 00:48:51+00:00 betad5c BETA-BLOCKERS WITH DIURETICS +74 Medication/supplement use 83101 phv00083101.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:49:42+00:00 2018-10-22 00:49:42+00:00 bgnd1c BIGUANIDES +74 Medication/supplement use 85346 phv00085346.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:49:53+00:00 2018-10-22 00:49:53+00:00 bgnd1c BIGUANIDES +74 Medication/supplement use 86030 phv00086030.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:50:00+00:00 2018-10-22 00:50:00+00:00 bgnd2c BIGUANIDES +74 Medication/supplement use 86512 phv00086512.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:50:06+00:00 2018-10-22 00:50:06+00:00 bgnd3c BIGUANIDES +74 Medication/supplement use 86949 phv00086949.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:50:19+00:00 2018-10-22 00:50:19+00:00 bgnd4c BIGUANIDES +74 Medication/supplement use 87322 phv00087322.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:50:28+00:00 2018-10-22 00:50:28+00:00 bgndfc BIGUANIDES +74 Medication/supplement use 175347 phv00175347.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:50:36+00:00 2018-10-22 00:50:36+00:00 bgnd5c BIGUANIDES +74 Medication/supplement use 176770 phv00176770.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 00:50:44+00:00 2018-10-22 00:50:44+00:00 bgnd5c BIGUANIDES +74 Medication/supplement use 83102 phv00083102.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:08:51+00:00 2018-10-22 01:08:51+00:00 ccb1c ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT +74 Medication/supplement use 83103 phv00083103.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:08:59+00:00 2018-10-22 01:08:59+00:00 ccbir1c IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR +74 Medication/supplement use 83104 phv00083104.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:09:07+00:00 2018-10-22 01:09:07+00:00 ccbsr1c SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD +74 Medication/supplement use 83105 phv00083105.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:09:15+00:00 2018-10-22 01:09:15+00:00 ccbt1c T-TYPE CALCIUM-CHANNEL BLOCKER +74 Medication/supplement use 85347 phv00085347.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:09:35+00:00 2018-10-22 01:09:35+00:00 ccb1c ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT +74 Medication/supplement use 85348 phv00085348.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:09:42+00:00 2018-10-22 01:09:42+00:00 ccbir1c IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR +74 Medication/supplement use 85349 phv00085349.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:09:53+00:00 2018-10-22 01:09:53+00:00 ccbsr1c SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD +74 Medication/supplement use 85350 phv00085350.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:10:00+00:00 2018-10-22 01:10:00+00:00 ccbt1c T-TYPE CALCIUM-CHANNEL BLOCKER +74 Medication/supplement use 86006 phv00086006.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:10:13+00:00 2018-10-22 01:10:13+00:00 ccb2c ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT +74 Medication/supplement use 86031 phv00086031.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:10:19+00:00 2018-10-22 01:10:19+00:00 ccbir2c IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR +74 Medication/supplement use 86032 phv00086032.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:10:29+00:00 2018-10-22 01:10:29+00:00 ccbsr2c SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD +74 Medication/supplement use 86033 phv00086033.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:10:35+00:00 2018-10-22 01:10:35+00:00 ccbt2c T-TYPE CALCIUM-CHANNEL BLOCKER +74 Medication/supplement use 86488 phv00086488.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:10:43+00:00 2018-10-22 01:10:43+00:00 ccb3c ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT +74 Medication/supplement use 86513 phv00086513.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:10:51+00:00 2018-10-22 01:10:51+00:00 ccbir3c IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR +74 Medication/supplement use 86514 phv00086514.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:10:57+00:00 2018-10-22 01:10:57+00:00 ccbsr3c SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD +74 Medication/supplement use 86515 phv00086515.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:11:03+00:00 2018-10-22 01:11:03+00:00 ccbt3c T-TYPE CALCIUM-CHANNEL BLOCKER +74 Medication/supplement use 86925 phv00086925.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:11:09+00:00 2018-10-22 01:11:09+00:00 ccb4c ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT +74 Medication/supplement use 86950 phv00086950.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:11:15+00:00 2018-10-22 01:11:15+00:00 ccbir4c IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR +74 Medication/supplement use 86951 phv00086951.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:11:27+00:00 2018-10-22 01:11:27+00:00 ccbsr4c SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD +74 Medication/supplement use 86952 phv00086952.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:11:37+00:00 2018-10-22 01:11:37+00:00 ccbt4c T-TYPE CALCIUM-CHANNEL BLOCKER +74 Medication/supplement use 87323 phv00087323.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:11:45+00:00 2018-10-22 01:11:45+00:00 ccbfc ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT +74 Medication/supplement use 87324 phv00087324.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:11:52+00:00 2018-10-22 01:11:52+00:00 ccbirfc IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR +74 Medication/supplement use 87325 phv00087325.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:11:59+00:00 2018-10-22 01:11:59+00:00 ccbsrfc SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD +74 Medication/supplement use 87326 phv00087326.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:12:06+00:00 2018-10-22 01:12:06+00:00 ccbtfc T-TYPE CALCIUM-CHANNEL BLOCKER +74 Medication/supplement use 175348 phv00175348.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:12:13+00:00 2018-10-22 01:12:13+00:00 ccb5c ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT +74 Medication/supplement use 175349 phv00175349.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:12:20+00:00 2018-10-22 01:12:20+00:00 ccbir5c IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR +74 Medication/supplement use 175350 phv00175350.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:12:26+00:00 2018-10-22 01:12:26+00:00 ccbsr5c SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD +74 Medication/supplement use 175351 phv00175351.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:12:34+00:00 2018-10-22 01:12:34+00:00 ccbt5c T-TYPE CALCIUM-CHANNEL BLOCKER +74 Medication/supplement use 176771 phv00176771.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:12:41+00:00 2018-10-22 01:12:41+00:00 ccb5c ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT +74 Medication/supplement use 176772 phv00176772.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:12:48+00:00 2018-10-22 01:12:48+00:00 ccbir5c IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR +74 Medication/supplement use 176773 phv00176773.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:12:55+00:00 2018-10-22 01:12:55+00:00 ccbsr5c SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD +74 Medication/supplement use 176774 phv00176774.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:13:02+00:00 2018-10-22 01:13:02+00:00 ccbt5c T-TYPE CALCIUM-CHANNEL BLOCKER +74 Medication/supplement use 83106 phv00083106.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:13:57+00:00 2018-10-22 01:13:57+00:00 cox21c COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE +74 Medication/supplement use 85351 phv00085351.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:14:04+00:00 2018-10-22 01:14:04+00:00 cox21c COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE +74 Medication/supplement use 86007 phv00086007.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:14:10+00:00 2018-10-22 01:14:10+00:00 cox22c COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE +74 Medication/supplement use 86489 phv00086489.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:14:17+00:00 2018-10-22 01:14:17+00:00 cox23c COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE +74 Medication/supplement use 86926 phv00086926.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:14:24+00:00 2018-10-22 01:14:24+00:00 cox24c COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE +74 Medication/supplement use 87327 phv00087327.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:14:32+00:00 2018-10-22 01:14:32+00:00 cox2fc COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE +74 Medication/supplement use 175352 phv00175352.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:14:40+00:00 2018-10-22 01:14:40+00:00 cox25c COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE +74 Medication/supplement use 176775 phv00176775.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:14:46+00:00 2018-10-22 01:14:46+00:00 cox25c COX-2 INHIBITORS (NSAID AGENTS); SEPARATE FROM NSAID VARIABLE +74 Medication/supplement use 83107 phv00083107.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:15:36+00:00 2018-10-22 01:15:36+00:00 dig1c DIGITALIS PREPARATIONS +74 Medication/supplement use 85352 phv00085352.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:15:43+00:00 2018-10-22 01:15:43+00:00 dig1c DIGITALIS PREPARATIONS +74 Medication/supplement use 86034 phv00086034.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:15:49+00:00 2018-10-22 01:15:49+00:00 dig2c DIGITALIS PREPARATIONS +74 Medication/supplement use 86516 phv00086516.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:15:56+00:00 2018-10-22 01:15:56+00:00 dig3c DIGITALIS PREPARATIONS +74 Medication/supplement use 86953 phv00086953.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:16:03+00:00 2018-10-22 01:16:03+00:00 dig4c DIGITALIS PREPARATIONS +74 Medication/supplement use 87328 phv00087328.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:16:10+00:00 2018-10-22 01:16:10+00:00 digfc DIGITALIS PREPARATIONS +74 Medication/supplement use 175353 phv00175353.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:16:16+00:00 2018-10-22 01:16:16+00:00 dig5c DIGITALIS PREPARATIONS +74 Medication/supplement use 176776 phv00176776.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:16:23+00:00 2018-10-22 01:16:23+00:00 dig5c DIGITALIS PREPARATIONS +74 Medication/supplement use 83108 phv00083108.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:17:35+00:00 2018-10-22 01:17:35+00:00 dihir1c IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE +74 Medication/supplement use 83109 phv00083109.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:17:55+00:00 2018-10-22 01:17:55+00:00 dihsr1c SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE +74 Medication/supplement use 85353 phv00085353.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:18:51+00:00 2018-10-22 01:18:51+00:00 dihir1c IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE +74 Medication/supplement use 85354 phv00085354.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:20:37+00:00 2018-10-22 01:20:37+00:00 dihsr1c SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE +74 Medication/supplement use 86035 phv00086035.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:21:27+00:00 2018-10-22 01:21:27+00:00 dihir2c IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE +74 Medication/supplement use 86036 phv00086036.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:21:34+00:00 2018-10-22 01:21:34+00:00 dihsr2c SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE +74 Medication/supplement use 86517 phv00086517.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:21:40+00:00 2018-10-22 01:21:40+00:00 dihir3c IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE +74 Medication/supplement use 86518 phv00086518.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:21:49+00:00 2018-10-22 01:21:49+00:00 dihsr3c SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE +74 Medication/supplement use 86954 phv00086954.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:21:55+00:00 2018-10-22 01:21:55+00:00 dihir4c IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE +74 Medication/supplement use 86955 phv00086955.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:22:02+00:00 2018-10-22 01:22:02+00:00 dihsr4c SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE +74 Medication/supplement use 87329 phv00087329.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:22:10+00:00 2018-10-22 01:22:10+00:00 dihirfc IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE +74 Medication/supplement use 87330 phv00087330.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:22:19+00:00 2018-10-22 01:22:19+00:00 dihsrfc SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE +74 Medication/supplement use 175354 phv00175354.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:22:45+00:00 2018-10-22 01:22:45+00:00 dihir5c IMMEDIATE-RELEASE DIHYROPYRIDINES OTHER THAN NIFEDIPINE +74 Medication/supplement use 175355 phv00175355.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:23:01+00:00 2018-10-22 01:23:01+00:00 dihsr5c SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE +74 Medication/supplement use 176777 phv00176777.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:23:15+00:00 2018-10-22 01:23:15+00:00 dihir5c IMMEDIATE-RELEASE DIHYROPYRIDINES OTHER THAN NIFEDIPINE +74 Medication/supplement use 176778 phv00176778.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:23:22+00:00 2018-10-22 01:23:22+00:00 dihsr5c SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE +74 Medication/supplement use 83110 phv00083110.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:24:53+00:00 2018-10-22 01:24:53+00:00 dltir1c IMMEDIATE-RELEASE DILTIAZEM +74 Medication/supplement use 83111 phv00083111.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:00+00:00 2018-10-22 01:25:00+00:00 dltsr1c SLOW-RELEASE DILTIAZEM +74 Medication/supplement use 85355 phv00085355.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:07+00:00 2018-10-22 01:25:07+00:00 dltir1c IMMEDIATE-RELEASE DILTIAZEM +74 Medication/supplement use 85356 phv00085356.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:14+00:00 2018-10-22 01:25:14+00:00 dltsr1c SLOW-RELEASE DILTIAZEM +74 Medication/supplement use 86037 phv00086037.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:24+00:00 2018-10-22 01:25:24+00:00 dltir2c IMMEDIATE-RELEASE DILTIAZEM +74 Medication/supplement use 86038 phv00086038.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:30+00:00 2018-10-22 01:25:30+00:00 dltsr2c SLOW-RELEASE DILTIAZEM +74 Medication/supplement use 86519 phv00086519.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:37+00:00 2018-10-22 01:25:37+00:00 dltir3c IMMEDIATE-RELEASE DILTIAZEM +74 Medication/supplement use 86520 phv00086520.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:43+00:00 2018-10-22 01:25:43+00:00 dltsr3c SLOW-RELEASE DILTIAZEM +74 Medication/supplement use 86956 phv00086956.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:50+00:00 2018-10-22 01:25:50+00:00 dltir4c IMMEDIATE-RELEASE DILTIAZEM +74 Medication/supplement use 86957 phv00086957.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:25:56+00:00 2018-10-22 01:25:56+00:00 dltsr4c SLOW-RELEASE DILTIAZEM +74 Medication/supplement use 87331 phv00087331.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:26:03+00:00 2018-10-22 01:26:03+00:00 dltirfc IMMEDIATE-RELEASE DILTIAZEM +74 Medication/supplement use 87332 phv00087332.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:26:10+00:00 2018-10-22 01:26:10+00:00 dltsrfc SLOW-RELEASE DILTIAZEM +74 Medication/supplement use 175356 phv00175356.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:26:19+00:00 2018-10-22 01:26:19+00:00 dltir5c IMMEDIATE-RELEASE DILTIAZEM +74 Medication/supplement use 175357 phv00175357.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:26:25+00:00 2018-10-22 01:26:25+00:00 dltsr5c SLOW-RELEASE DILTIAZEM +74 Medication/supplement use 176779 phv00176779.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:26:32+00:00 2018-10-22 01:26:32+00:00 dltir5c IMMEDIATE-RELEASE DILTIAZEM +74 Medication/supplement use 176780 phv00176780.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:26:39+00:00 2018-10-22 01:26:39+00:00 dltsr5c SLOW-RELEASE DILTIAZEM +74 Medication/supplement use 191178 phv00191178.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:27:27+00:00 2018-10-22 01:27:27+00:00 dpp4i1c DIPEPTIDYL PEPTIDASE-4 INHIBITOR +74 Medication/supplement use 195570 phv00195570.v1.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:27:34+00:00 2018-10-22 01:27:34+00:00 dpp4i2c DIPEPTIDYL PEPTIDASE-4 INHIBITOR +74 Medication/supplement use 191186 phv00191186.v1.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:27:48+00:00 2018-10-22 01:27:48+00:00 dpp4i3c DIPEPTIDYL PEPTIDASE-4 INHIBITOR +74 Medication/supplement use 191193 phv00191193.v1.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:28:00+00:00 2018-10-22 01:28:00+00:00 dpp4i4c DIPEPTIDYL PEPTIDASE-4 INHIBITOR +74 Medication/supplement use 191198 phv00191198.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:28:07+00:00 2018-10-22 01:28:07+00:00 dpp4i5c DIPEPTIDYL PEPTIDASE-4 INHIBITOR +74 Medication/supplement use 191696 phv00191696.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:28:14+00:00 2018-10-22 01:28:14+00:00 dpp4i5c DIPEPTIDYL PEPTIDASE-4 INHIBITOR +74 Medication/supplement use 83112 phv00083112.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:29:02+00:00 2018-10-22 01:29:02+00:00 edd1c ERECTILE DYSFUNCTION DRUGS +74 Medication/supplement use 85357 phv00085357.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:29:09+00:00 2018-10-22 01:29:09+00:00 edd1c ERECTILE DYSFUNCTION DRUGS +74 Medication/supplement use 86039 phv00086039.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:29:14+00:00 2018-10-22 01:29:14+00:00 edd2c ERECTILE DYSFUNCTION DRUGS +74 Medication/supplement use 86521 phv00086521.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:29:21+00:00 2018-10-22 01:29:21+00:00 edd3c ERECTILE DYSFUNCTION DRUGS +74 Medication/supplement use 86958 phv00086958.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:29:28+00:00 2018-10-22 01:29:28+00:00 edd4c ERECTILE DYSFUNCTION DRUGS +74 Medication/supplement use 87333 phv00087333.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:29:35+00:00 2018-10-22 01:29:35+00:00 eddfc ERECTILE DYSFUNCTION DRUGS +74 Medication/supplement use 175358 phv00175358.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:29:42+00:00 2018-10-22 01:29:42+00:00 edd5c ERECTILE DYSFUNCTION DRUGS +74 Medication/supplement use 176781 phv00176781.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:29:50+00:00 2018-10-22 01:29:50+00:00 edd5c ERECTILE DYSFUNCTION DRUGS +74 Medication/supplement use 83113 phv00083113.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:35:21+00:00 2018-10-22 01:35:21+00:00 estrgn1c ESTROGENS, EXCLUDING VAGINAL CREAMS +74 Medication/supplement use 85358 phv00085358.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:35:29+00:00 2018-10-22 01:35:29+00:00 estrgn1c ESTROGENS, EXCLUDING VAGINAL CREAMS +74 Medication/supplement use 86040 phv00086040.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:35:36+00:00 2018-10-22 01:35:36+00:00 estrgn2c ESTROGENS, EXCLUDING VAGINAL CREAMS +74 Medication/supplement use 86522 phv00086522.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:35:43+00:00 2018-10-22 01:35:43+00:00 estrgn3c ESTROGENS, EXCLUDING VAGINAL CREAMS +74 Medication/supplement use 86959 phv00086959.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:35:51+00:00 2018-10-22 01:35:51+00:00 estrgn4c ESTROGENS, EXCLUDING VAGINAL CREAMS +74 Medication/supplement use 87334 phv00087334.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:35:59+00:00 2018-10-22 01:35:59+00:00 estrgnfc ESTROGENS, EXCLUDING VAGINAL CREAMS +74 Medication/supplement use 175359 phv00175359.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:36:06+00:00 2018-10-22 01:36:06+00:00 estrgn5c ESTROGENS, EXCLUDING VAGINAL CREAMS +74 Medication/supplement use 176782 phv00176782.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:36:13+00:00 2018-10-22 01:36:13+00:00 estrgn5c ESTROGENS, EXCLUDING VAGINAL CREAMS +74 Medication/supplement use 83114 phv00083114.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:37:42+00:00 2018-10-22 01:37:42+00:00 fibr1c FIBRATES +74 Medication/supplement use 85359 phv00085359.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:37:48+00:00 2018-10-22 01:37:48+00:00 fibr1c FIBRATES +74 Medication/supplement use 86041 phv00086041.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:37:54+00:00 2018-10-22 01:37:54+00:00 fibr2c FIBRATES +74 Medication/supplement use 86523 phv00086523.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:38:03+00:00 2018-10-22 01:38:03+00:00 fibr3c FIBRATES +74 Medication/supplement use 86960 phv00086960.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:38:10+00:00 2018-10-22 01:38:10+00:00 fibr4c FIBRATES +74 Medication/supplement use 87335 phv00087335.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:38:18+00:00 2018-10-22 01:38:18+00:00 fibrfc FIBRATES +74 Medication/supplement use 175360 phv00175360.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:38:25+00:00 2018-10-22 01:38:25+00:00 fibr5c FIBRATES +74 Medication/supplement use 176783 phv00176783.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:38:31+00:00 2018-10-22 01:38:31+00:00 fibr5c FIBRATES +74 Medication/supplement use 175361 phv00175361.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:39:15+00:00 2018-10-22 01:39:15+00:00 gout5c ANY GOUT MEDICATIONS +74 Medication/supplement use 176784 phv00176784.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:39:21+00:00 2018-10-22 01:39:21+00:00 gout5c ANY GOUT MEDICATIONS +74 Medication/supplement use 83115 phv00083115.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:40:35+00:00 2018-10-22 01:40:35+00:00 h2b1c H-2 BLOCKERS +74 Medication/supplement use 83137 phv00083137.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:40:41+00:00 2018-10-22 01:40:41+00:00 otch2b1c OVER-THE-COUNTER H-2 BLOCKERS +74 Medication/supplement use 85360 phv00085360.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:40:49+00:00 2018-10-22 01:40:49+00:00 h2b1c H-2 BLOCKERS +74 Medication/supplement use 85382 phv00085382.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:40:56+00:00 2018-10-22 01:40:56+00:00 otch2b1c OVER-THE-COUNTER H-2 BLOCKERS +74 Medication/supplement use 86042 phv00086042.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:41:02+00:00 2018-10-22 01:41:02+00:00 h2b2c H-2 BLOCKERS +74 Medication/supplement use 86060 phv00086060.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:41:10+00:00 2018-10-22 01:41:10+00:00 otch2b2c OVER-THE-COUNTER H-2 BLOCKERS +74 Medication/supplement use 86524 phv00086524.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:41:17+00:00 2018-10-22 01:41:17+00:00 h2b3c H-2 BLOCKERS +74 Medication/supplement use 86542 phv00086542.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:41:23+00:00 2018-10-22 01:41:23+00:00 otch2b3c ('60) OVER-THE-COUNTER H-2 BLOCKERS' +74 Medication/supplement use 86961 phv00086961.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:41:29+00:00 2018-10-22 01:41:29+00:00 h2b4c H-2 BLOCKERS +74 Medication/supplement use 86979 phv00086979.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:41:35+00:00 2018-10-22 01:41:35+00:00 otch2b4c ('60) OVER-THE-COUNTER H-2 BLOCKERS' +74 Medication/supplement use 87336 phv00087336.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:41:43+00:00 2018-10-22 01:41:43+00:00 h2bfc H-2 BLOCKERS +74 Medication/supplement use 87357 phv00087357.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:41:53+00:00 2018-10-22 01:41:53+00:00 otch2bfc OVER-THE-COUNTER H-2 BLOCKERS +74 Medication/supplement use 175362 phv00175362.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:42:07+00:00 2018-10-22 01:42:07+00:00 h2b5c H-2 BLOCKERS +74 Medication/supplement use 175384 phv00175384.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:42:15+00:00 2018-10-22 01:42:15+00:00 otch2b5c OVER-THE-COUNTER H-2 BLOCKERS +74 Medication/supplement use 176785 phv00176785.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:42:22+00:00 2018-10-22 01:42:22+00:00 h2b5c H-2 BLOCKERS +74 Medication/supplement use 176807 phv00176807.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:42:29+00:00 2018-10-22 01:42:29+00:00 otch2b5c OVER-THE-COUNTER H-2 BLOCKERS +74 Medication/supplement use 83116 phv00083116.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:47:53+00:00 2018-10-22 01:47:53+00:00 hctz1c THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS +74 Medication/supplement use 83117 phv00083117.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:48:01+00:00 2018-10-22 01:48:01+00:00 hctzk1c THIAZIDE DIURETICS WITH K-SPARING AGENTS +74 Medication/supplement use 85361 phv00085361.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:48:08+00:00 2018-10-22 01:48:08+00:00 hctz1c THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS +74 Medication/supplement use 85362 phv00085362.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:48:15+00:00 2018-10-22 01:48:15+00:00 hctzk1c THIAZIDE DIURETICS WITH K-SPARING AGENTS +74 Medication/supplement use 86043 phv00086043.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:48:25+00:00 2018-10-22 01:48:25+00:00 hctz2c THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS +74 Medication/supplement use 86044 phv00086044.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:48:32+00:00 2018-10-22 01:48:32+00:00 hctzk2c THIAZIDE DIURETICS WITH K-SPARING AGENTS +74 Medication/supplement use 86525 phv00086525.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:48:39+00:00 2018-10-22 01:48:39+00:00 hctz3c THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS +74 Medication/supplement use 86526 phv00086526.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:48:50+00:00 2018-10-22 01:48:50+00:00 hctzk3c THIAZIDE DIURETICS WITH K-SPARING AGENTS +74 Medication/supplement use 86962 phv00086962.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:48:58+00:00 2018-10-22 01:48:58+00:00 hctz4c THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS +74 Medication/supplement use 86963 phv00086963.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:49:20+00:00 2018-10-22 01:49:20+00:00 hctzk4c THIAZIDE DIURETICS WITH K-SPARING AGENTS +74 Medication/supplement use 87337 phv00087337.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:49:28+00:00 2018-10-22 01:49:28+00:00 hctzfc THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS +74 Medication/supplement use 87338 phv00087338.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:49:41+00:00 2018-10-22 01:49:41+00:00 hctzkfc THIAZIDE DIURETICS WITH K-SPARING AGENTS +74 Medication/supplement use 175363 phv00175363.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:49:50+00:00 2018-10-22 01:49:50+00:00 hctz5c THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS +74 Medication/supplement use 175364 phv00175364.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:49:57+00:00 2018-10-22 01:49:57+00:00 hctzk5c THIAZIDE DIURETICS WITH K-SPARING AGENTS +74 Medication/supplement use 176786 phv00176786.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:50:04+00:00 2018-10-22 01:50:04+00:00 hctz5c THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS +74 Medication/supplement use 176787 phv00176787.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:50:10+00:00 2018-10-22 01:50:10+00:00 hctzk5c THIAZIDE DIURETICS WITH K-SPARING AGENTS +74 Medication/supplement use 83118 phv00083118.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:52:00+00:00 2018-10-22 01:52:00+00:00 hprns1c HEPARINS +74 Medication/supplement use 85363 phv00085363.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:52:06+00:00 2018-10-22 01:52:06+00:00 hprns1c HEPARINS +74 Medication/supplement use 86045 phv00086045.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:52:13+00:00 2018-10-22 01:52:13+00:00 hprns2c HEPARINS +74 Medication/supplement use 86527 phv00086527.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:52:19+00:00 2018-10-22 01:52:19+00:00 hprns3c HEPARINS +74 Medication/supplement use 86964 phv00086964.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:52:31+00:00 2018-10-22 01:52:31+00:00 hprns4c HEPARINS +74 Medication/supplement use 87339 phv00087339.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:52:37+00:00 2018-10-22 01:52:37+00:00 hprnsfc HEPARINS +74 Medication/supplement use 175365 phv00175365.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:52:43+00:00 2018-10-22 01:52:43+00:00 hprns5c HEPARINS +74 Medication/supplement use 176788 phv00176788.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:52:49+00:00 2018-10-22 01:52:49+00:00 hprns5c HEPARINS +74 Medication/supplement use 83119 phv00083119.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:53:42+00:00 2018-10-22 01:53:42+00:00 insln1c INSULINS +74 Medication/supplement use 85364 phv00085364.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:53:49+00:00 2018-10-22 01:53:49+00:00 insln1c INSULINS +74 Medication/supplement use 86008 phv00086008.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:53:56+00:00 2018-10-22 01:53:56+00:00 insln2c INSULINS +74 Medication/supplement use 86490 phv00086490.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:54:11+00:00 2018-10-22 01:54:11+00:00 insln3c INSULINS +74 Medication/supplement use 86927 phv00086927.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:54:18+00:00 2018-10-22 01:54:18+00:00 insln4c INSULINS +74 Medication/supplement use 87340 phv00087340.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:54:35+00:00 2018-10-22 01:54:35+00:00 inslnfc INSULINS +74 Medication/supplement use 175366 phv00175366.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:55:31+00:00 2018-10-22 01:55:31+00:00 insln5c INSULINS +74 Medication/supplement use 176789 phv00176789.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:55:39+00:00 2018-10-22 01:55:39+00:00 insln5c INSULINS +74 Medication/supplement use 83120 phv00083120.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:57:45+00:00 2018-10-22 01:57:45+00:00 iprtr1c ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) +74 Medication/supplement use 85365 phv00085365.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:57:54+00:00 2018-10-22 01:57:54+00:00 iprtr1c ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) +74 Medication/supplement use 86046 phv00086046.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:58:27+00:00 2018-10-22 01:58:27+00:00 iprtr2c ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) +74 Medication/supplement use 86528 phv00086528.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:58:34+00:00 2018-10-22 01:58:34+00:00 iprtr3c ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) +74 Medication/supplement use 86965 phv00086965.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 01:59:22+00:00 2018-10-22 01:59:22+00:00 iprtr4c ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) +74 Medication/supplement use 87341 phv00087341.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:00:17+00:00 2018-10-22 02:00:17+00:00 iprtrfc ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) +74 Medication/supplement use 175367 phv00175367.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:00:24+00:00 2018-10-22 02:00:24+00:00 iprtr5c ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) +74 Medication/supplement use 176790 phv00176790.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:00:31+00:00 2018-10-22 02:00:31+00:00 iprtr5c ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST (121200) +74 Medication/supplement use 83121 phv00083121.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:01:46+00:00 2018-10-22 02:01:46+00:00 istrd1c INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 85366 phv00085366.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:01:55+00:00 2018-10-22 02:01:55+00:00 istrd1c INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 86047 phv00086047.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:02:05+00:00 2018-10-22 02:02:05+00:00 istrd2c INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 86529 phv00086529.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:02:11+00:00 2018-10-22 02:02:11+00:00 istrd3c INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 86966 phv00086966.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:02:23+00:00 2018-10-22 02:02:23+00:00 istrd4c INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 87342 phv00087342.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:02:31+00:00 2018-10-22 02:02:31+00:00 istrdfc INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 175368 phv00175368.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:02:38+00:00 2018-10-22 02:02:38+00:00 istrd5c INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 175874 phv00175874.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:02:45+00:00 2018-10-22 02:02:45+00:00 istrd1c INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 175958 phv00175958.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:02:51+00:00 2018-10-22 02:02:51+00:00 istrdfc FAMILY COHORT: INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 176791 phv00176791.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:02:58+00:00 2018-10-22 02:02:58+00:00 istrd5c INHALED STEROIDS FOR ASTHMA +74 Medication/supplement use 83122 phv00083122.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:03:46+00:00 2018-10-22 02:03:46+00:00 kblkr1c K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS +74 Medication/supplement use 85367 phv00085367.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:04:19+00:00 2018-10-22 02:04:19+00:00 kblkr1c K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS +74 Medication/supplement use 86009 phv00086009.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:04:24+00:00 2018-10-22 02:04:24+00:00 kblkr2c K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS +74 Medication/supplement use 86491 phv00086491.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:04:31+00:00 2018-10-22 02:04:31+00:00 kblkr3c K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS +74 Medication/supplement use 86928 phv00086928.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:04:38+00:00 2018-10-22 02:04:38+00:00 kblkr4c K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS +74 Medication/supplement use 87343 phv00087343.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:04:44+00:00 2018-10-22 02:04:44+00:00 kblkrfc K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS +74 Medication/supplement use 175369 phv00175369.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:04:51+00:00 2018-10-22 02:04:51+00:00 kblkr5c K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS +74 Medication/supplement use 176792 phv00176792.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:04:57+00:00 2018-10-22 02:04:57+00:00 kblkr5c K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS +74 Medication/supplement use 83123 phv00083123.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:07:10+00:00 2018-10-22 02:07:10+00:00 kcl1c POTASSIUM SUPPLEMENTS +74 Medication/supplement use 85368 phv00085368.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:07:17+00:00 2018-10-22 02:07:17+00:00 kcl1c POTASSIUM SUPPLEMENTS +74 Medication/supplement use 86048 phv00086048.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:07:23+00:00 2018-10-22 02:07:23+00:00 kcl2c POTASSIUM SUPPLEMENTS +74 Medication/supplement use 86530 phv00086530.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:07:36+00:00 2018-10-22 02:07:36+00:00 kcl3c POTASSIUM SUPPLEMENTS +74 Medication/supplement use 86967 phv00086967.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:07:42+00:00 2018-10-22 02:07:42+00:00 kcl4c POTASSIUM SUPPLEMENTS +74 Medication/supplement use 87344 phv00087344.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:08:01+00:00 2018-10-22 02:08:01+00:00 kclfc POTASSIUM SUPPLEMENTS +74 Medication/supplement use 175370 phv00175370.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:08:11+00:00 2018-10-22 02:08:11+00:00 kcl5c POTASSIUM SUPPLEMENTS +74 Medication/supplement use 176793 phv00176793.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:08:39+00:00 2018-10-22 02:08:39+00:00 kcl5c POTASSIUM SUPPLEMENTS +74 Medication/supplement use 83124 phv00083124.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:09:52+00:00 2018-10-22 02:09:52+00:00 kspr1c POTASSIUM-SPARING AGENTS ALONE +74 Medication/supplement use 85369 phv00085369.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:10:01+00:00 2018-10-22 02:10:01+00:00 kspr1c POTASSIUM-SPARING AGENTS ALONE +74 Medication/supplement use 86049 phv00086049.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:10:14+00:00 2018-10-22 02:10:14+00:00 kspr2c POTASSIUM-SPARING AGENTS ALONE +74 Medication/supplement use 86531 phv00086531.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:10:21+00:00 2018-10-22 02:10:21+00:00 kspr3c POTASSIUM-SPARING AGENTS ALONE +74 Medication/supplement use 86968 phv00086968.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:10:29+00:00 2018-10-22 02:10:29+00:00 kspr4c POTASSIUM-SPARING AGENTS ALONE +74 Medication/supplement use 87345 phv00087345.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:10:56+00:00 2018-10-22 02:10:56+00:00 ksprfc POTASSIUM-SPARING AGENTS ALONE +74 Medication/supplement use 175371 phv00175371.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:11:05+00:00 2018-10-22 02:11:05+00:00 kspr5c POTASSIUM-SPARING AGENTS ALONE +74 Medication/supplement use 176794 phv00176794.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:11:14+00:00 2018-10-22 02:11:14+00:00 kspr5c POTASSIUM-SPARING AGENTS ALONE +74 Medication/supplement use 83125 phv00083125.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:12:17+00:00 2018-10-22 02:12:17+00:00 loop1c LOOP DIURETICS +74 Medication/supplement use 85370 phv00085370.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:12:25+00:00 2018-10-22 02:12:25+00:00 loop1c LOOP DIURETICS +74 Medication/supplement use 86050 phv00086050.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:12:31+00:00 2018-10-22 02:12:31+00:00 loop2c LOOP DIURETICS +74 Medication/supplement use 86532 phv00086532.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:12:40+00:00 2018-10-22 02:12:40+00:00 loop3c LOOP DIURETICS +74 Medication/supplement use 86969 phv00086969.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:12:49+00:00 2018-10-22 02:12:49+00:00 loop4c LOOP DIURETICS +74 Medication/supplement use 87346 phv00087346.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:12:55+00:00 2018-10-22 02:12:55+00:00 loopfc LOOP DIURETICS +74 Medication/supplement use 175372 phv00175372.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:13:03+00:00 2018-10-22 02:13:03+00:00 loop5c LOOP DIURETICS +74 Medication/supplement use 176795 phv00176795.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:13:10+00:00 2018-10-22 02:13:10+00:00 loop5c LOOP DIURETICS +74 Medication/supplement use 83126 phv00083126.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:29:43+00:00 2018-10-22 02:29:43+00:00 maoi1c MAO INHIBITORS +74 Medication/supplement use 85371 phv00085371.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:29:50+00:00 2018-10-22 02:29:50+00:00 maoi1c MAO INHIBITORS +74 Medication/supplement use 86051 phv00086051.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:29:56+00:00 2018-10-22 02:29:56+00:00 maoi2c MAO INHIBITORS +74 Medication/supplement use 86533 phv00086533.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:30:03+00:00 2018-10-22 02:30:03+00:00 maoi3c MAO INHIBITORS +74 Medication/supplement use 86970 phv00086970.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:30:10+00:00 2018-10-22 02:30:10+00:00 maoi4c MAO INHIBITORS +74 Medication/supplement use 87347 phv00087347.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:30:34+00:00 2018-10-22 02:30:34+00:00 maoifc MAO INHIBITORS +74 Medication/supplement use 175373 phv00175373.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:30:40+00:00 2018-10-22 02:30:40+00:00 maoi5c MAO INHIBITORS +74 Medication/supplement use 176796 phv00176796.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:30:46+00:00 2018-10-22 02:30:46+00:00 maoi5c MAO INHIBITORS +74 Medication/supplement use 83127 phv00083127.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:31:45+00:00 2018-10-22 02:31:45+00:00 mlpd1c MISCELLANEOUS LIPID-LOWERING DRUGS +74 Medication/supplement use 85372 phv00085372.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:31:52+00:00 2018-10-22 02:31:52+00:00 mlpd1c MISCELLANEOUS LIPID-LOWERING DRUGS +74 Medication/supplement use 86010 phv00086010.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:32:03+00:00 2018-10-22 02:32:03+00:00 mlpd2c MISCELLANEOUS LIPID-LOWERING DRUGS +74 Medication/supplement use 86492 phv00086492.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:32:09+00:00 2018-10-22 02:32:09+00:00 mlpd3c MISCELLANEOUS LIPID-LOWERING DRUGS +74 Medication/supplement use 86929 phv00086929.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:32:15+00:00 2018-10-22 02:32:15+00:00 mlpd4c MISCELLANEOUS LIPID-LOWERING DRUGS +74 Medication/supplement use 87348 phv00087348.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:32:24+00:00 2018-10-22 02:32:24+00:00 mlpdfc MISCELLANEOUS LIPID-LOWERING DRUGS +74 Medication/supplement use 175374 phv00175374.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:32:31+00:00 2018-10-22 02:32:31+00:00 mlpd5c MISCELLANEOUS LIPID-LOWERING DRUGS +74 Medication/supplement use 176797 phv00176797.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:32:40+00:00 2018-10-22 02:32:40+00:00 mlpd5c MISCELLANEOUS LIPID-LOWERING DRUGS +74 Medication/supplement use 191179 phv00191179.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:33:14+00:00 2018-10-22 02:33:14+00:00 ndri1c NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR +74 Medication/supplement use 195571 phv00195571.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:33:20+00:00 2018-10-22 02:33:20+00:00 ndri2c NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR +74 Medication/supplement use 191187 phv00191187.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:33:26+00:00 2018-10-22 02:33:26+00:00 ndri3c NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR +74 Medication/supplement use 191194 phv00191194.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:33:33+00:00 2018-10-22 02:33:33+00:00 ndri4c NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR +74 Medication/supplement use 191199 phv00191199.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:33:39+00:00 2018-10-22 02:33:39+00:00 ndri5c NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR +74 Medication/supplement use 191697 phv00191697.v2.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:33:51+00:00 2018-10-22 02:33:51+00:00 ndri5c NOREPINEPHRINE-DOPAMINE REUPTAKE INHIBITOR +74 Medication/supplement use 83128 phv00083128.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:34:36+00:00 2018-10-22 02:34:36+00:00 niac1c NIACIN AND NICOTINIC ACID +74 Medication/supplement use 85373 phv00085373.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:34:43+00:00 2018-10-22 02:34:43+00:00 niac1c NIACIN AND NICOTINIC ACID +74 Medication/supplement use 86052 phv00086052.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:34:49+00:00 2018-10-22 02:34:49+00:00 niac2c NIACIN AND NICOTINIC ACID +74 Medication/supplement use 86534 phv00086534.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:34:56+00:00 2018-10-22 02:34:56+00:00 niac3c NIACIN AND NICOTINIC ACID +74 Medication/supplement use 86971 phv00086971.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:35:02+00:00 2018-10-22 02:35:02+00:00 niac4c NIACIN AND NICOTINIC ACID +74 Medication/supplement use 87349 phv00087349.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:35:08+00:00 2018-10-22 02:35:08+00:00 niacfc NIACIN AND NICTOTINIC ACID +74 Medication/supplement use 175375 phv00175375.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:35:15+00:00 2018-10-22 02:35:15+00:00 niac5c NIACIN AND NICOTINIC ACID +74 Medication/supplement use 176798 phv00176798.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:35:22+00:00 2018-10-22 02:35:22+00:00 niac5c NIACIN AND NICOTINIC ACID +74 Medication/supplement use 83130 phv00083130.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:48:40+00:00 2018-10-22 02:48:40+00:00 nifsr1c SLOW-RELEASE NIFEDIPINE +74 Medication/supplement use 85374 phv00085374.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:48:46+00:00 2018-10-22 02:48:46+00:00 nifir1c IMMEDIATE-RELEASE NIFEDIPINE +74 Medication/supplement use 85375 phv00085375.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:01+00:00 2018-10-22 02:49:01+00:00 nifsr1c SLOW-RELEASE NIFEDIPINE +74 Medication/supplement use 86053 phv00086053.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:09+00:00 2018-10-22 02:49:09+00:00 nifir2c IMMEDIATE-RELEASE NIFEDIPINE +74 Medication/supplement use 86054 phv00086054.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:15+00:00 2018-10-22 02:49:15+00:00 nifsr2c SLOW-RELEASE NIFEDIPINE +74 Medication/supplement use 86535 phv00086535.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:23+00:00 2018-10-22 02:49:23+00:00 nifir3c IMMEDIATE-RELEASE NIFEDIPINE +74 Medication/supplement use 86536 phv00086536.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:30+00:00 2018-10-22 02:49:30+00:00 nifsr3c SLOW-RELEASE NIFEDIPINE +74 Medication/supplement use 86972 phv00086972.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:37+00:00 2018-10-22 02:49:37+00:00 nifir4c IMMEDIATE-RELEASE NIFEDIPINE +74 Medication/supplement use 86973 phv00086973.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:44+00:00 2018-10-22 02:49:44+00:00 nifsr4c SLOW-RELEASE NIFEDIPINE +74 Medication/supplement use 87350 phv00087350.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:51+00:00 2018-10-22 02:49:51+00:00 nifirfc IMMEDIATE-RELEASE NIFEDIPINE +74 Medication/supplement use 87351 phv00087351.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:49:58+00:00 2018-10-22 02:49:58+00:00 nifsrfc SLOW-RELEASE NIFEDIPINE +74 Medication/supplement use 175376 phv00175376.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:50:05+00:00 2018-10-22 02:50:05+00:00 nifir5c IMMEDIATE-RELEASE NIFEDIPINE +74 Medication/supplement use 175377 phv00175377.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:50:12+00:00 2018-10-22 02:50:12+00:00 nifsr5c SLOW-RELEASE NIFEDIPINE +74 Medication/supplement use 176799 phv00176799.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:50:18+00:00 2018-10-22 02:50:18+00:00 nifir5c IMMEDIATE-RELEASE NIFEDIPINE +74 Medication/supplement use 176800 phv00176800.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:50:25+00:00 2018-10-22 02:50:25+00:00 nifsr5c SLOW-RELEASE NIFEDIPINE +74 Medication/supplement use 83129 phv00083129.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 02:50:33+00:00 2018-10-22 02:50:33+00:00 nifir1c IMMEDIATE-RELEASE NIFEDIPINE +74 Medication/supplement use 83131 phv00083131.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:10:54+00:00 2018-10-22 03:10:54+00:00 nsaid1c NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN +74 Medication/supplement use 85376 phv00085376.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:11:01+00:00 2018-10-22 03:11:01+00:00 nsaid1c NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN +74 Medication/supplement use 86055 phv00086055.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:11:09+00:00 2018-10-22 03:11:09+00:00 nsaid2c NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN +74 Medication/supplement use 86537 phv00086537.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:11:15+00:00 2018-10-22 03:11:15+00:00 nsaid3c NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN +74 Medication/supplement use 86974 phv00086974.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:11:23+00:00 2018-10-22 03:11:23+00:00 nsaid4c NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN +74 Medication/supplement use 87352 phv00087352.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:11:31+00:00 2018-10-22 03:11:31+00:00 nsaidfc NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN +74 Medication/supplement use 175378 phv00175378.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:11:38+00:00 2018-10-22 03:11:38+00:00 nsaid5c NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN +74 Medication/supplement use 176801 phv00176801.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:11:44+00:00 2018-10-22 03:11:44+00:00 nsaid5c NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN +74 Medication/supplement use 83132 phv00083132.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:12:41+00:00 2018-10-22 03:12:41+00:00 ntca1c NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI +74 Medication/supplement use 85377 phv00085377.v3.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:12:47+00:00 2018-10-22 03:12:47+00:00 ntca1c NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI +74 Medication/supplement use 86056 phv00086056.v3.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:12:53+00:00 2018-10-22 03:12:53+00:00 ntca2c NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI +74 Medication/supplement use 86538 phv00086538.v3.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:13:00+00:00 2018-10-22 03:13:00+00:00 ntca3c NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI +74 Medication/supplement use 86975 phv00086975.v3.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:13:08+00:00 2018-10-22 03:13:08+00:00 ntca4c NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI +74 Medication/supplement use 87353 phv00087353.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:13:14+00:00 2018-10-22 03:13:14+00:00 ntcafc NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI +74 Medication/supplement use 175379 phv00175379.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:13:21+00:00 2018-10-22 03:13:21+00:00 ntca5c NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI +74 Medication/supplement use 176802 phv00176802.v2.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:13:29+00:00 2018-10-22 03:13:29+00:00 ntca5c NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN MAOI +74 Medication/supplement use 83133 phv00083133.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:14:19+00:00 2018-10-22 03:14:19+00:00 ntg1c NITRATES +74 Medication/supplement use 85378 phv00085378.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:14:25+00:00 2018-10-22 03:14:25+00:00 ntg1c NITRATES +74 Medication/supplement use 86057 phv00086057.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:14:32+00:00 2018-10-22 03:14:32+00:00 ntg2c NITRATES +74 Medication/supplement use 86539 phv00086539.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:14:38+00:00 2018-10-22 03:14:38+00:00 ntg3c NITRATES +74 Medication/supplement use 86976 phv00086976.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:14:44+00:00 2018-10-22 03:14:44+00:00 ntg4c NITRATES +74 Medication/supplement use 87354 phv00087354.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:14:51+00:00 2018-10-22 03:14:51+00:00 ntgfc NITRATES +74 Medication/supplement use 175380 phv00175380.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:14:56+00:00 2018-10-22 03:14:56+00:00 ntg5c NITRATES +74 Medication/supplement use 176803 phv00176803.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:15:03+00:00 2018-10-22 03:15:03+00:00 ntg5c NITRATES +74 Medication/supplement use 83134 phv00083134.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:15:47+00:00 2018-10-22 03:15:47+00:00 oaia1c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 85379 phv00085379.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:15:57+00:00 2018-10-22 03:15:57+00:00 oaia1c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 86058 phv00086058.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:16:03+00:00 2018-10-22 03:16:03+00:00 oaia2c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 86540 phv00086540.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:16:09+00:00 2018-10-22 03:16:09+00:00 oaia3c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 86977 phv00086977.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:16:17+00:00 2018-10-22 03:16:17+00:00 oaia4c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 87355 phv00087355.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:16:23+00:00 2018-10-22 03:16:23+00:00 oaiafc ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 175381 phv00175381.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:16:31+00:00 2018-10-22 03:16:31+00:00 oaia5c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 175959 phv00175959.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:16:38+00:00 2018-10-22 03:16:38+00:00 oaiafc FAMILY COHORT: ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 176804 phv00176804.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:16:46+00:00 2018-10-22 03:16:46+00:00 oaia5c ORAL ANTI-INFLAMMATORY ASTHMA DRUGS LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE +74 Medication/supplement use 83135 phv00083135.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:17:33+00:00 2018-10-22 03:17:33+00:00 ohga1c ORAL HYPOGLYCEMIC AGENTS-NOW CONTRUCTED FROM: +74 Medication/supplement use 85380 phv00085380.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:17:40+00:00 2018-10-22 03:17:40+00:00 ohga1c ORAL HYPOGLYCEMIC AGENTS-NOW CONSTRUCTED FROM: +74 Medication/supplement use 86011 phv00086011.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:17:49+00:00 2018-10-22 03:17:49+00:00 ohga2c ORAL HYPOGLYCEMIC AGENTS-NOW CONTRUCTED FROM: +74 Medication/supplement use 86493 phv00086493.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:17:56+00:00 2018-10-22 03:17:56+00:00 ohga3c ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 86930 phv00086930.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:18:04+00:00 2018-10-22 03:18:04+00:00 ohga4c ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 87103 phv00087103.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:18:10+00:00 2018-10-22 03:18:10+00:00 ohgafc ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 175382 phv00175382.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:18:16+00:00 2018-10-22 03:18:16+00:00 ohga5c ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 176805 phv00176805.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:18:23+00:00 2018-10-22 03:18:23+00:00 ohga5c ORAL HYPOGLYCEMIC AGENTS +74 Medication/supplement use 83136 phv00083136.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:19:06+00:00 2018-10-22 03:19:06+00:00 ostrd1c ORAL STEROIDS +74 Medication/supplement use 85381 phv00085381.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:19:13+00:00 2018-10-22 03:19:13+00:00 ostrd1c ORAL STEROIDS +74 Medication/supplement use 86059 phv00086059.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:19:20+00:00 2018-10-22 03:19:20+00:00 ostrd2c ORAL STEROIDS +74 Medication/supplement use 86541 phv00086541.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:19:26+00:00 2018-10-22 03:19:26+00:00 ostrd3c ORAL STEROIDS +74 Medication/supplement use 86978 phv00086978.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:19:32+00:00 2018-10-22 03:19:32+00:00 ostrd4c ORAL STEROIDS +74 Medication/supplement use 87356 phv00087356.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:19:38+00:00 2018-10-22 03:19:38+00:00 ostrdfc ORAL STEROIDS +74 Medication/supplement use 175383 phv00175383.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:19:45+00:00 2018-10-22 03:19:45+00:00 ostrd5c ORAL STEROIDS +74 Medication/supplement use 176806 phv00176806.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:19:52+00:00 2018-10-22 03:19:52+00:00 ostrd5c ORAL STEROIDS +74 Medication/supplement use 83138 phv00083138.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:20:51+00:00 2018-10-22 03:20:51+00:00 pdei1c PHOSPHODIESTERASE INHIBITORS +74 Medication/supplement use 85383 phv00085383.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:20:58+00:00 2018-10-22 03:20:58+00:00 pdei1c PHOSPHODIESTERASE INHIBITORS +74 Medication/supplement use 86061 phv00086061.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:21:05+00:00 2018-10-22 03:21:05+00:00 pdei2c PHOSPHODIESTERASE INHIBITORS +74 Medication/supplement use 86543 phv00086543.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:21:18+00:00 2018-10-22 03:21:18+00:00 pdei3c PHOSPHODIESTERASE INHIBITORS +74 Medication/supplement use 86980 phv00086980.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:21:25+00:00 2018-10-22 03:21:25+00:00 pdei4c PHOSPHODIESTERASE INHIBITORS +74 Medication/supplement use 87358 phv00087358.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:21:32+00:00 2018-10-22 03:21:32+00:00 pdeifc PHOSPHODIESTERASE INHIBITORS +74 Medication/supplement use 175385 phv00175385.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:21:38+00:00 2018-10-22 03:21:38+00:00 pdei5c PHOSPHODIESTERASE INHIBITORS +74 Medication/supplement use 176808 phv00176808.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:21:45+00:00 2018-10-22 03:21:45+00:00 pdei5c PHOSPHODIESTERASE INHIBITORS +74 Medication/supplement use 83139 phv00083139.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:22:32+00:00 2018-10-22 03:22:32+00:00 ppi1c PROTON PUMP INHIBITORS +74 Medication/supplement use 85384 phv00085384.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:22:39+00:00 2018-10-22 03:22:39+00:00 ppi1c PROTON PUMP INHIBITORS +74 Medication/supplement use 86062 phv00086062.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:22:47+00:00 2018-10-22 03:22:47+00:00 ppi2c PROTON PUMP INHIBITORS +74 Medication/supplement use 86544 phv00086544.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:22:54+00:00 2018-10-22 03:22:54+00:00 ppi3c PROTON PUMP INHIBITORS +74 Medication/supplement use 86981 phv00086981.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:23:01+00:00 2018-10-22 03:23:01+00:00 ppi4c PROTON PUMP INHIBITORS +74 Medication/supplement use 87359 phv00087359.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:23:08+00:00 2018-10-22 03:23:08+00:00 ppifc PROTON PUMP INHIBITORS +74 Medication/supplement use 175386 phv00175386.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:23:23+00:00 2018-10-22 03:23:23+00:00 ppi5c PROTON PUMP INHIBITORS +74 Medication/supplement use 176809 phv00176809.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:23:30+00:00 2018-10-22 03:23:30+00:00 ppi5c PROTON PUMP INHIBITORS +74 Medication/supplement use 83140 phv00083140.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:24:25+00:00 2018-10-22 03:24:25+00:00 prgstn1c PROGESTINS +74 Medication/supplement use 85385 phv00085385.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:24:34+00:00 2018-10-22 03:24:34+00:00 prgstn1c PROGESTINS +74 Medication/supplement use 86063 phv00086063.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:24:40+00:00 2018-10-22 03:24:40+00:00 prgstn2c PROGESTINS +74 Medication/supplement use 86545 phv00086545.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:24:47+00:00 2018-10-22 03:24:47+00:00 prgstn3c PROGESTINS +74 Medication/supplement use 86982 phv00086982.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:24:54+00:00 2018-10-22 03:24:54+00:00 prgstn4c PROGESTINS +74 Medication/supplement use 87360 phv00087360.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:25:00+00:00 2018-10-22 03:25:00+00:00 prgstnfc PROGESTINS +74 Medication/supplement use 175387 phv00175387.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:25:07+00:00 2018-10-22 03:25:07+00:00 prgstn5c PROGESTINS +74 Medication/supplement use 176810 phv00176810.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:25:14+00:00 2018-10-22 03:25:14+00:00 prgstn5c PROGESTINS +74 Medication/supplement use 83141 phv00083141.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:37:43+00:00 2018-10-22 03:37:43+00:00 prknsn1c DRUGS USED TO TREAT PARKINSON'S +74 Medication/supplement use 86064 phv00086064.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:38:12+00:00 2018-10-22 03:38:12+00:00 prknsn2c DRUGS USED TO TREAT PARKINSON'S +74 Medication/supplement use 86546 phv00086546.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:38:44+00:00 2018-10-22 03:38:44+00:00 prknsn3c DRUGS USED TO TREAT PARKINSON'S +74 Medication/supplement use 86983 phv00086983.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:39:19+00:00 2018-10-22 03:39:19+00:00 prknsn4c DRUGS USED TO TREAT PARKINSON'S +74 Medication/supplement use 85386 phv00085386.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:39:44+00:00 2018-10-22 03:39:44+00:00 prknsn1c DRUGS USED TO TREAT PARKINSON'S +74 Medication/supplement use 87361 phv00087361.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:40:01+00:00 2018-10-22 03:40:01+00:00 prknsnfc DRUGS USED TO TREAT PARKINSON'S +74 Medication/supplement use 175388 phv00175388.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:40:15+00:00 2018-10-22 03:40:15+00:00 prknsn5c DRUGS USED TO TREAT PARKINSON'S +74 Medication/supplement use 176811 phv00176811.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:40:27+00:00 2018-10-22 03:40:27+00:00 prknsn5c DRUGS USED TO TREAT PARKINSON'S +74 Medication/supplement use 83142 phv00083142.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:41:21+00:00 2018-10-22 03:41:21+00:00 prmrn1c PREMARIN (CONJUGATED ESTROGENS) +74 Medication/supplement use 85387 phv00085387.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:41:30+00:00 2018-10-22 03:41:30+00:00 prmrn1c PREMARIN (CONJUGATED ESTROGENS) +74 Medication/supplement use 86065 phv00086065.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:41:43+00:00 2018-10-22 03:41:43+00:00 prmrn2c PREMARIN (CONJUGATED ESTROGENS) +74 Medication/supplement use 86547 phv00086547.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:41:50+00:00 2018-10-22 03:41:50+00:00 prmrn3c PREMARIN (CONJUGATED ESTROGENS) +74 Medication/supplement use 86984 phv00086984.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:41:57+00:00 2018-10-22 03:41:57+00:00 prmrn4c PREMARIN (CONJUGATED ESTROGENS) +74 Medication/supplement use 87362 phv00087362.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:42:04+00:00 2018-10-22 03:42:04+00:00 prmrnfc PREMARIN (CONJUGATED ESTROGENS) +74 Medication/supplement use 175389 phv00175389.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:42:28+00:00 2018-10-22 03:42:28+00:00 prmrn5c PREMARIN (CONJUGATED ESTROGENS) +74 Medication/supplement use 176812 phv00176812.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:42:34+00:00 2018-10-22 03:42:34+00:00 prmrn5c PREMARIN (CONJUGATED ESTROGENS) +74 Medication/supplement use 83143 phv00083143.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:43:42+00:00 2018-10-22 03:43:42+00:00 prob1c PROBUCOL +74 Medication/supplement use 85388 phv00085388.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:43:53+00:00 2018-10-22 03:43:53+00:00 prob1c PROBUCOL +74 Medication/supplement use 86066 phv00086066.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:44:00+00:00 2018-10-22 03:44:00+00:00 prob2c PROBUCOL +74 Medication/supplement use 86548 phv00086548.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:44:17+00:00 2018-10-22 03:44:17+00:00 prob3c PROBUCOL +74 Medication/supplement use 86985 phv00086985.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:44:24+00:00 2018-10-22 03:44:24+00:00 prob4c PROBUCOL +74 Medication/supplement use 87363 phv00087363.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:44:31+00:00 2018-10-22 03:44:31+00:00 probfc PROBUCOL +74 Medication/supplement use 175390 phv00175390.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:44:38+00:00 2018-10-22 03:44:38+00:00 prob5c PROBUCOL +74 Medication/supplement use 176813 phv00176813.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:44:44+00:00 2018-10-22 03:44:44+00:00 prob5c PROBUCOL +74 Medication/supplement use 83144 phv00083144.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:49:57+00:00 2018-10-22 03:49:57+00:00 pvdl1c PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE +74 Medication/supplement use 85389 phv00085389.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:50:18+00:00 2018-10-22 03:50:18+00:00 pvdl1c PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE +74 Medication/supplement use 86067 phv00086067.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:50:25+00:00 2018-10-22 03:50:25+00:00 pvdl2c PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE +74 Medication/supplement use 86549 phv00086549.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:52:33+00:00 2018-10-22 03:52:33+00:00 pvdl3c PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE +74 Medication/supplement use 86986 phv00086986.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:52:44+00:00 2018-10-22 03:52:44+00:00 pvdl4c PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE +74 Medication/supplement use 87364 phv00087364.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:52:52+00:00 2018-10-22 03:52:52+00:00 pvdlfc PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE +74 Medication/supplement use 175391 phv00175391.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:52:58+00:00 2018-10-22 03:52:58+00:00 pvdl5c PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE +74 Medication/supplement use 176814 phv00176814.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:53:05+00:00 2018-10-22 03:53:05+00:00 pvdl5c PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE +74 Medication/supplement use 191180 phv00191180.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:53:36+00:00 2018-10-22 03:53:36+00:00 sari1c SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR +74 Medication/supplement use 195572 phv00195572.v1.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:53:45+00:00 2018-10-22 03:53:45+00:00 sari2c SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR +74 Medication/supplement use 191188 phv00191188.v1.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:53:51+00:00 2018-10-22 03:53:51+00:00 sari3c SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR +74 Medication/supplement use 191195 phv00191195.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:53:58+00:00 2018-10-22 03:53:58+00:00 sari4c SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR +74 Medication/supplement use 191200 phv00191200.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:54:05+00:00 2018-10-22 03:54:05+00:00 sari5c SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR +74 Medication/supplement use 191698 phv00191698.v2.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:54:11+00:00 2018-10-22 03:54:11+00:00 sari5c SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR +74 Medication/supplement use 83145 phv00083145.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:55:13+00:00 2018-10-22 03:55:13+00:00 slf11c FIRST GENERATION SULFONYLUREAS +74 Medication/supplement use 85390 phv00085390.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:55:19+00:00 2018-10-22 03:55:19+00:00 slf11c FIRST GENERATION SULFONYLUREAS +74 Medication/supplement use 86068 phv00086068.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:55:26+00:00 2018-10-22 03:55:26+00:00 slf12c FIRST GENERATION SULFONYLUREAS +74 Medication/supplement use 86550 phv00086550.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:55:32+00:00 2018-10-22 03:55:32+00:00 slf13c FIRST GENERATION SULFONYLUREAS +74 Medication/supplement use 86987 phv00086987.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:55:39+00:00 2018-10-22 03:55:39+00:00 slf14c FIRST GENERATION SULFONYLUREAS +74 Medication/supplement use 87365 phv00087365.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:55:45+00:00 2018-10-22 03:55:45+00:00 slf1fc FIRST GENERATION SULFONYLUREAS +74 Medication/supplement use 175392 phv00175392.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:55:53+00:00 2018-10-22 03:55:53+00:00 slf15c FIRST GENERATION SULFONYLUREAS +74 Medication/supplement use 176815 phv00176815.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:56:01+00:00 2018-10-22 03:56:01+00:00 slf15c FIRST GENERATION SULFONYLUREAS +74 Medication/supplement use 83146 phv00083146.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:56:43+00:00 2018-10-22 03:56:43+00:00 slf21c SECOND GENERATION SURLFONYLUREAS +74 Medication/supplement use 85391 phv00085391.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:56:49+00:00 2018-10-22 03:56:49+00:00 slf21c SECOND GENERATION SURLFONYLUREAS +74 Medication/supplement use 86069 phv00086069.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:57:01+00:00 2018-10-22 03:57:01+00:00 slf22c SECOND GENERATION SURLFONYLUREAS +74 Medication/supplement use 86551 phv00086551.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:57:08+00:00 2018-10-22 03:57:08+00:00 slf23c SECOND GENERATION SURLFONYLUREAS +74 Medication/supplement use 86988 phv00086988.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:57:15+00:00 2018-10-22 03:57:15+00:00 slf24c SECOND GENERATION SURLFONYLUREAS +74 Medication/supplement use 87366 phv00087366.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:57:23+00:00 2018-10-22 03:57:23+00:00 slf2fc SECOND GENERATION SURLFONYLUREAS +74 Medication/supplement use 175393 phv00175393.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:57:29+00:00 2018-10-22 03:57:29+00:00 slf25c SECOND GENERATION SURLFONYLUREAS +74 Medication/supplement use 176816 phv00176816.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:57:37+00:00 2018-10-22 03:57:37+00:00 slf25c SECOND GENERATION SURLFONYLUREAS +74 Medication/supplement use 191181 phv00191181.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:03+00:00 2018-10-22 03:59:03+00:00 snri1c SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS +74 Medication/supplement use 191182 phv00191182.v1.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:09+00:00 2018-10-22 03:59:09+00:00 ssri1c SELECTIVE SEROTONIN REUPTAKE INHIBITORS +74 Medication/supplement use 195573 phv00195573.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:16+00:00 2018-10-22 03:59:16+00:00 snri2c SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS +74 Medication/supplement use 195574 phv00195574.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:24+00:00 2018-10-22 03:59:24+00:00 ssri2c SELECTIVE SEROTONIN REUPTAKE INHIBITORS +74 Medication/supplement use 191189 phv00191189.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:31+00:00 2018-10-22 03:59:31+00:00 snri3c SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS +74 Medication/supplement use 191190 phv00191190.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:37+00:00 2018-10-22 03:59:37+00:00 ssri3c SELECTIVE SEROTONIN REUPTAKE INHIBITORS +74 Medication/supplement use 191196 phv00191196.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:44+00:00 2018-10-22 03:59:44+00:00 snri4c SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS +74 Medication/supplement use 191197 phv00191197.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:50+00:00 2018-10-22 03:59:50+00:00 ssri4c SELECTIVE SEROTONIN REUPTAKE INHIBITORS +74 Medication/supplement use 191201 phv00191201.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 03:59:56+00:00 2018-10-22 03:59:56+00:00 snri5c SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS +74 Medication/supplement use 191202 phv00191202.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:00:03+00:00 2018-10-22 04:00:03+00:00 ssri5c SELECTIVE SEROTONIN REUPTAKE INHIBITORS +74 Medication/supplement use 191699 phv00191699.v2.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:00:10+00:00 2018-10-22 04:00:10+00:00 snri5c SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS +74 Medication/supplement use 191700 phv00191700.v2.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:00:17+00:00 2018-10-22 04:00:17+00:00 ssri5c SELECTIVE SEROTONIN REUPTAKE INHIBITORS +74 Medication/supplement use 83147 phv00083147.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:01:12+00:00 2018-10-22 04:01:12+00:00 sttn1c HMG COA REDUCTASE INHIBITORS (STATINS) +74 Medication/supplement use 85392 phv00085392.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:01:18+00:00 2018-10-22 04:01:18+00:00 sttn1c HMG COA REDUCTASE INHIBITORS (STATINS) +74 Medication/supplement use 86070 phv00086070.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:01:25+00:00 2018-10-22 04:01:25+00:00 sttn2c HMG COA REDUCTASE INHIBITORS (STATINS) +74 Medication/supplement use 86552 phv00086552.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:01:31+00:00 2018-10-22 04:01:31+00:00 sttn3c HMG COA REDUCTASE INHIBITORS (STATINS) +74 Medication/supplement use 86989 phv00086989.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:01:38+00:00 2018-10-22 04:01:38+00:00 sttn4c HMG COA REDUCTASE INHIBITORS (STATINS) +74 Medication/supplement use 87367 phv00087367.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:01:44+00:00 2018-10-22 04:01:44+00:00 sttnfc HMG COA REDUCTASE INHIBITORS (STATINS) +74 Medication/supplement use 175394 phv00175394.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:01:50+00:00 2018-10-22 04:01:50+00:00 sttn5c HMG COA REDUCATACE INHIBITORS (STATINS) +74 Medication/supplement use 176817 phv00176817.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:01:56+00:00 2018-10-22 04:01:56+00:00 sttn5c HMG COA REDUCATACE INHIBITORS (STATINS) +74 Medication/supplement use 83148 phv00083148.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:02:38+00:00 2018-10-22 04:02:38+00:00 sympth1c SYMPATHOMIMETICS, ORAL AND INHALED +74 Medication/supplement use 85393 phv00085393.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:02:45+00:00 2018-10-22 04:02:45+00:00 sympth1c SYMPATHOMIMETICS, ORAL AND INHALED +74 Medication/supplement use 86071 phv00086071.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:02:51+00:00 2018-10-22 04:02:51+00:00 sympth2c SYMPATHOMIMETICS, ORAL AND INHALED +74 Medication/supplement use 86553 phv00086553.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:02:58+00:00 2018-10-22 04:02:58+00:00 sympth3c SYMPATHOMIMETICS, ORAL AND INHALED +74 Medication/supplement use 86990 phv00086990.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:03:04+00:00 2018-10-22 04:03:04+00:00 sympth4c SYMPATHOMIMETICS, ORAL AND INHALED +74 Medication/supplement use 87368 phv00087368.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:03:11+00:00 2018-10-22 04:03:11+00:00 sympthfc SYMPATHOMIMETICS, ORAL AND INHALED +74 Medication/supplement use 175395 phv00175395.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:03:17+00:00 2018-10-22 04:03:17+00:00 sympth5c SYMPATHOMIMETICS, ORAL AND INHALED +74 Medication/supplement use 176818 phv00176818.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:03:24+00:00 2018-10-22 04:03:24+00:00 sympth5c SYMPATHOMIMETICS, ORAL AND INHALED +74 Medication/supplement use 83149 phv00083149.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:04:40+00:00 2018-10-22 04:04:40+00:00 tca1c TRICYCLIC ANTI-DEPRESSANTS +74 Medication/supplement use 83150 phv00083150.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:04:46+00:00 2018-10-22 04:04:46+00:00 tcap1c TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS COMBINATIONS +74 Medication/supplement use 85394 phv00085394.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:04:52+00:00 2018-10-22 04:04:52+00:00 tca1c TRICYCLIC ANTI-DEPRESSANTS +74 Medication/supplement use 85395 phv00085395.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:00+00:00 2018-10-22 04:05:00+00:00 tcap1c TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS COMBINATIONS +74 Medication/supplement use 86072 phv00086072.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:06+00:00 2018-10-22 04:05:06+00:00 tca2c TRICYCLIC ANTI-DEPRESSANTS +74 Medication/supplement use 86073 phv00086073.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:12+00:00 2018-10-22 04:05:12+00:00 tcap2c TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS COMBINATIONS +74 Medication/supplement use 86554 phv00086554.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:19+00:00 2018-10-22 04:05:19+00:00 tca3c TRICYCLIC ANTI-DEPRESSANTS +74 Medication/supplement use 86555 phv00086555.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:25+00:00 2018-10-22 04:05:25+00:00 tcap3c TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS +74 Medication/supplement use 86991 phv00086991.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:32+00:00 2018-10-22 04:05:32+00:00 tca4c TRICYCLIC ANTI-DEPRESSANTS +74 Medication/supplement use 86992 phv00086992.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:38+00:00 2018-10-22 04:05:38+00:00 tcap4c TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS +74 Medication/supplement use 87369 phv00087369.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:45+00:00 2018-10-22 04:05:45+00:00 tcafc TRICYCLIC ANTI-DEPRESSANTS +74 Medication/supplement use 87370 phv00087370.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:52+00:00 2018-10-22 04:05:52+00:00 tcapfc TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS +74 Medication/supplement use 175396 phv00175396.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:05:59+00:00 2018-10-22 04:05:59+00:00 tca5c TRICYCLIC ANTI-DEPRESSANTS +74 Medication/supplement use 175397 phv00175397.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:06:06+00:00 2018-10-22 04:06:06+00:00 tcap5c TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS +74 Medication/supplement use 176819 phv00176819.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:06:13+00:00 2018-10-22 04:06:13+00:00 tca5c TRICYCLIC ANTI-DEPRESSANTS +74 Medication/supplement use 176820 phv00176820.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:06:20+00:00 2018-10-22 04:06:20+00:00 tcap5c TRICYCLIC ANTI-DEPRESSANTS PLUS ANTI-PSYCHOTICS +74 Medication/supplement use 83151 phv00083151.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:09:21+00:00 2018-10-22 04:09:21+00:00 thry1c THYROID AGENTS +74 Medication/supplement use 85396 phv00085396.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:09:28+00:00 2018-10-22 04:09:28+00:00 thry1c THYROID AGENTS +74 Medication/supplement use 86074 phv00086074.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:09:35+00:00 2018-10-22 04:09:35+00:00 thry2c THYROID AGENTS +74 Medication/supplement use 86556 phv00086556.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:09:41+00:00 2018-10-22 04:09:41+00:00 thry3c THYROID AGENTS +74 Medication/supplement use 86993 phv00086993.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:09:48+00:00 2018-10-22 04:09:48+00:00 thry4c THYROID AGENTS +74 Medication/supplement use 87371 phv00087371.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:09:56+00:00 2018-10-22 04:09:56+00:00 thryfc THYROID AGENTS +74 Medication/supplement use 175398 phv00175398.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:10:03+00:00 2018-10-22 04:10:03+00:00 thry5c THYROID AGENTS +74 Medication/supplement use 176821 phv00176821.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:10:10+00:00 2018-10-22 04:10:10+00:00 thry5c THYROID AGENTS +74 Medication/supplement use 176822 phv00176822.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:10:57+00:00 2018-10-22 04:10:57+00:00 thzd5c THIAZOLIDINEDIONES +74 Medication/supplement use 175399 phv00175399.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:11:03+00:00 2018-10-22 04:11:03+00:00 thzd5c THIAZOLIDINEDIONES +74 Medication/supplement use 87372 phv00087372.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:11:10+00:00 2018-10-22 04:11:10+00:00 thzdfc THIAZOLIDINEDIONES +74 Medication/supplement use 86994 phv00086994.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:11:16+00:00 2018-10-22 04:11:16+00:00 thzd4c THIAZOLIDINEDIONES +74 Medication/supplement use 86557 phv00086557.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:11:22+00:00 2018-10-22 04:11:22+00:00 thzd3c THIAZOLIDINEDIONES +74 Medication/supplement use 86075 phv00086075.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:11:29+00:00 2018-10-22 04:11:29+00:00 thzd2c THIAZOLIDINEDIONES +74 Medication/supplement use 85397 phv00085397.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:11:35+00:00 2018-10-22 04:11:35+00:00 thzd1c THIAZOLIDINEDIONES +74 Medication/supplement use 83152 phv00083152.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:11:41+00:00 2018-10-22 04:11:41+00:00 thzd1c THIAZOLIDINEDIONES +74 Medication/supplement use 111944 phv00111944.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:12:45+00:00 2018-10-22 04:12:45+00:00 uazqtd1c UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 111945 phv00111945.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:12:53+00:00 2018-10-22 04:12:53+00:00 uazqtp1c UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 111946 phv00111946.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:00+00:00 2018-10-22 04:13:00+00:00 uazqtd2c UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 111947 phv00111947.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:07+00:00 2018-10-22 04:13:07+00:00 uazqtp2c UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 111949 phv00111949.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:14+00:00 2018-10-22 04:13:14+00:00 uazqtd3c UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 111950 phv00111950.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:20+00:00 2018-10-22 04:13:20+00:00 uazqtp3c UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 111953 phv00111953.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:26+00:00 2018-10-22 04:13:26+00:00 uazqtd4c UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 111954 phv00111954.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:32+00:00 2018-10-22 04:13:32+00:00 uazqtp4c UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 175411 phv00175411.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:38+00:00 2018-10-22 04:13:38+00:00 uazqtd5c UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 175412 phv00175412.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:45+00:00 2018-10-22 04:13:45+00:00 uazqtp5c UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 176834 phv00176834.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:51+00:00 2018-10-22 04:13:51+00:00 uazqtd5c UAZ DEFINITE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 176835 phv00176835.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:13:57+00:00 2018-10-22 04:13:57+00:00 uazqtp5c UAZ POSSIBLE ECG QT INTERVAL-ALTERING MEDICATION +74 Medication/supplement use 83153 phv00083153.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:14:43+00:00 2018-10-22 04:14:43+00:00 urcos1c URICOSURICS +74 Medication/supplement use 85398 phv00085398.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:14:49+00:00 2018-10-22 04:14:49+00:00 urcos1c URICOSURICS +74 Medication/supplement use 86076 phv00086076.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:14:55+00:00 2018-10-22 04:14:55+00:00 urcos2c URICOSURICS +74 Medication/supplement use 86558 phv00086558.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:15:02+00:00 2018-10-22 04:15:02+00:00 urcos3c URICOSURICS +74 Medication/supplement use 86995 phv00086995.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:15:09+00:00 2018-10-22 04:15:09+00:00 urcos4c URICOSURICS +74 Medication/supplement use 87373 phv00087373.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:15:15+00:00 2018-10-22 04:15:15+00:00 urcosfc URICOSURICS +74 Medication/supplement use 175400 phv00175400.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:15:21+00:00 2018-10-22 04:15:21+00:00 urcos5c URICOSURICS +74 Medication/supplement use 176823 phv00176823.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:15:27+00:00 2018-10-22 04:15:27+00:00 urcos5c URICOSURICS +74 Medication/supplement use 83154 phv00083154.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:06+00:00 2018-10-22 04:18:06+00:00 vaso1c VASODILATORS, A MIXED GROUP +74 Medication/supplement use 83155 phv00083155.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:12+00:00 2018-10-22 04:18:12+00:00 vasod1c VASODILATORS WITH DIURETICS, A MIXED GROUP +74 Medication/supplement use 85399 phv00085399.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:18+00:00 2018-10-22 04:18:18+00:00 vaso1c VASODILATORS, A MIXED GROUP +74 Medication/supplement use 85400 phv00085400.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:25+00:00 2018-10-22 04:18:25+00:00 vasod1c VASODILATORS WITH DIURETICS, A MIXED GROUP +74 Medication/supplement use 86077 phv00086077.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:32+00:00 2018-10-22 04:18:32+00:00 vaso2c VASODILATORS, A MIXED GROUP +74 Medication/supplement use 86078 phv00086078.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:41+00:00 2018-10-22 04:18:41+00:00 vasod2c VASODILATORS WITH DIURETICS, A MIXED GROUP +74 Medication/supplement use 86559 phv00086559.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:47+00:00 2018-10-22 04:18:47+00:00 vaso3c VASODILATORS, A MIXED GROUP +74 Medication/supplement use 86560 phv00086560.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:53+00:00 2018-10-22 04:18:53+00:00 vasod3c VASODILATORS WITH DIURETICS, A MIXED GROUP +74 Medication/supplement use 86996 phv00086996.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:18:59+00:00 2018-10-22 04:18:59+00:00 vaso4c VASODILATORS, A MIXED GROUP +74 Medication/supplement use 86997 phv00086997.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:19:05+00:00 2018-10-22 04:19:05+00:00 vasod4c VASODILATORS WITH DIURETICS, A MIXED GROUP +74 Medication/supplement use 87374 phv00087374.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:19:11+00:00 2018-10-22 04:19:11+00:00 vasofc VASODILATORS, A MIXED GROUP +74 Medication/supplement use 87375 phv00087375.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:19:18+00:00 2018-10-22 04:19:18+00:00 vasodfc VASODILATORS WITH DIURETICS, A MIXED GROUP +74 Medication/supplement use 175401 phv00175401.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:19:25+00:00 2018-10-22 04:19:25+00:00 vaso5c VASODILATORS, A MIXED GROUP +74 Medication/supplement use 175402 phv00175402.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:19:31+00:00 2018-10-22 04:19:31+00:00 vasod5c VASODILATORS WITH DIURETICS, A MIXED GROUP +74 Medication/supplement use 176824 phv00176824.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:19:37+00:00 2018-10-22 04:19:37+00:00 vaso5c VASODILATORS, A MIXED GROUP +74 Medication/supplement use 176825 phv00176825.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:19:44+00:00 2018-10-22 04:19:44+00:00 vasod5c VASODILATORS WITH DIURETICS, A MIXED GROUP +74 Medication/supplement use 83156 phv00083156.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:22:07+00:00 2018-10-22 04:22:07+00:00 verir1c IMMEDIATE-RELEASE VERAPAMIL +74 Medication/supplement use 83157 phv00083157.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:22:13+00:00 2018-10-22 04:22:13+00:00 versr1c SLOW-RELEASE VERAPAMIL +74 Medication/supplement use 85401 phv00085401.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:22:21+00:00 2018-10-22 04:22:21+00:00 verir1c IMMEDIATE-RELEASE VERAPAMIL +74 Medication/supplement use 85402 phv00085402.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:22:28+00:00 2018-10-22 04:22:28+00:00 versr1c SLOW-RELEASE VERAPAMIL +74 Medication/supplement use 86079 phv00086079.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:22:35+00:00 2018-10-22 04:22:35+00:00 verir2c IMMEDIATE-RELEASE VERAPAMIL +74 Medication/supplement use 86080 phv00086080.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:22:41+00:00 2018-10-22 04:22:41+00:00 versr2c SLOW-RELEASE VERAPAMIL +74 Medication/supplement use 86561 phv00086561.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:22:47+00:00 2018-10-22 04:22:47+00:00 verir3c IMMEDIATE-RELEASE VERAPAMIL +74 Medication/supplement use 86562 phv00086562.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:22:53+00:00 2018-10-22 04:22:53+00:00 versr3c SLOW-RELEASE VERAPAMIL +74 Medication/supplement use 86998 phv00086998.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:23:00+00:00 2018-10-22 04:23:00+00:00 verir4c IMMEDIATE-RELEASE VERAPAMIL +74 Medication/supplement use 86999 phv00086999.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:23:08+00:00 2018-10-22 04:23:08+00:00 versr4c SLOW-RELEASE VERAPAMIL +74 Medication/supplement use 87376 phv00087376.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:23:14+00:00 2018-10-22 04:23:14+00:00 verirfc IMMEDIATE-RELEASE VERAPAMIL +74 Medication/supplement use 87377 phv00087377.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:23:20+00:00 2018-10-22 04:23:20+00:00 versrfc SLOW-RELEASE VERAPAMIL +74 Medication/supplement use 175403 phv00175403.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:23:27+00:00 2018-10-22 04:23:27+00:00 verir5c IMMEDIATE-RELEASE VERAPAMIL +74 Medication/supplement use 175404 phv00175404.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:23:33+00:00 2018-10-22 04:23:33+00:00 versr5c SLOW-RELEASE VERAPAMIL +74 Medication/supplement use 176826 phv00176826.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:23:39+00:00 2018-10-22 04:23:39+00:00 verir5c IMMEDIATE-RELEASE VERAPAMIL +74 Medication/supplement use 176827 phv00176827.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:23:46+00:00 2018-10-22 04:23:46+00:00 versr5c SLOW-RELEASE VERAPAMIL +74 Medication/supplement use 83158 phv00083158.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:24:43+00:00 2018-10-22 04:24:43+00:00 warf1c ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE +74 Medication/supplement use 85403 phv00085403.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:24:49+00:00 2018-10-22 04:24:49+00:00 warf1c ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE +74 Medication/supplement use 86081 phv00086081.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:24:55+00:00 2018-10-22 04:24:55+00:00 warf2c ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE +74 Medication/supplement use 86563 phv00086563.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:25:03+00:00 2018-10-22 04:25:03+00:00 warf3c ORAL ANTICOAGULANTS +74 Medication/supplement use 87000 phv00087000.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:25:09+00:00 2018-10-22 04:25:09+00:00 warf4c ORAL ANTICOAGULANTS +74 Medication/supplement use 87378 phv00087378.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:25:16+00:00 2018-10-22 04:25:16+00:00 warffc ORAL ANTICOAGULANTS +74 Medication/supplement use 175405 phv00175405.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:25:22+00:00 2018-10-22 04:25:22+00:00 warf5c ORAL ANTICOAGULANTS +74 Medication/supplement use 176004 phv00176004.v1.p3 pht003090.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:25:29+00:00 2018-10-22 04:25:29+00:00 warf1c ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE +74 Medication/supplement use 176828 phv00176828.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:25:35+00:00 2018-10-22 04:25:35+00:00 warf5c ORAL ANTICOAGULANTS +74 Medication/supplement use 83159 phv00083159.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:26:17+00:00 2018-10-22 04:26:17+00:00 wtls1c WEIGHT LOSS DRUGS +74 Medication/supplement use 85404 phv00085404.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:26:24+00:00 2018-10-22 04:26:24+00:00 wtls1c WEIGHT LOSS DRUGS +74 Medication/supplement use 86082 phv00086082.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:26:35+00:00 2018-10-22 04:26:35+00:00 wtls2c WEIGHT LOSS DRUGS +74 Medication/supplement use 86564 phv00086564.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:26:42+00:00 2018-10-22 04:26:42+00:00 wtls3c WEIGHT LOSS DRUGS +74 Medication/supplement use 87001 phv00087001.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:26:50+00:00 2018-10-22 04:26:50+00:00 wtls4c WEIGHT LOSS DRUGS +74 Medication/supplement use 87379 phv00087379.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:26:59+00:00 2018-10-22 04:26:59+00:00 wtlsfc WEIGHT LOSS DRUGS +74 Medication/supplement use 175406 phv00175406.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:27:04+00:00 2018-10-22 04:27:04+00:00 wtls5c WEIGHT LOSS DRUGS +74 Medication/supplement use 176829 phv00176829.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:27:15+00:00 2018-10-22 04:27:15+00:00 wtls5c WEIGHT LOSS DRUGS +74 Medication/supplement use 83160 phv00083160.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:27:53+00:00 2018-10-22 04:27:53+00:00 xoi1c XANTHINE OXIDASE INHIBITORS +74 Medication/supplement use 85405 phv00085405.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:27:59+00:00 2018-10-22 04:27:59+00:00 xoi1c XANTHINE OXIDASE INHIBITORS +74 Medication/supplement use 86083 phv00086083.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:28:06+00:00 2018-10-22 04:28:06+00:00 xoi2c XANTHINE OXIDASE INHIBITORS +74 Medication/supplement use 86565 phv00086565.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:28:13+00:00 2018-10-22 04:28:13+00:00 xoi3c XANTHINE OXIDASE INHIBITORS +74 Medication/supplement use 87002 phv00087002.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:28:20+00:00 2018-10-22 04:28:20+00:00 xoi4c XANTHINE OXIDASE INHIBITORS +74 Medication/supplement use 87380 phv00087380.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:28:26+00:00 2018-10-22 04:28:26+00:00 xoifc XANTHINE OXIDASE INHIBITORS +74 Medication/supplement use 175407 phv00175407.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:28:33+00:00 2018-10-22 04:28:33+00:00 xoi5c XANTHINE OXIDASE INHIBITORS +74 Medication/supplement use 176830 phv00176830.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:28:39+00:00 2018-10-22 04:28:39+00:00 xoi5c XANTHINE OXIDASE INHIBITORS +74 Medication/supplement use 83161 phv00083161.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:29:17+00:00 2018-10-22 04:29:17+00:00 diur1c ANY DIURETIC +74 Medication/supplement use 85406 phv00085406.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:29:25+00:00 2018-10-22 04:29:25+00:00 diur1c ANY DIURETIC +74 Medication/supplement use 86012 phv00086012.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:29:32+00:00 2018-10-22 04:29:32+00:00 diur2c ANY DIURETIC +74 Medication/supplement use 86494 phv00086494.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:29:38+00:00 2018-10-22 04:29:38+00:00 diur3c ANY DIURETIC +74 Medication/supplement use 86931 phv00086931.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:29:46+00:00 2018-10-22 04:29:46+00:00 diur4c ANY DIURETIC +74 Medication/supplement use 87381 phv00087381.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:29:53+00:00 2018-10-22 04:29:53+00:00 diurfc ANY DIURETIC +74 Medication/supplement use 175408 phv00175408.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:30:01+00:00 2018-10-22 04:30:01+00:00 diur5c ANY DIURETIC +74 Medication/supplement use 176831 phv00176831.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:30:08+00:00 2018-10-22 04:30:08+00:00 diur5c ANY DIURETIC +74 Medication/supplement use 83162 phv00083162.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:31:31+00:00 2018-10-22 04:31:31+00:00 lipid1c ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 85407 phv00085407.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:31:38+00:00 2018-10-22 04:31:38+00:00 lipid1c ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 86013 phv00086013.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:31:45+00:00 2018-10-22 04:31:45+00:00 lipid2c ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 86495 phv00086495.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:31:52+00:00 2018-10-22 04:31:52+00:00 lipid3c ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 86932 phv00086932.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:31:59+00:00 2018-10-22 04:31:59+00:00 lipid4c ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 87104 phv00087104.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:32:06+00:00 2018-10-22 04:32:06+00:00 lipidfc ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 175409 phv00175409.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:32:15+00:00 2018-10-22 04:32:15+00:00 lipid5c ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 175868 phv00175868.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:32:22+00:00 2018-10-22 04:32:22+00:00 lipid1c ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 175952 phv00175952.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:32:28+00:00 2018-10-22 04:32:28+00:00 lipidfc FAMILY COHORT: ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 176832 phv00176832.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:32:38+00:00 2018-10-22 04:32:38+00:00 lipid5c ANY LIPID-LOWERING MEDICATION +74 Medication/supplement use 83163 phv00083163.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:33:25+00:00 2018-10-22 04:33:25+00:00 htnmed1c HYPERTENSION MEDICATION +74 Medication/supplement use 85324 phv00085324.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:33:46+00:00 2018-10-22 04:33:46+00:00 htnmed1c HYPERTENSION MEDICATION +74 Medication/supplement use 86014 phv00086014.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:33:52+00:00 2018-10-22 04:33:52+00:00 htnmed2c HYPERTENSION MEDICATION +74 Medication/supplement use 86496 phv00086496.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:33:58+00:00 2018-10-22 04:33:58+00:00 htnmed3c ANY HYPERTENSION MEDICATION +74 Medication/supplement use 86933 phv00086933.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:34:05+00:00 2018-10-22 04:34:05+00:00 htnmed4c ANY HYPERTENSION MEDICATION +74 Medication/supplement use 87093 phv00087093.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:34:12+00:00 2018-10-22 04:34:12+00:00 htnmedfc ANY HYPERTENSION MEDICATION +74 Medication/supplement use 175410 phv00175410.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:34:19+00:00 2018-10-22 04:34:19+00:00 htnmed5c ANY HYPERTENSION MEDICATION +74 Medication/supplement use 175864 phv00175864.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:34:25+00:00 2018-10-22 04:34:25+00:00 htnmed1c HYPERTENSION MEDICATION +74 Medication/supplement use 175949 phv00175949.v1.p3 pht003087.v1.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:34:31+00:00 2018-10-22 04:34:31+00:00 htnmedfc FAMILY COHORT: ANY HYPERTENSION MEDICATION +74 Medication/supplement use 176833 phv00176833.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:34:37+00:00 2018-10-22 04:34:37+00:00 htnmed5c ANY HYPERTENSION MEDICATION +74 Medication/supplement use 83302 phv00083302.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:39:28+00:00 2018-10-22 04:39:28+00:00 diabins1 INSULIN OR ORAL HYPOGLYCEMICS FOR DIABETES? +74 Medication/supplement use 84979 phv00084979.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:39:37+00:00 2018-10-22 04:39:37+00:00 diabins1 INSULIN OR ORAL HYPOGLYCEMICS FOR DIABETES? +74 Medication/supplement use 85926 phv00085926.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:39:45+00:00 2018-10-22 04:39:45+00:00 diabins2 INSULIN OR ORAL HYPOGLYCEMICS FOR DIABETES? +74 Medication/supplement use 86409 phv00086409.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:39:51+00:00 2018-10-22 04:39:51+00:00 diabins3 INSULIN OR ORAL HYPOGLYCEMICS FOR DIABETES? +74 Medication/supplement use 175455 phv00175455.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:39:59+00:00 2018-10-22 04:39:59+00:00 diabins5 INSULIN OR HYPOGLYCEMICS FOR DIABETES +74 Medication/supplement use 176889 phv00176889.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:40:07+00:00 2018-10-22 04:40:07+00:00 diabins5 INSULIN OR HYPOGLYCEMICS FOR DIABETES +74 Medication/supplement use 83067 phv00083067.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:47:11+00:00 2018-10-22 04:47:11+00:00 aspirin1 ASPIRIN: EVER USED ON REGULAR BASIS +74 Medication/supplement use 83068 phv00083068.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:47:18+00:00 2018-10-22 04:47:18+00:00 aspsage1 ASPIRIN: AGE STARTED REGULAR USE +74 Medication/supplement use 83069 phv00083069.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:47:28+00:00 2018-10-22 04:47:28+00:00 aspnow1 ASPIRIN: CURRENTLY USING REGULARLY +74 Medication/supplement use 83070 phv00083070.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:47:36+00:00 2018-10-22 04:47:36+00:00 aspdays1 ASPIRIN: DAYS PER WEEK +74 Medication/supplement use 83071 phv00083071.v1.p3 pht001111.v4.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:47:43+00:00 2018-10-22 04:47:43+00:00 aspeage1 ASPIRIN: AGE STOPPED USING REGULARLY +74 Medication/supplement use 85304 phv00085304.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:48:29+00:00 2018-10-22 04:48:29+00:00 aspirin1 ASPIRIN: EVER USED ON REGULAR BASIS +74 Medication/supplement use 85305 phv00085305.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:48:36+00:00 2018-10-22 04:48:36+00:00 aspsage1 ASPIRIN: AGE STARTED REGULAR USE +74 Medication/supplement use 85306 phv00085306.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:48:42+00:00 2018-10-22 04:48:42+00:00 aspnow1 ASPIRIN: CURRENTLY USING REGULARLY +74 Medication/supplement use 85307 phv00085307.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:48:50+00:00 2018-10-22 04:48:50+00:00 aspdays1 ASPIRIN: DAYS PER WEEK +74 Medication/supplement use 85308 phv00085308.v2.p3 pht001116.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:48:56+00:00 2018-10-22 04:48:56+00:00 aspeage1 ASPIRIN: AGE STOPPED USING REGULARLY +74 Medication/supplement use 85955 phv00085955.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:49:06+00:00 2018-10-22 04:49:06+00:00 aspirin2 TAKING ASPIRIN ON REGULAR BASIS +74 Medication/supplement use 85956 phv00085956.v2.p3 pht001118.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:49:12+00:00 2018-10-22 04:49:12+00:00 aspdays2 DAYS PER WEEK TAKING ASPIRIN +74 Medication/supplement use 86437 phv00086437.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:49:21+00:00 2018-10-22 04:49:21+00:00 aspirin3 TAKING ASPIRIN ON REGULAR BASIS +74 Medication/supplement use 86438 phv00086438.v2.p3 pht001119.v8.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:49:29+00:00 2018-10-22 04:49:29+00:00 aspdays3 DAYS PER WEEK TAKING ASPIRIN +74 Medication/supplement use 86881 phv00086881.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:49:38+00:00 2018-10-22 04:49:38+00:00 aspirin4 TAKING ASPIRIN ON REGULAR BASIS +74 Medication/supplement use 86882 phv00086882.v2.p3 pht001120.v10.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:49:45+00:00 2018-10-22 04:49:45+00:00 aspdays4 DAYS PER WEEK TAKING ASPIRIN +74 Medication/supplement use 87220 phv00087220.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:49:55+00:00 2018-10-22 04:49:55+00:00 aspirinf ASPIRIN USAGE ON REGULAR BASIS EVER +74 Medication/supplement use 87221 phv00087221.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:50:03+00:00 2018-10-22 04:50:03+00:00 aspsagef AGE STARTED REGULAR ASPIRIN USAGE +74 Medication/supplement use 87222 phv00087222.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:50:09+00:00 2018-10-22 04:50:09+00:00 aspnowf CURRENT REGULAR ASPIRIN USER +74 Medication/supplement use 87223 phv00087223.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:50:15+00:00 2018-10-22 04:50:15+00:00 aspdaysf CURRENT REGULAR ASPIRIN USER: NUMBER OF DAYS PER WEEK OF USAGE +74 Medication/supplement use 87224 phv00087224.v1.p3 pht001121.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:50:21+00:00 2018-10-22 04:50:21+00:00 aspeagef NO LONGER CURRENT REGULAR ASPIRIN USER: AGE STOPPED +74 Medication/supplement use 175271 phv00175271.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:50:28+00:00 2018-10-22 04:50:28+00:00 aspirin5 TAKING ASPIRIN ON REGULAR BASIS +74 Medication/supplement use 175272 phv00175272.v1.p3 pht003086.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:50:35+00:00 2018-10-22 04:50:35+00:00 aspdays5 DAYS PER WEEK TAKING ASPIRIN +74 Medication/supplement use 176694 phv00176694.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:50:42+00:00 2018-10-22 04:50:42+00:00 aspirin5 TAKING ASPIRIN ON REGULAR BASIS +74 Medication/supplement use 176695 phv00176695.v1.p3 pht003091.v3.p3 phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) 209 13 2018-10-22 04:50:49+00:00 2018-10-22 04:50:49+00:00 aspdays5 DAYS PER WEEK TAKING ASPIRIN +74 Medication/supplement use 207837 phv00207837.v1.p1 pht004129.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-11-20 20:14:24+00:00 2018-11-20 20:14:24+00:00 MSRAFLAG MSRAFLAG [Medication Survey Form, exam 1] \ No newline at end of file diff --git a/docker-compose.yaml b/docker-compose.yaml index d544cd5d..7556703b 100644 --- a/docker-compose.yaml +++ b/docker-compose.yaml @@ -45,6 +45,8 @@ services: "--workers=$API_WORKERS", "--name=dug", "--bind=0.0.0.0:$API_PORT", "--timeout=$API_TIMEOUT", "--log-level=DEBUG", "--enable-stdio-inheritance", "--reload", "dug.api:app" ] + volumes: + - ./src:/home/dug/dug/ ports: - $API_PORT:$API_PORT diff --git a/pytest.ini b/pytest.ini index df2f39fa..f8823763 100644 --- a/pytest.ini +++ b/pytest.ini @@ -2,5 +2,8 @@ [pytest] addopts = -p no:cacheprovider +markers = + api: mark a test as an api test + cli: mark a test as a cli test testpaths = tests \ No newline at end of file diff --git a/src/dug/_version.py b/src/dug/_version.py index dac77789..1f8197ce 100644 --- a/src/dug/_version.py +++ b/src/dug/_version.py @@ -1 +1 @@ -__version__ = "2.1.0" \ No newline at end of file +__version__ = "2.2.0" \ No newline at end of file diff --git a/src/dug/api.py b/src/dug/api.py index 8cd4c7a9..0794fc4d 100644 --- a/src/dug/api.py +++ b/src/dug/api.py @@ -272,15 +272,18 @@ def post(self): api.add_resource(DugSearchVarResource, '/search_var') api.add_resource(DugAggDataType, '/agg_data_types') +def main(args=None): + parser = argparse.ArgumentParser(description='Dug Search API') + parser.add_argument('-p', '--port', type=int, help='Port to run service on.', default=5551) + parser.add_argument('-d', '--debug', help="Debug log level.", default=False, action='store_true') + args = parser.parse_args(args) + + """ Configure """ + if args.debug: + debug = True + logging.basicConfig(level=logging.DEBUG) + logger.info(f"starting dug on port={args.port} with debug={args.debug}") + app.run(host='0.0.0.0', port=args.port, debug=args.debug, threaded=True) + if __name__ == "__main__": - parser = argparse.ArgumentParser(description='Dug Search API') - parser.add_argument('-p', '--port', type=int, help='Port to run service on.', default=5551) - parser.add_argument('-d', '--debug', help="Debug log level.", default=False, action='store_true') - args = parser.parse_args () - - """ Configure """ - if args.debug: - debug = True - logging.basicConfig(level=logging.DEBUG) - logger.info (f"starting dug on port={args.port} with debug={args.debug}") - app.run(host='0.0.0.0', port=args.port, debug=args.debug, threaded=True) + main() diff --git a/src/dug/cli.py b/src/dug/cli.py index 5839d41f..d1b5c0f0 100755 --- a/src/dug/cli.py +++ b/src/dug/cli.py @@ -121,11 +121,11 @@ def status(args): print("Status check is not implemented yet!") -def main(): +def main(args=None): arg_parser = get_argparser() - args = arg_parser.parse_args() + args = arg_parser.parse_args(args) try: logger.setLevel(args.log_level) diff --git a/src/dug/config.py b/src/dug/config.py index 79c809ec..f17478cf 100644 --- a/src/dug/config.py +++ b/src/dug/config.py @@ -39,7 +39,7 @@ class Config: # Normalizer config that will be passed to annotate.Normalizer constructor normalizer: dict = field(default_factory=lambda: { - "url": "https://nodenormalization-sri.renci.org/get_normalized_nodes?curie=" + "url": "https://nodenormalization-sri.renci.org/1.1/get_normalized_nodes?curie=" }) # Synonym service config that will be passed to annotate.SynonymHelper constructor diff --git a/src/dug/core/annotate.py b/src/dug/core/annotate.py index e792d56c..2d8fa6e8 100644 --- a/src/dug/core/annotate.py +++ b/src/dug/core/annotate.py @@ -352,10 +352,16 @@ def make_request(self, curie: str, http_session: Session): url = f"{self.url}{urllib.parse.quote(curie)}" try: - response = http_session.get(url).json() - return response + response = http_session.get(url) + if response.status_code == 400: + logger.error(f"No synonyms returned for: `{curie}`. Validation error.") + return [] + if response.status_code == 500: + logger.error(f"No synonyms returned for: `{curie}`. Internal server error from {self.url}.") + return [] + return response.json() except json.decoder.JSONDecodeError as e: - logger.error(f"No synonyms returned for: {curie}") + logger.error(f"Json parse error for response from `{url}`. Exception: {str(e)}") return [] def handle_response(self, curie: str, raw_synonyms: List[dict]) -> List[str]: diff --git a/src/dug/core/parsers/_base.py b/src/dug/core/parsers/_base.py index a3943cbc..56f0ff69 100644 --- a/src/dug/core/parsers/_base.py +++ b/src/dug/core/parsers/_base.py @@ -85,7 +85,7 @@ def set_search_terms(self): # Traverse set of identifiers to determine set of search terms search_terms = self.search_terms for ident_id, ident in self.identifiers.items(): - search_terms.extend([ident.label, ident.description] + ident.search_text + ident.synonyms) + search_terms.extend(ident.search_text + ident.synonyms) self.search_terms = list(set(search_terms)) def set_optional_terms(self): diff --git a/src/dug/core/parsers/topmed_tag_parser.py b/src/dug/core/parsers/topmed_tag_parser.py index 448a84b5..64b4064b 100644 --- a/src/dug/core/parsers/topmed_tag_parser.py +++ b/src/dug/core/parsers/topmed_tag_parser.py @@ -55,12 +55,14 @@ def __call__(self, input_file: InputFile) -> List[Indexable]: reader = csv.DictReader(csvfile, delimiter='\t') for row in reader: row = {k.strip(): v for k, v in row.items()} - elem = DugElement(elem_id=row['variable_full_accession'], - name=row['variable_name'] if 'variable_name' in row else row['variable_full_accession'], - desc=row['variable_desc'] if 'variable_name' in row else row['variable_full_accession'], - elem_type="DbGaP", - collection_id=row['study_full_accession'], - collection_name=row['study_name']) + elem = DugElement( + elem_id=row['variable_full_accession'], + name=row['variable_name'] if 'variable_name' in row else row['variable_full_accession'], + desc=row['variable_description'] if 'variable_description' in row else row['variable_full_accession'], + elem_type="DbGaP", + collection_id=row['study_full_accession'], + collection_name=row['study_name'] + ) # Create DBGaP links as study/variable actions elem.collection_action = utils.get_dbgap_study_link(study_id=elem.collection_id) diff --git a/src/dug/core/search.py b/src/dug/core/search.py index fc25a112..4f7e8370 100644 --- a/src/dug/core/search.py +++ b/src/dug/core/search.py @@ -153,16 +153,99 @@ def update_doc(self, index, doc, doc_id): def search_concepts(self, index, query, offset=0, size=None, fuzziness=1, prefix_length=3): """ - Changed to query_string for and/or and exact matches with quotations. + Changed to a long boolean match query to optimize search results """ query = { - 'query_string': { - 'query': query, - 'fuzziness': fuzziness, - 'fuzzy_prefix_length': prefix_length, - 'fields': ["name", "description", "search_terms", "optional_terms"], - 'quote_field_suffix': ".exact" - }, + "bool": { + "should": [ + { + "match_phrase": { + "name": { + "query": query, + "boost": 10 + } + } + }, + { + "match_phrase": { + "description": { + "query": query, + "boost": 6 + } + } + }, + { + "match_phrase": { + "search_terms": { + "query": query, + "boost": 8 + } + } + }, + { + "match": { + "name": { + "query": query, + "fuzziness": fuzziness, + "prefix_length": prefix_length, + "operator": "and", + "boost": 4 + } + } + }, + { + "match": { + "search_terms": { + "query": query, + "fuzziness": fuzziness, + "prefix_length": prefix_length, + "operator": "and", + "boost": 5 + } + } + }, + { + "match": { + "description": { + "query": query, + "fuzziness": fuzziness, + "prefix_length": prefix_length, + "operator": "and", + "boost": 3 + } + } + }, + { + "match": { + "description": { + "query": query, + "fuzziness": fuzziness, + "prefix_length": prefix_length, + "boost": 2 + } + } + }, + { + "match": { + "search_terms": { + "query": query, + "fuzziness": fuzziness, + "prefix_length": prefix_length, + "boost": 1 + } + } + }, + { + "match": { + "optional_terms": { + "query": query, + "fuzziness": fuzziness, + "prefix_length": prefix_length + } + } + } + ] + } } body = json.dumps({'query': query}) total_items = self.es.count(body=body, index=index) diff --git a/tests/integration/data/test_tags_v2.0.json b/tests/integration/data/test_tags_v2.0.json new file mode 100644 index 00000000..c490f065 --- /dev/null +++ b/tests/integration/data/test_tags_v2.0.json @@ -0,0 +1,13 @@ +[{ + "model": "tags.tag", + "pk": 51, + "fields": { + "created": "2018-03-13t18:39:53z", + "modified": "2018-05-15t17:50:57z", + "title": "vte", + "lower_title": "vte", + "description": "qualitative indicator of venous thromboembolism (vte) status", + "instructions": "include variables that represent whether or when a subject has experienced vte. vte includes both deep venous thrombosis and pulmonary embolism. vte does not include arterial thrombosis or arterial embolism. include variables that represent prevalent and/or incident vte status. include variables that represent vte event data, including event status and time-to-event variables. include variables that indicate age at vte events, e.g. self-reported age at a vte event or followup time to a vte event. include variables indicating vte status based on any method of determination, including self report, adjudication, clinical verification, medical records, icd codes, or calculation/inference from related traits. include all instances of duplicated variables, e.g. vte variables included in multiple datasets. include variables indicating deep vein thrombosis (dvt) status, pulmonary embolism status, and vte status of unknown type. include variables that specify vte type. do not include variables that indicate possible vte treatments, e.g. surgical procedures. do not include variables that indicate medication use related to vte, e.g. anticoagulant or thrombolytic use.", + "creator": 7 + } +}] diff --git a/tests/integration/data/test_variables_v2.0.csv b/tests/integration/data/test_variables_v2.0.csv new file mode 100644 index 00000000..67d50cfe --- /dev/null +++ b/tests/integration/data/test_variables_v2.0.csv @@ -0,0 +1,62 @@ +tag_pk tag_title variable_phv variable_full_accession dataset_full_accession study_full_accession study_name study_phs study_version created modified variable_name variable_description +51 VTE 202930 phv00202930.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 13:58:00+00:00 2018-04-25 13:58:00+00:00 AFUcomp7e_G [General health]. Has a doctor ever said you had any of the following? Blood clot in a leg [deep vein thrombosis] [Annual Follow-up Questionnaire Form, AFUG] +51 VTE 202992 phv00202992.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 13:58:15+00:00 2018-04-25 13:58:15+00:00 AFUcomp16d_L [General health]. Were you hospitalized for a blood clot in a leg or deep vein thrombosis at that time? [Annual Follow-up Questionnaire Form, AFUL] +51 VTE 203035 phv00203035.v1.p1 pht004030.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 13:58:28+00:00 2018-04-25 13:58:28+00:00 AFUcomp16_M [General health]. Since we last contacted you has a doctor said that you had a blood clot in a leg or deep vein thrombosis? [Annual Follow-up Questionnaire Form, AFUM] +51 VTE 207698 phv00207698.v1.p1 pht004125.v1.p1 phs000280.v3.p1 Atherosclerosis Risk in Communities (ARIC) 280 3 2018-04-25 13:58:42+00:00 2018-04-25 13:58:42+00:00 MHQA9A Has a doctor ever told you that you had a blood clot in a leg (deep vein thrombosis)? This does not include varicose veins or phlebitis. Q9A [Medical History Questionnaire, exam 4] +51 VTE 121341 phv00121341.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-14 20:01:56+00:00 2018-07-14 20:01:56+00:00 Y01VTD VENOUS THROMBOEMBOLIC DISEASE +51 VTE 121466 phv00121466.v2.p2 pht001870.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-14 20:02:20+00:00 2018-07-14 20:02:20+00:00 Y00VT_PE DISCHG DIAG - VENOUS THROMB/PULMONARY EMBOL +51 VTE 121560 phv00121560.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-07-14 20:03:18+00:00 2018-07-14 20:03:18+00:00 Y01VTD VENOUS THROMBOEMBOLIC DISEASE +51 VTE 273565 phv00273565.v1.p1 pht005981.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:43:46+00:00 2018-07-30 16:43:46+00:00 vt Lite: VT case (through dec01) +51 VTE 273566 phv00273566.v1.p1 pht005981.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:44:00+00:00 2018-07-30 16:44:00+00:00 ttoevent Days from baseline to VT or censoring (through dec01) +51 VTE 273567 phv00273567.v1.p1 pht005981.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:44:12+00:00 2018-07-30 16:44:12+00:00 vtpehx01 LITE : Self-report of DVT or PE at baseline +51 VTE 273568 phv00273568.v1.p1 pht005981.v1.p1 phs000287.v6.p1 Cardiovascular Health Study (CHS) 287 6 2018-07-30 16:44:23+00:00 2018-07-30 16:44:23+00:00 second LITE: primary or secondary VTE by MD review (through dec01) +51 VTE 276977 phv00276977.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:02:27+00:00 2018-08-09 15:02:27+00:00 EVENT1 First event Collection Interval: 1975 through 2014 +51 VTE 276978 phv00276978.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:02:46+00:00 2018-08-09 15:02:46+00:00 EVENT2 Second event Collection Interval: 1975 through 2014 +51 VTE 276979 phv00276979.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:03:15+00:00 2018-08-09 15:03:15+00:00 EVENT3 Third event Collection Interval: 1975 through 2014 +51 VTE 276980 phv00276980.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:03:36+00:00 2018-08-09 15:03:36+00:00 EVENT4 Fourth event Collection Interval: 1975 through 2014 +51 VTE 7028 phv00007028.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:04:27+00:00 2018-08-09 15:04:27+00:00 FS434 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - LEFT +51 VTE 7029 phv00007029.v1.p10 pht000028.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:04:54+00:00 2018-08-09 15:04:54+00:00 FS435 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - RIGHT +51 VTE 7461 phv00007461.v1.p10 pht000029.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:05:33+00:00 2018-08-09 15:05:33+00:00 FT437 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) +51 VTE 10342 phv00010342.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:06:29+00:00 2018-08-09 15:06:29+00:00 G220 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - LEFT +51 VTE 10343 phv00010343.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:07:13+00:00 2018-08-09 15:07:13+00:00 G221 VENOUS DISEASE: DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) - RIGHT +51 VTE 70486 phv00070486.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:08:05+00:00 2018-08-09 15:08:05+00:00 FU149 VENOUS DISEASE: SINCE LAST EXAM HAVE YOU HAD A DEEP VEIN THROMBOSIS (BLOOD CLOTS IN LEGS OR ARMS) +51 VTE 70487 phv00070487.v1.p10 pht000692.v2.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:08:45+00:00 2018-08-09 15:08:45+00:00 FU150 VENOUS DISEASE: SINCE LAST EXAM HAVE YOU HAD A PULMONARY EMBOLUS (BLOOD CLOTS IN LUNGS) +51 VTE 255326 phv00255326.v1.p10 pht005142.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:09:42+00:00 2018-08-09 15:09:42+00:00 fw597 Circulatory Problems - Since the date of the last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for: Blood clot or embolism in leg or lung Variable appears on Form B only Collection Interval: Original Cohort Exam 30 +51 VTE 275051 phv00275051.v1.p10 pht006007.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:11:38+00:00 2018-08-09 15:11:38+00:00 FX597 Circulatory Problems (Form B) - Since your last FHS exam or health history update, have you seen a doctor or been hospitalized for blood clot or embolism in leg or lung? Collection Interval: Original Cohort Exam 31 +51 VTE 275385 phv00275385.v1.p10 pht006008.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:12:11+00:00 2018-08-09 15:12:11+00:00 fy597 Circulatory Problems (Form B) - Since your last FHS exam or health update, have you seen a doctor or other healthcare provider or been hospitalized for blood clot or embolism in leg or lung? Collection Interval: Original Cohort Exam 32 +51 VTE 21065 phv00021065.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:20:09+00:00 2018-08-09 15:20:09+00:00 G3A230 HAVE YOU EVER HAD A DEEP VEIN THROMBOSIS (BLOOD IN LEG OR ARMS) +51 VTE 273898 phv00273898.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:20:31+00:00 2018-08-09 15:20:31+00:00 g3a230 Have you ever had a deep vein thrombosis (blood in leg or arms) Collection Interval: Exam 1 +51 VTE 274391 phv00274391.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:20:55+00:00 2018-08-09 15:20:55+00:00 g3a230 Have you ever had a deep vein thrombosis (blood in leg or arms) +51 VTE 1100 phv00001100.v1.p10 pht000010.v3.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:21:38+00:00 2018-08-09 15:21:38+00:00 FA81 HOSPITALIZED SINCE LAST EXAM FOR PULMONARY EMBOLUS +51 VTE 21066 phv00021066.v4.p10 pht000074.v10.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:22:24+00:00 2018-08-09 15:22:24+00:00 G3A231 HAVE YOU EVER HAD A PULMONARY EMBOLUS (BLOOD CLOT IN LUNGS) +51 VTE 273899 phv00273899.v1.p10 pht006005.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:22:52+00:00 2018-08-09 15:22:52+00:00 g3a231 Have you ever had a pulmonary embolus (blood clot in lungs) Collection Interval: Exam 1 +51 VTE 274392 phv00274392.v1.p10 pht006006.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:23:17+00:00 2018-08-09 15:23:17+00:00 g3a231 Have you ever had a pulmonary embolus (blood clot in lungs) +51 VTE 257557 phv00257557.v1.p10 pht005150.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:24:10+00:00 2018-08-09 15:24:10+00:00 j803 Ankle Brachial Blood Pressure Measurements: Had any problems with blood clots in legs? +51 VTE 71923 phv00071923.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:26:48+00:00 2018-08-09 15:26:48+00:00 PE024 PE FINAL DIAGNOSTIC SUMMARY: SOE 110 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71924 phv00071924.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:27:16+00:00 2018-08-09 15:27:16+00:00 PE025 PE FINAL DIAGNOSTIC SUMMARY: SOE 111 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71925 phv00071925.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:27:36+00:00 2018-08-09 15:27:36+00:00 PE026 PE FINAL DIAGNOSTIC SUMMARY: SOE 112 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71926 phv00071926.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:28:00+00:00 2018-08-09 15:28:00+00:00 PE027 PE FINAL DIAGNOSTIC SUMMARY: SOE 113 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71927 phv00071927.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:28:22+00:00 2018-08-09 15:28:22+00:00 PE028 PE FINAL DIAGNOSTIC SUMMARY: Other PE 1 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71930 phv00071930.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:29:17+00:00 2018-08-09 15:29:17+00:00 PE031 DVT FINAL DIAGNOSTIC SUMMARY: SOE 114 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71931 phv00071931.v2.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:30:12+00:00 2018-08-09 15:30:12+00:00 PE032 DVT FINAL DIAGNOSTIC SUMMARY: Other DVT 1 Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 10478 phv00010478.v5.p10 pht000036.v8.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-08-09 15:34:22+00:00 2018-08-09 15:34:22+00:00 G404 CDI: DEEP VEIN THROMBOSIS +51 VTE 193695 phv00193695.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:15:48+00:00 2018-08-21 00:15:48+00:00 F33VTEHOSP F33 Hospitalized Blood Clot (DVT or PE) +51 VTE 193696 phv00193696.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:15:48+00:00 2018-08-21 00:15:48+00:00 F33VTEHOSPDY Days enrollment to F33 Hospitalized Blood Clot +51 VTE 193697 phv00193697.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:15:48+00:00 2018-08-21 00:15:48+00:00 F33VTEOP F33 Outpatient DVT or PE +51 VTE 193698 phv00193698.v3.p3 pht003414.v3.p3 phs000200.v11.p3 Women's Health Initiative (WHI) 200 11 2018-08-21 00:15:48+00:00 2018-08-21 00:15:48+00:00 F33VTEOPDY Days enrollment to F33 Outpatient DVT or PE +51 VTE 121342 phv00121342.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:30:43+00:00 2018-08-30 00:30:43+00:00 Y01DVTDG DIAGNOSIS FOR DEEP VEIN THROMBOSIS +51 VTE 121349 phv00121349.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 00:31:38+00:00 2018-08-30 00:31:38+00:00 Y01PEDG DIAGNOSIS FOR PULMONARY EMBOLISM +51 VTE 121486 phv00121486.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:43:49+00:00 2018-08-30 19:43:49+00:00 Y01VTDEP ENDPT - DEEP VEIN THROMB/PULMONARY EMBOL +51 VTE 121270 phv00121270.v2.p2 pht001869.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:43:57+00:00 2018-08-30 19:43:57+00:00 Y01VTDEP ENDPT - DEEP VEIN THROMB/PULMONARY EMBOL +51 VTE 121561 phv00121561.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:52:40+00:00 2018-08-30 19:52:40+00:00 Y01DVTDG DIAGNOSIS FOR DEEP VEIN THROMBOSIS +51 VTE 121568 phv00121568.v2.p2 pht001871.v2.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 19:53:25+00:00 2018-08-30 19:53:25+00:00 Y01PEDG DIAGNOSIS FOR PULMONARY EMBOLISM +51 VTE 121735 phv00121735.v1.p2 pht001874.v1.p2 phs000285.v3.p2 Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort 285 3 2018-08-30 20:12:00+00:00 2018-08-30 20:12:00+00:00 Z33EPE PULMONARY EMOBOLUS +51 VTE 121860 phv00121860.v2.p1 pht001886.v2.p1 phs000289.v2.p1 GENEVA GWAS of VTE 289 2 2018-09-07 15:50:48+00:00 2018-09-07 15:50:48+00:00 VTE Ever had a blood clot in your vein +51 VTE 71936 phv00071936.v3.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:56:53+00:00 2018-09-28 14:56:53+00:00 pe004 PULMONARY EMBOLUS: Date of clinical occurrence Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 71942 phv00071942.v3.p10 pht000744.v5.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:57:08+00:00 2018-09-28 14:57:08+00:00 pe011 DEEP VENOUS THROMBOSIS: Date of clinical occurrence Collection Interval: Cases reviewed from 1994 to 2012 (data collection began in 1994) +51 VTE 277005 phv00277005.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:57:52+00:00 2018-09-28 14:57:52+00:00 EDATE1 First event date Collection Interval: 1975 through 2014 +51 VTE 277006 phv00277006.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:58:07+00:00 2018-09-28 14:58:07+00:00 EDATE2 Second event date Collection Interval: 1975 through 2014 +51 VTE 277007 phv00277007.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:58:24+00:00 2018-09-28 14:58:24+00:00 EDATE3 Third event date Collection Interval: 1975 through 2014 +51 VTE 277008 phv00277008.v1.p10 pht006025.v1.p10 phs000007.v29.p10 Framingham Heart Study 7 29 2018-09-28 14:58:38+00:00 2018-09-28 14:58:38+00:00 EDATE4 Fourth event date Collection Interval: 1975 through 2014 +51 VTE 259384 phv00259384.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:14:09+00:00 2018-12-20 19:14:09+00:00 priorvt Prior VT +51 VTE 259388 phv00259388.v1.p2 pht005311.v1.p2 phs001013.v2.p2 Heart and Vascular Health Study (HVH) 1013 2 2018-12-20 19:14:20+00:00 2018-12-20 19:14:20+00:00 vttype VT type \ No newline at end of file diff --git a/tests/integration/test_loaders.py b/tests/integration/test_loaders.py index 3e956bea..49227144 100644 --- a/tests/integration/test_loaders.py +++ b/tests/integration/test_loaders.py @@ -17,7 +17,7 @@ def test_filesystem_loader(): targets = load_from_filesystem( filepath=TEST_DATA_DIR, ) - assert len(list(targets)) == 3 + assert len(list(targets)) == 5 with pytest.raises(ValueError): targets = load_from_filesystem( diff --git a/tests/integration/test_parsers.py b/tests/integration/test_parsers.py index 1d78f98b..ea90ef72 100644 --- a/tests/integration/test_parsers.py +++ b/tests/integration/test_parsers.py @@ -11,6 +11,9 @@ def test_db_gap_parser(): def test_topmed_tag_parser(): parser = TOPMedTagParser() - parse_file = str(TEST_DATA_DIR / "test_variables_v1.0.csv") + parse_file = str(TEST_DATA_DIR / "test_variables_v2.0.csv") elements = parser(parse_file) assert len(elements) == 62 + for element in elements: + assert element.name != element.id + assert element.description != element.id diff --git a/tests/unit/conftest.py b/tests/unit/conftest.py index d3c89efb..85f4adcb 100644 --- a/tests/unit/conftest.py +++ b/tests/unit/conftest.py @@ -9,14 +9,14 @@ @dataclass class MockResponse: text: str - code: int = 200 + status_code: int = 200 def json(self): return json.loads(self.text) class MockApiService: - def __init__(self, urls: Dict[str, str]): + def __init__(self, urls: Dict[str, list]): self.urls = urls def get(self, url, params: dict = None): @@ -24,11 +24,11 @@ def get(self, url, params: dict = None): qstr = urllib.parse.urlencode(params, quote_via=urllib.parse.quote) url = f"{url}?{qstr}" - text = self.urls.get(url) + text, status_code = self.urls.get(url) if text is None: - return MockResponse(text="{}", code=404) - return MockResponse(text) + return MockResponse(text="{}", status_code=404) + return MockResponse(text, status_code=status_code) @pytest.fixture @@ -41,7 +41,7 @@ def _(keyword): ) urls = { - _("heart attack"): json.dumps({ + _("heart attack"): [json.dumps({ "content": "heart attack", "spans": [ { @@ -158,7 +158,7 @@ def _(keyword): ] } ] - }), + }), 200], } return MockApiService( @@ -176,7 +176,7 @@ def _(curie): ) urls = { - _("UBERON:0007100"): json.dumps( + _("UBERON:0007100"): [json.dumps( { "UBERON:0007100": { "id": { @@ -198,7 +198,7 @@ def _(curie): ] } }, - ), + ), 200], } @@ -216,14 +216,21 @@ def _(curie): curie=urllib.parse.quote(curie), ) return MockApiService(urls={ - _("UBERON:0007100"): json.dumps([ + _("UBERON:0007100"): [json.dumps([ { "desc": "adult heart", "scope": "RELATED", "syn_type": None, "xref": "" } - ]) + ]), 200], + _("MONDO"): [json.dumps({ + "validation error": "format should be :" + }), 400], + _("UNSUPPORTED_PREFIX:XXX"): [json.dumps({ + "validation error": "UNSUPPORTED_PREFIX is not supported" + }), 400], + }) @@ -237,7 +244,7 @@ def _(curie): ) return MockApiService(urls={ - _("UBERON:0007100"): json.dumps( + _("UBERON:0007100"): [json.dumps( { "taxon": { "id": None, @@ -278,6 +285,6 @@ def _(curie): "anatomical entity" ] } - ) + ), 200] }) diff --git a/tests/unit/test_annotate.py b/tests/unit/test_annotate.py index fe60604f..053c80d4 100644 --- a/tests/unit/test_annotate.py +++ b/tests/unit/test_annotate.py @@ -211,6 +211,18 @@ def test_synonym_finder(synonym_api): synonym_api, ) assert result == ["adult heart"] + curie = "MONDO" + result = finder.get_synonyms( + curie, + synonym_api, + ) + assert result == [] + curie = "UNSUPPORTED_PREFIX:XXX" + result = finder.get_synonyms( + curie, + synonym_api, + ) + assert result == [] def test_ontology_helper(ontology_api): diff --git a/tests/unit/test_api.py b/tests/unit/test_api.py new file mode 100644 index 00000000..4dbf7d44 --- /dev/null +++ b/tests/unit/test_api.py @@ -0,0 +1,122 @@ +import json + +from unittest.mock import patch, Mock + +import pytest +from pytest import mark + +from dug.api import app, main, DugResource + + +@pytest.fixture +def dug_api_test_client(): + with app.test_client() as client: + yield client + + +@pytest.fixture +def mock_g_object(): + with patch('dug.api.dug') as g: + yield g + + +@pytest.fixture +def mock_search_concepts(mock_g_object): + mock_g_object().search_concepts.return_value = {'hits': {'hits': [ + {'_type': '_doc', + '_id': 'UBERON:0001638', + '_source': {'id': 'UBERON:0001638', + 'name': 'vein', + 'description': 'some vessels that carry blood.', + 'type': 'anatomical entity' + } + } + ] + }} + + +@pytest.fixture +def mock_search_kg(mock_g_object): + mock_g_object().search_kg.return_value = {'hits': {'hits': [ + {'_type': '_doc', '_id': 'MEDDRA:10047249'} + ]}} + + +@pytest.fixture +def mock_search_variables(mock_g_object): + mock_g_object().search_variables.return_value = {'hits': {'hits': [ + {'_type': '_doc', '_id': 'MEDDRA:10047249'} + ]}} + + +@pytest.fixture +def mock_agg_data_types(mock_g_object): + mock_g_object().agg_data_type.return_value = ["DBGaP"] + + +def resp_decode(resp): + resp_data = resp.data + resp_json = json.loads(resp_data.decode('utf-8')) + return resp_json + + +@mark.api +def test_dug_search_resource(dug_api_test_client, mock_search_concepts): + resp = dug_api_test_client.post('/search', + json={"index": "concepts_index", "query": "heart attack"} + ) + resp_json = resp_decode(resp) + + assert resp_json['status'] == 'success' + assert len(resp_json['result']) > 0 + assert resp.status_code == 200 + + +@mark.api +def test_dug_search_kg_resource(dug_api_test_client, mock_search_kg): + resp = dug_api_test_client.post('/search_kg', + json={"index": "concepts", "unique_id": "id_001", "query": "cough"}) + resp_json = resp_decode(resp) + + assert resp_json['status'] == 'success' + assert len(resp_json['result']) > 0 + assert resp.status_code == 200 + + +@mark.api +def test_dug_search_variable_resource(dug_api_test_client, mock_search_variables): + resp = dug_api_test_client.post('/search_var', + json={"index": "concepts", "unique_id": "id_001", "query": "cough"}) + resp_json = resp_decode(resp) + + assert resp_json['status'] == 'success' + assert len(resp_json['result']) > 0 + assert resp.status_code == 200 + + +@mark.api +def test_dug_agg_data_type_resource(dug_api_test_client, mock_agg_data_types): + resp = dug_api_test_client.post('/agg_data_types', + json={"index": "concepts"}) + resp_json = resp_decode(resp) + + assert resp_json['status'] == 'success' + assert len(resp_json['result']) > 0 + assert resp.status_code == 200 + + +@mark.api +def test_create_response_raises_exception(): + error_exception = Mock() + error_exception.side_effect = Exception + dr = DugResource() + resp = dr.create_response(exception=error_exception) + + assert resp["status"] == 'error' + + +@mark.api +@patch('dug.api.app.run') +def test_main(api_app_run): + api_app_run.side_effect = "I am running!" + main(["-p", "8000", "-d"]) \ No newline at end of file diff --git a/tests/unit/test_cli.py b/tests/unit/test_cli.py new file mode 100644 index 00000000..27276df2 --- /dev/null +++ b/tests/unit/test_cli.py @@ -0,0 +1,35 @@ +from pytest import mark + +from unittest.mock import patch + +from dug.cli import main, get_argparser + + +@mark.cli +def test_dug_cli_parser(): + parser = get_argparser() + parsed_log_level = parser.parse_args(["-l", "DEBUG"]) + parsed_crawl = parser.parse_args(["crawl", "somefile.csv", "--parser", "topmedtag"]) + parsed_search = parser.parse_args(["search", "-q", "heart attack", "-t", "variables", "-k", "namespace=default"]) + + assert parsed_log_level.log_level == "DEBUG" + + assert parsed_crawl.target == "somefile.csv" + assert parsed_crawl.parser_type == "topmedtag" + + assert parsed_search.target == "variables" + assert parsed_search.query == "heart attack" + + +@mark.cli +@patch('dug.cli.Dug') +def test_dug_cli_main_crawl(mock_dug): + mock_dug.search = "Crawling!" + main(["crawl", "somefile.csv", "--parser", "topmedtag"]) + + +@mark.cli +@patch('dug.cli.Dug') +def test_dug_cli_main_search(mock_dug): + mock_dug.search.return_value = "Searching!" + main(["search", "-q", "heart attack", "-t", "variables", "-k", "namespace=default"])